PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lagoda, G; Sezen, SF; Hurt, KJ; Cabrini, MR; Mohanty, DK; Burnett, AL				Lagoda, Gwen; Sezen, Sena F.; Hurt, K. Joseph; Cabrini, Marcelo R.; Mohanty, Dillip K.; Burnett, Arthur L.			Sustained nitric oxide ( NO)-releasing compound reverses dysregulated NO signal transduction in priapism	FASEB JOURNAL			English	Article						sickle cell; oxidative stress; NO bioavailability	SICKLE-CELL-DISEASE; MEDIATES PENILE ERECTION; SMOOTH-MUSCLE-CELLS; NADPH OXIDASE; MICROVASCULAR DYSFUNCTION; OXIDATIVE STRESS; MOUSE PENIS; SYNTHASE; MICE; PATHOPHYSIOLOGY	We evaluated the therapeutic potential of a sustained nitric oxide (NO)-releasing compound to correct the molecular hallmarks and pathophysiology of priapism, an important but poorly characterized erectile disorder. 1,5-Bis-(dihexyl-N-nitrosoamino)-2,4-dinitrobenzene (C6) and an inactive form of the compound [1,5-bis-(dihexylamino)-2,4-dinitrobenzene (C6)] were tested in neuronal cell cultures and penile lysates for NO release (Griess assay) and biological activity (cGMP production). The effect of local depot C6 or C6 was evaluated in mice with a priapic phenotype due to double neuronal and endothelial NO synthase deletion (dNOS(-/-)) or human sickle hemoglobin transgenic expression (Sickle). Changes in NO signaling molecules and reactive oxygen species (ROS) surrogates were assessed by Western blot. The physiological response after C6 treatment was assessed using an established model of electrically stimulated penile erection. C6 generated NO, increased cGMP, and dose dependently increased NO metabolites. C6 treatment reversed abnormalities in key penile erection signaling molecules, including phosphodiesterase type 5, phosphorylated endothelial nitric oxide synthase, and phosphorylated vasodilator-stimulated phosphoprotein. In Sickle mice, C6 also attenuated the increased ROS markers gp91(phox), 4-hydroxynonenal, and 3-nitrotyrosine. Finally, C6 corrected the excessive priapic erection response of dNOS(-/-) mice. Exogenous sustained NO release from C6 corrects pathological erectile signaling in mouse models of priapism and suggests novel approaches to human therapy.Lagoda, G., Sezen, S. F., Hurt, K. J., Cabrini, M. R., Mohanty, D. K., Burnett, A. L. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.	[Lagoda, Gwen; Sezen, Sena F.; Cabrini, Marcelo R.; Burnett, Arthur L.] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Lagoda, Gwen; Cabrini, Marcelo R.; Burnett, Arthur L.] Johns Hopkins Univ Hosp, Dept Urol, Baltimore, MD 21287 USA; [Hurt, K. Joseph] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA; [Mohanty, Dillip K.] Cent Michigan Univ, Dept Chem, Mt Pleasant, MI 48859 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Central Michigan University	Burnett, AL (corresponding author), Johns Hopkins Univ Hosp, Dept Urol, 600 N Wolfe St,Marburg 407, Baltimore, MD 21287 USA.	aburnett@jhmi.edu	Sezen, Sena/AAK-5264-2021; Cabrini, Marcelo/I-6676-2016; Hurt, K. Joseph/J-8266-2019	Cabrini, Marcelo/0000-0002-6081-3412; Hurt, K. Joseph/0000-0001-6906-350X	U.S. National Institutes of Health [HL090515, R01-DK067223, R15-HL106600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090515, R15HL106600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067223] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants HL090515, R01-DK067223 (to A. L. B.), and R15-HL106600 (to D.K.M.).	Adeyoju AB, 2002, BJU INT, V90, P898, DOI 10.1046/j.1464-410X.2002.03022.x; Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Andersson KE, 2001, PHARMACOL REV, V53, P417; Bivalacqua TJ, 2012, J SEX MED, V9, P79, DOI 10.1111/j.1743-6109.2011.02288.x; Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Burnett AL, 2006, UROLOGY, V67, P1043, DOI 10.1016/j.urology.2005.11.045; Burnett AL, 2003, INT J IMPOT RES, V15, pS80, DOI 10.1038/sj.ijir.3901077; Burnett AL, 2002, J ANDROL, V23, pS20; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Burnett AL, 2012, J SEX MED, V9, P104, DOI 10.1111/j.1743-6109.2011.02411.x; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen J, 1999, BJU INT, V83, P269; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Fujii H, 1997, J BIOL CHEM, V272, P32773, DOI 10.1074/jbc.272.52.32773; Han TH, 2003, P NATL ACAD SCI USA, V100, P12504, DOI 10.1073/pnas.2133409100; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hurt KJ, 2006, P NATL ACAD SCI USA, V103, P3440, DOI 10.1073/pnas.0511326103; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Kanika ND, 2010, INT J IMPOT RES, V22, P363, DOI 10.1038/ijir.2010.27; Kato GJ, 2012, J SEX MED, V9, P70, DOI 10.1111/j.1743-6109.2011.02287.x; Kato Gregory J, 2008, Hematology Am Soc Hematol Educ Program, P186, DOI 10.1182/asheducation-2008.1.186; Lagoda G, 2013, J UROLOGY, V189, P762, DOI 10.1016/j.juro.2012.08.198; Mack AK, 2006, INT J BIOCHEM CELL B, V38, P1237, DOI 10.1016/j.biocel.2006.01.010; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Munarriz R, 2003, UROLOGY, V62, P760, DOI 10.1016/S0090-4295(03)00484-9; Musicki B, 2012, J SEX MED, V9, P1980, DOI 10.1111/j.1743-6109.2012.02798.x; Musicki B, 2011, J SEX MED, V8, P419, DOI 10.1111/j.1743-6109.2010.02123.x; Muzaffar S, 2004, CIRCULATION, V110, P1140, DOI 10.1161/01.CIR.0000139851.50067.E4; Naghavi N, 2013, SMALL, V9, P22, DOI 10.1002/smll.201200458; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Patel RP, 2000, CARDIOVASC RES, V47, P465, DOI 10.1016/S0008-6363(00)00086-9; von Knethen A, 1999, MOL BIOL CELL, V10, P361, DOI 10.1091/mbc.10.2.361; Wang J, 2009, POLYM J, V41, P715, DOI 10.1295/polymj.PJ2008335; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Wood KC, 2005, FASEB J, V19, P989, DOI 10.1096/fj.04-3218fje; Wood KC, 2006, FREE RADICAL BIO MED, V40, P1443, DOI 10.1016/j.freeradbiomed.2005.12.015; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yu H, 2011, CHEM BIOL DRUG DES, V78, P527, DOI 10.1111/j.1747-0285.2011.01174.x; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P756, DOI 10.2174/157016112803520738	44	29	30	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					76	84		10.1096/fj.13-228817	http://dx.doi.org/10.1096/fj.13-228817			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24076963	Green Published			2022-12-25	WOS:000333526100010
J	Brink-Jensen, K; Bak, S; Jorgensen, K; Ekstrom, CT				Brink-Jensen, Kasper; Bak, Soren; Jorgensen, Kirsten; Ekstrom, Claus Thorn			Integrative Analysis of Metabolomics and Transcriptomics Data: A Unified Model Framework to Identify Underlying System Pathways	PLOS ONE			English	Article							GENE-EXPRESSION; PARAFAC; SELECTION; NUMBER	The abundance of high-dimensional measurements in the form of gene expression and mass spectroscopy calls for models to elucidate the underlying biological system. For widely studied organisms like yeast, it is possible to incorporate prior knowledge from a variety of databases, an approach used in several recent studies. However if such information is not available for a particular organism these methods fall short. In this paper we propose a statistical method that is applicable to a dataset consisting of Liquid Chromatography-Mass Spectroscopy (LC-MS) and gene expression (DNA microarray) measurements from the same samples, to identify genes controlling the production of metabolites. Due to the high dimensionality of both LC-MS and DNA microarray data, dimension reduction and variable selection are key elements of the analysis. Our proposed approach starts by identifying the basis functions ("building blocks") that constitute the output from a mass spectrometry experiment. Subsequently, the weights of these basis functions are related to the observations from the corresponding gene expression data in order to identify which genes are associated with specific patterns seen in the metabolite data. The modeling framework is extremely flexible as well as computationally fast and can accommodate treatment effects and other variables related to the experimental design. We demonstrate that within the proposed framework, genes regulating the production of specific metabolites can be identified correctly unless the variation in the noise is more than twice that of the signal.	[Brink-Jensen, Kasper] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Bak, Soren; Jorgensen, Kirsten] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen, Denmark; [Ekstrom, Claus Thorn] Univ Southern Denmark, Dept Biostat, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark	Brink-Jensen, K (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	kbrink@life.ku.dk	Bak, Soren/H-4404-2014; jørgensen, kirsten/H-4346-2014	Bak, Soren/0000-0003-4100-115X; jørgensen, kirsten/0000-0003-2855-7735; Ekstrom, Claus Thorn/0000-0003-1191-373X	University of Copenhagen	University of Copenhagen	Funding was provided by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Andersen MD, 2000, J BIOL CHEM, V275, P1966, DOI 10.1074/jbc.275.3.1966; Antikainen J, 2011, PARALLEL DISTRIBUTED, V22, P1; Bondell HD, 2008, BIOMETRICS, V64, P115, DOI 10.1111/j.1541-0420.2007.00843.x; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; HARSHMAN RA, 1994, COMPUT STAT DATA AN, V18, P39, DOI 10.1016/0167-9473(94)90132-5; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hoggard JC, 2007, ANAL CHEM, V79, P1611, DOI 10.1021/ac061710b; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li Z, 2004, J BIOL CHEM, V279, P27124, DOI 10.1074/jbc.M403494200; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Smilde A, 2004, MULTI WAY ANALYSIS W, V978; Smolka B, 2005, LECT NOTES COMPUT SC, V3656, P990, DOI 10.1007/11559573_120; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Su G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S36; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Witting amd M, 2012, PLOS ONE; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	23	11	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72116	10.1371/journal.pone.0072116	http://dx.doi.org/10.1371/journal.pone.0072116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086255	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700003
J	Etang, J; Nwane, P; Piameu, M; Manga, B; Souop, D; Awono-Ambene, P				Etang, Josiane; Nwane, Philippe; Piameu, Michael; Manga, Blaise; Souop, Daniel; Awono-Ambene, Parfait			Evaluation of New Tools for Malaria Vector Control in Cameroon: Focus on Long Lasting Insecticidal Nets	PLOS ONE			English	Article							TREATED NETS; WASH-RESISTANCE; ANOPHELES-ARABIENSIS; TANZANIA; EFFICACY; INDIA; INTERCEPTOR(R); AREA	Background: From 2006 to 2011, biological activity of insecticides for Indoor Residual Spraying (IRS), conventional treatment of nets (CTNs) or long lasting insecticidal nets (LLINs) was evaluated before their approval in Cameroon. The objective of the study was to select the best tools for universal malaria vector control coverage. Methodology: Bioassays were performed using WHO cones and the Kisumu susceptible strain of Anopheles gambiae s.s.. Among tested products, residual activity and wash resistance of Alpha-cypermethrin LLINs (Interceptor) and CTNs (Fendona) were assessed during 5 months in the Ntougou neighborhood. Principal Findings: All the 14 tested products were found effective (95-100% knockdown and mortality rates), although a significant decrease of efficacy was seen with lambda-cyhalothrinWP IRS, alpha-cypermethrin CTNs and LLINs (p< 0.05). However, the efficacy of Interceptor nets did not decrease during the 5 months evaluation, even after 25 washes (0.07<p<0.9). Meanwhile Fendona SC nets displayed a drastic decrease of activity after 5 washes, odds ratio was 3.07 (1.0-8.59). Conclusion: This study provided useful data for decision making and community education toward universal coverage of malaria vector control in Cameroon.	[Etang, Josiane; Piameu, Michael; Awono-Ambene, Parfait] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Med Entomol, Yaounde, Cameroon; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Nwane, Philippe] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Piameu, Michael] Univ Catholique Afrique Cent, Ctr Super Sci Sante, Yaounde, Cameroon; [Manga, Blaise] Minist Publ Hlth, Div Hlth Promot, Yaounde, Cameroon; [Souop, Daniel] Minist Agr & Rural Dev, Serv Pesticide Regulat, Yaounde, Cameroon	University of Yaounde I	Etang, J (corresponding author), Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Med Entomol, Yaounde, Cameroon.	josyet2@gmail.com		PIAMEU, Michael/0000-0001-7409-3359	Ministry of Public Health; Ministry of Agriculture and Rural development in Cameroon	Ministry of Public Health; Ministry of Agriculture and Rural development in Cameroon	The study was funded by partners of the Ministry of Public Health and the Ministry of Agriculture and Rural development in Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Banek K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-84; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Darriet F, 1998, Med Trop (Mars), V58, P349; Dev V, 2010, T ROY SOC TROP MED H, V104, P273, DOI 10.1016/j.trstmh.2009.08.010; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Etang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-333; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Hougard JM, 2003, B WORLD HEALTH ORGAN, V81, P324; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Miller JE, 1999, TROP MED INT HEALTH, V4, P167, DOI 10.1046/j.1365-3156.1999.43378.x; Mosha FW, 2008, ANN TROP MED PARASIT, V102, P367, DOI 10.1179/136485908X278829; Norris LC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-254; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Tanner M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-24; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2005, WHOCDSWHOPESGCDPP200; WHO, 2011, GUID MON DUR LONG LA; WHO, 2004, WHOCDSCPEPCV200410; WHO, 2006, WHO GUID TEST MOSQ A; WHO, GLOB PLAN INS RES MA; WHO, 2007, WHO REC INS PROD TRE; [WHO] World Health Organization, 2009, WHO REC INS IND RES; World Health Organisation WHO, 2012, WHO REC LONG LAST IN; World Health Organization, 2012, 15 WHOPES WORK GROUP	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74929	10.1371/journal.pone.0074929	http://dx.doi.org/10.1371/journal.pone.0074929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086399	gold, Green Submitted, Green Published			2022-12-25	WOS:000326520200055
J	Afeli, SAY; Malysz, J; Petkov, GV				Afeli, Serge A. Y.; Malysz, John; Petkov, Georgi V.			Molecular Expression and Pharmacological Evidence for a Functional Role of Kv7 Channel Subtypes in Guinea Pig Urinary Bladder Smooth Muscle	PLOS ONE			English	Article							POTASSIUM CHANNELS; K(V)7 CHANNELS; K+ CHANNEL; KCNQ; ACTIVATION; EXCITABILITY; RETIGABINE; CONTRACTILITY; TARGETS; CELLS	Voltage-gated Kv7 (KCNQ) channels are emerging as essential regulators of smooth muscle excitability and contractility. However, their physiological role in detrusor smooth muscle (DSM) remains to be elucidated. Here, we explored the molecular expression and function of Kv7 channel subtypes in guinea pig DSM by RT-PCR, qRT-PCR, immunohistochemistry, electrophysiology, and isometric tension recordings. In whole DSM tissue, mRNAs for all Kv7 channel subtypes were detected in a rank order: Kv7.1 similar to Kv7.2Kv7.3 similar to Kv7.5Kv7.4. In contrast, freshly-isolated DSM cells showed mRNA expression of: Kv7.1 similar to Kv7.2Kv7.5Kv7.3 similar to Kv7.4. Immunohistochemical confocal microscopy analyses of DSM, conducted by using co-labeling of Kv7 channel subtype-specific antibodies and alpha-smooth muscle actin, detected protein expression for all Kv7 channel subtypes, except for the Kv7.4, in DSM cells. L-364373 (R-L3), a Kv7.1 channel activator, and retigabine, a Kv7.2-7.5 channel activator, inhibited spontaneous phasic contractions and the 10-Hz electrical field stimulation (EFS)-induced contractions of DSM isolated strips. Linopiridine and XE991, two pan-Kv7 (effective at Kv7.1-Kv7.5 subtypes) channel inhibitors, had opposite effects increasing DSM spontaneous phasic and 10 Hz EFS-induced contractions. EFS-induced DSM contractions generated by a wide range of stimulation frequencies were decreased by L-364373 (10 mu M) or retigabine (10 mu M), and increased by XE991 (10 mu M). Retigabine (10 mu M) induced hyperpolarization and inhibited spontaneous action potentials in freshly-isolated DSM cells. In summary, Kv7 channel subtypes are expressed at mRNA and protein levels in guinea pig DSM cells. Their pharmacological modulation can control DSM contractility and excitability; therefore, Kv7 channel subtypes provide potential novel therapeutic targets for urinary bladder dysfunction.	[Afeli, Serge A. Y.; Malysz, John; Petkov, Georgi V.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Petkov, GV (corresponding author), Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	petkov@cop.sc.edu			National Institutes of Health [DK084284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health DK084284 to Georgi V. Petkov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G W, 2001, Mol Interv, V1, P95; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V302, pF251, DOI 10.1152/ajprenal.00378.2011; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Argentieri TM, 2006, METHODS SELECTING CO; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brickel N, 2012, EPILEPSIA, V53, P606, DOI 10.1111/j.1528-1167.2012.03441.x; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Brueggemann LI, 2012, AM J PHYSIOL-LUNG C, V302, pL120, DOI 10.1152/ajplung.00194.2011; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Chadha PS, 2012, BRIT J PHARMACOL, V166, P1377, DOI 10.1111/j.1476-5381.2012.01863.x; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Davies AM, 2002, J UROLOGY, V167, P1881, DOI 10.1016/S0022-5347(05)65254-8; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Heppner TJ, 2011, AM J PHYSIOL-REG I, V301, pR351, DOI 10.1152/ajpregu.00656.2010; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1599, DOI 10.1152/ajpcell.00447.2011; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC360, DOI 10.1152/ajpcell.00303.2010; Ipavec V, 2011, PHARMACOL RES, V64, P397, DOI 10.1016/j.phrs.2011.06.016; Jepps TA, 2013, BRIT J PHARMACOL, V168, P19, DOI 10.1111/j.1476-5381.2012.02133.x; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Mani BK, 2011, BRIT J PHARMACOL, V164, P237, DOI 10.1111/j.1476-5381.2011.01273.x; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Navarro-Lopez J, 2009, J MOL NEUROSCI, V37, P263, DOI 10.1007/s12031-008-9130-2; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; Ohya Susumu, 2000, Journal of Smooth Muscle Research, V36, P101, DOI 10.1540/jsmr.36.101; Orhan G, 2012, EXPERT OPIN PHARMACO, V13, P1807, DOI 10.1517/14656566.2012.706278; Parajuli SP, 2012, J PHARMACOL EXP THER, V340, P114, DOI 10.1124/jpet.111.186213; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; Rode F, 2010, EUR J PHARMACOL, V638, P121, DOI 10.1016/j.ejphar.2010.03.050; Smith AC, 2013, AM J PHYSIOL-CELL PH, V304, pC467, DOI 10.1152/ajpcell.00169.2012; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Streng T, 2004, J UROLOGY, V172, P2054, DOI 10.1097/01.ju.0000138155.33749.f4; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Svalo J, 2013, EUR J PHARMACOL, V715, P312, DOI 10.1016/j.ejphar.2013.05.005; Svalo J, 2012, BASIC CLIN PHARMACOL, V110, P145, DOI 10.1111/j.1742-7843.2011.00765.x; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Xin WK, 2012, AM J PHYSIOL-CELL PH, V302, pC1361, DOI 10.1152/ajpcell.00432.2011; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Yeung SYM, 2008, BIOCHEM BIOPH RES CO, V371, P741, DOI 10.1016/j.bbrc.2008.04.129; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	60	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75875	10.1371/journal.pone.0075875	http://dx.doi.org/10.1371/journal.pone.0075875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073284	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000094
J	Chang, SLY; Chou, RH; Zeng, HJ; Lin, YH; Chiu, TY; Yang, DM; Hung, SC; Lai, CH; Hsieh, JT; Shyu, WC; Yu, YL				Chang, Sunny Li-Yun; Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Chiu, Tai-Yu; Yang, De-Ming; Hung, Shih-Chieh; Lai, Chih-Ho; Hsieh, Jer-Tsong; Shyu, Woei-Cherng; Yu, Yung-Luen			Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							PROTEIN HDAB2IP GENE; NEURITE OUTGROWTH; SIGNALING PATHWAY; MOUSE; METHYLATION; DISABLED-1; SCRAMBLER; REELIN; CANCER; BRAIN	The DOC-2/DAB2 interactive protein (DAB2IP) is a new member of the Ras GTPase-activating protein family. Recent studies have shown that, in addition to its tumor suppressive role in various tumors, DAB2IP also plays an important role in regulating neuronal migration and positioning during brain development. In this study, we determined the roles of DAB2IP in the neuronal differentiation of human mesenchymal stem cells (hMSCs). We found that lentiviral short hairpin RNA (shRNA)-mediated knockdown of DAB2IP promoted the mesenchymal-to-neuroepithelial stem cell transition (MtNeST) and neuronal differentiation, which were accompanied by a reduction of cell proliferation but not apoptosis or cellular senescence. This suggests that DAB2IP plays an important role in the neuronal induction of hMSCs. Moreover, our finding that reduction of glycogen synthase kinase 3 beta (GSK3 beta) activity upon LiCl pretreatment inhibited both the MtNeST and production of MAP2-positive cells upon DAB2IP knockdown suggests that this transition is most likely mediated by regulation of the GSK3 beta signaling pathway. Our study demonstrates that DAB2IP participates in the first step of neuron induction of hMSCs, which implies a potentially important role for DAB2IP in the MtNeST during neurogenesis.	[Chang, Sunny Li-Yun] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Sunny Li-Yun] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Sch Med Technol & Engn, Taipei 112, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ Orthopaed & Traumatol, Stem Cell Lab, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Inst Clin Med, Taipei 112, Taiwan; [Lai, Chih-Ho] China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan; [Hsieh, Jer-Tsong] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Shyu, WC (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	shyu9423@gmail.com; ylyu@mail.cmu.edu.tw	Chou, Ruey-Hwang/K-8541-2013; Yang, De-Ming/AAW-9886-2020; Lai, Chih-Ho/M-2433-2013	Chou, Ruey-Hwang/0000-0002-2297-2180; Yang, De-Ming/0000-0002-6923-4855; Lai, Chih-Ho/0000-0001-9229-818X	National Science Council [NSC-98-2320-B-039-034-MY3, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039-004, NSC101-2311-B-039-001]; National Health Research Institutes [NHRI-EX102-10245BI]; China Medical University [CMU 98-N1-32, CMU100-N2-09]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); China Medical University(China Medical University)	This work were supported by the National Science Council (NSC-98-2320-B-039-034-MY3, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039-004, and NSC101-2311-B-039-001), National Health Research Institutes (NHRI-EX102-10245BI), and China Medical University (CMU 98-N1-32, and CMU100-N2-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054485; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Chen YH, 2011, J BIOL CHEM, V286, P10671, DOI 10.1074/jbc.M110.199612; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Guicciardi ME, 2003, J CLIN INVEST, V111, P1813, DOI 10.1172/JCI200318911; Homayouni R, 2003, MOL BRAIN RES, V115, P121, DOI 10.1016/S0169-328X(03)00176-1; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang CH, 2007, CELL SIGNAL, V19, P1339, DOI 10.1016/j.cellsig.2007.01.019; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kanehira M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032185; Kitada M, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/873706; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lee GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046592; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Noel A, 2011, J NEUROSCI RES, V89, P755, DOI 10.1002/jnr.22587; Qiao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053635; Rice DS, 1998, DEVELOPMENT, V125, P3719; Santiago JA, 2009, TISSUE ENG PT A, V15, P3911, DOI 10.1089/ten.tea.2008.0603; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508; Zhang XJ, 2012, J GASTROEN HEPATOL, V27, P1117, DOI 10.1111/j.1440-1746.2011.07049.x	45	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75884	10.1371/journal.pone.0075884	http://dx.doi.org/10.1371/journal.pone.0075884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073285	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000095
J	Fritz, KS; Green, MF; Petersen, DR; Hirschey, MD				Fritz, Kristofer S.; Green, Michelle F.; Petersen, Dennis R.; Hirschey, Matthew D.			Ethanol Metabolism Modifies Hepatic Protein Acylation in Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE PROPIONYLATION; SIRT3; ACETALDEHYDE; ACETYLATION; ADDUCTS; ENZYMES; LIVER	Mitochondrial protein acetylation increases in response to chronic ethanol ingestion in mice, and is thought to reduce mitochondrial function and contribute to the pathogenesis of alcoholic liver disease. The mitochondrial deacetylase SIRT3 regulates the acetylation status of several mitochondrial proteins, including those involved in ethanol metabolism. The newly discovered desuccinylase activity of the mitochondrial sirtuin SIRT5 suggests that protein succinylation could be an important post-translational modification regulating mitochondrial metabolism. To assess the possible role of protein succinylation in ethanol metabolism, we surveyed hepatic sub-cellular protein fractions from mice fed a control or ethanol-supplemented diet for succinyl-lysine, as well as acetyl-, propionyl-, and butyryl-lysine post-translational modifications. We found mitochondrial protein propionylation increases, similar to mitochondrial protein acetylation. In contrast, mitochondrial protein succinylation is reduced. These mitochondrial protein modifications appear to be primarily driven by ethanol metabolism, and not by changes in mitochondrial sirtuin levels. Similar trends in acyl modifications were observed in the nucleus. However, comparatively fewer acyl modifications were observed in the cytoplasmic or the microsomal compartments, and were generally unchanged by ethanol metabolism. Using a mass spectrometry proteomics approach, we identified several candidate acetylated, propionylated, and succinylated proteins, which were enriched using antibodies against each modification. Additionally, we identified several acetyl and propionyl lysine residues on the same sites for a number of proteins and supports the idea of the overlapping nature of lysine-specific acylation. Thus, we show that novel post-translational modifications are present in hepatic mitochondrial, nuclear, cytoplasmic, and microsomal compartments and ethanol ingestion, and its associated metabolism, induce specific changes in these acyl modifications. These data suggest that protein acylation, beyond protein acetylation, contributes to the overall metabolic regulatory network and could play an important role in the pathogenesis of alcoholic liver disease.	[Fritz, Kristofer S.; Petersen, Dennis R.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Green, Michelle F.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; Duke University	Fritz, KS (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	kristofer.fritz@ucdenver.edu; matthew.hirschey@duke.edu		Fritz, Kristofer/0000-0002-1499-6174; Hirschey, Matthew/0000-0003-4541-5376; Green, Michelle/0000-0002-6055-4342	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse [R37AA09300, R01DK074487, 1R01AA022146-01]; American Heart Association [12SDG8840004, 12IRG9010008]; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R01DK074487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, R01AA022146] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Studies were supported by the National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse grants R37AA09300 (DRP), R01DK074487 (DRP), 1R01AA022146-01 (KSF & MDH), and by the American Heart Association grants 12SDG8840004 (MDH) and 12IRG9010008 (MDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birt JEEC, 1998, CHEM RES TOXICOL, V11, P136, DOI 10.1021/tx970169z; Bootorabi Fatemeh, 2008, BMC Biochemistry, V9, P32, DOI 10.1186/1471-2091-9-32; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DU J, 2011, SCI IN PRESS; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; FRITZ KS, 2012, J PROTEOME RES, P39000; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; NIEMELA O, 1991, J CLIN INVEST, V87, P1367, DOI 10.1172/JCI115141; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; VEECH RL, 1972, BIOCHEM J, V127, P387, DOI 10.1042/bj1270387; Verdin E, 2004, METHOD ENZYMOL, V377, P180; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; XIE Z, 2012, MOL CELLULA IN PRESS; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	33	38	38	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75868	10.1371/journal.pone.0075868	http://dx.doi.org/10.1371/journal.pone.0075868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073283	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000093
J	Shen, M; Zhang, YQ; Saba, N; Austin, CP; Wiestner, A; Auld, DS				Shen, Min; Zhang, Yaqin; Saba, Nakhle; Austin, Christopher P.; Wiestner, Adrian; Auld, Douglas S.			Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; UNTREATED PATIENTS; INITIAL THERAPY; FLUDARABINE; CYCLOPHOSPHAMIDE; DISEASE; PREGABALIN; RITUXIMAB; AGENT; PHASE	Chronic lymphocytic leukemia (CLL) is an adult lymphoid malignancy with a variable clinical course. There is considerable interest in the identification of new treatments, as most current approaches are not curative. While most patients respond to initial chemotherapy, relapsed disease is often resistant to the drugs commonly used in CLL and patients are left with limited therapeutic options. In this study, we used a luminescent cell viability assay based on ATP levels to find compounds that were potent and efficacious in killing CLL cells. We employed an in-house process of quantitative high throughput screening (qHTS) to assess 8 concentrations of each member of a 2,816 compound library (including FDA-approved drugs and those known to be bio-active from commercial suppliers). Using qHTS we generated potency values on each compound in lymphocytes donated from each of six individuals with CLL and five unaffected individuals. We found 102 compounds efficacious against cells from all six individuals with CLL ("consensus" drugs) with five of these showing low or no activity on lymphocytes from a majority of normal donors, suggesting some degree of specificity for the leukemic cells. To our knowledge, this is the first study to screen a drug library against primary CLL cells to identify candidate agents for anti-cancer therapy. The results presented here offer possibilities for the development of novel drug candidates for therapeutic uses to treat CLL and other diseases.	[Shen, Min; Zhang, Yaqin; Austin, Christopher P.; Auld, Douglas S.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Saba, Nakhle; Wiestner, Adrian] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shen, M (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA.	shenmin@mail.nih.gov; douglas.auld@novartis.com			Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARCHIMBAUD E, 1989, CANCER CHEMOTH PHARM, V25, P223, DOI 10.1007/BF00689589; Blommel ML, 2007, AM J HEALTH-SYST PH, V64, P1475, DOI 10.2146/ajhp060371; Bosch F, 2008, CLIN CANCER RES, V14, P155, DOI 10.1158/1078-0432.CCR-07-1371; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; DENNYBROWN D, 1951, NEW ENGL J MED, V245, P917, DOI 10.1056/NEJM195112132452401; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; Dutcher JP, 1997, LEUKEMIA RES, V21, P375, DOI 10.1016/S0145-2126(96)00108-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gandin V, 1981, BIOCHEM PHARMACOL, V41, P94; GREVER MR, 1988, NOUV REV FR HEMATOL, V30, P457; Gribben JG, 2011, J CLIN ONCOL, V29, P544, DOI 10.1200/JCO.2010.32.3865; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jacobson J M, 2000, Expert Opin Pharmacother, V1, P849, DOI 10.1517/14656566.1.4.849; JOHNSON IS, 1963, CANCER RES, V23, P1390; Kean WF, 1997, BRIT J RHEUMATOL, V36, P560; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; KEATING MJ, 1989, BLOOD, V74, P19; KENNEDY BJ, 1995, MED PEDIATR ONCOL, V24, P327, DOI 10.1002/mpo.2950240511; KENNEDY BJ, 1968, CANCER RES, V28, P91; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; Malik A, 2012, CLIN LYMPHOMA MYELOM, V13, P292; Mazerski J, 1998, ACTA BIOCHIM POL, V45, P1; Mease PJ, 2008, J RHEUMATOL, V35, P502; Muckter H, 1997, HUM EXP TOXICOL, V16, P460, DOI 10.1177/096032719701600807; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Rao R, 2011, BLOOD, V118, P929; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Saba N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.865.865; Sellner L, 2012, CURR HEMATOL MALIG R, V7, P3, DOI 10.1007/s11899-011-0110-1; Simon TM, 1985, CANCER RES, V45, P32; Spaeth M, 2008, NAT CLIN PRACT RHEUM, V4, P514, DOI 10.1038/ncprheum0906; Takimoto CH., 2008, CANC MANAGEMENT MULT, V11; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Tournilhac O, 2004, BLOOD, V103, P363, DOI 10.1182/blood-2003-05-1449; Vilensky JA, 2003, ANN EMERG MED, V41, P378, DOI 10.1067/mem.2003.72; Von Hoff D D, 1976, Ann Intern Med, V85, P237; Wierda WG, 2007, BLOOD, V109, P4679, DOI 10.1182/blood-2005-12-051458; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Xu H, 2009, CURR MED CHEM, V16, P327, DOI 10.2174/092986709787002682; You YJ, 2005, CURR PHARM DESIGN, V11, P1695, DOI 10.2174/1381612053764724	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75252	10.1371/journal.pone.0075252	http://dx.doi.org/10.1371/journal.pone.0075252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073257	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000066
J	Yuan, ML; Tong, ZH; Jin, XG; Zhang, JC; Wang, XJ; Ma, WL; Yin, W; Zhou, Q; Ye, H; Shi, HZ				Yuan, Ming-Li; Tong, Zhao-Hui; Jin, Xiao-Guang; Zhang, Jian-Chu; Wang, Xiao-Juan; Ma, Wan-Li; Yin, Wen; Zhou, Qiong; Ye, Hong; Shi, Huan-Zhong			Regulation of CD4(+) T Cells by Pleural Mesothelial Cells via Adhesion Molecule-Dependent Mechanisms in Tuberculous Pleurisy	PLOS ONE			English	Article							ICAM-1; RECRUITMENT; IMMUNITY	Background: Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been demonstrated to be expressed on pleural mesothelial cells (PMCs), and to mediate leukocyte adhesion and migration; however, little is known about whether adhesion molecule-dependent mechanisms are involved in the regulation of CD4(+) T cells by PMCs in tuberculous pleural effusion (TPE). Methods: Expressions of ICAM-1 and VCAM-1 on PMCs, as well as expressions of CD11a and CD29, the counter-receptors for ICAM-1 and VCAM-1, respectively, expressed on CD4(+) T cells in TPE were determined using flow cytometry. The immune regulations on adhesion, proliferation, activation, selective expansion of CD4(+) helper T cell subgroups exerted by PMCs via adhesion molecule-dependent mechanisms were explored. Results: Percentages of ICAM-1-positive and VCAM-1-positive PMCs in TPE were increased compared with PMC line. Interferon-gamma enhanced fluorescence intensity of ICAM-1, while IL-4 promoted VCAM-1 expression on PMCs. Percentages of CD11a(high)CD4(+) and CD29(high)CD4(+) T cells in TPE significantly increased as compared with peripheral blood. Prestimulation of PMCs with anti-ICAM-1 or -VCAM-1 mAb significantly inhibited adhesion, activation, as well as effector regulatory T cell expansion induced by PMCs. Conclusions: Our current data showed that adhesion molecule pathways on PMCs regulated adhesion and activation of CD4(+) T cells, and selectively promoted the expansion of effector regulatory T cells.	[Yuan, Ming-Li; Tong, Zhao-Hui; Jin, Xiao-Guang; Wang, Xiao-Juan; Yin, Wen; Shi, Huan-Zhong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Yuan, Ming-Li; Zhang, Jian-Chu; Ma, Wan-Li; Yin, Wen; Zhou, Qiong; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Dept Resp & Crit Care Med, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China; [Ye, Hong] Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tong, Zhao-Hui; Shi, Huan-Zhong] Beijing Inst Resp Dis, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, HZ (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	shihuanzhong@sina.com			National Natural Science Foundation of China [81270149, 81272591]; National Science Fund for Distinguished Young Scholars of China [30925032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported in part by grants from National Natural Science Foundation of China (No. 81270149 and No. 81272591); in part by a grant from National Science Fund for Distinguished Young Scholars of China (No. 30925032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PF, 1989, J IMMUNOL, V142, P1114; Choe N, 1999, AM J PHYSIOL-LUNG C, V277, pL292, DOI 10.1152/ajplung.1999.277.2.L292; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Leitner J, 2010, IMMUNOL LETT, V128, P89, DOI 10.1016/j.imlet.2009.11.009; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Mutti L., 1993, Pathologica (Genoa), V85, P725; Nasreen N, 1999, J INFECT DIS, V180, P1616, DOI 10.1086/315057; National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P665; OKUMURA M, 1993, EUR J IMMUNOL, V23, P1057, DOI 10.1002/eji.1830230512; Parameswaran N, 2005, J IMMUNOL, V175, P2201, DOI 10.4049/jimmunol.175.4.2201; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Salomon B, 1998, J IMMUNOL, V161, P5138; Schierlohl P, 2009, EUR J IMMUNOL, V39, P2450, DOI 10.1002/eji.200939515; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Takamoto M, 1998, IMMUNOLOGY, V95, P419, DOI 10.1046/j.1365-2567.1998.00616.x; VANDERMEEREN A, 1993, AM J RESP CELL MOL, V8, P214, DOI 10.1165/ajrcmb/8.2.214; Verma NK, 2012, J BIOL CHEM, V287, P27204, DOI 10.1074/jbc.M112.376616; Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002; Windish HP, 2009, J LEUKOCYTE BIOL, V86, P713, DOI 10.1189/jlb.1208740; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74624	10.1371/journal.pone.0074624	http://dx.doi.org/10.1371/journal.pone.0074624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069325	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300037
J	Hu, J; Hopping, KA; Bump, JK; Kang, SC; Klein, JA				Hu, Jia; Hopping, Kelly A.; Bump, Joseph K.; Kang, Sichang; Klein, Julia A.			Climate Change and Water Use Partitioning by Different Plant Functional Groups in a Grassland on the Tibetan Plateau	PLOS ONE			English	Article							ARCTIC TUNDRA; SOIL-MOISTURE; CO2 FLUX; HIGH-ELEVATION; LONG-TERM; KOBRESIA-PYGMAEA; STABLE-ISOTOPES; FIELD RESPONSES; CARBON STORAGE; WINTER SNOW	Tibetan Plateau (TP) is predicted to experience increases in air temperature, increases in snowfall, and decreases in monsoon rains; however, there is currently a paucity of data that examine the ecological responses to such climate changes. In this study, we examined the effects of increased air temperature and snowfall on: 1) water use partitioning by different plant functional groups, and 2) ecosystem CO2 fluxes throughout the growing season. At the individual plant scale, we used stable hydrogen isotopes (delta D) to partition water use between shallow-and deep-rooted species. Prior to the arrival of summer precipitation (typically mid-July), snowmelt was the main water source in the soils. During this time, shallow and deep-rooted species partitioned water use by accessing water from shallow and deep soils, respectively. However, once the monsoon rains arrived, all plants used rainwater from the upper soils as the main water source. Snow addition did not result in increased snowmelt use throughout the growing season; instead, snowmelt water was pushed down into deeper soils when the rains arrived. At the larger plot scale, CO2 flux measurements demonstrated that rain was the main driver for net ecosystem productivity (NEP). NEP rates were low during June and July and reached a maximum during the monsoon season in August. Warming decreased NEP through a reduction in gross primary productivity (GPP), and snow additions did not mitigate the negative effects of warming by increasing NEP or GPP. Both the isotope and CO2 flux results suggest that rain drives productivity in the Nam Tso region on the TP. This also suggests that the effects of warming-induced drought on the TP may not be mitigated by increased snowfall. Further decreases in summer monsoon rains may affect ecosystem productivity, with large implications for livestock-based livelihoods.	[Hu, Jia] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Hopping, Kelly A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Bump, Joseph K.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Kang, Sichang] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Klein, Julia A.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Montana State University System; Montana State University Bozeman; Colorado State University; Michigan Technological University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Colorado State University	Hu, J (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	jia.hu02@montana.edu	Kang, Shichang/I-6830-2018	Kang, Shichang/0000-0003-2115-9005; Hopping, Kelly/0000-0002-0557-0526; Hu, Jia/0000-0001-6858-6659	National Science Foundation [SBE-0624315]; National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship; National Science Foundation East Asia and Pacific Summer Institute Fellowship; Office Of The Director [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship; National Science Foundation East Asia and Pacific Summer Institute Fellowship; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by the following grant agencies: National Science Foundation SBE-0624315, National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship, and an National Science Foundation East Asia and Pacific Summer Institute Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Berdanier AB, 2011, ECOSYSTEMS, V14, P963, DOI 10.1007/s10021-011-9459-1; BILLINGS WD, 1959, ECOLOGY, V40, P388, DOI 10.2307/1929755; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chu D, 2007, ARCT ANTARCT ALP RES, V39, P635, DOI 10.1657/1523-0430(07-501)[CHU]2.0.CO;2; CINCOTTA RP, 1991, ARCTIC ALPINE RES, V23, P149, DOI 10.2307/1551379; DANSGAARD W, 1964, TELLUS, V16, P436; Ehleringer J. R., 1989, Plant physiological ecology: field methods and instrumentation., P281; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; Feng L, 2011, ADV ATMOS SCI, V28, P464, DOI 10.1007/s00376-010-0016-1; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Gao XJ, 2012, CLIM RES, V52, P213, DOI 10.3354/cr01084; GAT JR, 1994, GEOPHYS RES LETT, V21, P557, DOI 10.1029/94GL00069; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; Golluscio RA, 1998, OECOLOGIA, V115, P17, DOI 10.1007/s004420050486; Grogan P, 2000, OECOLOGIA, V125, P512, DOI 10.1007/s004420000490; Grogan P, 2003, ECOLOGY, V84, P202, DOI 10.1890/0012-9658(2003)084[0202:COANCI]2.0.CO;2; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Henry GHR, 1997, GLOB CHANGE BIOL, V3, P1, DOI 10.1111/j.1365-2486.1997.gcb132.x; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hollister RD, 2005, GLOBAL CHANGE BIOL, V11, P525, DOI 10.1111/j.1365-2486.2005.00926.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Kang S. C, 2011, MODERN ENV PROCESSES; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Lafleur PM, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001983; Li GP, 2001, ADV ATMOS SCI, V18, P1207; Li Na, 2011, Soil Biology & Biochemistry, V43, P942, DOI 10.1016/j.soilbio.2011.01.009; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Loik ME, 1997, ENVIRON EXP BOT, V37, P115, DOI 10.1016/S0098-8472(96)01043-X; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Miehe G, 2008, AMBIO, V37, P272, DOI 10.1579/0044-7447(2008)37[272:SADOTK]2.0.CO;2; Miller DJ, 2005, TIBETAN STEPPE GRASS, P305; Miller DJ., 1998, RANGELANDS, V20, P24; Monson RK, 2006, INTEGR COMP BIOL, V46, P35, DOI 10.1093/icb/icj006; Monson RK, 2002, GLOBAL CHANGE BIOL, V8, P459, DOI 10.1046/j.1365-2486.2002.00480.x; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; Street LE, 2007, J ECOL, V95, P139, DOI 10.1111/j.1365-2745.2006.01187.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Su Z, 2011, HYDROL EARTH SYST SC, V15, P2303, DOI 10.5194/hess-15-2303-2011; Suyker AE, 2001, GLOBAL CHANGE BIOL, V7, P279, DOI 10.1046/j.1365-2486.2001.00407.x; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916; WALKER DA, 1993, BIOSCIENCE, V43, P287, DOI 10.2307/1312061; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wang GX, 2011, CLIMATIC CHANGE, V106, P463, DOI 10.1007/s10584-010-9952-0; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Welker JM, 1999, ARCT ANTARCT ALP RES, V31, P272, DOI 10.2307/1552257; Welker JM, 2000, CLIMATIC CHANGE, V44, P139, DOI 10.1023/A:1005555012742; Welker JM, 2004, ARCT ANTARCT ALP RES, V36, P11, DOI 10.1657/1523-0430(2004)036[0011:AGCEAN]2.0.CO;2; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; WILLIAMS MW, 1995, BIOGEOCHEMISTRY, V28, P1, DOI 10.1007/BF02178059; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Wu TW, 2003, J CLIMATE, V16, P2038, DOI [10.1175/1520-0442(2003)016<2038:TRBTTW>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;2038:TRBTTW&gt;2.0.CO;2]; Xu YW, 2011, CHINESE SCI BULL, V56, P1511, DOI 10.1007/s11434-011-4467-2; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yang Y, 2012, ACTA OECOL, V39, P109, DOI 10.1016/j.actao.2012.01.012; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; You QL, 2010, GLOBAL PLANET CHANGE, V72, P11, DOI 10.1016/j.gloplacha.2010.04.003; Yu WS, 2008, ATMOS RES, V87, P158, DOI 10.1016/j.atmosres.2007.08.004; Zhang B, 2011, J HYDROL, V405, P161, DOI 10.1016/j.jhydrol.2011.05.018; Zhang YQ, 1996, ARCTIC ALPINE RES, V28, P203, DOI 10.2307/1551761	72	27	29	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75503	10.1371/journal.pone.0075503	http://dx.doi.org/10.1371/journal.pone.0075503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069425	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300086
J	Azmat, SK; Shaikh, BT; Hameed, W; Mustafa, G; Hussain, W; Asghar, J; Ishaque, M; Ahmed, A; Bilgrami, M				Azmat, Syed Khurram; Shaikh, Babar Tasneem; Hameed, Waqas; Mustafa, Ghulam; Hussain, Wajahat; Asghar, Jamshaid; Ishaque, Muhammad; Ahmed, Aftab; Bilgrami, Mohsina			Impact of Social Franchising on Contraceptive Use When Complemented by Vouchers: A Quasi-Experimental Study in Rural Pakistan	PLOS ONE			English	Article							PRIVATE-SECTOR; HEALTH; SERVICES; NEED	Background: Pakistan has had a low contraceptive prevalence rate for the last two decades; with preference for natural birth spacing methods and condoms. Family planning services offered by the public sector have never fulfilled the demand for contraception, particularly in rural areas. In the private sector, cost is a major constraint. In 2008, Marie Stopes Society - a local NGO started a social franchise programme along with a free voucher scheme to promote uptake of IUCDs amongst the poor. This paper evaluates the effectiveness of this approach, which is designed to increase modern long term contraceptive awareness and use in rural areas of Pakistan. Methodology: We used a quasi-experimental study design with controls, selecting one intervention district and one control district from the Sindh and Punjab provinces. In each district, we chose a total of four service providers. A baseline survey was carried out among 4,992 married women of reproductive age (MWRA) in February 2009. Eighteen months after the start of intervention, an independent endline survey was conducted among 4,003 women. We used multilevel logistic regression for analysis using Stata 11. Results: Social franchising used alongside free vouchers for long term contraceptive choices significantly increased the awareness of modern contraception. Awareness increased by 5% in the intervention district. Similarly, the ever use of modern contraceptive increased by 28.5%, and the overall contraceptive prevalence rate increased by 19.6%. A significant change (11.1%) was recorded in the uptake of IUCDs, which were being promoted with vouchers. Conclusion: Family planning franchise model promotes awareness and uptake of contraceptives. Moreover, supplemented with vouchers, it may enhance the use of IUCDs, which have a significant cost attached. Our research also supports a multi-pronged approach-generating demand through counselling, overcoming financial constraints by offering vouchers, training, accreditation and branding of the service providers, and ensuring uninterrupted contraceptive supplies.	[Azmat, Syed Khurram; Shaikh, Babar Tasneem; Hameed, Waqas; Mustafa, Ghulam; Hussain, Wajahat; Asghar, Jamshaid; Ishaque, Muhammad; Ahmed, Aftab; Bilgrami, Mohsina] Marie Stopes Soc, Karachi, Pakistan		Shaikh, BT (corresponding author), Marie Stopes Soc, Karachi, Pakistan.	shaikh.babar@gmail.com	Shaikh, Babar Tasneem/J-4900-2017; Azmat, Syed Khurram/C-7244-2019	Shaikh, Babar Tasneem/0000-0002-2056-4132; Azmat, Syed Khurram/0000-0003-0158-8734	Marie Stopes International	Marie Stopes International	Marie Stopes International provided the necessary funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Azmat SK, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-8; Bank World, 1993, WORLD DEV REP 1993; Basinga P, 2011, B WORLD HEALTH ORGAN, V89, P698, DOI 10.2471/BLT.11.089912; Beyeler N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060669; Chandani T, 2006, PRIVATE PROVIDER NET; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Frost N, 2006, SOCIAL FRANCHISING S; Gold RB, 2010, GUTTMACHER POLICY RE, V13; Government of Pakistan, 2011, PAK SURV LIV STAND M; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Hardee K., 2008, POPULATION ACTION IN, P1; Khan A, 2012, POLICY BRIEFS SERIES, V1; Koehlmoos TP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007136.pub2; Kumaranayake I, 2000, HEALTH POLICY PLANN, V15, P357, DOI 10.1093/heapol/15.4.357; Lassner K J, 1995, Bull Pan Am Health Organ, V29, P206; Marek T., 2005, TRENDS OPPORTUNITIES; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Montagu D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-5; National Institute of Population Studies (NIPS) [Pakistan] and Macro International Inc, 2008, PAK DEM HLTH SURV 20; O'Connell K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028364; Prata N, 2005, B WORLD HEALTH ORGAN, V83, P274; Preker AS, 2000, B WORLD HEALTH ORGAN, V78, P779; Qureshi AM, 2010, BMC INT HEALTH HUM R, V10, P25, DOI [10.1186/1472-698X-10-25, DOI 10.1186/1472-698X-10-25]; Shah NM, 2011, HEALTH POLICY PLANN, V26, pi63, DOI 10.1093/heapol/czr027; Shaikh BT, 2010, OPEN ACCESS J CONTR, V1, P113, DOI 10.2147/OAJC.S13715; Shaikh BT., 2008, WORLD HLTH POPUL, V10, P44; Smith E, 2001, WORKING PRIVATE SECT; Stephenson R, 2004, HEALTH SERV RES, V39, P2053, DOI 10.1111/j.1475-6773.2004.00332.x; Swan M, 1997, PRIVATE PRACTITIONER; Winfrey W, 2000, POLICY PROJECT WORKI, V6; World Health Organization, 2007, PUBL POL FRANCH REPR; World Health Organization, 2000, WORLD HLTH REP 2000	34	37	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74260	10.1371/journal.pone.0074260	http://dx.doi.org/10.1371/journal.pone.0074260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069287	gold, Green Submitted, Green Published			2022-12-25	WOS:000326240100094
J	Surya, W; Li, Y; Millet, O; Diercks, T; Torres, J				Surya, Wahyu; Li, Yan; Millet, Oscar; Diercks, Tammo; Torres, Jaume			Transmembrane and Juxtamembrane Structure of alpha L Integrin in Bicelles	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; CYTOPLASMIC DOMAINS; BINDING PROTEIN; SIGNAL-TRANSDUCTION; NMR SYSTEM; ALPHA(IIB)BETA(3); ASSOCIATION; ACTIVATION; SUBUNIT; CRYSTALLOGRAPHY	The accepted model for the interaction of alpha and beta integrins in the transmembrane (TM) domain is based on the pair alpha IIb beta 3. This involves the so-called outer and inner membrane association clasps (OMC and IMC, respectively). In the alpha chain, the OMC involves a GxxxG-like motif, whereas in the IMC a conserved juxtamembrane GFFKR motif experiences a backbone reversal that partially fills the void generated by TM separation towards the cytoplasmic half. However, the GFFKR motif of several alpha integrin cytoplasmic tails in non-bicelle environments has been shown to adopt an alpha-helical structure that is not membrane-embedded and which was shown to bind a variety of cytoplasmic proteins. Thus it is not known if a membrane-embedded backbone reversal is a conserved structural feature in alpha integrins. We have studied the system alpha L beta 2 because of its importance in leukocytes, where integrin deactivation is particularly important. Herein we show that the backbone reversal feature is not only present in alpha IIb but also in alpha L-TM when reconstituted in bicelles. Additionally, titration with beta 2 TM showed eight residues clustering along one side of alpha L-TM, forming a plausible interacting face with beta 2. The latter orientation is consistent with a previously predicted reported polar interaction between alpha L Ser-1071 and beta 2 Thr-686.	[Surya, Wahyu; Li, Yan; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Millet, Oscar; Diercks, Tammo] CIC BioGUNE, Struct Biol Unit, Derio Vizcaya, Spain	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; CIC bioGUNE	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	jtorres@ntu.edu.sg	Millet, Oscar/F-9696-2011; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Diercks, Tammo/G-1167-2011; Diercks, Tammo/AAT-3731-2021; Li, Yan/G-4642-2013	Millet, Oscar/0000-0001-8748-4105; Torres, Jaume/0000-0002-1282-9727; Diercks, Tammo/0000-0002-5200-0905; Diercks, Tammo/0000-0002-5200-0905; Li, Yan/0000-0003-1963-839X; Surya, Wahyu/0000-0001-9240-371X	National Research Foundation of Singapore [NRF-CRP4-2008-02]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This work has been funded by the National Research Foundation of Singapore (www.nrf.gov.sg) grant NRF-CRP4-2008-02 (J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Armulik A, 1999, J BIOL CHEM, V274, P37030, DOI 10.1074/jbc.274.52.37030; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chng CP, 2011, PROTEINS, V79, P2203, DOI 10.1002/prot.23044; Chua GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055184; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hemler M, 1999, EXTRACELLULAR MATRIX; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062954; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nevo J, 2010, ONCOGENE, V29, P6452, DOI 10.1038/onc.2010.376; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Travis MA, 2003, TRENDS PHARMACOL SCI, V24, P192, DOI 10.1016/S0165-6147(03)00069-5; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vararattanavech A, 2010, J MOL BIOL, V398, P569, DOI 10.1016/j.jmb.2010.03.027; Vararattanavech A, 2009, J BIOL CHEM, V284, P3239, DOI 10.1074/jbc.M802782200; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	56	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74281	10.1371/journal.pone.0074281	http://dx.doi.org/10.1371/journal.pone.0074281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069290	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100096
J	Nakano, S; Ikebe, E; Tsukamoto, Y; Wang, Y; Matsumoto, T; Mitsui, T; Yahiro, T; Inoue, K; Kawazato, H; Yasuda, A; Ito, K; Yokoyama, S; Takahashi, N; Hori, M; Shimada, T; Moriyama, M; Kubota, T; Ono, K; Fujibuchi, W; Jeang, KT; Iha, H; Nishizono, A				Nakano, Satoko; Ikebe, Emi; Tsukamoto, Yoshiyuki; Wang, Yan; Matsumoto, Takashi; Mitsui, Takahiro; Yahiro, Takaaki; Inoue, Kunimitsu; Kawazato, Hiroaki; Yasuda, Aiko; Ito, Kanako; Yokoyama, Shigeo; Takahashi, Naohiko; Hori, Mitsuo; Shimada, Tatsuo; Moriyama, Masatsugu; Kubota, Toshiaki; Ono, Katsushige; Fujibuchi, Wataru; Jeang, Kuan-Teh; Iha, Hidekatsu; Nishizono, Akira			Commensal Microbiota Contributes to Chronic Endocarditis in TAX1BP1 Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-I; TAX PROTEIN; HTLV-1 TAX; TNF-ALPHA; INFECTION; INFLAMMATION; CELLS; OSTEOPONTIN; ASSOCIATION	Tax1-binding protein 1 (Tax1bp1) negatively regulates NF-kappa B by editing the ubiquitylation of target molecules by its catalytic partner A20. Genetically engineered TAX1BP1-deficient (KO) mice develop age-dependent inflammatory constitutions in multiple organs manifested as valvulitis or dermatitis and succumb to premature death. Laser capture dissection and gene expression microarray analysis on the mitral valves of TAX1BP1-KO mice (8 and 16 week old) revealed 588 gene transcription alterations from the wild type. SAA3 (serum amyloid A3), CHI3L1, HP, IL1B and SPP1/OPN were induced 1,180-, 361-, 187-, 122- and 101-fold respectively. WIF1 (Wnt inhibitory factor 1) exhibited 11-fold reduction. Intense Saa3 staining and significant I-kappa B alpha reduction were reconfirmed and massive infiltration of inflammatory lymphocytes and edema formation were seen in the area. Antibiotics-induced 'germ free' status or the additional MyD88 deficiency significantly ameliorated TAX1BP1-KO mice's inflammatory lesions. These pathological conditions, as we named 'pseudo-infective endocarditis' were boosted by the commensal microbiota who are usually harmless by their nature. This experimental outcome raises a novel mechanistic linkage between endothelial inflammation caused by the ubiquitin remodeling immune regulators and fatal cardiac dysfunction.	[Nakano, Satoko; Ikebe, Emi; Matsumoto, Takashi; Mitsui, Takahiro; Yahiro, Takaaki; Inoue, Kunimitsu; Iha, Hidekatsu; Nishizono, Akira] Oita Univ, Fac Med, Dept Microbiol, Oita 87011, Japan; [Nakano, Satoko; Kubota, Toshiaki] Oita Univ, Fac Med, Dept Ophthalmol, Oita 87011, Japan; [Tsukamoto, Yoshiyuki; Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan; [Wang, Yan; Ono, Katsushige] Oita Univ, Fac Med, Dept Pathophysiol, Oita 87011, Japan; [Kawazato, Hiroaki; Yasuda, Aiko] Oita Univ, Fac Med, Res Promot Inst, Oita 87011, Japan; [Ito, Kanako] Oita Univ, Fac Med, Dept Internal Med 2, Oita 87011, Japan; [Yokoyama, Shigeo] Oita Univ, Fac Med, Dept Diagnost Pathol, Oita 87011, Japan; [Takahashi, Naohiko] Oita Univ, Fac Med, Dept Lab Examinat & Diagnost, Oita 87011, Japan; [Hori, Mitsuo] Ibaragi Prefectural Cent Hosp, Div Hematol, Kasama, Ibaraki, Japan; [Shimada, Tatsuo] Oita Univ, Sch Nursing, Dept Hlth Sci, Oita 87011, Japan; [Fujibuchi, Wataru] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Jeang, Kuan-Teh] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Iha, H (corresponding author), Oita Univ, Fac Med, Dept Microbiol, Oita 87011, Japan.	hiha@oita-u.ac.jp	Kubota, Toshiaki/AAN-4334-2021; Inoue, Kunimitsu/ABA-5951-2020	Iha, Hidekatsu/0000-0002-0999-5636; Nakano, Satoko/0000-0003-4016-7676; Ono, Katsushige/0000-0001-7949-1823; Yahiro, Takaaki/0000-0003-1094-4497; yong mei, chi bian/0000-0003-0285-0466	Ministry of Education, Culture, Sports, Science, and Technology; Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation; Hita Tenryosui Co. Ltd.; Grants-in-Aid for Scientific Research [24591952] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation; Hita Tenryosui Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology; Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation. E. I. is a research fellow of the OSTPC and was a recipient of the Hita Tenryosui Research Scholarship from Hita Tenryosui Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128/JVI.77.9.5286-5294.2003; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hayashi Jun, 2008, Fukuoka Acta Medica, V99, P67; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Hida A, 2010, ANN RHEUM DIS, V69, P2056, DOI 10.1136/ard.2010.128736; Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; ISHIGURO N, 1992, J EXP MED, V176, P981, DOI 10.1084/jem.176.4.981; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; Jang SY, 2012, GLIA, V60, P1619, DOI 10.1002/glia.22382; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kira J, 1997, ACTA NEUROL SCAND, V96, P305, DOI 10.1111/j.1600-0404.1997.tb00288.x; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Martin F, 2011, AIDS REV, V13, P161; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Newton K., 2012, COLD SPRING HARB PER; Obici L, 2012, AUTOIMMUN REV, V12, P14, DOI 10.1016/j.autrev.2012.07.016; Ohsugi T, 2007, NAT MED, V13, P527, DOI 10.1038/nm0507-527; Oliere S, 2011, CYTOKINE GROWTH F R, V22, P197, DOI 10.1016/j.cytogfr.2011.08.002; Peloponese JM, 2006, IMMUNOL RES, V34, P1, DOI 10.1385/IR:34:1:1; Poynter ME, 2012, PULM PHARMACOL THER, V25, P438, DOI 10.1016/j.pupt.2012.04.005; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roufosse FE, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-37; Ruiz MT, 2010, BRAZ J OTORHINOLAR, V76, P193, DOI 10.1590/S1808-86942010000200008; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; Tattermusch S, 2012, TRENDS MICROBIOL, V20, P494, DOI 10.1016/j.tim.2012.07.004; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Verstrepen L, 2011, TRENDS BIOCHEM SCI, V36, P347, DOI 10.1016/j.tibs.2011.03.004; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wilson W, 2008, J AM DENT ASSOC, V139, p3S, DOI 10.14219/jada.archive.2008.0346; Yagi H, 2003, J DERMATOL, V30, P641, DOI 10.1111/j.1346-8138.2003.tb00451.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	64	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73205	10.1371/journal.pone.0073205	http://dx.doi.org/10.1371/journal.pone.0073205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086273	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900012
J	Coletta, A; Castelli, S; Chillemi, G; Sanna, N; Cushman, M; Pommier, Y; Desideri, A				Coletta, Andrea; Castelli, Silvia; Chillemi, Giovanni; Sanna, Nico; Cushman, Mark; Pommier, Yves; Desideri, Alessandro			Solvent Dependency of the UV-Vis Spectrum of Indenoisoquinolines: Role of Keto-Oxygens as Polarity Interaction Probes	PLOS ONE			English	Article							TOPOISOMERASE-I INHIBITORS; TOPOTECAN ANTICANCER DRUG; DNA COVALENT COMPLEX; CLEAVAGE COMPLEX; AQUEOUS-SOLUTION; NORINDENOISOQUINOLINE; RESISTANCE; MECHANISM; DENSITY; BINDING	Indenoisoquinolines are the most promising non-campthotecins topoisomerase IB inhibitors. We present an integrated experimental/computational investigation of the UV-Vis spectra of the IQNs parental compound (NSC314622) and two of its derivatives (NSC724998 and NSC725776) currently undergoing Phase I clinical trials. In all the three compounds a similar dependence of the relative absorption intensities at 270 nm and 290 nm on solvent polarity is found. The keto-oxygens in positions 5 and 11 of the molecular scaffold of the molecule are the principal chromophores involved in this dependence. Protic interactions on these sites are also found to give rise to absorptions at wavelength <250 nm observed in water solution, due to the stabilization of highly polarized tautomers of the molecule. These results suggest that the keto-oxygens are important polarizable groups that can act as useful interactors with the molecular receptor, providing at the same time an useful fingerprint for the monitoring of the drug binding to topoisomerase IB.	[Coletta, Andrea; Castelli, Silvia; Desideri, Alessandro] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Chillemi, Giovanni; Sanna, Nico] Consorzio Interuniv Applicaz Supercalcolo Univ &, Rome, Italy; [Cushman, Mark] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	University of Rome Tor Vergata; CINECA, Italy; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy.	desideri@uniroma2.it	Sanna, Nico/AAB-7170-2020; Chillemi, Giovanni/O-2825-2019; Coletta, Andrea/H-9856-2012; Coletta, Andrea/GXF-2972-2022; SANNA, Nico/R-8799-2016; Chillemi, Giovanni/E-5201-2010	Sanna, Nico/0000-0002-1947-7939; Chillemi, Giovanni/0000-0003-3901-6926; Coletta, Andrea/0000-0003-4032-394X; SANNA, Nico/0000-0002-1947-7939; Chillemi, Giovanni/0000-0003-3901-6926; desideri, alessandro/0000-0003-1541-4217	Associazione Italiana per la Ricerca sul Cancro Research Project [IG-10121]; National Institutes of Health Research Grant [UO1 CA89566]; CASPUR/CINECA [std11-434]; National Cancer Institute Intramural Program, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006161, U01CA089566] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro Research Project(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CASPUR/CINECA(CINECA, Italy); National Cancer Institute Intramural Program, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding from Associazione Italiana per la Ricerca sul Cancro Research Project IG-10121; National Institutes of Health Research Grant UO1 CA89566; CASPUR/CINECA std11-434, "Characterization of anticancer drug selectively targeting human topoisomerase IB by ab-initio calculations"; and National Cancer Institute Intramural Program, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Aschi M, 2001, CHEM PHYS LETT, V344, P374, DOI 10.1016/S0009-2614(01)00638-8; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Chillemi G, 2010, THEOR CHEM ACC, V127, P293, DOI 10.1007/s00214-009-0715-9; Chillemi Giovanni, 2007, Ital J Biochem, V56, P110; Coletta A, 2010, J PHYS CHEM A, V114, P7121, DOI 10.1021/jp101494d; Craig IM, 2009, CHEM PHYS LETT, V477, P319, DOI 10.1016/j.cplett.2009.07.041; CUSHMAN M, 1978, J ORG CHEM, V43, P3781, DOI 10.1021/jo00413a036; Cushman M, 2000, J MED CHEM, V43, P3688, DOI 10.1021/jm000029d; Fiorani P, 2009, NUCLEIC ACIDS RES, V37, P6849, DOI 10.1093/nar/gkp669; Frisch M., 2016, GAUSSIAN 16 REVISION; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Losasso C, 2008, NUCLEIC ACIDS RES, V36, P5635, DOI 10.1093/nar/gkn557; Malcioglu OB, 2011, J AM CHEM SOC, V133, P15425, DOI 10.1021/ja201733v; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Sanna N, 2005, J AM CHEM SOC, V127, P15429, DOI 10.1021/ja052637u; Sanna N, 2009, J PHYS CHEM B, V113, P5369, DOI 10.1021/jp809801y; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Song Y, 2010, J MED CHEM; Song YL, 2008, J PHYS CHEM B, V112, P9484, DOI 10.1021/jp8005603; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; Strumberg D, 1999, J MED CHEM, V42, P446, DOI 10.1021/jm9803323; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Tonzani S, 2008, J AM CHEM SOC, V130, P7607, DOI 10.1021/ja7103894; Xiao XS, 2005, J MED CHEM, V48, P3231, DOI 10.1021/jm050017y; Zazza C, 2010, J PHYS CHEM B, V114, P6770, DOI 10.1021/jp1015824	38	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73881	10.1371/journal.pone.0073881	http://dx.doi.org/10.1371/journal.pone.0073881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086299	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000004
J	Moreno, D; Balasiddaiah, A; Lamas, O; Duret, C; Neri, L; Guembe, L; Galarraga, M; Larrea, E; Daujat-Chavanieu, M; Muntane, J; Maurel, P; Riezu, JI; Prieto, J; Aldabe, R				Moreno, Daniel; Balasiddaiah, Anangi; Lamas, Oscar; Duret, Cedric; Neri, Leire; Guembe, Laura; Galarraga, Miguel; Larrea, Esther; Daujat-Chavanieu, Martine; Muntane, Jordi; Maurel, Patrick; Ignacio Riezu, Jose; Prieto, Jesus; Aldabe, Rafael			Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CHIMERIC MICE; HUMANIZED LIVER; C VIRUS; IN-VIVO; INFECTION; MODEL; TRANSPLANTATION; METABOLISM; RESPONSES	It has been shown that the liver of immunodeficient mice can be efficiently repopulated with human hepatocytes when subjected to chronic hepatocellular damage. Mice with such chimeric livers represent useful reagents for medical and clinical studies. However all previously reported models of humanized livers are difficult to implement as they involve cross-breeding of immunodeficient mice with mice exhibiting genetic alterations causing sustained hepatic injury. In this paper we attempted to create chimeric livers by inducing persistent hepatocellular damage in immunodeficient Rag2(-/-) gamma c(-/-) mice using an adenovirus encoding herpes virus thymidine kinase (AdTk) and two consecutive doses of ganciclovir (GCV). We found that this treatment resulted in hepatocellular damage persisting for at least 10 weeks and enabled efficient engraftment and proliferation within the liver of either human or allogenic hepatocytes. Interestingly, while the nodules generated from the transplanted mouse hepatocytes were well vascularized, the human hepatocytes experienced progressive depolarization and exhibited reduced numbers of murine endothelial cells inside the nodules. In conclusion, AdTk/GCV-induced liver damage licenses the liver of immunodeficient mice for allogenic and xenogenic hepatocyte repopulation. This approach represents a simple alternative strategy for chimeric liver generation using immunodeficient mice without additional genetic manipulation of the germ line.	[Moreno, Daniel; Balasiddaiah, Anangi; Lamas, Oscar; Neri, Leire; Larrea, Esther; Ignacio Riezu, Jose; Prieto, Jesus; Aldabe, Rafael] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] INSERM, U1040, Montpellier, France; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] Univ Montpellier I, UMR S1040, F-34006 Montpellier, France; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] Hop St Eloi, CHU Montpellier, Inst Rech Biotherapie, Montpellier, France; [Guembe, Laura] Univ Navarra, Dept Morphol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Galarraga, Miguel] Univ Navarra, Dept Imaging, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Muntane, Jordi] Reina Sofia Univ Hosp, Liver Res Unit, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Muntane, Jordi; Prieto, Jesus] Univ Navarra, Univ Clin, CIBER EHD, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Liver Unit, Univ Clin, E-31080 Pamplona, Spain	University of Navarra; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; University of Navarra	Aldabe, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain.	raldabe@unav.es	Larrea, Esther/L-7586-2014; Aldabe, Rafael/F-3112-2015; Daujat-Chavanieu, Martine/T-5155-2018; Riezu-Boj, Jose Ignacio/M-3748-2014; Daujat-Chavanieu, Martine/AAU-2908-2020; Moreno-Luqui, Daniel/AAE-4121-2021	Larrea, Esther/0000-0002-1443-6513; Aldabe, Rafael/0000-0002-9461-020X; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Riezu-Boj, Jose Ignacio/0000-0002-1885-8457; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Guembe, Laura/0000-0002-5157-8588; Moreno-Luqui, Daniel/0000-0003-0802-9695; Duret, Cedric/0000-0003-1769-8081; Prieto, Jesus/0000-0002-1091-9593	UTE project CIMA	UTE project CIMA	This work has been funded by UTE project CIMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Braun KM, 2000, NAT MED, V6, P320; Bustos M, 2000, AM J PATHOL, V157, P549, DOI 10.1016/S0002-9440(10)64565-8; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Douglas DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009209; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Gilgenkrantz H, 2010, METHODS MOL BIOL, V640, P475, DOI 10.1007/978-1-60761-688-7_26; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; LOKE SL, 1990, J CLIN PATHOL, V43, P654, DOI 10.1136/jcp.43.8.654; Lootens L, 2009, DRUG TEST ANAL, V1, P531, DOI 10.1002/dta.67; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Okumura H, 2007, TOXICOL SCI, V97, P533, DOI 10.1093/toxsci/kfm041; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Peterson Richard A, 2010, Drug Metab Lett, V4, P180; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; RHIM JA, 1995, P NATL ACAD SCI USA, V92, P4942, DOI 10.1073/pnas.92.11.4942; Sato Y, 2008, TOXICOL PATHOL, V36, P581, DOI 10.1177/0192623308318212; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; Sheahan T, 2010, EXPERT REV GASTROENT, V4, P541, DOI [10.1586/egh.10.53, 10.1586/EGH.10.53]; Steenbergen RHG, 2010, AM J PHYSIOL-GASTR L, V299, pG844, DOI 10.1152/ajpgi.00200.2010; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Utoh R, 2010, AM J PATHOL, V177, P654, DOI 10.2353/ajpath.2010.090430; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Yoshizato K, 2009, EXPERT OPIN DRUG MET, V5, P1435, DOI 10.1517/17425250903216664	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74948	10.1371/journal.pone.0074948	http://dx.doi.org/10.1371/journal.pone.0074948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086405	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200018
J	Seminati, E; Nardello, F; Zamparo, P; Ardigo, LP; Faccioli, N; Minetti, AE				Seminati, Elena; Nardello, Francesca; Zamparo, Paola; Ardigo, Luca P.; Faccioli, Niccolo; Minetti, Alberto E.			Anatomically Asymmetrical Runners Move More Asymmetrically at the Same Metabolic Cost	PLOS ONE			English	Article							ABLE-BODIED GAIT; ENERGY-COST; LENGTH DISCREPANCY; DISTANCE RUNNERS; RUNNING ECONOMY; SYMMETRY; LOCOMOTION; PERFORMANCE; WALKING; HUMANS	We hypothesized that, as occurring in cars, body structural asymmetries could generate asymmetry in the kinematics/dynamics of locomotion, ending up in a higher metabolic cost of transport, i.e. more 'fuel' needed to travel a given distance. Previous studies found the asymmetries in horses' body negatively correlated with galloping performance. In this investigation, we analyzed anatomical differences between the left and right lower limbs as a whole by performing 3D cross-correlation of Magnetic Resonance Images of 19 male runners, clustered as Untrained Runners, Occasional Runners and Skilled Runners. Running kinematics of their body centre of mass were obtained from the body segments coordinates measured by a 3D motion capture system at incremental running velocities on a treadmill. A recent mathematical procedure quantified the asymmetry of the body centre of mass trajectory between the left and right steps. During the same sessions, runners' metabolic consumption was measured and the cost of transport was calculated. No correlations were found between anatomical/kinematic variables and the metabolic cost of transport, regardless of the training experience. However, anatomical symmetry significant correlated to the kinematic symmetry, and the most trained subjects showed the highest level of kinematic symmetry during running. Results suggest that despite the significant effects of anatomical asymmetry on kinematics, either those changes are too small to affect economy or some plastic compensation in the locomotor system mitigates the hypothesized change in energy expenditure of running.	[Seminati, Elena; Minetti, Alberto E.] Univ Milan, Fac Med, Dept Pathophysiol & Transplantat, Milan, Italy; [Nardello, Francesca; Zamparo, Paola; Ardigo, Luca P.] Univ Verona, Sch Exercise & Sport Sci, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Faccioli, Niccolo] Univ Verona, Dept Pathol & Diagnost, Sect Radiol, I-37100 Verona, Italy	University of Milan; University of Verona; University of Verona	Seminati, E (corresponding author), Univ Milan, Fac Med, Dept Pathophysiol & Transplantat, Milan, Italy.	elena.seminati@unimi.it	Minetti, Alberto Enrico/P-2320-2017; Ardigò, Luca Paolo/H-8955-2019; Zamparo, Paola/AAF-7700-2020	Minetti, Alberto Enrico/0000-0002-0120-4406; Ardigò, Luca Paolo/0000-0001-7677-5070; Zamparo, Paola/0000-0002-6919-6721; NARDELLO, FRANCESCA/0000-0001-8942-3920; Seminati, Elena/0000-0002-6736-893X; Faccioli, Niccolo'/0000-0001-6655-9825	Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan	Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan	The project was supported by the Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Ambrosini RD, 2010, J MAGN RESON IMAGING, V31, P85, DOI 10.1002/jmri.22009; Beneke R, 2005, MED SCI SPORT EXER, V37, P1794, DOI 10.1249/01.mss.0000176399.67121.02; Cavanagh P R, 1977, Ann N Y Acad Sci, V301, P328, DOI 10.1111/j.1749-6632.1977.tb38211.x; CUK T, 2001, VAR EVOL, V9, P19; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; DEMPSTER WT, 1959, AM J PHYS ANTHROPOL, V17, P289, DOI 10.1002/ajpa.1330170405; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Forczek W, 2012, J HUM KINET, V35, P47, DOI 10.2478/v10078-012-0078-5; Gurney B, 2002, GAIT POSTURE, V15, P195, DOI 10.1016/S0966-6362(01)00148-5; Gurney B, 2001, J BONE JOINT SURG AM, V83A, P907, DOI 10.2106/00004623-200106000-00013; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Kong PW, 2009, BRIT J SPORT MED, V43, P745, DOI 10.1136/bjsm.2008.047761; Lee Y, 2001, IEEE T MED IMAGING, V20, P595, DOI 10.1109/42.932744; Lewis J, 1996, FAST NORMALIZED CROS; Lund FH, 1930, AM J PSYCHOL, V42, P51, DOI 10.2307/1414419; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Manning JT, 1998, INT J SPORTS MED, V19, P205, DOI 10.1055/s-2007-971905; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Mattes SJ, 2000, ARCH PHYS MED REHAB, V81, P561, DOI 10.1016/S0003-9993(00)90035-2; Maupas E, 1999, CLIN BIOMECH, V14, P403, DOI 10.1016/S0268-0033(99)00005-4; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2009, GAIT POSTURE, V30, pS153, DOI [10.1016/j.gaitpost.2009.08.230, DOI 10.1016/J.GAITPOST.2009.08.230]; Minetti AE, 2011, J BIOMECH, V44, P1471, DOI 10.1016/j.jbiomech.2011.03.014; Nakayama Y, 2010, GAIT POSTURE, V31, P331, DOI 10.1016/j.gaitpost.2009.12.003; Nardello F, 2009, GAIT POSTURE, V30, pS80; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Seeley MK, 2010, J SPORT SCI MED, V9, P572; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Thomsen MH, 2010, J BIOMECH, V43, P2608, DOI 10.1016/j.jbiomech.2010.05.004; Wang P, 2007, MED PHYS, V34, P915, DOI 10.1118/1.2436970; Winter D, 2005, BIOMECHANICS MOTOR C	37	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74134	10.1371/journal.pone.0074134	http://dx.doi.org/10.1371/journal.pone.0074134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086316	Green Submitted, gold, Green Published			2022-12-25	WOS:000325025200010
J	Koochekpour, S; Marlowe, T; Singh, KK; Attwood, K; Chandra, D				Koochekpour, Shahriar; Marlowe, Timothy; Singh, Keshav K.; Attwood, Kristopher; Chandra, Dhyan			Reduced Mitochondrial DNA Content Associates with Poor Prognosis of Prostate Cancer in African American Men	PLOS ONE			English	Article							INDUCED CELL-DEATH; COMPLEX-I; MUTATIONS; P53; CARCINOMA; ACTIVATION; NUCLEAR; PROGRESSION; TUMORS; RESPIRATION	Reduction or depletion of mitochondrial DNA (mtDNA) has been associated with cancer progression. Although imbalanced mtDNA content is known to occur in prostate cancer, differences in mtDNA content between African American (AA) and Caucasian American (CA) men are not defined. We provide the first evidence that tumors in AA men possess reduced level of mtDNA compared to CA men. The median tumor mtDNA content was reduced in AA men. mtDNA content was also reduced in normal prostate tissues of AA men compared to CA men, suggesting a possible predisposition to cancer in AA men. mtDNA content was also reduced in benign prostatic hyperplasia (BPH) tissue from AA men. Tumor and BPH tissues from patients >= 60 years of age possess reduced mtDNA content compared to patients,60 years of age. In addition, mtDNA content was higher in normal tissues from patients with malignant T3 stage disease compared to patients with T2 stage disease. mtDNA levels in matched normal prostate tissues were nearly doubled in Gleason grade of >7 compared to <= 7, whereas reduced mtDNA content was observed in tumors of Gleason grade >7 compared to <= 7. Together, our data suggest that AA men possess lower mtDNA levels in normal and tumor tissues compared to CA men, which could contribute to higher risk and more aggressive prostate cancer in AA men.	[Koochekpour, Shahriar] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Koochekpour, Shahriar] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Marlowe, Timothy; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Dept Genet Pathol & Environm Hlth, Birmingham, AL USA; [Singh, Keshav K.] Univ Alabama Birmingham, Sch Med, Ctr Free Rad Biol, Birmingham, AL USA; [Attwood, Kristopher] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org		Chandra, Dhyan/0000-0001-7272-9384	National Cancer Institute of National Institutes of Health [R01CA160685, K01CA123142]; American Cancer Society [RSG-12-214-01 - CCG]; National Cancer Institute Center Support Grant [P30 CA016056];  [R01MD005824];  [R21CA149137];  [R21CA143589];  [R01 CA121904];  [R21 CA153097]; NATIONAL CANCER INSTITUTE [R21CA149137, R21CA153097, R21CA143589, P30CA016056, K01CA123142, R01CA160685, R01CA121904, T32CA009072] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD005824] Funding Source: NIH RePORTER	National Cancer Institute of National Institutes of Health; American Cancer Society(American Cancer Society); National Cancer Institute Center Support Grant; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study received financial support from the National Cancer Institute of the National Institutes of Health under Award Number R01CA160685 and K01CA123142, and the American Cancer Society Research Scholar Grant RSG-12-214-01 - CCG to DC and the National Cancer Institute Center Support Grant P30 CA016056 to the Roswell Park Cancer Institute. Additional support was provided by R01MD005824, R21CA149137, and R21CA143589 to SK and R01 CA121904 and R21 CA153097 to KKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Chen JJZ, 2002, CANCER RES, V62, P6470; Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Godley PA, 2003, JNCI-J NATL CANCER I, V95, P1702, DOI 10.1093/jnci/djg094; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Heddi A, 1996, BBA-MOL BASIS DIS, V1316, P203, DOI 10.1016/0925-4439(96)00026-9; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeronimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; Jones JB, 2001, CANCER RES, V61, P1299; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; LUCIAKOVA K, 1992, EUR J BIOCHEM, V205, P1187, DOI 10.1111/j.1432-1033.1992.tb16889.x; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Meyers FJ, 1998, CANCER, V83, P2534, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2534::AID-CNCR19>3.3.CO;2-M; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Prabhu V, 2012, MITOCHONDRION; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454	50	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74688	10.1371/journal.pone.0074688	http://dx.doi.org/10.1371/journal.pone.0074688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086362	gold, Green Submitted, Green Published			2022-12-25	WOS:000326520200038
J	Lu, RQ; Jiang, ML; Chen, ZJ; Xu, XF; Hu, HF; Zhao, XM; Gao, X; Guo, L				Lu, Renquan; Jiang, Minglei; Chen, Zhujun; Xu, Xiaofeng; Hu, Hongfeng; Zhao, Xinmin; Gao, Xiang; Guo, Lin			Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis	PLOS ONE			English	Article							CELL LUNG-CANCER; LDH-5 EXPRESSION; FACTOR PATHWAY; TUMOR-CELLS; HIF-1-ALPHA; GLYCOLYSIS; METABOLISM; SURVIVAL; TARGET; LINK	Lactate dehydrogenase 5 (LDH-5) is one of the major isoenzymes catalyzing the biochemical process of pyruvate to lactate. The purpose of this study was to investigate the expression of serum LDH-5 and test whether this enzyme is regulated by tumor hypoxia and represents a prognostic marker in patients with Non-Hodgkin's lymphoma (NHL). In this study, LDH-5 levels were detected using agarose gel electrophoresis in NHL patients (n = 266) and non-NHL controls including benign lymphadenectasis (n = 30) and healthy cohorts (n = 233). We also explored the expression of LDH-5 and hypoxia-inducible factor (HIF) 1 alpha in NHL and benign controls by immunohistochemistry and immunofluorescence staining, respectively. Moreover, the role of LDH-5 in the progression of NHL was assessed by multivariate Cox analyses and Kaplan-Meier survival estimates. Serum concentrations of LDH-5 were significantly higher in NHL patients (9.3%) than in benign patients and healthy controls (7.5% and 7.2%, respectively, P < 0.01). Application of LDH-5 detection increased the sensitivity of NHL detection, identifying 53.4% of NHL patients as positive, compared with the measurement of total LDH levels (36.5% sensitivity). LDH-5 concentrations increased with clinical stage, extra-nodal site involvement, and WHO performance status of patients with NHL. Exposure to a hypoxic environment induced the expression of LDH-5 and its overexpression correlated with HIF1 alpha cytoplasmic accumulation in NHL cells. In multivariate analyses, LDH-5 was an independent marker for progression-free survival in patients with NHL (P < 0.001). Overall, the expression of LDH-5 was elevated in NHL, showing an association with tumor hypoxia and unfavorable prognosis. Thus, LDH-5 emerges as a promising prognostic predictor for NHL patients.	[Lu, Renquan; Jiang, Minglei; Chen, Zhujun; Xu, Xiaofeng; Hu, Hongfeng; Gao, Xiang; Guo, Lin] Fudan Univ, Shanghai Canc Ctr, Dept Clin Lab, Shanghai 200433, Peoples R China; [Lu, Renquan; Zhao, Xinmin; Gao, Xiang; Guo, Lin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhao, Xinmin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Guo, L (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Clin Lab, Shanghai 200433, Peoples R China.	guolin500@hotmail.com			Science and Technology Commission of Shanghai Municipality [124119a0202, 114119a0400]; National Basic Research Program of China [2010CB933902]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Science and Technology Commission of Shanghai Municipality (124119a0202; 114119a0400), and National Basic Research Program of China (2010CB933902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 2000, BLOOD, V96, P1921; Armstrong AJ, 2012, J CLIN ONCOL, V30, P3402, DOI 10.1200/JCO.2011.40.9631; Baker LCJ, 2012, BRIT J CANCER, V106, P1638, DOI 10.1038/bjc.2012.131; Boehme V, 2007, ANN ONCOL, V18, P149, DOI 10.1093/annonc/mdl327; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Giatromanolaki A, 2008, LEUKEMIA LYMPHOMA, V49, P2181, DOI 10.1080/10428190802450629; Giatromanolaki A, 2006, GYNECOL ONCOL, V103, P912, DOI 10.1016/j.ygyno.2006.05.043; Giatromanolaki A, 2012, CANCER BIOL THER, V13, P1284, DOI 10.4161/cbt.21785; Granchi C, 2011, BIOORG MED CHEM LETT, V21, P7331, DOI 10.1016/j.bmcl.2011.10.031; Grimm M, 2013, CLIN EXP METASTAS, V30, P529, DOI 10.1007/s10585-012-9557-2; Guo L, 2003, J DIAGN CONCEPTS PRA, V2, P300; Hecht JR, 2005, J CLIN ONCOL, V23, p2S; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Langhammer S, 2011, TARGET ONCOL, V6, P155, DOI 10.1007/s11523-011-0184-7; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lu R, 2013, ONCOGENE, DOI DOI 10.1038/0NC.2013.103; Lu RQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-607; Lu RQ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-270; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Prensner JR, 2012, CLIN EXP METASTAS, V29, P645, DOI 10.1007/s10585-012-9507-z; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Serganova I, 2011, CLIN CANCER RES, V17, P6250, DOI 10.1158/1078-0432.CCR-11-0397; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Swerdlow SH, 2008, WHO CLASSIFICATION T; Xue QF, 1996, J CHROMATOGR B, V677, P233, DOI 10.1016/0378-4347(95)00467-X; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	36	28	33	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74853	10.1371/journal.pone.0074853	http://dx.doi.org/10.1371/journal.pone.0074853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086384	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200043
J	Nativel, B; Marimoutou, M; Thon-Hon, VG; Gunasekaran, MK; Andries, J; Stanislas, G; Planesse, C; Da Silva, CR; Cesari, M; Iwema, T; Gasque, P; Viranaicken, W				Nativel, Brice; Marimoutou, Mery; Thon-Hon, Vincent G.; Gunasekaran, Manoj Kumar; Andries, Jessica; Stanislas, Giovedie; Planesse, Cynthia; Da Silva, Christine Robert; Cesari, Maya; Iwema, Thomas; Gasque, Philippe; Viranaicken, Wildriss			Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GLYCATION END-PRODUCTS; SUBCUTANEOUS ADIPOSE-TISSUE; DNA-BINDING PROTEINS; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; FACTOR-ALPHA; THERAPEUTIC TARGET; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAY	Low-grade inflammation (LGI) is a central phenomenon in the genesis of obesity and insulin-resistance characterized by IL-6 in human serum. Whereas this LGI was initially thought to be mainly attributed to macrophage activation, it is now known that pre-adipocytes and adipocytes secrete several adipokines including IL-6 and participate to LGI and associated pathologies. In macrophages, HMGB1 is a nuclear yet secreted protein and acts as a cytokine to drive the production of inflammatory molecules through RAGE and TLR2/4. In this paper we tested the secretion of HMGB1 and the auto-and paracrine contribution to fat inflammation using the human preadipocyte cell line SW872 as a model. We showed that 1) human SW872 secreted actively HMGB1, 2) IL-6 production was positively linked to high levels of secreted HMGB1, 3) recombinant HMGB1 boosted IL-6 expression and this effect was mediated by the receptor RAGE and did not involve TLR2 or TLR4. These results suggest that HMGB1 is a major adipokine contributing to LGI implementation and maintenance, and can be considered as a target to develop news therapeutics in LGI associated pathologies such as obesity and type II diabetes.				wildriss.viranaicken@univ-reunion.fr		CESARI, Maya/0000-0002-2795-6059; NATIVEL, Brice/0000-0003-3719-7903	CPER-FEDER GRII, University of La Reunion; "Structure Federative Environnement, Biodiversite, Sante'' University of La La Reunion; Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion; Regional Council of La Reunion; French Ministry	CPER-FEDER GRII, University of La Reunion; "Structure Federative Environnement, Biodiversite, Sante'' University of La La Reunion; Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion; Regional Council of La Reunion; French Ministry	This work was supported by grants from CPER-FEDER GRII, University of La Reunion and the the "Structure Federative Environnement, Biodiversite, Sante ''University of La La Reunion. BN holds a fellowship from the Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion. MM and MKG hold fellowships from Regional Council of La Reunion. VGTH is a fellow from the French Ministry (contrat doctoral). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Carmel JF, 2009, J CELL BIOCHEM, V106, P608, DOI 10.1002/jcb.22037; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Considine RV, 1996, AM J PHYSIOL-ENDOC M, V270, pE895, DOI 10.1152/ajpendo.1996.270.5.E895; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Fasshauer M, 2003, HORM METAB RES, V35, P147, DOI 10.1055/s-2003-39075; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Flyvbjerg A, 2004, DIABETES, V53, P166, DOI 10.2337/diabetes.53.1.166; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hoareau L, 2006, CYTOKINE, V34, P291, DOI 10.1016/j.cyto.2006.06.005; Hoch M, 2008, CYTOKINE, V41, P29, DOI 10.1016/j.cyto.2007.10.008; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Izem L, 2007, J BIOL CHEM, V282, P21856, DOI 10.1074/jbc.M701075200; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Lehrke M, 2008, CRIT CARE, V12, DOI 10.1186/cc7152; Leuner B, 2012, Z GERONTOL GERIATR, V45, P102, DOI 10.1007/s00391-011-0279-x; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Mantell LL, 2006, SHOCK, V25, P4, DOI 10.1097/01.shk.0000188710.04777.9e; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Ogawa W, 2008, SCIENCE, V322, P1483, DOI 10.1126/science.1167571; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Rodino-Janeiro BK, 2011, EUR J ENDOCRINOL, V164, P529, DOI 10.1530/EJE-10-0904; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Samuvel DJ, 2010, J BIOL CHEM, V285, P3916, DOI 10.1074/jbc.M109.033951; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Tarnus E, 2009, FEBS LETT, V583, P2042, DOI 10.1016/j.febslet.2009.05.016; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Unoki H, 2008, CURR PHARM DESIGN, V14, P987, DOI 10.2174/138161208784139747; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Wassef H, 2004, J NUTR, V134, P2935, DOI 10.1093/jn/134.11.2935; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648	57	71	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76039	10.1371/journal.pone.0076039	http://dx.doi.org/10.1371/journal.pone.0076039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073286	Green Published, gold			2022-12-25	WOS:000324768000096
J	Slezak-Prochazka, I; Kluiver, J; de Jong, D; Kortman, G; Halsema, N; Poppema, S; Kroesen, BJ; van den Berg, A				Slezak-Prochazka, Izabella; Kluiver, Joost; de Jong, Debora; Kortman, Gertrud; Halsema, Nancy; Poppema, Sibrand; Kroesen, Bart-Jan; van den Berg, Anke			Cellular Localization and Processing of Primary Transcripts of Exonic MicroRNAs	PLOS ONE			English	Article							MICROPROCESSOR COMPLEX; LYMPHOMA; HODGKIN; EXPRESSION; GENE; MIR-155; SITES; RNA; BIOGENESIS; CELLS	Processing of miRNAs occurs simultaneous with the transcription and splicing of their primary transcripts. For the small subset of exonic miRNAs it is unclear if the unspliced and/or spliced transcripts are used for miRNA biogenesis. We assessed endogenous levels and cellular location of primary transcripts of three exonic miRNAs. The ratio between unspliced and spliced transcripts varied markedly, i.e. >1 for BIC, <1 for pri-miR-146a and variable for pri-miR-22. Endogenous unspliced transcripts were located almost exclusively in the nucleus and thus available for miRNA processing for all three miRNAs. Endogenous spliced pri-miRNA transcripts were present both in the nucleus and in the cytoplasm and thus only partly available for miRNA processing. Overexpression of constructs containing the 5' upstream exonic or intronic sequence flanking pre-miR-155 resulted in strongly enhanced miR-155 levels, indicating that the flanking sequence does not affect processing efficiency. Exogenously overexpressed full-length spliced BIC transcripts were present both in the nucleus and in the cytoplasm, were bound by the Microprocessor complex and resulted in enhanced miR-155 levels. We conclude that both unspliced and spliced transcripts of exonic miRNAs can be used for pre-miRNA cleavage. Splicing and cytoplasmic transport of spliced transcripts may present a mechanism to regulate levels of exonic microRNAs.	[Slezak-Prochazka, Izabella; Kluiver, Joost; de Jong, Debora; Kortman, Gertrud; Halsema, Nancy; Poppema, Sibrand; Kroesen, Bart-Jan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen	van den Berg, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	van den Berg, Anke/H-1718-2011; Slezak-Prochazka, Izabella/F-7674-2019; Kluiver, Joost/G-6406-2014; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Slezak-Prochazka, Izabella/0000-0002-0707-2213; Kluiver, Joost/0000-0001-7650-2937; 	Dutch Cancer Society [RUG 2009-4279]; Ubbo Emmius Foundation	Dutch Cancer Society(KWF Kankerbestrijding); Ubbo Emmius Foundation	This study was supported by a grant from the Dutch Cancer Society (RUG 2009-4279) to B.J.K. and A.v.d.B and by a grant from the Ubbo Emmius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; Atayar C, 2006, HUM PATHOL, V37, P675, DOI 10.1016/j.humpath.2006.01.018; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Copie-Bergman C, 2003, BLOOD, V101, P2756, DOI 10.1182/blood-2002-07-2215; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; DIEHL V, 1985, CANCER SURV, V4, P399; DIEHL V, 1982, CANCER TREAT REP, V66, P615; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Janas MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002330; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Mader A, 2007, CYTOGENET GENOME RES, V119, P204, DOI 10.1159/000112062; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Pawlicki JM, 2009, CELL CYCLE, V8, P345, DOI 10.4161/cc.8.3.7494; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; SCHAADT M, 1980, INT J CANCER, V26, P723, DOI 10.1002/ijc.2910260605; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; TWEEDDALE ME, 1987, BLOOD, V69, P1307; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang T, 2008, LEUKEMIA, V22, P1795, DOI 10.1038/leu.2008.62	60	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76647	10.1371/journal.pone.0076647	http://dx.doi.org/10.1371/journal.pone.0076647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073292	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000102
J	Wysocka-Kapcinska, M; Torocsik, B; Turiak, L; Tsaprailis, G; David, CL; Hunt, AM; Vekey, K; Adam-Vizi, V; Kucharczyk, R; Chinopoulos, C				Wysocka-Kapcinska, Monika; Torocsik, Beata; Turiak, Lilla; Tsaprailis, George; David, Cynthia L.; Hunt, Andrea M.; Vekey, Karoly; Adam-Vizi, Vera; Kucharczyk, Roza; Chinopoulos, Christos			The Suppressor of AAC2 Lethality SAL1 Modulates Sensitivity of Heterologously Expressed Artemia ADP/ATP Carrier to Bongkrekate in Yeast	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ADENINE-NUCLEOTIDE TRANSLOCASE; TANDEM MASS-SPECTROMETRY; BEEF-HEART MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; ATP SYNTHASE; FRANCISCANA EMBRYOS; CALCIUM UNIPORTER; OXIDATIVE STRESS; PROTEIN	The ADP/ATP carrier protein (AAC) expressed in Artemia franciscana is refractory to bongkrekate. We generated two strains of Saccharomyces cerevisiae where AAC1 and AAC3 were inactivated and the AAC2 isoform was replaced with Artemia AAC containing a hemagglutinin tag (ArAAC-HA). In one of the strains the suppressor of Delta AAC2 lethality, SAL1, was also inactivated but a plasmid coding for yeast AAC2 was included, because the ArAAC Delta sal1 Delta strain was lethal. In both strains ArAAC-HA was expressed and correctly localized to the mitochondria. Peptide sequencing of ArAAC expressed in Artemia and that expressed in the modified yeasts revealed identical amino acid sequences. The isolated mitochondria from both modified strains developed 85% of the membrane potential attained by mitochondria of control strains, and addition of ADP yielded bongkrekate-sensitive depolarizations implying acquired sensitivity of ArAAC-mediated adenine nucleotide exchange to this poison, independent from SAL1. However, growth of ArAAC-expressing yeasts in glycerol-containing media was arrested by bongkrekate only in the presence of SAL1. We conclude that the mitochondrial environment of yeasts relying on respiratory growth conferred sensitivity of ArAAC to bongkrekate in a SAL1-dependent manner.	[Wysocka-Kapcinska, Monika; Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, H-1085 Budapest, Hungary; [Turiak, Lilla; Vekey, Karoly] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Organ Chem, Budapest, Hungary; [Tsaprailis, George; David, Cynthia L.; Hunt, Andrea M.] Univ Arizona, Coll Pharm, Ctr Toxicol, Tucson, AZ 85721 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Arizona	Kucharczyk, R (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	roza@ibb.waw.pl; chinopoulos.christos@eok.sote.hu	Kucharczyk, Roza/H-8154-2012	Chinopoulos, Christos/0000-0003-0183-4149; Kucharczyk, Roza/0000-0002-8712-7535; Tsaprailis, George/0000-0003-1239-2358; Adam-Vizi, Vera/0000-0002-8350-8701; Torocsik, Beata/0000-0002-9838-3710	National Science Centre of Poland [1932/B/P01/2010/39]; Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division [95003]; Orszagos Tudomanyos Kutatasi Alapprogram [NNF 78905, NNF2 85658, K 100918]; European Community grant ASSEMBLE [227799]; OTKA [81983, 83857]; MTA grants; NIEHS [ES06694]; NIH/NCI [CA023074]; BIO5 Institute of the University of Arizona; NIH/NCRR [1S10 RR028868-01]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Science Centre of Poland(National Science Centre, Poland); Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division; Orszagos Tudomanyos Kutatasi Alapprogram; European Community grant ASSEMBLE; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA grants; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Centre of Poland nr 1932/B/P01/2010/39 to R.K., Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division grant 95003 and the Orszagos Tudomanyos Kutatasi Alapprogram grants NNF 78905, NNF2 85658, and K 100918 and the European Community grant ASSEMBLE (project agreement no. 227799, BKA binding on ANT) to C.C, OTKA 81983 and MTA grants to V.A.-V., and OTKA grant 83857 to K.V. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the AZCC and by the BIO5 Institute of the University of Arizona. The Thermo Fisher LTQ Orbitrap Velos mass spectrometer was provided by grant 1S10 RR028868-01 from NIH/NCRR to G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo I, 2013, J BIOL CHEM, V288, P7791, DOI 10.1074/jbc.M112.409144; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; AQUILA H, 1978, EUR J BIOCHEM, V85, P549, DOI 10.1111/j.1432-1033.1978.tb12270.x; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Clegg JS, 1997, J EXP BIOL, V200, P467; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Csaba K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039839; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guerin B, 1979, Methods Enzymol, V55, P149; Hamazaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019250; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151; HENDERSON PJ, 1970, BIOCHEMISTRY-US, V9, P3453, DOI 10.1021/bi00819a026; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KEMP A JR, 1970, Biochimica et Biophysica Acta, V223, P460, DOI 10.1016/0005-2728(70)90210-0; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konrad C, 2011, FEBS J, V278, P822, DOI 10.1111/j.1742-4658.2010.08001.x; KRAMER R, 1977, BIOCHEMISTRY-US, V16, P4954; Kucejova B, 2008, MOL GENET GENOMICS, V280, P25, DOI 10.1007/s00438-008-0342-5; KWAST KE, 1993, AM J PHYSIOL, V265, pR1238, DOI 10.1152/ajpregu.1993.265.6.R1238; Laco J, 2010, FEMS YEAST RES, V10, P290, DOI 10.1111/j.1567-1364.2010.00606.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUQUIN G, 1973, FEBS LETT, V35, P198, DOI 10.1016/0014-5793(73)80283-2; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2323, DOI 10.1021/bi00656a012; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491; Menze MA, 2005, AM J PHYSIOL-REG I, V289, pR68, DOI 10.1152/ajpregu.00844.2004; Ozohanics O, 2012, J CHROMATOGR A, V1259, P200, DOI 10.1016/j.chroma.2012.05.031; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parvin R, 1969, METHODS ENZYMOL, P16; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Reynolds JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P366, DOI 10.1086/420950; RICKEY TM, 1986, MOL CELL BIOL, V6, P488, DOI 10.1128/MCB.6.2.488; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Szabadkai G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00140; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; WOLDEGIORGIS G, 1985, J BIOL CHEM, V260, P7585; Zheleznova NN, 2012, PHYSIOL GENOMICS, V44, P829, DOI 10.1152/physiolgenomics.00060.2012	63	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74187	10.1371/journal.pone.0074187	http://dx.doi.org/10.1371/journal.pone.0074187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073201	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324768000010
J	Lam, MHY; Emili, A				Lam, Mandy H. Y.; Emili, Andrew			Ubp2 Regulates Rsp5 Ubiquitination Activity In Vivo and In Vitro	PLOS ONE			English	Article							RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME UBP2; MULTIVESICULAR BODY PATHWAY; AMINO-ACID PERMEASE; PROTEIN LIGASE; MEMBRANE-PROTEINS; ENDOCYTOSIS; FAMILY; ITCH	The yeast HECT-family E3 ubiquitin ligase Rsp5 has been implicated in diverse cell functions. Previously, we and others [1,2] reported the physical and functional interaction of Rsp5 with the deubiquitinating enzyme Ubp2, and the ubiquitin associated (UBA) domain-containing cofactor Rup1. To investigate the mechanism and significance of the Rsp5-Rup1-Ubp2 complex, we examined Rsp5 ubiquitination status in the presence or absence of these cofactors. We found that, similar to its mammalian homologues, Rsp5 is auto-ubiquitinated in vivo. Association with a substrate or Rup1 increased Rsp5 self-ubiquitination, whereas Ubp2 efficiently deubiquitinates Rsp5 in vivo and in vitro. The data reported here imply an auto-modulatory mechanism of Rsp5 regulation common to other E3 ligases.	[Lam, Mandy H. Y.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Emili, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada.	andrew.emili@utoronto.ca			Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships; University of Toronto Open Fellowships	Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Toronto Open Fellowships	This work was supported by funds from the Protein Engineering Network Centre of Excellence of Canada (PENCE) to A. E., and Ontario Graduate Scholarships and University of Toronto Open Fellowships to M.H.Y.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RT, 1992, J BIOL CHEM, V267, P23364; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jarmoszewicz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039582; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kus B, 2005, J BIOL CHEM, V280, P29470, DOI 10.1074/jbc.M502197200; Lam MHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004259; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Macdonald C, 2011, TRAFFIC; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Marchenko ND, 2009, CELL DEATH DIFFER; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	55	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75372	10.1371/journal.pone.0075372	http://dx.doi.org/10.1371/journal.pone.0075372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069405	gold, Green Submitted, Green Published			2022-12-25	WOS:000324777300074
J	Ho, CH; Yu, HJ; Wang, CY; Jaw, FS; Hsieh, JT; Liao, WC; Pu, YS; Liu, SP				Ho, Chen-Hsun; Yu, Hong-Jeng; Wang, Chih-Yuan; Jaw, Fu-Shan; Hsieh, Ju-Ton; Liao, Wan-Chung; Pu, Yeong-Shiau; Liu, Shih-Ping			Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; IMPAIRED FASTING GLUCOSE; POSTPRANDIAL BLOOD-GLUCOSE; TYPE-2 DIABETES-MELLITUS; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; OLDER MEN; ANDROGEN DEFICIENCY; CARDIOVASCULAR EVENTS; SERUM TESTOSTERONE	Objective: The association between type 2 diabetes and low testosterone has been well recognized. However, testosterone levels in men with prediabetes have been rarely reported. We aimed to investigate whether prediabetes was associated with an increased risk of testosterone deficiency. Methods: This study included 1,306 men whose sex hormones was measured during a medical examination. Serum total testosterone and sex hormone-binding globulin were measured; free and bioavailable testosterone concentrations were calculated by Vermeulen's formula. Prediabetes was defined by impaired fasting glucose (IFG), impaired postprandial glucose (IPG), or glycated hemoglobin (HbA1c) 5.7%-6.4%. Logistic regression was performed to obtain the odds ratios (OR) for subnormal total testosterone (<300 ng/dL) or free testosterone (<6 ng/dL) in prediabetic and diabetic men compared with normoglycemic individuals, while adjusting for age, BMI, waist circumference, and metabolic syndrome (MetS). Results: Normoglycemia, prediabetes, and diabetes were diagnosed in 577 (44.2%), 543 (41.6%), and 186 (14.2%) men, respectively. Prediabetes was associated with an increased risk of subnormal total testosterone compared to normoglycemic individuals (age-adjusted OR=1.87; 95%CI=1.38-2.54). The risk remained significant in all multivariate analyses. After adjusting for MetS, the OR in prediabetic men equals that of diabetic patients (1.49 versus 1.50). IFG, IPG, and HbA1c 5.7%-6.4% were all associated with an increased risk of testosterone deficiency, with different levels of significance in multivariate analyses. However, neither prediabetes nor diabetes was associated with subnormal free testosterone in multivariate analyses. Conclusions: Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and MetS. After adjusting for MetS, the risk equals that of diabetes. Our data suggest that testosterone should be measured routinely in men with prediabetes.	[Ho, Chen-Hsun] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Ho, Chen-Hsun; Yu, Hong-Jeng; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Ho, Chen-Hsun; Yu, Hong-Jeng; Wang, Chih-Yuan; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Wang, Chih-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Liao, Wan-Chung] Natl Taiwan Univ Hosp, Hlth Management Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Liu, SP (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	spliu@ntuh.gov.tw		WANG, CHIH-YUAN/0000-0002-6742-3935; YU, HONG-JENG/0000-0003-3287-5736; Ho, Chen-Hsun/0000-0002-8706-7464; HSIEH, JU-TON/0000-0001-7545-8487; PU, YEONG-SHIAU/0000-0002-2859-3966; LIU, SHIH-PING/0000-0002-8015-0695				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Avogaro A, 2011, DIABETES CARE, V34, P2333, DOI 10.2337/dc11-1442; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; Basu R, 2013, J CLIN ENDOCR METAB, V98, pE409, DOI 10.1210/jc.2012-3056; Bergman M, 2013, ENDOCRINE, V43, P504, DOI 10.1007/s12020-012-9830-9; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Cichosz SL, 2013, DIABETES TECHNOL THE, V15, P78, DOI 10.1089/dia.2012.0199; Corona G, 2012, J SEX MED, V9, P1669, DOI 10.1111/j.1743-6109.2012.02717.x; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Haffner SM, 1996, AM J EPIDEMIOL, V143, P889; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164/jandrol.108.007005; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakshman KM, 2010, J GERONTOL A-BIOL, V65, P503, DOI 10.1093/gerona/glq002; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Meyer C, 2006, DIABETES CARE, V29, P1909, DOI 10.2337/dc06-0438; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; ONAT A, 2011, ACTA DIABETOL, DOI DOI 10.1007/S00592-011-0313-X.PUBMED:21769500; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Saukkonen T, 2011, DIABETES CARE, V34, P2314, DOI 10.2337/dc11-0183; SIMON D, 1992, DIABETOLOGIA, V35, P173, DOI 10.1007/BF00402551; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tsai EC, 2004, DIABETES CARE, V27, P861, DOI 10.2337/diacare.27.4.861; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; Yeap BB, 2009, EUR J ENDOCRINOL, V161, P591, DOI 10.1530/EJE-09-0348	43	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74173	10.1371/journal.pone.0074173	http://dx.doi.org/10.1371/journal.pone.0074173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069277	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100088
J	Sasaki, T; Hwang, H; Nguyen, C; Kloner, RA; Kahn, M				Sasaki, Tomoyo; Hwang, Hyosook; Cu Nguyen; Kloner, Robert A.; Kahn, Michael			The Small Molecule Wnt Signaling Modulator ICG-001 Improves Contractile Function in Chronically Infarcted Rat Myocardium	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; CARDIAC PROGENITOR CELLS; EPICARDIUM-DERIVED CELLS; EMBRYONIC STEM-CELLS; BINDING-PROTEIN; MOUSE EPICARDIUM; CATENIN PATHWAY; SELF-RENEWAL; HEART; FIBROSIS	The adult mammalian heart has limited capability for self-repair after myocardial infarction. Therefore, therapeutic strategies that improve post-infarct cardiac function are critically needed. The small molecule ICG-001 modulates Wnt signaling and increased the expression of genes beneficial for cardiac regeneration in epicardial cells. Lineage tracing experiments, demonstrated the importance of beta-catenin/p300 mediated transcription for epicardial progenitor contribution to the myocardium. Female rats given ICG-001 for 10 days post-occlusion significantly improved ejection fraction by 8.4%, compared to controls (P<0.05). Taken together, Wnt modulation via beta-catenin/CBP inhibition offers a promising therapeutic strategy towards restoration of myocardial tissues and an enhancement of cardiac functions following infarction.	[Sasaki, Tomoyo; Cu Nguyen; Kahn, Michael] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Hwang, Hyosook; Kloner, Robert A.] Good Samaritan Hosp, Inst Heart, Los Angeles, CA USA; [Kloner, Robert A.] Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Los Angeles, CA 90033 USA; [Kahn, Michael] Univ So Calif, Norris Comprehens Canc Res Ctr, Los Angeles, CA USA; [Hwang, Hyosook] Chonbuk Natl Univ, Med Sch & Hosp, Dept Nucl Med, Jeonju, Jeonbuk, South Korea	University of Southern California; University of Southern California; University of Southern California; Jeonbuk National University	Kahn, M (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	kahnm@usc.edu			University of Southern California; Heart Institute of Good Samaritan Hospital	University of Southern California; Heart Institute of Good Samaritan Hospital	This study was supported by funding from the University of Southern California and the Heart Institute of Good Samaritan Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Dai WD, 2010, METHODS MOL BIOL, V660, P99, DOI 10.1007/978-1-60761-705-1_7; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Daskalopoulos EP, 2012, TRENDS CARDIOVASC ME; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; el-Khoueiry A., 2013, J CLIN ONC ABSTR, V31, P2501, DOI DOI 10.1200/jco.2013.31.15_suppl.2501; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gravning J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052120; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Horb ME, 1999, DEVELOPMENT, V126, P1739; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2011, NAT MED; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lim MJ, 2013, PROG CARDIOVASC DIS, V55, P504, DOI 10.1016/j.pcad.2013.01.003; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Lukaszewicz AI, 2010, J MED CHEM, V53, P3439, DOI 10.1021/jm901361d; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Singh AM, 2007, CIRCULATION, V115, P617, DOI 10.1161/CIRCULATIONAHA.106.642298; Singla DK, 2010, J CARDIOVASC TRANSL, V3, P73, DOI 10.1007/s12265-009-9151-4; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Vieira JM, 2011, HEART, V97, P15, DOI 10.1136/hrt.2010.193292; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Yao M, 2003, J MOL CELL CARDIOL, V35, P661, DOI 10.1016/S0022-2828(03)00098-1; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105; Zhou B, 2008, REGEN MED, V3, P633, DOI 10.2217/17460751.3.5.633; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	63	41	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75010	10.1371/journal.pone.0075010	http://dx.doi.org/10.1371/journal.pone.0075010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069374	gold, Green Published, Green Submitted			2022-12-25	WOS:000326240100118
J	Tan, MHE; Zhou, XE; Soon, FF; Li, XD; Li, J; Yong, EL; Melcher, K; Xu, HE				Tan, M. H. Eileen; Zhou, X. Edward; Soon, Fen-Fen; Li, Xiaodan; Li, Jun; Yong, Eu-Leong; Melcher, Karsten; Xu, H. Eric			The Crystal Structure of the Orphan Nuclear Receptor NR2E3/PNR Ligand Binding Domain Reveals a Dimeric Auto-Repressed Conformation	PLOS ONE			English	Article							S-CONE-SYNDROME; PHOTORECEPTOR DEVELOPMENT; TRANSCRIPTIONAL REGULATION; MOLECULAR RECOGNITION; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; PROTEIN; ROD; MUTATIONS; HORMONE	Photoreceptor-specific nuclear receptor (PNR, NR2E3) is a key transcriptional regulator of human photoreceptor differentiation and maintenance. Mutations in the NR2E3-encoding gene cause various retinal degenerations, including Enhanced S-cone syndrome, retinitis pigmentosa, and Goldman-Favre disease. Although physiological ligands have not been identified, it is believed that binding of small molecule agonists, receptor desumoylation, and receptor heterodimerization may switch NR2E3 from a transcriptional repressor to an activator. While these features make NR2E3 a potential therapeutic target for the treatment of retinal diseases, there has been a clear lack of structural information for the receptor. Here, we report the crystal structure of the apo NR2E3 ligand binding domain (LBD) at 2.8 angstrom resolution. Apo NR2E3 functions as transcriptional repressor in cells and the structure of its LBD is in a dimeric auto-repressed conformation. In this conformation, the putative ligand binding pocket is filled with bulky hydrophobic residues and the activation-function-2 (AF2) helix occupies the canonical cofactor binding site. Mutations designed to disrupt either the AF2/cofactor-binding site interface or the dimer interface compromised the transcriptional repressor activity of this receptor. Together, these results reveal several conserved structural features shared by related orphan nuclear receptors, suggest that most disease-causing mutations affect the receptor's structural integrity, and allowed us to model a putative active conformation that can accommodate small ligands in its pocket.	[Tan, M. H. Eileen; Zhou, X. Edward; Soon, Fen-Fen; Li, Xiaodan; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA; [Tan, M. H. Eileen; Soon, Fen-Fen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Natl Univ Hosp, Singapore 117595, Singapore; [Li, Xiaodan] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Van Andel Res Inst,Shanghai Inst Mat Med Ctr, Shanghai 200031, Peoples R China	Van Andel Institute; National University of Singapore; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA.	Karsten.Melcher@vai.org; Eric.Xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Tan, Min/GQQ-2702-2022; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Yong, Eu-Leong/0000-0001-6511-770X	Jay and Betty Van Andel Foundation; Amway (China) Limited; National Institutes of Health [5R01DK071662-08]; National Research Foundation Singapore [NMRC/CSA/026/2011]; NUS Graduate School for Integrative Sciences Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	Jay and Betty Van Andel Foundation; Amway (China) Limited; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); NUS Graduate School for Integrative Sciences Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Jay and Betty Van Andel Foundation (HEX and KM - vai.org), Amway (China) Limited (HEX), National Institutes of Health 5R01DK071662-08 (HEX - http://projectreporter.nih.gov/project_info_description.cfm?icde=0&aid=8326720), and by the National Research Foundation Singapore under its Clinician Scientist Award (NMRC/CSA/026/2011) and administered by Singapore Ministry of Health's National Medical Research Council (E-LY). MHET is supported by a PhD scholarship from the NUS Graduate School for Integrative Sciences & Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal S, 2008, CLIN GENET, V73, P360, DOI 10.1111/j.1399-0004.2008.00963.x; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Fradot M, 2007, MOL VIS, V13, P594; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Kanda A, 2009, MOL VIS, V15, P2174; Kannabiran C, 2012, MOL VIS, V18, P1165; Kapitskaya M, 2006, ASSAY DRUG DEV TECHN, V4, P253, DOI 10.1089/adt.2006.4.253; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lam BL, 2007, AM J OPHTHALMOL, V144, P157, DOI 10.1016/j.ajo.2007.03.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; O'Brien KMB, 2004, INVEST OPHTH VIS SCI, V45, P2807, DOI 10.1167/iovs.03-1317; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pachydaki SI, 2009, ARCH OPHTHALMOL-CHIC, V127, P71, DOI 10.1001/archophthalmol.2008.534; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Qin Q, 2013, J OCUL PHARMACOL TH, V29, P298, DOI 10.1089/jop.2012.0135; Roduit R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007379; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Ruggiero A, 2012, PROTEIN PEPTIDE LETT, V19, P732, DOI 10.2174/092986612800793172; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Schorderet DF, 2009, HUM MUTAT, V30, P1475, DOI 10.1002/humu.21096; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Wolkenberg SE, 2006, BIOORG MED CHEM LETT, V16, P5001, DOI 10.1016/j.bmcl.2006.07.056; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489; Yang YP, 2010, INVEST OPHTH VIS SCI, V51, P2229, DOI 10.1167/iovs.09-4299; Zhou XE, 2011, J BIOL CHEM, V286, P2877, DOI 10.1074/jbc.M110.168740; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	70	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74359	10.1371/journal.pone.0074359	http://dx.doi.org/10.1371/journal.pone.0074359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069298	gold, Green Published, Green Submitted			2022-12-25	WOS:000326240100102
J	Villarreal, MF; Cerquetti, D; Caruso, S; Aranguren, VSL; Gerschcovich, ER; Frega, AL; Leiguarda, RC				Villarreal, Mirta F.; Cerquetti, Daniel; Caruso, Silvina; Lopez Aranguren, Violeta Schwarcz; Roldan Gerschcovich, Eliana; Lucia Frega, Ana; Leiguarda, Ramon C.			Neural Correlates of Musical Creativity: Differences between High and Low Creative Subjects	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN; PERFORMANCE; GENERATION; NETWORKS; FMRI	Previous studies of musical creativity suggest that this process involves multi-regional intra and interhemispheric interactions, particularly in the prefrontal cortex. However, the activity of the prefrontal cortex and that of the parieto-temporal regions, seems to depend on the domains of creativity that are evaluated and the task that is performed. In the field of music, only few studies have investigated the brain process of a creative task and none of them have investigated the effect of the level of creativity on the recruit networks. In this work we used magnetic resonance imaging to explore these issues by comparing the brain activities of subjects with higher creative abilities to those with lesser abilities, while the subjects improvised on different rhythmic fragments. We evaluated the products the subjects created during the fMRI scan using two musical parameters: fluidity and flexibility, and classified the subjects according to their punctuation. We examined the relation between brain activity and creativity level. Subjects with higher abilities generated their own creations based on modifications of the original rhythm with little adhesion to it. They showed activation in prefrontal regions of both hemispheres and the right insula. Subjects with lower abilities made only partial changes to the original musical patterns. In these subjects, activation was only observed in left unimodal areas. We demonstrated that the activations of prefrontal and paralimbic areas, such as the insula, are related to creativity level, which is related to a widespread integration of networks that are mainly associated with cognitive, motivational and emotional processes.	[Cerquetti, Daniel; Roldan Gerschcovich, Eliana; Leiguarda, Ramon C.] FLENI, Dept Neurol Cognit, Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Lopez Aranguren, Violeta Schwarcz] Univ Salvador, Fac Med, Buenos Aires, DF, Argentina; [Caruso, Silvina] Univ CAECE, Dept Humanidades & Ciencias Sociales, Buenos Aires, DF, Argentina; [Lucia Frega, Ana; Leiguarda, Ramon C.] Natl Acad Educ, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Villarreal, MF (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	mvillarreal@fleni.org.ar			Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina	Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina	This work was supported by the Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; CARLSSON I, 1990, SCAND J PSYCHOL, V31, P241, DOI 10.1111/j.1467-9450.1990.tb00836.x; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; Di Pietro M, 2004, NEUROPSYCHOLOGIA, V42, P868, DOI 10.1016/j.neuropsychologia.2003.12.004; DYKES M, 1976, BRIT J PSYCHIAT, V128, P50, DOI 10.1192/bjp.128.1.50; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; FORD DY, 1992, J CREATIVE BEHAV, V26, P186, DOI 10.1002/j.2162-6057.1992.tb01175.x; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Geiser E, 2009, CORTEX, V45, P93, DOI 10.1016/j.cortex.2007.09.010; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; GUILFORD JP, 1967, P NATL ACAD SCI USA, V58, P1812, DOI 10.1073/pnas.58.4.1812; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Hoppe K. D., 1990, CREATIVITY RES J, V3, P150, DOI DOI 10.1080/10400419009534348; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pressing J., 1988, GENERATIVE PROCESSES, P129, DOI DOI 10.1093/ACPROF:OSO/9780198508465.003.0007; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Simons JS, 2008, J COGNITIVE NEUROSCI, V20, P447, DOI 10.1162/jocn.2008.20036; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; TREFFINGER DJ, 1986, GIFTED CHILD QUART, V30, P15, DOI 10.1177/001698628603000103; Wager TD, 2004, AFFECT CONTROL FUNCT; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; YOUNG JG, 1985, J CREATIVE BEHAV, V19, P77, DOI 10.1002/j.2162-6057.1985.tb00640.x; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	43	23	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75427	10.1371/journal.pone.0075427	http://dx.doi.org/10.1371/journal.pone.0075427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069414	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100124
J	Billington, N; Wang, AB; Mao, J; Adelstein, RS; Sellers, JR				Billington, Neil; Wang, Aibing; Mao, Jian; Adelstein, Robert S.; Sellers, James R.			Characterization of Three Full-length Human Nonmuscle Myosin II Paralogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ATPases; Cytoskeleton; Electron Microscopy (EM); Molecular Motors; Myosin	LIGHT-CHAIN PHOSPHORYLATION; HUMAN PLATELET MYOSIN; SMOOTH-MUSCLE MYOSIN; VERTEBRATE NONMUSCLE; CELL-ADHESION; COILED-COILS; HEAD-HEAD; ACTIN; MEROMYOSIN; PURIFICATION	Nonmuscle myosin IIs (NM IIs) are a group of molecular motors involved in a wide variety of cellular processes including cytokinesis, migration, and control of cell morphology. There are three paralogs of the NM II heavy chain in humans (IIA, IIB, and IIC), each encoded by a separate gene. These paralogs are expressed at different levels according to cell type and have different roles and intracellular distributions in vivo. Most previous studies on NM II used tissue-purified protein or expressed fragments of the molecule, which presents potential drawbacks for characterizing individual paralogs of the intact protein in vitro. To circumvent current limitations and approach their native properties, we have successfully expressed and purified the three full-length human NM II proteins with their light chains, using the baculovirus/Sf9 system. The enzymatic and structural properties of the three paralogs were characterized. Although each NM II is capable of forming bipolar filaments, those formed by IIC tend to contain fewer constituent molecules than those of IIA and IIB. All paralogs adopt the compact conformation in the presence of ATP. Phosphorylation of the regulatory light chain leads to assembly into filaments, which bind to actin in the presence of ATP. The nature of interactions with actin filaments is shown with different paralogs exhibiting different actin binding behaviors under equivalent conditions. The data show that although NM IIA and IIB form filaments with similar properties, NM IIC forms filaments that are less well suited to roles such as tension maintenance within the cell.	[Billington, Neil; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Wang, Aibing; Mao, Jian; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adelstein, RS (corresponding author), NHLBI, Mol Cardiol Lab, NIH, 10 Ctr Dr,10-6C103B, Bethesda, MD 20892 USA.	Adelster@nhlbi.nih.gov; sellersj@nhlbi.nih.gov		Adelstein, Robert/0000-0002-8683-2144; Billington, Neil/0000-0003-2306-0228; WANG, AIBING/0000-0002-0470-8220	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL001786] Funding Source: NIH RePORTER	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Electron Microscopy Core Facility of the NHLBI for support, advice, and use of facilities. We also thank Mary Anne Conti for critical reading of the manuscript.	Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; BURNS CG, 1995, J CELL BIOL, V130, P605, DOI 10.1083/jcb.130.3.605; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792; COLLINS JH, 1981, J BIOL CHEM, V256, P2586; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; CRAIG R, 1977, J CELL BIOL, V75, P990, DOI 10.1083/jcb.75.3.990; DAVIS JS, 1986, BIOPHYS J, V50, P417, DOI 10.1016/S0006-3495(86)83477-4; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; JOSEPHS R, 1966, BIOCHEMISTRY-US, V5, P3474, DOI 10.1021/bi00875a013; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Jung HS, 2008, P NATL ACAD SCI USA, V105, P6022, DOI 10.1073/pnas.0707846105; KAMINER B, 1966, J MOL BIOL, V20, P391, DOI 10.1016/0022-2836(66)90070-2; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; KENDRICKJONES J, 1982, METHOD ENZYMOL, V85, P364; Kiboku T, 2013, GENES CELLS, V18, P90, DOI 10.1111/gtc.12021; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kovacs M, 2004, BIOCHEMISTRY-US, V43, P4219, DOI 10.1021/bi036007l; Kuhne W., 1864, UNTERSUCHUNGEN PROTP; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Li Y, 2008, DNA CELL BIOL, V27, P117, DOI 10.1089/dna.2007.0661; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; ONISHI H, 1984, J BIOCHEM-TOKYO, V95, P903, DOI 10.1093/oxfordjournals.jbchem.a134686; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLLARD TD, 1974, ANAL BIOCHEM, V60, P258, DOI 10.1016/0003-2697(74)90152-3; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; REISLER E, 1982, BIOCHEMISTRY-US, V21, P701, DOI 10.1021/bi00533a018; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Rosenberg MM, 2013, J BIOL CHEM, V288, P9779, DOI 10.1074/jbc.M112.430173; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SCHOLEY JM, 1982, J BIOL CHEM, V257, P7737; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	79	123	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33398	33410		10.1074/jbc.M113.499848	http://dx.doi.org/10.1074/jbc.M113.499848			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072716	Green Published, hybrid			2022-12-25	WOS:000328841700053
J	Zhang, WX; Kou, YB; Xu, JT; Cao, YL; Zhao, GL; Shao, J; Wang, H; Wang, ZX; Bao, XM; Chen, GJ; Liu, WF				Zhang, Weixin; Kou, Yanbo; Xu, Jintao; Cao, Yanli; Zhao, Guolei; Shao, Jing; Wang, Hai; Wang, Zhixing; Bao, Xiaoming; Chen, Guanjun; Liu, Weifeng			Two Major Facilitator Superfamily Sugar Transporters from Trichoderma reesei and Their Roles in Induction of Cellulase Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Fungi; Gene Transcription; Sugar Transport; Transporters; Trichoderma reesei	DEGRADING ENZYMES; TRANSFORMATION; YEAST; GENE; SYSTEM; INVOLVEMENT; EXPRESSION; SOPHOROSE; ENCODES; SENSOR	Background: The molecular mechanism underlying the regulation of cellulase production by T. reesei is unclear. Results: The absence of sugar transporter Stp1 enhanced cellulase gene induction whereas the absence of Crt1 abolished cellulase gene expression. Conclusion: Crt1 is essential in cellulase gene induction independent of intracellular sugar delivery. Significance: These data shed light on the mechanism by which T. reesei senses and transmits cellulose signal. Proper perception of the extracellular insoluble cellulose is key to initiating the rapid synthesis of cellulases by cellulolytic Trichoderma reesei. Uptake of soluble oligosaccharides derived from cellulose hydrolysis represents a potential point of control in the induced cascade. In this study, we identified a major facilitator superfamily sugar transporter Stp1 capable of transporting cellobiose by reconstructing a cellobiose assimilation system in Saccharomyces cerevisiae. The absence of Stp1 in T. reesei resulted in differential cellulolytic response to Avicel versus cellobiose. Transcriptional profiling revealed a different expression profile in the stp1 strain from that of wild-type strain in response to Avicel and demonstrated that Stp1 somehow repressed induction of the bulk of major cellulase and hemicellulose genes. Two other putative major facilitator superfamily sugar transporters were, however, up-regulated in the profiling. Deletion of one of them identified Crt1 that was required for growth and enzymatic activity on cellulose or lactose, but was not required for growth or hemicellulase activity on xylan. The essential role of Crt1 in cellulase induction did not seem to rely on its transporting activity because the overall uptake of cellobiose or sophorose by T. reesei was not compromised in the absence of Crt1. Phylogenetic analysis revealed that orthologs of Crt1 exist in the genomes of many filamentous ascomycete fungi capable of degrading cellulose. These data thus shed new light on the mechanism by which T. reesei senses and transmits the cellulose signal and offers potential strategies for strain improvement.	[Zhang, Weixin; Kou, Yanbo; Xu, Jintao; Cao, Yanli; Zhao, Guolei; Wang, Zhixing; Bao, Xiaoming; Chen, Guanjun; Liu, Weifeng] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Shao, Jing; Wang, Hai] Qingdao Vland Biotech Grp Co Ltd, Qingdao 266061, Shandong, Peoples R China	Shandong University	Liu, WF (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	weifliu@sdu.edu.cn	Xu, Jintao/D-8308-2018	Xu, Jintao/0000-0002-9946-8601	National Basic Research Program of China [2011CB707402]; National Natural Science Foundation [31270116, 31300059]; New Century Excellent Talents in University [NCET-10-0546]; Shandong Provincial Funds for Distinguished Young Scientists [JQ201108]; Independent Innovation Foundation of Shandong University [2012GN021]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shandong Provincial Funds for Distinguished Young Scientists; Independent Innovation Foundation of Shandong University	This work was supported by National Basic Research Program of China Grant 2011CB707402, National Natural Science Foundation Grants 31270116 and 31300059, New Century Excellent Talents in University Grant NCET-10-0546, Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201108, and Independent Innovation Foundation of Shandong University Grant 2012GN021.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; FRITSCHER C, 1990, EXP MYCOL, V14, P405, DOI 10.1016/0147-5975(90)90063-Y; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRUBER F, 1990, CURR GENET, V18, P447, DOI 10.1007/BF00309915; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; KUBICEK CP, 1993, J BIOL CHEM, V268, P19364; KUBICEK CP, 1988, J GEN MICROBIOL, V134, P1215; KUBICEK CP, 1993, ENZYME MICROB TECH, V15, P90, DOI 10.1016/0141-0229(93)90030-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MACH RL, 1995, MOL MICROBIOL, V16, P687, DOI 10.1111/j.1365-2958.1995.tb02430.x; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Porciuncula JD, 2013, BIOSCI BIOTECH BIOCH, V77, P1014, DOI 10.1271/bbb.120992; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Sambrook J., 2001, MOL CLONING LAB MANU, p[18, 54]; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; SZAKMARY K, 1991, J GEN MICROBIOL, V137, P2873, DOI 10.1099/00221287-137-12-2873; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VAHERI MP, 1979, EUR J APPL MICROBIOL, V8, P73, DOI 10.1007/BF00510268; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie X, 2004, FUNGAL GENET BIOL, V41, P1104, DOI 10.1016/j.fgb.2004.08.009; Zhou QX, 2012, EUKARYOT CELL, V11, P1371, DOI 10.1128/EC.00170-12; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	35	101	108	6	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32861	32872		10.1074/jbc.M113.505826	http://dx.doi.org/10.1074/jbc.M113.505826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085297	Green Published, hybrid			2022-12-25	WOS:000328841700005
J	Jia, HL; Li, JS; Zhu, JG; Fan, TT; Qian, D; Zhou, YL; Wang, JJ; Ren, HY; Xiang, Y; An, LZ				Jia, Honglei; Li, Jisheng; Zhu, Jingen; Fan, Tingting; Qian, Dong; Zhou, Yuelong; Wang, Jiaojiao; Ren, Haiyun; Xiang, Yun; An, Lizhe			Arabidopsis CROLIN1, a Novel Plant Actin-binding Protein, Functions in Cross-linking and Stabilizing Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; Cell Polarity; Plant; Plant Biochemistry; CROLIN1; Actin-cross-linking Protein; Novel Actin-binding Protein	II FORMIN FH5; POLLEN GERMINATION; MICROTUBULES; ORGANIZATION; CYTOSKELETON; GROWTH; HISACTOPHILIN; INTERACTS; DYNAMICS; ENCODES	Higher order actin filament structures are necessary for cytoplasmic streaming, organelle movement, and other physiological processes. However, the mechanism by which the higher order cytoskeleton is formed in plants remains unknown. In this study, we identified a novel actin-cross-linking protein family (named CROLIN) that is well conserved only in the plant kingdom. There are six isovariants of CROLIN in the Arabidopsis genome, with CROLIN1 specifically expressed in pollen. In vitro biochemical analyses showed that CROLIN1 is a novel actin-cross-linking protein with binding and stabilizing activities. Remarkably, CROLIN1 can cross-link actin bundles into actin networks. CROLIN1 loss of function induces pollen germination and pollen tube growth hypersensitive to latrunculin B. All of these results demonstrate that CROLIN1 may play an important role in stabilizing and remodeling actin filaments by binding to and cross-linking actin filaments.	[Jia, Honglei; Li, Jisheng; Zhu, Jingen; Fan, Tingting; Qian, Dong; Zhou, Yuelong; Xiang, Yun; An, Lizhe] Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China; [Wang, Jiaojiao; Ren, Haiyun] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing 100875, Peoples R China; [Wang, Jiaojiao; Ren, Haiyun] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Lanzhou University; Beijing Normal University; Beijing Normal University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn; lizhean@lzu.edu.cn	; Yang, Xiaoming/GRJ-9483-2022	Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954200]; National Natural Science Foundation of China [31270326, 30800079]; Fundamental Research Funds for the Central Universities [lzujbky-2013-94]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program Grant 2014CB954200, National Natural Science Foundation of China Grants 31270326 and 30800079, and Fundamental Research Funds for the Central Universities Grant lzujbky-2013-94 (to Y. X.).	Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Deeks MJ, 2010, J CELL SCI, V123, P1209, DOI 10.1242/jcs.065557; Fan TT, 2013, PLANT CELL REP, V32, P149, DOI 10.1007/s00299-012-1349-2; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Grazi E, 1997, FEBS LETT, V405, P249, DOI 10.1016/S0014-5793(97)00214-7; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Hussey PJ, 2002, PHILOS T R SOC B, V357, P791, DOI 10.1098/rstb.2002.1086; Ikawa T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018101; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Li YH, 2010, PLANT CELL, V22, P2710, DOI 10.1105/tpc.110.075507; Liu CS, 2002, PROTEIN SCI, V11, P669, DOI 10.1110/ps.31702; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; MEAGHER RB, 1994, ARABIDOPSIS, P1049; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Pintsch T, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-10; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Ren HY, 2007, PROTOPLASMA, V230, P171, DOI 10.1007/s00709-006-0231-x; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Tholl S, 2011, FEBS LETT, V585, P1821, DOI 10.1016/j.febslet.2011.05.019; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; Wang HJ, 2008, PLANT PHYSIOL, V147, P1619, DOI 10.1104/pp.108.118604; Whippo CW, 2011, CURR BIOL, V21, P59, DOI 10.1016/j.cub.2010.11.059; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Xue XH, 2011, MOL PLANT, V4, P264, DOI 10.1093/mp/ssq085; Yang WB, 2011, PLANT CELL, V23, P661, DOI 10.1105/tpc.110.081802; Ye JR, 2009, PLANT CELL, V21, P3868, DOI 10.1105/tpc.109.068700; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2011, NEW PHYTOL, V190, P667, DOI 10.1111/j.1469-8137.2010.03632.x; Zhang Z, 2011, PLANT CELL, V23, P681, DOI 10.1105/tpc.110.081349; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546	43	29	31	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32277	32288		10.1074/jbc.M113.483594	http://dx.doi.org/10.1074/jbc.M113.483594			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072702	hybrid, Green Published			2022-12-25	WOS:000328681700015
J	Campos, AH; Vassallo, J; Soares, FA				Campos, Antonio Hugo; Vassallo, Jose; Soares, Fernando Augusto			Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NITRIC-OXIDE SYNTHASES; MEMBRANE-PROTEIN 1; MATRIX METALLOPROTEINASES; DISEASE; CANCER; ICAM-1; ACTIVATION; INFECTION; PREDICTS	Previous studies have investigated the prognostic relevance of MMP9 in classical Hodgkin lymphoma (cHL), with negative results. However, we have found that MMP9 immunoistochemical expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in a subset of young adult Brazilian patients diagnosed with cHL. Additionally, we have observed that MMP9 expression by neoplastic cells in cHL is associated with EBV positivity. These results may support a rational basis for additional studies on the role of this metalloproteinase as a target for therapy in classical Hodgkin lymphoma.	[Campos, Antonio Hugo; Vassallo, Jose; Soares, Fernando Augusto] AC Camargo Canc Care Ctr, Dept Anat Pathol, Sao Paulo, Brazil; [Vassallo, Jose] Univ Estadual Campinas, Fac Med Sci, Lab Invest & Mol Pathol CIPED, Campinas, SP, Brazil	A.C.Camargo Cancer Center; Universidade Estadual de Campinas	Campos, AH (corresponding author), AC Camargo Canc Care Ctr, Dept Anat Pathol, Sao Paulo, Brazil.	ahcampos@hcancer.org.br	VASSALLO, JOSE/AAP-4600-2021; Campos, Antonio Hugo/AAB-9287-2019	VASSALLO, JOSE/0000-0002-2192-4865; Campos, Antonio Hugo/0000-0001-5322-7549; Soares, Fernando Augusto/0000-0003-1647-7842; Soares, Fernando/0000-0002-1212-9093	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/02183-1]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant #06/02183-1, www.fapesp.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred V, 2008, LEUKEMIA LYMPHOMA, V49, P2198, DOI 10.1080/10428190802239170; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Benson HL, 2011, AM J RESP CELL MOL, V44, P700, DOI 10.1165/rcmb.2010-0125OC; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; CHRISTIANSEN I, 1995, LEUKEMIA LYMPHOMA, V19, P243, DOI 10.3109/10428199509107894; Creighton Chad, 2003, In Silico Biology, V3, P301; Cunha IW, 2006, APPL IMMUNOHISTO M M, V14, P404, DOI 10.1097/01.pai.0000190175.98576.a3; Diehl Volker, 2003, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2003.1.225; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Flavell JR, 2000, J CLIN PATHOL-MOL PA, V53, P145, DOI 10.1136/mp.53.3.145; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gulley ML, 2002, AM J CLIN PATHOL, V117, P259; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kuittinen O, 2002, EUR J HAEMATOL, V69, P205, DOI 10.1034/j.1600-0609.2002.02751.x; Raffo D, 2011, CURR PHARM BIOTECHNO, V12, P1937, DOI 10.2174/138920111798377085; Rassidakis GZ, 2002, BLOOD, V100, P3935, DOI 10.1182/blood.V100.12.3935; Re D, 2005, BLOOD, V105, P4553, DOI 10.1182/blood-2004-12-4750; Sakata K, 2004, CANCER, V100, P356, DOI 10.1002/cncr.11905; Schmitz R, 2009, ANNU REV PATHOL-MECH, V4, P151, DOI 10.1146/annurev.pathol.4.110807.092209; Soares A, 2007, INT J CANCER, V120, P875, DOI 10.1002/ijc.22417; Souza EM, 2012, MED ONCOL, V29, P2148, DOI 10.1007/s12032-011-0063-1; Syrigos KN, 2004, ANTICANCER RES, V24, P1243; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; Uchihara JN, 2006, INT J CANCER, V118, P1098, DOI 10.1002/ijc.21427; Vassallo J, 2001, HAEMATOLOGICA, V86, P1227; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Wang BQ, 2011, J CANCER RES CLIN, V137, P1525, DOI 10.1007/s00432-011-1010-4; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74793	10.1371/journal.pone.0074793	http://dx.doi.org/10.1371/journal.pone.0074793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086377	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200017
J	Dammermann, W; Schipper, P; Ullrich, S; Fraedrich, K; zur Wiesch, JS; Frundt, T; Tiegs, G; Lohse, A; Luth, S				Dammermann, Werner; Schipper, Pim; Ullrich, Sebastian; Fraedrich, Katharina; zur Wiesch, Julian Schulze; Fruendt, Thorben; Tiegs, Gisa; Lohse, Ansgar; Lueth, Stefan			Increased Expression of Complement Regulators CD55 and CD59 on Peripheral Blood Cells in Patients with EAHEC O104:H4 Infection	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HEMOLYTIC-UREMIC SYNDROME; INHIBITOR ECULIZUMAB; GENE-EXPRESSION; T-CELLS; ANEMIA; ERYTHROCYTES; IMMUNITY; DEFICIENCY; ACTIVATION	Background: An outbreak of Shiga Toxin 2 (Stx-2) producing enterohemorrhagic and enteroaggregative E. coli (EAHEC) O104H4 infection in May 2011 caused enterocolitis and an unprecedented high 22% rate of hemolytic uremic syndrome (HUS). The monoclonal anti-C5 antibody Eculizumab (ECU) has been used experimentally in EAHEC patients with HUS but treatment efficacy is uncertain. ECU can effectively prevent hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) caused by a lack of complement-regulating CD55 and CD59 on blood cells. We hypothesized a low expression of CD55 and CD59, as seen in PNH, might correlate with HUS development in EAHEC patients. Methods: 76 EAHEC patients (34 only gastrointestinal symptoms [GI], 23: HUS, 19: HUS and neurological symptoms [HUS/N]) and 12 healthy controls (HC) were tested for the expression of CD55 and CD59 on erythrocytes and leukocytes retrospectively. Additionally, the effect of Stx-2 on CD55 and CD59 expression on erythrocytes and leukocytes was studied ex vivo. Results: CD55 expression on erythrocytes was similar in all patient groups and HC while CD59 showed a significantly higher expression in HUS and HUS/N patients compared to HC and the GI group. CD55 and CD59 expression on leukocytes and their subsets was significantly higher in all patient groups compared to HC regardless of treatment type. However, CD59 expression on erythrocytes was significantly higher in HUS and HUS/N patients treated combined with plasma separation (PS) and ECU compared to HC. Adding Stx-2 ex vivo had no effect on CD55 and CD59 expression on leukocytes from HC or patients. Conclusion: HUS evolved independently from CD55 and CD59 expression on peripheral blood cells in EAHEC O104:H4 infected patients. Our data do not support a role for CD55 and CD59 in HUS development during EAHEC O104:H4 infection and point to a different mechanism within the complement system for HUS development in EAHEC patients.	[Dammermann, Werner; Schipper, Pim; Fraedrich, Katharina; zur Wiesch, Julian Schulze; Fruendt, Thorben; Lohse, Ansgar; Lueth, Stefan] Univ Med Ctr Eppendorf, Dept Med, Hamburg, Germany; [Ullrich, Sebastian] Univ Med Ctr Eppendorf, Dept Anat & Expt Morphol, Hamburg, Germany; [Tiegs, Gisa] Univ Med Ctr Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Luth, S (corresponding author), Univ Med Ctr Eppendorf, Dept Med, Hamburg, Germany.	s.lueth@uke.de	Wiesch, Julian Schulze zur/AAT-8452-2021; Dammermann, Werner/G-5811-2016; Dammermann, Werner/GZN-1268-2022	Dammermann, Werner/0000-0001-6847-3769; Luth, Stefan/0000-0001-9946-0960	German Federal Ministry of Health; Deutsche Forschungsgemeinschaft (DFG) [LU 1362/2-1 581069]	German Federal Ministry of Health; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study is funded by the German Federal Ministry of Health and the Deutsche Forschungsgemeinschaft (DFG), grant # LU 1362/2-1 581069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MMO, 2009, TRANSFUSION, V49, P154, DOI 10.1111/j.1537-2995.2008.01936.x; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Geelen J, 2008, NEPHROL DIAL TRANSPL, V23, P3091, DOI 10.1093/ndt/gfn244; German EHEC-HUS registry, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI [10.1093/ndt/gfr462, DOI 10.1093/NDT/GFR462]; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Gwamaka M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-386; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kavanagh D, 2007, MOL IMMUNOL, V44, P3162, DOI 10.1016/j.molimm.2007.01.036; Kawamoto Y, 1997, IMMUNOLOGY, V91, P7, DOI 10.1046/j.1365-2567.1997.00188.x; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Mahajan RC, 2011, INDIAN J MED RES, V133, P662; Mahtout H, 2011, FEMS IMMUNOL MED MIC, V62, P295, DOI 10.1111/j.1574-695X.2011.00813.x; Martin BK, 2007, IMMUNOL RES, V39, P146, DOI 10.1007/s12026-007-0078-z; Matthes T, 2002, TRANSFUSION, V42, P1448, DOI 10.1046/j.1537-2995.2002.00214.x; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; Pettigrew HD, 2009, ANN NY ACAD SCI, V1173, P108, DOI 10.1111/j.1749-6632.2009.04633.x; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Robert Koch Institute, 2012, FIN PRES EV EP FIND; Ruiz-Arguelles A, 2007, AUTOIMMUN REV, V6, P155, DOI 10.1016/j.autrev.2006.09.008; Stahl AL, 2011, BLOOD, V117, P5503, DOI 10.1182/blood-2010-09-309161; Stoute JA, 2003, J INFECT DIS, V187, P522, DOI 10.1086/367712; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; TAGUCHI R, 1990, FEBS LETT, V261, P142, DOI 10.1016/0014-5793(90)80656-4; Terpos E, 2008, MED SCI MONITOR, V14, pCR276; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Wiesner J, 1997, EUR J IMMUNOL, V27, P2708, DOI 10.1002/eji.1830271034; WILCOX LA, 1991, BLOOD, V78, P820, DOI 10.1182/blood.V78.3.820.bloodjournal783820	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74880	10.1371/journal.pone.0074880	http://dx.doi.org/10.1371/journal.pone.0074880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086391	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200049
J	Surbanovski, N; Sargent, DJ; Else, MA; Simpson, DW; Zhang, HM; Grant, OM				Surbanovski, Nada; Sargent, Daniel J.; Else, Mark A.; Simpson, David W.; Zhang, Hanma; Grant, Olga M.			Expression of Fragaria vesca PIP Aquaporins in Response to Drought Stress: PIP Down-Regulation Correlates with the Decline in Substrate Moisture Content	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; MAJOR INTRINSIC PROTEINS; WATER TRANSPORT; GENE FAMILY; HYDRAULIC CONDUCTIVITY; PLANT AQUAPORINS; ROOT PRESSURE; LEAF GROWTH; ARABIDOPSIS; CONDUCTANCE	PIP aquaporin responses to drought stress can vary considerably depending on the isoform, tissue, species or level of stress; however, a general down-regulation of these genes is thought to help reduce water loss and prevent backflow of water to the drying soil. It has been suggested therefore, that it may be necessary for the plant to limit aquaporin production during drought stress, but it is unknown whether aquaporin down-regulation is gradual or triggered by a particular intensity of the stress. In this study, ten Fragaria PIP genes were identified from the woodland strawberry (Fragaria vesca L.) genome sequence and characterised at the sequence level. The water relations of F. vesca were investigated and the effect of different intensities of drought stress on the expression of four PIP genes, as well as how drought stress influences their diurnal transcription was determined. PIP down-regulation in the root corresponded to the level of drought stress. Moreover, transcript abundance of two genes highly expressed in the root (FvPIP1;1 and FvPIP2;1) was strongly correlated to the decline in substrate moisture content. The amplitude of diurnal aquaporin expression in the leaves was down-regulated by drought without altering the pattern, but showing an intensity-dependent effect. The results show that transcription of PIP aquaporins can be fine-tuned with the environment in response to declining water availability.	[Surbanovski, Nada; Sargent, Daniel J.] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Trentino, Italy; [Surbanovski, Nada; Else, Mark A.; Simpson, David W.] East Malling Res, East Malling, Kent, England; [Zhang, Hanma] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Grant, Olga M.] Univ Coll Dublin, Univ Coll Dublin Forestry, Dublin 2, Ireland	Fondazione Edmund Mach; University of Leeds; University College Dublin	Surbanovski, N (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Trentino, Italy.	nada.surbanovski@fmach.it	Sargent, Daniel James/A-2933-2014	Sargent, Daniel James/0000-0002-6686-7147	East Malling Trust for Horticultural Research; Autonomous Province of Trento, Italy	East Malling Trust for Horticultural Research; Autonomous Province of Trento, Italy(Autonomous Province of Trento)	This work was funded by the East Malling Trust for Horticultural Research. DJS acknowledges funding for Applied Rosaceous Genomics from the Autonomous Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Alleva K, 2010, J EXP BOT, V61, P3935, DOI 10.1093/jxb/erq210; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Beaudette PC, 2007, J EXP BOT, V58, P1291, DOI 10.1093/jxb/erl289; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Cochard H, 2007, PLANT PHYSIOL, V143, P122, DOI 10.1104/pp.106.090092; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; FOWLER J, 1992, PRACTICAL STAT FIELD; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2008, PLANT MOL BIOL, V68, P337, DOI 10.1007/s11103-008-9373-x; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Henzler T, 1999, PLANTA, V210, P50, DOI 10.1007/s004250050653; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knight CD, 2002, PRACT APPROACH SER, V259, P285; Knipfer T, 2010, NEW PHYTOL, V187, P159, DOI 10.1111/j.1469-8137.2010.03240.x; Kramer P.J., 1983, WATER RELATIONS PLAN; Kramer P.J., 1995, WATER RELATIONS PLAN; Lopez M, 2003, PLANT CELL PHYSIOL, V44, P1384, DOI 10.1093/pcp/pcg168; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; MacRobbie EAC, 2006, P NATL ACAD SCI USA, V103, P1135, DOI 10.1073/pnas.0510023103; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Mut P, 2008, PHYSIOL PLANTARUM, V132, P538, DOI 10.1111/j.1399-3054.2007.01046.x; Nardini A, 2005, PLANT CELL ENVIRON, V28, P750, DOI 10.1111/j.1365-3040.2005.01320.x; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakurai-Ishikawa J, 2011, PLANT CELL ENVIRON, V34, P1150, DOI 10.1111/j.1365-3040.2011.02313.x; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Secchi F, 2007, ANN APPL BIOL, V150, P163, DOI 10.1111/j.1744-7348.2007.00118.x; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sugaya S, 2003, ACTA HORTIC, P363, DOI 10.17660/ActaHortic.2003.618.42; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tardieu F, 2010, PLANT CELL ENVIRON, V33, P636, DOI 10.1111/j.1365-3040.2009.02091.x; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415	60	34	37	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74945	10.1371/journal.pone.0074945	http://dx.doi.org/10.1371/journal.pone.0074945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086403	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200058
J	Cong, HL; Ning, D; Tian, HC; Yang, Y; Zhang, W; Zhang, H; Zhang, WL; Song, L; Tien, P				Cong Haolong; Ning Du; Tian Hongchao; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang; Song Lei; Tien Po			Enterovirus 71 VP1 Activates Calmodulin-Dependent Protein Kinase II and Results in the Rearrangement of Vimentin in Human Astrocyte Cells	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; VIRAL INTERACTIONS; CLINICAL-FEATURES; VIRUS-INFECTION; PHOSPHORYLATION; CYTOSKELETON; AGGRESOMES; SITES; AUTOPHOSPHORYLATION; MICROTUBULES	Enterovirus 71 (EV71) is one of the main causative agents of foot, hand and mouth disease. Its infection usually causes severe central nervous system diseases and complications in infected infants and young children. In the present study, we demonstrated that EV71 infection caused the rearrangement of vimentin in human astrocytoma cells. The rearranged vimentin, together with various EV71 components, formed aggresomes-like structures in the perinuclear region. Electron microscopy and viral RNA labeling indicated that the aggresomes were virus replication sites since most of the EV71 particles and the newly synthesized viral RNA were concentrated here. Further analysis revealed that the vimentin in the virus factories was serine-82 phosphorylated. More importantly, EV71 VP1 protein is responsible for the activation of calmodulin-dependent protein kinase II (CaMK-II) which phosphorylated the N-terminal domain of vimentin on serine 82. Phosphorylation of vimentin and the formation of aggresomes were required for the replication of EV71 since the latter was decreased markedly after phosphorylation was blocked by KN93, a CaMK-II inhibitor. Thus, as one of the consequences of CaMK-II activation, vimentin phosphorylation and rearrangement may support virus replication by playing a structural role for the formation of the replication factories. Collectively, this study identified the replication centers of EV71 in human astrocyte cells. This may help us understand the replication mechanism and pathogenesis of EV71 in human.	[Cong Haolong; Ning Du; Tian Hongchao; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang; Song Lei; Tien Po] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Ning Du; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tien, P (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	tienpo@sun.im.ac.cn			National Basic Research Program of China (973 Program) [2011CB504703, 2010CB530102]; National Natural Science Foundation of China (NSFC) [81021003, 31270211]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the grants from the National Basic Research Program of China (973 Program, Nos. 2011CB504703 and 2010CB530102) and the National Natural Science Foundation of China (NSFC, Grant Nos. 81021003 and 31270211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; AZUMI N, 1987, AM J CLIN PATHOL, V88, P286, DOI 10.1093/ajcp/88.3.286; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Dohner K, 2005, CURR TOP MICROBIOL, V285, P67; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FERREIRA LRL, 1994, ARCH VIROL, V138, P273; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hanson LK, 2009, J VIROL, V83, P7449, DOI 10.1128/JVI.00325-09; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; HOOGHEPETERS EL, 1979, J VIROL, V29, P666, DOI 10.1128/JVI.29.2.666-676.1979; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Irvine EE, 2006, TRENDS NEUROSCI, V29, P459, DOI 10.1016/j.tins.2006.06.009; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; MURTI KG, 1983, J CELL BIOL, V96, P1248, DOI 10.1083/jcb.96.5.1248; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; OKERBLOM C, 1983, J VIROL, V46, P964, DOI 10.1128/JVI.46.3.964-973.1983; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vyboh K, 2012, JOVE-J VIS EXP, DOI 10.3791/4002; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407	48	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73900	10.1371/journal.pone.0073900	http://dx.doi.org/10.1371/journal.pone.0073900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073199	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000008
J	Murray, SE				Murray, Susan E.			Cell-Intrinsic Role for NF-kappa B-Inducing Kinase in Peripheral Maintenance but Not Thymic Development of Foxp3(+) Regulatory T Cells in Mice	PLOS ONE			English	Article							C-REL; RECEPTOR; DIFFERENTIATION; ACTIVATION; EXPRESSION; EFFECTOR; ALYMPHOPLASIA; AUTOIMMUNITY; NF-KAPPA-B2; INDUCTION	NF-kappa B inducing kinase (NIK, MAP3K14) is a key signaling molecule in non-canonical NF-kappa B activation, and NIK deficient mice have been instrumental in deciphering the immunologic role of this pathway. Global ablation of NIK prevents lymph node development, impairs thymic stromal development, and drastically reduces B cells. Despite altered thymic selection, T cell numbers are near normal in NIK deficient mice. The exception is CD4(+) regulatory T cells (Tregs), which are reduced in the thymus and periphery. Defects in thymic stroma are known to contribute to impaired Treg generation, but whether NIK also plays a cell intrinsic role in Tregs is unknown. Here, we compared intact mice with single and mixed BM chimeric mice to assess the intrinsic role of NIK in Treg generation and maintenance. We found that while NIK expression in stromal cells suffices for normal thymic Treg development, NIK is required cell-intrinsically to maintain peripheral Tregs. In addition, we unexpectedly discovered a cell-intrinsic role for NIK in memory phenotype conventional T cells that is masked in intact mice, but revealed in BM chimeras. These results demonstrate a novel role for NIK in peripheral regulatory and memory phenotype T cell homeostasis.	Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University	Murray, SE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	murrays@ohsu.edu		Murray, Susan/0000-0002-6470-3827	National Institutes of Health [AI077032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077032, R01AI092080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (http://www.nih.gov/) grant number AI077032 to David C. Parker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lu LF, 2005, J IMMUNOL, V175, P1651, DOI 10.4049/jimmunol.175.3.1651; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Rowe AM, 2013, J IMMUNOL IN PRESS; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Tamura C, 2006, AUTOIMMUNITY, V39, P445, DOI 10.1080/08916930600833390; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76216	10.1371/journal.pone.0076216	http://dx.doi.org/10.1371/journal.pone.0076216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073289	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000099
J	Nakano, M; Nishihara, M; Yoshioka, H; Takahashi, H; Sawasaki, T; Ohnishi, K; Hikichi, Y; Kiba, A				Nakano, Masahito; Nishihara, Masahiro; Yoshioka, Hirofumi; Takahashi, Hirotaka; Sawasaki, Tatsuya; Ohnishi, Kouhei; Hikichi, Yasufumi; Kiba, Akinori			Suppression of DS1 Phosphatidic Acid Phosphatase Confirms Resistance to Ralstonia solanacearum in Nicotiana benthamiana	PLOS ONE			English	Article							PHOSPHOLIPASE-D ACTIVITY; POWDERY MILDEW; DIACYLGLYCEROL PYROPHOSPHATE; DISEASE RESISTANCE; DEFENSE RESPONSES; SACCHAROMYCES-CEREVISIAE; PENETRATION RESISTANCE; SIGNAL-TRANSDUCTION; MOLECULAR-PATTERNS; LIPID-METABOLISM	Nicotiana benthamiana is susceptible to Ralstonia solanacearum. To analyze molecular mechanisms for disease susceptibility, we screened a gene-silenced plant showing resistance to R. solanacearum, designated as DS1 (Disease suppression 1). The deduced amino acid sequence of DS1 cDNA encoded a phosphatidic acid phosphatase (PAP) 2. DS1 expression was induced by infection with a virulent strain of R. solanacearum in an hrp-gene-dependent manner. DS1 rescued growth defects of the temperature-sensitive Delta lpp1 Delta dpp1 Delta pah1 mutant yeast. Recombinant DS1 protein showed Mg2+-independent PAP activity. DS1 plants showed reduced PAP activity and increased phosphatidic acid (PA) content. After inoculation with R. solanacearum, DS1 plants showed accelerated cell death, over-accumulation of reactive oxygen species (ROS), and hyper-induction of PR-4 expression. In contrast, DS1-overexpressing tobacco plants showed reduced PA content, greater susceptibility to R. solanacearum, and reduced ROS production and PR-4 expression. The DS1 phenotype was partially compromised in the plants in which both DS1 and NbCoi1 or DS1 and NbrbohB were silenced. These results show that DS1 PAP may affect plant immune responses related to ROS and JA cascades via regulation of PA levels. Suppression of DS1 function or DS1 expression could rapidly activate plant defenses to achieve effective resistance against Ralstonia solanacearum.	[Nakano, Masahito; Hikichi, Yasufumi; Kiba, Akinori] Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan; [Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Cell Free Sci & Technol Res Ctr, Div Proteomed Sci, Matsuyama, Ehime, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan	Kochi University; Iwate Biotechnology Research Center; Nagoya University; Ehime University; Kochi University	Kiba, A (corresponding author), Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan.	akiba@kochi-u.ac.jp	Nakano, Masahito/AAA-8370-2020; Ohnishi, Kouhei/AAN-9527-2020	Nakano, Masahito/0000-0002-2842-0977; Sawasaki, Tatsuya/0000-0002-7952-0556; Nishihara, Masahiro/0000-0002-1454-8785	Ministry of Education, Culture, Sports, Science and Technology, Japan [16780031, 18780029, 15028214, 16380037]; Asahi Glass Foundation;  [25-7248]; Grants-in-Aid for Scientific Research [25117719] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid for Scientific Research to AK (16780031 and 18780029) and YH (15028214 and 16380037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. AK is also grateful for financial support from the Asahi Glass Foundation. Grant-in-Aid for Japan Society for the Promotion of Science Fellows M. Nakano (25-7248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai S, 2011, J GEN PLANT PATHOL, V77, P152, DOI 10.1007/s10327-011-0304-3; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanda A, 2003, MOL PLANT MICROBE IN, V16, P447, DOI 10.1094/MPMI.2003.16.5.447; Kanda Ayami, 2003, Journal of General Plant Pathology, V69, P250, DOI 10.1007/s10327-003-0041-3; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kiba A, 2006, MOL PLANT MICROBE IN, V19, P112, DOI 10.1094/MPMI-19-0112; Kiba A, 2003, PLANT CELL PHYSIOL, V44, P287, DOI 10.1093/pcp/pcg037; Kiba A, 2007, PLANT BIOTECHNOL-NAR, V24, P409, DOI 10.5511/plantbiotechnology.24.409; Kiba A, 2012, J PLANT PHYSIOL, V169, P1017, DOI 10.1016/j.jplph.2012.04.002; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Koo SC, 2009, MOL CELLS, V27, P563, DOI 10.1007/s10059-009-0081-4; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Liu YL, 2004, PLANT J, V38, P800, DOI 10.1111/j.1365-313X.2004.02085.x; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Maimbo M, 2010, PLANT PHYSIOL, V152, P2023, DOI 10.1104/pp.109.148189; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1998, PLANTA, V207, P133, DOI 10.1007/s004250050465; MUNNIK T, 1994, PLANTA, V193, P89, DOI 10.1007/BF00191611; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Rathjen JP, 2003, CURR OPIN PLANT BIOL, V6, P300, DOI 10.1016/S1369-5266(03)00057-8; Ryu SB, 1996, BBA-LIPID LIPID MET, V1303, P243, DOI 10.1016/0005-2760(96)00096-3; RYU SB, 1995, PLANT PHYSIOL, V108, P713, DOI 10.1104/pp.108.2.713; Sang YM, 2001, PLANT PHYSIOL, V126, P1449, DOI 10.1104/pp.126.4.1449; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Testerink C, 2008, PLANT SIGNAL BEHAV, V3, P681, DOI 10.4161/psb.3.9.5814; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	62	36	37	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75124	10.1371/journal.pone.0075124	http://dx.doi.org/10.1371/journal.pone.0075124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073238	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000047
J	Bello, JP; Modrono, C; Marcano, F; Gonzalez-Mora, JL				Plata Bello, Julio; Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose			Observation of Simple Intransitive Actions: The Effect of Familiarity	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; THUMB OPPOSITION TASK; FUNCTIONAL-ANATOMY; CORTICAL ACTIVITY; MOTOR; MOVEMENTS; FMRI; EXECUTION; RECOGNITION; MODULATION	Introduction: Humans are more familiar with index - thumb than with any other finger to thumb grasping. The effect of familiarity has been previously tested with complex, specialized and/or transitive movements, but not with simple intransitive ones. The aim of this study is to evaluate brain activity patterns during the observation of simple and intransitive finger movements with differing degrees of familiarity. Methodology: A functional Magnetic Resonance Imaging (fMRI) study was performed using a paradigm consisting of the observation of 4 videos showing a finger opposition task between the thumb and the other fingers (index, middle, ring and little) in a repetitive manner with a fixed frequency (1 Hz). This movement is considered as the pantomime of a precision grasping action. Results: Significant activity was identified in the bilateral Inferior Parietal Lobule and premotor regions with the selected level of significance (FDR [False Discovery Rate] = 0.01). The extent of the activation in both regions tended to decrease when the finger that performed the action was further from the thumb. More specifically, this effect showed a linear trend (index>middle>ring>little) in the right parietal and premotor regions. Conclusions: The observation of less familiar simple intransitive movements produces less activation of parietal and premotor areas than familiar ones. The most important implication of this study is the identification of differences in brain activity during the observation of simple intransitive movements with different degrees of familiarity.	[Plata Bello, Julio; Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose] Univ La Laguna, Fac Med, Dept Physiol, San Cristobal La Laguna, Spain; [Plata Bello, Julio] Hosp Univ Canarias, Dept Neurosurg, Santa Cruz de Tenerife, Spain; [Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose] Univ La Laguna, SRMIB, San Cristobal La Laguna, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Bello, JP (corresponding author), Univ La Laguna, Fac Med, Dept Physiol, San Cristobal La Laguna, Spain.	jplata5@hotmail.com	Modroño, Cristián/M-1985-2014; González-Mora, José Luis/L-6100-2014; Marcano, Francisco J/I-1723-2015; Modrono, Cristian/N-6378-2019	Modroño, Cristián/0000-0001-5623-8681; González-Mora, José Luis/0000-0001-8920-1375; Marcano, Francisco J/0000-0003-3310-4722; 	Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2008-06867-C02-01/TIN, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2010-346]; Gobierno de Canarias [SolSubC200801000142]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Industria, Turismo y Comercio(Spanish Government); Gobierno de Canarias	Financial support was provided by the following national public projects: Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2008-06867-C02-01/TIN, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2010-346]; and Gobierno de Canarias [SolSubC200801000142]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chen X K, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1877; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Faillenot I, 1991, CEREB CORTEX, V7, P77; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gemignani A, 2004, ARCH ITAL BIOL, V142, P1; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kollias SS, 2001, BRAIN RES REV, V36, P185, DOI 10.1016/S0165-0173(01)00094-7; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Lui F, 2008, SOC NEUROSCI-UK, V3, P261, DOI 10.1080/17470910701458551; Matsumura M, 1996, NEUROREPORT, V7, P749, DOI 10.1097/00001756-199602290-00017; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008034; Van Vaerenbergh J, 2001, J REHABIL MED, V33, P256; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844	33	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74485	10.1371/journal.pone.0074485	http://dx.doi.org/10.1371/journal.pone.0074485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073213	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000022
J	Prochnow, H; Gollan, R; Rohne, P; Hassemer, M; Koch-Brandt, C; Baiersdorfer, M				Prochnow, Hans; Gollan, Rene; Rohne, Philipp; Hassemer, Matthias; Koch-Brandt, Claudia; Baiersdoerfer, Markus			Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; BREAST-CANCER CELLS; NUCLEAR CLUSTERIN; CLUSTERIN/APOLIPOPROTEIN-J; APOLIPOPROTEIN-J; GENE-EXPRESSION; CYTOPROTECTIVE CHAPERONE; OXIDATIVE STRESS; EPITHELIAL-CELLS; GROWTH-FACTOR	Clusterin, also known as apolipoprotein J, is expressed from a variety of tissues and implicated in pathological disorders such as neurodegenerative diseases, ischemia and cancer. In contrast to secretory clusterin (sCLU), which acts as an extracellular chaperone, the synthesis, subcellular localization and function(s) of intracellular CLU isoforms is currently a matter of intense discussion. By investigating human CLU mRNAs we here unravel mechanisms leading to the synthesis of distinct CLU protein isoforms and analyze their subcellular localization and their impact on apoptosis and on NF-kappa B-activity. Quantitative PCR-analyses revealed the expression of four different stress-inducible CLU mRNA variants in non-cancer and cancer cell lines. In all cell lines variant 1 represents the most abundant mRNA, whereas all other variants collectively account for no more than 0.34% of total CLU mRNA, even under stressed conditions. Overexpression of CLU cDNAs combined with in vitro mutagenesis revealed distinct translational start sites including a so far uncharacterized non-canonical CUG start codon. We show that all exon 2-containing mRNAs encode sCLU and at least three non-glycosylated intracellular isoforms, CLU1-449, CLU21-449 and CLU34-449, which all reside in the cytosol of unstressed and stressed HEK-293 cells. The latter is the only form expressed from an alternatively spliced mRNA variant lacking exon 2. Functional analysis revealed that none of these cytosolic CLU forms modulate caspase-mediated intrinsic apoptosis or significantly affects TNF-alpha-induced NF-kappa B-activity. Therefore our data challenge some of the current ideas regarding the physiological functions of CLU isoforms in pathologies.	[Prochnow, Hans; Rohne, Philipp; Hassemer, Matthias; Koch-Brandt, Claudia; Baiersdoerfer, Markus] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Gollan, Rene] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Neurol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Baiersdorfer, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	mbaiersdoerfer@gmx.de						Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Baiersdorfer M, 2010, EXP CELL RES, V316, P3489, DOI 10.1016/j.yexcr.2010.07.022; Balantinou E, 2009, FREE RADICAL BIO MED, V46, P1267, DOI 10.1016/j.freeradbiomed.2009.01.025; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Bhutia SK, 2012, J CELL PHYSIOL, V227, P1805, DOI 10.1002/jcp.22904; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Caccamo AE, 2006, J CELL PHYSIOL, V207, P208, DOI 10.1002/jcp.20561; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHOI I, 2013, EXP CELL RES; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dumont P, 2002, CELL STRESS CHAPERON, V7, P23, DOI 10.1379/1466-1268(2002)007<0023:OOAJIH>2.0.CO;2; Essabbani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054920; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hamada N, 2011, J ATHEROSCLER THROMB, V18, P209, DOI 10.5551/jat.5819; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Leskov KS, 2011, J BIOL CHEM, V286, P40083, DOI 10.1074/jbc.M111.252957; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Miyake H, 2004, PROSTATE, V61, P318, DOI 10.1002/pros.20087; Moretti RM, 2007, CANCER RES, V67, P10325, DOI 10.1158/0008-5472.CAN-07-0516; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Redondo M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1835; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rizzi F, 2009, ADV CANCER RES, V104, P9, DOI 10.1016/S0065-230X(09)04002-0; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, CANCER RES, V64, P6174, DOI 10.1158/0008-5472.CAN-04-0920; Schepeler Troels, 2007, J Mol Signal, V2, P6, DOI 10.1186/1750-2187-2-6; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; So A, 2005, MOL CANCER THER, V4, P1837, DOI 10.1158/1535-7163.MCT-05-0178; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2005, FREE RADICAL BIO MED, V38, P436, DOI 10.1016/j.freeradbiomed.2004.10.038; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; van Dijk A, 2010, EUR J CLIN INVEST, V40, P893, DOI 10.1111/j.1365-2362.2010.02345.x; Viard I, 1999, J INVEST DERMATOL, V112, P290, DOI 10.1046/j.1523-1747.1999.00531.x; Wei L, 2009, INT J CANCER, V125, P791, DOI 10.1002/ijc.24316; WONG P, 1994, EUR J BIOCHEM, V221, P917, DOI 10.1111/j.1432-1033.1994.tb18807.x; Xue J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035848; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	70	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75303	10.1371/journal.pone.0075303	http://dx.doi.org/10.1371/journal.pone.0075303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073260	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000069
J	Rodriguez-Hernandez, I; Garcia, JL; Santos-Briz, A; Hernandez-Lain, A; Gonzalez-Valero, JM; Gomez-Moreta, JA; Toldos-Gonzalez, O; Cruz, JJ; Martin-Vallejo, J; Gonzalez-Sarmiento, R				Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Hernandez-Lain, Aurelio; Maria Gonzalez-Valero, Jose; Antonio Gomez-Moreta, Juan; Toldos-Gonzalez, Oscar; Jesus Cruz, Juan; Martin-Vallejo, Javier; Gonzalez-Sarmiento, Rogelio			Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; HMSH2 PROTEIN EXPRESSION; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; PROMOTER METHYLATION; GLIOBLASTOMA-MULTIFORME; ADJUVANT TEMOZOLOMIDE; BRAIN-TUMORS; GLIOMAS; MLH1	Malignant astrocytomas are the most aggressive primary brain tumors with a poor prognosis despite optimal treatment. Dysfunction of mismatch repair (MMR) system accelerates the accumulation of mutations throughout the genome causing uncontrolled cell growth. The aim of this study was to characterize the MMR system defects that could be involved in malignant astrocytoma pathogenesis. We analyzed protein expression and promoter methylation of MLH1, MSH2 and MSH6 as well as microsatellite instability (MSI) and MMR gene mutations in a set of 96 low-and high-grade astrocytomas. Forty-one astrocytomas failed to express at least one MMR protein. Loss of MSH2 expression was more frequent in low-grade astrocytomas. Loss of MLH1 expression was associated with MLH1 promoter hypermethylation and MLH1 -93G>A promoter polymorphism. However, MSI was not related with MMR protein expression and only 5% of tumors were MSI-High. Furthermore, the incidence of tumors carrying germline mutations in MMR genes was low and only one glioblastoma was associated with Lynch syndrome. Interestingly, survival analysis identified that tumors lacking MSH6 expression presented longer overall survival in high-grade astrocytoma patients treated only with radiotherapy while MSH6 expression did not modify the prognosis of those patients treated with both radiotherapy and chemotherapy. Our findings suggest that MMR system alterations are a frequent event in malignant astrocytomas and might help to define a subgroup of patients with different outcome.	[Rodriguez-Hernandez, Irene; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Dept Med, Mol Med Unit, E-37008 Salamanca, Spain; [Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Maria Gonzalez-Valero, Jose; Jesus Cruz, Juan; Gonzalez-Sarmiento, Rogelio] USAL CSIC Univ Hosp, IBMCC, Salamanca, Spain; [Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Maria Gonzalez-Valero, Jose; Jesus Cruz, Juan; Gonzalez-Sarmiento, Rogelio] USAL CSIC Univ Hosp, IBSAL, Salamanca, Spain; [Luis Garcia, Juan; Maria Gonzalez-Valero, Jose] Inst Hlth Sci Studies Castilla & Leon, Salamanca, Spain; [Santos-Briz, Angel] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain; [Hernandez-Lain, Aurelio; Toldos-Gonzalez, Oscar] Univ Hosp 12 Octubre, Dept Pathol, Madrid, Spain; [Antonio Gomez-Moreta, Juan] Univ Hosp Salamanca, Dept Neurosurg, Salamanca, Spain; [Jesus Cruz, Juan] Univ Hosp Salamanca, Dept Oncol, Salamanca, Spain; [Martin-Vallejo, Javier] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Hospital Universitario 12 de Octubre; University of Salamanca; University of Salamanca	Gonzalez-Sarmiento, R (corresponding author), Univ Salamanca, Dept Med, Mol Med Unit, E-37008 Salamanca, Spain.	gonzalez@usal.es	Vallejo, Francisco Javier F J Martin/B-4029-2012; Santos-Briz, Ángel/AAS-4156-2021; Lain, Aurelio Hernandez/S-6172-2018; Gonzalez-Sarmiento, Rogelio/V-5526-2019; Santos-Briz, Ángel/AFR-7833-2022; garcia, Juan/B-4617-2017	Vallejo, Francisco Javier F J Martin/0000-0003-3962-7356; Lain, Aurelio Hernandez/0000-0003-1642-4505; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; garcia, Juan/0000-0002-2146-5726; Cruz Hernandez, Juan Jesus/0000-0003-1980-2751; Rodriguez-Hernandez, Irene/0000-0002-6487-452X	Fondo de Investigacion Sanitaria [FIS PI 10/00219]; Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL; Junta de Castilla y Leon y Fondo Social Europeo [Orden EDU/330/2008]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL; Junta de Castilla y Leon y Fondo Social Europeo	This work was supported by Fondo de Investigacion Sanitaria (FIS PI 10/00219), Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL and Junta de Castilla y Leon y Fondo Social Europeo (Orden EDU/330/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Alldinger I, 2007, J CANCER RES CLIN, V133, P749, DOI 10.1007/s00432-007-0220-2; Arita M, 2003, GENE, V306, P57, DOI 10.1016/S0378-1119(03)00385-8; Barnetson RA, 2008, HUM MUTAT, V29, P367, DOI 10.1002/humu.20635; Belvederesi L, 2006, EUR J HUM GENET, V14, P853, DOI 10.1038/sj.ejhg.5201628; Boland CR, 1998, CANCER RES, V58, P5248; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Capel E, 2007, ONCOGENE, V26, P7596, DOI 10.1038/sj.onc.1210581; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DeAngelis LM, 2009, J CLIN ONCOL, V27, P5861, DOI 10.1200/JCO.2009.24.5985; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Hussein MR, 2006, INT J EXP PATHOL, V87, P297, DOI 10.1111/j.1365-2613.2006.00482.x; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kastrinos F, 2012, J CLIN ONCOL, V30, P1024, DOI 10.1200/JCO.2011.40.7171; Koornstra JJ, 2009, LANCET ONCOL, V10, P400, DOI 10.1016/S1470-2045(09)70041-5; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; Maxwell JA, 2008, CLIN CANCER RES, V14, P4859, DOI 10.1158/1078-0432.CCR-07-4807; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mrkonjic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013314; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Rass K, 2001, HISTOCHEM J, V33, P459, DOI 10.1023/A:1014472314354; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Schleinitz D, 2011, METHODS MOL BIOL, V700, P77, DOI 10.1007/978-1-61737-954-3_6; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shahi A, 2011, NUCLEIC ACIDS RES, V39, P2130, DOI 10.1093/nar/gkq1095; Srivastava T, 2004, J NEURO-ONCOL, V66, P51, DOI 10.1023/B:NEON.0000013482.99032.b0; Stark AM, 2010, NEUROL RES, V32, P816, DOI 10.1179/016164110X12645013515052; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Viana-Pereira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020588; Viana-Pereira M, 2009, NEURO-ONCOLOGY, V11, P458, DOI 10.1215/15228517-2008-115; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Wehming FM, 2012, CLIN NEUROL NEUROSUR, V114, P617, DOI 10.1016/j.clineuro.2011.12.024; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	52	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76401	10.1371/journal.pone.0076401	http://dx.doi.org/10.1371/journal.pone.0076401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073290	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000100
J	Schijf, MA; Kerperien, J; Bastiaans, J; Szklany, K; Meerding, J; Hofman, G; Boon, L; van Wijk, F; Garssen, J; van't Land, B				Schijf, Marcel A.; Kerperien, Joann; Bastiaans, Jacqueline; Szklany, Kirsten; Meerding, Jenny; Hofman, Gerard; Boon, Louis; van Wijk, Femke; Garssen, Johan; van't Land, Belinda			Alterations in Regulatory T Cells Induced by Specific Oligosaccharides Improve Vaccine Responsiveness in Mice	PLOS ONE			English	Article							VIRUS-INFECTION; RESPONSES; HOMEOSTASIS; REG; BET	Prophylactic vaccinations are generally performed to protect nave individuals with or without suppressed immune responsiveness. In a mouse model for Influenza vaccinations the specific alterations of CD4(+)CD25(+)Foxp3(+) regulatory T-cells (Tregs) in the immune modulation induced by orally supplied oligosaccharides containing scGOS/lcFOS/pAOS was assessed. This dietary intervention increased vaccine specific DTH responses. In addition, a significant increased percentage of T-bet(+) (Th1) activated CD69(+)CD4(+) T cells (p<0.001) and reduced percentage of Gata-3(+) (Th2) activated CD69(+)CD4(+) T cells (p<0.001) was detected in the mesenteric lymph nodes (MLN) of mice receiving scGOS/lcFOS/pAOS compared to control mice. Although no difference in the number or percentage of Tregs (CD4(+)Foxp3(+)) could be determined after scGOS/lcFOS/pAOS intervention, the percentage of CXCR3(+)/T-bet(+) (Th1-Tregs) was significantly reduced (p<0.05) in mice receiving scGOS/lcFOS/pAOS as compared to mice receiving placebo diets. Moreover, although no absolute difference in suppressive capacity could be detected, an alteration in cytokine profile suggests a regulatory T cell shift towards a reducing Th1 suppression profile, supporting an improved vaccination response. In conclusion: These data are indicative for improved vaccine responsiveness due to reduced Th1 suppressive capacity in the Treg population of mice fed the oligosaccharide specific diet, showing compartmentalization within the Treg population. The modulation of Tregs to control immune responses provides an additional arm of intervention using alternative strategies possibly leading to the development of improved vaccines.	[Schijf, Marcel A.; Meerding, Jenny; van Wijk, Femke; van't Land, Belinda] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands; [Schijf, Marcel A.; Bastiaans, Jacqueline; Szklany, Kirsten; Garssen, Johan; van't Land, Belinda] Nutricia Res, Dept Immunol, Utrecht, Netherlands; [Kerperien, Joann; Bastiaans, Jacqueline; Hofman, Gerard; Garssen, Johan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Boon, Louis] Bioceros, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Danone Nutricia; Utrecht University	van't Land, B (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands.	b.vantland@umcutrecht.nl	Boon, Laurence/HCI-3629-2022; Land, Belinda van't/K-2986-2012; garssen, johan/I-7159-2016	Land, Belinda van't/0000-0001-8601-5032; Boon, Louis/0000-0002-0937-9171	TIpharma	TIpharma	The work is funded by TIpharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Barnes MJ, 2009, NAT IMMUNOL, V10, P563, DOI 10.1038/ni0609-563; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Brandenburg AH, 2000, J MED VIROL, V62, P267, DOI 10.1002/1096-9071(200010)62:2&lt;267::AID-JMV20&gt;3.0.CO;2-8; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Ishikawa H, 2008, CLIN EXP IMMUNOL, V153, P127, DOI 10.1111/j.1365-2249.2008.03668.x; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schijf MA, 2012, J VIROL, V86, P11472, DOI 10.1128/JVI.06708-11; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schouten B., 2011, BR J NUTR, P1; Suchard MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011762; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Van't Land B, 2011, DIETARY COMPONENTS I; van't Land B, 2011, EUR J PHARMACOL, V668, pS101, DOI 10.1016/j.ejphar.2011.05.082; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75148	10.1371/journal.pone.0075148	http://dx.doi.org/10.1371/journal.pone.0075148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073243	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000052
J	Le Coz, C; Joublin, A; Pasquali, JL; Korganow, AS; Dumortier, H; Monneaux, F				Le Coz, Carole; Joublin, Aurelie; Pasquali, Jean-Louis; Korganow, Anne-Sophie; Dumortier, Helene; Monneaux, Fanny			Circulating T-FH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease	PLOS ONE			English	Article							INCREASED FREQUENCY; CELLS EXPRESS; BLOOD; IL-21; ERYTHEMATOSUS; CD27; POPULATION; PHENOTYPE; IGD	Follicular helper T cells (T-FH) represent a distinct subset of CD4(+) T cells specialized in providing help to B lymphocytes, which may play a central role in autoimmune diseases having a major B cell component such as systemic lupus erythematosus. Recently, T-FH subsets that share common phenotypic and functional characteristics with T-FH cells from germinal centers, have been described in the peripheral blood from healthy individuals. The aim of this study was to analyze the distribution of such populations in lupus patients. Circulating T-FH cell subsets were defined by multicolor flow cytometry as T(FH)17 (CXCR3(-)CCR6(+)), T(FH)1 (CXCR3(+) CCR6(-)) or T(FH)2 (CXCR3(-)CCR6(-)) cells among CXCR5(+) CD45RA(-)CD4(+) T cells in the peripheral blood of 23 SLE patients and 23 sex and age-matched healthy controls. IL-21 receptor expression by B cells was analyzed by flow cytometry and the serum levels of IL-21 and Igs were determined by ELISA tests. We found that the T(FH)2 cell subset frequency is strongly and significantly increased in lupus patients with an active disease (SLEDAI score>8), while the T(FH)1 cell subset percentage is greatly decreased. The T(FH)2 and T(FH)1 cell subset frequency alteration is associated with the presence of high Ig levels and autoantibodies in patient's sera. Moreover, the T(FH)2 cell subset enhancement correlates with an increased frequency of double negative memory B cells (CD27(-)IgD(-)CD19(+) cells) expressing the IL-21R. Finally, we found that IgE levels in lupus patients' sera correlate with disease activity and seem to be associated with high T(FH)2 cell subset frequency. In conclusion, our study describes for the first time the distribution of circulating T-FH cell subsets in lupus patients. Interestingly, we found an increased frequency of T(FH)2 cells, which correlates with disease activity. Our results suggest that this subset might play a key role in lupus pathogenesis.	[Le Coz, Carole; Joublin, Aurelie; Pasquali, Jean-Louis; Korganow, Anne-Sophie; Dumortier, Helene; Monneaux, Fanny] CNRS, Inst Biol Mol & Cellulaire, Lab Excellence MEDALIS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Monneaux, F (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Lab Excellence MEDALIS, F-67084 Strasbourg, France.	f.monneaux@ibmc-cnrs.unistra.fr		Korganow, Anne-Sophie/0000-0002-1664-6311; Le Coz, Carole/0000-0002-9228-5896	French Centre National de la Recherche Scientifique (CNRS); Fondation Athritis-Courtin; Hopitaux Universitaires de Strasbourg (PHRC)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation Athritis-Courtin; Hopitaux Universitaires de Strasbourg (PHRC)	This study was supported by the French Centre National de la Recherche Scientifique (CNRS), by grants from the Fondation Athritis-Courtin and from the Hopitaux Universitaires de Strasbourg (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; FENG W, 2012, PLOS ONE, V7, P51982, DOI DOI 10.1371/J0URNAL.P0NE.0051982.PUBMED:23284839; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Korganow AS, 2010, J AUTOIMMUN, V34, P426, DOI 10.1016/j.jaut.2009.11.002; Lacotte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058140; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Mazerolles F, 2013, J ALLERGY CLIN IMMUN, V131, P1146, DOI 10.1016/j.jaci.2012.12.1519; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Rodriguez-Bayona B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3042; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Stemmer C, 1997, J MOL BIOL, V273, P52, DOI 10.1006/jmbi.1997.1270; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang Xiao-Fei, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P1041; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	40	132	133	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75319	10.1371/journal.pone.0075319	http://dx.doi.org/10.1371/journal.pone.0075319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069401	gold, Green Published			2022-12-25	WOS:000324777300072
J	Xu, Z; Li, S; Li, J; Li, Y; Feng, XH; Wang, RX; Xu, H; Zhou, JH				Xu, Zheng; Li, Sha; Li, Jie; Li, Yan; Feng, Xiaohai; Wang, Renxiao; Xu, Hong; Zhou, Jiahai			The Structural Basis of Erwinia rhapontici Isomaltulose Synthase	PLOS ONE			English	Article							SUCROSE ISOMERASE; SYNTHESIZING ENZYME; PRODUCT SPECIFICITY; MECHANISM; CONVERSION; SITE; VALIDATION; PREVENTION; ALGORITHM; RESIDUES	Sucrose isomerase NX-5 from Erwinia rhapontici efficiently catalyzes the isomerization of sucrose to isomaltulose (main product) and trehalulose (by-product). To investigate the molecular mechanism controlling sucrose isomer formation, we determined the crystal structures of native NX-5 and its mutant complexes E295Q/sucrose and D241A/glucose at 1.70 angstrom, 1.70 angstrom and 2.00 angstrom, respectively. The overall structure and active site architecture of NX-5 resemble those of other reported sucrose isomerases. Strikingly, the substrate binding mode of NX-5 is also similar to that of trehalulose synthase from Pseudomonas mesoacidophila MX-45 (MutB). Detailed structural analysis revealed the catalytic RXDRX motif and the adjacent 10-residue loop of NX-5 and isomaltulose synthase PalI from Klebsiella sp. LX3 adopt a distinct orientation from those of trehalulose synthases. Mutations of the loop region of NX-5 resulted in significant changes of the product ratio between isomaltulose and trehalulose. The molecular dynamics simulation data supported the product specificity of NX-5 towards isomaltulose and the role of the loop330-339 in NX-5 catalysis. This work should prove useful for the engineering of sucrose isomerase for industrial carbohydrate biotransformations.	[Xu, Zheng; Li, Sha; Feng, Xiaohai; Xu, Hong] Nanjing Univ Technol, Coll Food Sci & Light Ind, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Zheng; Li, Jie; Li, Yan; Wang, Renxiao; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Nanjing Tech University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Xu, H (corresponding author), Nanjing Univ Technol, Coll Food Sci & Light Ind, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.	xuh@njut.edu.cn; jiahai@mail.sioc.ac.cn	Li, Yan/AAB-8280-2021		National Basic Research Program of China [2009CB724700, 2013CB733600, 2009CB918600, 2011CB710800]; National High Technology Research and Development Program of China [2012AA021503]; Specialized Research Fund for the Doctoral Program of Higher Education [20103221110006]; Program for Changjiang Scholars and Innovative Research Team in University; National Nature Science Foundation of China [21176123, 21276082]; State Key Laboratory of Material-Oriented Chemical Engineering	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Material-Oriented Chemical Engineering	This work was supported by the National Basic Research Program of China (2009CB724700 and 2013CB733600 to H. X.; 2009CB918600 and 2011CB710800 to J.Z.), the National High Technology Research and Development Program of China (2012AA021503 to H. X.), the Specialized Research Fund for the Doctoral Program of Higher Education (20103221110006 to H. X.), the Program for Changjiang Scholars and Innovative Research Team in University (to H. X.), and the National Nature Science Foundation of China (21176123 to H. X.; 21276082 to J.Z.). This work is also funded by the open grant from the State Key Laboratory of Material-Oriented Chemical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aroonnual A, 2007, ENZYME MICROB TECH, V40, P1221, DOI 10.1016/j.enzmictec.2006.09.011; BAER A, 1989, LEBENSM WISS TECHNOL, V22, P46; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case D, 2006, AMBER 9; CHEETHAM PSJ, 1982, NATURE, V299, P628, DOI 10.1038/299628a0; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho MH, 2007, BIOTECHNOL LETT, V29, P453, DOI 10.1007/s10529-006-9257-6; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRISCH M, 1990, CHEM PHYS, V141, P189, DOI 10.1016/0301-0104(90)87055-G; Gorl J, 2012, CHEMBIOCHEM, V13, P149, DOI 10.1002/cbic.201100576; Goulter KC, 2012, ENZYME MICROB TECH, V50, P57, DOI 10.1016/j.enzmictec.2011.09.011; Hamada S, 2002, PURE APPL CHEM, V74, P1293, DOI 10.1351/pac200274071293; Huang JH, 1998, J IND MICROBIOL BIOT, V21, P22, DOI 10.1038/sj.jim.2900552; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KAWAI K, 1985, ENDOCRINOL JAPON, V32, P933; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HC, 2008, APPL ENVIRON MICROB, V74, P5183, DOI 10.1128/AEM.00181-08; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li S, 2011, APPL BIOCHEM BIOTECH, V163, P52, DOI 10.1007/s12010-010-9015-z; Lichtenthaler FW, 2004, CR CHIM, V7, P65, DOI 10.1016/j.crci.2004.02.002; Lina BAR, 2002, FOOD CHEM TOXICOL, V40, P1375, DOI 10.1016/S0278-6915(02)00105-9; Lipski A, 2013, ACTA CRYSTALLOGR D, V69, P298, DOI 10.1107/S0907444912045532; Matsukubo T, 2006, INT DENT J, V56, P119; MCALLISTER M, 1990, BIOTECHNOL LETT, V12, P667, DOI 10.1007/BF01088191; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MIYATA Y, 1992, BIOSCI BIOTECH BIOCH, V56, P1680, DOI 10.1271/bbb.56.1680; NAGAI Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1789, DOI 10.1271/bbb.58.1789; NAGAIMIYATA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P2049, DOI 10.1271/bbb.57.2049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; Ren B, 2011, BIOPROC BIOSYST ENG, V34, P629, DOI 10.1007/s00449-010-0512-9; Takazoe I., 1989, PROGR SWEETENERS, P143; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Veronese T, 1998, FEBS LETT, V441, P348, DOI 10.1016/S0014-5793(98)01582-8; Veronese T, 1999, ENZYME MICROB TECH, V24, P263, DOI 10.1016/S0141-0229(98)00115-X; Wu L, 2004, J APPL MICROBIOL, V97, P93, DOI 10.1111/j.1365-2672.2004.02274.x; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8; Zhang DH, 2002, APPL ENVIRON MICROB, V68, P2676, DOI 10.1128/AEM.68.6.2676-2682.2002; Zhou X, 2011, PROTEIN PEPTIDE LETT, V18, P1028, DOI 10.2174/092986611796378774	48	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74788	10.1371/journal.pone.0074788	http://dx.doi.org/10.1371/journal.pone.0074788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069347	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300045
J	Olmedo, SB; De Vincentiis, S; De Martino, E; Bedecarras, P; Blanco, AM; Freire, A; Buffone, MG; Rey, RA				Brugo Olmedo, Santiago; De Vincentiis, Sabrina; De Martino, Evelyn; Bedecarras, Patricia; Maria Blanco, Ana; Freire, Analia; Buffone, Mariano G.; Rey, Rodolfo A.			Prediction of Reproductive Outcomes According to Different Serum Anti-Mullerian Hormone Levels in Females Undergoing Intracystoplasmic Sperm Injection	PLOS ONE			English	Article							ANTRAL FOLLICLE COUNT; INHIBITING SUBSTANCE LEVELS; POLYCYSTIC-OVARY-SYNDROME; ANTIMULLERIAN-HORMONE; STIMULATED CYCLES; TECHNOLOGY CYCLES; MENSTRUAL-CYCLE; EMBRYO QUALITY; OOCYTE QUALITY; MARKER	Background and aim of the study: Serum anti-Mullerian hormone (AMH) is a reliable marker of ovarian reserve, and it has been shown to be correlated with reproductive outcomes in grouped analyses. However, practical data is scarce for the physician and the patients to predict these outcomes in an individual couple according to serum AMH measured prior to assisted reproduction technology (ART) procedures. Study Design: To address this question, we performed an analytic observational study including 145 females undergoing intracytoplasmic sperm injection (ICSI) in a single center. Results were analyzed according to serum AMH; subgroup analyses were performed by grouping patients according to patient's age and FSH levels. Results: The risk of cycle cancelation decreased from 64% in patients with serum AMH <= 3 pmol/L (0.42 ng/mL) to 21% with AMH >= 15 pmol/L (2.10 ng/mL). Cycle cancelation occurred in approximately two-thirds of the patients with AMH <= 3 pmol/L irrespective of the FSH level. However, with higher AMH values the risk of cycle cancelation decreased more significantly in patients with normal FSH. The rate of good response increased from almost null in patients with AMH <= 3 pmol/L to 61% in those with AMH >= 15 pmol/L. The positive correlation between good response and AMH was also significant, but with lower absolute rates, when patients were grouped according to their age or FSH levels. Pregnancy rate increased moderately, but significantly, from 31% with AMH <= 3 pmol/L to 35% with AMH >= 15 pmol/L. Conclusions: We provide estimates of reproductive outcomes according to individualized values of serum AMH, in general and in subgroups according to patient's age or serum FSH, which are helpful for the clinician and the couple in their decision making about starting an assisted reproductive treatment.	[Brugo Olmedo, Santiago; De Vincentiis, Sabrina; De Martino, Evelyn; Buffone, Mariano G.] Seremas, Ctr Med, Buenos Aires, DF, Argentina; [Bedecarras, Patricia; Freire, Analia; Rey, Rodolfo A.] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, CONICET, FEI,Div Endocrinol, Buenos Aires, DF, Argentina; [Maria Blanco, Ana] Ctr Estudios Bioquim Androl & Ginecol, Buenos Aires, DF, Argentina; [Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Rey, RA (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, CONICET, FEI,Div Endocrinol, Buenos Aires, DF, Argentina.	rodolforey@cedie.org.ar	Rey, Rodolfo/E-5552-2012	Rey, Rodolfo/0000-0002-1100-3843	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially funded by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina) to cover the cost of AMH assay reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson RA, 2012, MATURITAS, V71, P28, DOI 10.1016/j.maturitas.2011.11.008; BAKER ML, 1990, J CLIN ENDOCR METAB, V70, P11, DOI 10.1210/jcem-70-1-11; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Cook CL, 2002, FERTIL STERIL, V77, P141, DOI 10.1016/S0015-0282(01)02944-2; Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1; Ebner T, 2006, HUM REPROD, V21, P2022, DOI 10.1093/humrep/del127; Fallat ME, 1997, FERTIL STERIL, V67, P962, DOI 10.1016/S0015-0282(97)81417-3; Fanchin R, 2003, HUM REPROD, V18, P328, DOI 10.1093/humrep/deg043; Feyereisen E, 2006, REPROD BIOMED ONLINE, V12, P695, DOI 10.1016/S1472-6483(10)61081-4; Fong SL, 2008, REPROD BIOMED ONLINE, V16, P664, DOI 10.1016/S1472-6483(10)60480-4; Freour T, 2007, CLIN CHIM ACTA, V375, P162, DOI 10.1016/j.cca.2006.06.013; Friden B, 2011, AUST NZ J OBSTET GYN, V51, P411, DOI 10.1111/j.1479-828X.2011.01374.x; Grinspon RP, 2012, CLIN ENDOCRINOL, V76, P698, DOI 10.1111/j.1365-2265.2011.04297.x; Hagen CP, 2010, J CLIN ENDOCR METAB, V95, P5003, DOI 10.1210/jc.2010-0930; Hazout A, 2004, FERTIL STERIL, V82, P1323, DOI 10.1016/j.fertnstert.2004.03.061; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; Hendriks DJ, 2007, FERTIL STERIL, V87, P764, DOI 10.1016/j.fertnstert.2006.11.006; HUDSON PL, 1990, J CLIN ENDOCR METAB, V70, P16, DOI 10.1210/jcem-70-1-16; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; JOSSO N, 1990, J CLIN ENDOCR METAB, V70, P23, DOI 10.1210/jcem-70-1-23; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; La Marca A, 2006, HUM REPROD, V21, P3103, DOI 10.1093/humrep/del291; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lekamge DN, 2007, REPROD BIOMED ONLINE, V14, P602, DOI 10.1016/S1472-6483(10)61053-X; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; McIlveen M, 2007, HUM REPROD, V22, P778, DOI 10.1093/humrep/del435; Muttukrishna S, 2005, BJOG-INT J OBSTET GY, V112, P1384, DOI 10.1111/j.1471-0528.2005.00670.x; Muttukrishna S, 2004, BJOG-INT J OBSTET GY, V111, P1248, DOI 10.1111/j.1471-0528.2004.00452.x; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P204, DOI 10.1016/j.rbmo.2011.05.006; Olmedo SB, 2000, ASIAN J ANDROL, V2, P125; Penarrubia J, 2005, HUM REPROD, V20, P915, DOI 10.1093/humrep/deh718; Pigny P, 2006, J CLIN ENDOCR METAB, V91, P941, DOI 10.1210/jc.2005-2076; Rey R, 2000, HUM PATHOL, V31, P1202, DOI 10.1053/hupa.2000.18498; Rey RA, 1996, AM J OBSTET GYNECOL, V174, P958, DOI 10.1016/S0002-9378(96)70333-2; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Seifer DB, 2002, FERTIL STERIL, V77, P468, DOI 10.1016/S0015-0282(01)03201-0; Silberstein T, 2006, HUM REPROD, V21, P159, DOI 10.1093/humrep/dei270; Smeenk JMJ, 2007, FERTIL STERIL, V87, P223, DOI 10.1016/j.fertnstert.2006.06.019; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; VIGIER B, 1984, ENDOCRINOLOGY, V114, P1315, DOI 10.1210/endo-114-4-1315	44	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75685	10.1371/journal.pone.0075685	http://dx.doi.org/10.1371/journal.pone.0075685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069435	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300091
J	Park, J; Munagala, I; Xu, H; Blankenship, D; Maffucci, P; Chaussabel, D; Banchereau, J; Pascual, V; Cunningham-Rundles, C				Park, Joon; Munagala, Indira; Xu, Hui; Blankenship, Derek; Maffucci, Patrick; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia; Cunningham-Rundles, Charlotte			Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency	PLOS ONE			English	Article							MEMORY B-CELLS; ANTIBODY-DEFICIENCY; IMMUNODEFICIENCY DISORDERS; TRANSCRIPTIONAL SIGNATURE; PERIPHERAL-BLOOD; EXPRESSION; MUTATIONS; PATTERNS; PATIENT; ALPHA	About half of all subjects with common variable immune deficiency (CVID) are afflicted with inflammatory complications including hematologic autoimmunity, granulomatous infiltrations, interstitial lung disease, lymphoid hyperplasia and/or gastrointestinal inflammatory disease. The pathogenesis of these conditions is poorly understood but singly and in aggregate, these lead to significantly increased (11 fold) morbidity and mortality, not experienced by CVID subjects without these complications. To explore the dysregulated networks in these subjects, we applied whole blood transcriptional profiling to 91 CVID subjects, 47 with inflammatory conditions and 44 without, in comparison to subjects with XLA and healthy controls. As compared to other CVID subjects, males with XLA or healthy controls, the signature of CVID subjects with inflammatory complications was distinguished by a marked up-regulation of IFN responsive genes. Chronic up-regulation of IFN pathways is known to occur in autoimmune disease due to activation of TLRs and other still unclarified cytoplasmic sensors. As subjects with inflammatory complications were also more likely to be lymphopenic, have reduced B cell numbers, and a greater reduction of B, T and plasma cell networks, we suggest that more impaired adaptive immunity in these subjects may lead to chronic activation of innate IFN pathways in response to environmental antigens. The unbiased use of whole blood transcriptome analysis may provides a tool for distinguishing CVID subjects who are at risk for increased morbidity and earlier mortality. As more effective therapeutic options are developed, whole blood transcriptome analyses could also provide an efficient means of monitoring the effects of treatment of the inflammatory phenotype.	[Park, Joon; Maffucci, Patrick; Cunningham-Rundles, Charlotte] Mt Sinai, Icahn Sch Med, Dept Med, New York, NY 10029 USA; [Park, Joon; Maffucci, Patrick; Cunningham-Rundles, Charlotte] Mt Sinai, Icahn Sch Med, Inst Immunol, New York, NY USA; [Munagala, Indira; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Xu, Hui; Blankenship, Derek] Baylor HealthCare Syst, Inst Hlth Care Res & Improvement, Dept Quantitat Sci, Dallas, TX USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor Scott & White Health; Benaroya Research Institute; Baylor Health Care System	Cunningham-Rundles, C (corresponding author), Mt Sinai, Icahn Sch Med, Dept Med, New York, NY 10029 USA.	Charlotte.Cunningham-Rundles@mssm.edu	Pascual, Virginia/ABD-3099-2020; Chaussabel, Damien/AAX-1909-2020	Chaussabel, Damien/0000-0002-6131-7242	National Institutes of Health [AI-101093, AI-086037, AI-48693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101093, U24AI086037, R18AI048693, P01AI061093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI-101093, AI-086037, AI-48693. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Allantaz F, 2007, CURR OPIN IMMUNOL, V19, P623, DOI 10.1016/j.coi.2007.10.003; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Ardeniz O, 2009, CLIN IMMUNOL, V133, P198, DOI 10.1016/j.clim.2009.05.001; Baldovino S, 2013, AUTOIMMUN REV, V12, P796, DOI 10.1016/j.autrev.2012.11.003; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernink J, 2013, IMMUNOL REV, V252, P133, DOI 10.1111/imr.12034; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Cunningham-Rundles C, 2001, Curr Allergy Asthma Rep, V1, P421, DOI 10.1007/s11882-001-0027-1; Cunningham-Rundles C, 2002, BLOOD REV, V16, P61, DOI 10.1054/blre.2001.0185; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Greenfest-Allen E, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-38; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hardy GA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056527, DOI 10.1371/J0URNAL.P0NE.0056527.PUBMED:23437155]; Hinze CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3061; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Kwok SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2382; Lubbers J, 2013, ANN RHEUM DIS, V72, P776, DOI 10.1136/annrheumdis-2012-202753; Marashi SM, 2012, J ALLERGY CLIN IMMUN, V129, P1349, DOI 10.1016/j.jaci.2012.02.011; Morimoto Y, 2005, CURR ALLERGY ASTHM R, V5, P370, DOI 10.1007/s11882-005-0008-x; Park JH, 2011, ANN NY ACAD SCI, V1246, P41, DOI 10.1111/j.1749-6632.2011.06338.x; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6; Shi MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041292; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wheat WH, 2005, J EXP MED, V202, P479, DOI 10.1084/jem.20050381; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Yu JE, 2012, J CLIN IMMUNOL, V32, P50, DOI 10.1007/s10875-011-9602-y; Yu JE, 2009, J ALLERGY CLIN IMMUN, V124, P349, DOI 10.1016/j.jaci.2009.05.019	62	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74893	10.1371/journal.pone.0074893	http://dx.doi.org/10.1371/journal.pone.0074893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069364	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300065
J	Jarvandi, S; Davidson, NO; Schootman, M				Jarvandi, Soghra; Davidson, Nicholas O.; Schootman, Mario			Increased Risk of Colorectal Cancer in Type 2 Diabetes Is Independent of Diet Quality	PLOS ONE			English	Article							HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; BODY-MASS INDEX; COLON-CANCER; NATIONAL-INSTITUTES; POOLED ANALYSIS; WOMENS HEALTH; MELLITUS; COHORT; METAANALYSIS	Background: Poor diet increases the risk of both colorectal cancer and type 2 diabetes. We investigated the role of diet in the association between diabetes and colorectal cancer. Methods: We analyzed data from 484,020 individuals, aged 50-71 years who participated in the prospective National Institutes of Health-AARP Diet and Health Study and were cancer free at baseline (1995-1996). History of diabetes was self-reported. Diet quality was measured with the Healthy Eating Index-2005 (HEI-2005), using a self-administered food-frequency questionnaire. Cox regression models were constructed to estimate the hazard ratios (HR) and 95% confidence intervals (CI) of first primary incident colorectal cancer, overall and by anatomical location. Results: During an average follow-up of 9.2 years, we identified 7,598 new cases of colorectal cancer. After controlling for non-dietary confounders, diabetes was associated with increased risk of colorectal cancer (HR 1.27, 95% CI: 1.18, 1.36). Further adjustment for diet quality did not attenuate this association. Diabetes was associated with a HR of 1.23 (95% CI: 1.07, 1.40) in individuals with good diet (quartile 4 of HEI-2005) and 1.58 (95% CI: 1.34, 1.86) in those with poor diet (quartile 1 of HEI-2005), compared to those with no diabetes and good diet. Moreover, diabetes was associated with a stronger risk of proximal than distal colon cancer (HR: 1.33 vs. HR: 1.20), while poor diet was associated with a weaker risk of proximal colon cancer (HR: 1.18 vs. HR: 1.46). Conclusion: Diabetes and poor diet, independently and additively are associated with the increased risk of colorectal cancer.	[Jarvandi, Soghra; Schootman, Mario] Washington Univ, Sch Med, Dept Med, Div Hlth Behav Res, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Davidson, Nicholas O.; Schootman, Mario] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; [Davidson, Nicholas O.; Schootman, Mario] Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Jarvandi, S (corresponding author), Washington Univ, Sch Med, Dept Med, Div Hlth Behav Res, St Louis, MO 63110 USA.	sjarvand@dom.wustl.edu	Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health [CA112159]; DDRCC [P30 DK-52574]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA112159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DDRCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Washington University School of Medicine and a grant from the National Cancer Institute at the National Institutes of Health (grant number CA112159). NOD was supported in part by DDRCC grant P30 DK-52574. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Campbell PT, 2010, GASTROENTEROLOGY, V139, P1138, DOI 10.1053/j.gastro.2010.06.072; Chang CK, 2003, DIABETOLOGIA, V46, P595, DOI 10.1007/s00125-003-1109-5; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; HELZLSOUER KJ, 1994, CANCER RES, V54, pS2044; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; IBER FL, 1993, DIGEST DIS SCI, V38, P45, DOI 10.1007/BF01296772; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Koushik A, 2007, JNCI-J NATL CANCER I, V99, P1471, DOI 10.1093/jnci/djm155; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Larsson SC, 2005, DIABETES CARE, V28, P1805, DOI 10.2337/diacare.28.7.1805; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LeMarchand L, 1997, CANCER RES, V57, P4787; Li CY, 2011, DIABETES CARE, V34, P1365, DOI 10.2337/dc11-0020; Limburg PJ, 2006, AM J GASTROENTEROL, V101, P1872, DOI 10.1111/j.1572-0241.2006.00725.x; Limburg PJ, 2005, CANCER EPIDEM BIOMAR, V14, P133; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Murphy TK, 2000, AM J EPIDEMIOL, V152, P847, DOI 10.1093/aje/152.9.847; Reedy J, 2008, AM J EPIDEMIOL, V168, P38, DOI 10.1093/aje/kwn097; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Shin A, 2006, INT J CANCER, V119, P2938, DOI 10.1002/ijc.22196; Slattery ML, 2003, CANCER CAUSE CONTROL, V14, P75, DOI 10.1023/A:1022545017867; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; WEST DW, 1989, AM J EPIDEMIOL, V130, P883, DOI 10.1093/oxfordjournals.aje.a115421; Will JC, 1998, AM J EPIDEMIOL, V147, P816, DOI 10.1093/oxfordjournals.aje.a009534; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; YOUNG TB, 1988, INT J CANCER, V42, P167, DOI 10.1002/ijc.2910420205; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301	43	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74616	10.1371/journal.pone.0074616	http://dx.doi.org/10.1371/journal.pone.0074616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069323	gold, Green Published			2022-12-25	WOS:000326240100113
J	Rey, M; Hess, P; Clozel, M; Delahaye, S; Gatfield, J; Nayler, O; Steiner, B				Rey, Markus; Hess, Patrick; Clozel, Martine; Delahaye, Stephane; Gatfield, John; Nayler, Oliver; Steiner, Beat			Desensitization by Progressive Up-Titration Prevents First-Dose Effects on the Heart: Guinea Pig Study with Ponesimod, a Selective S1P(1) Receptor Modulator	PLOS ONE			English	Article							G-PROTEIN; ATRIAL MYOCYTES; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; ELECTROCARDIOGRAM; SUBTYPES; AGONISTS; FTY720	Ponesimod, a selective S1P(1) receptor modulator, reduces the blood lymphocyte count in all tested species by preventing egress of T and B cells from thymus and peripheral lymphoid organs. In addition, ponesimod transiently affects heart rate and atrioventricular (AV) conduction in humans, effects not observed in mice, rats, and dogs with selective S1P(1) receptor modulators, suggesting that the regulation of heart rate and rhythm is species dependent. In the present study, we used conscious guinea pigs implanted with a telemetry device to investigate the effects of single and multiple oral doses of ponesimod on ECG variables, heart rate, and blood pressure. Oral administration of ponesimod did not affect the sinus rate (P rate) but dose-dependently induced AV block type I to III. A single oral dose of 0.1 mg/kg had no effect on ECG variables, while a dose of 3 mg/kg induced AV block type III in all treated guinea pigs. Repeated oral dosing of 1 or 3 mg/kg ponesimod resulted in rapid desensitization, so that the second dose had no or a clearly reduced effect on ECG variables as compared with the first dose. Resensitization of the S1P(1) receptor in the heart was concentration dependent. After desensitization had been induced by the first dose of ponesimod, the cardiac system remained desensitized as long as the plasma concentration was >= 75 ng/ml. By using a progressive up-titration regimen, the first-dose effect of ponesimod on heart rate and AV conduction was significantly reduced due to desensitization of the S1P(1) receptor. In summary, conscious guinea pigs implanted with a telemetry device represent a useful model to study first-dose effects of S1P(1) receptor modulators on heart rate and rhythm. This knowledge was translated to a dosing regimen of ponesimod to be tested in humans to avoid or significantly reduce the first-dose effects.	[Rey, Markus; Hess, Patrick; Clozel, Martine; Delahaye, Stephane; Gatfield, John; Nayler, Oliver; Steiner, Beat] Actel Pharmaceut Ltd, Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	markus.rey@actelion.com						BELARDINELLI L, 1980, CIRC RES, V47, P684, DOI 10.1161/01.RES.47.5.684; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Bolli MH, 2011, CURR TOP MED CHEM, V11, P726; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brossard P, 2013, BR J CLIN PHARM, DOI 10.1111/bcp.12129; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Bunemann M, 1995, J PHYSIOL-LONDON, V489, P701; Drici MD, 2000, BRIT J PHARMACOL, V131, P569, DOI 10.1038/sj.bjp.0703611; Farraj AK, 2011, TOXICOL SCI, V121, P11, DOI 10.1093/toxsci/kfr021; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Gatfield J, 2012, ECTRIMS 2012 28 C EU, P926; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Hess P, 2007, LAB ANIM-UK, V41, P470, DOI 10.1258/002367707782314337; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Ochi R, 2006, CARDIOVASC RES, V70, P88, DOI 10.1016/j.cardiores.2006.01.010; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shiotani Motohiro, 2005, Journal of Toxicological Sciences, V30, P239, DOI 10.2131/jts.30.239; Zu Heringdorf D. M., 2013, HDB EXP PHARM, V215, P239, DOI [10.1007/978-3-7091-1368-4_13, DOI 10.1007/978-3-7091-1368-4_13]	29	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74285	10.1371/journal.pone.0074285	http://dx.doi.org/10.1371/journal.pone.0074285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069292	Green Submitted, gold, Green Published			2022-12-25	WOS:000326240100098
J	Dey, P; Strom, A; Gustafsson, JA				Dey, P.; Stroem, A.; Gustafsson, J-A			Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer	ONCOGENE			English	Article						ER beta; apoptosis; p53; FOXO3a; PUMA	FORKHEAD TRANSCRIPTION FACTOR; HUMAN BREAST-CANCER; ER-BETA; CELL-PROLIFERATION; OPPOSING ROLES; PATHWAY; 5-ALPHA-ANDROSTANE-3-BETA,17-BETA-DIOL; EXPRESSION; GROWTH; MICE	Estrogen receptor beta (ER beta) is emerging as a critical factor in understanding prostate cancer biology. Although reduced in prostate cancer above Gleason grade 3, ER beta is a potential drug target at the initial stage of the disease. In human prostate cancer cells, we found that ERb causes apoptosis by increasing the expression of pro-apoptotic factor p53-upregulated modulator of apoptosis (PUMA), independent of p53, but dependent on the forkhead transcription factor class-O family member, FOXO3a. FOXO3a has previously been shown to induce PUMA after growth factor withdrawal and inhibition of the Akt pathway. Surprisingly, the phosphorylation of FOXO3a remained unchanged, while the mRNA and total protein levels of FOXO3a were increased in response to ER beta expression or treatment of PC3, 22Rv1 and LNCaP cells with the ER beta-specific ligands 3 beta-Adiol (5 alpha-androstane-3 beta, 17 beta-diol), DPN (diarylpropionitrile) or 8 beta-VE2 (8-vinylestra-1,3,5 (10)-triene-3,17 beta-diol). Knockdown of FOXO3a or ER beta expression abolished the increase of PUMA in response to 3 beta-Adiol in LNCaP and PC3 cells, suggesting that FOXO3a mediates the apoptotic effect of 3 beta-Adiol-activated ER beta. Moreover, the ventral prostate of ER beta-/- mice had decreased expression of FOXO3a and PUMA compared with the ERb-/- mice, indicating a relationship between ER beta and FOXO3a expression. The regulation of FOXO3a by ER beta in normal basal epithelial cells indicates a function of ER beta in cell differentiation and maintenance of cells in a quiescent state. In addition, the expression of ER beta, FOXO3a and PUMA is comparable and higher in benign prostatic hyperplasia than in prostate cancer Gleason grade 4 or higher, where there is substantial loss of ER beta, FOXO3a and PUMA. We conclude that ER beta induces apoptosis of prostate cancer cells by increasing transcription of FOXO3a, leading to an increase of PUMA and subsequent triggering of apoptosis via the intrinsic pathway involving caspase-9. Furthermore, we conclude that ligands specifically activating ER beta could be useful pharmaceuticals in the treatment of prostate cancer.	[Dey, P.; Stroem, A.; Gustafsson, J-A] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Gustafsson, J-A] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	University of Houston System; University of Houston; Karolinska Institutet	Strom, A (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, 3605 Cullen Blvd,Sci & Engn Res Ctr Bldg 545, Houston, TX 77204 USA.	amstrom@uh.edu			Cancer Prevention and Research Institute of Texas (CPRIT) [HIRP100680, RP110444]; Texas Emerging Technology Fund [300-9-1958]; Robert A. Welch Foundation [E-0004]; Swedish Cancer Fund	Cancer Prevention and Research Institute of Texas (CPRIT); Texas Emerging Technology Fund; Robert A. Welch Foundation(The Welch Foundation); Swedish Cancer Fund	This work was supported by The Cancer Prevention and Research Institute of Texas (CPRIT) grants HIRP100680 and RP110444, the Texas Emerging Technology Fund under Agreement number 300-9-1958, the Robert A. Welch Foundation (E-0004) and the Swedish Cancer Fund. We are grateful to Linda Waage, Department of Urology at Danderyd Hospital, Stockholm, Sweden, for providing us the human prostate cancer samples, and Ulf Bergerheim for Gleason grading the tissue samples.	Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Ellem SJ, 2009, ANN NY ACAD SCI, V1155, P174, DOI 10.1111/j.1749-6632.2009.04360.x; Giroux V, 2008, INT J CANCER, V123, P303, DOI 10.1002/ijc.23532; Giroux V, 2011, MOL CARCINOGEN, V50, P359, DOI 10.1002/mc.20719; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hartman J, 2004, ONCOGENE, V23, P8826, DOI 10.1038/sj.onc.1208139; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Helguero LA, 2006, ENDOCRINOLOGY, V147, P3249, DOI 10.1210/en.2005-1651; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Hussain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040732; Ji Q, 2005, MOL CELL ENDOCRINOL, V229, P103, DOI 10.1016/j.mce.2004.08.012; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Maggiolini M, 2004, J MOL ENDOCRINOL, V32, P777, DOI 10.1677/jme.0.0320777; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Olsson M, 2007, PROSTATE, V67, P1439, DOI 10.1002/pros.20630; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Roberts CG, 2011, ONCOGENE, V30, P3186, DOI 10.1038/onc.2011.36; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saleiro D, 2010, CANCER PREV RES, V3, P1198, DOI 10.1158/1940-6207.CAPR-10-0044; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slusarz A, 2012, ENDOCRINOLOGY, V153, P4160, DOI 10.1210/en.2012-1030; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016841; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	43	81	88	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4213	4225		10.1038/onc.2013.384	http://dx.doi.org/10.1038/onc.2013.384			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24077289				2022-12-25	WOS:000341155800003
J	Okunishi, K; DeGraaf, AJ; Zaslona, Z; Peters-Golden, M				Okunishi, Katsuhide; DeGraaf, Angela J.; Zaslona, Zbigniew; Peters-Golden, Marc			Inhibition of protein translation as a novel mechanism for prostaglandin E2 regulation of cell functions	FASEB JOURNAL			English	Article						protein kinase A; ribosomal protein S6; mammalian target of rapamycin; fibroblasts; macrophages	LUNG FIBROBLASTS; E-PROSTANOID-2 RECEPTOR; MAMMALIAN TARGET; DNA METHYLATION; CYCLIC-AMP; S6 KINASE; COLLAGEN; CAMP; GROWTH; EXPRESSION	Prostaglandin E-2 (PGE(2)) regulates numerous biological processes by modulating transcriptional activation, epigenetic control, proteolysis, and secretion of various proteins. Scar formation depends on fibroblast elaboration of matrix proteins such as collagen, and this process is strongly suppressed by PGE(2) through activation of cAMP-dependent protein kinase A (PKA). However, the actual mechanism by which PGE(2)-PKA signaling inhibits collagen expression in fibroblasts has never been delineated, and that was the objective of this study. PGE(2) unexpectedly induced a rapid reduction in procollagen I protein expression in adult lung fibroblasts, with a half-maximum effect at 1.5 h. This effect reflected its inhibition of translation rather than transcription. Global protein synthesis was also inhibited by PGE(2). This action was mediated by PKA and involved both activation of ribosomal protein (rpS6) and suppression of mammalian target of rapamycin (mTOR). Similar effects of PGE(2) were demonstrated in mouse peritoneal macrophages (PMs). These findings identify inhibition of translation as a new mechanism by which PGE(2) regulates cellular function and a novel example of translational inhibition mediated by opposing actions on two distinct translational control pathways. Translational inhibition would be expected to contribute to dynamic alterations in cell function that accompany the changing PGE(2) levels observed in disease states and with various pharmacotherapies.Okunishi K., DeGraaf, A. J., Zasona, Z., Peters-Golden, M. Inhibition of protein translation as a novel mechanism for prostaglandin E-2 regulation of cell functions.	[Okunishi, Katsuhide; DeGraaf, Angela J.; Zaslona, Zbigniew; Peters-Golden, Marc] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu		Zaslona, Zbigniew/0000-0003-3361-4140	American Lung Association; Deutsche Forschungsgemeinschaft (German Research Foundation); U.S. National Institutes of Health [HL094311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094311] Funding Source: NIH RePORTER	American Lung Association; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Scott H. Wettlaufer for technical contributions, Teresa M. Murphy and Sally Przybranowski for general technical assistance, and members of the laboratory of M.P.-G. for constructive input. This work was supported by an American Lung Association Senior Research Training Fellowship (K.O.), Japanese Grants-in-Aid for Scientific Research (K.O.), Deutsche Forschungsgemeinschaft (German Research Foundation; Z.Z.), and U.S. National Institutes of Health grant HL094311 (M.P.-G.).	af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Canetti C, 2006, J LEUKOCYTE BIOL, V79, P1234, DOI 10.1189/jlb.0705374; ELIAS JA, 1985, AM REV RESPIR DIS, V131, P94; FINE A, 1989, J BIOL CHEM, V264, P16988; FINE A, 1992, BIOCHIM BIOPHYS ACTA, V1135, P67, DOI 10.1016/0167-4889(92)90167-A; Gilroy DW, 2001, AM J PHYSIOL-CELL PH, V281, pC188, DOI 10.1152/ajpcell.2001.281.1.C188; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Jensen LT, 1997, CARDIOVASC RES, V33, P535, DOI 10.1016/S0008-6363(96)00247-7; Ji R, 2012, BRIT J PHARMACOL, V166, P1033, DOI 10.1111/j.1476-5381.2011.01817.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Moore CEJ, 2009, J MOL BIOL, V389, P480, DOI 10.1016/j.jmb.2009.04.020; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Poulalhon N, 2006, J BIOL CHEM, V281, P33045, DOI 10.1074/jbc.M606366200; Rennard S. I., 1982, J INVESTIGATIVE D S1, V79, p77S; Rocchi S, 2000, BIOCHEM J, V352, P483, DOI 10.1042/0264-6021:3520483; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schweda F, 2004, AM J PHYSIOL-RENAL, V287, pF427, DOI 10.1152/ajprenal.00072.2004; Scott PH, 1998, J BIOL CHEM, V273, P34496, DOI 10.1074/jbc.273.51.34496; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Xie JL, 2011, CELL SIGNAL, V23, P1927, DOI 10.1016/j.cellsig.2011.06.025; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73; Zito CI, 2007, J BIOL CHEM, V282, P6946, DOI 10.1074/jbc.M608338200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					56	66		10.1096/fj.13-231720	http://dx.doi.org/10.1096/fj.13-231720			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24072780	Green Published, Green Submitted			2022-12-25	WOS:000333526100008
J	Kang, HW; Ozdemir, C; Kawano, Y; LeClair, KB; Vernochet, C; Kahn, CR; Hagen, SJ; Cohen, DE				Kang, Hye Won; Ozdemir, Cafer; Kawano, Yuki; LeClair, Katherine B.; Vernochet, Cecile; Kahn, C. Ronald; Hagen, Susan J.; Cohen, David E.			Thioesterase Superfamily Member 2/Acyl-CoA Thioesterase 13 (Them2/Acot13) Regulates Adaptive Thermogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy metabolism; Fatty acid; Fatty acid oxidation; Mitochondrial metabolism; Obesity; Brown adipose tissue; Fatty acyl-CoA	BROWN ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLISM; OXIDATION; PROTECTS; DELETION; OBESITY	Members of the acyl-CoA thioesterase (Acot) gene family hydrolyze fatty acyl-CoAs, but their biological functions remain incompletely understood. Thioesterase superfamily member 2 (Them2; synonym Acot13) is enriched in oxidative tissues, associated with mitochondria, and relatively specific for long chain fatty acyl-CoA substrates. Using Them2(-/-) mice, we have demonstrated key roles for Them2 in regulating hepatic glucose and lipid metabolism. However, reduced body weights and decreased adiposity in Them2(-/-) mice observed despite increased food consumption were not well explained. To explore a role in thermogenesis, mice were exposed to ambient temperatures ranging from thermoneutrality (30 degrees C) to cold (4 degrees C). In response to short term (24-h) exposures to decreasing ambient temperatures, Them2(-/-) mice exhibited increased adaptive responses in physical activity, food consumption, and energy expenditure when compared with Them2(+/+) mice. By contrast, genotype-dependent differences were not observed in mice that were equilibrated (96 h) at each ambient temperature. In brown adipose tissue, the absence of Them2 was associated with reduced lipid droplets, alterations in the ultrastructure of mitochondria, and increased expression of thermogenic genes. Indicative of a direct regulatory role for Them2 in heat production, cultured primary brown adipocytes from Them2(-/-) mice exhibited increased norepinephrine-mediated triglyceride hydrolysis and increased rates of O-2 consumption, together with elevated expression of thermogenic genes. At least in part by regulating intracellular fatty acid channeling, Them2 functions in brown adipose tissue to suppress adaptive increases in energy expenditure.	[Kang, Hye Won; Ozdemir, Cafer; Kawano, Yuki; LeClair, Katherine B.; Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Vernochet, Cecile; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Hagen, Susan J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Cohen, DE (corresponding author), Brigham & Womens Hosp, 77 Ave Louis Pasteur,HIM 941, Boston, MA 02115 USA.	dcohen@partners.org	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Ozdemir, Cafer/0000-0002-5546-983X	National Institutes of Health/National Center for Research Resources [S10-RR-023010]; NCI Cancer Center Support Grant, National Institutes of Health [P30 CA06516]; National Institutes of Health [U24 DK76169]; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, U24DK076169, R01DK056626, P30DK034854, R37DK048873] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI Cancer Center Support Grant, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The use of the Longwood Small Animal Imaging Facility at Beth Israel Deaconess Medical Center (Boston, MA) was supported in part by National Institutes of Health/National Center for Research Resources shared instrumentation Grant S10-RR-023010. The use of the Rodent Histopathology Core Facility of Dana-Farber/Harvard Cancer Center (Boston, MA) was supported in part by an NCI Cancer Center Support Grant, National Institutes of Health Grant P30 CA06516. The use of the Mouse Metabolic Phenotype Center at Yale University School of Medicine (New Haven, CT) was supported in part by National Institutes of Health Grant U24 DK76169.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Brocker Chad, 2010, Hum Genomics, V4, P411; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V350, P850, DOI 10.1016/j.bbrc.2006.09.105; Clapham JC, 2012, NEUROPHARMACOLOGY, V63, P111, DOI 10.1016/j.neuropharm.2011.10.014; Cohen DE, 2013, ADIPOCYTE, V2, P3, DOI 10.4161/adip.21853; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; McLean J., 1987, ANIMAL HUMAN CALORIM; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; Souza SC, 2007, J LIPID RES, V48, P1273, DOI 10.1194/jlr.M700047-JLR200; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Zhang YZ, 2012, P NATL ACAD SCI USA, V109, P5417, DOI 10.1073/pnas.1116011109	26	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33376	33386		10.1074/jbc.M113.481408	http://dx.doi.org/10.1074/jbc.M113.481408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072708	Green Published, hybrid			2022-12-25	WOS:000328841700051
J	Tseng, LTL; Lin, CL; Tzen, KY; Chang, SC; Chang, MF				Tseng, Linda Tzu-Ling; Lin, Chieh-Liang; Tzen, Kai-Yuan; Chang, Shin C.; Chang, Ming-Fu			LMBD1 Protein Serves as a Specific Adaptor for Insulin Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Antisense RNA; Cell Signaling; Cell Surface Receptor; Confocal Microscopy; Endocytosis; Flow Cytometry; Glucose Metabolism; In Vivo Imaging; Insulin	CLATHRIN-MEDIATED ENDOCYTOSIS; POSITRON-EMISSION-TOMOGRAPHY; GROWTH-FACTOR RECEPTOR; ENDOPLASMIC-RETICULUM; STRUCTURAL EXPLANATION; TRANSFERRIN RECEPTOR; PATHWAY; BINDING; CELLS; AP2	Energy homeostasis is crucial for maintaining normally functioning cells; disturbances in this balance often cause various diseases. The limb region 1 (LMBR1) domain containing 1 gene (lmbrd1) encodes the LMBD1 protein that possesses 9 putative transmembrane domains. LMBD1 has been suggested to be involved in the lysosome in aiding the export of cobalamin. In this study, we determined that LMBD1 plays a regulatory role in the plasma membrane. A micro-positron emission tomography analysis showed that a single-allele knock-out of lmbrd1 increased the F-18-fluorodeoxyglucose uptake in murine hearts. In addition, the knockdown of lmbrd1 resulted in an up-regulated signaling of the insulin receptor (IR) and its downstream signaling molecule, Akt. Confocal and live total internal reflection fluorescence microscopy showed that LMBD1 co-localized and co-internalized with clathrin and the IR, but not with the transferrin receptor. The results of the mutation analysis and phenotypic rescue experiments indicate that LMBD1 interacts with adaptor protein-2 and is involved in the unique clathrin-mediated endocytosis of the IR. LMBD1 selectively interacts with the IR. The knockdown of lmbrd1 attenuated IR endocytosis, resulting in the perturbation of the IR recycling pathway and consequential enhancement of the IR signaling cascade. In summary, LMBD1 plays an imperative role in mediating and regulating the endocytosis of the IR.	[Tseng, Linda Tzu-Ling; Lin, Chieh-Liang; Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan; [Chang, Shin C.] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10051, Taiwan; [Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 10041, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, MF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, 1 Jen Ai Rd,Sect 1, Taipei 10051, Taiwan.	mfchang@ntu.edu.tw		TZEN, KAI-YUAN/0000-0002-5657-8579; CHANG, MING-FU/0000-0001-7062-3578	National Science Council, Republic of China;  [NSC98-2320-B-002-051-MY3];  [NSC101-2320-B-002-039]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); ; 	This work was supported by Research Grants NSC98-2320-B-002-051-MY3 and NSC101-2320-B-002-039 from the National Science Council, Republic of China.	BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Fang KM, 2008, CARDIOVASC RES, V78, P533, DOI 10.1093/cvr/cvn030; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hsu WC, 2009, ACTA OTO-LARYNGOL, V129, P423, DOI 10.1080/00016480802593497; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schafers KP, 2005, EUR J NUCL MED MOL I, V32, P383, DOI 10.1007/s00259-004-1628-4; Su MJ, 1997, BRIT J PHARMACOL, V122, P1285, DOI 10.1038/sj.bjp.0701510; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Wang YH, 2005, J VIROL, V79, P8113, DOI 10.1128/JVI.79.13.8113-8120.2005; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Warren RA, 1997, J BIOL CHEM, V272, P2116; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200	31	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32424	32432		10.1074/jbc.M113.479527	http://dx.doi.org/10.1074/jbc.M113.479527			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078630	Green Published, hybrid			2022-12-25	WOS:000328681700027
J	Morozov, A; Petrovskii, S				Morozov, Andrew; Petrovskii, Sergei			Feeding on Multiple Sources: Towards a Universal Parameterization of the Functional Response of a Generalist Predator Allowing for Switching	PLOS ONE			English	Article							ECOSYSTEM MODELS; PLANKTON DYNAMICS; PREY; PHYTOPLANKTON; COMMUNITY; BIODIVERSITY; GROWTH; RATES; PRODUCTIVITY; PHAEOCYSTIS	Understanding of complex trophic interactions in ecosystems requires correct descriptions of the rate at which predators consume a variety of different prey species. Field and laboratory data on multispecies communities are rarely sufficient and usually cannot provide an unambiguous test for the theory. As a result, the conventional way of constructing a multi-prey functional response is speculative, and often based on assumptions that are difficult to verify. Predator responses allowing for prey selectivity and active switching are thought to be more biologically relevant compared to the standard proportion-based consumption. However, here we argue that the functional responses with switching may not be applicable to communities with a broad spectrum of resource types. We formulate a set of general rules that a biologically sound parameterization of a predator functional response should satisfy, and show that all existing formulations for the multispecies response with prey selectivity and switching fail to do so. Finally, we propose a universal framework for parameterization of a multi-prey functional response by combining patterns of food selectivity and proportion-based feeding.	[Morozov, Andrew; Petrovskii, Sergei] Univ Leicester, Dept Math, Leicester, Leics, England	University of Leicester	Morozov, A (corresponding author), Univ Leicester, Dept Math, Leicester, Leics, England.	am379@leicester.ac.uk	Morozov, Andrew/AAI-6528-2020	Petrovskii, Sergei/0000-0001-6259-2695				Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Adamson MW, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0500; Adjou M, 2012, ECOL MODEL, V225, P19, DOI 10.1016/j.ecolmodel.2011.11.005; AKRE BG, 1979, J ANIM ECOL, V48, P703, DOI 10.2307/4191; Anderson TR, 2010, PROG OCEANOGR, V87, P201, DOI 10.1016/j.pocean.2010.06.003; [Anonymous], 2005, FUNDAMENTALS ECOLOGY; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Arditi R., 1995, FOOD WEBS INTEGRATIO, P122; Armstrong RA, 1999, J PLANKTON RES, V21, P445, DOI 10.1093/plankt/21.3.445; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COLTON TF, 1987, ECOLOGY, V68, P900, DOI 10.2307/1938361; COMINS HN, 1976, J THEOR BIOL, V62, P93, DOI 10.1016/0022-5193(76)90053-9; DALE BW, 1994, J ANIM ECOL, V63, P644, DOI 10.2307/5230; DEMOTT WR, 1982, LIMNOL OCEANOGR, V27, P518, DOI 10.4319/lo.1982.27.3.0518; Diekmann O, 2010, J MATH BIOL, V61, P277, DOI 10.1007/s00285-009-0299-y; Edwards AM, 1999, B MATH BIOL, V61, P303, DOI 10.1006/bulm.1998.0082; Elliott JM, 2006, FRESHWATER BIOL, V51, P913, DOI 10.1111/j.1365-2427.2006.01549.x; Elliott JM, 2004, FRESHWATER BIOL, V49, P709, DOI 10.1111/j.1365-2427.2004.01222.x; Erbach A, 2013, ECOL COMPLEX, V14, P48, DOI 10.1016/j.ecocom.2013.02.005; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; FASHAM MJR, 1990, J MAR RES, V48, P591, DOI 10.1357/002224090784984678; Flora C, 2011, J THEOR BIOL, V283, P82, DOI 10.1016/j.jtbi.2011.05.021; Franks PJS, 2009, J PLANKTON RES, V31, P1299, DOI 10.1093/plankt/fbp069; Fussmann GF, 2005, BIOL LETTERS, V1, P9, DOI 10.1098/rsbl.2004.0246; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; HANSEN B, 1990, J PLANKTON RES, V12, P1173, DOI 10.1093/plankt/12.6.1173; HAYDON D, 1994, AM NAT, V144, P14, DOI 10.1086/285658; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; HOLT RD, 1983, AM NAT, V122, P521, DOI 10.1086/284153; HUSTON M, 1985, CORAL REEFS, V4, P19, DOI 10.1007/BF00302200; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HUTSON V, 1984, MATH BIOSCI, V68, P233, DOI 10.1016/0025-5564(84)90033-6; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Johnson PTJ, 2006, ECOLOGY, V87, P1973, DOI 10.1890/0012-9658(2006)87[1973:DODHIB]2.0.CO;2; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; KOENALONSO M, 2007, ENERGETICS ECOSYSTEM; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Leising AW, 2005, PROG OCEANOGR, V67, P384, DOI 10.1016/j.pocean.2005.09.008; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; MCNAIR JN, 1981, THEOR POPUL BIOL, V19, P147, DOI 10.1016/0040-5809(81)90014-9; Morozov AY, 2010, J THEOR BIOL, V262, P346, DOI 10.1016/j.jtbi.2009.09.023; Morozov AY, 2010, J THEOR BIOL, V265, P45, DOI 10.1016/j.jtbi.2010.04.016; MURDOCH W W, 1975, P1; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nejstgaard JC, 2007, BIOGEOCHEMISTRY, V83, P147, DOI 10.1007/s10533-007-9098-y; PACE ML, 1984, MAR BIOL, V82, P47, DOI 10.1007/BF00392763; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Prowe AEF, 2012, ECOL MODEL, V225, P167, DOI 10.1016/j.ecolmodel.2011.11.018; Raymont J.E.G., 1980, PLANKTON PRODUCTIVIT, V1, DOI 10.1016/c2009-0-10951-0; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Ryabchenko VA, 1997, J MARINE SYST, V13, P33, DOI 10.1016/S0924-7963(96)00110-8; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Stephens D.W., 1986, pi; Stock CA, 2008, J MARINE SYST, V74, P134, DOI 10.1016/j.jmarsys.2007.12.004; STOECKER DK, 1986, J EXP MAR BIOL ECOL, V95, P113, DOI 10.1016/0022-0981(86)90196-6; Strom SL, 1998, J PLANKTON RES, V20, P831, DOI 10.1093/plankt/20.5.831; TANSKY M, 1978, J THEOR BIOL, V70, P263, DOI 10.1016/0022-5193(78)90376-4; Vallina SM, 2012, COMM ASLO M 2012; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; van Leeuwen E, 2013, J THEOR BIOL, V328, P89, DOI 10.1016/j.jtbi.2013.02.003; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Visser AW, 2013, MAR ECOL PROG SER, V473, P91, DOI 10.3354/meps10079; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	72	34	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74586	10.1371/journal.pone.0074586	http://dx.doi.org/10.1371/journal.pone.0074586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086356	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700027
J	Zhao, GJ; Tang, SL; Lv, YC; Ouyang, XP; He, PP; Yao, F; Chen, WJ; Lu, Q; Tang, YY; Zhang, M; Fu, YC; Zhang, DW; Yin, K; Tang, CK				Zhao, Guo-Jun; Tang, Shi-Lin; Lv, Yun-Cheng; Ouyang, Xin-Ping; He, Ping-Ping; Yao, Feng; Chen, Wu-Jun; Lu, Qian; Tang, Yan-Yan; Zhang, Min; Fu, Yuchang; Zhang, Da-Wei; Yin, Kai; Tang, Chao-Ke			Antagonism of Betulinic Acid on LPS-Mediated Inhibition of ABCA1 and Cholesterol Efflux through Inhibiting Nuclear Factor-kappaB Signaling Pathway and miR-33 Expression	PLOS ONE			English	Article							CASSETTE TRANSPORTER A1; REGULATES ABCA1; B ACTIVATION; LXR-ALPHA; INFLAMMATION; ATHEROSCLEROSIS; CONTRIBUTES; MACROPHAGES; METABOLISM; MODULATION	ATP-binding cassette transporter A1 (ABCA1) is critical in exporting cholesterol from macrophages and plays a protective role in the development of atherosclerosis. The purpose of this study was to investigate the effects of betulinic acid (BA), a pentacyclic triterpenoid, on ABCA1 expression and cholesterol efflux, and to further determine the underlying mechanism. BA promoted ABCA1 expression and cholesterol efflux, decreased cellular cholesterol and cholesterol ester content in LPS-treated macrophages. Furthermore, we found that BA promoted ABCA1 expression via down-regulation of miR-33s. The inhibition of LPS-induced NF-kappa B activation further decreased miR-33s expression and enhanced ABCA1 expression and cholesterol efflux when compared with BA only treatment. In addition, BA suppressed I kappa B phosphorylation, p65 phosphorylation and nuclear translocation, and the transcription of NF-kappa B-dependent related gene. Moreover, BA reduced atherosclerotic lesion size, miR-33s levels and NF-kappa B activation, and promoted ABCA1 expression in apoE(-/-) mice. Taken together, these results reveal a novel mechanism for the BA-mediated ABCA1 expression, which may provide new insights for developing strategies for modulating vascular inflammation and atherosclerosis.	[Zhao, Guo-Jun; Tang, Shi-Lin; Lv, Yun-Cheng; Ouyang, Xin-Ping; He, Ping-Ping; Yao, Feng; Chen, Wu-Jun; Lu, Qian; Tang, Yan-Yan; Zhang, Min; Yin, Kai; Tang, Chao-Ke] Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang, Hunan, Peoples R China; [Zhao, Guo-Jun] Univ South China, Dept Histol & Embryol, Hengyang, Hunan, Peoples R China; [He, Ping-Ping] Univ South China, Sch Nursing, Hengyang, Hunan, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Zhang, Da-Wei] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zhang, Da-Wei] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada	University of South China; University of South China; University of South China; University of Alabama System; University of Alabama Birmingham; University of Alberta; University of Alberta	Yin, K (corresponding author), Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang, Hunan, Peoples R China.	kaiyinby@yahoo.com.cn; tangchaoke@qq.com	; Zhang, Dawei/ABD-8990-2022	, Wujun/0000-0002-1256-3201; Zhang, Dawei/0000-0001-8279-8041	National Natural Sciences Foundation of China [81200218, 81070220, 81170278]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Human Province, China [2008-244]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Human Province, China	The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81200218, 81070220 and 81170278), and Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions (2008-244) of Human Province, China. http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2012, CIRC J, V76, P995, DOI 10.1253/circj.CJ-11-0344; de Melo CL, 2009, J AGR FOOD CHEM, V57, P8776, DOI 10.1021/jf900768w; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Hao XR, 2009, ATHEROSCLEROSIS, V203, P417, DOI 10.1016/j.atherosclerosis.2008.07.029; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lee D, 2012, ANN NY ACAD SCI, V1271, P118, DOI 10.1111/j.1749-6632.2012.06745.x; Lee J, 2012, J NUTR BIOCHEM, V23, P1, DOI [10.1016/j.jnutbio.2011.03.001, 10.6107/JKHA.2012.23.5.001]; Maitra U, 2013, ARTERIOSCL THROM VAS, V33, P24, DOI 10.1161/ATVBAHA.112.300049; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tang SL, 2012, ATHEROSCLEROSIS, V222, P344, DOI 10.1016/j.atherosclerosis.2012.03.005; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; Viji V, 2010, INT IMMUNOPHARMACOL, V10, P843, DOI 10.1016/j.intimp.2010.04.013; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yin K, 2012, J ATHEROSCLER THROMB, V19, P823, DOI 10.5551/jat.12823; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Yu XH, 2012, CIRC J, V76, P1780, DOI 10.1253/circj.CJ-11-1338; Yuan Y, 2012, PROTEIN CELL, V3, P173, DOI 10.1007/s13238-012-2025-6; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183	32	35	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74782	10.1371/journal.pone.0074782	http://dx.doi.org/10.1371/journal.pone.0074782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086374	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700036
J	Adler, UC; Kruger, S; Teut, M; Ludtke, R; Schutzler, L; Martins, F; Willich, SN; Linde, K; Witt, CM				Adler, Ubiratan C.; Krueger, Stephanie; Teut, Michael; Luedtke, Rainer; Schuetzler, Lena; Martins, Friederike; Willich, Stefan N.; Linde, Klaus; Witt, Claudia M.			Homeopathy for Depression: A Randomized, Partially Double-Blind, Placebo-Controlled, Four-Armed Study (DEP-HOM)	PLOS ONE			English	Article							COMMUNICATION; OUTCOMES	Background: The specific clinical benefit of the homeopathic consultation and of homeopathic remedies in patients with depression has not yet been investigated. Aims: To investigate the 1) specific effect of individualized homeopathic Q-potencies compared to placebo and 2) the effect of an extensive homeopathic case taking (case history I) compared to a shorter, rather conventional one (case history II) in the treatment of acute major depression (moderate episode) after six weeks. Methods: A randomized, partially double-blind, placebo-controlled, four-armed trial using a 262 factorial design with a six-week study duration per patient was performed. Results: A total of 44 from 228 planned patients were randomized (2:1:2:1 randomization: 16 homeopathic Q-potencies/case history I, 7 placebo/case history I, 14 homeopathic Q-potencies/case history II, 7 placebo/case history II). Because of recruitment problems, the study was terminated prior to full recruitment, and was underpowered for the preplanned confirmatory hypothesis testing. Exploratory data analyses showed heterogeneous and inconclusive results with large variance in the sample. The mean difference for the Hamilton-D after 6 weeks was 2.0 (95% CI -1.2; 5.2) for Q-potencies vs. placebo and -3.1 (-5.9; 20.2) for case history I vs. case history II. Overall, no consistent or clinically relevant results across all outcomes between homeopathic Q-potencies versus placebo and homeopathic versus conventional case taking were observed. The frequency of adverse events was comparable for all groups. Conclusions: Although our results are inconclusive, given that recruitment into this trial was very difficult and we had to terminate early, we cannot recommend undertaking a further trial addressing this question in a similar setting. Prof. Dr. Claudia Witt had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. registration:	[Adler, Ubiratan C.; Teut, Michael; Schuetzler, Lena; Martins, Friederike; Willich, Stefan N.; Witt, Claudia M.] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Krueger, Stephanie] Charite, Teaching Hosp, Head Ctr Womens Mental Hlth, Vivantes Humboldt Klin, D-13353 Berlin, Germany; [Luedtke, Rainer] Karl & Veron Carstens Fdn, Essen, Germany; [Linde, Klaus] Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; University System of Maryland; University of Maryland Baltimore	Witt, CM (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	claudia.witt@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Linde, Klaus/0000-0002-2902-970X; Teut, Michael/0000-0001-7150-7165	chair for complementary medicine research, Carstens Foundation	chair for complementary medicine research, Carstens Foundation	This project was funded within the grant of the chair for complementary medicine research by the Carstens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler UC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep114; Adler UC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-43; Adler UC, 2009, INT J HIGH DILUTION, V8, P173; Bawden S, 2012, HOMEOPATHY, V101, P51, DOI 10.1016/j.homp.2011.10.003; Becker-Witt C, 2004, FORSCH KOMP KLAS NAT, V11, P98, DOI 10.1159/000078231; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Finset A, 2006, PATIENT EDUC COUNS, V60, P115, DOI 10.1016/j.pec.2005.03.005; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frei H, 2009, HOMEOPATHY, V98, P49, DOI 10.1016/j.homp.2008.10.002; Grolleau A, 2011, EUR PSYCHIAT; Hahnemann S, 1992, ORGANON HEILKUNST; Hautzinger M, 1995, BECK DEPRESSIONS INV, P5; Jacobs J, 1998, ARCH FAM MED, V7, P537, DOI 10.1001/archfami.7.6.537; Katz T, 2005, Homeopathy, V94, P145, DOI 10.1016/j.homp.2005.04.002; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; National Institute for Clinical Excellence, DEPR TREATM MAN DEPR; Posner K, COLUMBIA BEURTEILUNK; Sevar R, 2000, Br Homeopath J, V89, P178, DOI 10.1054/homp.1999.0438; Siebenwirth J, 2009, FORSCH KOMPLEMENTMED, V16, P315, DOI 10.1159/000242434; Spence DS, 2005, J ALTERN COMPLEM MED, V11, P793, DOI 10.1089/acm.2005.11.793; Steinsbekk A, 2008, HOMEOPATHY, V97, P178, DOI 10.1016/j.homp.2008.08.005; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Thompson EA, 2008, HOMEOPATHY, V97, P114, DOI 10.1016/j.homp.2008.06.005; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weyer G, 2004, INT SKALEN PSYCHIAT; Witt CM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-413; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zajecka J, 2010, J CLIN PSYCHOPHARM, V30, P135, DOI 10.1097/JCP.0b013e3181d420a7	28	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74537	10.1371/journal.pone.0074537	http://dx.doi.org/10.1371/journal.pone.0074537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086352	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200034
J	Mu, DW; Gao, Z; Guo, HQ; Zhou, GB; Sun, B				Mu, Dawei; Gao, Zhuo; Guo, Heqing; Zhou, Gaobiao; Sun, Bin			Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1	PLOS ONE			English	Article							DECREASED EXPRESSION; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; DOWN-REGULATION; BLADDER-CANCER; GASTRIC-CANCER; DIFFERENTIATION; GENE; OVEREXPRESSION; ADENOCARCINOMA	Background: Sodium butyrate, a histone deacetylase inhibitor, has emerged as a promising anticancer drug for multiple cancers. Recent studies have indicated that sodium butyrate could inhibit the progression of prostate cancer; however, the exact mechanism is still unclear. The aim of this study was to investigate the mechanism of sodium butyrate action in prostate cancer DU145 cells. Methods: The inhibitory effects of NaB on cell growth were detected by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrrazolium bromide assay. Cell apoptosis was determined by flow cytometric analysis of DU145 cells stained with annexin V and PI. Hoechst 33258 and fluorescence microscopes were used to observe the nuclear morphology of DU145 cells after treatment with NaB. ANXA1 knockdown cells were established through transfection with ANXA1 siRNA. ANXA1 mRNA levels were measured by qRT-PCR. Bcl-2, Bax, ANXA1, ERK1/2 and pERK1/2 were detected by western blot. Results: NaB significantly inhibited the growth and induction apoptosis of DU145 and PC3 cells in a dose-dependent manner. Expression of the anti-apoptosis gene Bcl-xl and Bcl-2 in DU145 cells are decreased and expression of the pro-apoptosis gene Bax and Bak increased after NaB treatment. Further studies have demonstrated that NaB up-regulated the expression of ANXA1 and that the tumor inhibition action of NaB was reduced markedly through knockdown of the ANXA1 gene in DU145 cells. Moreover, the siANXA1 cells showed that cell proliferation increased and cell apoptosis was induced by the inactivation of extracellular regulated kinase (ERK). Conclusion: Our results support a significant correlation between NaB functions and ANXA1 expression in prostate cancer, and pave the way for further studying the molecular mechanism of NaB actions in cancers.	[Mu, Dawei; Guo, Heqing; Zhou, Gaobiao; Sun, Bin] AF Gen Hosp, Dept Urol, Beijing, Peoples R China; [Gao, Zhuo] AF Gen Hosp, Dept Nephrol, Beijing, Peoples R China		Guo, HQ (corresponding author), AF Gen Hosp, Dept Urol, Beijing, Peoples R China.	heqingguo010@163.com						Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bai ZG, 2010, CELL BIOL INT, V34, P1141, DOI 10.1042/CBI20090481; BARNARD JA, 1993, CELL GROWTH DIFFER, V4, P495; Chopin V, 2009, BRIT J PHARMACOL, V135, P79; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Giuliano M, 1999, CANCER RES, V59, P5586; Jani AB, 2003, LANCET, V361, P1045, DOI 10.1016/S0140-6736(03)12833-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaiser M, 2006, HAEMATOL-HEMATOL J, V91, P248; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin JG, 2006, J UROLOGY, V175, P343, DOI 10.1016/S0022-5347(05)00005-4; Liu JW, 2003, ONCOGENE, V22, P1475, DOI 10.1038/sj.onc.1206196; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; Mollenhauer J, 1997, CELL MOL LIFE SCI, V53, P506, DOI 10.1007/s000180050063; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Patton KT, 2005, HISTOPATHOLOGY, V47, P597, DOI 10.1111/j.1365-2559.2005.02300.x; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Wang KL, 2006, CLIN CANCER RES, V12, P4598, DOI 10.1158/1078-0432.CCR-06-0483; Wang LD, 2008, J INT MED RES, V36, P665, DOI 10.1177/147323000803600407; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Yu GZ, 2008, CLIN EXP METASTAS, V25, P695, DOI 10.1007/s10585-008-9178-y	35	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74922	10.1371/journal.pone.0074922	http://dx.doi.org/10.1371/journal.pone.0074922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086397	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200054
J	Zuniga, J; Yu, N; Barquera, R; Alosco, S; Ohashi, M; Lebedeva, T; Acuna-Alonzo, V; Yunis, M; Granados-Montiel, J; Cruz-Lagunas, A; Vargas-Alarcon, G; Rodriguez-Reyna, TS; Fernandez-Vina, M; Granados, J; Yunis, EJ				Zuniga, Joaquin; Yu, Neng; Barquera, Rodrigo; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana; Acuna-Alonzo, Victor; Yunis, Maria; Granados-Montiel, Julio; Cruz-Lagunas, Alfredo; Vargas-Alarcon, Gilberto; Rodriguez-Reyna, Tatiana S.; Fernandez-Vina, Marcelo; Granados, Julio; Yunis, Edmond J.			HLA Class I and Class II Conserved Extended Haplotypes and Their Fragments or Blocks in Mexicans: Implications for the Study of Genetic Diversity in Admixed Populations	PLOS ONE			English	Article							AMERINDIAN POPULATIONS; ALLELE FREQUENCIES; MESTIZO POPULATION; CABO-VERDE; B-ALLELES; C ALLELES; LOCI; RESOLUTION; ADMIXTURE; EVOLUTION	Major histocompatibility complex (MHC) genes are highly polymorphic and informative in disease association, transplantation, and population genetics studies with particular importance in the understanding of human population diversity and evolution. The aim of this study was to describe the HLA diversity in Mexican admixed individuals. We studied the polymorphism of MHC class I (HLA-A, -B, -C), and class II (HLA-DRB1, -DQB1) genes using high-resolution sequence based typing (SBT) method and we structured the blocks and conserved extended haplotypes (CEHs) in 234 non-related admixed Mexican individuals (468 haplotypes) by a maximum likelihood method. We found that HLA blocks and CEHs are primarily from Amerindian and Caucasian origin, with smaller participation of African and recent Asian ancestry, demonstrating a great diversity of HLA blocks and CEHs in Mexicans from the central area of Mexico. We also analyzed the degree of admixture in this group using short tandem repeats (STRs) and HLA-B that correlated with the frequency of most probable ancestral HLA-C/-B and -DRB1/-DQB1 blocks and CEHs. Our results contribute to the analysis of the diversity and ancestral contribution of HLA class I and HLA class II alleles and haplotypes of Mexican admixed individuals from Mexico City. This work will help as a reference to improve future studies in Mexicans regarding allotransplantation, immune responses and disease associations.	[Zuniga, Joaquin; Cruz-Lagunas, Alfredo] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Immunol, Mexico City, DF, Mexico; [Yu, Neng; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana] Amer Red Cross, HLA Lab, Northeast Div, Dedham, MA USA; [Barquera, Rodrigo; Acuna-Alonzo, Victor] Natl Sch Anthropol & Hist, Mol Genet Lab, Mexico City, DF, Mexico; [Yunis, Maria; Yunis, Edmond J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Granados-Montiel, Julio] Inst Nacl Rehabil, Tissue Engn Cell Therapy & Regenerat Med Res Unit, Mexico City, DF, Mexico; [Vargas-Alarcon, Gilberto] Inst Nacl Cardiol Ignacio Chavez, Lab Genom, Mexico City, DF, Mexico; [Rodriguez-Reyna, Tatiana S.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Fernandez-Vina, Marcelo] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City, DF, Mexico	American Red Cross; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institute of Cardiology - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Stanford University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Granados, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City, DF, Mexico.	julgrate@yahoo.com; Edmond_yunis@dfci.harvard.edu	Reyna, Tatiana Sofía Rodríguez/ABB-7864-2020	Reyna, Tatiana Sofía Rodríguez/0000-0002-5799-5016; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Zuniga, Joaquin/0000-0002-7143-0281; CRUZ-LAGUNAS, ALFREDO/0000-0001-5487-5919; Fernandez-Vina, Marcelo A./0000-0002-5707-2588; Barquera, Rodrigo/0000-0003-0518-4518				Alfirevic A, 2012, GENOME MED, V4, DOI 10.1186/gm350; Arnaiz-Villena A, 2009, INT J IMMUNOGENET, V36, P159, DOI 10.1111/j.1744-313X.2009.00841.x; Arrieta-Bolanos E, 2012, BONE MARROW RES, DOI 10.1155/2012/136087; Barquera R., 2012, CAUSES CONSEQUENCES, P201; Barquera R, 2008, MOL IMMUNOL, V45, P1171, DOI 10.1016/j.molimm.2007.07.042; Barrot C, 2005, INT J LEGAL MED, V119, P111, DOI 10.1007/s00414-004-0488-6; Calzada P, 2005, INT J LEGAL MED, V119, P107, DOI 10.1007/s00414-004-0505-9; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Ceppellini R, 1967, HISTOCOMPATIBILITY T, P189; CERNA M, 1993, HUM IMMUNOL, V37, P213, DOI 10.1016/0198-8859(93)90504-T; Chu C, 2007, IMMUNOBIOLOGY HUMAN, P611; de Pablo R, 1997, TISSUE ANTIGENS, V50, P593; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Dunne C, 2008, INT J IMMUNOGENET, V35, P295, DOI 10.1111/j.1744-313X.2008.00779.x; Ellis JM, 2000, TISSUE ANTIGENS, V56, P291, DOI 10.1034/j.1399-0039.2000.560401.x; Erlich HA, 1997, HEREDITAS, V127, P19, DOI 10.1111/j.1601-5223.1997.00019.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FernandezVina MA, 1997, TISSUE ANTIGENS, V50, P233, DOI 10.1111/j.1399-0039.1997.tb02867.x; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gomez-Casado E, 2003, TISSUE ANTIGENS, V61, P425, DOI 10.1034/j.1399-0039.2003.00040.x; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gonzalez-Martin A, 2008, AM J HUM BIOL, V20, P605, DOI 10.1002/ajhb.20787; Granados J, 1996, LUPUS, V5, P184, DOI 10.1177/096120339600500304; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hollenbach JA, 2001, HUM IMMUNOL, V62, P378, DOI 10.1016/S0198-8859(01)00212-9; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu-Dehart E., 1995, CAMBRIDGE SURVEY WOR, P220; Infante E, 2007, IMMUNOBIOLOGY HUMAN, P633; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kijak GH, 2009, TISSUE ANTIGENS, V73, P262, DOI 10.1111/j.1399-0039.2008.01192.x; Layrisse Z, 2001, HUM IMMUNOL, V62, P992, DOI 10.1016/S0198-8859(01)00297-X; Leal CA, 2005, TISSUE ANTIGENS, V66, P666, DOI 10.1111/j.1399-0039.2005.00495.x; Lebedeva TV, 2011, TISSUE ANTIGENS, V77, P247, DOI 10.1111/j.1399-0039.2010.01616.x; Leffell MS, 2002, HUM IMMUNOL, V63, P614, DOI 10.1016/S0198-8859(02)00415-9; LISKER R, 1990, HUM BIOL, V62, P791; Loiseau P, 2007, BIOL BLOOD MARROW TR, V13, P965, DOI 10.1016/j.bbmt.2007.04.010; Mack SJ, 2007, IMMUNOBIOLOGY HUMAN, VI, P605; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Marr JS, 2000, MED HIST, V44, P341; Martinez-Cortes G, 2013, AM J PHYS ANTHROPOL, V151, P526, DOI 10.1002/ajpa.22293; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Middleton D, 2000, HUM IMMUNOL, V61, P1285, DOI 10.1016/S0198-8859(00)00186-5; Monsalve MV, 1998, HUM IMMUNOL, V59, P48, DOI 10.1016/S0198-8859(97)00251-6; Moscoso J, 2008, MOL IMMUNOL, V45, P1018, DOI 10.1016/j.molimm.2007.07.024; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Rani R, 2007, INT J IMMUNOGENET, V34, P201, DOI 10.1111/j.1744-313X.2007.00677.x; Renquin J, 2001, TISSUE ANTIGENS, V58, P211, DOI 10.1034/j.1399-0039.2001.580401.x; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Rosenmayr A, 2011, TRANSFUS MED HEMOTH, V38, P292, DOI 10.1159/000332579; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Saldanha N, 2009, J GENETIC GENEALOGY, V5, P76; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sanz P, 2001, FORENSIC SCI INT, V119, P113, DOI 10.1016/S0379-0738(00)00422-9; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shankarkumar U, 2004, HUM IMMUNOL, V65, P992, DOI 10.1016/j.humimm.2004.08.069; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Spinola H, 2005, HUM IMMUNOL, V66, P1082, DOI 10.1016/j.humimm.2005.09.001; Spinola H, 2005, TISSUE ANTIGENS, V66, P217, DOI 10.1111/j.1399-0039.2005.00471.x; Spinola H, 2002, ANN HUM GENET, V66, P285, DOI [10.1046/j.1469-1809.2002.00118.x, 10.1017/S0003480002001185]; Tereba A, 1999, PROFILES DNA, P14; Torimiro JN, 2006, TISSUE ANTIGENS, V67, P30, DOI 10.1111/j.1399-0039.2005.00527.x; Tratchenberg E, 2007, IMMUNOBIOLOGY HUMAN, P616; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; VRIES RRPD, 1979, J IMMUNOGENET, V6, P271; Wang JL, 2003, GENETICS, V164, P747; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Williams R, 2009, TISSUE ANTIGENS, V74, P520, DOI 10.1111/j.1399-0039.2009.01381.x; Yan Chunxia, 2003, Genomics Proteomics & Bioinformatics, V1, P304; YASUDA N, 1988, JPN J HUM GENET, V33, P385, DOI 10.1007/BF02032870; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Yunis EJ, 2005, ENCY MOL CELL BIOL M, V13, P191; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232	86	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74442	10.1371/journal.pone.0074442	http://dx.doi.org/10.1371/journal.pone.0074442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086347	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200031
J	Garcia-Martin, E; Agundez, JAG; Maestro, ML; Suarez, A; Vidaurreta, M; Martinez, C; Fernandez-Perez, C; Ortega, L; Ladero, JM				Garcia-Martin, Elena; Agundez, Jose A. G.; Maestro, Maria L.; Suarez, Avelina; Vidaurreta, Marta; Martinez, Carmen; Fernandez-Perez, Cristina; Ortega, Luis; Ladero, Jose M.			Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C	PLOS ONE			English	Article							PLUS RIBAVIRIN; D DEFICIENCY; FIBROSIS	Background and Aims: Vitamin D exerts immunomodulatory effects on the host response against infection with hepatitis C virus (HCV). This study was performed to assess the putative influence of polymorphisms in vitamin D-related genes on the response to antiviral therapy in patients with chronic hepatitis C (CHC). Methods: Single nucleotide polymorphisms (SNPs) in CYP27B-1260 gene promoter (rs10877012AC) and in vitamin D receptor (VDR) gene rs2228570TC, rs1544410CT, rs7975232AC and rs731236AT were analyzed in a cohort of 238 Caucasian CHC patients treated with pegylated interferon (Peg-IFN) plus ribavirin (RBV). Multivariate analyses were performed to exclude confounding effects of well-known baseline predictors of response to therapy (HCV genotype and load, IL28B genotype, age, and GGT and serum cholesterol). Results: Three SNPs at the VDR gene (rs1544410, rs7975232 and rs731236) were in strong linkage disequilibrium, with the CCA haplotype predicting therapeutic failure [Odds ratio 2.743; (95% C. I. 1.313-5.731), p = 0.007]. The carrier state of the VDR rs2228570 T allele was inversely related to the probability of therapeutic failure [Odds ratio 0.438; 95 C. I. (0.204-0.882), p = 0.021]. No relation existed between CYP27B-1260 rs10877012 polymorphism and response to therapy. The area under the operating curve (AUROC) based on the model including all variables significantly related to the response to therapy was 0.846 (95% confidence interval = 0.793-0.899). Conclusion: VDR gene polymorphisms are independently related to the response to Peg-IFN+RBV therapy in chronic hepatitis C and could be used as complementary biomarkers of response when included in a prediction algorithm in association with demographic, virologic, biochemical and genetic traits.	[Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Agundez, Jose A. G.; Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Maestro, Maria L.; Vidaurreta, Marta] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Genom Unit,Clin Lab Dept, Madrid, Spain; [Suarez, Avelina] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Serv Clin Microbiol, Madrid, Spain; [Fernandez-Perez, Cristina] Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Clin Res & Methodol Unit,Hosp Clin San Carlos,Med, E-28040 Madrid, Spain; [Ortega, Luis] Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Inst Invest Sanitaria, Serv Pathol, Madrid, Spain; [Ladero, Jose M.] Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria,Med Sch, Serv Gastroenterol,Hosp Clin San Carlos,Dept Med, E-28040 Madrid, Spain	Universidad de Extremadura; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Ladero, JM (corresponding author), Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria,Med Sch, Serv Gastroenterol,Hosp Clin San Carlos,Dept Med, E-28040 Madrid, Spain.	jladero.hcsc@salud.madrid.org	Pérez, Cristina Fernández/K-8078-2019; Agúndez, José A. G./A-5503-2008; Pérez, Cristina Fernández/I-2220-2015; García-Martin, Elena/H-9828-2016	Pérez, Cristina Fernández/0000-0001-9853-6257; Agúndez, José A. G./0000-0001-6895-9160; Pérez, Cristina Fernández/0000-0001-9853-6257; García-Martin, Elena/0000-0002-8094-046X; Vidaurreta, Marta/0000-0002-7790-6252; Ortega, Luis/0000-0002-7987-8531	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [PS09/00943, PS09/00469, PI12/00241, PI12/00324, RETICS RIRAAF RD12/0013/0002]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	This work was supported by PS09/00943, PS09/00469, PI12/00241, PI12/00324, RETICS RIRAAF RD12/0013/0002 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Arteh J, 2010, DIGEST DIS SCI, V55, P513; Baur K, 2012, ANTIVIR THER, V17, P541, DOI 10.3851/IMP2018; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bitetto D, 2013, HEPATOLOGY, V57, P925, DOI 10.1002/hep.26186; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cuenca F, 2010, REV ESP ENFERM DIG, V102, P234, DOI 10.4321/s1130-01082010000400003; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Gonzalez-Molero I, 2011, EUR J CLIN NUTR, V65, P321, DOI 10.1038/ejcn.2010.265; Gutierrez JA, 2011, SEMIN LIVER DIS, V31, P387, DOI 10.1055/s-0031-1297927; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kitanaka S, 2012, ENDOCR J, V59, P1007, DOI 10.1507/endocrj.EJ12-0143; Kitson MT, 2013, J HEPATOL, V58, P467, DOI 10.1016/j.jhep.2012.11.017; Ladero JM, 2013, ANN HEPATOL, V12, P199, DOI 10.1016/S1665-2681(19)31357-2; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Maekawa S, 2012, HEPATOLOGY, V56, P1611, DOI 10.1002/hep.25826; Miroliaee A, 2010, HEPATOL INT, V4, P634, DOI 10.1007/s12072-010-9194-2; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Witthoft T, 2007, J VIRAL HEPATITIS, V14, P788, DOI 10.1111/j.1365-2893.2007.00871.x	27	32	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74764	10.1371/journal.pone.0074764	http://dx.doi.org/10.1371/journal.pone.0074764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073221	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000030
J	Strain, EMA; Johnson, CR; Thomson, RJ				Strain, Elisabeth M. A.; Johnson, Craig R.; Thomson, Russell J.			Effects of a Range-Expanding Sea Urchin on Behaviour of Commercially Fished Abalone	PLOS ONE			English	Article							COMPETITION; COMMUNITY; HALIOTIS; HABITAT; EXPANSION; RESPONSES; IMPACTS; ECOLOGY	Background: Global climate change has resulted in a southerly range expansion of the habitat modifying sea urchin Centrostephanus rodgersii to the east coast of Tasmania, Australia. Various studies have suggested that this urchin outcompetes black-lipped abalone (Haliotis rubra) for resources, but experiments elucidating the mechanisms are lacking. Methodology/Principal Findings: We outline a new framework involving experimental manipulations and Markov chain and Pareto modelling to examine the effects of interspecific competition between urchins and abalone and the effect of intraspecific competition in abalone, assessed as effects on behaviour. Manipulations of abalone densities had no detectable effect on urchin behavioural transitions, movement patterns or resightability through time. In contrast, additions of urchins resulted in abalone shifting microhabitats from exposed to sheltered positions, an increase in the proportion of mobile abalone, and declines in abalone resightability through time relative to controls without the urchins. Our results support the hypothesis of asymmetrical competitive interactions between urchins and abalone. Conclusions/Significance: The introduction of urchins to intact algal beds causes abalone to flee and seek shelter in cryptic microhabitat which will negatively impact both their accessibility to such microhabitats, and productivity of the abalone fishery, and will potentially affect their growth and survival, while the presence of the abalone has no detectable effect on the urchin. Our approach involving field-based experiments and modelling could be used to test the effects of other invasive species on native species behaviour.	[Strain, Elisabeth M. A.] Univ Bologna, Ravenna, Italy; [Strain, Elisabeth M. A.; Johnson, Craig R.; Thomson, Russell J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Bologna; University of Tasmania	Strain, EMA (corresponding author), Univ Bologna, Ravenna, Italy.	strain.beth@gmail.com	Johnson, Craig R/E-1788-2013; Thomson, Russell J/H-5653-2012; Strain, Elisabeth/U-3520-2017	Johnson, Craig R/0000-0002-9511-905X; Thomson, Russell J/0000-0003-4949-4120; Strain, Elisabeth/0000-0003-2165-9544	Australian Postgraduate Award; Commonwealth Scientific and Industrial Research Organisation; University of Tasmania Quantitative Marine Science Program; Tasmanian Aquaculture and Fisheries Institute; Tasmanian Abalone Council	Australian Postgraduate Award(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Tasmania Quantitative Marine Science Program; Tasmanian Aquaculture and Fisheries Institute; Tasmanian Abalone Council	This study was part of a PhD supported by an Australian Postgraduate Award and the Commonwealth Scientific and Industrial Research Organisation and University of Tasmania Quantitative Marine Science Program. The research was supported by Tasmanian Aquaculture and Fisheries Institute and Tasmanian Abalone Council grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NL, 1992, MAR FRESHWATER RES, V43, P547; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Carlton JT, 1993, BIO CON, V78, P97; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Edgar G.J., 1997, REED BOOKS; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; Flukes EB, 2012, MAR ECOL PROG SER, V464, P179, DOI 10.3354/meps09881; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huchette SMH, 2003, AQUACULT INT, V11, P411, DOI 10.1023/B:AQUI.0000004194.85299.38; Johnson C., 2005, ESTABLISHMENT LONG S; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Mieszkowska N, 2006, HYDROBIOLOGIA, V555, P241, DOI 10.1007/s10750-005-1120-6; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Naylor R, 2001, WATER ATMOS, V9, P16; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; SHEPHERD SA, 1973, AUST J MAR FRESH RES, V24, P217, DOI 10.1071/MF9730217; Shepherd SA, 1973, AUST FISH, V4, P4; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Strain EMA, 2013, BIOL INVASIONS, V15, P1391, DOI 10.1007/s10530-012-0378-7; Strain EMA, 2009, MAR ECOL PROG SER, V377, P169, DOI 10.3354/meps07816; Stuart-Smith RD, 2010, GLOBAL CHANGE BIOL, V16, P122, DOI 10.1111/j.1365-2486.2009.01955.x; TODD CD, 1994, J EXP MAR BIOL ECOL, V181, P159, DOI 10.1016/0022-0981(94)90126-0; TUTSCHULTE TC, 1988, MAR ECOL PROG SER, V49, P57, DOI 10.3354/meps049057; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021	37	6	6	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73477	10.1371/journal.pone.0073477	http://dx.doi.org/10.1371/journal.pone.0073477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073195	Green Published, gold			2022-12-25	WOS:000324768000004
J	Chidlow, G; Wood, JPM; Sharma, S; Dimasi, DP; Burdon, KP; Casson, RJ; Craig, JE				Chidlow, Glyn; Wood, John P. M.; Sharma, Shiwani; Dimasi, David P.; Burdon, Kathryn P.; Casson, Robert J.; Craig, Jamie E.			Ocular Expression and Distribution of Products of the POAG-Associated Chromosome 9p21 Gene Region	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; TUMOR-SUPPRESSOR GENE; SQUAMOUS-CELL CARCINOMA; TO-DISC RATIO; METHYLTHIOADENOSINE PHOSPHORYLASE; SUSCEPTIBILITY LOCI; P15(INK4B) PROTEIN; COMMON VARIANTS; DOWN-REGULATION	It has recently been shown that there are highly significant associations for common single nucleotide polymorphisms (SNPs) near the CDKN2B-AS1 gene region at the 9p21 locus with primary open angle glaucoma (POAG), a leading cause of irreversible blindness. This gene region houses the CDKN2B/p15(INK4B), CDKN2A/p16(INK4A) and p14ARF (rat equivalent, p19(ARF)) tumour suppressor genes and is adjacent to the S-methyl-59-thioadenosine phosphorylase (MTAP) gene. In order to understand the ocular function of these genes and, therefore, how they may be involved in the pathogenesis of POAG, we studied the distribution patterns of each of their products within human and rat ocular tissues. MTAP mRNA was detected in the rat retina and optic nerve and its protein product was localised to the corneal epithelium, trabecular meshwork and retinal glial cells in both human and rat eyes. There was a very low level of p16(INK4A) mRNA present within the rat retina and slightly more in the optic nerve, although no protein product could be detected in either rat or human eyes with any of the antibodies tested. P19(ARF) mRNA was likewise only present at very low levels in rat retina and slightly higher levels in the optic nerve. However, no unambiguous evidence was found to indicate expression of specific P19(ARF)/p14(ARF) proteins in either rat or human eyes, respectively. In contrast, p15(INK4B) mRNA was detected in much higher amounts in both retina and optic nerve compared with the other genes under analysis. Moreover, p15(INK4B) protein was clearly localised to the retinal inner nuclear and ganglion cell layers and the corneal epithelium and trabecular meshwork in rat and human eyes. The presented data provide the basis for future studies that can explore the roles that these gene products may play in the pathogenesis of glaucoma and other models of optic nerve damage.	[Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Hanson Inst Ctr Neurol Dis, South Australian Inst Ophthalmol, Ophthalm Res Labs, Adelaide, SA, Australia; [Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Univ Adelaide, Dept Ophthalmol & Visual Sci, Adelaide, SA, Australia; [Sharma, Shiwani; Dimasi, David P.; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia	Hanson Institute; University of Adelaide; Flinders University South Australia	Wood, JPM (corresponding author), Hanson Inst Ctr Neurol Dis, South Australian Inst Ophthalmol, Ophthalm Res Labs, Adelaide, SA, Australia.	john.wood@health.sa.gov.au	Burdon, Kathryn/A-5026-2009; Burdon, Kathryn/AAD-2334-2022	Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X	National Health and Medical Research Council [APP1031347]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support from the National Health and Medical Research Council (http://www.nhmrc.gov.au/) in terms of a project grant (number APP1031347) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MM, 2000, FEBS LETT, V483, P160, DOI 10.1016/S0014-5793(00)02108-6; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Bulten J, 2006, GYNECOL ONCOL, V101, P487, DOI 10.1016/j.ygyno.2005.11.036; Burdon KP, 2012, OPHTHALMOLOGY, V119, P1539, DOI 10.1016/j.ophtha.2012.02.004; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Chidlow G, 2011, J HISTOCHEM CYTOCHEM, V59, P884, DOI 10.1369/0022155411418115; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Christopher SA, 2002, CANCER RES, V62, P6639; Cunnington MS, 2011, CURR ATHEROSCLER REP, V13, P193, DOI 10.1007/s11883-011-0178-z; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Feng W, 2007, MODERN PATHOL, V20, P961, DOI 10.1038/modpathol.3800927; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; GARBERS DL, 1978, BIOCHIM BIOPHYS ACTA, V523, P82, DOI 10.1016/0005-2744(78)90011-6; Gibson J, 2012, MOL VIS, V18, P1083; HALL M, 1995, ONCOGENE, V11, P1581; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Huang HY, 2009, CLIN CANCER RES, V15, P6963, DOI 10.1158/1078-0432.CCR-09-1511; Indovina P, 2010, J CELL PHYSIOL, V223, P143, DOI 10.1002/jcp.22019; Kim J, 2011, GENE CHROMOSOME CANC, V50, P421, DOI 10.1002/gcc.20867; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Legrier ME, 2001, NEUROREPORT, V12, P3127, DOI 10.1097/00001756-200110080-00029; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Mabuchi F, 2012, OPHTHALMOLOGY, V119, P1819, DOI 10.1016/j.ophtha.2012.02.044; MAO L, 1995, CANCER RES, V55, P2995; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Moad AI, 2009, J CUTAN PATHOL, V36, P183, DOI 10.1111/j.1600-0560.2008.00989.x; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Mulvany NJ, 2008, PATHOLOGY, V40, P335, DOI 10.1080/00313020802035907; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Robertson KD, 1999, ONCOGENE, V18, P3810, DOI 10.1038/sj.onc.1202737; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sato K, 2010, ONCOL REP, V24, P701, DOI 10.3892/or_00000910; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharma S, 2012, INVEST OPHTH VIS SCI, V53, P4917, DOI 10.1167/iovs.11-9047; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takamoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040107; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Watanabe G, 1998, DEV BRAIN RES, V108, P77, DOI 10.1016/S0165-3806(98)00032-7; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Wood JPM, 2005, J NEUROCHEM, V93, P686, DOI 10.1111/j.1471-4159.2005.03059.x; Zimling ZG, 2012, HISTOPATHOLOGY, V60, pE96, DOI 10.1111/j.1365-2559.2012.04196.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	71	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75067	10.1371/journal.pone.0075067	http://dx.doi.org/10.1371/journal.pone.0075067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069379	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300063
J	Rosenfeld, CS; Johnson, SA; Ellersieck, MR; Roberts, RM				Rosenfeld, Cheryl S.; Johnson, Sarah A.; Ellersieck, Mark R.; Roberts, R. Michael			Interactions between Parents and Parents and Pups in the Monogamous California Mouse (Peromyscus californicus)	PLOS ONE			English	Article							VOLE MICROTUS-PENNSYLVANICUS; MALE MONGOLIAN GERBILS; MATERNAL-CARE; PATERNAL BEHAVIOR; REPRODUCTIVE SUCCESS; STRESS RESPONSES; SEXUAL-BEHAVIOR; BIPARENTAL CARE; TESTOSTERONE; EXPRESSION	The California mouse (Peromyscus californicus) may be a valuable animal model to study parenting as it is one of the few monogamous and biparental rodent species. By using automated infra-red imaging and video documentation of established pairs spanning two days prior to birth of the litter until d 5 of post natal development (PND), it was possible to follow interactions between parents and between parents and pups. The paired males were attentive to their partners in the form of grooming and sniffing throughout the time period studied. Both these and other activities of the partners, such as eating and drinking, peaked during late light/mid-dark period. Beginning the day before birth, and most significantly on PND 0, the female made aggressive attempts to exclude the male from nest-attending, acts that were not reciprocated by the male, although he made repeated attempts to mate his partner during that period. By PND 1, males were permitted to return to the nest, where they initiated grooming, licking, and huddling over the litter, although time spent by the male on parental care was still less than that of the female. Male and female pups were of similar size and grew at the same rate. Pups, which are believed to be exothermic for at least the first two weeks post-natally, maintained a body temperature higher than that of their parents until PND 16. Data are consistent with the inference that the male California mouse parent is important in helping retain pup body heat and permit dams increased time to procure food to accommodate her increased energy needs for lactation. These assessments provide indices that may be used to assess the effects of extrinsic factors, such as endocrine disrupting chemicals, on biparental behaviors and offspring development.	[Rosenfeld, Cheryl S.; Johnson, Sarah A.; Roberts, R. Michael] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Rosenfeld, Cheryl S.; Johnson, Sarah A.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri, Agr Expt Stn Stat, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu			University of Missouri College of Veterinary Medicine	University of Missouri College of Veterinary Medicine	The project was funded by a grant from the University of Missouri College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TH, 2011, DEV PSYCHOBIOL, V53, P118, DOI 10.1002/dev.20498; Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; ALEXANDER G, 1964, SCIENCE, V146, P665, DOI 10.1126/science.146.3644.665; Bagot RC, 2012, BIOL PSYCHIAT, V72, P491, DOI 10.1016/j.biopsych.2012.03.016; Becker EA, 2010, HORM BEHAV, V58, P385, DOI 10.1016/j.yhbeh.2010.03.019; Bredy TW, 2007, EUR J NEUROSCI, V25, P567, DOI 10.1111/j.1460-9568.2006.05266.x; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cameron NM, 2011, J NEUROENDOCRINOL, V23, P393, DOI 10.1111/j.1365-2826.2011.02124.x; Cameron NM, 2008, HORM BEHAV, V54, P178, DOI 10.1016/j.yhbeh.2008.02.013; Cantoni D, 1997, ANIM BEHAV, V54, P377, DOI 10.1006/anbe.1996.0583; CAPEK K, 1956, Physiol Bohemoslov, V5, P91; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; CHANDLER T, 1979, POPULATION BIOL COAS; Clark MM, 2001, DEV PSYCHOBIOL, V39, P179, DOI 10.1002/dev.1043; Clark MM, 1999, J COMP PSYCHOL, V113, P388, DOI 10.1037/0735-7036.113.4.388; Clark MM, 2000, ANIM BEHAV, V59, P801, DOI 10.1006/anbe.1999.1365; Clark MM, 2000, DEV PSYCHOBIOL, V36, P177, DOI 10.1002/(SICI)1098-2302(200004)36:3<177::AID-DEV1>3.0.CO;2-W; Clark MM, 1998, DEV PSYCHOBIOL, V32, P177, DOI 10.1002/(SICI)1098-2302(199804)32:3<177::AID-DEV2>3.0.CO;2-L; Clark MM, 1997, ANIM BEHAV, V54, P635, DOI 10.1006/anbe.1997.0468; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DEWSBURY DA, 1985, AM ZOOL, V25, P841; DRICKAMER LC, 1973, J MAMMAL, V54, P523, DOI 10.2307/1379147; DUDLEY D, 1974, BEHAV BIOL, V11, P155, DOI 10.1016/S0091-6773(74)90305-8; DUDLEY D, 1974, BEHAV BIOL, V11, P247, DOI 10.1016/S0091-6773(74)90433-7; EISENBERG JOHN F., 1963, AMER MIDLAND NAT, V69, P240, DOI 10.2307/2422858; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; ELWOOD RW, 1975, ANIM BEHAV, V23, P766, DOI 10.1016/0003-3472(75)90104-9; ELWOOD RW, 1983, PARENTAL BEHAVIOUR R, P235; Ewer, 1968, ETHOLOGY MAMMALS; Farrell WJ, 2007, BEHAV NEUROSCI, V121, P1333, DOI 10.1037/0735-7044.121.6.1333; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; GAULIN SJC, 1990, J COMP PSYCHOL, V104, P88, DOI 10.1037/0735-7036.104.1.88; Gerrish CJ, 1996, DEV PSYCHOBIOL, V29, P483, DOI 10.1002/(SICI)1098-2302(199609)29:6<483::AID-DEV1>3.0.CO;2-I; Gerrish CJ, 1998, PHYSIOL BEHAV, V64, P463, DOI 10.1016/S0031-9384(98)00077-8; Gilbert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033553; Gleason ED, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0824; Gleason ED, 2010, HORM BEHAV, V57, P147, DOI 10.1016/j.yhbeh.2009.10.006; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; Harshaw C, 2012, PHYSIOL BEHAV, V106, P670, DOI 10.1016/j.physbeh.2012.05.002; HARTUNG TG, 1979, BEHAV NEURAL BIOL, V26, P466, DOI 10.1016/S0163-1047(79)91500-0; HATFIELD DM, 1935, J MAMMAL, V116, P261; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Jasarevic E, 2013, J COMP PSYCHOL, V127, P91, DOI 10.1037/a0027936; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Kleiman D.G., 1981, P347; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Layne JN, 1968, BIOL PEROMYSCUS RODE; Lent PC, 1974, BEHAV UNGULATES ITS; Littell RC, 1998, J ANIM SCI, V76, P1216; Liu HX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2336; LOPEZ G, 2013, J NONDESTR EVAL; Luis J, 2009, REV BIOL TROP, V57, P433; Marler CA, 2008, NEUROBIOLOGY OF THE PARENTAL BRAIN, P435, DOI 10.1016/B978-012374285-8.00028-7; MARTEN GG, 1973, J MAMMAL, V54, P169, DOI 10.2307/1378878; MCCARTY R, 1977, ANIM BEHAV, V25, P945, DOI 10.1016/0003-3472(77)90044-6; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; MCGUIRE B, 1984, ANIM BEHAV, V32, P1132, DOI 10.1016/S0003-3472(84)80229-8; MCGUIRE B, 1992, BIOL REPROD, V47, P37, DOI 10.1095/biolreprod47.1.37; McInroy JKE, 2000, HORM BEHAV, V37, P399, DOI 10.1006/hbeh.2000.1591; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; OLIVERAS D, 1986, ANIM BEHAV, V34, P519, DOI 10.1016/S0003-3472(86)80120-8; Parent CI, 2008, DEV PSYCHOBIOL, V50, P767, DOI 10.1002/dev.20342; PARENT CI, 2012, DEV PSYCHOBIOL, P86820; Reyes-Meza V, 2011, PHYSIOL BEHAV, V104, P778, DOI 10.1016/j.physbeh.2011.07.019; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; ROOD JP, 1966, AM MIDL NAT, V76, P496, DOI 10.2307/2423101; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Vieira ML, 2003, DEV PSYCHOBIOL, V42, P246, DOI 10.1002/dev.10097; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weaver ICG, 2002, J NEUROCHEM, V82, P998, DOI 10.1046/j.1471-4159.2002.01054.x; Wright SL, 2002, BEHAV PROCESS, V60, P41, DOI 10.1016/S0376-6357(02)00101-8; WYNNEEDWARDS KE, 1989, PHYSIOL BEHAV, V45, P465, DOI 10.1016/0031-9384(89)90059-0; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149	86	29	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75725	10.1371/journal.pone.0075725	http://dx.doi.org/10.1371/journal.pone.0075725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069441	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300092
J	Sobral, M; Guitian, J; Guitian, P; Larrinaga, AR				Sobral, Mar; Guitian, Jose; Guitian, Pablo; Larrinaga, Asier R.			Selective Pressure along a Latitudinal Gradient Affects Subindividual Variation in Plants	PLOS ONE			English	Article							HAWTHORN CRATAEGUS-MONOGYNA; SEED SIZE; FRUIT-SIZE; PHENOTYPIC PLASTICITY; BIRDS; ESTABLISHMENT; CONSEQUENCES; PREFERENCES; VARIABILITY; GERMINATION	Individual plants produce repeated structures such as leaves, flowers or fruits, which, although belonging to the same genotype, are not phenotypically identical. Such subindividual variation reflects the potential of individual genotypes to vary with micro-environmental conditions. Furthermore, variation in organ traits imposes costs to foraging animals such as time, energy and increased predation risk. Therefore, animals that interact with plants may respond to this variation and affect plant fitness. Thus, phenotypic variation within an individual plant could be, in part, an adaptive trait. Here we investigated this idea and we found that subindividual variation of fruit size of Crataegus monogyna, in different populations throughout the latitudinal gradient in Europe, was explained at some extent by the selective pressures exerted by seed-dispersing birds. These findings support the hypothesis that within-individual variation in plants is an adaptive trait selected by interacting animals which may have important implications for plant evolution.	[Sobral, Mar] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Guitian, Jose] Univ Santiago de Compostela, Dept Cellular Biol & Ecol, Santiago De Compostela, Spain; [Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Santiago De Compostela, Spain; [Larrinaga, Asier R.] Mediterranean Inst Adv Studies, Esporles, Spain	Stanford University; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Sobral, M (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sobral@stanford.edu	Sobral, Mar/Q-9812-2017; Larrinaga, Asier/B-3826-2013	Sobral, Mar/0000-0001-6995-0491; Larrinaga, Asier/0000-0001-6813-8784	Spanish Ministry of Science and Education [CGL2005-03826]; European Commission; Maria Barbeito fellowship (Galicia regional government, Spain); Fundacion Pedro Barrie de la Maza grant; Spanish Research Council	Spanish Ministry of Science and Education(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Maria Barbeito fellowship (Galicia regional government, Spain); Fundacion Pedro Barrie de la Maza grant; Spanish Research Council	This work was supported by the Spanish Ministry of Science and Education (project CGL2005-03826) and the European Commission (FEDER program). M.S. was the recipient of a Maria Barbeito fellowship (Galicia regional government, Spain) and a Fundacion Pedro Barrie de la Maza grant. A.R.L. received financial support from the Spanish Research Council (JAEDoc program, partially funded by the European Social Fund) during the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMPLETE BOOK BRIT B; Banuelos MJ, 2003, EVOL ECOL, V17, P19, DOI 10.1023/A:1022430302689; Bertin N, 1998, J HORTIC SCI BIOTECH, V73, P541, DOI 10.1080/14620316.1998.11511012; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; Conner J. K., 2004, PRIMER ECOLOGICAL GE; DIGGLE PK, 1995, ANNU REV ECOL SYST, V26, P531, DOI 10.1146/annurev.es.26.110195.002531; GUITIAN J., 2000, ZORZALES ESPINOS SER; Herrera C.M., 2009, MULTIPLICITY UNITY P; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Martinez I, 2007, EVOL ECOL, V21, P517, DOI 10.1007/s10682-006-9132-x; Moegenburg SM, 1996, OECOLOGIA, V106, P539, DOI 10.1007/BF00329713; MOSSOP R, 1994, FUNCT ECOL, V8, P410, DOI 10.2307/2389835; Murray BR, 2004, J BIOGEOGR, V31, P379, DOI 10.1046/j.0305-0270.2003.00993.x; PAXMAN G. J., 1956, Annals of Botany, V20, P331; Pearson K, 1901, PHILOS T R SOC LOND, V197, P285, DOI 10.1098/rsta.1901.0020; PETERS RH, 1988, OECOLOGIA, V74, P612, DOI 10.1007/BF00380061; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Quinn GP, 2003, EXPT DESIGN DATA ANA; SALLABANKS R, 1992, OECOLOGIA, V91, P296, DOI 10.1007/BF00317800; SEBURN CNL, 1990, J EVOLUTION BIOL, V3, P103, DOI 10.1046/j.1420-9101.1990.3010103.x; SEYFFERT W, 1983, THEOR APPL GENET, V64, P205, DOI 10.1007/BF00303765; Sobral M, 2010, SELECCION EJERCIDA M; Sobral M, 2010, EVOL ECOL, V24, P1277, DOI 10.1007/s10682-010-9380-7; Sobral M, 2010, AUK, V127, P532, DOI 10.1525/auk.2010.09079; Thompson JN, 1994, COEVOLUTIONARY PROCE; Traveset A, 2008, ECOLOGY, V89, P95, DOI 10.1890/07-0094.1; WHEELWRIGHT NT, 1993, VEGETATIO, V108, P163; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Winn AA, 1996, J EVOLUTION BIOL, V9, P737, DOI 10.1046/j.1420-9101.1996.9060737.x; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; Zar JH., 2010, BIOSTAT ANAL	36	25	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74356	10.1371/journal.pone.0074356	http://dx.doi.org/10.1371/journal.pone.0074356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069297	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300031
J	Tang, Z; Araysi, LM; Fathallah-Shaykh, HM				Tang, Zhuo; Araysi, Lita M.; Fathallah-Shaykh, Hassan M.			c-Src and Neural Wiskott-Aldrich Syndrome Protein (NWASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas	PLOS ONE			English	Article							RECURRENT MALIGNANT GLIOMAS; INDUCIBLE FACTOR-I; ARP2/3 COMPLEX; N-WASP; CELL-MIGRATION; ORGANOTYPIC CULTURES; TUMOR PROGRESSION; NERVOUS-TISSUE; HYPOXIA; GLIOBLASTOMA	Malignant gliomas remain associated with poor prognosis and high morbidity because of their ability to invade the brain; furthermore, human gliomas exhibit a phenotype of accelerated brain invasion in response to anti-angiogenic drugs. Here, we study 8 human glioblastoma cell lines; U251, U87, D54 and LN229 show accelerated motility in low ambient oxygen. Src inhibition by Dasatinib abrogates this phenotype. Molecular discovery and validation studies evaluate 46 molecules related to motility or the src pathway in U251 cells. Demanding that the molecular changes induced by low ambient oxygen are reversed by Dasatinib in U251 cells, identifies neural Wiskott-Aldrich syndrome protein (NWASP), Focal adhesion Kinase (FAK), beta-Catenin, and Cofilin. However, only Src-mediated NWASP phosphorylation distinguishes the four cell lines that exhibit enhanced motility in low ambient oxygen. Downregulating c-Src or NWASP by RNA interference abrogates the low-oxygen-induced enhancement in motility by in vitro assays and in organotypic brain slice cultures. The findings support the idea that c-Src and NWASP play key roles in mediating the molecular pathogenesis of low oxygen-induced accelerated brain invasion by gliomas.	[Tang, Zhuo; Araysi, Lita M.; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Mech Engn, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Neurosci Ctr, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hfathall@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685	Gaining Life Initiative Foundation	Gaining Life Initiative Foundation	The research is funded in part by the Gaining Life Initiative Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agha CA, 2010, ANTICANCER RES, V30, P609; BIGNER DD, 1977, J NEUROPATH EXP NEUR, V36, P593, DOI 10.1097/00005072-197705000-00027; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fathallah-Shaykh HM, 2005, BIOCHEM BIOPH RES CO, V336, P1278, DOI 10.1016/j.bbrc.2005.08.254; Fathallah-Shaykh HM, 2000, GENE THER, V7, P2094, DOI 10.1038/sj.gt.3301346; Fujiwara S, 2007, INT J ONCOL, V30, P793; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gerlee P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002556; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hatzikirou H, 2010, MATH MED BIOL; Hockel M, 1999, CANCER RES, V59, P4525; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ji HT, 2011, J NEURO-ONCOL, V103, P445, DOI 10.1007/s11060-010-0413-4; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Levin VA, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-5; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MILLER LDP, 1993, SYNAPSE, V13, P195, DOI 10.1002/syn.890130302; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pham K, 2012, J BIOL DYNAM, V6, P54, DOI 10.1080/17513758.2011.590610; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; PIGUET V, 1985, SPRINGER SEMIN IMMUN, V8, P111, DOI 10.1007/BF00197250; Plasswilm L, 2000, PATHOBIOLOGY, V68, P99, DOI 10.1159/000055909; Ponten J, 1975, HUMAN TUMOR CELLS IN, P175, DOI [10.1007/9781-47571647-4_7, DOI 10.1007/9781-47571647-4_7]; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; SCHNEGG JF, 1981, CANCER RES, V41, P1209; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takahashi K, 2011, J CELL BIOCHEM, V112, P3421, DOI 10.1002/jcb.23276; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Thompson EM, 2011, J NEURO-ONCOL, V103, P353, DOI 10.1007/s11060-010-0397-0; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WELCH WC, 1995, IN VITRO CELL DEV-AN, V31, P610; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zhu SK, 2011, MOL CARCINOGEN, V50, P770, DOI 10.1002/mc.20678	61	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75436	10.1371/journal.pone.0075436	http://dx.doi.org/10.1371/journal.pone.0075436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069415	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300079
J	Han, XJ; Sun, LF; Nishiyama, Y; Feng, B; Michiue, H; Seno, M; Matsui, H; Tomizawa, K				Han, Xiao-Jian; Sun, Ling-Fei; Nishiyama, Yuki; Feng, Bin; Michiue, Hiroyuki; Seno, Masaharu; Matsui, Hideki; Tomizawa, Kazuhito			Theranostic Protein Targeting ErbB2 for Bioluminescence Imaging and Therapy for Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; IN-VIVO; GAUSSIA LUCIFERASE; BREAST-CANCER; TRANSDUCTION THERAPY; SIGNALING NETWORK; BLADDER-CANCER; OVARIAN-CANCER; MUTANT P53; CELLS	A combination of molecular-targeted cancer imaging and therapy is an emerging strategy to improve cancer diagnosis and minimize the side effects of conventional treatments. Here, we generated a recombinant protein, EC1-GLuc-p53C, by fusing EC1 peptide, an artificial ligand of ErbB2, with Gaussia luciferase (GLuc) and a p53-activating peptide, p53C. EC1-GLuc-p53C was expressed and purified from E. coli BL21. In vitro experiments showed that EC1-GLuc-p53c was stable in luminescent activity and selectively targeted ErbB2-overexpressing BT474 cells for bioluminescence imaging. Moreover, the internalized EC1-GLuc-p53C in BT474 cells exerted its function to reactivate p53 and significantly inhibited cellular proliferation. In tumor-bearing mice, the ErbB2-targeted bioluminescence imaging and therapeutic effect of EC1-GLuc-p53C were also observed specifically in BT474 tumors but not in MCF7 tumors, which does not overexpress ErbB2. Thus, the present study demonstrates EC1-GLuc-p53C to be an effective theranostic reagent targeting ErbB2 for bioluminescence imaging and cancer therapy.	[Han, Xiao-Jian; Sun, Ling-Fei; Nishiyama, Yuki; Feng, Bin; Michiue, Hiroyuki; Matsui, Hideki] Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan; [Han, Xiao-Jian] Japan Soc Promot Sci, Tokyo, Japan; [Seno, Masaharu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan; [Han, Xiao-Jian] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China; [Feng, Bin] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China	Okayama University; Kumamoto University; Japan Society for the Promotion of Science; Okayama University; Nanchang University; Dalian Medical University	Tomizawa, K (corresponding author), Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan.	tomikt@kumamoto-u.ac.jp	Tomizawa, Kazuhito/F-2405-2015; MICHIUE, Hiroyuki/B-2320-2011	Tomizawa, Kazuhito/0000-0002-5663-2627; 	Ministry of Education, Science, Sports and Culture of Japan [21790202]; Japan Society for the Promotion of Science [22.00119]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grant-in-aid for Young Scientists (B) from the Ministry of Education, Science, Sports and Culture of Japan (No: 21790202, http://www.waseda.jp/rps/en/manual/kakenhi_honbun.html) and by Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (No: 22.00119, http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki D, 2010, UROLOGY, V75, P813, DOI 10.1016/j.urology.2009.10.002; BERCHUCK A, 1990, CANCER RES, V50, P4087; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Del Vecchio S, 2007, Q J NUCL MED MOL IM, V51, P152; Ding H, 2012, THERANOSTICS, V2, P1040, DOI 10.7150/thno.4652; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Feng B, 2010, BIOMATERIALS, V31, P4139, DOI 10.1016/j.biomaterials.2010.01.086; Feng B, 2009, BIOMATERIALS, V30, P1746, DOI 10.1016/j.biomaterials.2008.12.010; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Funkhouser J., 2002, CURR DRUG DISCOV, V2, P17; Govindarajan S, 2012, BIOMATERIALS, V33, P2570, DOI 10.1016/j.biomaterials.2011.12.003; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Haberkorn U, 2011, Q J NUCL MED MOL IM, V55, P655; Hashizume T, 2008, CELL BIOL INT, V32, P814, DOI 10.1016/j.cellbi.2008.03.012; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Inoue M, 2006, EUR UROL, V49, P161, DOI 10.1016/j.eururo.2005.08.019; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kim R, 2002, ONCOL REP, V9, P3; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P5217, DOI 10.1021/bi00643a009; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pero SC, 2004, INT J CANCER, V111, P951, DOI 10.1002/ijc.20306; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vaidyanath A, 2011, J CELL MOL MED, V15, P2525, DOI 10.1111/j.1582-4934.2011.01277.x; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463	43	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75288	10.1371/journal.pone.0075288	http://dx.doi.org/10.1371/journal.pone.0075288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069396	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300075
J	Wen, J; Xiong, ZQ; Nie, ZL; Mao, LK; Zhu, YB; Kan, XZ; Ickert-Bond, SM; Gerrath, J; Zimmer, EA; Fang, XD				Wen, Jun; Xiong, Zhiqiang; Nie, Ze-Long; Mao, Likai; Zhu, Yabing; Kan, Xian-Zhao; Ickert-Bond, Stefanie M.; Gerrath, Jean; Zimmer, Elizabeth A.; Fang, Xiao-Dong			Transcriptome Sequences Resolve Deep Relationships of the Grape Family	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; NUCLEAR GENE DATA; RNA-SEQ DATA; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; ANGIOSPERM DIVERSIFICATION; PARTHENOCISSUS VITACEAE; SEED MORPHOLOGY; EVOLUTION	Previous phylogenetic studies of the grape family (Vitaceae) yielded poorly resolved deep relationships, thus impeding our understanding of the evolution of the family. Next-generation sequencing now offers access to protein coding sequences very easily, quickly and cost-effectively. To improve upon earlier work, we extracted 417 orthologous single-copy nuclear genes from the transcriptomes of 15 species of the Vitaceae, covering its phylogenetic diversity. The resulting transcriptome phylogeny provides robust support for the deep relationships, showing the phylogenetic utility of transcriptome data for plants over a time scale at least since the mid-Cretaceous. The pros and cons of transcriptome data for phylogenetic inference in plants are also evaluated.	[Wen, Jun; Zimmer, Elizabeth A.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC166, Washington, DC 20560 USA; [Xiong, Zhiqiang; Mao, Likai; Zhu, Yabing; Fang, Xiao-Dong] BGI Shenzhen, Shenzhen, Peoples R China; [Nie, Ze-Long] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Kan, Xian-Zhao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Ickert-Bond, Stefanie M.] Univ Alaska Fairbanks, UA Museum North Herbarium, Fairbanks, AK USA; [Ickert-Bond, Stefanie M.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Gerrath, Jean] Univ No Iowa, Dept Biol, Cedar Falls, IA 50614 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Anhui Normal University; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Northern Iowa	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC166, Washington, DC 20560 USA.	wenj@si.edu; fangxd@genomics.org.cn	Kan, Xianzhao/AAA-5050-2021; Hou, Chen/L-2249-2015; Fang, Xiaodong/K-6743-2018; Nie, Ze-Long/N-8471-2015; Ickert-Bond, Stefanie M./B-3216-2012	Kan, Xianzhao/0000-0002-9225-407X; Fang, Xiaodong/0000-0001-7061-3337; Nie, Ze-Long/0000-0001-8065-3981; Ickert-Bond, Stefanie M./0000-0001-8198-8898	Office of the Smithsonian Undersecretary of Science; US National Science Foundation [DEB 0743474, DEB 0743499]; National Museum of Natural History of the Smithsonian Institution; trust funds	Office of the Smithsonian Undersecretary of Science; US National Science Foundation(National Science Foundation (NSF)); National Museum of Natural History of the Smithsonian Institution(Smithsonian InstitutionSmithsonian National Museum of Natural History); trust funds	This study was funded by grants from the Office of the Smithsonian Undersecretary of Science, the US National Science Foundation (grant DEB 0743474 to S. R. Manchester and J. Wen, and grant DEB 0743499 to J. Gerrath), the Small Grants Program of the National Museum of Natural History of the Smithsonian Institution to JW, and trust funds generated by EAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bell CD, 2012, MOL PHYLOGENET EVOL, V63, P724, DOI 10.1016/j.ympev.2012.02.015; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Chen I, 2007, AM J BOT, V94, P1534, DOI 10.3732/ajb.94.9.1534; Chen I, 2011, INT J PLANT SCI, V172, P1, DOI 10.1086/657283; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Franzke A, 2009, TAXON, V58, P425, DOI 10.1002/tax.582009; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grover CE, 2012, AM J BOT, V99, P312, DOI 10.3732/ajb.1100323; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Lartillot NS, 2012, PHYLOBAYES P 3 3 BAY; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu XQ, 2013, MOL PHYLOGENET EVOL, V66, P43, DOI 10.1016/j.ympev.2012.09.003; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Lu LM, 2012, BOT J LINN SOC, V168, P43, DOI 10.1111/j.1095-8339.2011.01186.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McKain MR, 2012, AM J BOT, V99, P397, DOI 10.3732/ajb.1100537; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Plunkett GM, 2004, PLANT SYST EVOL, V245, P1, DOI 10.1007/s00606-003-0101-3; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen J, 2001, SYST BOT, V26, P144; Wen J, 2007, VITACEAE K KUBITZKI, V9, P466; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015	59	76	79	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74394	10.1371/journal.pone.0074394	http://dx.doi.org/10.1371/journal.pone.0074394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069307	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300039
J	Egge, E; Bittner, L; Andersen, T; Audic, S; de Vargas, C; Edvardsen, B				Egge, Elianne; Bittner, Lucie; Andersen, Tom; Audic, Stephane; de Vargas, Colomban; Edvardsen, Bente			454 Pyrosequencing to Describe Microbial Eukaryotic Community Composition, Diversity and Relative Abundance: A Test for Marine Haptophytes	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; CHRYSOCHROMULINA-POLYLEPIS; BLOOM DYNAMICS; RARE BIOSPHERE; GENOME SIZE; GROWTH-RATE; COMPLEXITY; SEQUENCES; ACCURACY; WRINKLES	Next generation sequencing of ribosomal DNA is increasingly used to assess the diversity and structure of microbial communities. Here we test the ability of 454 pyrosequencing to detect the number of species present, and assess the relative abundance in terms of cell numbers and biomass of protists in the phylum Haptophyta. We used a mock community consisting of equal number of cells of 11 haptophyte species and compared targeting DNA and RNA/cDNA, and two different V4 SSU rDNA haptophyte-biased primer pairs. Further, we tested four different bioinformatic filtering methods to reduce errors in the resulting sequence dataset. With sequencing depth of 11000-20000 reads and targeting cDNA with Haptophyta specific primers Hap454 we detected all 11 species. A rarefaction analysis of expected number of species recovered as a function of sampling depth suggested that minimum 1400 reads were required here to recover all species in the mock community. Relative read abundance did not correlate to relative cell numbers. Although the species represented with the largest biomass was also proportionally most abundant among the reads, there was generally a weak correlation between proportional read abundance and proportional biomass of the different species, both with DNA and cDNA as template. The 454 sequencing generated considerable spurious diversity, and more with cDNA than DNA as template. With initial filtering based only on match with barcode and primer we observed 100-fold more operational taxonomic units (OTUs) at 99% similarity than the number of species present in the mock community. Filtering based on quality scores, or denoising with PyroNoise resulted in ten times more OTU99% than the number of species. Denoising with AmpliconNoise reduced the number of OTU99% to match the number of species present in the mock community. Based on our analyses, we propose a strategy to more accurately depict haptophyte diversity using 454 pyrosequencing.	[Egge, Elianne; Andersen, Tom; Edvardsen, Bente] Univ Oslo, Dept Biosci, Oslo, Norway; [Bittner, Lucie; Audic, Stephane; de Vargas, Colomban] CNRS, UMR7144, Roscoff, France; [Bittner, Lucie; Audic, Stephane; de Vargas, Colomban] UPMC, Stn Biol Roscoff, Roscoff, France; [Bittner, Lucie] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, Germany	University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Kaiserslautern	Egge, E (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	e.s.egge@ibv.uio.no; bente.edvardsen@ibv.uio.no	Bittner, Lucie/ABF-4617-2020; Bittner, Lucie/AAD-8921-2019	Bittner, Lucie/0000-0001-8291-7063; de Vargas, Colomban/0000-0002-6476-6019; Edvardsen, Bente/0000-0002-6806-4807; Audic, Stephane/0000-0001-6193-4374	Norwegian Research Council [190307 HAPTODIV]; ASSEMBLE [227799]; EU	Norwegian Research Council(Research Council of NorwayEuropean Commission); ASSEMBLE; EU(European Commission)	Financial support was given by the Norwegian Research Council (www.forskningsradet.no), through grant 190307 HAPTODIV to ESE and BE, by ASSEMBLE (www.assemblemarine.org) FP7 grant agreement no 227799 (research stay for ESE at the SBR), and through the EU project BioMarKs (www.biomarks.eu) to LB, CdV and BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Binder BJ, 1998, APPL ENVIRON MICROB, V64, P3346; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Dittami SM, 2012, J PHYCOL, V48, P1050, DOI 10.1111/j.1529-8817.2012.01183.x; DORTCH Q, 1983, MAR ECOL PROG SER, V13, P61, DOI 10.3354/meps013061; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edvardsen B, 2000, PHYCOLOGIA, V39, P19, DOI 10.2216/i0031-8884-39-1-19.1; Edvardsen B., 1998, NATO ASI Series Series G Ecological Sciences, V41, P193; Edvardsen B, 1998, PHYCOLOGIA, V37, P275, DOI 10.2216/i0031-8884-37-4-275.1; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Eller G, 2007, J PLANKTON RES, V29, P629, DOI 10.1093/plankt/fbm045; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P208; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Green JC, 1994, HAPTOPHYTE ALGAE; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jacobs J, 2009, R FUNCTION RAREFACTI; John U, 2010, EUR J PHYCOL, V45, P215, DOI 10.1080/09670261003746193; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; KJELDGAARD NO, 1963, J MOL BIOL, V6, P341, DOI 10.1016/S0022-2836(63)80093-5; Koid A, 2012, APPL ENVIRON MICROB, V78, P3958, DOI 10.1128/AEM.06941-11; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lange M, 1996, J PHYCOL, V32, P858, DOI 10.1111/j.0022-3646.1996.00858.x; Lekve K, 2006, P ROY SOC B-BIOL SCI, V273, P3047, DOI 10.1098/rspb.2006.3656; Lepere C, 2011, FEMS MICROBIOL ECOL, V76, P513, DOI 10.1111/j.1574-6941.2011.01072.x; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Malin G, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P127; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; Nosenko T, 2007, J PHYCOL, V43, P763, DOI 10.1111/j.1529-8817.2007.00365.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Development Core Team, 2012, R LANG ENV STAT COMP; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Thomsen Helge A., 1994, Systematics Association Special Volume Series, V51, P187; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P218; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von Dassow P, 2008, J PHYCOL, V44, P335, DOI 10.1111/j.1529-8817.2008.00476.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wintzingerode F., 1997, MICROBIOLOGY REV, V21, P213, DOI DOI 10.1111/J.1574-6976.1997.TB00351.X.PUBMED:9451814	67	93	97	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74371	10.1371/journal.pone.0074371	http://dx.doi.org/10.1371/journal.pone.0074371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069303	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100103
J	de la Camara, CMF; Salom, D; Sequedo, MD; Hervas, D; Marin-Lambies, C; Aller, E; Jaijo, T; Diaz-LLopis, M; Millan, JM; Rodrigo, R				Martinez-Fernandez de la Camara, Cristina; Salom, David; Dolores Sequedo, Ma; Hervas, David; Marin-Lambies, Cristina; Aller, Elena; Jaijo, Teresa; Diaz-LLopis, Manuel; Maria Millan, Jose; Rodrigo, Regina			Altered Antioxidant-Oxidant Status in the Aqueous Humor and Peripheral Blood of Patients with Retinitis Pigmentosa	PLOS ONE			English	Article							CONE CELL-DEATH; EXTRACELLULAR-SUPEROXIDE DISMUTASE; CHRONIC INFLAMMATORY REACTION; OXIDATIVE STRESS; NITRIC-OXIDE; GLUTATHIONE-PEROXIDASE; RETINAL DEGENERATION; PHOTORECEPTOR CELLS; PLASMA-LEVELS; FLOW	Retinitis Pigmentosa is a common form of hereditary retinal degeneration constituting the largest Mendelian genetic cause of blindness in the developed world. It has been widely suggested that oxidative stress possibly contributes to its pathogenesis. We measured the levels of total antioxidant capacity, free nitrotyrosine, thiobarbituric acid reactive substances (TBARS) formation, extracellular superoxide dismutase (SOD3) activity, protein, metabolites of the nitric oxide/cyclic GMP pathway, heme oxygenase-I and inducible nitric oxide synthase expression in aqueous humor or/and peripheral blood from fifty-six patients with retinitis pigmentosa and sixty subjects without systemic or ocular oxidative stress-related disease. Multivariate analysis of covariance revealed that retinitis pigmentosa alters ocular antioxidant defence machinery and the redox status in blood. Patients with retinitis pigmentosa present low total antioxidant capacity including reduced SOD3 activity and protein concentration in aqueous humor. Patients also show reduced SOD3 activity, increased TBARS formation and upregulation of the nitric oxide/cyclic GMP pathway in peripheral blood. Together these findings confirmed the hypothesis that patients with retinitis pigmentosa present reduced ocular antioxidant status. Moreover, these patients show changes in some oxidative-nitrosative markers in the peripheral blood. Further studies are needed to clarify the relationship between these peripheral markers and retinitis pigmentosa.	[Martinez-Fernandez de la Camara, Cristina; Dolores Sequedo, Ma; Aller, Elena; Jaijo, Teresa; Maria Millan, Jose; Rodrigo, Regina] Hlth Res Inst La Fe, Valencia, Spain; [Salom, David; Marin-Lambies, Cristina; Diaz-LLopis, Manuel] La Fe Univ Hosp, Dept Ophthalmol, Valencia, Spain; [Hervas, David] Hlth Res Inst La Fe, Biostat Unit, Valencia, Spain; [Aller, Elena; Jaijo, Teresa; Maria Millan, Jose] Ctr Biomed Network Res Rare Dis CIBERER, Valencia, Spain; [Maria Millan, Jose] La Fe Univ Hosp, Genet Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rodrigo, R (corresponding author), Hlth Res Inst La Fe, Valencia, Spain.	regina.rodrigo@yahoo.es	Rodrigo, Regina/I-1868-2015; Salom, David/ABH-6567-2020; Hervas, David/L-1322-2016; Jaijo, Teresa/A-4801-2010; Martinez, Cristina/ABH-7295-2020; Aller, Elena/A-4803-2010	Rodrigo, Regina/0000-0001-5875-986X; Hervas, David/0000-0003-0635-4961; Martinez, Cristina/0000-0002-6612-6162; Aller, Elena/0000-0001-7973-5250; Jaijo, Teresa/0000-0003-0973-9146; Marin-Lambies, Cristina/0000-0002-2334-1313; Salom, David/0000-0002-6341-2905	European Regional Development Fund, Institute of Health Carlos III; Spanish Ministry of Science and Innovation (MICINN) [PI10/01825]; Institute of Health Carlos III [CP09/118]	European Regional Development Fund, Institute of Health Carlos III; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III)	This work was supported by the European Regional Development Fund, Institute of Health Carlos III and PI10/01825 from the Spanish Ministry of Science and Innovation (MICINN). CIBERER is an initiative of the Institute of Health Carlos III from the MICINN. Regina Rodrigo has a researcher-contract SNS Miguel Servet (CP09/118) from Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja-Jensen P, 2007, NEUROREPORT, V18, P797, DOI 10.1097/WNR.0b013e3280c1e344; Akeo K, 1999, PIGM CELL RES, V12, P107, DOI 10.1111/j.1600-0749.1999.tb00750.x; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; BAZAN NG, 1994, J OCUL PHARMACOL, V10, P591, DOI 10.1089/jop.1994.10.591; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1306, DOI 10.1001/archopht.122.9.1306; Berson EL, 2012, ARCH OPHTHALMOL-CHIC, V130, P707, DOI 10.1001/archophthalmol.2011.2580; Beutelspacher SC, 2011, GRAEF ARCH CLIN EXP, V249, P1855, DOI 10.1007/s00417-011-1757-y; Break TJ, 2012, J IMMUNOL, V188, P3342, DOI 10.4049/jimmunol.1102341; Catala Angel, 2011, Front Biosci (Schol Ed), V3, P52, DOI 10.2741/s131; Romero CC, 2012, REV ESP SALUD PUBLIC, V86, P177; Cellini M, 2002, OPHTHALMOLOGICA, V216, P265, DOI 10.1159/000063841; Cellini M, 2010, CAN J PHYSIOL PHARM, V88, P630, DOI 10.1139/Y10-036; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Falsini B, 2011, INVEST OPHTH VIS SCI, V52, P1064, DOI 10.1167/iovs.10-5964; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; FLANAGAN JG, 1993, GRAEF ARCH CLIN EXP, V231, P465, DOI 10.1007/BF02044233; Frank RN, 1999, AM J OPHTHALMOL, V127, P694, DOI 10.1016/S0002-9394(99)00032-X; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Grunwald JE, 1996, AM J OPHTHALMOL, V122, P502, DOI 10.1016/S0002-9394(14)72109-9; Guo L, 1994, Yan Ke Xue Bao, V10, P224; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Huberty C., 2006, APPL MANOVA DISCRIMI; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KIMURA S, 1987, J IMMUNOL, V138, P4387; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; LANGHAM ME, 1990, EYE, V4, P374, DOI 10.1038/eye.1990.50; Lau LI, 2010, INVEST OPHTH VIS SCI, V51, P5486, DOI 10.1167/iovs.10-5663; Lee SY, 2011, J CELL PHYSIOL, V226, P1843, DOI 10.1002/jcp.22508; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Mamo LB, 2004, AM J RESP CRIT CARE, V170, P313, DOI 10.1164/rccm.200309-1282OC; Mancino R, 2011, MOL VIS, V17, P1298; Massof RW, 2010, ARCH OPHTHALMOL-CHIC, V128, P493, DOI 10.1001/archophthalmol.2010.46; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Ohguro H, 2010, CLIN OPHTHALMOL, V4, P569; PETERS RM, 1995, AM J CARDIOL, V76, P648, DOI 10.1016/S0002-9149(99)80190-8; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254; Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Rosenbaum PR, 2005, SENSITIVITY ANAL OBS; Salom D, 2008, INVEST OPHTH VIS SCI, V49, P3499, DOI 10.1167/iovs.07-1168; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; SCHAUMBERGER M, 1995, INVEST OPHTH VIS SCI, V36, P1390; Schmidt KG, 2001, BRIT J OPHTHALMOL, V85, P678, DOI 10.1136/bjo.85.6.678; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; STANZIAL AM, 1991, J ENDOCRINOL INVEST, V14, P367, DOI 10.1007/BF03349085; Sun MH, 2007, INVEST OPHTH VIS SCI, V48, P5699, DOI 10.1167/iovs.07-0340; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Vingolo EM, 2010, REGUL PEPTIDES, V160, P64, DOI 10.1016/j.regpep.2009.12.006; Wittes J, 2011, ARCH OPHTHALMOL-CHIC, V129, P675, DOI 10.1001/archophthalmol.2011.76; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845	69	60	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74223	10.1371/journal.pone.0074223	http://dx.doi.org/10.1371/journal.pone.0074223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069283	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100091
J	Shen, J; Kassir, MA; Wu, JL; Zhang, Q; Zhou, SY; Xuan, SY; Li, QH; Ye, YQ; Hu, JN				Shen, Jing; Kassir, Mohammad A.; Wu, Jianlin; Zhang, Qing; Zhou, Shiyu; Xuan, Stephanie Y.; Li, Qinghang; Ye, Yongquan; Hu, Jiani			MR Volumetric Study of Piriform-Cortical Amygdala and Orbitofrontal Cortices: The Aging Effect	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; ODOR IDENTIFICATION; PARKINSONS-DISEASE; IN-VIVO; CORTEX; DISCRIMINATION; SCHIZOPHRENIA; DYSFUNCTION; DEMENTIA; SUGGEST	Introduction: The piriform cortex and cortical amygdala (PCA) and the orbitofrontal cortex (OFC) are considered olfactory-related brain regions. This study aims to elucidate the normal volumes of PCA and OFC of each age groups (20.0-70.0 year old), and whether the volumes of PCA and OFC decline with increasing age and diminishing olfactory function. Methods: One hundred and eleven healthy right-handed participants (54 males, 57 females), age 20.0 to 70.0 years were recruited to join this study after excluding all the major causes of olfactory dysfunction. Volumetric measurements of PCA and OFC were performed using consecutive 1-mm thick coronal slices of high-resolution 3-D MRIs. A validated olfactory function test (Sniffin' Sticks) assessed olfactory function, which measured odor threshold (THD), odor discrimination (DIS), and odor identification (ID) as well as their sum score (TDI). Results: The volume of OFC decreased with age and significantly correlated with age-related declines in olfactory function. The volume of OFC showed significant age-group differences, particularly after 40 years old (p < 0.001), while olfactory function decreased significantly after 60 years old (p < 0.001). Similar age-related volumetric changes were not found for PCA (p = 0.772). Additionally, there was significant correlation between OFC and DIS on the Right Side (p = 0.028) and between OFC and TDI on both sides (p < 0.05). There was no similar correlation for PCA. Conclusions: Aging can have a great impact on the volume of OFC and olfactory function while it has much smaller effect on the volume of PCA. The result could be useful to establish normal volumes of PCA and OFC of each age group to assess neurological disorders that affect olfactory function.	[Shen, Jing; Wu, Jianlin; Zhang, Qing] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Peoples R China; [Kassir, Mohammad A.; Ye, Yongquan; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Zhou, Shiyu] Dalian Med Univ, Dept Mental Hlth, Dalian, Peoples R China; [Xuan, Stephanie Y.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Li, Qinghang] Wayne State Univ, Dept Neurol Surg, Detroit, MI USA	Dalian University; Wayne State University; Dalian Medical University; University of Toronto; Wayne State University	Wu, JL (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Peoples R China.	cjr.wujianlin@vip.163.com			National Natural Science Foundation of China [30470515, 30770768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30470515 and No. 30770768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; CAIN WS, 1989, ANN NY ACAD SCI, V561, P29; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Chase HW, 2008, NEUROPSYCHOLOGIA, V46, P1326, DOI 10.1016/j.neuropsychologia.2007.12.011; Crespo-Facorro B, 1999, NEUROIMAGE, V10, P500, DOI 10.1006/nimg.1999.0489; CURCIO CA, 1985, J COMP NEUROL, V235, P519, DOI 10.1002/cne.902350409; Delon-Martin C, 2013, NEUROIMAGE, V68, P55, DOI 10.1016/j.neuroimage.2012.11.044; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1989, ANN NY ACAD SCI, V561, P76, DOI 10.1111/j.1749-6632.1989.tb20971.x; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kolb B, 1996, FUNDAMENTALS HUMAN N; Koritnik B, 2009, PULM PHARMACOL THER, V22, P97, DOI 10.1016/j.pupt.2008.10.009; Moscovich M, 2012, J NEUROL NEUROSUR PS, V83, P970, DOI 10.1136/jnnp-2012-302770; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Pardini M, 2009, ARCH NEUROL-CHICAGO, V66, P92, DOI 10.1001/archneurol.2008.521; Pereira PMG, 2005, AM J NEURORADIOL, V26, P319; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Seubert J, 2012, CEREB CORTEX; Shen J, 2012, MR VOLUMETRIC ANAL P; Shu CH, 2008, EUR ARCH OTO-RHINO-L, V265, P787, DOI 10.1007/s00405-007-0551-2; TANABE T, 1975, J NEUROPHYSIOL, V38, P1269, DOI 10.1152/jn.1975.38.5.1269; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Turkheimer F, 2000, NEUROIMAGE, V12, P219, DOI 10.1006/nimg.2000.0608; Wilson DA, 2010, NEUROBIOLOGY OLFACTI, P14; ZATORRE RJ, 1991, BRAIN, V114, P71; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032; Zhou SY, 2005, PSYCHIAT RES-NEUROIM, V139, P127, DOI 10.1016/j.pscychresns.2005.05.005; Zhou SY, 2003, BIOL PSYCHIAT, V54, P427, DOI 10.1016/S0006-3223(03)00007-6	48	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74526	10.1371/journal.pone.0074526	http://dx.doi.org/10.1371/journal.pone.0074526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069317	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100109
J	Tsa, CH; Muo, CH; Tzeng, HE; Tang, CH; Hsu, HC; Sung, FC				Tsa, Chun-Hao; Muo, Chih-Hsin; Tzeng, Huey-En; Tang, Chih-Hsin; Hsu, Horng-Chang; Sung, Fung-Chang			Fracture in Asian Women with Breast Cancer Occurs at Younger Age	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OSTEOPOROTIC FRACTURES; ADJUVANT CHEMOTHERAPY; INTERGROUP EXEMESTANE; EARLY MENOPAUSE; OLDER WOMEN	Background: Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast cancer occurs 10 to 20 years earlier in Asian women than in Western women. We investigated if younger Asian women with breast cancer also have increased risk of fracture. Methods: We used the universal insurance claims data from 2000 to 2003 to identify 22,076 patients with breast cancer and 88,304 women without cancer, frequency matched with age and index date (the date for a health care visit). The incidence of fracture in both cohorts and the hazard ratios (HRs) of fracture in the cancer cohort were estimated by the end of 2009. Results: The incidence of all types of fracture was higher in the breast cancer cohort than in the comparison cohort (46.72 vs. 42.52 per 10,000 person-years), with adjusted HRs (aHRs) of 1.18 (95% confidence intervals [CI], 1.03-1.35) for hip fractures, 1.12 (95% CI, 0.98-1.28) for forearm fractures and 1.24 (95% CI, 1.04-1.48) for vertebral fractures. The aHRs were significant in both non-traumatic fractures (1.29; 95% CI, 1.11-1.51) and traumatic fractures (1.12; 95% CI, 1.01-1.23). The age-specific aHR was higher for younger breast cancer patients, and was significant for,50 years old patients in both traumatic (aHR 1.35; 95% CI 1.08-1.68) and non-traumatic (aHR, 1.72; 95% CI, 1.21-2.44) fractures. Conclusion: This study suggests that Asian women with breast cancer might have an increased risk of fracture.	[Tsa, Chun-Hao; Tzeng, Huey-En; Hsu, Horng-Chang] China Med Univ, Grad Inst Med, Taichung, Taiwan; [Tsa, Chun-Hao; Tang, Chih-Hsin; Hsu, Horng-Chang] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tzeng, Huey-En] Taichung Vet Gen Hosp, Div Hematol Oncol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	ritsai8615@gmail.com	Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	Executive Yuan National Science Council [NSC 100-2621-M-039-001]; Department of Health [DOH100-TD-B-111-004, DOH100-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	This study was supported in part by Executive Yuan National Science Council (Grant No. NSC 100-2621-M-039-001), the Department of Health (Grant Nos. DOH100-TD-B-111-004 and DOH100-TD-C-111-005), and the China Medical University Hospital (Grant No. 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami S, 2010, BONE, V46, P244, DOI 10.1016/j.bone.2009.10.011; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; [Anonymous], 1997, OSTEOPOROS INT S3, V7, P1; Brufsky A, 2006, SEMIN ONCOL, V33, pS13, DOI 10.1053/j.seminoncol.2006.03.022; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chen Z, 2005, ARCH INTERN MED, V165, P552, DOI 10.1001/archinte.165.5.552; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; Coleman RE, 2010, BREAST CANCER RES TR, V124, P153, DOI 10.1007/s10549-010-1121-7; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Fogelman I, 2003, OSTEOPOROSIS INT, V14, P1001, DOI 10.1007/s00198-003-1508-y; Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d; Ganry O, 2001, BREAST, V10, P313, DOI 10.1054/brst.2000.0247; Gnant MFX, 2007, J CLIN ONCOL, V25, P820, DOI 10.1200/JCO.2005.02.7102; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hadji P, 2012, CANCER TREAT REV, V38, P798, DOI 10.1016/j.ctrv.2012.02.008; Hershman DL, 2010, J CLIN ENDOCR METAB, V95, P559, DOI 10.1210/jc.2009-1366; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Jacoby VL, 2011, ARCH INTERN MED, V171, P760, DOI 10.1001/archinternmed.2011.121; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kerlikowske K, 2005, J NATL CANCER I, V97, P368, DOI 10.1093/jnci/dji056; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khan MN, 2008, CURR ONCOL, V15, pS30; Kim JE, 2011, BREAST CANCER RES TR, V125, P99, DOI 10.1007/s10549-010-1201-8; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Malpe R, 1997, J BONE MINER RES, V12, P423, DOI 10.1359/jbmr.1997.12.3.423; Neuner JM, 2011, OSTEOPOROSIS INT, V22, P2847, DOI 10.1007/s00198-010-1493-x; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; Newcomb PA, 2001, AM J EPIDEMIOL, V153, P1071, DOI 10.1093/aje/153.11.1071; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Qu X, 2013, BREAST CANC RES TREA; Rabaglio M, 2009, ANN ONCOL, V20, P1489, DOI 10.1093/annonc/mdp033; Ramaswamy B, 2003, SEMIN ONCOL, V30, P763, DOI 10.1053/j.seminoncol.2003.08.028; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; van der Klift M, 2003, BONE, V32, P211, DOI 10.1016/S8756-3282(02)00972-9; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	42	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75109	10.1371/journal.pone.0075109	http://dx.doi.org/10.1371/journal.pone.0075109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069386	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100121
J	Franceschetti, T; Kessler, CB; Lee, SK; Delany, AM				Franceschetti, Tiziana; Kessler, Catherine B.; Lee, Sun-Kyeong; Delany, Anne M.			miR-29 Promotes Murine Osteoclastogenesis by Regulating Osteoclast Commitment and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Differentiation; Cell Migration; MicroRNA; Osteoclast; 3-UTR; miRNA; Post-transcriptional Regulation	TRANSCRIPTION FACTORS; DIFFERENTIATION; MICRORNA; BONE; EXPRESSION; PATHWAY; IDENTIFICATION; SUPPRESSION; OSTEOBLASTS; CELLS	Background: miR-29 is a positive regulator of osteoblastogenesis, but its role in osteoclastogenesis is undefined. Results: Expression of all miR-29 family members increased during osteoclastic differentiation. miR-29 knockdown impaired migration, osteoclast commitment, and formation. Six novel miR-29 targets were identified. Conclusion: miR-29 promotes osteoclastogenesis. Significance: These data expand our understanding of osteoclastogenesis, providing insight into miR-29 function in hematopoietic cells and other lineages. Osteoclast differentiation is regulated by transcriptional, post-transcriptional, and post-translational mechanisms. MicroRNAs are fundamental post-transcriptional regulators of gene expression. The function of the miR-29 (a/b/c) family in cells of the osteoclast lineage is not well understood. In primary cultures of mouse bone marrow-derived macrophages, inhibition of miR-29a, -29b, or -29c diminished formation of TRAP (tartrate-resistant acid phosphatase-positive) multinucleated osteoclasts, and the osteoclasts were smaller. Quantitative RT-PCR showed that all miR-29 family members increased during osteoclast differentiation, in concert with mRNAs for the osteoclast markers Trap (Acp5) and cathepsin K. Similar regulation was observed in the monocytic cell line RAW264.7. In stably transduced RAW264.7 cell lines expressing an inducible miR-29 competitive inhibitor (sponge construct), miR-29 knockdown impaired osteoclastic commitment and migration of pre-osteoclasts. However, miR-29 knockdown did not affect cell viability, actin ring formation, or apoptosis in mature osteoclasts. To better understand how miR-29 regulates osteoclast function, we validated miR-29 target genes using Luciferase 3-UTR reporter assays and specific miR-29 inhibitors. We demonstrated that miR-29 negatively regulates RNAs critical for cytoskeletal organization, including Cdc42 (cell division control protein 42) and Srgap2 (SLIT-ROBO Rho GTPase-activating protein 2). Moreover, miR-29 targets RNAs associated with the macrophage lineage: Gpr85 (G protein-coupled receptor 85), Nfia (nuclear factor I/A), and Cd93. In addition, Calcr (calcitonin receptor), which regulates osteoclast survival and resorption, is a novel miR-29 target. Thus, miR-29 is a positive regulator of osteoclast formation and targets RNAs important for cytoskeletal organization, commitment, and osteoclast function. We hypothesize that miR-29 controls the tempo and amplitude of osteoclast differentiation.	[Franceschetti, Tiziana; Kessler, Catherine B.; Delany, Anne M.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Lee, Sun-Kyeong] Univ Connecticut, Ctr Hlth, Ctr Aging, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Delany, AM (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Franceschetti, Tiziana/0000-0002-8839-0247	National Institutes of Health [AR44877, AR055143]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044877, R01AR055143, R01AR044877, R56AR044877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR44877 (to A. M. D.) and AR055143 (to S.-K. L.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beyer M, 2012, PLOS ONE, V7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Cao JJ, 2005, J BONE MINER RES, V20, P1659, DOI 10.1359/JBMR.050503; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; HE L, 2004, NAT REV GENET, V5, P522; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Huang YC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569034; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Jeon JW, 2010, J IMMUNOL, V185, P4921, DOI 10.4049/jimmunol.0904011; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kinugawa S, 2012, J IMMUNOL, V188, P1772, DOI 10.4049/jimmunol.1101174; Kuo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040272; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SK, 2006, J BONE MINER RES, V21, P695, DOI 10.1359/JBMR.060117; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liang MY, 2009, PHYSIOL GENOMICS, V38, P113, DOI 10.1152/physiolgenomics.00080.2009; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Marzi MJ, 2012, J CELL BIOL, V199, P77, DOI 10.1083/jcb.201206033; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6133, DOI 10.1073/pnas.0710717105; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Moreau V, 2006, EUR J CELL BIOL, V85, P319, DOI 10.1016/j.ejcb.2005.09.009; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mughal MZ, 2009, ENDOCR DEV, V16, P191, DOI 10.1159/000223696; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Ostergaard M, 2008, BEST PRACT RES CL RH, V22, P1019, DOI 10.1016/j.berh.2008.09.014; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; van Helden SFG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042563; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhu CL, 2013, CLIN BIOCHEM, V46, P49, DOI 10.1016/j.clinbiochem.2012.09.002	65	90	96	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33347	33360		10.1074/jbc.M113.484568	http://dx.doi.org/10.1074/jbc.M113.484568			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085298	hybrid, Green Published			2022-12-25	WOS:000328841700049
J	Lee, KW; Cho, JG; Kim, CM; Kang, AY; Kim, M; Ahn, BY; Chung, SS; Lim, KH; Baek, KH; Sung, JH; Park, KS; Park, SG				Lee, Kyeong Won; Cho, Jin Gu; Kim, Chul Min; Kang, A. Young; Kim, Min; Ahn, Byung Yong; Chung, Sung Soo; Lim, Key-Hwan; Baek, Kwang-Hyun; Sung, Jong-Hyuk; Park, Kyong Soo; Park, Sang Gyu			Herpesvirus-associated Ubiquitin-specific Protease (HAUSP) Modulates Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Stability through Its Deubiquitinating Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Diabetes; Glucose Metabolism; Metabolism; Peroxisome Proliferator-activated receptor (PPAR)	KINASE-MEDIATED PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; DEPENDENT DEGRADATION; DIABETES-MELLITUS; P53-MDM2 PATHWAY; BREAST-CANCER; CELLS; P53; MICE	Background: The increase of PPAR stability could contribute to lower blood glucose levels. Results: PPAR stability is increased by the deubiquitinating activity of HAUSP. Conclusion: HAUSP overexpression could decrease blood glucose and triglyceride levels at least in part by deubiquitinating and stabilizing PPAR in the liver. Significance: Identification of a novel enzyme (HAUSP) that deubiquitinates and stabilizes PPAR and its potential role in liver glucose and lipid metabolism are significant. The peroxisome proliferator-activated receptor (PPAR) is a central regulator of adipogenesis and modulates glucose and lipid metabolism. In this study, herpesvirus-associated ubiquitin-specific protease (HAUSP) was isolated as a binding partner of PPAR. Both endogenous and exogenous PPAR associated with HAUSP in co-immunoprecipitation analysis. HAUSP, but not the catalytically inactive HAUSP C223S mutant, increased the stability of both endogenous and exogenous PPAR through its deubiquitinating activity. Site-directed mutagenesis experiments showed that the Lys(462) residue of PPAR is critical for ubiquitination. HBX 41,108, a specific inhibitor of HAUSP, abolished the increase in PPAR stability induced by HAUSP. In addition, knockdown of endogenous HAUSP using siRNA decreased PPAR protein levels. HAUSP enhanced the transcriptional activity of both exogenous and endogenous PPAR in luciferase activity assays. Quantitative RT-PCR analysis showed that HAUSP increased the transcript levels of PPAR target genes in HepG2 cells, resulting in the enhanced uptake of glucose and fatty acids, and vice versa, upon siRNA knockdown of HAUSP. In vivo analysis using adenoviruses confirmed that HAUSP, but not the HAUSP C223S mutant, decreased blood glucose and triglyceride levels, which are associated with the increased expression of endogenous PPAR and lipid accumulation in the liver. Our results demonstrate that the stability and activity of PPAR are modulated by the deubiquitinating activity of HAUSP, which may be a target for the development of anti-diabetic drugs.	[Lee, Kyeong Won; Kim, Min; Ahn, Byung Yong; Chung, Sung Soo; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Cho, Jin Gu; Kim, Chul Min; Kang, A. Young; Lim, Key-Hwan; Baek, Kwang-Hyun; Park, Sang Gyu] CHA Univ, Dept Biomed Sci, Sungnamsi 463840, Gyunggido, South Korea; [Sung, Jong-Hyuk] CHA Univ, Dept Appl Biosci, Sungnamsi 463840, Gyunggido, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, World Class Univ Dept Mol Med & Biopharmaceut Sci, Seoul 110744, South Korea	Seoul National University (SNU); Pochon Cha University; Pochon Cha University; Seoul National University (SNU)	Park, KS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 28 Yongon Dong, Seoul 110744, South Korea.	kspark@snu.ac.kr; sgpark@cha.ac.kr	Park, Kyong Soo/C-2265-2008; Cho, JinGu/GQB-2969-2022; Ahn, Byungyong/AHB-6077-2022	Park, Kyong Soo/0000-0003-3597-342X; Baek, Kwang-Hyun/0000-0001-7662-7190; Ahn, Byungyong/0000-0002-9871-5180	Bio and Medical Technology Development Program of the National Research Foundation; Korean Government [2012M3A9C6049719]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012R1A1A2005546, 2010-0008279]; Basic Research Program through the National Research Foundation of Korea	Bio and Medical Technology Development Program of the National Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Bio and Medical Technology Development Program of the National Research Foundation funded by Korean Government Grant 2012M3A9C6049719 (to S. G. P.), Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2012R1A1A2005546 (to K. S. P.), and the Basic Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0008279 (K.-H. B.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Chung SS, 2011, BIOCHEM J, V433, P155, DOI 10.1042/BJ20100749; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DuBois RN, 1998, CARCINOGENESIS, V19, P49, DOI 10.1093/carcin/19.1.49; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Kilroy GE, 2009, OBESITY, V17, P665, DOI 10.1038/oby.2008.616; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagashima K, 2005, J CLIN INVEST, V115, P1323, DOI 10.1172/JCI200523219; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Palakurthi SS, 2001, CANCER RES, V61, P6213; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	48	16	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32886	32896		10.1074/jbc.M113.496331	http://dx.doi.org/10.1074/jbc.M113.496331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072712	hybrid, Green Published			2022-12-25	WOS:000328841700007
J	Murakami, Y; Takada, S				Murakami, Yohei; Takada, Shoji			Bayesian Parameter Inference by Markov Chain Monte Carlo with Hybrid Fitness Measures: Theory and Test in Apoptosis Signal Transduction Network	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELL FATE DECISION; MODEL SELECTION; BIOCHEMICAL PATHWAYS; P53 PULSES; OPTIMIZATION; CASPASE-3; DYNAMICS; FRAGMENTATION; COORDINATION	When model parameters in systems biology are not available from experiments, they need to be inferred so that the resulting simulation reproduces the experimentally known phenomena. For the purpose, Bayesian statistics with Markov chain Monte Carlo (MCMC) is a useful method. Conventional MCMC needs likelihood to evaluate a posterior distribution of acceptable parameters, while the approximate Bayesian computation (ABC) MCMC evaluates posterior distribution with use of qualitative fitness measure. However, none of these algorithms can deal with mixture of quantitative, i.e., likelihood, and qualitative fitness measures simultaneously. Here, to deal with this mixture, we formulated Bayesian formula for hybrid fitness measures (HFM). Then we implemented it to MCMC (MCMC-HFM). We tested MCMC-HFM first for a kinetic toy model with a positive feedback. Inferring kinetic parameters mainly related to the positive feedback, we found that MCMC-HFM reliably infer them using both qualitative and quantitative fitness measures. Then, we applied the MCMC-HFM to an apoptosis signal transduction network previously proposed. For kinetic parameters related to implicit positive feedbacks, which are important for bistability and irreversibility of the output, the MCMC-HFM reliably inferred these kinetic parameters. In particular, some kinetic parameters that have experimental estimates were inferred without using these data and the results were consistent with experiments. Moreover, for some parameters, the mixed use of quantitative and qualitative fitness measures narrowed down the acceptable range of parameters.	[Murakami, Yohei; Takada, Shoji] Kyoto Univ, Dept Biophys, Div Biol, Grad Sch Sci, Kyoto, Japan	Kyoto University	Murakami, Y (corresponding author), Kyoto Univ, Dept Biophys, Div Biol, Grad Sch Sci, Kyoto, Japan.	murakami@theory.biophys.kyoto-u.ac.jp	Takada, Shoji/A-1163-2009		MEXT; MEXT, Japan	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Science of Fluctuations toward Biological Functions" of the MEXT, and by Grants for Excellent Graduate Schools, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Barnes CP, 2011, P NATL ACAD SCI USA, V108, P15190, DOI 10.1073/pnas.1017972108; Beaumont MA, 2002, GENETICS, V162, P2025; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; EIBING T, 2005, IEE P SYST BIOL, V152, P221; Eydgahi H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.69; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Iba Yukito, 2001, T JPN SOC ARTIF INTE, V16, P279, DOI DOI 10.1527/TJSAI.16.279; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Murakami Yohei, 2012, Biophysics (Nagoya-shi), V8, P41, DOI 10.2142/biophysics.8.41; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sisson SA, 2011, CH CRC HANDB MOD STA, P313; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Sun TZ, 2010, FEBS LETT, V584, P954, DOI 10.1016/j.febslet.2010.01.034; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Tian XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038164; Toni T, 2012, MOL BIOSYST, V8, P1921, DOI 10.1039/c2mb05493k; Toni T, 2010, METHODS MOL BIOL, V673, P283, DOI 10.1007/978-1-60761-842-3_18; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Whitley D, 2001, INFORM SOFTWARE TECH, V43, P817, DOI 10.1016/S0950-5849(01)00188-4; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zi ZK, 2005, J COMPUT SCI TECH-CH, V20, P491, DOI 10.1007/s11390-005-0491-5	52	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74178	10.1371/journal.pone.0074178	http://dx.doi.org/10.1371/journal.pone.0074178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086320	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900022
J	Rahman, KS; Cui, GY; Harvey, SC; McCarty, NA				Rahman, Kazi S.; Cui, Guiying; Harvey, Stephen C.; McCarty, Nael A.			Modeling the Conformational Changes Underlying Channel Opening in CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; CHLORIDE CHANNEL; ABC TRANSPORTER; MOLECULAR-DYNAMICS; ATP-BINDING; DELTA-F508 MUTATION; PORE ARCHITECTURE; POSITIVE CHARGES	Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR) cause cystic fibrosis (CF), the most common life-shortening genetic disease among Caucasians. Although general features of the structure of CFTR have been predicted from homology models, the conformational changes that result in channel opening and closing have yet to be resolved. We created new closed-and open-state homology models of CFTR, and performed targeted molecular dynamics simulations of the conformational transitions in a channel opening event. The simulations predict a conformational wave that starts at the nucleotide binding domains and ends with the formation of an open conduction pathway. Changes in side-chain interactions are observed in all major domains of the protein, and experimental confirmation was obtained for a novel intra-protein salt bridge that breaks near the end of the transition. The models and simulation add to our understanding of the mechanism of ATP-dependent gating in this disease-relevant ion channel.	[Rahman, Kazi S.; Harvey, Stephen C.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Rahman, Kazi S.; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Cui, Guiying; McCarty, Nael A.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Cui, Guiying; McCarty, Nael A.] Emory Univ, Cyst Fibrosis Res Ctr, Atlanta, GA 30322 USA; [Cui, Guiying; McCarty, Nael A.] Childrens Healthcare Atlanta Inc, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	McCarty, NA (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	namccar@emory.edu			NIH [5R01-DK-056481]; Emory University Center for Respiratory Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Center for Respiratory Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant 5R01-DK-056481 to N.A.M. and by the Emory University Center for Respiratory Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; FIELD M, 1993, ANNU REV PHYSIOL, V55, P631, DOI 10.1146/annurev.ph.55.030193.003215; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Furukawa-Hagiya T, 2013, J PHYS CHEM B, V117, P83, DOI 10.1021/jp308315w; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Gupta J, 2001, BIOCHEMISTRY-US, V40, P6620, DOI 10.1021/bi002819v; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Liu XH, 2011, BIOCHEMISTRY-US, V50, P10311, DOI 10.1021/bi201176q; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marcus Y., 1997, ION PROPERTIES; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schriml LM, 2000, GENOMICS, V64, P24, DOI 10.1006/geno.1999.6102; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St-Pierre JF, 2012, J PHYS CHEM B, V116, P2934, DOI 10.1021/jp209126c; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wallin E, 1997, PROTEIN SCI, V6, P808; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030465; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	73	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74574	10.1371/journal.pone.0074574	http://dx.doi.org/10.1371/journal.pone.0074574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086355	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900028
J	Theilhaber, J; Rakhade, SN; Sudhalter, J; Kothari, N; Klein, P; Pollard, J; Jensen, FE				Theilhaber, Joachim; Rakhade, Sanjay N.; Sudhalter, Judy; Kothari, Nayantara; Klein, Peter; Pollard, Jack; Jensen, Frances E.			Gene Expression Profiling of a Hypoxic Seizure Model of Epilepsy Suggests a Role for mTOR and Wnt Signaling in Epileptogenesis	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; MAMMALIAN TARGET; BETA-CATENIN; SYNAPTIC PLASTICITY; PERINATAL HYPOXIA; HIPPOCAMPAL-NEURONS; TUBEROUS SCLEROSIS; RAPAMYCIN PATHWAY; NEONATAL SEIZURES	Microarray profiling was used to investigate gene expression in the hypoxic seizure model of acquired epilepsy in the rat, with the aim of characterizing functional pathways which are persistently activated or repressed during epileptogenesis. Hippocampal and cortical tissues were transcriptionally profiled over a one week period following an initial series of seizures induced by mild hypoxia at post-natal day 10 (P10), and the gene expression data was then analyzed with a focus on gene set enrichment analysis, an approach which emphasizes regulation of entire pathways rather than of individual genes. Animals were subjected to one of three conditions: a control with no hypoxia, hypoxic seizures, and hypoxic seizures followed by treatment with the AMPAR antagonist NBQX, a compound currently proposed to be a modulator of epileptogenesis. While temporal gene expression in the control samples was found to be consistent with known processes of neuronal maturation in the rat for the given time window, the hypoxic seizure response was found to be enriched for components of the PI3K/mTOR and Wnt signaling pathways, alongside gene sets representative of glutamatergic, synaptic and axonal processes, perhaps regulated as a downstream consequence of activation of these pathways. Wnt signaling components were also found enriched in the more specifically epileptogenic NBQX-responsive gene set. While activation of the mTOR pathway is consistent with its known role in epileptogenesis and strengthens the case for mTOR or PI3K pathway inhibitors as potential anti-epileptogenic drugs, investigation of the role of Wnt signaling and the effect of appropriate inhibitors might offer a parallel avenue of research toward anti-epileptogenic treatment of epilepsy.	[Theilhaber, Joachim; Sudhalter, Judy; Kothari, Nayantara; Pollard, Jack] Sanofi Cambridge Res Ctr, Cambridge, MA 08807 USA; [Rakhade, Sanjay N.] Genzyme, Dept Clin Studies, Cambridge, MA USA; [Klein, Peter] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Jensen, Frances E.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	Sanofi-Aventis; Sanofi-Aventis; Genzyme Corporation; University of Virginia; University of Pennsylvania; Pennsylvania Medicine	Theilhaber, J (corresponding author), Sanofi Cambridge Res Ctr, Cambridge, MA 08807 USA.	joachim.theilhaber@sanofi.com		Klein, Peter/0000-0002-3232-3387	National Institutes of Health (from the Office of the Director) [NS 031718, DP1 OD003347]; Intellectual Developmental Disabilities Research Center (National Institute of Child Health and Human Development) [P30 HD18655]; Sanofi Research and Development, Biological Sciences Department; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031718, R29NS031718, R56NS031718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003347] Funding Source: NIH RePORTER	National Institutes of Health (from the Office of the Director); Intellectual Developmental Disabilities Research Center (National Institute of Child Health and Human Development); Sanofi Research and Development, Biological Sciences Department; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants NS 031718 and DP1 OD003347 (FEJ) (from the Office of the Director), Intellectual Developmental Disabilities Research Center Grant P30 HD18655 (National Institute of Child Health and Human Development) (FEJ), and Sanofi Research and Development, Biological Sciences Department (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PLACEBOCONTROLLED ST; [Anonymous], 2012, CONN MAP 02; [Anonymous], 2010, EVEROLIMUS RAD001 TH; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bayer S.A., 1991, NEOCORTICAL DEV; Borges K, 2007, NEUROBIOL DIS, V26, P66, DOI 10.1016/j.nbd.2006.12.001; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Das N, 2012, DRUG DISCOV THER, V6, P178, DOI 10.5582/ddt.2012.v6.4.178; Elliott RC, 2003, J NEUROSCI, V23, P2218; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Haberman RP, 2008, P NATL ACAD SCI USA, V105, P10601, DOI 10.1073/pnas.0804292105; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73, DOI 10.1152/jn.1998.79.1.73; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Keeping ES, 1995, INTRO STAT INFERENCE, P256; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Maguschak KA, 2011, J NEUROSCI, V31, P13057, DOI 10.1523/JNEUROSCI.3248-11.2011; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Newton SS, 2003, J NEUROSCI, V23, P10841; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Opazo P, 2003, J NEUROSCI, V23, P3679; R Development Core Team, 2008, R LANG ENV STAT COMP; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Theilhaber J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-195; Theilhaber J, 2001, J COMPUT BIOL, V8, P585, DOI 10.1089/106652701753307502; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Yang PC, 2008, J BIOL CHEM, V283, P2631, DOI 10.1074/jbc.M706954200; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng Ling-Hui, 2009, Mol Cell Pharmacol, V1, P124; Zeng LH, 2010, CELL CYCLE, V9, P2281, DOI 10.4161/cc.9.12.11866; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	64	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74428	10.1371/journal.pone.0074428	http://dx.doi.org/10.1371/journal.pone.0074428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086344	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900026
J	Sharon, H; Pasternak, Y; Ben Simon, E; Gruberger, M; Giladi, N; Krimchanski, B; Hassin, D; Hendler, T				Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Gruberger, Michal; Giladi, Nir; Krimchanski, Ben Zion; Hassin, David; Hendler, Talma			Emotional Processing of Personally Familiar Faces in the Vegetative State	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ANTERIOR CINGULATE; BRAIN ACTIVITY; CONSCIOUSNESS; PERCEPTION; DISORDERS; AWARENESS; STIMULATION; ACTIVATION; MECHANISMS	Background: The Vegetative State (VS) is a severe disorder of consciousness in which patients are awake but display no signs of awareness. Yet, recent functional magnetic resonance imaging (fMRI) studies have demonstrated evidence for covert awareness in VS patients by recording specific brain activations during a cognitive task. However, the possible existence of incommunicable subjective emotional experiences in VS patients remains largely unexplored. This study aimed to probe the question of whether VS patients retain a brain ability to selectively process external stimuli according to their emotional value and look for evidence of covert emotional awareness in patients. Methods and Findings: In order to explore these questions we employed the emotive impact of observing personally familiar faces, known to provoke specific perceptual as well as emotional brain activations. Four VS patients and thirteen healthy controls first underwent an fMRI scan while viewing pictures of non-familiar faces, personally familiar faces and pictures of themselves. In a subsequent imagery task participants were asked to actively imagine one of their parent's faces. Analyses focused on face and familiarity selective regional brain activations and inter-regional functional connectivity. Similar to controls, all patients displayed face selective brain responses with further limbic and cortical activations elicited by familiar faces. In patients as well as controls, Connectivity was observed between emotional, visual and face specific areas, suggesting aware emotional perception. This connectivity was strongest in the two patients who later recovered. Notably, these two patients also displayed selective amygdala activation during familiar face imagery, with one further exhibiting face selective activations, indistinguishable from healthy controls. Conclusions: Taken together, these results show that selective emotional processing can be elicited in VS patients both by external emotionally salient stimuli and by internal cognitive processes, suggesting the ability for covert emotional awareness of self and the environment in VS patients.	[Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Gruberger, Michal; Hendler, Talma] Sourasky Med Ctr, Funct Brain Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; [Sharon, Haggai; Hassin, David] Sourasky Med Ctr, Dept Internal Med, Tel Aviv, Israel; [Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Giladi, Nir; Hassin, David; Hendler, Talma] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Gruberger, Michal; Hendler, Talma] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Giladi, Nir] Sourasky Med Ctr, Dept Neurol, Tel Aviv, Israel; [Giladi, Nir; Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Krimchanski, Ben Zion] Loewenstein Hosp & Rehabil Ctr, Rehabil Intens Care Unit, Raanana, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Sharon, H (corresponding author), Sourasky Med Ctr, Funct Brain Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel.	haggais@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522; Ben Simon, Eti/0000-0002-3862-8288; Sharon, Haggai/0000-0003-1981-658X				[Anonymous], 1993, ANN NEUROL, V33, P386; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P13722, DOI 10.1073/pnas.2235214100; Ffytche DH, 2011, BRAIN, V134, P247, DOI 10.1093/brain/awq305; Flavell JH, 2001, PSYCHOL SCI, V12, P430, DOI 10.1111/1467-9280.00379; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2011, NEUROL CLIN, V29, P723, DOI 10.1016/j.ncl.2011.08.001; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koenigs M., 2009, COGNITIVE NEUROSCIEN, P1181; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Rees G, 2007, PHILOS T R SOC B, V362, P877, DOI 10.1098/rstb.2007.2094; Rodriguez V, 2012, J COGNITIVE NEUROSCI, V24, P396, DOI 10.1162/jocn_a_00137; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shah SA, 2010, EUR J NEUROSCI, V32, P1135, DOI 10.1111/j.1460-9568.2010.07420.x; Talairarch J, 1998, COPLANAR STEREOTAXIC; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Terasawa Y, 2011, HUMAN BRAIN MAPPING; Yu T, 2013, NEUROLOGY, V80, P345, DOI 10.1212/WNL.0b013e31827f0846	32	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74711	10.1371/journal.pone.0074711	http://dx.doi.org/10.1371/journal.pone.0074711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086365	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700032
J	Wintermann, GB; Donix, M; Joraschky, P; Gerber, J; Petrowski, K				Wintermann, Gloria-Beatrice; Donix, Markus; Joraschky, Peter; Gerber, Johannes; Petrowski, Katja			Altered Olfactory Processing of Stress-Related Body Odors and Artificial Odors in Patients with Panic Disorder	PLOS ONE			English	Article							FACIAL AFFECT; CHEMOSENSORY CUES; ACTIVATION; ANXIETY; FMRI; FEAR; AMYGDALA; NETWORK; EMOTION; DISCRIMINATION	Background: Patients with Panic Disorder (PD) direct their attention towards potential threat, followed by panic attacks, and increased sweat production. Ones own anxiety sweat odor influences the attentional focus, and discrimination of threat or non-threat. Since olfactory projection areas overlap with neuronal areas of a panic-specific fear network, the present study investigated the neuronal processing of odors in general and of stress-related sweat odors in particular in patients with PD. Methods: A sample of 13 patients with PD with/without agoraphobia and 13 age-and gender-matched healthy controls underwent an fMRI investigation during olfactory stimulation with their stress-related sweat odors (TSST, ergometry) as well as artificial odors (peach, artificial sweat) as non-fearful non-body odors. Principal Findings: The two groups did not differ with respect to their olfactory identification ability. Independent of the kind of odor, the patients with PD showed activations in fronto-cortical areas in contrast to the healthy controls who showed activations in olfaction-related areas such as the amygdalae and the hippocampus. For artificial odors, the patients with PD showed a decreased neuronal activation of the thalamus, the posterior cingulate cortex and the anterior cingulate cortex. Under the presentation of sweat odor caused by ergometric exercise, the patients with PD showed an increased activation in the superior temporal gyrus, the supramarginal gyrus, and the cingulate cortex which was positively correlated with the severity of the psychopathology. For the sweat odor from the anxiety condition, the patients with PD showed an increased activation in the gyrus frontalis inferior, which was positively correlated with the severity of the psychopathology. Conclusions: The results suggest altered neuronal processing of olfactory stimuli in PD. Both artificial odors and stress-related body odors activate specific parts of a fear-network which is associated with an increased severity of the psychopathology.	[Wintermann, Gloria-Beatrice; Joraschky, Peter; Petrowski, Katja] Tech Univ Dresden, Sch Med, Dept Psychotherapy & Psychosomat Med, Dresden, Germany; [Donix, Markus] Univ Klinikum Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Gerber, Johannes] Tech Univ Dresden, Sch Med, Dept Neuroradiol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Wintermann, GB (corresponding author), Tech Univ Dresden, Sch Med, Dept Psychotherapy & Psychosomat Med, Dresden, Germany.	gloria.wintermann@uniklinikum-dresden.de	Wintermann, Gloria-Beatrice/AAN-3318-2021; Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700	Medical Faculty of Dresden University of Technology	Medical Faculty of Dresden University of Technology	Funding for the present study was provided by the Medical Faculty of Dresden University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Bandelow B, 1997, PANIC AGORAPHOBIA SC; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Crespo-Facorro B, 2001, JAMA-J AM MED ASSOC, V286, P427, DOI 10.1001/jama.286.4.427; Croy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009362; de Carvalho MR, 2010, WORLD J BIOL PSYCHIA, V11, P188, DOI [10.3109/15622970903178176, 10.1080/15622970903178176]; de Carvalho MR, 2010, EXPERT REV NEUROTHER, V10, P291, DOI [10.1586/ern.09.161, 10.1586/ERN.09.161]; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fichtenholtz HM, 2004, COGNITIVE BRAIN RES, V20, P67, DOI 10.1016/j.cogbrainres.2004.01.006; Franke GH, 2002, SCL90R BELTZ TEST; Friedman BH, 1998, BIOL PSYCHOL, V47, P243, DOI 10.1016/S0301-0511(97)00027-6; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Haegler K, 2010, NEUROPSYCHOLOGIA, V48, P3901, DOI 10.1016/j.neuropsychologia.2010.09.019; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hinton DE, 2004, GEN HOSP PSYCHIAT, V26, P390, DOI 10.1016/j.genhosppsych.2004.04.007; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Javanmard M, 1999, BIOL PSYCHIAT, V45, P872, DOI 10.1016/S0006-3223(98)00348-5; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lautenbacher S, 2002, EUR ARCH PSY CLIN N, V252, P210, DOI 10.1007/s00406-002-0382-5; Laux L., 1981, STATE TRAIT ANGSTINV; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lueken U, 2011, NEUROIMAGE, V56, P363, DOI 10.1016/j.neuroimage.2011.02.015; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Miller LA, 2005, J NEUROPSYCH CLIN N, V17, P1, DOI 10.1176/appi.neuropsych.17.1.1; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Nishimura Y, 2009, PSYCHIAT RES-NEUROIM, V172, P168, DOI 10.1016/j.pscychresns.2009.01.001; Ottaviani C, 2012, PSYCHIAT RES-NEUROIM, V203, P159, DOI 10.1016/j.pscychresns.2011.12.010; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 1998, GENETICA, V104, P285, DOI 10.1023/A:1026462701154; Pfleiderer B, 2007, WORLD J BIOL PSYCHIA, V8, P269, DOI 10.1080/15622970701216673; Pillay SS, 2007, J ANXIETY DISORD, V21, P381, DOI 10.1016/j.janxdis.2006.04.001; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; Rosen J, 2004, BEHAV COGN NEUROSCI, V73, P49; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Sass H., 2003, DIAGNOSTISCHES STAT; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Sobel N., 2003, HDB OLFACTION GUSTAT; SPITZER RL, 1990, SCID USERS GUIDE STR; Uhlmann C., 2013, PSYCHOL MED, P1; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Wittmann A, 2011, EUR ARCH PSY CLIN N, V261, P185, DOI 10.1007/s00406-010-0167-1; Zatorre RJ, 2000, BRAIN MAPPING SYSTEM; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	72	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74655	10.1371/journal.pone.0074655	http://dx.doi.org/10.1371/journal.pone.0074655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086358	Green Submitted, gold, Green Published			2022-12-25	WOS:000325025200015
J	Yamashita, F; Sasa, Y; Yoshida, S; Hisaka, A; Asai, Y; Kitano, H; Hashida, M; Suzuki, H				Yamashita, Fumiyoshi; Sasa, Yukako; Yoshida, Shuya; Hisaka, Akihiro; Asai, Yoshiyuki; Kitano, Hiroaki; Hashida, Mitsuru; Suzuki, Hiroshi			Modeling of Rifampicin-Induced CYP3A4 Activation Dynamics for the Prediction of Clinical Drug-Drug Interactions from In Vitro Data	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; REDUCES PLASMA-CONCENTRATIONS; PRIMARY HUMAN HEPATOCYTES; CYTOCHROME-P450 INDUCTION; QUANTITATIVE PREDICTION; HEALTHY-VOLUNTEERS; GENERAL FRAMEWORK; SYSTEMS BIOLOGY; PHARMACOKINETICS; VIVO	Induction of cytochrome P450 3A4 (CYP3A4) expression is often implicated in clinically relevant drug-drug interactions (DDI), as metabolism catalyzed by this enzyme is the dominant route of elimination for many drugs. Although several DDI models have been proposed, none have comprehensively considered the effects of enzyme transcription/translation dynamics on induction-based DDI. Rifampicin is a well-known CYP3A4 inducer, and is commonly used as a positive control for evaluating the CYP3A4 induction potential of test compounds. Herein, we report the compilation of in vitro induction data for CYP3A4 by rifampicin in human hepatocytes, and the transcription/translation model developed for this enzyme using an extended least squares method that can account for inherent inter-individual variability. We also developed physiologically based pharmacokinetic (PBPK) models for the CYP3A4 inducer and CYP3A4 substrates. Finally, we demonstrated that rifampicin-induced DDI can be predicted with reasonable accuracy, and that a static model can be used to simulate DDI once the blood concentration of the inducer reaches a steady state following repeated dosing. This dynamic PBPK-based DDI model was implemented on a new multi-hierarchical physiology simulation platform named PhysioDesigner.	[Yamashita, Fumiyoshi; Sasa, Yukako; Yoshida, Shuya; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan; [Hisaka, Akihiro] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharmacol & Pharmacokinet, Tokyo 113, Japan; [Asai, Yoshiyuki; Kitano, Hiroaki] Grad Univ, Okinawa Inst Sci & Technol, Open Biol Unit, Okinawa, Japan; [Kitano, Hiroaki] Sony Comp Sci Labs Inc, Tokyo, Japan; [Hashida, Mitsuru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Suzuki, Hiroshi] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan	Kyoto University; University of Tokyo; Okinawa Institute of Science & Technology Graduate University; Sony Corporation; Kyoto University; University of Tokyo	Yamashita, F (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan.	yama@pharm.kyoto-u.ac.jp		hashida, mitsuru/0000-0001-7383-8080; , Akihiro/0000-0003-4863-9308	Ministry of Education, Culture, Sports, Science and Technology, Japan [23136102]; Grants-in-Aid for Scientific Research [25730180, 23136102, 22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas (23136102) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOCELLA G, 1978, CLIN PHARMACOKINET, V3, P108, DOI 10.2165/00003088-197803020-00002; ACOCELLA G, 1971, CHEMOTHERAPY, V16, P356, DOI 10.1159/000220750; Almond LM, 2009, CURR DRUG METAB, V10, P420, DOI 10.2174/138920009788498978; Asai Y, 2008, J PHYSIOL SCI, V58, P447, DOI 10.2170/physiolsci.RP013308; Backman JT, 2005, CLIN PHARMACOL THER, V78, P154, DOI 10.1016/j.clpt.2005.04.007; Backman JT, 1996, CLIN PHARMACOL THER, V59, P7, DOI 10.1016/S0009-9236(96)90018-1; Bolton AE, 2004, CANCER CHEMOTH PHARM, V53, P102, DOI 10.1007/s00280-003-0722-9; Capone D, 1996, INT J CLIN PHARM RES, V16, P73; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Chen YP, 2004, J PHARMACOL EXP THER, V308, P495, DOI 10.1124/jpet.103.058818; Chung E, 2006, CLIN PHARMACOL THER, V79, P350, DOI 10.1016/j.clpt.2005.11.016; Chung JY, 2011, DRUG METAB DISPOS, V39, P92, DOI 10.1124/dmd.110.035246; Fahmi OA, 2009, DRUG METAB DISPOS, V37, P1658, DOI 10.1124/dmd.108.026252; Friedman EJ, 2011, J CLIN PHARMACOL, V51, P1561, DOI 10.1177/0091270010387141; FURESZ S, 1967, ARZNEI-FORSCHUNG, V17, P534; Galetin A, 2006, DRUG METAB DISPOS, V34, P166, DOI 10.1124/dmd.105.006874; Garcia M, 2003, IN VITRO CELL DEV-AN, V39, P283; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Grime K, 2010, CURR DRUG METAB, V11, P870, DOI 10.2174/138920010794479637; Grub S, 2001, EUR J CLIN PHARMACOL, V57, P115, DOI 10.1007/s002280100277; Hariparsad N, 2004, J CLIN PHARMACOL, V44, P1273, DOI 10.1177/0091270004269142; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453, DOI 10.1038/clpt.1992.171; HEIMARK LD, 1987, CLIN PHARMACOL THER, V42, P388, DOI 10.1038/clpt.1987.168; Holtbecker N, 1996, DRUG METAB DISPOS, V24, P1121; HONIG PK, 1993, JAMA-J AM MED ASSOC, V269, P1513, DOI 10.1001/jama.269.12.1513; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ito K, 2004, BRIT J CLIN PHARMACO, V57, P473, DOI 10.1111/j.1365-2125.2003.02041.x; Josephson F, 2010, J INTERN MED, V268, P530, DOI 10.1111/j.1365-2796.2010.02301.x; Kanamitsu S, 2000, PHARMACEUT RES, V17, P336, DOI 10.1023/A:1007509324428; Kato M, 2008, PHARM RES-DORDR, V25, P1891, DOI 10.1007/s11095-008-9607-2; Kato Motohiro, 2005, Drug Metab Pharmacokinet, V20, P236, DOI 10.2133/dmpk.20.236; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kivisto KT, 1999, PHARMACOL TOXICOL, V84, P94, DOI 10.1111/j.1600-0773.1999.tb00880.x; Kyrklund C, 2000, CLIN PHARMACOL THER, V68, P592, DOI 10.1067/mcp.2000.111414; Lattes R, 1999, Transpl Infect Dis, V1, P98, DOI 10.1034/j.1399-3062.1999.010203.x; LeCluyse E, 2000, J BIOCHEM MOL TOXIC, V14, P177, DOI 10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4; Li AP, 1997, CELL BIOL TOXICOL, V13, P365, DOI 10.1023/A:1007451911843; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Li TG, 2006, DRUG METAB DISPOS, V34, P756, DOI 10.1124/dmd.105.007575; MCALLISTER WAC, 1983, BRIT MED J, V286, P923, DOI 10.1136/bmj.286.6369.923; MODRY DL, 1985, TRANSPLANTATION, V39, P313; Nakajima A, 2011, BIOCHEM PHARMACOL, V82, P1747, DOI 10.1016/j.bcp.2011.08.003; Nebot N, 2010, BRIT J PHARMACOL, V161, P1059, DOI 10.1111/j.1476-5381.2010.00946.x; Niemi M, 2000, CLIN PHARMACOL THER, V68, P495, DOI 10.1067/mcp.2000.111183; Ohno Y, 2008, CLIN PHARMACOKINET, V47, P669, DOI 10.2165/00003088-200847100-00004; Ohno Y, 2007, CLIN PHARMACOKINET, V46, P681, DOI 10.2165/00003088-200746080-00005; OREILLY RA, 1974, ANN INTERN MED, V81, P337, DOI 10.7326/0003-4819-81-3-337; Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Poulin P, 2002, J PHARM SCI-US, V91, P129, DOI 10.1002/jps.10005; Prueksaritanont T, 2005, PHARM RES-DORDR, V22, P71, DOI 10.1007/s11095-004-9011-5; Ridtitid W, 2000, J PHARM PHARMACOL, V52, P1265, DOI 10.1211/0022357001777243; Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007; SHEINER LB, 1985, J PHARMACOKINET BIOP, V13, P185, DOI 10.1007/BF01059398; SHEINER LB, 1984, DRUG METAB REV, V15, P293, DOI 10.3109/03602538409015067; Shi J, 2005, CLIN PHARMACOKINET, V44, P915, DOI 10.2165/00003088-200544090-00003; Shou MG, 2008, DRUG METAB DISPOS, V36, P2355, DOI 10.1124/dmd.108.020602; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1067, DOI 10.2165/00003088-200544100-00005; Villikka K, 1997, CLIN PHARMACOL THER, V62, P629, DOI 10.1016/S0009-9236(97)90082-5; Villikka K, 1997, CLIN PHARMACOL THER, V61, P8, DOI 10.1016/S0009-9236(97)90176-4; Villikka K, 1997, BRIT J CLIN PHARMACO, V43, P471, DOI 10.1046/j.1365-2125.1997.00579.x; Wang YH, 2010, DRUG METAB DISPOS, V38, P1094, DOI 10.1124/dmd.110.032177; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Yang J, 2007, TOXICOL SCI, V95, P13, DOI 10.1093/toxsci/kfl120; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Zhang J G, 2010, Drug Metab Lett, V4, P185; Zhang ZY, 2009, J PHARMACEUT BIOMED, V50, P200, DOI 10.1016/j.jpba.2009.04.013	69	63	74	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e70330	10.1371/journal.pone.0070330	http://dx.doi.org/10.1371/journal.pone.0070330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086247	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200003
J	Aravinthan, A; Pietrosi, G; Hoare, M; Jupp, J; Marshall, A; Verrill, C; Davies, S; Bateman, A; Sheron, N; Allison, M; Alexander, GJM				Aravinthan, Aloysious; Pietrosi, Giada; Hoare, Matthew; Jupp, James; Marshall, Aileen; Verrill, Clare; Davies, Susan; Bateman, Adrian; Sheron, Nick; Allison, Michael; Alexander, Graeme J. M.			Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease	PLOS ONE			English	Article							CELLULAR SENESCENCE; DNA-DAMAGE; CELLS; PROGRESSION	Background and Aim: Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Methods: Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively. Results: In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. Conclusions: The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.	[Aravinthan, Aloysious; Pietrosi, Giada; Hoare, Matthew; Marshall, Aileen; Allison, Michael; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Hoare, Matthew] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Jupp, James; Verrill, Clare; Sheron, Nick] Southampton Univ Hosp, Dept Hepatol, Southampton, Hants, England; [Davies, Susan] Cambridge Univ Hosp, Dept Histopathol, Cambridge, England; [Bateman, Adrian] Southampton Univ Hosp, Dept Histopathol, Southampton, Hants, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Southampton; University of Cambridge; University of Southampton	Alexander, GJM (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	gja1000@doctors.org.uk	Aravinthan, Aloysious D/I-2557-2019; Pietrosi, Giada/R-5493-2016	Aravinthan, Aloysious D/0000-0003-0527-5137; Sheron, Nick/0000-0002-6156-8367; Pietrosi, Giada/0000-0002-2299-7118; Sheron, Nick/0000-0001-5232-8292; Hoare, Matthew/0000-0001-5990-9604; Allison, Michael/0000-0003-3677-3294; Bateman, Adrian/0000-0003-2222-4104; Verrill, Clare/0000-0002-4905-8233	Hepatology Endowment Fund; Addenbrooke's Charitable Fund	Hepatology Endowment Fund; Addenbrooke's Charitable Fund	This work received support from the Hepatology Endowment Fund and Addenbrooke's Charitable Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Bell H, 2004, SCAND J GASTROENTERO, V39, P858, DOI 10.1080/00365520410006350; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Borel F, 2002, J CELL SCI, V115, P2829; Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GONZALEZREIMERS E, 1988, DRUG ALCOHOL DEPEN, V22, P195, DOI 10.1016/0376-8716(88)90018-X; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Ozen A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0357-y; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013	18	59	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e72904	10.1371/journal.pone.0072904	http://dx.doi.org/10.1371/journal.pone.0072904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086266	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000326520200004
J	Mialet, B; Majdi, N; Tackx, M; Azemar, F; Buffan-Dubau, E				Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne			Selective Feeding of Bdelloid Rotifers in River Biofilms	PLOS ONE			English	Article							CYANOBACTERIAL BIOFILMS; MICROCYSTIS-AERUGINOSA; MEIOFAUNA; CAROTENOIDS; CARBON; COMMUNITY; CHLOROPHYLLS; ZOOPLANKTON; TOLERANCE; PREDATION	In situ pigment contents of biofilm-dwelling bdelloid rotifers of the Garonne River (France) were measured by high performance liquid chromatography (HPLC) and compared with pigment composition of surrounding biofilm microphytobenthic communities. Among pigments that were detected in rotifers, the presence of carotenoids fucoxanthin and myxoxanthophyll showed that the rotifers fed on diatoms and cyanobacteria. Unexpectedly, while diatoms strongly dominated microphytobenthic communities in terms of biomass, HPLC results hinted that rotifers selectively ingested benthic filamentous cyanobacteria. In doing so, rotifers could daily remove a substantial fraction (up to 28%) of this cyanobacterial biomass. The possibility that the rotifers hosted symbiotic myxoxanthophyll-containing cyanobacteria was examined by localisation of chlorophyll fluorescence within rotifers using confocal laser scanning microscopy (CLSM). CLSM results showed an even distribution of quasi-circular fluorescent objects (FO) throughout rotifer bodies, whereas myxoxanthophyll is a biomarker pigment of filamentous cyanobacteria, so the hypothesis was rejected. Our results also suggest that rotifers converted beta-carotene (provided by ingested algae) into echinenone, a photoprotective pigment. This study, which is the first one to detail in situ pigment contents of rotifers, clearly shows that the role of cyanobacteria as a food source for meiobenthic invertebrates has been underestimated so far, and deserves urgent consideration.	[Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne] Univ Toulouse, UPS, INP, Ecolab,Lab Ecol Fonct & Environm, Toulouse, France; [Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne] Ctr Natl Rech Sci, Ecolab, Toulouse, France; [Mialet, Benoit] Univ Rochelle, CNRS, UMR LIENSs Littoral Environm & Soc 7266, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Mialet, B (corresponding author), Univ Toulouse, UPS, INP, Ecolab,Lab Ecol Fonct & Environm, Toulouse, France.	benoit.mialet@hotmail.fr	Azémar, Frédéric/A-9041-2010; Majdi, Nabil/J-8578-2016	Azémar, Frédéric/0000-0002-3098-8676; Majdi, Nabil/0000-0001-7052-4297	national CNRS EC2CO-CYTRIX program	national CNRS EC2CO-CYTRIX program	This study was funded by a national CNRS EC2CO-CYTRIX program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Azim M. E., 2005, Periphyton: ecology, exploitation and management, P15, DOI 10.1079/9780851990965.0015; Baker JR, 1988, ADV PARASIT, P263; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Battaglia B, 1997, ANTARCTIC COMMUNITIE; BORCHARDT MA, 1995, J N AM BENTHOL SOC, V14, P278, DOI 10.2307/1467780; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Bouletreau S, 2006, FRESHWATER BIOL, V51, P901, DOI 10.1111/j.1365-2427.2006.01541.x; Brotas V, 2003, ACTA OECOL, V24, pS109, DOI 10.1016/S1146-609X(03)00013-4; Buffan-Dubau E, 2000, LIMNOL OCEANOGR, V45, P381, DOI 10.4319/lo.2000.45.2.0381; BuffanDubau E, 1996, MAR ECOL PROG SER, V137, P71, DOI 10.3354/meps137071; Caramujo MJ, 2012, MAR DRUGS, V10, P998, DOI 10.3390/md10050998; CLEMENT P, 1983, HYDROBIOLOGIA, V104, P89, DOI 10.1007/BF00045957; de Quiros ARB, 2001, EUR FOOD RES TECHNOL, V212, P687, DOI 10.1007/s002170100316; Eulin A, 1998, ARCH HYDROBIOL, V143, P79; Evrard V, 2010, MAR ECOL PROG SER, V416, P1, DOI 10.3354/meps08770; Gaudes A, 2006, NEMATOLOGY, V8, P909, DOI 10.1163/156854106779799169; Giere, 2009, MEIOBENTHOLOGY THE M; GILCHRIST BM, 1962, NATURE, V195, P905, DOI 10.1038/195905a0; Goldfinch AC, 2000, ESTUARIES, V23, P536, DOI 10.2307/1353144; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; Gullberg KR, 1997, LIMNOL OCEANOGR, V42, P452, DOI 10.4319/lo.1997.42.3.0452; Guo NC, 2006, ENVIRON POLLUT, V143, P513, DOI 10.1016/j.envpol.2005.11.044; Hall RI, 1999, LIMNOL OCEANOGR, V44, P739, DOI 10.4319/lo.1999.44.3_part_2.0739; Hildrew A.G., 1992, P309; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Irigoien X, 2000, FEEDING SELECTIVITY; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Kathol M, 2011, FRESHWATER BIOL, V56, P1160, DOI 10.1111/j.1365-2427.2010.02561.x; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keesing JK, 2012, MAR FRESHWATER RES, V63, P403, DOI 10.1071/MF11216; LAMBERTI GA, 1983, ECOLOGY, V64, P1124, DOI 10.2307/1937823; Lauritano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047262; Leflaive J, 2008, FUND APPL LIMNOL, V173, P121, DOI 10.1127/1863-9135/2008/0173-0121; LOCK MA, 1984, OIKOS, V42, P10, DOI 10.2307/3544604; Lurling M, 2003, HYDROBIOLOGIA, V491, P145, DOI 10.1023/A:1024436508387; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Majdi N, 2012, FRESHWATER BIOL, V57, P1180, DOI 10.1111/j.1365-2427.2012.02784.x; Majdi N, 2012, FRESHW SCI, V31, P38, DOI 10.1899/11-073.1; Majdi N, 2012, HYDROBIOLOGIA, V680, P219, DOI 10.1007/s10750-011-0920-0; Majdi N, 2011, HYDROBIOLOGIA, V673, P229, DOI 10.1007/s10750-011-0781-6; Maoka T, 2005, J AGR FOOD CHEM, V53, P8357, DOI 10.1021/jf058088t; Marotta R, 2012, J MORPHOL, V273, P1, DOI 10.1002/jmor.11000; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; Melone G, 1998, CAN J ZOOL, V76, P1755, DOI 10.1139/cjz-76-9-1755; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moens T, 1999, MAR BIOL, V133, P69, DOI 10.1007/s002270050444; Moens T, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P105, DOI 10.1079/9780851990095.0105; Novakova E, 2012, MOL BIOL EVOL, V29, P313, DOI 10.1093/molbev/msr206; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; Pinckney JL, 2003, AQUAT MICROB ECOL, V31, P99, DOI 10.3354/ame031099; Reiss J, 2010, ECOLOGY, V91, P497, DOI 10.1890/08-1248.1; Ricci C, 2000, FRESHWATER BIOL, V44, P15, DOI 10.1046/j.1365-2427.2000.00584.x; Romani A. M., 2010, BIOFOULING, P137; Rowell K, 2003, FRESHWATER BIOL, V48, P247, DOI 10.1046/j.1365-2427.2003.00999.x; Sabater S, 2003, AQUAT MICROB ECOL, V32, P175, DOI 10.3354/ame032175; Schmid PE, 2002, FRESHWATER MEIOFAUNA: BIOLOGY AND ECOLOGY, P295; Schmid PE, 1997, FRESHWATER BIOL, V38, P67, DOI 10.1046/j.1365-2427.1997.00197.x; Schmid-Araya JM, 2002, ECOLOGY, V83, P1271, DOI 10.1890/0012-9658(2002)083[1271:TIOMIF]2.0.CO;2; Soares MCS, 2010, J PLANKTON RES, V32, P999, DOI 10.1093/plankt/fbq042; Spieth HR, 2011, J FISH BIOL, V78, P138, DOI 10.1111/j.1095-8649.2010.02850.x; Tekwani N, 2013, AQUAT MICROB ECOL, V69, P47, DOI 10.3354/ame01616; Teneva I, 2005, TOXICON, V45, P711, DOI 10.1016/j.toxicon.2005.01.018; Traunspurger W, 1997, OECOLOGIA, V112, P118, DOI 10.1007/s004420050291; UHLIG G, 1973, HELGOLAND WISS MEER, V25, P173, DOI 10.1007/BF01609968; Vega IA, 2006, BIOCELL, V30, P367; WALLACE RL, 1983, HYDROBIOLOGIA, V104, P379, DOI 10.1007/BF00045995; Ward JV, 1998, FRESHWATER BIOL, V40, P531, DOI 10.1046/j.1365-2427.1998.00368.x; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	71	18	20	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75352	10.1371/journal.pone.0075352	http://dx.doi.org/10.1371/journal.pone.0075352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073263	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000072
J	Toledano, N; Gur-Wahnon, D; Ben-Yehuda, A; Rachmilewitz, J				Toledano, Natan; Gur-Wahnon, Devorah; Ben-Yehuda, Adi; Rachmilewitz, Jacob			Novel CD47: SIRP alpha Dependent Mechanism for the Activation of STAT3 in Antigen-Presenting Cell	PLOS ONE			English	Article							SIGNAL-REGULATORY-PROTEIN; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; APOPTOTIC CELLS; T-CELL; NEGATIVE REGULATION; TUMOR-CELLS; TOLERANCE; INFLAMMATION; MATURATION	Cell surface CD47 interacts with its receptor, signal-regulatory-protein alpha (SIRP alpha) that is expressed predominantly on macrophages, to inhibit phagocytosis of normal, healthy cells. This "don't eat me" signal is mediated through tyrosine phosphorylation of SIRP alpha at the cytoplasmic ITIM motifs and the recruitment of the phosphatase, SHP-1. We previously revealed a novel mechanism for the activation of the STAT3 pathway and the regulation of human APC maturation and function that is based on cell: cell interaction. In this study, we present evidence supporting the notion that CD47: SIRP alpha serves as a cell surface receptor: ligand pair involved in this contact-dependent STAT3 activation and regulation of APC maturation. We show that upon co-culturing APC with various primary and tumor cell lines STAT3 phosphorylation and IL-10 expression are induced, and such regulation could be suppressed by specific CD47 siRNAs and shRNAs. Significantly, >50% reduction in CD47 expression abolished the contact-dependent inhibition of T cell activation. Furthermore, co-immunoprecipitation experiments revealed a physical association between SIRP alpha and STAT3. Thus, we suggest that in addition to signaling through the ITIM-SHP-1 complex that transmit an anti-phagocytotic, CD47: SIRP alpha also triggers STAT3 signaling that is linked to an immature APC phenotype and peripheral tolerance under steady state and pathological conditions.	[Toledano, Natan; Gur-Wahnon, Devorah; Ben-Yehuda, Adi; Rachmilewitz, Jacob] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Rachmilewitz, J (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rjacob@cc.huji.ac.il			Israel Science Foundation (ISF) [337/08]	Israel Science Foundation (ISF)(Israel Science Foundation)	This research was supported by the Israel Science Foundation (ISF; grant No. 337/08). (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550; Cappellesso-Fleury S, J CLIN IMMUNOL, V30, P607; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gur-Wahnon D, 2007, EXP HEMATOL, V35, P426, DOI 10.1016/j.exphem.2006.11.001; Gur-Wahnon D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006846; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lee WY, 2007, J IMMUNOL, V179, P7741, DOI 10.4049/jimmunol.179.11.7741; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Nilsson A, 2009, BIOCHEM BIOPH RES CO, V387, P58, DOI 10.1016/j.bbrc.2009.06.121; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Roos A, 2004, EUR J IMMUNOL, V34, P921, DOI 10.1002/eji.200424904; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Singh NJ, 2006, NAT CLIN PRACT RHEUM, V2, P44, DOI 10.1038/ncprheum0049; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75595	10.1371/journal.pone.0075595	http://dx.doi.org/10.1371/journal.pone.0075595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073274	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000084
J	Wu, JH; Shen, SD; Yang, JL; Xia, ZW; Zhong, XP				Wu, Jinhong; Shen, Shudan; Yang, Jialong; Xia, Zhenwei; Zhong, Xiao-Ping			Diacylglycerol Kinase Zeta Positively Controls the Development of iNKT-17 Cells	PLOS ONE			English	Article							INVARIANT NKT CELLS; SCLEROSIS COMPLEX 1; KILLER T-CELLS; ROR-GAMMA-T; CYTOKINE PRODUCTION; ACTIVATION; RECEPTOR; PATHWAY; IDENTIFICATION; EXPRESSION	Invariant natural killer T (iNKT) cells play important roles in bridging innate and adaptive immunity via rapidly producing a variety of cytokines. A small subset of iNKT cells produces IL-17 and is generated in the thymus during iNKT-cell ontogeny. The mechanisms that control the development of these IL-17-producing iNKT-17 cells (iNKT-17) are still not well defined. Diacylglycerol kinase zeta (DGK zeta) belongs to a family of enzymes that catalyze the phosphorylation and conversion of diacylglycerol to phosphatidic acid, two important second messengers involved in signaling from numerous receptors. We report here that DGK zeta plays an important role in iNKT-17 development. A deficiency of DGK zeta in mice causes a significant reduction of iNKT-17 cells, which is correlated with decreased ROR gamma t and IL-23 receptor expression. Interestingly, iNKT-17 defects caused by DGK zeta deficiency can be corrected in chimeric mice reconstituted with mixed wild-type and DGK zeta deficient bone marrow cells. Taken together, our data identify DGK zeta as an important regulator of iNKT-17 development through iNKT-cell extrinsic mechanisms.	[Wu, Jinhong; Shen, Shudan; Yang, Jialong; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Wu, Jinhong; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Shanghai 200030, Peoples R China; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Shanghai Jiao Tong University; Duke University	Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	zhong001@mc.duke.edu			National Institutes of Health [AI076357, AI079088, AI101206]; American Cancer Society [RSG-08-186-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076357, R01AI101206, R01AI079088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by the National Institutes of Health (AI076357, AI079088, and AI101206) and the American Cancer Society (RSG-08-186-01-LIB) to X-PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brutkiewicz RR, 2002, CRIT REV ONCOL HEMAT, V41, P287, DOI 10.1016/S1040-8428(01)00198-6; Cerundolo V, 2010, SEMIN IMMUNOL, V22, P59, DOI 10.1016/j.smim.2010.01.002; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Enders A, 2012, J IMMUNOL, V189, P5240, DOI 10.4049/jimmunol.1201486; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Krishna S, 2013, CRIT REV IMMUNOL, V33, P97, DOI 10.1615/CritRevImmunol.2013006696; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Milpied P, 2011, BLOOD, V118, P2993, DOI 10.1182/blood-2011-01-329268; Monteiro M, 2013, J IMMUNOL, V190, P805, DOI 10.4049/jimmunol.1201010; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Pan HJ, 2013, J IMMUNOL, V191, P699, DOI 10.4049/jimmunol.1201443; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Shen SD, 2011, J IMMUNOL, V187, P4467, DOI 10.4049/jimmunol.1003798; Shen SD, 2011, J IMMUNOL, V187, P2122, DOI 10.4049/jimmunol.1100495; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wondimu Z, 2010, AM J PATHOL, V177, P2334, DOI 10.2353/ajpath.2010.100028; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2011, IMMUNOL RES, V49, P109, DOI 10.1007/s12026-010-8175-9; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75202	10.1371/journal.pone.0075202	http://dx.doi.org/10.1371/journal.pone.0075202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073253	gold, Green Submitted, Green Published			2022-12-25	WOS:000324768000062
J	Chai, W; Lian, ZJ; Chen, C; Liu, JY; Shi, LL; Wang, Y				Chai, Wei; Lian, Zijian; Chen, Chao; Liu, Jingyi; Shi, Lewis L.; Wang, Yan			JARID1A, JMY, and PTGER4 Polymorphisms Are Related to Ankylosing Spondylitis in Chinese Han Patients: A Case-Control Study	PLOS ONE			English	Article							PROGRESSION; COFACTOR	Susceptibility to ankylosing spondylitis (AS) is largely genetically determined. JARID1A, JMY and PTGER4 have recently been found to be associated with AS in patients of western European descent. We aim to examine the influence of JARID1A, JMY, and PTGER4 polymorphisms on the susceptibility to and the severity of ankylosing spondylitis in Chinese ethnic majority Han population. This work can lead the clinical doctors to intervene earlier. Blood samples were drawn from 396 AS patients and 404 unrelated healthy controls. Both the AS patients and the controls are Han Chinese. The AS patients are classified based on the severity of the disease. Thirteen tag single nucleotide polymorphisms (tagSNPs) in JARID1A, JMY and PTGER4 are selected and genotyped. Frequencies of different genotypes and alleles are analyzed among the different severity AS patients and the controls. The rs2284336 SNP in JARID1A, the rs16876619 and rs16876657 SNPs in JMY are associated with susceptibility of AS. The rs11062357 SNP in JARID1A, the rs2607142 SNP in JMY and rs10440635 in PTGER4 are related to severity of AS. Haplotype analyses indicate PTGER4 is related to susceptibility to AS; JARID1A and JMY are related to severity of AS.	[Chai, Wei; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Lian, Zijian; Chen, Chao] Tianjin Hosp, Dept Orthopaed, Tianjin, Peoples R China; [Liu, Jingyi; Wang, Yan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Shi, Lewis L.] Univ Chicago Hosp, Dept Orthopaed, Chicago, IL 60637 USA	Chinese People's Liberation Army General Hospital; Nankai University; University of Chicago; University of Illinois System	Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	wangyaneasy@163.com		Chen, Chao/0000-0002-8397-4294	Natural Science Foundation of Beijing [7102146]	Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of Beijing (7102146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR B, 1994, J RHEUMATOL, V21, P1883; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; CALIN A, 1994, J RHEUMATOL, V21, P2281; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gran JT, 1997, BRIT J RHEUMATOL, V36, P766; Hamersma J, 2001, ARTHRITIS RHEUM, V44, P1396, DOI 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A; Kiaer T, 2010, EUR SPINE J, V19, P57, DOI 10.1007/s00586-009-1104-8; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pointon JJ, 2011, GENES IMMUN, V12, P395, DOI 10.1038/gene.2011.23; Prijatelj M, 2011, PROSTAG OTH LIPID M, V95, P19, DOI 10.1016/j.prostaglandins.2011.04.001; Robertson FM, 2010, CANCER-AM CANCER SOC, V116, P2806, DOI 10.1002/cncr.25167; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; *TASC, 2011, NATURE GENETICS; Tost J, 2005, CLIN BIOCHEM, V38, P335, DOI 10.1016/j.clinbiochem.2004.12.005; Van der Heijde DMFM, 2004, ANN RHEUM DIS, V63, P98; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74794	10.1371/journal.pone.0074794	http://dx.doi.org/10.1371/journal.pone.0074794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069348	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300046
J	Gaudart, J; Cloutman-Green, E; Guillas, S; D'Arcy, N; Hartley, JC; Gant, V; Klein, N				Gaudart, Jean; Cloutman-Green, Elaine; Guillas, Serge; D'Arcy, Nikki; Hartley, John C.; Gant, Vanya; Klein, Nigel			Healthcare Environments and Spatial Variability of Healthcare Associated Infection Risk: Cross-Sectional Surveys	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; SURFACES; HOSPITALS; STANDARDS; DESIGN; UNIT	Prevalence of healthcare associated infections remains high in patients in intensive care units (ICU), estimated at 23.4% in 2011. It is important to reduce the overall risk while minimizing the cost and disruption to service provision by targeted infection control interventions. The aim of this study was to develop a monitoring tool to analyze the spatial variability of bacteriological contamination within the healthcare environment to assist in the planning of interventions. Within three cross-sectional surveys, in two ICU wards, air and surface samples from different heights and locations were analyzed. Surface sampling was carried out with tryptic Soy Agar contact plates and Total Viable Counts (TVC) were calculated at 48hrs (incubation at 37 C). TVCs were analyzed using Poisson Generalized Additive Mixed Model for surface type analysis, and for spatial analysis. Through three cross-sectional survey, 370 samples were collected. Contamination varied from place-to-place, height-to-height, and by surface type. Hard-to-reach surfaces, such as bed wheels and floor area under beds, were generally more contaminated, but the height level at which maximal TVCs were found changed between cross-sectional surveys. Bedside locations and bed occupation were risk factors for contamination. Air sampling identified clusters of contamination around the nursing station and surface sampling identified contamination clusters at numerous bed locations. By investigating dynamic hospital wards, the methodology employed in this study will be useful to monitor contamination variability within the healthcare environment and should help to assist in the planning of interventions.	[Gaudart, Jean] Aix Marseille Univ, INSERM, IRD, SESSTIM UMR912, Marseille, France; [Gaudart, Jean; Guillas, Serge] UCL, Dept Stat Sci, London, England; [Cloutman-Green, Elaine; D'Arcy, Nikki; Hartley, John C.] Great Ormond St Hosp NHS Trust, Camelia Botnar Labs, Dept Microbiol, London, England; [Gant, Vanya] Univ Coll London Hosp, Dept Microbiol, London, England; [Klein, Nigel] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Gaudart, J (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM UMR912, Marseille, France.	jean.gaudart@univ-amu.fr	gaudart, jean/D-9071-2013; Guillas, Serge/A-2700-2012	gaudart, jean/0000-0001-9006-5729; Klein, Nigel/0000-0003-3925-9258; Cloutman-Green, Elaine/0000-0001-7534-3196; Guillas, Serge/0000-0002-3910-3408	Health and Care Infrastructure Research Centre; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital; Institute of Child Health; Association for the development of research in biology and medicine at the Department of Statistical Science University College London; EPSRC [EP/I029788/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I029788/1] Funding Source: researchfish; National Institute for Health Research [HCS/D10/010] Funding Source: researchfish	Health and Care Infrastructure Research Centre; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital; Institute of Child Health; Association for the development of research in biology and medicine at the Department of Statistical Science University College London; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was undertaken with funding provided by the Health and Care Infrastructure Research Centre supported by the Engineering and Physical Sciences Research Council. ECG received salary funding from the National Institute of Health Research during the course of this research. NK was supported in part by the National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital and the Institute of Child Health. JG received a research fellowship from the Association for the development of research in biology and medicine during his 2012 stay at the Department of Statistical Science University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agvald-Ohman C, 2006, SCAND J INFECT DIS, V38, P441, DOI 10.1080/00365540600561751; Allegranzi B, 2011, REPORT BURDEN ENDEMI; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Augustin NH, 2012, COMPUT STAT DATA AN, V56, P2404, DOI 10.1016/j.csda.2012.01.026; Bartley J, 2010, CRIT CARE MED, V38, pS388, DOI 10.1097/CCM.0b013e3181e6d0c1; Bartley JM, 2010, AM J INFECT CONTROL, V38, pS1, DOI 10.1016/j.ajic.2010.04.195; Beggs CB, 2008, AM J INFECT CONTROL, V36, P250, DOI 10.1016/j.ajic.2007.07.012; Bogusz A., 2013, Healthcare Infection, V18, P3, DOI 10.1071/HI12063; Campos GB, 2012, NEW MICROBIOL, V35, P183; D'Arcy N, 2012, AEROBIOLOGIA, V28, P1, DOI [10.1007/s10453-011-9206-2, DOI 10.1007/S10453-011-9206-2]; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Department of Health, 2006, HLTH ACT 2006 COD PR; Department of Health, 2007, SAV LIV RED INF DEL; Dettenkofer M, 2011, J HOSP INFECT, V77, P7, DOI 10.1016/j.jhin.2010.07.025; Frabetti A, 2009, AM J INFECT CONTROL, V37, P658, DOI 10.1016/j.ajic.2009.03.011; Griffith CJ, 2007, J HOSP INFECT, V66, P352, DOI 10.1016/j.jhin.2007.05.016; Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717; Hathway EA, 2011, INDOOR BUILT ENVIRON, V22, P410; Health Protection Agency, 2012, ENGL NAT POINT PREV; HOLAH JT, 1988, J APPL BACTERIOL, V65, P215, DOI 10.1111/j.1365-2672.1988.tb01888.x; King MF, 2013, BUILD ENVIRON, V59, P436, DOI 10.1016/j.buildenv.2012.09.011; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lewis T, 2008, J HOSP INFECT, V69, P156, DOI 10.1016/j.jhin.2008.03.013; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Mitt P, 2009, J HOSP INFECT, V71, P365, DOI 10.1016/j.jhin.2009.01.008; Moore G, 2013, INFECT CONT HOSP EP, V34, P500, DOI 10.1086/670219; Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006; National Audit Office, 2009, RED HEALTHC ASS INF; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; White LF, 2008, AM J INFECT CONTROL, V36, P381, DOI 10.1016/j.ajic.2007.10.015; Wilson APR, 2011, CRIT CARE MED, V39, P651, DOI 10.1097/CCM.0b013e318206bc66; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76249	10.1371/journal.pone.0076249	http://dx.doi.org/10.1371/journal.pone.0076249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069459	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300105
J	Holmoy, T; Loken-Amsrud, KI; Bakke, SJ; Beiske, AG; Bjerve, KS; Hovdal, H; Lilleas, F; Midgard, R; Pedersen, T; Benth, JS; Torkildsen, O; Wergeland, S; Myhr, KM; Michelsen, AE; Aukrust, P; Ueland, T				Holmoy, Trygve; Loken-Amsrud, Kristin Ingeleiv; Bakke, Soren Jacob; Beiske, Antonie G.; Bjerve, Kristian S.; Hovdal, Harald; Lilleas, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jutrate Saltyte; Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten; Michelsen, Annika E.; Aukrust, Pal; Ueland, Thor			Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CIRCULATING ADHESION MOLECULES; POLYUNSATURATED FATTY-ACIDS; NECROSIS-FACTOR RECEPTOR; CEREBROSPINAL-FLUID; TGF-BETA; PROTECT NEURONS; UP-REGULATION; SERUM-LEVELS; T-CELLS	Background: Serum markers of inflammation are candidate biomarkers in multiple sclerosis (MS). omega-3 fatty acids are suggested to have anti-inflammatory properties that might be beneficial in MS. We aimed to explore the relationship between serum levels of inflammation markers and MRI activity in patients with relapsing remitting MS, as well as the effect of omega-3 fatty acids on these markers. Methods: We performed a prospective cohort study in 85 relapsing remitting MS patients who participated in a randomized clinical trial of omega-3 fatty acids versus placebo (the OFAMS study). During a period of 24 months 12 repeated magnetic resonance imaging (MRI) scans and nine serum samples were obtained. We measured 10 inflammation markers, including general down-stream markers of inflammation, specific markers of up-stream inflammatory pathways, endothelial action, and matrix regulation. Results: After Bonferroni correction, increasing serum levels of CXCL16 and osteoprotegerin were associated with low odds ratio for simultaneous MRI activity, whereas a positive association was observed for matrix metalloproteinase (MMP) 9. CXCL16 were also associated with low MRI activity the next month, but this was not significant after Bonferroni correction. In agreement with previously reported MRI and clinical results, omega-3 fatty acid treatment did not induce any change in the inflammation markers. Conclusions: Serum levels of CXCL16, MMP-9, and osteoprotegerin reflect disease activity in MS, but are not affected by omega-3 fatty acid treatment. CXCL16 could be a novel biomarker and potential predictor of disease activity in MS.	[Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Holmoy, Trygve; Loken-Amsrud, Kristin Ingeleiv; Benth, Jutrate Saltyte; Aukrust, Pal; Ueland, Thor] Univ Oslo, Inst Clin Med, Oslo, Norway; [Loken-Amsrud, Kristin Ingeleiv] Innlandet Hosp Trust, Dept Neurol, Lillehammer, Norway; [Bakke, Soren Jacob] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Beiske, Antonie G.] Multiple Sclerosis Ctr Hakadal, Hakadal, Norway; [Bjerve, Kristian S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Biochem, Trondheim, Norway; [Hovdal, Harald] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Lilleas, Finn] Curato Oslo, Oslo, Norway; [Midgard, Rune] Molde Hosp, Dept Neurol, Molde, Norway; [Midgard, Rune] Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7034 Trondheim, Norway; [Pedersen, Tom] Unilabs Drammen, Drammen, Norway; [Benth, Jutrate Saltyte] Akershus Univ Hosp, Helse Sor Ost Hlth Serv Res Ctr, Lorenskog, Norway; [Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, KG KG Jebsen MS Res Ctr, Bergen, Norway; [Michelsen, Annika E.; Aukrust, Pal; Ueland, Thor] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway	University of Oslo; University of Oslo; Innlandet Hospital Trust; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Holmoy, T (corresponding author), Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway.	trygve.holmoy@medisin.uio.no	Torkildsen, Øivind/A-1606-2008; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X	Merck-Serono; Pronova Biocare; Bayer Schering; Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society	Merck-Serono(Merck & Company); Pronova Biocare; Bayer Schering(Bayer AG); Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society	The study was partly supported by Merck-Serono, Pronova Biocare, Bayer Schering, Innlandet Hospital Trust, The Western Norway Regional Health Authority, Odd Fellow Research Foundation for multiple sclerosis, Kare Waerner's Legacy and The Norwegian MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; [Anonymous], J NEUROL SCI, V305, P1, DOI [10.1016/j.jns.2011.03.026, DOI 10.1016/J.JNS.2011.03.026.PUBMED:21463872]; Bilinska M, 2002, MED SCI MONITOR, V8; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Franciotta D, 2001, J NEUROIMMUNOL, V115, P192, DOI 10.1016/S0165-5728(01)00261-2; Fukumoto N, 2004, J IMMUNOL, V173, P1620, DOI 10.4049/jimmunol.173.3.1620; GALLAI V, 1995, J NEUROIMMUNOL, V56, P143, DOI 10.1016/0165-5728(94)00140-J; HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Hofbauer LC, 2004, ACTA NEUROPATHOL, V107, P575, DOI 10.1007/s00401-004-0854-y; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Johnson GH, 2012, J ACAD NUTR DIET, V112, P1029, DOI 10.1016/j.jand.2012.03.029; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kurban S, 2008, MULT SCLER, V14, P431, DOI 10.1177/1352458507084028; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; le Blanc LMP, 2006, NEUROSCI LETT, V397, P145, DOI 10.1016/j.neulet.2005.12.029; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Mirshafiey A, 2009, NEUROPHARMACOLOGY, V56, P929, DOI 10.1016/j.neuropharm.2009.02.007; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; O'Connor RA, 2012, J IMMUNOL, V188, P2093, DOI 10.4049/jimmunol.1101118; RIECKMANN P, 1994, NEUROLOGY, V44, P2367, DOI 10.1212/WNL.44.12.2367; Romi F, 2012, EUR NEUROL, V67, P121, DOI 10.1159/000334862; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Schwarz S, 2008, MULT SCLER J, V14, P1113, DOI 10.1177/1352458508092808; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; SELMAJ K, 1995, J NEUROIMMUNOL, V56, P135, DOI 10.1016/0165-5728(94)00139-F; Shinto L, 2009, PROSTAG LEUKOTR ESS, V80, P131, DOI 10.1016/j.plefa.2008.12.001; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Voltz R, 1997, J NEUROL NEUROSUR PS, V62, P200, DOI 10.1136/jnnp.62.2.200-b; Wang HH, 2013, MULT SCLER J, V19, P926, DOI 10.1177/1352458512457845; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Waubant E, 2006, DIS MARKERS, V22, P235, DOI 10.1155/2006/709869; Weinstock-Guttman B, 2005, PROSTAG LEUKOTR ESS, V73, P397, DOI 10.1016/j.plefa.2005.05.024; Zhang WT, 2011, FRONT BIOSCI-LANDMRK, V16, P2653, DOI 10.2741/3878	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75021	10.1371/journal.pone.0075021	http://dx.doi.org/10.1371/journal.pone.0075021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069377	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300061
J	Ottis, P; Topic, B; Loos, M; Li, KW; de Souza, A; Schulz, D; Smit, AB; Huston, JP; Korth, C				Ottis, Philipp; Topic, Bianca; Loos, Maarten; Li, Ka Wan; de Souza, Angelica; Schulz, Daniela; Smit, August B.; Huston, Joseph P.; Korth, Carsten			Aging-Induced Proteostatic Changes in the Rat Hippocampus Identify ARP3, NEB2 and BRAG2 as a Molecular Circuitry for Cognitive Impairment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GENE-EXPRESSION ATLAS; ARP2/3 COMPLEX; DENDRITIC SPINES; WATER MAZE; AGED RATS; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; SPATIAL INFORMATION; PROTEOMIC ANALYSIS	Disturbed proteostasis as a particular phenotype of the aging organism has been advanced in C. elegans experiments and is also conceived to underlie neurodegenerative diseases in humans. Here, we investigated whether particular changes in non-disease related proteostasis can be identified in the aged mammalian brain, and whether a particular signature of aberrant proteostasis is related to behavioral performance of learning and memory. Young (adult, n = 30) and aged (2 years, n = 50) Wistar rats were tested in the Morris Water Maze (MWM) to distinguish superior and inferior performers. For both young and old rats, the best and worst performers in the MWM were selected and the insoluble proteome, termed aggregome, was purified from the hippocampus as evidence for aberrant proteostasis. Quantitative proteomics (iTRAQ) was performed. The aged inferior performers were considered as a model for spontaneous, age-associated cognitive impairment. Whereas variability of the insoluble proteome increased with age, absolute changes in the levels of insoluble proteins were small compared to the findings in the whole C. elegans insoluble proteome. However, we identified proteins with aberrant proteostasis in aging. For the cognitively impaired rats, we identified a changed molecular circuitry of proteins selectively involved in F-actin remodeling, synapse building and long-term depression: actin related protein 3 (ARP3), neurabin II (NEB2) and IQ motif and SEC7 domain-containing protein 1 (BRAG2). We demonstrate that aberrant proteostasis is a specific phenotype of brain aging in mammals. We identify a distinct molecular circuitry where changes in proteostasis are characteristic for poor learning and memory performance in the wild type, aged rat. Our findings 1. establish the search for aberrant proteostasis as a successful strategy to identify neuronal dysfunction in deficient cognitive behavior, 2. reveal a previously unknown functional network of proteins (ARP3, NEB2, BRAG2) involved in age-associated cognitive dysfunction.	[Ottis, Philipp; Korth, Carsten] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Topic, Bianca; de Souza, Angelica; Schulz, Daniela; Huston, Joseph P.] Univ Dusseldorf, Dept Expt Psychol, Ctr Behav Neurosci, D-40225 Dusseldorf, Germany; [Loos, Maarten; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Loos, Maarten] Synaptologics BV, Amsterdam, Netherlands	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Vrije Universiteit Amsterdam	Korth, C (corresponding author), Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany.	ckorth@uni-duesseldorf.de	Loos, Maarten/A-2768-2012	Loos, Maarten/0000-0003-1629-2928; li, ka wan/0000-0001-6983-5055	KNDD BMBF [01ED1201B]; EU-FP7-PRIORITY; DFG [Hu 306/27-2]; EU-FP7 project 'SynSys' [242167];  [DFG-GRK1033]	KNDD BMBF(Federal Ministry of Education & Research (BMBF)); EU-FP7-PRIORITY; DFG(German Research Foundation (DFG)); EU-FP7 project 'SynSys'; 	Funding for this project was provided by DFG-GRK1033, KNDD BMBF 01ED1201B), EU-FP7-PRIORITY to CK, and DFG Hu 306/27-2 to JPH. ABS and KWL received funding from the EU-FP7 project 'SynSys' (grant # 242167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Calhoun ME, 2008, NEUROBIOL AGING, V29, P1256, DOI 10.1016/j.neurobiolaging.2007.02.013; Carrette O, 2006, PROTEOMICS, V6, P4940, DOI 10.1002/pmic.200600084; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chen WQ, 2007, ELECTROPHORESIS, V28, P4392, DOI 10.1002/elps.200700336; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fitzjohn SM, 2010, NEURON, V66, P627, DOI 10.1016/j.neuron.2010.05.027; Focking M, 2006, PROTEOMICS, V6, P4914, DOI 10.1002/pmic.200600269; Freeman WM, 2009, NEUROSCIENCE, V159, P183, DOI 10.1016/j.neuroscience.2008.12.004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; GALLAGHER M, 1993, BEHAV BRAIN RES, V57, P155, DOI 10.1016/0166-4328(93)90131-9; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Grossman SD, 2004, J NEUROCHEM, V90, P317, DOI 10.1111/j.1471-4159.2004.02491.x; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Guo J, 2011, J PROTEOMICS, V74, P2370, DOI 10.1016/j.jprot.2011.07.009; Hasenohrl RU, 1997, EXP BRAIN RES, V114, P205, DOI 10.1007/PL00005629; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henninger N, 2007, GENES BRAIN BEHAV, V6, P128, DOI 10.1111/j.1601-183X.2006.00239.x; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kosik KS, 2012, J GERONTOL A-BIOL, V67, P741, DOI 10.1093/gerona/gls110; KRAUTH J, 1980, J NEUROSCI METH, V2, P239, DOI 10.1016/0165-0270(80)90013-8; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lupien SJ, 2004, PHILOS T R SOC B, V359, P1413, DOI 10.1098/rstb.2004.1516; Machesky LM, 1997, BIOCHEM J, V328, P105; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; McNair K, 2007, NEUROSCIENCE, V145, P413, DOI 10.1016/j.neuroscience.2006.12.033; McNair K, 2006, EUR J NEUROSCI, V23, P575, DOI 10.1111/j.1460-9568.2005.04542.x; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1372, DOI 10.1210/en.2004-0416; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; ONEILL C, 2010, BIOCHEM SOC T, V40, P721; Ottis P, 2012, PROTEOMICS, V12, P2445, DOI 10.1002/pmic.201100668; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poon HF, 2006, NEUROBIOL AGING, V27, P1020, DOI 10.1016/j.neurobiolaging.2005.05.014; Racz B, 2008, J NEUROSCI, V28, P5654, DOI 10.1523/JNEUROSCI.0756-08.2008; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; RAPP PR, 1987, BEHAV NEUROSCI, V101, P3, DOI 10.1037/0735-7044.101.1.3; RAPP PR, 1992, TRENDS NEUROSCI, V15, P340, DOI 10.1016/0166-2236(92)90051-9; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; REISBERG B, 1988, DRUG DEVELOP RES, V15, P101, DOI 10.1002/ddr.430150203; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; SAITO S, 1994, J BIOL CHEM, V269, P29710; Sato Y, 2005, NEUROSCI LETT, V382, P22, DOI 10.1016/j.neulet.2005.02.053; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schulz D, 2004, EUR J NEUROSCI, V19, P1373, DOI 10.1111/j.1460-9568.2004.03234.x; Schulz D, 2002, EUR J NEUROSCI, V16, P2175, DOI 10.1046/j.1460-9568.2002.02282.x; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Schutt F, 2002, FEBS LETT, V528, P217, DOI 10.1016/S0014-5793(02)03312-4; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Topic B, 2007, HIPPOCAMPUS, V17, P68, DOI 10.1002/hipo.20246; Topic B, 2005, BEHAV NEUROSCI, V119, P127, DOI 10.1037/0735-7044.119.1.127; Uematsu K, 2005, J NEUROCHEM, V95, P1642, DOI 10.1111/j.1471-4159.2005.03491.x; VanGuilder HD, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00008; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vauti F, 2007, FEBS LETT, V581, P5691, DOI 10.1016/j.febslet.2007.11.031; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weinreb O, 2007, ANTIOXID REDOX SIGN, V9, P169, DOI 10.1089/ars.2007.9.169; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	100	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75112	10.1371/journal.pone.0075112	http://dx.doi.org/10.1371/journal.pone.0075112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069387	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300067
J	Vrzal, R; Frauenstein, K; Proksch, P; Abel, J; Dvorak, Z; Haarmann-Stemmann, T				Vrzal, Radim; Frauenstein, Katrin; Proksch, Peter; Abel, Josef; Dvorak, Zdenek; Haarmann-Stemmann, Thomas			Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ARYLHYDROCARBON RECEPTOR; TRANSCRIPTIONAL REGULATION; CYTOCHROME-P450 1A1; MICE LACKING; SRC KINASE; REPRESSOR; DIOXIN; PHARMACOKINETICS; ACTIVATION	Khellin and visnagin are two furanochromones that can be frequently found in ethnomedical formulations in Asia and the Middle East. Both compounds possess anti-inflammatory and analgesic properties, therefore modern medicine uses these compounds or structurally related derivatives for treatment of vitiligo, bronchial asthma and renal colics. Despite their frequent usage, the potential toxic properties of visnagin and khellin are not well characterized up-to-now. Many natural compounds modulate the expression and activity of cytochrome P450 1A1 (CYP1A1), which is well-known to bioactivate pro-carcinogens. The expression of this enzyme is controlled by the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor and regulator of drug metabolism. Here, we investigated the influence of both furanochromones on AHR signaling in human HepG2 hepatocarcinoma cells and primary human hepatocytes. Both compounds transactivated xenobiotic response element (XRE)-driven reporter gene activity in a dose-dependent manner and induced CYP1A1 transcription in HepG2 cells and primary hepatocytes. The latter was abolished in presence of a specific AHR antagonist. CYP1A enzyme activity assays done in HepG2 cells and primary hepatocytes revealed an inhibition of enzyme activity by both furanochromones, which may become relevant regarding the metabolism of xenobiotics and co-administered therapeutic drugs. The observed induction of several other members of the AHR gene battery, whose gene products are involved in regulation of cell growth, differentiation and migration, indicates that a further toxicological characterization of visnagin and khelllin is urgently required in order to minimize potential drug-drug interactions and other toxic side-effects that may occur during therapeutic usage of these furanochromones.	[Vrzal, Radim; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Frauenstein, Katrin; Abel, Josef; Haarmann-Stemmann, Thomas] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Proksch, Peter] Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, D-40225 Dusseldorf, Germany	Palacky University Olomouc; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf	Vrzal, R (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic.	radim.vrzal@email.cz	Proksch, Peter/AAR-4593-2020	Dvorak, Zdenek/0000-0002-3938-3585	Grant Agency of Czech Republic [GACR 303/12/0472, GACR 303/12/G163]; Palacky University [PRF-2013-002]; Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG)	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Palacky University; Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG)	This research was supported by the Grant Agency of Czech Republic GACR 303/12/0472 (RV) and GACR 303/12/G163 (ZD, RV), Student grant from Palacky University PRF-2013-002 (ZD, RV) and the Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Abu-Hashem AA, 2011, MOLECULES, V16, P1956, DOI 10.3390/molecules16031956; Aitchison KJ, 2000, J PSYCHOPHARMACOL, V14, P353, DOI 10.1177/026988110001400403; Atta SMS, 2010, EUR J MED CHEM, V45, P4920, DOI 10.1016/j.ejmech.2010.07.065; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Baumgart A, 2005, BIOCHEM PHARMACOL, V69, P657, DOI 10.1016/j.bcp.2004.11.017; Chao HR, 2007, J HAZARD MATER, V149, P234, DOI 10.1016/j.jhazmat.2007.07.022; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; de Leeuw J, 2011, J EUR ACAD DERMATOL, V25, P74, DOI 10.1111/j.1468-3083.2010.03701.x; Dong B, 2008, MOL PHARMACOL, V74, P255, DOI 10.1124/mol.107.044669; DUARTE J, 1995, EUR J PHARMACOL, V286, P115, DOI 10.1016/0014-2999(95)00418-K; DUSCHET P, 1989, J AM ACAD DERMATOL, V21, P592, DOI 10.1016/S0190-9622(89)80248-8; Dvorak Z, 2008, BIOCHEM PHARMACOL, V75, P580, DOI 10.1016/j.bcp.2007.09.013; EDENHARDER R, 1995, MUTAT RES-GENET TOX, V345, P57, DOI 10.1016/0165-1218(95)90070-5; Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847; Fernandez-Soria V, 2006, INT J ONCOL, V28, P143; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fritsche E, 2005, ENVIRON HEALTH PERSP, V113, P871, DOI 10.1289/ehp.7793; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; FUHR U, 1992, EUR J CLIN PHARMACOL, V42, P463; GROSSMAN SJ, 1993, DRUG METAB DISPOS, V21, P1029; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Haarmann-Stemmann T, 2010, ARCH TOXICOL, V84, P619, DOI 10.1007/s00204-010-0548-2; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hasa D, 2013, EUR J PHARM BIOPHARM, V84, P138, DOI 10.1016/j.ejpb.2012.11.025; Hasebe Y, 2003, BIOL PHARM BULL, V26, P1379, DOI 10.1248/bpb.26.1379; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Ide F, 2004, CANCER LETT, V214, P35, DOI 10.1016/j.canlet.2004.04.014; Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269; Lee JK, 2010, ARCH PHARM RES, V33, P1843, DOI 10.1007/s12272-010-1117-1; Lee SK, 2007, ARCH PHARM RES, V30, P1629, DOI 10.1007/BF02977334; LU YF, 1995, ARCH BIOCHEM BIOPHYS, V316, P470, DOI 10.1006/abbi.1995.1062; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; MORLIERE P, 1988, J INVEST DERMATOL, V90, P720, DOI 10.1111/1523-1747.ep13083852; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; ORTEL B, 1988, J AM ACAD DERMATOL, V18, P693, DOI 10.1016/S0190-9622(88)70092-4; OSHER HL, 1951, NEW ENGL J MED, V244, P315, DOI 10.1056/NEJM195103012440901; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Park S, 2007, BIOCHEMISTRY-US, V46, P899, DOI 10.1021/bi061925f; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Ragab FAF, 2010, CHEM PHARM BULL, V58, P1148, DOI 10.1248/cpb.58.1148; Rapisarda A, 2012, ADV CANCER RES, V114, P237, DOI 10.1016/B978-0-12-386503-8.00006-5; RAUWALD HW, 1994, PLANTA MED, V60, P101, DOI 10.1055/s-2006-959426; Schimmer O, 1998, MUTAGENESIS, V13, P385, DOI 10.1093/mutage/13.4.385; SCOTT RC, 1951, CIRCULATION, V3, P80, DOI 10.1161/01.CIR.3.1.80; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; Ueng YF, 2005, J PHARM PHARMACOL, V57, P227, DOI 10.1211/0022357055489; Vanachayangkul P, 2011, UROL RES, V39, P189, DOI 10.1007/s00240-010-0333-y; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	57	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74917	10.1371/journal.pone.0074917	http://dx.doi.org/10.1371/journal.pone.0074917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069365	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300054
J	Ren, ZG; Chen, XH; Cui, GY; Yin, SY; Chen, LY; Jiang, JW; Hu, ZH; Xie, HY; Zheng, SS; Zhou, L				Ren, Zhigang; Chen, Xinhua; Cui, Guangying; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin			Nanosecond Pulsed Electric Field Inhibits Cancer Growth Followed by Alteration in Expressions of NF-kappa B and Wnt/beta-Catenin Signaling Molecules	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; GENE-EXPRESSION; APOPTOSIS; WNT; MELANOMAS; SURVIVAL; PROTEIN; NOTCH; PROLIFERATION	Cancer remains a leading cause of death worldwide and total number of cases globally is increasing. Novel treatment strategies are therefore desperately required for radical treatment of cancers and long survival of patients. A new technology using high pulsed electric field has emerged from military application into biology and medicine by applying nsPEF as a means to inhibit cancer. However, molecular mechanisms of nsPEF on tumors or cancers are still unclear. In this paper, we found that nsPEF had extensive biological effects in cancers, and clarified its possible molecular mechanisms in vitro and in vivo. It could not only induce cell apoptosis via dependent-mitochondria intrinsic apoptosis pathway that was triggered by imbalance of anti-or pro-apoptosis Bcl-2 family proteins, but also inhibit cell proliferation through repressing NF-kappa B signaling pathway to reduce expressions of cyclin proteins. Moreover, nsPEF could also inactivate metastasis and invasion in cancer cells by suppressing Wnt/beta-Catenin signaling pathway to down-regulating expressions of VEGF and MMPs family proteins. More importantly, nsPEF could function safely and effectively as an anti-cancer therapy through inducing tumor cell apoptosis, destroying tumor microenvironment, and depressing angiogenesis in tumor tissue in vivo. These findings may provide a creative and effective therapeutic strategy for cancers.	[Ren, Zhigang; Chen, Xinhua; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ren, Zhigang; Chen, Xinhua; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Guangying] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	zhoulin99@zju.edu.cn	Ren, Zhigang/AAO-8576-2020		National S&T Major Project of China [2012ZX10002-017, 2012ZX10002-004]; NSFC for Innovative Research Group of China [81121002]; Zhejiang Medical Research Funding [2008B079, LY13H180003]; SRF for ROCS, SEM [J20120279]; Xinjiang Science and Technology Bureau Project [2013911131]	National S&T Major Project of China; NSFC for Innovative Research Group of China; Zhejiang Medical Research Funding; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Xinjiang Science and Technology Bureau Project	This work was supported by the National S&T Major Project of China (2012ZX10002-017, 2012ZX10002-004), NSFC for Innovative Research Group of China (81121002), Zhejiang Medical Research Funding (2008B079, LY13H180003), SRF for ROCS, SEM (J20120279), and Xinjiang Science and Technology Bureau Project (2013911131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos-De-Souza P, 2012, BBA-MOL CELL RES, V1823, P1990, DOI 10.1016/j.bbamcr.2012.07.012; Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Chen XH, 2009, MELANOMA RES, V19, P361, DOI 10.1097/CMR.0b013e32832f1558; Cheng J, 2010, PROTEOMICS, V10, P1557, DOI 10.1002/pmic.200900646; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Davis JL, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-129; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang JW, 2011, HEPATOB PANCREAT DIS, V10, P380, DOI 10.1016/S1499-3872(11)60064-7; Jiang W, 2012, WORLD J SURG; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Meulenbeld HJ, 2013, BJU INT, V111, P44, DOI 10.1111/j.1464-410X.2012.11404.x; Meyer C, 2011, ORAL ONCOL, V47, P818, DOI 10.1016/j.oraloncology.2011.06.010; Mulier S, 2005, ANN SURG, V242, P158, DOI 10.1097/01.sla.0000171032.99149.fe; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2013, INT J CANCER, V132, P1933, DOI 10.1002/ijc.27860; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schoenbach KH, 2004, P ANN INT IEEE EMBS, V26, P5447; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Wu LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014460; Xing CY, 2013, MOL CANCER THER, V12, P94, DOI 10.1158/1535-7163.MCT-12-0672; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang F, 2008, ANN SURG ONCOL, V15, P3494, DOI 10.1245/s10434-008-0146-1; Zhu HP, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-1; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	49	27	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74322	10.1371/journal.pone.0074322	http://dx.doi.org/10.1371/journal.pone.0074322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069295	gold, Green Submitted, Green Published			2022-12-25	WOS:000324547300034
J	Vargas-Alarcon, G; Posadas-Romero, C; Villarreal-Molina, T; Alvarez-Leon, E; Angeles, J; Vallejo, M; Posadas-Sanchez, R; Cardoso, G; Medina-Urrutia, A; Kimura-Hayama, E				Vargas-Alarcon, Gilberto; Posadas-Romero, Carlos; Villarreal-Molina, Teresa; Alvarez-Leon, Edith; Angeles, Javier; Vallejo, Maite; Posadas-Sanchez, Rosalinda; Cardoso, Guillermo; Medina-Urrutia, Aida; Kimura-Hayama, Eric			Single Nucleotide Polymorphisms within LIPA (Lysosomal Acid Lipase A) Gene Are Associated with Susceptibility to Premature Coronary Artery Disease. A Replication in the Genetic of Atherosclerotic Disease (GEA) Mexican Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHOLESTEROL; LOCI	Aim: The rs1412444 and rs2246833 polymorphisms within the LIPA gene were recently found to be significantly associated with coronary artery disease (CAD) in genome-wide association studies in Caucasian and Asian populations. The aim of the present study was to replicate this association in an independent population with a different genetic background. Methods: The rs1412444 and rs2246833 polymorphisms of the LIPA gene were genotyped by 5' exonuclease TaqMan genotyping assays in a sample of 899 Mexican patients with premature CAD, 270 individuals with subclinical atherosclerosis, and 677 healthy unrelated controls. Haplotypes were constructed after linkage disequilibrium analysis. Results: Under recessive and additive models, the rs1412444 T and rs2246833 T alleles were associated with an increased risk of premature CAD when compared to controls adjusting for age, gender, BMI, and total cholesterol (OR = 1.53, P-Rec = 0.0013 and OR = 1.34, P-Add = 5 x 10(-4) for rs1412444 and OR = 1.45, P-Rec = 0.0039 and OR = 1.28, P-Add = 0.0023 for rs2246833). The effect of the two polymorphisms on various metabolic cardiovascular risk factors was analyzed in premature CAD and controls (CAC score = 0). The T alleles in both polymorphisms after adjusting for age, gender, BMI, and medication were associated with hypo-a-lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, and type 2 diabetes mellitus using recessive and additive models. The polymorphisms were in strong linkage disequilibrium and, based on SNP functional prediction software, only the rs1412444 polymorphism seemed to be functional. Conclusions: These results indicate that the rs1412444 and rs2246833 of the LIPA gene are shared susceptibility polymorphisms for CAD among different ethnicities.	[Vargas-Alarcon, Gilberto; Alvarez-Leon, Edith; Angeles, Javier] Inst Nacl Cardiol Ignacio, Dept Mol Biol, Mexico City, DF, Mexico; [Posadas-Romero, Carlos; Posadas-Sanchez, Rosalinda; Cardoso, Guillermo; Medina-Urrutia, Aida] Inst Nacl Cardiol Ignacio, Dept Endocrinol, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] Inst Nacl Med Genom INMEGEN, Cardiovasc Genom Lab, Mexico City, DF, Mexico; [Vallejo, Maite] Inst Nacl Cardiol Ignacio, Sociomed Dept, Mexico City, DF, Mexico; [Kimura-Hayama, Eric] Inst Nacl Cardiol Ignacio, Dept Tomog, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com		Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Cardoso, Guillermo/0000-0001-9525-1731; Angeles Martinez, Javier/0000-0001-5405-0482; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Consejo Nacional de Ciencia y Tecnologia [156911, 112547]; Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	This work was supported in part by grants from the Consejo Nacional de Ciencia y Tecnologia (projects 156911 and 112547) and Fundacion Gonzalo Rio Arronte, Mexico City, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS GENET, V7; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Garcia-Moll X, 2005, REV ESP CARDIOL, V58, P615, DOI 10.1157/13076412; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Muntoni S, 2013, NUTR METAB CARDIOVAS, V23, P732, DOI 10.1016/j.numecd.2012.05.009; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Villarreal-Molina T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049285; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zschenker O, 2006, J BIOCHEM, V140, P23, DOI 10.1093/jb/mvj137	20	18	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74703	10.1371/journal.pone.0074703	http://dx.doi.org/10.1371/journal.pone.0074703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069331	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300050
J	Wang, H; Zheng, HH; Cao, JY; Zhou, WT; Yi, Y; Jia, ZY; Bi, SL				Wang, Hao; Zheng, Huihui; Cao, Jingyuan; Zhou, Wenting; Yi, Yao; Jia, Zhiyuan; Bi, Shengli			Genetic Diversity of Hepatitis A Virus in China: VP3-VP1-2A Genes and Evidence of Quasispecies Distribution in the Isolates	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; UNITED-STATES; CODON USAGE; OUTBREAK; VARIABILITY; CIRCULATION; MULTISTATE; INFECTION; EVOLUTIONARY; CONFIRMATION	Hepatitis A virus (HAV) is the most common cause of infectious hepatitis throughout the world, spread largely by the fecal-oral route. To characterize the genetic diversity of the virus circulating in China where HAV in endemic, we selected the outbreak cases with identical sequences in VP1-2A junction region and compiled a panel of 42 isolates. The VP3-VP1-2A regions of the HAV capsid-coding genes were further sequenced and analyzed. The quasispecies distribution was evaluated by cloning the VP3 and VP1-2A genes in three clinical samples. Phylogenetic analysis demonstrated that the same genotyping results could be obtained whether using the complete VP3, VP1, or partial VP1-2A genes for analysis in this study, although some differences did exist. Most isolates clustered in sub-genotype IA, and fewer in sub-genotype IB. No amino acid mutations were found at the published neutralizing epitope sites, however, several unique amino acid substitutions in the VP3 or VP1 region were identified, with two amino acid variants closely located to the immunodominant site. Quasispecies analysis showed the mutation frequencies were in the range of 7.22x10(-4)-2.33x10(-3) substitutions per nucleotide for VP3, VP1, or VP1-2A. When compared with the consensus sequences, mutated nucleotide sites represented the minority of all the analyzed sequences sites. HAV replicated as a complex distribution of closely genetically related variants referred to as quasispecies, and were under negative selection. The results indicate that diverse HAV strains and quasispecies inside the viral populations are presented in China, with unique amino acid substitutions detected close to the immunodominant site, and that the possibility of antigenic escaping mutants cannot be ruled out and needs to be further analyzed.	[Wang, Hao; Zheng, Huihui; Cao, Jingyuan; Zhou, Wenting; Yi, Yao; Jia, Zhiyuan; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Cao, JY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	caojy@126.com; shengli_bi@163.com		Wang, Hao/0000-0001-9425-4666; Wang, Hao/0000-0001-7988-6120; Bi, Shengli/0000-0002-0380-5790	863 Hi-Tech Research and Development program of China [2011AA02A114]	863 Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China)	This study was supported by grant from the 863 Hi-Tech Research and Development program of China (2011AA02A114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LA, 2011, J MED VIROL, V83, P768, DOI 10.1002/jmv.22045; Amon JJ, 2005, J INFECT DIS, V192, P1323, DOI 10.1086/462425; Aragones L, 2008, J VIROL, V82, P1688, DOI 10.1128/JVI.01842-07; Belalov IS, 2011, J GEN VIROL, V92, P860, DOI 10.1099/vir.0.024786-0; Bialek SR, 2007, CLIN INFECT DIS, V44, P838, DOI 10.1086/511874; Cao JY, 2011, J MED VIROL, V83, P1134, DOI 10.1002/jmv.22086; Chudy M, 1999, J MED VIROL, V57, P91, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;91::AID-JMV1&gt;3.0.CO;2-L; Costa-Mattioli M, 2006, J GEN VIROL, V87, P115, DOI 10.1099/vir.0.81286-0; Costa-Mattioli M, 2003, J GEN VIROL, V84, P3191, DOI 10.1099/vir.0.19532-0; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Costa-Mattioli M, 2001, J GEN VIROL, V82, P2647, DOI 10.1099/0022-1317-82-11-2647; Cristina J, 2007, VIRUS RES, V127, P151, DOI 10.1016/j.virusres.2007.01.005; Cui FQ, 2009, J EPIDEMIOL, V19, P189, DOI 10.2188/jea.JE20080087; De Serres G, 1999, J INFECT DIS, V179, P37, DOI 10.1086/314565; Desbois D, 2010, J CLIN MICROBIOL, V48, P3306, DOI 10.1128/JCM.00667-10; Hollinger FB., 2001, FIELDS VIROLOGY, P799; Hutin YJF, 1999, NEW ENGL J MED, V340, P595, DOI 10.1056/NEJM199902253400802; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Joshi MS, 2010, J MED VIROL, V82, P913, DOI 10.1002/jmv.21757; Klevens RM, 2010, ARCH INTERN MED, V170, P1811, DOI 10.1001/archinternmed.2010.401; Kulkarni MA, 2009, INFECT GENET EVOL, V9, P1287, DOI 10.1016/j.meegid.2009.08.009; Lam TTY, 2010, CRIT REV CL LAB SCI, V47, P5, DOI 10.3109/10408361003633318; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NAINAN OV, 1992, VIROLOGY, V191, P984, DOI 10.1016/0042-6822(92)90277-V; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Donovan D, 2001, EPIDEMIOL INFECT, V127, P469, DOI 10.1017/S0950268801006185; Perez-Sautu U, 2011, J CLIN VIROL, V52, P98, DOI 10.1016/j.jcv.2011.06.011; Perez-Sautu U, 2011, EMERG INFECT DIS, V17, P734, DOI 10.3201/eid1704.101169; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Pinto RM, 2007, VIRUS RES, V127, P158, DOI 10.1016/j.virusres.2007.04.010; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; Sanchez G, 2002, J CLIN MICROBIOL, V40, P4148, DOI 10.1128/JCM.40.11.4148-4155.2002; Shieh YC, 2007, J FOOD PROTECT, V70, P145, DOI 10.4315/0362-028X-70.1.145; Sulbaran Y, 2010, J MED VIROL, V82, P1829, DOI 10.1002/jmv.21856; Tallon LA, 2008, APPL ENVIRON MICROB, V74, P6158, DOI 10.1128/AEM.02872-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; Zhu Y, 2012, EPIDEMIOL INFECT, V1, P1	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74752	10.1371/journal.pone.0074752	http://dx.doi.org/10.1371/journal.pone.0074752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069343	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300056
J	Ferrari, J; Knoflach, M; Seyfang, L; Lang, W				Ferrari, Julia; Knoflach, Michael; Seyfang, Leonhard; Lang, Wilfried		Austrian Stroke Unit Registry	Differences in Process Management and In-Hospital Delays in Treatment with iv Thrombolysis	PLOS ONE			English	Article							STROKE UNIT REGISTRY; ACUTE ISCHEMIC-STROKE; ALTEPLASE; INTERVENTION; THERAPY; SCALE; TIME	Objectives: Rapid initiation of intravenous thrombolysis improves patient's outcome in acute stroke. We analyzed intercenter variability and factors that influence the door-to-needle time with a special focus on process measurements in all Austrian stroke units. Methods: Case level data of patients receiving intravenous thrombolysis in the Austrian Stroke Unit Registry were enriched with information of a structured questionnaire on center specific process measures of all Austrian stroke units. Influence of case and center specific variables was determined by LASSO procedure. Results: Center specific median door-to-needle time ranged between 30 and 78 minutes. Between April 2004 and November 2012, 6246 of 57991 patients treated in Austrian stroke units with acute ischemic stroke received intravenous thrombolysis. An onset-to-door time >120 minutes, patients with total anterior circulation stroke, recent year of admission, patient transportation with ambulance crew and emergency physician, the use of point of care tests reduced the door-to-needle time, whereas onset-to-door <= 60 minutes, unknown onset-to-door, patients with an NIHSS <= 4 or posterior circulation stroke, initial admission to a general emergency department, a distant radiology department, primary imaging modality other than plain CT and waiting for the lab results were associated with an increase in door-to-needle time. Case level and center specific factors could explain the inter center variability of door-to-needle times in 31 of 34 stroke units in Austria. Conclusions: In light of our results it seems crucial that every single stroke center documents and critically reviews possibilities of optimizing practice strategies in acute stroke care.	[Ferrari, Julia; Lang, Wilfried] Hosp Barmherzige Brueder, Dept Neurol, Vienna, Austria; [Knoflach, Michael] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Seyfang, Leonhard] Danube Univ, Dept Clin Neurosci & Prevent Med, Krems, Austria; Gesundheit Osterreich GmbH BIQG, Vienna, Austria	Konventhospital Der Barmherzigen Bruder; Medical University of Innsbruck; Danube University Krems	Knoflach, M (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	michael.knoflach@i-med.ac.at		Trinka, Eugen/0000-0002-5950-2692; Knoflach, Michael/0000-0001-5576-6562				Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Ferrari J, 2010, STROKE, V41, P2001, DOI 10.1161/STROKEAHA.110.590372; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hastie T., 2011, LARS LEAST ANGLE REG; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Linfante I, 2001, ARCH NEUROL-CHICAGO, V58, P621, DOI 10.1001/archneur.58.4.621; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Mikulik R, 2012, STROKE, V43, P1578, DOI 10.1161/STROKEAHA.111.644120; R Development Core Team, 2010, R LANG ENV STAT COMP; Rizos T, 2009, STROKE, V40, P3547, DOI 10.1161/STROKEAHA.109.562769; Rost NS, 2009, NEUROLOGY, V73, P1957, DOI 10.1212/WNL.0b013e3181c5b46d; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Topakian R, 2011, EUR J NEUROL, V18, P306, DOI 10.1111/j.1468-1331.2010.03141.x; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	22	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75378	10.1371/journal.pone.0075378	http://dx.doi.org/10.1371/journal.pone.0075378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069406	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100123
J	Lachance, C; Wojewodka, G; Skinner, TAA; Guilbault, C; De Sanctis, JB; Radzioch, D				Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; De Sanctis, Juan B.; Radzioch, Danuta			Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA-MESSENGER-RNA; 3'-UNTRANSLATED REGION; CERAMIDE DEFICIENCY; MURINE MACROPHAGES; NECROSIS; TRISTETRAPROLIN; EXPRESSION; STABILITY; BINDING	We previously identified Fragile X-related protein 1 (FXR1) as an RNA-binding protein involved in the post-transcriptional control of TNF and other cytokines in macrophages. Macrophages derived from FXR1-KO mice overexpress several inflammatory cytokines including TNF. Recently, we showed that fenretinide (4HPR) is able to inhibit several inflammatory cytokines in the lungs of cystic fibrosis mice, which also have abnormal immune responses. Therefore, we hypothesized that 4HPR might also be able to downregulate excessive inflammation even in macrophages with ablated FXR1. Indeed, our results demonstrate that 4HPR inhibited the excessive production of inflammatory mediators, including TNF, IL-6, CCL2 and CCL-5 in LPS-stimulated FXR1-KO macrophages, by selectively inhibiting phosphorylation of ERK1/2, which is naturally more phosphorylated in FXR1-KO cells. We also found that LPS stimulation of FXR1-KO macrophages led to significantly higher ratio of arachidonic acid/docosahexaenoic acid than observed in FXR1-WT macrophages. Interestingly, treatment with 4HPR was associated with the normalization of arachidonic acid/docosahexaenoic acid ratio in macrophages, which we found to impact phosphorylation of ERK1/2. Overall, this study shows for the first time that 4HPR modulates inflammatory cytokine expression in macrophages by correcting a phospholipid-bound fatty acid imbalance that impacts the phosphorylation of ERK1/2.	[Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; Radzioch, Danuta] McGill Univ, Dept Med, Montreal, PQ, Canada; [Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; Radzioch, Danuta] McGill Univ, Ctr Hlth, Res Inst, Dept Human Genet, Montreal, PQ, Canada; [De Sanctis, Juan B.] Cent Univ Venezuela, Inst Immunol, Caracas, Venezuela	McGill University; McGill University; University of Central Venezuela	Radzioch, D (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	danuta.radzioch@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757; De Sanctis, Juan/0000-0002-5480-4608	Canadian Cystic Fibrosis Foundation [216714(DR)]; Natural Sciences and Engineering Research Council of Canada [201406]; Canadian Institute of Health Research; Universidad Central de Venezuela/CDCH grant [ICC09-0219-2008]; FRSQ; CIHR	Canadian Cystic Fibrosis Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Universidad Central de Venezuela/CDCH grant; FRSQ(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cystic Fibrosis Foundation grant (216714(DR)), Natural Sciences and Engineering Research Council of Canada grant (NSERC (201406)), Canadian Institute of Health Research grant (CIHR- Proof of Principle 1), and Universidad Central de Venezuela/CDCH grant (ICC09-0219-2008). C. L. was a recipient of a Doctoral Scholarship from FRSQ. G. W. was a recipient of a Doctoral Scholarship from CIHR. T. A. S. was a recipient of a Master Scholarship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; GEPPERT TD, 1994, MOL MED, V1, P93; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Guilbault C, 2009, AM J RESP CELL MOL, V41, P100, DOI 10.1165/rcmb.2008-0279OC; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Katsanou V, 2007, ERNST SCHERING FOUND, V4, P37, DOI 10.1007/2789_2007_038; Kim JY, 2005, IMMUNOGENETICS, V57, P297, DOI 10.1007/s00251-005-0800-8; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lachance C, 2007, FEMS IMMUNOL MED MIC, V51, P422, DOI 10.1111/j.1574-695X.2007.00317.x; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CJ, 2000, JPEN-PARENTER ENTER, V24, P159, DOI 10.1177/0148607100024003159; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Saeed Z, 2008, J CYST FIBROS, V7, P222, DOI 10.1016/j.jcf.2007.09.001; SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun HG, 2011, CARCINOGENESIS, V32, P1518, DOI 10.1093/carcin/bgr132; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Vilela RM, 2006, INT IMMUNOPHARMACOL, V6, P1651, DOI 10.1016/j.intimp.2006.06.012; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Ye YZ, 1996, METHOD ENZYMOL, V269, P201	52	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74875	10.1371/journal.pone.0074875	http://dx.doi.org/10.1371/journal.pone.0074875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069363	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100117
J	Linderoth, E; Pilia, G; Mahajan, NP; Ferby, I				Linderoth, Emma; Pilia, Giulia; Mahajan, Nupam P.; Ferby, Ingvar			Activated Cdc42-associated Kinase 1 (Ack1) Is Required for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor Recruitment to Lipid Rafts and Induction of Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Signaling; TRAIL; Tyrosine-Protein Kinase (Tyrosine Kinase); Lipid Rafts	NONRECEPTOR TYROSINE KINASE; COLON-CARCINOMA CELLS; EGF RECEPTOR; CANCER-CELLS; SIGNALING COMPLEX; PHOSPHORYLATION; CDC42; DR4; REDISTRIBUTION; PALMITOYLATION	Background: Activated TRAIL receptors accumulate in lipid raft membrane domains to trigger cell death. Results: Ack1 is required for ligand-induced TRAIL receptor recruitment to lipid rafts and induction of cell death. Conclusion: Ack1 is a novel key regulator of TRAIL receptor membrane dynamics. Significance: Insights gained into the spatiotemporal control of TRAIL receptors may help to predict or modulate therapeutic responsiveness to TRAIL. TNF-related apoptosis-inducing ligand (TRAIL) holds promise for treatment of cancer due to its ability to selectively kill cancer cells while sparing normal cells. Ligand-induced translocation of TRAIL receptors (TRAIL-R) 1 and 2 (also called DR4 and DR5, respectively) into lipid raft membrane microdomains is required for TRAIL-induced cell death by facilitating receptor clustering and formation of the death-inducing signaling complex, yet the underlying regulatory mechanisms remain largely unknown. We show here that the non-receptor tyrosine kinase Ack1, previously implicated in the spatiotemporal regulation of the EGF receptor, is required for TRAIL-induced cell death in multiple epithelial cell lines. TRAIL triggered a transient up-regulation of Ack1 and its recruitment to lipid rafts along with TRAIL-R1/2. siRNA-mediated depletion of Ack1 disrupted TRAIL-induced accumulation of TRAIL-R1/2 in lipid rafts and efficient recruitment of caspase-8 to the death-inducing signaling complex. Pharmacological inhibition of Ack1 did not affect TRAIL-induced cell death, indicating that Ack1 acts in a kinase-independent manner to promote TRAIL-R1/2 accumulation in lipid rafts. These findings identify Ack1 as an essential player in the spatial regulation of TRAIL-R1/2.	[Linderoth, Emma; Ferby, Ingvar] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Pilia, Giulia; Ferby, Ingvar] Ludwig Inst Canc Res, Sci Life Lab, S-75124 Uppsala, Sweden; [Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of London; University College London; Ludwig Institute for Cancer Research; H Lee Moffitt Cancer Center & Research Institute	Ferby, I (corresponding author), Ludwig Inst Canc Res, Uppsala Branch, Box 595, S-75124 Uppsala, Sweden.	ingvar.ferby@licr.uu.se		Pilia, Giulia/0000-0003-1311-4827; Ferby, Ingvar/0000-0002-3435-1728	Cancerfonden Grant [CAN 2012/581]; BBSRC; Ludwig Institute for Cancer Research; National Institutes of Health [1R01CA135328]; NATIONAL CANCER INSTITUTE [R01CA135328] Funding Source: NIH RePORTER	Cancerfonden Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ludwig Institute for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancerfonden Grant CAN 2012/581, BBSRC, and the Ludwig Institute for Cancer Research.; Supported by National Institutes of Health Grant 1R01CA135328.	Chua BT, 2010, MOL ONCOL, V4, P323, DOI 10.1016/j.molonc.2010.03.001; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Harper N, 2008, METHOD ENZYMOL, V446, P293, DOI 10.1016/S0076-6879(08)01618-2; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martin S, 2005, CANCER RES, V65, P11447, DOI 10.1158/0008-5472.CAN-05-1494; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; VanOosten RL, 2005, MOL THER, V11, P542, DOI 10.1016/j.ymthe.2004.12.008; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yoshida T, 2007, ONCOL REP, V18, P1239	39	9	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32922	32931		10.1074/jbc.M113.481507	http://dx.doi.org/10.1074/jbc.M113.481507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085293	Green Published, hybrid			2022-12-25	WOS:000328841700010
J	Xiong, YQ; Lee, HJ; Mariko, B; Lu, YC; Dannenberg, AJ; Haka, AS; Maxfield, FR; Camerer, E; Proia, RL; Hla, T				Xiong, Yuquan; Lee, Hyeuk Jong; Mariko, Boubacar; Lu, Yi-Chien; Dannenberg, Andrew J.; Haka, Abigail S.; Maxfield, Frederick R.; Camerer, Eric; Proia, Richard L.; Hla, Timothy			Sphingosine Kinases Are Not Required for Inflammatory Responses in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Ceramide; Inflammation; Lysosomes; Macrophages; Sphingolipid; Sphingosine 1-Phosphate	FUNCTIONAL-CHARACTERIZATION; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE; AUTOPHAGY; TYPE-2; 1-PHOSPHATE; ACTIVATION; DISEASE; CELLS	Sphingosine kinases (Sphks), which catalyze the formation of sphingosine 1-phosphate (S1P) from sphingosine, have been implicated as essential intracellular messengers in inflammatory responses. Specifically, intracellular Sphk1-derived S1P was reported to be required for NFB induction during inflammatory cytokine action. To examine the role of intracellular S1P in the inflammatory response of innate immune cells, we derived murine macrophages that lack both Sphk1 and Sphk2 (M phi Sphk dKO). Compared with WT counterparts, M phi Sphk dKO cells showed marked suppression of intracellular S1P levels whereas sphingosine and ceramide levels were strongly up-regulated. Cellular proliferation and apoptosis were similar in M phi Sphk dKO cells compared with WT counterparts. Treatment of WT and M phi Sphk dKO with inflammatory mediators TNF or Escherichia coli LPS resulted in similar NFB activation and cytokine expression. Furthermore, LPS-induced inflammatory responses, mortality, and thioglycolate-induced macrophage recruitment to the peritoneum were indistinguishable between M phi Sphk dKO and littermate control mice. Interestingly, autophagic markers were constitutively induced in bone marrow-derived macrophages from Sphk dKO mice. Treatment with exogenous sphingosine further enhanced intracellular sphingolipid levels and autophagosomes. Inhibition of autophagy resulted in caspase-dependent cell death. Together, these data suggest that attenuation of Sphk activity, particularly Sphk2, leads to increased intracellular sphingolipids and autophagy in macrophages.	[Xiong, Yuquan; Lee, Hyeuk Jong; Lu, Yi-Chien; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Lee, Hyeuk Jong; Dannenberg, Andrew J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Haka, Abigail S.; Maxfield, Frederick R.] Cornell Univ, Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Mariko, Boubacar] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France; [Mariko, Boubacar; Camerer, Eric] Univ Paris 05, F-75015 Paris, France; [Proia, Richard L.] NIDDK, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hla, T (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	tih2002@med.cornell.edu	Proia, Richard L/A-7908-2012; Maxfield, Fred/M-6747-2019; Camerer, Eric/K-4161-2017; Hla, Timothy/G-5873-2012	Maxfield, Fred/0000-0003-4396-8866; Hla, Timothy/0000-0001-8355-4065; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [HL67330, HL70694, HL89934]; INSERM Avenir; Marie Curie Actions; French National Research Agency; Fondation de France; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE [P20 RR017677]; NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL093324, R37HL067330, R01HL089934, R01HL067330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083, ZIADK056015, ZIADK056014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie Actions(European Commission); French National Research Agency(French National Research Agency (ANR)); Fondation de France(Fondation de France); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67330, HL70694, and HL89934 (to T. H). This work was also supported by INSERM Avenir, Marie Curie Actions, the French National Research Agency, Fondation de France, and the Ile-de-France Region (to E.C.). Sphingolipid measurements were supported by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313 and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant P20 RR017677.; Supported by the intramural funds of the NIDDK, National Institutes of Health.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Coward J, 2009, AUTOPHAGY, V5, P184, DOI 10.4161/auto.5.2.7361; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Edmonds Y, 2011, PHARMACOL THERAPEUT, V132, P352, DOI 10.1016/j.pharmthera.2011.08.004; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HLA T, 1990, J BIOL CHEM, V265, P9308; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lavieu Gregory, 2008, V445, P159, DOI 10.1007/978-1-59745-157-4_11; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Limaye V, 2009, CELL MOL BIOL LETT, V14, P424, DOI 10.2478/s11658-009-0009-1; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; O'Neill LAJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001299; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Prakash H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010657; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Worgall TS, 2004, ARTERIOSCL THROM VAS, V24, P943, DOI 10.1161/01.ATV.0000125703.20434.4d; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	58	53	54	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32563	32573		10.1074/jbc.M113.483750	http://dx.doi.org/10.1074/jbc.M113.483750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24081141	Green Published, hybrid			2022-12-25	WOS:000328681700039
J	Mao, YH; Li, Q; Zhang, YW; Zhang, JJ; Wei, GH; Tao, SH				Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng			Genome-Wide Analysis of Selective Constraints on High Stability Regions of mRNA Reveals Multiple Compensatory Mutations in Escherichia coli	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SECONDARY STRUCTURE; NONCODING RNA; CODON USAGE; TRANSLATIONAL EFFICIENCY; EVOLUTION; BIAS; DETERMINANTS; ARCHITECTURE; PRESSURES	Message RNA (mRNA) carries a large number of local secondary structures, with structural stability to participate in the regulations of gene expression. A worthy question is how the local structural stability is maintained under the constraint that multiple selective pressures are imposed on mRNA local regions. Here, we performed the first genome-wide study of natural selection operating on high structural stability regions (HSRs) of mRNAs in Escherichia coli. We found that HSR tends to adjust the folded conformation to reduce the harm of mutations, showing a high level of mutational robustness. Moreover, guanine preference in HSR was observed, supporting the hypothesis that the selective constraint for high structural stability may partly account for the high percentage of G content in Escherichia coli genome. Notably, we found a substantially reduced synonymous substitution rate in HSRs compared with that in their adjacent regions. Surprisingly and interestingly, the non-key sites in HSRs, which have slight effect on structural stability, have synonymous substitution rate equivalent to background regions. To explain this result, we identified compensatory mutations in HSRs based on structural stability, and found that a considerable number of synonymous mutations occur to restore the structural stability decreased heavily by the mutations on key sites. Overall, these results suggest a significant role of local structural stability as a selective force operating on mRNA, which furthers our understanding of the constraints imposed on protein-coding RNAs.	[Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	weigehong@nwsuaf.edu.cn; shihengt@nwsuaf.edu.cn	zhang, yinwen/HHZ-1518-2022	zhang, yinwen/0000-0001-8776-6823	PhD Programs Foundation of the Ministry of Education of China [20100204110026]; National Science Foundation of China [31125007]	PhD Programs Foundation of the Ministry of Education of China(Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the PhD Programs Foundation of the Ministry of Education of China (20100204110026) and project from National Science Foundation of China (31125007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Carmel I, 2012, RNA, V18, P1947, DOI 10.1261/rna.032185.111; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheng N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044376; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Dutheil JY, 2010, MOL BIOL EVOL, V27, P1868, DOI 10.1093/molbev/msq069; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gingold H, 2012, NUCLEIC ACIDS RES, V40, P10053, DOI 10.1093/nar/gks772; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gu WJ, 2012, MOL BIOL EVOL, V29, P3037, DOI 10.1093/molbev/mss109; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knies JL, 2008, MOL BIOL EVOL, V25, P1778, DOI 10.1093/molbev/msn130; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lee MT, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000150; Levin BR, 2000, GENETICS, V154, P985; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Lind PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063373; Mao YH, 2013, GENOME BIOL EVOL, V5, P484, DOI 10.1093/gbe/evt020; Mao YH, 2013, GENE, V517, P230, DOI 10.1016/j.gene.2012.12.062; Mimouni NK, 2009, MOL BIOL EVOL, V26, P209, DOI 10.1093/molbev/msn240; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Park C, 2013, P NATL ACAD SCI USA, V110, pE678, DOI 10.1073/pnas.1218066110; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225; Piskol R, 2011, MOL BIOL EVOL, V28, P1519, DOI 10.1093/molbev/msq343; Price N, 2011, MOL BIOL EVOL, V28, P2115, DOI 10.1093/molbev/msr029; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rocha EPC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001104; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu CH, 2011, NUCLEIC ACIDS RES, V39, P8952, DOI 10.1093/nar/gkr579; Zur H, 2012, EMBO REP, V13, P272, DOI 10.1038/embor.2011.262	57	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73299	10.1371/journal.pone.0073299	http://dx.doi.org/10.1371/journal.pone.0073299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086278	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900013
J	Endlein, T; Barnes, WJP; Samuel, DS; Crawford, NA; Biaw, AB; Grafe, U				Endlein, Thomas; Barnes, W. Jon P.; Samuel, Diana S.; Crawford, Niall A.; Biaw, Ang Bee; Grafe, Ulmar			Sticking under Wet Conditions: The Remarkable Attachment Abilities of the Torrent Frog, Staurois guttatus	PLOS ONE			English	Article							TOE-PADS; TREE FROG; ADHESIVE SURFACE; MECHANISMS; DETACHMENT; MORPHOLOGY	Tree frogs climb smooth surfaces utilising capillary forces arising from an air-fluid interface around their toe pads, whereas torrent frogs are able to climb in wet environments near waterfalls where the integrity of the meniscus is at risk. This study compares the adhesive capabilities of a torrent frog to a tree frog, investigating possible adaptations for adhesion under wet conditions. We challenged both frog species to cling to a platform which could be tilted from the horizontal to an upside-down orientation, testing the frogs on different levels of roughness and water flow. On dry, smooth surfaces, both frog species stayed attached to overhanging slopes equally well. In contrast, under both low and high flow rate conditions, the torrent frogs performed significantly better, even adhering under conditions where their toe pads were submerged in water, abolishing the meniscus that underlies capillarity. Using a transparent platform where areas of contact are illuminated, we measured the contact area of frogs during platform rotation under dry conditions. Both frog species not only used the contact area of their pads to adhere, but also large parts of their belly and thigh skin. In the tree frogs, the belly and thighs often detached on steeper slopes, whereas the torrent frogs increased the use of these areas as the slope angle increased. Probing small areas of the different skin parts with a force transducer revealed that forces declined significantly in wet conditions, with only minor differences between the frog species. The superior abilities of the torrent frogs were thus due to the large contact area they used on steep, overhanging surfaces. SEM images revealed slightly elongated cells in the periphery of the toe pads in the torrent frogs, with straightened channels in between them which could facilitate drainage of excess fluid underneath the pad.	[Endlein, Thomas; Barnes, W. Jon P.; Samuel, Diana S.; Crawford, Niall A.] Univ Glasgow, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Biaw, Ang Bee; Grafe, Ulmar] Univ Brunei Darussalam, Belalong Field Studies Ctr, Fac Sci Biol, Gadong, Brunei	University of Glasgow; University Brunei Darussalam	Endlein, T (corresponding author), Univ Glasgow, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	thomas.endlein@glasgow.ac.uk			Deutsche Forschungsgemeinschaft [SPP1420]; Company of Biologists; Carnegie Trust for the Universities of Scotland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Company of Biologists; Carnegie Trust for the Universities of Scotland	This study was supported by grants from the Deutsche Forschungsgemeinschaft (program SPP1420, http://spp1420.mpikg.mpg.de/) awarded to Dr Jon Barnes, a travel grant from The Company of Biologists (http://workshops.biologists.com/grant_information.html) awarded to Dr Thomas Endlein and a grant from the Carnegie Trust for the Universities of Scotland (http://www.carnegie-trust.org/) awarded to Dr Jon Barnes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Barnes J, 2006, COMP BIOCHEM PHYS A, V143, pS94; Barnes J, 2002, TIRE TECHNOL INT, P56; Barnes WJP, 2006, J COMP PHYSIOL A, V192, P1179, DOI 10.1007/s00359-006-0146-1; BETTS RP, 1980, J MED ENG TECHNOL, V4, P136, DOI 10.3109/03091908009161107; Crawford N, 2012, J EXP BIOL, V215, P3965, DOI 10.1242/jeb.073809; Drotlef D.-M., 2012, ADV FUNCTIONAL MAT, V9, P1094; Duellman W.E., 1985, BIOL AMPHIBIANS; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; Endlein T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0838; ERNST VV, 1973, TISSUE CELL, V5, P97, DOI 10.1016/S0040-8166(73)80008-4; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe T. Ulmar, 2009, Salamandra, V45, P25; GREEN DM, 1979, CAN J ZOOL, V57, P2033, DOI 10.1139/z79-268; GREEN DM, 1981, COPEIA, P790, DOI 10.2307/1444179; Gupta R, 2012, LANGMUIR, V28, P14703, DOI 10.1021/la303508x; HANNA G, 1991, J EXP BIOL, V155, P103; Matz D, 2008, COMP BIOCHEM PHYS A, V150, pS90, DOI 10.1016/j.cbpa.2008.04.169; Ohler Annemarie, 1995, Asiatic Herpetological Research, V6, P85; Scholz I, 2009, J EXP BIOL, V212, P155, DOI 10.1242/jeb.019232; Smith JM, 2006, J ZOOL, V270, P372, DOI 10.1111/j.1469-7998.2006.00145.x; Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4	26	52	52	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73810	10.1371/journal.pone.0073810	http://dx.doi.org/10.1371/journal.pone.0073810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086297	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325218700013
J	Pera, M; Camps, P; Munoz-Torrero, D; Perez, B; Badia, A; Guillen, MVC				Pera, Marta; Camps, Pelayo; Munoz-Torrero, Diego; Perez, Belen; Badia, Albert; Victoria Clos Guillen, M.			Undifferentiated and Differentiated PC12 Cells Protected by Huprines Against Injury Induced by Hydrogen Peroxide	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; RAT PHEOCHROMOCYTOMA CELLS; NERVE GROWTH-FACTOR; OXYGEN-GLUCOSE DEPRIVATION; GLOBAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GLUTAMATE NEUROTOXICITY; MUSCARINIC RECEPTORS; SUPEROXIDE-DISMUTASE	Oxidative stress is implicated in the pathogenesis of neurodegenerative disorders and hydrogen peroxide (H2O2) plays a central role in the stress. Huprines, a group of potent acetylcholinesterase inhibitors (AChEIs), have shown a broad cholinergic pharmacological profile. Recently, it has been observed that huprine X (HX) improves cognition in non transgenic middle aged mice and shows a neuroprotective activity (increased synaptophysin expression) in 3xTg-AD mice. Consequently, in the present experiments the potential neuroprotective effect of huprines (HX, HY, HZ) has been analyzed in two different in vitro conditions: undifferentiated and NGF-differentiated PC12 cells. Cells were subjected to oxidative insult (H2O2, 200 mu M) and the protective effects of HX, HY and HZ (0.01 mM(-1) mu M) were analyzed after a pre-incubation period of 24 and 48 hours. All huprines showed protective effects in both undifferentiated and NGF-differentiated cells, however only in differentiated cells the effect was dependent on cholinergic receptors as atropine (muscarinic antagonist, 0.1 mu M) and mecamylamine (nicotinic antagonist, 100 mu M) reverted the neuroprotection action of huprines. The decrease in SOD activity observed after oxidative insult was overcome in the presence of huprines and this effect was not mediated by muscarinic or nicotinic receptors. In conclusion, huprines displayed neuroprotective properties as previously observed in in vivo studies. In addition, these effects were mediated by cholinergic receptors only in differentiated cells. However, a non-cholinergic mechanism, probably through an increase in SOD activity, seems to be also involved in the neuroprotective effects of huprines.	[Pera, Marta; Perez, Belen; Badia, Albert; Victoria Clos Guillen, M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain; [Camps, Pelayo; Munoz-Torrero, Diego] Univ Barcelona, Fac Farm, Quim Farmaceut Lab, Unitat Associada CSIC,Inst Biomed IBUB, E-08028 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Guillen, MVC (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain.	Victoria.clos@uab.es	Muñoz-Torrero, Diego/K-9787-2014; Camps, Pelayo/D-4421-2014; Perez, Belen/K-7721-2014	Muñoz-Torrero, Diego/0000-0002-8140-8555; Camps, Pelayo/0000-0002-9633-3525; Perez, Belen/0000-0001-5801-1704; Pera, Marta/0000-0003-4317-6623	Ministerio de Ciencia e Innovacion [SAF 2006-04339, SAF 2009-10553, CTQ2008-03768/PPQ]; Generalitat de Catalunya [2009SGR1396]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Funding for this study was provided by the Ministerio de Ciencia e Innovacion (SAF 2006-04339, SAF 2009-10553, CTQ2008-03768/PPQ) and the Generalitat de Catalunya (2009SGR1396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Alcala MM, 2005, NEUROSCI LETT, V379, P106, DOI 10.1016/j.neulet.2004.12.044; Almasieh M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.23; AMY CM, 1983, J NEUROSCI, V3, P1547; Arias E, 2004, NEUROPHARMACOLOGY, V46, P103, DOI 10.1016/S0028-3908(03)00317-4; Arias E, 2005, J PHARMACOL EXP THER, V315, P1346, DOI 10.1124/jpet.105.090365; Badia A, 1998, BIOORGAN MED CHEM, V6, P427, DOI 10.1016/S0968-0896(98)00015-7; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041; Bianchetti A, 2006, AGING CLIN EXP RES, V18, P158, DOI 10.1007/BF03327433; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e; BUTTERFIELD DA, 1994, BIOCHEM BIOPH RES CO, V200, P710, DOI 10.1006/bbrc.1994.1508; Camps P, 2000, J MED CHEM, V43, P4657, DOI 10.1021/jm000980y; Francis PT, 2005, TRENDS PHARMACOL SCI, V26, P104, DOI 10.1016/j.tips.2004.12.010; Giacobini E, 2000, ALZ DIS ASSOC DIS, V14, pS3, DOI 10.1097/00002093-200000001-00002; Giordano G, 2009, J NEUROCHEM, V109, P525, DOI 10.1111/j.1471-4159.2009.05969.x; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; GREENE LA, 1981, J BIOL CHEM, V256, P6363; Hedberg MM, 2010, NEURODEGENER DIS, V7, P379, DOI 10.1159/000287954; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; JUMBLATT JE, 1982, NATURE, V297, P152, DOI 10.1038/297152a0; Kimura M, 2005, BRAIN RES, V1047, P72, DOI 10.1016/j.brainres.2005.04.014; Kita Y, 2013, PSYCHOPHARMACOLOGY, V225, P543, DOI 10.1007/s00213-012-2841-7; Kumar P, 2009, EUR J PHARMACOL, V615, P91, DOI 10.1016/j.ejphar.2009.04.058; Lorrio S, 2007, J PHARMACOL EXP THER, V322, P591, DOI 10.1124/jpet.107.122747; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; Martorana A, 2010, CNS NEUROSCI THER, V16, P235, DOI 10.1111/j.1755-5949.2010.00175.x; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Min DY, 2012, NEUROSCI LETT, V510, P29, DOI 10.1016/j.neulet.2011.12.064; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Nakamura S, 2001, ALCOHOL, V24, P79, DOI 10.1016/S0741-8329(01)00150-1; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; Pera M, 2006, BIOCHEM BIOPH RES CO, V346, P89, DOI 10.1016/j.bbrc.2006.04.187; Pera M, 2009, MOL CELL NEUROSCI, V40, P217, DOI 10.1016/j.mcn.2008.10.008; Picconi B, 2006, NEUROPHARMACOLOGY, V50, P917, DOI 10.1016/j.neuropharm.2006.01.002; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Ratia M, 2013, NEURODEGENER DIS, V11, P129, DOI 10.1159/000336427; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Roman S, 2005, BRAIN RES, V1061, P73, DOI 10.1016/j.brainres.2005.07.042; Roman S, 2004, NEUROPHARMACOLOGY, V46, P95, DOI 10.1016/j.neuropharm.2003.08.005; Roman S, 2002, NEUROSCI LETT, V325, P103, DOI 10.1016/S0304-3940(02)00245-8; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Shang YZ, 1999, ACTA PHARMACOL SIN, V20, P824; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Takada-Takatori Y, 2006, EUR J PHARMACOL, V549, P19, DOI 10.1016/j.ejphar.2006.08.017; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Wang R, 2001, NEUROREPORT, V12, P2629, DOI 10.1097/00001756-200108280-00009; Wang ZF, 2002, ACTA PHARMACOL SIN, V23, P1193; Xiao XQ, 2000, J NEUROSCI RES, V61, P564; Yamashima T, 2013, PROG NEUROBIOL; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhou J, 2001, NEUROREPORT, V12, P2073, DOI 10.1097/00001756-200107200-00007; Zhu Xiongwei, 2006, Current Alzheimer Research, V3, P393, DOI 10.2174/156720506778249470	60	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74344	10.1371/journal.pone.0074344	http://dx.doi.org/10.1371/journal.pone.0074344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086337	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200029
J	Readman, GD; Owen, SF; Murrell, JC; Knowles, TG				Readman, Gareth D.; Owen, Stewart F.; Murrell, Joanna C.; Knowles, Toby G.			Do Fish Perceive Anaesthetics as Aversive?	PLOS ONE			English	Article							TRICAINE METHANESULFONATE; COMPARATIVE EFFICACY; AVOIDANCE-BEHAVIOR; CARBON-DIOXIDE; CLOVE OIL; STRESS; 2-PHENOXYETHANOL; EUTHANASIA; WELFARE; MS-222	This study addresses a fundamental question in fish welfare: are the anaesthetics used for fish aversive? Despite years of routine general use of many agents, within both scientific research and aquaculture, there is a paucity of information regarding their tolerance and associated behavioural responses by fish. This study examined nine of the most commonly used fish anaesthetic agents, and performed preference tests using adult mixed sex zebrafish (Danio rerio), the most commonly held laboratory fish. Video tracking software quantified swimming behaviour related to aversion for each anaesthetic at 50% of its standard recommended dose compared with clean water in a flow-through chemotaxic choice chamber. Results suggest that several commonly used anaesthetics were aversive, including two of the most commonly recommended and used: MS222 (ethyl 3-aminobenzoate methanesulphate) and benzocaine. For ethical best practice, it is recommended that compounds that are aversive, even at low concentration, should no longer be used routinely for anaesthesia or indeed the first step of humane euthanasia of adult zebrafish. Two agents were found not to induce aversive behavioural responses: etomidate and 2,2,2 tribromoethanol. For the millions of adult zebrafish used in laboratories and breeding worldwide, etomidate appears best suited for future routine humane use.	[Readman, Gareth D.; Owen, Stewart F.] AstraZeneca, Brixham Environm Lab, Brixham, Devon, England; [Readman, Gareth D.; Murrell, Joanna C.; Knowles, Toby G.] Univ Bristol, Sch Vet Sci, Langford, North Somerset, England	AstraZeneca; University of Bristol	Readman, GD (corresponding author), AstraZeneca, Brixham Environm Lab, Brixham, Devon, England.	gareth.readman@astrazeneca.com	Owen, Stewart/ABF-1216-2021; Knowles, Toby G/A-2026-2008	Knowles, Toby G/0000-0002-3845-0942; Readman, Gareth/0000-0003-3736-8186; Owen, Stewart/0000-0003-1398-7142	AstraZeneca under the Saftey Health and Environment research programme	AstraZeneca under the Saftey Health and Environment research programme	This work was funded by AstraZeneca under the Saftey Health and Environment research programme. AstraZeneca does not have any products, patents, or products under development that are marketed as fish-specific anaesthetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2007, ANAESTHETICS 2007 07; AMEND DF, 1982, T AM FISH SOC, V111, P337, DOI 10.1577/1548-8659(1982)111&lt;337:E&gt;2.0.CO;2; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; Delicio Helton Carlos, 2006, Journal of Experimental Animal Science, V43, P141, DOI 10.1016/j.jeas.2006.01.001; Gressler LT, 2012, J FISH BIOL, V81, P1436, DOI 10.1111/j.1095-8649.2012.03409.x; Gressler LT, 2012, AQUAC RES, P1, DOI [10.1111/are.12043, DOI 10.1111/ARE.12043)]; HIDAKA H, 1989, ENVIRON POLLUT, V56, P299, DOI 10.1016/0269-7491(89)90075-4; HOUSTON AH, 1973, J FISH RES BOARD CAN, V30, P1705, DOI 10.1139/f73-270; Ilkiw JE, 1999, CLIN TECH SMALL AN P, V14, P27, DOI 10.1016/S1096-2867(99)80024-3; JOSA A, 1992, VET REC, V131, P468, DOI 10.1136/vr.131.20.468; Kazun K., 2012, Archives of Polish Fisheries, V20, P173; Kristiansen TS, 2004, AQUACULTURE, V230, P137, DOI 10.1016/S0044-8486(03)00436-8; Kucuk S, 2010, AFR J BIOTECHNOL, V9, P755; Leach MC, 2004, ANIM WELFARE, V13, pS77; Leach MC, 2002, COMPARATIVE MED, V52, P249; Lewbart G, 1998, SELF ASSESSMENT COLO; LIMSUWAN C, 1983, CAN J FISH AQUAT SCI, V40, P2105, DOI 10.1139/f83-244; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; MCFARLAND WN, 1969, FED PROC, V28, P1535; MCNICOL RE, 1991, ENVIRON TOXICOL CHEM, V10, P225, DOI 10.1002/etc.5620100211; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; Pelkowski SD, 2011, BEHAV BRAIN RES, V223, P135, DOI 10.1016/j.bbr.2011.04.033; PLUMB JA, 1983, PROG FISH CULT, V45, P30, DOI 10.1577/1548-8659(1983)45[30:EAOTSO]2.0.CO;2; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; RAJ ABM, 1995, ANIM WELFARE, V4, P273; Rasbash J, 2009, MLWIN VERSION 21; Reed B, 2011, GUIDANCE ON THE HOUS; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; Roberts R, 1997, HANDBOOK OF TROUT AN, P152; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P69; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Statistics of Scientific Procedures on Living Animals, 2011, STAT SCI PROC LIV AN; Stockman J, 2013, VET ANAESTH ANALG, V40, P35, DOI 10.1111/j.1467-2995.2012.00739.x; Strieck F, 1924, J COMP PHYSIOL A, V2, P122, DOI [10.1007/BF00339042, DOI 10.1007/BF00339042]; Thienpoint D., 1965, International Zoo Yearbook, V5, P202, DOI 10.1111/j.1748-1090.1965.tb01646.x; Toth LA, 2006, REPORT OF THE ACLAM; Velisek J, 2007, VET MED-CZECH, V52, P103, DOI 10.17221/2011-VETMED; Weber E. Scott III, 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P21, DOI 10.1016/j.cvex.2010.09.002; WEDEMEYER G, 1970, J FISH RES BOARD CAN, V27, P909, DOI 10.1139/f70-097; Weyl O., 1996, Aquaculture Research, V27, P757, DOI 10.1111/j.1365-2109.1996.tb01234.x; Williams TD, 2009, LAB ANIM-UK, V43, P107, DOI 10.1258/la.2007.007023; Winter Matthew J., 2008, Journal of Pharmacological and Toxicological Methods, V57, P176, DOI 10.1016/j.vascn.2008.01.004; Woody CA, 2002, J FISH BIOL, V60, P340, DOI [10.1006/jfbi.2001.1842, 10.1111/j.1095-8649.2002.tb00284.x]; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2	52	105	108	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73773	10.1371/journal.pone.0073773	http://dx.doi.org/10.1371/journal.pone.0073773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086294	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200014
J	Stevenson, LM; Dickson, H; Klanjscek, T; Keller, AA; McCauley, E; Nisbet, RM				Stevenson, Louise M.; Dickson, Helen; Klanjscek, Tin; Keller, Arturo A.; McCauley, Edward; Nisbet, Roger M.			Environmental Feedbacks and Engineered Nanoparticles: Mitigation of Silver Nanoparticle Toxicity to Chlamydomonas reinhardtii by Algal-Produced Organic Compounds	PLOS ONE			English	Article							ION-RELEASE KINETICS	The vast majority of nanotoxicity studies measures the effect of exposure to a toxicant on an organism and ignores the potentially important effects of the organism on the toxicant. We investigated the effect of citrate-coated silver nanoparticles (AgNPs) on populations of the freshwater alga Chlamydomonas reinhardtii at different phases of batch culture growth and show that the AgNPs are most toxic to cultures in the early phases of growth. We offer strong evidence that reduced toxicity occurs because extracellular dissolved organic carbon (DOC) compounds produced by the algal cells themselves mitigate the toxicity of AgNPs. We analyzed this feedback with a dynamic model incorporating algal growth, nanoparticle dissolution, bioaccumulation of silver, DOC production and DOC-mediated inactivation of nanoparticles and ionic silver. Our findings demonstrate how the feedback between aquatic organisms and their environment may impact the toxicity and ecological effects of engineered nanoparticles.	[Stevenson, Louise M.; Dickson, Helen; Klanjscek, Tin; McCauley, Edward; Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klanjscek, Tin] Rudjer Boskovic Inst, Zagreb, Croatia; [Keller, Arturo A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [McCauley, Edward] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of California System; University of California Santa Barbara; Rudjer Boskovic Institute; University of California System; University of California Santa Barbara; University of Calgary	Stevenson, LM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	louise.stevenson@lifesci.ucsb.edu	Nisbet, Roger M/B-6951-2014	Stevenson, Louise/0000-0003-4967-9897; Klanjscek, Tin/0000-0002-9341-344X	US National Science Foundation; US Environmental Protection Agency [EF-0830117]; National Science Foundation [DGE-1144085]; Croatian Ministry for Science, Education and Sport [098-0982934-2719]	US National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); Croatian Ministry for Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	This research was supported by the US National Science Foundation (http://www.nsf.gov/) and the US Environmental Protection Agency (http://www.epa.gov/) under Cooperative Agreement Number EF-0830117, the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/) under Grant No. DGE-1144085, and the Croatian Ministry for Science, Education and Sport (http://public.mzos.hr/) Grant 098-0982934-2719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; FOGG GE, 1965, PROC R SOC SER B-BIO, V162, P517, DOI 10.1098/rspb.1965.0054; Gao J, 2012, CHEMOSPHERE, V89, P96, DOI 10.1016/j.chemosphere.2012.04.024; Janes N, 1995, ENV TOXICOLOGY CHEM; Kaegi R, 2010, ENVIRON POLLUT, V158, P2900, DOI 10.1016/j.envpol.2010.06.009; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Kilham SS, 1998, HYDROBIOLOGIA; Kim IG, 2002, BIOTECHNOL LETT, V24, P1299, DOI 10.1023/A:1019812202099; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim JY, 2013, ECOTOX ENVIRON SAFE, V92, P57, DOI 10.1016/j.ecoenv.2013.02.004; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lee YJ, 2012, ENVIRON TOXICOL CHEM, V31, P155, DOI 10.1002/etc.717; Li X, 2012, ENVIRON SCI TECHNOL, V46, P5378, DOI 10.1021/es204531y; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ostroumov SA, 2011, ECOLOGICA, V18, P3; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Perreault F, 2012, CHEMOSPHERE, V87, P1388, DOI 10.1016/j.chemosphere.2012.02.046; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Thio BJR, 2012, ENVIRON SCI TECHNOL, V46, P6985, DOI 10.1021/es203596w; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2	33	49	50	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74456	10.1371/journal.pone.0074456	http://dx.doi.org/10.1371/journal.pone.0074456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086348	Green Published, gold			2022-12-25	WOS:000326520200032
J	Tzartos, JS; Stergiou, C; Kilidireas, K; Zisimopoulou, P; Thomaidis, T; Tzartos, SJ				Tzartos, John S.; Stergiou, Christos; Kilidireas, Konstantinos; Zisimopoulou, Paraskevi; Thomaidis, Thomas; Tzartos, Socrates J.			Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; AQUAPORIN EXPRESSION; MYASTHENIA-GRAVIS; WATER CHANNELS; DIAGNOSIS; DISEASE; MULTICENTER; ANTIBODIES; MARKER; TISSUE	Autoantibodies against aquaporin-4 (AQP4), a water channel in CNS astrocytes, are detected in,50-80% of patients with neuromyelitis optica spectrum disorders (NMOsd), characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis. Although these autoantibodies present an invaluable biomarker for NMOsd and for the differential diagnosis of multiple sclerosis (MS), diagnosis of anti-AQP4-seronegative NMOsd remains challenging. We hypothesized that seronegative NMOsd patients might have autoantibodies against aquaporin-1 (AQP1), another water channel in CNS astrocytes. We initially developed a radioimmunoprecipitation assay to search for anti-AQP1 antibodies in sera from 632 individuals. Anti-AQP1 or anti-AQP4 autoantibodies were detected in 16.7% and 12%, respectively, of 348 patients with suspected NMOsd. Anti-AQP1 specificity was confirmed by competition, protein immunoblotting and ELISA assays, whereas epitope localization was studied by immunoadsorption on intact cells expressing AQP1 and peptide mapping experiments. Most anti-AQP1 autoantibodies were of the complement-activating IgG1 subclass and the majority bound to the extracellular domain of AQP1, suggesting a possible pathogenic role. Five out of 42 MS patients had anti-AQP1 antibodies, but 2 of them also had spinal cord lesions, while the anti-AQP1 antibodies in the other 3 bound to the cytoplasmic domain of AQP1. Anti-AQP1 antibodies were not detected in 100 healthy individuals or 142 patients with non-demyelinating neuroimmune diseases. Analysis of 17 anti-AQP1+/anti-AQP4-patients with suspected NMOsd showed that 5 had NMO and 11 had LETM. 12/17 of these sera bound predominantly to the extracellular AQP1 loop-A. Overall, we found that anti-AQP1 autoantibodies are present in a subgroup of patients with chronic demyelination in the CNS and similarities with anti-AQP4-seronegative NMOsd, offering a novel potential biomarker for CNS demyelination disorders.	[Tzartos, John S.; Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Tzartos, John S.; Thomaidis, Thomas] Gen Hosp Red Cross, Dept Neurol, Athens, Greece; [Kilidireas, Konstantinos] Natl & Kapodistrian Univ, Sch Med, Aeginit Hosp, Dept Neurol, Athens, Greece; [Tzartos, Socrates J.] Univ Patras, Dept Pharm, Patras, Greece	Athens Medical School; National & Kapodistrian University of Athens; University of Patras	Tzartos, JS (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Athens, Greece.	jtzartos@gmail.com; tzartos@pasteur.gr	Zisimopoulou, P/B-4105-2017		Department of Biochemistry of the Hellenic Pasteur Institute; EU (European Social Fund); Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''	Department of Biochemistry of the Hellenic Pasteur Institute; EU (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''	This work was supported by overheads of the Department of Biochemistry of the Hellenic Pasteur Institute and co-financed by the EU (European Social Fund) and Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Chang KH, 2012, MULT SCLER; Dolman D, 2005, J NEUROCHEM, V93, P825, DOI 10.1111/j.1471-4159.2005.03111.x; Gao JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046379; Iorio R, 2012, J AUTOIMMUN; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P629, DOI 10.1001/archneur.65.5.629; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Siritho S, 2011, NEUROLOGY, V77, P827, DOI 10.1212/WNL.0b013e31822c61b1; Talbot NC, 2003, CELLS TISSUES ORGANS, V174, P117, DOI 10.1159/000071152; Trakas N, 2011, J NEUROIMMUNOL, V240, P79, DOI 10.1016/j.jneuroim.2011.09.007; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Weinshenker BG, 2010, NEUROLOGY, V75, P1404, DOI 10.1212/WNL.0b013e3181f88382; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	33	43	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74773	10.1371/journal.pone.0074773	http://dx.doi.org/10.1371/journal.pone.0074773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086369	gold, Green Submitted, Green Published			2022-12-25	WOS:000326520200040
J	Hwang, CC; Umeki, S; Kubo, M; Hayashi, T; Shimoda, H; Mochizuki, M; Maeda, K; Baba, K; Hiraoka, H; Coffey, M; Okuda, M; Mizuno, T				Hwang, Chung Chew; Umeki, Saori; Kubo, Masahito; Hayashi, Toshiharu; Shimoda, Hiroshi; Mochizuki, Masami; Maeda, Ken; Baba, Kenji; Hiraoka, Hiroko; Coffey, Matt; Okuda, Masaru; Mizuno, Takuya			Oncolytic Reovirus in Canine Mast Cell Tumor	PLOS ONE			English	Article							TYROSINE KINASE; MUTATIONS; INFECTION; APOPTOSIS; THERAPY; ANTIBODIES; RELEASE; PATHWAY; VIRUS; LINES	The usage of reovirus has reached phase II and III clinical trials in human cancers. However, this is the first study to report the oncolytic effects of reovirus in veterinary oncology, focusing on canine mast cell tumor (MCT), the most common cutaneous tumor in dogs. As human and canine cancers share many similarities, we hypothesized that the oncolytic effects of reovirus can be exploited in canine cancers. The objective of this study was to determine the oncolytic effects of reovirus in canine MCT in vitro, in vivo and ex vivo. We demonstrated that MCT cell lines were highly susceptible to reovirus as indicated by marked cell death, high production of progeny virus and virus replication. Reovirus induced apoptosis in the canine MCT cell lines with no correlation to their Ras activation status. In vivo studies were conducted using unilateral and bilateral subcutaneous MCT xenograft models with a single intratumoral reovirus treatment and apparent reduction of tumor mass was exhibited. Furthermore, cell death was induced by reovirus in primary canine MCT samples in vitro. However, canine and murine bone marrow-derived mast cells (BMCMC) were also susceptible to reovirus. The combination of these results supports the potential value of reovirus as a therapy in canine MCT but warrants further investigation on the determinants of reovirus susceptibility.	[Hwang, Chung Chew; Umeki, Saori; Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, United Grad Sch Vet Sci, Lab Vet Internal Med, Yamaguchi, Japan; [Kubo, Masahito; Hayashi, Toshiharu] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, Yamaguchi, Japan; [Shimoda, Hiroshi; Maeda, Ken] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, Yamaguchi, Japan; [Mochizuki, Masami] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 890, Japan; [Baba, Kenji; Hiraoka, Hiroko] Yamaguchi Univ, Anim Med Ctr, Yamaguchi, Japan; [Coffey, Matt] Oncolyt Biotech Inc, Calgary, AB, Canada; [Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Internal Med, Yamaguchi, Japan; [Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, United Grad Sch Vet Sci, Biomed Sci Ctr Translat Res, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Kagoshima University; Yamaguchi University; Oncolytics Biotech; Yamaguchi University; Yamaguchi University	Mizuno, T (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Lab Vet Internal Med, Yamaguchi, Japan.	mizutaku@yamaguchi-u.ac.jp		Mizuno, Takuya/0000-0002-9580-7557; Okuda, Masaru/0000-0003-4690-8244	Grants-in-Aid for Scientific Research [24580460, 25850208] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adair RA, 2013, INT J CANCER, V132, P2327, DOI 10.1002/ijc.27918; Alain T, 2002, BLOOD, V100, P4146, DOI 10.1182/blood-2002-02-0503; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Butler M., 2013, SMALL ANIMAL CLIN ON, P68; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Cho IR, 2010, INT J ONCOL, V36, P1023, DOI 10.3892/ijo_00000583; Clarke P, 2004, J VIROL, V78, P13132, DOI 10.1128/JVI.78.23.13132-13138.2004; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; Decaro N, 2005, VET MICROBIOL, V109, P19, DOI 10.1016/j.vetmic.2005.05.014; DUNCAN MR, 1978, J VIROL, V28, P444, DOI 10.1128/JVI.28.2.444-449.1978; Errington F, 2008, GENE THER, V15, P1257, DOI 10.1038/gt.2008.58; Errington F, 2008, J IMMUNOL, V180, P6018, DOI 10.4049/jimmunol.180.9.6018; Escobar HM, 2004, ANTICANCER RES, V24, P3027; FUKUMI H, 1969, JPN J MED SCI BIOL, V22, P13, DOI 10.7883/yoken1952.22.13; Gordon IK, 2010, ILAR J, V51, P214, DOI 10.1093/ilar.51.3.214; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Ilett EJ, 2011, CLIN CANCER RES, V17, P2767, DOI 10.1158/1078-0432.CCR-10-3266; Ishiguro T, 2001, J VET MED SCI, V63, P1031, DOI 10.1292/jvms.63.1031; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kawarai S, 2010, J VET MED SCI, V72, P131, DOI 10.1292/jvms.09-0281; Kim M, 2010, ONCOGENE, V29, P3990, DOI 10.1038/onc.2010.137; Lin TY, 2006, VET IMMUNOL IMMUNOP, V113, P37, DOI 10.1016/j.vetimm.2006.03.024; Loken SD, 2004, CANCER BIOL THER, V3, P734, DOI 10.4161/cbt.3.8.963; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; London CA, 2013, WITHROW MACEWENS SMA, P335; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Meerani S, 2010, EUROPEAN J SCI RES, V40, P156; Metcalfe Dean D, 2005, Trans Am Clin Climatol Assoc, V116, P185; MURAKAMI T, 1975, NATL I ANIM HEALTH Q, V15, P8; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Ohmori K, 2008, VET IMMUNOL IMMUNOP, V126, P43, DOI 10.1016/j.vetimm.2008.06.014; Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054006; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; SELB B, 1994, J VIROL METHODS, V47, P15, DOI 10.1016/0166-0934(94)90062-0; Strong JE, 1996, J VIROL, V70, P612, DOI 10.1128/JVI.70.1.612-616.1996; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Takahashi T, 2001, INT ARCH ALLERGY IMM, V125, P228, DOI 10.1159/000053820; Takeuchi Y, 2012, J VET PHARMACOL THER, V35, P97, DOI 10.1111/j.1365-2885.2011.01296.x; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Thirukkumaran CM, 2003, BLOOD, V102, P377, DOI 10.1182/blood-2002-08-2508; Twigger K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-368; Umeki S, 2011, VET IMMUNOL IMMUNOP, V142, P119, DOI 10.1016/j.vetimm.2011.04.009; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2; Watzinger F, 2001, MOL CARCINOGEN, V30, P190, DOI 10.1002/mc.1027	51	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73555	10.1371/journal.pone.0073555	http://dx.doi.org/10.1371/journal.pone.0073555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073198	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000007
J	Zou, T; Yang, Y; Xia, F; Huang, AF; Gao, XM; Fang, DY; Xiong, SD; Zhang, JP				Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Fang, Deyu; Xiong, Sidong; Zhang, Jinping			Resveratrol Inhibits CD4(+) T Cell Activation by Enhancing the Expression and Activity of Sirt1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FRENCH PARADOX; MICE; MECHANISMS; PROTECTS; WINE; P53; DEACETYLATION; ACETYLATION; EXPLANATION	Resveratrol, a natural polyphenol compound, has broad effects on critical events, including inflammation, oxidation, cancer and aging. However, the function and molecular mechanisms of resveratrol on T cell activation are controversial. In the present study, we found that resveratrol significantly inhibits the activation and cytokine production of T cells in vitro and in vivo. Sirt1 expression was up-regulated in resveratrol-treated T cells. Once Sirt1 was down-regulated in the T cells, the resveratrol-induced inhibition of T cell activation noticeably diminished. The acetylation of c-Jun decreased and its translocation was impeded in the resveratrol-treated T cells. The incidence and severity of collagen-induced arthritis in the resveratrol-treated mice were considerably reduced.	[Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Xiong, Sidong; Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China; [Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Xiong, Sidong; Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Soochow University - China; Soochow University - China; Northwestern University; Feinberg School of Medicine	Xiong, SD (corresponding author), Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China.	sdxiong@suda.edu.cn; j_pzhang@suda.edu.cn	Fang, Deyu/I-7245-2013; zhang, jin/GXV-9154-2022	Fang, Deyu/0000-0002-4211-2751; 	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Soochow University [Q413401810, Q313406711]; National Natural Science Foundation of China [31270939, 31200660]; Natural Science Foundation of Jiangsu Province [BK2012617]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Soochow University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University, and intramural research funding to Jinping Zhang (Q413401810, Q313406711) from Soochow University, National Natural Science Foundation of China to Jinping Zhang (number 31270939) and Fei Xia (number 31200660) and Natural Science Foundation of Jiangsu Province to Jinping Zhang (BK2012617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong MH, 2012, INT IMMUNOPHARMACOL, V14, P328, DOI 10.1016/j.intimp.2012.07.018; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kopp P, 1998, EUR J ENDOCRINOL, V138, P619, DOI 10.1530/eje.0.1380619; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Williams Richard O., 2007, V136, P191; Wu SL, 2006, TRANSPL P, V38, P3052, DOI 10.1016/j.transproceed.2006.08.150; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	43	63	66	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75139	10.1371/journal.pone.0075139	http://dx.doi.org/10.1371/journal.pone.0075139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073240	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000049
J	delBarco-Trillo, J; Tourmente, M; Roldan, ERS				delBarco-Trillo, Javier; Tourmente, Maximiliano; Roldan, Eduardo R. S.			Metabolic Rate Limits the Effect of Sperm Competition on Mammalian Spermatogenesis	PLOS ONE			English	Article							CYCLE LENGTH; TESTIS SIZE; EVOLUTION	Sperm competition leads to increased sperm production in many taxa. This response may result from increases in testes size, changes in testicular architecture or changes in the kinetics of spermatogenesis, but the impact of each one of these processes on sperm production has not been studied in an integrated manner. Furthermore, such response may be limited in species with low mass-specific metabolic rate (MSMR), i.e., large-bodied species, because they cannot process energy and resources efficiently enough both at the organismic and cellular levels. Here we compare 99 mammalian species and show that higher levels of sperm competition correlated with a) higher proportions of seminiferous tubules, b) shorter seminiferous epithelium cycle lengths (SECL) which reduce the time required to produce sperm, and c) higher efficiencies of Sertoli cells (involved in sperm maturation). These responses to sperm competition, in turn, result in higher daily sperm production, more sperm stored in the epididymides, and more sperm in the ejaculate. However, the two processes that require processing resources at faster rates (SECL and efficiency of Sertoli cells) only respond to sperm competition in species with high MSMR. Thus, increases in sperm production with intense sperm competition occur via a complex network of mechanisms, but some are constrained by MSMR.	[delBarco-Trillo, Javier; Tourmente, Maximiliano; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	delBarco-Trillo, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	delbarcotrillo@gmail.com	Roldan, Eduardo R.S./M-7947-2014; delBarco-Trillo, Javier/F-6728-2010; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; delBarco-Trillo, Javier/0000-0002-9948-6674; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness [CGL-2011-26341, CGL2012-37423]; Ramon y Cajal fellowship from Spanish Ministry of Economy and Competitiveness [RYC-2011-07943]; "Juan de la Cierva" fellowship from Spanish Ministry of Economy and Competitiveness [JCI-2011-10381]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal fellowship from Spanish Ministry of Economy and Competitiveness; "Juan de la Cierva" fellowship from Spanish Ministry of Economy and Competitiveness	This work was supported by the Spanish Ministry of Economy and Competitiveness (grants CGL-2011-26341 to ERSR and CGL2012-37423 to JdT). JdT was supported by a Ramon y Cajal fellowship (RYC-2011-07943) whereas MT was supported by a "Juan de la Cierva" fellowship (JCI-2011-10381), both from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; DelBarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P1706, DOI 10.1111/j.1420-9101.2011.02293.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fujii-Hanamoto H, 2011, AM J PRIMATOL, V73, P570, DOI 10.1002/ajp.20930; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Lupold S, 2011, REPRODUCTION, V141, P595, DOI 10.1530/REP-10-0501; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; Nakai M, 2004, TISSUE CELL, V36, P439, DOI 10.1016/j.tice.2004.08.003; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peirce EJ, 2001, REPRODUCTION, V121, P239, DOI 10.1530/rep.0.1210239; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; ROOSENRUNGE EC, 1962, BIOL REV, V37, P343, DOI 10.1111/j.1469-185X.1962.tb01616.x; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; Schultz AH, 1938, ANAT REC, V72, P387, DOI 10.1002/ar.1090720310; Segatelli TM, 2004, J ANDROL, V25, P872; Setchell BP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P771; Simmons L. W., 2001, MG BEH ECOL; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12	30	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76510	10.1371/journal.pone.0076510	http://dx.doi.org/10.1371/journal.pone.0076510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069461	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300107
J	Gerlach, JQ; Kruger, A; Gallogly, S; Hanley, SA; Hogan, MC; Ward, CJ; Joshi, L; Griffin, MD				Gerlach, Jared Q.; Krueger, Anja; Gallogly, Susan; Hanley, Shirley A.; Hogan, Marie C.; Ward, Christopher J.; Joshi, Lokesh; Griffin, Matthew D.			Surface Glycosylation Profiles of Urine Extracellular Vesicles	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHRONIC KIDNEY-DISEASE; LECTIN MICROARRAY; RENAL BIOPSY; EXOSOMES; GLYCAN; BIOMARKERS; PROTEOMICS; STRATEGY; PROTEIN	Urinary extracellular vesicles (uEVs) are released by cells throughout the nephron and contain biomolecules from their cells of origin. Although uEV-associated proteins and RNA have been studied in detail, little information exists regarding uEV glycosylation characteristics. Surface glycosylation profiling by flow cytometry and lectin microarray was applied to uEVs enriched from urine of healthy adults by ultracentrifugation and centrifugal filtration. The carbohydrate specificity of lectin microarray profiles was confirmed by competitive sugar inhibition and carbohydrate-specific enzyme hydrolysis. Glycosylation profiles of uEVs and purified Tamm Horsfall protein were compared. In both flow cytometry and lectin microarray assays, uEVs demonstrated surface binding, at low to moderate intensities, of a broad range of lectins whether prepared by ultracentrifugation or centrifugal filtration. In general, ultracentrifugation-prepared uEVs demonstrated higher lectin binding intensities than centrifugal filtration-prepared uEVs consistent with lesser amounts of co-purified non-vesicular proteins. The surface glycosylation profiles of uEVs showed little inter-individual variation and were distinct from those of Tamm Horsfall protein, which bound a limited number of lectins. In a pilot study, lectin microarray was used to compare uEVs from individuals with autosomal dominant polycystic kidney disease to those of age-matched controls. The lectin microarray profiles of polycystic kidney disease and healthy uEVs showed differences in binding intensity of 6/43 lectins. Our results reveal a complex surface glycosylation profile of uEVs that is accessible to lectin-based analysis following multiple uEV enrichment techniques, is distinct from co-purified Tamm Horsfall protein and may demonstrate disease-specific modifications.	[Gerlach, Jared Q.; Krueger, Anja; Gallogly, Susan; Hanley, Shirley A.; Griffin, Matthew D.] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Regenerat Med Inst REMEDI, Galway, Ireland; [Gerlach, Jared Q.; Krueger, Anja; Joshi, Lokesh] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Glycosci Grp, Galway, Ireland; [Hogan, Marie C.; Ward, Christopher J.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Griffin, MD (corresponding author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Regenerat Med Inst REMEDI, Galway, Ireland.	matthew.griffin@nuigalway.ie	Griffin, Matthew/A-1688-2009; Gerlach, Jared Q/K-2698-2013	Griffin, Matthew/0000-0002-8701-8056; Gerlach, Jared Q/0000-0001-7343-7201; Joshi, Lokesh/0000-0002-3612-0747; Krueger, Anja/0000-0003-0227-8674	Health Research Board of Ireland [HRA_HSR/2010/63]; Science Foundation Ireland [SFI 09/SRC/B1794]; SFI Alimentary Glycoscience Research Cluster grant [08/SRC/B1393]; SFI Stokes Professor for Glycosciences grant [07/SK/B1250]; Higher Education Authority of Ireland; European Regional Development Fund; National Institutes of Health NIDDK ARRA Challenge grant [5RC1DK086161-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086161] Funding Source: NIH RePORTER	Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); SFI Alimentary Glycoscience Research Cluster grant(Science Foundation Ireland); SFI Stokes Professor for Glycosciences grant(Science Foundation Ireland); Higher Education Authority of Ireland; European Regional Development Fund(European Commission); National Institutes of Health NIDDK ARRA Challenge grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Health Research Board of Ireland (www.hrb.ie/) under grant HRA_HSR/2010/63 (JQG, AK, MG, LJ), by Science Foundation Ireland (www.sfi.ie/) under grant SFI 09/SRC/B1794 (MG), SFI Alimentary Glycoscience Research Cluster grant 08/SRC/B1393, SFI Stokes Professor for Glycosciences grant 07/SK/B1250 (LJ), the Higher Education Authority of Ireland (www.hea.ie/) (SAH), by the European Regional Development Fund (http://europa.eu/) and by National Institutes of Health NIDDK (http://www2.niddk.nih.gov/) ARRA Challenge grant 5RC1DK086161-02 (MCH, CJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Afshin S., 2012, ENDOPLASMIC RETICULU, P23; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; Chen P, 2008, J CANCER RES CLIN, V134, P851, DOI 10.1007/s00432-008-0357-7; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Dickhout JG, 2009, ANTIOXID REDOX SIGN, V11, P2341, DOI [10.1089/ars.2009.2705, 10.1089/ARS.2009.2705]; Ebe Y, 2006, J BIOCHEM, V139, P323, DOI 10.1093/jb/mvj070; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gerlach JQ, 2012, MOL BIOSYST, V8, P1472, DOI 10.1039/c2mb05455h; Gerlach JQ, 2010, BIOCHEM SOC T, V38, P1333, DOI 10.1042/BST0381333; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; Gonzales P, 2008, NEPHROL DIAL TRANSPL, V23, P1799, DOI 10.1093/ndt/gfn058; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Grabska Teresa, 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P241; Hashii N, 2009, IMMUNOLOGY, V126, P336, DOI 10.1111/j.1365-2567.2008.02898.x; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Joseph AJ, 2010, NEPHROLOGY, V15, P544, DOI 10.1111/j.1440-1797.2010.01293.x; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; Kojima K, 2011, KIDNEY INT, V79, P311, DOI 10.1038/ki.2010.403; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Matsumura K, 2009, ANAL BIOCHEM, V386, P217, DOI 10.1016/j.ab.2008.11.044; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; O'Riordan E, 2007, ACTA PHYSIOL HUNG, V94, P133, DOI 10.1556/APhysiol.94.2007.1-2.12; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Raj DAA, 2012, KIDNEY INT, V81, P1263, DOI 10.1038/ki.2012.25; Robinson LN, 2012, ELECTROPHORESIS, V33, P797, DOI 10.1002/elps.201100231; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; Rosenfeld R, 2007, J BIOCHEM BIOPH METH, V70, P415, DOI 10.1016/j.jbbm.2006.09.008; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stanley P, 2009, ESSENTIALS GLYCOBIOL; Staubach S, 2012, J PROTEOME RES, V11, P906, DOI 10.1021/pr200711w; Stratta P, 2007, EUR J CLIN INVEST, V37, P954, DOI 10.1111/j.1365-2362.2007.01885.x; TAMM I, 1952, J EXP MED, V95, P71, DOI 10.1084/jem.95.1.71; Tanaka M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/470803; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Thery C., 2006, CURR PROTOC CELL BIO, V30; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Whittier WL, 2004, J AM SOC NEPHROL, V15, P142, DOI 10.1097/01.ASN.0000102472.37947.14; Wu TH, 2008, TRANSPL IMMUNOL, V18, P237, DOI 10.1016/j.trim.2007.07.001; Yang L, 2012, PHARM RES-DORDR, V29, P2578, DOI 10.1007/s11095-012-0788-3; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	61	77	78	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74801	10.1371/journal.pone.0074801	http://dx.doi.org/10.1371/journal.pone.0074801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069349	Green Published, gold			2022-12-25	WOS:000324777300047
J	Hofmann, JC; Tegha-Dunghu, J; Drager, S; Will, CL; Luhrmann, R; Gruss, OJ				Hofmann, Jennifer C.; Tegha-Dunghu, Justus; Draeger, Stefanie; Will, Cindy L.; Luehrmann, Reinhard; Gruss, Oliver J.			The Prp19 Complex Directly Functions in Mitotic Spindle Assembly	PLOS ONE			English	Article							MECHANISMS; MICROTUBULES; COMPONENTS; SEPARATION; PROTEINS; GENOME; RAN	The conserved Prp19 (pre-RNA processing 19) complex is required for pre-mRNA splicing in eukaryotic nuclei. Recent RNAi screens indicated that knockdown of Prp19 complex subunits strongly delays cell proliferation. Here we show that knockdown of the smallest subunit, BCAS2/Spf27, destabilizes the entire complex and leads to specific mitotic defects in human cells. These could result from splicing failures in interphase or reflect a direct function of the complex in open mitosis. Using Xenopus extracts, in which cell cycle progression and spindle formation can be reconstituted in vitro, we tested Prp19 complex functions during a complete cell cycle and directly in open mitosis. Strikingly, immunodepletion of the complex either before or after interphase significantly reduces the number of intact spindles, and increases the percentage of spindles with lower microtubule density and impaired metaphase alignment of chromosomes. Our data identify the Prp19 complex as the first spliceosome subcomplex that directly contributes to mitosis in vertebrates independently of its function in interphase.	[Hofmann, Jennifer C.; Tegha-Dunghu, Justus; Draeger, Stefanie; Gruss, Oliver J.] DKFZ ZMBH Alliance, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany; [Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Gruss, OJ (corresponding author), DKFZ ZMBH Alliance, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany.	o.gruss@zmbh.uni-heidelberg.de			DKFZ-ZMBH Alliance; DFG Normalverfahren [1737/4]; DGF [SFB 860]	DKFZ-ZMBH Alliance; DFG Normalverfahren(German Research Foundation (DFG)); DGF(German Research Foundation (DFG))	The project was supported by the DKFZ-ZMBH Alliance and DFG Normalverfahren 1737/4 to OG, and a grant from the DGF SFB 860 to RL (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cassimeris Lynne, 2003, Current Issues in Molecular Biology, V5, P99; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gatlin JC, 2010, SEMIN CELL DEV BIOL, V21, P248, DOI 10.1016/j.semcdb.2010.01.015; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; TOVEY ER, 1987, J BIOCHEM BIOPH METH, V14, P1, DOI 10.1016/0165-022X(87)90002-9; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	33	31	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74851	10.1371/journal.pone.0074851	http://dx.doi.org/10.1371/journal.pone.0074851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069358	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300052
J	Iacovakis, C; Mamuris, Z; Moutou, KA; Touloudi, A; Hammer, AS; Valiakos, G; Giannoulis, T; Stamatis, C; Spyrou, V; Athanasiou, LV; Kantere, M; Asferg, T; Giannakopoulos, A; Salomonsen, CM; Bogdanos, D; Birtsas, P; Petrovska, L; Hannant, D; Billinis, C				Iacovakis, Christos; Mamuris, Zissis; Moutou, Katerina A.; Touloudi, Antonia; Hammer, Anne Sofie; Valiakos, George; Giannoulis, Themis; Stamatis, Costas; Spyrou, Vassiliki; Athanasiou, Labrini V.; Kantere, Maria; Asferg, Tommy; Giannakopoulos, Alexios; Salomonsen, Charlotte M.; Bogdanos, Dimitrios; Birtsas, Periklis; Petrovska, Liljana; Hannant, Duncan; Billinis, Charalambos			Polarisation of Major Histocompatibility Complex II Host Genotype with Pathogenesis of European Brown Hare Syndrome Virus	PLOS ONE			English	Article							RABBIT HEMORRHAGIC-DISEASE; PARASITE RESISTANCE; MITOCHONDRIAL-DNA; LEPUS-EUROPAEUS; EVOLUTIONARY GENETICS; MHC POLYMORPHISM; ASSOCIATION; SUSCEPTIBILITY; SELECTION; GENES	A study was conducted in order to determine the occurrence of European Brown Hare Syndrome virus (EBHSV) in Denmark and possible relation between disease pathogenesis and Major Histocompatibility Complex (MHC) host genotype. Liver samples were examined from 170 brown hares (hunted, found sick or dead), collected between 2004 and 2009. Macroscopical and histopathological findings consistent with EBHS were detected in 24 (14.1%) hares; 35 (20.6%) had liver lesions not typical of the syndrome, 50 (29.4%) had lesions in other tissues and 61 (35.9%) had no lesions. Sixty five (38.2%) of 170 samples were found to be EBHSV-positive (RT-PCR, VP60 gene). In order to investigate associations between viral pathogenesis and host genotype, variation within the exon 2 DQA gene of MHC was assessed. DQA exon 2 analysis revealed the occurrence of seven different alleles in Denmark. Consistent with other populations examined so far in Europe, observed heterozygosity of DQA (H-o = 0.1180) was lower than expected (H-e = 0.5835). The overall variation for both nucleotide and amino acid differences (2.9% and 14.9%, respectively) were lower in Denmark than those assessed in other European countries (8.3% and 16.9%, respectively). Within the peptide binding region codons the number of nonsynonymous substitutions (dN) was much higher than synonymous substitutions (dS), which would be expected for MHC alleles under balancing selection. Allele frequencies did not significantly differ between EBHSV-positive and -negative hares. However, allele Leeu-DQA*30 was detected in significantly higher (P = 0.000006) frequency among the positive hares found dead with severe histopathological lesions than among those found sick or apparently healthy. In contrast, the latter group was characterized by a higher frequency of the allele Leeu-DQA*14 as well as the proportion of heterozygous individuals (P = 0.000006 and P = 0.027). These data reveal a polarisation between EBHSV pathogenesis and MHC class II genotype within the European brown hare in Denmark.	[Iacovakis, Christos; Touloudi, Antonia; Valiakos, George; Athanasiou, Labrini V.; Kantere, Maria; Giannakopoulos, Alexios; Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Iacovakis, Christos; Touloudi, Antonia; Valiakos, George; Athanasiou, Labrini V.; Billinis, Charalambos] Inst Res & Technol Thessaly, Larisa, Greece; [Mamuris, Zissis; Moutou, Katerina A.; Giannoulis, Themis; Stamatis, Costas] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Hammer, Anne Sofie] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Spyrou, Vassiliki] Technol Educ Inst Larissa, Dept Anim Prod, Larisa, Greece; [Asferg, Tommy] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Salomonsen, Charlotte M.] Tech Univ Denmark, Natl Vet Inst, Sect Anim & Wildlife Dis, Aarhus, Denmark; [Bogdanos, Dimitrios] Univ Thessaly, Dept Med, Larisa, Greece; [Bogdanos, Dimitrios] Kings Coll London, Inst Liver Studies, London, England; [Birtsas, Periklis] Technol Educ Inst Larissa, Dept Forestry & Nat Environm Adm, Kardhitsa, Greece; [Petrovska, Liljana] Vet Labs Agcy, Dept Bacteriol, Weybridge, Surrey, England; [Hannant, Duncan] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England	University of Thessaly; University of Thessaly; University of Copenhagen; Aarhus University; Technical University of Denmark; University of Thessaly; University of London; King's College London; Veterinary Laboratories Agency; University of Nottingham	Billinis, C (corresponding author), Univ Thessaly, Fac Vet Med, Kardhitsa, Greece.	billinis@vet.uth.gr	Athanasiou, Labrini V/AAI-2744-2020; Hannant, Duncan/G-4185-2011; Giannoulis, Themistoklis/AAM-5042-2021; Petrovska, Liljana/D-7319-2011; Bogdanos, Dimitrios/AAF-8620-2020; ATHANASIOU, LABRINI/H-7463-2019; Valiakos, George/C-5328-2011; Kantere, Maria/ABC-6726-2021; Mamuris, Zissis/AAN-2576-2021	Athanasiou, Labrini V/0000-0001-8723-2629; Hannant, Duncan/0000-0003-0792-7418; Bogdanos, Dimitrios/0000-0002-9697-7902; Valiakos, George/0000-0002-3869-5026; Kantere, Maria/0000-0002-5383-5031; MOUTOU, KATERINA/0000-0002-6429-3776; Giannoulis, Themistoklis/0000-0002-1842-5432	European Union [222633]	European Union(European Commission)	The research leading to these results received partial funding from the European Union Seventh Framework Programme (2007-2013) under grant agreement no. 222633 (WildTech) (http://www.wildtechproject.com/wildtech/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Alves PC, 2008, MOL PHYLOGENET EVOL, V46, P1191, DOI 10.1016/j.ympev.2007.11.010; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI [10.1139/f02-066, 10.1139/F02-066]; Bascunana CR, 1997, J CLIN MICROBIOL, V35, P2492; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Billinis C, 2005, J WILDLIFE DIS, V41, P783, DOI 10.7589/0090-3558-41.4.783; Billinis C., 2005, Wildlife Biology in Practice, V1, P118; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Bowen L, 2006, MOL ECOL, V15, P529, DOI 10.1111/j.1365-294X.2005.02612.x; Boytim ML, 1998, J IMMUNOL, V160, P2215; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Capucci L, 1991, Rev Sci Tech, V10, P347; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Chapman JA., 1990, RABBITS HARES PIKAS; CHASEY D, 1990, VET REC, V126, P623; CHASEY D, 1992, ARCH VIROL, V124, P363, DOI 10.1007/BF01309816; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Deter J, 2008, INFECT GENET EVOL, V8, P450, DOI 10.1016/j.meegid.2007.07.003; Ditchkoff SS, 2005, WILDLIFE SOC B, V33, P1164, DOI 10.2193/0091-7648(2005)33[1164:FTFCOW]2.0.CO;2; Drews B, 2011, VET MICROBIOL, V154, P37, DOI 10.1016/j.vetmic.2011.06.021; Eisenlohr LC, 2013, MOL IMMUNOL, V55, P169, DOI 10.1016/j.molimm.2012.10.020; ESKENS U, 1989, DEUT TIERARZTL WOCH, V96, P464; Fain MA, 2001, TISSUE ANTIGENS, V57, P332, DOI 10.1034/j.1399-0039.2001.057004332.x; de Mera IGF, 2008, DEV COMP IMMUNOL, V32, P85, DOI 10.1016/j.dci.2007.05.001; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Frolich K, 1996, J WILDLIFE DIS, V32, P280; Frolich K, 2001, J WILDLIFE DIS, V37, P803, DOI 10.7589/0090-3558-37.4.803; FRYLESTAM B, 1980, HOLARCTIC ECOL, V3, P74; Garrigan D, 2003, EVOLUTION, V57, P1707; Gavier-Widen D., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P453; GAVIERWIDEN D, 1993, J WILDLIFE DIS, V29, P15, DOI 10.7589/0090-3558-29.1.15; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Harf R, 2005, MOL ECOL, V14, P85, DOI 10.1111/j.1365-294X.2004.02402.x; Hasegawa A, 1985, Nucleic Acids Symp Ser, P269; Hedrick P.W., 2000, EVOL GENET, P204; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; HENRIKSEN P, 1989, VET REC, V125, P486, DOI 10.1136/vr.125.19.486; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AM, 2010, TISSUE ANTIGENS, V75, P684, DOI 10.1111/j.1399-0039.2010.01440.x; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Ilmonen P, 2007, GENETICS, V176, P2501, DOI 10.1534/genetics.107.074815; It V, 2010, TISSUE ANTIGENS, V76, P67, DOI 10.1111/j.1399-0039.2010.01463.x; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Koutsogiannouli EA, 2012, MAMM BIOL, V77, P428, DOI 10.1016/j.mambio.2012.01.005; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Larruskain A, 2010, IMMUNOGENETICS, V62, P75, DOI 10.1007/s00251-009-0419-2; LeGall G, 1996, J GEN VIROL, V77, P1693, DOI 10.1099/0022-1317-77-8-1693; Lenghaus Cor, 2001, P280, DOI 10.1002/9780470344880.ch16; Marcato P.S., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P371; Martin MP, 1999, METH MOLEC MED, V17, P205, DOI 10.1385/0-89603-369-4:205; McClelland EE, 2003, INFECT IMMUN, V71, P4815, DOI 10.1128/IAI.71.8.4815-4817.2003; Melo-Ferreira J, 2007, MOL ECOL, V16, P605, DOI 10.1111/j.1365-294X.2006.03166.x; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; NAUWYNCK H, 1993, J WILDLIFE DIS, V29, P203, DOI 10.7589/0090-3558-29.2.203; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; Ohlinger V F, 1991, Rev Sci Tech, V10, P311; Okerman L, 1989, BELGIE VLAAMS DIERGE, V59, P44; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rakus KL, 2009, FISH SHELLFISH IMMUN, V26, P737, DOI 10.1016/j.fsi.2009.03.001; SALMELA P, 1993, ACTA VET SCAND, V34, P215; Schad J, 2005, EVOLUTION, V59, P439, DOI 10.1111/j.0014-3820.2005.tb01002.x; Schmidt Niels M., 2004, BMC Ecology, V4, P15, DOI 10.1186/1472-6785-4-15; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Sert H, 2005, MAMM BIOL, V70, P171, DOI 10.1016/j.mambio.2004.10.003; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Slamecka Jaroslav, 1997, Acta Scientarium Naturalium Academiae Scientarum Bohemicae Brno, V31, P1; Smith S, 2011, IMMUNOGENETICS, V63, P743, DOI 10.1007/s00251-011-0539-3; Smith S, 2010, MOL ECOL, V19, P4131, DOI 10.1111/j.1365-294X.2010.04765.x; SOSTARIC B, 1991, Veterinarski Arhiv, V61, P133; Stamatis A, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/23286; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Stamatis C, 2008, GENE, V410, P154, DOI 10.1016/j.gene.2007.12.010; STEINECK T, 1993, TIERARZTL UMSCHAU, V48, P225; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Thursz MR, 1997, J VIRAL HEPATITIS, V4, P215, DOI 10.1046/j.1365-2893.1997.00052.x; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; Tobias JA, 2008, SCIENCE, V319, DOI 10.1126/science.1150568; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683; WIRBLICH C, 1994, J VIROL, V68, P5164, DOI 10.1128/JVI.68.8.5164-5173.1994; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Zachos FE, 2010, J ZOOL, V282, P47, DOI 10.1111/j.1469-7998.2010.00710.x; Zhang Chenhong, 2006, Journal of Bioinformatics and Computational Biology, V4, P959, DOI 10.1142/S0219720006002314; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151	108	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74360	10.1371/journal.pone.0074360	http://dx.doi.org/10.1371/journal.pone.0074360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069299	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300032
J	la Cour, JM; Schindler, AJ; Berchtold, MW; Schekman, R				la Cour, Jonas M.; Schindler, Adam J.; Berchtold, Martin W.; Schekman, Randy			ALG-2 Attenuates COPII Budding In Vitro and Stabilizes the Sec23/Sec31A Complex	PLOS ONE			English	Article							RETICULUM EXIT SITES; COATED VESICLE FORMATION; LINKED PROTEIN ALG-2; STRUCTURAL BASIS; CALCIUM-BINDING; ER; SEC31A; CARGO; RECONSTITUTION; LOCALIZATION	Coated vesicles mediate the traffic of secretory and membrane cargo proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. The coat protein complex (COPII) involved in vesicle budding is constituted by a GTPase, Sar1, the inner coat components of Sec23/Sec24 and the components of the outer coat Sec13/Sec31A. The Ca2+-binding protein ALG-2 was recently identified as a Sec31A binding partner and a possible link to Ca2+ regulation of COPII vesicle budding. Here we show that ALG-2/Ca2+ is capable of attenuating vesicle budding in vitro through interaction with an ALG-2 binding domain in the proline rich region of Sec31A. Binding of ALG-2 to Sec31A and inhibition of COPII vesicle budding is furthermore dependent on an intact Ca2+-binding site at EF-hand 1 of ALG-2. ALG-2 increased recruitment of COPII proteins Sec23/24 and Sec13/31A to artificial liposomes and was capable of mediating binding of Sec13/31A to Sec23. These results introduce a regulatory role for ALG-2/Ca2+ in COPII tethering and vesicle budding.	[la Cour, Jonas M.; Berchtold, Martin W.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Schindler, Adam J.] Duke Univ, Dept Biol, Durham, NC USA; [Schekman, Randy] Univ Calif Berkeley, Dept Cellular Biochem, Berkeley, CA 94720 USA	University of Copenhagen; Duke University; University of California System; University of California Berkeley	la Cour, JM (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	jonaslacour@gmail.com	Berchtold, Martin/L-1695-2014; la Cour, Jonas/M-5088-2016	Berchtold, Martin/0000-0001-8995-9047; Schindler, Adam/0000-0001-5408-9141; Schekman, Randy/0000-0001-8615-6409; la Cour, Jonas/0000-0002-1588-0608	Danish Cancer Society; Danish Research Council (FNU); Lundbeck Foundation; Hansen Foundation; Danielsens Foundation; Fraenkel Foundation; Willumsen Foundation; Weddel-Weddelsborg Foundation	Danish Cancer Society(Danish Cancer Society); Danish Research Council (FNU)(Danish Natural Science Research CouncilDet Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Hansen Foundation; Danielsens Foundation; Fraenkel Foundation; Willumsen Foundation; Weddel-Weddelsborg Foundation	This work was supported by a grant from The Danish Cancer Society to JMC and grants by the Danish Research Council (FNU), Lundbeck, Hansen, Danielsens, Fraenkel, Willumsen and Weddel-Weddelsborg Foundations to MWB. RS is a Senior Fellow of the Miller Institute, UC Berkeley and an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Hoj BR, 2009, BIOCHEM BIOPH RES CO, V378, P145, DOI 10.1016/j.bbrc.2008.11.021; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Subramanian L, 2004, BIOCHEMISTRY-US, V43, P11175, DOI 10.1021/bi048848d; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765	39	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75309	10.1371/journal.pone.0075309	http://dx.doi.org/10.1371/journal.pone.0075309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069399	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300071
J	Park, IW; Ndjomou, J; Wen, YH; Liu, ZQ; Ridgway, ND; Kao, CC; He, JJ				Park, In-Woo; Ndjomou, Jean; Wen, Yahong; Liu, Ziqing; Ridgway, Neale D.; Kao, C. Cheng; He, Johnny J.			Inhibition of HCV Replication by Oxysterol-Binding Protein-Related Protein 4 (ORP4) through Interaction with HCV NS5B and Alteration of Lipid Droplet Formation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONVESICULAR STEROL TRANSPORT; DEPENDENT RNA-POLYMERASE; 3' NONTRANSLATED REGION; CORE PROTEIN; NONSTRUCTURAL PROTEINS; ENDOPLASMIC-RETICULUM; UNTRANSLATED REGION; GENOME REPLICATION; VIRAL REPLICATION	Hepatitis C virus (HCV) RNA replication involves complex interactions among the 3'x RNA element within the HCV 3' untranslated region, viral and host proteins. However, many of the host proteins remain unknown. In this study, we devised an RNA affinity chromatography /2D/MASS proteomics strategy and identified nine putative 3' X-associated host proteins; among them is oxysterol-binding protein-related protein 4 (ORP4), a cytoplasmic receptor for oxysterols. We determined the relationship between ORP4 expression and HCV replication. A very low level of constitutive ORP4 expression was detected in hepatocytes. Ectopically expressed ORP4 was detected in the endoplasmic reticulum and inhibited luciferase reporter gene expression in HCV subgenomic replicon cells and HCV core expression in JFH-1-infected cells. Expression of ORP4S, an ORP4 variant that lacked the N-terminal pleckstrin-homology domain but contained the C-terminal oxysterol-binding domain also inhibited HCV replication, pointing to an important role of the oxysterol-binding domain in ORP4-mediated inhibition of HCV replication. ORP4 was found to associate with HCV NS5B and its expression led to inhibition of the NS5B activity. ORP4 expression had little effect on intracellular lipid synthesis and secretion, but it induced lipid droplet formation in the context of HCV replication. Taken together, these results demonstrate that ORP4 is a negative regulator of HCV replication, likely via interaction with HCV NS5B in the replication complex and regulation of intracellular lipid homeostasis. This work supports the important role of lipids and their metabolism in HCV replication and pathogenesis.	[Park, In-Woo; Ndjomou, Jean; Liu, Ziqing; He, Johnny J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Park, In-Woo; He, Johnny J.] Indiana Univ Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [Park, In-Woo; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Wen, Yahong; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Health Science Center; Indiana University System; Indiana University Bloomington; Dalhousie University	He, JJ (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	johnny.he@unthsc.edu		Ridgway, Neale/0000-0002-0441-6228				Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Clouston AD, 2002, BEST PRACT RES CL GA, V16, P767, DOI 10.1053/bega.2002.0329; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gontarek RR, 1999, NUCLEIC ACIDS RES, V27, P1457, DOI 10.1093/nar/27.6.1457; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GUINEA R, 1990, EMBO J, V9, P2011, DOI 10.1002/j.1460-2075.1990.tb08329.x; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Laitinen S, 2002, J LIPID RES, V43, P245; Lee EG, 2000, J VIROL, V74, P9167, DOI 10.1128/JVI.74.19.9167-9174.2000; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Quadri R, 2001, ANTIVIR RES, V52, P161, DOI 10.1016/S0166-3542(01)00181-4; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spangberg K, 1999, J HUMAN VIROL, V2, P296; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tsuchihara K, 1997, J VIROL, V71, P6720, DOI 10.1128/JVI.71.9.6720-6726.1997; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003	89	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75648	10.1371/journal.pone.0075648	http://dx.doi.org/10.1371/journal.pone.0075648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069433	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300089
J	Roales, J; Duran, J; Bechtold, HA; Groffman, PM; Rosi-Marshall, EJ				Roales, Javier; Duran, Jorge; Bechtold, Heather A.; Groffman, Peter M.; Rosi-Marshall, Emma J.			High Resolution Measurement of Light in Terrestrial Ecosystems Using Photodegrading Dyes	PLOS ONE			English	Article							PHOTON FLUX-DENSITY; PLANT LITTER DECOMPOSITION; RHODAMINE-WT; RAIN-FOREST; UNDERSTORY; TEMPERATE; REGIMES; GAPS	Incoming solar radiation is the main determinant of terrestrial ecosystem processes, such as primary production, litter decomposition, or soil mineralization rates. Light in terrestrial ecosystems is spatially and temporally heterogeneous due to the interaction among sunlight angle, cloud cover and tree-canopy structure. To integrate this variability and to know light distribution over time and space, a high number of measurements are needed, but tools to do this are usually expensive and limited. An easy-to-use and inexpensive method that can be used to measure light over time and space is needed. We used two photodegrading fluorescent organic dyes, rhodamine WT (RWT) and fluorescein, for the quantification of light. We measured dye photodegradation as the decrease in fluorescence across an irradiance gradient from full sunlight to deep shade. Then, we correlated it to accumulated light measured with PAR quantum sensors and obtained a model for this behavior. Rhodamine WT and fluorescein photodegradation followed an exponential decay curve with respect to accumulated light. Rhodamine WT degraded slower than fluorescein and remained unaltered after exposure to temperature changes. Under controlled conditions, fluorescence of both dyes decreased when temperatures increased, but returned to its initial values after cooling to the pre-heating temperature, indicating no degradation. RWT and fluorescein can be used to measure light under a varying range of light conditions in terrestrial ecosystems. This method is particularly useful to integrate solar radiation over time and to measure light simultaneously at different locations, and might be a better alternative to the expensive and time consuming traditional light measurement methods. The accuracy, low price and ease of this method make it a powerful tool for intensive sampling of large areas and for developing high resolution maps of light in an ecosystem.	[Roales, Javier] Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain; [Roales, Javier; Duran, Jorge; Bechtold, Heather A.; Groffman, Peter M.; Rosi-Marshall, Emma J.] Cary Inst Ecosyst Studies, Millbrook, NY USA	Universidad Pablo de Olavide; Cary Institute of Ecosystem Studies	Roales, J (corresponding author), Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain.	javier.roales@gmail.com	Duran, Jorge/AFN-5619-2022; Rosi-Marshall, Emma J/F-1777-2011; Roales, Javier/D-4399-2013	Duran, Jorge/0000-0002-7375-5290; Rosi-Marshall, Emma J/0000-0002-3476-6368; Roales, Javier/0000-0003-2110-5023; Groffman, Peter/0000-0001-8371-6255	US National Science Foundation [DEB 0423259]; Hubbard Brook Experimental Forest; Fulbright fellowship of the Spanish Ministry of Education	US National Science Foundation(National Science Foundation (NSF)); Hubbard Brook Experimental Forest; Fulbright fellowship of the Spanish Ministry of Education	This research was supported by US National Science Foundation Grant DEB 0423259 (Hubbard Brook Long Term Ecological Research), and conducted at the Hubbard Brook Experimental Forest, which is operated by the Northeastern Research Station, USDA Forest Service, Newtown Square, PA. J. Duran was supported by a Fulbright fellowship of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MC, 1970, AGR METEOROL, V7, P19, DOI 10.1016/0002-1571(70)90003-8; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; BALDOCCHI D, 1994, EXPLOITATION ENV HET, P21; Bechtold HA, 2012, FRESHW SCI, V31, P1070, DOI 10.1899/12-003.1; Brackmann U, 1997, LAMBDACHROME LASER G; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CANHAM CD, 1988, ECOLOGY, V69, P1634, DOI 10.2307/1941664; FRIEND DT, 1961, ECOLOGY, V42, P577, DOI 10.2307/1932246; Gendron F, 1998, AGR FOREST METEOROL, V92, P55, DOI 10.1016/S0168-1923(98)00082-3; Gendron F, 2001, AGR FOREST METEOROL, V106, P23, DOI 10.1016/S0168-1923(00)00174-X; Givnish T.J., 1988, FUNCTIONAL PLANT BIO, V15, P63; KUBIN RF, 1982, J LUMIN, V27, P455, DOI 10.1016/0022-2313(82)90045-X; KURACHI N, 1994, JARQ-JPN AGR RES Q, V28, P62; Lee DW, 1996, ECOLOGY, V77, P568, DOI 10.2307/2265631; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Machado JL, 1999, CAN J FOREST RES, V29, P1438, DOI 10.1139/cjfr-29-9-1438; Marquis D, 1962, CHEM LIGHT METER FOR; Mines CH, 2009, HYDROL EARTH SYST SC, V13, P2169, DOI 10.5194/hess-13-2169-2009; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Reche I, 2000, ECOSYSTEMS, V3, P419, DOI 10.1007/s100210000038; Replogle A, 1976, J HYDRAULICS DIVISIO, V5, P1; Schmitz OJ, 2006, ECOSYSTEMS, V9, P659, DOI 10.1007/s10021-006-0006-4; SMART PL, 1977, WATER RESOUR RES, V13, P15, DOI 10.1029/WR013i001p00015; Smith SA, 2002, WATER SA, V28, P403; Stracke F, 1999, J PHOTOCH PHOTOBIO A, V126, P51, DOI 10.1016/S1010-6030(99)00123-9; SUIJLEN JM, 1994, LIMNOL OCEANOGR, V39, P1411, DOI 10.4319/lo.1994.39.6.1411; SULLIVAN TJ, 1983, ENVIRON SCI TECHNOL, V17, P127, DOI 10.1021/es00108a014; Taggart MJ, 2011, GEODERMA, V163, P238, DOI 10.1016/j.geoderma.2011.04.020; TAI DY, 1988, CHEMOSPHERE, V17, P559, DOI 10.1016/0045-6535(88)90031-8; TURNBULL MH, 1993, AGR FOREST METEOROL, V64, P111, DOI 10.1016/0168-1923(93)90096-Z; Upstill-Goddard RC, 2001, LIMNOL OCEANOGR, V46, P927, DOI 10.4319/lo.2001.46.4.0927; Warren DR, 2013, AQUAT SCI, V75, P547, DOI 10.1007/s00027-013-0299-2; Wilhelm P, 2007, J PHOTOCH PHOTOBIO A, V185, P19, DOI 10.1016/j.jphotochem.2006.05.003; Wilson JF, 1986, FLUOROMETRIC PROCEDU, P34	37	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75715	10.1371/journal.pone.0075715	http://dx.doi.org/10.1371/journal.pone.0075715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069440	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300092
J	Tadros, M; Williams, V; Coleman, BL; McGeer, AJ; Haider, S; Lee, C; Iacovides, H; Rubinstein, E; John, M; Johnston, L; McNeil, S; Katz, K; Laffin, N; Suh, KN; Powis, J; Smith, S; Taylor, G; Watt, C; Simor, AE				Tadros, Manal; Williams, Victoria; Coleman, Brenda L.; McGeer, Allison J.; Haider, Shariq; Lee, Christine; Iacovides, Harris; Rubinstein, Ethan; John, Michael; Johnston, Lynn; McNeil, Shelly; Katz, Kevin; Laffin, Nancy; Suh, Kathryn N.; Powis, Jeff; Smith, Stephanie; Taylor, Geoff; Watt, Christine; Simor, Andrew E.			Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ACQUIRED PNEUMONIA; NECROTIZING PNEUMONIA; NOSOCOMIAL PNEUMONIA; CLINICAL-OUTCOMES; INFLUENZA SEASON; INFECTIONS; SURVEILLANCE; VANCOMYCIN; STRAINS	Background: MRSA remains a leading cause of hospital-acquired (HAP) and healthcare-associated pneumonia (HCAP). We describe the epidemiology and outcome of MRSA pneumonia in Canadian hospitals, and identify factors contributing to mortality. Methods: Prospective surveillance for MRSA pneumonia in adults was done for one year (2011) in 11 Canadian hospitals. Standard criteria for MRSA HAP, HCAP, ventilator-associated pneumonia (VAP), and community-acquired pneumonia (CAP) were used to identify cases. MRSA isolates underwent antimicrobial susceptibility testing, and were characterized by pulsed-field gel electrophoresis (PFGE) and Panton-Valentine leukocidin (PVL) gene detection. The primary outcome was all-cause mortality at 30 days. A multivariable analysis was done to examine the association between various host and microbial factors and mortality. Results: A total of 161 patients with MRSA pneumonia were identified: 90 (56%) with HAP, 26 (16%) HCAP, and 45 (28%) CAP; 23 (14%) patients had VAP. The mean (+/- SD) incidence of MRSA HAP was 0.32 (+/- 0.26) per 10,000 patient-days, and of MRSA VAP was 0.30 (+/- 0.5) per 1,000 ventilator-days. The 30-day all-cause mortality was 28.0%. In multivariable analysis, variables associated with mortality were the presence of multiorgan failure (OR 8.1; 95% CI 2.5-26.0), and infection with an isolate with reduced susceptibility to vancomycin (OR 2.5, 95% CI 1.0-6.3). Conclusions: MRSA pneumonia is associated with significant mortality. Severity of disease at presentation, and infection caused by an isolate with elevated MIC to vancomcyin are associated with increased mortality. Additional studies are required to better understand the impact of host and microbial variables on outcome.	[Tadros, Manal; Coleman, Brenda L.; McGeer, Allison J.; Powis, Jeff; Simor, Andrew E.] Univ Toronto, Toronto, ON, Canada; [Williams, Victoria; Watt, Christine; Simor, Andrew E.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Coleman, Brenda L.; McGeer, Allison J.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Haider, Shariq] Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Lee, Christine] St Josephs Hlth Care, Hamilton, ON, Canada; [Iacovides, Harris; Rubinstein, Ethan] Hlth Sci Ctr, Winnipeg, MB, Canada; [John, Michael] London Hlth Sci Ctr, London, ON, Canada; [Johnston, Lynn; McNeil, Shelly] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Katz, Kevin] North York Gen Hosp, Toronto, ON, Canada; [Laffin, Nancy; Suh, Kathryn N.] Ottawa Hosp, Ottawa, ON, Canada; [Powis, Jeff] Toronto East Gen Hosp, Toronto, ON, Canada; [Smith, Stephanie; Taylor, Geoff] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Toronto East General Hospital; University of Alberta	Simor, AE (corresponding author), Univ Toronto, Toronto, ON, Canada.	andrew.simor@sunnybrook.ca	Tadros, Manal/W-8169-2019; Tadros, Manal/AAF-2646-2020; McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	Tadros, Manal/0000-0002-5546-0261; McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Coleman, Brenda L./0000-0002-7144-4827; McNeil, Shelly/0000-0001-5444-4166; Powis, Jeff/0000-0003-2053-6083; Iacovides, Harris/0000-0002-9244-1019	Pfizer Canada, Inc.	Pfizer Canada, Inc.	This work was supported by an investigator-initiated grant from Pfizer Canada, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bouza E, 2012, J HOSP INFECT, V80, P150, DOI 10.1016/j.jhin.2011.11.013; Choi EY, 2011, INTENS CARE MED, V37, P639, DOI 10.1007/s00134-011-2130-7; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; DeRyke CA, 2005, CHEST, V128, P1414, DOI 10.1378/chest.128.3.1414; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Hague NZ, 2010, CHEST, V138, P1356, DOI 10.1378/chest.09-2453; Haque NZ, 2012, J CLIN MICROBIOL, V50, P1640, DOI 10.1128/JCM.06701-11; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jeffres MN, 2006, CHEST, V130, P947, DOI 10.1378/chest.130.4.947; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Lobo LJ, 2010, CHEST, V138, P130, DOI 10.1378/chest.09-1562; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Moalla M, 2008, INFECT CONT HOSP EP, V29, P454, DOI 10.1086/533547; Moran GJ, 2012, CLIN INFECT DIS, V54, P1126, DOI 10.1093/cid/cis022; Peyrani P, 2011, CLIN INFECT DIS, V53, P766, DOI 10.1093/cid/cir541; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Sharma-Kuinkel BK, 2012, J CLIN MICROBIOL, V50, P848, DOI 10.1128/JCM.06219-11; Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4934; Shorr AF, 2010, J CLIN MICROBIOL, V48, P3258, DOI 10.1128/JCM.02529-09; Simor AE, 2010, INFECT CONT HOSP EP, V31, P348, DOI 10.1086/651313; Tsai YF, 2012, CURR OPIN PULM MED, V18, P246, DOI 10.1097/MCP.0b013e3283521022; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vardakas KZ, 2009, EUR RESPIR J, V34, P1148, DOI 10.1183/09031936.00041009; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895	39	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75171	10.1371/journal.pone.0075171	http://dx.doi.org/10.1371/journal.pone.0075171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069391	Green Submitted, gold, Green Published			2022-12-25	WOS:000324547300071
J	Dogan, T; Karacali, B				Dogan, Tunca; Karacali, Bilge			Automatic Identification of Highly Conserved Family Regions and Relationships in Genome Wide Datasets Including Remote Protein Sequences	PLOS ONE			English	Article							DOMAIN; ALGORITHM; DATABASE; IMPLEMENTATION; CDD	Identifying shared sequence segments along amino acid sequences generally requires a collection of closely related proteins, most often curated manually from the sequence datasets to suit the purpose at hand. Currently developed statistical methods are strained, however, when the collection contains remote sequences with poor alignment to the rest, or sequences containing multiple domains. In this paper, we propose a completely unsupervised and automated method to identify the shared sequence segments observed in a diverse collection of protein sequences including those present in a smaller fraction of the sequences in the collection, using a combination of sequence alignment, residue conservation scoring and graph-theoretical approaches. Since shared sequence fragments often imply conserved functional or structural attributes, the method produces a table of associations between the sequences and the identified conserved regions that can reveal previously unknown protein families as well as new members to existing ones. We evaluated the biological relevance of the method by clustering the proteins in gold standard datasets and assessing the clustering performance in comparison with previous methods from the literature. We have then applied the proposed method to a genome wide dataset of 17793 human proteins and generated a global association map to each of the 4753 identified conserved regions. Investigations on the major conserved regions revealed that they corresponded strongly to annotated structural domains. This suggests that the method can be useful in predicting novel domains on protein sequences.	[Dogan, Tunca] Izmir Inst Technol, Biotechnol & Bioengn Grad Program, Izmir, Turkey; [Dogan, Tunca] Dokuz Eylul Univ, Inst Hlth Sci, Izmir, Turkey; [Karacali, Bilge] Izmir Inst Technol, Elect & Elect Engn Dept, Izmir, Turkey	Izmir Institute of Technology; Dokuz Eylul University; Izmir Institute of Technology	Dogan, T (corresponding author), Izmir Inst Technol, Biotechnol & Bioengn Grad Program, Izmir, Turkey.	tuncadogan@gmail.com	Dogan, Tunca/B-5274-2017; KARAÇALI, Bilge/A-1347-2018	Dogan, Tunca/0000-0002-1298-9763; KARAÇALI, Bilge/0000-0002-7765-6329				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apeltsin L, 2011, BIOINFORMATICS, V27, P326, DOI 10.1093/bioinformatics/btq655; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard DH, 1982, COMPUTER VISION; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boyle R, 1988, COMPUTER VISION 1 CO; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Camacho C, 2008, BLAST COMMAND LINE A; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fariselli P, 2007, LECT NOTES COMPUT SC, V4414, P292; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Joseph JM, 2009, BIOINFORMATICS, V25, pI45, DOI 10.1093/bioinformatics/btp207; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75458	10.1371/journal.pone.0075458	http://dx.doi.org/10.1371/journal.pone.0075458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069417	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100126
J	Fuller, C; Robotham, J; Savage, J; Hopkins, S; Deeny, SR; Stone, S; Cookson, B				Fuller, Christopher; Robotham, Julie; Savage, Joanne; Hopkins, Susan; Deeny, Sarah R.; Stone, Sheldon; Cookson, Barry			The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012	PLOS ONE			English	Article							INFECTION; COMMUNITY; HOSPITALS	Introduction: The English Department of Health introduced universal MRSA screening of admissions to English hospitals in 2010. It commissioned a national audit to review implementation, impact on patient management, admission prevalence and extra yield of MRSA identified compared to "high-risk" specialty or "checklist-activated" screening (CLAS) of patients with MRSA risk factors. Methods: National audit May 2011. Questionnaires to infection control teams in all English NHS acute trusts, requesting number patients admitted and screened, new or previously known MRSA; MRSA point prevalence; screening and isolation policies; individual risk factors and patient management for all new MRSA patients and random sample of negatives. Results: 144/167 (86.2%) trusts responded. Individual patient data for 760 new MRSA patients and 951 negatives. 61% of emergency admissions (median 67.3%), 81% (median 59.4%) electives and 47% (median 41.4%) day-cases were screened. MRSA admission prevalence: 1% (median 0.9%) emergencies, 0.6% (median 0.4%) electives, 0.4% (median 0%) day-cases. Approximately 50% all MRSA identified was new. Inpatient MRSA point prevalence: 3.3% (median 2.9%). 104 (77%) trusts pre-emptively isolated patients with previous MRSA, 63 (35%) pre-emptively isolated admissions to "high-risk" specialties; 7 (5%) used PCR routinely. Mean time to MRSA positive result: 2.87 days (+/- 1.33); 37% (219/596) newly identified MRSA patients discharged before result available; 55% remainder (205/376) isolated post-result. In an average trust, CLAS would reduce screening by 50%, identifying 81% of all MRSA. "High risk" specialty screening would reduce screening by 89%, identifying 9% of MRSA. Conclusions: Implementation of universal screening was poor. Admission prevalence (new cases) was low. CLAS reduced screening effort for minor decreases in identification, but implementation may prove difficult. Cost effectiveness of this and other policies, awaits evaluation by transmission dynamic economic modelling, using data from this audit. Until then trusts should seek to improve implementation of current policy and use of isolation facilities.	[Fuller, Christopher; Savage, Joanne; Stone, Sheldon; Cookson, Barry] UCL, London, England; [Robotham, Julie; Hopkins, Susan; Deeny, Sarah R.] Publ Hlth England, London, England; [Hopkins, Susan; Stone, Sheldon] Royal Free Hosp, London NW3 2QG, England; [Cookson, Barry] Hlth Protect Agcy, London, England	University of London; University College London; Public Health England; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency	Fuller, C (corresponding author), UCL, London, England.	christopher.fuller@ucl.ac.uk		Robotham, Julie/0000-0003-2515-4084; Deeny, Sarah/0000-0001-5994-1583; Hopkins, Susan/0000-0001-5179-5702	Department of Health	Department of Health	This study was funded by the Department of Health. The funders had no role in data collection, analysis, decision ot publish or preparation of this manuscript. Representatives of the Department were members of the study steering group. The views of the authors are not necessarily those of the Department of Health.	[Anonymous], 2011, NHS SCOTL MRSA SCREE, V1; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Cooper B S, 2003, Health Technol Assess, V7, P1; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Creamer E, 2010, INFECT CONT HOSP EP, V31, P374, DOI 10.1086/651093; Department of Health, 2008, IMP ASS SCREEN EL PA; Department of Health, 2006, COD PRACT PREV CONTR; Department of Health, 2010, OP FRAM 2011 12 NHS; Department of Health, 2005, SAV LIV DEL PROGR RE; Fuller C, 2012, NOW PREVALENCE AUDIT, P150; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Health Protection Agency, 2012, Q EP COMM MAND MRSA; Health Scotland Protection, 2011, NHS SCOTL MRSA SCREE, V2; Health Scotland Protection, 2011, NAT SERV SCOTL FIN R, V3; Health Scotland Protection, 2011, NAT SERV SCOTL FIN R, V4; HPA, 2004, CDR WKLY, V14; Hubben G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014783; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Kessel AS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1601; Kjonegaard R, 2013, AM J INFECT CONTROL, V41, P45, DOI 10.1016/j.ajic.2012.01.038; Lee BY, 2009, INFECT CONT HOSP EP, V30, P1158, DOI 10.1086/648087; Leonhardt KK, 2011, INFECT CONT HOSP EP, V32, P797, DOI 10.1086/660875; Murthy A, 2010, CLIN MICROBIOL INFEC, V16, P1747, DOI 10.1111/j.1469-0691.2010.03220.x; National Audit Office, 2009, COMPTR AUD GEN HC 56; NPSA, 2004, READ STEAD GO FULL G; Public accounts Committee, 2009, 52 SESS 2008 9; Rao GG, 2007, J HOSP INFECT, V66, P15, DOI 10.1016/j.jhin.2007.01.013; Ritchie K, 2007, HLTH TECHNOL ASSESS; Robotham JV, 2011, PRIP08070410026 DH; Smith A, 2011, HLTH PROTECTION SCOT; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74219	10.1371/journal.pone.0074219	http://dx.doi.org/10.1371/journal.pone.0074219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069282	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100090
J	Kennedy, KM; Scarbrough, PM; Ribeiro, A; Richardson, R; Yuan, H; Sonveaux, P; Landon, CD; Chi, JT; Pizzo, S; Schroeder, T; Dewhirst, MW				Kennedy, Kelly M.; Scarbrough, Peter M.; Ribeiro, Anthony; Richardson, Rachel; Yuan, Hong; Sonveaux, Pierre; Landon, Chelsea D.; Chi, Jen-Tsan; Pizzo, Salvatore; Schroeder, Thies; Dewhirst, Mark W.			Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer	PLOS ONE			English	Article							GLUCOSE DEPRIVATION; OXIDATIVE STRESS; TRANSPORTER MCT4; TUMOR-CELLS; EXPRESSION; HYPOXIA; METASTASES; CARCINOMA; SURVIVAL; TISSUE	Lactate accumulation in tumors has been associated with metastases and poor overall survival in cancer patients. Lactate promotes angiogenesis and metastasis, providing rationale for understanding how it is processed by cells. The concentration of lactate in tumors is a balance between the amount produced, amount carried away by vasculature and if/how it is catabolized by aerobic tumor or stromal cells. We examined lactate metabolism in human normal and breast tumor cell lines and rat breast cancer: 1. at relevant concentrations, 2. under aerobic vs. hypoxic conditions, 3. under conditions of normo vs. hypoglucosis. We also compared the avidity of tumors for lactate vs. glucose and identified key lactate catabolites to reveal how breast cancer cells process it. Lactate was non-toxic at clinically relevant concentrations. It was taken up and catabolized to alanine and glutamate by all cell lines. Kinetic uptake rates of lactate in vivo surpassed that of glucose in R3230Ac mammary carcinomas. The uptake appeared specific to aerobic tumor regions, consistent with the proposed "metabolic symbiont'' model; here lactate produced by hypoxic cells is used by aerobic cells. We investigated whether treatment with alpha-cyano-4-hydroxycinnamate (CHC), a MCT1 inhibitor, would kill cells in the presence of high lactate. Both 0.1 mM and 5 mM CHC prevented lactate uptake in R3230Ac cells at lactate concentrations at <= 20 mM but not at 40 mM. 0.1 mM CHC was well-tolerated by R3230Ac and MCF7 cells, but 5 mM CHC killed both cell lines +/- lactate, indicating off-target effects. This study showed that breast cancer cells tolerate and use lactate at clinically relevant concentrations in vitro (+/- glucose) and in vivo. We provided additional support for the metabolic symbiont model and discovered that breast cells prevailingly take up and catabolize lactate, providing rationale for future studies on manipulation of lactate catabolism pathways for therapy.	[Kennedy, Kelly M.; Landon, Chelsea D.; Pizzo, Salvatore; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Richardson, Rachel; Schroeder, Thies; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Scarbrough, Peter M.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Ribeiro, Anthony] Duke Univ, Duke Univ Shared Resources NMR Facil, Durham, NC USA; [Chi, Jen-Tsan] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA; [Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC USA; [Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Sonveaux, Pierre] UCL, IREC, Brussels, Belgium	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Universite Catholique Louvain	Dewhirst, MW (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	mark.dewhirst@duke.edu	Chi, Jen-Tsan/AAI-4125-2020; Dewhirst, Mark/Q-1302-2019; Schroeder, Thies/G-5244-2014	Chi, Jen-Tsan/0000-0003-3433-903X; Dewhirst, Mark/0000-0003-3459-6546; Sonveaux, Pierre/0000-0001-6484-8834; Yuan, Hong/0000-0002-0535-3214	NIH-NCI [CA40355]; BCRP [BC083154]; ERC [243188]; NATIONAL CANCER INSTITUTE [R01CA040355, T32CA078586, R01CA125618] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCRP; ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded through the following grants: NIH-NCI CA40355 (covering the majority of the work, P. I. Mark Dewhirst), BCRP BC083154 (Postdoctoral grant, US Department of Defense, supporting Kelly Kennedy), ERC Starting Grant 243188 TUMETABO (Pierre Sonveaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Asada K, 2003, ONCOLOGY-BASEL, V64, P380, DOI 10.1159/000070297; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Boidot R, CANC RES, V72, P939; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Bonuccelli G, 2010, CELL CYCLE, V9, P1960, DOI 10.4161/cc.9.10.11601; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Bouzier-Sore AK, 2001, J NEUROSCI RES, V65, P543, DOI 10.1002/jnr.1184; Brizel DM, 1996, CANCER RES, V56, P941; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Dhup S, CURR PHARM DES, V18, P1319; Diers AR, BIOCH J, V444, P561; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Duh S-H, 2005, LAB REFERENCE RANGE; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; FELIG P, 1970, SCIENCE, V167, P1003, DOI 10.1126/science.167.3920.1003; Filyak O. S., 2005, Ukrainskii Biokhimicheskii Zhurnal, V77, P136; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GENTON B, 1990, INTENS CARE MED, V16, P196, DOI 10.1007/BF01724802; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Halestrap AP, 2008, ELETTERS J CLIN INVE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrero P, 2007, J NUCL MED, V48, P2046, DOI 10.2967/jnumed.107.044503; HILF R, 1986, CANCER RES, V46, P211; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Hussien R, PHYSL GENOMICS, V43, P255; Ibrahim E, 2009, MED ONCOL, V26, P372, DOI 10.1007/s12032-008-9131-6; Katayose D, 1995, CLIN CANCER RES, V1, P889; Kellen JA, 1996, IN VIVO, V10, P511; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Kim HS, 2012, BJU INT, V110, P1062, DOI 10.1111/j.1464-410X.2012.10971.x; Komarova EA, 1997, CANCER RES, V57, P5217; Kumar A, 2013, ANTI-CANCER DRUG, V24, P158, DOI 10.1097/CAD.0b013e3283586743; Kumar V, 2014, ROBBINS COTRAN PATHO; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; MUELLERKLIESER W, 1993, HISTOCHEM J, V25, P407, DOI 10.1007/BF00157805; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Pavlides S, AGING ALBANY NY, V2, P185; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Peltz C, 2005, ADV EXP MED BIOL, V566, P343; Pinheiro C, 2008, INT J GYNECOL PATHOL, V27, P568, DOI 10.1097/PGP.0b013e31817b5b40; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Porporato PE, FRONT PHARM, V2, P49; Rasschaert J, 2001, INT J MOL MED, V8, P63; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Richardson RA, 2003, ADV EXP MED BIOL, V510, P375; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; SAUER LA, 1994, METABOLISM, V43, P1488, DOI 10.1016/0026-0495(94)90006-X; SAUER LA, 1986, CANCER RES, V46, P689; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Schwickert G, 1996, EXPERIENTIA, V52, P460, DOI 10.1007/BF01919316; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2003, J CANCER RES CLIN, V129, P321, DOI 10.1007/s00432-003-0450-x; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; Walenta S, 1997, AM J PATHOL, V150, P409; WARBURG O, 1930, METABOLISM TUMORS; Warburg O.H., 1930, METABOLISM TUMOURS I; Warburg OH, 1926, AOEBER STOFFWECHSEL; Yaligar J, 2012, NMR BIOMED, V25, P113, DOI 10.1002/nbm.1723; Yokota H, 2007, J MAGN RESON IMAGING, V25, P992, DOI 10.1002/jmri.20902; ZIELKE HR, 1980, J CELL PHYSIOL, V104, P433, DOI 10.1002/jcp.1041040316	88	121	123	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75154	10.1371/journal.pone.0075154	http://dx.doi.org/10.1371/journal.pone.0075154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069390	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100122
J	Saito, T; Yano, M; Kawai, Y; Asada, A; Wada, M; Doi, H; Hisanaga, S				Saito, Taro; Yano, Masashi; Kawai, Yusei; Asada, Akiko; Wada, Mitsuhito; Doi, Hirofumi; Hisanaga, Shin-ichi			Structural Basis for the Different Stability and Activity between the Cdk5 Complexes with p35 and p39 Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Computer Modeling; Cyclins; Neurons; Serine-Threonine Protein Kinase; Cdk5; Hydrogen Bond; p35; p39; Subunit Interaction	DEPENDENT KINASE-5 ACTIVATOR; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; BRAIN-DEVELOPMENT; CLEAVAGE; P25; LOCALIZATION; INHIBITORS; TOXICITY; CALPAIN	Cyclin-dependent kinase 5 (Cdk5) is a brain-specific membrane-bound protein kinase that is activated by binding to the p35 or p39 activator. Previous studies have focused on p35-Cdk5, and little is known regarding p39-Cdk5. The lack of functional understanding of p39-Cdk5 is due, in part, to the labile property of p39-Cdk5, which dissociates and loses kinase activity in nonionic detergent conditions. Here we investigated the structural basis for the instability of p39-Cdk5. p39 and p35 contain N-terminal p10 regions and C-terminal Cdk5 activation domains (AD). Although p35 and p39 show higher homology in the C-terminal AD than the N-terminal region, the difference in stability is derived from the C-terminal AD. Based on the crystal structures of the p25 (p35 C-terminal region including AD)-Cdk5 complex, we simulated the three-dimensional structure of the p39 AD-Cdk5 complex and found differences in the hydrogen bond network between Cdk5 and its activators. Three amino acids of p35, Asp-259, Asn-266, and Ser-270, which are involved in hydrogen bond formation with Cdk5, are changed to Gln, Gln, and Pro in p39. Because these three amino acids in p39 do not participate in hydrogen bond formation, we predicted that the number of hydrogen bonds between p39 and Cdk5 was reduced compared with p35 and Cdk5. Using substitution mutants, we experimentally validated that the difference in the hydrogen bond network contributes to the different properties between Cdk5 and its activators.	[Saito, Taro; Yano, Masashi; Kawai, Yusei; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Wada, Mitsuhito; Doi, Hirofumi] Celestar Lexico Sci Inc, Mihama Ku, Chiba 2618501, Japan; [Doi, Hirofumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538914, Japan	Tokyo Metropolitan University; University of Tokyo	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp			MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Area from MEXT of Japan (to S. H.).	Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Ledee DR, 2005, J BIOL CHEM, V280, P21376, DOI 10.1074/jbc.M501215200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x	30	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32433	32439		10.1074/jbc.M113.512293	http://dx.doi.org/10.1074/jbc.M113.512293			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085300	hybrid, Green Published			2022-12-25	WOS:000328681700028
J	Anel, JA; Allen, DR; Saenz, G; Gimeno, L; de la Torre, L				Anel, Juan A.; Allen, Douglas R.; Saenz, Guadalupe; Gimeno, Luis; de la Torre, Laura			Equivalent Latitude Computation Using Regions of Interest (ROI)	PLOS ONE			English	Article							REANALYSIS; TRANSPORT	This paper introduces a novel algorithm to compute equivalent latitude by applying regions of interest (ROI). The technique is illustrated using code written in Interactive Data Language (IDL). The ROI method is compared with the "piecewise-constant'' method, the approach commonly used in atmospheric sciences, using global fields of atmospheric potential vorticity. The ROI method is considerably more accurate and computationally faster than the piecewise-constant method, and it also works well with irregular grids. Both the ROI and piecewise-constant IDL codes for equivalent latitude are included as a useful reference for the research community.	[Anel, Juan A.; Saenz, Guadalupe] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; Gimeno, Luis; de la Torre, Laura] Univ Vigo, EPhysLab, Fac Ciencias, Orense, Spain; [Allen, Douglas R.] Naval Res Lab, Washington, DC USA; [Saenz, Guadalupe] Univ Extremadura, Fac Ciencias, Dept Fis, E-06071 Badajoz, Spain	University of Oxford; Universidade de Vigo; United States Department of Defense; United States Navy; Naval Research Laboratory; Universidad de Extremadura	Anel, JA (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England.	juan.anel@smithschool.ox.ac.uk	de la Torre, Laura/Y-3723-2019; , Juan Antonio Añel Cabanelas/N-1866-2019; Allen, Douglas Ray/GWZ-8901-2022; GIMENO, LUIS/B-8137-2008	de la Torre, Laura/0000-0001-5305-6946; , Juan Antonio Añel Cabanelas/0000-0003-2448-4647; Allen, Douglas/0000-0003-2747-9712; GIMENO, LUIS/0000-0002-0778-3605	TRODIM project [CGL2007-65891-C05-01]; ExCirEs project [CGL2011-24826]; Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competitiveness; Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)"; European Regional Development Fund; University of Oxford; Engineering and Physical Sciences Research Council of the United Kingdom; United States Office of Naval Research	TRODIM project; ExCirEs project; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)"; European Regional Development Fund(European Commission); University of Oxford; Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); United States Office of Naval Research(Office of Naval Research)	This work was partially supported by the TRODIM (CGL2007-65891-C05-01) and ExCirEs projects (CGL2011-24826) funded by the Spanish Ministry of Science and Innovation, Spanish Ministry of Economy and Competitiveness and by the Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)'' funded by European Regional Development Fund. JAA research is partially supported by the University of Oxford and the Engineering and Physical Sciences Research Council of the United Kingdom. Work at the Naval Research Lab is sponsored by the United States Office of Naval Research. Part of the simulations performed were carried out in the Centro de Supercomputacion de Galicia through a "Reto Computacional 2009'' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DR, 2003, J ATMOS SCI, V60, P287, DOI 10.1175/1520-0469(2003)060<0287:TELADT>2.0.CO;2; Anel JA, PLOS ONE UNPUB; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Bowman K.P., 2006, INTRO PROGRAMMING ID; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; Garcia RR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007485; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; LARY DJ, 1995, Q J ROY METEOR SOC, V121, P187; McIntyre M. E., 2003, ENCY ATMOS SCI, V2, P685; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Schoeberl MR, 2003, ENCY ATMOSPHERIC SCI, V3, P1321; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	14	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72970	10.1371/journal.pone.0072970	http://dx.doi.org/10.1371/journal.pone.0072970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086267	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700006
J	Finones, RR; Yeargin, J; Lee, M; Kaur, AP; Cheng, C; Sun, P; Wu, C; Nguyen, C; Wang-Rodriguez, J; Meyer, AN; Baird, SM; Donoghue, DJ; Haas, M				Finones, Rita R.; Yeargin, Jo; Lee, Melissa; Kaur, Aman Preet; Cheng, Clari; Sun, Paulina; Wu, Christopher; Nguyen, Catherine; Wang-Rodriguez, Jessica; Meyer, April N.; Baird, Stephen M.; Donoghue, Daniel J.; Haas, Martin			Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; STEM-LIKE CELLS; EPITHELIAL-CELLS; PROSPECTIVE IDENTIFICATION; STEM/PROGENITOR CELLS; MALIGNANT PROSTATE; UROGENITAL SINUS; INITIATING CELLS; PROGENITOR CELLS; SIDE POPULATION	Although blockade of androgen receptor (AR) signaling represents the main treatment for advanced prostate cancer (PrCa), many patients progress to a lethal phenotype of "Castration-Resistant'' prostate cancer (CR-PrCa). With the hypothesis that early PrCa may harbor a population of androgen-unresponsive cancer cells as precursors to CR-recurrent disease, we undertook the propagation of androgen-independent cells from PrCa-prostatectomy samples of early, localized (Stage-I) cases. A collection of 120 surgical specimens from prostatectomy cases was established, among which 54 were adenocarcinomas. Hormone-free cell culture conditions were developed allowing routine propagation of cells expressing prostate basal cell markers and stem/progenitor cell markers, and which proliferated as spheres/spheroids in suspension cultures. Colonies of androgen-independent epithelial cells grew out from 30/43 (70%) of the adenocarcinoma cases studied in detail. Fluorescence microscopy and flow cytometry showed that CR-PrCa cells were positive for CD44, CD133, CK5/14, c-kit, integrin alpha 2b1, SSEA4, E-Cadherin and Aldehyde Dehydrogenase (ALDH). All 30 CR-PrCa cell cultures were also TERT-positive, but negative for TMPRSS2-ERG. Additionally, a subset of 22 of these CR-PrCa cell cultures was examined by orthotopic xenografting in intact and castrated SCID mice, generating histologically typical locally-invasive human PrCa or undifferentiated cancers, respectively, in 6-8 weeks. Cultured PrCa cells and orthotopically-induced in vivo cancers lacked PSA expression. We report here the propagation of Cancer Initiating Cells (CIC) directly from Stage I human PrCa tissue without selection or genetic manipulation. The propagation of stem/progenitor-like CR-PrCa cells derived from early human prostate carcinomas suggests the existence of a subpopulation of cells resistant to androgen-deprivation therapy and which may drive the subsequent emergence of disseminated CR-PrCa.	[Finones, Rita R.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Yeargin, Jo; Donoghue, Daniel J.; Haas, Martin] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Baird, Stephen M.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kaur, Aman Preet; Cheng, Clari; Sun, Paulina; Wu, Christopher; Nguyen, Catherine; Haas, Martin] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lee, Melissa; Meyer, April N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Donoghue, DJ (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			UC San Diego Foundation	UC San Diego Foundation	All funds were generously provided through the UC San Diego Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bastus NC, 2010, CANCER RES, V70, P9544, DOI 10.1158/0008-5472.CAN-10-1638; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Buhler P, 2010, ONCOL REP, V23, P465, DOI 10.3892/or_00000656; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1991, CANCER SURV, V11, P73; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dhillon PK, 2009, CANCER EPIDEM BIOMAR, V18, P595, DOI 10.1158/1055-9965.EPI-08-0785; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; HAYASHI N, 1993, EPITHELIAL CELL BIOL, V2, P66; Hayward SW, 2001, CANCER RES, V61, P8135; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lee SO, 2013, J MOL CELL BIOL, V5, P14, DOI 10.1093/jmcb/mjs042; Li H, 2008, EXP CELL RES, V314, P92, DOI 10.1016/j.yexcr.2007.08.011; Li XH, 2009, DIFFERENTIATION, V77, P95, DOI 10.1016/j.diff.2008.09.012; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Masters JR, 2008, PROSTATE CANCER P D, V11, P316, DOI 10.1038/pcan.2008.22; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Norris PS, 1998, J VIROL METHODS, V75, P161, DOI 10.1016/S0166-0934(98)00108-6; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; Ruiz M, 2001, CLIN CANCER RES, V7, P4086; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Signoretti S, 2006, CELL CYCLE, V5, P138, DOI 10.4161/cc.5.2.2340; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Taubert I, 2011, CYTOTHERAPY, V13, P459, DOI 10.3109/14653249.2010.530652; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; WONG YC, 1992, ACTA ANAT, V143, P139; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74438	10.1371/journal.pone.0074438	http://dx.doi.org/10.1371/journal.pone.0074438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086346	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700025
J	Kushwaha, AK; Sangwan, NS; Trivedi, PK; Negi, AS; Misra, L; Sangwan, RS				Kushwaha, Amit Kumar; Sangwan, Neelam Singh; Trivedi, Prabodh Kumar; Negi, Arvind Singh; Misra, Laxminarain; Sangwan, Rajender Singh			Tropine Forming Tropinone Reductase Gene from Withania somnifera (Ashwagandha): Biochemical Characteristics of the Recombinant Enzyme and Novel Physiological Overtones of Tissue-Wide Gene Expression Patterns	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-CLONING; NATURAL-PRODUCTS; DIFFERENT STEREOSPECIFICITIES; CALYSTEGINE DISTRIBUTION; DATURA-STRAMONIUM; ROOT; BIOSYNTHESIS; PURIFICATION; DERIVATIVES	Withania somnifera is one of the most reputed medicinal plants of Indian systems of medicine synthesizing diverse types of secondary metabolites such as withanolides, alkaloids, withanamides etc. Present study comprises cloning and E. coli overexpression of a tropinone reductase gene (WsTR-I) from W. somnifera, and elucidation of biochemical characteristics and physiological role of tropinone reductase enzyme in tropane alkaloid biosynthesis in aerial tissues of the plant. The recombinant enzyme was demonstrated to catalyze NADPH-dependent tropinone to tropine conversion step in tropane metabolism, through TLC, GC and GC-MS-MS analyses of the reaction product. The functionally active homodimeric similar to 60 kDa enzyme catalyzed the reaction in reversible manner at optimum pH 6.7. Catalytic kinetics of the enzyme favoured its forward reaction (tropine formation). Comparative 3-D models of landscape of the enzyme active site contours and tropinone binding site were also developed. Tissue-wide and ontogenic stage-wise assessment of WsTR-I transcript levels revealed constitutive expression of the gene with relatively lower abundance in berries and young leaves. The tissue profiles of WsTR-I expression matched those of tropine levels. The data suggest that, in W. somnifera, aerial tissues as well possess tropane alkaloid biosynthetic competence. In vivo feeding of U-[C-14]-sucrose to orphan shoot (twigs) and [C-14]-chasing revealed substantial radiolabel incorporation in tropinone and tropine, confirming the de novo synthesizing ability of the aerial tissues. This inherent independent ability heralds a conceptual novelty in the backdrop of classical view that these tissues acquire the alkaloids through transportation from roots rather than synthesis. The TR-I gene expression was found to be up-regulated on exposure to signal molecules (methyl jasmonate and salicylic acid) and on mechanical injury. The enzyme's catalytic and structural properties as well as gene expression profiles are discussed with respect to their physiological overtones.	[Kushwaha, Amit Kumar; Sangwan, Neelam Singh; Negi, Arvind Singh; Misra, Laxminarain; Sangwan, Rajender Singh] CSIR CIMAP, Lucknow, Uttar Pradesh, India; [Trivedi, Prabodh Kumar] CSIR NBRI, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] Govt India, Dept Biotechnol, Interim Facil, Bioproc Unit, Mohali, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Department of Biotechnology (DBT) India; Center of Innovative & Applied Bioprocessing (CIAB)	Sangwan, RS (corresponding author), CSIR CIMAP, Lucknow, Uttar Pradesh, India.	sangwan.lab@gmail.com	Sangwan, Neelam/AAF-4010-2021; Negi, arvind singh/AAS-1530-2021	sangwan, Neelam singh/0000-0003-2761-702X; Kushwaha, Amit Kumar/0000-0003-0011-7738	New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India [SSP-97]; CSIR, India	New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India (Project #SSP-97) and CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkouche K, 2001, PHYTOCHEMISTRY, V58, P455, DOI 10.1016/S0031-9422(01)00283-7; Brock A, 2008, PLANT J, V54, P388, DOI 10.1111/j.1365-313X.2008.03422.x; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen W, 2013, MOL BIOL REP, V40, P1145, DOI 10.1007/s11033-012-2156-0; Cheng X, 2013, J PLANT PHYSL, DOI 10.1016/j.jplph.2013.02.007; Cordell GA, 2001, PHYTOTHER RES, V15, P183, DOI 10.1002/ptr.890; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Dehghan E, 2013, PLANT PHYSL BIOCH, DOI 10.1016/j.plaphy.2013.05.007; DRAGER B, 1988, AGR BIOL CHEM TOKYO, V52, P2663; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; Griffin WJ, 2000, PHYTOCHEMISTRY, V53, P623, DOI 10.1016/S0031-9422(99)00475-6; Grynkiewicz G, 2008, PHARMACOL REP, V60, P439; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; HASHIMOTO T, 1992, PLANT PHYSIOL, V100, P836, DOI 10.1104/pp.100.2.836; Jayaprakasam B, 2004, TETRAHEDRON, V60, P3109, DOI 10.1016/j.tet.2004.01.016; Kai GY, 2009, BIOTECHNOL APPL BIOC, V54, P177, DOI 10.1042/BA20090171; Kaiser H, 2006, PLANTA, V225, P127, DOI 10.1007/s00425-006-0335-8; Keiner R, 2002, PLANT MOL BIOL, V48, P299, DOI 10.1023/A:1013315110746; Keiner R, 2000, PLANT SCI, V150, P171, DOI 10.1016/S0168-9452(99)00184-3; Kushwaha AK, 2013, GENE, V516, P238, DOI 10.1016/j.gene.2012.11.091; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2012, VACCINE, V30, P1083, DOI 10.1016/j.vaccine.2011.12.031; Kutchan TM, 2008, ADV PL BIOCH MOL BIO, V1, P283, DOI 10.1016/S1755-0408(07)01010-7; Lal P, 2006, Z NATURFORSCH B, V61, P1143, DOI 10.1515/znb-2006-0914; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Majumdar DN, 1955, J IND I SCI A, V16A, P29; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mandal S, 2012, PLOS ONE, V7; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Misra L, 2005, PHYTOCHEMISTRY, V66, P2702, DOI 10.1016/j.phytochem.2005.10.001; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Mondal S, 2012, ADV EXP MED BIOL, V749, P295, DOI 10.1007/978-1-4614-3381-1_20; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Nakajima K, 1999, J BIOL CHEM, V274, P16563, DOI 10.1074/jbc.274.23.16563; Nakajima K, 1998, P NATL ACAD SCI USA, V95, P4876, DOI 10.1073/pnas.95.9.4876; Nakajima K, 1999, PLANT CELL PHYSIOL, V40, P1099, DOI 10.1093/oxfordjournals.pcp.a029494; NAKAJIMA K, 1993, P NATL ACAD SCI USA, V90, P9591, DOI 10.1073/pnas.90.20.9591; NAKAJIMA K, 1993, PLANT PHYSIOL, V103, P1465, DOI 10.1104/pp.103.4.1465; NAKAJIMA K, 1994, J BIOL CHEM, V269, P11695; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Ortholand JY, 2004, CURR OPIN CHEM BIOL, V8, P271, DOI 10.1016/j.cbpa.2004.04.011; Peacock SM, 1944, AM J BOT, V31, P463, DOI 10.2307/2437406; PORTSTEFFEN A, 1994, PHYTOCHEMISTRY, V37, P391, DOI 10.1016/0031-9422(94)85066-6; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; SANGWAN RS, 1993, J PLANT PHYSIOL, V142, P129, DOI 10.1016/S0176-1617(11)80952-1; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Tuli R, 2010, ASHWAGANDHA WITHANIA; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; YAMADA Y, 1990, CURR PLANT SCI BIOT, V9, P547	56	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74777	10.1371/journal.pone.0074777	http://dx.doi.org/10.1371/journal.pone.0074777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086372	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700034
J	Sabri, A; Vandermoten, S; Leroy, PD; Haubruge, E; Hance, T; Thonart, P; De Pauw, E; Francis, F				Sabri, Ahmed; Vandermoten, Sophie; Leroy, Pascal D.; Haubruge, Eric; Hance, Thierry; Thonart, Philippe; De Pauw, Edwin; Francis, Frederic			Proteomic Investigation of Aphid Honeydew Reveals an Unexpected Diversity of Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PEA APHID; SUGAR COMPOSITION; ACYRTHOSIPHON-PISUM; NUTRITIONAL QUALITY; PHLOEM SAP; HYMENOPTERA; PLANT; SPECIFICITY; DETERMINES	Aphids feed on the phloem sap of plants, and are the most common honeydew-producing insects. While aphid honeydew is primarily considered to comprise sugars and amino acids, its protein diversity has yet to be documented. Here, we report on the investigation of the honeydew proteome from the pea aphid Acyrthosiphon pisum. Using a two-Dimensional Differential in-Gel Electrophoresis (2D-Dige) approach, more than 140 spots were isolated, demonstrating that aphid honeydew also represents a diverse source of proteins. About 66% of the isolated spots were identified through mass spectrometry analysis, revealing that the protein diversity of aphid honeydew originates from several organisms (i.e. the host aphid and its microbiota, including endosymbiotic bacteria and gut flora). Interestingly, our experiments also allowed to identify some proteins like chaperonin, GroEL and Dnak chaperones, elongation factor Tu (EF-Tu), and flagellin that might act as mediators in the plant-aphid interaction. In addition to providing the first aphid honeydew proteome analysis, we propose to reconsider the importance of this substance, mainly acknowledged to be a waste product, from the aphid ecology perspective.	[Vandermoten, Sophie; Leroy, Pascal D.; Haubruge, Eric; Francis, Frederic] Univ Liege, Lab Funct & Evolutionary Entomol, Gembloux, Belgium; [Sabri, Ahmed; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-3000 Louvain, Belgium; [Thonart, Philippe] Univ Liege, Walloon Ctr Ind Biol, Liege, Belgium; [De Pauw, Edwin] Univ Liege, Dept Chem, Mass Spectrometry Lab, Liege, Belgium	University of Liege; Universite Catholique Louvain; University of Liege; University of Liege	Francis, F (corresponding author), Univ Liege, Lab Funct & Evolutionary Entomol, Gembloux, Belgium.	Frederic.Francis@ulg.ac.be		De Pauw, Edwin/0000-0003-3475-1315; Haubruge, Eric/0000-0002-8138-0476	Walloon Region Ministry Grant [WALEO2: SOLAPHIDRW/FUSAGX 061/6287]	Walloon Region Ministry Grant	This research was funded by the Walloon Region Ministry Grant (WALEO2: SOLAPHIDRW/FUSAGX 061/6287). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Arakaki N, 1998, APPL ENTOMOL ZOOL, V33, P357, DOI 10.1303/aez.33.357; AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; Baumann P, 1996, CURR MICROBIOL, V32, P279, DOI 10.1007/s002849900050; Casas J, 2003, J ANIM ECOL, V72, P691, DOI 10.1046/j.1365-2656.2003.00740.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; CLOUTIER C, 1986, J INSECT PHYSIOL, V32, P263, DOI 10.1016/0022-1910(86)90037-5; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; ELLIOTT NC, 1987, J KANSAS ENTOMOL SOC, V60, P25; England S, 1997, ENVIRON ENTOMOL, V26, P1437, DOI 10.1093/ee/26.6.1437; Evans EW, 2000, ENTOMOL EXP APPL, V94, P141, DOI 10.1023/A:1003914509181; Faria CA, 2008, BASIC APPL ECOL, V9, P286, DOI 10.1016/j.baae.2007.02.001; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Gilbert F, 1998, BIOL J LINN SOC, V63; Hansen AK, 2011, PROCEEDINGS OF THE N; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Hogervorst P, 2007, ENTOMOL EXP APPL, V122; IDOINE K, 1988, ENVIRON ENTOMOL, V17, P941, DOI 10.1093/ee/17.6.941; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Karley AJ, 2002, J EXP BIOL, V205, P3009; Kay A, 2002, ECOLOGY, V83, P1935, DOI 10.1890/0012-9658(2002)083[1935:AOFTTA]2.0.CO;2; Kay A, 2004, BEHAV ECOL, V15, P63, DOI 10.1093/beheco/arg106; Kloft W, 1985, WALDTRACHT UND WALDH; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; Leroy PD, 2011, ARTHROPOD-PLANT INTE, V5, P193, DOI 10.1007/s11829-011-9128-5; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; Malcolm S.B., 1990, Chemoecology, V1, P12, DOI 10.1007/BF01240581; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Mittler T, 1958, J EXP BIOL, V35; Moller H, 1987, FOREST BIRD, V18, P14; Nomikou M, 2003, EXP APPL ACAROL, V31, P15, DOI 10.1023/B:APPA.0000005142.31959.e8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sabri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018847; Saheed SA, 2007, PHYSIOL PLANTARUM, V129, P429, DOI 10.1111/j.1399-3054.2006.00821.x; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; SASAKI T, 1990, J INSECT PHYSIOL, V36, P35, DOI 10.1016/0022-1910(90)90148-9; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; Singh R, 2000, J ADV ZOOL, V21; Smith KM, 1926, ANN APPL BIOL, V13, P109, DOI 10.1111/j.1744-7348.1926.tb04254.x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Wackers F, 2005, SUITABILITY OF EXTRA; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Waeckers F.L., 2003, IOBC-WPRS Bulletin, V26, P203; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Woodring J, 2004, PHYSIOL ENTOMOL, V29, P311, DOI 10.1111/j.0307-6962.2004.00386.x; Yao I, 2002, ECOL ENTOMOL, V27, P745, DOI 10.1046/j.1365-2311.2002.00455.x; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003; ZOEBELEIN G, 1955, Z ANG ENT, V38, P369	56	49	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74656	10.1371/journal.pone.0074656	http://dx.doi.org/10.1371/journal.pone.0074656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086359	Green Published, gold			2022-12-25	WOS:000325218700029
J	Inui, T; Chano, T; Takikita-Suzuki, M; Nishikawa, M; Yamamoto, G; Okabe, H				Inui, Takuma; Chano, Tokuhiro; Takikita-Suzuki, Mikiko; Nishikawa, Masanori; Yamamoto, Gaku; Okabe, Hidetoshi			Association of p62/SQSTM1 Excess and Oral Carcinogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; SQUAMOUS-CELL CARCINOMA; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROXIMITY LIGATION; PROTEIN COMPLEXES; IN-SITU; KEAP1; ACTIVATION; EXPRESSION	p62/SQSTM1 (sequestosome1) has never been evaluated in oral epithelium. In order to clarify the role of p62/SQSTM1 in carcinogenesis in oral epithelium, both p62/SQSTM1 and Nrf2 were immunohistochemically evaluated in 54 carcinomas and 14 low grade dysplasias. p62/SQSTM1 knockdowns were also designed in oral cancer cells, and we analyzed the Nrf2 pathway, GSH contents and ROS accumulation. The association between p62/SQSTM1 excess and prognosis was addressed in a clinical cohort of oral carcinoma cases. p62/SQSTM1 excess was more obvious in carcinomas, but Nrf2 was abundant in almost all samples of the oral epithelium. In oral carcinoma cells, p62/SQSTM1 knockdown did not affect the Nrf2-Keap1 pathway but did significantly reduce GSH content with subsequent ROS accumulation, and caused cell growth inhibition in the irradiated condition. Finally, p62/SQSTM1 excess was associated with poor prognosis in a clinical cohort. In oral epithelial carcinogenesis, p62/SQSTM1 excess played a role in GSH induction rather than Nrf2 accumulation, and may cause resistance to cytotoxic stresses such as radiation or chemotherapy. Immunohistochemical evaluation of p62/SQSTM1 may be a potential significant marker to identify early carcinogenesis, chemo- radiotherapeutic resistance or poor prognosis of oral squamous cell carcinomas.	[Inui, Takuma; Chano, Tokuhiro; Takikita-Suzuki, Mikiko; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Inui, Takuma; Nishikawa, Masanori; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was partly supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. No additional external funding received for this study. The funding source had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Arai A, 2011, CANCER RES, V71, P4598, DOI 10.1158/0008-5472.CAN-11-0320; Barnes L, 2005, PATHOLOGY GENETICS H; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bohn SK, 2006, CANCER LETT, V238, P240, DOI 10.1016/j.canlet.2005.07.027; Bui CB, 2011, BIOCHEM BIOPH RES CO, V412, P347, DOI 10.1016/j.bbrc.2011.07.101; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lu ML, 2001, AM J PATHOL, V159, P945, DOI 10.1016/S0002-9440(10)61770-1; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; OGUNBIYI OA, 1993, J CLIN PATHOL, V46, P23, DOI 10.1136/jcp.46.1.23; Qian Hong-liu, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P329; Salzman R, 2010, INT J CLIN ONCOL; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Su YX, 2005, CLIN IMMUNOL, V116, P118, DOI 10.1016/j.clim.2005.04.004; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang JY, 1999, J EXP MED, V189, P1101, DOI 10.1084/jem.189.7.1101; Zieba A, 2010, CLIN CHEM, V56, P99, DOI 10.1373/clinchem.2009.134452; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	32	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74398	10.1371/journal.pone.0074398	http://dx.doi.org/10.1371/journal.pone.0074398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086340	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200014
J	Esmaeili, A; Pourbabaee, AA; Alikhani, HA; Shabani, F; Esmaeili, E				Esmaeili, Atefeh; Pourbabaee, Ahmad Ali; Alikhani, Hossein Ali; Shabani, Farzin; Esmaeili, Ensieh			Biodegradation of Low-Density Polyethylene (LDPE) by Mixed Culture of Lysinibacillus xylanilyticus and Aspergillus niger in Soil	PLOS ONE			English	Article							DISPOSABLE POLYETHYLENE; DEGRADATION; FILMS	In this study, two strains of Aspergillus sp. and Lysinibacillus sp. with remarkable abilities to degrade low-density polyethylene (LDPE) were isolated from landfill soils in Tehran using enrichment culture and screening procedures. The biodegradation process was performed for 126 days in soil using UV- and non-UV-irradiated pure LDPE films without pro-oxidant additives in the presence and absence of mixed cultures of selected microorganisms. The process was monitored by measuring the microbial population, the biomass carbon, pH and respiration in the soil, and the mechanical properties of the films. The carbon dioxide measurements in the soil showed that the biodegradation in the un-inoculated treatments were slow and were about 7.6% and 8.6% of the mineralisation measured for the non-UV-irradiated and UV-irradiated LDPE, respectively, after 126 days. In contrast, in the presence of the selected microorganisms, biodegradation was much more efficient and the percentages of biodegradation were 29.5% and 15.8% for the UV-irradiated and non-UV-irradiated films, respectively. The percentage decrease in the carbonyl index was higher for the UV-irradiated LDPE when the biodegradation was performed in soil inoculated with the selected microorganisms. The percentage elongation of the films decreased during the biodegradation process. The Fourier transform infra-red (FT-IR), x-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to determine structural, morphological and surface changes on polyethylene. These analyses showed that the selected microorganisms could modify and colonise both types of polyethylene. This study also confirmed the ability of these isolates to utilise virgin polyethylene without pro-oxidant additives and oxidation pretreatment, as the carbon source.	[Esmaeili, Atefeh; Pourbabaee, Ahmad Ali; Alikhani, Hossein Ali] Univ Tehran, Univ Coll Agr & Nat Resources, Fac Agr Engn & Technol, Dept Soil Sci, Karaj, Iran; [Shabani, Farzin] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Esmaeili, Ensieh] Dept Environm, Tehran, Iran	University of Tehran; University of New England	Esmaeili, A (corresponding author), Univ Tehran, Univ Coll Agr & Nat Resources, Fac Agr Engn & Technol, Dept Soil Sci, Karaj, Iran.	aesmaeili@ut.ac.ir	Alikhani, Hossein Ali/Y-8783-2018; Pourbabaee, Ahmad/ABD-9376-2021; shabani, Farzin/P-1033-2019	Alikhani, Hossein Ali/0000-0002-8740-6059; shabani, Farzin/0000-0002-5100-8921; pourbabaei, Ahmad Ali/0000-0002-5273-2161				Abd El-Rehim HA, 2004, J PHOTOCH PHOTOBIO A, V163, P547, DOI 10.1016/j.jphotochem.2004.02.003; Abrusci C, 2011, INT BIODETER BIODEGR, V65, P451, DOI 10.1016/j.ibiod.2010.10.012; ALBERTSSON AC, 1980, EUR POLYM J, V16, P623, DOI 10.1016/0014-3057(80)90100-7; ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X; ALBERTSSON AC, 1978, J APPL POLYM SCI, V22, P3419, DOI 10.1002/app.1978.070221207; American Society for Testing and Materials (ASTM), 2003, D5988 ASTM; [Anonymous], 1999, D1293 ASTM; [Anonymous], 2003, ISO17556; [Anonymous], 2003, D882 ASTM; Chiellini E, 2003, POLYM DEGRAD STABIL, V81, P341, DOI 10.1016/S0141-3910(03)00105-8; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; CORNELL JH, 1984, J APPL POLYM SCI, V29, P2581, DOI 10.1002/app.1984.070290814; Corti A, 2010, POLYM DEGRAD STABIL, V95, P1106, DOI 10.1016/j.polymdegradstab.2010.02.018; El-Shafei HA, 1998, POLYM DEGRAD STABIL, V62, P361, DOI 10.1016/S0141-3910(98)00019-6; Fontanella S, 2010, POLYM DEGRAD STABIL, V95, P1011, DOI 10.1016/j.polymdegradstab.2010.03.009; Gilan I, 2004, APPL MICROBIOL BIOT, V65, P97, DOI 10.1007/s00253-004-1584-8; Hadad D, 2005, J APPL MICROBIOL, V98, P1093, DOI 10.1111/j.1365-2672.2005.02553.x; Jakubowicz I, 2006, POLYM DEGRAD STABIL, V91, P1556, DOI 10.1016/j.polymdegradstab.2005.09.018; Jakubowicz I, 2011, POLYM DEGRAD STABIL, V96, P919, DOI 10.1016/j.polymdegradstab.2011.01.031; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Lau AK, 2009, J ENVIRON MANAGE, V90, P668, DOI 10.1016/j.jenvman.2008.03.001; LEE BT, 1991, APPL ENVIRON MICROB, V57, P678, DOI 10.1128/AEM.57.3.678-685.1991; Manzur A, 2004, J APPL POLYM SCI, V92, P265, DOI 10.1002/app.13644; Nowak B., 2011, INT BIODETER BIODEGR, V42, P1; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; Orhan Y, 2000, INT BIODETER BIODEGR, V45, P49, DOI 10.1016/S0964-8305(00)00048-2; Page AL, 2008, METHODS SOIL ANAL 2, P139; Roy PK, 2008, POLYM DEGRAD STABIL, V93, P1917, DOI 10.1016/j.polymdegradstab.2008.07.016; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Siotto M, 2012, J ENVIRON MANAGE, V93, P31, DOI 10.1016/j.jenvman.2011.08.018; Sivan A, 2006, APPL MICROBIOL BIOT, V72, P346, DOI 10.1007/s00253-005-0259-4; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Volke-Sepulveda T, 2002, J APPL POLYM SCI, V83, P305, DOI 10.1002/app.2245; Watanabe T., 2002, PICTORIAL ATLAS SOIL, V2nd; WEILAND M, 1995, POLYM DEGRAD STABIL, V48, P275, DOI 10.1016/0141-3910(95)00040-S; YABANNAVAR AV, 1994, APPL ENVIRON MICROB, V60, P3608, DOI 10.1128/AEM.60.10.3608-3614.1994; Zahra S, 2010, WASTE MANAGE, V30, P396, DOI 10.1016/j.wasman.2009.09.027	37	143	161	13	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e71720	10.1371/journal.pone.0071720	http://dx.doi.org/10.1371/journal.pone.0071720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086254	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200002
J	Lim, HC; Xie, L; Zhang, W; Li, R; Chen, ZC; Wu, GZ; Cui, SS; Tan, EK; Zeng, L				Lim, Han Chi; Xie, Li; Zhang, Wei; Li, Rong; Chen, Zhong-Can; Wu, Guang-Zhi; Cui, Shu-Sen; Tan, Eng King; Zeng, Li			Ribosomal S6 Kinase 2 (RSK2) Maintains Genomic Stability by Activating the Atm/p53-Dependent DNA Damage Pathway	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; ATAXIA-TELANGIECTASIA GENE; CELL-CYCLE; INTERACTING PROTEIN; C-ABL; ATM; PHOSPHORYLATION; REPAIR; P53; APOPTOSIS	Ribosomal S6 Kinase 2 (RSK2) is a member of the p90 RSK family of serine/threonine kinases, which are widely expressed and respond to many growth factors, peptide hormones, and neurotransmitters. Loss-of function mutations in the RPS6KA3 gene, which encodes the RSK2 protein, have been implicated in Coffin-Lowry Syndrome (CLS), an X-linked mental retardation disorder associated with cognitive deficits and behavioral impairments. However, the cellular and molecular mechanisms underlying this neurological disorder are not known. Recent evidence suggests that defective DNA damage signaling might be associated with neurological disorders, but the role of RSK2 in the DNA damage pathway remains to be elucidated. Here, we show that Adriamycin-induced DNA damage leads to the phosphorylation of RSK2 at Ser227 and Thr577 in the chromatin fraction, promotes RSK2 nuclear translocation, and enhances RSK2 and Atm interactions in the nuclear fraction. Furthermore, using RSK2 knockout mouse fibroblasts and RSK2-deficient cells from CLS patients, we demonstrate that ablation of RSK2 impairs the phosphorylation of Atm at Ser1981 and the phosphorylation of p53 at Ser18 (mouse) or Ser15 (human) in response to genotoxic stress. We also show that RSK2 affects p53-mediated downstream cellular events in response to DNA damage, that RSK2 knockout relieves cell cycle arrest at the G2/M phase, and that an increased number of cH2AX foci, which are associated with defects in DNA repair, are present in RSK2-deficient cells. Taken together, our findings demonstrated that RSK2 plays an important role in the DNA damage pathway that maintains genomic stability by mediating cell cycle progression and DNA repair.	[Lim, Han Chi; Xie, Li; Zhang, Wei; Zeng, Li] Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore, Singapore; [Li, Rong] ASTAR, Biomed Sci Inst BMSI, Ctr Expt Therapeut, Singapore, Singapore; [Li, Rong; Chen, Zhong-Can] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Wu, Guang-Zhi; Cui, Shu-Sen] Jilin Univ, Dept Hand Surg, China Japan Union Hosp, Changchun 130023, Jinlin Province, Peoples R China; [Tan, Eng King] Natl Neurosci Inst, Res Dept, Singapore, Singapore; [Tan, Eng King] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Tan, Eng King; Zeng, Li] DUKE NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore	National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; Jilin University; National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); National University of Singapore	Zeng, L (corresponding author), Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore, Singapore.	Li_ZENG@nni.com.sg	Xie, Li/ABE-2011-2020	Xie, Li/0000-0002-5555-5762	Singapore Ministry of Health's National Medical Research Council [NMRC/1200/2009]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its NMRC/1200/2009 to L.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Cescutti R, 2010, EMBO J, V29, P3723, DOI 10.1038/emboj.2010.238; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dugani CB, 2010, DEV BIOL, V347, P348, DOI 10.1016/j.ydbio.2010.08.035; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; HARPER JW, 1993, CELL, V75, P805; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Kesler SR, 2007, NEUROGENETICS, V8, P143, DOI 10.1007/s10048-007-0080-6; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Konat GW, 2008, METAB BRAIN DIS, V23, P325, DOI 10.1007/s11011-008-9100-y; Mehmood T, 2011, HUM GENET, V129, P255, DOI 10.1007/s00439-010-0918-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; O'Driscoll M, 2004, DNA REPAIR, V3, P1227, DOI 10.1016/j.dnarep.2004.03.025; Pereira PM, 2010, EUR J HUM GENET, V18, P627, DOI 10.1038/ejhg.2009.189; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Strachan RT, 2010, BIOCHEMISTRY-US, V49, P2657, DOI 10.1021/bi901921k; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Watson K, 2005, MOL PHARMACOL, V67, P757, DOI 10.1124/mol.104.004812; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zeng L, 2005, J BIOL CHEM, V280, P29374, DOI 10.1074/jbc.M503016200; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhu F, 2011, CANCER RES, V71, P393, DOI 10.1158/0008-5472.CAN-10-2012; Zykova TA, 2007, CARCINOGENESIS, V28, P1543, DOI 10.1093/carcin/bgm070	48	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74334	10.1371/journal.pone.0074334	http://dx.doi.org/10.1371/journal.pone.0074334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086335	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200028
J	Hu, JY; Luo, ZJ; Zhao, XQ; Chen, Q; Chen, ZY; Qin, H; Qin, YF; Liang, XH; Suo, YJ				Hu, Jieyu; Luo, Zuojie; Zhao, Xiaoqin; Chen, Qiang; Chen, Zhaoyan; Qin, Hua; Qin, Yingfen; Liang, Xinghuan; Suo, Yingjun			Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study	PLOS ONE			English	Article							D DEFICIENCY; INCREASED MORTALITY; HYPOVITAMINOSIS-D; CATHELICIDIN; HYPOCALCEMIA; PREVALENCE; SEVERITY; RECEPTOR; OUTCOMES; OLD	Objective: Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals. Methods: A prospective observational study was conducted on 216 patients admitted to a university-affiliated, tertiary-care medical intensive care unit(MICU) between June 2011 and December 2012. Serum levels of 25-hydroxyvitamin D, ionised calcium and intact PTH were determined within 24 h of MICU admission. The primary end point was all-cause hospital mortality within 90-days of admission. Results: 95 patients (44%) showed 25-hydroxyvitamin D deficiency. Patients deficient in vitamin D showed significantly higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score, rate of positive blood culture, incidence of multiple organ dysfunction syndrome, and 90-day mortality rate than did patients with vitamin D insufficiency or sufficiency (P<0.05), as well as lower levels of serum IgG. 25-Hydroxyvitamin D deficiency was identified as an independent risk factor for mortality (OR = 3.018, 95%CI 1.329-6.854, P = 0.008). Hypovitaminosis D in PTH-responders was associated with higher mortality than was the same condition in non-responders (P<0.05). Conclusions: These results suggest that vitamin D deficiency is prevalent among MICU patients, suggesting a significant derangement of the calcium-PTH-vitamin D axis in critically ill patients. Vitamin D deficiency is an independent risk factor for 90-day mortality, and hypovitaminosis D in PTH-responders is associated with higher mortality than is the same condition in non-responders.	[Hu, Jieyu; Zhao, Xiaoqin; Chen, Qiang; Chen, Zhaoyan; Qin, Hua] Guangxi Med Univ, Affiliated Hosp 1, Intens Care Unit, Nanning, Peoples R China; [Luo, Zuojie; Qin, Yingfen; Liang, Xinghuan; Suo, Yingjun] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Luo, ZJ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Peoples R China.	1144532347@qq.com						Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Bjelakovic G, 2011, COCHRANE DATABASE SY, V7; Bjorkman MP, 2008, EUR J ENDOCRINOL, V158, P749, DOI 10.1530/EJE-07-0849; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Carlstedt F, 1997, EUR J CLIN INVEST, V27, P977, DOI 10.1046/j.1365-2362.1997.2310778.x; Chen JS, 2008, CLIN ENDOCRINOL, V68, P290, DOI 10.1111/j.1365-2265.2007.03040.x; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fisher A, 2010, BONE, V47, P400, DOI 10.1016/j.bone.2010.04.610; Flynn L, 2011, AM J SURG, V203, P379; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Higgins DM, 2012, JPEN-PARENTER ENTER, V36, P713, DOI 10.1177/0148607112444449; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horl Walter H, 2004, Nephrol Dial Transplant, V19 Suppl 5, pV2, DOI 10.1093/ndt/gfh1049; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Matthews LR, 2012, AM J SURG, V204, P37, DOI 10.1016/j.amjsurg.2011.07.021; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Pincikova T, 2011, EUR J CLIN NUTR, V65, P102, DOI 10.1038/ejcn.2010.194; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Sambrook PN, 2004, J CLIN ENDOCR METAB, V89, P5477, DOI 10.1210/jc.2004-0307; Selvaraj P, 2011, VITAM HORM, V86, P307, DOI 10.1016/B978-0-12-386960-9.00013-7; Thomas MK, 1998, NEW ENGL J MED, V338, P777, DOI 10.1056/NEJM199803193381201; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	35	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75441	10.1371/journal.pone.0075441	http://dx.doi.org/10.1371/journal.pone.0075441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073266	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000076
J	Kishimoto-Yamada, K; Kamiya, K; Meleng, P; Diway, B; Kaliang, H; Chong, L; Itioka, T; Sakai, S; Ito, M				Kishimoto-Yamada, Keiko; Kamiya, Koichi; Meleng, Paulus; Diway, Bibian; Kaliang, Het; Chong, Lucy; Itioka, Takao; Sakai, Shoko; Ito, Motomi			Wide Host Ranges of Herbivorous Beetles? Insights from DNA Bar Coding	PLOS ONE			English	Article							DIPTEROCARP FOREST; TROPICAL FORESTS; INSECT HERBIVORES; PINUS-PUMILA; SPECIFICITY; COLEOPTERA; PATTERNS; TREES; SPECIALIZATION; IDENTIFICATION	There are very few studies that have investigated host-specificity among tropical herbivorous insects. Indeed, most of the trophic interactions of herbivorous insects in Southeast Asian tropical rainforests remain unknown, and whether polyphagous feeding is common in the herbivores of this ecosystem has not been determined. The present study employed DNA bar coding to reveal the trophic associations of adult leaf-chewing chrysomelid beetles in a Bornean rainforest. Plant material ingested by the adults was retrieved from the bodies of the insects, and a portion of the chloroplast rbcL sequence was then amplified from this material. The plants were identified at the family level using an existing reference database of chloroplast DNA. Our DNA-based diet analysis of eleven chrysomelid species successfully identified their host plant families and indicated that five beetle species fed on more than two families within the angiosperms, and four species fed on several families of gymnosperms and/or ferns together with multiple angiosperm families. These findings suggest that generalist chrysomelid beetles associated with ecologically and taxonomically distant plants constitute a part of the plant-insect network of the Bornean rainforest.	[Kishimoto-Yamada, Keiko; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Kamiya, Koichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Meleng, Paulus] Sarawak Forest Dept, Res Dev & Innovat Div, Kuching, Sarawak, Malaysia; [Diway, Bibian; Kaliang, Het; Chong, Lucy] Sarawak Forestry Corp, Appl Forest Sci & Ind Dev, Kuching, Sarawak, Malaysia; [Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Sakai, Shoko] Res Inst Humanity & Nat, Kyoto, Japan	University of Tokyo; Ehime University; Jabatan Hutan Sarawak; Kyoto University; Research Institute for Humanity & Nature (RIHN)	Kishimoto-Yamada, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	kky_kei@yahoo.co.jp	Sakai, Shoko/AFN-1913-2022	Sakai, Shoko/0000-0002-4267-8405; Kamiya, Koichi/0000-0003-3614-9029	Ministry of Education, Culture, Sports, Science and Technology-Japan [FY2012-2016];  [23-6333]; Grants-in-Aid for Scientific Research [21255004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National BioResource Project (FY2012-2016) from the Ministry of Education, Culture, Sports, Science and Technology-Japan, and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (23-6333 to KKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; APPANAH S, 1993, J BIOSCIENCES, V18, P457, DOI 10.1007/BF02703079; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BASSET Y, 1992, BIOL J LINN SOC, V47, P115, DOI 10.1111/j.1095-8312.1992.tb00659.x; Basset Y, 1996, BIOL J LINN SOC, V59, P201, DOI 10.1111/j.1095-8312.1996.tb01461.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Chai PKP, 1984, SOME ORNAMENTAL ROAD; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Coode MJE, 1996, CHECKLIST FLOWERING; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Ichie T, 2004, J TROP ECOL, V20, P697, DOI 10.1017/S0266467404001713; JOLIVET P, 1995, HOST PLANTS CHRYSOME; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishimoto-Yamada K, 2009, B ENTOMOL RES, V99, P217, DOI 10.1017/S000748530800624X; Kishimoto-Yamada K, 2008, BIOTROPICA, V40, P600, DOI 10.1111/j.1744-7429.2008.00410.x; Kishimoto-Yamada K, 2010, INSECT CONSERV DIVER, V3, P266, DOI 10.1111/j.1752-4598.2010.00099.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kubisz D, 2012, CENT EUR J BIOL, V7, P69, DOI 10.2478/s11535-011-0099-4; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Lee H. S., 2002, The 52-Hectare Forest Research Plot at Lambir Hills, Sarawak, Malaysia: tree distribution maps, diameter tables and species documentation; Leigh EG, 2004, BIOTROPICA, V36, P447, DOI 10.1111/j.1744-7429.2004.tb00342.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Mawdsley N. A., 1997, P104; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Nagamasu H, 1997, GEN FLOWERING TROPIC, P20; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2002, J ANIM ECOL, V71, P400, DOI 10.1046/j.1365-2656.2002.00608.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2003, ARTHROPODS OF TROPICAL FORESTS, P40; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2012, AM NAT, V179, P351, DOI 10.1086/664082; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Piggott A. G., 1988, FERNS MALAYSIA COLOU; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; Stork NE, 2006, P ROY SOC B-BIOL SCI, V273, P1969, DOI 10.1098/rspb.2006.3521; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wardhaugh CW, 2012, J ANIM ECOL, V81, P1086, DOI 10.1111/j.1365-2656.2012.01988.x; Watano Y, 1995, J PLANT RES, V108, P493, DOI 10.1007/BF02344239; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Webber BL, 2006, AUST SYST BOT, V19, P541, DOI 10.1071/SB06001; Weiblen GD, 2006, ECOLOGY, V87, pS62, DOI 10.1890/0012-9658(2006)87[62:PDOHUI]2.0.CO;2; Whitmore T.C., 1984, TROPICAL RAM FORESTS; Yumoto T, 2005, ECOL STU AN, V174, P13	70	22	26	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74426	10.1371/journal.pone.0074426	http://dx.doi.org/10.1371/journal.pone.0074426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073210	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000019
J	Lin, YC; Chen, BM; Lu, WC; Su, CI; Prijovich, ZM; Chung, WC; Wu, PY; Chen, KC; Lee, IC; Juan, TY; Roffler, SR				Lin, Yi-Chieh; Chen, Bing-Mae; Lu, Wei-Cheng; Su, Chien-I; Prijovich, Zeljko M.; Chung, Wen-Chuan; Wu, Pei-Yu; Chen, Kai-Chuan; Lee, I-Chiao; Juan, Ting-Yi; Roffler, Steve R.			The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; ENDOPLASMIC-RETICULUM LOCALIZATION; COPII-DEPENDENT EXPORT; POTASSIUM CHANNEL; MEMBRANE-PROTEINS; TRANSMEMBRANE PROTEINS; BETA-GLUCURONIDASE; COUPLED RECEPTORS; VESICLE FORMATION; SELECTIVE EXPORT	Membrane-tethered proteins (mammalian surface display) are increasingly being used for novel therapeutic and biotechnology applications. Maximizing surface expression of chimeric proteins on mammalian cells is important for these applications. We show that the cytoplasmic domain from the B7-1 antigen, a commonly used element for mammalian surface display, can enhance the intracellular transport and surface display of chimeric proteins in a Sar1 and Rab1 dependent fashion. However, mutational, alanine scanning and deletion analysis demonstrate the absence of linear ER export motifs in the B7 cytoplasmic domain. Rather, efficient intracellular transport correlated with the presence of predicted secondary structure in the cytoplasmic tail. Examination of the cytoplasmic domains of 984 human and 782 mouse type I transmembrane proteins revealed that many previously identified ER export motifs are rarely found in the cytoplasmic tail of type I transmembrane proteins. Our results suggest that efficient intracellular transport of B7 chimeric proteins is associated with the structure rather than to the presence of a linear ER export motif in the cytoplasmic tail, and indicate that short (less than similar to 10-20 amino acids) and unstructured cytoplasmic tails should be avoided to express high levels of chimeric proteins on mammalian cells.	[Lin, Yi-Chieh; Chen, Bing-Mae; Lu, Wei-Cheng; Su, Chien-I; Prijovich, Zeljko M.; Chung, Wen-Chuan; Wu, Pei-Yu; Chen, Kai-Chuan; Lee, I-Chiao; Juan, Ting-Yi; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	sroff@ibms.sinica.edu.tw	LU, Wei-Cheng/O-5577-2017; Roffler, Steve R/N-7791-2018	Roffler, Steve R/0000-0003-2543-7295	National Science Council, Taiwan [NSC-99-2320-B001-011-MY3, NSC-102-2320-B001-013-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants to SRR from the National Science Council, Taiwan (NSC-99-2320-B001-011-MY3 and NSC-102-2320-B001-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Castro-Fernandez C, 2005, ENDOCR REV, V26, P479, DOI 10.1210/er.2004-0010; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Chen KC, 2013, MOL PHARMACEUT, V10, P1773, DOI 10.1021/mp300581u; Chen KC, 2008, CHEM BIOL, V15, P1277, DOI 10.1016/j.chembiol.2008.10.008; Cheng TL, 2008, MED RES REV, V28, P885, DOI 10.1002/med.20127; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Chuang KH, 2010, MOL CANCER THER, V9, P1903, DOI 10.1158/1535-7163.MCT-09-0899; Chuang KH, 2010, J NUCL MED, V51, P933, DOI 10.2967/jnumed.109.071977; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Doty RT, 1996, J IMMUNOL, V157, P3270; Doty RT, 1998, J IMMUNOL, V161, P2700; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Huang PT, 2011, CANCER GENE THER, V18, P381, DOI 10.1038/cgt.2011.3; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KANG HS, 1991, J BIOL CHEM, V266, P5643; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liao KW, 2003, CANCER GENE THER, V10, P779, DOI 10.1038/sj.cgt.7700637; Liao KW, 2001, BIOTECHNOL BIOENG, V73, P313, DOI 10.1002/bit.1064; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2005, MOL BIOL CELL, V16, P3719, DOI 10.1091/mbc.E05-03-0262; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; MORINAGA T, 1983, P NATL ACAD SCI-BIOL, V80, P4604, DOI 10.1073/pnas.80.15.4604; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2002, J CELL SCI, V115, P619; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Pan WY, 2012, MOL THER, V20, P927, DOI 10.1038/mt.2012.10; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Shieh SJ, 2009, J IMMUNOL, V183, P2277, DOI 10.4049/jimmunol.0900679; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Su YC, 2010, BIOCONJUGATE CHEM, V21, P1264, DOI 10.1021/bc100067t; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Volna P, 2007, NUCLEIC ACIDS RES, V35, P2748, DOI 10.1093/nar/gkm182; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Wang TT, 2012, AM J PHYSIOL-CELL PH, V303, pC963, DOI 10.1152/ajpcell.00217.2012; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wolkowicz R, 2005, J BIOL CHEM, V280, P15195, DOI 10.1074/jbc.M500254200; Xia X, 2002, MOL BIOL EVOL, V19, P58, DOI 10.1093/oxfordjournals.molbev.a003982; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	101	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75084	10.1371/journal.pone.0075084	http://dx.doi.org/10.1371/journal.pone.0075084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073236	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000045
J	Sha, W; Martins, AM; Laubenbacher, R; Mendes, P; Shulaev, V				Sha, Wei; Martins, Ana M.; Laubenbacher, Reinhard; Mendes, Pedro; Shulaev, Vladimir			The Genome-Wide Early Temporal Response of Saccharomyces cerevisiae to Oxidative Stress Induced by Cumene Hydroperoxide	PLOS ONE			English	Article							OXYGEN-FREE-RADICALS; GENE-EXPRESSION; MITOCHONDRIAL-FUNCTION; ALCOHOL-DEHYDROGENASE; ERYTHROASCORBIC ACID; YEAST; CELLS; YAP1; SENSITIVITY; PROTEASOME	Oxidative stress is a well-known biological process that occurs in all respiring cells and is involved in pathophysiological processes such as aging and apoptosis. Oxidative stress agents include peroxides such as hydrogen peroxide, cumene hydroperoxide, and linoleic acid hydroperoxide, the thiol oxidant diamide, and menadione, a generator of superoxide, amongst others. The present study analyzed the early temporal genome-wide transcriptional response of Saccharomyces cerevisiae to oxidative stress induced by the aromatic peroxide cumene hydroperoxide. The accurate dataset obtained, supported by the use of temporal controls, biological replicates and well controlled growth conditions, provided a detailed picture of the early dynamics of the process. We identified a set of genes previously not implicated in the oxidative stress response, including several transcriptional regulators showing a fast transient response, suggesting a coordinated process in the transcriptional reprogramming. We discuss the role of the glutathione, thioredoxin and reactive oxygen species-removing systems, the proteasome and the pentose phosphate pathway. A data-driven clustering of the expression patterns identified one specific cluster that mostly consisted of genes known to be regulated by the Yap1p and Skn7p transcription factors, emphasizing their mediator role in the transcriptional response to oxidants. Comparison of our results with data reported for hydrogen peroxide identified 664 genes that specifically respond to cumene hydroperoxide, suggesting distinct transcriptional responses to these two peroxides. Genes up-regulated only by cumene hydroperoxide are mainly related to the cell membrane and cell wall, and proteolysis process, while those down-regulated only by this aromatic peroxide are involved in mitochondrial function.	[Sha, Wei; Martins, Ana M.; Laubenbacher, Reinhard; Mendes, Pedro; Shulaev, Vladimir] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Sha, Wei] Univ North Carolina Charlotte, Bioinformat Res Div, Kannapolis, NC USA; [Martins, Ana M.] Univ Sharjah, Dept Appl Biol, Sharjah, U Arab Emirates; [Laubenbacher, Reinhard] Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT USA; [Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Mendes, Pedro] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Shulaev, Vladimir] Univ N Texas, Dept Biol Sci, Coll Arts & Sci, Denton, TX 76203 USA	Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Charlotte; University of Sharjah; University of Connecticut; University of Manchester; University of Manchester; University of North Texas System; University of North Texas Denton	Martins, AM (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	amtbs.martins@gmail.com	Martons, Ana Margarida/AAP-4337-2021; Martins, Samir/P-6251-2014	Martons, Ana Margarida/0000-0003-4822-3249; Martins, Samir/0000-0003-1702-8504; Mendes, Pedro/0000-0001-6507-9168	National Institute for General Medical Sciences [GM068947]; Virginia Bioinformatics Institute; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BPD/8033/2002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068947, R01GM080219] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Bioinformatics Institute; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (GM068947) to RL from the National Institute for General Medical Sciences (http://www.nigms.nih.gov), supplemented with funds from the Virginia Bioinformatics Institute (www.vbi.vt.edu), and a fellowship to AMM from the Portuguese Fundacao para a Ciencia e Tecnologia (SFRH/BPD/8033/2002)(www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; Amako K, 2006, BIOSCI BIOTECH BIOCH, V70, P3004, DOI 10.1271/bbb.60399; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Cohen BA, 2002, MOL BIOL CELL, V13, P1608, DOI 10.1091/mbc.01-10-0472; Cyrne L, 2003, FREE RADICAL BIO MED, V34, P385, DOI 10.1016/S0891-5849(02)01300-X; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Delneri D, 1999, YEAST, V15, P1681, DOI 10.1002/(SICI)1097-0061(199911)15:15<1681::AID-YEA486>3.0.CO;2-A; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreher D, 1996, EUR J CANCER, V32A, P30, DOI 10.1016/0959-8049(95)00531-5; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; HAMMEL KE, 1986, P NATL ACAD SCI USA, V83, P3708, DOI 10.1073/pnas.83.11.3708; Hancock RD, 2000, FEMS MICROBIOL LETT, V186, P245, DOI 10.1016/S0378-1097(00)00155-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, pW213, DOI 10.1093/nar/gkh402; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Hochstrasser M, 1999, PHILOS T ROY SOC B, V354, P1513, DOI 10.1098/rstb.1999.0495; Horan S, 2006, YEAST, V23, P519, DOI 10.1002/yea.1372; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kosikova B, 1996, FOLIA MICROBIOL, V41, P430, DOI 10.1007/BF02815694; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martins AM, 2004, CURR GENOMICS, V5, P649, DOI 10.2174/1389202043348643; Martins AM, 2007, YEAST, V24, P181, DOI 10.1002/yea.1442; MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nevitt T, 2004, YEAST, V21, P1365, DOI 10.1002/yea.1188; NICK JA, 1986, PLANT SCI, V46, P181, DOI 10.1016/0168-9452(86)90190-1; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Toledano MB, 2003, OXIDATIVE STRESS RES; Tsuzi D, 2004, FEBS LETT, V565, P148, DOI 10.1016/j.febslet.2004.03.091; VROEGOP SM, 1995, FREE RADICAL BIO MED, V18, P141, DOI 10.1016/0891-5849(94)00107-U; Winzeler EA, 1999, PARASITOLOGY, V118, pS73, DOI 10.1017/S0031182099004047; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	79	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74939	10.1371/journal.pone.0074939	http://dx.doi.org/10.1371/journal.pone.0074939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073228	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000037
J	Klop, B; van de Geijn, GJM; Bovenberg, SA; van der Meulen, N; Elte, JWF; Birnie, E; Njo, TL; Janssen, HW; van Miltenburg, A; Jukema, JW; Cabezas, MC				Klop, Boudewijn; van de Geijn, Gert-Jan M.; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Birnie, Erwin; Njo, Tjin L.; Janssen, Hans W.; van Miltenburg, Addy; Jukema, J. Wouter; Cabezas, Manuel Castro			Erythrocyte-Bound Apolipoprotein B in Relation to Atherosclerosis, Serum Lipids and ABO Blood Group	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTOR; CHOLESTEROL; LIPOPROTEINS; ASSOCIATION; PLASMA; CELLS	Introduction: Erythrocytes carry apolipoprotein B on their membrane, but the determining factors of erythrocyte-bound apolipoprotein B (ery-apoB) are unknown. We aimed to explore the determinants of ery-apoB to gain more insight into potential mechanisms. Methods: Subjects with and without CVD were included (N=398). Ery-apoB was measured on fresh whole blood samples using flow cytometry. Subjects with ery-apoB levels <= 0.20 a.u. were considered deficient. Carotid intima media thickness (CIMT) was determined as a measure of (subclinical) atherosclerosis. Results: Mean ery-apoB value was 23.2% lower in subjects with increased CIMT (0.80 +/- 0.09 mm, N = 140) compared to subjects with a normal CIMT (0.57 +/- 0.08 mm, N = 258) (P = 0.007, adjusted P<0.001). CIMT and ery-apoB were inversely correlated (Spearman's n =0.116, P=0.021). A total of 55 subjects (13.6%) were considered ery-apoB deficient, which was associated with a medical history of CVD (OR: 1.86, 95% CI 1.04-3.33; adjusted OR: 1.55; 95% CI 0.85-2.82). Discontinuation of statins in 54 subjects did not influence ery-apoB values despite a 58.4% increase in serum apolipoprotein B. Subjects with blood group O had significantly higher ery-apoB values (1.56 +/- 0.94 a.u.) when compared to subjects with blood group A (0.89 +/- 1.15 a.u), blood group B (0.73 +/- 0.1.12 a.u.) or blood group AB (0.69 +/- 0.69 a.u.) (P-ANOVA = 0.002). Conclusion: Absence or very low values of ery-apoB are associated with clinical and subclinical atherosclerosis. While serum apolipoprotein B is not associated with ery-apoB, the ABO blood group seems to be a significant determinant.	[Klop, Boudewijn; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Cabezas, Manuel Castro] St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands; [Klop, Boudewijn; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Cabezas, Manuel Castro] St Franciscus Gasthuis, Diabet & Vasc Ctr, Rotterdam, Netherlands; [van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.] St Franciscus Gasthuis, Dept Clin Chem, Rotterdam, Netherlands; [Birnie, Erwin] St Franciscus Gasthuis, Dept Stat & Educ, Rotterdam, Netherlands; [van Miltenburg, Addy] St Franciscus Gasthuis, Dept Cardiol, Rotterdam, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cabezas, MC (corresponding author), St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands.	m.castrocabezas@sfg.nl	Jukema, J. Wouter/ABD-6503-2021	Jukema, J. Wouter/0000-0002-3246-8359				Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Bovenberg SA, 2010, ATHEROSCLEROSIS SUPP, V11, P25, DOI 10.1016/j.atherosclerosissup.2010.04.003; Bovenberg SA, 2011, EUR J CLIN INVEST; Carpeggiani C, 2010, ATHEROSCLEROSIS, V211, P461, DOI 10.1016/j.atherosclerosis.2010.03.012; GARRISON RJ, 1976, ATHEROSCLEROSIS, V25, P311, DOI 10.1016/0021-9150(76)90036-8; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P267, DOI 10.1002/gepi.1370040405; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; He MA, 2012, ARTERIOSCL THROM VAS, V32, P2314, DOI 10.1161/ATVBAHA.112.248757; Hinderling PH, 1997, PHARMACOL REV, V49, P279; HUI DY, 1981, BIOCHIM BIOPHYS ACTA, V664, P513, DOI 10.1016/0005-2760(81)90129-6; HUI DY, 1979, BIOCHIM BIOPHYS ACTA, V550, P407, DOI 10.1016/0005-2736(79)90145-7; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LANGMAN MJS, 1969, LANCET, V2, P607; Mora S, 2008, CIRCULATION, V118; OLIVER MF, 1969, LANCET, V2, P605; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; SASAK WV, 1991, BIOCHEM J, V274, P159, DOI 10.1042/bj2740159; van Oostrom AJHHM, 2004, DRUGS, V64, P19, DOI 10.2165/00003495-200464002-00004; Verseyden C, 2004, J CLIN ENDOCR METAB, V89, P5021, DOI 10.1210/jc.2003-032171; WONG FL, 1992, GENET EPIDEMIOL, V9, P405; Zhang HR, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/641917	24	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75573	10.1371/journal.pone.0075573	http://dx.doi.org/10.1371/journal.pone.0075573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069429	Green Published, gold			2022-12-25	WOS:000324777300085
J	Zhang, XM; Shao, B; Wu, YL; Qi, O				Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang			A Reverse Engineering Approach to Optimize Experiments for the Construction of Biological Regulatory Networks	PLOS ONE			English	Article							GENE NETWORKS; INFERENCE; DREAM	One of the major objectives in systems biology is to understand the relation between the topological structures and the dynamics of biological regulatory networks. In this context, various mathematical tools have been developed to deduct structures of regulatory networks from microarray expression data. In general, from a single data set, one cannot deduct the whole network structure; additional expression data are usually needed. Thus how to design a microarray expression experiment in order to get the most information is a practical problem in systems biology. Here we propose three methods, namely, maximum distance method, trajectory entropy method, and sampling method, to derive the optimal initial conditions for experiments. The performance of these methods is tested and evaluated in three well-known regulatory networks (budding yeast cell cycle, fission yeast cell cycle, and E. coli. SOS network). Based on the evaluation, we propose an efficient strategy for the design of microarray expression experiments.	[Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China; [Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Qi, O (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China.	qi@pku.edu.cn	Zhang, Xiaoming/L-2904-2013; SHAO, BIN/ABE-4975-2021	SHAO, BIN/0000-0001-8697-2174	Natural Science Foundation of China [11074009, 10721463]; Minister of Science and Technology of China [2009CB918500]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minister of Science and Technology of China	Natural Science Foundation of China (11074009, 10721463), Minister of Science and Technology of China(2009CB918500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; de la Fuente A, 2006, IEE P SYST BIOL, V153, P257, DOI 10.1049/ip-syb:20050061; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marbach D, 2009, ANN NY ACAD SCI, V1158, P234, DOI 10.1111/j.1749-6632.2008.03944.x; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442	17	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75931	10.1371/journal.pone.0075931	http://dx.doi.org/10.1371/journal.pone.0075931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069453	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300100
J	Maynard, BF; Bass, C; Katanski, C; Thakur, K; Manoogian, B; Leander, M; Nichols, R				Maynard, Benjamin F.; Bass, Chloe; Katanski, Chris; Thakur, Kiran; Manoogian, Beth; Leander, Megan; Nichols, Ruthann			Structure-Activity Relationships of FMRF-NH2 Peptides Demonstrate A Role for the Conserved C Terminus and Unique N-Terminal Extension in Modulating Cardiac Contractility	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; PROTEIN; NEUROPEPTIDE; IDENTIFICATION; BINDING; RECEPTORS; ACCURACY; MODELS	FMRF-NH2 peptides which contain a conserved, identical C-terminal tetrapeptide but unique N terminus modulate cardiac contractility; yet, little is known about the mechanisms involved in signaling. Here, the structure-activity relationships (SARs) of the Drosophila melanogaster FMRF-NH2 peptides, PDNFMRF-NH2, SDNFMRF-NH2, DPKQDFMRF-NH2, SPKQDFMRF-NH2, and TPAEDFMRF-NH2, which bind FMRFa-R, were investigated. The hypothesis tested was the C-terminal tetrapeptide FMRF-NH2, particularly F1, makes extensive, strong ligand-receptor contacts, yet the unique N terminus influences docking and activity. To test this hypothesis, docking, binding, and bioactivity of the C-terminal tetrapeptide and analogs, and the FMRF-NH2 peptides were compared. Results for FMRF-NH2 and analogs were consistent with the hypothesis; F1 made extensive, strong ligand-receptor contacts with FMRFa-R; Y -> F (YMRF-NH2) retained binding, yet A -> F (AMRF-NH2) did not. These findings reflected amino acid physicochemical properties; the bulky, aromatic residues F and Y formed strong pi-stacking and hydrophobic contacts to anchor the ligand, interactions which could not be maintained in diversity or number by the small, aliphatic A. The FMRF-NH2 peptides modulated heart rate in larva, pupa, and adult distinctly, representative of the contact sites influenced by their unique N-terminal structures. Based on physicochemical properties, the peptides each docked to FMRFa-R with one best pose, except FMRF-NH2 which docked with two equally favorable poses, consistent with the N terminus influencing docking to define specific ligand-receptor contacts. Furthermore, SDNAMRF-NH2 was designed and, despite lacking the aromatic properties of one F, it binds FMRFa-R and demonstrated a unique SAR, consistent with the N terminus influencing docking and conferring binding and activity; thus, supporting our hypothesis.	[Maynard, Benjamin F.; Bass, Chloe; Katanski, Chris; Thakur, Kiran; Manoogian, Beth; Leander, Megan; Nichols, Ruthann] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Maynard, Benjamin F.; Katanski, Chris; Leander, Megan; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Biochem Honors Res Program, Ann Arbor, MI 48109 USA; [Bass, Chloe; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Chem Honors Res Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nichols, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	nicholsr@umich.edu			NIH [R21HL093627]; University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH grant R21HL093627, Concept to Commercialization Funding from the University of Michigan Medical Innovation Center, and a University of Michigan Cardiovascular Center Innovative Grant to Ruthann Nichols. Chloe Bass received the Seyhan N. Ege-WISE Award to support her research to support his research in the Nichols' lab, and Ben Maynard received an Albert Euclid Hinsdale Award to support his research in the Nichols' lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bass C, 2013, PEPTIDES IN PRESS; Bortolato Andrea, 2013, Methods Mol Biol, V924, P339, DOI 10.1007/978-1-62703-017-5_13; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claeys I, 2005, VITAM HORM, V73, P217, DOI 10.1016/S0083-6729(05)73007-7; Clark J, 2008, PEPTIDES, V29, P1140, DOI 10.1016/j.peptides.2008.02.013; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Dunn TW, 2005, PEPTIDES, V26, P269, DOI 10.1016/j.peptides.2004.09.010; Duttlinger A, 2002, PEPTIDES, V23, P1953, DOI 10.1016/S0196-9781(02)00179-1; Foucaud M, 2008, REGUL PEPTIDES, V145, P17, DOI 10.1016/j.regpep.2007.09.024; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Hewes RS, 1998, J NEUROSCI, V18, P7138; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Klose MK, 2010, J NEUROSCI, V30, P14724, DOI 10.1523/JNEUROSCI.3612-10.2010; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McCormick J, 1999, CELL TISSUE RES, V297, P197, DOI 10.1007/s004410051347; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; NICHOLS R, 1988, J BIOL CHEM, V263, P12167; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Nichols R, 1999, J NEUROGENET, V13, P89, DOI 10.3109/01677069909083468; Nichols R, 2009, FRONT BIOSCI-LANDMRK, V14, P4035, DOI 10.2741/3510; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; Staljanssens D, 2011, PEPTIDES, V32, P607, DOI 10.1016/j.peptides.2010.11.025; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; WHITE K, 1986, J COMP NEUROL, V247, P430, DOI 10.1002/cne.902470403; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75502	10.1371/journal.pone.0075502	http://dx.doi.org/10.1371/journal.pone.0075502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069424	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300085
J	Sancisi, V; Gandolfi, G; Ragazzi, M; Nicoli, D; Tamagnini, I; Piana, S; Ciarrocchi, A				Sancisi, Valentina; Gandolfi, Greta; Ragazzi, Moira; Nicoli, Davide; Tamagnini, Ione; Piana, Simonetta; Ciarrocchi, Alessia			Cadherin 6 Is a New RUNX2 Target in TGF-beta Signalling Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA CELL-LINE; GENE-EXPRESSION; EMT; ACTIVATION; INHIBITOR	Modifications in adhesion molecules profile may change the way tumor cells interact with the surrounding microenvironment. The Cadherin family is a large group of transmembrane proteins that dictate the specificity of the cellular interactions. The Cadherin switch that takes place during epithelial-mesenchymal transition (EMT) contributes to loosening the rigid organization of epithelial tissues and to enhancing motility and invasiveness of tumor cells. Recently, we found Cadherin-6 (CDH6, also known as K-CAD) highly expressed in thyroid tumor cells that display mesenchymal features and aggressive phenotype, following the overexpression of the transcriptional regulator Id1. In this work, we explored the possibility that CDH6 is part of the EMT program in thyroid tumors. We demonstrate that CDH6 is a new transforming growth factor-beta (TGF-beta) target and that its expression is modulated similarly to other EMT mesenchymal markers, both in vitro and in thyroid tumor patients. We show for the first time that CDH6 is expressed in human thyroid carcinomas and that its expression is enhanced at the invasive front of the tumor. Finally, we show that CDH6 is under the control of the transcription factor RUNX2, which we previously described as a crucial mediator of the Id1 pro-invasive function in thyroid tumor cells. Overall, these observations provide novel information on the mechanism of the EMT program in tumor progression and indicate CDH6 as a potential regulator of invasiveness in thyroid tumors.	[Sancisi, Valentina; Gandolfi, Greta; Nicoli, Davide; Ciarrocchi, Alessia] Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Mol Biol Lab, Reggio Emilia, Italy; [Ragazzi, Moira; Tamagnini, Ione; Piana, Simonetta] Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Pathol Unit, Reggio Emilia, Italy	IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova	Ciarrocchi, A (corresponding author), Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Mol Biol Lab, Reggio Emilia, Italy.	Alessia.Ciarrocchi@asmn.re.it	Ragazzi, Moira/J-5737-2018; PIANA, SIMONETTA/AAC-9158-2019; Sancisi, Valentina/H-6701-2018; Ciarrocchi, Alessia/AAA-1130-2019	Ragazzi, Moira/0000-0002-8761-9265; PIANA, SIMONETTA/0000-0003-4875-6977; Sancisi, Valentina/0000-0003-4357-1228; Ciarrocchi, Alessia/0000-0002-5541-2075; Gandolfi, Greta/0000-0001-7498-424X	Italian Association for Cancer Research (AIRC) [MFAG: 10745]; Guido Berlucchi Foundation	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Guido Berlucchi Foundation	This work was supported by grants from the Italian Association for Cancer Research (AIRC, MFAG: 10745)(http://www.airc.it/) and the Guido Berlucchi Foundation (http://www.fondazioneberlucchi.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Call G, 2012, ENDOCRINOLOGY, V153, P522, DOI 10.1210/en.2011-1572; Cheung PY, 2011, J CELL BIOCHEM, V112, P157, DOI 10.1002/jcb.22911; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Cho EA, 1998, DEVELOPMENT, V125, P803; Ciarrocchi A, 2011, EUR J CANCER, V47, P934, DOI 10.1016/j.ejca.2010.11.009; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Endo T, 2008, J CLIN ENDOCR METAB, V93, P2409, DOI 10.1210/jc.2007-2805; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue T, 1997, DEV BIOL, V183, P183, DOI 10.1006/dbio.1996.8501; Inoue YU, 2008, MOL CELL NEUROSCI, V39, P95, DOI 10.1016/j.mcn.2008.05.020; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Paul R, 1997, CANCER RES, V57, P2741; Paul R, 2004, J UROLOGY, V171, P97, DOI 10.1097/01.ju.0000101512.47242.79; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133; Sancisi V, 2012, J CLIN ENDOCR METAB, V97, pE2006, DOI 10.1210/jc.2012-1903; Shimazui T, 1998, CLIN CANCER RES, V4, P2419; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	42	49	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75489	10.1371/journal.pone.0075489	http://dx.doi.org/10.1371/journal.pone.0075489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069422	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100127
J	Pan, LR; Patterson, JC				Pan, Lurong; Patterson, James C.			Molecular Dynamics Study of Zn(A beta) and Zn(A beta)(2)	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ZINC-BINDING SITE; ALZHEIMER A-BETA; INDUCED AGGREGATION; 1ST-ROW ELEMENTS; METAL-BINDING; BASIS-SET; IN-VITRO; DISEASE; A-BETA-40	The aggregation of A beta-peptide (A beta) is widely considered to be the critical step in the pathology of Alzheimer's disease. Small, soluble A beta oligomers have been shown to be more neurotoxic than large, insoluble aggregates and fibrils. Recent studies suggest that biometal ions, including Zn(II), may play an important role in the aggregation process. Experimentally determining the details of the binding process is complicated by the kinetic lability of zinc. To study the dynamic nature of the zinc-bound A beta complexes and the potential mechanisms by which Zn(II) affects A beta oligomerization we have performed atomistic molecular dynamics (MD) simulations of Zn(A beta) and Zn(A beta)(2). The models were based on NMR data and predicted coordination environments from previous density functional theory calculations. When modeled as 4-coordinate covalently bound Zn(A beta)(n) complexes (where n = 1 or 2), zinc imposes conformational changes in the surrounding A beta residues. Moreover, zinc reduces the helix content and increases the random coil content of the full peptide. Although zinc binds at the N-terminus of A beta, beta-sheet formation is observed exclusively at the C-terminus in the Zn(A beta) and most of the Zn(A beta)(2) complexes. Furthermore, initial binding to zinc promotes the formation of intra-chain salt-bridges, while subsequent dissociation promotes the formation of inter-chain salt-bridges. These results suggest that Zn-binding to A beta accelerates the aggregation of A beta by unfolding the helical structure in A beta peptide and stabilizing the formation of vital salt-bridges within and between A beta peptides.	[Pan, Lurong; Patterson, James C.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Patterson, JC (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.	pattersj@uab.edu		Pan, Lurong/0000-0001-9321-8348	Department of Chemistry, University of Alabama at Birmingham	Department of Chemistry, University of Alabama at Birmingham	The work was supported by Department of Chemistry, University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2009, ALZHEIMERS DEMENT, V5, P3; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Beauchemin D, 1998, ANAL CHEM, V70, P1026, DOI 10.1021/ac970783f; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768530; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Deeth RJ, 2008, INORG CHEM, V47, P7377, DOI 10.1021/ic800628j; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Esler WP, 1996, J NEUROCHEM, V66, P723; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gaggelli E, 2008, J PHYS CHEM B, V112, P100, DOI 10.1021/jp075168m; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kozin SA, 2001, BIOCHEM BIOPH RES CO, V285, P959, DOI 10.1006/bbrc.2001.5284; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MacKerell AD, 2001, COMPUTATIONAL BIOCHEMISTRY AND BIOPHYSICS, P7; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mekmouche Y, 2005, CHEMBIOCHEM, V6, P1663, DOI 10.1002/cbic.200500057; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; PARR RG, 1979, P NATL ACAD SCI USA, V76, P2522, DOI 10.1073/pnas.76.6.2522; PETERSSON GA, 1988, J CHEM PHYS, V89, P2193, DOI 10.1063/1.460448; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajendran R, 2009, BIOCHEM BIOPH RES CO, V382, P91, DOI 10.1016/j.bbrc.2009.02.136; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shin BK, 2008, BIOCHEMISTRY-US, V47, P9117, DOI 10.1021/bi801014x; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Stellato F, 2006, EUR BIOPHYS J BIOPHY, V35, P340, DOI 10.1007/s00249-005-0041-7; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Talmard C, 2009, J BIOL INORG CHEM, V14, P449, DOI 10.1007/s00775-008-0461-9; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	56	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70681	10.1371/journal.pone.0070681	http://dx.doi.org/10.1371/journal.pone.0070681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086248	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900003
J	Van Hemelrijck, M; Garmo, H; Michaelsson, K; Thorstenson, A; Akre, O; Stattin, P; Holmberg, L; Adolfsson, J				Van Hemelrijck, Mieke; Garmo, Hans; Michaelsson, Karl; Thorstenson, Andreas; Akre, Olof; Stattin, Par; Holmberg, Lars; Adolfsson, Jan			Mortality following Hip Fracture in Men with Prostate Cancer	PLOS ONE			English	Article							SKELETAL-RELATED EVENTS; OSTEOPOROTIC FRACTURE; BONE METASTASIS; RISK; SURVIVAL; REGISTER; SWEDEN; WOMEN	Background: Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT. Methods: PCa dataBase Sweden (PCBaSe 2.0) is based on the National PCa Register and also contains age and county-matched PCa-free men. We selected all men (n = 14,205) who had been hospitalized with a hip fracture between 2006 and 2010; 2,300 men had a prior PCa diagnosis of whom 1,518 (66%) were on ADT prior to date of fracture. Risk of death was estimated with cumulative incidence and standardized mortality ratios (SMRs) to make comparisons with the entire PCa population and the general population. Results: Cumulative incidences indicated that there was a higher risk of death following a hip fracture for PCa men on ADT than for PCa men not on ADT or PCa-free men, particularly in the first year. The SMRs showed that PCa men on ADT with a hip fracture were 2.44 times more likely to die than the comparison cohort of all PCa men (95% CI: 2.29-2.60). This risk was especially increased during the first month (5.64 (95% CI: 4.16-7.48)). In absolute terms, hip fractures were associated with 20 additional deaths per 1,000 person-years in PCa men not on ADT, but 30 additional deaths per 1,000 person-years for PCa men on ADT, compared to all PCa men. Conclusion: Hip fractures are associated with higher all-cause mortality in PCa men on ADT than in PCa men not on ADT or PCa-free men, especially within the first three months.	[Van Hemelrijck, Mieke; Garmo, Hans; Holmberg, Lars] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England; [Van Hemelrijck, Mieke] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Garmo, Hans; Holmberg, Lars] Reg Canc Ctr, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Thorstenson, Andreas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Thorstenson, Andreas] Capio ST Gorans Hosp, Dept Surg, Urol Sect, Stockholm, Sweden; [Akre, Olof] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Adolfsson, Jan] Karolinska Insititutet, CLINTEC Dept, Stockholm, Sweden	University of London; King's College London; Karolinska Institutet; Uppsala University; Karolinska Institutet; Saint Goran's Hospital; Karolinska Institutet; Umea University; Memorial Sloan Kettering Cancer Center; Uppsala University; Karolinska Institutet	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England.	mieke.vanhemelrijck@kcl.ac.uk	Michaelsson, Karl/AAM-9094-2021	Adolfsson, Jan/0000-0003-2992-1869; Michaelsson, Karl/0000-0003-2815-1217; Van Hemelrijck, Mieke/0000-0002-7317-0858; Garmo, Hans/0000-0001-7181-7083	Swedish Research Council [825-2008-5910]; Swedish Council for Working Life and Social Research; Stockholm Cancer Society; Cancer Research-UK; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm Cancer Society; Cancer Research-UK(Cancer Research UK); Vasterbotten County Council	Funding came from the Swedish Research Council 825-2008-5910, the Swedish Council for Working Life and Social Research, Stockholm Cancer Society, Cancer Research-UK and Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Breslow N, 1987, IARC SCI PUBL, V82, P406; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Conti Giario, 2008, Arch Ital Urol Androl, V80, P59; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Gonzalez-Rozas M, 2012, AGING CLIN EXP RES, V24, P181; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hagel E, 2009, SCAND J UROL NEPHROL, V43, P342, DOI 10.3109/00365590903024577; Hakimian P, 2008, BJU INT; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Petrylak PJ, 2002, PROSTATE CANC PRINCI; Rothman KJGS., 2008, MEASURES EFFECT MEAS; Ryan CJ, 2007, CANCER-AM CANCER SOC, V110, P81, DOI 10.1002/cncr.22736; Sathiakumar N, 2011, PROSTATE CANCER P D, V14, P177, DOI 10.1038/pcan.2011.7; Sprenkle PC, 2007, CURR OPIN UROL, V17, P424, DOI 10.1097/MOU.0b013e3282f0ebef; The National Board of Health and Wealth Fare, 2010, SWED PRESCR DRUG REG; The National Board of Health and Welfare, 2007, STAT AR HLTH MED CAR; Thorstenson A, 2012, EUR J CANC; Thorstenson A, 2012, EUR J CANCER, V48, P1672, DOI 10.1016/j.ejca.2012.01.035; Valizadeh M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-143; Van Hemelrijck M, 2012, INT J EPIDE IN PRESS; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567; Van Hemelrijck M, 2010, LANCET ONCOL, V11, P450, DOI 10.1016/S1470-2045(10)70038-3; Zar N, 2008, EUR J CANCER, V44, P718, DOI 10.1016/j.ejca.2007.12.003	30	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74492	10.1371/journal.pone.0074492	http://dx.doi.org/10.1371/journal.pone.0074492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086350	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900027
J	Lowther, AD; Harcourt, RG; Page, B; Goldsworthy, SD				Lowther, Andrew D.; Harcourt, Robert G.; Page, Bradley; Goldsworthy, Simon D.			Steady as He Goes: At-Sea Movement of Adult Male Australian Sea Lions in a Dynamic Marine Environment	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; STABLE-ISOTOPES; NEW-ZEALAND; FORAGING BEHAVIOR; SURFACE TEMPERATURES; SATELLITE TELEMETRY; HABITAT SELECTION; ELEPHANT SEALS; STRATEGIES; ECOLOGY	The southern coastline of Australia forms part of the worlds' only northern boundary current system. The Bonney Upwelling occurs every austral summer along the south-eastern South Australian coastline, a region that hosts over 80% of the worlds population of an endangered endemic otariid, the Australian sea lion. We present the first data on the movement characteristics and foraging behaviour of adult male Australian sea lions across their South Australian range. Synthesizing telemetric, oceanographic and isotopic datasets collected from seven individuals enabled us to characterise individual foraging behaviour over an approximate two year time period. Data suggested seasonal variability in stable carbon and nitrogen isotopes that could not be otherwise explained by changes in animal movement patterns. Similarly, animals did not change their foraging patterns despite fine-scale spatial and temporal variability of the upwelling event. Individual males tended to return to the same colony at which they were tagged and utilized the same at-sea regions for foraging irrespective of oceanographic conditions or time of year. Our study contrasts current general assumptions that male otariid life history strategies should result in greater dispersal, with adult male Australian sea lions displaying central place foraging behaviour similar to males of other otariid species in the region.	[Lowther, Andrew D.; Goldsworthy, Simon D.] SARDI Aquat Sci, Threatened Endangered & Protected Species, Adelaide, SA, Australia; [Harcourt, Robert G.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Page, Bradley] Dept Environm Water & Nat Resources, Sci Monitoring & Knowledge Branch, Adelaide, SA, Australia	Macquarie University	Lowther, AD (corresponding author), Norwegian Polar Res Inst, Biodivers Sect, Tromso, Norway.	Andrew.Lowther@npolar.no	Lowther, Andrew/T-2511-2019	Lowther, Andrew/0000-0003-4294-3157; Harcourt, Robert/0000-0003-4666-2934; Goldsworthy, Simon/0000-0003-4988-9085	Integrated Marine Observing System (IMOS); Australian Government through the National Collaborative Research Infrastructure Strategy; Super Science Initiative	Integrated Marine Observing System (IMOS); Australian Government through the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Super Science Initiative	Funding was received from the Integrated Marine Observing System (IMOS) - IMOS is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy and the Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Awkerman JA, 2007, CAN J ZOOL, V85, P273, DOI 10.1139/Z06-202; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Bailleul F, 2010, ECOLOGICAL MODELLING; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; Calenge C., 2011, HOME RANGE ESTIMATIO; CAMPAGNA C, 1995, J ZOOL, V236, P55, DOI 10.1111/j.1469-7998.1995.tb01784.x; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Crocker DE, 2001, J ZOOL, V254, P267, DOI 10.1017/S0952836901000784; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Cronin MA, 2008, J EXP MAR BIOL ECOL, V362, P43, DOI 10.1016/j.jembe.2008.05.010; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Field I, 2002, ANTARCTIC S IN PRESS, V13; Forero MG, 2003, SCI MAR, V67, P23, DOI 10.3989/scimar.2003.67s223; Freitas C, 2008, J APPL ECOL, V45, P1213, DOI 10.1111/j.1365-2664.2008.01505.x; Freitas C, 2009, MAR ECOL PROG SER, V375, P247, DOI 10.3354/meps07725; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Gales NJ, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P78; Gardner G, 1980, J R STAT SOC SER C A, V29, P311, DOI [10.2307/2346910, DOI 10.2307/2346910]; Gentry R.L., 1986, FUR SEALS MATERNAL S; Gentry RL, 1986, FUR SEALS MATERNAL S, P220; Georges JY, 2000, MAR ECOL PROG SER, V196, P291, DOI 10.3354/meps196291; Goldsworthy S, 2008, NEOPHOCA CINEREA IUC; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Guinet C, 1997, MAR ECOL PROG SER, V150, P11, DOI 10.3354/meps150011; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hanson CE, 2005, MAR FRESHWATER RES, V56, P1011, DOI 10.1071/MF04288; Harcourt RG, 2002, MAR ECOL PROG SER, V227, P11, DOI 10.3354/meps227011; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Hindell MA, 2002, MAR ECOL PROG SER, V242, P275, DOI 10.3354/meps242275; Hindell MA, 1997, MAR MAMMAL SCI, V13, P219, DOI 10.1111/j.1748-7692.1997.tb00629.x; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Huyer A, 2005, J MAR RES, V63, P901, DOI 10.1357/002224005774464238; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kampf J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019221; Kirkwood R, 2006, CAN J ZOOL, V84, P1781, DOI 10.1139/Z06-164; Klimley AP, 1999, MAR BIOL, V133, P307, DOI 10.1007/s002270050469; Langton Richard W., 1995, Reviews in Fisheries Science, V3, P201; Le Boeuf Burney J., 1994, P237; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Longhlin TR, 1999, UASGCP REP, V99, P615; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Lowther AD, 2010, MARINE MAMMAL SCI, V27; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; McClatchie S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002699; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McDougall T., 2010, INT THERMODYNAMIC EQ; Menge BA, 2004, ECOL MONOGR, V74, P663, DOI 10.1890/03-4060; Menge BA, 2002, ECOL RES, V17, P1, DOI 10.1046/j.1440-1703.2002.00458.x; Middleton JF, 2007, PROG OCEANOGR, V75, P1, DOI 10.1016/j.pocean.2007.07.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Nordstrom CA, 2012, DEEP SEA RES 2; OLSON DB, 1985, J MAR RES, V43, P113, DOI 10.1357/002224085788437325; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Rochford D, 1977, REV POSSIBLE UPWELLI; Rudnick DL, 1999, SCIENCE, V283, P526, DOI 10.1126/science.283.5401.526; Schlitzer R, 2002, COMPUT GEOSCI-UK, V28, P1211, DOI 10.1016/S0098-3004(02)00040-7; Schneider D.C., 1990, Polar Research, V8, P17, DOI 10.1111/j.1751-8369.1990.tb00370.x; SCHOENHERR JR, 1991, CAN J ZOOL, V69, P583, DOI 10.1139/z91-088; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whiteway T., 2009, AUSTR BATHYMETRY TOP, DOI DOI 10.4225/25/53D99B6581B9A; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	88	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74348	10.1371/journal.pone.0074348	http://dx.doi.org/10.1371/journal.pone.0074348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086338	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700023
J	Youssar, L; Gruning, BA; Gunther, S; Huttel, W				Youssar, Loubna; Gruening, Bjoern Andreas; Guenther, Stefan; Huettel, Wolfgang			Characterization and Phylogenetic Analysis of the Mitochondrial Genome of Glarea lozoyensis Indicates High Diversity within the Order Helotiales	PLOS ONE			English	Article							TRANSFER-RNA GENES; GROUP-I INTRON; HOMING ENDONUCLEASES; ZALERION-ARBORICOLA; EVOLUTION; SEQUENCE; DNA; FUNGI; PROGRAM; IDENTIFICATION	Background: Glarea lozoyensis is a filamentous fungus used for the industrial production of non-ribosomal peptide pneumocandin B-0. In the scope of a whole genome sequencing the complete mitochondrial genome of the fungus has been assembled and annotated. It is the first one of the large polyphyletic Helotiaceae family. A phylogenetic analysis was performed based on conserved proteins of the oxidative phosphorylation system in mitochondrial genomes. Results: The total size of the mitochondrial genome is 45,038 bp. It contains the expected 14 genes coding for proteins related to oxidative phosphorylation, two rRNA genes, six hypothetical proteins, three intronic genes of which two are homing endonucleases and a ribosomal protein rps3. Additionally there is a set of 33 tRNA genes. All genes are located on the same strand. Phylogenetic analyses based on concatenated mitochondrial protein sequences confirmed that G. lozoyensis belongs to the order of Helotiales and that it is most closely related to Phialocephala subalpina. However, a comparison with the three other mitochondrial genomes known from Helotialean species revealed remarkable differences in size, gene content and sequence. Moreover, it was found that the gene order found in P. subalpina and Sclerotinia sclerotiorum is not conserved in G. lozoyensis. Conclusion: The arrangement of genes and other differences found between the mitochondrial genome of G. lozoyensis and those of other Helotiales indicates a broad genetic diversity within this large order. Further mitochondrial genomes are required in order to determine whether there is a continuous transition between the different forms of mitochondrial genomes or G. lozoyensis belongs to a distinct subgroup within Helotiales.	[Youssar, Loubna; Gruening, Bjoern Andreas; Guenther, Stefan; Huettel, Wolfgang] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany	University of Freiburg	Youssar, L (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	lyoussar@gmail.com	Günther, Stefan/AAY-8944-2020; Huettel, Wolfgang/B-3095-2016	Huttel, Wolfgang/0000-0002-7842-6365; Gruning, Bjorn/0000-0002-3079-6586	Alexander von Humboldt Research Fellowship; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	L.Y. was supported by an Alexander von Humboldt Research Fellowship. The project was supported partially by the German Research Foundation (DFG). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bertrand H, 2000, ANNU REV PHYTOPATHOL, V38, P397, DOI 10.1146/annurev.phyto.38.1.397; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; CLARKWALKER GD, 1992, INT REV CYTOL, V141, P89, DOI 10.1016/S0074-7696(08)62064-1; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Duo A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-166; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Ferandon C, 2010, PLOS ONE, V18, P11; FOX TD, 1987, ANNU REV GENET, V21, P67, DOI 10.1146/annurev.ge.21.120187.000435; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Ghikas DV, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-174; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Guhan N, 2003, CRIT REV BIOCHEM MOL, V38, P199, DOI 10.1080/713609235; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Keating GM, 2003, DRUGS, V63, P2235, DOI 10.2165/00003495-200363200-00008; KIRK PM, 2001, DICT FUNGI; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; Korab-Laskowska M, 1998, NUCLEIC ACIDS RES, V26, P138, DOI 10.1093/nar/26.1.138; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MASUREKAR PS, 1992, J ANTIBIOT, V45, P1867, DOI 10.7164/antibiotics.45.1867; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1996, J MOL BIOL, V255, P688, DOI 10.1006/jmbi.1996.0056; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pelaez F., 2011, Mycology - An International Journal on Fungal Biology, V2, P1, DOI 10.1080/21501203.2010.544334; Pellenz S, 2002, J MOL EVOL, V55, P302, DOI 10.1007/s00239-001-2327-4; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Schafer B, 2003, CURR GENET, V43, P311, DOI 10.1007/s00294-003-0404-5; SCHWARTZ RE, 1992, J ANTIBIOT, V45, P1853, DOI 10.7164/antibiotics.45.1853; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sideris E G, 1988, Prog Clin Biol Res, V259, P13; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; van Diepeningen AD, 2010, MECH AGEING DEV, V131, P315, DOI 10.1016/j.mad.2010.03.001; Woo PCY, 2003, FEBS LETT, V555, P469, DOI 10.1016/S0014-5793(03)01307-3; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Youssar L, 2012, EUKARYOT CELL, V11, P250, DOI 10.1128/EC.05302-11; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	65	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74792	10.1371/journal.pone.0074792	http://dx.doi.org/10.1371/journal.pone.0074792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086376	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700038
J	Parey, K; Demmer, U; Warkentin, E; Wynen, A; Ermler, U; Dahl, C				Parey, Kristian; Demmer, Ulrike; Warkentin, Eberhard; Wynen, Astrid; Ermler, Ulrich; Dahl, Christiane			Structural, Biochemical and Genetic Characterization of Dissimilatory ATP Sulfurylase from Allochromatium vinosum	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATE SULFURYLASE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; CHROMATIUM-VINOSUM; RIFTIA-PACHYPTILA; AQUIFEX-AEOLICUS; MUTAGENESIS	ATP sulfurylase (ATPS) catalyzes a key reaction in the global sulfur cycle by reversibly converting inorganic sulfate (SO42-) with ATP to adenosine 5'-phosphosulfate (APS) and pyrophosphate (PPi). In this work we report on the sat encoded dissimilatory ATP sulfurylase from the sulfur-oxidizing purple sulfur bacterium Allochromatium vinosum. In this organism, the sat gene is located in one operon and co-transcribed with the aprMBA genes for membrane-bound APS reductase. Like APS reductase, Sat is dispensible for growth on reduced sulfur compounds due to the presence of an alternate, so far unidentified sulfite-oxidizing pathway in A. vinosum. Sulfate assimilation also proceeds independently of Sat by a separate pathway involving a cysDN-encoded assimilatory ATP sulfurylase. We produced the purple bacterial sat-encoded ATP sulfurylase as a recombinant protein in E. coli, determined crucial kinetic parameters and obtained a crystal structure in an open state with a ligand-free active site. By comparison with several known structures of the ATPS-APS complex in the closed state a scenario about substrate-induced conformational changes was worked out. Despite different kinetic properties ATPS involved in sulfur-oxidizing and sulfate-reducing processes are not distinguishable on a structural level presumably due to the interference between functional and evolutionary processes.	[Parey, Kristian; Demmer, Ulrike; Warkentin, Eberhard; Ermler, Ulrich] Max Planck Inst Biophys, Frankfurt, Germany; [Parey, Kristian] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Wynen, Astrid; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany	Max Planck Society; University of Regensburg; University of Bonn	Wynen, A (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany.	ulrich.ermler@mpibp-frankfurt.mpg.de	Dahl, Christiane/H-4786-2019	Dahl, Christiane/0000-0001-8288-7546; Parey, Kristian/0000-0002-4842-6479	Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck Society and the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beynon JD, 2001, BIOCHEMISTRY-US, V40, P14509, DOI 10.1021/bi015643l; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAHL C, 1994, METHOD ENZYMOL, V243, P400; Dahl C, 1996, MICROBIOL-SGM, V142, P3363, DOI 10.1099/13500872-142-12-3363; Deyrup AT, 1999, J BIOL CHEM, V274, P28929, DOI 10.1074/jbc.274.41.28929; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; Friedrich CG, 1998, ADV MICROB PHYSIOL, V39, P235; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Fritz G, 2005, J MOL MICROB BIOTECH, V10, P223, DOI 10.1159/000091567; Gavel OY, 1998, BIOCHEMISTRY-US, V37, P16225, DOI 10.1021/bi9816709; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Hanna E, 2002, ARCH BIOCHEM BIOPHYS, V406, P275, DOI 10.1016/S0003-9861(02)00428-9; HANSEN TA, 1994, ANTON LEEUW INT J G, V66, P165, DOI 10.1007/BF00871638; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karamohamed S, 1999, PROTEIN EXPRES PURIF, V15, P381, DOI 10.1006/prep.1999.1032; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LEYH TS, 1988, J BIOL CHEM, V263, P2409; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; Logan HM, 1996, J BIOL CHEM, V271, P12227, DOI 10.1074/jbc.271.21.12227; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann S, 2000, MOL BIOL REP, V27, P27, DOI 10.1023/A:1007058421714; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; PATTARAGULWANIT K, 1995, ARCH MICROBIOL, V164, P217, DOI 10.1007/BF02529974; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; Postgate JR, 1984, SULPHATE REDUCING BA, V2nd; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Ramos AR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00137; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V290, P66, DOI 10.1016/0003-9861(91)90592-7; Rodriguez J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00112; Sanchez O, 2001, ARCH MICROBIOL, V176, P301, DOI 10.1007/s002030100327; Schwenn Jens D., 1997, P39; SEGEL IH, 1987, METHOD ENZYMOL, V143, P334; SEUBERT PA, 1985, ARCH BIOCHEM BIOPHYS, V240, P509, DOI 10.1016/0003-9861(85)90057-8; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Taguchi Y, 2004, BIOCHEMISTRY-US, V43, P4111, DOI 10.1021/bi036052t; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ullrich TC, 2001, J MOL BIOL, V313, P1117, DOI 10.1006/jmbi.2001.5098; Ullrich TC, 2001, EMBO J, V20, P316, DOI 10.1093/emboj/20.3.316; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; Weissgerber T, 2011, STAND GENOMIC SCI, V5, P311, DOI 10.4056/sigs.2335270; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	51	27	28	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74707	10.1371/journal.pone.0074707	http://dx.doi.org/10.1371/journal.pone.0074707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073218	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000027
J	Kashyap, RS; Nayak, AR; Gaherwar, HM; Bhullar, SS; Husain, AA; Shekhawat, SD; Jain, RK; Gaikwad, SS; Satav, AR; Purohit, HJ; Taori, GM; Daginawala, HF				Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Bhullar, Shraddha S.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Gaikwad, Sonali S.; Satav, Ashish R.; Purohit, Hemant J.; Taori, Girdhar M.; Daginawala, Hatim F.			Laboratory Investigations on the Diagnosis of Tuberculosis in the Malnourished Tribal Population of Melghat, India	PLOS ONE			English	Article							ANTIGEN-85 COMPLEX; MYCOBACTERIUM-TUBERCULOSIS; INDIRECT ELISA; SUPPLEMENTATION; MALNUTRITION; MENINGITIS; RESPONSES; BLOOD; BCG	Background: Malnutrition is a major risk factor for the development of tuberculosis (TB). In India, Melghat is among the tribal regions which consist of highest number of malnutrition cases. Because of the paucity of TB data from these malnourished areas there is an urgent need for the development and evaluation of improved TB diagnostic tests. In the present study, three in house developed diagnostic tests namely TB-Ag(antigen) ELISA, Adenosine deaminase (ADA) estimation and IS6110 polymerase chain reaction (PCR) assay were investigated for the detection of Mycobacterium tuberculosis (M. tb.) infection. Methods: For investigation, blood samples were collected from 128 study subjects from six villages of Melghat tribal area and evaluated using three in house developed assays, namely TB-Ag ELISA, ADA estimation and IS6110 PCR. Results: The TB-Ag ELISA method yielded 83% sensitivity and 94% specificity. The ADA and PCR assay gave a sensitivity of 61% and 49% and specificity of 62% and 98% respectively. A considerable good agreement of 82.81% (k=0.472) between TB-Ag ELISA and PCR was observed. The overall sensitivity of TB-Ag ELISA was significantly higher (p<0.05) than the ADA and PCR while PCR yielded highest specificity among all the three evaluated tests. Conclusions: We concluded that the routine use of TB-Ag ELISA can be useful for screening of suspected TB patients in the malnourished population where sophisticated laboratory set up is difficult.	[Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Bhullar, Shraddha S.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Gaikwad, Sonali S.; Taori, Girdhar M.; Daginawala, Hatim F.] Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India; [Purohit, Hemant J.] CO Mahatma Gandhi Tribal Hosp, Meditat AIDS Hlth Addict & Nutr MAHAN Trust, Amaravati, Maharashtra, India; [Satav, Ashish R.] Natl Environm Engn Res Inst, Environm Genom Unit, Nagpur 440020, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI)	Kashyap, RS (corresponding author), Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India.	raj_ciims@rediffmail.com	Kashyap, Rajpal/AAP-8461-2020		Central India Institute of Medical Sciences, Nagpur	Central India Institute of Medical Sciences, Nagpur	This work was supported by Central India Institute of Medical Sciences, Nagpur. The funders had also supported in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1995, J ISLAMIC ACAD SCI, V8, P155; Ahmed N, 1998, J CLIN MICROBIOL, V36, P3094, DOI 10.1128/JCM.36.10.3094-3095.1998; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Condos R, 1996, LANCET, V347, P1082, DOI 10.1016/S0140-6736(96)90281-0; da Silva EB, 2011, VET J, V187, P276, DOI 10.1016/j.tvjl.2009.11.017; Deshpande PS, 2007, FLUIDS BARRIERS CNS, V4, DOI 10.1186/1743-8454-4-10; GiustiG HV, 1974, METHODS ENZYMATIC AN, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Kashyap RS, 2010, BIOMARK INSIGHTS, V5, P87; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Kashyap RS, 2006, CEREBROSPINAL FLUID, V3, P1, DOI 10.1186/1743-8454-3-5; Kumar G, 2010, ARCH IMMUNOL THER EX, V58, P57, DOI 10.1007/s00005-009-0055-4; Launois P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/640309; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Meena LS, 2002, J CLIN LAB ANAL, V16, P151, DOI 10.1002/jcla.10031; Nagdev KJ, 2010, INT J TUBERC LUNG D, V14, P1032; Nagdev KJ, 2010, MED SCI MONITOR, V16, pCR289; Schmidt CW, 2008, ENVIRON HEALTH PERSP, V116, pA478, DOI 10.1289/ehp.116-a478; Singh R, 2008, STUD TRIBES TRIBALS, V6, P35; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Wallis RS, 1998, J INFECT DIS, V178, P1115, DOI 10.1086/515701; Webb AL, 2007, NUTR REV, V65, P181, DOI 10.1111/j.1753-4887.2007.tb00298.x; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74652	10.1371/journal.pone.0074652	http://dx.doi.org/10.1371/journal.pone.0074652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069327	gold, Green Submitted, Green Published			2022-12-25	WOS:000326240100114
J	Mailu, BM; Ramasamay, G; Mudeppa, DG; Li, L; Lindner, SE; Peterson, MJ; DeRocher, AE; Kappe, SHI; Rathod, PK; Gardner, MJ				Mailu, Boniface M.; Ramasamay, Gowthaman; Mudeppa, Devaraja G.; Li, Ling; Lindner, Scott E.; Peterson, Megan J.; DeRocher, Amy E.; Kappe, Stefan H. I.; Rathod, Pradipsinh K.; Gardner, Malcolm J.			A Nondiscriminating Glutamyl-tRNA Synthetase in the Plasmodium Apicoplast THE FIRST ENZYME IN AN INDIRECT AMINOACYLATION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthetase; Malaria; Nucleic Acid Enzymology; Plasmodium; Transfer RNA (tRNA); Apicoplast	MULTIPLE SEQUENCE ALIGNMENTS; ZINC-BINDING SITE; ESCHERICHIA-COLI; AMINO-ACID; GENOME SEQUENCE; ANTICODON RECOGNITION; HELICOBACTER-PYLORI; MALARIA PARASITES; STRUCTURAL BASIS; CIRCULAR DNA	The malaria parasite Plasmodium falciparum and related organisms possess a relict plastid known as the apicoplast. Apicoplast protein synthesis is a validated drug target in malaria because antibiotics that inhibit translation in prokaryotes also inhibit apicoplast protein synthesis and are sometimes used for malaria prophylaxis or treatment. We identified components of an indirect aminoacylation pathway for Gln-tRNA(Gln) biosynthesis in Plasmodium that we hypothesized would be essential for apicoplast protein synthesis. Here, we report our characterization of the first enzyme in this pathway, the apicoplast glutamyl-tRNA synthetase (GluRS). We expressed the recombinant P. falciparum enzyme in Escherichia coli, showed that it is nondiscriminating because it glutamylates both apicoplast tRNA(Glu) and tRNA(Gln), determined its kinetic parameters, and demonstrated its inhibition by a known bacterial GluRS inhibitor. We also localized the Plasmodium berghei ortholog to the apicoplast in blood stage parasites but could not delete the PbGluRS gene. These data show that Gln-tRNA(Gln) biosynthesis in the Plasmodium apicoplast proceeds via an essential indirect aminoacylation pathway that is reminiscent of bacteria and plastids.	[Peterson, Megan J.; DeRocher, Amy E.; Kappe, Stefan H. I.; Gardner, Malcolm J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Mudeppa, Devaraja G.; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Kappe, Stefan H. I.; Rathod, Pradipsinh K.; Gardner, Malcolm J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gardner, MJ (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N,Ste 500, Seattle, WA 98109 USA.	malcolm.gardner@seattlebiomed.org			National Institutes of Health Grant from the NIAID [R21AI81097]; Murdock Trust; Seattle Biomedical Research Institute; Puget Sound Partners for Global Health;  [AI 093380];  [AI 099280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093380, R21AI081097, R01AI099280] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIAID; Murdock Trust; Seattle Biomedical Research Institute; Puget Sound Partners for Global Health; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI81097 from the NIAID (to M. J. G.) and Grants AI 093380 and AI 099280 (to P. K. R.). This work was also supported by the Murdock Trust, Seattle Biomedical Research Institute, and Puget Sound Partners for Global Health (to M. J. G.).	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baick JW, 2004, J MICROBIOL, V42, P111; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Banerjee R, 2004, EUR J BIOCHEM, V271, P724, DOI 10.1111/j.1432-1033.2003.03976.x; Bernier S, 2005, J ENZYM INHIB MED CH, V20, P61, DOI 10.1080/14756360400002007; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brown P, 1999, BIOORGAN MED CHEM, V7, P2473, DOI 10.1016/S0968-0896(99)00192-3; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; FREIST W, 1989, EUR J BIOCHEM, V186, P535, DOI 10.1111/j.1432-1033.1989.tb15239.x; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V44, P115, DOI 10.1016/0166-6851(91)90227-W; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V48, P77, DOI 10.1016/0166-6851(91)90166-4; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GEARY TG, 1983, AM J TROP MED HYG, V32, P221, DOI 10.4269/ajtmh.1983.32.221; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GINSBURG H, 1986, J PROTOZOOL, V33, P121, DOI 10.1111/j.1550-7408.1986.tb05570.x; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunther S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005510; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Hoen R, 2013, CHEMBIOCHEM, V14, P499, DOI 10.1002/cbic.201200620; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Huot JL, 2011, NUCLEIC ACIDS RES, V39, P9306, DOI 10.1093/nar/gkr619; ILAN J, 1969, SCIENCE, V164, P560, DOI 10.1126/science.164.3879.560; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Ito T, 2010, NATURE, V467, P612, DOI 10.1038/nature09411; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jortzik E, 2011, BIOCHEM J, V436, P641, DOI 10.1042/BJ20110170; Katz A, 2010, BIOCHEM BIOPH RES CO, V398, P51, DOI 10.1016/j.bbrc.2010.06.031; Khan S., 2013, PLOS ONE, V8; Khan S, 2013, ACTA CRYSTALLOGR D, V69, P785, DOI 10.1107/S0907444913001923; Koh CY, 2013, MOL BIOCHEM PARASIT, V189, P26, DOI 10.1016/j.molbiopara.2013.04.007; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lee J, 2004, J MOL BIOL, V344, P1167, DOI 10.1016/j.jmb.2004.10.013; LIU JH, 1995, J BIOL CHEM, V270, P15162, DOI 10.1074/jbc.270.25.15162; Lv PC, 2012, CURR MED CHEM, V19, P3550, DOI 10.2174/092986712801323199; MASSON JM, 1986, GENE, V47, P179, DOI 10.1016/0378-1119(86)90061-2; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Mikolajczak SA, 2008, MOL BIOCHEM PARASIT, V158, P213, DOI 10.1016/j.molbiopara.2007.12.006; Mudeppa DG, 2007, MOL BIOCHEM PARASIT, V151, P216, DOI 10.1016/j.molbiopara.2006.10.016; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Pedroni MJ, 2012, EXP PARASITOL, V131, P261, DOI 10.1016/j.exppara.2012.04.013; Pino P, 2010, MOL MICROBIOL, V76, P706, DOI 10.1111/j.1365-2958.2010.07128.x; Puri SK, 2000, EXP PARASITOL, V94, P8, DOI 10.1006/expr.1999.4465; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Saad NY, 2012, J BIOL CHEM, V287, P20382, DOI 10.1074/jbc.M111.332304; Schulze JO, 2006, J MOL BIOL, V361, P888, DOI 10.1016/j.jmb.2006.06.054; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sullivan M, 2000, MOL BIOCHEM PARASIT, V109, P17, DOI 10.1016/S0166-6851(00)00226-7; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; World Health Organization, 2010, GUID TREATM TUB, P53; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	108	14	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32539	32552		10.1074/jbc.M113.507467	http://dx.doi.org/10.1074/jbc.M113.507467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072705	Green Published, hybrid			2022-12-25	WOS:000328681700037
J	Noval, MG; Gallo, M; Perrone, S; Salvay, AG; Chemes, LB; de Prat-Gay, G				Noval, Maria G.; Gallo, Mariana; Perrone, Sebastian; Salvay, Andres G.; Chemes, Lucia B.; de Prat-Gay, Gonzalo			Conformational Dissection of a Viral Intrinsically Disordered Domain Involved in Cellular Transformation	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; HUMAN PAPILLOMAVIRUS-E7 PROTEIN; POLYPROLINE-II; IONIZABLE GROUPS; STRUCTURAL BASIS; MOLECULAR-BASIS; E7 ONCOPROTEIN; ADENOVIRUS E1A; PK VALUES; RECOGNITION	Intrinsic disorder is abundant in viral genomes and provides conformational plasticity to its protein products. In order to gain insight into its structure-function relationships, we carried out a comprehensive analysis of structural propensities within the intrinsically disordered N-terminal domain from the human papillomavirus type-16 E7 oncoprotein (E7N). Two E7N segments located within the conserved CR1 and CR2 regions present transient alpha-helix structure. The helix in the CR1 region spans residues L8 to L13 and overlaps with the E2F mimic linear motif. The second helix, located within the highly acidic CR2 region, presents a pH-dependent structural transition. At neutral pH the helix spans residues P17 to N29, which include the retinoblastoma tumor suppressor LxCxE binding motif (residues 21-29), while the acidic CKII-PEST region spanning residues E33 to I38 populates polyproline type II (PII) structure. At pH 5.0, the CR2 helix propagates up to residue I38 at the expense of loss of PII due to charge neutralization of acidic residues. Using truncated forms of HPV-16 E7, we confirmed that pH-induced changes in alpha-helix content are governed by the intrinsically disordered E7N domain. Interestingly, while at both pH the region encompassing the LxCxE motif adopts alpha-helical structure, the isolated 21-29 fragment including this stretch is unable to populate an alpha-helix even at high TFE concentrations. Thus, the E7N domain can populate dynamic but discrete structural ensembles by sampling alpha-helix-coil-PII-beta-sheet structures. This high plasticity may modulate the exposure of linear binding motifs responsible for its multi-target binding properties, leading to interference with key cell signaling pathways and eventually to cellular transformation by the virus.	[Noval, Maria G.; Perrone, Sebastian; Chemes, Lucia B.; de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; [Noval, Maria G.; Gallo, Mariana; Perrone, Sebastian; Chemes, Lucia B.; de Prat-Gay, Gonzalo] Consejo Nacl Invest Cient & Tecn, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Gallo, Mariana] Fdn Inst Leloir, NMR Lab, Buenos Aires, DF, Argentina; [Salvay, Andres G.] Univ Nacl La Plata, Inst Phys Liquids & Biol Syst, La Plata, Buenos Aires, Argentina; [Salvay, Andres G.] Univ Nacl Quilmes, Dept Sci & Technol, Bernal, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; National University of La Plata	de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar	Noval, Maria Gabriela/GLV-0239-2022; Perrone, Sebastian/Z-4825-2019; Salvay, Andrés Gerardo/AAC-8505-2021	Prat Gay, Gonzalo/0000-0001-5748-6863; Salvay, Andres/0000-0003-4020-1336; Chemes, Lucia Beatriz/0000-0003-0192-9906; Gallo, Mariana/0000-0002-0022-4499	Instituto Nacional del Cancer-Ministerio de Salud-Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Instituto Nacional del Cancer-Ministerio de Salud-Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Instituto Nacional del Cancer-Ministerio de Salud-Argentina (Basic Research Grant 2012-2014) (http://www.msal.gov.ar/inc/). MGN holds a graduate fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). MG, AGS, LBC and GPG are career researchers from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2006, BIOCHEMISTRY-US, V45, P657, DOI 10.1021/bi0522549; Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chemes LB, 2012, WILEY SER PROTEIN P, P313; Chemes LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047661; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Chen K, 2004, P NATL ACAD SCI USA, V101, P15352, DOI 10.1073/pnas.0406657101; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fassolari M, 2013, J BIOL CHEM, V288, P13110, DOI 10.1074/jbc.M112.444554; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Howley Peter M., 1996, P947; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kashtanov Stepan, 2012, Methods Mol Biol, V895, P139, DOI 10.1007/978-1-61779-927-3_11; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Ma K, 1999, J AM CHEM SOC, V121, P8698, DOI 10.1021/ja990864o; Makowska J, 2007, BIOPHYS J, V92, P2904, DOI 10.1529/biophysj.106.097550; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; Meszaros B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046829; Mikhonin AV, 2005, J AM CHEM SOC, V127, P7712, DOI 10.1021/ja044636s; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MUNGER K, 1993, BIOCHIM BIOPHYS ACTA, V1155, P111, DOI 10.1016/0304-419X(93)90025-8; NICOLAUJUNIOR N, 2013, J MOL MODEL IN PRESS; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Salvay Andres G, 2012, Methods Mol Biol, V896, P91, DOI 10.1007/978-1-4614-3704-8_6; Schmidt JM, 2011, PROTEINS, V79, P428, DOI 10.1002/prot.22893; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Smal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036457; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; Stubenrauch F, 1999, SEMIN CANCER BIOL, V9, P379, DOI 10.1006/scbi.1999.0141; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2012, WILEY SER PROTEIN P, pIX; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; UVERSKY VN, 2012, BIOCHIM BIOPHYS ACTA, V1834, P932; Uversky VN, 2012, METHODS MOL BIOL, V1; VUISTER GW, 1993, J BIOMOL NMR, V3, P67; WHISHART DS, 1994, NUCL MAGNETIC RESONA, V293, P363; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	78	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72760	10.1371/journal.pone.0072760	http://dx.doi.org/10.1371/journal.pone.0072760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086265	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900009
J	Fassett, JT; Xu, X; Kwak, D; Wang, H; Liu, XY; Hu, XL; Bache, RJ; Chen, YJ				Fassett, John T.; Xu, Xin; Kwak, Dongmin; Wang, Huan; Liu, Xiaoyu; Hu, Xinli; Bache, Robert J.; Chen, Yingjie			Microtubule Actin Cross-Linking Factor 1 Regulates Cardiomyocyte Microtubule Distribution and Adaptation to Hemodynamic Overload	PLOS ONE			English	Article							KINASE-C-ALPHA; CONTRACTILE DYSFUNCTION; CYTOSKELETAL ROLE; PROTEINS; DYNAMICS; MICE; LOCALIZATION; MIGRATION; PLAKIN; ADULT	Aberrant cardiomyocyte microtubule growth is a feature of pressure overload induced cardiac hypertrophy believed to contribute to left ventricular (LV) dysfunction. Microtubule Actin Cross-linking Factor 1 (MACF1/Acf7) is a 600 kd spectraplakin that stabilizes and guides microtubule growth along actin filaments. MACF1 is expressed in the heart, but its impact on cardiac microtubules, and how this influences cardiac structure, function, and adaptation to hemodynamic overload is unknown. Here we used inducible cardiac-specific MACF1 knockout mice (MACF1 KO) to determine the impact of MACF1 on cardiac microtubules and adaptation to pressure overload (transverse aortic constriction (TAC). In adult mouse hearts, MACF1 expression was low under basal conditions, but increased significantly in response to TAC. While MACF1 KO had no observable effect on heart size or function under basal conditions, MACF1 KO exacerbated TAC induced LV hypertrophy, LV dilation and contractile dysfunction. Interestingly, subcellular fractionation of ventricular lysates revealed that MACF1 KO altered microtubule distribution in response to TAC, so that more tubulin was associated with the cell membrane fraction. Moreover, TAC induced microtubule redistribution into this cell membrane fraction in both WT and MACF1 KO mice correlated strikingly with the level of contractile dysfunction (r(2) = 0.786, p < .001). MACF1 disruption also resulted in reduction of membrane caveolin 3 levels, and increased levels of membrane PKC alpha and beta 1 integrin after TAC, suggesting MACF1 function is important for spatial regulation of several physiologically relevant signaling proteins during hypertrophy. Together, these data identify for the first time, a role for MACF1 in cardiomyocyte microtubule distribution and in adaptation to hemodynamic overload.	[Chen, Yingjie] Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chen, YJ (corresponding author), Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	chenx106@umn.edu	Chen, Yingjie/AAX-5295-2020; Bache, Robert/AAW-7602-2021	Chen, Yingjie/0000-0002-4059-7847; 	United States Public Health Service from the National Institutes of Health [R21HL098669, R21HL098719, R21HL102597, RO1HL105406, HL021872]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021872, R01HL105406, R21HL102597, R21HL098719, R21HL098669] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by United States Public Health Service Grants R21HL098669, R21HL098719, R21HL102597, RO1HL105406, and HL021872 from the National Institutes of Health. JF is recipient of a Scientist Development Award from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Battistella-Patterson AS, 2000, ACTA PHYSIOL SCAND, V170, P87, DOI 10.1046/j.1365-201x.2000.00755.x; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Dykes AC, 2003, AM J PHYSIOL-CELL PH, V285, pC76, DOI 10.1152/ajpcell.00515.2002; Fassett JT, 2013, AM J PHYSIOL-HEART C, V304, pH749, DOI 10.1152/ajpheart.00935.2011; Fassett JT, 2009, AM J PHYSIOL-HEART C, V297, pH523, DOI 10.1152/ajpheart.00462.2009; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Nakamura Y, 2004, CARDIOVASC RES, V64, P322, DOI 10.1016/j.cardiores.2004.07.013; Perhonen M, 1998, J MOL CELL CARDIOL, V30, P1713, DOI 10.1006/jmcc.1998.0734; Prevostel C, 2000, J CELL SCI, V113, P2575; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tagawa H, 1998, CIRC RES, V82, P751, DOI 10.1161/01.RES.82.7.751; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	32	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73887	10.1371/journal.pone.0073887	http://dx.doi.org/10.1371/journal.pone.0073887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086300	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000005
J	Gonzalez-Porter, GP; Maldonado, JE; Flores-Villela, O; Vogt, RC; Janke, A; Fleischer, RC; Hailer, F				Gonzalez-Porter, Gracia P.; Maldonado, Jesus E.; Flores-Villela, Oscar; Vogt, Richard C.; Janke, Axel; Fleischer, Robert C.; Hailer, Frank			Cryptic Population Structuring and the Role of the Isthmus of Tehuantepec as a Gene Flow Barrier in the Critically Endangered Central American River Turtle	PLOS ONE			English	Article							COMPUTER-PROGRAM; EVOLUTIONARY PROCESSES; CONSERVATION GENETICS; F-STATISTICS; NUCLEAR; MITOCHONDRIAL; DIVERSIFICATION; PHYLOGEOGRAPHY; BOTTLENECK; DIVERSITY	The critically endangered Central American River Turtle (Dermatemys mawii) is the only remaining member of the Dermatemydidae family, yet little is known about its population structuring. In a previous study of mitochondrial (mt) DNA in the species, three main lineages were described. One lineage (Central) was dominant across most of the range, while two other lineages were restricted to Papaloapan (PAP; isolated by the Isthmus of Tehuantepec and the Sierra de Santa Marta) or the south-eastern part of the range (1D). Here we provide data from seven polymorphic microsatellite loci and the R35 intron to re-evaluate these findings using DNA from the nuclear genome. Based on a slightly expanded data set of a total of 253 samples from the same localities, we find that mtDNA and nuclear DNA markers yield a highly congruent picture of the evolutionary history and population structuring of D. mawii. While resolution provided by the R35 intron (sequenced for a subset of the samples) was very limited, the microsatellite data revealed pronounced population structuring. Within the Grijalva-Usumacinta drainage basin, however, many populations separated by more than 300 kilometers showed signals of high gene flow. Across the entire range, neither mitochondrial nor nuclear DNA show a significant isolation-by-distance pattern, but both genomes highlight that the D. mawii population in the Papaloapan basin is genetically distinctive. Further, both marker systems detect unique genomic signals in four individuals with mtDNA clade 1D sampled on the southeast edge of the Grijalva-Usumacinta basin. These individuals may represent a separate cryptic taxon that is likely impacted by recent admixture.	[Gonzalez-Porter, Gracia P.; Maldonado, Jesus E.; Fleischer, Robert C.; Hailer, Frank] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Gonzalez-Porter, Gracia P.; Flores-Villela, Oscar] Univ Nacl Autonoma Mexico, Museo Zool, Fac Ciencias, Mexico City 04510, DF, Mexico; [Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [Vogt, Richard C.] Coordinacao Biodiversidade, Inst Nacl Pesquisas Amazonia, Manaus, Amazonas, Brazil; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Biologicum, D-60054 Frankfurt, Germany; [Janke, Axel; Hailer, Frank] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Janke, Axel; Hailer, Frank] Senckenberg Gesell Nat Forsch, Frankfurt, Germany	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidad Nacional Autonoma de Mexico; Smithsonian Institution; Smithsonian National Museum of Natural History; Institute Nacional de Pesquisas da Amazonia; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Gonzalez-Porter, GP (corresponding author), Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC 20008 USA.	graciasyed@gmail.com; frashai@gmx.net	Hailer, Frank/C-9114-2012; Hailer, Frank/Y-3595-2019; Maldonado, Jesus/AIE-8664-2022	Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Maldonado, Jesus/0000-0002-4282-1072; Flores-Villela, Oscar/0000-0002-2849-6912	Consejo Nacional de Ciencia y Tecnologia fellowship [210994]; Turtle Conservation Fund; Conservation International grants; Philadelphia Zoo Conservation Program; Philadelphia Zoo Docent council; Smithsonian Restricted Endowment funds; EA Schreiber; Seabird Research, Inc; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	Consejo Nacional de Ciencia y Tecnologia fellowship; Turtle Conservation Fund; Conservation International grants; Philadelphia Zoo Conservation Program; Philadelphia Zoo Docent council; Smithsonian Restricted Endowment funds; EA Schreiber; Seabird Research, Inc; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	Funding was provided by Consejo Nacional de Ciencia y Tecnologia fellowship No. 210994; the Turtle Conservation Fund grants in 2004, 2006 and 2009; Conservation International grants in 2007 and 2009; the Philadelphia Zoo Conservation Program Financial Support for 2005, 2006, 2007, 2008; and an award from the Philadelphia Zoo Docent council in 2007. FH received support from the Smithsonian Restricted Endowment funds, EA Schreiber, Seabird Research, Inc, and "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Ichthyologists and Herpetologists, 2013, GUID US LIV AMPH REP; Andree K, 2010, MOL ECOL RESOUR, V10, P1098, DOI 10.1111/j.1755-0998.2010.02898.x; Athie LM, 1987, CALIDAD CANTIDAD AGU; Barber BR, 2010, P ROY SOC B-BIOL SCI, V277, P2675, DOI 10.1098/rspb.2010.0343; BELKHIR K, 2000, GENETIX 4 02 LOGICIE; Beu AG, 2001, J PALEONTOL, V75, P706, DOI 10.1017/S0022336000039743; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Campbell Jonathan A., 1989, AMPHIBIANS REPTILES; Castellanos-Cabrera J, 2007, BUENAVISTA NUEVO SAN; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONABIO-DGVS-CONANP, 2006, ESTR NAC CONS MAN SO; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Croizat L, 1976, B ACAD CIENCIAS FISI; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DUELLMAN WILLIAM E., 1960, UNIV KANSAS PUBL MUS NAT HIST, V13, P19; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Elson C. M., 2005, ANCIENT MESOAM, V16, P195; Emery K., 2001, CRAFTING BONE SKELET, V937, P73; Emery KF, 2005, ANIMALES RITUALES AC; ERVYNCK A., 2004, BEHAV BONES ZOOARCHA; Escalona T, 2009, CONSERV GENET, V10, P1683, DOI 10.1007/s10592-008-9746-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Gonzalez-Porter GP, 2011, CONSERV GENET, V12, P1229, DOI 10.1007/s10592-011-0225-x; Guevara-Chumacero LM, 2010, J MAMMAL, V91, P220, DOI 10.1644/08-MAMM-A-212R3.1; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Helander B, 2007, J ORNITHOL, V148, P435, DOI 10.1007/s10336-007-0156-y; Hobbs RJ, 1998, CONSERV BIOL, V12, P271, DOI 10.1046/j.1523-1739.1998.96233.x; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Huidobro L, 2006, J BIOGEOGR, V33, P731, DOI 10.1111/j.1365-2699.2005.01400.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; LAMB T, 1994, SYST BIOL, V43, P543, DOI 10.2307/2413551; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Maldonado JE, 2001, MOL ECOL, V10, P127, DOI 10.1046/j.1365-294X.2001.01178.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mulcahy DG, 2006, J BIOGEOGR, V33, P1889, DOI 10.1111/j.1365-2699.2006.01546.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols RA, 2004, MOL ECOL, V13, P775, DOI 10.1111/j.1365-294X.2004.02112.x; Paquette SR, 2007, CONSERV GENET, V8, P797, DOI 10.1007/s10592-006-9227-5; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Polisar John, 1994, Herpetological Review, V25, P47; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rico Y, 2008, CONSERV GENET, V9, P1467, DOI 10.1007/s10592-007-9480-2; Robertson JM, 2009, J HERED, V100, P715, DOI 10.1093/jhered/esp041; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schwartz TS, 2005, CONSERV GENET, V6, P917, DOI 10.1007/s10592-005-9078-5; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; SEMARNAT, 2000, LEY GEN VID SILV; Soustelle J, 2003, OLMECAS; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velo-Anton G, 2008, CONSERV GENET, V9, P1263, DOI 10.1007/s10592-007-9457-1; Vogt RC, 2006, IUCN 2012 IUCN RED L; Vogt RC., 1997, HIST NATURAL TUXTLAS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Zarza E, 2008, MOL ECOL, V17, P3259, DOI 10.1111/j.1365-294X.2008.03826.x	77	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e71668	10.1371/journal.pone.0071668	http://dx.doi.org/10.1371/journal.pone.0071668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086253	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325218700002
J	Botchkina, GI; Zuniga, ES; Rowehl, RH; Park, R; Bhalla, R; Bialkowska, AB; Johnson, F; Golub, LM; Zhang, Y; Ojima, I; Shroyer, KR				Botchkina, Galina I.; Zuniga, Edison S.; Rowehl, Rebecca H.; Park, Rosa; Bhalla, Rahuldev; Bialkowska, Agnieszka B.; Johnson, Francis; Golub, Lorne M.; Zhang, Yu; Ojima, Iwao; Shroyer, Kenneth R.			Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24	PLOS ONE			English	Article							Y-CHROMOSOME; INITIATING CELLS; GENE-EXPRESSION; SIDE POPULATION; TUMOR-GROWTH; RESISTANCE; IDENTIFICATION; MARKERS; NESTIN; CD44	Background: Prostate cancer is the second leading cause of cancer death among men. Multiple evidence suggests that a population of tumor-initiating, or cancer stem cells (CSCs) is responsible for cancer development and exceptional drug resistance, representing a highly important therapeutic target. The present study evaluated CSC-specific alterations induced by new-generation taxoid SBT-1214 and a novel polyenolic zinc-binding curcuminoid, CMC2.24, in prostate CSCs. Principal Findings: The CD133(high)/CD44(high) phenotype was isolated from spontaneously immortalized patient-derived PPT2 cells and highly metastatic PC3MM2 cells. Weekly treatment of the NOD/SCID mice bearing PPT2- and PC3MM3-induced tumors with the SBT-1214 led to dramatic suppression of tumor growth. Four of six PPT2 and 3 of 6 PC3MM2 tumors have shown the absence of viable cells in residual tumors. In vitro, SBT-1214 (100nM-1 mu M; for 72 hr) induced about 60% cell death in CD133h(igh)/CD44(+/high) cells cultured on collagen I in stem cell medium (in contrast, the same doses of paclitaxel increased proliferation of these cells). The cytotoxic effects were increased when SBT-1214 was combined with the CMC2.24. A stem cell-specific PCR array assay revealed that this drug combination mediated massive inhibition of multiple constitutively up-regulated stem cell-related genes, including key pluripotency transcription factors. Importantly, this drug combination induced expression of p21 and p53, which were absent in CD133(high)/CD44(high) cells. Viable cells that survived this treatment regimen were no longer able to induce secondary spheroids, exhibited significant morphological abnormalities and died in 2-5 days. Conclusions: We report here that the SBT-1214 alone, or in combination with CMC2.24, possesses significant activity against prostate CD133(high)/CD44(+/high) tumor-initiating cells. This drug combination efficiently inhibits expression of the majority of stem cell-related genes and pluripotency transcription factors. In addition, it induces a previously absent expression of p21 and p53 ("gene wake-up"), which can potentially reverse drug resistance by increasing sensitivity to anti-cancer drugs.	[Botchkina, Galina I.; Rowehl, Rebecca H.; Shroyer, Kenneth R.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Botchkina, Galina I.; Zuniga, Edison S.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Dev, Stony Brook, NY 11794 USA; [Zuniga, Edison S.; Johnson, Francis; Zhang, Yu; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Park, Rosa; Bhalla, Rahuldev] SUNY Stony Brook, Med Ctr, Dept Urol, Stony Brook, NY 11794 USA; [Bialkowska, Agnieszka B.] SUNY Stony Brook, Dept Med, Med Ctr, Stony Brook, NY 11794 USA; [Johnson, Francis] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Johnson, Francis] SUNY Stony Brook, Chem Master Int Inc, Stony Brook, NY 11794 USA; [Golub, Lorne M.] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Botchkina, GI (corresponding author), SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA.	gbotchkina@stonybrookmedicine.edu		Ojima, Iwao/0000-0002-3628-1161	NIH [R21 CA150085]; NYSTAR [1072170]; Stony Brook University Institute of Chemical Biology & Drug Discovery (ICBDD); Stony Brook University Cancer Center, NY; ChemMaster International, NY; SBU VP for Research; NATIONAL CANCER INSTITUTE [R21CA150085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR; Stony Brook University Institute of Chemical Biology & Drug Discovery (ICBDD); Stony Brook University Cancer Center, NY; ChemMaster International, NY; SBU VP for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R21 CA150085, NYSTAR grant 1072170, and in part, by the Stony Brook University Institute of Chemical Biology & Drug Discovery (ICB & DD); Stony Brook University Cancer Center, NY; ChemMaster International, NY and SBU VP for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2001, EUR UROL, V39, P138, DOI 10.1159/000052428; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Alam TN, 2004, J HISTOCHEM CYTOCHEM, V52, P1083, DOI 10.1369/jhc.4a6256.2004; Attard G, 2009, PROSTATE, V69, P1507, DOI 10.1002/pros.20997; Bae KM, 2011, AM J CANCER RES, V1, P71; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; BARETTON GB, 1994, CANCER RES, V54, P4472; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Botchkina GI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-192; BOTCHKINA GI, 2011, CANC STEM CELLS THEO, P135; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Cheng L, 2000, CLIN CANCER RES, V6, P1896; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fong D, 2010, CANCER LETT, V293, P65, DOI 10.1016/j.canlet.2009.12.018; Fusi A, 2011, J INVEST DERMATOL, V131, P487, DOI 10.1038/jid.2010.285; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Hall CL, 2010, CANCER RES, V70, P9916, DOI 10.1158/0008-5472.CAN-10-0440; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirata T, 1998, CANCER RES, V58, P1108; Hour TC, 2002, PROSTATE, V51, P211, DOI 10.1002/pros.10089; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; KOIVISTO P, 1995, AM J PATHOL, V147, P1608; Kuznetsova L, 2006, BIOORG MED CHEM LETT, V16, P974, DOI 10.1016/j.bmcl.2005.10.089; Luo Jian-Hua, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006057; Marin-Aguilera M, 2012, MOL CANCER THER, V11, P329, DOI 10.1158/1535-7163.MCT-11-0289; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Matsushima H, 1998, HUM PATHOL, V29, P778, DOI 10.1016/S0046-8177(98)90445-2; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, HISTOL HISTOPATHOL, V25, P1057, DOI 10.14670/HH-25.1057; Mimeault M, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-31; Miyoshi Y, 2000, PROSTATE, V43, P225, DOI 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7; Nautiyal J, 2012, AM J PHYSIOL-GASTR L, V302, pG655, DOI 10.1152/ajpgi.00323.2011; Nielander I, 2008, HAEMATOLOGICA, V93, P949, DOI 10.3324/haematol.12656; Oliai BR, 2002, AM J SURG PATHOL, V26, P1151, DOI 10.1097/00000478-200209000-00005; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Peehl DM, 2004, J CELL BIOCHEM, V91, P185, DOI 10.1002/jcb.10691; Perinchery G, 2000, J UROLOGY, V163, P1339, DOI 10.1016/S0022-5347(05)67774-9; Piantino CB, 2009, INT BRAZ J UROL, V35, P354, DOI 10.1590/S1677-55382009000300012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Shah RB, 2002, AM J SURG PATHOL, V26, P1161, DOI 10.1097/00000478-200209000-00006; Shankar S, 2007, INT J ONCOL, V30, P905; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040021; Su CC, 2006, ANTICANCER RES, V26, P4379; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TORTORETO M, 2009, P NATL ACAD SCI USA, V106; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Brussel JR, 2003, ONKOLOGIE, V26, P175, DOI 10.1159/000071510; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zhang Y, 2012, CURR MED CHEM, V19, P4348, DOI 10.2174/092986712802884295; Zhao Y, 2008, CELL BIOCHEM FUNCT, V26, P571, DOI 10.1002/cbf.1478; Zivi A, 2010, CLIN GENITOURIN CANC, V8, P17, DOI 10.3816/CGC.2010.n.003	71	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e69884	10.1371/journal.pone.0069884	http://dx.doi.org/10.1371/journal.pone.0069884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086245	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200002
J	Martin-Vazquez, G; Makarova, J; Makarov, VA; Herreras, O				Martin-Vazquez, Gonzalo; Makarova, Julia; Makarov, Valeri A.; Herreras, Oscar			Determining the True Polarity and Amplitude of Synaptic Currents Underlying Gamma Oscillations of Local Field Potentials	PLOS ONE			English	Article							SOURCE DENSITY ANALYSIS; CA1 PYRAMIDAL CELLS; INDEPENDENT COMPONENT; RAT HIPPOCAMPUS; DENDRITIC MORPHOLOGY; OLFACTORY-BULB; COHERENCE; NEURONS; SPIKES; THETA	Fluctuations in successive waves of oscillatory local field potentials (LFPs) reflect the ongoing processing of neuron populations. However, their amplitude, polarity and synaptic origin are uncertain due to the blending of electric fields produced by multiple converging inputs, and the lack of a baseline in standard AC-coupled recordings. Consequently, the estimation of underlying currents by laminar analysis yields spurious sequences of inward and outward currents. We devised a combined analytical/experimental approach that is suitable to study laminated structures. The approach was essayed on an experimental oscillatory LFP as the Schaffer-CA1 gamma input in anesthetized rats, and it was verified by parallel processing of model LFPs obtained through a realistic CA1 aggregate of compartmental units. This approach requires laminar LFP recordings and the isolation of the oscillatory input from other converging pathways, which was achieved through an independent component analysis. It also allows the spatial and temporal components of pathway-specific LFPs to be separated. While reconstructed Schaffer-specific LFPs still show spurious inward/outward current sequences, these were clearly stratified into distinct subcellular domains. These spatial bands guided the localized delivery of neurotransmitter blockers in experiments. As expected, only Glutamate but not GABA blockers abolished Schaffer LFPs when applied to the active but not passive subcellular domains of pyramidal cells. The known chemical nature of the oscillatory LFP allowed an empirical offset of the temporal component of Schaffer LFPs, such that following reconstruction they yield only sinks or sources at the appropriate sites. In terms of number and polarity, some waves increased and others decreased proportional to the concomitant inputs in native multisynaptic LFPs. Interestingly, the processing also retrieved the initiation time for each wave, which can be used to discriminate afferent from postsynaptic cells in standard spike-phase correlations. The applicability of this approach to other pathways and structures is discussed.	[Martin-Vazquez, Gonzalo; Makarova, Julia; Herreras, Oscar] CSIC, Inst Cajal, Dept Syst Neurosci, Madrid, Spain; [Makarov, Valeri A.] Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Complutense University of Madrid	Herreras, O (corresponding author), CSIC, Inst Cajal, Dept Syst Neurosci, Madrid, Spain.	herreras@cajal.csic.es	Makarova, Julia/K-5912-2014; Makarov, Valeri A/L-5031-2014; Makarov, Valeri/AAF-4790-2019; Makarova, Julia/AAI-1213-2019; herreras, oscar/D-5256-2016; Herreras, Oscar/O-1711-2019	Makarova, Julia/0000-0001-9307-6167; Makarov, Valeri A/0000-0001-8789-7532; Makarov, Valeri/0000-0001-8789-7532; Makarova, Julia/0000-0001-9307-6167; herreras, oscar/0000-0002-8210-3710; Herreras, Oscar/0000-0002-8210-3710; Martin-Vazquez, Gonzalo/0000-0001-7761-3962	Spanish Ministry of Science and Innovation [BFU2010-19192/BFI, FIS2010-20054]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the grants BFU2010-19192/BFI and FIS2010-20054 from the former Spanish Ministry of Science and Innovation; http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BENITO N, 2013, CEREB CORTEX, DOI DOI 10.1093/CERC0R/BHT022.PUBMED:23395845; BOSS BD, 1987, BRAIN RES, V406, P280, DOI 10.1016/0006-8993(87)90793-1; Bower JM, 1998, BOOK GENESIS EXPLORI; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; BRESSLER SL, 1987, BRAIN RES, V409, P285, DOI 10.1016/0006-8993(87)90713-X; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Canals S, 2005, J NEUROPHYSIOL, V93, P909, DOI 10.1152/jn.00686.2004; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; Chen AY, 2006, LECT NOTES COMPUT SC, V3889, P24; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Elul R., 1972, INT REV NEUROBIOL, V15, P228; Fernandez-Ruiz A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00071; Fernandez-Ruiz A, 2012, J NEUROSCI, V32, P5165, DOI 10.1523/JNEUROSCI.4499-11.2012; FERNANDEZRUIZ A, 2013, J NEUROSCI IN PRESS; FERNANDEZRUIZ A, 2013, J COMPUT NEUROSCI, V5, P7, DOI DOI 10.3389/FNC0M.2013.00005; Florian G, 1998, ELECTROEN CLIN NEURO, V106, P87, DOI 10.1016/S0013-4694(97)00105-3; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; GLOOR P, 1985, J CLIN NEUROPHYSIOL, V2, P327, DOI 10.1097/00004691-198510000-00002; Golarai G, 1996, J NEUROPHYSIOL, V75, P329, DOI 10.1152/jn.1996.75.1.329; HERRERAS O, 1990, J NEUROPHYSIOL, V64, P1429, DOI 10.1152/jn.1990.64.5.1429; HERRERAS O, 1988, BRAIN RES, V461, P290, DOI 10.1016/0006-8993(88)90259-4; Ibarz JM, 2006, EUR J NEUROSCI, V23, P1219, DOI 10.1111/j.1460-9568.2006.04615.x; KETCHUM KL, 1993, J NEUROSCI, V13, P3980; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Korovaichuk A, 2010, J NEUROPHYSIOL, V104, P484, DOI 10.1152/jn.00297.2010; Leski S, 2010, J COMPUT NEUROSCI, V29, P459, DOI 10.1007/s10827-009-0203-1; Lopez-Aguado L, 2002, J NEUROPHYSIOL, V88, P2809, DOI 10.1152/jn.00183.2002; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; LORENTE de NO R, 1947, Stud Rockefeller Inst Med Res Repr, V132, P384; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarova J, 2007, BIOPHYS J, V92, P4216, DOI 10.1529/biophysj.106.090332; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; MITZDORF U, 1977, J NEUROPHYSIOL, V40, P1227, DOI 10.1152/jn.1977.40.6.1227; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Niedermeyer E, 1996, CLIN ELECTROENCEPHAL, V27, P121, DOI 10.1177/155005949602700305; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pavlov Alexey, 2007, Natural Computing, V6, P269, DOI 10.1007/s11047-006-9014-8; Pavlov AN, 2006, BRIEF BIOINFORM, V7, P375, DOI 10.1093/bib/bbl041; Plonsey R., 1969, BIOELECTRIC PHENOMEN; RAPPELSBERGER P, 1981, PFLUG ARCH EUR J PHY, V389, P159, DOI 10.1007/BF00582108; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; RODRIGUEZ R, 1989, J NEUROPHYSIOL, V61, P702, DOI 10.1152/jn.1989.61.4.702; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Varona P, 2000, J NEUROPHYSIOL, V83, P2192, DOI 10.1152/jn.2000.83.4.2192; Woodbury JW., 1960, MEDICAL PHYSL BIOPHY, P83; Wu K, 1998, HIPPOCAMPUS, V8, P217, DOI 10.1002/(SICI)1098-1063(1998)8:3<217::AID-HIPO5>3.3.CO;2-Y; YLINEN A, 1995, J NEUROSCI, V15, P30	61	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75499	10.1371/journal.pone.0075499	http://dx.doi.org/10.1371/journal.pone.0075499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073269	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000079
J	Golet, WJ; Galuardi, B; Cooper, AB; Lutcavage, ME				Golet, Walter J.; Galuardi, Benjamin; Cooper, Andrew B.; Lutcavage, Molly E.			Changes in the Distribution of Atlantic Bluefin Tuna (Thunnus thynnus) in the Gulf of Maine 1979-2005	PLOS ONE			English	Article							LONG-TERM FLUCTUATIONS; POPULATION-STRUCTURE; FISH; TEMPERATURE; VARIABILITY; MOVEMENTS; MIGRATION; DYNAMICS; DECLINE; COMPLEX	The Gulf of Maine, NW Atlantic Ocean, is a productive, seasonal foraging ground for Atlantic bluefin tuna (Thunnus thynnus), but commercial landings of adult size classes were up to 40% below the allocated total allowable catch between 2004 to 2008 for the rod and reel, harpoon, and purse seine categories in the Gulf of Maine. Reduction in Atlantic bluefin tuna catches in the Gulf of Maine could represent a decline in spawning stock biomass, but given wide-ranging, complex migration patterns, and high energetic requirements, an alternative hypothesis is that their dispersal patterns shifted to regions with higher prey abundance or profitability, reducing availability to U. S. fishing fleets. This study fit generalized linear models to Atlantic bluefin tuna landings data collected from fishermen's logbooks (1979-2005) as well as the distances between bluefin tuna schools and Atlantic herring (Clupea harengus), a primary prey species, to test alternative hypotheses for observed shifts in Atlantic bluefin tuna availability in the Gulf of Maine. For the bluefin model, landings varied by day of year, latitude and longitude. The effect of latitude differed by day of year and the effect of longitude differed by year. The distances between Atlantic bluefin tuna schools and Atlantic herring schools were significantly smaller (p<0.05) than would be expected from a randomly distributed population. A time series of average bluefin tuna school positions was positively correlated with the average number of herring captured per tow on Georges Bank in spring and autumn surveys respectively (p<0.01, r(2)=0.24, p<0.01, r(2)=0.42). Fishermen's logbooks contributed novel spatial and temporal information towards testing these hypotheses for the bluefin tuna fishery.	[Golet, Walter J.] Univ Maine, Sch Marine Sci, Orono, ME USA; [Golet, Walter J.] Gulf Maine Res Inst, Portland, ME USA; [Galuardi, Benjamin; Lutcavage, Molly E.] UMass Amherst & Marine Fisheries Inst, Large Pelag Res Ctr, Gloucester, MA USA; [Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; Simon Fraser University	Golet, WJ (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME USA.	walter.golet@maine.edu			NOAA [NA04NMF4550391]; Division Of Ocean Sciences [1041731] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by NOAA grant #NA04NMF4550391 to Molly Lutcavage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ICCAT COL VOL SCI PA, V67, P505; Anthony VC, 1980, P V REUN CONS INT EX, V177, P72; Arni Magnusson, 2011, GMT INTERFACE GMT MA, P1; Atlantic Bluefin Tuna Status Review Team, 2011, STAT REV REP ATL BLU, P22; Bigelow H. B., 1954, Fishery Bulletin United States, V53, P1; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Brown CA, 2009, ICCAT COL VOL SCI PA, V64, P454; Brown CA, 2007, ICCAT COL VOL SCI PA, V60, P1087; Butler CM, 2009, FISH B, V108, P56; Butler M, 1971, BIOL INVESTIGATION A, p[1970, 1]; Butler M.J.A., 1977, ICCAT COL VOL SCI PA, V6, P318; Caddy JF, 1975, 1395 J FISHRESBOARD; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P205, DOI 10.1016/0010-406X(69)91336-X; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Chase BC, 2002, FISH B-NOAA, V100, P168; Crane J., 1936, ZOOLOGICA, V212, P207; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; Drinkwater KF, 2002, AM FISH S S, V32, P113; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fromentin JM, 2009, FISH FISH, V10, P197, DOI 10.1111/j.1467-2979.2008.00311.x; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fromentin JM, 2001, ICCAT COL VOL SCI, V50, P1780; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gartside DF, 1999, FISH RES, V63, P405; Golet WJ, 2007, FISH B-NOAA, V105, P390; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Gutenkunst R, 2007, J THEOR BIOL, V245, P243, DOI 10.1016/j.jtbi.2006.10.014; Hamre J, 1968, CONSEIL PERMANENT IN, V38, P1; HILBORN R, 1992; Humston R, 2000, FISH OCEANOGR, V9, P136, DOI 10.1046/j.1365-2419.2000.00132.x; Hurley PCF, 1983, P INT WORKSH AG DET; Kane J, 2011, ICES J MAR SCI, V68, P1833, DOI 10.1093/icesjms/fsr122; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage M., 1997, INT COMM CONSERV ATL, V47, P332; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Maguire J, 2012, 2012002 FISH OC CAN; Marsac Francis, 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P346; Mather FJ, 1995, NMFSSEFSC370 NAT OC; McAllister Murdoch K., 2008, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V62, P1298; Melvin GD, 2007, ICES J MAR SCI, V64, P69, DOI 10.1093/icesjms/fsl018; Mesnil B, 2009, AQUAT LIVING RESOUR, V22, P207, DOI 10.1051/alr/2009003; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Mountain DG, 2010, MAR ECOL PROG SER, V398, P81, DOI 10.3354/meps08323; Neilson J.D., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P976; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Nottestad L, 2009, COL ICCAT VOL SCI PA, V63, P231; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Overholtz WJ, 2002, FISH B-NOAA, V100, P593; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Pershing AJ, 2006, EOS T AM GEOPHYS UNI, V87; Polacheck T., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P61; Porch CE, 2006, FISH B-NOAA, V104, P89; Quin JT, 1999, QUANTITATIVE FISH DY; R Development Core Team, 2011, R LANG ENV STAT COMP; Ravier C, 2004, FISH OCEANOGR, V13, P145, DOI 10.1111/j.1365-2419.2004.00284.x; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Rivas LR, 1955, P GULF CAR FISH I 7, V7, P133; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Schick RS, 2009, FISH OCEANOGR, V18, P77, DOI 10.1111/j.1365-2419.2008.00499.x; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Takeuchi Y, 2009, ICCAT VOL SCI PAP, V63, P186; Tiews K., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P301; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108	75	20	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75480	10.1371/journal.pone.0075480	http://dx.doi.org/10.1371/journal.pone.0075480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069420	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300081
J	Hafid, SRA; Chakravarthi, S; Nesaretnam, K; Radhakrishnan, AK				Hafid, Sitti Rahma Abdul; Chakravarthi, Srikumar; Nesaretnam, Kalanithi; Radhakrishnan, Ammu Kutty			Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer	PLOS ONE			English	Article							TOCOPHERYL SUCCINATE; EXPRESSION; VACCINES; RECEPTOR	Tocotrienol-rich fraction (TRF) from palm oil is reported to possess anti-cancer and immune-enhancing effects. In this study, TRF supplementation was used as an adjuvant to enhance the anti-cancer effects of dendritic cells (DC)-based cancer vaccine in a syngeneic mouse model of breast cancer. Female BALB/c mice were inoculated with 4T1 cells in mammary pad to induce tumor. When the tumor was palpable, the mice in the experimental groups were injected subcutaneously with DC-pulsed with tumor lysate (TL) from 4T1 cells (DC+TL) once a week for three weeks and fed daily with 1 mg TRF or vehicle. Control mice received unpulsed DC and were fed with vehicle. The combined therapy of using DC+TL injections and TRF supplementation (DC+TL+TRF) inhibited (p<0.05) tumor growth and metastasis. Splenocytes from the DC+TL+TRF group cultured with mitomycin-C (MMC)-treated 4T1 cells produced higher (p<0.05) levels of IFN-gamma and IL-12. The cytotoxic T-lymphocyte (CTL) assay also showed enhanced tumorspecific killing (p<0.05) by CD8(+) T-lymphocytes isolated from mice in the DC+TL+TRF group. This study shows that TRF has the potential to be used as an adjuvant to enhance effectiveness of DC-based vaccines.	[Hafid, Sitti Rahma Abdul; Chakravarthi, Srikumar; Radhakrishnan, Ammu Kutty] Int Med Univ, Div Pathol, Fac Med & Hlth, Kuala Lumpur 57000, Malaysia; [Hafid, Sitti Rahma Abdul; Nesaretnam, Kalanithi] Malaysian Palm Oil Board, Nutr Unit, Bandar Baru Bangi, Selangor, Malaysia	International Medical University Malaysia; Malaysian Palm Oil Board	Radhakrishnan, AK (corresponding author), Int Med Univ, Div Pathol, Fac Med & Hlth, Kuala Lumpur 57000, Malaysia.	ammu_radhakrishnan@imu.edu.my	Chakravarthi, Srikumar/AHB-7872-2022; Hafid, Sitti Rahma Abd/AAC-5198-2021; Radhakrishnan, Ammu Kutty/F-2877-2015	Chakravarthi, Srikumar/0000-0002-9888-3301; Radhakrishnan, Ammu Kutty/0000-0003-2638-907X; Abd Hafid, Sitti Rahma/0000-0002-1131-4617	International Medical University (IMU); Malaysian Palm Oil Board (MPOB)	International Medical University (IMU); Malaysian Palm Oil Board (MPOB)	This study was supported by a research grant from the International Medical University (IMU) and the Malaysian Palm Oil Board (MPOB). This work is part of the work that the first author did for her PhD, which is supported by the MPOB and IMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Choo YM, 2005, LIPIDS, V40, P429, DOI 10.1007/s11745-006-1400-6; Choo ZW, 2010, ONCOL LETT, V1, P215, DOI 10.3892/ol_00000039; Das S, 2008, AM J PHYSIOL-HEART C, V294, pH970, DOI 10.1152/ajpheart.01200.2007; Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227; Hafid SRA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-5; Herr W, 2000, BLOOD, V96, P1857, DOI 10.1182/blood.V96.5.1857.h8001857_1857_1864; Ingrid ED, 2005, J IMMUNOL, V174, P7506; Mihret Adane, 2011, BMC Res Notes, V4, P247, DOI 10.1186/1756-0500-4-247; Nagaraj S, 2004, INDIAN J MED RES, V119, P133; Nesaretnam K, 2004, LIPIDS, V39, P459, DOI 10.1007/s11745-004-1251-1; Nesaretnam K, 1998, LIPIDS, V33, P461, DOI 10.1007/s11745-998-0229-3; NESARETNAM K, 1995, LIPIDS, V30, P1139, DOI 10.1007/BF02536615; Nesaretnam K, 2000, PALM OILS DEV, V32; Porgador A, 1996, J IMMUNOL, V156, P2918; Puddu P, 1997, J IMMUNOL, V159, P3490; Radhakrishnan AK, 2012, BIORESEARCH OPEN ACC, V1, P239, DOI 10.1089/biores.2012.0229; Ramanathapuram LV, 2005, NUTR CANCER, V53, P177, DOI 10.1207/s15327914nc5302_7; Ramanathapuram LV, 2004, CANCER IMMUNOL IMMUN, V53, P580, DOI 10.1007/s00262-004-0499-7; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sato M, 2003, INT IMMUNOL, V15, P837, DOI 10.1093/intimm/dxg081; Schuler G, 1997, J EXP MED, V186, P1183, DOI 10.1084/jem.186.8.1183; Selvaduray KR, 2010, J INTERF CYTOK RES, V30, P909, DOI 10.1089/jir.2010.0021; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P2268, DOI 10.1073/pnas.96.5.2268; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Steinman RM, 2001, INT J CANCER, V94, P459, DOI 10.1002/ijc.1503; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Suzana M., 2005, EUR J SCI RES, V7, P41; Takahashi K, 2004, BIOCHEM PHARMACOL, V67, P315, DOI 10.1016/j.bcp.2003.07.015; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Weng-Yew W, 2009, NUTR CANCER, V61, P367, DOI 10.1080/01635580802582736; Wu RS, 2001, CANCER IMMUNOL IMMUN, V50, P229, DOI 10.1007/s002620100197; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	35	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74753	10.1371/journal.pone.0074753	http://dx.doi.org/10.1371/journal.pone.0074753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069344	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300043
J	Pereira, HABD; Leite, AD; Charone, S; Lobo, JGVM; Cestari, TM; Peres-Buzalaf, C; Buzalaf, MAR				Barbosa da Silva Pereira, Heloisa Aparecida; Leite, Aline de Lima; Charone, Senda; Vaz Madureira Lobo, Janete Gualiume; Cestari, Tania Mary; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso			Proteomic Analysis of Liver in Rats Chronically Exposed to Fluoride	PLOS ONE			English	Article							INDUCED APOPTOSIS; SODIUM-FLUORIDE; PROTEINS; STRESS; TRANSLATION; PEROXISOMES; PHOSPHATASE; INHIBITION; METABOLISM; ACTIVATION	Fluoride (F) is a potent anti-cariogenic element, but when ingestion is excessive, systemic toxicity may be observed. This can occur as acute or chronic responses, depending on both the amount of F and the time of exposure. The present study identified the profile of protein expression possibly associated with F-induced chronic hepatotoxicity. Weanling male Wistar rats (three-weeks old) were divided into three groups and treated with drinking water containing 0, 5 or 50 mg/L F for 60 days (n=6/group). At this time point, serum and livers were collected for F analysis, which was done using the ion-sensitive electrode, after hexamethyldisiloxane-facilitated diffusion. Livers were also submitted to histological and proteomic analyses (2D-PAGE followed by LC-MS/MS). Western blotting was done for confirmation of the proteomic data A dose-response was observed in serum F levels. In the livers, F levels were significantly increased in the 50 mg/L F group compared to groups treated with 0 and 5 mg/L F. Liver morphometric analysis did not reveal alterations in the cellular structures and lipid droplets were present in all groups. Proteomic quantitative intensity analysis detected 33, 44, and 29 spots differentially expressed in the comparisons between control vs. 5 mg/L F, control vs. 50 mg/L F, and 5 mg/L vs. 50 mg/L F, respectively. From these, 92 proteins were successfully identified. In addition, 18, 1, and 5 protein spots were shown to be exclusive in control, 5, and 50 mg/L F, respectively. Most of proteins were related to metabolic process and pronounced alterations were seen for the high-F level group. In F-treated rats, changes in the apolipoprotein E (ApoE) and GRP-78 expression may account for the F-induced toxicity in the liver. This can contribute to understanding the molecular mechanisms underlying hepatoxicity induced by F, by indicating key-proteins that should be better addressed in future studies.	[Barbosa da Silva Pereira, Heloisa Aparecida; Leite, Aline de Lima; Charone, Senda; Vaz Madureira Lobo, Janete Gualiume; Cestari, Tania Mary; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Sao Paulo, Brazil	Universidade de Sao Paulo	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Sao Paulo, Brazil.	mbuzalaf@fob.usp.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Heloisa Aparecida Barbosa da Silva, Pereira/M-1766-2013; Charone, Senda SC/D-1218-2017; Peres-Buzalaf, Camila/C-5109-2012; Charone, Senda/J-8393-2013; Cestari, Tania Mary/E-7060-2012; Leite, Aline/J-9748-2012; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Heloisa Aparecida Barbosa da Silva, Pereira/0000-0002-1839-2546; Charone, Senda/0000-0002-9713-8676; Cestari, Tania Mary/0000-0003-1287-5974; Leite, Aline/0000-0002-2112-1309; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951	Sao Paulo State Support Foundation (FAPESP) [2008/07263-9, 2009/06892-5]	Sao Paulo State Support Foundation (FAPESP)	This work was supported by Sao Paulo State Support Foundation (FAPESP) (grants 2008/07263-9 and 2009/06892-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; BAYKOV AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P238, DOI 10.1016/0003-9861(92)90163-Q; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Bonomini F, 2010, EXP GERONTOL, V45, P149, DOI 10.1016/j.exger.2009.11.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chattopadhyay A, 2011, ARCH TOXICOL, V85, P327, DOI 10.1007/s00204-010-0588-7; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Cheng TJ, 1998, J CELL BIOCHEM, V69, P221, DOI 10.1002/(SICI)1097-4644(19980501)69:2<221::AID-JCB12>3.0.CO;2-H; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Dabrowska E, 2006, Adv Med Sci, V51 Suppl 1, P91; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Ge YM, 2011, ARCH TOXICOL, V85, P27, DOI 10.1007/s00204-010-0537-5; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Ikemoto M, 2001, CLIN CHEM, V47, P946; JANCKILA AJ, 1992, LEUKEMIA, V6, P199; Jo H, 2013, HEPATOLOGY; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Kobayashi CAN, 2009, CHEM-BIOL INTERACT, V180, P305, DOI 10.1016/j.cbi.2009.03.009; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; Lee JH, 2008, TOXICOLOGY, V243, P340, DOI 10.1016/j.tox.2007.10.026; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Moura LP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-2; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Nelson DLC, 2002, LEHNINGER PRINCIPLES, P975; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pinkse MWH, 1999, BIOCHEMISTRY-US, V38, P9926, DOI 10.1021/bi990446w; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Refsnes M, 2003, HUM EXP TOXICOL, V22, P111, DOI 10.1191/0960327103ht322oa; Refsnes M, 2001, TOXICOLOGY, V167, P145, DOI 10.1016/S0300-483X(01)00448-6; Rison Stuart C. G., 2000, Functional and Integrative Genomics, V1, P56; Shanthakumari D, 2004, TOXICOLOGY, V204, P219, DOI 10.1016/j.tox.2004.06.058; Strunecka A, 2007, CURR SIGNAL TRANSD T, V2, P190, DOI 10.2174/157436207781745300; TAVES DR, 1968, TALANTA, V15, P969, DOI 10.1016/0039-9140(68)80097-9; Thomas AB, 1996, J CLIN ENDOCR METAB, V81, P2570, DOI 10.1210/jc.81.7.2570; Thongboonkerd V, 2004, CONTRIB NEPHROL, V141, P11; Tucci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045429; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wang Y, 2005, PROTEOMICS, V5, P4496, DOI 10.1002/pmic.200401317; Warburg O, 1941, BIOCH Z, V37; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wong MCM, 2011, J DENT RES, V90, P573, DOI 10.1177/0022034510393346; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Xu H, 2005, TOXICOL LETT, V160, P69, DOI 10.1016/j.toxlet.2005.06.009; Xu H, 2008, BIOL TRACE ELEM RES, V123, P91, DOI 10.1007/s12011-007-8086-3; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Zhan XA, 2006, J TRACE ELEM MED BIO, V20, P83, DOI 10.1016/j.jtemb.2005.11.003	55	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75343	10.1371/journal.pone.0075343	http://dx.doi.org/10.1371/journal.pone.0075343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069403	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300080
J	Chabbi-Achengli, Y; Launay, JM; Maroteaux, L; de Vernejoul, MC; Collet, C				Chabbi-Achengli, Yasmine; Launay, Jean-Marie; Maroteaux, Luc; de Vernejoul, Marie Christine; Collet, Corinne			Serotonin 2B Receptor (5-HT2B R) Signals through Prostacyclin and PPAR-beta/delta in Osteoblasts	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; DEFICIENT MICE; BONE MASS; ACTIVATION; EXPRESSION; DIFFERENTIATION; QUANTIFICATION; RECRUITMENT; INVOLVEMENT; SURVIVAL	Osteoporosis is due to an imbalance between decreased bone formation by osteoblasts and increased resorption by osteoclasts. Deciphering factors controlling bone formation is therefore of utmost importance for the understanding and the treatment of osteoporosis. Our previous in vivo results showed that bone formation is reduced in the absence of the serotonin receptor 5-HT2B, causing impaired osteoblast proliferation, recruitment, and matrix mineralization. In this study, we investigated the signaling pathways responsible for the osteoblast defect in 5-HT2BR-/- mice. Notably, we investigated the phospholipase A2 pathway and synthesis of eicosanoids in 5-HT2BR-/- compared to wild type (WT) osteoblasts. Compared to control osteoblasts, the lack of 5-HT2B receptors was only associated with a 10-fold over-production of prostacyclin (PGI(2)). Also, a specific prostacyclin synthase inhibitor (U51605) rescued totally osteoblast aggregation and matrix mineralization in the 5-HT2BR-/- osteoblasts without having any effect on WT osteoblasts. Prostacyclin is the endogenous ligand of the nuclear peroxisome proliferator activated receptor beta/delta (PPAR-beta/delta), and its inhibition in 5-HT2BR-/- cells rescued totally the alkaline phosphatase and osteopontin mRNA levels, cell-cell adhesion, and matrix mineralization. We conclude that the absence of 5-HT2B receptors leads to the overproduction of prostacyclin, inducing reduced osteoblast differentiation due to PPAR-beta/delta -dependent target regulation and defective cell-cell adhesion and matrix mineralization. This study thus reveals a previously unrecognized cell autonomous osteoblast defect in the absence of 5-HT2BR and highlights a new pathway linking 5-HT2B receptors and nuclear PPAR-beta/delta via prostacyclin.	[Chabbi-Achengli, Yasmine; de Vernejoul, Marie Christine; Collet, Corinne] Hop Lariboisiere, INSERM, UMR606, F-75475 Paris, France; [Chabbi-Achengli, Yasmine; de Vernejoul, Marie Christine] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Launay, Jean-Marie; Collet, Corinne] Hop Lariboisiere, Serv Biochim, F-75475 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, U942, F-75475 Paris, France; [Maroteaux, Luc] Inst Fer Moulin, INSERM, UMR S839, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Collet, C (corresponding author), Hop Lariboisiere, INSERM, UMR606, F-75475 Paris, France.	corinne.collet@lrb.aphp.fr	Maroteaux, Luc/H-4585-2019	Maroteaux, Luc/0000-0002-9499-8603; collet, corinne/0000-0001-6990-863X	Ministere Superieur de l'Enseignement et de la Recherche; ECTS SERVIER grant; Fondation Pour La Recherche Medicale Subventions; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; European Union (DEVANX)	Ministere Superieur de l'Enseignement et de la Recherche; ECTS SERVIER grant; Fondation Pour La Recherche Medicale Subventions; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union (DEVANX)	YCA was the recipient of a fellowship from the Ministere Superieur de l'Enseignement et de la Recherche. CC was supported by an ECTS SERVIER 2012 grant. MCdV was supported by the Fondation Pour La Recherche Medicale Subventions. LM was supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, and the European Union (DEVANX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2; Cao H, 2008, ANAL BIOCHEM, V372, P41, DOI 10.1016/j.ab.2007.08.041; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; DANIEL VC, 1994, J CHROMATOGR B, V653, P117, DOI 10.1016/0378-4347(93)E0432-P; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; Jaffre F, 2004, CIRCULATION, V110, P969, DOI 10.1161/01.CIR.0000139856.20505.57; Launay JM, 2012, BLOOD, V119, P1772, DOI 10.1182/blood-2011-06-358374; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Launay JM, 2005, 5 HYDROXYTRYPTAMINE; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Locker M, 2006, CELL SIGNAL, V18, P628, DOI 10.1016/j.cellsig.2005.06.006; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; Merciris D, 2007, AM J PATHOL, V170, P1676, DOI 10.2353/ajpath.2007.061069; Muller R, 2008, PPAR RES, V2008, DOI 10.1155/2008/614852; Nakalekha C, 2010, J ENDOCRINOL, V204, P125, DOI 10.1677/JOE-09-0376; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Nebigil CG, 2003, FASEB J, V17, P1373, DOI 10.1096/fj.02-1122fje; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; ROBIN JC, 1982, RES COMMUN CHEM PATH, V35, P43; Rosenblum WD, 2010, CARDIOL REV, V18, P58, DOI 10.1097/CRD.0b013e3181cd2c9e; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Tuncbilek G, 2008, J CRANIOFAC SURG, V19, P1472, DOI 10.1097/SCS.0b013e318188a31b; Wainscott DB, 1996, J PHARMACOL EXP THER, V276, P720; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zou MH, 2011, AM J PATHOL, V179, P2835, DOI 10.1016/j.ajpath.2011.08.041	40	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75783	10.1371/journal.pone.0075783	http://dx.doi.org/10.1371/journal.pone.0075783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069449	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300095
J	Chen, JJ; Patel, A; Sodani, K; Xiao, ZJ; Tiwari, AK; Zhang, DM; Li, YJ; Yang, DH; Ye, WC; Chen, SD; Chen, ZS				Chen, Jun-Jiang; Patel, Atish; Sodani, Kamlesh; Xiao, Zhi-Jie; Tiwari, Amit K.; Zhang, Dong-Mei; Li, Ying-Jie; Yang, Dong-Hua; Ye, Wen-Cai; Chen, Si-Dong; Chen, Zhe-Sheng			BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10)	PLOS ONE			English	Article							CASSETTE DRUG TRANSPORTERS; CHINENSIS BUNGE REGEL; CELL LUNG-CANCER; 23-HYDROXYBETULINIC ACID; IN-VIVO; PROTEIN-7 ABCC10; CHEMOTHERAPY; EXPRESSION; ABCB1; VITRO	Natural products are frequently used for adjuvant chemotherapy in cancer treatment. 23-O-(1,4'-bipiperidine-1-carbonyl) betulinic acid (BBA) is a synthetic derivative of 23-hydroxybutulinic acid (23-HBA), which is a natural pentacyclic triterpene and the major active constituent of the root of Pulsatilla chinensis. We previously reported that BBA could reverse P-glycoprotein (P-gp/ABCB1)-mediated multidrug resistance (MDR). In the present study, we investigated whether BBA has the potential to reverse multidrug resistance protein 7 (MRP7/ABCC10)-mediated MDR. We found that BBA concentration-dependently enhanced the sensitivity of MRP7-transfected HEK293 cells to paclitaxel, docetaxel and vinblastine. Accumulation and efflux experiments demonstrated that BBA increased the intracellular accumulation of [H-3]-paclitaxel by inhibiting the efflux of [H-3]-paclitaxel from HEK293/MRP7 cells. In addition, immunoblotting and immunofluorescence analyses indicated no significant alteration of MRP7 protein expression and localization in plasma membranes after treatment with BBA. These results demonstrate that BBA reverses MRP7-mediated MDR through blocking the drug efflux function of MRP7 without affecting the intracellular ATP levels. Our findings suggest that BBA has the potential to be used in combination with conventional chemotherapeutic agents to augment the response to chemotherapy.	[Chen, Jun-Jiang; Chen, Si-Dong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Jun-Jiang; Patel, Atish; Sodani, Kamlesh; Xiao, Zhi-Jie; Tiwari, Amit K.; Chen, Zhe-Sheng] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY USA; [Zhang, Dong-Mei; Li, Ying-Jie; Ye, Wen-Cai] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Yang, Dong-Hua] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Guangdong Pharmaceutical University; Saint John's University; Jinan University; Fox Chase Cancer Center	Chen, SD (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	sdchen2@126.com; chenz@stjohns.edu	; Patel, Atish/J-4699-2014	Sodani, Kamlesh/0000-0003-4488-2984; Chen, Zhe-Sheng/0000-0002-8289-097X; Tiwari, Amit/0000-0002-0275-0724; TIWARI, AMIT K./0000-0002-7427-7155; Patel, Atish/0000-0002-5549-9166	National Institutes of Health [1R15CA143701]; Science and Technology Bureau of Guangzhou City [2011J5200017]; NATIONAL CANCER INSTITUTE [R15CA143701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Bureau of Guangzhou City; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health (No. 1R15CA143701 to Z. S. C.) and Science and Technology Bureau of Guangzhou City (No. 2011J5200017 to S. D. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2001, JPN J CANCER RES, V92, P886, DOI 10.1111/j.1349-7006.2001.tb01177.x; Batrakova EV, 2001, BRIT J CANCER, V85, P1987, DOI 10.1054/bjoc.2001.2165; Bessho Y, 2009, ONCOL REP, V21, P263, DOI 10.3892/or_00000217; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; Chen JJ, 2012, CANCER SCI, V103, P1531, DOI 10.1111/j.1349-7006.2012.02328.x; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; Cheng L, 2008, RAPID COMMUN MASS SP, V22, P3783, DOI 10.1002/rcm.3801; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Ding PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019329; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopper E, 2001, CANCER LETT, V162, P181, DOI 10.1016/S0304-3835(00)00646-7; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Kruh GD, 2007, PFLUG ARCH EUR J PHY, V453, P675, DOI 10.1007/s00424-006-0114-1; Kuang YH, 2010, BIOCHEM PHARMACOL, V79, P154, DOI 10.1016/j.bcp.2009.08.021; Lan P, 2011, EUR J MED CHEM, V46, P2490, DOI 10.1016/j.ejmech.2011.03.038; Lee CH, 2010, METHODS MOL BIOL, V596, P325, DOI 10.1007/978-1-60761-416-6_14; Naramoto H, 2007, INT J ONCOL, V30, P393; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schmidt C, 2008, J NATL CANCER I, V100, P1428, DOI 10.1093/jnci/djn375; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takayanagi Shin-Ichiro, 2004, J Exp Ther Oncol, V4, P239; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Yang M, 2005, RAPID COMMUN MASS SP, V19, P1619, DOI 10.1002/rcm.1961; Zhang DM, 2012, MOL PHARMACEUT, V9, P3147, DOI 10.1021/mp300249s; Zheng YT, 2010, J ETHNOPHARMACOL, V128, P615, DOI 10.1016/j.jep.2010.02.004; Zhou Y, 2009, BIOCHEM PHARMACOL, V77, P993, DOI 10.1016/j.bcp.2008.12.005; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	48	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74573	10.1371/journal.pone.0074573	http://dx.doi.org/10.1371/journal.pone.0074573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069321	gold, Green Submitted, Green Published			2022-12-25	WOS:000324547300045
J	Kozak, I; Sasik, R; Freeman, WR; Sprague, LJ; Gomez, ML; Cheng, LY; El-Emam, S; Mojana, F; Bartsch, DU; Bosten, J; Ayyagari, R; Hardiman, G				Kozak, Igor; Sasik, Roman; Freeman, William R.; Sprague, L. James; Gomez, Maria Laura; Cheng, Lingyun; El-Emam, Sharif; Mojana, Francesca; Bartsch, Dirk-Uwe; Bosten, Jenny; Ayyagari, Radha; Hardiman, Gary			A Degenerative Retinal Process in HIV-Associated Non-Infectious Retinopathy	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR OUTER SEGMENTS; OBJECTIVE ANALYSIS; POSITIVE PATIENTS; UNITED-STATES; MOUSE MODEL; HAART ERA; DYSTROPHY; CALCIUM	HIV retinopathy is the most common non-infectious complication in the eyes of HIV-positive individuals. Oncotic lesions in the retinal nerve fiber layer, referred to as cotton wool spots (CWS), and intraretinal (IR) hemorrhages are frequently observed but are not unique to this pathology. HIV-positive patients have impaired color vision and contrast sensitivity, which worsens with age. Evidence of inner-retinal lesions and damage have been documented ophthalmoscopically, however their long term structural effect has not been investigated. It has been hypothesized that they may be partially responsible for loss of visual function and visual field. In this study we utilized clinical data, retinal imaging and transcriptomics approaches to comprehensively interrogate non-infectious HIV retinopathy. The methods employed encompassed clinical examinations, fundus photography, indirect ophthalmoscopy, Farmsworth-Munsell 100 hue discrimination testing and Illumina BeadChip analyses. Here we show that changes in the outer retina, specifically in the retinal pigment epithelium (RPE) and photoreceptor outer segments (POS) contribute to vision changes in non-infectious HIV retinopathy. We find that in HIV-positive retinae there is an induction of rhodopsin and other transcripts (including PDE6A, PDE6B, PDE6G, CNGA1, CNGB1, CRX, NRL) involved in visual transduction, as well as structural components of the rod photoreceptors (ABCA4 and ROM1). This is consistent with an increased rate of renewal of rod outer segments induced via increased phagocytosis by HIV-infected RPE previously reported in culture. Cone-specific transcripts (OPN1SW, OPN1LW, PDE6C, PDE6H and GRK7) are uniformly downregulated in HIV positive retina, likely due to a partial loss of cone photoreceptors. Active cotton wool spots and intraretinal hemorrhages (IRH) may not affect photoreceptors directly and the interaction of photoreceptors with the aging RPE may be the key to the progressive vision changes in HIV-positive patients.	[Kozak, Igor; Freeman, William R.; Gomez, Maria Laura; Cheng, Lingyun; El-Emam, Sharif; Mojana, Francesca; Bartsch, Dirk-Uwe; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA 92093 USA; [Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sasik, Roman; Sprague, L. James; Hardiman, Gary] Univ Calif San Diego, Sch Med, BIOGEM, La Jolla, CA 92093 USA; [Bosten, Jenny] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Freeman, WR (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA 92093 USA.	wrfreeman@ucsd.edu; gthardiman@ucsd.edu	Kozak, Igor/AAC-4645-2019; Bosten, Jenny/AAB-1559-2019; Emam, Sharif El/AAA-6627-2020; Bosten, Jenny M/N-6211-2015	Bosten, Jenny/0000-0001-8944-0990; Emam, Sharif El/0000-0001-6357-0471; Bosten, Jenny M/0000-0001-8944-0990; Hardiman, Gary/0000-0003-4558-0400	National Eye Institute (NEI) National Institutes of Health (NIH)-NEI [EY16323]; NIH [EY07366, DK063491, CA023100, DK080506]; Research to Prevent Blindness, New York City, New York; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007366, P30EY022589, R01EY016323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R24DK080506] Funding Source: NIH RePORTER	National Eye Institute (NEI) National Institutes of Health (NIH)-NEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York City, New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Eye Institute (NEI) National Institutes of Health (NIH)-NEI grant EY16323 (DUB), NIH grant #EY07366 (WRF), Research to Prevent Blindness, New York City, New York (WRF is the recipient of an RPB Physician Scientist award and an unrestricted grant to University of California San Diego (UCSD)), and unrestricted grants to the UCSD Jacobs Retina Center. GH gratefully acknowledge support from NIH grants DK063491, CA023100 and DK080506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Canki M, 2000, AIDS RES HUM RETROV, V16, P453, DOI 10.1089/088922200309115; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; DERETIC D, 1994, J BIOL CHEM, V269, P16853; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; EISENFELD AJ, 1984, J COMP NEUROL, V223, P22, DOI 10.1002/cne.902230103; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Falkenstein IA, 2008, AM J OPHTHALMOL, V146, P579, DOI 10.1016/j.ajo.2007.12.021; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fliesler SJ, 2010, ADV EXP MED BIOL, V664, P481, DOI 10.1007/978-1-4419-1399-9_55; FREEMAN WR, 1984, AM J OPHTHALMOL, V97, P133, DOI 10.1016/S0002-9394(14)76082-9; Fulton AB, 1999, INVEST OPHTH VIS SCI, V40, P1878; Goldbaum Michael H, 2008, Trans Am Ophthalmol Soc, V106, P196; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Kozak I, 2010, RETINA, V30, P910; Kozak Igor, 2007, Trans Am Ophthalmol Soc, V105, P111; Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Lansky A, 2010, JAIDS-J ACQ IMM DEF, V55, pS64, DOI 10.1097/QAI.0b013e3181fbbe15; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; MCLEOD D, 1981, J ROY SOC MED, V74, P682, DOI 10.1177/014107688107400912; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Moschos MM, 2007, OCUL IMMUNOL INFLAMM, V15, P319, DOI 10.1080/09273940701375154; NEWMAN NM, 1987, BRIT J OPHTHALMOL, V71, P21, DOI 10.1136/bjo.71.1.21; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Roy SS, 2008, METHODS, V46, P213, DOI 10.1016/j.ymeth.2008.09.024; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Shah KH, 2006, AM J OPHTHALMOL, V142, P284, DOI 10.1016/j.ajo.2006.03.046; Strettoi E, 2002, J NEUROSCI, V22, P5492; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson DA, 2002, AM J HUM GENET, V70, P224, DOI 10.1086/338455; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; Werner JS, 2011, EYE, V25, P279, DOI 10.1038/eye.2010.218; Zhang L, 2011, EYE, V25, P519, DOI 10.1038/eye.2011.7	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74712	10.1371/journal.pone.0074712	http://dx.doi.org/10.1371/journal.pone.0074712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069333	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324547300051
J	Theobaldo, MC; Llimona, F; Petroni, RC; Rios, ECS; Velasco, IT; Soriano, FG				Theobaldo, Mariana Cardillo; Llimona, Flavia; Petroni, Ricardo Costa; Rios, Ester Correia Sarmento; Velasco, Irineu Tadeu; Soriano, Francisco Garcia			Hypertonic Saline Solution Drives Neutrophil from Bystander Organ to Infectious Site in Polymicrobial Sepsis: A Cecal Ligation and Puncture Model	PLOS ONE			English	Article							SEVERE HEMORRHAGIC-SHOCK; SEPTIC SHOCK; RESUSCITATION; MORTALITY; EPIDEMIOLOGY; PATHOGENESIS; PERITONITIS; RECRUITMENT; STRATEGIES; CLEARANCE	The effects of hypertonic saline solution (HSS) have been shown in several animal models of ischemia and shock. Literature has shown potential benefits of HSS modulating inflammatory response after sepsis in an animal model. We studied the HSS effects in sepsis through cecal ligation and puncture (CLP) in Balb-C mice. Groups studied: 1-CLP without treatment (CLP-C); 2-CLP treated with normal saline solution NaCl 0.9% - 34 ml/Kg (CLP-S); 3-CLP treated with HSS NaCl 7.5% - 4 ml/Kg (CLPH); and 4-group (Basal) without no CLP or treatment. Volume infusion was always applied 30 min after CLP. Lung and peritoneal lavage were harvested after 6h and 24h of CLP to analyze cytokines amount, oxide nitric, lipid peroxidation and neutrophil infiltration. Neutrophil infiltration, ICAM-1, CXCR-2, and CXCL-1 in lung were reduced by HSS (CLP-H) compared to CLP-C or CLP-S. Neutrophil in peritoneal lavage was increased in 24h with HSS (CLP-H) compared to CLP and CLP-S. Peritoneal CXCR-2 was increased in CLP-C and CLP-S but presented a lower increase with HSS (CLP-H) after 6 hours. GRK-2 presented difference among the groups at 24 h, showing a profile similar to neutrophil infiltration. Pro-inflammatory cytokines (TNF-alpha and IL-6) were reduced by HSS treatment; CLP-S increased TNF-alpha IL-10 was increased in lung tissue by the HSS treatment. The oxidative stress (TBARS and nitric oxide biochemistry markers) was reduced with HSS. Animal survival was 33.3% in CLP-C group, 46.6% in CLP-S group and 60% in the CLP-H group after the sixth day. The HSS protects the animal against sepsis. Our results suggest that the volume replacement modulate pro and anti-inflammatory mediators of an inflammatory response, but HSS presented a more effective and potent effect.	[Theobaldo, Mariana Cardillo; Llimona, Flavia; Petroni, Ricardo Costa; Rios, Ester Correia Sarmento; Velasco, Irineu Tadeu; Soriano, Francisco Garcia] Univ Sao Paulo, Fac Med, Emergency Med Div, Sao Paulo, Brazil	Universidade de Sao Paulo	Soriano, FG (corresponding author), Univ Sao Paulo, Fac Med, Emergency Med Div, Sao Paulo, Brazil.	gsoriano@usp.br	Petroni, Ricardo/K-5144-2013; Soriano, Francisco/C-3382-2012	Soriano, Francisco/0000-0003-4898-0135	FAPESP [2009/15530-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP grant 2009/15530-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; da Silva FP, 2009, FRONT BIOSCI-LANDMRK, V14, P4464, DOI 10.2741/3542; Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; GLAUSER MP, 1994, CLIN INFECT DIS, V18, pS205, DOI 10.1093/clinids/18.Supplement_2.S205; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Noppens RR, 2012, CRIT CARE MED, V40, P2149, DOI 10.1097/CCM.0b013e31824e6750; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Conde KAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064790; Petroni RC, 2012, SHOCK, V37, P524, DOI 10.1097/SHK.0b013e31824c7665; Remick DG, 1998, CRIT CARE MED, V26, P895, DOI 10.1097/00003246-199805000-00025; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rios ECS, 2011, CLINICS, V66, P469, DOI 10.1590/S1807-59322011000300019; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SILVA MRF, 1987, AM J PHYSIOL, V253, pH751, DOI 10.1152/ajpheart.1987.253.4.H751; Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008; Soriano FG, 2001, CRIT CARE MED, V29, P703, DOI 10.1097/00003246-200104000-00001; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Haren FMP, 2012, SHOCK, V37, P268, DOI 10.1097/SHK.0b013e31823f152f; VELASCO IT, 1989, CRIT CARE MED, V17, P261, DOI 10.1097/00003246-198903000-00012; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; ZAPATASIRVENT RL, 1995, BURNS, V21, P185, DOI 10.1016/0305-4179(95)80006-A	43	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74369	10.1371/journal.pone.0074369	http://dx.doi.org/10.1371/journal.pone.0074369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069301	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300037
J	Weibel, R; Reiss, D; Karchewski, L; Gardon, O; Matifas, A; Filliol, D; Becker, JAJ; Wood, JN; Kieffer, BL; Gaveriaux-Ruff, C				Weibel, Raphael; Reiss, David; Karchewski, Laurie; Gardon, Olivier; Matifas, Audrey; Filliol, Dominique; Becker, Jerome A. J.; Wood, John N.; Kieffer, Brigitte L.; Gaveriaux-Ruff, Claire			Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout Mice	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; MESSENGER-RNA EXPRESSION; SPINAL-CORD; SENSORY NEURONS; RELATIVE CONTRIBUTION; NEUROPATHIC PAIN; RAT MODEL; MORPHINE; DELTA; GENE	Opiates are powerful drugs to treat severe pain, and act via mu opioid receptors distributed throughout the nervous system. Their clinical use is hampered by centrally-mediated adverse effects, including nausea or respiratory depression. Here we used a genetic approach to investigate the potential of peripheral mu opioid receptors as targets for pain treatment. We generated conditional knockout (cKO) mice in which mu opioid receptors are deleted specifically in primary afferent Nav1.8-positive neurons. Mutant animals were compared to controls for acute nociception, inflammatory pain, opiate-induced analgesia and constipation. There was a 76% decrease of mu receptor-positive neurons and a 60% reduction of mu-receptor mRNA in dorsal root ganglia of cKO mice. Mutant mice showed normal responses to heat, mechanical, visceral and chemical stimuli, as well as unchanged morphine antinociception and tolerance to antinociception in models of acute pain. Inflammatory pain developed similarly in cKO and controls mice after Complete Freund's Adjuvant. In the inflammation model, however, opiate-induced (morphine, fentanyl and loperamide) analgesia was reduced in mutant mice as compared to controls, and abolished at low doses. Morphine-induced constipation remained intact in cKO mice. We therefore genetically demonstrate for the first time that mu opioid receptors partly mediate opiate analgesia at the level of Nav1.8-positive sensory neurons. In our study, this mechanism operates under conditions of inflammatory pain, but not nociception. Previous pharmacology suggests that peripheral opiates may be clinically useful, and our data further demonstrate that Nav1.8 neuron-associated mu opioid receptors are feasible targets to alleviate some forms of persistent pain.	[Weibel, Raphael; Reiss, David; Karchewski, Laurie; Gardon, Olivier; Matifas, Audrey; Filliol, Dominique; Becker, Jerome A. J.; Kieffer, Brigitte L.; Gaveriaux-Ruff, Claire] UdS Univ Strasbourg, IGBMC, Translat Med & Neurogenet Programme, INSERM,U964,CNRS,UMR7104, Illkirch Graffenstaden, France; [Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Gaveriaux-Ruff, Claire] UdS Univ Strasbourg, ESBS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Gaveriaux-Ruff, C (corresponding author), UdS Univ Strasbourg, IGBMC, Translat Med & Neurogenet Programme, INSERM,U964,CNRS,UMR7104, Illkirch Graffenstaden, France.	gaveriau@igbmc.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Becker, Jerome/I-7879-2016	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Becker, Jerome/0000-0002-0039-0067	Universite de Strasbourg (UdS); CNRS; INSERM; ANR LYMPHOPIOID (CG-R); National Institute of Health, USA [NIAAA 016658, NIDA 005010, NIDA 016768]; European Union [GENADDICT/FP6 005166]; Wellcome Trust; MRC; BBSRC; Universite de Strasbourg (CG-R); NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; Medical Research Council [G0901905] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; MRC [G0901905] Funding Source: UKRI	Universite de Strasbourg (UdS); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR LYMPHOPIOID (CG-R)(French National Research Agency (ANR)); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Universite de Strasbourg (CG-R); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by: Universite de Strasbourg (UdS, CG-R), CNRS, INSERM, ANR LYMPHOPIOID (CG-R), the National Institute of Health, USA (NIAAA 016658, BLK; NIDA 005010, BLK; NIDA 016768, BLK and RM), and the European Union (GENADDICT/FP6 005166, BLK RM); the Wellcome Trust, MRC and BBSRC (JNW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2002, BRAIN RES, V930, P150, DOI 10.1016/S0006-8993(02)02242-4; Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Baamonde A, 2005, N-S ARCH PHARMACOL, V372, P213, DOI 10.1007/s00210-005-0013-6; Ballet S, 2003, NEUROPEPTIDES, V37, P211, DOI 10.1016/S0143-4179(03)00045-3; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; BESSE D, 1992, BRAIN RES, V578, P115, DOI 10.1016/0006-8993(92)90237-4; Boue J, 2012, PAIN, V153, P485, DOI 10.1016/j.pain.2011.11.013; Cabanero D, 2009, PAIN, V141, P88, DOI 10.1016/j.pain.2008.10.011; Calza L, 2000, EXP NEUROL, V164, P333, DOI 10.1006/exnr.2000.7442; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chattopadhyay M, 2008, J NEUROSCI, V28, P6652, DOI 10.1523/JNEUROSCI.5530-07.2008; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; Dehaven-Hudkins DL, 1999, J PHARMACOL EXP THER, V289, P494; Dominguez JE, 2013, CURR OPIN ANESTHESIO, V26, P288, DOI 10.1097/ACO.0b013e328360b086; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Gautron L, 2011, J COMP NEUROL, V519, P3085, DOI 10.1002/cne.22667; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; GAVERIAUXRUFF C, 2013, CURR PHARM DESIGN, P48470; Gonzalez-Rodriguez S, 2010, CELL MOL NEUROBIOL, V30, P113, DOI 10.1007/s10571-009-9436-9; GUSTAFSSON LL, 1985, ANESTHESIOLOGY, V63, P483, DOI 10.1097/00000542-198511000-00003; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Joseph EK, 2010, NEUROSCIENCE, V171, P344, DOI 10.1016/j.neuroscience.2010.08.035; Khalefa BI, 2012, EUR J PAIN, V16, P690, DOI 10.1002/j.1532-2149.2011.00070.x; Kreek MJ, 2012, J CLIN INVEST, V122, P3387, DOI 10.1172/JCI60390; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; LAMOTTE C, 1976, BRAIN RES, V112, P407, DOI 10.1016/0006-8993(76)90296-1; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lewanowitsch T, 2006, LIFE SCI, V78, P682, DOI 10.1016/j.lfs.2005.05.062; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; Lutz PE, 2013, CURR OPIN NEUROBIOL, V23, P473, DOI 10.1016/j.conb.2013.02.005; Lynch JL, 2008, BRAIN RES, V1191, P180, DOI 10.1016/j.brainres.2007.11.034; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Negus SS, 2006, J PHARMACOL EXP THER, V319, P507, DOI 10.1124/jpet.106.106377; Nozaki C, 2011, NAT NEUROSCI, V14, P1017, DOI 10.1038/nn.2844; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pol O, 2006, NEUROPHARMACOLOGY, V50, P123, DOI 10.1016/j.neuropharm.2005.11.002; Pradhan AAA, 2010, J NEUROSCI, V30, P16459, DOI 10.1523/JNEUROSCI.3748-10.2010; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Ringkamp M, 2012, EUR J PAIN, V16, P621, DOI 10.1002/j.1532-2149.2012.00110.x; Roy S, 1998, MOL BRAIN RES, V56, P281, DOI 10.1016/S0169-328X(98)00051-5; Sasaki A, 2008, NEUROREPORT, V19, P975, DOI 10.1097/WNR.0b013e328302f123; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schramm CL, 2010, PAIN, V151, P763, DOI 10.1016/j.pain.2010.09.009; Schug SA, 2006, CNS DRUGS, V20, P917, DOI 10.2165/00023210-200620110-00005; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; Shinoda K, 2007, NEUROSCI LETT, V411, P143, DOI 10.1016/j.neulet.2006.10.027; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thibault K, 2008, EUR J PHARMACOL, V600, P71, DOI 10.1016/j.ejphar.2008.10.004; Vetter I, 2012, EMBO J, V31, P3795, DOI 10.1038/emboj.2012.207; Wang H, 2001, J COMP NEUROL, V429, P590, DOI 10.1002/1096-9861(20010122)429:4<590::AID-CNE6>3.0.CO;2-V; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Zhang GH, 2008, ANESTHESIOLOGY, V108, P305, DOI 10.1097/01.anes.0000299836.61785.79; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	72	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74706	10.1371/journal.pone.0074706	http://dx.doi.org/10.1371/journal.pone.0074706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069332	Green Published, gold			2022-12-25	WOS:000326240100116
J	Xu, YX; Ma, AN; Liu, L				Xu, Yu-Xin; Ma, Anna; Liu, Li			Transforming Growth Factor beta Signaling Upregulates the Expression of Human GDP-Fucose Transporter by Activating Transcription Factor Sp1	PLOS ONE			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; RNA-POLYMERASE-II; BINDING-PROTEIN; TGF-BETA; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; MESSENGER-RNA; GLYCOSYLATION; INITIATOR; PROMOTER	GDP-fucose transporter plays a crucial role in fucosylation of glycoproteins by providing activated fucose donor, GDPfucose, for fucosyltransferases in the lumen of the Golgi apparatus. Fucose-containing glycans are involved in many biological processes, which are essential for growth and development. Mutations in the GDP-fucose transporter gene cause leukocyte adhesion deficiency syndrome II, a disease characterized by slow growth, mental retardation and immunodeficiency. However, no information is available regarding its transcriptional regulation. Here, by using human cells, we show that TGF-beta 1 specifically induces the GDP-fucose transporter expression, but not other transporters tested such as CMP-sialic acid transporter, suggesting a diversity of regulatory pathways for the expression of these transporters. The regulatory elements that are responsive to the TGF-beta 1 stimulation are present in the region between bp -330 and -268 in the GDP-fucose transporter promoter. We found that this region contains two identical octamer GC-rich motifs (GGGGCGTG) that were demonstrated to be essential for the transporter expression. We also show that the transcription factor Sp1 specifically binds to the GC-rich motifs in vitro and Sp1 coupled with phospho-Smad2 is associated with the promoter region covering the Sp1-beta inding motifs in vivo using chromatin immunoprecipitation (ChIP) assays. In addition, we further confirmed that Sp1 is essential for the GDP-fucose transporter expression stimulated by TGF-beta 1 using a luciferase reporter system. These results highlight the role of TGF-beta signaling in regulation of the GDP-fucose transporter expression via activating Sp1. This is the first transcriptional study for any nucleotide sugar transporters that have been identified so far. Notably, TGF-beta 1 receptor itself is known to be modified by fucosylation. Given the essential role of GDP-fucose transporter in fucosylation, the finding that TGF-beta 1 stimulates the expression of this transporter, suggests a possible intracellular link between the function of nucleotide sugar transporter and the TGF-beta signaling pathway.	[Xu, Yu-Xin; Ma, Anna; Liu, Li] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Xu, Yu-Xin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Xu, Yu-Xin] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liu, L (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	liul@bu.edu		Xu, Yu-Xin/0000-0002-0200-4633	NIH [GM30365]; American Heart Association SDG [11SDG7670007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association SDG(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work was financially supported by NIH Grant R01 (GM30365) to Carlos B. Hirschberg and by American Heart Association SDG (11SDG7670007) to Yu-Xin Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; CARCAMO J, 1991, P NATL ACAD SCI USA, V88, P8052, DOI 10.1073/pnas.88.18.8052; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Kumamoto K, 2001, CANCER RES, V61, P4620; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Liu L, 2013, J BIOL CHEM; Liu L, 2013, GLYCOCONJUGATE J, V30, P5, DOI 10.1007/s10719-012-9375-4; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MARTINEZ E, 1994, EMBO J, V13, P3115, DOI 10.1002/j.1460-2075.1994.tb06610.x; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P91, DOI 10.2133/dmpk.24.91; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PURNELL BA, 1993, MOL CELL BIOL, V13, P2593, DOI 10.1128/MCB.13.4.2593; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Schachter H, 2005, P NATL ACAD SCI USA, V102, P15721, DOI 10.1073/pnas.0507659102; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Taylor IW, 2008, CELL, V133, DOI 10.1016/j.cell.2008.04.007; Thanabalasingham G, 2013, DIABETES, V62, P1329, DOI 10.2337/db12-0880; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Xu YX, 2010, J BIOL CHEM, V285, P24600, DOI 10.1074/jbc.M110.134544; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503	49	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74424	10.1371/journal.pone.0074424	http://dx.doi.org/10.1371/journal.pone.0074424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069312	gold, Green Submitted, Green Published			2022-12-25	WOS:000326240100106
J	Chen, KH; Dasgupta, A; Ding, JH; Indig, FE; Ghosh, P; Longo, DL				Chen, Kuang-Hueih; Dasgupta, Asish; Ding, Jinhui; Indig, Fred E.; Ghosh, Paritosh; Longo, Dan L.			Role of mitofusin 2 ( Mfn2) in controlling cellular proliferation	FASEB JOURNAL			English	Article						HSG; Ras; Raf; ERK	TUMOR-SUPPRESSOR; RASSF FAMILY; APOPTOSIS; DOMAIN; EXPRESSION; MUTATIONS; PATHWAY	It has been reported that Mitofusin2 (Mfn2) inhibits cell proliferation when overexpressed. We wanted to study the role of endogenous Mfn2 in cell proliferation, along with the structural features of Mfn2 that influence its mitochondrial localization and control of cell proliferation. Mfn2-knockdown clones of a B-cell lymphoma cell line BJAB exhibited an increased rate of cell proliferation. A 2-fold increase in cell proliferation was also observed in Mfn2-knockout mouse embryonic fibroblast (MEF) cells as compared with the control wild-type cells, and the proliferative advantage of the knockout MEF cells was blocked on reintroduction of the Mfn2 gene. Mfn2 exerts its antiproliferative effect by acting as an effector molecule of Ras, resulting in the inhibition of the Ras-Raf-ERK signaling pathway. Furthermore, both the N-terminal (aa 1-264) and the C-terminal (aa 265-757) fragments of Mfn2 blocked cell proliferation through distinct mechanisms: the N-terminal-mediated inhibition was due to its interaction with Raf-1, whereas the C-terminal fragment of Mfn2 inhibited cell proliferation by interacting with Ras. The inhibition of proliferation by the N-terminal fragment was independent of its mitochondrial localization. Collectively, our data provide new insights regarding the role of Mfn2 in controlling cellular proliferation.Chen, K.-H., Dasgupta, A., Ding, J., Indig, F. E., Ghosh, P., Longo, D. L. Role of Mitofusin 2 (Mfn2) in controlling cellular proliferation.	[Chen, Kuang-Hueih; Dasgupta, Asish; Ghosh, Paritosh; Longo, Dan L.] NIA, Lymphocyte Cell Biol Unit, Genet Lab, Biomed Res Ctr,NIH, Baltimore, MD 21224 USA; [Ding, Jinhui] NIA, Bioinformat Facil, Neurogenet Lab, NIH, Baltimore, MD 21224 USA; [Indig, Fred E.] NIA, Confocal Imaging Facil, NIH, Baltimore, MD 21224 USA; [Chen, Kuang-Hueih] MedStar Res Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ghosh, P (corresponding author), NIA, Lymphocyte Cell Biol Unit, Genet Lab, NIH,Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	kuanghueihchen@yahoo.com; ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000451, ZICAG000615] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Dr. David C. Chan (Division of Biology, California Institute of Technology, Pasadena, CA, USA) for WT and Mfn2-knockout MEFs. The authors thank Drs. Carl Sasaki and Jessica Curtis for technical assistance and Rachel Munk for help in editing the paper. The authors also thank the Flow Cytometry facility at the National Institute on Aging for help in cell cycle analysis. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Institute on Aging.	Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chien KR, 2004, NAT CELL BIOL, V6, P807, DOI 10.1038/ncb0904-807; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rojo M, 2002, J CELL SCI, V115, P1663; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Wu L, 2008, MOL CANCER THER, V7, P222, DOI 10.1158/1535-7163.MCT-07-0382; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	26	79	89	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					382	394		10.1096/fj.13-230037	http://dx.doi.org/10.1096/fj.13-230037			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24081906	Green Published			2022-12-25	WOS:000333526100036
J	Park, M; Kim, HJ; Lim, B; Wylegala, A; Toborek, M				Park, Minseon; Kim, Hyun-Jung; Lim, Brian; Wylegala, Adam; Toborek, Michal			Methamphetamine-induced Occludin Endocytosis Is Mediated by the Arp2/3 Complex-regulated Actin Rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Brain; Cytoskeleton; Endocytosis; Endothelium; Tight Junctions; Methamphetamine; Arp2; 3 Complex; Actin; Nucleation; Blood-Brain Barrier; Occludin; Endocytosis; Endo	BLOOD-BRAIN-BARRIER; TIGHT JUNCTION PERMEABILITY; OXIDATIVE STRESS; CORONIN 1B; N-WASP; PROTEIN; BINDING; EXPRESSION; PHOSPHORYLATION; CYTOSKELETON	Background: Methamphetamine is a drug of abuse that disrupts the blood-brain barrier. Results: Blocking actin nucleation protects against methamphetamine-induced occludin internalization and disruption of blood-brain barrier integrity. Conclusion: Methamphetamine-induced transendothelial breaches may result from actin-mediated redistribution of occludin. Significance: Actin cytoskeletal dynamics modulates redistribution of occludin and blood-brain barrier integrity. Methamphetamine (METH) is a drug of abuse with neurotoxic and neuroinflammatory effects, which include disruption of the blood-brain barrier (BBB) and alterations of tight junction protein expression. This study focused on the actin cytoskeletal rearrangement as a modulator of METH-induced redistribution of tight junction protein occludin in brain endothelial cells. Exposure to METH resulted in a shift of occludin localization from plasma membranes to endosomes. These changes were accompanied by activation of the actin-related protein 2/3 (Arp2/3) complex, which stimulates actin polymerization by promoting actin nucleation. In addition, METH-induced coronin-1b phosphorylation diminishes the inhibitory effect of nonphosphorylated coronin-1b on actin nucleation. Blocking actin nucleation with CK-666, a specific inhibitor of the Arp2/3 complex, protected against METH-induced occludin internalization and increased transendothelial monocyte migration. Importantly, treatment with CK-666 attenuated a decrease in occludin levels in brain microvessels and BBB permeability of METH-injected mice. These findings indicate that actin cytoskeletal dynamics is detrimental to METH-induced BBB dysfunction by increasing internalization of occludin.	[Park, Minseon; Kim, Hyun-Jung; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Lim, Brian; Wylegala, Adam] Univ Kentucky, Dept Neurosurg, Lexington, KY 40536 USA	University of Miami; University of Kentucky	Park, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.	mspark@med.miami.edu; mtoborek@med.miami.edu	Wylęgała, Adam/AAK-5951-2020	Wylegala, Adam/0000-0001-7295-4936	National Institutes of Health [DA027569, MH072567, MH098891, MH063022]; Miami Center for AIDS Research at the University of Miami [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098891, R01MH063022, R01MH072567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Center for AIDS Research at the University of Miami; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA027569, MH072567, and MH098891 (to M. T.) and MH063022 (to M. P.). This work was also supported by Grant P30AI073961 (to M. P.) from the Miami Center for AIDS Research at the University of Miami.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen Jack P, 2007, J Invasive Cardiol, V19, pE89; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Colfax Grant, 2005, Curr HIV/AIDS Rep, V2, P194, DOI 10.1007/s11904-005-0016-4; Cunha-Oliveira T, 2008, BRAIN RES REV, V58, P192, DOI 10.1016/j.brainresrev.2008.03.002; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hirase T, 1997, J CELL SCI, V110, P1603; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Martins T, 2011, BRAIN RES, V1411, P28, DOI 10.1016/j.brainres.2011.07.013; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Ohta K, 2005, J EMERG MED, V28, P165, DOI 10.1016/j.jemermed.2004.06.015; Park M, 2012, J CELL MOL MED, V16, P362, DOI 10.1111/j.1582-4934.2011.01320.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Srikanth S, 2008, CARDIOLOGY, V109, P188, DOI 10.1159/000106681; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Toborek M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-22; Torii H, 2007, PHARMACOL RES, V55, P104, DOI 10.1016/j.phrs.2006.10.010; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	64	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33324	33334		10.1074/jbc.M113.483487	http://dx.doi.org/10.1074/jbc.M113.483487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24081143	Green Published, hybrid			2022-12-25	WOS:000328841700047
J	Kang, GY; Pyun, BJ; Seo, HR; Jin, YB; Lee, HJ; Lee, YJ; Lee, YS				Kang, Ga-Young; Pyun, Bo-Jeong; Seo, Haeng Ran; Jin, Yeung Bae; Lee, Hae-June; Lee, Yoon-Jin; Lee, Yun-Sil			Inhibition of Snail1-DNA-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Migration; p53; Peptides; Phosphorylation; DNA-PKcs; Sensitization; Snail1; Snail1 Phosphorylation	EPITHELIAL-MESENCHYMAL TRANSITION; DNA-PK; TELOMERE LENGTH; CATALYTIC SUBUNIT; HISTONE H2AX; TGF-BETA; SNAIL; EXPRESSION; RESISTANCE; MICE	Our previous study suggested that the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) interacts with Snail1, which affects genomic instability, sensitivity to DNA-damaging agents, and migration of tumor cells by reciprocal regulation between DNA-PKcs and Snail1. Here, we further investigate that a peptide containing 7-amino acid sequences (amino acids 15-21) of Snail1 (KPNYSEL, SP) inhibits the endogenous interaction between DNA-PKcs and Snail1 through primary interaction with DNA-PKcs. SP restored the inhibited DNA-PKcs repair activity and downstream pathways. On the other hand, DNA-PKcs-mediated phosphorylation of Snail1 was inhibited by SP, which resulted in decreased Snail1 stability and Snail1 functions. However, these phenomena were only shown in p53 wild-type cells, not in p53-defective cells. From these results, it is suggested that interfering with the protein interaction between DNA-PKcs and Snail1 might be an effective strategy for sensitizing cancer cells and inhibiting tumor migration, especially in both Snail1-overexpressing and DNA-PKcs-overexpressing cancer cells with functional p53.	[Kang, Ga-Young; Pyun, Bo-Jeong; Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Seo, Haeng Ran; Lee, Hae-June; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Radiat Effects, Seoul 139706, South Korea; [Jin, Yeung Bae] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si 580185, Jeollabuk Do, South Korea	Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Korea Atomic Energy Research Institute (KAERI)	Lee, YS (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	yslee0425@ewha.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Advanced Research Center for Nuclear Excellence [2011-0031696]; National Research Foundation of Korea (NRF) [2011-0013364]; Korean government (MEST); Ewha Womans University	Advanced Research Center for Nuclear Excellence; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University	This work was supported by a grant from the Advanced Research Center for Nuclear Excellence (2011-0031696), a grant from the Mid-career Researcher Program (2011-0013364) of the National Research Foundation of Korea (NRF), and funding by the Korean government (MEST). This work was also supported by an Ewha Global Top 5 Grant 2013 from Ewha Womans University.	ALLALUNISTURNER MJ, 1995, CANCER RES, V55, P5200; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chiang C, 2013, CYTOKINE GROWTH F R, V24, P123, DOI 10.1016/j.cytogfr.2012.09.002; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Garcia-Barros M, 2010, CANCER RES, V70, P8179, DOI 10.1158/0008-5472.CAN-10-1871; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kajiyama H, 2007, INT J ONCOL, V31, P277; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LEE KB, 1993, CARCINOGENESIS, V14, P2177, DOI 10.1093/carcin/14.10.2177; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pyun BJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.43; Reitsema T, 2005, DNA REPAIR, V4, P1172, DOI 10.1016/j.dnarep.2005.06.005; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Wong RHF, 2009, CELL CYCLE, V8, P1977; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Youn CK, 2004, CANCER RES, V64, P4849, DOI 10.1158/0008-5472.CAN-04-0348; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	43	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32506	32516		10.1074/jbc.M113.479840	http://dx.doi.org/10.1074/jbc.M113.479840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085291	hybrid, Green Published			2022-12-25	WOS:000328681700034
J	He, J; Stewart, K; Kinnell, HL; Anderson, RA; Childs, AJ				He, Jing; Stewart, Kayleigh; Kinnell, Hazel L.; Anderson, Richard A.; Childs, Andrew J.			A Developmental Stage-Specific Switch from DAZL to BOLL Occurs during Fetal Oogenesis in Humans, but Not Mice	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; RNA-BINDING PROTEIN; IN-VIVO; FAMILY PROTEINS; PUMILIO-2 PUM2; REGULATOR DAZL; HUMAN OVARY; DIFFERENTIATION; TRANSLATION; GENE	The Deleted in Azoospermia gene family encodes three germ cell-specific RNA-binding proteins (DAZ, DAZL and BOLL) that are essential for gametogenesis in diverse species. Targeted disruption of Boll in mice causes male-specific spermiogenic defects, but females are apparently fertile. Overexpression of human BOLL promotes the derivation of germ cell-like cells from genetically female (XX), but not male (XY) human ES cells however, suggesting a functional role for BOLL in regulating female gametogenesis in humans. Whether BOLL is expressed during oogenesis in mammals also remains unclear. We have therefore investigated the expression of BOLL during fetal oogenesis in humans and mice. We demonstrate that BOLL protein is expressed in the germ cells of the human fetal ovary, at a later developmental stage than, and almost mutually-exclusive to, the expression of DAZL. Strikingly, BOLL is downregulated, and DAZL re-expressed, as primordial follicles form, revealing BOLL expression to be restricted to a narrow window during fetal oogenesis. By quantifying the extent of co-expression of DAZL and BOLL with markers of meiosis, we show that this window likely corresponds to the later stages of meiotic prophase I. Finally, we demonstrate that Boll is also transiently expressed during oogenesis in the fetal mouse ovary, but is simultaneously co-expressed within the same germ cells as Dazl. These data reveal significant similarities and differences between the expression of BOLL homologues during oogenesis in humans and mice, and raise questions as to the validity of the Boll(-/-) mouse as a model for understanding BOLL function during human oogenesis.	[He, Jing; Stewart, Kayleigh; Kinnell, Hazel L.; Anderson, Richard A.; Childs, Andrew J.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Childs, Andrew J.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Edinburgh; University of London; University of London Royal Veterinary College	Childs, AJ (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	achilds@rvc.ac.uk		Childs, Andrew/0000-0003-3937-4037	Medical Research Foundation [354FRG]; Medical Research Council [G1100357]; University of Edinburgh Darwin Scholarship; Society for Reproduction and Fertility Summer Vacation Scholarship; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; Medical Research Council [G1002033, G1002118] Funding Source: researchfish	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Darwin Scholarship; Society for Reproduction and Fertility Summer Vacation Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Foundation [grant 354FRG to AJC] and the Medical Research Council [grant G1100357 to RAA]. J.H. is supported by a University of Edinburgh Darwin Scholarship and K.S. is the recipient of a Society for Reproduction and Fertility Summer Vacation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020249; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Hamer G, 2004, BIOL REPROD, V70, P1206, DOI 10.1095/biolreprod.103.024950; Hartley PS, 2002, J CLIN ENDOCR METAB, V87, P3417, DOI 10.1210/jc.87.7.3417; Hartshorne GM, 2009, MOL HUM REPROD, V15, P805, DOI 10.1093/molehr/gap055; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; He Jing, 2013, Methods Mol Biol, V957, P59, DOI 10.1007/978-1-62703-191-2_4; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Maines JZ, 1999, NAT CELL BIOL, V1, P171, DOI 10.1038/11091; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Roig I, 2004, CHROMOSOMA, V113, P22, DOI 10.1007/s00412-004-0290-8; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Urano J, 2005, MOL REPROD DEV, V71, P290, DOI 10.1002/mrd.20270; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; Zeng M, 2008, BMB REP, V41, P300, DOI 10.5483/BMBRep.2008.41.4.300; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1; Zheng P, 2010, BIOL REPROD, V82, P543, DOI 10.1095/biolreprod.109.079590	51	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73996	10.1371/journal.pone.0073996	http://dx.doi.org/10.1371/journal.pone.0073996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086306	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700016
J	Landa, I; Boullosa, C; Inglada-Perez, L; Sastre-Perona, A; Pastor, S; Velazquez, A; Mancikova, V; Ruiz-Llorente, S; Schiavi, F; Marcos, R; Malats, N; Opocher, G; Diaz-Uriarte, R; Santisteban, P; Valencia, A; Robledo, M				Landa, Inigo; Boullosa, Cesar; Inglada-Perez, Lucia; Sastre-Perona, Ana; Pastor, Susana; Velazquez, Antonia; Mancikova, Veronika; Ruiz-Llorente, Sergio; Schiavi, Francesca; Marcos, Ricard; Malats, Nuria; Opocher, Giuseppe; Diaz-Uriarte, Ramon; Santisteban, Pilar; Valencia, Alfonso; Robledo, Mercedes			An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility	PLOS ONE			English	Article							CARCINOMA CELL-LINE; DEGREE RELATIVES; RISK; ASSOCIATION; RECEPTOR; DISEASE; TSHR; POLYMORPHISMS; POPULATION; EXPRESSION	Papillary Thyroid Cancer (PTC) is a heterogeneous and complex disease; susceptibility to PTC is influenced by the joint effects of multiple common, low-penetrance genes, although relatively few have been identified to date. Here we applied a rigorous combined approach to assess both the individual and epistatic contributions of genetic factors to PTC susceptibility, based on one of the largest series of thyroid cancer cases described to date. In addition to identifying the involvement of TSHR variation in classic PTC, our pioneer study of epistasis revealed a significant interaction between variants in STK17B and PAX8. The interaction was detected by MD-MBR (p = 0.00010) and confirmed by other methods, and then replicated in a second independent series of patients (MD-MBR p = 0.017). Furthermore, we demonstrated an inverse correlation between expression of PAX8 and STK17B in a set of cell lines derived from human thyroid carcinomas. Overall, our work sheds additional light on the genetic basis of thyroid cancer susceptibility, and suggests a new direction for the exploration of the inherited genetic contribution to disease using association studies.	[Landa, Inigo; Inglada-Perez, Lucia; Mancikova, Veronika; Robledo, Mercedes] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid, Spain; [Boullosa, Cesar; Valencia, Alfonso] Spanish Natl Canc Res Ctr, Struct & Computat Biol Grp, Madrid, Spain; [Inglada-Perez, Lucia; Robledo, Mercedes] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Sastre-Perona, Ana; Ruiz-Llorente, Sergio; Santisteban, Pilar] Autonomous Univ Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Autonomous Univ Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid, Spain; [Ruiz-Llorente, Sergio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Schiavi, Francesca; Opocher, Giuseppe] Veneto Inst Oncol, Familial Canc Clin & Oncoendocrinol, Padua, Italy; [Malats, Nuria] Spanish Natl Canc Res Ctr, Genet & Mol Epidemiol Grp, Madrid, Spain; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Diaz-Uriarte, Ramon] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Memorial Sloan Kettering Cancer Center; IRCCS Istituto Oncologico Veneto (IOV); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Padua; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Santisteban, P (corresponding author), Autonomous Univ Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain.	psantisteban@iib.uam.es; avalencia@cnio.es; mrobledo@cnio.es	Malats, Nuria/H-7041-2015; Pastor, Susana/H-7545-2015; Marcos, Ricard/G-9671-2015; Robledo, Mercedes/O-2230-2013; Santisteban, Pilar/E-7829-2016; Valencia, Alfonso/I-3127-2015; Landa, Iñigo/AAK-8789-2020; Sastre-Perona, Ana/AAC-1202-2021; Diaz-Uriarte, Ramon/M-5517-2013; Opocher, Giuseppe/F-3950-2014; inglada-perez, lucia/H-5378-2015; Valencia, Alfonso/AAN-9230-2020; Schiavi, Francesca/AAB-9908-2022; Inglada-Perez, Lucia/Z-3020-2019	Malats, Nuria/0000-0003-2538-3784; Pastor, Susana/0000-0003-2454-5163; Marcos, Ricard/0000-0001-7891-357X; Robledo, Mercedes/0000-0001-6256-5902; Santisteban, Pilar/0000-0002-2758-796X; Valencia, Alfonso/0000-0002-8937-6789; Landa, Iñigo/0000-0002-2817-8295; Diaz-Uriarte, Ramon/0000-0002-6637-9039; Opocher, Giuseppe/0000-0002-9845-9623; Valencia, Alfonso/0000-0002-8937-6789; Schiavi, Francesca/0000-0001-8529-4455; Ruiz-Llorente, Sergio/0000-0002-5003-1759; INGLADA, LUCIA/0000-0001-9523-2717; Inglada-Perez, Lucia/0000-0001-9814-4368	Fondo de Investigaciones Sanitarias (FIS) [PI11/01359]; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III [RD12/0030/0060, RD12/0036/0050]; Comunidad de Madrid [S2011/BMD-2328 TIRONET]; European Regional Development Fund; FIS [FI07/00326, CD05-0055]; FPI [BES-2008-006332]; Centro de Investigacion Biomedica en Red de Enfermedades Raras; Spanish Ministry of Economy and Innovation [BIO2009-12458]; Generalitat de Catalunya, CIRIT [2009SGR-725]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); European Regional Development Fund(European Commission); FIS(Instituto de Salud Carlos III); FPI(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Raras; Spanish Ministry of Economy and Innovation(Spanish Government); Generalitat de Catalunya, CIRIT(Generalitat de Catalunya)	This work was supported by Grants from the Fondo de Investigaciones Sanitarias (FIS) project PI11/01359 (to MR), the Red Tematica de Investigacion Cooperativa en Cancer, the Instituto de Salud Carlos III, RD12/0030/0060 (to PS), RD12/0036/0050 (to NM) and S2011/BMD-2328 TIRONET from the Comunidad de Madrid (to MR and PS), and European Regional Development Fund. IL is supported by FIS grant FI07/00326; CB is supported by the FPI grant BES-2008-006332; LI-P is supported by Centro de Investigacion Biomedica en Red de Enfermedades Raras, and AS-P is a predoctoral fellows of the FPU program (MICINN) respectively. SR-LL is a postdoctoral fellow of the FIS (contract # CD05-0055). RDU is supported by project BIO2009-12458 from the Spanish Ministry of Economy and Innovation. RM, SP and AV are supported by the Generalitat de Catalunya, CIRIT (2009SGR-725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjadj E, 2009, LANCET ONCOL, V10, P181, DOI 10.1016/S1470-2045(09)70020-8; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Davies TF, 2010, THYROID, V20, P727, DOI 10.1089/thy.2010.1638; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; DeLellis R, 2004, PATHOLOGY GENETICS T; Dimas AS, 2009, CURR OPIN GENET DEV, V19, P586, DOI 10.1016/j.gde.2009.10.012; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Ferlay J, 2010, INT J CANC; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Gudmundsson J, 2009, NAT GENET; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heldin N E, 1991, Thyroidology, V3, P127; Hemminki K, 2004, INT J CANCER, V111, P944, DOI 10.1002/ijc.20355; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Ii M, 2011, MUTAT RES-FUND MOL M, V714, P33, DOI 10.1016/j.mrfmmm.2011.06.007; ISHIZAKA Y, 1989, JPN J CANCER RES, V80, P1149, DOI 10.1111/j.1349-7006.1989.tb01645.x; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kong M, 2011, PSYCHIAT GENET, V21, P37, DOI 10.1097/YPG.0b013e3283413496; Landa I, 2011, J MOL ENDOCRINOL, V47, pR43, DOI 10.1530/JME-11-0005; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lonn S, 2007, CANCER EPIDEM BIOMAR, V16, P174, DOI 10.1158/1055-9965.EPI-06-0665; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Matakidou A, 2004, CARCINOGENESIS, V25, P369, DOI 10.1093/carcin/bgh027; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Naushad SM, 2010, MOL BIOL REP; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Pal T, 2001, J CLIN ENDOCR METAB, V86, P5307, DOI 10.1210/jc.86.11.5307; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruiz-Llorente S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-147; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Snitkin ES, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001294; Sturgis EM, 2009, THYROID, V19, P1031, DOI 10.1089/thy.2009.1597; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wu SH, 2010, CLIN CHIM ACTA, V411, P1705, DOI 10.1016/j.cca.2010.07.007; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang X, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-1; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74765	10.1371/journal.pone.0074765	http://dx.doi.org/10.1371/journal.pone.0074765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086368	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200039
J	Tran, TD; Biggs, BA; Tran, T; Simpson, JA; Hanieh, S; Dwyer, T; Fisher, J				Thach Duc Tran; Biggs, Beverley-Ann; Tuan Tran; Simpson, Julie Anne; Hanieh, Sarah; Dwyer, Terence; Fisher, Jane			Impact on Infants' Cognitive Development of Antenatal Exposure to Iron Deficiency Disorder and Common Mental Disorders	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; TERM-FOLLOW-UP; CHILD-DEVELOPMENT; MATERNAL STRESS; POSTNATAL DEPRESSION; DEVELOPING-COUNTRIES; INCOME COUNTRIES; PREGNANCY; FETAL; GROWTH	Objectives: The aim of this study was to examine the effects of antenatal exposure to iron deficiency anemia (IDA) and common mental disorders (CMD) on cognitive development of 6 months old infants in a developing country. Methods: A prospective population-based study in a rural province in Vietnam, which enrolled pregnant women at 12-20 weeks gestation and followed them up with their infants until six months postpartum. Criteria for IDA were Hb < 11 g/dL and serum ferritin <15 ng/mL. CMD symptoms were assessed by the Edinburgh Postnatal Depression Scale-Vietnam validation. Infant cognitive development was assessed by Bayley Scales of Infant and Toddler Development, 3rd Ed. Path analyses were performed to determine the direct and indirect, partly or fully mediated, causal effects of the antenatal exposures. Results: A total of 497 pregnant women were recruited, of those 378 women provided complete data which were included in the analyses. Statistically significant direct adverse effects of persistent antenatal IDA (estimated difference of -11.62 points; 95% CI -23.01 to -0.22) and antenatal CMD (-4.80 points; 95% CI: -9.40 to -0.20) on infant Bayley cognitive scores at six months were found. Higher birthweight, household wealth, and self-rated sufficient supply of breastmilk were associated with higher cognitive scores. Maternal age >30 years and primiparity had an indirect adverse effect on infants' Bayley cognitive scores. Conclusions: These findings suggest that antenatal IDA and CMD both have adverse effects on child cognitive development, which if unrecognized and unaddressed are likely to be lasting. It is crucial that both these risks are considered by policy makers, clinicians, and researchers seeking to improve child cognitive function in developing countries.	[Thach Duc Tran; Tuan Tran] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Fisher, Jane] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Thach Duc Tran; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia; [Biggs, Beverley-Ann; Hanieh, Sarah] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Melbourne, Vic 3050, Australia; [Simpson, Julie Anne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Dwyer, Terence] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Melbourne; Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Tran, TD (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.	indthach@yahoo.com	TRAN, THACH DUC/H-7734-2014; Mireku, Michael/D-5262-2016; Simpson, Julie A/P-7299-2014; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Simpson, Julie/0000-0002-2660-2013; Biggs, Beverley-Ann/0000-0002-2961-9793; Tran, Tuan/0000-0002-4947-9169; Fisher, Jane/0000-0002-1959-6807	Australian Research Council [DP0986594]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	The study was funded by Australian Research Council Discovery Project Grant DP0986594. TDT is supported by a University of Melbourne International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Amin SB, 2010, J PEDIATR-US, V156, P377, DOI 10.1016/j.jpeds.2009.09.049; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bayley N, 1993, BAYLEY SCALES INFANT; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Buitelaar JK, 2003, NEUROBIOL AGING, V24, pS53, DOI 10.1016/S0197-4580(03)00050-2; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; deRegnier R-A, 2010, WILEY BLACKWELL HDB; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher J, 2011, B WORLD HEALTH ORGAN, V89, P813, DOI 10.2471/BLT.11.089763; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Fleming RE, 2002, J PEDIATR-US, V140, P145, DOI 10.1067/mpd.2002.121931; Galler JR, 2000, J CHILD PSYCHOL PSYC, V41, P747, DOI 10.1017/S0021963099005910; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Geelhoed D, 2006, ACTA OBSTET GYN SCAN, V85, P49, DOI 10.1080/00016340500334794; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Gulmezoglu AM, 1996, J PERINAT MED, V24, P687, DOI 10.1515/jpme.1996.24.6.687; Hadley C, 2008, ANN HUM BIOL, V35, P259, DOI 10.1080/03014460802043624; Hernandez-Martinez C, 2011, EARLY HUM DEV, V87, P165, DOI 10.1016/j.earlhumdev.2010.12.006; Jaleel R, 2008, J SURG PAK, V13, P147; Kidanto HL, 2009, SAMJ S AFR MED J, V99, P98; Kline RB, 2011, METHODOLOGY SOCIAL S, pxvi; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Laungani P, 2000, INT J HLTH PROMOTION, V38, P86, DOI DOI 10.1080/14635240.2000.10806156; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; Marahatta R, 2007, Nepal Med Coll J, V9, P270; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Murray L., 2010, WILEY BLACKWELL HDB, V2, P192, DOI [10.1002/9781444327588.ch8, DOI 10.1002/9781444327588.CH8]; National Institute of Nutrition/UNICEF, 2011, REV NUTR SIT VIET NA; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Pearl J., 2009, CAUSALITY MODELS REA; Petraglia F, 1996, ENDOCR REV, V17, P156, DOI 10.1210/er.17.2.156; Riggins T, 2009, DEVELOPMENTAL SCI, V12, P209, DOI 10.1111/j.1467-7687.2008.00757.x; Rioux FM, 2011, CAN J DIET PRACT RES, V72, P76, DOI 10.3148/72.2.2011.76; Servili C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-693; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tamura T, 2002, J PEDIATR-US, V140, P165, DOI 10.1067/mpd.2002.120688; Tran T, 2004, COMMUNITY BASED EVID; Tran TD, 2011, J AFFECT DISORDERS, V133, P281, DOI 10.1016/j.jad.2011.03.038; Trinh Lieu Thi Thuy, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P927; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO/UNICEF/ICCIDD, 2001, WHONHD011 UNICEFICCI; World Health Organization, 2001, IR DEF AN ASS PREV C; Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112, DOI 10.1093/ajcn/83.5.1112; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	65	31	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74876	10.1371/journal.pone.0074876	http://dx.doi.org/10.1371/journal.pone.0074876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086390	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200048
J	Bastir, M; Martinez, DG; Recheis, W; Barash, A; Coquerelle, M; Rios, L; Pena-Melian, A; Rio, FG; O'Higgins, P				Bastir, Markus; Garcia Martinez, Daniel; Recheis, Wolfgang; Barash, Alon; Coquerelle, Michael; Rios, Luis; Pena-Melian, Angel; Garcia Rio, Francisco; O'Higgins, Paul			Differential Growth and Development of the Upper and Lower Human Thorax	PLOS ONE			English	Article							RIB CAGE; PRETERM INFANTS; VENTILATION; GEOMETRY; CHEST; CHILDREN; ONTOGENY; GENDER; CO2	The difficulties in quantifying the 3D form and spatial relationships of the skeletal components of the ribcage present a barrier to studies of the growth of the thoracic skeleton. Thus, most studies to date have relied on traditional measurements such as distances and indices from single or few ribs. It is currently known that adult-like thoracic shape is achieved early, by the end of the second postnatal year, with the circular cross-section of the newborn thorax transforming into the ovoid shape of adults; and that the ribs become inclined such that their anterior borders come to lie inferior to their posterior. Here we present a study that revisits growth changes using geometric morphometrics applied to extensive landmark data taken from the ribcage. We digitized 402 (semi) landmarks on 3D reconstructions to assess growth changes in 27 computed tomography-scanned modern humans representing newborns to adults of both sexes. Our analyses show a curved ontogenetic trajectory, resulting from different ontogenetic growth allometries of upper and lower thoracic units. Adult thoracic morphology is achieved later than predicted, by diverse modifications in different anatomical regions during different ontogenetic stages. Besides a marked increase in antero-posterior dimensions, there is an increase in medio-lateral dimensions of the upper thorax, relative to the lower thorax. This transforms the pyramidal infant thorax into the barrel-shaped one of adults. Rib descent is produced by complex changes in 3D curvature. Developmental differences between upper and lower thoracic regions relate to differential timings and rates of maturation of the respiratory and digestive systems, the spine and the locomotor system. Our findings are relevant to understanding how changes in the relative rates of growth of these systems and structures impacted on the development and evolution of modern human body shape.	[Bastir, Markus; Garcia Martinez, Daniel; Coquerelle, Michael] Museo Nacl Ciencias Nat CSIC, Paleoanthropol Grp, Madrid, Spain; [Garcia Martinez, Daniel; Rios, Luis] Univ Autonoma Madrid, Fac Ciencias, E-28049 Madrid, Spain; [Recheis, Wolfgang] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Barash, Alon] Galilee Bar Ilan Univ, Fac Med, Safed, Israel; [Barash, Alon] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Rios, Luis] Fdn Aranzadi, San Sebastian, Spain; [Pena-Melian, Angel] Univ Complutense Madrid, Dept Anat & Embriol, Madrid, Spain; [Garcia Rio, Francisco] Hosp Univ La Paz, Biomed Res Inst IdiPAZ, Madrid, Spain; [O'Higgins, Paul] Univ York, HYMS, York YO10 5DD, N Yorkshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Autonomous University of Madrid; Medical University of Innsbruck; Tel Aviv University; Sackler Faculty of Medicine; Complutense University of Madrid; Hospital Universitario La Paz; University of York - UK	Bastir, M (corresponding author), Museo Nacl Ciencias Nat CSIC, Paleoanthropol Grp, Madrid, Spain.	mbastir@mncn.csic.es	Garcia-Rio, Francisco/AAC-9981-2020; Rios, Luis/G-3533-2015; Bastir, Markus/G-8987-2013	Rios, Luis/0000-0002-6720-2534; GARCIA-MARTINEZ, DANIEL/0000-0001-7518-3866; Barash, Alon/0000-0001-9682-6875; Bastir, Markus/0000-0002-3141-3401; Coquerelle, Michael/0000-0001-5183-3297; O'Higgins, Paul/0000-0002-9797-0809; Garcia-Rio, Francisco/0000-0002-7227-2238	(Spanish Ministry for Economy and Competition) Fyssen-foundation [CGL2012-37279]	(Spanish Ministry for Economy and Competition) Fyssen-foundation	CGL2012-37279 (Spanish Ministry for Economy and Competition) Fyssen-foundation (http://www.fondationfyssen.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Aiello LC, 1997, BRAZ J GENET, V20, P141, DOI 10.1590/S0100-84551997000100023; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; BASTIR M, 2012, PESHE 2012 21 22 09; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Bastir M, 2007, P ROY SOC B-BIOL SCI, V274, P1125, DOI 10.1098/rspb.2006.0448; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bastir M, 2008, J ANTHROPOL SCI, V86, P37; BAUME RM, 1983, AM J ORTHOD DENTOFAC, V83, P477, DOI 10.1016/S0002-9416(83)90246-4; Bellemare F, 2006, RESP PHYSIOL NEUROBI, V150, P233, DOI 10.1016/j.resp.2005.04.002; Berry M., 1995, GRAYS ANATOMY; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; Dworzak J, 2010, INT J COMPUT ASS RAD, V5, P111, DOI 10.1007/s11548-009-0390-2; Ferretti GR, 2001, EUR RESPIR J, V18, P381, DOI 10.1183/09031936.01.00217701; GARCIAMARTINEZ D, 2013, BILBAO IN PRESS; GARCIAMARTINEZ D, 2012, WHOLE ITS PARTS 3D G; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; GEA J, 2007, ACTA BRONCONEUM, V44, P263; Glass RBJ, 2002, RADIOGRAPHICS, V22, P87, DOI 10.1148/radiographics.22.1.g02ja1287; Goldfield EC, 1999, ECOL PSYCHOL, V11, P209, DOI 10.1207/s15326969eco1103_2; Gomez-Olivencia A, 2009, J HUM EVOL, V57, P75, DOI 10.1016/j.jhevol.2009.02.009; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; HIBBERT M, 1995, PEDIATR PULM, V19, P129, DOI 10.1002/ppul.1950190208; Jellema Lyman M., 1993, P294; JORDANOGLOU J, 1969, THORAX, V24, P407, DOI 10.1136/thx.24.4.407; Kagaya M, 2008, PRIMATES, V49, P89, DOI 10.1007/s10329-007-0064-z; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KLINGENBERG CP, 2013, SYST BIOL; Li S., 2011, ASIAN J MATH STAT, V4, P66, DOI [10.3923/ajms.2011.66.70, DOI 10.3923/AJMS.2011.66.70, DOI 10.3923/ajms.2011.66.70]; LoMauro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035965; MANN RW, 1993, J FORENSIC SCI, V38, P151; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mohr M, 2007, J BIOMECH, V40, P1310, DOI 10.1016/j.jbiomech.2006.05.017; MORIETTE G, 1985, RESP PHYSIOL, V62, P387, DOI 10.1016/0034-5687(85)90093-3; Nysom K, 1997, EUR RESPIR J, V10, P1591, DOI 10.1183/09031936.97.10071591; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; O'Higgins P., 2006, INT C SER, V1296, P55, DOI DOI 10.1016/J.ICS.2006.03.036; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; OPENSHAW P, 1984, THORAX, V39, P624, DOI 10.1136/thx.39.8.624; Pham TMT, 2011, EUR RESPIR J, V37, P919, DOI 10.1183/09031936.00034310; Ravenel JG, 2003, RADIOL CLIN N AM, V41, P475, DOI 10.1016/S0033-8389(03)00032-0; REDDING GJ, 2012, PEDIAT PULMONOL; REIS FJC, 1994, BIOL NEONATE, V65, P69; Rios L, 2009, AM J PHYS ANTHROPOL, V140, P265, DOI 10.1002/ajpa.21065; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sokal RR, 1998, BIOMETRY; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Tsai A, 2012, J BIOMECH, V45, P1861, DOI 10.1016/j.jbiomech.2012.05.049; Wagner H, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-13; Ward J., 2005, SURGERY, V23, P419, DOI DOI 10.1383/surg.2005.23.11.419; WARD ME, 1992, J APPL PHYSIOL, V72, P1338, DOI 10.1152/jappl.1992.72.4.1338; Weitz CA, 2004, ANN HUM BIOL, V31, P292, DOI 10.1080/0301446042000196316; WILSON TA, 1987, J APPL PHYSIOL, V62, P1872, DOI 10.1152/jappl.1987.62.5.1872; Yoganandan N, 1998, J BIOMECH ENG-T ASME, V120, P100, DOI 10.1115/1.2834288; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	64	59	59	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75128	10.1371/journal.pone.0075128	http://dx.doi.org/10.1371/journal.pone.0075128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073239	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000048
J	Lorite, GS; Janissen, R; Clerici, JH; Rodrigues, CM; Tomaz, JP; Mizaikoff, B; Kranz, C; de Souza, AA; Cotta, MA				Lorite, Gabriela S.; Janissen, Richard; Clerici, Joao H.; Rodrigues, Carolina M.; Tomaz, Juarez P.; Mizaikoff, Boris; Kranz, Christine; de Souza, Alessandra A.; Cotta, Monica A.			Surface Physicochemical Properties at the Micro and Nano Length Scales: Role on Bacterial Adhesion and Xylella fastidiosa Biofilm Development	PLOS ONE			English	Article							PROBE FORCE MICROSCOPY; EXTRACELLULAR POLYMERIC SUBSTANCES; ESCHERICHIA-COLI; AXENIC CULTURE; DLVO THEORY; PLANT; EXPRESSION; VIRULENCE; TRANSMISSION; ATTACHMENT	The phytopathogen Xylella fastidiosa grows as a biofilm causing vascular occlusion and consequently nutrient and water stress in different plant hosts by adhesion on xylem vessel surfaces composed of cellulose, hemicellulose, pectin and proteins. Understanding the factors which influence bacterial adhesion and biofilm development is a key issue in identifying mechanisms for preventing biofilm formation in infected plants. In this study, we show that X. fastidiosa biofilm development and architecture correlate well with physicochemical surface properties after interaction with the culture medium. Different biotic and abiotic substrates such as silicon (Si) and derivatized cellulose films were studied. Both biofilms and substrates were characterized at the micro-and nanoscale, which corresponds to the actual bacterial cell and membrane/protein length scales, respectively. Our experimental results clearly indicate that the presence of surfaces with different chemical composition affect X. fastidiosa behavior from the point of view of gene expression and adhesion functionality. Bacterial adhesion is facilitated on more hydrophilic surfaces with higher surface potentials; XadA1 adhesin reveals different strengths of interaction on these surfaces. Nonetheless, despite different architectural biofilm geometries and rates of development, the colonization process occurs on all investigated surfaces. Our results univocally support the hypothesis that different adhesion mechanisms are active along the biofilm life cycle representing an adaptation mechanism for variations on the specific xylem vessel composition, which the bacterium encounters within the infected plant.	[Lorite, Gabriela S.; Janissen, Richard; Clerici, Joao H.; Cotta, Monica A.] Univ Estadual Campinas, Dept Fis Aplicada, Inst Fis Gleb Wataghin, Sao Paulo, Brazil; [Rodrigues, Carolina M.; Tomaz, Juarez P.; de Souza, Alessandra A.] Inst Agron Campinas, Ctr APTA Citros Sylvio Moreira, Sao Paulo, Brazil; [Mizaikoff, Boris; Kranz, Christine] Univ Ulm, Inst Analyt & Bioanalyt Chem, D-89069 Ulm, Germany	Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Ulm University	Cotta, MA (corresponding author), Univ Estadual Campinas, Dept Fis Aplicada, Inst Fis Gleb Wataghin, Sao Paulo, Brazil.	monica@ifi.unicamp.br	de Souza, Alessandra Alves/GLR-7357-2022; Mizaikoff, Boris/G-9959-2013; De Souza, Alessandra/C-3458-2012; Janissen, Richard/V-4973-2019; Kranz, Christine/F-3838-2014; Cotta, Monica A/H-3505-2012; Lorite, Gabriela S/M-9095-2016; Tomaz, Juarez/AAA-5067-2022	de Souza, Alessandra Alves/0000-0003-4589-8355; Mizaikoff, Boris/0000-0002-5583-7962; Janissen, Richard/0000-0003-0901-3433; Kranz, Christine/0000-0002-6001-0580; Cotta, Monica A/0000-0002-2779-5179; Lorite, Gabriela S/0000-0002-6530-5281; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/51748-7, 2009/53021-0, 2006/06397-6]; DAAD (Deutscher Akademischer Austauschdienst); DFG (Deutsche Forschungsgemeinschaft); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was financially supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, through grant #2010/51748-7 and fellowships #2009/53021-0, 2006/06397-6), DAAD (Deutscher Akademischer Austauschdienst), DFG (Deutsche Forschungsgemeinschaft), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenne C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00111; Albenne C, 2009, MOL PLANT, V2, P977, DOI 10.1093/mp/ssp059; Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4; Bakker DP, 2003, COLLOID SURFACE B, V32, P179, DOI 10.1016/S0927-7765(03)00159-0; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Cobine PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054936; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Lima JEO, 1998, PLANT DIS, V82, P94, DOI 10.1094/PDIS.1998.82.1.94; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dorobantu LS, 2009, LANGMUIR, V25, P6968, DOI 10.1021/la9001237; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Enevoldsen GH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236104; Feil H, 2007, PHYTOPATHOLOGY, V97, P318, DOI 10.1094/PHYTO-97-3-0318; Gubner R, 2000, BIOFOULING, V15, P25, DOI 10.1080/08927010009386295; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hogg R, 1966, FARADAY SOC, V66, P1638; Hubbe MA, 2006, BIORESOURCES, V1, P116; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Ishii M, 2004, APPL PHYS LETT, V85, P1610, DOI 10.1063/1.1787162; Jacobs HO, 1998, J APPL PHYS, V84, P1168, DOI 10.1063/1.368181; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Jin HJ, 2012, SOFT MATTER, V8, P2194, DOI 10.1039/c1sm06518a; Killiny N, 2010, APPL ENVIRON MICROB, V76, P6134, DOI 10.1128/AEM.01036-10; Killiny N, 2009, P NATL ACAD SCI USA, V106, P22416, DOI 10.1073/pnas.0908562106; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y; Liu DL, 2010, J ADHES SCI TECHNOL, V24, P2383, DOI 10.1163/016942410X508280; Liu DL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2763981; Lorite GS, 2013, COLLOID SURFACE B, V102, P519, DOI 10.1016/j.colsurfb.2012.08.027; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Melitz W, 2011, SURF SCI REP, V66, P1, DOI 10.1016/j.surfrep.2010.10.001; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; Moller J, 2012, NANO LETT, V12, P2901, DOI 10.1021/nl3004896; Moreau ALD, 2009, J APPL PHYS, V106, DOI 10.1063/1.3173172; Muranaka LS, 2012, J BACTERIOL, V194, P4561, DOI 10.1128/JB.00436-12; Narvaez AC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/46/465705; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042; Osiro D, 2004, FEMS MICROBIOL LETT, V236, P313, DOI [10.1111/j.1574-6968.2004.tb09663.x, 10.1016/j.femsle.2004.06.003]; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Robledo M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-125; Saha N, 2013, BIOMACROMOLECULES, V14, P520, DOI 10.1021/bm301774a; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Sheng XX, 2008, J COLLOID INTERF SCI, V321, P256, DOI 10.1016/j.jcis.2008.02.038; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shusterman S, 2007, NANO LETT, V7, P2089, DOI 10.1021/nl071031w; Teixeira P, 1999, J ADHES SCI TECHNOL, V13, P1287, DOI 10.1163/156856199X00190; WEAVER JMR, 1991, J VAC SCI TECHNOL B, V9, P1559, DOI 10.1116/1.585423; Wulff NA, 2006, CURR MICROBIOL, V53, P198, DOI 10.1007/s00284-005-0475-2	58	35	35	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75247	10.1371/journal.pone.0075247	http://dx.doi.org/10.1371/journal.pone.0075247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073256	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000065
J	Wang, JY; Zhang, JX; Zhang, XL; Zhou, H				Wang, Jingyu; Zhang, Jinxiu; Zhang, Xiaoli; Zhou, Hao			A Protein-Based Hydrogel for In Vitro Expansion of Mesenchymal Stem Cells	PLOS ONE			English	Article							DESIGN; SCAFFOLDS	Hydrogels are widely used as scaffolds in tissue engineering because they can provide excellent environments for bioactive components including growth factors and cells. We reported in this study on a physical hydrogel formed by a specific protein-peptide interaction, which could be used for the three dimensional (3D) cell culture of murine mesenchymal stem cells (mMSC). The mMSC kept dividing during the 7-day culture period and the metabolic-active cell number at day 7 was 359% more than that at day 1. This kind of physical hydrogel could be converted to a homogeneous solution by firstly adding an equal volume of culture medium and then pipeting for several times. Therefore, mMSC post culture could be easily separated from cell-gel constructs. We believed that the protein-based hydrogel system in this study could be developed into a promising scaffold for in vitro expansion of stem cells and cell therapy. This work would be in the general interests of researchers in the fields of biomaterials and supramolecular chemistry.	[Wang, Jingyu; Zhang, Xiaoli; Zhou, Hao] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Jingyu; Zhang, Xiaoli; Zhou, Hao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhang, Jinxiu] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China	Nankai University; Nankai University; Hebei Normal University	Zhou, H (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	haozhou@nankai.edu.cn	Zhou, Hao/G-9693-2019	Zhou, Hao/0000-0001-6813-648X	Fundamental Research Funds for the Central Universities [65011621]; National Natural Science Foundation of China [31100527]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the Fundamental Research Funds for the Central Universities (65011621) and National Natural Science Foundation of China (31100527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c; Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250; Ehrick JD, 2009, MACROMOL BIOSCI, V9, P864, DOI 10.1002/mabi.200800337; Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352; Esser-Kahn AP, 2008, ANGEW CHEM INT EDIT, V47, P3751, DOI 10.1002/anie.200705564; Esser-Kahn AP, 2010, J AM CHEM SOC, V132, P13264, DOI 10.1021/ja103038p; Esser-Kahn AP, 2008, J AM CHEM SOC, V130, P15820, DOI 10.1021/ja807095r; Fischer SE, 2007, BIOMATERIALS, V28, P3325, DOI 10.1016/j.biomaterials.2007.03.026; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Grove TZ, 2010, J AM CHEM SOC, V132, P14024, DOI 10.1021/ja106619w; Grzanka A, 2012, POL J PATHOL, V63, P101; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Ito F, 2010, BIOMATERIALS, V31, P58, DOI 10.1016/j.biomaterials.2009.09.026; Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p; Mosiewicz KA, 2010, J AM CHEM SOC, V132, P5972, DOI 10.1021/ja9098164; Mulyasasmita W, 2011, BIOMACROMOLECULES, V12, P3406, DOI 10.1021/bm200959e; Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005; Sui ZJ, 2008, ADV FUNCT MATER, V18, P1824, DOI 10.1002/adfm.200701288; Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092; Tang Y, 2001, ANGEW CHEM INT EDIT, V40, P1494, DOI 10.1002/1521-3773(20010417)40:8<1494::AID-ANIE1494>3.0.CO;2-X; Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i; Wang HM, 2013, CHEM SOC REV, V42, P891, DOI 10.1039/c2cs35358j; Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Yuan WW, 2008, J AM CHEM SOC, V130, P15760, DOI 10.1021/ja805634x; Zhang XL, 2012, ANGEW CHEM INT EDIT, V51, P4388, DOI 10.1002/anie.201108612; Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010	33	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75727	10.1371/journal.pone.0075727	http://dx.doi.org/10.1371/journal.pone.0075727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069442	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300093
J	Zhu, B; Xu, T; Yuan, JL; Guo, XD; Liu, DJ				Zhu, Bing; Xu, Teng; Yuan, Jianlong; Guo, Xudong; Liu, Dongjun			Transcriptome Sequencing Reveals Differences between Primary and Secondary Hair Follicle-derived Dermal Papilla Cells of the Cashmere Goat (Capra hircus)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OSTEOPONTIN INDUCES ANGIOGENESIS; NITRIC-OXIDE SYNTHASE; EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; TGF-BETA; IN-VIVO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REGULATES ANGIOGENESIS	The dermal papilla is thought to establish the character and control the size of hair follicles. Inner Mongolia Cashmere goats (Capra hircus) have a double coat comprising the primary and secondary hair follicles, which have dramatically different sizes and textures. The Cashmere goat is rapidly becoming a potent model for hair follicle morphogenesis research. In this study, we established two dermal papilla cell lines during the anagen phase of the hair growth cycle from the primary and secondary hair follicles and clarified the similarities and differences in their morphology and growth characteristics. High-throughput transcriptome sequencing was used to identify gene expression differences between the two dermal papilla cell lines. Many of the differentially expressed genes are involved in vascularization, ECM-receptor interaction and Wnt/beta-catenin/Lef1 signaling pathways, which intimately associated with hair follicle morphogenesis. These findings provide valuable information for research on postnatal morphogenesis of hair follicles.	[Zhu, Bing; Xu, Teng; Yuan, Jianlong; Guo, Xudong; Liu, Dongjun] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China	Inner Mongolia University	Guo, XD (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China.	xudguo@yahoo.com; nmliudongjun@sina.com		Zhu, Bing/0000-0002-5224-0829; Xu, Teng/0000-0001-6859-4202	Program of National Natural Science Foundation of China [31160228]; National High Technology Research and Development Program of China (863 Program) [2013AA102506]; National Genetically Modified Organisms Breeding Major Projects [2011ZX08008-002]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Genetically Modified Organisms Breeding Major Projects	The Program of National Natural Science Foundation of China (Grant No. 31160228); The National High Technology Research and Development Program of China (863 Program)(Grant No. 2013AA102506); The National Genetically Modified Organisms Breeding Major Projects (Grant No. 2011ZX08008-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2001, CANCER RES, V61, P3561; Adluri RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034790; AHARINEJAD S, 1995, BONE, V16, P315, DOI 10.1016/8756-3282(94)00044-1; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; BARRIE R, 1993, J SURG RES, V55, P446, DOI 10.1006/jsre.1993.1167; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P1, DOI 10.1016/j.tem.2005.11.009; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Dube A, 2001, CIRC RES, V88, P237; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Florio T, 2003, ENDOCRINOLOGY, V144, P1574, DOI 10.1210/en.2002-220949; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Fukushima T, 2007, ANTICANCER RES, V27, P3685; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Han DD, 2011, BIOCHEM BIOPH RES CO, V415, P608, DOI 10.1016/j.bbrc.2011.10.118; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hashimoto Y, 2011, J UROLOGY, V185, pE512, DOI 10.1016/j.juro.2011.02.966; HORNE KA, 1986, J EMBRYOL EXP MORPH, V97, P111; Hu HJ, 2005, BIOCHEM BIOPH RES CO, V329, P661, DOI 10.1016/j.bbrc.2005.01.158; Huang XL, 2006, BLOOD, V107, P3153, DOI 10.1182/blood-2005-08-3206; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAHEEM M, 1994, J ANAT, V185, P135; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivanciu L, 2007, ARTERIOSCL THROM VAS, V27, P310, DOI 10.1161/01.ATV.0000254147.89321.cf; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1992, DEVELOPMENT, V115, P1103; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kampmann A, 2009, MOL CELL BIOCHEM, V322, P15, DOI 10.1007/s11010-008-9935-x; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Khew-Goodall Y, 2012, EMBO J, V31, P786, DOI 10.1038/emboj.2011.504; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kozlowska U, 1998, ARCH DERMATOL RES, V290, P661, DOI 10.1007/s004030050370; Kwack MH, 2013, EXP DERMATOL, V22, P229, DOI 10.1111/exd.12101; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lachgar S, 1996, J INVEST DERMATOL, V106, P17, DOI 10.1111/1523-1747.ep12326964; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maeda T, 2006, ONCOGENE, V25, P1408, DOI 10.1038/sj.onc.1209168; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; MCDONALD BJ, 1987, AUST J AGR RES, V38, P597, DOI 10.1071/AR9870597; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Muller-Rover S, 1998, MOL BASIS EPITHELIAL, P283; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; NIXON AJ, 1991, J ZOOL, V224, P589, DOI 10.1111/j.1469-7998.1991.tb03787.x; OBrien T, 1996, CANCER RES, V56, P2515; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Park JA, 2008, GLIA, V56, P247, DOI 10.1002/glia.20600; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Puxeddu I, 2009, ALLERGY, V64, P368, DOI 10.1111/j.1398-9995.2008.01822.x; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Ribatti D, 2003, HISTOPATHOLOGY, V42, P246, DOI 10.1046/j.1365-2559.2003.01581.x; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rutberg SE, 2006, J INVEST DERMATOL, V126, P2583, DOI 10.1038/sj.jid.5700454; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Seabrook TJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-95; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Shimizu H, 2004, J INVEST DERMATOL, V122, P239, DOI 10.1046/j.0022-202X.2004.22224.x; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; TETI A, 1992, J AM SOC NEPHROL, V2, pS83; Tokes AM, 1999, PATHOL RES PRACT, V195, P821; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; VOLPERT OV, 1995, BIOCHEM BIOPH RES CO, V217, P326, DOI 10.1006/bbrc.1995.2780; WESSELLS NK, 1965, DEV BIOL, V12, P419, DOI 10.1016/0012-1606(65)90007-2; Widelitz RB, 2004, J INVEST DERMATOL, V123, pVIII, DOI 10.1111/j.0022-202X.2004.23239.x; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zhang L, 2011, MED ONCOL, V28, P907, DOI 10.1007/s12032-010-9537-9; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	139	46	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76282.	10.1371/journal.pone.0076282	http://dx.doi.org/10.1371/journal.pone.0076282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069460	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300106
J	Brownlow, ML; Benner, L; D'Agostino, D; Gordon, MN; Morgan, D				Brownlow, Milene L.; Benner, Leif; D'Agostino, Dominic; Gordon, Marcia N.; Morgan, Dave			Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer's Pathology	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ENERGY-METABOLISM; BRAIN METABOLISM; MEMORY DEFICITS; DISEASE; DECLINE; KETONES; PROTEIN	Dietary manipulations are increasingly viewed as possible approaches to treating neurodegenerative diseases. Previous studies suggest that Alzheimer's disease (AD) patients present an energy imbalance with brain hypometabolism and mitochondrial deficits. Ketogenic diets (KDs), widely investigated in the treatment and prevention of seizures, have been suggested to bypass metabolic deficits present in AD brain by providing ketone bodies as an alternative fuel to neurons. We investigated the effects of a ketogenic diet in two transgenic mouse lines. Five months old APP/PS1 (a model of amyloid deposition) and Tg4510 (a model of tau deposition) mice were offered either a ketogenic or a control (NIH-31) diet for 3 months. Body weight and food intake were monitored throughout the experiment, and blood was collected at 4 weeks and 4 months for ketone and glucose assessments. Both lines of transgenic mice weighed less than nontransgenic mice, yet, surprisingly, had elevated food intake. The ketogenic diet did not affect these differences in body weight or food consumption. Behavioral testing during the last two weeks of treatment found that mice offered KD performed significantly better on the rotarod compared to mice on the control diet independent of genotype. In the open field test, both transgenic mouse lines presented increased locomotor activity compared to nontransgenic, age-matched controls, and this effect was not influenced by KD. The radial arm water maze identified learning deficits in both transgenic lines with no significant differences between diets. Tissue measures of amyloid, tau, astroglial and microglial markers in transgenic lines showed no differences between animals fed the control or the ketogenic diet. These data suggest that ketogenic diets may play an important role in enhancing motor performance in mice, but have minimal impact on the phenotype of murine models of amyloid or tau deposition.	[Brownlow, Milene L.; D'Agostino, Dominic; Gordon, Marcia N.; Morgan, Dave] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Brownlow, Milene L.; Benner, Leif; Gordon, Marcia N.; Morgan, Dave] USF Hlth Byrd Alzheimers Inst, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Morgan, D (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	scientist.dave@gmail.com	D'Agostino, Dominic/GPJ-9744-2022; Brownlow, Milene/ABC-1063-2020; Morgan, David G/J-5989-2012	Brownlow, Milene/0000-0002-5804-6445	 [IIRG-10-174448]		This research was supported by: IIRG-10-174448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; ANISMAN H, 1975, PSYCHOL REV, V82, P359; BECKETT TL, 2013, BRAIN RES; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bough K, 2008, EPILEPSIA, V49, P91, DOI 10.1111/j.1528-1167.2008.01846.x; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Caraballo Roberto H, 2012, Handb Clin Neurol, V108, P783, DOI 10.1016/B978-0-444-52899-5.00027-7; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; HAMMAMI MM, 1997, ANN SAUDI MED, V17, P264; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; KASHIWAYA Y, 2012, NEUROBIOL AGING; Kim Do Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0035476.PUBMED:22567104; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Liu YMC, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01830.x; Mohamed HE, 2010, J CLIN NEUROSCI, V17, P899, DOI 10.1016/j.jocn.2009.11.005; Morgan D, 2008, BEHAV NEUROSCI, V122, P730, DOI 10.1037/0735-7044.122.3.730; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; NASH KR, 2013, NEUROBIOL AGING; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-34; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; Wang PN, 2004, J NEUROL, V251, P314, DOI 10.1007/s00415-004-0316-4; Westman Eric C, 2003, Curr Atheroscler Rep, V5, P476, DOI 10.1007/s11883-003-0038-6; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; YEH YY, 1976, J NUTR, V106, P58, DOI 10.1093/jn/106.1.58; Zhao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049191; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	49	88	93	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75713	10.1371/journal.pone.0075713	http://dx.doi.org/10.1371/journal.pone.0075713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069439	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100128
J	Guo, Z; Hou, XM; Goody, RS; Itzen, A				Guo, Zhong; Hou, Xiaomin; Goody, Roger S.; Itzen, Aymelt			Intermediates in the Guanine Nucleotide Exchange Reaction of Rab8 Protein Catalyzed by Guanine Nucleotide Exchange Factors Rabin8 and GRAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Guanine Nucleotide Exchange Factor (GEF); Intracellular Trafficking; Rab Proteins; Small GTPases; Intracellular Trafficking	POLARIZED MEMBRANE-TRANSPORT; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GTPASE; COMPLEX; ACTIVATION; LEGIONELLA; DOMAIN; GDP; REGULATOR	Small G-proteins of the Ras superfamily control the temporal and spatial coordination of intracellular signaling networks by acting as molecular on/off switches. Guanine nucleotide exchange factors (GEFs) regulate the activation of these G-proteins through catalytic replacement of GDP by GTP. During nucleotide exchange, three distinct substrateenzyme complexes occur: a ternary complex with GDP at the start of the reaction (G-proteinGEFGDP), an intermediary nucleotide-free binary complex (G-proteinGEF), and a ternary GTP complex after productive G-protein activation (G-proteinGEFGTP). Here, we show structural snapshots of the full nucleotide exchange reaction sequence together with the G-protein substrates and products using Rabin8/GRAB (GEF) and Rab8 (G-protein) as a model system. Together with a thorough enzymatic characterization, our data provide a detailed view into the mechanism of Rabin8/GRAB-mediated nucleotide exchange.	[Guo, Zhong; Hou, Xiaomin; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Hou, Xiaomin] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China; [Itzen, Aymelt] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany	Max Planck Society; Qingdao Agricultural University; Technical University of Munich	Goody, RS (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	roger.goody@mpi-dortmund.mpg.de; aymelt.itzen@tum.de	Itzen, Aymelt/F-5157-2014; GUO, Zhong/J-8723-2014; Goody, Roger S/J-8845-2014; GUO, Zhong/J-8723-2014	Itzen, Aymelt/0000-0002-4249-5617; GUO, Zhong/0000-0003-0285-5021; Goody, Roger S/0000-0002-0772-0444; GUO, Zhong/0000-0002-2277-0087	German Research Foundation (DFG) Sonderforschungsbereich [SFB1035, B05, SFB642, A4]; National Natural Science Foundation of China [31200554]	German Research Foundation (DFG) Sonderforschungsbereich(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by German Research Foundation (DFG) Sonderforschungsbereich SFB1035 (Projekt B05) and SFB642 (Projekt A4).; Supported by National Natural Science Foundation of China Grant 31200554.	Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bleimling N, 2009, PROTEIN EXPRES PURIF, V65, P190, DOI 10.1016/j.pep.2008.12.002; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasper R, 2008, J MOL BIOL, V379, P51, DOI 10.1016/j.jmb.2008.03.011; Gazdag EM, 2013, EMBO REP, V14, P199, DOI 10.1038/embor.2012.211; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Uejima T, 2010, J BIOL CHEM, V285, P36689, DOI 10.1074/jbc.M110.152132; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wixler V, 2011, BIOL CHEM, V392, P239, DOI 10.1515/BC.2011.022; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051	42	38	38	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32466	32474		10.1074/jbc.M113.498329	http://dx.doi.org/10.1074/jbc.M113.498329			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072714	Green Published, hybrid			2022-12-25	WOS:000328681700031
J	Zhang, XS; Zhang, BL; Gao, JD; Wang, X; Liu, ZH				Zhang, Xusen; Zhang, Bailin; Gao, Jidong; Wang, Xiang; Liu, Zhihua			Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKT; Apoptosis; ERK; ETS Family Transcription Factor; MicroRNA	EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; MIR-200 FAMILY; DOWN-REGULATION; E-CADHERIN; REPRESSORS ZEB1; ISOMERASE PIN1; GROWTH; ACTIVATION; ERK	Background: The role of miRNA-200b in the regulation of anoikis is not well understood. Results: miRNA-200b controls anoikis by targeting Pin1, and its expression is regulated by PEA3 and ELK-1. Conclusion: Pin1 acts as a functional target gene of miRNA-200b. Significance: These findings characterize the self-regulation of miRNA-200b and its role in the regulation of anoikis. MicroRNA (miRNA) 200s regulate E-cadherin by directly targeting ZEB1/ZEB2, which are transcriptional repressors of E-cadherin. Decreased expression of E-cadherin results in cancer cells losing interaction with the extracellular matrix and detaching from the primary tumor. Normally, cells will undergo anoikis after losing interaction with the extracellular matrix. Cancer cells must, therefore, possess the ability to resist anoikis during the process of metastasis. Here we show that miRNA-200b regulates anoikis by directly targeting the 3 UTR of Pin1 mRNA and regulating Pin1 expression at the translational level. We found that down-regulation of miRNA-200b promotes cancer cells survival during metastasis, and the homeless state of these cells resulted in decreased expression of miRNA-200b in the MCF-7 cell line. We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis, which has a significant negative correlation with Pin1 expression. Two members of the ETS (E-26) family (PEA3 and ELK-1) regulate the expression of miRNA-200b. PEA3 promotes the expression of miRNA-200b, and ELK-1 is a transcriptional repressor of miRNA-200b. In addition, miRNA-200b regulates the activity of PEA3 and ELK-1 via the Pin1-pERK pathway and forms self-regulated feedback loops. This study characterizes the role of miRNA-200b in the regulation of anoikis and demonstrates the regulation of its own expression in the process of metastasis.	[Zhang, Xusen; Liu, Zhihua] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Zhang, Bailin; Gao, Jidong; Wang, Xiang] Chinese Acad Med Sci, Dept Abdominal Surg, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Zhang, Bailin/0000-0003-2759-7727	National Natural Science Foundation of China [91019009, 81130043]; National Basic Research Program of China [2011CB504205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 91019009 and 81130043 and by National Basic Research Program of China Grant 2011CB504205.	A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Aydogdu E, 2012, CARCINOGENESIS, V33, P1502, DOI 10.1093/carcin/bgs161; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Castaneda CA, 2011, EXPERT REV ANTICANC, V11, P1265, DOI [10.1586/era.11.40, 10.1586/ERA.11.40]; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukuchi M, 2006, INT J ONCOL, V29, P329; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kim JB, 2010, PHYTOMEDICINE, V17, P436, DOI 10.1016/j.phymed.2009.08.012; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Mathiesen RR, 2012, INT J CANCER, V131, pE405, DOI 10.1002/ijc.26444; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; Uchida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031823; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	61	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32742	32752		10.1074/jbc.M113.478016	http://dx.doi.org/10.1074/jbc.M113.478016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072701	Green Published, hybrid			2022-12-25	WOS:000328681700058
J	Dasenbrook, EC; Lu, L; Donnola, S; Weaver, DE; Gulani, V; Jakob, PM; Konstan, MW; Flask, CA				Dasenbrook, Elliott C.; Lu, Lan; Donnola, Shannon; Weaver, David E.; Gulani, Vikas; Jakob, Peter M.; Konstan, Michael W.; Flask, Chris A.			Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study	PLOS ONE			English	Article							INFANTS; DISEASE; VENTILATION; GUIDELINES; INFECTION; DIAGNOSIS; CHILDREN	Background: Cystic fibrosis (CF) patients would benefit from a safe and effective tool to detect early-stage, regional lung disease to allow for early intervention. Magnetic Resonance Imaging (MRI) is a safe, non-invasive procedure capable of providing quantitative assessments of disease without ionizing radiation. We developed a rapid normalized T1 MRI technique to detect regional lung disease in early-stage CF patients. Materials and Methods: Conventional multislice, pulmonary T1 relaxation time maps were obtained for 10 adult CF patients with normal spirometry and 5 healthy non-CF control subjects using a rapid Look-Locker MRI acquisition (5 seconds/imaging slice). Each lung absolute T1 map was separated into six regions of interest (ROI) by manually selecting upper, central, and lower lung regions in the left and right lungs. In order to reduce the effects of subject-to-subject variation, normalized T1 maps were calculated by dividing each pixel in the absolute T1 maps by the mean T1 time in the central lung region. The primary outcome was the differences in mean normalized T1 values in the upper lung regions between CF patients with normal spirometry and healthy volunteers. Results: Normalized T1 (nT1) maps showed visibly reduced subject-to-subject variation in comparison to conventional absolute T1 maps for healthy volunteers. An ROI analysis showed that the variation in the nT1 values in all regions was <= 2% of the mean. The primary outcome, the mean (SD) of the normalized T1 values in the upper right lung regions, was significantly lower in the CF subjects [.914 (.037)] compared to the upper right lung regions of the healthy subjects [.983 (.003)] [difference of .069 (95% confidence interval .032-.105); p=.001). Similar results were seen in the upper left lung region. Conclusion: Rapid normalized T1 MRI relaxometry obtained in 5 seconds/imaging slice may be used to detect regional early-stage lung disease in CF patients.	[Dasenbrook, Elliott C.; Weaver, David E.; Konstan, Michael W.; Flask, Chris A.] Case Western Reserve Univ, Sch Med, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Lu, Lan; Donnola, Shannon; Weaver, David E.; Gulani, Vikas; Konstan, Michael W.; Flask, Chris A.] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.] Case Western Reserve Univ, Dept Med, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lu, Lan; Donnola, Shannon; Gulani, Vikas; Flask, Chris A.] Case Western Reserve Univ, Dept Radiol, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Biomed Engn, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Jakob, Peter M.] Univ Wurzburg, Dept Phys, D-97070 Wurzburg, Germany	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of Wurzburg	Dasenbrook, EC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	ecd28@case.edu		Konstan, Michael/0000-0002-0557-7277; Dasenbrook, Elliott/0000-0001-9811-8004; Flask, Chris/0000-0002-1066-333X	National Institutes of Health (NIH) [P30-DK027651, CTSA-UL1TR000439]; Cystic Fibrosis Foundation [DASENB10A0, KONSTA03Y2]; Seimens Medical System; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Seimens Medical System; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health (NIH) grants P30-DK027651 and CTSA-UL1TR000439, the Cystic Fibrosis Foundation (DASENB10A0 and KONSTA03Y2), and Seimens Medical System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Bannier E, 2010, RADIOLOGY, V255, P225, DOI 10.1148/radiol.09090039; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; Dasenbrook EC, 2012, JAMA-J AM MED ASSOC, V307, P2316, DOI 10.1001/jama.2012.5853; Dasenbrook EC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d726; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Eichinger M, 2010, J MAGN RESON IMAGING, V32, P1370, DOI 10.1002/jmri.22374; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Hopkins SR, 2007, J APPL PHYSIOL, V102, P1244, DOI 10.1152/japplphysiol.00738.2006; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Kirby M, 2011, ACAD RADIOL, V18, P1006, DOI 10.1016/j.acra.2011.03.005; Koscik RE, 2000, PEDIATR PULM, V29, P457, DOI 10.1002/(SICI)1099-0496(200006)29:6<457::AID-PPUL8>3.3.CO;2-0; Linnane BM, 2008, AM J RESP CRIT CARE, V178, P1238, DOI 10.1164/rccm.200804-551OC; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Schraml C, 2012, MAGN RESON MATER PHY, V25, P155, DOI 10.1007/s10334-011-0271-x; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73286	10.1371/journal.pone.0073286	http://dx.doi.org/10.1371/journal.pone.0073286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086277	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700007
J	Wynns, AA; Jensen, AB; Eilenberg, J				Wynns, Anja A.; Jensen, Annette B.; Eilenberg, Jorgen			Ascosphaera callicarpa, a New Species of Bee-Loving Fungus, with a Key to the Genus for Europe	PLOS ONE			English	Article							ALFALFA LEAFCUTTING BEE; AGGREGATA SKOU; APIS; MEGACHILIDAE; HYMENOPTERA; LARVAE	We studied the bee specialist fungus Ascosphaera in wild solitary bees to investigate the diversity of the genus in nature and the ecology of these fungi with their bee hosts. A new morphologically distinctive species was discovered which also has a unique nrITS sequence. This new species, here named Ascosphaera callicarpa, is common on the larval feces of the solitary bee Chelostoma florisomne which nests in the Phragmites reeds of thatched roofs in Europe. Because collections of Ascosphaera from wild bees are scarce and because little is known about the ecology and distribution of the majority of the species in the genus, a key to the species thus far reported for Europe is included.	[Wynns, Anja A.; Jensen, Annette B.; Eilenberg, Jorgen] Univ Copenhagen, Ctr Social Evolut, Dept Plant & Environm Sci, Frederiksberg, Denmark	University of Copenhagen	Wynns, AA (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Plant & Environm Sci, Frederiksberg, Denmark.	aaw@life.ku.dk	Eilenberg, Jorgen/F-7444-2014; Jensen, Annette B/G-7558-2014; Jensen, Annette Bruun/AAH-1732-2021	Eilenberg, Jorgen/0000-0002-9273-5252; Jensen, Annette B/0000-0002-2044-2274; Jensen, Annette Bruun/0000-0002-2044-2274; Amtoft Wynns, Anja/0000-0002-6013-9456	University of Copenhagen; Danish National Research Foundation	University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the University of Copenhagen and the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 1998, AUST SYST BOT, V11, P53, DOI 10.1071/SB96026; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; BAKER GM, 1968, MYCOLOGIA, V60, P189, DOI 10.2307/3757322; BERBEE ML, 1992, MOL BIOL EVOL, V9, P278; BISSETT J, 1988, CAN J BOT, V66, P2541, DOI [10.1139/b88-346, 10.1139/b88-057]; Claussen P., 1921, Arbeiten aus der Biologischen Reichsanstalt fuer Land- u Forstwirtschaft Berlin, V10, P467; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; GILLIAM M, 1994, J INVERTEBR PATHOL, V63, P307, DOI 10.1006/jipa.1994.1057; GILLIAM M, 1993, J INVERTEBR PATHOL, V61, P111, DOI 10.1006/jipa.1993.1021; GOERZEN DW, 1990, CAN ENTOMOL, V122, P1269, DOI 10.4039/Ent1221269-11; GOERZEN DW, 1992, CAN ENTOMOL, V124, P557, DOI 10.4039/Ent124557-3; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HERMOSO-DE-MENDOZA M, 1989, J APICULT RES, V28, P61; HITCHCOCK JD, 1972, MYCOLOGIA, V64, P1193, DOI 10.2307/3758091; HOLM S N, 1972, Entomologica Scandinavica, V3, P169; James Rosalind R., 2008, P124; James RR, 2005, J INVERTEBR PATHOL, V90, P98, DOI 10.1016/j.jip.2005.08.004; James RR, 2005, APIDOLOGIE, V36, P15, DOI 10.1051/apido:2004065; Maasen A, 1916, MITT KAISERL BIOL AN, V16, P51; Maurizio A, 1935, BER SCHWEIZ BOT GES, V44, P676; Melville R, 1944, NATURE, V153, P112, DOI 10.1038/153112a0; PROKSCHL H, 1953, ARCH MIKROBIOL, V18, P198; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; SKOU J P, 1972, Friesia, V10, P1; SKOU JP, 1989, MYCOTAXON, V35, P211; Skou JP., 1986, APIMONDIA, V30, P260; Skou JP, 1979, VET MICROBIOL, V149, P200; SPILTOIR CF, 1955, MYCOLOGIA, V47, P238, DOI 10.2307/3755414; SPILTOIR CF, 1955, AM J BOT, V42, P501, DOI 10.2307/2438686; Stephen WP, 1969, BIOL EXTERNAL MORPHO; Stephen WP, 1981, OREGON STATE U AGR E; Thiers B., 2008, INDEX HERBARIORUM GL; Westrich P., 1990, WILDBIENEN BADEN WUR; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wynns A, 2012, THESIS U COPENHAGEN; Wynns AA, 2012, MYCOLOGIA, V104, P108, DOI 10.3852/10-047; YOUSSEF NN, 1984, J INVERTEBR PATHOL, V43, P11, DOI 10.1016/0022-2011(84)90059-4	40	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73419	10.1371/journal.pone.0073419	http://dx.doi.org/10.1371/journal.pone.0073419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086280	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700008
J	Kalani, K; Agarwal, J; Alam, S; Khan, F; Pal, A; Srivastava, SK				Kalani, Komal; Agarwal, Jyoti; Alam, Sarfaraz; Khan, Feroz; Pal, Anirban; Srivastava, Santosh Kumar			In Silico and In Vivo Anti-Malarial Studies of 18 beta Glycyrrhetinic Acid from Glycyrrhiza glabra	PLOS ONE			English	Article							FALCIPARUM LACTATE-DEHYDROGENASE; PLASMODIUM-FALCIPARUM; OLEANOLIC ACID; PHARMACOLOGY; DERIVATIVES; DOCKING; MALARIA; MICE	Malaria is one of the most prevailing fatal diseases causing between 1.2 and 2.7 million deaths all over the world each year. Further, development of resistance against the frontline anti-malarial drugs has created an alarming situation, which requires intensive drug discovery to develop new, more effective, affordable and accessible anti-malarial agents possessing novel modes of action. Over the past few years triterpenoids from higher plants have shown a wide range of anti-malarial activities. As a part of our drug discovery program for anti-malarial agents from Indian medicinal plants, roots of Glycyrrhiza glabra were chemically investigated, which resulted in the isolation and characterization of 18 beta-glycyrrhetinic acid (GA) as a major constituent. The in vitro studies against P. falciparum showed significant (IC50 1.69 mu g/ml) anti-malarial potential for GA. Similarly, the molecular docking studies showed adequate docking (LibDock) score of 71.18 for GA and 131.15 for standard anti-malarial drug chloroquine. Further, in silico pharmacokinetic and drug-likeness studies showed that GA possesses drug-like properties. Finally, in vivo evaluation showed a dose dependent anti-malarial activity ranging from 68-100% at doses of 62.5-250mg/kg on day 8. To the best of our knowledge this is the first ever report on the anti-malarial potential of GA. Further work on optimization of the anti-malarial lead is under progress.	[Kalani, Komal; Srivastava, Santosh Kumar] CSIR Cent Inst Med & Aromat Plants, Dept Med Chem, Lucknow, Uttar Pradesh, India; [Agarwal, Jyoti; Pal, Anirban] CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India; [Alam, Sarfaraz; Khan, Feroz] CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Pal, A (corresponding author), CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India.	drapaul@gmail.com; santoshkumar_1955@yahoo.com	Alam, Sarfaraz/H-2802-2019; Pal, Anirban/AAG-9077-2020; Alam, Sarfaraz/A-9180-2012; Khan, Feroz/AHC-3474-2022	Alam, Sarfaraz/0000-0002-7246-8687; Alam, Sarfaraz/0000-0002-7246-8687; Khan, Feroz/0000-0002-2704-5925; Pal, Anirban/0000-0003-2688-7714	CSIR-network [BSC-0121]	CSIR-network(Council of Scientific & Industrial Research (CSIR) - India)	The funding source is CSIR-network project BSC-0121 and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EMAHMPC5711222010; Boniface PK, 2013, J ETHNOPHARMACOL, V145, P373, DOI 10.1016/j.jep.2012.10.025; Cimanga RK, 2006, PHARM BIOL, V44, P677, DOI 10.1080/13880200601009123; Daily JP, 2006, J CLIN PHARMACOL, V46, P1487, DOI 10.1177/0091270006294276; Gao DW, 2012, INT J NANOMED, V7, P3517, DOI 10.2147/IJN.S31725; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Kalani K, 2013, BIOORG MED CHEM LETT, V23, P2566, DOI 10.1016/j.bmcl.2013.02.115; Khare C.P., 2004, ENCY INDIAN MED PLAN; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; MACIAS A, 1994, MECH DEVELOP, V46, P15, DOI 10.1016/0925-4773(94)90034-5; Nick A, 1995, J ETHNOPHARMACOL, V49, P147, DOI 10.1016/0378-8741(95)01315-6; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; Qidwai T, 2012, CURR PHARM DESIGN, V18, P6133, DOI 10.2174/138161212803582397; Ramalhete C, 2011, BIOORGAN MED CHEM, V19, P7474, DOI 10.1016/j.bmc.2011.10.044; Ramalhete C, 2010, BIOORGAN MED CHEM, V18, P5254, DOI 10.1016/j.bmc.2010.05.054; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; Roy KK, 2011, CHEM BIOL DRUG DES, V78, P483, DOI 10.1111/j.1747-0285.2011.01158.x; Sen D, 2013, J ADV PHARM TECHNOL, V4, P50, DOI 10.4103/2231-4040.107501; Sessions RB, 1997, PROTEIN ENG, V10, P301, DOI 10.1093/protein/10.4.301; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; Takenaka T, 2001, BJU INT, V88, P7; W.H.O, 2012, ORLD MAL REP 2012; Zhu YM, 2001, BIOORG MED CHEM LETT, V11, P3115, DOI 10.1016/S0960-894X(01)00647-3	26	55	55	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74761	10.1371/journal.pone.0074761	http://dx.doi.org/10.1371/journal.pone.0074761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086367	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200016
J	Edwards, CTT; Rasmussen, GSA; Riordan, P; Courchamp, F; Macdonald, DW				Edwards, Charles T. T.; Rasmussen, Gregory S. A.; Riordan, Philip; Courchamp, Franck; Macdonald, David W.			Non-Adaptive Phenotypic Evolution of the Endangered Carnivore Lycaon pictus	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; INBREEDING DEPRESSION; DEVELOPMENTAL STABILITY; CONTEMPORARY EVOLUTION; HABITAT DISTURBANCE; GENETIC DIVERSITY; CONSERVATION; EXTINCTION; FITNESS; STRESS	Decline in wild populations as a result of anthropogenic impact is widely considered to have evolutionary consequences for the species concerned. Here we examine changes in developmental stability in the painted hunting dog (Lycaon pictus), which once occupied most of sub-Saharan Africa but has undergone a dramatic population decline in the last century. Fluctuating asymmetry (FA) was used as an indicator of developmental stability and measured in museum skull specimens spanning a hundred year period. A comparison with the more ubiquitous black-backed jackal (Canis mesomelas) revealed FA in L. pictus to be high. Furthermore, the data indicate a temporal increase in FA over time in L. pictus, corresponding to the period of its population decline. The high rate of change is compatible with genetic drift although environmental factors are also likely to be important. Lowering developmental stability over time may have direct fitness consequences and as such represents an unacknowledged threat to future resilience of the population.	[Edwards, Charles T. T.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Rasmussen, Gregory S. A.; Riordan, Philip; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England; [Rasmussen, Gregory S. A.] Nat Hist Museum, Painted Dog Res Project, Bulawayo, Zimbabwe; [Courchamp, Franck] Univ Paris Sud, UMR CNRS 8079, Orsay, France	Imperial College London; University of Oxford; UDICE-French Research Universities; Universite Paris Saclay	Edwards, CTT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England.	charles.edwards@niwa.co.nz	Courchamp, Franck/ABE-7204-2020; Riordan, Philip/AAY-6420-2020	Courchamp, Franck/0000-0001-7605-4548; Riordan, Philip/0000-0001-6285-8596	Painted Dog Conservation, Ganda lodge, Hwange National Park, Dete, Zimbabwe; Peoples' Trust for Endangered Species	Painted Dog Conservation, Ganda lodge, Hwange National Park, Dete, Zimbabwe; Peoples' Trust for Endangered Species	This work was made possible through financial support of Painted Dog Conservation, Ganda lodge, Hwange National Park, P.O. Box 72, Dete, Zimbabwe. DWM is grateful for a grant from the Peoples' Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados CL, 1995, CAN J ZOOL, V73, P1967, DOI 10.1139/z95-231; Ansell W. F. H., 1978, MAMMALS ZAMBIA; Bechshoft TO, 2008, ANN ZOOL FENN, V45, P32, DOI 10.5735/086.045.0103; Benitez HA, 2011, INT J MORPHOL, V29, P1459, DOI 10.4067/S0717-95022011000400066; BRADSHAW AD, 1989, BIOL J LINN SOC, V37, P137, DOI 10.1111/j.1095-8312.1989.tb02099.x; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Carter AJR, 2011, EVOLUTION, V65, P3558, DOI 10.1111/j.1558-5646.2011.01393.x; CHILDES SL, 1988, BIOL CONSERV, V44, P301, DOI 10.1016/0006-3207(88)90022-5; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Dworkin I, 2005, VARIATION CENTRAL CO; Eldridge MDB, 1999, CONSERV BIOL, V13, P531, DOI 10.1046/j.1523-1739.1999.98115.x; Fanshawe JH, 1997, AFRICAN WILD DOG STA; Faraway J., 2004, LINEAR MODELS R; Faraway JJ., 2005, EXTENDING LINEAR MOD; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; FRANKEL OH, 1974, GENETICS, V78, P53; Frankel OH, 1981, CONSERVATION EVOLUTI; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Fuller Rebecca C., 2003, P157; FULLER TK, 1992, WILDLIFE 2001 : POPULATIONS, P1125; GINGERICH PD, 1993, AM J SCI, V293A, P453, DOI 10.2475/ajs.293.A.453; Girman DJ, 2001, MOL ECOL, V10, P1703, DOI 10.1046/j.0962-1083.2001.01302.x; GIRMAN DJ, 1993, J HERED, V84, P450, DOI 10.1093/oxfordjournals.jhered.a111371; Girman DJ, 1997, AFRICAN WILD DOG STA; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 2010, EVOL APPL, V3, P97, DOI 10.1111/j.1752-4571.2009.00117.x; Grether GF, 2005, AM NAT, V166, pE115, DOI 10.1086/432023; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; HARTT L, 1995, EVOL ECOL, V9, P1, DOI 10.1007/BF01237691; Helle S, 2011, ECOL INDIC, V11, P861, DOI 10.1016/j.ecolind.2010.11.004; Hendrickx F, 2003, J EVOLUTION BIOL, V16, P1270, DOI 10.1046/j.1420-9101.2003.00633.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Lens L, 2000, ECOL LETT, V3, P516, DOI 10.1046/j.1461-0248.2000.00181.x; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1055, DOI 10.1098/rspb.1999.0743; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lerner IM, 1954, GENETIC HOMEOSTASIS; Leung B, 1997, OIKOS, V78, P397, DOI 10.2307/3546309; Leung B, 2000, AM NAT, V155, P101, DOI 10.1086/303298; Lovatt FM, 2011, BIOL J LINN SOC, V102, P798, DOI 10.1111/j.1095-8312.2011.01600.x; Loveridge A. J., 2004, CANIDS FOXES WOLVES; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; LYNCH M, 1996, CONSERVATION GENETIC; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Marsden CD, 2009, J HERED, V100, pS54, DOI 10.1093/jhered/esp031; Masona T, 1987, COLONIAL GAME POLICY; MILLS LS, 1994, AM NAT, V144, P412, DOI 10.1086/285684; Morris MR, 2012, FUNCT ECOL, V26, P723, DOI 10.1111/j.1365-2435.2012.01983.x; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. R., 2003, DEV INSTABILITY DI C; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pringle J., 1982, CONSERVATIONISTS KIL; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.es.22.110191.000433; Sokal R. R., 2012, BIOMETRY; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spinage C., 1991, 3 BOTSW SOC; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Talloen W, 2010, BIOL J LINN SOC, V100, P103, DOI 10.1111/j.1095-8312.2010.01422.x; Vangestel C, 2011, ECOL INDIC, V11, P389, DOI 10.1016/j.ecolind.2010.06.009; VANVALEN L, 1962, EVOLUTION, V16, P125; Velickovic M, 2007, BELG J ZOOL, V137, P147; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x; VRIJENHOEK RC, 1994, EXS, V68, P37; Waddington C., 1957, STRATEGY GENES; WAYNE RK, 1986, EVOLUTION, V40, P78, DOI 10.1111/j.1558-5646.1986.tb05719.x; White TA, 2008, J EVOLUTION BIOL, V21, P636, DOI 10.1111/j.1420-9101.2007.01481.x; Woodroffe R., 2012, IUCN 2013 IUCN RED L; WOODROFFE R, 2004, CANIDS FOXES WOLVES; Woodroffe Rosie, 1997, P58; Wright S., 1977, EVOLUTION GENETICS P, V3	91	5	5	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73856	10.1371/journal.pone.0073856	http://dx.doi.org/10.1371/journal.pone.0073856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086298	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200015
J	Jordanovski, D; Herwartz, C; Pawlowski, A; Taute, S; Frommolt, P; Steger, G				Jordanovski, Darko; Herwartz, Christine; Pawlowski, Anna; Taute, Stefanie; Frommolt, Peter; Steger, Gertrud			The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by I kappa B Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer	PLOS ONE			English	Article							PAPILLOMAVIRUS BINDING-FACTOR; CELL-LINE; EXPRESSION; PROTEIN; PHOSPHORYLATION; ALPHA; BETA; INHIBITION; TARGET; FAMILY	Activation of the hypoxia inducible transcription factor HIF and the NF-kappa B pathway promotes inflammation-mediated tumor progression. The cellular transcription factor ZNF395 has repeatedly been found overexpressed in various human cancers, particularly in response to hypoxia, implying a functional relevance. To understand the biological activity of ZNF395, we identified target genes of ZNF395 through a genome-wide expression screen. Induced ZNF395 expression led to the upregulation of genes known to play a role in cancer as well as a subset of interferon (IFN)-stimulated genes (ISG) involved in antiviral responses such as IFIT1/ISG56, IFI44 and IFI16. In cells that lack ZNF395, the IFN-alpha-mediated stimulation of these factors was impaired, demonstrating that ZNF395 is required for the full induction of these antiviral genes. Transient transfections revealed that ZNF395-mediated activation of the IFIT1/ISG56 promoter depends on the two IFN-stimulated response elements within the promoter and on the DNA-binding domain of ZNF395, a so-called C-clamp. We also show that I kappa B alpha kinase (IKK)-signaling is necessary to allow ZNF395 to activate transcription and simultaneously enhances its proteolytic degradation. Thus, ZNF395 becomes activated at the level of protein modification by IKK. Moreover, we confirm that the expression of ZNF395 is induced by hypoxia. Our results characterize ZNF395 as a novel factor that contributes to the maximal stimulation of a subset of ISGs. This transcriptional activity depends on IKK signaling further supporting a role of ZNF395 in the innate immune response. Given these results it is possible that under hypoxic conditions, elevated levels of ZNF395 may support inflammation and cancer progression by activating the target genes involved in the innate immune response and cancer.	[Jordanovski, Darko; Herwartz, Christine; Pawlowski, Anna; Taute, Stefanie; Steger, Gertrud] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Frommolt, Peter] CECAD Cologne, Bioinformat Core Facil, Cologne, Germany; [Frommolt, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Steger, G (corresponding author), Univ Cologne, Inst Virol, D-50931 Cologne, Germany.	Gertrud.Steger@uni-koeln.de	Frommolt, Peter/L-9656-2016	Frommolt, Peter/0000-0002-1966-8014	Deutsche Forschungsgemeinschaft [STE604/5-1]; Deutsche Krebshilfe; Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany [220/2010]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (grant to G. Steger, number STE604/5-1), the Deutsche Krebshilfe and the Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany, grant number 220/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Blazkova H, 2007, CELL CYCLE, V6, P2531, DOI 10.4161/cc.6.20.4807; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dalgin GS, 2007, CANCER INFORM, V3, P65; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hong SW, 2009, MOL CELLS, V27, P243, DOI 10.1007/s10059-009-0030-2; Hoverter NP, 2012, MOL CELL BIOL, V32, P3648, DOI 10.1128/MCB.06769-11; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hufbauer M, 2010, VIROLOGY, V403, P128, DOI 10.1016/j.virol.2010.04.013; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang YD, 2003, MOL CANCER RES, V1, P453; JORDANOVSKI D, 2012, HUNTINGTONS DIS CORE; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim SS, 2010, PATHOLOGY, V42, P50, DOI 10.3109/00313020903434421; KITAMURA A, 1994, EUR J BIOCHEM, V224, P877, DOI 10.1111/j.1432-1033.1994.00877.x; KOONG AC, 1994, CANCER RES, V54, P1425; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Muller A, 2002, J VIROL, V76, P11042, DOI 10.1128/JVI.76.21.11042-11053.2002; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PURDIE KJ, 1993, CANCER RES, V53, P5328; Rehtanz M, 2004, MOL CELL BIOL, V24, P2153, DOI 10.1128/MCB.24.5.2153-2168.2004; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V467, P67, DOI 10.1016/j.abb.2007.08.015; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Skubitz KM, 2006, J LAB CLIN MED, V147, P250, DOI 10.1016/j.lab.2006.04.001; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Tsuji K, 2010, CANCER GENET CYTOGEN, V198, P118, DOI 10.1016/j.cancergencyto.2010.01.004; Tsukahara T, 2004, CANCER RES, V64, P5442, DOI 10.1158/0008-5472.CAN-04-0522; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wallmen B, 2012, NUCLEIC ACIDS RES, V40, P9455, DOI 10.1093/nar/gks690; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yabe H, 2008, ONCOL REP, V19, P129; Yang CK, 2006, J BIOL CHEM, V281, P3389, DOI 10.1074/jbc.M510403200	64	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74911	10.1371/journal.pone.0074911	http://dx.doi.org/10.1371/journal.pone.0074911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086395	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200052
J	Zhou, X; Luo, YC; Ji, WJ; Zhang, L; Dong, Y; Ge, L; Lu, RY; Sun, HY; Guo, ZZ; Yang, GH; Jiang, TM; Li, YM				Zhou, Xin; Luo, Yue-Chen; Ji, Wen-Jie; Zhang, Li; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming			Modulation of Mononuclear Phagocyte Inflammatory Response by Liposome-Encapsulated Voltage Gated Sodium Channel Inhibitor Ameliorates Myocardial Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							MEDIATED DEPLETION; REPERFUSION INJURY; GENE-EXPRESSION; MACROPHAGES; PHENYTOIN; MONOCYTES; ATHEROSCLEROSIS; INFARCTION; CELLS; REPAIR	Background: Emerging evidence shows that anti-inflammatory strategies targeting inflammatory monocyte subset could reduce excessive inflammation and improve cardiovascular outcomes. Functional expression of voltage-gated sodium channels (VGSCs) have been demonstrated in monocytes and macrophages. We hypothesized that mononuclear phagocyte VGSCs are a target for monocyte/macrophage phenotypic switch, and liposome mediated inhibition of mononuclear phagocyte VGSC may attenuate myocardial ischemia/reperfusion (I/R) injury and improve post-infarction left ventricular remodeling. Methodology/Principal Findings: Thin film dispersion method was used to prepare phenytoin (PHT, a non-selective VGSC inhibitor) entrapped liposomes. Pharmacokinetic study revealed that the distribution and elimination half-life of PHT entrapped liposomes were shorter than those of free PHT, indicating a rapid uptake by mononuclear phagocytes after intravenous injection. In rat peritoneal macrophages, several VGSC a subunits (NaV1.1, NaV1.3, NaV1.4, NaV1.5, NaV1.6, NaV1.7, NaVX, Scn1b, Scn3b and Scn4b) and beta subunits were expressed at mRNA level, and PHT could suppress lipopolysaccharide induced M1 polarization (decreased TNF-alpha and CCL5 expression) and facilitate interleukin-4 induced M2 polarization (increased Arg1 and TGF-beta 1 expression). In vivo study using rat model of myocardial I/R injury, demonstrated that PHT entrapped liposome could partially suppress I/R injury induced CD43+ inflammatory monocyte expansion, along with decreased infarct size and left ventricular fibrosis. Transthoracic echocardiography and invasive hemodynamic analysis revealed that PHT entrapped liposome treatment could attenuate left ventricular structural and functional remodeling, as shown by increased ejection fraction, reduced end-systolic and end-diastolic volume, as well as an amelioration of left ventricular systolic (+dP/dt(max)) and diastolic (-dP/dt(min)) functions. Conclusions/Significance: Our work for the first time demonstrates the therapeutic potential of VGSC antagonism via liposome mediated monocyte/macrophage targeting in acute phase after myocardial I/R injury. These results suggest that VGSCs in mononuclear phagocyte system might be a novel target for immunomodulation and treatment of myocardial I/R injury.	[Zhou, Xin; Luo, Yue-Chen; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Inst Cardiovasc Dis, Pingjin Hosp, Tianjin, Peoples R China; [Zhou, Xin; Luo, Yue-Chen; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Ctr Heart, Pingjin Hosp, Tianjin, Peoples R China; [Zhou, Xin; Luo, Yue-Chen; Ji, Wen-Jie; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin, Peoples R China; [Zhang, Li] Logist Univ Chinese Peoples Armed Police Forces, Dept Pharmacognosy & Pharmaceut, Tianjin, Peoples R China		Li, YM (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Inst Cardiovasc Dis, Pingjin Hosp, Tianjin, Peoples R China.	cardiolab@gmail.com	JI, WENJIE/H-1274-2015; Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	National Natural Science Foundation of China [81070121, 81102088, 81170238]; Tianjin Municipal Science and Technology Committee [09ZCZDSF04200, 11JCYBJC12000, 12JCYBJC16600]; Tianjin Public Health Bureau [2010KZ122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Committee; Tianjin Public Health Bureau	Funding provided by National Natural Science Foundation of China (81070121, 81102088 and 81170238), Tianjin Municipal Science and Technology Committee (09ZCZDSF04200, 11JCYBJC12000 and 12JCYBJC16600) and Tianjin Public Health Bureau (2010KZ122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Anstead GM, 1996, ANN PHARMACOTHER, V30, P768, DOI 10.1177/106002809603000712; Baruch A, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0327-7; BUITING AMJ, 1994, J DRUG TARGET, V2, P357, DOI 10.3109/10611869408996810; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Diaz D, 2007, J CELL PHYSIOL, V210, P469, DOI 10.1002/jcp.20871; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dill RE, 1997, J PERIODONTOL, V68, P375, DOI 10.1902/jop.1997.68.4.375; DILL RE, 1993, J PERIODONTOL, V64, P169, DOI 10.1902/jop.1993.64.3.169; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fraser SP, 2004, FEBS LETT, V569, P191, DOI 10.1016/j.febslet.2004.05.063; Gao F, 2011, CLIN EXP HYPERTENS, V33, P492, DOI 10.3109/10641963.2010.551795; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Liu HM, 2011, CARDIOVASC DRUG THER, V25, P203, DOI 10.1007/s10557-011-6294-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Luo YC, 2013, ACTA BIOCH BIOPH SIN, V45, P561, DOI 10.1093/abbs/gmt045; Luo Yuechen, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P225; Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; NAKADE O, 1995, J DENT RES, V74, P331, DOI 10.1177/00220345950740010801; Rougier JS, 2012, J MOL CELL CARDIOL, V53, P589, DOI 10.1016/j.yjmcc.2012.08.011; Shaw J, 2007, BRIT J DERMATOL, V157, P997, DOI 10.1111/j.1365-2133.2007.08160.x; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Turan M, 2004, INT J COLORECTAL DIS, V19, P250, DOI 10.1007/s00384-003-0533-9; WEIHRAUCH D, 1995, MOL CELL BIOCHEM, V147, P13, DOI 10.1007/BF00944778; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang XK, 2009, J DRUG TARGET, V17, P399, DOI 10.1080/10611860902795407; Zhou X, 2006, INT J CARDIOL, V107, P21, DOI 10.1016/j.ijcard.2004.12.098; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74390	10.1371/journal.pone.0074390	http://dx.doi.org/10.1371/journal.pone.0074390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069305	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300034
J	Currow, DC; Clark, K; Mitchell, GK; Johnson, MJ; Abernethy, AP				Currow, David C.; Clark, Katherine; Mitchell, Geoffrey K.; Johnson, Miriam J.; Abernethy, Amy P.			Prospectively Collected Characteristics of Adult Patients, Their Consultations and Outcomes as They Report Breathlessness When Presenting to General Practice in Australia	PLOS ONE			English	Article							PHYSICAL SYMPTOMS; DYSPNEA; PREVALENCE; EMERGENCY; DISEASE; VISITS	Introduction: Breathlessness is a subjective sensation, so understanding its impacts requires patients' reports, including prospective patient-defined breathlessness as a reason for presenting to general practitioners (GP). The aim of this study was to define the prevalence of breathlessness as a reason for GP consultations while defining the clinico-demographic factors of these patients and the characteristics and outcomes of those consultations. Methods: Using nine years of the Family Medicine Research Centre database of 100 consecutive encounters from 1,000 practices annually, the patient-defined reason for encounter 'breathlessness' was explored using prospectively collected data in people >= 18 years with clinical data coded using the International Classification for Primary Care V2. Dichotomous variables were analysed using chi square and 95% confidence intervals calculated using Kish's formula for a single stage clustered design. Results: Of all the 755,729 consultations collected over a nine year period from 1 April, 2000, 7255 included breathlessness as a reason for encounter (0.96%; 95% CI 0.93 to 0.99) most frequently attributed to chronic obstructive pulmonary disease. Only 48.3% of GPs saw someone reporting breathlessness. The proportion of consultations with breathlessness increased with age. Breathlessness trebled the likelihood that the consultation occurred in the community rather than the consulting room (p<0.0001) and increased 2.5 fold the likelihood of urgent referral to hospital (p<0.0001). Of those with breathlessness, 12% had undiagnosed breathlessness at the end of the consultation (873/7255) with higher likelihood of being younger females. Discussion: Breathlessness is a prevalent symptom in general practitioner. Such prevalence enables future research focused on understanding the temporal pattern of breathlessness and the longitudinal care offered to, and outcomes for these patients, including those who leave the consultation without a diagnosis.	[Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Discipline Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Palliat Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Support Serv, Bedford Pk, SA 5042, Australia; [Clark, Katherine] Univ Newcastle, Newcastle, NSW 2300, Australia; [Clark, Katherine] Calvary Mater Hosp, Hunter New England Area Palliat Care Serv, Waratah, NSW, Australia; [Mitchell, Geoffrey K.] Univ Queensland, Ipswich Clin Sch, Sch Med, Ipswich, Qld, Australia; [Johnson, Miriam J.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Abernethy, Amy P.] Duke Univ, Med Ctr, Durham, NC USA	Flinders University South Australia; Flinders University South Australia; Flinders University South Australia; University of Newcastle; Calvary Mater Newcastle Hospital; University of Queensland; University of Hull; University of York - UK; Duke University	Currow, DC (corresponding author), Flinders Univ S Australia, Discipline Serv, Bedford Pk, SA 5042, Australia.	david.currow@flinders.edu.au	Mitchell, Geoffrey/F-1489-2010	Mitchell, Geoffrey/0000-0001-7817-6821; Johnson, Miriam/0000-0001-6204-9158; Currow, David/0000-0003-1988-1250	Discipline, Palliative and Supportive Services, Flinders University	Discipline, Palliative and Supportive Services, Flinders University	This study was supported by discretionary funding from the Discipline, Palliative and Supportive Services, Flinders University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; [Anonymous], 2010, ENZ NOUS AUSTR HLTH; Britt H, 2001, GEN PRACTICE SERIES, V30; Britt H, 2011, GEN PRACTICE SERIES, V31; Charles Janice, 2005, Aust Fam Physician, V34, P520; Currow DC, 2012, J PAIN SYMPTOM MANAG, V44, pE1, DOI 10.1016/j.jpainsymman.2012.07.005; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Currow DC, 2009, J PAIN SYMPTOM MANAG, V38, P533, DOI 10.1016/j.jpainsymman.2009.01.006; Frese Thomas, 2011, J Clin Med Res, V3, P239, DOI 10.4021/jocmr642w; Gysels M, 2010, J PAIN SYMPTOM MANAG, V39, P555, DOI 10.1016/j.jpainsymman.2009.08.009; ICPC, ICPC 2 INT CLASS PRI; Johnson MJ, 2012, J PALLIAT MED, V15, P744, DOI 10.1089/jpm.2011.0430; Kish L, 1965, SURVEY SAMPLING; Mahler DA, 2012, COPD, V9, P522, DOI 10.3109/15412555.2012.701678; Morgan DD, 2012, J PALLIAT CARE, V6, P138; Nielsen LS, 2001, J INTERN MED, V250, P422, DOI 10.1046/j.1365-2796.2001.00901.x; Niska Richard, 2010, Natl Health Stat Report, P1; Parshall MB, 2001, HEART LUNG, V30, P47; Parshall MB, 1999, NURS RES, V48, P62, DOI 10.1097/00006199-199903000-00004; Pedersen F, 2007, INT J CLIN PRACT, V61, P1481, DOI 10.1111/j.1742-1241.2007.01428.x; Pratter MR, 2011, RESP MED, V105, P1014, DOI 10.1016/j.rmed.2010.12.009; van Wijk CMTG, 1999, SOC SCI MED, V49, P1061, DOI 10.1016/S0277-9536(99)00196-3; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; VERBRUGGE L M, 1980, Journal of Behavioral Medicine, V3, P327, DOI 10.1007/BF00845289; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wiseman R, 2013, AUST FAM PHYSICIAN, V42, P137; Zhang J, 2013, RESPIROLOGY, V18, P297, DOI 10.1111/j.1440-1843.2012.02282.x	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74814	10.1371/journal.pone.0074814	http://dx.doi.org/10.1371/journal.pone.0074814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069352	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300058
J	Ma, LN; Liu, XQ; Zhao, YY; Chen, BD; Li, XG; Qi, RM				Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Li, Xingguang; Qi, Ruomei			Ginkgolide B Reduces LOX-1 Expression by Inhibiting Akt Phosphorylation and Increasing Sirt1 Expression in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; LECTIN-LIKE; ACTIVATION; ATHEROSCLEROSIS; NRF2; RECEPTOR; PATHWAY; ATHEROGENESIS; INFLAMMATION	Oxidized low-density lipoprotein (ox-LDL) is an important risk factor in the development of atherosclerosis. LOX-1, a lectin-like receptor for ox-LDL, is present primarily on endothelial cells and upregulated by ox-LDL, tumor necrosis factor a, shear stress, and cytokines in atherosclerosis. Recent studies demonstrated that ginkgolide B, a platelet-activating factor receptor antagonist, has antiinflammatory and antioxidant effects on endothelial and nerve cells. The present study investigated the effects of ginkgolide B on LOX-1 expression and the possible mechanism of action. Our results showed that ginkgolide B inhibited LOX-1 and intercellular cell adhesion molecule-1 (ICAM-1) expression in ox-LDL-stimulated endothelial cells through a mechanism associated with the attenuation of Akt activation. Similar data were obtained by silencing Akt and LY294002. We also evaluated Sirt1 and nuclear factor erythroid 2-related factor 2 (Nrf2) expression. These molecules play a protective role in endothelial cell injury. The results showed that ginkgolide B increased Sirt1 expression in ox-LDL-treated cells. The inhibitory effects of ginkgolide B on LOX-1 and ICAM-1 expression were reduced in Sirt1 siRNA-transfected cells. Nrf2 expression was increased in ox-LDL-treated cells, and ginkgolide B downregulated Nrf2 expression. These results suggest that ginkgolide B reduces Nrf2 expression by inhibiting LOX-1 expression, consequently reducing oxidative stress injury in ox-LDL-stimulated cells. Altogether, these results indicate that the protective effect of ginkgolide B on endothelial cells may be attributable to a decrease in LOX-1 expression and an increase in Sirt1 expression in ox-LDL-stimulated endothelial cells, the mechanism of which is linked to the inhibition of Akt activation. Ginkgolide B may be a multiple-target drug that exerts protective effects in ox-LDL-treated human umbilical vein endothelial cells.	[Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Qi, Ruomei] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Qi, Ruomei] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Ma, Lina; Li, Xingguang] Beijing Univ Chinese Med, Beijing, Peoples R China	Beijing Hospital; Beijing University of Chinese Medicine	Qi, RM (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	ruomeiqi@163.com			National Natural Science Foundation of China [81270379, 81070231, 81101859]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81270379, 81070231 and 81101859). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Birukov Konstantin G, 2006, Curr Atheroscler Rep, V8, P223, DOI 10.1007/s11883-006-0077-x; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; Carter S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035110; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Daub K, 2010, SEMIN THROMB HEMOST, V36, P146, DOI 10.1055/s-0030-1251498; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fougerat A, 2009, CLIN SCI, V116, P791, DOI 10.1042/CS20080549; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kuhn AM, 2011, FREE RADICAL BIO MED, V50, P1382, DOI 10.1016/j.freeradbiomed.2011.02.036; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 1999, CIRC RES, V84, P1043, DOI 10.1161/01.RES.84.9.1043; Li L, 2004, CIRC RES, V95, P877, DOI 10.1161/01.RES.0000147309.54227.42; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P103, DOI 10.1093/abbs/gmq104; Li R, 2009, J PHARMACOL SCI, V110, P362, DOI 10.1254/jphs.08275FP; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036237; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Navarra T, 2010, J ATHEROSCLER THROMB, V17, P317, DOI 10.5551/jat.3228; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Steinberg D, 1997, CIRCULATION, V95, P1062; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1415, DOI 10.1089/ars.2010.3433; TANAKA M, 1993, BIOL PHARM BULL, V16, P538, DOI 10.1248/bpb.16.538; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6; Yuan Q, 2011, CAN J PHYSIOL PHARM, V89, P713, DOI [10.1139/Y11-069, 10.1139/y11-069]; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhang S, 2011, J CARDIOVASC PHARM, V57, P721, DOI 10.1097/FJC.0b013e31821a50a8	38	33	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74769	10.1371/journal.pone.0074769	http://dx.doi.org/10.1371/journal.pone.0074769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069345	gold, Green Submitted, Green Published			2022-12-25	WOS:000324547300057
J	Wu, F; Guo, YF; Kowal, P; Jiang, Y; Yu, M; Li, XJ; Zheng, Y; Xu, JY				Wu, Fan; Guo, Yanfei; Kowal, Paul; Jiang, Yong; Yu, Min; Li, Xinjian; Zheng, Yang; Xu, Jiying			Prevalence of Major Chronic Conditions among Older Chinese Adults: The Study on Global AGEing and Adult Health (SAGE) Wave 1	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; DIABETES PREVALENCE; NATIONAL NUTRITION; CHRONIC DISEASES; DEPRESSION; POPULATION; DEMENTIA; HYPERTENSION; AWARENESS; PEOPLE	Background: The likely corresponding increase in prevalence of chronic disease will be a major challenge for the health care system. Few nationwide epidemiological studies include a large enough sample of older adults to provide estimates of chronic conditions in the older adult population. This study aimed to estimate the prevalence of eight common chronic health conditions and examine socioeconomic inequalities in the diseases among older adults in China. Method: Data are from SAGE-China Wave 1, including 13,157 people aged 50-plus years. Respondents were asked if they had been diagnosed with any of the following chronic medical conditions: angina, arthritis, asthma, stroke, diabetes, depression, chronic lung disease and hypertension. A set of validated symptom-based questions and related diagnostic algorithms were also used to estimate disease prevalence for angina, arthritis, asthma and depression. Multivariate logistic regression was performed to examine the probability of developing chronic conditions in relation to sociodemographic variables such as gender, age, urban/rural setting and household wealth level. Results: Fifty percent of respondents reported having one of the selected chronic conditions, 18.9% two conditions, 5.8% three conditions, and 1.4% reported having four or more chronic conditions. Self-reported prevalence was generated for angina (8%), arthritis (22%), asthma (2%), stroke (3%), diabetes (7%), depression (0.3%), chronic lung disease (8%) and hypertension (27%). The symptom-based prevalence of angina, arthritis, asthma and depression was 10%, 20%, 4% and 2%, respectively. Conclusion: This study provides the best available prevalence estimates for major chronic health conditions among older Chinese adults. Findings from this study indicated that major chronic conditions were common, so prevention and early intervention targeting adults aged 50 years and older should be prioritized.	[Wu, Fan; Guo, Yanfei; Li, Xinjian; Zheng, Yang; Xu, Jiying] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jiang, Yong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Kowal, Paul] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Yu, Min] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Kowal, Paul] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	Shanghai Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization; Zhejiang Provincial Center for Disease Control & Prevention; University of Newcastle	Wu, F (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China.	wufan68@gmail.com	JIANG, Yong/GYU-9887-2022	JIANG, Yong/0000-0001-7700-6054; Kowal, Paul/0000-0002-6314-8753	US National Institute on Aging [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; Science and Technology Commission of Shanghai Municipality [10XD1403600]; Shanghai Municipal Organization Department; shanghai Bureau of Human Resource and Social Security; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Organization Department; shanghai Bureau of Human Resource and Social Security; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the US National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479); Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1403600); Shanghai Municipal Organization Department & The shanghai Bureau of Human Resource and Social Security ("leading talents" project for Fan Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; Black HR, 1997, ARCH INTERN MED, V157, P2413; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chen R, 1999, INT J GERIATR PSYCH, V14, P821, DOI 10.1002/(SICI)1099-1166(199910)14:10<821::AID-GPS21>3.0.CO;2-0; Chen R, 2012, PREVALENCE ANGINA OL; Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension, 2005, CHIN J HYPERTENS, V134, P2; Llibre JD, 2011, MEDICC REV, V13, P30, DOI 10.37757/MR2011V13.N4.7; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; KIVELA SL, 1988, ACTA PSYCHIAT SCAND, V78, P401, DOI 10.1111/j.1600-0447.1988.tb06358.x; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033881; Liu SQ, 2011, PREV CHRONIC DIS, V8; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; McCracken CFM, 1997, BRIT J PSYCHIAT, V171, P269, DOI 10.1192/bjp.171.3.269; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Center for Chronic and Non-communicable Disease Control and Prevention, 2007, REP CHRON DIS RISK F, P64; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Rasch EK, 2003, ARTHRITIS RHEUM, V48, P917, DOI 10.1002/art.10897; Shi J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-277; UN Population Division, 2009, WORLD POP AG 2009; United Nations Educational Scientific and Cultural Organization, 1997, INT STAND CLASS ED I; Venketasubramanian N, 2005, STROKE, V36, P551, DOI 10.1161/01.STR.0000155687.18818.13; WHO, 2010, GLOB STAT REP NONC D; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	31	76	84	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74176	10.1371/journal.pone.0074176	http://dx.doi.org/10.1371/journal.pone.0074176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069278	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300030
J	Yasutaka, T; Naito, W; Nakanishi, J				Yasutaka, Tetsuo; Naito, Wataru; Nakanishi, Junko			Cost and Effectiveness of Decontamination Strategies in Radiation Contaminated Areas in Fukushima in Regard to External Radiation Dose	PLOS ONE			English	Article							POWER-PLANT ACCIDENT; REMEDIATION STRATEGIES; LONG-TERM; RADIONUCLIDES; MANAGEMENT	The objective of the present study is to evaluate the cost and effectiveness of decontamination strategies in the special decontamination areas in Fukushima in regard to external radiation dose. A geographical information system (GIS) was used to relate the predicted external dose in the affected areas to the number of potential inhabitants and the land use in the areas. A comprehensive review of the costs of various decontamination methods was conducted as part of the analysis. The results indicate that aerial decontamination in the special decontamination areas in Fukushima would be effective for reducing the air dose rate to the target level in a short period of time in some but not all of the areas. In a standard scenario, analysis of cost and effectiveness suggests that decontamination costs for agricultural areas account for approximately 80% of the total decontamination cost, of which approximately 60% is associated with storage. In addition, the costs of decontamination per person per unit area are estimated to vary greatly. Appropriate selection of decontamination methods may significantly decrease decontamination costs, allowing more meaningful decontamination in terms of the limited budget. Our analysis can help in examining the prioritization of decontamination areas from the viewpoints of cost and effectiveness in reducing the external dose. Decontamination strategies should be determined according to air dose rates and future land-use plans.	[Yasutaka, Tetsuo] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm GREEN, Higashi Ku, Tsukuba, Ibaraki, Japan; [Naito, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan; [Nakanishi, Junko] Natl Inst Adv Ind Sci & Technol, AIST, Higashi Ku, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Naito, W (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan.	w-naito@aist.go.jp	Naito, Wataru/M-1928-2018; Yasutaka, Tetsuo/N-6727-2016	Naito, Wataru/0000-0003-2064-7170; Yasutaka, Tetsuo/0000-0001-6000-663X	AIST Environment and Energy Unit	AIST Environment and Energy Unit	This work was supported by AIST Environment and Energy Unit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIST, 2011, NAT I ADV IND SCI TE; [Anonymous], 2012, FUK PREF SURF DEC MO; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Fesenko S, 2013, J ENVIRON RADIOACTIV, V119, P39, DOI 10.1016/j.jenvrad.2010.08.012; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; IAEA, 2000, GEN PROC ASS RESP RA; Jacob P, 2009, SCI TOTAL ENVIRON, V408, P14, DOI 10.1016/j.scitotenv.2009.09.006; Jacob P, 2001, J ENVIRON RADIOACTIV, V56, P51, DOI 10.1016/S0265-931X(01)00047-9; JAEA, 2012, IMPL REP DEC REL FUK; JAEA, 2012, 2012020 JAEA; JAEA, 2012, RES DEC MOD PROJ 11; METI, 2012, RESTR AR AR WHICH EV, P2012; MEXT, 2011, DISTR MAP RAD DOS ET; MEXT (Ministry of Education Culture Sports Science and Technology), 2011, RES 4 AIRB MON SURV; MLIT, 2012, NAT LAND NUM INF DOW; MOE, 2012, PROV CALC STAND DEC; MOE, 2011, DEC GUID VER 1; MOE, 2012, BUDG REQ MIN ENV 201; MOE, 2012, POL DEC SPEC DEC AR; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; NAIIC, 2012, OFF REP FUK NUCL ACC; Nisbet A, 2000, J ENVIRON RADIOACTIV, V51, P239, DOI 10.1016/S0265-931X(00)00080-1; Oughton D, 2004, J ENVIRON RADIOACTIV, V74, P171, DOI 10.1016/j.jenvrad.2004.01.009; Statistics Bureau of Japan Ministry of Internal Affairs and Communications, 2014, RES PROD RES SPEC CR; Taira Y, 2012, RADIAT PROT DOSIM, V151, P537, DOI 10.1093/rpd/ncs040; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 2000, UNSCEAR 2000 REP, VII; Yasutaka T, 2013, CHEMOSPHERE IN PRESS	27	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75308	10.1371/journal.pone.0075308	http://dx.doi.org/10.1371/journal.pone.0075308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069398	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300077
J	Kumar, S; Pan, CC; Bloodworth, JC; Nixon, AB; Theuer, C; Hoyt, DG; Lee, NY				Kumar, S.; Pan, C. C.; Bloodworth, J. C.; Nixon, A. B.; Theuer, C.; Hoyt, D. G.; Lee, N. Y.			Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-beta signaling	ONCOGENE			English	Article						endoglin; soluble endoglin; TRC105; angiogenesis; TGF-beta	ENDOTHELIAL-CELL PROLIFERATION; TUMOR VASCULATURE; SOLUBLE ENDOGLIN; CORECEPTOR ENDOGLIN; RECEPTOR COMPLEXES; GROWTH; ANGIOGENESIS; CANCER; MICE; EXPRESSION	Endoglin is a transforming growth factor beta (TGF-beta) coreceptor that serves as a prognostic, diagnostic and therapeutic vascular target in human cancer. A number of endoglin ectodomain-targeting antibodies (Abs) can effectively suppress both normal and tumor-associated angiogenesis, but their molecular actions remain poorly characterized. Here we define a key mechanism for TRACON105 (TRC105), a humanized monoclonal Ab in clinical trials for treatment of advanced or metastatic tumors. TRC105, along with several other endoglin Abs tested, enhance endoglin shedding through direct coupling of endoglin and the membrane-type 1 matrix metalloproteinase (MMP)-14 at the cell surface to release the antiangiogenic factor, soluble endoglin (sEng). In addition to this coupling process, endoglin shedding is further amplified by increased MMP-14 expression that requires TRC105 concentration-dependent c-Jun N-terminal kinase (JNK) activation. There were also notable counterbalancing effects on canonical Smad signaling in which TRC105 abrogated both the steady-state and TGF-beta-induced Smad1/5/8 activation while augmenting Smad2/3 activation. Interestingly, TRC105-induced sEng and aberrant Smad signaling resulted in an excessive migratory response through enhanced stress fiber formation and disruption of endothelial cell-cell junctions. Collectively, our study defines endoglin shedding and deregulated TGF-beta signaling during migration as major mechanisms by which TRC105 inhibits angiogenesis.	[Kumar, S.; Pan, C. C.; Bloodworth, J. C.; Hoyt, D. G.; Lee, N. Y.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Nixon, A. B.] Duke Canc Inst, Durham, NC USA; [Theuer, C.] TRACON Pharmaceut, San Diego, CA USA; [Lee, N. Y.] Davis Heart & Lung Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; Duke University; University System of Ohio; Ohio State University	Lee, NY (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmacol, 500 West 12th Ave, Columbus, OH 43210 USA.	lee.5064@osu.edu	Lee, Nam/H-3073-2016; Nixon, Andrew/AAJ-4712-2020	Nixon, Andrew/0000-0003-3971-2964	National Institute of Health [R00 HL103791]; College of Pharmacy, Division of Pharmacology; Davis Heart and Lung Research Institute, at The Ohio State University; NATIONAL CANCER INSTITUTE [P30CA014236, R01CA178443] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103791] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Pharmacy, Division of Pharmacology; Davis Heart and Lung Research Institute, at The Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (R00 HL103791 to NYL) and internal funds from the College of Pharmacy, Division of Pharmacology, and Davis Heart and Lung Research Institute, at The Ohio State University. We thank Dr Jian Cao for the MMP-14 construct (Stony Brook University) and Dr Charles Theuer for the TRC105 antibody (TRACON Pharmaceuticals).	Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Cherney RJ, 2006, BIOORG MED CHEM LETT, V16, P1028, DOI 10.1016/j.bmcl.2005.10.078; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Landt S, 2011, ANTICANCER RES, V31, P2651; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Lee NY, 2009, FASEB J, V23, P3712, DOI 10.1096/fj.09-131607; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lowrey GE, 2008, RESP MED, V102, P845, DOI 10.1016/j.rmed.2008.01.006; Marom B, 2011, J BIOL CHEM, V286, P19287, DOI 10.1074/jbc.M110.210377; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Nasser MW, 2012, CANCER RES, V72, P604, DOI 10.1158/0008-5472.CAN-11-0669; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Pan CC, 2012, BIOCHEM BIOPH RES CO, V424, P620, DOI 10.1016/j.bbrc.2012.06.163; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Santibanez JF, 2010, CARCINOGENESIS, V31, P2145, DOI 10.1093/carcin/bgq199; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Tsirakis G, 2012, EUR J INTERN MED, V23, P368, DOI 10.1016/j.ejim.2012.01.012; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Uneda S, 2009, INT J CANCER, V125, P1446, DOI 10.1002/ijc.24482; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007	45	29	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3970	3979		10.1038/onc.2013.386	http://dx.doi.org/10.1038/onc.2013.386			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24077288	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000339394700009
J	Bai, L; Livnat, I; Romanova, EV; Alexeeva, V; Yau, PM; Vilim, FS; Weiss, KR; Jing, J; Sweedler, JV				Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Alexeeva, Vera; Yau, Peter M.; Vilim, Ferdinand S.; Weiss, Klaudiusz R.; Jing, Jian; Sweedler, Jonathan V.			Characterization of GdFFD, a D-Amino Acid-containing Neuropeptide That Functions as an Extrinsic Modulator of the Aplysia Feeding Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Chemistry; Invertebrates; Mass Spectrometry (MS); Peptides; Post-translational Modification; Aplysia; D-Amino Acid-containing peptides; Epimer; MALDI-TOF; TOF MS; Stereoselective	CONTAINING PEPTIDE; CARDIOACTIVE PEPTIDES; MASS-SPECTROMETRY; MOTOR PROGRAMS; NERVOUS-SYSTEM; AMPHIBIAN SKIN; HIGH-AFFINITY; ACHATIN-I; D-SERINE; RESIDUE	Background: l-to-d conversion of an amino acid in a neuropeptide can be required for bioactivity. Results: A new d-amino acid-containing peptide (DAACP), GdFFD, shows stereospecific bioactivity in the feeding circuit. Conclusion: Our findings broaden the importance of this unusual post-translational modification, providing new methods to accelerate DAACP discovery. Significance: GdFFD is the first DAACP showing bioactivity in a well defined circuit. During eukaryotic translation, peptides/proteins are created using l-amino acids. However, a d-amino acid-containing peptide (DAACP) can be produced through post-translational modification via an isomerase enzyme. General approaches to identify novel DAACPs and investigate their function, particularly in specific neural circuits, are lacking. This is primarily due to the difficulty in characterizing this modification and due to the limited information on neural circuits in most species. We describe a multipronged approach to overcome these limitations using the sea slug Aplysia californica. Based on bioinformatics and homology to known DAACPs in the land snail Achatina fulica, we targeted two predicted peptides in Aplysia, GFFD, similar to achatin-I (GdFAD versus GFAD, where dF stands for d-phenylalanine), and YAEFLa, identical to fulyal (YdAEFLa versus YAEFLa), using stereoselective analytical methods, i.e. MALDI MS fragmentation analysis and LC-MS/MS. Although YAEFLa in Aplysia was detected only in an all l-form, we found that both GFFD and GdFFD were present in the Aplysia CNS. In situ hybridization and immunolabeling of GFFD/GdFFD-positive neurons and fibers suggested that GFFD/GdFFD might act as an extrinsic modulator of the feeding circuit. Consistent with this hypothesis, we found that GdFFD induced robust activity in the feeding circuit and elicited egestive motor patterns. In contrast, the peptide consisting of all l-amino acids, GFFD, was not bioactive. Our data indicate that the modification of an l-amino acid-containing neuropeptide to a DAACP is essential for peptide bioactivity in a motor circuit, and thus it provides a functional significance to this modification.	[Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Alexeeva, Vera; Vilim, Ferdinand S.; Weiss, Klaudiusz R.; Jing, Jian] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Yau, Peter M.] Univ Illinois, Roy J Carver Biotechnol Ctr, Prot Sci Facil, Urbana, IL 61801 USA; [Jing, Jian] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing University	Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	jingj01@gmail.com; jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Yau, Peter/0000-0002-1984-185X; Jing, Jian/0000-0003-1422-143X; Romanova, Elena/0000-0002-2040-3312	National Institutes of Health from NINDS [NS031609, NS066587, NS070583]; NIGMS [5T32-GM070421]; NIDA [P30 DA018310]; National Science Foundation of China [31371104]; National Science Foundation, Division of Chemistry [CHE-11-11705]; Division of Biological Infrastructure; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070583, R01NS031609, R29NS031609, R01NS066587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1111705] Funding Source: National Science Foundation	National Institutes of Health from NINDS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation, Division of Chemistry(National Science Foundation (NSF)); Division of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS031609, NS066587, and NS070583 from NINDS, 5T32-GM070421 from NIGMS, and P30 DA018310 from NIDA. This work was also supported by Grant 31371104 from National Science Foundation of China and Grant CHE-11-11705 from the National Science Foundation, Division of Chemistry (with co-funding from the Division of Biological Infrastructure).	Adams CM, 2004, J AM SOC MASS SPECTR, V15, P1087, DOI 10.1016/j.jasms.2004.04.026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai Lu, 2009, Bioanal Rev, V1, P7; Bai L, 2011, ANAL CHEM, V83, P2794, DOI 10.1021/ac200142m; BARRA D, 1994, PEPTIDES, V15, P199, DOI 10.1016/0196-9781(94)90002-7; Blitz DM, 2012, J NEUROSCI, V32, P9182, DOI 10.1523/JNEUROSCI.1461-12.2012; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Cooks RG, 1998, ACCOUNTS CHEM RES, V31, P379, DOI 10.1021/ar960242x; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Ewing MA, 2008, ANAL CHEM, V80, P2874, DOI 10.1021/ac7025173; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; FUJISAWA Y, 1992, COMP BIOCHEM PHYS C, V102, P91, DOI 10.1016/0742-8413(92)90049-D; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; Han YH, 2008, FEBS J, V275, P1976, DOI 10.1111/j.1742-4658.2008.06352.x; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; HECK SD, 1994, J AM CHEM SOC, V116, P10426, DOI 10.1021/ja00102a009; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Hummon AB, 2003, J PROTEOME RES, V2, P650, DOI 10.1021/pr034046d; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; Jacobsen R, 1998, J PEPT RES, V51, P173; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jimenez EC, 1997, BIOCHEMISTRY-US, V36, P989, DOI 10.1021/bi962840p; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Jimenez EC, 2001, TOXICON, V39, P803, DOI 10.1016/S0041-0101(00)00210-5; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2002, J NEUROSCI, V22, P6228; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2011, J NEUROSCI, V31, P15438, DOI 10.1523/JNEUROSCI.3741-11.2011; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; Jing J, 2009, REV NEUROSCIENCE, V20, P405; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; KREIL G, 1989, EUR J PHARMACOL, V162, P123, DOI 10.1016/0014-2999(89)90611-0; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; KUWADA M, 1994, MOL PHARMACOL, V46, P587; Li LJ, 2008, ANNU REV ANAL CHEM, V1, P451, DOI 10.1146/annurev.anchem.1.031207.113053; Li LJ, 2000, TRENDS BIOTECHNOL, V18, P151, DOI 10.1016/S0167-7799(00)01427-X; LLOYD PE, 1985, J NEUROSCI, V5, P1851; MIGNOGNA G, 1993, EMBO J, V12, P4829, DOI 10.1002/j.1460-2075.1993.tb06172.x; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; MOR A, 1989, FEBS LETT, V255, P269, DOI 10.1016/0014-5793(89)81104-4; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R; Phares GA, 1996, J NEUROSCI, V16, P7841; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Predel R, 2007, BIOESSAYS, V29, P416, DOI 10.1002/bies.20571; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; Proekt A, 2007, J NEUROPHYSIOL, V97, P3046, DOI 10.1152/jn.01301.2006; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Redeker V, 1998, ANAL CHEM, V70, P1805, DOI 10.1021/ac971309c; Romanova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048764; Sachon E, 2009, ANAL CHEM, V81, P4389, DOI 10.1021/ac9002886; Satake H, 1999, EUR J BIOCHEM, V261, P130, DOI 10.1046/j.1432-1327.1999.00252.x; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; Serafin SV, 2005, ANAL CHEM, V77, P5480, DOI 10.1021/ac050490j; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; SOSSIN WS, 1987, J NEUROSCI, V7, P671; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Soyez D, 2011, J CHROMATOGR B, V879, P3102, DOI 10.1016/j.jchromb.2011.03.032; Strand F. L., 1999, NEUROPEPTIDES REGULA, P121; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Torres AM, 2006, FEBS LETT, V580, P1587, DOI 10.1016/j.febslet.2006.01.089; Torres AM, 2005, BIOCHEM J, V391, P215, DOI 10.1042/BJ20050900; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; Vilim FS, 2001, PEPTIDES, V22, P2027, DOI 10.1016/S0196-9781(01)00561-7; Wu JS, 2010, J NEUROPHYSIOL, V103, P2174, DOI 10.1152/jn.01054.2009; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; YASUDAKAMATANI Y, 1995, J NEUROCHEM, V64, P2248; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9	83	31	32	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32837	32851		10.1074/jbc.M113.486670	http://dx.doi.org/10.1074/jbc.M113.486670			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078634	Green Published, hybrid			2022-12-25	WOS:000328841700003
J	Faingold, O; Ashkenazi, A; Kaushansky, N; Ben-Nun, A; Shai, Y				Faingold, Omri; Ashkenazi, Avraham; Kaushansky, Nathali; Ben-Nun, Avraham; Shai, Yechiel			An Immunomodulating Motif of the HIV-1 Fusion Protein Is Chirality-independent IMPLICATIONS FOR ITS MODE OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Immunosuppression; Membrane Fusion; Protein-Protein Interactions; T-cell; Viral Fusion Protein; Membrane Recognition	T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 LOOP REGION; TRANSMEMBRANE DOMAINS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; TCR-ALPHA; IN-VITRO; PEPTIDE; RECOGNITION	Background: Recently, an immunosuppressive motif was identified in the HIV-1 envelope glycoprotein complex. Results: Both d- and l-stereoisomers of the motif inhibit T-cell receptor activation and preferentially bind T-cells over B-cells. Conclusion: The motif immunomodulates T-cells through interactions occurring within the membrane milieu. Significance: This study provides new insights into the immunosuppressive activity of the envelope glycoprotein complex and the molecular recognition within the membrane. An immunosuppressive motif was recently found within the HIV-1 gp41 fusion protein (termed immunosuppressive loop-associated determinant core motif (ISLAD CM)). Peptides containing the motif interact with the T-cell receptor (TCR) complex; however, the mechanism by which the motif exerts its immunosuppressive activity is yet to be determined. Recent studies showed that interactions between protein domains in the membrane milieu are not always sterically controlled. Therefore, we utilized the unique membrane leniency toward association between d- and l-stereoisomers to investigate the detailed mechanism by which ISLAD CM inhibits T-cell activation. We show that a d-enantiomer of ISLAD CM (termed ISLAD d-CM) inhibited the proliferation of murine myelin oligodendrocyte glycoprotein (MOG)-(35-55)-specific line T-cells to the same extent as the l-motif form. Moreover, the d- and l-forms preferentially bound spleen-derived T-cells over B-cells by 13-fold. Furthermore, both forms of ISLAD CM co-localized with the TCR on activated T-cells and interacted with the transmembrane domain of the TCR. FRET experiments revealed the importance of basic residues for the interaction between ISLAD CM forms and the TCR transmembrane domain. Ex vivo studies demonstrated that ISLAD d-CM administration inhibited the proliferation (72%) and proinflammatory cytokine secretion of pathogenic MOG(35-55)-specific T-cells. This study provides insights into the immunosuppressive mechanism of gp41 and demonstrates that chirality-independent interactions in the membrane can take place in diverse biological systems. Apart from HIV pathogenesis, the d-peptide reported herein may serve as a potential tool for treating T-cell-mediated pathologies.	[Faingold, Omri; Ashkenazi, Avraham; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kaushansky, Nathali; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation.	Ashkenazi A, 2013, TRENDS BIOCHEM SCI, V38, P345, DOI 10.1016/j.tibs.2013.04.003; Ashkenazi A, 2013, BLOOD, V121, P2244, DOI 10.1182/blood-2012-11-468900; Ashkenazi A, 2012, BIOCHEMISTRY-US, V51, P6981, DOI 10.1021/bi300868f; Ashkenazi A, 2011, FASEB J, V25, P2156, DOI 10.1096/fj.10-175752; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; BENNUN A, 1983, J IMMUNOL, V130, P1205; Bloch I, 2007, FASEB J, V21, P393, DOI 10.1096/fj.06-7061com; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen LR, 2009, BIOPHYS J, V96, P4622, DOI 10.1016/j.bpj.2009.03.004; CHIRMULE N, 1995, J IMMUNOL, V155, P917; Cohen T, 2008, BIOCHEMISTRY-US, V47, P4826, DOI 10.1021/bi800100p; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fernando K, 2007, BLOOD, V109, P2538, DOI 10.1182/blood-2006-08-038661; Fink A, 2013, J IMMUNOL, V190, P6410, DOI 10.4049/jimmunol.1202033; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2002, J MOL BIOL, V322, P491, DOI 10.1016/S0022-2836(02)00807-0; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Kaushansky N, 2007, EUR J IMMUNOL, V37, P3281, DOI 10.1002/eji.200737438; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Masci AM, 2003, J LEUKOCYTE BIOL, V74, P1117, DOI 10.1189/jlb.0503239; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Pascual R, 2005, J VIROL, V79, P5142, DOI 10.1128/JVI.79.8.5142-5152.2005; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2007, BIOPOLYMERS, V88, P217, DOI 10.1002/bip.20668; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; Sackett K, 2003, J MOL BIOL, V333, P47, DOI 10.1016/j.jmb.2003.07.008; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1984, J IMMUNOL, V133, P123; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731	57	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32852	32860		10.1074/jbc.M113.512038	http://dx.doi.org/10.1074/jbc.M113.512038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078631	Green Published, hybrid			2022-12-25	WOS:000328841700004
J	Pilla, E; Kilisch, M; Lenz, C; Urlaub, H; Geiss-Friedlander, R				Pilla, Esther; Kilisch, Markus; Lenz, Christof; Urlaub, Henning; Geiss-Friedlander, Ruth			The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Enzyme Inhibitors; Enzyme Kinetics; Peptidases; Peptide Interactions; Protease Inhibitor; DPP9; Dipeptidyl Peptidase; Prolylpeptidase; Prolylpeptidase; DPP8	CELL-PENETRATING PEPTIDES; IV INHIBITOR; DPP-IV; POTENT; EXPRESSION; LOCALIZATION; ACTIVATION; PROTEINS; DELIVERY; HOMOLOG	Background: SUMO1 binds to an arm motif in the prolyl-peptidase DPP9, leading to allosteric activation of the peptidase. Results: A SUMO1 peptide covering the DPP9 interaction surface inhibits DPP9 activity. Inhibition is dependent on residues in the DPP9 arm motif. Conclusion: The SUMO1 peptide and its variants are allosteric DPP9 inhibitors. Significance: This work highlights the potential use of peptides mimicking interaction surfaces for modulating enzyme activity. The intracellular peptidases dipeptidyl peptidase (DPP) 8 and DPP9 are involved in multiple cellular pathways including antigen maturation, cellular homeostasis, energy metabolism, and cell viability. Previously we showed that the small ubiquitin-like protein modifier SUMO1 interacts with an armlike structure in DPP9, leading to allosteric activation of the peptidase. Here we demonstrate that the E67-interacting loop (EIL) peptide, which corresponds to the interaction surface of SUMO1 with DPP9, acts as a noncompetitive inhibitor of DPP9. Moreover, by analyzing the sensitivity of DPP9 arm mutants to the EIL peptide, we mapped specific residues in the arm that are important for inhibition by the EIL, suggesting that the peptide acts as an allosteric inhibitor of DPP9. By modifying the EIL peptide, we constructed peptide variants with more than a 1,000-fold selectivity toward DPP8 (147 nm) and DPP9 (170 nm) over DPPIV (200 m). Furthermore, application of these peptides to cells leads to a clear inhibition of cellular prolyl peptidase activity. Importantly, in line with previous publications, inhibition of DPP9 with these novel allosteric peptide inhibitors leads to an increase in EGF-mediated phosphorylation of Akt. This work highlights the potential use of peptides that mimic interaction surfaces for modulating enzyme activity.	[Pilla, Esther; Kilisch, Markus; Geiss-Friedlander, Ruth] Univ Gottingen, Dept Mol Biol, Fac Med, D-37073 Gottingen, Germany; [Lenz, Christof; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Lenz, Christof; Urlaub, Henning] Univ Gottingen, Fac Med, Inst Clin Chem, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Geiss-Friedlander, R (corresponding author), Univ Gottingen, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de	Geiss-Friedlander, Ruth/G-3569-2013; Geiss-Friedlander, Ruth/AAT-8768-2020	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Geiss-Friedlander, Ruth/0000-0002-1720-3440	Deutsche Forschungsgemeinschaft [2234/1-1, 1086/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant 2234/1-1. SPR measurements were performed on a machine funded by Deutsche Forschungsgemeinschaft Grant 1086/2 (to M. K.).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; Jiaang WT, 2005, BIOORG MED CHEM LETT, V15, P687, DOI 10.1016/j.bmcl.2004.11.023; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Matheeussen V, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0350-4; McIntosh CHS, 2005, REGUL PEPTIDES, V128, P159, DOI 10.1016/j.regpep.2004.06.001; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Van der Veken P, 2007, J MED CHEM, V50, P5568, DOI 10.1021/jm701005a; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Vigneron N, 2011, CELL MOL LIFE SCI, V68, P1503, DOI 10.1007/s00018-011-0658-x; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Wilson CH, 2013, J BIOL CHEM, V288, P13936, DOI 10.1074/jbc.M112.445841; Wolf BB, 2008, MINI-REV MED CHEM, V8, P719, DOI 10.2174/138955708784567449; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang H., 2013, MOL CANC RES, DOI 10.1158/1541-7786.MCR-13-0272	40	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32787	32796		10.1074/jbc.M113.489179	http://dx.doi.org/10.1074/jbc.M113.489179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072711	Green Published, hybrid			2022-12-25	WOS:000328681700062
J	Leger, MM; Gawryluk, RMR; Gray, MW; Roger, AJ				Leger, Michelle M.; Gawryluk, Ryan M. R.; Gray, Michael W.; Roger, Andrew J.			Evidence for a Hydrogenosomal-Type Anaerobic ATP Generation Pathway in Acanthamoeba castellanii	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUCCINATE-COA-TRANSFERASE; FERREDOXIN OXIDOREDUCTASE; PYRUVATE METABOLISM; GENE-TRANSFER; PHYLOGENETIC DISTRIBUTIONS; TRICHOMONAS-VAGINALIS; TRITRICHOMONAS-FETUS; IRON HYDROGENASES; FE-HYDROGENASE	Diverse, distantly-related eukaryotic lineages have adapted to low-oxygen environments, and possess mitochondrion-related organelles that have lost the capacity to generate adenosine triphosphate (ATP) through oxidative phosphorylation. A subset of these organelles, hydrogenosomes, has acquired a set of characteristic ATP generation enzymes commonly found in anaerobic bacteria. The recipient of these enzymes could not have survived prior to their acquisition had it not still possessed the electron transport chain present in the ancestral mitochondrion. In the divergence of modern hydrogenosomes from mitochondria, a transitional organelle must therefore have existed that possessed both an electron transport chain and an anaerobic ATP generation pathway. Here, we report a modern analog of this organelle in the habitually aerobic opportunistic pathogen, Acanthamoeba castellanii. This organism possesses a complete set of enzymes comprising a hydrogenosome-like ATP generation pathway, each of which is predicted to be targeted to mitochondria. We have experimentally confirmed the mitochondrial localizations of key components of this pathway using tandem mass spectrometry. This evidence is the first supported by localization and proteome data of a mitochondrion possessing both an electron transport chain and hydrogenosome-like energy metabolism enzymes. Our work provides insight into the first steps that might have occurred in the course of the emergence of modern hydrogenosomes.	[Leger, Michelle M.; Gawryluk, Ryan M. R.; Gray, Michael W.; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada	Dalhousie University	Roger, AJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada.	aroger@dal.ca	Leger, Michelle M/M-4813-2016	Leger, Michelle M/0000-0001-5500-5480; Gawryluk, Ryan/0000-0003-1251-882X; Gray, Michael/0000-0001-7125-2625	Canadian Institutes of Health Research [MOP-62809, MOP-4124]; National Research Fund, Luxembourg; Nova Scotia Health Research Foundation; Killam Trusts; Tula Foundation; Canada Research Chairs Program; Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity; NIH/NHGRI [U01 HG02051]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Research Fund, Luxembourg(Luxembourg National Research Fund); Nova Scotia Health Research Foundation; Killam Trusts; Tula Foundation; Canada Research Chairs Program(Canada Research Chairs); Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity(Canadian Institute for Advanced Research (CIFAR)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work and R. M. R. G. were supported by grant MOP-62809 awarded to A.J.R. by the Canadian Institutes of Health Research. M. M. L. is supported by the National Research Fund, Luxembourg, and by the Nova Scotia Health Research Foundation. R. M. R. G. was supported by a Predoctoral Scholarship from the Killam Trusts. Operating grant support to M. W. G. from the Canadian Institutes of Health Research (MOP-4124) as well as funding from the Tula Foundation is gratefully acknowledged. A.J.R. acknowledges support from the Canada Research Chairs Program, the Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity and the Tula Foundation. Preliminary sequence data was obtained from Baylor College of Medicine Human Genome Sequencing Center website at http://www.hgsc.bcm.tmc.edu. The DNA sequence of Acanthamoeba castellanii was supported by grant number U01 HG02051 from NIH/NHGRI to Richard Gibbs at the BCM-HGSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-51; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Andersson Jan O., 2009, V532, P473, DOI [10.1007/978-1-60327-853-9-27, 10.1007/978-1-60327-853-9_27]; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Buetow D.E., 1989, P247; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Cometa I, 2011, ACTA PROTOZOOL, V50, P33, DOI 10.4467/16890027AP.11.004.0004; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Ctrnacta V, 2006, J EUKARYOT MICROBIOL, V53, P225, DOI 10.1111/j.1550-7408.2006.00099.x; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS SW, 1978, BIOCHEM J, V174, P203, DOI 10.1042/bj1740203; ELLIS JE, 1993, FEBS LETT, V325, P196, DOI 10.1016/0014-5793(93)81072-8; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gelius-Dietrich G, 2004, J EUKARYOT MICROBIOL, V51, P456, DOI 10.1111/j.1550-7408.2004.tb00394.x; Hackstein JHP, 2005, BIOCHEM SOC T, V33, P47, DOI 10.1042/BST0330047; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Horner DS, 2002, TRENDS BIOCHEM SCI, V27, P148, DOI 10.1016/S0968-0004(01)02053-9; Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 1995, J MOL EVOL, V41, P388, DOI 10.1007/BF01215186; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lantsman Y, 2008, MICROBIOL-SGM, V154, P2757, DOI 10.1099/mic.0.2008/017897-0; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LINDMARK DG, 1973, J BIOL CHEM, V248, P7724; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MARVINSIKKEMA FD, 1993, ARCH MICROBIOL, V160, P388; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Rodriguez MA, 1996, MOL BIOCHEM PARASIT, V78, P273, DOI 10.1016/S0166-6851(96)02613-8; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stairs CW, 2011, MOL BIOL EVOL, V28, P2087, DOI 10.1093/molbev/msr032; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Takishita K, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-5; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Tsaousis AD, 2012, CELL ORIG LIFE EXTRE, V21, P53; Turner NA, 1997, FEMS MICROBIOL LETT, V157, P149, DOI 10.1111/j.1574-6968.1997.tb12766.x; van Grinsven KWA, 2008, J BIOL CHEM, V283, P1411, DOI 10.1074/jbc.M702528200; van Grinsven KWA, 2009, MOL BIOCHEM PARASIT, V164, P74, DOI 10.1016/j.molbiopara.2008.11.008; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Voncken FGJ, 2002, GENE, V284, P103, DOI 10.1016/S0378-1119(02)00388-8; WILLIAMS K, 1987, BIOCHEM J, V246, P529, DOI 10.1042/bj2460529	76	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e69532	10.1371/journal.pone.0069532	http://dx.doi.org/10.1371/journal.pone.0069532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086244	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900001
J	Zago, M; Sheridan, JA; Nair, P; de Souza, AR; Gallouzi, IE; Rousseau, S; Di Marco, S; Hamid, Q; Eidelman, DH; Baglole, CJ				Zago, Michela; Sheridan, Jared A.; Nair, Parameswaran; de Souza, Angela Rico; Gallouzi, Imed-Eddine; Rousseau, Simon; Di Marco, Sergio; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.			Aryl Hydrocarbon Receptor-Dependent Retention of Nuclear HuR Suppresses Cigarette Smoke-Induced Cyclooxygenase-2 Expression Independent of DNA-Binding	PLOS ONE			English	Article							CONTAINING MESSENGER-RNAS; HUMAN LUNG FIBROBLASTS; AH DIOXIN RECEPTOR; GENE-EXPRESSION; PROTEIN HUR; 3'-UNTRANSLATED REGION; PROSTAGLANDIN E-2; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POSTTRANSCRIPTIONAL REGULATION; MEDIATED TRANSCRIPTION	The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that responds to man-made environmental toxicants, has emerged as an endogenous regulator of cyclooxygenase-2 (Cox-2) by a mechanism that is poorly understood. In this study, we first used AhR-deficient (AhR(-/-)) primary pulmonary cells, together with pharmacological tools to inhibit new RNA synthesis, to show that the AhR is a prominent factor in the destabilization of Cox-2 mRNA. The destabilization of Cox-2 mRNA and subsequent suppression of cigarette smoke-induced COX-2 protein expression by the AhR was independent of its ability to bind the dioxin response element (DRE), thereby differentiating the DRE-driven toxicological AhR pathway from its anti-inflammatory abilities. We further describe that the AhR destabilizes Cox-2 mRNA by sequestering HuR within the nucleus. The role of HuR in AhR stabilization of Cox-2 mRNA was confirmed by knockdown of HuR, which resulted in rapid Cox-2 mRNA degradation. Finally, in the lungs of AhR(-/-) mice exposed to cigarette smoke, there was little Cox-2 mRNA despite robust COX-2 protein expression, a finding that correlates with almost exclusive cytoplasmic HuR within the lungs of AhR(-/-) mice. Therefore, we propose that the AhR plays an important role in suppressing the expression of inflammatory proteins, a function that extends beyond the ability of the AhR to respond to man-made toxicants. These findings open the possibility that a DRE-independent AhR pathway may be exploited therapeutically as an anti-inflammatory target.	[Zago, Michela; Sheridan, Jared A.; Rousseau, Simon; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [de Souza, Angela Rico; Rousseau, Simon; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Gallouzi, Imed-Eddine; Di Marco, Sergio] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Gallouzi, Imed-Eddine; Di Marco, Sergio] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Nair, Parameswaran] McMaster Univ, Dept Med, Hamilton, ON, Canada	McGill University; McGill University; McGill University; McGill University; McMaster University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	Carolyn.baglole@McGill.ca		Di Marco, Sergio/0000-0002-4039-0600; Rousseau, Simon/0000-0002-8773-575X	American Thoracic Society; Department of Medicine of McGill University; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation-Leaders Opportunities Fund; Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec-Sante (FRQ-S); Meakins-Christie Post-Doctoral Fellowship Award; Canada Research Chair in Airway Inflammometry	American Thoracic Society; Department of Medicine of McGill University; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation-Leaders Opportunities Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec-Sante (FRQ-S); Meakins-Christie Post-Doctoral Fellowship Award; Canada Research Chair in Airway Inflammometry(Canada Research Chairs)	This work was supported by the American Thoracic Society Research Grant; the Department of Medicine of McGill University; the Research Institute of the McGill University Health Centre; the Canada Foundation for Innovation-Leaders Opportunities Fund and the Natural Sciences and Engineering Research Council of Canada. CJB was supported by a salary award from the Fonds de recherche du Quebec-Sante (FRQ-S). MZ is the recipient of a Meakins-Christie Post-Doctoral Fellowship Award. Dr Nair is supported by a Canada Research Chair in Airway Inflammometry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Atasoy U, 1998, J CELL SCI, V111, P3145; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Bonelli MA, 2004, EXP GERONTOL, V39, P423, DOI 10.1016/j.exger.2003.12.004; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chen Y, 2008, RESPIROLOGY, V13, P1014, DOI 10.1111/j.1440-1843.2008.01365.x; Cheng YH, 2012, TOXICOL APPL PHARM, V259, P293, DOI 10.1016/j.taap.2012.01.005; Cho YC, 2004, TOXICOL APPL PHARM, V199, P220, DOI 10.1016/j.taap.2003.12.025; CHRISTOU M, 1995, MOL CELL ENDOCRINOL, V115, P41, DOI 10.1016/0303-7207(95)03668-W; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dong B, 2010, BIOCHEM PHARMACOL, V79, P487, DOI 10.1016/j.bcp.2009.08.031; Eltom SE, 1998, CARCINOGENESIS, V19, P1437, DOI 10.1093/carcin/19.8.1437; EMA M, 1994, J BIOCHEM-TOKYO, V116, P845, DOI 10.1093/oxfordjournals.jbchem.a124605; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gasiewicz TA, 1996, BIOCHEM PHARMACOL, V52, P1787, DOI 10.1016/S0006-2952(96)00600-4; Guyot E, 2012, DRUG DISCOV TODAY; HAYASHI S, 1994, CARCINOGENESIS, V15, P801, DOI 10.1093/carcin/15.5.801; Hel Z, 1998, NUCLEIC ACIDS RES, V26, P2803, DOI 10.1093/nar/26.11.2803; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Henry EC, 1999, MOL PHARMACOL, V55, P716; Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; HYMAN RW, 1970, J MOL BIOL, V50, P421, DOI 10.1016/0022-2836(70)90202-0; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; LANDERS JP, 1991, BIOCHEM J, V276, P273, DOI 10.1042/bj2760273; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; LOFROTH G, 1988, TOXICOL LETT, V42, P131, DOI 10.1016/0378-4274(88)90070-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Meisner NC, 2010, ADV EXP MED BIOL, V700, P106, DOI 10.1007/978-1-4419-7823-3_10; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Montuschi P, 2003, THORAX, V58, P585, DOI 10.1136/thorax.58.7.585; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murray IA, 2011, MOL PHARMACOL, V79, P508, DOI 10.1124/mol.110.069369; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nowotarski SL, 2010, J BIOL CHEM, V285, P31885, DOI 10.1074/jbc.M110.148767; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; POLAND A, 1976, J BIOL CHEM, V251, P4936; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Racky J, 2004, ARCH BIOCHEM BIOPHYS, V421, P91, DOI 10.1016/j.abb.2003.10.005; Roemer E, 2004, TOXICOLOGY, V195, P31, DOI 10.1016/j.tox.2003.08.006; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Safe S, 1999, Expert Opin Investig Drugs, V8, P1385, DOI 10.1517/13543784.8.9.1385; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Sgantzis N, 2011, DEV BIOL, V354, P267, DOI 10.1016/j.ydbio.2011.04.003; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217	89	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74953	10.1371/journal.pone.0074953	http://dx.doi.org/10.1371/journal.pone.0074953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086407	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900033
J	Trouvay, M; Palazon, G; Berger, F; Volney, B; Blanchet, D; Faway, E; Donato, D; Legrand, E; Carme, B; Musset, L				Trouvay, Melanie; Palazon, Georges; Berger, Franck; Volney, Beatrice; Blanchet, Denis; Faway, Emilie; Donato, Damien; Legrand, Eric; Carme, Bernard; Musset, Lise			High Performance of Histidine-Rich Protein 2 Based Rapid Diagnostic Tests in French Guiana Are Explained by the Absence of pfhrp2 Gene Deletion in P. falciparum	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SEQUENCE VARIATION; MALARIA; DIVERSITY; PARASITES; RESISTANCE; PFCRT; VIVAX	Background: Care for malaria patients in endemic areas has been improved through the increasing use of Rapid Diagnostic Tests (RDTs). Most RDTs target the histidine-rich protein-2 antigen (PfHRP2) to detect P. falciparum, as it is abundant and shows great heat stability. However, their use in South America has been widely questioned following a recent publication that pinpoints the high prevalence of Peruvian field isolates lacking the gene encoding this protein. In the remote rural health centers of French Guiana, RDTs are the main diagnosis tools. Therefore, a study of PfHRP2 RDT performances and pfhrp2 genotyping was conducted to determine whether a replacement of the current pLDH-based kit could be considered. Methods: The performance study compared the SD Malaria Ag test P. f/PanH kit with the current gold standard diagnosis by microscopy. The prevalence of pfhrp2 and pfhrp3 deletions were evaluated from 221 P. falciparum isolates collected between 2009 and 2011 in French Guiana. Results: Between January 2010 and August 2011, 960 suspected cases of malaria were analyzed using microscopy and RDTs. The sensitivity of the SD Malaria Ag test P. f/PanH for detection of P. falciparum was 96.8% (95% CI: 90.9-99.3), and 86.0% (95% CI: 78.9-91.5) for the detection of P. vivax. No isolates (95% CI: 0-4.5) lacking either exon of the pfhrp2 gene were identified among the 221 P. falciparum isolates analyzed, but 7.4% (95% CI: 2.8-15.4) lacked the exon 2 part of the pfhrp3 gene. Conclusions: Field isolates lacking either exon of the pfhrp2 gene are absent in this western part of South America. Despite its sensibility to detect P. vivax, the SD Malaria Ag test P. f/PanH kit is a satisfying alternative to microscopy in remote health centers, where it is difficult to provide highly skilled microscopists and to maintain the necessary equipment.	[Trouvay, Melanie; Volney, Beatrice; Faway, Emilie; Donato, Damien; Legrand, Eric; Musset, Lise] Inst Pasteur Guyane, Parasitol Lab, Ctr Natl Reference Chimioresistance Paludisme, Cayenne, French Guiana, France; [Palazon, Georges; Blanchet, Denis; Carme, Bernard] Univ Antilles Guyane, Lab Hosp Univ Parasitol & Mycol Med, Equipe Accueil 3593, Unite Format & Rech Med, Cayenne, French Guiana, France; [Berger, Franck] Inst Pasteur Guyane, Unite Epidemiol, Cayenne, French Guiana, France		Musset, L (corresponding author), Inst Pasteur Guyane, Parasitol Lab, Ctr Natl Reference Chimioresistance Paludisme, Cayenne, French Guiana, France.	lisemusset@gmail.com		Faway, Emilie/0000-0003-3406-1103; Legrand, Eric/0000-0003-4725-0712; Blanchet, Denis/0000-0003-3270-2093	French Ministry of Health (InVS agency, Paris)	French Ministry of Health (InVS agency, Paris)	This project was supported by the French Ministry of Health (InVS agency, Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GOOD PRACT SEL PROC; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2009, MAL RAP DIAGN TEST P; [Anonymous], 2012, MAL RAP DIAGN TEST P; Ariey F, 1999, AM J TROP MED HYG, V61, P978, DOI 10.4269/ajtmh.1999.61.978; AVILA Priscilla Elisangela, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P293, DOI 10.1590/S0036-46652002000500012; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Berger F, 2012, AM J TROP MED HYG, V86, P591, DOI 10.4269/ajtmh.2012.11-0582; Carme B, 2005, TROP MED INT HEALTH, V10, P154, DOI 10.1111/j.1365-3156.2004.01365.x; Carme B, 2009, Med Trop (Mars), V69, P19; Carme B, 2002, CONS C MAL TRET FREN; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Griffing S, 2010, ANTIMICROB AGENTS CH, V54, P1572, DOI 10.1128/AAC.01243-09; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Lee N, 2012, J CLIN MICROBIOL, V50, P1397, DOI 10.1128/JCM.06533-11; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Legrand E, 2012, ANTIMICROB AGENTS CH, V56, P1382, DOI 10.1128/AAC.05280-11; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Palmer CJ, 1998, J CLIN MICROBIOL, V36, P203, DOI 10.1128/JCM.36.1.203-206.1998; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Peek R, 2005, AM J TROP MED HYG, V73, P833, DOI 10.4269/ajtmh.2005.73.833; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; World Health Organization, 2018, MAL RAP DIAGN TEST P	31	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74269	10.1371/journal.pone.0074269	http://dx.doi.org/10.1371/journal.pone.0074269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086328	Green Published, gold			2022-12-25	WOS:000326520200026
J	Murdock, CC; Foufopoulos, J; Simon, CP				Murdock, Courtney C.; Foufopoulos, Johannes; Simon, Carl P.			A Transmission Model for the Ecology of an Avian Blood Parasite in a Temperate Ecosystem	PLOS ONE			English	Article							MALARIA PLASMODIUM-RELICTUM; SENSITIVITY ANALYSIS TECHNIQUES; WHITE-CROWNED SPARROWS; ST-LOUIS ENCEPHALITIS; 7 LARVAL INSTARS; LEUCOCYTOZOON-SIMONDI; REPRODUCTIVE SUCCESS; TEMPORAL VARIATION; PARENTAL EFFORT; DIPTERA	Most of our knowledge about avian haemosporidian parasites comes from the Hawaiian archipelago, where recently introduced Plasmodium relictum has contributed to the extinction of many endemic avian species. While the ecology of invasive malaria is reasonably understood, the ecology of endemic haemosporidian infection in mainland systems is poorly understood, even though it is the rule rather than the exception. We develop a mathematical model to explore and identify the ecological factors that most influence transmission of the common avian parasite, Leucocytozoon fringillinarum (Apicomplexa). The model was parameterized from White-crowned Sparrow (Zonotrichia leucophrys) and S. silvestre / craigi black fly populations breeding in an alpine ecosystem. We identify and examine the importance of altricial nestlings, the seasonal relapse of infected birds for parasite persistence across breeding seasons, and potential impacts of seasonal changes in black fly emergence on parasite prevalence in a high elevation temperate system. We also use the model to identify and estimate the parameters most influencing transmission dynamics. Our analysis found that relapse of adult birds and young of the year birds were crucial for parasite persistence across multiple seasons. However, distinguishing between nude nestlings and feathered young of the year was unnecessary. Finally, due to model sensitivity to many black fly parameters, parasite prevalence and sparrow recruitment may be most affected by seasonal changes in environmental temperature driving shifts in black fly emergence and gonotrophic cycles.	[Murdock, Courtney C.; Foufopoulos, Johannes] Univ Michigan, Sch Nat Resources, Ann Arbor, MI 48109 USA; [Murdock, Courtney C.; Foufopoulos, Johannes] Univ Michigan, Program Environm, Ann Arbor, MI 48109 USA; [Murdock, Courtney C.] Penn State Univ, Dept Entomol, Ctr Infect Dis, University Pk, PA 16802 USA; [Simon, Carl P.] Univ Michigan, Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Simon, Carl P.] Univ Michigan, Ctr Study Complex Syst, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Murdock, CC (corresponding author), Univ Michigan, Sch Nat Resources, Ann Arbor, MI 48109 USA.	ccm15@psu.edu		Foufopoulos, Johannes/0000-0002-8341-8271	NIH; School of Natural Resources, University of Michigan Alumni Incentive Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Natural Resources, University of Michigan Alumni Incentive Award	This research was funded by: NIH (http://sitemaker.umich.edu/macepid/ipid_training_program): Interdisciplinary Perspectives of Infectious Diseases Training Grant, and School of Natural Resources, University of Michigan Alumni Incentive Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PH, 2004, BLACK FLIES SIMULIID; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; ALLAN RA, 1989, AM MIDL NAT, V121, P341, DOI 10.2307/2426038; Allander K, 1997, FUNCT ECOL, V11, P358, DOI 10.1046/j.1365-2435.1997.00095.x; ALVERSON DR, 1977, J MED ENTOMOL, V14, P132, DOI 10.1093/jmedent/14.1.132; ANDERSON R M, 1991; [Anonymous], 2001, ERKELEY MADONNA MODE; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P91; APPLEGATE J E, 1970, Journal of Parasitology, V56, P8; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P37; APPLEGATE JE, 1970, J PARASITOL, V56, P439, DOI 10.2307/3277599; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; BAKER MC, 1981, ECOLOGY, V62, P636, DOI 10.2307/1937731; BALL GH, 1964, J PARASITOL, V50, P50; BEAUDOIN R L, 1971, Journal of Wildlife Diseases, V7, P5; BECKER CD, 1973, AM MIDL NAT, V89, P246, DOI 10.2307/2424158; BENNETT GF, 1992, CAN J ZOOL, V70, P2007, DOI 10.1139/z92-271; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bonier F, 2007, BEHAV ECOL, V18, P121, DOI 10.1093/beheco/arl050; BRIGGS N. THEODORE, 1960, PROC HELMINTHOL SOC WASHINGTON, V27, P151; CHERNIN E, 1952, AM J HYG, V56, P101, DOI 10.1093/oxfordjournals.aje.a119545; Chilton G, 1995, WHITECROWNED SPARROW; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Cornet S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-179; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DESSER SS, 1976, CAN J ZOOL, V54, P634, DOI 10.1139/z76-075; DESSER SS, 1968, CAN J ZOOLOG, V46, P281, DOI 10.1139/z68-041; Deviche P, 2010, PARASITOLOGY, V137, P261, DOI 10.1017/S003118200999134X; FIALHO RF, 1995, J ANIM ECOL, V64, P553, DOI 10.2307/5799; Finn DS, 2008, ARCT ANTARCT ALP RES, V40, P638, DOI 10.1657/1523-0430(07-072)[FINN]2.0.CO;2; FREDEEN FJH, 1981, CAN ENTOMOL, V113, P161, DOI 10.4039/Ent113161-2; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hellgren O, 2008, MOL ECOL, V17, P1605, DOI 10.1111/j.1365-294X.2007.03680.x; Hobbelen PHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049594; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; Ishii Y, 2008, PARASITE, V15, P121, DOI 10.1051/parasite/2008152121; JACQUEZ JA, 1996, COMPARTMENTAL ANAL B; KHAN RA, 1970, J PROTOZOOL, V17, P642, DOI 10.1111/j.1550-7408.1970.tb04742.x; KHAN RA, 1970, CAN J ZOOLOG, V48, P451, DOI 10.1139/z70-077; Kilpatrick AM, 2006, AUK, V123, P764, DOI 10.1642/0004-8038(2006)123[764:EOCAMP]2.0.CO;2; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Lachish S, 2013, ECOGRAPHY, V36, P587, DOI 10.1111/j.1600-0587.2012.07801.x; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lack D., 1954, P343; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P299, DOI 10.1089/15303660160025921; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P317, DOI 10.1089/15303660160025930; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; MERRITT RW, 1982, ECOLOGY, V63, P1322, DOI 10.2307/1938860; Millington OR, 2007, PLOS PATHOG, V3, P1380, DOI 10.1371/journal.ppat.0030143; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Morton ML., 2002, STUD AVIAN BIOL; Murdock C., 2009, THESIS U MICHIGAN; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; NORRIS K, 1994, J ANIM ECOL, V63, P601, DOI 10.2307/5226; Ots I, 1996, P ROY SOC B-BIOL SCI, V263, P1443, DOI 10.1098/rspb.1996.0210; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Press W. H., 1992, ART SCI COMPUTING; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; Rao RU, 2009, T ROY SOC TROP MED H, V103, P365, DOI 10.1016/j.trstmh.2008.07.012; Rock KS, 2012, ECOL MODEL, V235, P26, DOI 10.1016/j.ecolmodel.2012.04.004; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; ROLLER NF, 1973, CAN J ZOOL, V51, P1, DOI 10.1139/z73-001; ROSS DH, 1979, CAN J ZOOL, V57, P290, DOI 10.1139/z79-032; Ross DH, 1988, BLACKFLIES ECOLOGY P, P90; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Tomas G, 2007, FUNCT ECOL, V21, P125, DOI 10.1111/j.1365-2435.2006.01214.x; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Valkiunas G, 2005, AVIAN MALARIA PARASI; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Vieira JC, 2005, T ROY SOC TROP MED H, V99, P178, DOI 10.1016/j.trstmh.2004.03.012; Wingfield JC, 2003, GEN COMP ENDOCR, V131, P143, DOI 10.1016/S0016-6480(02)00648-2	86	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76126	10.1371/journal.pone.0076126	http://dx.doi.org/10.1371/journal.pone.0076126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073288	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000098
J	Steinwand, MA; Young, HA; Bragg, JN; Tobias, CM; Vogel, JP				Steinwand, Michael A.; Young, Hugh A.; Bragg, Jennifer N.; Tobias, Christian M.; Vogel, John P.			Brachypodium sylvaticum, a Model for Perennial Grasses: Transformation and Inbred Line Development	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; FUNCTIONAL GENOMICS; WHEAT; ARABIDOPSIS; MUTAGENESIS; PROSPECTS; SECURITY; MARKERS; MAIZE; FOOD	Perennial species offer significant advantages as crops including reduced soil erosion, lower energy inputs after the first year, deeper root systems that access more soil moisture, and decreased fertilizer inputs due to the remobilization of nutrients at the end of the growing season. These advantages are particularly relevant for emerging biomass crops and it is projected that perennial grasses will be among the most important dedicated biomass crops. The advantages offered by perennial crops could also prove favorable for incorporation into annual grain crops like wheat, rice, sorghum and barley, especially under the dryer and more variable climate conditions projected for many grain-producing regions. Thus, it would be useful to have a perennial model system to test biotechnological approaches to crop improvement and for fundamental research. The perennial grass Brachypodium sylvaticum is a candidate for such a model because it is diploid, has a small genome, is self-fertile, has a modest stature, and short generation time. Its close relationship to the annual model Brachypodium distachyon will facilitate comparative studies and allow researchers to leverage the resources developed for B. distachyon. Here we report on the development of two keystone resources that are essential for a model plant: high-efficiency transformation and inbred lines. Using Agrobacterium tumefaciens-mediated transformation we achieved an average transformation efficiency of 67%. We also surveyed the genetic diversity of 19 accessions from the National Plant Germplasm System using SSR markers and created 15 inbred lines.	[Steinwand, Michael A.; Young, Hugh A.; Bragg, Jennifer N.; Tobias, Christian M.; Vogel, John P.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA; [Young, Hugh A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bragg, Jennifer N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California Davis	Vogel, JP (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	john.vogel@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Vogel, John/0000-0003-1786-2689	Office of Science (BER), US Department of Energy; USDA-ARS CRIS [5325-21000-017-00]	Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Office of Science (BER), US Department of Energy, and by USDA-ARS CRIS project 5325-21000-017-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2006, PLANT CELL REP, V25, P651, DOI 10.1007/s00299-005-0099-9; Bell LW, 2010, CROP PASTURE SCI, V61, P679, DOI 10.1071/CP10064; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Bragg JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041916; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Cao MX, 2006, PLANT CELL TISS ORG, V85, P307, DOI 10.1007/s11240-006-9081-7; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cox TS, 2010, CROP PASTURE SCI, V61, P513, DOI 10.1071/CP09201; Cox TS, 2006, BIOSCIENCE, V56, P649, DOI 10.1641/0006-3568(2006)56[649:PFDPGC]2.0.CO;2; Cox TS, 2002, CRIT REV PLANT SCI, V21, P59, DOI 10.1080/0735-260291044188; Doe, 2006, BREAKING BIOL BARRIE; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Glover JD, 2010, ISSUES SCI TECHNOL, V26, P41; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Han N, 2005, PLANT CELL TISS ORG, V81, P131, DOI 10.1007/s11240-004-4042-5; Hayes RC, 2012, FIELD CROP RES, V133, P68, DOI 10.1016/j.fcr.2012.03.014; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Khaleda L., 2006, Biotechnology, V5, P379; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; Kim SJ, 2007, J PLANT BIOL, V50, P577, DOI 10.1007/BF03030712; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; LONG GM, 1989, MORPHOLOGICAL PHYSL; Luo H, 2004, PLANT CELL REP, V22, P645, DOI 10.1007/s00299-003-0734-2; PALMER JW, 1988, J APPL ECOL, V25, P569, DOI 10.2307/2403845; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Ramakrishnan AP, 2008, MOL ECOL RESOUR, V8, P1297, DOI 10.1111/j.1755-0998.2008.02174.x; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; SHI Y, 1993, PLANT SYST EVOL, V188, P125; Somleva MN, 2002, CROP SCI, V42, P2080, DOI 10.2135/cropsci2002.2080; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Tassel DL, 2010, EVOL APPL, V3, P434, DOI 10.1111/j.1752-4571.2010.00132.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wang ZY, 2005, FUNCT PLANT BIOL, V32, P769, DOI 10.1071/FP05083; Young HA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-117; Zhang Peng, 2009, P365, DOI 10.1007/978-3-540-70581-9_32	45	22	23	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75180	10.1371/journal.pone.0075180	http://dx.doi.org/10.1371/journal.pone.0075180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073248	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000057
J	Yan, BC; Park, JH; Shin, BN; Ahn, H; Kim, IH; Lee, JC; Yoo, KY; Hwang, IK; Choi, JH; Park, JH; Lee, YL; Suh, HW; Jun, JG; Kwon, YG; Kim, YM; Kwon, SH; Her, S; Kim, JS; Hyun, BH; Kim, CK; Cho, JH; Lee, CH; Won, MH				Yan, Bing Chun; Park, Joon Ha; Shin, Bich Na; Ahn, Ji Hyeon; Kim, In Hye; Lee, Jae-Chul; Yoo, Ki-Yeon; Hwang, In Koo; Choi, Jung Hoon; Park, Jeong Ho; Lee, Yun Lyul; Suh, Hong-Won; Jun, Jong-Gab; Kwon, Young-Guen; Kim, Young-Myeong; Kwon, Seung-Hae; Her, Song; Kim, Jin Su; Hyun, Byung-Hwa; Kim, Chul-Kyu; Cho, Jun Hwi; Lee, Choong Hyun; Won, Moo-Ho			Neuroprotective Effect of a New Synthetic Aspirin-decursinol Adduct in Experimental Animal Models of Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL CA1 REGION; OXYGEN-GLUCOSE DEPRIVATION; DELAYED NEURONAL DEATH; OXIDATIVE STRESS; CYTOCHROME-C; MICE; RAT; GERBIL; RELEASE	Stroke is the second leading cause of death. Experimental animal models of cerebral ischemia are widely used for researching mechanisms of ischemic damage and developing new drugs for the prevention and treatment of stroke. The present study aimed to comparatively investigate neuroprotective effects of aspirin (ASA), decursinol (DA) and new synthetic aspirin-decursinol adduct (ASA-DA) against transient focal and global cerebral ischemic damage. We found that treatment with 20 mg/kg, not 10 mg/kg, ASA-DA protected against ischemia-induced neuronal death after transient focal and global ischemic damage, and its neuroprotective effect was much better than that of ASA or DA alone. In addition, 20 mg/kg ASA-DA treatment reduced the ischemia-induced gliosis and maintained antioxidants levels in the corresponding injury regions. In brief, ASA-DA, a new synthetic drug, dramatically protected neurons from ischemic damage, and neuroprotective effects of ASA-DA may be closely related to the attenuation of ischemia-induced gliosis and maintenance of antioxidants.	[Yan, Bing Chun] Yangzhou Univ, Inst Integrat Tradit & Western Med, Coll Med, Yangzhou, Peoples R China; [Park, Joon Ha; Ahn, Ji Hyeon; Kim, In Hye; Lee, Jae-Chul; Lee, Yun Lyul; Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon, South Korea; [Shin, Bich Na] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Shin, Bich Na] Hallym Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Yoo, Ki-Yeon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Anat, Kangnung, South Korea; [Hwang, In Koo] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Vet Med, Seoul, South Korea; [Hwang, In Koo] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [Choi, Jung Hoon; Suh, Hong-Won] Kangwon Natl Univ, Dept Anat, Coll Vet Med, Chunchon, South Korea; [Park, Jeong Ho] Hanbat Natl Univ, Div Appl Chem & Biotechnol, Taejon, South Korea; [Suh, Hong-Won] Hallym Univ, Coll Med, Dept Pharmacol, Chunchon, South Korea; [Suh, Hong-Won] Hallym Univ, Coll Med, Inst Nat Med, Chunchon, South Korea; [Jun, Jong-Gab] Hallym Univ, Dept Chem, Chunchon, South Korea; [Jun, Jong-Gab] Hallym Univ, Inst Appl Chem, Chunchon, South Korea; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Vasc Syst Res Ctr, Chunchon, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon, South Korea; [Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Analyt Bioimaging, Chunchon, Kangwon, South Korea; [Kim, Jin Su] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Hyun, Byung-Hwa; Kim, Chul-Kyu] OSONG Med Innovat Fdn, Lab Anim Ctr, Osong, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Emergency Med, Chunchon, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Inst Med Sci, Chunchon, South Korea; [Lee, Choong Hyun] Dankook Univ, Coll Pharm, Dept Anat & Physiol, Cheonan, South Korea	Yangzhou University; Kangwon National University; Hallym University; Hallym University; Kangnung Wonju National University; Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Hanbat National University; Hallym University; Hallym University; Hallym University; Hallym University; Yonsei University; Yonsei University; Kangwon National University; Kangwon National University; Korea Basic Science Institute (KBSI); Korea Institute of Radiological & Medical Sciences; Osong Medical Innovation Foundation; Kangwon National University; Kangwon National University Hospital; Kangwon National University; Kangwon National University Hospital; Dankook University	Lee, CH (corresponding author), Dankook Univ, Coll Pharm, Dept Anat & Physiol, Cheonan, South Korea.	anaphy@dankook.ac.kr; mhwon@kangwon.ac.kr	KIM, JIN SU/U-2112-2019	KIM, JIN SU/0000-0001-8965-9538	Brain Research Center of the 21st Century Frontier Research Program [2010K000823]; Ministry of Education, Science and Technology, the Republic of Korea; National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0010580]; Osong Innovation Center [2010K000823]	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Osong Innovation Center	This research was supported by a grant (2010K000823) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea, by the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0010580), and by a grant (2010K000823) from Osong Innovation Center funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MB, 1997, BEHAV NEUROSCI, V111, P1205, DOI 10.1037/0735-7044.111.6.1205; Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; Berger C, 2004, BRAIN RES, V998, P237, DOI 10.1016/j.brainres.2003.11.049; Castillo J, 2003, NEUROSCI LETT, V339, P248, DOI 10.1016/S0304-3940(03)00029-6; Choi SS, 2003, LIFE SCI, V73, P471, DOI 10.1016/S0024-3205(03)00311-4; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Cuenca-Lopez MD, 2010, REV NEUROLOGIA, V51, P30, DOI 10.33588/rn.5101.2009667; De Cristobal J, 2002, STROKE, V33, P261, DOI 10.1161/hs0102.101299; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fredduzzi S, 2001, NEUROSCI LETT, V302, P121, DOI 10.1016/S0304-3940(01)01672-X; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Fujimura M, 1999, J NEUROSCI, V19, P3414; Guo RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049701; Hirvonen J, 2011, DIABETES, V60, P443, DOI 10.2337/db10-0940; Hsieh CH, 2009, J NUCL MED, V50, P2049, DOI 10.2967/jnumed.108.061234; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Hwang IK, 2006, NEUROCHEM RES, V31, P957, DOI 10.1007/s11064-006-9101-3; Ishiguro M, 2011, YAKUGAKU ZASSHI, V131, P513, DOI 10.1248/yakushi.131.513; Janac B, 2006, BEHAV BRAIN RES, V175, P362, DOI 10.1016/j.bbr.2006.09.008; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kang SY, 2007, J PHARM PHARMACOL, V59, P863, DOI 10.1211/jpp.59.6.0013; Kang SY, 2003, NEUROBIOL LEARN MEM, V79, P11, DOI 10.1016/S1074-7427(02)00007-2; Kang SY, 2001, J NAT PROD, V64, P683, DOI 10.1021/np000441w; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; Kim SW, 2010, NEUROTOX RES, V17, P39, DOI 10.1007/s12640-009-9075-4; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Lee CH, 2011, EXP NEUROL, V229, P450, DOI 10.1016/j.expneurol.2011.03.015; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee JK, 2003, PLANTA MED, V69, P230, DOI 10.1055/s-2003-38475; Li L, 2011, BIOSCI BIOTECH BIOCH, V75, P434, DOI 10.1271/bbb.100606; LIN CS, 1990, NEUROSCIENCE, V35, P289, DOI 10.1016/0306-4522(90)90083-G; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Mergenthaler P, 2012, DIS MODEL MECH, V5, P718, DOI 10.1242/dmm.010033; Murakami K, 1998, J NEUROSCI, V18, P205; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P557, DOI 10.1097/00004647-200105000-00010; Omote Y, 2012, STROKE, V43, P1639, DOI 10.1161/STROKEAHA.111.643098; Pu F, 2009, J PHARMACOL SCI, V109, P424, DOI 10.1254/jphs.08245FP; RICKELS E, 1993, NEUROSURGERY, V32, P479, DOI 10.1097/00006123-199303000-00030; Rosa AO, 2008, EXP NEUROL, V212, P93, DOI 10.1016/j.expneurol.2008.03.008; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011888; Whitehead SN, 2007, STROKE, V38, P381, DOI 10.1161/01.STR.0000254464.05561.72; Yan BC, 2011, BRAIN RES, V1425, P142, DOI 10.1016/j.brainres.2011.09.063; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]	45	41	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74886	10.1371/journal.pone.0074886	http://dx.doi.org/10.1371/journal.pone.0074886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073226	gold, Green Submitted, Green Published			2022-12-25	WOS:000324768000035
J	Yehuda-Shnaidman, E; Nimri, L; Tarnovscki, T; Kirshtein, B; Rudich, A; Schwartz, B				Yehuda-Shnaidman, Einav; Nimri, Lili; Tarnovscki, Tanya; Kirshtein, Boris; Rudich, Assaf; Schwartz, Betty			Secreted Human Adipose Leptin Decreases Mitochondrial Respiration in HCT116 Colon Cancer Cells	PLOS ONE			English	Article							METABOLIC SYNDROME; PYRUVATE-KINASE; BREAST-CANCER; TUMOR-GROWTH; MOUSE MODEL; PROGRESSION; OBESITY; EXPRESSION; PROMOTES; TISSUE	Obesity is a key risk factor for the development of colon cancer; however, the endocrine/paracrine/metabolic networks mediating this connection are poorly understood. Here we hypothesize that obesity results in secreted products from adipose tissue that induce malignancy-related metabolic alterations in colon cancer cells. Human HCT116 colon cancer cells, were exposed to conditioned media from cultured human adipose tissue fragments of obese vs. non-obese subjects. Oxygen consumption rate (OCR, mostly mitochondrial respiration) and extracellular acidification rate (ECAR, mostly lactate production via glycolysis) were examined vis-a-vis cell viability and expression of related genes and proteins. Our results show that conditioned media from obese (vs. non-obese) subjects decreased basal (40%, p<0.05) and maximal (50%, p<0.05) OCR and gene expression of mitochondrial proteins and Bax without affecting cell viability or expression of glycolytic enzymes. Similar changes could be recapitulated by incubating cells with leptin, whereas, leptin-receptor specific antagonist inhibited the reduced OCR induced by conditioned media from obese subjects. We conclude that secreted products from the adipose tissue of obese subjects inhibit mitochondrial respiration and function in HCT116 colon cancer cells, an effect that is at least partly mediated by leptin. These results highlight a putative novel mechanism for obesity-associated risk of gastrointestinal malignancies, and suggest potential new therapeutic avenues.	[Yehuda-Shnaidman, Einav; Nimri, Lili; Schwartz, Betty] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Tarnovscki, Tanya; Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Kirshtein, Boris] Soroka Acad Med Ctr, Dept Surg A, Beer Sheva, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Yehuda-Shnaidman, E (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel.	yseinav@gmail.com		Kirshtein, Boris/0000-0001-5463-0065; Rudich, Assaf/0000-0002-1366-1444	Israel Science Foundation [134/06]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 134/06 to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Anubhuti Arora S, 2008, DIABETES OBES METAB, V10, P973, DOI [10.1111/j.1463-1326.2008.00852.x, DOI 10.1111/J.1463-1326.2008.00852.X.PUBMED:18284436]; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Bluemlein K, 2011, ONCOTARGET, V2, P393; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; BRESALIER RS, 1995, CANCER RES, V55, P2476; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Collins S, MODERATION ALL THING; Collins S, 2012, PIGM CELL MELANOMA R, V25, P2, DOI 10.1111/j.1755-148X.2011.00937.x; Cook CC, 2012, BBA-GEN SUBJECTS, V1820, P652, DOI 10.1016/j.bbagen.2011.08.017; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Friedman JM, 1998, NUTR REV, V56, pS38; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huysentruyt LC, 2010, INT J CANCER, V126, P65, DOI 10.1002/ijc.24649; Jaffe T, 2008, INT J CANCER, V123, P2543, DOI 10.1002/ijc.23821; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; KUAN SF, 1987, CANCER RES, V47, P5715; Lavi I, 2010, APPL MICROBIOL BIOT, V85, P1977, DOI 10.1007/s00253-009-2296-x; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; SCHMIDT H, 1991, EXP CELL RES, V194, P122, DOI 10.1016/0014-4827(91)90140-P; Schnabele K, 2009, EUR J NUTR, V48, P154, DOI 10.1007/s00394-009-0775-6; SCHWARTZ B, 1992, INT J CANCER, V52, P60, DOI 10.1002/ijc.2910520113; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	49	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74843	10.1371/journal.pone.0074843	http://dx.doi.org/10.1371/journal.pone.0074843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073224	gold, Green Submitted, Green Published			2022-12-25	WOS:000324768000033
J	Marimpietri, D; Petretto, A; Raffaghello, L; Pezzolo, A; Gagliani, C; Tacchetti, C; Mauri, P; Melioli, G; Pistoia, V				Marimpietri, Danilo; Petretto, Andrea; Raffaghello, Lizzia; Pezzolo, Annalisa; Gagliani, Cristina; Tacchetti, Carlo; Mauri, Pierluigi; Melioli, Giovanni; Pistoia, Vito			Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC STEM; METASTATIC NEUROBLASTOMA; CELL DIFFERENTIATION; MEMBRANE-VESICLES; PROGENITOR CELLS; CANCER CELLS; MICROENVIRONMENT; CARCINOMA; INVASION; CD133	Neuroblastoma (NB) is the most common extracranial solid tumor in childhood, with grim prognosis in a half of patients. Exosomes are nanometer-sized membrane vesicles derived from the multivesicular bodies (MVBs) of the endocytic pathway and released by normal and neoplastic cells. Tumor-derived exosomes have been shown in different model systems to carry molecules that promote cancer growth and dissemination. In this respect, we have here performed the first characterization and proteomic analysis of exosomes isolated from human NB cell lines by filtration and ultracentrifugation. Electron microscopy demonstrated that NB-derived exosomes exhibited the characteristic cup-shaped morphology. Dynamic light scattering studies showed a bell-shaped curve and a polydispersity factor consistent with those of exosomes. Zeta potential values suggested a good nanoparticle stability. We performed proteomic analysis of NB-derived exosomes by two dimension liquid chromatography separation and mass spectrometry analyses using the multidimensional protein identification technology strategy. We found that the large majority of the proteins identified in NB derived exosomes are present in Exocarta database including tetraspanins, fibronectin, heat shock proteins, MVB proteins, cytoskeleton-related proteins, prominin-1 (CD133), basigin (CD147) and B7-H3 (CD276). Expression of the CD9, CD63 and CD81 tetraspanins, fibronectin, CD133, CD147 and CD276 was validated by flow cytometry. Noteworthy, flow cytometric analysis showed that NB-derived exosomes expressed the GD2 disialoganglioside, the most specific marker of NB. In conclusion, this study shows that NB-derived exosomes express a discrete set of molecules involved in defense response, cell differentiation, cell proliferation and regulation of other important biological process. Thus, NB-derived exosomes may play an important role in the modulation of tumor microenvironment and represent potential tumor biomarkers.	[Marimpietri, Danilo; Raffaghello, Lizzia; Pezzolo, Annalisa; Pistoia, Vito] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Lab Oncol, I-16148 Genoa, Italy; [Petretto, Andrea] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Core Facil, I-16148 Genoa, Italy; [Melioli, Giovanni] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Clin Pathol Labs, I-16148 Genoa, Italy; [Gagliani, Cristina] Univ Genoa, Dept Expt Med, Genoa, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy; [Mauri, Pierluigi] CNR, Inst Biomed Technol, I-20133 Milan, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Marimpietri, D (corresponding author), Ist Giannina Gaslini, Dept Translat Res & Lab Med, Lab Oncol, I-16148 Genoa, Italy.	danilomarimpietri@ospedale-gaslini.ge.it	Marimpietri, Danilo/AAA-7283-2020; Pezzolo, Annalisa/AAA-7424-2020; Mauri, Pietro Luigi/AAC-3095-2019; Marimpietri, Danilo/J-5975-2016; Petretto, Andrea/AAA-7342-2020	Marimpietri, Danilo/0000-0001-6360-1661; Mauri, Pietro Luigi/0000-0003-4364-0393; TACCHETTI, CARLO/0000-0003-4602-000X; Raffaghello, Lizzia/0000-0003-2357-0607; Petretto, Andrea/0000-0001-7811-8517	"Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria"; Finanziamento Ricerca Corrente, Ministero Salute; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 13003]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Compagnia San Paolo to Carlo Tacchetti	"Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria"; Finanziamento Ricerca Corrente, Ministero Salute; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Compagnia San Paolo to Carlo Tacchetti(Compagnia di San Paolo)	This study was supported by: "Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria", Finanziamento Ricerca Corrente, Ministero Salute and by Associazione Italiana per la Ricerca sul Cancro (AIRC) project IG 13003 to Vito Pistoia; funds from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Fondazione Compagnia San Paolo to Carlo Tacchetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Bougatef F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012265; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hathout Y, 2007, EXPERT REV PROTEOMIC, V4, P239, DOI 10.1586/14789450.4.2.239; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Kong Y, 1998, BBA-LIPID LIPID MET, V1394, P43, DOI 10.1016/S0005-2760(98)00096-4; Kshirsagar SK, 2012, PLACENTA, V33, P982, DOI 10.1016/j.placenta.2012.10.005; LADISCH S, 1994, P NATL ACAD SCI USA, V91, P1974, DOI 10.1073/pnas.91.5.1974; LADISCH S, 1987, INT J CANCER, V39, P73; Liang QC, 2005, CANCER BIOL THER, V4, P759, DOI 10.4161/cbt.4.7.1828; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; McKallip R, 1999, J IMMUNOL, V163, P3718; McPherson PS, 2010, PROTEOMICS, V10, P4025, DOI 10.1002/pmic.201000253; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Sweeny L, 2012, EXP CELL RES, V318, P1788, DOI 10.1016/j.yexcr.2012.04.022; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; THERY C, 2006, CURR PROTOC CELL BIO, V3; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhang Y, 2010, INT J ONCOL, V36, P133, DOI 10.3892/ijo_00000484; Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	73	105	110	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75054	10.1371/journal.pone.0075054	http://dx.doi.org/10.1371/journal.pone.0075054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069378	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300062
J	Semple, MG; Myles, PR; Nicholson, KG; Lim, WS; Read, RC; Taylor, BL; Brett, SJ; Openshaw, PJM; Enstone, JE; McMenamin, J; Bannister, B; Nguyen-Van-Tam, JS				Semple, Malcolm G.; Myles, Puja R.; Nicholson, Karl G.; Lim, Wei Shen; Read, Robert C.; Taylor, Bruce L.; Brett, Stephen J.; Openshaw, Peter J. M.; Enstone, Joanne E.; McMenamin, James; Bannister, Barbara; Nguyen-Van-Tam, Jonathan S.			An Evaluation of Community Assessment Tools (CATs) in Predicting Use of Clinical Interventions and Severe Outcomes during the A(H1N1)pdm09 Pandemic	PLOS ONE			English	Article							INFLUENZA	During severe influenza pandemics healthcare demand can exceed clinical capacity to provide normal standards of care. Community Assessment Tools (CATs) could provide a framework for triage decisions for hospital referral and admission. CATs have been developed based on evidence that supports the recognition of severe influenza and pneumonia in the community (including resource limited settings) for adults, children and infants, and serious feverish illness in children. CATs use six objective criteria and one subjective criterion, any one or more of which should prompt urgent referral and admission to hospital. A retrospective evaluation of the ability of CATs to predict use of hospital-based interventions and patient outcomes in a pandemic was made using the first recorded routine clinical assessment on or shortly after admission from 1520 unselected patients (800 female, 480 children,16 years) admitted with PCR confirmed A(H1N1)pdm09 infection (the FLU-CIN cohort). Outcome measures included: any use of supplemental oxygen; mechanical ventilation; intravenous antibiotics; length of stay; intensive or high dependency care; death; and "severe outcome'' (combined: use of intensive or high dependency care or death during admission). Unadjusted and multivariable analyses were conducted for children (age,16 years) and adults. Each CATs criterion independently identified both use of clinical interventions that would in normal circumstances only be provided in hospital and patient outcome measures. "Peripheral oxygen saturation <= 92% breathing air, or being on oxygen'' performed well in predicting use of resources and outcomes for both adults and children; supporting routine measurement of peripheral oxygen saturation when assessing severity of disease. In multivariable analyses the single subjective criterion in CATs "other cause for clinical concern'' independently predicted death in children and in adults predicted length of stay, mechanical ventilation and "severe outcome''; supporting the role of clinical acumen as an important independent predictor of serious illness.	[Semple, Malcolm G.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Myles, Puja R.; Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Nicholson, Karl G.] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Infect Dis Unit, Leicester, Leics, England; [Lim, Wei Shen] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham, England; [Read, Robert C.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Resp Infect, London, England; [McMenamin, James] NHS Natl Serv, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Bannister, Barbara] Royal Free Hampstead NHS Trust, Dept Infect Dis, London, England	University of Liverpool; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester; Nottingham University Hospital NHS Trust; University of Southampton; Portsmouth Hospitals NHS Trust; Imperial College London; Imperial College London; NHS National Services Scotland; University of London; University College London	Semple, MG (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	m.g.semple@liverpool.ac.uk	Openshaw, Peter/AAL-9442-2020; Nguyen-Van-Tam, Jonathan/I-2162-2019; Semple, Malcolm Gracie/A-8790-2008	Openshaw, Peter/0000-0002-7220-2555; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Semple, Malcolm Gracie/0000-0001-9700-0418; Myles, Puja/0000-0002-8976-890X; Read, Robert/0000-0002-4297-6728	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; NHS North West Strategic Health Authority; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Medical Research Council [MC_G1001212, G1000758] Funding Source: researchfish; National Institute for Health Research [11/46/22] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; MRC [MC_G1001212] Funding Source: UKRI	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; NHS North West Strategic Health Authority; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Department of Health in England was the main funder for FLU-CIN (United Kingdom Influenza Clinical Information Network). The Scottish Government Chief Medical Officer and Public Health Directorate supported the centre in Scotland. Chairmanship of the FLU-CIN Strategy Group (that includes MGS, KGN, WSL, RCR, BLT, SJB, PJMO, JEE, JM, BB and JSNVT as members) was provided by the Department of Health, England. The FLU-CIN Strategy Group had final responsibility for the interpretation of findings and decision to submit for publication. NHS North West Strategic Health Authority supported the development of the Community Assessment Tool for Children and the Alder Hey Children's Hospital NHS Foundation Trust Pandemic Influenza Group. PJMO and SJB were supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews A, 2001, COLUMN, V13, P7; [Anonymous], 2009, GUID IND PAT REP OUT; British Thoracic Society, 2002, THORAX, V57; British Thoracic Society, 2004, GUID MAN COMM ACQ PN; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chief Medical Officer Great Britain Ministry of Health, 1920, REP PUBL HLTH MED SU; Department of Health, 2007, 8979 COI DEP HLTH GA; Department of Health, 2009, 11697 COI DEP HLTH G; Department of Health, 2007, 8443 COI DEP HLTH GA; Department of Health & NHS, 2009, 12368 COI DEP HLTH G; Lim WS, 2007, THORAX, V62, P1, DOI 10.1136/thx.2006.073080; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Myles PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034428; *NAT COLL CTR CHRO, 2004, CHRON OBSTR PULM DIS; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Scottish Intercollegiate Guidelines Network, 2006, BRONCH CHILDR; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; WHO, 2002, WHOFCHCAH0223; *WHO, 1991, WHOARI9120; World Health Organization, 2001, WHOFCHCAH0110 DEP CH; World Health Organization, 1994, WHOARI9431	23	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75384	10.1371/journal.pone.0075384	http://dx.doi.org/10.1371/journal.pone.0075384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069409	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000324777300077
J	Perdiguero, B; Gomez, CE; Di Pilato, M; Sorzano, COS; Delaloye, J; Roger, T; Calandra, T; Pantaleo, G; Esteban, M				Perdiguero, Beatriz; Elena Gomez, Carmen; Di Pilato, Mauro; Sorzano, Carlos Oscar S.; Delaloye, Julie; Roger, Thierry; Calandra, Thierry; Pantaleo, Giuseppe; Esteban, Mariano			Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; KAPPA-B KINASE; TIR-DOMAIN; CRYSTAL-STRUCTURE; PATHOGEN RECOGNITION; IMMUNE-RESPONSES; STRUCTURAL BASIS; INNATE IMMUNITY; I INTERFERON	Viruses have developed strategies to counteract signalling through Toll-like receptors (TLRs) that are involved in the detection of viruses and induction of proinflammatory cytokines and IFNs. Vaccinia virus (VACV) encodes A46 protein which disrupts TLR signalling by interfering with TLR: adaptor interactions. Since the innate immune response to viruses is critical to induce protective immunity, we studied whether deletion of A46R gene in a NYVAC vector expressing HIV-1 Env, Gag, Pol and Nef antigens (NYVAC-C) improves immune responses against HIV-1 antigens. This question was examined in human macrophages and in mice infected with a single A46R deletion mutant of the vaccine candidate NYVAC-C (NYVAC-C-.A46R). The viral gene A46R is not required for virus replication in primary chicken embryo fibroblast (CEF) cells and its deletion in NYVAC-C markedly increases TNF, IL-6 and IL-8 secretion by human macrophages. Analysis of the immune responses elicited in BALB/c mice after DNA prime/NYVAC boost immunization shows that deletion of A46R improves the magnitude of the HIV-1-specific CD4 and CD8 T cell immune responses during adaptive and memory phases, maintains the functional profile observed with the parental NYVAC-C and enhances anti-gp120 humoral response during the memory phase. These findings establish the immunological role of VACV A46R on innate immune responses of macrophages in vitro and antigen-specific T and B cell immune responses in vivo and suggest that deletion of viral inhibitors of TLR signalling is a useful approach for the improvement of poxvirus-based vaccine candidates.	[Perdiguero, Beatriz; Elena Gomez, Carmen; Di Pilato, Mauro; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry; Pantaleo, Giuseppe] Univ Lausanne, Lausanne, Switzerland; [Pantaleo, Giuseppe] CHU Vaudois, Dept Med, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Perdiguero, Beatriz/K-6587-2017; Pantaleo, Giuseppe/K-6163-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021; Esteban, Mariano/ABG-5375-2020; Calandra, Thierry/D-9017-2015; Sorzano, Carlos Oscar S S./F-2639-2016; Gomez, Carmen Elena/K-1940-2014; Roger, Thierry/G-2007-2012	Perdiguero, Beatriz/0000-0001-6276-7766; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Esteban, Mariano/0000-0003-0846-2827; Calandra, Thierry/0000-0003-3051-1285; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Roger, Thierry/0000-0002-9358-0109; Di Pilato, Mauro/0000-0003-3902-7406	Ministry of Science and Innovation of Spain [SAF2008-02036]; Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This investigation was supported by grants from the Ministry of Science and Innovation of Spain (SAF2008-02036), Foundation FIPSE and PTVDC/CAVD program with support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Gomez CE, 2012, J VIROL, V86, P5026, DOI 10.1128/JVI.06684-11; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12; Garber DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005445; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda SI, 2011, MOL IMMUNOL, V48, P2144, DOI 10.1016/j.molimm.2011.07.014; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1995, J LEUKOCYTE BIOL, V58, P1; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanchez-Sampedro L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038859; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2012, J BIOL CHEM, V287, P22672, DOI 10.1074/jbc.M112.349225; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; TARTAGLIA J, 1992, AIDS RES HUM RETROV, V8, P1445, DOI 10.1089/aid.1992.8.1445; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	71	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74831	10.1371/journal.pone.0074831	http://dx.doi.org/10.1371/journal.pone.0074831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069354	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300059
J	Redondo, BB; Bunz, M; Halder, P; Sadanandappa, MK; Muhlbauer, B; Erwin, F; Hofbauer, A; Rodrigues, V; VijayRaghavan, K; Ramaswami, M; Rieger, D; Wegener, C; Forster, C; Buchner, E				Redondo, Beatriz Blanco; Bunz, Melanie; Halder, Partho; Sadanandappa, Madhumala K.; Muehlbauer, Barbara; Erwin, Felix; Hofbauer, Alois; Rodrigues, Veronica; VijayRaghavan, K.; Ramaswami, Mani; Rieger, Dirk; Wegener, Christian; Foerster, Charlotte; Buchner, Erich			Identification and Structural Characterization of Interneurons of the Drosophila Brain by Monoclonal Antibodies of the Wurzburg Hybridoma Library	PLOS ONE			English	Article							PIGMENT-DISPERSING HORMONE; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; VISUAL-SYSTEM; OPTIC LOBE; MELANOGASTER; PROTEIN; LAMINA; GENE	Several novel synaptic proteins have been identified by monoclonal antibodies (mAbs) of the Wurzburg hybridoma library generated against homogenized Drosophila brains, e.g. cysteine string protein, synapse-associated protein of 47 kDa, and Bruchpilot. However, at present no routine technique exists to identify the antigens of mAbs of our library that label only a small number of cells in the brain. Yet these antibodies can be used to reproducibly label and thereby identify these cells by immunohistochemical staining. Here we describe the staining patterns in the Drosophila brain for ten mAbs of the Wurzburg hybridoma library. Besides revealing the neuroanatomical structure and distribution of ten different sets of cells we compare the staining patterns with those of antibodies against known antigens and GFP expression patterns driven by selected Gal4 lines employing regulatory sequences of neuronal genes. We present examples where our antibodies apparently stain the same cells in different Gal4 lines suggesting that the corresponding regulatory sequences can be exploited by the split-Gal4 technique for transgene expression exclusively in these cells. The detection of Gal4 expression in cells labeled by mAbs may also help in the identification of the antigens recognized by the antibodies which then in addition to their value for neuroanatomy will represent important tools for the characterization of the antigens. Implications and future strategies for the identification of the antigens are discussed.	[Redondo, Beatriz Blanco; Halder, Partho; Sadanandappa, Madhumala K.; Buchner, Erich] Univ Wurzburg, Inst Clin Neurobiol, D-97070 Wurzburg, Germany; [Bunz, Melanie; Halder, Partho; Muehlbauer, Barbara; Erwin, Felix; Rieger, Dirk; Wegener, Christian; Foerster, Charlotte; Buchner, Erich] Univ Wurzburg, Dept Neurobiol & Genet, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Hofbauer, Alois] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany; [Sadanandappa, Madhumala K.; Rodrigues, Veronica; VijayRaghavan, K.; Ramaswami, Mani] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Ramaswami, Mani] Univ Dublin Trinity Coll, Sch Genet & Microbiol, Dublin 2, Ireland; [Ramaswami, Mani] Univ Dublin Trinity Coll, Sch Nat Sci, Smurfit Inst Genet, Dublin 2, Ireland; [Ramaswami, Mani] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland	University of Wurzburg; University of Wurzburg; University of Regensburg; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Buchner, E (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, D-97070 Wurzburg, Germany.	buchner@biozentrum.uni-wuerzburg.de	Rieger, Dirk/X-8583-2019; Sadanandappa, Madhumala K/M-5375-2019	Rieger, Dirk/0000-0001-5597-5858; Sadanandappa, Madhumala K/0000-0001-6071-365X; Wegener, Christian/0000-0003-4481-3567; Ramaswami, Mani/0000-0001-7631-0468; Helfrich-Forster, Charlotte/0000-0002-0859-9092; Blanco Redondo, Beatriz/0000-0003-0246-2893	German Research Foundation (DFG); University of Wuerzburg; German Science Foundation [DFG-SFB554, DFG-SFB581, DFG-GRK1156, DFG-SFB1047]; Science Foundation Ireland; German Excellence Initiative; INSPIRE fellowship from Department of Science and Technology (DST), India; DAAD, Germany; NCBS-TIFR grants	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Science Foundation(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); German Excellence Initiative; INSPIRE fellowship from Department of Science and Technology (DST), India(Department of Science & Technology (India)); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); NCBS-TIFR grants	This publication was funded by the German Research Foundation (DFG, http://www.dfg.de/en/) and the University of Wuerzburg (http://www.uni-wuerzburg.de/) in the funding programme Open Access Publishing. The work was supported by the German Science Foundation, grants DFG-SFB554, -SFB581, and -GRK1156 (to E.B.) and -SFB1047 to C.F., C.W. and D.R., and by the Science Foundation Ireland (http://www.sfi.ie/) (to M.R.). B.B.R. and P.H. were supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. M.K.S. was supported by INSPIRE fellowship from Department of Science and Technology (DST), India, (www.dst.gov.in/) and by a short-term fellowship of the DAAD, Germany (https://www.daad.de/en/). K.V.R's research was supported by the NCBS-TIFR (www.ncbs.res.in/) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; FUJITA SC, 1988, ANNU REV ENTOMOL, V33, P1, DOI 10.1146/annurev.en.33.010188.000245; Halder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029352; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster Charlotte, 2007, Methods Mol Biol, V362, P533; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hofbauer A, 1991, THESIS U WUERZBURG G; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; LOHR J, 1993, COMP BIOCHEM PHYS B, V104, P699, DOI 10.1016/0305-0491(93)90200-O; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; NASSEL DR, 1984, NEUROSCI LETT, V48, P203, DOI 10.1016/0304-3940(84)90020-X; NASSEL DR, 1985, J COMP NEUROL, V232, P190, DOI 10.1002/cne.902320205; NASSEL DR, 1983, BRAIN RES, V280, P361, DOI 10.1016/0006-8993(83)90068-9; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; REICHMUTH C, 1995, MOL BRAIN RES, V32, P45, DOI 10.1016/0169-328X(95)00058-Z; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75420	10.1371/journal.pone.0075420	http://dx.doi.org/10.1371/journal.pone.0075420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069413	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300083
J	Zheng, JX; Li, Y; Zhang, H; Fan, HJ; Lu, CP				Zheng, Jun-xi; Li, Yue; Zhang, Hui; Fan, Hong-jie; Lu, Cheng-ping			Identification and Characterization of a Novel Hemolysis-Related Gene in Streptococcus suis Serotype 2	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; IV SECRETION SYSTEM; VIRULENCE; EXPRESSION; VECTORS; TYPE-2; VIRB6	Streptococcus suis serotype 2 (SS 2) is an important zoonotic pathogen that has caused two major infectious outbreaks of streptococcal toxic shock syndrome (STSS) in China. A novel gene located in the 89K pathogenicity island (PAI) encoding a putative hemolysin-III-related protein (Hhly3) has been previously characterized. In this study, the SS2 deletion mutant of the exogenous gene hhly3 was constructed by homologous recombination. This protein was found to exhibit cytolytic activity, and hemolytic activity of the hhly3 gene knockout mutant (Delta hhly3) was significantly lower than that in the wild-type strain ZY05719. In addition, qRT-PCR revealed that Hhly3 played an important role in the expression of the secreted hemolysin SLY, which may be the key reason for the decreased hemolytic activity. Consequently, compared with the WT strain, the infection and pathogenicity of Delta hhly3 was also decreased, as evidenced by in vitro bacterial growth in whole blood and by the in vivo zebrafish test, suggesting that hhly3 is a novel exogenous hemolysis-related gene in SS2 strains.	[Zheng, Jun-xi; Li, Yue; Zhang, Hui; Fan, Hong-jie; Lu, Cheng-ping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China; [Fan, Hong-jie] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Fan, HJ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation of China [31172319]; Key Technology R&D Program of Jiangsu [BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program of Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the Program from the National Basic Research Program (973) of China (2012CB518804), the National Natural Science Foundation of China (31172319), the Key Technology R&D Program of Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 1998, LETT APPL MICROBIOL, V27, P270, DOI 10.1046/j.1472-765X.1998.00435.x; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen YC, 2004, CURR MICROBIOL, V49, P175, DOI 10.1007/s00284-004-4288-5; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Higgins R, 2000, CAN VET J, V41, P414; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jiang H, 2009, VET MICROBIOL, V133, P309, DOI 10.1016/j.vetmic.2008.07.014; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tan C, 2008, FEMS MICROBIOL LETT, V278, P108, DOI 10.1111/j.1574-6968.2007.00980.x; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Wu T, 2009, FEMS MICROBIOL LETT, V292, P170, DOI 10.1111/j.1574-6968.2008.01486.x; Xu LF, 2010, PROTEIN CELL, V1, P96, DOI 10.1007/s13238-010-0012-3; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zheng F, 2011, INFECT IMMUN, V79, P1319, DOI 10.1128/IAI.00193-10; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	21	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74674	10.1371/journal.pone.0074674	http://dx.doi.org/10.1371/journal.pone.0074674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069329	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300049
J	Liu, WY; Wong, CF; Chung, KMK; Jiang, JW; Leung, FCC				Liu, Wing-Yee; Wong, Chi-Fat; Chung, Karl Ming-Kar; Jiang, Jing-Wei; Leung, Frederick Chi-Ching			Comparative Genome Analysis of Enterobacter cloacae	PLOS ONE			English	Article							VI SECRETION SYSTEM; ESCHERICHIA-COLI; IV SECRETION; BACILLUS-THURINGIENSIS; CHITINASE GENE; SEQUENCE; PLANT; BIOCONTROL; PURIFICATION; EXPRESSION	The Enterobacter cloacae species includes an extremely diverse group of bacteria that are associated with plants, soil and humans. Publication of the complete genome sequence of the plant growth-promoting endophytic E. cloacae subsp. cloacae ENHKU01 provided an opportunity to perform the first comparative genome analysis between strains of this dynamic species. Examination of the pan-genome of E. cloacae showed that the conserved core genome retains the general physiological and survival genes of the species, while genomic factors in plasmids and variable regions determine the virulence of the human pathogenic E. cloacae strain; additionally, the diversity of fimbriae contributes to variation in colonization and host determination of different E. cloacae strains. Comparative genome analysis further illustrated that E. cloacae strains possess multiple mechanisms for antagonistic action against other microorganisms, which involve the production of siderophores and various antimicrobial compounds, such as bacteriocins, chitinases and antibiotic resistance proteins. The presence of Type VI secretion systems is expected to provide further fitness advantages for E. cloacae in microbial competition, thus allowing it to survive in different environments. Competition assays were performed to support our observations in genomic analysis, where E. cloacae subsp. cloacae ENHKU01 demonstrated antagonistic activities against a wide range of plant pathogenic fungal and bacterial species.	[Liu, Wing-Yee; Wong, Chi-Fat; Chung, Karl Ming-Kar; Jiang, Jing-Wei; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Jing-Wei; Leung, Frederick Chi-Ching] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	University of Hong Kong; Nanjing Agricultural University	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk			Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong	Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong	This project was partially supported by the Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong and a start-up fund for Bioinformatics Center, Nanjing Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, V5th, P26; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhattacharya D, 2007, CRIT REV BIOTECHNOL, V27, P21, DOI 10.1080/07388550601168223; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Chang WT, 2003, CURR MICROBIOL, V47, P102, DOI 10.1007/s00284-002-3955-7; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chernin LS, 1997, APPL ENVIRON MICROB, V63, P834, DOI 10.1128/AEM.63.3.834-839.1997; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, MOL MEMBR BIOL, V22, P51, DOI 10.1080/09687860500063316; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeAngelis KM, 2011, STAND GENOMIC SCI, V5, P69, DOI 10.4056/sigs.2104875; DIENE SM, 2012, MOL BIOL EVOL; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; Garbeva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027266; Gomaa EZ, 2012, J MICROBIOL, V50, P103, DOI 10.1007/s12275-012-1343-y; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hoffmann H, 2005, J CLIN MICROBIOL, V43, P3297, DOI 10.1128/JCM.43.7.3297-3303.2005; HUMANN JL, 2011, STANDARDS GENOMICS S, V5; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jiang LQ, 2012, BIORESOURCE TECHNOL, V107, P405, DOI 10.1016/j.biortech.2011.12.083; JONES JDG, 1986, EMBO J, V5, P467, DOI 10.1002/j.1460-2075.1986.tb04235.x; Joseph S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049455; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Keller R, 1998, INFECT IMMUN, V66, P645, DOI 10.1128/IAI.66.2.645-649.1998; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Li J, 2012, GENE, V494, P57, DOI 10.1016/j.gene.2011.11.051; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Liu SY, 2007, MICROBIOL-SGM, V153, P3196, DOI 10.1099/mic.0.2006/005538-0; Liu WY, 2012, J BACTERIOL, V194, P5965, DOI 10.1128/JB.01394-12; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Manter DK, 2011, CURR MICROBIOL, V62, P1044, DOI 10.1007/s00284-010-9809-9; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mehmood MA, 2009, WORLD J MICROB BIOT, V25, P1955, DOI 10.1007/s11274-009-0094-3; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; NELSON EB, 1988, PLANT DIS, V72, P140, DOI 10.1094/PD-72-0140; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sarris PF, 2011, INFECT GENET EVOL, V11, P157, DOI 10.1016/j.meegid.2010.09.006; Schroeder BK, 2010, PLANT DIS, V94, P236, DOI 10.1094/PDIS-94-2-0236; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shin SH, 2012, J BACTERIOL, V194, P2373, DOI 10.1128/JB.00028-12; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Smits THM, 2010, FEMS MICROBIOL LETT, V308, P48, DOI 10.1111/j.1574-6968.2010.01994.x; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Suarez-Estrella F, 2007, CROP PROT, V26, P46, DOI 10.1016/j.cropro.2006.04.003; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; van Dijk K, 2000, APPL ENVIRON MICROB, V66, P5340, DOI 10.1128/AEM.66.12.5340-5347.2000; WATANABE T, 1990, J BIOL CHEM, V265, P15659; Xu YQ, 2012, J BACTERIOL, V194, P897, DOI 10.1128/JB.06495-11; Xue QY, 2009, BIOL CONTROL, V48, P252, DOI 10.1016/j.biocontrol.2008.11.004; Zees AC, 2009, BBA-PROTEINS PROTEOM, V1794, P23, DOI 10.1016/j.bbapap.2008.09.018; Zhu B, 2011, INT J SYST EVOL MICR, V61, P2769, DOI 10.1099/ijs.0.028613-0	91	36	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74487	10.1371/journal.pone.0074487	http://dx.doi.org/10.1371/journal.pone.0074487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069314	gold, Green Published, Green Submitted			2022-12-25	WOS:000326240100107
J	Reyes, L; Eiler-McManis, E; Rodrigues, PH; Chadda, AS; Wallet, SM; Belanger, M; Barrett, AG; Alvarez, S; Akin, D; Dunn, WA; Progulske-Fox, A				Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Alvarez, Sophie; Akin, Debra; Dunn, William A., Jr.; Progulske-Fox, Ann			Deletion of Lipoprotein PG0717 in Porphyromonas gingivalis W83 Reduces Gingipain Activity and Alters Trafficking in and Response by Host Cells	PLOS ONE			English	Article							C-TERMINAL-DOMAIN; BIOFILM FORMATION; IMMUNE-RESPONSE; VIRULENCE; EXPRESSION; AUTOPHAGY; SURVIVAL; INTERLEUKIN-8; INVASION; SEQUENCE	P. gingivalis (Pg), a causative agent of chronic generalized periodontitis, has been implicated in promoting cardiovascular disease. Expression of lipoprotein gene PG0717 of Pg strain W83 was found to be transiently upregulated during invasion of human coronary artery endothelial cells (HCAEC), suggesting this protein may be involved in virulence. We characterized the virulence phenotype of a PG0717 deletion mutant of pg W83. There were no differences in the ability of W83 Delta 717 to adhere and invade HCAEC. However, the increased proportion of internalized W83 at 24 hours post-inoculation was not observed with W83 Delta 717. Deletion of PG0717 also impaired the ability of W83 to usurp the autophagic pathway in HCAEC and to induce autophagy in Saos-2 sarcoma cells. HCAEC infected with W83 Delta 717 also secreted significantly greater amounts of MCP-1, IL-8, IL-6, GM-CSF, and soluble ICAM-1, VCAM-1, and E-selectin when compared to W83. Further characterization of W83 Delta 717 revealed that neither capsule nor lipid A structure was affected by deletion of PG0717. Interestingly, the activity of both arginine (Rgp) and lysine (Kgp) gingipains was reduced in whole-cell extracts and culture supernatant of W83 Delta 717. RT-PCR revealed a corresponding decrease in transcription of rgpB but not rgpA or kgp. Quantitative proteome studies of the two strains revealed that both RgpA and RgpB, along with putative virulence factors peptidylarginine deiminase and Clp protease were significantly decreased in the W83 Delta 717. Our results suggest that PG0717 has pleiotropic effects on W83 that affect microbial induced manipulation of host responses important for microbial clearance and infection control.	[Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Progulske-Fox, Ann] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Progulske-Fox, Ann] Ctr Mol Microbiol, Gainesville, FL USA; [Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Alvarez, Sophie] Donald Danforth Plant Sci Ctr, Prote & Mass Spectrometry Core, St Louis, MO USA; [Akin, Debra; Dunn, William A., Jr.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Donald Danforth Plant Science Center; State University System of Florida; University of Florida	Reyes, L (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	lreyes@ufl.edu	Reyes, Leticia/H-7338-2019; Rodrigues, Paulo/O-2689-2017; Alvarez, Sophie/K-9231-2013	Rodrigues, Paulo/0000-0002-4646-6805; Alvarez, Sophie/0000-0001-8550-2832	National Institutes of Health [R01 DE13545, T90 DE021990]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01 DE13545 and T90 DE021990. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Allam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051345; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aruni AW, 2013, MOL ORAL MICROBIOL, V28, P167, DOI 10.1111/omi.12017; BARTH K, 2012, J CELL PHYSL; BELANGER M, 2007, CURRENT PROTOCOLS MI; Belanger M, 2012, ANAEROBE, V18, P128, DOI 10.1016/j.anaerobe.2011.10.005; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Braunersreuther V, 2006, CELL MOL LIFE SCI, V63, P2079, DOI 10.1007/s00018-006-6127-2; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-252; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chen T, 2004, J BACTERIOL, V186, P5473, DOI 10.1128/JB.186.16.5473-5479.2004; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; ENERSEN M, 2011, J ORAL MICROBIOL, P3; Fletcher J, 1998, CURR MICROBIOL, V36, P216, DOI 10.1007/s002849900297; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; HAYASHI H, 1993, ORAL MICROBIOL IMMUN, V8, P386, DOI 10.1111/j.1399-302X.1993.tb00616.x; Hiratsuka K, 2008, MICROB PATHOGENESIS, V44, P320, DOI 10.1016/j.micpath.2007.10.006; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Kozarov E, 2000, INFECT IMMUN, V68, P732, DOI 10.1128/IAI.68.2.732-739.2000; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Lepine G, 1996, INFECT IMMUN, V64, P1467; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Lin Li, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P734; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; Madrigal AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002723; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Rivera FE, 2012, PROTEOMICS, V12, P263, DOI 10.1002/pmic.201100298; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Singh A, 2011, INFECT IMMUN, V79, P4533, DOI 10.1128/IAI.05016-11; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tufano A, 2012, SEMIN THROMB HEMOST, V38, P515, DOI 10.1055/s-0032-1315759; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WOO DDL, 1979, J INFECT DIS, V139, P534, DOI 10.1093/infdis/139.5.534; Yamatake K, 2007, INFECT IMMUN, V75, P2090, DOI 10.1128/IAI.01013-06; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Yuan LH, 2007, FEMS IMMUNOL MED MIC, V51, P388, DOI 10.1111/j.1574-695X.2007.00326.x	77	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74230	10.1371/journal.pone.0074230	http://dx.doi.org/10.1371/journal.pone.0074230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069284	gold, Green Published, Green Submitted			2022-12-25	WOS:000326240100092
J	Ren, G; Liu, Y; Zhao, X; Zhang, J; Zheng, B; Yuan, ZR; Zhang, L; Qu, X; Tischfield, JA; Shao, C; Shi, Y				Ren, G.; Liu, Y.; Zhao, X.; Zhang, J.; Zheng, B.; Yuan, Z-R; Zhang, L.; Qu, X.; Tischfield, J. A.; Shao, C.; Shi, Y.			Tumor resident mesenchymal stromal cells endow naive stromal cells with tumor-promoting properties	ONCOGENE			English	Article						mesenchymal stem/stromal cells; lymphoma; tumor promotion; tumor microenvironment; chemokines; macrophages	STEM-CELLS; RECRUITMENT; FIBROBLASTS; TRANSITION; NICHE	Bone marrow mesenchymal stem/stromal cells (BM-MSCs) can infiltrate into tumors and subsequently evolve into tumor resident MSCs in tumor microenvironment. In this study, using a mouse lymphoma model, we showed that the lymphoma resident MSCs (L-MSCs) are able to confer tumor-promoting property to the naive cocultured BM-MSCs. Examination of cytokines and chemokines showed that post exposure to L-MSCs, BM-MSCs acquired an expression profile that is similar to that in L-MSCs. In vivo, BM-MSCs educated by L-MSCs (BM-L-MSCs) possess a greatly enhanced ability in promoting lymphoma growth. Consistent with an elevated CCL-2 expression in BM-L-MSCs, the tumor-promoting effect of BM-L-MSCs largely depends on CCR2-mediated macrophage recruitment to tumor sites. We further showed that the transmission of tumor-promoting effect is partially mediated by soluble factors. Our findings thus revealed a novel reinforcing mechanism in the maintenance of tumor microenvironment.	[Ren, G.; Zhang, J.; Yuan, Z-R; Zhang, L.; Shi, Y.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Rutgers Biomed & Hlth Sci, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Ren, G.; Shi, Y.] Chinese Acad Sci, Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci,Inst Hlth Sci, Shanghai, Peoples R China; [Liu, Y.; Qu, X.] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Dept Med Oncol, Jinan 250100, Shandong, Peoples R China; [Liu, Y.; Zhao, X.; Zheng, B.; Tischfield, J. A.; Shao, C.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Liu, Y.; Zhao, X.; Zheng, B.; Tischfield, J. A.; Shao, C.] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway, NJ 08854 USA; [Shao, C.] Shandong Univ, Sch Med, Inst Mol Med & Genet, Minist Educ Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shandong University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Shandong University	Shao, C (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	shao@biology.rutgers.edu; shiyu@rwjms.rutgers.edu	Shao, Changshun/AAD-8977-2022; Shi, Yufang/AAE-4431-2020	Shao, Changshun/0000-0003-2618-9342; Shi, Yufang/0000-0001-8964-319X; Ren, Guangwen/0000-0003-2436-9593; Qu, Xun/0000-0002-2521-3761; Tischfield, Jay/0000-0003-3217-8287	National Institutes of Health of the United States of America [GM866889, DE014913, DE019932, ES005022]; Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; Human Genetics Institute of New Jersey; Robert Wood Johnson Foundation of the Child Health Institute of New Jersey [67038]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM866889] Funding Source: NIH RePORTER	National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Human Genetics Institute of New Jersey; Robert Wood Johnson Foundation of the Child Health Institute of New Jersey; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Institutes of Health of the United States of America (GM866889, DE014913, DE019932 and ES005022), Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630) and a grant from the Human Genetics Institute of New Jersey. We would also like to thank the Robert Wood Johnson Foundation (Grant 67038) for their support of the Child Health Institute of New Jersey.	Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guilloton F, 2012, BLOOD, V119, P2556, DOI 10.1182/blood-2011-08-370908; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kabashima-Niibe A, 2013, CANCER SCI, V104, P157, DOI 10.1111/cas.12059; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122	18	29	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					4016	4020		10.1038/onc.2013.387	http://dx.doi.org/10.1038/onc.2013.387			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24077286				2022-12-25	WOS:000339394700013
J	Koutsokeras, A; Purkayashta, N; Rigby, A; Subang, MC; Sclanders, M; Vessillier, S; Mullen, L; Chernajovsky, Y; Gould, D				Koutsokeras, Apostolos; Purkayashta, Nirupam; Rigby, Anne; Subang, Maria C.; Sclanders, Michelle; Vessillier, Sandrine; Mullen, Lisa; Chernajovsky, Yuti; Gould, David			Generation of an efficiently secreted, cell penetrating NF-kB inhibitor	FASEB JOURNAL			English	Article						protein transduction domain; inflammation; MMP; gene therapy	KAPPA-B-ALPHA; TAT FUSION PROTEINS; GENE-THERAPY; IN-VIVO; TRANSDUCTION DOMAINS; BINDING DOMAIN; INFLAMMATION; ACTIVATION; PEPTIDE; CYTOKINES	Gene therapy is a powerful approach to treat disease locally. However, if the therapeutic target is intracellular, the therapeutic will be effective only in the cells where the therapeutic gene is delivered. We have engineered a fusion protein containing an intracellular inhibitor of the transcription factor NF-B pathway that can be effectively secreted from producing cells. This fusion protein is cleaved extracellularly by metalloproteinases allowing release of a protein transduction domain (PTD) linked to the NF-B inhibitor for translocation into neighboring cells. We show that engineered molecules can be efficiently secreted (>80%); are cleaved with matrix metalloprotease-1; inhibit NF-B driven transcription in a biological assay with a human reporter cell line; and display significant inhibition in mouse paw inflammation models when delivered by lentivirus or secreting cells. No inhibition of NF-B transcription or therapeutic effect was seen using molecules devoid of the PTD and NF-B inhibitory domains. By creating a fusion protein with an endogenous secretion partner, we demonstrate a novel approach to efficiently secrete PTD-containing protein domains, overcoming previous limitations, and allowing for potent paracrine effects.Koutsokeras, A., Purkayashta, N., Rigby, A., Subang, M. C., Sclanders, M., Vessillier, S., Mullen, L., Chernajovsky, Y., Gould, D. Generation of an efficiently secreted, cell penetrating NF-B inhibitor.	[Koutsokeras, Apostolos; Purkayashta, Nirupam; Rigby, Anne; Subang, Maria C.; Sclanders, Michelle; Vessillier, Sandrine; Mullen, Lisa; Chernajovsky, Yuti; Gould, David] Queen Mary Univ London, Bone & Joint Res Unit, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	Gould, D (corresponding author), Queen Mary Univ London, Bone & Joint Res Unit, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	d.j.gould@qmul.ac.uk	Vessillier, Sandrine/E-2502-2013	Vessillier, Sandrine/0000-0002-9697-1834; Mullen, Lisa/0000-0001-8278-2226; Purkayastha, Nirupam/0000-0003-3870-1147	Arthritis Research UK [17428, 17559, 17208, 18401]; British Heart Foundation [PG/09/093]; Medical Research Council [G0800795]; National Multiple Sclerosis Society USA; Wellcome Trust [073271]; MRC [G0800795] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Multiple Sclerosis Society USA(National Multiple Sclerosis Society); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Ron Hay (Dundee University, Dundee, UK) for providing the 57A Hela cells, Adrian Thrasher (Institute of Child Health, London, UK) for providing the HRSIN-CSGW vector, and Mauro Perretti and Neil Dufton for technical assistance. The authors thank Arthritis Research UK for support of A. K., C. S., N.P., and D. G. (grants 17428, 17559, 17208, and 18401); the British Heart Foundation (grant PG/09/093) for support of S. V.; the Medical Research Council (grant G0800795) for support of L. M.; the National Multiple Sclerosis Society USA (promise 2010 program) for support of A. R. and M. S.; and the Wellcome Trust (grant 073271). Conflict of interest declaration: Y.C. is founder and director of Stealthyx Therapeutics, which develops the LAP-delivery technology.	Adams G, 2003, NAT BIOTECHNOL, V21, P1314, DOI 10.1038/nbt888; Barka T, 2004, J HISTOCHEM CYTOCHEM, V52, P469, DOI 10.1177/002215540405200405; Blackwell NM, 2004, ARTHRITIS RHEUM-US, V50, P2675, DOI 10.1002/art.20467; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; di Meglio P, 2005, ARTHRITIS RHEUM-US, V52, P951, DOI 10.1002/art.20960; Flinterman M, 2009, MOL THER, V17, P334, DOI 10.1038/mt.2008.256; Ho A, 2001, CANCER RES, V61, P474; Kabouridis PS, 2002, J IMMUNOL, V169, P2587, DOI 10.4049/jimmunol.169.5.2587; Koutsokeras A, 2009, BBA-GEN SUBJECTS, V1790, P147, DOI 10.1016/j.bbagen.2008.11.005; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Mullen L., 2013, EXPERT OPIN IN PRESS; Mullen L., 2013, ANN RHEUM DIS; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Roomi MW, 2010, ONCOL REP, V23, P605, DOI 10.3892/or_00000675; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Sambrook J., 2002, MOL CLONING LAB MANU; Schropfer A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-553; Shaw PA, 2008, BIOCHEMISTRY-US, V47, P1157, DOI 10.1021/bi701542p; Shen Y, 2011, MOL THER, V19, P903, DOI 10.1038/mt.2010.283; Strickland I, 2006, ANN RHEUM DIS, V65, P75, DOI 10.1136/ard.2006.058438; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Tas SW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1958; Tomita T, 1999, ARTHRITIS RHEUM, V42, P2532, DOI 10.1002/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2; Triantaphyllopoulos KA, 1998, GENE THER, V5, P253, DOI 10.1038/sj.gt.3300570; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Vessillier S, 2004, PROTEIN ENG DES SEL, V17, P829, DOI 10.1093/protein/gzh097; Vessillier S, 2012, ANN RHEUM DIS, V71, P143, DOI 10.1136/annrheumdis-2011-200100; Zhang HG, 2000, ARTHRITIS RHEUM-US, V43, P1094, DOI 10.1002/1529-0131(200005)43:5<1094::AID-ANR20>3.0.CO;2-V	34	7	7	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					373	381		10.1096/fj.13-236570	http://dx.doi.org/10.1096/fj.13-236570			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24072781				2022-12-25	WOS:000333526100035
J	Singh, S; Saraiva, L; Elkington, PTG; Friedland, JS				Singh, Shivani; Saraiva, Luisa; Elkington, Paul T. G.; Friedland, Jon S.			Regulation of matrix metalloproteinase-1,-3, and-9 in Mycobacterium tuberculosis-dependent respiratory networks by the rapamycin- sensitive PI3K/p70(S6K) cascade	FASEB JOURNAL			English	Article						collagenase; stromelysin; gelatinase; immunopathology; epithelial cell; pulmonary; human	ACTIVATED PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PHAGOLYSOSOME BIOGENESIS; EPITHELIAL-CELLS; INHIBITION; SECRETION; MATRIX-METALLOPROTEINASE-9; EXPRESSION; AUTOPHAGY; GROWTH	This study was designed to investigate the role of the phosphatidyl inositol 3-kinase (PI3K)/AKT/p70(S6K) signaling path on regulation of primary normal human bronchial epithelial cell-derived matrix metalloproteinase (MMP)-1, -3, and -9 expression in tuberculosis (TB). These MMPs are key in pathological extracellular matrix degradation in TB. Normal human bronchial epithelials were stimulated with conditioned medium from monocytes infected with virulent TB (CoMTb) and components of the PI3K/AKT signaling pathway blocked using specific chemical inhibitors and siRNA. MMP gene expression was measured by RT-PCR and secretion by ELISA, luminex, or zymography. Phospho-p70 S6K was detected by Western blot analysis and activity blocked by rapamycin. Chemical blockade of the proximal catalytic PI3K p110 subunit augmented MMP-1 and MMP-9 in a dose-dependent manner (all P<0.001) but suppressed MMP-3 (P<0.01). Targeted siRNA studies identified the p110 isoform as key causing 5-fold increase in TB network-dependent MMP-1 secretion to 4900 +/- 1100 pg/ml. Specific inhibition of the AKT node suppressed all 3 MMPs. Phospho-p70(S6K) was identified in the cellular model, and rapamycin, a p70(S6K) inhibitor, inhibited MMP-1 (P<0.001) and MMP-3 (P<0.01) but not MMP-9. Controls were epithelial cells that were unstimulated or exposed to conditioned medium from monocytes not exposed to TB. In summary, blockade of the proximal PI3K catalytic subunit increases MMP-1 and MMP-9, whereas rapamycin decreased both MMP-1 and MMP-3. The regulation of the PI3K path in TB is complex, MMP specific, and a potential immunotherapeutic target in diseases characterized by tissue destruction.Singh, S., Saraiva, L., Elkington, P. T. G., Friedland, J. S. Regulation of matrix metalloproteinase-1, -3, and -9 in Mycobacterium tuberculosis-dependent respiratory networks by the rapamycin-sensitive PI 3-kinase/p70(S6K) cascade.	[Singh, Shivani; Saraiva, Luisa; Elkington, Paul T. G.; Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London W12 0NN, England	Imperial College London	Friedland, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, 8th Floor Commonwealth Bldg, Hammersmith Campus, London W12 0NN, England.	j.friedland@imperial.ac.uk	Singh, Shivani/M-4164-2019	Elkington, Paul/0000-0003-0390-0613; Friedland, Jonathan S/0000-0001-7789-9649	Medical Research Council (UK); UK National Institute for Health Research Biomedical Research Centres funding scheme at Imperial College London; National Institute for Health Research [DHCS/06/05/012] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research Centres funding scheme at Imperial College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Medical Research Council (UK) Clinical Research Training Fellowship to S. S. The authors thank Abteen Mostofi (Cambridge University Hospitals, Cambridge, UK) for help with the signaling diagram and Dr. Daniel Lowther for help with the RT-PCR experiments. J.S.F. and P. E. are grateful for support from the UK National Institute for Health Research Biomedical Research Centres funding scheme at Imperial College London.	Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cho JE, 2010, MOL CELLS, V29, P35, DOI 10.1007/s10059-010-0003-5; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Huang GC, 2012, J BIOL CHEM, V287, P23196, DOI 10.1074/jbc.M112.351940; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jung SB, 2005, J CLIN IMMUNOL, V25, P482, DOI 10.1007/s10875-005-5431-1; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lu YB, 2005, J LEUKOCYTE BIOL, V78, P259, DOI 10.1189/jlb.0904498; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Nuttall RK, 2003, MOL CANCER RES, V1, P333; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okane CM, 2008, EUR J IMMUNOL, V38, P1321, DOI 10.1002/eji.200737855; Osman B, 2011, BIOCHEM PHARMACOL, V81, P134, DOI 10.1016/j.bcp.2010.09.011; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pende Mario, 2006, Bull Cancer, V93, pE39; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Rand L, 2009, J IMMUNOL, V182, P5865, DOI 10.4049/jimmunol.0801935; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauty A, 1999, J IMMUNOL, V162, P3549; Sharma M, 2007, IMMUNOL CELL BIOL, V85, P229, DOI 10.1038/sj.icb.7100037; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Thomas M, 2008, CURR OPIN PHARMACOL, V8, P267, DOI 10.1016/j.coph.2008.02.004; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wang X, 2010, INT J IMMUNOGENET, V37, P97, DOI 10.1111/j.1744-313X.2010.00897.x; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404	47	19	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					85	93		10.1096/fj.13-235507	http://dx.doi.org/10.1096/fj.13-235507			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24076964				2022-12-25	WOS:000333526100011
J	Zhang, Y; Wolfle, T; Rospert, S				Zhang, Ying; Woelfle, Tina; Rospert, Sabine			Interaction of Nascent Chains with the Ribosomal Tunnel Proteins Rpl4, Rpl17, and Rpl39 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Folding; Protein Synthesis; Ribosomes; Translation; Yeast; Newly Synthesized Polypeptides; Site-specific Cross-linking	EXIT TUNNEL; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; TRANSMEMBRANE SEGMENTS; ENDOPLASMIC-RETICULUM; SIDE-CHAINS; YEAST; POLYPEPTIDE; PEPTIDE	As translation proceeds, nascent polypeptides pass through an exit tunnel that traverses the large ribosomal subunit. Three ribosomal proteins, termed Rpl4, Rpl17, and Rpl39 expose domains to the interior of the exit tunnel of eukaryotic ribosomes. Here we generated ribosome-bound nascent chains in a homologous yeast translation system to analyze contacts between the tunnel proteins and nascent chains. As model proteins we employed Dap2, which contains a hydrophobic signal anchor (SA) segment, and the chimera Dap2, in which the SA was replaced with a hydrophilic segment, with the propensity to form an -helix. Employing a newly developed FLAG exposure assay, we find that the nascent SA segment but not the hydrophilic segment adopted a stable, -helical structure within the tunnel when the most C-terminal SA residue was separated by 14 residues from the peptidyl transferase center. Using UV cross-linking, antibodies specifically recognizing Rpl17 or Rpl39, and a His(6)-tagged version of Rpl4, we established that all three tunnel proteins of yeast contact the SA, whereas only Rpl4 and Rpl39 also contact the hydrophilic segment. Consistent with the localization of the tunnel exposed domains of Rpl17 and Rpl39, the SA was in contact with Rpl17 in the middle region and with Rpl39 in the exit region of the tunnel. In contrast, Rpl4 was in contact with nascent chain residues throughout the ribosomal tunnel.	[Zhang, Ying; Woelfle, Tina; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, Ctr Biochem & Mol Cell Res, ZBMZ, D-79104 Freiburg, Germany; [Zhang, Ying; Rospert, Sabine] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Rospert, S (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Ctr Biochem & Mol Cell Res, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	sabine.rospert@biochemie.uni-freiburg.de	Abou Hachem, Maher/M-4772-2019	Abou Hachem, Maher/0000-0001-8250-1842; Lee, Sang-Kyu/0000-0002-3367-5229; Rospert, Sabine/0000-0002-3089-9614	SFB [746]; Forschergruppe [967]; Excellence Initiative of the German federal and state governments [EXC 294]	SFB(Austrian Science Fund (FWF)); Forschergruppe; Excellence Initiative of the German federal and state governments	This work was supported by SFB 746, Forschergruppe 967, and by the Excellence Initiative of the German federal and state governments (EXC 294) ( to S. R).	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Lu JL, 2011, J MOL BIOL, V411, P499, DOI 10.1016/j.jmb.2011.05.038; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Roosild TP, 2006, ACTA CRYSTALLOGR F, V62, P835, DOI 10.1107/S1744309106029125; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112	40	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33697	33707		10.1074/jbc.M113.508283	http://dx.doi.org/10.1074/jbc.M113.508283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24072706	Green Published, hybrid			2022-12-25	WOS:000327250200017
J	Kvist, T; Steffensen, TB; Greenwood, JR; Tabrizi, F; Hansen, KB; Gajhede, M; Pickering, DS; Traynelis, SF; Kastrup, JS; Brauner-Osborne, H				Kvist, Trine; Steffensen, Thomas Bielefeldt; Greenwood, Jeremy R.; Mehrzad Tabrizi, Fatemeh; Hansen, Kasper B.; Gajhede, Michael; Pickering, Darryl S.; Traynelis, Stephen F.; Kastrup, Jette Sandholm; Braeuner-Osborne, Hans			Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-D-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ion Channels; Ligand-binding Protein; Molecular Pharmacology; Neurotransmitter Receptors; NMDA Receptor; Schild Analysis; Bioisoster; Competitive Antagonist; Glycine Site	GLUTAMATE; ACTIVATION; DOMAIN; CRYSTALLOGRAPHY; INHIBITION; COMPLEX; ROLES; MODEL; TOOL	Background: The glycine-binding GluN1 and GluN3 subunits of NMDA receptors have distinctive selectivity profiles. Results: TK40 binds to the GluN1 orthosteric binding site and competitively reduces the potency of glycine. Conclusion: TK40 is a novel glycine site antagonist with selectivity for the GluN1 subunit compared with GluN3. Significance: The imino acetamido moiety acts as an -amino acid bioisostere, as predicted by virtual screening. NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain. They are tetrameric complexes composed of glycine-binding GluN1 and GluN3 subunits together with glutamate-binding GluN2 subunits. Subunit-selective antagonists that discriminate between the glycine sites of GluN1 and GluN3 subunits would be valuable pharmacological tools for studies on the function and physiological roles of NMDA receptor subtypes. In a virtual screening for antagonists that exploit differences in the orthosteric binding site of GluN1 and GluN3 subunits, we identified a novel glycine site antagonist, 1-thioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (TK40). Here, we show by Schild analysis that TK40 is a potent competitive antagonist with K-b values of 21-63 nm at the GluN1 glycine-binding site of the four recombinant GluN1/N2A-D receptors. In addition, TK40 displayed >100-fold selectivity for GluN1/N2 NMDA receptors over GluN3A- and GluN3B-containing NMDA receptors and no appreciable effects at AMPA receptors. Binding experiments on rat brain membranes and the purified GluN1 ligand-binding domain using glycine site GluN1 radioligands further confirmed the competitive interaction and high potency. To delineate the binding mechanism, we have solved the crystal structure of the GluN1 ligand-binding domain in complex with TK40 and show that TK40 binds to the orthosteric binding site of the GluN1 subunit with a binding mode that was also predicted by virtual screening. Furthermore, the structure reveals that the imino acetamido group of TK40 acts as an -amino acid bioisostere, which could be of importance in bioisosteric replacement strategies for future ligand design.	[Kvist, Trine; Steffensen, Thomas Bielefeldt; Mehrzad Tabrizi, Fatemeh; Gajhede, Michael; Pickering, Darryl S.; Kastrup, Jette Sandholm; Braeuner-Osborne, Hans] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Greenwood, Jeremy R.] Schrodinger Inc, New York, NY 10036 USA; [Hansen, Kasper B.; Traynelis, Stephen F.] Emory Univ, Dept Pharmacol, Rollins Res Ctr, Sch Med, Atlanta, GA 30322 USA	University of Copenhagen; Emory University	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Fruebjergvej 3, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Bräuner-Osborne, Hans/D-7260-2011; Hansen, Kasper B/C-4062-2008	Bräuner-Osborne, Hans/0000-0001-9495-7388; Hansen, Kasper B/0000-0002-3303-4819; Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510	Lundbeck Foundation; GluTarget Programme of Excellence at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; Augustinus Foundation DanScatt; Danish Council for Independent Research-Medical Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065371] Funding Source: NIH RePORTER; Lundbeck Foundation [R34-2009-3779] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); GluTarget Programme of Excellence at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; Augustinus Foundation DanScatt; Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation; the GluTarget Programme of Excellence at the University of Copenhagen; the Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; the Augustinus Foundation DanScatt; and the Danish Council for Independent Research-Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Awobuluyi M, 2007, MOL PHARMACOL, V71, P112, DOI 10.1124/mol.106.03070; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Danysz W, 1998, PHARMACOL REV, V50, P597; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gellert L, 2011, EUR J PHARMACOL, V667, P182, DOI 10.1016/j.ejphar.2011.05.069; GRIMWOOD S, 1992, MOL PHARMACOL, V41, P923; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hess SD, 1998, J NEUROCHEM, V70, P1269; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang YH, 2011, J NEUROSCI, V31, P18453, DOI 10.1523/JNEUROSCI.3824-11.2011; Jansen M, 2003, EUR J MED CHEM, V38, P661, DOI 10.1016/S0223-5234(03)00113-2; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kvist T, 2013, NEUROPHARMACOLOGY, V75, P324, DOI 10.1016/j.neuropharm.2013.08.003; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laube B, 1998, J NEUROSCI, V18, P2954; LEESON PD, 1992, J MED CHEM, V35, P1954, DOI 10.1021/jm00089a004; LEESON PD, 1991, J MED CHEM, V34, P1243, DOI 10.1021/jm00108a002; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Madry C, 2007, BIOCHEM BIOPH RES CO, V354, P102, DOI 10.1016/j.bbrc.2006.12.153; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nielsen BS, 1998, EUR J PHARMACOL, V360, P227, DOI 10.1016/S0014-2999(98)00668-2; Nilsson A, 2007, NEUROPHARMACOLOGY, V52, P1151, DOI 10.1016/j.neuropharm.2006.12.002; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yao YN, 2006, J NEUROSCI, V26, P4559, DOI 10.1523/JNEUROSCI.0560-06.2006; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140	45	19	21	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33124	33135		10.1074/jbc.M113.480210	http://dx.doi.org/10.1074/jbc.M113.480210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072709	hybrid, Green Published			2022-12-25	WOS:000328841700028
J	Larsen, KK; Christensen, B; Sondergaard, J; Vestergaard, M				Larsen, Karen Kjaer; Christensen, Bo; Sondergaard, Jens; Vestergaard, Mogens			Depressive Symptoms and Risk of New Cardiovascular Events or Death in Patients with Myocardial Infarction: A Population-Based Longitudinal Study Examining Health Behaviors and Health Care Interventions	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; PROGNOSTIC ASSOCIATION; COLLABORATIVE CARE; HOSPITAL ANXIETY; MORTALITY; MORBIDITY; RECOMMENDATIONS; REHABILITATION; EPIDEMIOLOGY; METAANALYSIS	Background: Depressive symptoms is associated with adverse cardiovascular outcomes in patients with myocardial infarction (MI), but the underlying mechanisms are unclear and it remains unknown whether subgroups of patients are at a particularly high relative risk of adverse outcomes. We examined the risk of new cardiovascular events and/or death in patients with depressive symptoms following first-time MI taking into account other secondary preventive factors. We further explored whether we could identify subgroups of patients with a particularly high relative risk of adverse outcomes. Methods and Results: We conducted a prospective population-based cohort study of 897 patients discharged with first-time MI between 1 January 2009 and 31 December 2009, and followed up until 31 July 2012. Depressive symptoms were found in 18.6% using the Hospital Anxiety and Depression Scale (HADS-D >= 8). A total of 239 new cardiovascular events, 95 deaths, and 288 composite events (239 new cardiovascular events and 49 deaths) occurred during 1,975 person-years of follow-up. Event-free survival was evaluated using Cox regression analysis. Compared to the 730 patients without depressive symptoms (HADS-D<8), the 167 patients with depressive symptoms (HADS-D >= 8) had age-and sex-adjusted hazard ratios [HR] (95% confidence interval [CI]) of 1.53 (95% CI, 1.14-2.05) for a new cardiovascular event, 3.10 (95% CI, 2.04-4.71) for death and 1.77 (95% CI, 1.36-2.31) for a composite event. The associations were attenuated when adjusted for disease severity, comorbid conditions and physical inactivity; HR = 1.17 (95% CI, 0.85-1.61) for a new cardiovascular event, HR = 2.01 (95% CI, 1.28-3.16) for death, and HR = 1.33 (95% CI, 1.00-1.76) for a composite event. No subgroups of patients had a particularly high risk of adverse outcomes. Conclusions: Depressive symptoms following first-time MI was an independent prognostic risk factor for death, but not for new cardiovascular events. We found no subgroups of patients with a particularly high relative risk of adverse outcomes.	[Larsen, Karen Kjaer; Christensen, Bo; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Sondergaard, Jens] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark	Aarhus University; Aarhus University; University of Southern Denmark	Larsen, KK (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark.	kkl@alm.au.dk	Vestergaard, Mogens/M-9333-2014; Søndergaard, Jens js/F-3031-2013	Vestergaard, Mogens/0000-0001-8830-2174; Søndergaard, Jens js/0000-0002-1629-1864	Tryg Foundation [7844-07]; Danish Health Insurance Faoundation [2010B013]; Lundbeck Foundation; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish	Tryg Foundation; Danish Health Insurance Faoundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Tryg Foundation (grant number 7844-07), the Danish Health Insurance Faoundation (grant number 2010B013), and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baumeister H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008012.pub3; Blumenthal JA, 2012, J AM COLL CARDIOL, V60, P1053, DOI 10.1016/j.jacc.2012.04.040; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Danish Society of Cardiology, NAT GUID CARD CARD R; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; FRASURESMITH N, 1995, HEALTH PSYCHOL, V14, P388, DOI 10.1037/0278-6133.14.5.388; Giannuzzi P, 2003, EUR HEART J, V24, P1273, DOI 10.1016/S0195-668X(03)00198-2; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Glassman AH, 2006, ARCH GEN PSYCHIAT, V63, P283, DOI 10.1001/archpsyc.63.3.283; Green LA, 2009, ANN FAM MED, V7, P71, DOI 10.1370/afm.918; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; LADWIG KH, 1991, EUR HEART J, V12, P959; Larsen KK, 2011, SCAND J PRIM HEALTH, V29, P210, DOI 10.3109/02813432.2011.629147; Larsen KK, 2010, CIRCULATION, V122, P2388, DOI 10.1161/CIRCULATIONAHA.110.956136; Larsen KK, 2012, EUR J PREV CARDIOL; Lauzon C, 2003, CAN MED ASSOC J, V168, P547; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; National Collaborating Centre for Mental Health, 2010, DEPR AD CHRON PHYS H; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Rumsfeld JS, 2005, AM HEART J, V150, P961, DOI 10.1016/j.ahj.2005.02.036; Shiotani I, 2002, J CARDIOVASC RISK, V9, P153, DOI 10.1097/00043798-200206000-00004; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Sorensen C, 2006, ACTA PSYCHIAT SCAND, V113, P290, DOI 10.1111/j.1600-0447.2006.00777.x; Spijkerman T, 2005, GEN HOSP PSYCHIAT, V27, P411, DOI 10.1016/j.genhosppsych.2005.05.007; Statistics Denmark, 1991, IDA INT DAT LAB MARK; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tylee A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-58; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; VESTBO J, 1988, AM REV RESPIR DIS, V137, P1114, DOI 10.1164/ajrccm/137.5.1114; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuidersma M, 2013, INT J CARDIOL, V167, P2775, DOI 10.1016/j.ijcard.2012.07.002	50	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74393	10.1371/journal.pone.0074393	http://dx.doi.org/10.1371/journal.pone.0074393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086339	Green Published, gold			2022-12-25	WOS:000325218700024
J	Sommer, K; Sander, AL; Albig, M; Weber, R; Henrich, D; Frank, J; Marzi, I; Jakob, H				Sommer, Katharina; Sander, Anna Lena; Albig, Michael; Weber, Roxane; Henrich, Dirk; Frank, Johannes; Marzi, Ingo; Jakob, Heike			Delayed Wound Repair in Sepsis Is Associated with Reduced Local Pro-Inflammatory Cytokine Expression	PLOS ONE			English	Article								Sepsis is one of the main causes for morbidity and mortality in hospitalized patients. Moreover, sepsis associated complications involving impaired wound healing are common. Septic patients often require surgical interventions that in-turn may lead to further complications caused by impaired wound healing. We established a mouse model to the study delayed wound healing during sepsis distant to the septic focus point. For this reason cecal ligation and puncture (CLP) was combined with the creation of a superficial wound on the mouse ear. Control animals received the same procedure without CPL. Epithelialization was measured every second day by direct microscopic visualization up to complete closure of the wound. As interplay of TNF-alpha, TGF-beta, matrix metalloproteinases (MMP), and tissue inhibitors of metalloproteinases (TIMP) is important in wound healing in general, TNF-alpha, TGF-beta, MMP7, and TIMP1 were assessed immunohistochemical in samples of wounded ears harvested on days 2, 6, 10 and 16 after wounding. After induction of sepsis, animals showed a significant delay in wound epithelialization from day 2 to 12 compared to control animals. Complete wound healing was attained after mean 12.2 +/- standard deviation (SD) 3.0 days in septic animals compared to 8.7 +/- SD 1.7 days in the control group. Septic animals showed a significant reduction in local pro-inflammatory cytokine level of TNF-alpha on day 2 and day 6 as well as a reduced expression of TGF-beta on day 2 in wounds. A significant lower expression of MMP7 as well as TIMP1 was also observed on day 2 after wounding. The induction of sepsis impairs wound healing distant to the septic focus point. We could demonstrate that expression of important cytokines for wound repair is deregulated after induction of sepsis. Thus restoring normal cytokine response locally in wounds could be a good strategy to enhance wound repair in sepsis.	[Sommer, Katharina; Sander, Anna Lena; Albig, Michael; Weber, Roxane; Henrich, Dirk; Frank, Johannes; Marzi, Ingo; Jakob, Heike] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sommer, K (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	katharina.sommer@kgu.de			"Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany	"Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany	This work was partly supported by the "Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker John H., 1994, Wound Repair and Regeneration, V2, P138, DOI 10.1046/j.1524-475X.1994.20208.x; BARRIERE SL, 1995, CRIT CARE MED, V23, P376, DOI 10.1097/00003246-199502000-00026; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Frank J, 2003, EUR J TRAUMA, V29, P208; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GREENHALGH DG, 1987, SURGERY, V102, P306; Kanno E, 2011, WOUND REPAIR REGEN, V19, P608, DOI 10.1111/j.1524-475X.2011.00721.x; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Maish G, 1998, J SURG RES, V78, P108, DOI 10.1006/jsre.1998.5315; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; STEENFOS HH, 1994, SCAND J PLAST RECONS, V28, P95, DOI 10.3109/02844319409071186; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Weinstein DA, 2010, J AM ACAD DERMATOL, V63, P146, DOI 10.1016/j.jaad.2009.08.004; Wolfe RR, 1999, EUR J CLIN NUTR, V53, pS136, DOI 10.1038/sj.ejcn.1600754	25	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73992	10.1371/journal.pone.0073992	http://dx.doi.org/10.1371/journal.pone.0073992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086305	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700015
J	Godino, A; Pitra, S; Carrer, HF; Vivas, L				Godino, Andrea; Pitra, Soledad; Carrer, Hugo F.; Vivas, Laura			Body Sodium Overload Modulates the Firing Rate and Fos Immunoreactivity of Serotonergic Cells of Dorsal Raphe Nucleus	PLOS ONE			English	Article							PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; LATERAL PARABRACHIAL NUCLEUS; C-FOS; HYPERTONIC SALINE; SUBFORNICAL ORGAN; VOLUME EXPANSION; WATER-INTAKE; NEURONS; IDENTIFICATION; VASOPRESSIN	In order to determine whether serotonergic (5HT) dorsal raphe nucleus (DRN) cells are involved in body sodium status regulation, the effect of a s.c. infusion of either 2 M or 0.15 M NaCl on 5HT DRN neuron firing was studied using single unit extracellular recordings. In separate groups of 2 M and 0.15 M NaCl-infused rats, water intake, oxytocin (OT) plasma concentration, urine and plasma sodium and protein concentrations were also measured. Also, to determine the involvement of particular brain nuclei and neurochemical systems in body sodium overload (SO), animals from both groups were perfused for brain immunohistochemical detection of Fos, Fos-OT and Fos-5HT expression. SO produced a significant increase in serotonergic DRN neuron firing rate compared to baseline and 0.15 M NaCl-infused rats. As expected, 2 M NaCl s.c. infusion also induced a significant increase of water intake, diuresis and natriuresis, plasma sodium concentration and osmolality, even though plasma volume did not increase as indicated by changes in plasma protein concentration. The distribution of neurons along the forebrain and brainstem expressing Fos after SO showed the participation of the lamina terminalis, extended amygdala, supraoptic and paraventricular hypothalamic nuclei in the neural network that controls osmoregulatory responses. Both Fos-OT immunoreactive and plasma OT concentration increased after s.c. hypertonic sodium infusion. Finally, matching the "in vivo'' electrophysiological study, SO doubled the number of Fos-5HT immunolabeled cells within the DRN. In summary, the results characterize the behavioral, renal and endocrine responses after body sodium overload without volume expansion and specify the cerebral nuclei that participate at different CNS levels in the control of these responses. The electrophysiological approach also allows us to determine in an "in vivo" model that DRN 5HT neurons increase their firing frequency during an increase in systemic sodium concentration and osmolality, possibly to modulate sodium and water intake/excretion and avoid extracellular volume expansion.	[Godino, Andrea; Pitra, Soledad; Carrer, Hugo F.; Vivas, Laura] Univ Nacl Cordoba, CONICET, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Godino, A (corresponding author), Univ Nacl Cordoba, CONICET, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina.	agodino@immf.uncor.edu			SECyT [05/1649]; CONICET [PIP 2561]; ANPCyT [PICT-2010-2072, 000113/2011, 140/12]; MYNCyT Cordoba grant [000113/2011]; Fundacion Roemmers; ISN (International Society for Neurochemistry)	SECyT(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); MYNCyT Cordoba grant; Fundacion Roemmers; ISN (International Society for Neurochemistry)	This work was supported in part by grants from: SECyT grant 2010-2011. N: 05/1649; CONICET grant 2010-2012. PIP 2561; ANPCyT grant 2011-2014. Bicentenario, PICT-2010-2072 (Resolution No 098/11); MYNCyT Cordoba grant 2011-2013. PID (Resolution 000113/2011); Fundacion Roemmers grant to novel investigators. 2011-2013; ANPCyT grant 2012-2014 for young investigators. PICT 2011-2014 (Resolution 140/12); and ISN (International Society for Neurochemistry) Research supplies for use in the applicant's home laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, BRAIN RES, V153, P169, DOI 10.1016/0006-8993(78)91140-X; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Badaue-Passos D, 2007, EXP NEUROL, V206, P86, DOI 10.1016/j.expneurol.2007.04.008; BARABAN JM, 1980, EUR J PHARMACOL, V66, P287, DOI 10.1016/0014-2999(80)90461-6; Bisset GW, 1996, BRIT J PHARMACOL, V117, P309, DOI 10.1111/j.1476-5381.1996.tb15192.x; Cheema-Dhadli S, 2002, J PHYSIOL-LONDON, V541, P929, DOI 10.1113/jphysiol.2002.019430; Colombari DSA, 1996, AM J PHYSIOL-REG I, V271, pR1470, DOI 10.1152/ajpregu.1996.271.6.R1470; Davern PJ, 2010, BRAIN RES, V1339, P41, DOI 10.1016/j.brainres.2010.04.022; Duan PG, 2008, BRAIN RES, V1198, P68, DOI 10.1016/j.brainres.2008.01.035; Franchini LF, 1999, AM J PHYSIOL-REG I, V276, pR1180, DOI 10.1152/ajpregu.1999.276.4.R1180; Franchini LF, 2002, AM J PHYSIOL-REG I, V282, pR235, DOI 10.1152/ajpregu.00766.2000; Godino A, 2005, NEUROSCIENCE, V133, P493, DOI 10.1016/j.neuroscience.2005.02.035; Godino A, 2007, AM J PHYSIOL-REG I, V293, pR1027, DOI 10.1152/ajpregu.00078.2007; Godino A, 2010, EXP NEUROL, V221, P275, DOI 10.1016/j.expneurol.2009.11.001; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; Ho JM, 2007, AM J PHYSIOL-REG I, V292, pR1690, DOI 10.1152/ajpregu.00547.2006; HOCHSTENBACH SL, 1995, BRAIN RES, V674, P46, DOI 10.1016/0006-8993(94)01434-J; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Johnson AK, 1999, ANN NY ACAD SCI, V877, P258, DOI 10.1111/j.1749-6632.1999.tb09272.x; Kawano H, 2010, NEUROSCIENCE, V169, P1227, DOI 10.1016/j.neuroscience.2010.05.065; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; KOVACS KJ, 1993, P NATL ACAD SCI USA, V90, P7681, DOI 10.1073/pnas.90.16.7681; LARSEN PJ, 1995, J NEUROSCI, V15, P2609; Li CS, 2006, AM J PHYSIOL-REG I, V291, pR914, DOI 10.1152/ajpregu.00750.2005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundy RF, 2001, J NEUROPHYSIOL, V85, P770, DOI 10.1152/jn.2001.85.2.770; Margatho LO, 2008, J NEUROSCI RES, V86, P3613, DOI 10.1002/jnr.21806; Margatho LO, 2002, BRAIN RES, V956, P103, DOI 10.1016/S0006-8993(02)03486-8; Margatho LO, 2007, AM J PHYSIOL-REG I, V293, P1190; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; MCKINLEY MJ, 1994, BRAIN RES, V653, P305, DOI 10.1016/0006-8993(94)90405-7; Menani JV, 1998, AM J PHYSIOL-REG I, V274, pR555; Menani JV, 2004, BRAIN RES, V1030, P74, DOI 10.1016/j.brainres.2004.09.048; Menani JV, 1996, AM J PHYSIOL-REG I, V270, pR162, DOI 10.1152/ajpregu.1996.270.1.R162; Menani JV, 2000, AM J PHYSIOL-REG I, V279, pR126, DOI 10.1152/ajpregu.2000.279.1.R126; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORRIS M, 1989, HYPERTENSION, V13, P110, DOI 10.1161/01.HYP.13.2.110; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; OLDFIELD BJ, 1994, NEUROSCIENCE, V60, P255, DOI 10.1016/0306-4522(94)90219-4; Olivares EL, 2003, BRAZ J MED BIOL RES, V36, P1709, DOI 10.1590/S0100-879X2003001200013; OLSON BR, 1993, MOL CELL NEUROSCI, V4, P93, DOI 10.1006/mcne.1993.1011; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; RICHARD D, 1992, NEUROENDOCRINOLOGY, V55, P609, DOI 10.1159/000126174; Rinaman L, 1997, NEUROSCIENCE, V79, P1165, DOI 10.1016/S0306-4522(97)00022-5; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Stricker EM, 2002, AM J PHYSIOL-REG I, V282, pR1710, DOI 10.1152/ajpregu.00548.2001; STRICKER EM, 1986, AM J PHYSIOL, V250, pR267, DOI 10.1152/ajpregu.1986.250.2.R267; Tanaka J, 2004, NEUROSCI LETT, V357, P41, DOI 10.1016/j.neulet.2003.12.040; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; Verbalis J. G., 1995, CURR OPIN ENDOCRINOL, V2, P157; Vivas L., 2013, NEUROBIOLOGY BODY FL; Watanabe E, 2000, J NEUROSCI, V20, P7743	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74689	10.1371/journal.pone.0074689	http://dx.doi.org/10.1371/journal.pone.0074689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073217	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000026
J	Yeom, JH; Ryou, SM; Won, M; Park, M; Bae, J; Lee, K				Yeom, Ji-Hyun; Ryou, Sang-Mi; Won, Miae; Park, Mira; Bae, Jeehyeon; Lee, Kangseok			Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNA	PLOS ONE			English	Article							GENE DELIVERY; PROTEIN EXPRESSION; IN-VITRO; CELLS; TRANSFECTION; PROSPECTS; VECTORS; LIPIDS	Use of non-biological agents for mRNA delivery into living systems in order to induce heterologous expression of functional proteins may provide more advantages than the use of DNA and/or biological vectors for delivery. However, the low efficiency of mRNA delivery into live animals, using non-biological systems, has hampered the use of mRNA as a therapeutic molecule. Here, we show that gold nanoparticle-DNA oligonucleotide (AuNP-DNA) conjugates can serve as universal vehicles for more efficient delivery of mRNA into human cells, as well as into xenograft tumors generated in mice. Injections of BAX mRNA loaded on AuNP-DNA conjugates into xenograft tumors resulted in highly efficient mRNA delivery. The delivered mRNA directed the efficient production of biologically functional BAX protein, a pro-apoptotic factor, consequently inhibiting tumor growth. These results demonstrate that mRNA delivery by AuNP-DNA conjugates can serve as a new platform for the development of safe and efficient gene therapy.	[Yeom, Ji-Hyun; Ryou, Sang-Mi; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Won, Miae; Park, Mira] CHA Univ, Dept Pharm, Songnam, South Korea; [Bae, Jeehyeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University; Pochon Cha University; Chung Ang University	Bae, J (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr; kangseok@cau.ac.kr	Won, Miae/AAL-9049-2020		National Research Foundation of Korea [2011-0021810, 2011-0013856]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This research was supported by grants from the National Research Foundation of Korea (2011-0021810 and 2011-0013856) and the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009025), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882; Bragonzi A, 1999, GENE THER, V6, P1995, DOI 10.1038/sj.gt.3301039; Filion MC, 1998, INT J PHARM, V162, P159, DOI 10.1016/S0378-5173(97)00423-7; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Fisher KJ, 1997, BIOCHEM J, V321, P49, DOI 10.1042/bj3210049; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Hofland HEJ, 1997, PHARMACEUT RES, V14, P742, DOI 10.1023/A:1012146305040; Kariko K, 2001, J NEUROSCI METH, V105, P77, DOI 10.1016/S0165-0270(00)00355-1; Kim JH, 2011, J BIOTECHNOL, V155, P287, DOI 10.1016/j.jbiotec.2011.07.014; Kim JH, 2010, CHEM COMMUN, V46, P4151, DOI 10.1039/c0cc00103a; Kim JM, 2013, BIOTECHNOL BIOPROC E, V18, P637, DOI 10.1007/s12257-012-0546-8; Kim YJ, 2012, J MATER CHEM, V22, P25036, DOI 10.1039/c2jm34047j; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kreiter S, 2011, CURR OPIN IMMUNOL, V23, P399, DOI 10.1016/j.coi.2011.03.007; Kuhn AN, 2012, CURR GENE THER, V12, P347; LU D, 1994, CANCER GENE THER, V1, P245; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Park S, 2010, ACS NANO, V4, P2555, DOI 10.1021/nn100362m; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Ryou SM, 2011, BIOCHEM BIOPH RES CO, V416, P178, DOI 10.1016/j.bbrc.2011.11.020; Ryou SM, 2010, BIOCHEM BIOPH RES CO, V398, P542, DOI 10.1016/j.bbrc.2010.06.115; Schott JW, 2011, CURR GENE THER, V11, P382; Strobel I, 2000, GENE THER, V7, P2028, DOI 10.1038/sj.gt.3301326; Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; de Ilarduya CT, 2003, METHOD ENZYMOL, V373, P342; Yamamoto A, 2009, EUR J PHARM BIOPHARM, V71, P484, DOI 10.1016/j.ejpb.2008.09.016; Zhang X, 2012, J AM CHEM SOC, V134, P7266, DOI 10.1021/ja3014055; Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050	31	25	28	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75369	10.1371/journal.pone.0075369	http://dx.doi.org/10.1371/journal.pone.0075369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073264	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000073
J	Hraiech, S; Alingrin, J; Dizier, S; Brunet, J; Forel, JM; La Scola, B; Roch, A; Papazian, L; Pauly, V				Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Brunet, Julie; Forel, Jean-Marie; La Scola, Bernard; Roch, Antoine; Papazian, Laurent; Pauly, Vanessa			Time to Intubation Is Associated with Outcome in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INFECTIOUS-DISEASES-SOCIETY; NONINVASIVE VENTILATION; ACUTE PHYSIOLOGY; ADMISSION; SEVERITY; EPIDEMIOLOGY; VALIDATION; GUIDELINES; PROGNOSIS	Introduction: It has been suggested that delayed intensive care unit (ICU) transfer is associated with increased mortality for patients with community-acquired pneumonia (CAP). However, ICU admission policies and patient epidemiology vary widely across the world depending on local hospital practices and organizational constraints. We hypothesized that the time from the onset of CAP symptoms to invasive mechanical ventilation could be a relevant prognostic factor. Methods: One hundred patients with a CAP and necessitating invasive mechanical ventilation were included. Prospectively collected data were retrospectively analysed. Two study groups were identified based on the time of the initiation of invasive mechanical ventilation (rapid respiratory failure requiring mechanical ventilation within 72 h of the onset of CAP and progressive respiratory failure requiring invasive mechanical ventilation 4 or more days after the onset of CAP). Results: Excepting more COPD patients in the rapid respiratory failure group and more patients with diabetes in the progressive respiratory failure group, these patients had similar characteristics. The overall in-hospital mortality rate was 28% in the rapid respiratory failure group and 51% in the progressive respiratory failure group (P = 0.03). The ICU and the day 30 mortality rates were higher in the progressive respiratory failure group (47% vs. 23%, P = 0.02; and 37.7% vs. 21.3%, P = 0.03; respectively). After adjusting for the propensity score and other potential confounding factors, progressive respiratory failure remained associated with hospital mortality only after 12 days of invasive mechanical ventilation. Conclusions: This study suggested that the duration or delay in the time to intubation from the onset of CAP symptoms was associated with the outcomes in those patients who ultimately required invasive mechanical ventilation.	[Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Forel, Jean-Marie; Roch, Antoine; Papazian, Laurent] Aix Marseille Univ, URMITE CNRS UMR 7278, Marseille, France; [Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Forel, Jean-Marie; Roch, Antoine; Papazian, Laurent] Hop Nord Marseille, APHM, Marseille, France; [Brunet, Julie] Direct Rech Clin, Marseille, France; [La Scola, Bernard] Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,UMR CNRS 7278,Inst Rech Dev 198, Marseille, France; [Pauly, Vanessa] Aix Marseille Univ, Lab Sante Publ EA3279, Marseille, France; [Pauly, Vanessa] Hop Sud, APHM, Serv Sante Publ & Informat Med, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Aix Marseille Univ, URMITE CNRS UMR 7278, Marseille, France.	laurent.papazian@ap-hm.fr	LA SCOLA, Bernard/P-6477-2016	LA SCOLA, Bernard/0000-0001-8006-7704				Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; [Anonymous], 2000, MED MALADIES INFECT, V30, P566; Berger P, 2006, EMERG INFECT DIS, V12, P248; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Coisel Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051340; Demoule A, 2006, INTENS CARE MED, V32, P1756, DOI 10.1007/s00134-006-0324-1; Yandiola PPE, 2009, CHEST, V135, P1572, DOI 10.1378/chest.08-2179; Ewig S, 1999, Monaldi Arch Chest Dis, V54, P250; Ewig S, 2004, THORAX, V59, P421, DOI 10.1136/thx.2003.008110; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Georges H, 1999, INTENS CARE MED, V25, P198, DOI 10.1007/s001340050816; JACKSON GG, 1962, ARCH INTERN MED, V110, P663, DOI 10.1001/archinte.1962.03620230109016; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Labelle AJ, 2010, CHEST, V137, P1130, DOI 10.1378/chest.09-1652; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEROY O, 1995, INTENS CARE MED, V21, P24, DOI 10.1007/BF02425150; Leroy O, 1996, INTENS CARE MED, V22, P1307, DOI 10.1007/BF01709543; Liapikou A, 2009, CLIN INFECT DIS, V48, P377, DOI 10.1086/596307; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2007, MEDICINE, V86, P103, DOI 10.1097/MD.0b013e3180421c16; MOINE P, 1994, CHEST, V105, P1487, DOI 10.1378/chest.105.5.1487; Niederman MS, 2012, SEMIN RESP CRIT CARE, V33, P298, DOI 10.1055/s-0032-1315642; Niederman MS, 2004, CURR MED RES OPIN, V20, P969, DOI 10.1185/030079904125003944; Niederman MS, 2002, INTENS CARE MED, V28, P1003, DOI 10.1007/s00134-002-1324-4; Papazian L, N ENGL J MED, V363, P1107; Phua J, 2010, EUR RESPIR J, V36, P826, DOI 10.1183/09031936.00154209; Rello J, 2002, INTENS CARE MED, V28, P1030, DOI 10.1007/s00134-002-1325-3; Rello J, 1996, CLIN INFECT DIS, V23, P723, DOI 10.1093/clinids/23.4.723; Rello J, 2008, CRIT CARE, V12, DOI 10.1186/cc7025; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Renaud B, 2012, ACAD EMERG MED, V19, P294, DOI 10.1111/j.1553-2712.2012.01301.x; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; TORRES A, 1991, AM REV RESPIR DIS, V144, P312, DOI 10.1164/ajrccm/144.2.312; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	40	14	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74937	10.1371/journal.pone.0074937	http://dx.doi.org/10.1371/journal.pone.0074937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069367	Green Submitted, gold, Green Published			2022-12-25	WOS:000324777300056
J	Li, M; Huang, L; Qiu, H; Fu, Q; Li, W; Yu, QQ; Sun, L; Zhang, LH; Hu, GY; Hu, JB; Yuan, XL				Li, Miao; Huang, Liu; Qiu, Hong; Fu, Qiang; Li, Wen; Yu, Qianqian; Sun, Li; Zhang, Lihong; Hu, Guangyuan; Hu, Junbo; Yuan, Xianglin			Helicobacter pylori Infection Synergizes with Three Inflammation-Related Genetic Variants in the GWASs to Increase Risk of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; CYTOSOLIC PHOSPHOLIPASE A(2); PROSTAGLANDIN E-2 SYNTHESIS; SUSCEPTIBILITY LOCI; ENVIRONMENT INTERACTIONS; EPITHELIAL-CELLS; IN-VITRO; POLYMORPHISMS; EXPRESSION	Background: Three recent genome-wide association studies (GWASs) have reported that three SNPs (rs4072037, rs13361707 and rs2274223) located on genes related to host inflammatory response are significantly associated with susceptibility to gastric cancer (GC) in Chinese populations. Helicobacter pylori infection is also an important risk factor for GC through causing inflammatory response in the gastric mucosa. However, no study has established whether there are potential gene-environment interactions between these genetic variants and H. pylori infection to the risk of GC. Methods: We genotyped three polymorphisms (rs4072037 at 1q22, rs13361707 at 5p13, and rs2274223 at 10q23) in 335 Chinese gastric adenocarcinoma patients and 334 controls. H. pylori serology was examined by enzyme-linked immunosorbent assay. Multivariable logistic regression models were used to evaluate the association between the variables and GC risk. Results: We confirmed that the three SNPs (rs4072037, rs13361707 and rs2274223) were significantly associated with GC susceptibility. H. pylori infection also significantly increased the risk of GC. Furthermore, there were joint effects between H. pylori infection and the three SNPs on the risk of GC. The most elevated risk of GC was found in subjects with H. pylori seropositivity and AA genotypes for rs4072037 [ odds ratio (OR), 3.95; 95% confidence interval (CI), 2.29-6.79], H. pylori seropositivity and CT/CC genotypes for rs13361707 (OR, 2.68; 95% CI, 1.62-4.43), H. pylori seropositivity and AG/GG genotypes for rs2274223 (OR, 2.45; 95% CI, 1.55-3.88) compared with those with H. pylori seronegativity and other genotypes of each SNP. Significant interactions were observed between H. pylori seropositivity and the three SNPs (all P-Gx (E) < 0.05) to the risk of GC. Conclusion: These findings indicate that the three SNPs (rs4072037, rs13361707 and rs2274223) identified in the GWASs may interact with H. pylori infection to increase the risk of GC.	[Li, Miao; Huang, Liu; Qiu, Hong; Fu, Qiang; Li, Wen; Yu, Qianqian; Sun, Li; Zhang, Lihong; Hu, Guangyuan; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China; [Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China.	yxl@medmail.com.cn			National Natural Science Foundation of China [81071832, 81272492]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81071832, N0. 81272492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Baccarelli A, 2006, INT J CANCER, V119, P1970, DOI 10.1002/ijc.22075; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fu SD, 1999, GASTROENTEROLOGY, V116, P1319, DOI 10.1016/S0016-5085(99)70496-8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029643, 10.1371/journal.pone.0045348]; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Luo DW, 2011, J GASTROENTEROL, V46, P1260, DOI 10.1007/s00535-011-0445-3; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nardone G, 2001, INFECT IMMUN, V69, P5857, DOI 10.1128/IAI.69.9.5857-5863.2001; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Obst B, 2000, CARCINOGENESIS, V21, P1111, DOI 10.1093/carcin/21.6.1111; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pomorski T, 2001, J BIOL CHEM, V276, P804, DOI 10.1074/jbc.M003819200; Romano M, 1998, J BIOL CHEM, V273, P28560, DOI 10.1074/jbc.273.44.28560; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Silva F, 2003, EUR J HUM GENET, V11, P380, DOI 10.1038/sj.ejhg.5200978; Silva F, 2001, EUR J HUM GENET, V9, P548, DOI 10.1038/sj.ejhg.5200677; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu HL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-276; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang XX, 2012, ASIAN PAC J CANCER P, V13, P2519, DOI 10.7314/APJCP.2012.13.6.2519; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051	38	37	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74976	10.1371/journal.pone.0074976	http://dx.doi.org/10.1371/journal.pone.0074976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069371	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300058
J	Meng, LZ; Martin, K; Weigel, A; Yang, XD				Meng, Ling-Zeng; Martin, Konrad; Weigel, Andreas; Yang, Xiao-Dong			Tree Diversity Mediates the Distribution of Longhorn Beetles (Coleoptera: Cerambycidae) in a Changing Tropical Landscape (Southern Yunnan, SW China)	PLOS ONE			English	Article							DORCADION-FULIGINATOR COLEOPTERA; SAPROXYLIC BEETLES; TEMPERATE FORESTS; SPECIES RICHNESS; BIODIVERSITY; IMPACT; FIRE; XISHUANGBANNA; COMMUNITIES; MANAGEMENT	Longhorn beetles (Coleoptera : Cerambycidae) have been used to identify sites of high biological diversity and conservation value in cultivated landscapes, but were rarely studied in changing landscapes of humid tropics. This study was conducted in a region of southern Yunnan, China, which was dominated by natural rainforest until 30 years ago, but is successively transformed into commercial rubber monoculture plantations since that time. The objectives were to investigate longhorn beetle species diversity and distribution in the major land use types of this landscape and to estimate the effects of an expected expansion of rubber plantations on the longhorn beetle assemblages. The results showed that tree species diversity (181 species in total) and longhorn beetle diversity (220 species in total) were closely related with no significant differences between the tree and longhorn beetles assemblages shown by similarity distance analysis. There was a highly positive relationship between the estimated species richness of longhorn beetles and the number of tree species. Individual numbers of longhorn beetles and trees were also highly positive related at the sampling sites. Non-metric multidimensional scaling revealed that the degree of canopy coverage, succession age and tree diversity explained 78.5% of the total variation in longhorn beetle assemblage composition. Natural forest sites had significantly higher numbers of species and individuals than any other type of habitat. Although young rubber plantations bear the highest longhorn beetle diversity outside forests (half of the total number of longhorn beetle species recorded in total), they can not provide permanent habitats for most of these species, because they develop into closed canopy plantations with less suitable habitat conditions. Therefore, along with an expected expansion of rubber cultivation which largely proceeds at the expense of forest areas, the habitat conditions for longhorn beetles in this region might decrease dramatically in future.	[Meng, Ling-Zeng; Yang, Xiao-Dong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Yunnan, Peoples R China; [Meng, Ling-Zeng; Martin, Konrad] Univ Hohenheim, Agroecol Trop & Subtrop 380B, Stuttgart, Germany; [Weigel, Andreas] Rosalia Umweltmanagement, Wernburg, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University Hohenheim	Meng, LZ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Yunnan, Peoples R China.	mlz@xtbg.org.cn	Meng, Ling-Zeng/AAF-7916-2019		National Natural Science Foundation of China [NSFC-31200322]; Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences; project SURUMER (Sustainable Rubber Cultivation in the Mekong Region); German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences; project SURUMER (Sustainable Rubber Cultivation in the Mekong Region); German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''(Federal Ministry of Education & Research (BMBF))	This study was supported by National Natural Science Foundation of China (NSFC-31200322). Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences also partly funded this study. The work of the second author (K. Martin) was supported by the project SURUMER (Sustainable Rubber Cultivation in the Mekong Region), funded by the German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baur B, 2005, BIOL CONSERV, V124, P49, DOI 10.1016/j.biocon.2004.12.011; Baur B, 2002, BIOL CONSERV, V105, P133, DOI 10.1016/S0006-3207(01)00117-3; Bouget C, 2005, FOREST ECOL MANAG, V216, P1, DOI 10.1016/j.foreco.2005.05.037; Buse J, 2008, CONSERV BIOL, V22, P329, DOI 10.1111/j.1523-1739.2007.00880.x; Campbell JW, 2008, FOREST ECOL MANAG, V254, P134, DOI 10.1016/j.foreco.2007.07.032; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Collinge SK, 2001, BIOL CONSERV, V100, P103, DOI 10.1016/S0006-3207(00)00211-1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Corona AM, 2007, J BIOGEOGR, V34, P1008, DOI 10.1111/j.1365-2699.2006.01666.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; HANKS LM, 1993, OECOLOGIA, V95, P22, DOI 10.1007/BF00649502; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; HANSEN AJ, 1991, BIOSCIENCE, V41, P382, DOI 10.2307/1311745; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Holland JD, 2007, BIODIVERS CONSERV, V16, P2599, DOI 10.1007/s10531-006-9066-1; Hu HB, 2008, ENVIRON MONIT ASSESS, V146, P147, DOI 10.1007/s10661-007-0067-7; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Jansson N, 2009, J INSECT CONSERV, V13, P399, DOI 10.1007/s10841-008-9187-9; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Lu XT, 2010, J TROP FOR SCI, V22, P260; Maeto K, 2002, BIODIVERS CONSERV, V11, P1919, DOI 10.1023/A:1020849012649; Makino S, 2007, ECOL RES, V22, P372, DOI 10.1007/s11284-007-0359-y; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; McCune B., 2006, PC ORD MULTIVARIATE; Meng LZ, 2012, J INSECT CONSERV, V16, P423, DOI 10.1007/s10841-011-9428-1; Moretti M, 2004, FOREST ECOL MANAG, V187, P85, DOI 10.1016/S0378-1127(03)00314-1; Moretti M, 2004, ECOGRAPHY, V27, P173, DOI 10.1111/j.0906-7590.2004.03660.x; Moretti M, 2010, ECOGRAPHY, V33, P760, DOI 10.1111/j.1600-0587.2009.06172.x; MUONA J, 1994, ANN ZOOL FENN, V31, P109; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; Sugiura S, 2009, J INSECT CONSERV, V13, P377, DOI 10.1007/s10841-008-9185-y; Sugiura S, 2009, BIODIVERS CONSERV, V18, P2101, DOI 10.1007/s10531-009-9575-9; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; Talley TS, 2007, ECOLOGY, V88, P1476, DOI 10.1890/06-0555; TOWNES HENRY, 1962, PROC ENTOMOL SOC WASHINGTON, V64, P253; Ulyshen MD, 2004, FOREST ECOL MANAG, V199, P259, DOI 10.1016/j.foreco.2004.05.046; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Wermelinger B, 2007, J APPL ENTOMOL, V131, P104, DOI 10.1111/j.1439-0418.2006.01128.x; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Zar JH, 1999, BIOSTATISTICAL ANAL	43	27	31	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75481	10.1371/journal.pone.0075481	http://dx.doi.org/10.1371/journal.pone.0075481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069421	gold, Green Published			2022-12-25	WOS:000324777300082
J	Yin, J; Wang, LM; Yin, N; Tabuchi, A; Kuppe, H; Wolff, G; Kuebler, WM				Yin, Jun; Wang, Liming; Yin, Ning; Tabuchi, Arata; Kuppe, Hermann; Wolff, Gerhard; Kuebler, Wolfgang M.			Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TERM OXYGEN-THERAPY; GAS-EXCHANGE; RECEPTOR AGONIST; NATURAL-HISTORY; NITRIC-OXIDE; MICE LACKING; IN-VITRO; HYPERTENSION; VIP	Rationale: Stable analogs of vasoactive intestinal peptide (VIP) have been proposed as novel line of therapy in chronic obstructive pulmonary disease (COPD) based on their bronchodilatory and anti-inflammatory effects. We speculated that VIP analogs may provide additional benefits in that they exert vasodilatory properties in the lung, and tested this hypothesis in both ex vivo and in vivo models. Methods: In isolated perfused mouse lungs and in an in vivo rat model, pulmonary blood vessels were preconstricted by hypoxia and hemodynamic changes in response to systemic (ex vivo) or inhaled (in vivo) administration of the cyclic VIP analog RO 25-1553 were determined. Results: In mouse lungs, RO 25-1553 reduced intrinsic vascular resistance at normoxia, and attenuated the increase in pulmonary artery pressure in response to acute hypoxia. Consistently, inhalation of RO 25-1553 (1 mg.mL(-1) for 3 min) caused an extensive and sustained (> 60 min) inhibition of the pulmonary arterial pressure increase in response to hypoxia in vivo that was comparable to the effects of inhaled sildenafil. This effect was not attributable to systemic cardiovascular effects of RO 25-1553, but to a lung specific reduction in pulmonary vascular resistance, while cardiac output and systemic arterial hemodynamics remained unaffected. No adverse effects of RO 25-1553 inhalation on pulmonary gas exchange, ventilation-perfusion matching, or lung fluid content were detected. Conclusion: Our findings demonstrate that inhaled delivery of the stable VIP analog RO 25-1553 induces a potent and sustained vasodilatory effect in the pulmonary circulation with no detectable adverse effects. Therapeutic inhalation of RO 25-1553 may provide vascular benefits in addition to its reported anti-inflammatory and bronchodilatory effects in COPD, yet caution is warranted given the overall poor results of vasodilator therapies for pulmonary hypertension secondary to COPD in a series of recent clinical trials.	[Yin, Jun; Wang, Liming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Yin, Jun; Wang, Liming; Tabuchi, Arata; Kuebler, Wolfgang M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Yin, Jun; Wang, Liming; Yin, Ning; Kuppe, Hermann; Kuebler, Wolfgang M.] German Heart Inst, Inst Anesthesiol, Berlin, Germany; [Yin, Jun; Wang, Liming; Yin, Ning; Kuebler, Wolfgang M.] Charite, Inst Physiol, D-13353 Berlin, Germany; [Wolff, Gerhard] Hoffmann La Roche Ltd, Dept Translat Med, Nutley, NY USA; [Kuebler, Wolfgang M.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada	Jiangsu University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University of Toronto	Kuebler, WM (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	kueblerw@smh.ca		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Kuebler, Wolfgang/0000-0003-4100-2961	Hoffmann-La Roche Ltd.	Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	The present work was supported by Hoffmann-La Roche Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2013, EUR RESP J; Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; Boeck L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052248; BOLIN DR, 1995, BIOPOLYMERS, V37, P57, DOI 10.1002/bip.360370203; Bull T, 2012, COPD, V9, P211, DOI 10.3109/15412555.2012.683966; BURROWS B, 1972, NEW ENGL J MED, V286, P912, DOI 10.1056/NEJM197204272861703; Busto R, 2000, PEPTIDES, V21, P265, DOI 10.1016/S0196-9781(99)00202-8; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Christensen CC, 2004, EUR RESPIR J, V24, P580, DOI 10.1183/09031936.04.00118303; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Dehler M, 2006, EUR RESPIR J, V27, P600, DOI 10.1183/09031936.06.00061505; Dernaika TA, 2010, RESPIRATION, V79, P377, DOI 10.1159/000242498; Dewit D, 1998, IMMUNOL LETT, V60, P57, DOI 10.1016/S0165-2478(97)00129-6; DEY RD, 1981, CELL TISSUE RES, V220, P231; DOMSCHKE S, 1978, GUT, V19, P1049, DOI 10.1136/gut.19.11.1049; Dreher M, 2009, RESPIRATION, V78, P154, DOI 10.1159/000187717; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P543, DOI 10.1513/pats.200708-142ET; FENN WO, 1946, AM J PHYSIOL, V146, P637, DOI 10.1152/ajplegacy.1946.146.5.637; Galie N, 2010, AM J RESP CRIT CARE, V181, pA2516; GHATEI MA, 1982, ENDOCRINOLOGY, V111, P1248, DOI 10.1210/endo-111-4-1248; Groneberg DA, 2006, EUR J PHARMACOL, V533, P182, DOI 10.1016/j.ejphar.2005.12.055; HAMASAKI Y, 1983, T ASSOC AM PHYSICIAN, V96, P406; HASSAN M, 1994, NUCL MED BIOL, V21, P865, DOI 10.1016/0969-8051(94)90166-X; Hegewald MJ, 2009, CHEST, V135, P536, DOI 10.1378/chest.08-1515; Hentschel T, 2007, ANESTHESIOLOGY, V106, P124, DOI 10.1097/00000542-200701000-00021; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Ichinose F, 2001, CRIT CARE MED, V29, P1000, DOI 10.1097/00003246-200105000-00024; Kallstrom BL, 2001, EUR J PHARMACOL, V430, P335, DOI 10.1016/S0014-2999(01)01299-7; Kessler R, 2001, AM J RESP CRIT CARE, V164, P219, DOI 10.1164/ajrccm.164.2.2006129; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Leuchte HH, 2008, EUR RESPIR J, V32, P1289, DOI 10.1183/09031936.00050008; Linden A, 2003, THORAX, V58, P217, DOI 10.1136/thorax.58.3.217; LINEHAN JH, 1992, J APPL PHYSIOL, V73, P987, DOI 10.1152/jappl.1992.73.3.987; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; LUNDBERG JM, 1984, PEPTIDES, V5, P593, DOI 10.1016/0196-9781(84)90090-1; Marino WD, 2006, CHEST, V130, p178S, DOI 10.1378/chest.130.4_MeetingAbstracts.178S-c; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; MINKES RK, 1992, AM J PHYSIOL, V263, pH1659, DOI 10.1152/ajpheart.1992.263.6.H1659; MORICE A, 1983, LANCET, V2, P1225; NANDIWADA PA, 1985, J APPL PHYSIOL, V58, P1723, DOI 10.1152/jappl.1985.58.5.1723; ODONNELL M, 1994, J PHARMACOL EXP THER, V270, P1282; ODONNELL M, 1994, J PHARMACOL EXP THER, V270, P1289; Olschewski H, 2001, J LAB CLIN MED, V138, P287, DOI 10.1067/mlc.2001.119329; Onoue S, 2008, N-S ARCH PHARMACOL, V377, P579, DOI 10.1007/s00210-007-0232-0; Onoue S, 2007, PEPTIDES, V28, P1640, DOI 10.1016/j.peptides.2007.04.009; OSWALDMAMMOSSER M, 1991, RESPIRATION, V58, P304; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; PAUL S, 1987, J BIOL CHEM, V262, P158; PETERSON BT, 1982, J APPL PHYSIOL, V52, P1661, DOI 10.1152/jappl.1982.52.6.1661; Petkov V, 2003, J CLIN INVEST, V111, P1339, DOI 10.1172/JCI200317500; Rietema H, 2008, EUR RESPIR J, V31, P759, DOI 10.1183/09031936.00114207; SAGA T, 1984, T ASSOC AM PHYSICIAN, V97, P304; Said SI, 2007, CIRCULATION, V115, P1260, DOI 10.1161/CIRCULATIONAHA.106.681718; Said SI, 2006, AM J PHYSIOL-LUNG C, V291, pL547, DOI 10.1152/ajplung.00546.2005; Said SI, 2012, AM J RESP CRIT CARE, V185, P786, DOI 10.1164/ajrccm.185.7.786; Said SI, 2008, ANN NY ACAD SCI, V1144, P148, DOI 10.1196/annals.1418.014; SAID SI, 1991, ANN NY ACAD SCI, V629, P305; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Schmidt DT, 2001, N-S ARCH PHARMACOL, V364, P314; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Spohr F, 2007, ANESTHESIOLOGY, V107, P597; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Tannu SA, 2010, BRIT J PHARMACOL, V161, P1329, DOI 10.1111/j.1476-5381.2010.00975.x; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Urban N, 2012, CELL CALCIUM, V51, P194, DOI 10.1016/j.ceca.2012.01.001; USDIN TB, 1994, ENDOCRINOLOGY, V135, P2662, DOI 10.1210/en.135.6.2662; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; WEITZENBLUM E, 1985, AM REV RESPIR DIS, V131, P493, DOI 10.1164/arrd.1985.131.4.493; WHAYNE TF, 1968, J APPL PHYSIOL, V25, P729, DOI 10.1152/jappl.1968.25.6.729; Yin N, 2009, CRIT CARE MED, V37, P980, DOI 10.1097/CCM.0b013e3181962ce6; Yoshida M, 1997, AM J RESP CRIT CARE, V155, P526, DOI 10.1164/ajrccm.155.2.9032189; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	78	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75861	10.1371/journal.pone.0075861	http://dx.doi.org/10.1371/journal.pone.0075861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069452	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300099
J	Daniel, C; Roupioz, Y; Gasparutto, D; Livache, T; Buhot, A				Daniel, Camille; Roupioz, Yoann; Gasparutto, Didier; Livache, Thierry; Buhot, Arnaud			Solution-Phase vs Surface-Phase Aptamer-Protein Affinity from a Label-Free Kinetic Biosensor	PLOS ONE			English	Article							NONEQUILIBRIUM CAPILLARY-ELECTROPHORESIS; PLASMON RESONANCE; EQUILIBRIUM MIXTURES; HUMAN THROMBIN; DNA; BINDING; MOLECULES; LIGANDS; IMMOBILIZATION; HETEROGENEITY	Aptamers are selected DNA ligands that target biomolecules such as proteins. In recent years, they are showing an increasing interest as potential therapeutic agents or recognition elements in biosensor applications. In both cases, the need for characterizing the mating between the target and the aptamer either in solution or immobilized on a surface, is pressing. In this context, we have developed a kinetic biosensor made of micro-arrayed anti-thrombin aptamers to assess the kinetic parameters of this interaction. The binding of label-free thrombin on the biosensor was monitored in real-time by Surface Plasmon Resonance imaging. Remarkable performances were obtained for the quantification of thrombin without amplification (sub-nanomolar limit of detection and linear range of quantification to two orders of magnitude). The independent determinations of both the solution- and surface-phase affinities, respectively K-D(Sol) and K-D(Surf), revealed distinct values illustrating the importance of probes, targets or surface interactions in biosensors. Interestingly, K-D(Surf) values depend on the aptamer grafting density and linearly extrapolate towards K-D(Sol) for highly diluted probes. This suggests a lesser impact of the surface compared to the probe or target cooperativity interactions since the latter decrease with a reduced grafting density.	[Daniel, Camille; Roupioz, Yoann; Livache, Thierry; Buhot, Arnaud] UMR 5819 CEA CNRS UJF, Lab Struct & Proprietes Architectures Mol, Inst Nanosci & Cryogenie, Grenoble, France; [Gasparutto, Didier] UMR E3 CEA UJF, Serv Chim Inorgan & Biol, Inst Nanosci & Cryogenie, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Buhot, A (corresponding author), UMR 5819 CEA CNRS UJF, Lab Struct & Proprietes Architectures Mol, Inst Nanosci & Cryogenie, Grenoble, France.	arnaud.buhot@cea.fr	Buhot, Arnaud/O-5085-2019	Buhot, Arnaud/0000-0001-7643-4305	DSM-DRT/CEA Flagship Program; A3DN Project; Labex ARCANE program [ANR-11-LABX-0003-01]	DSM-DRT/CEA Flagship Program; A3DN Project; Labex ARCANE program	This work was partially supported by the DSM-DRT/CEA Flagship Program, "A3DN Project" and by the Labex ARCANE program (ANR-11-LABX-0003-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Berezovski M, 2003, ANAL CHEM, V75, P1382, DOI 10.1021/ac026214b; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Daniel C, 2013, BIOSENS BIOELECTRON, V40, P186, DOI 10.1016/j.bios.2012.07.016; Drolet DW, 1996, NAT BIOTECHNOL, V14, P1021, DOI 10.1038/nbt0896-1021; Edwards PR, 1997, ANAL BIOCHEM, V246, P1, DOI 10.1006/abio.1996.9922; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Ho HA, 2004, J AM CHEM SOC, V126, P1384, DOI 10.1021/ja037289f; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Jayasena SD, 1999, CLIN CHEM, V45, P1628; KARLSSON R, 1993, J IMMUNOL METHODS, V166, P75, DOI 10.1016/0022-1759(93)90330-A; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lee Y, 2012, J AM CHEM SOC, V134, P17448, DOI 10.1021/ja308437h; Levicky R, 2005, TRENDS BIOTECHNOL, V23, P143, DOI 10.1016/j.tibtech.2005.01.004; Li YL, 2008, ELECTROPHORESIS, V29, P2570, DOI 10.1002/elps.200700798; Lin PH, 2011, COLLOID SURFACE B, V88, P552, DOI 10.1016/j.colsurfb.2011.07.032; Lubin AA, 2010, ACCOUNTS CHEM RES, V43, P496, DOI 10.1021/ar900165x; Milgram S, 2012, METHODS, V56, P326, DOI 10.1016/j.ymeth.2011.10.016; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Olmsted IR, 2011, ANAL CHEM, V83, P8867, DOI 10.1021/ac202823m; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; Ostatna V, 2008, ANAL BIOANAL CHEM, V391, P1861, DOI 10.1007/s00216-008-2133-6; Potyrailo RA, 1998, ANAL CHEM, V70, P3419, DOI 10.1021/ac9802325; Rao AN, 2012, ANAL CHEM, V84, P9379, DOI 10.1021/ac302165h; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rotem D, 2012, J AM CHEM SOC, V134, P2781, DOI 10.1021/ja2105653; Salvi N, 2012, J AM CHEM SOC, V134, P11076, DOI 10.1021/ja303301w; Scarano S, 2010, BIOSENS BIOELECTRON, V25, P957, DOI 10.1016/j.bios.2009.08.039; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; Song SP, 2008, TRAC-TREND ANAL CHEM, V27, P108, DOI 10.1016/j.trac.2007.12.004; Steel AB, 2000, BIOPHYS J, V79, P975, DOI 10.1016/S0006-3495(00)76351-X; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; Wolf LK, 2007, J AM CHEM SOC, V129, P10503, DOI 10.1021/ja072401l; Zhang DP, 2011, J AM CHEM SOC, V133, P9188, DOI 10.1021/ja202141y; Zhao Q, 2008, ANAL CHEM, V80, P7586, DOI 10.1021/ac801206s; Zhu ZY, 2012, ANAL CHEM, V84, P7203, DOI 10.1021/ac301552e	40	35	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75419	10.1371/journal.pone.0075419	http://dx.doi.org/10.1371/journal.pone.0075419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069412	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300082
J	McLeod, DD; Beard, DJ; Parsons, MW; Levi, CR; Calford, MB; Spratt, NJ				McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.			Inadvertent Occlusion of the Anterior Choroidal Artery Explains Infarct Variability in the Middle Cerebral Artery Thread Occlusion Stroke Model	PLOS ONE			English	Article							SUTURE; RATS	Intraluminal occlusion of the middle cerebral artery (MCAo) in rodents is perhaps the most widely used model of stroke, however variability of infarct volume and the ramifications of this on sample sizes remains a problem, particularly for preclinical testing of potential therapeutics. Our data and that of others, has shown a dichotomous distribution of infarct volumes for which there had previously been no clear explanation. When studying perfusion computed tomography cerebral blood volume (CBV) maps obtained during intraluminal MCAo in rats, we observed inadvertent occlusion of the anterior choroidal artery (AChAo) in a subset of animals. We hypothesized that the combined occlusion of the MCA and AChA may be a predictor of larger infarct volume following stroke. Thus, we aimed to determine the correlation between AChAo and final infarct volume in rats with either temporary or permanent MCA occlusion (1 h, 2 h, or permanent MCAo). Outbred Wistar rats (n = 28) were imaged prior to and immediately following temporary or permanent middle cerebral artery occlusion. Presence of AChAo on CBV maps was shown to be a strong independent predictor of 24 h infarct volume (beta = 0.732, p < 0.001). This provides an explanation for the previously observed dichotomous distribution of infarct volumes. Interestingly, cortical infarct volumes were also larger in rats with AChAo, although the artery does not supply cortex. This suggests an important role for perfusion of the MCA territory beyond the proximal occlusion through AChA-MCA anastomotic collateral vessels in animals with a patent AChAo. Identification of combined MCAo and AChAo will allow other investigators to tailor their stroke model to reduce variability in infarct volumes, improve statistical power and reduce sample sizes in preclinical stroke research.	[McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.] Univ Newcastle, Callaghan, NSW 2308, Australia; [McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Parsons, Mark W.; Levi, Christopher R.; Spratt, Neil J.] Hunter New England Local Hlth Dist, New Lambton Hts, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	McLeod, DD (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Damian.McLeod@newcastle.edu.au	Parsons, Mark W./G-3750-2014; MCLEOD, DAMIAN/G-7704-2013; Spratt, Neil J/K-4208-2012; Beard, Daniel/AAP-1258-2020	MCLEOD, DAMIAN/0000-0002-1297-8984; Spratt, Neil J/0000-0002-9023-6177; Beard, Daniel/0000-0002-3720-7588; Levi, Christopher/0000-0002-9474-796X; Calford, Mike/0000-0002-5727-0234	National Health and Medical Research Council (NHMRC, Australia) [454417]; National Stroke Foundation (Australia) [2008-09/]; Hunter Medical Research Institute Stroke Research Project Grant [G0189810]; Greater Building Society; NHMRC [455632]	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Stroke Foundation (Australia); Hunter Medical Research Institute Stroke Research Project Grant; Greater Building Society; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC, Australia), Program Grant, #454417 (www.nhmrc.gov.au); the National Stroke Foundation (Australia), Small Project Grant (http://strokefoundation.com.au/research/research-grants-2008-09/); the Hunter Medical Research Institute Stroke Research Project Grant (Grant #G0189810) (www.newcastle.edu.au); and from funds donated by the Greater Building Society (http://www.greater.com.au). N. Spratt received a NHMRC training fellowship, #455632 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2002, EXP BRAIN RES, V142, P131, DOI 10.1007/s00221-001-0909-4; COYLE P, 1984, STROKE, V15, P711, DOI 10.1161/01.STR.15.4.711; COYLE P, 1975, EXP NEUROL, V49, P671, DOI 10.1016/0014-4886(75)90051-5; GHIKA JA, 1990, ARCH NEUROL-CHICAGO, V47, P1097, DOI 10.1001/archneur.1990.00530100063014; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; He Z, 2000, J NEUROL SCI, V182, P16, DOI 10.1016/S0022-510X(00)00434-2; Letourneur A, 2011, J CEREBR BLOOD F MET, V31, P504, DOI 10.1038/jcbfm.2010.118; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma JY, 2006, J NEUROSCI METH, V156, P76, DOI 10.1016/j.jneumeth.2006.02.006; McLeod DD, 2011, INT J STROKE, V6, P284, DOI 10.1111/j.1747-4949.2010.00564.x; McLeod DD, 2013, INT J STROK IN PRESS; OLIFF HS, 1995, BRAIN RES, V675, P20, DOI 10.1016/0006-8993(95)00033-M; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273; Riva M, 2012, EXP NEUROL, V233, P815, DOI 10.1016/j.expneurol.2011.12.006; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	19	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75779	10.1371/journal.pone.0075779	http://dx.doi.org/10.1371/journal.pone.0075779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069448	Green Published, gold			2022-12-25	WOS:000324547300094
J	Belghit, I; Panserat, S; Sadoul, B; Dias, K; Skiba-Cassy, S; Seiliez, I				Belghit, Ikram; Panserat, Stephane; Sadoul, Bastien; Dias, Karine; Skiba-Cassy, Sandrine; Seiliez, Iban			Macronutrient Composition of the Diet Affects the Feeding-Mediated Down Regulation of Autophagy in Muscle of Rainbow Trout (O. mykiss)	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; IN-VITRO ASSESSMENT; DEPENDENT PROTEOLYSIS; PROTEIN-TURNOVER; CELL-SURVIVAL; GLUCOSE; EXPRESSION; FOXO3; AMPK; VIVO	Autophagy functions as an important catabolic mechanism by mediating the turnover of intracellular organelles and protein complexes through a lysosome dependent degradative pathway. Although the induction of autophagy by starvation has been extensively studied, we still know very little about how autophagy is regulated under normal nutritional conditions. The purpose of the present study was to characterize both in vivo and in vitro the response of the autophagylysosomal degradative pathway to nutrient (amino acids and carbohydrates) availability in the muscle of the carnivorous rainbow trout. We report that meal feeding is accompanied by a rapid activation of Akt, FoxO1 and the Target of Rapamycin (TOR) signaling pathways and a concomitant decrease of autophagosome formation. We also show that this effect occurs only when the proportion of dietary proteins increases at the expense of carbohydrates. Concurrently, our in vitro study on primary culture of trout muscle cells demonstrates an opposite effect of amino acids and glucose on the regulation of autophagy-lysosomal pathways. More specifically, the addition of amino acids in cell culture medium inhibited the formation of autophagosomes, whereas the addition of glucose had an opposite effect. The effect of amino acids was accompanied by an activation of TOR, considered as an important regulator of autophagosomal formation. However, the mechanisms involved in the effect of glucose were independent of Akt, TOR and AMPK and remain to be determined. Together, these results demonstrated the specific role of macronutrients as well as that of their interactions in the regulation of autophagy and highlight the interest to consider the macronutrient composition of the diets in the control of this degradative pathway.	[Belghit, Ikram; Panserat, Stephane; Sadoul, Bastien; Dias, Karine; Skiba-Cassy, Sandrine; Seiliez, Iban] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Seiliez, I (corresponding author), INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France.	seiliez@st-pee.inra.fr		Sadoul, Bastien/0000-0001-5968-3983; Panserat, Stephane/0000-0002-4479-9868	European Union [288925]	European Union(European Commission)	This study was supported by the European Union 7th Framework project (Project Call Identifier: FP7-KBBE-2011-5, Project Number: 288925, Advanced Research Initiatives for Nutrition & Aquaculture (ARRAINA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaix D, 1998, ADV MOL CEL, V27, P235, DOI 10.1016/S1569-2558(08)60463-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Duan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019532; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamalam BS, 2012, J EXP BIOL, V215, P2567, DOI 10.1242/jeb.070581; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; Kee AJ, 2003, J PHYSIOL-LONDON, V546, P765, DOI 10.1113/jphysiol.2002.032367; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lee Youngjeon, 2012, Lab Anim Res, V28, P171, DOI 10.5625/lar.2012.28.3.171; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; MOORE S, 1968, J BIOL CHEM, V243, P6281; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; Seiliez I, 2012, AUTOPHAGY, V8, P364, DOI 10.4161/auto.18863; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Yabu T, 2012, MAR BIOTECHNOL, V14, P491, DOI 10.1007/s10126-012-9432-9; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	60	17	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74308	10.1371/journal.pone.0074308	http://dx.doi.org/10.1371/journal.pone.0074308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069294	Green Published, gold			2022-12-25	WOS:000326240100100
J	Witteveen, T; Zwart, JJ; Gast, KB; Bloemenkamp, KWM; van Roosmalen, J				Witteveen, Tom; Zwart, Joost J.; Gast, Karin B.; Bloemenkamp, Kitty W. M.; van Roosmalen, Jos			Overweight and Severe Acute Maternal Morbidity in a Low-Risk Pregnant Population in The Netherlands	PLOS ONE			English	Article							TRACHEAL INTUBATION; UTERINE RUPTURE; OBESITY; OUTCOMES; COMPLICATIONS; PREVALENCE; MORTALITY; BIRTH; CONSEQUENCES; METAANALYSIS	Objective: To investigate the association between overweight and severe acute maternal morbidity (SAMM) in a low-risk pregnant population. Design: Nationwide case-control study. Setting: The Netherlands, august 2004 to august 2006. Population: 1567 cases from initially primary care and 2994 women from primary care practices as controls, out of 371 012 women delivering in the Netherlands during the study period Methods: Cases were women with SAMM obtained from a nationwide prospective study. All women in this cohort who initially had low-risk pregnancies were compared with low-risk women without SAMM to calculate odd ratios (ORs) to develop SAMM by body mass index (BMI) category. We divided body mass index in three overweight categories and calculated the ORs (95% CI) of total SAMM and per specific endpoint by logistic regression, with normal weight as reference. We adjusted for age, parity and socio-economic status. Main Outcome Measures: SAMM, defined as Intensive Care Unit (ICU)-admission, Uterine Rupture, Eclampsia or Major Obstetric Haemorrhage (MOH) Results: SAMM was reported in 1567 cases which started as low-risk pregnancies. BMI was available in 1097 (70.0%) cases and 2994 control subjects were included. Analysis showed a dose response relation for overweight (aOR, 1.3; 95% CI, 1.0-1.5), obese (aOR, 1.4; 95% CI, 1.1-1.9) and morbidly obese (aOR, 2.1; 95% CI, 1.3-3.2) women to develop SAMM compared to normal weight. Sub analysis showed the same dose response relation for ICU-admission, Uterine Rupture and Eclampsia. We found no association for MOH. Conclusion: Overweight without pre-existent co-morbidity is an important risk-indicator for developing SAMM. This risk increases with an increasing body mass index.	[Witteveen, Tom; Bloemenkamp, Kitty W. M.; van Roosmalen, Jos] Leiden Univ Med Ctr, Dept Obstet, Leiden, Netherlands; [Zwart, Joost J.] Deventer Ziekenhuis, Dept Obstet & Gynaecol, Deventer, Netherlands; [Gast, Karin B.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Gast, Karin B.] Leiden Univ Med Ctr, Dept Internal Med, Leiden, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Med Humanities, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Witteveen, T (corresponding author), Leiden Univ Med Ctr, Dept Obstet, Leiden, Netherlands.	tom.witteveen@gmail.com			Dutch Organisation for Health Research; Matty Brand Foundation	Dutch Organisation for Health Research; Matty Brand Foundation	The authors hereby state that no external funding was used for this study. The LEMMoN-study was supported by the Dutch Organisation for Health Research and the Matty Brand Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barnardo PD, 2000, ANAESTHESIA, V55, P690, DOI 10.1046/j.1365-2044.2000.01536.x; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Dashe JS, 2009, OBSTET GYNECOL, V113, P1001, DOI 10.1097/AOG.0b013e3181a1d2f5; Denison FC, 2009, BJOG-INT J OBSTET GY, V116, P1467, DOI 10.1111/j.1471-0528.2009.02222.x; en College Verloskunde Commissievoor zorgverzekeringen, 2003, AD VERL LIST OBST RE; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; Gunatilake RP, 2011, AM J OBSTET GYNECOL, V204, P106, DOI 10.1016/j.ajog.2010.10.002; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Juvin P, 2003, ANESTH ANALG, V97, P595, DOI 10.1213/01.ANE.0000072547.75928.B0; Kaczmarczyk M, 2007, BJOG-INT J OBSTET GY, V114, P1208, DOI 10.1111/j.1471-0528.2007.01484.x; Katzmarzyk PT, 2002, OBES RES, V10, P666, DOI 10.1038/oby.2002.90; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Mills JL, 2010, AM J CLIN NUTR, V91, P1543, DOI 10.3945/ajcn.2009.28865; Neovius M, 2006, OBES REV, V7, P1, DOI 10.1111/j.1467-789x.2006.00190.x; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Patel A, 2006, INT J GYNECOL OBSTET, V93, P220, DOI 10.1016/j.ijgo.2006.02.014; Pevzner L, 2009, OBSTET GYNECOL, V114, P1315, DOI 10.1097/AOG.0b013e3181bfb39f; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Reece EA, 2008, AM J OBSTET GYNECOL, V198, P23, DOI 10.1016/j.ajog.2007.06.076; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Rode L, 2005, OBSTET GYNECOL, V105, P537, DOI 10.1097/01.AOG.0000152304.39492.1c; Rosenberg TJ, 2005, AM J PUBLIC HEALTH, V95, P1545, DOI 10.2105/AJPH.2005.065680; Saravanakumar K, 2006, ANAESTHESIA, V61, P36, DOI 10.1111/j.1365-2044.2005.04433.x; Schokker DF, 2007, OBES REV, V8, P101, DOI 10.1111/j.1467-789X.2006.00273.x; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Statistics Netherlands (CBS), 2007, STATL; van Duin C, 2002, MAANDSTATISTIEK BEVO, V2, P32; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2010, TRANSFUSION MED, V20, P118, DOI 10.1111/j.1365-3148.2009.00967.x; Zwart JJ, 2011, EUR J PUBLIC HEALTH, V21, P229, DOI 10.1093/eurpub/ckq046	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74494	10.1371/journal.pone.0074494	http://dx.doi.org/10.1371/journal.pone.0074494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069316	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100108
J	Shirey, C; Badieyan, S; Sobrado, P				Shirey, Carolyn; Badieyan, Somayesadat; Sobrado, Pablo			Role of Ser-257 in the Sliding Mechanism of NADP(H) in the Reaction Catalyzed by the Aspergillus fumigatus Flavin-dependent Ornithine N-5-Monooxygenase SidA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; Flavin; Molecular Dynamics; Mutagenesis; Siderophores; C4a-hydroperoxyflavin; N-Hydroxylating; SidA; Flavin-dependent Monooxygenase; NADP(H) Role	CONTAINING MONO-OXYGENASE; PSEUDOMONAS-AERUGINOSA; CYCLOHEXANONE MONOOXYGENASE; FLAVOPROTEIN MONOOXYGENASES; KINETIC MECHANISM; HYDROXYLASE; ACTIVATION; PURIFICATION; BIOCATALYSTS; COFACTOR	SidA (siderophore A) is a flavin-dependent N-hydroxylating monooxygenase that is essential for virulence in Aspergillus fumigatus. SidA catalyzes the NADPH- and oxygen-dependent formation of N-5-hydroxyornithine. In this reaction, NADPH reduces the flavin, and the resulting NADP(+) is the last product to be released. The presence of NADP(+) is essential for activity, as it is required for stabilization of the C4a-hydroperoxyflavin, which is the hydroxylating species. As part of our efforts to determine the molecular details of the role of NADP(H) in catalysis, we targeted Ser-257 for site-directed mutagenesis and performed extensive characterization of the S257A enzyme. Using a combination of steady-state and stopped-flow kinetic experiments, substrate analogs, and primary kinetic isotope effects, we show that the interaction between Ser-257 and NADP(H) is essential for stabilization of the C4a-hydroperoxyflavin. Molecular dynamics simulation results suggest that Ser-257 functions as a pivot point, allowing the nicotinamide of NADP(+) to slide into position for stabilization of the C4a-hydroperoxyflavin.	[Shirey, Carolyn; Badieyan, Somayesadat; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Sobrado, Pablo] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	psobrado@vt.edu			National Science Foundation [MCB 1021384]; Virginia Tech Biodesign and Bioprocessing Center; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech Biodesign and Bioprocessing Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB 1021384 and by the Virginia Tech Biodesign and Bioprocessing Center.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Badieyan S, 2012, PROTEIN ENG DES SEL, V25, P223, DOI 10.1093/protein/gzs010; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Han A, 2013, ARCH BIOCHEM BIOPHYS, V532, P46, DOI 10.1016/j.abb.2013.01.004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Romero E., 2013, FLAVINS FLAVOPROTEIN, P289; Romero E., 2012, J VIS EXP, V61, pe3803, DOI 10.3791/3803; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	37	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32440	32448		10.1074/jbc.M113.487181	http://dx.doi.org/10.1074/jbc.M113.487181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072704	hybrid, Green Published			2022-12-25	WOS:000328681700029
J	Binder, E; Bermudez-Silva, FJ; Andre, C; Elie, M; Romero-Zerbo, SY; Leste-Lasserre, T; Belluomo, I; Duchampt, A; Clark, S; Aubert, A; Mezzullo, M; Fanelli, F; Pagotto, U; Laye, S; Mithieux, G; Cota, D				Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Duchampt, Adeline; Clark, Samantha; Aubert, Agnes; Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto; Laye, Sophie; Mithieux, Gilles; Cota, Daniela			Leucine Supplementation Protects from Insulin Resistance by Regulating Adiposity Levels	PLOS ONE			English	Article							WEIGHT-LOSS; MAMMALIAN TARGET; ENERGY-BALANCE; AMINO-ACIDS; MICE; OBESITY; FAT; CHOLESTEROL; SENSITIVITY; HOMEOSTASIS	Background: Leucine supplementation might have therapeutic potential in preventing diet-induced obesity and improving insulin sensitivity. However, the underlying mechanisms are at present unclear. Additionally, it is unclear whether leucine supplementation might be equally efficacious once obesity has developed. Methodology/Principal Findings: Male C57BL/6J mice were fed chow or a high-fat diet (HFD), supplemented or not with leucine for 17 weeks. Another group of HFD-fed mice (HFD-pairfat group) was food restricted in order to reach an adiposity level comparable to that of HFD-Leu mice. Finally, a third group of mice was exposed to HFD for 12 weeks before being chronically supplemented with leucine. Leucine supplementation in HFD-fed mice decreased body weight and fat mass by increasing energy expenditure, fatty acid oxidation and locomotor activity in vivo. The decreased adiposity in HFD-Leu mice was associated with increased expression of uncoupling protein 3 (UCP-3) in the brown adipose tissue, better insulin sensitivity, increased intestinal gluconeogenesis and preservation of islets of Langerhans histomorphology and function. HFD-pairfat mice had a comparable improvement in insulin sensitivity, without changes in islets physiology or intestinal gluconeogenesis. Remarkably, both HFD-Leu and HFD-pairfat mice had decreased hepatic lipid content, which likely helped improve insulin sensitivity. In contrast, when leucine was supplemented to already obese animals, no changes in body weight, body composition or glucose metabolism were observed. Conclusions/Significance: These findings suggest that leucine improves insulin sensitivity in HFD-fed mice by primarily decreasing adiposity, rather than directly acting on peripheral target organs. However, beneficial effects of leucine on intestinal gluconeogenesis and islets of Langerhans's physiology might help prevent type 2 diabetes development. Differently, metabolic benefit of leucine supplementation is lacking in already obese animals, a phenomenon possibly related to the extent of the obesity before starting the supplementation.	[Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Clark, Samantha; Cota, Daniela] INSERM, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France; [Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Clark, Samantha] Univ Bordeaux, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France; [Bermudez-Silva, Francisco J.; Romero-Zerbo, Silvana Y.] IBIMA Hosp Carlos Haya, Lab Invest, Malaga, Spain; [Duchampt, Adeline; Mithieux, Gilles] INSERM, U855, F-69008 Lyon, France; [Duchampt, Adeline; Mithieux, Gilles; Cota, Daniela] Univ Lyon, Lyon, France; [Duchampt, Adeline; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Aubert, Agnes; Laye, Sophie] Univ Bordeaux, UMR 1286, Bordeaux, France; [Aubert, Agnes; Laye, Sophie] INRA, UMR 1286, Bordeaux, France; [Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto] Univ Bologna, Dept Clin Med, S Orsola Malpighi Hosp, Endocrinol Unit, Bologna, Italy; [Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto] Univ Bologna, Dept Clin Med, S Orsola Malpighi Hosp, Ctr Ric Biomed Applicata, Bologna, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universidad de Malaga; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Cota, D (corresponding author), INSERM, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France.	daniela.cota@inserm.fr	Belluomo, Ilaria/AAL-7855-2021; Laye, Sophie/AAX-2501-2020; Bermudez-Silva, Francisco-Javier/Q-6920-2016	Laye, Sophie/0000-0002-3843-1012; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; Gilles, Mithieux/0000-0003-3579-8529; MEZZULLO, MARCO/0000-0001-6748-3041; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; Cota, Daniela/0000-0002-6909-2156	INSERM; Aquitaine Region; Ajinomoto 3ARP research program; EquipEx OptoPath [ANR-10-EQPX-08]; European Community [FP7-People2009-IEF-251494]; Fondation Recherche Medicale; National System of Health (Instituto de Salud Carlos III) [CP07/00283]; BAE from Instituto de Salud Carlos III [BA09/90066];  [ANR-2010-1414-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aquitaine Region(Region Nouvelle-Aquitaine); Ajinomoto 3ARP research program; EquipEx OptoPath; European Community(European Commission); Fondation Recherche Medicale; National System of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); BAE from Instituto de Salud Carlos III(Instituto de Salud Carlos III); 	This work was supported by INSERM, Aquitaine Region, Ajinomoto 3ARP research program, ANR-2010-1414-01 and EquipEx OptoPath ANR-10-EQPX-08 (to DC), European Community's Seventh Framework Programme FP7-People2009-IEF-251494 (DC and EB) and Fondation Recherche Medicale. FJBS is recipient of a research contract from the National System of Health (Instituto de Salud Carlos III; CP07/00283) and of a BAE from Instituto de Salud Carlos III (BA09/90066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2012, P NUTR SOC, V71, P502, DOI 10.1017/S0029665112000754; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Cardinal P, 2012, ENDOCRINOLOGY, V153, P4136, DOI 10.1210/en.2012-1405; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Eller LK, 2013, J NUTR BIOCHEM, V24, P1285, DOI 10.1016/j.jnutbio.2012.10.004; HA J, 1994, J BIOL CHEM, V269, P22162; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; HAYEK A, 1979, DIABETES, V28, P565, DOI 10.2337/diabetes.28.6.565; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Mithieux G, 2009, CURR OPIN CLIN NUTR, V12, P419, DOI 10.1097/MCO.0b013e32832c4d6a; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pitman JL, 2011, J LIPID RES, V52, P1775, DOI 10.1194/jlr.M017277; Popkin BM, 2007, NAT REV CANCER, V7, P61, DOI 10.1038/nrc2029; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Proulx K, 2008, DIABETES, V57, P3231, DOI 10.2337/db07-1690; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Tuduri E, 2009, DIABETES, V58, P1616, DOI 10.2337/db08-1787; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vaughan RA, 2013, AMINO ACIDS; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	31	50	61	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74705	10.1371/journal.pone.0074705	http://dx.doi.org/10.1371/journal.pone.0074705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086364	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700031
J	Geiger, MF; McCrary, JK; Schliewen, UK				Geiger, Matthias F.; McCrary, Jeffrey K.; Schliewen, Ulrich K.			Crater Lake Apoyo Revisited - Population Genetics of an Emerging Species Flock	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MIDAS CICHLID COMPLEX; SYMPATRIC SPECIATION; TELEOSTEI CICHLIDAE; GENOMIC SIGNATURES; AMPHILOPHUS SPP.; SEXUAL SELECTION; WATER TURBIDITY; EVOLUTION; FISH	The polytypic Nicaraguan Midas cichlids (Amphilophus cf. citrinellus) have been established as a model system for studying the mechanisms of speciation and patterns of diversification in allopatry and sympatry. The species assemblage in Crater Lake Apoyo has been accepted as a textbook example for sympatric speciation. Here, we present a first comprehensive data set of population genetic (mtDNA & AFLPs) proxies of species level differentiation for a representative set of individuals of all six endemic Amphilophus species occurring in Crater Lake Apoyo. AFLP genetic differentiation was partitioned into a neutral and non-neutral component based on outlier-loci detection approaches, and patterns of species divergence were explored with Bayesian clustering methods. Substantial levels of admixture between species were detected, indicating different levels of reproductive isolation between the six species. Analysis of neutral genetic variation revealed several A. zaliosus as being introgressed by an unknown contributor, hereby rendering the sympatrically evolving L. Apoyo flock polyphyletic. This is contrasted by the mtDNA analysis delivering a clear monophyly signal with Crater Lake Apoyo private haplotypes characterising all six described species, but also demonstrating different demographic histories as inferred from pairwise mismatch distributions.	[Geiger, Matthias F.; Schliewen, Ulrich K.] Zool Staatssammlung Munchen, ZSM, Dept Ichthyol, Bavarian State Collect Zool, Munich, Germany; [McCrary, Jeffrey K.] Laguna de Apoyo Nat Reserve, Fdn Nicaraguense Prodesarrollo Comunitario Integr, Estn Biol, Masaya, Nicaragua		Geiger, MF (corresponding author), Zool Staatssammlung Munchen, ZSM, Dept Ichthyol, Bavarian State Collect Zool, Munich, Germany.	matthias.f.geiger@t-online.de	Geiger, Matthias/S-3459-2017	Geiger, Matthias/0000-0003-2403-0805	FUNDECI/GAIA; DAAD; LMU; Bavarian Elite Aid Act (BayEFG)	FUNDECI/GAIA; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); LMU; Bavarian Elite Aid Act (BayEFG)	This work was supported in part by FUNDECI/GAIA (www.gaianicaragua.org) and by grants provided to MFG by DAAD (www.daad.de), LMU (www.lmu.de) and the Bavarian Elite Aid Act (BayEFG, www.elitenetzwerk.bayern.de). Additional support for molecular analyses was provided by the DNA Bank Network (www.dnabank-network.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2003, EVOL ECOL RES, V5, P739; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANIC, 1999, ENCUENTRO, V51, P80; BARLOW GW, 1977, BEHAV ECOL SOCIOBIOL, V2, P49, DOI 10.1007/BF00299288; BARLOW GW, 1978, BIOL BEHAV, V3, P137; BARLOW GW, 1976, INVESTIGATIONS ICHTH; Barluenga M, 2004, MOL ECOL, V13, P2061, DOI 10.1111/j.1365-294X.2004.02211.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Butlin RK, 2009, HEREDITY, V102, P1, DOI 10.1038/hdy.2008.97; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; *CIRA UNAN MAN, 2008, PLAN INF LAG AP MAN; Coyne JA, 2004, SPECIATION, V37; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Donaldson KA, 1999, MOL PHYLOGENET EVOL, V13, P208, DOI 10.1006/mpev.1999.0625; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Elmer KR, 2013, EVOLUTION, V67, P281, DOI 10.1111/j.1558-5646.2012.01755.x; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Elmer KR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-60; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feulner Philine G.D., 2009, Communicative & Integrative Biology, V2, P329; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gaggiotti OE, 2000, P ROY SOC B-BIOL SCI, V267, P81, DOI 10.1098/rspb.2000.0970; GAVRILETS S, 2004, MONOGR POPUL BIOL, V41; Geiger MF, 2010, P BIOL SOC WASH, V123, P159, DOI 10.2988/09-20.1; Geiger MF, 2010, MOL PHYLOGENET EVOL, V56, P1011, DOI 10.1016/j.ympev.2010.05.015; Gross BL, 2004, AM NAT, V164, P145, DOI 10.1086/422223; Henning F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-171; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; Kautt AF, 2012, MOL ECOL, V21, P4770, DOI 10.1111/j.1365-294X.2012.05738.x; Kawata M, 2000, EVOL ECOL RES, V2, P897; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LINK W, 1995, THEOR APPL GENET, V90, P27, DOI 10.1007/BF00220992; Losos JB, 2010, EVOLUTION DARWIN 1 1; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Mayr E., 1942, SYSTEMATICS ORIGIN S; MCCRARY JK, 2008, REV NICARAGNENSE BIO, V1, P43; McKaye K.R., 1976, INVESTIGATIONS ICHTH; Nagl S, 1998, P NATL ACAD SCI USA, V95, P14238, DOI 10.1073/pnas.95.24.14238; Nielsen EE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-276; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Oleksiak MF, 2010, J FISH BIOL, V76, P1067, DOI 10.1111/j.1095-8649.2010.02563.x; Perez GAC, 2007, MOL PHYLOGENET EVOL, V43, P91, DOI 10.1016/j.ympev.2006.08.012; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Posada D., 2004, COLLAPSE VER 1 2 TOO; Pritchard JK, 2000, GENETICS, V155, P945; Recknagel H, 2013, G3-GENES GENOM GENET, V3, P65, DOI 10.1534/g3.112.003897; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Ripa J, 2009, EVOL ECOL, V23, P31, DOI 10.1007/s10682-008-9267-z; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salazar C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000930; Sato A, 2003, MOL BIOL EVOL, V20, P1448, DOI 10.1093/molbev/msg151; SCHENEKAR T, 2011, HEREDITY, DOI DOI 10.1038/HDY.2011.48.PUBMED:21731052; Schliewen UK, 2006, NATURE, V444, pE12, DOI 10.1038/nature05419; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; SCHMIDT DL, 1994, NATURE, V368, P39, DOI 10.1038/368039a0; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Stauffer JR, 2008, P BIOL SOC WASH, V121, P117, DOI 10.2988/06-37.1; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; SUSSMAN D, 1985, J VOLCANOL GEOTH RES, V24, P249, DOI 10.1016/0377-0273(85)90072-1; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	104	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74901	10.1371/journal.pone.0074901	http://dx.doi.org/10.1371/journal.pone.0074901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086393	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200050
J	Salpea, KD; Maubaret, CG; Kathagen, A; Ken-Dror, G; Gilroy, DW; Humphries, SE				Salpea, Klelia D.; Maubaret, Cecilia G.; Kathagen, Annegret; Ken-Dror, Gie; Gilroy, Derek W.; Humphries, Steve E.			The Effect of Pro-Inflammatory Conditioning and/or High Glucose on Telomere Shortening of Aging Fibroblasts	PLOS ONE			English	Article							OXIDATIVE STRESS; REPLICATIVE SENESCENCE; MITOCHONDRIAL-DNA; ENDOTHELIAL-CELLS; DISEASE-ACTIVITY; LENGTH; ASSOCIATION; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS; MAINTENANCE	Cardiovascular disease and diabetes have been linked to shorter telomeres, but it is not yet clear which risk factors contribute to shorter telomeres in patients. Our aim was to examine whether pro-inflammatory conditioning, in combination or not with high glucose, result in a higher rate of telomere shortening during in vitro cellular ageing. Human fibroblasts from four donors were cultured for 90 days in: 1) medium lacking ascorbic acid only, 2) 10 mM buthionine sulphoximine (BSO) (pro-oxidant), 3) 25 mM D-glucose, 4) 1 ng/ml IL1B and 5) 25 mM D-glucose+1 ng/ml IL1B. Telomere length was measured with qPCR and intracellular reactive oxygen species (ROS) content and cell death with flow cytometry. Cultures treated with high glucose and BSO displayed a significantly lower growth rate, and cultures treated with IL1B showed a trend towards a higher growth rate, compared to the control [Glucose: 0.14 PD/day, p<0.001, BSO: 0.11 PD/day, p=0.006 and IL1B: 0.19 PD/day, p=0.093 vs. Control: 0.16 PD/day]. Telomere shortening with time was significantly accelerated in cultures treated with IL1B compared to the control [IL1B: 20.8%/day (95% CI: -1.1, -0.5) vs. Control: -0.6%/day (95% CI: -0.8, -0.3), p=0.012]. The hastening of telomere shortening by IL1B was only in part attenuated after adjustment for the number of cell divisions [IL1B: -4.1%/PD (95% CI: -5.7, -2.4) vs. Control: -2.5%/PD (95% CI: -4.4, -0.7), p=0.067]. The intracellular ROS content displayed 69% increase (p=0.033) in BSO compared to the control. In aging fibroblasts, pro-inflammatory conditioning aggravates the shortening of telomeres, an effect which was only in part driven by increased cell turnover. High glucose alone did not result in greater production of ROS or telomere shortening.	UCL, Ctr Cardiovasc Genet, Div Med, London WC1E 6BT, England; [Salpea, Klelia D.; Kathagen, Annegret; Ken-Dror, Gie; Humphries, Steve E.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece; [Maubaret, Cecilia G.; Gilroy, Derek W.] UCL, Ctr Clin Pharmacol & Therapeut, Div Med, London, England	University of London; University College London; Alexander Fleming Biomedical Sciences Research Center; University of London; University College London	Salpea, KD (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece.	salpea@fleming.gr; cecilia.maubaret@isped.u-bordeaux2.fr	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020	Gilroy, Derek/0000-0003-3476-0844; Humphries, Stephen E/0000-0002-8221-6547	British Heart Foundation [FS/06/053, RG2005/014]; Binks Trust; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Binks Trust; British Heart Foundation(British Heart Foundation)	Funding was provided by the British Heart Foundation for Klelia D. Salpea (FS/06/053) and Steve E. Humphries (RG2005/014) and by the Binks Trust for Cecilia G. Maubaret. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chen W, 2009, ATHEROSCLEROSIS, V205, P620, DOI 10.1016/j.atherosclerosis.2009.01.021; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huda N, 2007, AGING CELL, V6, P709, DOI 10.1111/j.1474-9726.2007.00330.x; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; SCHONFELD P, 1990, FEBS LETT, V264, P246, DOI 10.1016/0014-5793(90)80259-L; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188; Uziel O, 2007, EXP GERONTOL, V42, P971, DOI 10.1016/j.exger.2007.07.005; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Wu CH, 2007, LUPUS, V16, P265, DOI 10.1177/0961203307077155; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73756	10.1371/journal.pone.0073756	http://dx.doi.org/10.1371/journal.pone.0073756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086293	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200013
J	Garcia-Garcera, M; Garcia-Etxebarria, K; Coscolla, M; Latorre, A; Calafell, F				Garcia-Garcera, Marc; Garcia-Etxebarria, Koldo; Coscolla, Mireia; Latorre, Amparo; Calafell, Francesc			A New Method for Extracting Skin Microbes Allows Metagenomic Analysis of Whole-Deep Skin	PLOS ONE			English	Article							GUT MICROBIOTA; FAST PROGRAM; DIVERSITY; HEALTH; COMMUNITY	In the last decade, an extensive effort has been made to characterize the human microbiota, due to its clinical and economic interests. However, a metagenomic approach to the skin microbiota is hampered by the high proportion of host DNA that is recovered. In contrast with the burgeoning field of gut metagenomics, skin metagenomics has been hindered by the absence of an efficient method to avoid sequencing the host DNA. We present here a method for recovering microbial DNA from skin samples, based on a combination of molecular techniques. We have applied this method to mouse skin, and have validated it by standard, quantitative PCR and amplicon sequencing of 16S rRNA. The taxonomic diversity recovered was not altered by this new method, as proved by comparing the phylogenetic structure revealed by 16S rRNA sequencing in untreated vs. treated samples. As proof of concept, we also present the first two mouse skin metagenomes, which allowed discovering new taxa (not only prokaryotes but also viruses and eukaryots) not reachable by 16S rRNA sequencing, as well as to characterize the skin microbiome functional landscape. Our method paves the way for the development of skin metagenomics, which will allow a much deeper knowledge of the skin microbiome and its relationship with the host, both in a healthy state and in relation to disease.	[Garcia-Garcera, Marc; Garcia-Etxebarria, Koldo; Coscolla, Mireia; Calafell, Francesc] Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Catalonia, Spain; [Garcia-Garcera, Marc; Latorre, Amparo] Univ Valencia, Ctr Publ Hlth Res CSISP, Joint Res Unit Genom & Hlth, Valencia, Spain; [Garcia-Garcera, Marc; Latorre, Amparo] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Coscolla, Mireia] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Valencia; University of Valencia; University of Basel; Swiss Tropical & Public Health Institute	Calafell, F (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Catalonia, Spain.	francesc.calafell@upf.edu	Latorre, Amparo/E-4997-2015; Calafell, Francesc/C-8595-2014; Coscolla, Mireia/ABD-7942-2021; Garcia-Etxebarria, Koldo/AAQ-4638-2021	Latorre, Amparo/0000-0002-9146-7284; Calafell, Francesc/0000-0002-1083-9438; Garcia-Etxebarria, Koldo/0000-0002-6107-9416; Garcia-Garcera, Marc/0000-0001-6408-7561; Coscolla, Mireia/0000-0003-0752-0538	Spanish Ministry of Science and Innovation (MICINN) [SAF2010-16240, BFU2009-12895-CO2-01, BES-2008-006029]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (MICINN)[grant numbers SAF2010-16240 and BFU2009-12895-CO2-01]. MGG was supported by a predoctoral fellowship from the Spanish Ministry of Scienceand Innovation [Grant number BES-2008-006029]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; BELDAFERRE P, 2011, ISME J, V6, P1, DOI DOI 10.1038/ISMEJ.2011.85.PUBMED:21716308; Bennett MF, 2008, J INVEST DERM SYMP P, V13, P15, DOI 10.1038/jidsymp.2008.3; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Butler JE, 2000, IMMUNOLOGY, V100, P119, DOI 10.1046/j.1365-2567.2000.00013.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Docktor MJ, 2012, INFLAMM BOWEL DIS, V18, P935, DOI 10.1002/ibd.21874; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garcia-Garcera M, 2012, ENVIRON MICROBIOL, V14, P2087, DOI 10.1111/j.1462-2920.2012.02756.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; MAKARENKOV V, 2002, ECOLOGY, V2, P1; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; NG KP, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GEN0MEA.00148-12.PUBMED:23409267; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369	44	14	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74914	10.1371/journal.pone.0074914	http://dx.doi.org/10.1371/journal.pone.0074914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073227	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000324768000036
J	Liu, CS; Wang, Q; Xian, M; Ding, YM; Zhao, G				Liu, Changshui; Wang, Qi; Xian, Mo; Ding, Yamei; Zhao, Guang			Dissection of Malonyl-Coenzyme A Reductase of Chloroflexus aurantiacus Results in Enzyme Activity Improvement	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEHYDROGENASE; PATHWAY; GENE; BIOSYNTHESIS; ACID	The formation of fusion protein in biosynthetic pathways usually improves metabolic efficiency either channeling intermediates and/or colocalizing enzymes. In the metabolic engineering of biochemical pathways, generating unnatural protein fusions between sequential biosynthetic enzymes is a useful method to increase system efficiency and product yield. Here, we reported a special case. The malonyl-CoA reductase (MCR) of Chloroflexus aurantiacus catalyzes the conversion of malonyl-CoA to 3-hydroxypropionate (3HP), and is a key enzyme in microbial production of 3HP, an important platform chemical. Functional domain analysis revealed that the N-terminal region of MCR (MCR-N; amino acids 1-549) and the C-terminal region of MCR (MCR-C; amino acids 550-1219) were functionally distinct. The malonyl-CoA was reduced into free intermediate malonate semialdehyde with NADPH by MCR-C fragment, and further reduced to 3HP by MCR-N fragment. In this process, the initial reduction of malonyl-CoA was rate limiting. Site-directed mutagenesis demonstrated that the TGXXXG(A)X(1-2) G and YXXXK motifs were important for enzyme activities of both MCR-N and MCR-C fragments. Moreover, the enzyme activity increased when MCR was separated into two individual fragments. Kinetic analysis showed that MCR-C fragment had higher affinity for malonyl-CoA and 4-time higher K-cat/K-m value than MCR. Dissecting MCR into MCR-N and MCR-C fragments also had a positive effect on the 3HP production in a recombinant Escherichia coli strain. Our study showed the feasibility of protein dissection as a new strategy in biosynthetic systems.	[Liu, Changshui; Wang, Qi; Xian, Mo; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Xian, Mo; Zhao, Guang] Chinese Acad Sci, Key Lab Biobased Mat, Qingdao, Shandong, Peoples R China; [Liu, Changshui; Wang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhao, G (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China.	zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972; ding, yamei/0000-0002-8972-9468	CAS [Y112141105, KSCX2-EW-G-13]; Director Innovation Foundation of QIBEBT; National Natural Scientific Foundation of China [31200030]; National Science and Technology Program [2012BAD32B06-2]; National 863 Program of China [SS2013AA050703-2]	CAS(Chinese Academy of Sciences); Director Innovation Foundation of QIBEBT; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Program; National 863 Program of China(National High Technology Research and Development Program of China)	This research was financially supported by the 100-Talent Project of CAS (for GZ), Director Innovation Foundation of QIBEBT, CAS (Y112141105), National Natural Scientific Foundation of China (31200030), Main Direction Program of Knowledge Innovation of CAS (KSCX2-EW-G-13), National Science and Technology Program (2012BAD32B06-2), and National 863 Program of China (SS2013AA050703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YJ, 2011, APPL MICROBIOL BIOT, V91, P1545, DOI 10.1007/s00253-011-3304-5; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Membrillo-Hernandez J, 2000, J BIOL CHEM, V275, P33869, DOI 10.1074/jbc.M005464200; Mendez-Perez D, 2012, METAB ENG, V14, P298, DOI 10.1016/j.ymben.2012.04.005; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Rathnasingh C, 2012, J BIOTECHNOL, V157, P633, DOI 10.1016/j.jbiotec.2011.06.008; ROSSMANN MG, 1978, MOL CELL BIOCHEM, V21, P161; Wang Q, 2012, J MICROBIOL, V50, P693, DOI 10.1007/s12275-012-2234-y; Werpy T, 2004, TOP VALUE ADDED CHEM, VI, DOI [10.2172/15008859, DOI 10.2172/15008859]; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486	15	24	26	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75554	10.1371/journal.pone.0075554	http://dx.doi.org/10.1371/journal.pone.0075554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073271	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000081
J	Gudiol, C; Ayats, J; Camoez, M; Dominguez, MA; Garcia-Vidal, C; Bodro, M; Ardanuy, C; Obed, M; Arnan, M; Antonio, M; Carratala, J				Gudiol, Carlota; Ayats, Josefina; Camoez, Mariana; Angeles Dominguez, M.; Garcia-Vidal, Carolina; Bodro, Marta; Ardanuy, Carmen; Obed, Mora; Arnan, Montserrat; Antonio, Maite; Carratala, Jordi			Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes	PLOS ONE			English	Article							RESISTANT ENTEROCOCCUS; BACTEREMIA; EMERGENCE; FAECALIS; VIRULENCE; MORTALITY	We conducted a prospective study to assess the risk factors, molecular epidemiology and outcome of bloodstream infection (BSI) due to Enterococcus faecium in hospitalized cancer patients. Between 2006 and 2012, a significant increase in vancomycin-susceptible E. faecium BSI was observed among cancer patients. Comparison of 54 episodes of BSI due to E. faecium with 38 episodes of BSI due to E. faecalis showed that previous use of carbapenems was the only independent risk factor for E. faecium acquisition (OR 10.24; 95% CI, 1.35-77.66). All E. faecium isolates were susceptible to glycopeptides, whereas 97% showed high-level resistance to ampicillin and ciprofloxacin. All 30 isolates available for genotyping belonged to the hospital-associated E. faecium lineages 17, 18 and 78. After 2009, most of the isolates belonged to ST117 (lineage 78). Patients with E. faecium BSI were more likely to receive inadequate initial empirical antibiotic therapy than patients with E. faecalis BSI, and time to adequate empirical antibiotic therapy was also longer in the former group. No significant differences were found between the two groups regarding early and overall case-fatality rates. Independent risk factors for overall case-fatality were current corticosteroids (OR 4.18; 95% CI, 1.34-13.01) and intensive care unit admission (OR 9.97; 95% CI, 1.96-50.63). The emergence of E. faecium among cancer patients is a concern since there are limited treatment options and it may presage the emergence of vancomycin-resistant enterococci. A rationale approach that combines infection control with antimicrobial stewardship.	[Gudiol, Carlota; Garcia-Vidal, Carolina; Bodro, Marta; Obed, Mora; Carratala, Jordi] Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Gudiol, Carlota; Garcia-Vidal, Carolina; Bodro, Marta; Obed, Mora; Carratala, Jordi] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Ayats, Josefina; Camoez, Mariana; Angeles Dominguez, M.; Ardanuy, Carmen] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Arnan, Montserrat] Univ Barcelona, Dept Haematol, Hosp Duran & Reynals, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Antonio, Maite] Univ Barcelona, Dept Oncol, Hosp Duran & Reynals, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Gudiol, Carlota; Camoez, Mariana; Angeles Dominguez, M.; Garcia-Vidal, Carolina; Bodro, Marta; Carratala, Jordi] Inst Salud Carlos III, REIPI Spanish Network Res Infect Dis, Madrid, Spain; [Ayats, Josefina; Ardanuy, Carmen] Inst Salud Carlos III, CIBERes CIBER Enfermedades Resp, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Gudiol, C (corresponding author), Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain.	cgudiol@iconcologia.net; jcarratala@bellvitgehospital.cat	Bodro, Marta/D-7022-2019; Carratalà, Jordi/B-8410-2011; Ardanuy, Carmen/C-4463-2015; Carratala, Jordi/AAC-2639-2020; Camoez, Mariana/ACK-3178-2022; Bodro, Marta/AEN-0866-2022; Bodro, Marta/E-4199-2018	Carratalà, Jordi/0000-0003-3209-2563; Carratala, Jordi/0000-0003-3209-2563; Bodro, Marta/0000-0002-0520-8279; Camoez, Mariana/0000-0002-7517-6874; Antonio, Maite/0000-0002-7611-8529; Garcia-Vidal, Carolina/0000-0002-8915-0683; Dominguez, M. Angeles/0000-0003-3107-9586; Gudiol, Carlota/0000-0003-3095-4422; Ardanuy, Carmen/0000-0003-0225-607X; Ayats, Josefina/0000-0002-9998-1325	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases(Instituto de Salud Carlos III); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain	This study was supported by research grant REIPI RD06/0008 from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases. MB is the recipient of a research grant from the Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain. The funding sources had no role in the study design, the collection, analysis and interpretation of the data or the decision to submit the manuscript for publication. Only the authors had full access to the data files for the study. The authors do not have any relationship that may constitute a dual or conflicting interest.	Almyroudis NG, 2011, INFECT CONT HOSP EP, V32, P490, DOI 10.1086/659408; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; BOYCE JM, 1992, ANTIMICROB AGENTS CH, V36, P1032, DOI 10.1128/AAC.36.5.1032; Cherif Honar, 2003, Hematol J, V4, P420, DOI 10.1038/sj.thj.6200334; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Conde-Estevez D, 2011, EUR J CLIN MICROBIOL, V30, P103, DOI 10.1007/s10096-010-1029-5; Coque TM, 2005, ANTIMICROB AGENTS CH, V49, P2693, DOI 10.1128/AAC.49.7.2693-2700.2005; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; Fortun J, 2002, J ANTIMICROB CHEMOTH, V50, P1003, DOI 10.1093/jac/dkf216; Freitas AR, 2010, ANTIMICROB AGENTS CH, V54, P2660, DOI 10.1128/AAC.00134-10; Garbutt JM, 2000, CLIN INFECT DIS, V30, P466, DOI 10.1086/313694; Ghanem G, 2007, INFECT CONT HOSP EP, V28, P1054, DOI 10.1086/519932; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Martinez-Odriozola P, 2007, ENFERM INFEC MICR CL, V25, P503, DOI 10.1157/13109986; McBride SJ, 2010, EUR J CLIN MICROBIOL, V29, P107, DOI 10.1007/s10096-009-0830-5; Mishra NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043958; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; NOSKIN GA, 1995, CLIN INFECT DIS, V20, P296, DOI 10.1093/clinids/20.2.296; Pan SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047297; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; Rice LB, 2003, J INFECT DIS, V187, P508, DOI 10.1086/367711; Rice LB, 2001, EMERG INFECT DIS, V7, P183, DOI 10.3201/eid0702.010205; Suppola JP, 1998, SCAND J INFECT DIS, V30, P153, DOI 10.1080/003655498750003546; Todeschini G, 2006, J INFECTION, V53, P266, DOI 10.1016/j.jinf.2005.11.012; Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07; Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Werner G, 2008, Euro Surveill, V13; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]	35	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74734	10.1371/journal.pone.0074734	http://dx.doi.org/10.1371/journal.pone.0074734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069339	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300040
J	Kiss-Toth, E; Harlock, E; Lath, D; Quertermous, T; Wilkinson, JM				Kiss-Toth, Endre; Harlock, Edward; Lath, Darren; Quertermous, Thomas; Wilkinson, J. Mark			A TNF Variant that Associates with Susceptibility to Musculoskeletal Disease Modulates Thyroid Hormone Receptor Binding to Control Promoter Activation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOTAL HIP-ARTHROPLASTY; RHEUMATOID-ARTHRITIS; WEAR DEBRIS; OSTEOCLAST DIFFERENTIATION; PERIPROSTHETIC OSTEOLYSIS; FUNCTIONAL-ANALYSIS; ADHERENT ENDOTOXIN; GENE-EXPRESSION; BONE-RESORPTION	Tumor necrosis factor (TNF) is a powerful pro-inflammatory cytokine and immuno-regulatory molecule, and modulates susceptibility to musculoskeletal diseases. Several meta-analyses and replicated association studies have implicated the minor 'A' variant within the TNF promoter single nucleotide polymorphism (SNP) rs361525 (-238A/G) as a risk allele in joint related disorders, including psoriatic and juvenile idiopathic arthritis, and osteolysis after joint arthroplasty. Here we characterized the effect of this variant on TNF promoter function. A transcriptional reporter, encoding the -238A variant of the TNF promoter, resulted in 2.2 to 2.8 times greater transcriptional activation versus the 'G' variant in murine macrophages when stimulated with pro-inflammatory stimuli. Bioinformatic analysis predicted a putative binding site for thyroid hormone receptor (TR) for the -238A but not the -238G allele. Overexpression of TR-alpha induced promoter expression 1.8-fold in the presence of the 'A' allele only. TR-alpha expression both potentiated and sensitized the -238A response to LPS or a titanium particulate stimulus, whilst siRNA knockdown of either THRA or THRB impaired transcriptional activation for the -238A variant only. This effect was independent of receptor-ligand binding of triiodothyronine. Immunohistochemical analysis of osteolysis interface membranes from patients undergoing revision surgery confirmed expression of TR-alpha within osteoclast nuclei at the resorption surface. The 'A' allele at rs361525 confers increased transcriptional activation of the TNF promoter and influences susceptibility to several arthritic conditions. This effect is modulated, at least in part, by binding of TR, which both sensitizes and potentiates transcriptional activation of the 'A' variant independent of its endogenous ligand.	[Kiss-Toth, Endre] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Harlock, Edward; Lath, Darren; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Quertermous, Thomas] Stanford Univ, Cardiovasc Res Inst, Stanford, CA 94305 USA	University of Sheffield; University of Sheffield; Stanford University; Stanford University	Kiss-Toth, E (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	e.kiss-toth@sheffield.ac.uk	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017	Sheffield NIHR Bone BRU; Fondation Leducq	Sheffield NIHR Bone BRU; Fondation Leducq(Leducq Foundation)	This work was funded by the Sheffield NIHR Bone BRU and the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu EO, 1997, BONE, V21, P137, DOI 10.1016/S8756-3282(97)00097-5; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bassett JHD, 2008, MOL ENDOCRINOL, V22, P501, DOI 10.1210/me.2007-0221; Bayley JP, 2001, CYTOKINE, V14, P316, DOI 10.1006/cyto.2001.0902; Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082; Childs LM, 2001, J BONE MINER RES, V16, P338, DOI 10.1359/jbmr.2001.16.2.338; Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; Gallo J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-109; Gordon A, 2010, J ORTHOP RES, V28, P1127, DOI 10.1002/jor.21135; Greenfield EM, 2008, J AM ACAD ORTHOP SUR, V16, pS56, DOI 10.5435/00124635-200800001-00012; Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6; Kaijzel EL, 1998, MOL MED, V4, P724, DOI 10.1007/BF03401767; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; LEE ME, 1991, J BIOL CHEM, V266, P19034; Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Monfoulet LE, 2011, J BONE MINER RES, V26, P2036, DOI 10.1002/jbmr.432; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Roux S, 2000, ARTHRITIS RES, V2, P451, DOI 10.1186/ar127; Sabokbar A, 2003, J ORTHOP RES, V21, P73, DOI 10.1016/S0736-0266(02)00106-7; Sapey E, 2010, AM J RESP CRIT CARE, V182, P192, DOI 10.1164/rccm.200912-1846OC; Schmeling H, 2006, CLIN EXP RHEUMATOL, V24, P103; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Suttamanatwong S, 2009, J CELL BIOCHEM, V107, P284, DOI 10.1002/jcb.22124; Takagi M, 2011, J CLIN EXP HEMATOP, V51, P77, DOI 10.3960/jslrt.51.77; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Touma Z, 2010, ARCH MED RES, V41, P142, DOI 10.1016/j.arcmed.2010.02.002; Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010; Wilkinson JM, 2003, J BONE MINER RES, V18, P1995, DOI 10.1359/jbmr.2003.18.11.1995; Zou YF, 2010, AUTOIMMUNITY, V43, P264, DOI 10.3109/08916930903509049	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76034	10.1371/journal.pone.0076034	http://dx.doi.org/10.1371/journal.pone.0076034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069456	Green Accepted, Green Published, gold			2022-12-25	WOS:000324777300103
J	Dodd, PJ; Knight, GM; Lawn, SD; Corbett, EL; White, RG				Dodd, Peter J.; Knight, Gwenan M.; Lawn, Stephen D.; Corbett, Elizabeth L.; White, Richard G.			Predicting the Long-Term Impact of Antiretroviral Therapy Scale-Up on Population Incidence of Tuberculosis	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; HIV-ASSOCIATED TUBERCULOSIS; INFECTION; COUNTRIES; SETTINGS; EPIDEMIC; BURDEN; WILL; AIDS	Objective: To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis disease (TB) incidence in sub-Saharan Africa. Methods: We used a mathematical model to consider the effect of different assumptions about life expectancy and TB risk during long-term ART under alternative scenarios for trends in population HIV incidence and ART coverage. Results: All the scenarios we explored predicted that the widespread introduction of ART would initially reduce population-level TB incidence. However, many modelled scenarios projected a rebound in population-level TB incidence after around 20 years. This rebound was predicted to exceed the TB incidence present before ART scale-up if decreases in HIV incidence during the same period were not sufficiently rapid or if the protective effect of ART on TB was not sustained. Nevertheless, most scenarios predicted a reduction in the cumulative TB incidence when accompanied by a relative decline in HIV incidence of more than 10% each year. Conclusions: Despite short-term benefits of ART scale-up on population TB incidence in sub-Saharan Africa, longer-term projections raise the possibility of a rebound in TB incidence. This highlights the importance of sustaining good adherence and immunologic response to ART and, crucially, the need for effective HIV preventive interventions, including early widespread implementation of ART.	[Dodd, Peter J.; Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Dodd, Peter J.; Knight, Gwenan M.; Lawn, Stephen D.; Corbett, Elizabeth L.; White, Richard G.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, HIV & TB Grp, Blantyre, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Malawi	Dodd, PJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.	peter.dodd@lshtm.ac.uk	Knight, Gwen/AAF-1176-2020; Knight, Gwen/AGE-2703-2022; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Corbett, Elizabeth/0000-0002-3552-3181; Dodd, Pete/0000-0001-5825-9347; Knight, Gwenan/0000-0002-7263-9896	Bill and Melinda Gates Foundation [19790.01, 21675]; Wellcome Trust, London, UK; Medical Research Council (UK) [G0802414, MR/J005088/1]; Medical Research Council [MR/J005088/1, G0802414] Funding Source: researchfish; MRC [G0802414, MR/J005088/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust, London, UK(Wellcome Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PJD is funded by the Consortium to Respond Effectively to the AIDS/TB Epidemic (19790.01) grant from the Bill and Melinda Gates Foundation. SDL and ELC are funded by the Wellcome Trust, London, UK. RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414), grant (MR/J005088/1), and the Consortium to Respond Effectively to the AIDS/TB Epidemic (19790.01) grant from the Bill and Melinda Gates Foundation (21675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB TUB CONTR WHO R; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, AM J RESP CRITICAL C, V170, P673; Cornell M, 2011, AIDS LONDON ENGLAND, V24, P2263; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Dimairo M, 2009, CROI; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Middelkoop K, 2011, INT J TUBERC LUNG D, V15, P1714, DOI 10.5588/ijtld.11.0545; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rangaka M, 2013, EFFECT TUBERCULIN SK; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	31	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75466	10.1371/journal.pone.0075466	http://dx.doi.org/10.1371/journal.pone.0075466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069418	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000324547300084
J	O'Connell, R; Chishinga, N; Kinyanda, E; Patel, V; Ayles, H; Weiss, HA; Seedat, S				O'Connell, Rebecca; Chishinga, Nathaniel; Kinyanda, Eugene; Patel, Vikram; Ayles, Helen; Weiss, Helen A.; Seedat, Soraya			Prevalence and Correlates of Alcohol Dependence Disorder among TB and HIV Infected Patients in Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; DSM-IV; ANTIRETROVIRAL THERAPY; DRINKING PATTERNS; MENTAL-DISORDERS; SEXUAL-BEHAVIOR; TUBERCULOSIS; RISK; ASSOCIATION	Objectives: To determine the prevalence and correlates of alcohol dependence disorders in persons receiving treatment for HIV and Tuberculosis (TB) at 16 Primary Health Care centres (PHC) across Zambia. Methods: 649 adult patients receiving treatment for HIV and/or TB at PHCs in Zambia (363 males, 286 females) were recruited between 1st December 2009 and 31st January 2010. Data on socio-demographic variables, clinical disease features (TB and HIV), and psychopathological status were collected. The Mini International Neuropsychiatric Interview (MINI) was used to diagnose alcohol dependence disorder. Correlates of alcohol dependence were analyzed for men only, due to low prevalence in women. Univariable and multivariable logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI), using general estimating equations to allow for within-PHC clustering. Results: The prevalence of alcohol dependence was 27.2% (95% CI: 17.7-39.5%) for men and 3.9% (95% CI: 1.4-0.1%) for women. Factors associated with alcohol dependence disorder in men included being single, divorced or widowed compared with married (adjusted OR = 1.47, 95% CI: 1.00-2.14) and being unemployed (adjusted OR = 1.30, 95% CI: 1.01-1.67). The highest prevalence of alcohol dependence was among HIV-test unknown TB patients (34.7%), and lowest was among HIV positive patients on treatment but without TB (14.1%), although the difference was not statistically significant (p = 0.38). Conclusions: Male TB/HIV patients in this population have high prevalence of alcohol dependence disorder, and prevalence differs by HIV/TB status. Further work is needed to explore interventions to reduce harmful drinking in this population.	[O'Connell, Rebecca; Chishinga, Nathaniel; Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Chishinga, Nathaniel; Ayles, Helen] Zambian Aids Related TB Project ZAMBART, Sch Med, Lusaka, Zambia; [Patel, Vikram] London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth Intervent Res, London WC1, England; [Kinyanda, Eugene] Uganda Virus Res Inst, AIDS Unit, Med Res Council, Entebbe, Uganda; [Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1, England; [Seedat, Soraya] Univ Stellenbosch, South African Res Chairs Program, ZA-7505 Tygerberg, Western Cape, South Africa; [Seedat, Soraya] Univ Stellenbosch, MRC Stress & Anxiety Disorders Unit, ZA-7505 Tygerberg, Western Cape, South Africa; [Seedat, Soraya] Univ Stellenbosch, Dept Psychiat, ZA-7505 Tygerberg, Western Cape, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; Stellenbosch University; Stellenbosch University	O'Connell, R (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	rebecca.oconnell@bartshealth.nhs.uk	kinyanda, eugene/HGC-3554-2022; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Seedat, Soraya/0000-0002-5118-786X; Ayles, Helen/0000-0003-4108-2842; Patel, Vikram/0000-0003-1066-8584	Evidence for Action on HIV treatment and care systems (EfA) research consortium; UK Department for International Development (DFID); MRC [MC_U950088495, G0700837] Funding Source: UKRI; Medical Research Council [G0700837, MC_U950088495] Funding Source: researchfish	Evidence for Action on HIV treatment and care systems (EfA) research consortium; UK Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by the Evidence for Action on HIV treatment and care systems (EfA) research consortium. EfA is funded by the UK Department for International Development (DFID), for the benefit of developing countries. The views expressed are not necessarily those of DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuda W, 2011, AM J ADDICTION, V20, P87, DOI 10.1111/j.1521-0391.2010.00111.x; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; APA, 2013, IAGN STAT MAN MENT D, V5; Azar MM, 2010, DRUG ALCOHOL DEPEND; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bernards S, 2009, ADDICTION, V104, P1658, DOI 10.1111/j.1360-0443.2009.02667.x; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Clausen T, 2009, ADDICTION, V104, P1147, DOI 10.1111/j.1360-0443.2009.02559.x; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; CSO CSOCZaMII, 2009, AMB 2007 DEM HLTH SU; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Greenfield SF, 2010, ALCOHOL CLIN EXP RES, V34, P317, DOI 10.1111/j.1530-0277.2009.01094.x; Greenfield TK, 2010, AIDS BEHAV, V14, P84, DOI 10.1007/s10461-010-9734-8; Hahn JA, 2010, AIDS BEHAV, V14, P1265, DOI 10.1007/s10461-010-9768-y; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hasin DS, 2004, ARCH GEN PSYCHIAT, V61, P891, DOI 10.1001/archpsyc.61.9.891; Jaquet A, 2010, ADDICTION, V105, P1416, DOI 10.1111/j.1360-0443.2010.02978.x; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Kalichman SC, 2007, JAIDS-J ACQ IMM DEF, V44, P594, DOI 10.1097/QAI.0b013e3180415e07; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman Seth C, 2011, Am J Public Health, V101, pe9, DOI 10.2105/AJPH.2011.300236; Kullgren G, 2009, AFR J PSYCHIATRY, V12, P52; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Li TK, 2007, ADDICTION, V102, P1522, DOI 10.1111/j.1360-0443.2007.01911.x; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Mavedzenge SN, 2011, JAIDS-J ACQ IMM DEF, V58, P89, DOI 10.1097/QAI.0b013e3182254038; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; National AIDS Council Z NAC, 2008, AT STRAT PREV HIV AI; Olley BO, 2003, SAMJ S AFR MED J, V93, P928; Papas RK, 2011, ADDICTION, V106, P2156, DOI 10.1111/j.1360-0443.2011.03518.x; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2007, ANN EPIDEMIOL, V17, pS87, DOI 10.1016/j.annepidem.2007.01.019; Pithey A, 2009, SAHARA J-J SOC ASP H, V6, P155, DOI 10.1080/17290376.2009.9724944; Ray LA, 2009, ADDICT BEHAV, V34, P587, DOI 10.1016/j.addbeh.2009.03.028; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Smit J, 2006, Afr Health Sci, V6, P215; Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965; Suliman S, 2010, J STUD ALCOHOL DRUGS, V71, P695, DOI 10.15288/jsad.2010.71.695; UNAIDS, 2010, UN COUNTR PROGR REP; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2008, WORLD HLTH SURV ZAMB; WHO, 2010, HO GLOB TUB CONTR; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2007, INT CLASS DIS; Wu ES, 2011, JAIDS-J ACQ IMM DEF, V56, pE129, DOI 10.1097/QAI.0b013e31820dc1c8; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	61	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74406	10.1371/journal.pone.0074406	http://dx.doi.org/10.1371/journal.pone.0074406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069309	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324547300040
J	Roubille, F; Delseny, D; Cristol, JP; Merle, D; Salvetat, N; Larue, C; Davy, JM; Leclercq, F; Pasquie, JL; Guerrier, L; Fareh, J; Dupuy, AM				Roubille, Francois; Delseny, Delphine; Cristol, Jean-Paul; Merle, Delphine; Salvetat, Nicolas; Larue, Catherine; Davy, Jean-Marc; Leclercq, Florence; Pasquie, Jean-Luc; Guerrier, Luc; Fareh, Jeannette; Dupuy, Anne-Marie			Depletion of proBNP(1-108) in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides	PLOS ONE			English	Article							GENERAL-POPULATION; NT-PROBNP; BNP; ASSAYS; DYSFUNCTION; PROHORMONE; PRECURSOR; BLOOD	Background: After synthesis by cardiomyocytes, precursor proBNP(1-108) is cleaved into NT-proBNP and BNP. Recently, cross-reactivity between these assays was discussed. The aim of this study was to characterize the cross-reactivities, through a new biochemical innovative approach consisting in the total depletion of the circulating proBNP1-108 in patients with heart failure (HF). Methods: This prospective study included 180 patients with chronic HF. BNP and NT-proBNP were dosed with commercial kits. ProBNP(1-108) was determined using an ELISA research assay specific to the precursor. ProBNP1-108 depletion was performed by immunocapture with a specific antibody targeting exclusively the ProBNP1-108 hinge region. ProBNP1-108, BNP and NT-proBNP levels were determined before and after depletion using this process in HF patients. Results: Mean age was 74.34 +/- 12.5 y, and 69% of patients were males. NYHA classes II and III were the most frequent (32% and 45% respectively). Before depletion, ProBNP1-108, NT-proBNP and BNP levels were 316.8+/-265.9 pg/ml; 6,054.0+/-11,539 pg/ml and 684.3+/-82.1 pg/ml respectively, and were closely correlated with NHYA classes. After immuno-depletion, proBNP1-108 was decreased in mean by 96% (p<0.0001), BNP by 53% (p<0.0001) and NT-proBNP by 5%. The relationship between BNP or NT-proBNP and NHYA classes remained unchanged. Conclusion: Current BNP and NT-proBNP assays measured as well proBNP molecule. This cross reactivity percentage has been controversial. Thanks to the removal of circulating proBNP1-108 with our immunodepletion process, we are now able to assess the remaining "true" BNP and NT-proBNP molecules and further evaluate their clinical relevance.	[Roubille, Francois; Delseny, Delphine; Davy, Jean-Marc; Leclercq, Florence; Pasquie, Jean-Luc] Univ Montpellier I, Dept Cardiol, Univ Hosp Montpellier, Montpellier, France; [Roubille, Francois] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Cristol, Jean-Paul; Dupuy, Anne-Marie] Univ Montpellier I, Dept Biochem, Univ Hosp Montpellier, Montpellier, France; [Merle, Delphine; Salvetat, Nicolas; Fareh, Jeannette] SysDiag, CNRS Biorad UMR3145, Montpellier, France; [Larue, Catherine; Guerrier, Luc] Biorad Labs, Marnes La Coquette, France	Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Universite de Montpellier; CHU de Montpellier	Roubille, F (corresponding author), Univ Montpellier I, Dept Cardiol, Univ Hosp Montpellier, Montpellier, France.	francois.roubille@gmail.com	Pasquié, Jean Luc/O-2216-2018	Pasquié, Jean Luc/0000-0003-3773-5804; LARUE, Catherine/0000-0002-5803-4671; dupuy, anne marie/0000-0001-6538-3944; SALVETAT, Nicolas/0000-0002-0759-5129	BIO-RAD; Federation Francaise de Cardiologie	BIO-RAD; Federation Francaise de Cardiologie	Both Association Calipso and Association Coeur et Recherche received grants for their research activities from BIO-RAD. Dr Roubille received grants for research from the Federation Francaise de Cardiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargnoux AS, 2008, CLIN CHEM LAB MED, V46, P1019, DOI 10.1515/CCLM.2008.192; Choi EY, 2012, AM HEART J, V164, P251, DOI 10.1016/j.ahj.2012.05.010; Clerico A, 2006, AM J PHYSIOL-HEART C, V290, pH17, DOI 10.1152/ajpheart.00684.2005; Dries DL, 2010, CIRC-HEART FAIL, V3, P220, DOI 10.1161/CIRCHEARTFAILURE.109.903153; Emdin M, 2011, J AM COLL CARDIOL, V57, P1396, DOI 10.1016/j.jacc.2010.09.075; Giuliani I, 2006, CLIN CHEM, V52, P1054, DOI 10.1373/clinchem.2005.061770; Goetze JP, 2010, RESULTS PROBL CELL D, V50, P97, DOI 10.1007/400_2009_25; Hawkridge AM, 2005, P NATL ACAD SCI USA, V102, P17442, DOI 10.1073/pnas.0508782102; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Lam CSP, 2007, J AM COLL CARDIOL, V49, P1193, DOI 10.1016/j.jacc.2006.12.024; Liang FQ, 2007, J AM COLL CARDIOL, V49, P1071, DOI 10.1016/j.jacc.2006.10.063; Luckenbill KN, 2008, CLIN CHEM, V54, P619, DOI 10.1373/clinchem.2007.097998; Macheret F, 2011, J AM COLL CARDIOL, V57, P1386, DOI 10.1016/j.jacc.2011.01.005; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miller WL, 2012, CLIN CHIM ACTA, V413, P920, DOI 10.1016/j.cca.2012.02.007; Mogelvang R, 2007, J AM COLL CARDIOL, V50, P1694, DOI 10.1016/j.jacc.2007.07.073; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Savic-Radojevic A, 2013, J CLIN LAB ANAL; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Seferian KR, 2008, CLIN CHEM, V54, P866, DOI 10.1373/clinchem.2007.100040; Seferian KR, 2007, CLIN CHEM, V53, P866, DOI 10.1373/clinchem.2006.076141; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75174	10.1371/journal.pone.0075174	http://dx.doi.org/10.1371/journal.pone.0075174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069392	Green Published, gold			2022-12-25	WOS:000324547300072
J	Nelson, CD; Sheng, M				Nelson, Christopher D.; Sheng, Morgan			GPR3 Stimulates A beta Production via Interactions with APP and beta-Arrestin2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; ALPHA(1B)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; CLATHRIN ADAPTER; MEIOTIC ARREST; GENERATION; PRECURSOR; MUTATION	The orphan G protein-coupled receptor (GPCR) GPR3 enhances the processing of Amyloid Precursor Protein (APP) to the neurotoxic beta-amyloid (A beta) peptide via incompletely understood mechanisms. Through overexpression and shRNA knockdown experiments in HEK293 cells, we show that beta-arrestin2 (barr2), a GPCR-interacting scaffold protein reported to bind c-secretase, is an essential factor for GPR3-stimulated A beta production. For a panel of GPR3 receptor mutants, the degree of stimulation of A beta production correlates with receptor-beta-arrestin binding and receptor trafficking to endocytic vesicles. However, GPR3's recruitment of barr2 cannot be the sole explanation, because interaction with barr2 is common to most GPCRs, whereas GPR3 is relatively unique among GPCRs in enhancing A beta production. In addition to beta-arrestin, APP is present in a complex with GPR3 and stimulation of A beta production by GPR3 mutants correlates with their level of APP binding. Importantly, among a broader selection of GPCRs, only GPR3 and prostaglandin E receptor 2 subtype EP2 (PTGER2; another GPCR that increases A beta production) interact with APP, and PTGER2 does so in an agonist-stimulated manner. These data indicate that a subset of GPCRs, including GPR3 and PTGER2, can associate with APP when internalized via barr2, and thereby promote the cleavage of APP to generate A beta.	[Nelson, Christopher D.; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech	Sheng, M (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	sheng.morgan@gene.com		Sheng, Morgan/0000-0002-8703-5366				Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; GUAN XM, 1992, J BIOL CHEM, V267, P21995; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2010, APP MUTATIONS TABLE; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Konvicka K, 2000, PROTEIN ENG, V13, P395, DOI 10.1093/protein/13.6.395; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Page RM, 2012, J NEUROSCI, V32, P18204, DOI 10.1523/JNEUROSCI.2681-12.2012; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Scheer A, 2000, MOL PHARMACOL, V57, P219; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	43	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74680	10.1371/journal.pone.0074680	http://dx.doi.org/10.1371/journal.pone.0074680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069330	gold, Green Submitted, Green Published			2022-12-25	WOS:000326240100115
J	Yang, Z; Garcia, A; Xu, SL; Powell, DR; Vertino, PM; Singh, S; Marcus, AI				Yang, Zhen; Garcia, Anapatricia; Xu, Songli; Powell, Doris R.; Vertino, Paula M.; Singh, Shivendra; Marcus, Adam I.			Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; WITHAFERIN-A; PROGNOSTIC-SIGNIFICANCE; INTERMEDIATE-FILAMENTS; REGULATED EXPRESSION; VIMENTIN EXPRESSION; UP-REGULATION; CELL-CYCLE; CARCINOMA; APOPTOSIS	Though clinicians can predict which patients are at risk for developing metastases, traditional therapies often prove ineffective and metastatic disease is the primary cause of cancer patient death; therefore, there is a need to develop anti-metastatic therapies that can be administered over long durations to specifically inhibit the motility of cancer cells. Withania somnifera root extracts (WRE) have anti-proliferative activity and the active component, Withaferin A, inhibits the pro-metastatic protein, vimentin. Vimentin is an intermediate filament protein and is part of the epithelial to mesenchymal transition (EMT) program to promote metastasis. Here, we determined whether WRE standardized to Withaferin A (sWRE) possesses anti-metastatic activity and whether it inhibits cancer motility via inhibition of vimentin and the EMT program. Several formulations of sWRE were created to enrich for Withaferin A and a stock solution of sWRE in EtOH could recover over 90% of the Withaferin A found in the original extract powder. This sWRE formulation inhibited breast cancer cell motility and invasion at concentrations less than 1 mu M while having negligible cytotoxicity at this dose. sWRE treatment disrupted vimentin morphology in cell lines, confirming its vimentin inhibitory activity. To determine if sWRE inhibited EMT, TGF-beta was used to induce EMT in MCF10A human mammary epithelial cells. In this case, sWRE prevented EMT induction and inhibited 3-D spheroid invasion. These studies were taken into a human xenograft and mouse mammary carcinoma model. In both models, sWRE and Withaferin A showed dose-dependent inhibition of tumor growth and metastatic lung nodule formation with minimal systemic toxicity. Taken together, these data support the hypothesis that low concentrations of sWRE inhibit cancer metastasis potentially through EMT inhibition. Moreover, these doses of sWRE have nearly no toxicity in normal mouse organs, suggesting the potential for clinical use of orally administered WRE capsules.	[Yang, Zhen; Xu, Songli; Marcus, Adam I.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Garcia, Anapatricia] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Powell, Doris R.; Vertino, Paula M.] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Sch Med, Atlanta, GA USA; [Singh, Shivendra] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA USA; [Singh, Shivendra] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marcus, AI (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	aimarcu@emory.edu			National Center for Complementary and Alternative Medicine [1R21AT005231]; Godfrey Charitable Trust; Golfer's Against Cancer; P30 CCSG [3P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA077337] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT005231] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Godfrey Charitable Trust; Golfer's Against Cancer; P30 CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by an R21 from the National Center for Complementary and Alternative Medicine (1R21AT005231) awarded to AIM, the Godfrey Charitable Trust, and Golfer's Against Cancer. This work was also supported by a P30 CCSG awarded to the Winship Cancer Institute (3P30CA138292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Ali M, 1997, PHYTOCHEMISTRY, V44, P1163, DOI 10.1016/S0031-9422(96)00656-5; ANDREOLI JM, 1995, CELL MOTIL CYTOSKEL, V32, P10, DOI 10.1002/cm.970320103; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; Choo Jennifer R, 2010, Cancers (Basel), V2, P1040, DOI 10.3390/cancers2021040; Christina AJM, 2004, J ETHNOPHARMACOL, V93, P359, DOI 10.1016/j.jep.2004.04.004; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Das Chaurasiya N, 2008, PHYTOCHEM ANALYSIS, V19, P148, DOI 10.1002/pca.1029; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Domagala W, 1996, CLIN CANCER RES, V2, P147; Eckes B, 2000, J CELL SCI, V113, P2455; Fan LY, 2012, SCAND J RHEUMATOL, V41, P354, DOI 10.3109/03009742.2012.670263; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Grogan PT, 2013, INVEST NEW DRUG, V31, P545, DOI 10.1007/s10637-012-9888-5; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Holwell TA, 1997, J CELL SCI, V110, P1947; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kusinska RU, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-118; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Leyon PV, 2004, PHYTOTHER RES, V18, P118, DOI 10.1002/ptr.1378; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Lund N, 2010, BIOCHEM BIOPH RES CO, V395, P401, DOI 10.1016/j.bbrc.2010.04.033; Mathur R, 2006, J ETHNOPHARMACOL, V105, P336, DOI 10.1016/j.jep.2005.11.020; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Misra L, 2008, PHYTOCHEMISTRY, V69, P1000, DOI 10.1016/j.phytochem.2007.10.024; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Prakash J, 2001, PHYTOTHER RES, V15, P240, DOI 10.1002/ptr.779; Rodriguez Luis G., 2004, V294, P23; Roxanis I, 2013, J CLIN PATHOL, V66, P517, DOI 10.1136/jclinpath-2012-201348; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Senthilnathan P, 2006, CHEM-BIOL INTERACT, V159, P180, DOI 10.1016/j.cbi.2005.11.003; Singh S, 2003, CANCER RES, V63, P2306; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Sun BC, 2008, CLIN CANCER RES, V14, P7050, DOI 10.1158/1078-0432.CCR-08-0520; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Urn HJ, 2012, BIOCHEM BIOPH RES CO, V427, P24, DOI 10.1016/j.bbrc.2012.08.133; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Viale Giuseppe, 2009, Eur J Cancer, V45 Suppl 1, P5, DOI 10.1016/S0959-8049(09)70011-5; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wei JC, 2008, ANTICANCER RES, V28, P327; Yamashita N, 2013, J CANCER RES CLIN, V139, P739, DOI 10.1007/s00432-013-1376-6; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	67	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75069	10.1371/journal.pone.0075069	http://dx.doi.org/10.1371/journal.pone.0075069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069380	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326240100120
J	Lim, KS; Lim, KJ; Price, AC; Orr, BA; Eberhart, CG; Bar, EE				Lim, K. S.; Lim, K. J.; Price, A. C.; Orr, B. A.; Eberhart, C. G.; Bar, E. E.			Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner	ONCOGENE			English	Article						hypoxia; monocarboxylate transporter-4; stem cells; glioma	HYPOXIA-INDUCIBLE FACTORS; MALIGNANT GLIOMA; LACTIC-ACID; OXYGEN; GROWTH; EXPRESSION; MCT4; ACTIVATION; EXPANSION; PATHWAY	Hypoxic regions are frequent in glioblastoma (GBM), the most common type of malignant adult brain tumor, and increased levels of tumor hypoxia have been associated with worse clinical outcomes. To unmask genes important in hypoxia, we treated GBM neurospheres in hypoxia and identified monocarboxylate transporter-4 (MCT4) as one of the most upregulated genes. To investigate the clinical importance of MCT4 in GBM, we examined clinical outcomes and found that MCT4 overexpression is associated with shorter patient survival. Consistent with this, MCT4 upregulation correlated with the aggressive mesenchymal subset of GBM, and MCT4 downregulation correlated with the less aggressive G-CIMP (Glioma CpG Methylator Phenotype) subset of GBM. Immunohistochemical analysis of tissue microarrays confirmed that MCT4 protein levels were increased in high-grade as compared with lower-grade astrocytomas, further suggesting that MCT4 is a clinically relevant target. To test the requirement for MCT4 in vitro, we transduced neurospheres with lentiviruses encoding short-hairpin RNAs (shRNAs) against MCT4, resulting in growth inhibition of 50-80% under hypoxia in two lines. MCT4 knockdown was associated with a decreased percentage of cells expressing the stem-cell marker CD133 and increased apoptotic fraction. We also found that flow-sorted CD133-positive cells had almost sixfold higher MCT4 levels than CD133-negative cells, suggesting that the stem-like population might have a greater requirement for MCT4. Most importantly, MCT4 silencing also slowed GBM intracranial xenograft growth in vivo. Interestingly, whereas MCT4 is a well-characterized lactate exporter, we found that both intracellular and extracellular lactate levels did not change following MCT4 silencing, suggesting a novel lactate export-independent mechanism for growth inhibition in GBMs. To identify this potential mechanism, we performed microarray analysis on control and shMCT4-expressing neurospheres and found a dramatic reduction in the expression of multiple Hypoxia-Inducible Factor (HIF)-regulated genes following MCT4 knockdown. The overall reduction in HIF transcriptional response was further validated using a hypoxia response element (HRE)dependent green-fluorescent protein (GFP) reporter line.	[Lim, K. S.; Lim, K. J.; Price, A. C.; Eberhart, C. G.; Bar, E. E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Orr, B. A.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Eberhart, C. G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Eberhart, C. G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bar, E. E.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA	Johns Hopkins University; St Jude Children's Research Hospital; Johns Hopkins University; Johns Hopkins University; Case Western Reserve University	Bar, EE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Robbins Bldg,Room E750A,10900 Euclid Ave, Cleveland, OH 44106 USA.	eli.bar@case.edu	Orr, Brent/N-8068-2018		Brain Tumor Funders Collaborative;  [R01 NS55089]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	Brain Tumor Funders Collaborative; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Brain Tumor Funders Collaborative and R01 NS55089.	Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Bar EE, 2011, BRAIN PATHOL, V21, P119, DOI 10.1111/j.1750-3639.2010.00460.x; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Cheng C, 2012, CELL ONCOL, V35, P217, DOI 10.1007/s13402-012-0081-9; Chiche J, 2012, INT J CANCER, V130, P1511, DOI 10.1002/ijc.26125; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Colen CB, 2011, NEOPLASIA, V13, P620, DOI 10.1593/neo.11134; Collins PC, 1998, BIOTECHNOL PROGR, V14, P466, DOI 10.1021/bp980032e; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Ehtesham M, 2007, ONCOGENE, V26, P5752, DOI 10.1038/sj.onc.1210359; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Froberg MK, 2001, NEUROREPORT, V12, P761, DOI 10.1097/00001756-200103260-00030; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1; Kobayashi M, 2005, BIOL PHARM BULL, V28, P1197, DOI 10.1248/bpb.28.1197; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lin Q, 2008, GENE REGUL SYST BIO, V2, P43; Mathupala SP, 2004, NEUROSURGERY, V55, P1410, DOI 10.1227/01.NEU.0000143034.62913.59; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Pistollato F, 2009, STEM CELLS, V27, P7, DOI 10.1634/stemcells.2008-0402; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Wang Q, 2013, MOL BIOL REP, V40, P3723, DOI 10.1007/s11033-012-2448-4; Westerman KA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-96; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Zhang KL, 2012, J NEUROIMMUNE PHARM, V7, P740, DOI 10.1007/s11481-012-9359-y; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935; Zhu LL, 2011, CELL REPROGRAM, V13, P113, DOI 10.1089/cell.2010.0043	49	48	48	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4433	4441		10.1038/onc.2013.390	http://dx.doi.org/10.1038/onc.2013.390			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24077291	Green Accepted			2022-12-25	WOS:000341157800008
J	Tannour-Louet, M; Lewis, SK; Louet, JF; Stewart, J; Addai, JB; Sahin, A; Vangapandu, HV; Lewis, AL; Dittmar, K; Pautler, RG; Zhang, LX; Smith, RG; Lamb, DJ				Tannour-Louet, Mounia; Lewis, Shaye K.; Louet, Jean-Francois; Stewart, Julie; Addai, Josephine B.; Sahin, Aysegul; Vangapandu, Hima V.; Lewis, Annisa L.; Dittmar, Kristin; Pautler, Robia G.; Zhang, Lixin; Smith, Roy G.; Lamb, Dolores J.			Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies	FASEB JOURNAL			English	Article						biomarkers; adjuvant therapy; RNAi; xenografts	DOSE PULSE CALCITRIOL; PHASE-II TRIAL; 24-HYDROXYLASE ACTIVITY; CANDIDATE ONCOGENE; OVARIAN-CANCER; D SYSTEM; CELLS; DEXAMETHASONE; CARCINOMAS; DOCETAXEL	A major limitation of exogenous vitamin D-3 administration for the treatment of prostate cancer is the marginal, if any, clinical efficacy. We dissected the basis for the resistance to the vitamin D-3 antitumor properties and specifically examined the effect of its major catabolic enzyme, CYP24A1, in prostate cancer. Local CYP24A1 expression levels and the effect of selective modulation were analyzed using tissue microarrays from needle core biopsy specimens and xenograft-bearing mouse models. CYP24A1 mRNA was elevated in malignant human prostate tissues compared to benign lesions. High CYP24A1 protein levels were seen in poorly differentiated and highly advanced stages of prostate cancer and correlated with parallel increase in the tumor proliferation rate. The use of CYP24A1 RNAi enhanced the cytostatic effects of vitamin D-3 in human prostate cancer cells. Remarkably, subcutaneous and orthotopic xenografts of prostate cancer cells harboring CYP24A1 shRNA resulted in a drastic reduction in tumor volume when mice were subjected to vitamin D-3 supplementation. CYP24A1 may be a predictive marker of vitamin D-3 clinical efficacy in patients with advanced prostate cancer. For those with up-regulated CYP24A1, combination therapy with RNAi targeting CYP24A1 could be considered to improve clinical responsiveness to vitamin D-3.Tannour-Louet, M., Lewis, S. K., Louet, J.-F., Stewart, J., Addai, J. B., Sahin, A., Vangapandu, H. V., Lewis, A. L., Dittmar, K., Pautler, R. G., Zhang, L., Smith, R. G., Lamb, D. J. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D-3-based therapies.	[Tannour-Louet, Mounia; Lewis, Shaye K.; Stewart, Julie; Addai, Josephine B.; Sahin, Aysegul; Vangapandu, Hima V.; Zhang, Lixin; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Louet, Jean-Francois; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Pautler, Robia G.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Pautler, Robia G.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Lamb, Dolores J.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Lewis, Annisa L.] Weill Cornell Med Coll, Dept Pathol, Houston, TX USA; [Dittmar, Kristin] Weill Cornell Med Coll, Dept Radiol, Houston, TX USA; [Dittmar, Kristin] Methodist Hosp, Houston, TX 77030 USA; [Smith, Roy G.] Scripps Res Inst Florida, Dept Metab & Aging, Jupiter, FL USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cornell University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Scripps Research Institute	Tannour-Louet, M (corresponding author), Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA.	mounia.louet@gmail.com	Dittmar, Kristin/E-8815-2015; Zhang, Li/GWM-7501-2022; TANNOUR LOUET, Mounia/G-5413-2017; Mounia, TANNOUR LOUET/T-2622-2019	TANNOUR LOUET, Mounia/0000-0003-0614-063X; Mounia, TANNOUR LOUET/0000-0003-0614-063X; Louet, Jean-Francois/0000-0002-1626-7098; Vangapandu, Hima/0000-0003-4762-1990	U.S. Department of Defense, Prostate Cancer Research Program Idea Development Award [W81XWH-07-1-0022 PC061154]; William and Ella Owens Medical Research Foundation; Prostate Cancer Research Initiative; U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) [1C76HF02799-01-00]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083014] Funding Source: NIH RePORTER	U.S. Department of Defense, Prostate Cancer Research Program Idea Development Award; William and Ella Owens Medical Research Foundation; Prostate Cancer Research Initiative; U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the U.S. Department of Defense, Prostate Cancer Research Program Idea Development Award W81XWH-07-1-0022 PC061154 to D.J.L.; a William and Ella Owens Medical Research Foundation grant to M. T. L. and D.J.L.; and a Prostate Cancer Research Initiative grant to D.J.L. The authors thank the Mouse Phenotype Core at Baylor College of Medicine, supported by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) grant 1C76HF02799-01-00. The authors declare no conflicts of interest.	Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Bareis P, 2001, BIOCHEM BIOPH RES CO, V285, P1012, DOI 10.1006/bbrc.2001.5289; Beer TM, 2004, CANCER EPIDEM BIOMAR, V13, P2225; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Cross HS, 2005, J STEROID BIOCHEM, V97, P121, DOI 10.1016/j.jsbmb.2005.06.005; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Flaig TW, 2006, CANCER-AM CANCER SOC, V107, P266, DOI 10.1002/cncr.21982; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Liu G, 2003, CLIN CANCER RES, V9, P4077; Ly LH, 1999, ENDOCRINOLOGY, V140, P2071, DOI 10.1210/en.140.5.2071; Miller GJ, 1995, CLIN CANCER RES, V1, P997; Mimori K, 2004, ANN ONCOL, V15, P236, DOI 10.1093/annonc/mdh056; Mitschele T, 2004, LAB INVEST, V84, P693, DOI 10.1038/labinvest.3700096; Parise RA, 2006, INT J CANCER, V119, P1819, DOI 10.1002/ijc.22058; Peehl DM, 2002, J UROLOGY, V168, P1583, DOI 10.1016/S0022-5347(05)64525-9; Schwartz GG, 2009, ANN EPIDEMIOL, V19, P96, DOI 10.1016/j.annepidem.2008.03.007; Schwartz GG, 2005, CLIN CANCER RES, V11, P8680, DOI 10.1158/1078-0432.CCR-05-1237; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tiffany NM, 2005, J UROLOGY, V174, P888, DOI 10.1097/01.ju.0000169261.42298.e6; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; Weiss MM, 2003, J PATHOL, V200, P320, DOI 10.1002/path.1359	26	43	45	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					364	372		10.1096/fj.13-236109	http://dx.doi.org/10.1096/fj.13-236109			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24081904	Green Published			2022-12-25	WOS:000333526100034
J	DeBerg, HA; Blehm, BH; Sheung, J; Thompson, AR; Bookwalter, CS; Torabi, SF; Schroer, TA; Berger, CL; Lu, Y; Trybus, KM; Selvin, PR				DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Thompson, Andrew R.; Bookwalter, Carol S.; Torabi, Seyed F.; Schroer, Trina A.; Berger, Christopher L.; Lu, Yi; Trybus, Kathleen M.; Selvin, Paul R.			Motor Domain Phosphorylation Modulates Kinesin-1 Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Jun N-terminal Kinase (JNK); Kinesin; Molecular Motors; Phosphorylation; Single-molecule Biophysics	AXONAL-TRANSPORT; ANDROGEN RECEPTOR; LIGHT-CHAINS; TAIL DOMAIN; DYNEIN; PURIFICATION; HUNTINGTIN; PROTEINS; BINDING; EXPRESSION	Disruptions in microtubule motor transport are associated with a variety of neurodegenerative diseases. Post-translational modification of the cargo-binding domain of the light and heavy chains of kinesin has been shown to regulate transport, but less is known about how modifications of the motor domain affect transport. Here we report on the effects of phosphorylation of a mammalian kinesin motor domain by the kinase JNK3 at a conserved serine residue (Ser-175 in the B isoform and Ser-176 in the A and C isoforms). Phosphorylation of this residue has been implicated in Huntington disease, but the mechanism by which Ser-175 phosphorylation affects transport is unclear. The ATPase, microtubule-binding affinity, and processivity are unchanged between a phosphomimetic S175D and a nonphosphorylatable S175A construct. However, we find that application of force differentiates between the two. Placement of negative charge at Ser-175, through phosphorylation or mutation, leads to a lower stall force and decreased velocity under a load of 1 piconewton or greater. Sedimentation velocity experiments also show that addition of a negative charge at Ser-175 favors the autoinhibited conformation of kinesin. These observations imply that when cargo is transported by both dynein and phosphorylated kinesin, a common occurrence in the cell, there may be a bias that favors motion toward the minus-end of microtubules. Such bias could be used to tune transport in healthy cells when properly regulated but contribute to a disease state when misregulated.	[DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Selvin, Paul R.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Selvin, Paul R.] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Torabi, Seyed F.; Lu, Yi] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Thompson, Andrew R.; Bookwalter, Carol S.; Berger, Christopher L.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Schroer, Trina A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Vermont; Johns Hopkins University	Selvin, PR (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	selvin@illinois.edu	liu, yi/GXE-9662-2022; Lu, Yi/GQQ-1069-2022; Lu, Yi/B-5461-2010	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709; Thompson, Andrew/0000-0001-8537-6776; Schroer, Trina/0000-0002-5065-1835	National Institutes of Health [GM068625, GM078097, GM101066, ES016865, GM044589]; National Science Foundation [1063188, 0822613]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044589, R01GM068625, R01GM101066, R56GM044589, R01GM078097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068625 (to P.R.S.), GM078097 (to K.M.T.), GM101066 (to C.L.B.), ES016865 (to Y.L.), and GM044589 (to T.A.S.). This work was also supported by National Science Foundation Grants 1063188 and 0822613 (to P.R.S.).	Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Blehm BH, 2013, P NATL ACAD SCI USA, V110, P3381, DOI 10.1073/pnas.1219961110; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Crowe J., 1992, QIAEXPRESSIONIST, p[79, 81, 82]; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Li MH, 2011, BIOCHEMISTRY-US, V50, P8645, DOI 10.1021/bi2008257; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Piccioni F, 2001, BRAIN RES BULL, V56, P215, DOI 10.1016/S0361-9230(01)00652-9; Pierce DW, 1998, METHOD ENZYMOL, V298, P154, DOI 10.1016/S0076-6879(98)98016-8; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	39	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32612	32621		10.1074/jbc.M113.515510	http://dx.doi.org/10.1074/jbc.M113.515510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072715	Green Published, hybrid			2022-12-25	WOS:000328681700043
J	Liu, JX; Newby, G; Brackery, A; Gueye, CS; Candari, CJ; Escubil, LR; Vestergaard, LS; Baquilod, M				Liu, Jenny X.; Newby, Gretchen; Brackery, Aprielle; Gueye, Cara Smith; Candari, Christine J.; Escubil, Luz R.; Vestergaard, Lasse S.; Baquilod, Mario			Determinants of Malaria Program Expenditures during Elimination: Case Study Evidence from Select Provinces in the Philippines	PLOS ONE			English	Article								Even though eliminating malaria from the endemic margins is a part of the Global Malaria Action Plan, little guidance exists on what resources are needed to transition from controlling malaria to eliminating it. Using Philippines as an example, this study aimed to (1) estimate the financial resources used by sub-national malaria programs in different phases during elimination and (2) understand how different environmental and organizational factors may influence expenditure levels and spending proportions. The Philippines provides an opportunity to study variations in sub-national programs because its epidemiological and ecological diversity, devolved health system, and progressive elimination strategy all allow greater flexibility for lower-level governments to direct activities, but also create challenges for coordination and resource mobilization. Through key informant interviews and archival record retrieval in four selected provinces chosen based on eco-epidemiological variation, expenditures associated with provincial malaria programs were collected for selected years (mid-1990s to 2010). Results show that expenditures per person at risk per year decrease as programs progress from a state of controlled low-endemic malaria to elimination to prevention of reintroduction regardless of whether elimination was deliberately planned. However, wide variation across provinces were found: expenditures were generally higher if mainly financed with donor grants, but were moderated by the level of economic development, the level of malaria transmission and receptivity, and the capacity of program staff. Across all provinces, strong leadership appears to be a necessary condition for maintaining progress and is vital in controlling outbreaks. While sampled provinces and years may not be representative of other sub-national malaria programs, these findings suggest that the marginal yearly cost declines with each phase during elimination.	[Liu, Jenny X.; Newby, Gretchen; Gueye, Cara Smith] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Brackery, Aprielle] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Candari, Christine J.; Baquilod, Mario] Govt Philippines, Dept Hlth, Manila, Philippines; [Vestergaard, Lasse S.] WHO, Philippines Country Off, Manila, Philippines	University of California System; University of California San Francisco; Columbia University; Philippine Department Health; WHO Western Pacific Regional Office; World Health Organization	Liu, JX (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	liuj@globalhealth.ucsf.edu		Candari, Christine Joy/0000-0002-0168-0947	Bill and Melinda Gates Foundation; World Health Organization Philippines Country Office; Asia Pacific Malaria Elimination Network through the Australian Agency for International Development (AusAID)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); World Health Organization Philippines Country Office; Asia Pacific Malaria Elimination Network through the Australian Agency for International Development (AusAID)	This study was supported by grants from the Bill and Melinda Gates Foundation, the World Health Organization Philippines Country Office, and the Asia Pacific Malaria Elimination Network through a grant from the Australian Agency for International Development (AusAID). Technical assistance and in-kind contributions were provided by the Philippines Department of Health. Lasse S. Vestergaard is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the World Health Organization. Mario Bauquilod and Christine J. Candari are staff members of the Philippines Department of Health. Their views expressed in this publication do not necessarily represent the views of the Government of the Philippines. No individuals from the Bill and Melinda Gates Foundation and the Asia Pacific Malaria Elimination Network had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; *BACK ROLL MAL PAR, 2008, GLOB MAL ACT PLAN MA; Beaver C., 2011, INT J GEOINFORMATICS, V7, P15; *CAV PROV HLTH TEA, 1998, MAL CAS; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; COTTER C, 2013, LANCET; Espino F, 2004, INT J HEALTH PLAN M, V19, pS155, DOI 10.1002/hpm.782; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; *INT REV SERV, 1987, REV PROC ACC COST RE; ISIDORO M, 2007, ENVIRON URBAN, V19, P191, DOI DOI 10.1177/0956247807076782; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; *REP PHI DEP HLTH, 2004, EV MAL SIT PROV BENG; *REP PHIL DEP HLTH, 2005, EV MAL SIT PROV CAV; *REP PHIL DEP HLTH, 2011, MAL MED TERM DEV PLA, P2011; *REP PHIL DEP HLTH, 2012, MAL CAS DEATHS; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832; *WORLD BANK, 2012, WORLD DEV IND 2012 P; World Health Organization, 2007, MAL EL FIELD MAN LOW	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73352	10.1371/journal.pone.0073352	http://dx.doi.org/10.1371/journal.pone.0073352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086279	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900014
J	Zhong, W; Hua, BZ				Zhong, Wen; Hua, Baozhen			Mating Behaviour and Copulatory Mechanism in the Scorpionfly Neopanorpa longiprocessa (Mecoptera: Panorpidae)	PLOS ONE			English	Article							RESOURCE-DEFENSE POLYGYNY; MALE-FEMALE CONFLICT; SEXUAL SELECTION; MALE GENITALIA; POSTGENITAL SEGMENTS; ANIMAL GENITALIA; SPERM TRANSFER; NUPTIAL GIFTS; NOTAL ORGAN; INSECTA	Sexual conflict during copulation may drive morphological and behavioral evolution in insects. Although nuptial feeding behaviour is well studied in Panorpa, whether this behaviour is universal in Panorpidae remains unknown. The scorpionfly Neopanorpa longiprocessa Hua & Chou, 1997 was investigated for its mating behaviour, functional morphology of the notal organ, and external genitalia using light microscopy and scanning electron microscopy. The results show that the mating behaviour is not associated with nuptial feeding in N. longiprocessa. The morphological basis of this non-nuptial copulation is likely related to the developed notal organ of the male. The notal organ serves a function to seize wings of the female during copulation. Only males that succeed in seizing the female with the notal organ are able to establish genital contact and copulate. The male genitalia exhibit distinct species-specific modification. The epandrium (tergum IX) has evolved a pair of ventral bulbs to grasp the subgenital plate of the female. The hypandrium (sternum IX) has a pair of dorsal processes to control the abdominal end of the female. These results indicate that nuptial feeding is not a universal behaviour in Panorpidae. Presumably, these grasping apparatuses compensate the scorpionflies that fail to provide nuptial gifts, as exemplified by N. longiprocessa.	[Zhong, Wen; Hua, Baozhen] Northwest A&F Univ, Entomol Museum, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Hua, BZ (corresponding author), Northwest A&F Univ, Entomol Museum, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125]; Ministry of Science and Technology of China (MOST) [2006FY120100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China)	This research was financially supported by the National Natural Science Foundation of China (grant no. 31172125) and the Ministry of Science and Technology of China (MOST grant no. 2006FY120100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; BYERS GEORGE W., 1963, ANN ENTOMOL SOC AMER, V56, P142; Byers George W., 1994, Annals of Carnegie Museum, V63, P185; BYERS GEORGE W., 1954, ANN ENT SOC AMER, V47, P484; BYERS GEORGE W., 1965, PACIFIC INSECTS, V7, P705; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CARPENTER FRANK M., 1931, PSYCHE, V38, P41, DOI 10.1155/1931/43706; Chapman R.F., 2012, INSECTS STRUCTURE FU; Chau H.C.-S., 1978, University of Kansas Science Bulletin, V51, P341; CHENG F. Y., 1957, BULL MUS COMP ZOOL HARVARD UNIV, V116, P1; Crampton G. C., 1922, Transactions of the American Entomological Society, V48, P207; CRAMPTON G. C., 1931, PSYCHE, V38, P1, DOI 10.1155/1931/28135; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard WG, 2004, ANN ENTOMOL SOC AM, V97, P1007, DOI 10.1603/0013-8746(2004)097[1007:FMOTMG]2.0.CO;2; Eberhard WG, 2004, BIOL REV, V79, P121, DOI 10.1017/S1464793103006237; Eberhard WG, 2003, TRENDS ECOL EVOL, V18, P438, DOI 10.1016/S0169-5347(03)00180-0; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Engels S, 2008, J ZOOL SYST EVOL RES, V46, P133, DOI 10.1111/j.1439-0469.2007.00438.x; Engels S, 2006, BEHAV ECOL, V17, P628, DOI 10.1093/beheco/ark007; Engqvist L, 2003, ETHOLOGY, V109, P911, DOI 10.1046/j.1439-0310.2003.00937.x; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; Engqvist L, 2007, EVOL ECOL, V21, P801, DOI 10.1007/s10682-006-9152-6; Engqvist L, 2007, EVOLUTION, V61, P1489, DOI 10.1111/j.1558-5646.2007.00107.x; Engqvist L, 2007, ECOL ENTOMOL, V32, P327, DOI 10.1111/j.1365-2311.2006.00835.x; Engqvist L, 2007, BEHAV ECOL SOCIOBIOL, V61, P703, DOI 10.1007/s00265-006-0300-3; Engqvist L, 2007, EVOL ECOL, V21, P49, DOI 10.1007/s10682-006-9123-y; Engqvist L, 2011, BEHAV ECOL, V22, P345, DOI 10.1093/beheco/arq211; Grell Karl Gottlieb, 1942, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V67, P513; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hua Baozheng, 1997, Entomotaxonomia, V19, P273; Hua Baozheng, 1997, Entomotaxonomia, V19, P213; ISSIKI SYUTI, 1933, JAPANESE JOUR ZOOL, V4, P315; Kock D, 2008, J ZOOL SYST EVOL RES, V46, P137, DOI 10.1111/j.1439-0469.2007.00454.x; Kock D, 2006, BEHAV ECOL SOCIOBIOL, V60, P528, DOI 10.1007/s00265-006-0196-y; Kock D, 2007, J CHEM ECOL, V33, P1249, DOI 10.1007/s10886-007-9304-3; Kock D, 2009, BEHAV ECOL, V20, P639, DOI 10.1093/beheco/arp043; Kullmann H, 2005, ZOOL ANZ, V244, P1, DOI 10.1016/j.jcz.2004.12.003; Kullmann H, 2009, ECOL ENTOMOL, V34, P153, DOI 10.1111/j.1365-2311.2008.01039.x; Lewis S, 2011, CURR BIOL, V21, pR644, DOI 10.1016/j.cub.2011.05.046; Ma N, 2012, SYST BIODIVERS, V10, P159, DOI 10.1080/14772000.2012.683459; Ma N, 2011, ACTA ZOOL-STOCKHOLM, V92, P398, DOI 10.1111/j.1463-6395.2010.00474.x; Ma N, 2011, EUR J ENTOMOL, V108, P493, DOI 10.14411/eje.2011.064; Ma N, 2010, MICRON, V41, P931, DOI 10.1016/j.micron.2010.07.008; MICKOLEIT G, 1976, ZOOMORPHOLOGIE, V85, P133, DOI 10.1007/BF00995408; MICKOLEIT G, 1975, Z MORPHOL TIERE, V80, P97; MICKOLEIT G, 1971, Z MORPHOL TIERE, V69, P1, DOI 10.1007/BF00294385; Missoweit M, 2008, EVOL ECOL, V22, P689, DOI 10.1007/s10682-007-9191-7; Missoweit M, 2007, ANIM BEHAV, V74, P1207, DOI 10.1016/j.anbehav.2006.10.028; MIYAKE T, 1913, J COLL AGR IMPERIAL, V4, P265; Palmer Christopher M., 2010, Terrestrial Arthropod Reviews, V3, P111, DOI 10.1163/187498310X519716; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; PENNY N D, 1979, Acta Amazonica, V9, P365; Potter E., 1938, T ROY ENT SOC LONDON, V87, P467; Sauer KP, 1998, NATURWISSENSCHAFTEN, V85, P219, DOI 10.1007/s001140050487; Sirot LK, 2003, FLA ENTOMOL, V86, P124, DOI 10.1653/0015-4040(2003)086[0124:TEOIMS]2.0.CO;2; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; THORNHILL R, 1979, ENVIRON ENTOMOL, V8, P886, DOI 10.1093/ee/8.5.886; THORNHILL R, 1981, ANNU REV ECOL SYST, V12, P355, DOI 10.1146/annurev.es.12.110181.002035; THORNHILL R, 1992, ANIM BEHAV, V44, P867, DOI 10.1016/S0003-3472(05)80583-4; Thornhill R, 1973, GREAT LAKES ENTOMOL, V6, P47; Thornhill R, 1991, BEHAV ECOL, V2, P156, DOI 10.1093/beheco/2.2.156; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P153; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P96	71	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74781	10.1371/journal.pone.0074781	http://dx.doi.org/10.1371/journal.pone.0074781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086373	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700035
J	Freeley, SJ; Giorgini, A; Tulone, C; Popat, RJ; Horsfield, C; Robson, MG				Freeley, Simon J.; Giorgini, Angela; Tulone, Calogero; Popat, Reena J.; Horsfield, Catherine; Robson, Michael G.			Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice	PLOS ONE			English	Article							IMMUNE-COMPLEX GLOMERULONEPHRITIS; INTRINSIC RENAL-CELLS; ACTIVATE B-CELLS; MURINE LUPUS; MEDIATED GLOMERULONEPHRITIS; INDUCTION; STIMULATION; ENGAGEMENT; EXPRESSION; NEPHRITIS	Systemic lupus erythematosus is an autoimmune disease with a high morbidity and nephritis is a common manifestation. Previous studies in murine lupus models have suggest a role for Toll-like receptor 2 and 4. We examined the role of these molecules in MRL lpr mice which is one of the most established and robust murine models. We compared disease parameters in Toll-like receptor 2 or Toll-like receptor 4 deficient mice with their littermate controls. We found no difference in the severity of glomerulonephritis as assessed by histology, serum creatinine and albuminuria when Toll-like receptor 2 or Toll-like receptor 4 deficient MRLlpr mice were compared with Toll-like receptor sufficient controls. We also found similar levels of anti-dsDNA and anti-ssDNA antibodies. These results show that Toll-like receptor 2 and Toll-like receptor 4 do not play a significant role in MRLlpr mice, and therefore they may not be important in human lupus.	[Freeley, Simon J.; Giorgini, Angela; Tulone, Calogero; Popat, Reena J.; Robson, Michael G.] Kings Coll London, MRC, Ctr Transplantat, London, England; [Horsfield, Catherine] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Robson, MG (corresponding author), Kings Coll London, MRC, Ctr Transplantat, London, England.	Michael.robson@kcl.ac.uk		Robson, Michael/0000-0002-1192-1353	Genzyme Renal Innovations Program; Sir Jules Thorn Charitable Trust; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); Sir Jules Thorn Charitable Trust; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College Hospital NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Genzyme Renal Innovations Program and the Sir Jules Thorn Charitable Trust. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The authors also acknowledge the support of the MRC Centre for Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2008, EUR J IMMUNOL, V38, P1795, DOI 10.1002/eji.200838478; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Brown HJ, 2006, J IMMUNOL, V177, P1925, DOI 10.4049/jimmunol.177.3.1925; Brown HJ, 2006, J AM SOC NEPHROL, V17, P1931, DOI 10.1681/ASN.2005111167; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Giorgini A, 2010, AM J PATHOL, V177, P644, DOI 10.2353/ajpath.2010.091279; HANG L, 1983, J EXP MED, V157, P874, DOI 10.1084/jem.157.3.874; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; Patole PS, 2006, NEPHROL DIAL TRANSPL, V21, P3062, DOI 10.1093/ndt/gfl336; Pawar RD, 2006, J AM SOC NEPHROL, V17, P141, DOI 10.1681/ASN.2005070714; Peng SL, 1996, BIOTECHNIQUES, V21, P362; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696	19	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74112	10.1371/journal.pone.0074112	http://dx.doi.org/10.1371/journal.pone.0074112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086313	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200009
J	Ben Aharon, I; Bar Joseph, H; Tzabari, M; Shenkman, B; Farzam, N; Levi, M; Shalgi, R; Stemmer, SM; Savion, N				Ben Aharon, Irit; Bar Joseph, Hadas; Tzabari, Moran; Shenkman, Boris; Farzam, Nahid; Levi, Mattan; Shalgi, Ruth; Stemmer, Salomon M.; Savion, Naphtali			Doxorubicin-Induced Vascular Toxicity - Targeting Potential Pathways May Reduce Procoagulant Activity	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; ELEVATION MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; CANCER-PATIENTS; CHEMOTHERAPEUTIC-AGENTS; ENDOTHELIAL-CELLS; BREAST-CANCER; EPTIFIBATIDE; SURVIVAL; CARDIOMYOCYTE	Introduction: Previous study in mice using real-time intravital imaging revealed an acute deleterious effect of doxorubicin (DXR) on the gonadal vasculature, as a prototype of an end-organ, manifested by a reduction in blood flow and disintegration of the vessel wall. We hypothesized that this pattern may represent the formation of microthrombi. We aimed to further characterize the effect of DXR on platelets' activity and interaction with endothelial cells (EC) and to examine potential protectants to reduce DXR acute effect on the blood flow. Methods: The effect of DXR on platelet adhesion and aggregation were studied in vitro. For in vivo studies, mice were injected with either low molecular weight heparin (LMWH; Enoxaparin) or with eptifibatide (Integrilin (c)) prior to DXR treatment. Testicular arterial blood flow was examined in real-time by pulse wave Doppler ultrasound. Results: Platelet treatment with DXR did not affect platelet adhesion to a thrombogenic surface but significantly decreased ADP-induced platelet aggregation by up to 40% (p<0.001). However, there was a significant increase in GPIIbIIIa-mediated platelet adhesion to DXR-exposed endothelial cells (EC; 5.7-fold; p<0.001) reflecting the toxic effect of DXR on EC. The testicular arterial blood flow was preserved in mice pre-treated with LMWH or eptifibatide prior to DXR (P<0.01). Conclusions: DXR-induced acute vascular toxicity may involve increased platelet-EC adhesion leading to EC-bound microthrombi formation resulting in compromised blood flow. Anti-platelet/anti-coagulant agents are effective in reducing the detrimental effect of DXR on the vasculature and thus may serve as potential protectants to lessen this critical toxicity.	[Ben Aharon, Irit; Stemmer, Salomon M.] Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel; [Ben Aharon, Irit; Stemmer, Salomon M.] Rabin Med Ctr, Petah Tiqwa, Israel; [Ben Aharon, Irit; Stemmer, Salomon M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Bar Joseph, Hadas; Tzabari, Moran; Levi, Mattan; Shalgi, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Shenkman, Boris] Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; [Farzam, Nahid] Tel Aviv Univ, Sackler Fac Med, Goldschleger Eye Res Inst, IL-69978 Tel Aviv, Israel; [Farzam, Nahid] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Ben Aharon, I (corresponding author), Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel.	iritbenaharon@gmail.com	Savion, Naphtali/K-1013-2019; Shenkman, Boris/AAB-1536-2020	Savion, Naphtali/0000-0001-8899-0624	Israel Cancer Association (ICA)	Israel Cancer Association (ICA)	This work was partially supported by a grant from the Israel Cancer Association (ICA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arola OJ, 2000, CANCER RES, V60, P1789; Baltabaeva A, 2009, J HYPERTENS, V27, P2086, DOI 10.1097/HJH.0b013e32832f4f3d; Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; Beinert T, 1999, Eur J Med Res, V4, P43; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Chaosuwannakit N, 2010, J CLIN ONCOL, V28, P166, DOI 10.1200/JCO.2009.23.8527; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; CLAHSEN PC, 1994, J CLIN ONCOL, V12, P1266, DOI 10.1200/JCO.1994.12.6.1266; Deepa PR, 2003, CHEM-BIOL INTERACT, V146, P201, DOI 10.1016/j.cbi.2003.08.003; Deepa PR, 2006, TOXICOLOGY, V16, P217; Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gibson CM, 2004, CIRCULATION, V110, P679, DOI 10.1161/01.CIR.0000137912.11655.F6; Goto S, 2004, J AM COLL CARDIOL, V44, P316, DOI 10.1016/j.jacc.2004.02.059; Hoshi A, 2011, BLOOD COAGUL FIBRIN, V22, P532, DOI 10.1097/MBC.0b013e328348629d; Hull R, 2003, THROMB HAEMOST S, p137a; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Kaushal V, 2001, ENDOTHELIUM, V11, P253; Kim EJ, 2009, J THROMB HAEMOST, V7, P1172, DOI 10.1111/j.1538-7836.2009.03477.x; Kirwan CC, 2008, BRIT J CANCER, V99, P1000, DOI 10.1038/sj.bjc.6604620; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Kuroda N, 2004, PATHOL INT, V54, P719, DOI 10.1111/j.1440-1827.2004.01685.x; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee AYY, 2005, J CLIN ONCOL, V23, P2123, DOI 10.1200/JCO.2005.03.133; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Moser M, 2003, J CARDIOVASC PHARM, V41, P586, DOI 10.1097/00005344-200304000-00011; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Murata T, 2004, BRIT J PHARMACOL, V132, P1365; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Otten HMMB, 2004, ARCH INTERN MED, V164, P190, DOI 10.1001/archinte.164.2.190; Paredes N, 2003, BRIT J HAEMATOL, V120, P315, DOI 10.1046/j.1365-2141.2003.03971.x; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; SAVION N, 1987, J CELL PHYSIOL, V130, P77, DOI 10.1002/jcp.1041300112; SAVION N, 1989, EUR J BIOCHEM, V183, P363, DOI 10.1111/j.1432-1033.1989.tb14937.x; Shah I, 2009, CORE EVID, V4, P49; Shenkman B, 2008, PLATELETS, V19, P440, DOI 10.1080/09537100802082256; Smith BS, 2001, J THROMB THROMBOLYS, V11, P39, DOI 10.1023/A:1008904310194; Sohn S, 2002, ECHOCARDIOGR-J CARD, V19, P207, DOI 10.1046/j.1540-8175.2002.00207.x; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; Swystun LL, 2011, J THROMB HAEMOST, V9, P2313, DOI 10.1111/j.1538-7836.2011.04465.x; Swystun LL, 2009, J THROMB HAEMOST, V7, P619, DOI 10.1111/j.1538-7836.2009.03300.x; Tcheng JE, 2000, LANCET, V356, P2037; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Varon D, 1997, THROMB RES, V85, P283, DOI 10.1016/S0049-3848(97)00014-5; WALSH J, 1992, BRIT J HAEMATOL, V81, P480, DOI 10.1111/j.1365-2141.1992.tb02978.x; Woodley-Cook J, 2006, MOL CANCER THER, V5, P3303, DOI 10.1158/1535-7163.MCT-06-0154; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamac D, 2006, ULTRASTRUCT PATHOL, V30, P103, DOI 10.1080/01913120500406335; Yatsu Y, 2008, ANESTH ANALG, V106, P530, DOI 10.1213/ane.0b013e31816071b0	49	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75157	10.1371/journal.pone.0075157	http://dx.doi.org/10.1371/journal.pone.0075157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073244	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000053
J	Dauer, JT; Jongejans, E				Dauer, Joseph T.; Jongejans, Eelke			Elucidating the Population Dynamics of Japanese Knotweed Using Integral Projection Models	PLOS ONE			English	Article							FALLOPIA-JAPONICA; REYNOUTRIA-JAPONICA; SEXUAL REPRODUCTION; BIOLOGICAL-CONTROL; CENTRAL DIEBACK; PERENNIAL HERB; GROWTH	Plant demographic studies coupled with population modeling are crucial components of invasive plant management because they inform managers when in a plant's life cycle it is most susceptible to control efforts. Providing land managers with appropriate data can be especially challenging when there is limited data on potentially important transitions that occur belowground. For 2 years, we monitored 4 clonal Japanese knotweed (Polygonum cuspidatum) infestations for emergence, survival, shoot height until leaf senescence, dry shoot biomass after senescence, and rhizome connections for 424 shoots. We developed an integral projection model using both final autumn shoot height and shoot biomass as predictors of survival between years, growth from year to year, and number of rhizomes produced by a shoot (fecundity). Numbers of new shoots within an infestation (population growth rate lambda) were projected to increase 13-233% in a year, with the greatest increase at the most frequently disturbed site. Elasticity analysis revealed population growth at 3 of the 4 sites was primarily due to ramet survival between years and to year-to-year growth in shoot height and shoot biomass. Population growth at the fourth site, the most disturbed, was due to the large production of new rhizomes and associated shoots. In contrast to previous studies, our excavation revealed that most of the shoots were not interconnected, suggesting rhizome production may be limited by the size or age of the plants, resource availability, disturbance frequency, or other factors. Future integration of plant population models with more data on belowground growth structures will clarify the critical stages in Japanese knotweed life cycle and support land managers in their management decisions.	[Dauer, Joseph T.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands	University of Nebraska System; University of Nebraska Lincoln; Radboud University Nijmegen	Dauer, JT (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.	jdauer@msu.edu	Jongejans, Eelke/B-4832-2008	Jongejans, Eelke/0000-0003-1148-7419	US Department of Agriculture [AFRI 2010-85320-30068]; Netherlands Organization for Scientific Research (NWO) [meerwaarde-840.11.001]	US Department of Agriculture(United States Department of Agriculture (USDA)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was partly funded by the US Department of Agriculture (AFRI 2010-85320-30068 to JD) and the Netherlands Organization for Scientific Research (NWO grant meerwaarde-840.11.001 to EJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 1996, ANN BOT-LONDON, V77, P477, DOI 10.1006/anbo.1996.0058; Adachi N, 1996, ANN BOT-LONDON, V78, P169, DOI 10.1006/anbo.1996.0110; Bailey J. P., 1994, Ecology and management of invasive riverside plants., P141; Barney JN, 2006, CAN J PLANT SCI, V86, P887, DOI 10.4141/P05-170; Bashtanova UB, 2009, WEED SCI, V57, P584, DOI 10.1614/WS-09-069.1; BEERLING DJ, 1991, BIOL CONSERV, V55, P329, DOI 10.1016/0006-3207(91)90036-9; BEERLING DJ, 1994, J ECOL, V82, P959, DOI 10.2307/2261459; Berg H, 2002, ECOGRAPHY, V25, P233, DOI 10.1034/j.1600-0587.2002.250211.x; Bram MR, 2004, WEED SCI, V52, P759, DOI 10.1614/P2002-053; Brock J, 1992, 9 C INT BIOL MAUV HE, P85; Bruno JF, 2011, ECOL MONOGR, V81, P123, DOI 10.1890/09-1178.1; CAIN ML, 1990, OECOLOGIA, V82, P201, DOI 10.1007/BF00323536; Dauer JT, 2012, J APPL ECOL, V49, P322, DOI 10.1111/j.1365-2664.2012.02117.x; Davis AS, 2006, ECOL APPL, V16, P2399, DOI 10.1890/1051-0761(2006)016[2399:DMISOB]2.0.CO;2; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; DEKROON H, 1991, FUNCT ECOL, V5, P360; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; Grevstad F, 2013, BIOL CONTROL, V65, P53, DOI 10.1016/j.biocontrol.2013.01.001; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Hay MJM, 2008, EVOL ECOL, V22, P461, DOI 10.1007/s10682-007-9193-5; Hegland SJ, 2010, OECOLOGIA, V163, P695, DOI 10.1007/s00442-010-1616-2; Hesse E, 2008, AM NAT, V172, pE196, DOI 10.1086/591683; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Jongejans E, 2008, PLANT ECOL, V198, P225, DOI 10.1007/s11258-008-9397-y; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; LOCANDRO RR, 1973, THESIS RUTGERS U NEW; Lyngstad A, 2010, THESIS NTNU NORWAY, P179; Maerz JC, 2005, BIODIVERS CONSERV, V14, P2901, DOI 10.1007/s10531-004-0223-0; Metcalf CJE, 2013, METHODS ECOL EVOL, V4, P195, DOI 10.1111/2041-210x.12001; PITELKA LF, 1985, J ECOL, V73, P169, DOI 10.2307/2259776; Price E, 2005, EVOL ECOL, V15, P347; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Seiger LA, 1997, NAT AREA J, V17, P341; Shaw RH, 2011, WEED RES, V51, P552, DOI 10.1111/j.1365-3180.2011.00880.x; Smith JMD, 2007, ECOL MODEL, V200, P421, DOI 10.1016/j.ecolmodel.2006.08.004; SUZUKI J, 1994, ANN BOT-LONDON, V73, P629, DOI 10.1006/anbo.1994.1079; Tickner DP, 2001, PROG PHYS GEOG, V25, P22, DOI 10.1177/030913330102500102; Wikberg S, 2006, PLANT ECOL, V183, P55, DOI 10.1007/s11258-005-9006-2	40	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75181	10.1371/journal.pone.0075181	http://dx.doi.org/10.1371/journal.pone.0075181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073249	Green Published, gold			2022-12-25	WOS:000324768000058
J	Fernandes, AM; Beddows, E; Filippi, A; Driever, W				Fernandes, Antonio M.; Beddows, Erin; Filippi, Alida; Driever, Wolfgang			Orthopedia Transcription Factor otpa and otpb Paralogous Genes Function during Dopaminergic and Neuroendocrine Cell Specification in Larval Zebrafish	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; IMPAIRED STRESS-RESPONSE; HOMEODOMAIN PROTEIN; HYPOTHALAMIC NEURONS; MICE LACKING; BRAIN; EXPRESSION; SYSTEMS; EVOLUTION; LINEAGES	The homeodomain transcription factor Orthopedia (Otp) is an important regulator for specification of defined subsets of neuroendocrine cells and dopaminergic neurons in vertebrates. In zebrafish, two paralogous otp genes, otpa and otpb, are present in the genome. Neither complete loss of Otp activity nor differential contributions of Otpa and Otpb to specification of defined neuronal populations have been analyzed in detail. We characterized zebrafish embryos and early larvae mutant for null alleles of otpa, otpb, or both genes to determine their individual contributions to the specification of th expressing dopaminergic neuronal populations as well as of crh, oxt, avp, trh or sst1.1 expressing neuroendocrine cells. otpa mutant larvae show an almost complete reduction of ventral diencephalic dopaminergic neurons, as reported previously. A small reduction in the number of trh cells in the preoptic region is detectable in otpa mutants, but no significant loss of crh, oxt and avp preoptic neuroendocrine cells. otpb single mutant larvae do not display a reduction in dopaminergic neurons or neuroendocrine cells in the otp expressing regions. In contrast, in otpa and otpb double mutant larvae specific groups of dopaminergic neurons as well as of crh, oxt, avp, trh and sst1.1-expressing neuroendocrine cells are completely lost. These observations suggest that the requirement for otpa and otpb function during development of the larval diencephalon is partially redundant. During evolutionary diversification of the paralogous otp genes, otpa maintained the prominent role in ventral diencephalic dopaminergic and neuroendocrine cell specification and is capable of partially compensating otpb loss of function. In addition, we identified a role of Otp in the development of a domain of somatostatin1-expressing cells in the rostral hindbrain, a region with strong otp expression but so far uncharacterized Otp function. Otp may thus be crucial for defined neuronal cell types also in the hindbrain.	[Driever, Wolfgang] Univ Freiburg, Fac Biol, Dev Biol Unit, D-79106 Freiburg, Germany; Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Fac Biol, Dev Biol Unit, Hugstetter Str 55, D-79106 Freiburg, Germany.	driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies) [EXC 294]; German Research Foundation [DFG-SFB780-B6]; EU ZF-HEALTH project [242048]	Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies); German Research Foundation(German Research Foundation (DFG)); EU ZF-HEALTH project	The work was supported by the following grants to W. D.: Excellence Initiative of the German Federal and State Governments (Centre for Biological Signalling Studies EXC 294; www.dfg.de & www.bioss.uni-freiburg. de), the German Research Foundation (DFG-SFB780-B6; www.dfg.de), and the EU ZF-HEALTH project (Grant number 242048; http://cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Amir-Zilberstein L, 2012, NEURON, V73, P279, DOI 10.1016/j.neuron.2011.11.019; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Del Giacco L, 2008, DEV DYNAM, V237, P2295, DOI 10.1002/dvdy.21668; Del Giacco L, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-50; Devos N, 2002, MECH DEVELOP, V115, P133, DOI 10.1016/S0925-4773(02)00082-5; Eaton JL, 2008, DEV DYNAM, V237, P995, DOI 10.1002/dvdy.21503; Eaton JL, 2007, DEV GENES EVOL, V217, P149, DOI 10.1007/s00427-006-0123-2; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Gahete MD, 2010, ANN NY ACAD SCI, V1200, P43, DOI 10.1111/j.1749-6632.2010.05511.x; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lin X, 1999, GENOMICS, V60, P96, DOI 10.1006/geno.1999.5882; Liu Y, 2010, GENE, V463, P21, DOI 10.1016/j.gene.2010.04.016; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; Martin SC, 1998, J COMP NEUROL, V396, P253; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Moret F, 2005, DEV BIOL, V277, P567, DOI 10.1016/j.ydbio.2004.11.004; Nair HP, 2006, PHYSIOLOGY, V21, P146, DOI 10.1152/physiol.00049.2005; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf A, 2013, DEVELOPMENT, V140, P1762, DOI 10.1242/dev.085357; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021	56	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75002	10.1371/journal.pone.0075002	http://dx.doi.org/10.1371/journal.pone.0075002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073233	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000042
J	Holler, Y; Thomschewski, A; Bergmann, J; Kronbichler, M; Crone, JS; Schmid, E; Butz, K; Holler, P; Trinka, E				Hoeller, Yvonne; Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Butz, Kevin; Hoeller, Peter; Trinka, Eugen			EEG-Response Consistency across Subjects in an Active Oddball Task	PLOS ONE			English	Article							BRAIN ACTIVITY; BEDSIDE DETECTION; VEGETATIVE STATE; MOTOR IMAGERY; DISORDERS; AWARENESS; COMPONENTS; CONSCIOUSNESS; VARIABILITY; ARTIFACTS	The active oddball paradigm is a candidate task for voluntary brain activation. Previous research has focused on group effects, and has largely overlooked the potential problem of interindividual differences. Interindividual variance causes problems with the interpretation of group-level results. In this study we want to demonstrate the degree of consistency in the active oddball task across subjects, in order to answer the question of whether this task is able to reliably detect conscious target processing in unresponsive patients. We asked 18 subjects to count rare targets and to ignore frequent standards and rare distractors in an auditory active oddball task. Event-related-potentials (ERPs) and time-frequency data were analyzed with permutation-t-tests on a single subject level. We plotted the group-average ERPs and time-frequency data, and evaluated the numbers of subjects showing significant differences between targets and distractors in certain time-ranges. The distinction between targets/distractors and standards was found to be significant in the time-range of the P300 in all participants. In contrast, significant differences between targets and distractors in the time-range of the P3a/b were found in 8 subjects, only. By including effects in the N1 and in a late negative component there remained 2 subjects who did not show a distinction between targets and distractors in the ERP. While time-frequency data showed prominent effects for target/distractor vs. standard, significant differences between targets and distractors were found in 2 subjects, only. The results suggest that time-frequency-and ERP-analysis of the active oddball task may not be sensitive enough to detect voluntary brain activation in unresponsive patients. In addition, we found that time-frequency analysis was even less informative than ERPs about the subject's task performance. Despite suggesting the use of more sensitive paradigms and/or analysis techniques, the present results give further evidence that electroencephalographic research should rely more strongly on single-subject analysis because interpretations of group-effects may be misleading.	[Hoeller, Yvonne; Thomschewski, Aljoscha; Crone, Julia S.; Butz, Kevin; Hoeller, Peter; Trinka, Eugen] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Trinka, Eugen] Paracelsus Med Univ, Inst Neurosci, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Trinka, Eugen] Paracelsus Med Univ, Ctr Neurocognit Res, Salzburg, Austria; [Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Salzburg University; Salzburg University	Holler, Y (corresponding author), Paracelsus Med Univ, Dept Neurol, Salzburg, Austria.	y.hoeller@salk.at	Kronbichler, Martin/AAY-1519-2021; Kronbichler, Martin/A-5599-2008; Höller, Yvonne/I-8928-2017	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Höller, Yvonne/0000-0002-1727-8557; Trinka, Eugen/0000-0002-5950-2692; Thomschewski, Aljoscha/0000-0002-1811-5469; Butz, Kevin/0000-0001-8070-4128; Butz, Kevin/0000-0003-4502-2492; Crone, Julia Sophia/0000-0002-0787-7003	Jubilaumsfonds of the National Bank of Austria [14201]	Jubilaumsfonds of the National Bank of Austria	This research project is being supported by the Jubilaumsfonds of the National Bank of Austria (project no. 14201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; CHILDERS DG, 1987, CRIT REV BIOMED ENG, V14, P185; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Damborska A, 2012, PHYSIOL RES, V61, P307, DOI 10.33549/physiolres.932237; Ebe M, 2002, LEITFADEN EEG PRAXIS; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Ferrari V, 2010, J COGNITIVE NEUROSCI, V22, P404, DOI 10.1162/jocn.2009.21244; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Hausfeld L, 2012, NEUROIMAGE, V59, P3641, DOI 10.1016/j.neuroimage.2011.11.056; Ho MC, 2012, NEUROSCI LETT, V507, P78, DOI 10.1016/j.neulet.2011.11.057; Holler Y, 2013, INT J PSYCHOPHYSIOL, V87, P35, DOI 10.1016/j.ijpsycho.2012.10.015; Holler Y, 2012, INT J PSYCHOPHYSIOL, V86, P206, DOI 10.1016/j.ijpsycho.2012.09.005; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P1744, DOI 10.1016/j.clinph.2011.02.009; Holler Y, 2011, INT J PSYCHOPHYSIOL, V80, P227, DOI 10.1016/j.ijpsycho.2011.03.012; John ER, 2011, BRAIN INJURY, V25, P426, DOI 10.3109/02699052.2011.558045; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 1998, ADV NEUR IN, V10, P894; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Kotchoubey B, 2004, BRAINWAVES MIND RECE, P75; Lechinger J, 2013, CLIN NEUROPHYSIOL, V124, P27, DOI 10.1016/j.clinph.2012.05.016; Liang XW, 2014, J NEUROIMAGING, V24, P31, DOI 10.1111/j.1552-6569.2012.00744.x; Makeig S, 1996, ADV NEUR IN, V8, P145; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Saville CWN, 2012, BIOL PSYCHOL, V91, P275, DOI 10.1016/j.biopsycho.2012.07.006; Saville CWN, 2011, BIOL PSYCHOL, V87, P74, DOI 10.1016/j.biopsycho.2011.02.005; Schiff S, 2008, CLIN NEUROPHYSIOL, V119, P1795, DOI 10.1016/j.clinph.2008.04.007; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; Tzovara A, 2012, DEV NEUROPSYCHOL, V37, P518, DOI 10.1080/87565641.2011.636851; Wronka E, 2012, ACTA NEUROBIOL EXP, V72, P51; Yordanova J, 2000, NEUROREPORT, V11, P1097, DOI 10.1097/00001756-200004070-00038	44	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74572	10.1371/journal.pone.0074572	http://dx.doi.org/10.1371/journal.pone.0074572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073216	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000025
J	Koberle, V; Pleli, T; Schmithals, C; Alonso, EA; Haupenthal, J; Bonig, H; Peveling-Oberhag, J; Biondi, RM; Zeuzem, S; Kronenberger, B; Waidmann, O; Piiper, A				Koeberle, Verena; Pleli, Thomas; Schmithals, Christian; Alonso, Eduardo Augusto; Haupenthal, Joerg; Boenig, Halvard; Peveling-Oberhag, Jan; Biondi, Ricardo M.; Zeuzem, Stefan; Kronenberger, Bernd; Waidmann, Oliver; Piiper, Albrecht			Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers	PLOS ONE			English	Article							SERUM; ENZYMES; RIBONUCLEASE; CANCER; QUANTITATION; DEGRADATION; SIRNAS; PLASMA; URINE; BLOOD	Background: MicroRNAs circulating in the blood, stabilized by complexation with proteins and/or additionally by encapsulation in lipid vesicles, are currently being evaluated as biomarkers. The consequences of their differential association with lipids/vesicles for their stability and use as biomarkers are largely unexplored and are subject of the present study. Methods: The levels of a set of selected microRNAs were determined by quantitative reverse-transcription PCR after extraction from sera or vesicle-and non-vesicle fractions prepared from sera. The stability of these microRNAs after incubation with RNase A or RNase inhibitor, an inhibitor of RNase A family enzymes was studied. Results: The levels of microRNA-1 and microRNA-122, but not those of microRNA-16, microRNA-21 and microRNA-142-3p, declined significantly during a 5-h incubation of the sera. RNase inhibitor prevented the loss of microRNAs in serum as well as the degradation of microRNA-122, a microRNA not expressed in blood cells, in whole blood. Stabilization of microRNA-122 was also achieved by hemolysis. Prolonged incubation of the sera led to enrichment of vesicle-associated relative to non-vesicle-associated microRNAs. Vesicle-associated microRNAs were more resistant to RNase A treatment than the respective microRNAs not associated with vesicles. Conclusions: Serum microRNAs showed differential stability upon prolonged incubation. RNase inhibitor might be useful to robustly preserve the pattern of cell-free circulating microRNAs. In the case of microRNAs not expressed in blood cells this can also be achieved by hemolysis. Vesicle-associated microRNAs appeared to be more stable than those not associated with vesicles, which might be useful to disclose additional biomarker properties of miRNAs.	[Koeberle, Verena; Pleli, Thomas; Schmithals, Christian; Alonso, Eduardo Augusto; Haupenthal, Joerg; Peveling-Oberhag, Jan; Biondi, Ricardo M.; Zeuzem, Stefan; Kronenberger, Bernd; Waidmann, Oliver; Piiper, Albrecht] Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany; [Boenig, Halvard] Univ Hosp Frankfurt, Inst Transfus Med & Immunohematol, German Red Cross Blood Serv Baden Wurttemberg Hes, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Piiper, A (corresponding author), Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Haupenthal, Jorg/0000-0003-3991-2800; Biondi, Ricardo/0000-0002-8873-7167	Paul und Ursula Klein-Stiftung; Deutsche Forschungsgemeinschaft [GRK1172]; Scholari Stiftung	Paul und Ursula Klein-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Scholari Stiftung	This work was supported in part by grants from the Paul und Ursula Klein-Stiftung (to VK) and the Deutsche Forschungsgemeinschaft (GRK1172) and the Scholari Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Haupenthal J, 2006, BIOCHEM PHARMACOL, V71, P702, DOI 10.1016/j.bcp.2005.11.015; Haupenthal J, 2007, INT J CANCER, V121, P206, DOI 10.1002/ijc.22665; Koberle V, 2013, J VIRAL HEPATITIS, V20, P530, DOI 10.1111/jvh.12075; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MORITA T, 1986, J BIOCHEM-TOKYO, V99, P17, DOI 10.1093/oxfordjournals.jbchem.a135456; NADANO D, 1995, INT J BIOCHEM CELL B, V27, P971, DOI 10.1016/1357-2725(95)00063-U; Paris C, 2012, MOL PHARMACEUT, V9, P3464, DOI 10.1021/mp300278b; SORRENTINO S, 1989, BIOCHIM BIOPHYS ACTA, V998, P97, DOI 10.1016/0167-4838(89)90125-8; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Turner JJ, 2007, MOL BIOSYST, V3, P43, DOI 10.1039/b611612d; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WEICKMANN JL, 1982, J BIOL CHEM, V257, P8705; Welker MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030796	30	141	146	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75184	10.1371/journal.pone.0075184	http://dx.doi.org/10.1371/journal.pone.0075184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073250	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000059
J	Li, SK; Zhou, JW; Yim, AKY; Leung, AKY; Tsui, SKW; Chan, TF; Lau, TCK				Li, Sai-Kam; Zhou, Jun-Wei; Yim, Aldrin Kay-Yuen; Leung, Alden King-Yung; Tsui, Stephen Kwok-Wing; Chan, Ting-Fung; Lau, Terrence Chi-Kong			Organism-Specific rRNA Capture System for Application in Next-Generation Sequencing	PLOS ONE			English	Article							MICROBIAL METATRANSCRIPTOMICS; GENE-EXPRESSION; HYBRIDIZATION	RNA-sequencing is a powerful tool in studying RNomics. However, the highly abundance of ribosomal RNAs (rRNA) and transfer RNA (tRNA) have predominated in the sequencing reads, thereby hindering the study of lowly expressed genes. Therefore, rRNA depletion prior to sequencing is often performed in order to preserve the subtle alteration in gene expression especially those at relatively low expression levels. One of the commercially available methods is to use DNA or RNA probes to hybridize to the target RNAs. However, there is always a concern with the non-specific binding and unintended removal of messenger RNA (mRNA) when the same set of probes is applied to different organisms. The degree of such unintended mRNA removal varies among organisms due to organism-specific genomic variation. We developed a computer-based method to design probes to deplete rRNA in an organism-specific manner. Based on the computation results, biotinylated-RNA-probes were produced by in vitro transcription and were used to perform rRNA depletion with subtractive hybridization. We demonstrated that the designed probes of 16S rRNAs and 23S rRNAs can efficiently remove rRNAs from Mycobacterium smegmatis. In comparison with a commercial subtractive hybridization-based rRNA removal kit, using organism-specific probes is better in preserving the RNA integrity and abundance. We believe the computer-based design approach can be used as a generic method in preparing RNA of any organisms for next-generation sequencing, particularly for the transcriptome analysis of microbes.	[Li, Sai-Kam; Lau, Terrence Chi-Kong] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; [Zhou, Jun-Wei; Tsui, Stephen Kwok-Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yim, Aldrin Kay-Yuen; Leung, Alden King-Yung; Chan, Ting-Fung] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Ting-Fung] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China.	chiklau@cityu.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015; Chan, TingFung/A-6161-2013; Lau, Terrence/ABB-7900-2021	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Chan, TingFung/0000-0002-0489-3884; Lau, Terrence/0000-0002-7505-7306; Leung, Alden/0000-0003-0559-2183	CityU [7200262]; City University of Hong Kong [7002753]; Research Fund for the Control of Infectious Diseases [9211027]; Hong Kong RGC Collaborative Research Fund [CUHK3/CRF/11G]; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation; Research Fund for the Control of Infectious Diseases (RFCID) [11100282]	CityU(City University of Hong Kong); City University of Hong Kong(City University of Hong Kong); Research Fund for the Control of Infectious Diseases; Hong Kong RGC Collaborative Research Fund; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation; Research Fund for the Control of Infectious Diseases (RFCID)	This work was supported by the CityU startup grant (7200262) the Strategic Research Grant (7002753) of the City University of Hong Kong, and the Research Fund for the Control of Infectious Diseases (9211027) granted to TCL. It was also supported by the Hong Kong RGC Collaborative Research Fund (CUHK3/CRF/11G), the Lo Kwee-Seong Biomedical Research Fund, and the Lee Hysan Foundation granted to TFC and the Research Fund for the Control of Infectious Diseases (RFCID) (11100282) granted to SKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], BIOCHEM, V66, P173, DOI [10.1146/annurev.biochem.66.1.173, DOI 10.1146/ANNUREV.BI0CHEM.66.1.173.PUBMED:9242905]; Binder H, 2005, BIOPHYS J, V89, P337, DOI 10.1529/biophysj.104.055343; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P7546, DOI 10.1073/pnas.89.16.7546; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Mao CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-72; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; PLUM G, 1994, INFECT IMMUN, V62, P476, DOI 10.1128/IAI.62.2.476-483.1994; ROBINSON KA, 1994, GENE, V148, P137, DOI 10.1016/0378-1119(94)90247-X; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	18	5	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74286	10.1371/journal.pone.0074286	http://dx.doi.org/10.1371/journal.pone.0074286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073205	gold, Green Submitted, Green Published			2022-12-25	WOS:000324768000014
J	Mutti, E; Ruetz, M; Birn, H; Krautler, B; Nexo, E				Mutti, Elena; Ruetz, Markus; Birn, Henrik; Kraeutler, Bernhard; Nexo, Ebba			4-Ethylphenyl-Cobalamin Impairs Tissue Uptake of Vitamin B-12 and Causes Vitamin B-12 Deficiency in Mice	PLOS ONE			English	Article							COBALAMIN DEFICIENCY; HUMAN-PLASMA; SPINAL-CORD; PROTEINS; HAPTOCORRIN; HOMEOSTASIS; ANALOGS; SYSTEM; KIDNEY	Co-beta-4-ethylphenyl-cob(III) alamin (EtPhCbl) is an organometallic analogue of vitamin B-12 (CNCbl) which binds to transcobalamin (TC), a plasma protein that facilitates the cellular uptake of cobalamin (Cbl). In vitro assays with key enzymes do not convert EtPhCbl to the active coenzyme forms of Cbl suggesting that administration of EtPhCbl may cause cellular Cbl deficiency. Here, we investigate the in vivo effect of EtPhCbl in mice and its ability, if any, to induce Cbl deficiency. We show that EtPhCbl binds to mouse TC and we examined mice that received 3.5 nmol/24h EtPhCbl (n=6), 3.5 nmol/24h CNCbl (n=7) or NaCl (control group) (n=5) through osmotic mini-pumps for four weeks. We analyzed plasma, urine, liver, spleen, submaxillary glands and spinal cord for Cbl and markers of Cbl deficiency including methylmalonic acid (MMA) and homocysteine (tHcy). Plasma MMA (mean +/- SEM) was elevated in animals treated with EtPhCbl (1.01 +/- 0.12 mu mol/L) compared to controls (0.30 +/- 0.02 mu mol/L) and CNCbl (0.29 +/- 0.01 mu mol/L) treated animals. The same pattern was observed for tHcy. Plasma total Cbl concentration was higher in animals treated with EtPhCbl (128.82 +/- 1.87 nmol/L) than in CNCbl treated animals (87.64 +/- 0.93 nmol/L). However, the organ levels of total Cbl were significantly lower in animals treated with EtPhCbl compared to CNCbl treated animals or controls, notably in the liver (157.07 +/- 8.56 pmol/g vs. 603.85 +/- 20.02 pmol/g, and 443.09 +/- 12.32 pmol/g, respectively). Differences between the three groups was analysed using one-way ANOVA and, Bonferroni post-hoc test. EtPhCbl was present in all tissues, except the spinal cord, accounting for 35-90% of total Cbl. In conclusion, treatment with EtPhCbl induces biochemical evidence of Cbl deficiency. This may in part be caused by a compromised tissue accumulation of Cbl.	[Mutti, Elena; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, A-6020 Innsbruck, Austria; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Birn, Henrik] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; University of Innsbruck; University of Innsbruck; Aarhus University; Aarhus University	Nexo, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	e.nexo@dadlnet.dk	Birn, Henrik/C-3931-2009; Mutti, Elena/M-8056-2016	Birn, Henrik/0000-0003-3715-7266; Mutti, Elena/0000-0001-5621-4786; Nexo, Ebba/0000-0001-9406-9081	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Lundbeck Foundation. The funders did not influence study design, data collection, or analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 1997, CHEM BIOL, V4, P175, DOI 10.1016/S1074-5521(97)90286-6; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Lildballe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046657; Mutti E, 2007, BRAIN RES, V1157, P92, DOI 10.1016/j.brainres.2007.04.055; Mutti E, 2013, BRAIN RES, V1503, P1, DOI 10.1016/j.brainres.2013.01.050; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; Scalabrino G, 1997, EXP NEUROL, V144, P258, DOI 10.1006/exnr.1996.6376; Scalabrino G, 2001, J NEUROPATH EXP NEUR, V60, P109, DOI 10.1093/jnen/60.2.109; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771	19	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75312	10.1371/journal.pone.0075312	http://dx.doi.org/10.1371/journal.pone.0075312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073261	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000070
J	Qiao, L; Yang, WZ; Fu, JZ; Song, ZB				Qiao, Liang; Yang, Weizhao; Fu, Jinzhong; Song, Zhaobin			Transcriptome Profile of the Green Odorous Frog (Odorrana margaretae)	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; RANA-CHENSINENSIS; SEQUENCE; GENOME; SKIN; ALIGNMENT; PROGRAM; PROTEIN	Transcriptome profiles provide a practical and inexpensive alternative to explore genomic data in non-model organisms, particularly in amphibians where the genomes are very large and complex. The odorous frog Odorrana margaretae (Anura: Ranidae) is a dominant species in the mountain stream ecosystem of western China. Limited knowledge of its genetic background has hindered research on this species, despite its importance in the ecosystem and as biological resources. Here we report the transcriptome of O. margaretae in order to establish the foundation for genetic research. Using an Illumina sequencing platform, 62,321,166 raw reads were acquired. After a de novo assembly, 37,906 transcripts were obtained, and 18,933 transcripts were annotated to 14,628 genes. We functionally classified these transcripts by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). A total of 11,457 unique transcripts were assigned to 52 GO terms, and 1,438 transcripts were assigned to 128 KEGG pathways. Furthermore, we identified 27 potential antimicrobial peptides (AMPs), 50,351 single nucleotide polymorphism (SNP) sites, and 2,574 microsatellite DNA loci. The transcriptome profile of this species will shed more light on its genetic background and provide useful tools for future studies of this species, as well as other species in the genus Odorrana. It will also contribute to the accumulation of amphibian genomic data.	[Qiao, Liang; Song, Zhaobin] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Peoples R China; [Qiao, Liang; Yang, Weizhao; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Song, Zhaobin] Sichuan Univ, Minist Educ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Guelph; Sichuan University	Fu, JZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	jfu@uoguelph.ca; zbsong@scu.edu.cn			National Natural Science Foundation of China [31172061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), grant number 31172061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARRA D, 1995, TRENDS BIOTECHNOL, V13, P205, DOI 10.1016/S0167-7799(00)88947-7; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Cho JH, 2009, BBA-BIOMEMBRANES, V1788, P1564, DOI 10.1016/j.bbamem.2008.10.025; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Gao HY, 2013, CONSERV GENET RESOUR, V5, P935, DOI 10.1007/s12686-013-9936-2; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JY, 2012, J PROTEOMICS, V75, P5807, DOI 10.1016/j.jprot.2012.08.004; Liu R, 2011, J PROTEOME RES, V10, P1806, DOI 10.1021/pr101285n; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; MOORE KS, 1991, J BIOL CHEM, V266, P19851; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novkovic M, 2012, BIOINFORMATICS, V28, P1406, DOI 10.1093/bioinformatics/bts141; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Reilly BD, 2013, PHYSIOL GENOMICS, V45, P377, DOI 10.1152/physiolgenomics.00163.2012; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Yang WZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-588; Yang XW, 2012, J PROTEOME RES, V11, P306, DOI 10.1021/pr200782u; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004	44	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75211	10.1371/journal.pone.0075211	http://dx.doi.org/10.1371/journal.pone.0075211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073255	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000064
J	Ueda, J; Matsuda, Y; Yamahatsu, K; Uchida, E; Naito, Z; Korc, M; Ishiwata, T				Ueda, J.; Matsuda, Y.; Yamahatsu, K.; Uchida, E.; Naito, Z.; Korc, M.; Ishiwata, T.			Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases	ONCOGENE			English	Article						ESRP1; pancreatic cancer; FGFR-2 IIIb; FGFR-2 IIIc; EMT	KERATINOCYTE GROWTH-FACTOR; IMMOBILIZED PH GRADIENTS; MESENCHYMAL TRANSITION; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; ENHANCED EXPRESSION; COLORECTAL-CANCER; RECEPTOR; CELLS; CARCINOMA	Epithelial splicing regulatory protein 1 (ESRP1) binds the FGFR-2 auxiliary cis-element ISE/ISS-3, located in the intron between exon IIIb and IIIc, and primarily promotes FGFR-2 IIIb expression. Here we assessed the role of ESRP1 in pancreatic ductal adenocarcinoma (PDAC). Immunohistochemical analysis was performed using anti-ESRP1, FGFR-2 IIIb and FGFR-2 IIIc antibodies in 123 PDAC cases. ESRP1 expression vector and small interference RNA (siRNA) targeting ESRP1 were transfected into human PDAC cells, and cell growth, migration and invasion were analyzed. In vivo heterotopic and orthotopic implantations using ESRP1 overexpression clones were performed and effects on pancreatic tumor volumes and hepatic and pulmonary metastases determined. ESRP1 immunoreactivity was strong in the nuclei of cancer cells in well-to-moderately differentiated PDACs but weak in poorly differentiated cancers. Well-to-moderately differentiated cancers also exhibited high FGFR-2 IIIb and low FGFR-2 IIIc expression, whereas this ratio was reversed in the poorly differentiated cancers. Increased ESRP1 expression was associated with longer survival in comparison with low ESRP1 expression, and PANC-1 cells engineered to express ESRP1 exhibited increased FGFR-2 IIIb expression and decreased migration and invasion in vitro, whereas ESRP1 siRNA-transfected KLM-1 cells exhibited increased FGFR-2 IIIc expression and increased cell growth, migration and invasion. In vivo, ESRP1-overexpressing clones formed significantly fewer liver metastases as compared with control clones. ESRP1 regulates the expression pattern of FGFR-2 isoforms, attenuates cell growth, migration, invasion and metastasis, and is a favorable prognostic factor in PDAC. Therefore, devising mechanisms to upregulate ESRP1 may exert a beneficial therapeutic effect in PDAC.	[Ueda, J.; Matsuda, Y.; Yamahatsu, K.; Naito, Z.; Ishiwata, T.] Nippon Med Sch, Dept Pathol, Tokyo 1138602, Japan; [Ueda, J.; Matsuda, Y.; Yamahatsu, K.; Naito, Z.; Ishiwata, T.] Nippon Med Sch, Dept Integrat Oncol Pathol, Tokyo 1138602, Japan; [Ueda, J.; Yamahatsu, K.; Uchida, E.] Nippon Med Sch, Grad Sch Med, Dept Surg Organ & Biol Regulat, Tokyo 1138602, Japan; [Korc, M.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Korc, M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Korc, M.] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA	Nippon Medical School; Nippon Medical School; Nippon Medical School; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ishiwata, T (corresponding author), Nippon Med Sch, Dept Pathol, 1-1-5 Sendagi, Tokyo 1138602, Japan.	ishiwata@nms.ac.jp	Ishiwata, Toshiyuki/H-1151-2014	Ishiwata, Toshiyuki/0000-0002-4180-0069	Japan Society for the Promotion of Science [22591531, 22689038, 23650604]; NIH [R37-CA-075059]; NATIONAL CANCER INSTITUTE [R01CA075059, R37CA075059] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We express our appreciation to Dr Masahito Hagio for helpful discussion and Dr Tetsushi Yamamoto, Mr Yuji Yanagisawa, Ms Taeko Suzuki, Ms Yoko Kawamoto and Ms Kiyoko Kawahara (Department of Pathology, Nippon Medical School) for their excellent technical assistance. We also thank Dr Shin-ichi Tsuchiya (Division of Surgical Pathology, Nippon Medical School Hospital) for preparing tissue blocks. This work was supported by Grants-in-Aid for Scientific Research (C, No.22591531 for TI), a Grant-in-Aid for Young Scientists (A, No. 22689038 for YM) a Grant-in-Aid for Challenging Exploratory Research (No. 23650604 for YM) from the Japan Society for the Promotion of Science, and in part by NIH grant R37-CA-075059 to MK.	Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gorg A, 1997, ELECTROPHORESIS, V18, P328, DOI 10.1002/elps.1150180306; Gorg A, 1999, ELECTROPHORESIS, V20, P712; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Ishiwata T, 1998, AM J PATHOL, V153, P213, DOI 10.1016/S0002-9440(10)65562-9; Ishiwata T, 2012, AM J PATHOL, V180, P1928, DOI 10.1016/j.ajpath.2012.01.020; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Katoh M, 2009, J INVEST DERMATOL, V129, P1861, DOI 10.1038/jid.2009.97; Kawase R, 2010, INT J ONCOL, V36, P331, DOI 10.3892/ijo_00000504; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Matsuda Y, 2008, INT J ONCOL, V33, P1177, DOI 10.3892/ijo_00000107; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851, DOI 10.1091/mbc.5.8.851; Seiden-Long I, 2008, CARCINOGENESIS, V29, P647, DOI 10.1093/carcin/bgn009; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suemizu H, 2007, INT J ONCOL, V31, P741; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tuveson DA, 2012, CELL, V148, P21, DOI 10.1016/j.cell.2011.12.021; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yan L, 2013, DIGEST DIS SCI, V58, P389, DOI 10.1007/s10620-012-2341-y	48	61	63	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4485	4495		10.1038/onc.2013.392	http://dx.doi.org/10.1038/onc.2013.392			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24077287	Green Submitted, Green Accepted			2022-12-25	WOS:000341158800004
J	Sharp, WW; Fang, YH; Han, M; Zhang, HJ; Hong, ZG; Banathy, A; Morrow, E; Ryan, JJ; Archer, SL				Sharp, Willard W.; Fang, Yong Hu; Han, Mei; Zhang, Hannah J.; Hong, Zhigang; Banathy, Alexandra; Morrow, Erik; Ryan, John J.; Archer, Stephen L.			Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia- reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission	FASEB JOURNAL			English	Article						Mdivi-1; reactive oxygen species; calcineurin; IR; cardiac arrest	CARDIAC-ARREST; FUSION; HEART; DEPHOSPHORYLATION; PHOSPHORYLATION	Mitochondrial fission, regulated by dynamin-related protein-1 (Drp1), is a newly recognized determinant of mitochondrial function, but its contribution to left ventricular (LV) impairment following ischemia-reperfusion (IR) injury is unknown. We report that Drp1 activation during IR results in LV dysfunction and that Drp1 inhibition is beneficial. In both isolated neonatal murine cardiomyocytes and adult rat hearts (Langendorff preparation) mitochondrial fragmentation and swelling occurred within 30 min of IR. Drp1-S637 (serine 637) dephosphorylation resulted in Drp1 mitochondrial translocation and increased mitochondrial fission. The Drp1 inhibitor Mdivi-1 preserved mitochondrial morphology, reduced cytosolic calcium, and prevented cell death. Drp1 siRNA similarly preserved mitochondrial morphology. In Langendorff hearts, Mdivi-1 reduced mitochondrial reactive oxygen species, improved LV developed pressure (92 +/- 5 vs. 28 +/- 10 mmHg, P<0.001), and lowered LV end diastolic pressure (10 +/- 1 vs. 86 +/- 13 mmHg, P<0.001) following IR. Mdivi-1 was protective if administered prior to or following ischemia. Because Drp1-S637 dephosphorylation is calcineurin sensitive, we assessed the effects of a calcineurin inhibitor, FK506. FK506 treatment prior to IR prevented Drp1-S637 dephosphorylation and preserved cardiac function. Likewise, therapeutic hypothermia (30 degrees C) inhibited Drp1-S637 dephosphorylation and preserved mitochondrial morphology and myocardial function. Drp1 inhibition is a novel strategy to improve myocardial function following IR.Sharp, W. S., Fang, Y. H., Han, M., Zhang, H. J., Hong, Z., Banathy, A., Morrow, E., Ryan, J. J., Archer, S. L. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission.	[Sharp, Willard W.; Fang, Yong Hu; Han, Mei; Zhang, Hannah J.; Banathy, Alexandra] Univ Chicago, Dept Med, Sect Emergency Med, Chicago, IL 60637 USA; [Hong, Zhigang; Morrow, Erik; Ryan, John J.; Archer, Stephen L.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Archer, Stephen L.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Chicago; University of Chicago; Queens University - Canada	Sharp, WW (corresponding author), Dept Med, Sect Emergency Med, 5841 S Maryland Ave,MC 5068, Chicago, IL 60637 USA.	wsharp@medicine.bsd.uchicago.edu	Sharp, Willard/AAB-9972-2020	Sharp, Willard/0000-0002-7175-3523; Banathy, Alexandra/0000-0002-8100-5238	U.S. National Institutes of Health (NIH) [NIH-K08-HL103901-02, NIH-RO1-HL071115]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103901, R01HL113003, R01HL071115] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Peter Toth for his assistance with confocal imaging. Funding was received from the U.S. National Institutes of Health (NIH), grants NIH-K08-HL103901-02 (W. W. S.) and NIH-RO1-HL071115 (S. L. A.), and from the American Heart Association (S.L.A.).	Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; EDOUTE Y, 1983, CIRC RES, V53, P663, DOI 10.1161/01.RES.53.5.663; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; HENRY TD, 1990, CIRC RES, V67, P1453, DOI 10.1161/01.RES.67.6.1453; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hong ZG, 2006, CIRCULATION, V114, P1372, DOI 10.1161/CIRCULATIONAHA.106.641126; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Kane LA, 2010, J MOL MED, V88, P971, DOI 10.1007/s00109-010-0674-6; Klouche K, 2002, CHEST, V122, P1006, DOI 10.1378/chest.122.3.1006; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; NIEMINEN AL, 1992, TOXICOL APPL PHARM, V115, P147, DOI 10.1016/0041-008X(92)90317-L; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sorrell VL, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-17; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yeh ST, 2009, J MOL CELL CARDIOL, V47, P789, DOI 10.1016/j.yjmcc.2009.09.003; Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	37	238	253	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					316	326		10.1096/fj.12-226225	http://dx.doi.org/10.1096/fj.12-226225			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24076965	Green Published			2022-12-25	WOS:000333526100030
J	Carlson, AE; Rosenbaum, JC; Brelidze, TI; Klevit, RE; Zagotta, WN				Carlson, Anne E.; Rosenbaum, Joel C.; Brelidze, Tinatin I.; Klevit, Rachel E.; Zagotta, William N.			Flavonoid Regulation of HCN2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); Electrophysiology; Flavonoids; Fluorescence Resonance Energy Transfer (FRET); Ion Channels; NMR; HCN; Fluorescence Anisotropy; Purine Ring	CARBOXY-TERMINAL REGION; STRUCTURAL BASIS; CAMP MODULATION; HEART-DISEASE; BINDING; INHIBITOR; EXCITABILITY; DROSOPHILA; GENISTEIN; FAMILY	Background: HCN2 channels are regulated by membrane potential and by the direct binding of cyclic nucleotides to their carboxyl-terminal region. Results: The flavonoid fisetin potentiates HCN2 channel activation. Conclusion: Fisetin acts as a partial agonist for HCN2 channels by binding to the channel's cyclic nucleotide-binding site. Significance: HCN2 may be a target for the physiologic action of flavonoids such as fisetin. The hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels are pacemaker channels whose currents contribute to rhythmic activity in the heart and brain. HCN channels open in response to hyperpolarizing voltages, and the binding of cAMP to their cyclic nucleotide-binding domain (CNBD) facilitates channel opening. Here, we report that, like cAMP, the flavonoid fisetin potentiates HCN2 channel gating. Fisetin sped HCN2 activation and shifted the conductance-voltage relationship to more depolarizing potentials with a half-maximal effective concentration (EC50) of 1.8 m. When applied together, fisetin and cAMP regulated HCN2 gating in a nonadditive fashion. Fisetin did not potentiate HCN2 channels lacking their CNBD, and two independent fluorescence-based binding assays reported that fisetin bound to the purified CNBD. These data suggest that the CNBD mediates the fisetin potentiation of HCN2 channels. Moreover, binding assays suggest that fisetin and cAMP partially compete for binding to the CNBD. NMR experiments demonstrated that fisetin binds within the cAMP-binding pocket, interacting with some of the same residues as cAMP. Together, these data indicate that fisetin is a partial agonist for HCN2 channels.	[Carlson, Anne E.; Brelidze, Tinatin I.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Rosenbaum, Joel C.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	zagotta@uw.edu	Klevit, Rachel/AAI-7038-2021; Carlson, Anne/I-9495-2019	Klevit, Rachel/0000-0002-3476-969X; Carlson, Anne/0000-0003-2724-1325; Brelidze, Tinatin/0000-0003-3046-8184	National Institutes of Health [R01 EY010329, F32 HL095241, 5T32CA080416-14, R01 EY017370]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010329, R01EY017370] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY010329 (to W. N. Z.), F32 HL095241 (to A. E. C.), 5T32CA080416-14 (to J. C. R.), and R01 EY017370 (to R. E. K.).	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Cavanagh J., 2005, PROTEIN NMR SPECTROS, P540; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Echalier A, 2012, CHEM BIOL, V19, P1028, DOI 10.1016/j.chembiol.2012.06.015; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Galli RL, 2002, ANN NY ACAD SCI, V959, P128, DOI 10.1111/j.1749-6632.2002.tb02089.x; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Inanami O, 1998, FREE RADICAL RES, V29, P359, DOI 10.1080/10715769800300401; Jacobson KA, 2002, ADV EXP MED BIOL, V505, P163; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P56; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Lu HS, 2005, J MED CHEM, V48, P737, DOI 10.1021/jm049353p; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Middleton E, 2000, PHARMACOL REV, V52, P673; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rozario AO, 2009, BBA-BIOMEMBRANES, V1788, P1939, DOI 10.1016/j.bbamem.2009.06.003; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	51	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33136	33145		10.1074/jbc.M113.501759	http://dx.doi.org/10.1074/jbc.M113.501759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085296	Green Published, hybrid			2022-12-25	WOS:000328841700029
J	Wunderlich, P; Glebov, K; Kemmerling, N; Tien, NT; Neumann, H; Walter, J				Wunderlich, Patrick; Glebov, Konstantin; Kemmerling, Nadja; Tien, Nguyen T.; Neumann, Harald; Walter, Jochen			Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and gamma-Secretase-dependent Intramembranous Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Intramembrane Proteolysis; Membrane; Presenilin; Protein Phosphorylation; Secretases; Signaling	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; PRESENILIN; MUTATIONS; DAP12; METALLOPROTEINASES; MICROGLIA; TRAFFICKING; NEUTROPHILS	Background: TREM2 is a microglial receptor, recently identified as a genetic risk factor for late onset AD. Results: Sequential proteolytic processing of TREM2 involves ectodomain shedding and intramembranous cleavage by -secretase and affects signaling via its adaptor protein DAP12. Conclusion: -Secretase-mediated intramembranous proteolysis modulates TREM2 signaling. Significance: Inhibition of -secretase could impair TREM2 function in neuroinflammation. Triggering receptor expressed on myeloid cells-2 (TREM2) and its signaling adaptor protein TYROBP/DAP12 play important roles in signal transduction in dendritic cells, osteoclasts, tissue macrophages, and microglia. Recently, TREM2 variants have been shown to be linked to late onset Alzheimer disease. Here, we demonstrate that TREM2 undergoes sequential proteolytic processing by ectodomain shedding and intramembrane proteolysis. The C-terminal fragment (CTF) of TREM2 generated by ectodomain shedding is cleaved by -secretase. Importantly, pharmacologic and genetic -secretase inhibition resulted in accumulation of TREM2 CTF at the plasma membrane that also interacts with the signaling adaptor protein DAP12. Thus, the accumulated TREM2 CTF thereby might limit the interaction of DAP12 with the functional full-length receptor, resulting in decreased DAP12 phosphorylation and impaired metabolism of phosphatidylinositol 4,5-bisphosphate. Together, these data demonstrate -secretase-mediated intramembranous proteolysis of TREM2 and functionally link two Alzheimer disease-associated proteins in one signaling pathway.	[Wunderlich, Patrick; Glebov, Konstantin; Kemmerling, Nadja; Tien, Nguyen T.; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Neumann, Harald] Univ Bonn, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Neumann, Harald/A-9718-2010; Wang, Caihong/T-5837-2019	Neumann, Harald/0000-0002-5071-5202; Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft [SFB695, KFO177, FOR1336, SFB704]; Hertie-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB695 and KFO177 to J. W.; FOR1336, SFB704, and KFO177 to H. N.) and by the Hertie-Foundation (to H. N.).	Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Farfara D, 2011, ANN NEUROL, V69, P170, DOI 10.1002/ana.22191; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hernandez-Pando R, 2000, INT J EXP PATHOL, V81, P199, DOI 10.1046/j.1365-2613.2000.00152.x; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jiang T, 2013, MOL NEUROBIOL, V48, P180, DOI 10.1007/s12035-013-8424-8; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lee J, 2002, NEUROMOL MED, V2, P29; Lowell CA, 2011, COLD SPRING HARB PER, V3; Mahdy AM, 2006, CLIN VACCINE IMMUNOL, V13, P492, DOI 10.1128/CVI.13.4.492-495.2006; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mendez Mario F, 2006, Am J Alzheimers Dis Other Demen, V21, P281, DOI 10.1177/1533317506290448; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Peraus GC, 1997, J NEUROSCI, V17, P7714; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	49	162	166	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33027	33036		10.1074/jbc.M113.517540	http://dx.doi.org/10.1074/jbc.M113.517540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078628	Green Published, hybrid			2022-12-25	WOS:000328841700019
J	Capecci, J; Forgac, M				Capecci, Joseph; Forgac, Michael			The Function of Vacuolar ATPase (V-ATPase) a Subunit Isoforms in Invasiveness of MCF10a and MCF10CA1a Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Breast Cancer; Invasion; Proton Pumps; Proton Transport; Vacuolar ATPase; a Subunit Isoforms	H+-ATPASE; A3 ISOFORM; PROTON PUMPS; METASTASIS; EXPRESSION; MEMBRANE; PH; HOMEOSTASIS; INHIBITION; INVASION	Background: The V-ATPase has been suggested to function in tumor cell invasion. Results: Invasion by MCF10CA1a cells is inhibited by knockdown of the a3 isoform, whereas a3 overexpression increases invasion and plasma membrane localization of V-ATPases in MCF10a cells. Conclusion: Invasion and plasma membrane V-ATPase localization can be controlled by expression of a3. Significance: a3 is a possible therapeutic target to limit metastasis. The vacuolar H+ ATPases (V-ATPases) are ATP-driven proton pumps that transport protons across both intracellular and plasma membranes. Previous studies have implicated V-ATPases in the invasiveness of various cancer cell lines. In this study, we evaluated the role of V-ATPases in the invasiveness of two closely matched human breast cancer lines. MCF10a cells are a non-invasive, immortalized breast epithelial cell line, and MCF10CA1a cells are a highly invasive, H-Ras-transformed derivative of MCF10a cells selected for their metastatic potential. Using an in vitro Matrigel assay, MCF10CA1a cells showed a much higher invasion than the parental MCF10a cells. Moreover, this increased invasion was completely sensitive to the specific V-ATPase inhibitor concanamycin. MCF10CA1a cells expressed much higher levels of both a1 and a3 subunit isoforms relative to the parental line. Isoforms of subunit a are responsible for subcellular localization of V-ATPases, with a3 and a4 targeting V-ATPases to the plasma membrane of specialized cells. Knockdown of either a3 alone or a3 and a4 together using isoform-specific siRNAs inhibited invasion by MCF10CA1a cells. Importantly, overexpression of a3 but not the other a subunit isoforms greatly increased the invasiveness of the parental MCF10a cells. Similarly, overexpression of a3 significantly increased expression of V-ATPases at the plasma membrane. These studies suggest that breast tumor cells employ particular a subunit isoforms to target V-ATPases to the plasma membrane, where they function in tumor cell invasion.	[Forgac, Michael] Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, Boston, MA 02111 USA; Tufts Univ, Program Cellular & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.).	Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cao XQ, 2012, AM J PHYSIOL-RENAL, V302, pF1121, DOI 10.1152/ajprenal.00278.2011; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Partridge J, 2009, JOVE-J VIS EXP, P1475; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AB, 2000, ORG LETT, V2, P1; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; SOULE HD, 1990, CANCER RES, V50, P6075; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772	42	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32731	32741		10.1074/jbc.M113.503771	http://dx.doi.org/10.1074/jbc.M113.503771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072707	Green Published, hybrid			2022-12-25	WOS:000328681700057
J	Schwend, T; Jin, ZG; Jiang, K; Mitchell, BJ; Jia, JH; Yang, J				Schwend, Tyler; Jin, Zhigang; Jiang, Kai; Mitchell, Brian J.; Jia, Jianhang; Yang, Jing			Stabilization of Speckle-type POZ Protein (Spop) by Daz Interacting Protein 1 (Dzip1) Is Essential for Gli Turnover and the Proper Output of Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cilia; Development; Hedgehog; Protein Degradation; Xenopus; Dzip1; Gli; Spop	ZINC-FINGER PROTEIN; SONIC HEDGEHOG; CUBITUS-INTERRUPTUS; UBIQUITIN LIGASE; PRIMARY CILIUM; CELL IDENTITY; FLOOR PLATE; GENE; SUPPRESSOR; ZEBRAFISH	Background: Although Dzip1 positively influences Hedgehog signaling by regulating ciliogenesis, it inhibits the Hedgehog pathway through an unclear mechanism. Results: Dzip1 knockdown destabilizes Spop E3 ubiquitin ligase, leading to increased Gli transcription factor levels and phenotypes resembling Hedgehog signaling activation. Conclusion: Dzip1 inhibits Hedgehog signaling through stabilizing Spop. Significance: We uncover a novel Gli regulatory mechanism. The Hedgehog (Hh) pathway is essential for embryonic development and adult tissue homeostasis. The Gli/Cubitus interruptus (Ci) family of transcription factors acts at the downstream end of the pathway to mediate Hh signaling. Both Hh-dependent and -independent Gli regulatory mechanisms are important for the output of Hh signaling. Daz interacting protein 1 (Dzip1) has bipartite positive and negative functions in the Hh pathway. The positive Hh regulatory function appears to be attributed to a requirement for Dzip1 during ciliogenesis. The mechanism by which Dzip1 inhibits Hh signaling, however, remains largely unclear. We recently found that Dzip1 is required for Gli turnover, which may account for its inhibitory function in Hh signaling. Here, we report that Dzip1 regulates Gli/Ci turnover by preventing degradation of speckle-type POZ protein (Spop), a protein that promotes proteasome-dependent turnover of Gli proteins. We provide evidence that Dzip1 regulates the stability of Spop independent of its function in ciliogenesis. Partial knockdown of Dzip1 to levels insufficient for perturbing ciliogenesis, sensitized Xenopus embryos to Hh signaling, leading to phenotypes that resemble activation of Hh signaling. Importantly, overexpression of Spop was able to restore proper Gli protein turnover and rescue phenotypes in Dzip1-depleted embryos. Consistently, depletion of Dzip1 in Drosophila S2 cells destabilized Hh-induced BTB protein (HIB), the Drosophila homolog of Spop, and increased the level of Ci. Thus, Dzip1-dependent stabilization of Spop/HIB is evolutionarily conserved and essential for proper regulation of Gli/Ci proteins in the Hh pathway.	[Schwend, Tyler; Jin, Zhigang; Yang, Jing] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61802 USA; [Jiang, Kai; Jia, Jianhang] Univ Kentucky, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA; [Mitchell, Brian J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Kentucky; Northwestern University; Feinberg School of Medicine	Yang, J (corresponding author), Univ Illinois, Coll Vet Med, Dept Comparat Biosci, 2001 South Lincoln Ave,3411 VMBSB, Urbana, IL 61802 USA.	yangj@illinois.edu	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968; Jiang, Kai/0000-0002-8507-1945; Mitchell, Brian/0000-0001-6281-1536; Jia, Jianhang/0000-0002-9313-3843	NICHD, National Institutes of Health; NATIONAL EYE INSTITUTE [F32EY021708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217, R01GM079684] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. A. Liu and R. Harland for plasmids. BA-F8 and 12/101 antibodies were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD, National Institutes of Health and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dammermann A, 2009, GENE DEV, V23, P2046, DOI 10.1101/gad.1810409; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Ding Q, 1998, DEVELOPMENT, V125, P2533; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jin ZG, 2011, J BIOL CHEM, V286, P36171, DOI 10.1074/jbc.M111.274761; Jin ZG, 2010, J BIOL CHEM, V285, P34493, DOI 10.1074/jbc.M110.169581; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lupo G, 2005, DEVELOPMENT, V132, P1737, DOI 10.1242/dev.01726; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Oro AE, 2007, CURR OPIN CELL BIOL, V19, P691, DOI 10.1016/j.ceb.2007.10.008; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Perron M, 2003, DEVELOPMENT, V130, P1565, DOI 10.1242/dev.00391; Peyrot SM, 2011, DEV BIOL, V352, P254, DOI 10.1016/j.ydbio.2011.01.021; PREAT T, 1992, GENETICS, V132, P725; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Sive H., 2000, LAB MANUAL, P91; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Vokes SA, 2004, CURR BIOL, V14, pR668, DOI 10.1016/j.cub.2004.08.015; Wang CB, 2013, J BIOL CHEM, V288, P29518, DOI 10.1074/jbc.M113.492066; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zhang XM, 2001, DEVELOPMENT, V128, P943	64	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32809	32820		10.1074/jbc.M113.512962	http://dx.doi.org/10.1074/jbc.M113.512962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072710	Green Published, hybrid			2022-12-25	WOS:000328681700064
J	Stamatakis, E; Chau, JY; Pedisic, Z; Bauman, A; Macniven, R; Coombs, N; Hamer, M				Stamatakis, Emmanuel; Chau, Josephine Y.; Pedisic, Zeljko; Bauman, Adrian; Macniven, Rona; Coombs, Ngaire; Hamer, Mark			Are Sitting Occupations Associated with Increased All-Cause, Cancer, and Cardiovascular Disease Mortality Risk? A Pooled Analysis of Seven British Population Cohorts	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; LEISURE-TIME; SEDENTARY BEHAVIORS; FINNISH SUBJECTS; HEALTH SURVEY; DEATH; NETHERLANDS; TRENDS; WORK; LIFE	Background: There is mounting evidence for associations between sedentary behaviours and adverse health outcomes, although the data on occupational sitting and mortality risk remain equivocal. The aim of this study was to determine the association between occupational sitting and cardiovascular, cancer and all-cause mortality in a pooled sample of seven British general population cohorts. Methods: The sample comprised 5380 women and 5788 men in employment who were drawn from five Health Survey for England and two Scottish Health Survey cohorts. Participants were classified as reporting standing, walking or sitting in their work time and followed up over 12.9 years for mortality. Data were modelled using Cox proportional hazard regression adjusted for age, waist circumference, self-reported general health, frequency of alcohol intake, cigarette smoking, nonoccupational physical activity, prevalent cardiovascular disease and cancer at baseline, psychological health, social class, and education. Results: In total there were 754 all-cause deaths. In women, a standing/walking occupation was associated with lower risk of all-cause (fully adjusted hazard ratio [HR] = 0.68, 95% CI 0.52-0.89) and cancer (HR = 0.60, 95% CI 0.43-0.85) mortality, compared to sitting occupations. There were no associations in men. In analyses with combined occupational type and leisure-time physical activity, the risk of all-cause mortality was lowest in participants with non-sitting occupations and high leisure-time activity. Conclusions: Sitting occupations are linked to increased risk for all-cause and cancer mortality in women only, but no such associations exist for cardiovascular mortality in men or women.	[Stamatakis, Emmanuel; Coombs, Ngaire; Hamer, Mark] UCL, Phys Act Res Grp, Div Populat Hlth, London, England; [Stamatakis, Emmanuel; Coombs, Ngaire; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London, England; [Stamatakis, Emmanuel; Chau, Josephine Y.; Pedisic, Zeljko; Bauman, Adrian; Macniven, Rona] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of London; University College London; University of London; University College London; University of Sydney	Stamatakis, E (corresponding author), UCL, Phys Act Res Grp, Div Populat Hlth, London, England.	e.stamatakis@ucl.ac.uk	Hamer, Mark/AAJ-6814-2021; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/C-1602-2008	Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992; Pedisic, Zeljko/0000-0003-2886-3556; Macniven, Rona/0000-0002-2967-7977; Chau, Josephine/0000-0001-6261-2545	National Institute for Health Research (United Kingdom); British Heart Foundation; Scottish Health Survey; Scottish Executive; Health Survey for England by the Health and Social Care Information Centre; Australian National Health and Medical Research Council Program [569940]; National Institute for Health Research [CDF-2010-03-30] Funding Source: researchfish	National Institute for Health Research (United Kingdom)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Scottish Health Survey; Scottish Executive; Health Survey for England by the Health and Social Care Information Centre; Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from the first author's (ES) Career Development Fellowship supported by the National Institute for Health Research (United Kingdom). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the English Department of Health. MH receives funding from the British Heart Foundation, The Scottish Health Survey is funded by the Scottish Executive and the Health Survey for England by the Health and Social Care Information Centre. AB, JYC and ZP are funded by Australian National Health and Medical Research Council Program Grant (No. 569940). None of the funding organisations listed above had any involvement in the data analysis and interpretation or the preparation, review and approval of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085; Bureau of Labor Statistics, 2012, AM TIM US SURV 2011; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Friedenreich CM, 2010, CANCER CAUSE CONTROL, V21, P1105, DOI 10.1007/s10552-010-9538-1; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Holtermann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054548; Hu G, 2004, CIRCULATION, V110, P666, DOI 10.1161/01.CIR.0000138102.23783.94; Hu G, 2007, AM J HYPERTENS, V20, P1242, DOI 10.1016/j.amjhyper.2007.07.015; Hu GC, 2014, ASIA-PAC J PUBLIC HE, V26, P604, DOI 10.1177/1010539512471966; JOHANSSON S, 1988, European Heart Journal, V9, P8; Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS; Joint Health Surveys Unit, 2009, HLTH SURV ENGL 2008; Jurakic D, 2010, SOCIOL PROST, V48, P113; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Kristal-Boneh E, 2000, J OCCUP ENVIRON MED, V42, P127, DOI 10.1097/00043764-200002000-00005; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V18, P11; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Messenger JC, 2011, CAMB J ECON, V35, P295, DOI 10.1093/cje/beq022; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Moe B, 2013, OCCUP ENVIRON MED, V70, P86, DOI 10.1136/oemed-2012-100734; MORRIS JN, 1953, LANCET, V265, P1111; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Proper KI, 2012, J OBES, V2012, DOI 10.1155/2012/607908; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; SALONEN JT, 1988, AM J EPIDEMIOL, V127, P87, DOI 10.1093/oxfordjournals.aje.a114794; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Simons CCJM, 2013, AM J EPIDEMIOL, V177, P514, DOI 10.1093/aje/kws280; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Stamatakis E, 2007, PREV MED, V45, P416, DOI 10.1016/j.ypmed.2006.12.014; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; SZRETER SRS, 1984, BRIT J SOCIOL, V35, P522, DOI 10.2307/590433; The Organisation for Economic Co-operation and Development, 2012, EMPL OUTL; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Williams ED, 2011, J EPIDEMIOL COMMUN H, V65, P517, DOI 10.1136/jech.2009.102509; Williams ED, 2011, HEART, V97, P655, DOI 10.1136/hrt.2010.201012; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	49	100	100	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73753	10.1371/journal.pone.0073753	http://dx.doi.org/10.1371/journal.pone.0073753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086292	Green Accepted, Green Published, gold			2022-12-25	WOS:000325220000002
J	Tanveer, SK; Wen, XX; Lu, XL; Zhang, JL; Liao, YC				Tanveer, Sikander Khan; Wen, Xiaoxia; Lu, Xing Li; Zhang, Junli; Liao, Yuncheng			Tillage, Mulch and N Fertilizer Affect Emissions of CO2 under the Rain Fed Condition	PLOS ONE			English	Article							CONTROLLING SOIL RESPIRATION; CARBON-DIOXIDE FLUXES; LAND-USE TYPES; ORGANIC-MATTER; CONSERVATION TILLAGE; MICROBIAL BIOMASS; LOESS PLATEAU; WATER-CONTENT; WHEAT FIELD; NITROGEN	A two year (2010-2012) study was conducted to assess the effects of different agronomic management practices on the emissions of CO2 from a field of non-irrigated wheat planted on China's Loess Plateau. Management practices included four tillage methods i.e. T-1: (chisel plow tillage), T-2: (zero-tillage), T-3: (rotary tillage) and T-4: (mold board plow tillage), 2 mulch levels i.e., M-0 (no corn residue mulch) and M-1 (application of corn residue mulch) and 5 levels of N fertilizer (0, 80, 160, 240, 320 kg N/ha). A factorial experiment having a strip split-split arrangement, with tillage methods in the main plots, mulch levels in the sub plots and N-fertilizer levels in the sub-sub plots with three replicates, was used for this study. The CO2 data were recorded three times per week using a portable GXH-3010E1 gas analyzer. The highest CO2 emissions were recorded following rotary tillage, compared to the lowest emissions from the zero tillage planting method. The lowest emissions were recorded at the 160 kg N/ha, fertilizer level. Higher CO2 emissions were recorded during the cropping year 2010-11 relative to the year 2011-12. During cropping year 2010-11, applications of corn residue mulch significantly increased CO2 emissions in comparison to the non-mulched treatments, and during the year 2011-12, equal emissions were recorded for both types of mulch treatments. Higher CO2 emissions were recorded immediately after the tillage operations. Different environmental factors, i.e., rain, air temperatures, soil temperatures and soil moistures, had significant effects on the CO2 emissions. We conclude that conservation tillage practices, i.e., zero tillage, the use of corn residue mulch and optimum N fertilizer use, can reduce CO2 emissions, give better yields and provide environmentally friendly options.	[Tanveer, Sikander Khan; Wen, Xiaoxia; Lu, Xing Li; Zhang, Junli; Liao, Yuncheng] Northwest A&F Univ Yangling, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Liao, YC (corresponding author), Northwest A&F Univ Yangling, Coll Agron, Yangling, Shaanxi, Peoples R China.	yunchengliao@163.com			National Natural Science foundation of China [31071375, 31171506]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science foundation of China (31071375 and 31171506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi H., 2009, AGR ENG INT CIGR EJO, VXI, P1; Alvaro-Fuentes J, 2007, SOIL TILL RES, V96, P331, DOI 10.1016/j.still.2007.08.003; ANDERSON TH, 1994, BEYOND THE BIOMASS, P67; Bao S.D., 2008, SOIL AGR CHEM ANAL M, Vthird ed; Bauer J, 2008, GEODERMA, V145, P17, DOI 10.1016/j.geoderma.2008.01.026; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P787, DOI 10.2136/sssaj1994.03615995005800030021x; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Calderon FJ, 2001, SOIL SCI SOC AM J, V65, P118, DOI 10.2136/sssaj2001.651118x; Chapin III FS, 1991, INTEGRATED RESPONSES, P67; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Ding WX, 2006, ATMOS ENVIRON, V40, P3294, DOI 10.1016/j.atmosenv.2006.01.045; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; Fisk MC, 2001, BIOGEOCHEMISTRY, V53, P201, DOI 10.1023/A:1010693614196; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; FRANZLUEBBERS AJ, 1995, SOIL TILL RES, V34, P41, DOI 10.1016/0167-1987(94)00450-S; Galantini J, 2006, SOIL TILL RES, V34, P41; Gao ChengDa, 2008, Journal of Beijing Forestry University, V30, P102; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2000, SOIL BIOL BIOCHEM, V32, P211, DOI 10.1016/S0038-0717(99)00148-0; Houghton R, 1990, EARTH TRANSFORMED HU, P393; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Hutchinson JJ, 2007, AGR FOREST METEOROL, V142, P288, DOI 10.1016/j.agrformet.2006.03.030; Iqbal J, 2008, SOIL BIOL BIOCHEM, V40, P2324, DOI 10.1016/j.soilbio.2008.05.010; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; Jacinthe PA, 2002, SOIL TILL RES, V67, P147, DOI 10.1016/S0167-1987(02)00058-2; JOHNSON MG, 1995, WATER AIR SOIL POLL, V82, P593, DOI 10.1007/BF00479414; KERN JS, 1993, SOIL SCI SOC AM J, V57, P200, DOI 10.2136/sssaj1993.03615995005700010036x; Kladivko EJ, 2001, SOIL TILL RES, V61, P61, DOI 10.1016/S0167-1987(01)00179-9; Koga N, 2003, AGR ECOSYST ENVIRON, V99, P213, DOI 10.1016/S0167-8809(03)00132-4; KOWALENKO CG, 1978, SOIL BIOL BIOCHEM, V10, P417, DOI 10.1016/0038-0717(78)90068-8; La Scala N, 2005, SOIL TILL RES, V84, P222, DOI 10.1016/j.still.2004.11.004; LADD JN, 1994, SOIL BIOL BIOCHEM, V26, P821, DOI 10.1016/0038-0717(94)90298-4; Lal R, 1997, NUTR CYCL AGROECOSYS, V49, P243, DOI 10.1023/A:1009794514742; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lal R, 1997, SOIL TILL RES, V42, P145, DOI 10.1016/S0167-1987(97)00006-8; Lal R., 1998, POTENTIAL US CROP LA; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li H, 2010, AGR ECOSYST ENVIRON, V135, P24, DOI 10.1016/j.agee.2009.08.003; LIANG BC, 1992, SOIL SCI, V153, P307, DOI 10.1097/00010694-199204000-00007; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Lou YZ, 2006, SOIL RESP ENV, P110; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Paustian K., 1997, SOIL ORGANIC MATTER; POST WM, 1990, AM SCI, V78, P310; Raich JW, 1992, SOIL SCI SOC AM J, V56, P476; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Reicosky DC, 2002, AGRICULTURAL PRACTICES AND POLICIES FOR CARBON SEQUESTRATION IN SOIL, P87; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; REICOSKY DC, 1993, AGRON J, V85, P1237, DOI 10.2134/agronj1993.00021962008500060027x; Ren XE, 2007, CHINESE SCI BULL, V52, P2722, DOI 10.1007/s11434-007-0346-2; Saiz G, 2007, GEODERMA, V139, P79, DOI 10.1016/j.geoderma.2006.12.005; Schlesinger W.H., 1986, CHANGES SOIL CARBON, P194, DOI DOI 10.1007/978-1-4757-1915-4_11; Schlesinger WH, 2006, SCIENCE, V314, P1217, DOI 10.1126/science.1137177; Smith P, 1998, GLOB CHANGE BIOL, V4, P679, DOI 10.1046/j.1365-2486.1998.00185.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wang XB, 2007, SOIL TILL RES, V93, P239, DOI 10.1016/j.still.2006.05.005; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Zhang HX, 2011, ECOL RES, V26, P735, DOI 10.1007/s11284-011-0832-5; Zhang HX, 2011, J ENVIRON SCI-CHINA, V23, P79, DOI 10.1016/S1001-0742(10)60376-2; Zou JW, 2004, CHINESE SCI BULL, V49, P381, DOI 10.1360/03wd0270	69	26	26	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72140	10.1371/journal.pone.0072140	http://dx.doi.org/10.1371/journal.pone.0072140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086256	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700004
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			Long-Range Correlations in Stride Intervals May Emerge from Non-Chaotic Walking Dynamics	PLOS ONE			English	Article							HUMAN GAIT; FRACTAL DYNAMICS; MOVEMENT VARIABILITY; STABILITY; DISEASE; NOISE; PATTERNS; CHAOS; MODEL	Stride intervals of normal human walking exhibit long-range temporal correlations. Similar to the fractal-like behaviors observed in brain and heart activity, long-range correlations in walking have commonly been interpreted to result from chaotic dynamics and be a signature of health. Several mathematical models have reproduced this behavior by assuming a dominant role of neural central pattern generators (CPGs) and/or nonlinear biomechanics to evoke chaos. In this study, we show that a simple walking model without a CPG or biomechanics capable of chaos can reproduce long-range correlations. Stride intervals of the model revealed long-range correlations observed in human walking when the model had moderate orbital stability, which enabled the current stride to affect a future stride even after many steps. This provides a clear counterexample to the common hypothesis that a CPG and/or chaotic dynamics is required to explain the long-range correlations in healthy human walking. Instead, our results suggest that the long-range correlation may result from a combination of noise that is ubiquitous in biological systems and orbital stability that is essential in general rhythmic movements.	[Ahn, Jooeun; Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	aje@mit.edu		Ahn, Jooeun/0000-0002-7964-5148	DARPA's Warrior Web program [BAA-11-72]; Eric P. and Evelyn E. Newman Fund; Gloria Blake Fund	DARPA's Warrior Web program; Eric P. and Evelyn E. Newman Fund; Gloria Blake Fund	This work was supported in part by DARPA's Warrior Web program, BAA-11-72, the Eric P. and Evelyn E. Newman Fund, and by the Gloria Blake Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047963; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gates DH, 2007, PHYSICA A, V380, P259, DOI 10.1016/j.physa.2007.02.061; Gerasimenko Y, 2010, J NEUROSCI, V30, P3700, DOI 10.1523/JNEUROSCI.4751-09.2010; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBERGER AL, 1990, SCI AM, V262, P43; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Nayfeh A. H., 2008, APPL NONLINEAR DYNAM; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; POOL R, 1989, SCIENCE, V243, P604, DOI 10.1126/science.2916117; SKINNER JE, 1990, BIO-TECHNOL, V8, P1018, DOI 10.1038/nbt1190-1018; Su JLS, 2007, J BIOMECH ENG-T ASME, V129, P802, DOI 10.1115/1.2800760; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Torre K, 2007, BRIT J MATH STAT PSY, V60, P85, DOI 10.1348/000711005X89513; Usatenko OV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.110601; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; West BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051917; West Bruce J, 2005, J Neuroeng Rehabil, V2, P24, DOI 10.1186/1743-0003-2-24; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8; XU N, 1988, B MATH BIOL, V50, P559; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151	38	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73239	10.1371/journal.pone.0073239	http://dx.doi.org/10.1371/journal.pone.0073239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086274	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200007
J	Bao, JJ; Huck, D; Gunther, LK; Sellers, JR; Sakamoto, T				Bao, Jianjun; Huck, Daniel; Gunther, Laura K.; Sellers, James R.; Sakamoto, Takeshi			Actin Structure-Dependent Stepping of Myosin 5a and 10 during Processive Movement	PLOS ONE			English	Article							MOLECULE FLUORESCENCE POLARIZATION; HAND-OVER-HAND; F-ACTIN; BUNDLED ACTIN; COILED-COIL; NECK LENGTH; V MOLECULES; FILOPODIA; MOTOR; PROTEINS	How myosin 10, an unconventional myosin, walks processively along actin is still controversial. Here, we used single molecule fluorescence techniques, TIRF and FIONA, to study the motility and the stepping mechanism of dimerized myosin 10 heavy-meromyosin-like fragment on both single actin filaments and two-dimensional F-actin rafts crosslinked by fascin or a-actinin. As a control, we also tracked and analyzed the stepping behavior of the well characterized processive motor myosin 5a. We have shown that myosin 10 moves processively along both single actin filaments and F-actin rafts with a step size of 31 nm. Moreover, myosin 10 moves more processively on fascin-F-actin rafts than on a-actinin-F-actin rafts, whereas myosin 5a shows no such selectivity. Finally, on fascin-F-actin rafts, myosin 10 has more frequent side steps to adjacent actin filaments than myosin 5a in the F-actin rafts. Together, these results reveal further single molecule features of myosin 10 on various actin structures, which may help to understand its cellular functions.	[Bao, Jianjun; Huck, Daniel; Gunther, Laura K.; Sakamoto, Takeshi] Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA; [Sakamoto, Takeshi] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48202 USA; [Sellers, James R.] NHLBI, NIH, Bethesda, MD 20892 USA	Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sakamoto, T (corresponding author), Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA.	ee4243@wayne.edu		Huck, Daniel/0000-0003-4221-8078; Gunther, Laura/0000-0003-4588-2572	National Institutes of Health [HL089350]; Department of Physics and Astronomy, Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL089350, ZIAHL004232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physics and Astronomy, Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (career development grant HL089350 to TS), the start-up fund from the Department of Physics and Astronomy, Wayne State University (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Forkey JN, 2000, PROG BIOPHYS MOL BIO, V74, P1, DOI 10.1016/S0079-6107(00)00015-8; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nagy A, 2009, BIOPHYS J, V97, P3123, DOI 10.1016/j.bpj.2009.09.033; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Ono S, 1997, J BIOL CHEM, V272, P2527; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sukow C, 2003, BIOPHYS J, V85, P525, DOI 10.1016/S0006-3495(03)74497-X; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; TAYLOR KA, 1992, J STRUCT BIOL, V108, P140, DOI 10.1016/1047-8477(92)90013-Z; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	53	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74936	10.1371/journal.pone.0074936	http://dx.doi.org/10.1371/journal.pone.0074936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069366	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300055
J	Broeckx, BJG; Coopman, F; Verhoeven, GEC; Van Haeringen, W; van de Goor, L; Bosmans, T; Gielen, I; Saunders, JH; Soetaert, SSA; Van Bree, H; Van Neste, C; Van Nieuwerburgh, F; Van Ryssen, B; Verelst, E; Van Steendam, K; Deforce, D				Broeckx, Bart J. G.; Coopman, Frank; Verhoeven, Geert E. C.; Van Haeringen, Wim; van de Goor, Leanne; Bosmans, Tim; Gielen, Ingrid; Saunders, Jimmy H.; Soetaert, Sandra S. A.; Van Bree, Henri; Van Neste, Christophe; Van Nieuwerburgh, Filip; Van Ryssen, Bernadette; Verelst, Elien; Van Steendam, Katleen; Deforce, Dieter			The Prevalence of Nine Genetic Disorders in a Dog Population from Belgium, the Netherlands and Germany	PLOS ONE			English	Article							CANINE DEGENERATIVE MYELOPATHY; EXERCISE-INDUCED COLLAPSE; HIP-DYSPLASIA; CENTRONUCLEAR MYOPATHY; MISSENSE MUTATION; ARYLSULFATASE-G; DNM1 MUTATION; BREEDS; FREQUENCY; SULFATASE	The objective of this study was to screen a dog population from Belgium, the Netherlands and Germany for the presence of mutant alleles associated with hip dysplasia (HD), degenerative myelopathy (DM), exercise-induced collapse (EIC), neuronal ceroid lipofuscinosis 4A (NCL), centronuclear myopathy (HMLR), mucopolysaccharidosis VII (MPS VII), myotonia congenita (MG), gangliosidosis (GM1) and muscular dystrophy (Duchenne type) (GRMD). Blood samples (K3EDTA) were collected for genotyping with Kompetitive Allele Specific PCR (n = 476). Allele and genotype frequencies were calculated in those breeds with at least 12 samples (n = 8). Hardy-Weinberg equilibrium was tested. Genetic variation was identified for 4 out of 9 disorders: mutant alleles were found in 49, 15, 3 and 2 breeds for HD, DM, EIC and NCL respectively. Additionally, mutant alleles were identified in crossbreeds for both HD and EIC. For HD, DM, EIC and NCL mutant alleles were newly discovered in 43, 13, 2 and 1 breed(s), respectively. In 9, 2 and 1 breed(s) for DM, EIC and NCL respectively, the mutant allele was detected, but the respective disorder has not been reported in those breeds. For 5 disorders (HMLR, MPS VII, MG, GM1, GRMD), the mutant allele could not be identified in our population. For the other 4 disorders (HD, DM, EIC, NCL), prevalence of associated mutant alleles seems strongly breed dependent. Surprisingly, mutant alleles were found in many breeds where the disorder has not been reported to date.	[Broeckx, Bart J. G.; Soetaert, Sandra S. A.; Van Neste, Christophe; Van Nieuwerburgh, Filip; Van Steendam, Katleen; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Coopman, Frank] Holbigenet NV, Waarschoot, Belgium; [Verhoeven, Geert E. C.; Gielen, Ingrid; Saunders, Jimmy H.; Van Bree, Henri; Van Ryssen, Bernadette] Univ Ghent, Fac Vet Med, Dept Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium; [Van Haeringen, Wim; van de Goor, Leanne] Dr Van Haeringen Lab bv, Wageningen, Netherlands; [Bosmans, Tim] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Verelst, Elien] Univ Coll Ghent, Fac Appl Bioengn, Melle, Belgium	Ghent University; Ghent University; Ghent University; HOGENT University College of Applied Sciences & Arts	Deforce, D (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium.	Dieter.Deforce@Ugent.be	Coopman, Frank/ABB-8083-2021; Van Ryssen, Bernadette/ABI-5258-2020; Deforce, Dieter LD/J-4725-2013; Broeckx, Bart/AAH-3940-2021; Van Nieuwerburgh, Filip/H-9697-2015; Van Neste, Christophe/AAE-5505-2020	Deforce, Dieter LD/0000-0002-0635-661X; Broeckx, Bart/0000-0001-6742-3911; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Van Neste, Christophe/0000-0002-5958-5731	Agency for Innovation by Science and Technology in Flanders (IWT); Royal Canin	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Royal Canin	The authors would like to thank the Agency for Innovation by Science and Technology in Flanders (IWT, http://www.iwt.be/) for their financial support and Royal Canin for their financial support to aid sample collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Gentilini F, 2011, J VET DIAGN INVEST, V23, P124, DOI 10.1177/104063871102300122; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; GREGORIUS HR, 1980, BIOMETRICS, V36, P643, DOI 10.2307/2556116; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Hytonen MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040281; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Karmi N, 2010, J VET INTERN MED, V24, P1337, DOI 10.1111/j.1939-1676.2010.0631.x; Mellersh C, 2012, MAMM GENOME, V23, P109, DOI 10.1007/s00335-011-9365-z; Minor KM, 2011, VET J, V189, P214, DOI 10.1016/j.tvjl.2011.06.022; Olby N, 2004, J VET INTERN MED, V18, P201, DOI 10.1892/0891-6640(2004)18&lt;201:CCDIAA&gt;2.0.CO;2; Patterson EE, 2008, NAT GENET, V40, P1235, DOI 10.1038/ng.224; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; Rettenmaier JL, 2002, VET RADIOL ULTRASOUN, V43, P313, DOI 10.1111/j.1740-8261.2002.tb01010.x; Rhodes TH, 1999, FEBS LETT, V456, P54, DOI 10.1016/S0014-5793(99)00926-6; Schnell G, 1935, AM KENNEL GAZ, V52, P25; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Wininger FA, 2011, J VET INTERN MED, V25, P1166, DOI [10.1111/j.1939-1676.2011.00760.x, 10.1111/j.1939-1676.2011.0760.x]; Yamato O, 2002, J INHERIT METAB DIS, V25, P525, DOI 10.1023/A:1021280007739	28	13	13	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74811	10.1371/journal.pone.0074811	http://dx.doi.org/10.1371/journal.pone.0074811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069350	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300048
J	Gordoa, A; Acuna, JL; Farres, R; Bacher, K				Gordoa, Ana; Luis Acuna, Jose; Farres, Roser; Bacher, Kathrin			Burst Feeding of Pelagia noctiluca ephyrae on Atlantic Bluefin Tuna (Thunnus thynnus) Eggs	PLOS ONE			English	Article							LONG-TERM FLUCTUATIONS; AURELIA-AURITA; NORTHEAST ATLANTIC; MEDITERRANEAN-SEA; JELLYFISH BLOOMS; FISH LARVAE; RATES; MORTALITY; ZOOPLANKTON; PREDATION	This study investigates the predation of P. noctiluca ephyrae on Atlantic Bluefin tuna (ABFT) eggs under different experimental conditions. The specific factors considered in the experimental design were: a) water mix conditions to explore predation under two-dimensional (2D) and three-dimensional (3D) prey distributions, b) prey density to investigate the ingestion rate capacity, and c) incubation time to inspect gut saturation. The eggs and jellyfish ephyrae were collected during the 2012 ABFT spawning survey off Ibiza (Balearic Isl., Western Mediterranean). The results showed that the proportion of feeding ephyrae increased with size. The mean clearance rate of feeding ephyrae, 4.14 L h(-1), was the highest ever recorded for ephyrae. Under calm conditions the eggs floated at the surface (2D spatial arrangement) and the clearance rates, at low prey densities, were at least twice those under mixed conditions (3D spatial arrangement). At high prey density, clearance rate did not differ between mix conditions, probably due to the fast gut saturation, which was reached in c.a. 15 min, as revealed by time series observations of gut contents. The fast saturation of ephyrae and their slow digestion time of approximately 18 h suggest the existence of a diel feeding periodicity. We conclude that in the Western Mediterranean, P. noctiluca ephyrae are capable of predating on ABFT eggs, a highly pulsed and spatially restricted resource that potentially switches from a 3D to a 2D configuration in the absence of wind-generated turbulence. The P. noctiluca and Atlantic Bluefin tuna egg system might represent an example of a general mechanism linking pelagic and neustonic food webs.	[Gordoa, Ana; Farres, Roser; Bacher, Kathrin] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain; [Luis Acuna, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Oviedo	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain.	gordoa@ceab.csic.es	Gordoa, Ana/A-1470-2013; Fernández, José Luis Acuña/I-7482-2016	Gordoa, Ana/0000-0003-1822-8196; Fernández, José Luis Acuña/0000-0003-3306-7212	Spanish Ministry of the Economy and Competitiveness	Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study is part of the project "Spatio-temporal overlap and trophic interactions between Atlantic Bluefin Tuna spawning and jellyfish in the Balearic spawning grounds" funded by the Spanish Ministry of the Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; BAILEY KM, 1984, MAR BIOL, V79, P303, DOI 10.1007/BF00393262; BAILEY KM, 1984, MAR BIOL, V83, P287, DOI 10.1007/BF00397461; Bernard P., 2011, ZOOPLANKTON SPATIAL, V4, P1; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Browman HI, 2003, ESTUARIES, V26, P30, DOI 10.1007/BF02691691; Cameron P, 1997, MAR POLLUT BULL, V34, P129, DOI 10.1016/S0025-326X(96)00069-0; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Compte J, 2010, MAR ECOL PROG SER, V402, P147, DOI 10.3354/meps08453; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Duffy JT, 1997, J EXP MAR BIOL ECOL, V212, P123, DOI 10.1016/S0022-0981(96)02741-4; Fancett Jenkins GP, 1988, J EXP MAR BIOL ECOL, V116, P63, DOI [10.1016/0022-0981(88)90246-8, DOI 10.1016/0022-0981(88)90246-8]; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FRANQUEVILLE C, 1971, Tethys, V3, P11; Giorgi R, 1991, JELLYFISH BLOOMS MED, P102; Gordoa A, 2013, COL ICCAT V IN PRESS, V69; Gordoa A, 2010, ICCAT COL VOL SCI PA, V65, P828; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham WM, 2001, J PLANKTON RES, V23, P67, DOI 10.1093/plankt/23.1.67; Hansson LJ, 2006, J PLANKTON RES, V28, P937, DOI 10.1093/plankt/fbl030; HUNTER JR, 1976, FISH B-NOAA, V74, P81; Hunter JR, 1975, C LARV FISH MORT STU, P1; LARSON RJ, 1991, HYDROBIOLOGIA, V216, P311, DOI 10.1007/BF00026480; LASKER R, 1985, CAN J FISH AQUAT SCI, V42, P31, DOI 10.1139/f85-260; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Acuna JL, 2011, SCIENCE, V333, P1627, DOI 10.1126/science.1205134; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; Lynam CP, 2005, MAR ECOL PROG SER, V298, P157, DOI 10.3354/meps298157; MacKenzie BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039998; Malej A, 1989, NOVA THALASSIA, V10, P89; Mariottini GL, 2008, MAR DRUGS, V6, P496, DOI 10.3390/md20080025; Mather FJ, 1995, NMFSSEFSC370 NOAA; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Meneses I, 2003, J PLANKTON RES, V25, P1177, DOI 10.1093/plankt/25.9.1177; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miyake P, 2003, COLLECTIVE VOLUME SC, V55, P114; Moller LF, 2010, HYDROBIOLOGIA, V645, P167, DOI 10.1007/s10750-010-0219-6; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; PURCELL JE, 1994, MAR ECOL PROG SER, V114, P47, DOI 10.3354/meps114047; Purcell JE, 2001, MAR ECOL PROG SER, V210, P67, DOI 10.3354/meps210067; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Richards WJ, 1976, ICCAT COLL VOL SCI P, V5, P267; Riisgard HU, 2011, J SEA RES, V65, P51, DOI 10.1016/j.seares.2010.07.002; Rodriguez-Roda J, 1981, COLLECTIVE VOLUME SC, V15, P278; Russell F. S., 1970, MEDUSAE BRIT ISLES; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; SANDRINI LR, 1989, MAR BIOL, V102, P49, DOI 10.1007/BF00391322; Sissenwine MP, 1984, WORKSH EXPL MAR COMM, P59; THEILACKER GH, 1986, FISH B-NOAA, V84, P1; Titelman J, 2006, MAR BIOL, V149, P297, DOI 10.1007/s00227-005-0200-5; Vucetic T, 1983, P WORKSH JELL BLOOMS, P167; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; [No title captured]	59	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74721	10.1371/journal.pone.0074721	http://dx.doi.org/10.1371/journal.pone.0074721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069335	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300038
J	Jacobelli, J; Matthews, ME; Chen, S; Krummel, MF				Jacobelli, Jordan; Matthews, Miriam Estin; Chen, Stephanie; Krummel, Matthew F.			Activated T Cell Trans-Endothelial Migration Relies on Myosin-IIA Contractility for Squeezing the Cell Nucleus through Endothelial Cell Barriers	PLOS ONE			English	Article							MOTILITY; ICAM-1; INFLAMMATION; ADHESION	Following activation, T cells are released from lymph nodes to traffic via the blood to effector sites. The re-entry of these activated T cells into tissues represents a critical step for them to carry out local effector functions. Here we have assessed defects in effector T cells that are acutely depleted in Myosin-IIA (MyoIIA) and show a T cell intrinsic requirement for this motor to facilitate the diapedesis step of extravasation. We show that MyoIIA accumulates at the rear of T cells undergoing trans-endothelial migration. T cells can extend protrusions and project a substantial portion of their cytoplasm through the endothelial wall in the absence of MyoIIA. However, this motor protein plays a crucial role in allowing T cells to complete the movement of their relatively rigid nucleus through the endothelial junctions. In vivo, this defect manifests as poor entry into lymph nodes, tumors and into the spinal cord, during tissue-specific autoimmunity, but not the spleen. This suggests that therapeutic targeting of this molecule may allow for differential attenuation of tissue-specific inflammatory responses.	[Jacobelli, Jordan; Matthews, Miriam Estin] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Jacobelli, Jordan; Matthews, Miriam Estin] Univ Colorado, Denver, CO 80202 USA; [Chen, Stephanie; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	National Jewish Health; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco	Jacobelli, J (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA.	jacobellij@njhealth.org; matthew.krummel@ucsf.edu		Chen, Stephanie/0000-0002-9004-3682	National Institutes of Health [RO1 AI52116]; National Multiple Sclerosis Society [PP1775]; NATIONAL CANCER INSTITUTE [U54CA163123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405, R01AI052116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health (RO1 AI52116 to MFK) and JJ was was supported (in part) by a Pilot Research Award (PP1775) from the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manes TD, 2013, J IMMUNOL, V190, P3079, DOI 10.4049/jimmunol.1201817; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	24	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75151	10.1371/journal.pone.0075151	http://dx.doi.org/10.1371/journal.pone.0075151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069389	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300069
J	Liesz, A; Ruger, H; Purrucker, J; Zorn, M; Dalpke, A; Mohlenbruch, M; Englert, S; Nawroth, PP; Veltkamp, R				Liesz, Arthur; Rueger, Holger; Purrucker, Jan; Zorn, Markus; Dalpke, Alexander; Moehlenbruch, Markus; Englert, Stefan; Nawroth, Peter P.; Veltkamp, Roland			Stress Mediators and Immune Dysfunction in Patients with Acute Cerebrovascular Diseases	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INDUCED IMMUNODEPRESSION; POSTSTROKE INFECTION; ACTIVATION; INJURY; IMMUNODEFICIENCY; COMPLICATIONS; RISK	Background: Post-stroke immune depression contributes to the development of infections which are major complications after stroke. Previous experimental and clinical studies suggested that humoral stress mediators induce immune dysfunction. However, prospective clinical studies testing this concept are missing and no data exists for other cerebrovascular diseases including intracerebral hemorrhage (ICH) and TIA. Methods: We performed a prospective clinical study investigating 166 patients with TIA, ischemic and hemorrhagic stroke. We measured a broad panel of stress mediators, leukocyte subpopulations, cytokines and infection markers from hospital admission to day 7 and on follow-up after 2-3 months. Multivariate regression analyses detected independent predictors of immune dysfunction and bacterial infections. ROC curves were used to test the diagnostic value of these parameters. Results: Only severe ischemic strokes and ICH increased some catecholamine metabolites, ACTH and cortisol levels. Immunodysfunction was eminent already on hospital admission after large brain lesions with lymphocytopenia as a key feature. None of the stress mediators was an independent predictor of lymphocytopenia or infections. However, lymphocytopenia on hospital admission was detected as an independent explanatory variable of later infections. NIHSSS and lymphocytopenia on admission were excellent predictors of infection. Conclusions: Our results question the present pathophysiological concept of stress-hormone mediated immunodysfunction after stroke. Early lymphocytopenia was identified as an early independent predictor of post-stroke infections. Absence of lymphocytopenia may serve as a negative predictive marker for stratification for early antibiotic treatment.	[Liesz, Arthur; Rueger, Holger; Purrucker, Jan; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Zorn, Markus; Nawroth, Peter P.] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany; [Dalpke, Alexander] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Moehlenbruch, Markus] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Englert, Stefan] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Liesz, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Arthur.Liesz@med.uni-heidelberg.de	Liesz, Arthur/AAT-7147-2021	Liesz, Arthur/0000-0002-9069-2594	Deutsche Forschungsgemeinschaft [VE196/3-1]; Else Kroner-Fresenius foundation [2012-A118]; Daimler-Benz foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius foundation; Daimler-Benz foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (VE196/3-1) and the Else Kroner-Fresenius foundation (2012-A118) and by a fellowship of the Daimler-Benz foundation to A. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P1410, DOI 10.1161/01.STR.24.9.1410; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Diamond B, 2011, P NATL ACAD SCI USA, V108, P3461, DOI 10.1073/pnas.1100329108; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Emsley HCA, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-5; Gumbinger C, 2012, J NEUROL SCI; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Hug A, 2010, NEUROCRIT CARE; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Smith CJ, 2006, J NEUROL SCI, V251, P77, DOI 10.1016/j.jns.2006.09.011; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; TARKOWSKI E, 1995, STROKE, V26, P57, DOI 10.1161/01.STR.26.1.57; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Urra X, 2009, CURR MOL MED, V9, P195, DOI 10.2174/156652409787581574; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Walter U, 2013, EUR J NEUROL, V20, P153, DOI 10.1111/j.1468-1331.2012.03818.x; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110	34	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74839	10.1371/journal.pone.0074839	http://dx.doi.org/10.1371/journal.pone.0074839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069356	gold, Green Submitted, Green Published			2022-12-25	WOS:000324777300051
J	Mathison, A; Grzenda, A; Lomberk, G; Velez, G; Buttar, N; Tietz, P; Hendrickson, H; Liebl, A; Xiong, YNY; Gores, G; Fernandez-Zapico, M; LaRusso, NF; Faubion, W; Shah, VH; Urrutia, R				Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Velez, Gabriel; Buttar, Navtej; Tietz, Pamela; Hendrickson, Helen; Liebl, Ann; Xiong, Yuning Y.; Gores, Gregory; Fernandez-Zapico, Martin; LaRusso, Nicholas F.; Faubion, William; Shah, Vijay H.; Urrutia, Raul			Role for Kruppel-Like Transcription Factor 11 in Mesenchymal Cell Function and Fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; INDUCED LIVER FIBROSIS; CANCER; EXPRESSION; PATHWAY; KLF6; TRANSPLANTATION; BIOSYNTHESIS; REGENERATION; RECRUITMENT	Kruppel-like factor 11 (KLF11) and the highly homologous KLF10 proteins are transcription factors originating from duplication of the Drosophila melanogaster ancestor cabut. The function of these proteins in epithelial cells has been previously characterized. In the current study, we report a functional role for KLF11 in mesenchymal cells and in mesenchymal cell dysfunction, namely, fibrosis, and subsequently perform a detailed cellular, molecular, and in vivo characterization of this phenomenon. We find that, in cultured mesenchymal cells, enhanced expression of KLF11 results in activated extracellular matrix pathways, including collagen gene silencing and matrix metalloproteinases activation without changes in tissue inhibitors of metalloproteinases. Combined, reporter and chromatin immunoprecipitation assays demonstrate that KLF11 interacts directly with the collagen 1a2 (COL1A2) promoter in mesenchymal cells to repress its activity. Mechanistically, KLF11 regulates collagen gene expression through the heterochromatin protein 1 gene-silencing pathway as mutants defective for coupling to this epigenetic modifier lose the ability to repress COL1A2. Expression studies reveal decreased levels of KLF11 during liver fibrogenesis after chemically induced injury in vivo. Congruently, KLF11(-/-) mice, which should be deficient in the hypothesized anti-fibrogenic brake imposed by this transcription factor, display an enhanced response to liver injury with increased collagen fibril deposition. Thus, KLFs expands the repertoire of transcription factors involved in the regulation of extracellular matrix proteins in mesenchymal cells and define a novel pathway that modulates the fibrogenic response during liver injury.	[Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Velez, Gabriel; Liebl, Ann; Xiong, Yuning Y.; Faubion, William; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Buttar, Navtej; Tietz, Pamela; Hendrickson, Helen; Liebl, Ann; Xiong, Yuning Y.; Gores, Gregory; LaRusso, Nicholas F.; Faubion, William; Shah, Vijay H.; Urrutia, Raul] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Fernandez-Zapico, Martin] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Translat Epigen Program, Ctr Individualized Med, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Biophys, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Med, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Biochem, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, R (corresponding author), Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Grzenda, Adrienne L/K-4421-2019; Lomberk, Gwen/AAL-8490-2020	Grzenda, Adrienne L/0000-0001-5952-6953; Lomberk, Gwen/0000-0001-5463-789X; Velez, Gabriel/0000-0003-0819-5933; Mathison, Angela/0000-0002-6763-2710	National Institutes of Health [DK52913]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic; NIH Training Grant in Tumor Microenvironment [T32CA148073]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK052913, R56DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021171, R37AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic; NIH Training Grant in Tumor Microenvironment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (DK52913); the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567); the Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic (RU); and NIH (T32CA148073) Training Grant in Tumor Microenvironment (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Das A, 2010, AM J PHYSIOL-GASTR L, V298, pG908, DOI 10.1152/ajpgi.00510.2009; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; Hedin KE, 2000, SURGERY, V128, P1, DOI 10.1067/msy.2000.106426; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2008, CURR OPIN GASTROEN, V24, P597, DOI 10.1097/MOG.0b013e32830b111d; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Ma XR, 2009, LAB INVEST, V89, P903, DOI 10.1038/labinvest.2009.51; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; Miele L, 2008, GASTROENTEROLOGY, V135, P282, DOI 10.1053/j.gastro.2008.04.004; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seo S, 2013, J PAIN, V14, P549, DOI 10.1016/j.jpain.2013.01.772; Seo S, 2012, J BIOL CHEM, V287, P12723, DOI 10.1074/jbc.M112.351395; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang KL, 2008, BIOCHEM BIOPH RES CO, V373, P219, DOI 10.1016/j.bbrc.2008.05.192; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang HB, 2013, J HEPATOL, V58, P763, DOI 10.1016/j.jhep.2012.11.024; Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75311	10.1371/journal.pone.0075311	http://dx.doi.org/10.1371/journal.pone.0075311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069400	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300078
J	Yang, SM; Hua, KF; Lin, YC; Chen, A; Chang, JM; Chao, LK; Ho, CL; Ka, SM				Yang, Shun-Min; Hua, Kuo-Feng; Lin, Yu-Chuan; Chen, Ann; Chang, Jia-Ming; Chao, Louis Kuoping; Ho, Chen-Lung; Ka, Shuk-Man			Citral Is Renoprotective for Focal Segmental Glomerulosclerosis by Inhibiting Oxidative Stress and Apoptosis and Activating Nrf2 Pathway in Mice	PLOS ONE			English	Article							NF-KAPPA-B; DIABETIC-NEPHROPATHY; BARDOXOLONE METHYL; INFLAMMATORY RESPONSE; PROTEIN-KINASES; KIDNEY; PROGRESSION; EXPRESSION; INJURY; FIBROSIS	The pathogenesis of focal segmental glomerulosclerosis (FSGS) is considered to be associated with oxidative stress, mononuclear leukocyte recruitment and infiltration, and matrix production and/or matrix degradation, although the exact etiology and pathogenic pathways remain to be determined. Establishment of a pathogenesis-based therapeutic strategy for the disease is clinically warranted. Citral (3,7-dimethyl-2,6-octadienal), a major active compound in Litsea cubeba, a traditional Chinese herbal medicine, can inhibit oxidant activity, macrophage and NF-kappa B activation. In the present study, first, we used a mouse model of FSGS with the features of glomerular epithelial hyperplasia lesions (EPHLs), a key histopathology index of progression of FSGS, peri-glomerular inflammation, and progressive glomerular hyalinosis/sclerosis. When treated with citral for 28 consecutive days at a daily dose of 200 mg/kg of body weight by gavage, the FSGS mice showed greatly reduced EPHLs, glomerular hyalinosis/sclerosis and peri-glomerular mononuclear leukocyte infiltration, suggesting that citral may be renoprotective for FSGS and act by inhibiting oxidative stress and apoptosis and early activating the Nrf2 pathway. Meanwhile, a macrophage model involved in anti-oxidative and anti-inflammatory activities was employed and confirmed the beneficial effects of citral on the FSGS model.	[Yang, Shun-Min; Lin, Yu-Chuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yang, Shun-Min; Chen, Ann] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Chang, Jia-Ming] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, Taipei, Taiwan; [Chao, Louis Kuoping] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Ho, Chen-Lung] Taiwan Forestry Res Inst, Div Wood Cellulose, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Ilan University; China Medical University Taiwan; National Defense Medical Center	Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	mariaka@ndmctsgh.edu.tw	Chang, Jia-Ming/P-4010-2019		Ministry of Economic Affairs [101-EC-17-A-19-S1-161]; National Science Council, Taiwan, ROC [NSC 100-2313-B-197-002, NSC 101-2321-B-016-003, NSC 102-2628-B-197-001-MY3]	Ministry of Economic Affairs; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Economic Affairs (101-EC-17-A-19-S1-161) and National Science Council (NSC 100-2313-B-197-002; NSC 101-2321-B-016-003; NSC 102-2628-B-197-001-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes MM, 2006, PEDIATR NEPHROL, V21, P1003, DOI 10.1007/s00467-006-0138-y; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Bachiega TF, 2011, J ETHNOPHARMACOL, V137, P909, DOI 10.1016/j.jep.2011.07.021; Barroso MF, 2011, J AGR FOOD CHEM, V59, P5062, DOI 10.1021/jf1048244; Benchimol C, 2003, CURR OPIN PEDIATR, V15, P171, DOI 10.1097/00008480-200304000-00006; Benz K, 2010, PEDIATR NEPHROL, V25, P1291, DOI 10.1007/s00467-010-1507-0; Braun N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003233.pub2; Bruschi M, 2011, J CHROMATOGR B, V879, P1338, DOI 10.1016/j.jchromb.2010.11.030; Cheel J, 2005, J AGR FOOD CHEM, V53, P2511, DOI 10.1021/jf0479766; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cravedi P, 2013, AM J TRANSPLANT, V13, P266, DOI 10.1111/ajt.12045; D'Agati VD, 2012, CLIN J AM SOC NEPHRO; Erkan E, 2005, J AM SOC NEPHROL, V16, P398, DOI 10.1681/ASN.2003100861; Goumenos DS, 2006, NEPHRON CLIN PRACT, V104, pC75, DOI 10.1159/000093993; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Ka SM, 2011, AM J PHYSIOL-RENAL, V301, pF1218, DOI 10.1152/ajprenal.00050.2011; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Korbet SM, 2000, RENAL FAILURE, V22, P685, DOI 10.1081/JDI-100101956; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Lee HJ, 2008, ARCH PHARM RES, V31, P342, DOI 10.1007/s12272-001-1162-0; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin CT, 2008, BIORESOURCE TECHNOL, V99, P8783, DOI 10.1016/j.biortech.2008.04.041; Liu GC, 2012, DIABETOLOGIA, V55, P2522, DOI 10.1007/s00125-012-2586-1; Liu S, 2013, AM J PHYSIOL-RENAL; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Munoz M, 2011, J RENIN-ANGIO-ALDO S, V12, P404, DOI 10.1177/1470320311410092; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Ortiz MI, 2010, PHYTOMEDICINE, V18, P74, DOI 10.1016/j.phymed.2010.05.009; Ory V, 2012, AM J PATHOL, V180, P2284, DOI 10.1016/j.ajpath.2012.02.008; Ozbek E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/465897; Pani A, 2012, AUTOIMMUN REV; Passerini P, 2009, G Ital Nefrol, V26, P563; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pouchert CJ, 1974, ALDRICH LIB NMR SPEC; Queisser N, 2012, FREE RADICAL BIO MED, V53, P314, DOI 10.1016/j.freeradbiomed.2012.05.011; Reisman SA, 2012, J AM SOC NEPHROL, V23, P1663, DOI 10.1681/ASN.2012050457; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Rojas-Rivera J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/321714; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Schachter AD, 2000, TRANSPLANTATION, V70, P1107, DOI 10.1097/00007890-200010150-00021; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shui HA, 2006, NEPHROL DIAL TRANSPL, V21, P1794, DOI 10.1093/ndt/gfl113; Shui HA, 2007, TRANSL RES, V150, P216, DOI 10.1016/j.trsl.2007.04.003; Sozeri B, 2010, SAUDI J KIDNEY DIS T, V21, P87; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Stirling CM, 2006, NEPHRON CLIN PRACT, V104, pC83, DOI 10.1159/000093994; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Therrien FJ, 2012, AM J NEPHROL, V36, P151, DOI 10.1159/000340033; Thornalley PJ, 2012, J RENAL NUTR, V22, P195, DOI 10.1053/j.jrn.2011.10.012; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Wang Y, 2001, KIDNEY INT, V59, P941, DOI 10.1046/j.1523-1755.2001.00577.x; Wang Y, 2008, AM J PATHOL, V172, P1491, DOI 10.2353/ajpath.2008.070825; Wang YP, 2001, KIDNEY INT, V59, P975, DOI 10.1046/j.1523-1755.2001.059003975.x; Wasilewska A, 2011, SCAND J UROL NEPHROL, V45, P52, DOI 10.3109/00365599.2010.526140; Watson D, 2009, INT J BIOCHEM CELL B, V41, P729, DOI 10.1016/j.biocel.2008.04.028; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; Wyburn KR, 2013, AM J PHYSIOL-RENAL, V304, pF68, DOI 10.1152/ajprenal.00669.2011; Yang B, 2002, KIDNEY INT, V62, P1301, DOI 10.1046/j.1523-1755.2002.00587.x; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807; Zoja C, 2013, AM J PHYSIOL-RENAL, V304, pF808, DOI 10.1152/ajprenal.00376.2012	74	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74871	10.1371/journal.pone.0074871	http://dx.doi.org/10.1371/journal.pone.0074871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069362	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300064
J	Bacon, S; Kyithar, MP; Schmid, J; Pozza, AC; Handberg, A; Byrne, MM				Bacon, Siobhan; Kyithar, Ma P.; Schmid, Jasmin; Pozza, Andre Costa; Handberg, Aase; Byrne, Maria M.			Circulating CD36 Is Reduced in HNF1A-MODY Carriers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; SCAVENGER RECEPTOR CD36; INSULIN-RESISTANCE; SOLUBLE CD36; CARDIOVASCULAR MORTALITY; SENSITIVITY; MUTATIONS; SECRETION; MARKERS	Introduction: Premature atherosclerosis is a significant cause of morbidity and mortality in type 2 diabetes mellitus. Maturity onset diabetes of the young (MODY) accounts for approximately 2% of all diabetes, with mutations in the transcription factor; hepatocyte nuclear factor 1 alpha (HNF1A) accounting for the majority of MODY cases. There is somewhat limited data available on the prevalence of macrovascular disease in HNF1A-MODY carriers with diabetes. Marked insulin resistance and the associated dyslipidaemia are not clinical features of HNF1A-MODY carriers. The scavenger protein CD36 has been shown to play a substantial role in the pathogenesis of atherosclerosis, largely through its interaction with oxidised LDL. Higher levels of monocyte CD36 and plasma CD36(sCD36) are seen to cluster with insulin resistance and diabetes. The aim of this study was to determine levels of sCD36 in participants with HNF1A-MODY diabetes and to compare them with unaffected normoglycaemic family members and participants with type 2 diabetes mellitus. Methods: We recruited 37 participants with HNF1A-MODY diabetes and compared levels of sCD36 with BMI-matched participants with type 2 diabetes mellitus and normoglycaemic HNF1A-MODY negative family controls. Levels of sCD36 were correlated with phenotypic and biochemical parameters. Results: HNF1A-MODY participants were lean, normotensive, with higher HDL and lower triglyceride levels when compared to controls and participants with type 2 diabetes mellitus. sCD36 was also significantly lower in HNF1A-MODY participants when compared to both the normoglycaemic family controls and to lean participants with type 2 diabetes mellitus. Conclusion: In conclusion, sCD36 is significantly lower in lean participants with HNF1A-MODY diabetes when compared to weight-matched normoglycaemic familial HNF1A-MODY negative controls and to lean participants with type 2 diabetes mellitus. Lower levels of this pro-atherogenic marker may result from the higher HDL component in the lipid profile of HNF1A-MODY participants.	[Bacon, Siobhan; Kyithar, Ma P.; Pozza, Andre Costa; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dept Endocrinol, Dublin, Ireland; [Schmid, Jasmin] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Handberg, Aase] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	Mater Misericordiae University Hospital; University College Dublin; Royal College of Surgeons - Ireland; Aalborg University; Aalborg University Hospital	Byrne, MM (corresponding author), Mater Misericordiae Univ Hosp, Dept Endocrinol, Dublin, Ireland.	mbyrne@mater.ie	Byrne, Maria/A-8310-2017; Schmid, Jasmin/C-3393-2012	Byrne, Maria/0000-0002-9394-8698; Schmid, Jasmin/0000-0001-5384-2242; Handberg, Aase/0000-0001-5719-203X	Mater College Foundation; Metabolic Research Unit	Mater College Foundation; Metabolic Research Unit	This research was funded in association with the Mater College Foundation and the Metabolic Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chmielewski M, 2010, CLIN CHIM ACTA, V411, P2079, DOI 10.1016/j.cca.2010.09.009; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Handberg A, 2012, J INTERN MED, V271, P294, DOI 10.1111/j.1365-2796.2011.02442.x; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; McDonald TJ, 2011, DIABETES CARE, V34, P1860, DOI 10.2337/dc11-0323; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Owen KR, 2002, DIABETIC MED, V19, P758, DOI 10.1046/j.1464-5491.2002.00766.x; Pearson ER, 2004, DIABETES CARE, V27, P1102, DOI 10.2337/diacare.27.5.1102; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Steele AM, 2010, DIABETIC MED, V27, P157, DOI 10.1111/j.1464-5491.2009.02913.x; Stride A, 2005, DIABETES CARE, V28, P1751, DOI 10.2337/diacare.28.7.1751; Tripathy D, 2000, DIABETOLOGIA, V43, P1476, DOI 10.1007/s001250051558; Yue P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009906	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74577	10.1371/journal.pone.0074577	http://dx.doi.org/10.1371/journal.pone.0074577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069322	gold, Green Submitted, Green Published			2022-12-25	WOS:000326240100112
J	Bengsch, F; Buck, A; Gunther, SC; Seiz, JR; Tacke, M; Pfeifer, D; von Elverfeldt, D; Sevenich, L; Hillebrand, LE; Kern, U; Sameni, M; Peters, C; Sloane, BF; Reinheckel, T				Bengsch, F.; Buck, A.; Guenther, S. C.; Seiz, J. R.; Tacke, M.; Pfeifer, D.; von Elverfeldt, D.; Sevenich, L.; Hillebrand, L. E.; Kern, U.; Sameni, M.; Peters, C.; Sloane, B. F.; Reinheckel, T.			Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression	ONCOGENE			English	Article						CTSB; breast cancer; macrophages; invasion	CYSTEINE CATHEPSINS; TUMOR-GROWTH; PLASMINOGEN-ACTIVATOR; PROMOTES PROGRESSION; PROTEASE ACTIVITY; MOUSE MODEL; EXPRESSION; METASTASIS; INVASION; MACROPHAGES	The cysteine protease cathepsin B (CTSB) is frequently overexpressed in human breast cancer and correlated with a poor prognosis. Genetic deficiency or pharmacological inhibition of CTSB attenuates tumor growth, invasion and metastasis in mouse models of human cancers. CTSB is expressed in both cancer cells and cells of the tumor stroma, in particular in tumor-associated macrophages (TAM). In order to evaluate the impact of tumor- or stromal cell-derived CTSB on Polyoma Middle T (PyMT)-induced breast cancer progression, we used in vivo and in vitro approaches to induce human CTSB overexpression in PyMT cancer cells or stromal cells alone or in combination. Orthotopic transplantation experiments revealed that CTSB overexpression in cancer cells rather than in the stroma affects PyMT tumor progression. In 3D cultures, primary PyMT tumor cells showed higher extracellular matrix proteolysis and enhanced collective cell invasion when CTSB was overexpressed and proteolytically active. Coculture of PyMT cells with bone marrow-derived macrophages induced a TAM-like macrophage phenotype in vitro, and the presence of such M2-polarized macrophages in 3D cultures enhanced sprouting of tumor spheroids. We employed a doxycycline (DOX)-inducible CTSB expression system to selectively overexpress human CTSB either in cancer cells or in macrophages in 3D cocultures. Tumor spheroid invasiveness was only enhanced when CTSB was overexpressed in cancer cells, whereas CTSB expression in macrophages alone did not further promote invasiveness of tumor spheroids. We conclude that CTSB overexpression in the PyMT mouse model promotes tumor progression not by a stromal effect, but by a direct, cancer cell-inherent mode of action: CTSB overexpression renders the PyMT cancers more invasive by increasing proteolytic extracellular matrix protein degradation fostering collective cell invasion into adjacent tissue.	[Bengsch, F.; Buck, A.; Guenther, S. C.; Seiz, J. R.; Tacke, M.; Sevenich, L.; Hillebrand, L. E.; Kern, U.; Peters, C.; Reinheckel, T.] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Bengsch, F.; Kern, U.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Bengsch, F.; Hillebrand, L. E.; Kern, U.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Pfeifer, D.] Univ Med Ctr, Genom Core Lab, Dept Hematol Oncol, Freiburg, Germany; [von Elverfeldt, D.] Univ Med Ctr, Dept Radiol, Freiburg, Germany; [Hillebrand, L. E.; Peters, C.; Reinheckel, T.] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Sameni, M.; Sloane, B. F.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Sloane, B. F.] Wayne State Univ, Barbara Ann Carmanos Canc Inst, Detroit, MI USA	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Wayne State University; Wayne State University	Reinheckel, T (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Reinheckel, Thomas/AAL-9761-2021; Buck, Achim/S-4843-2016; Buck, Achim/A-5092-2017; Sloane, Bonnie F/A-1050-2009	Reinheckel, Thomas/0000-0001-9866-9105; von Elverfeldt, Dominik/0000-0002-6219-3528; Buck, Achim/0000-0001-9135-9032	NIH [P30CA22453]; Excellence Initiative of the German Federal and State Governments [EXC 294, GSC-4]; Deutsche Forschungsgemeinschaft [SFB 850, B7]; NATIONAL CANCER INSTITUTE [R01CA140314, P30CA022453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The CTSB<SUP>+/0</SUP> mice were kindly provided by Dr L. Pennacchio, Genomics Division, Lawrence Berkeley Laboratory, Berkeley, USA. The immortalized macrophage cell line from FVB/n mice was kindly provided by Eike Latz, currently University of Bonn, Germany. We thank Nicole Klemm, Anja Faulhaber and Julia Wolanski for excellent technical assistance. Proteolysis imaging was mainly performed with kind help of the Microscopy, Imaging & Cytometry Resources Core at Wayne State University, Detroit, MI, USA, directed by Dr Kamiar Moin and supported in part by NIH Center grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University. This work was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294 and GSC-4, Spemann Graduate School), and the Deutsche Forschungsgemeinschaft SFB 850 project B7.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brisson L, 2012, EUR J CELL BIOL, V91, P847, DOI 10.1016/j.ejcb.2012.04.004; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Cavallo-Medved D, 2005, J CELL SCI, V118, P1493, DOI 10.1242/jcs.02278; Cesen MH, 2012, EXP CELL RES, V318, P1245, DOI 10.1016/j.yexcr.2012.03.005; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; GABRIJELCIC D, 1992, EUR J CLIN CHEM CLIN, V30, P69; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Gopinathan A, 2012, GUT, V61, P877, DOI 10.1136/gutjnl-2011-300850; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbeck N, 2001, CLIN CANCER RES, V7, P2757; Herroon MK, 2013, ONCOGENE, V32, P1580, DOI 10.1038/onc.2012.166; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Keppler D, 1996, ENZYME PROTEIN, V49, P94, DOI 10.1159/000468619; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Malla RR, 2011, CANCER GENE THER, V18, P419, DOI 10.1038/cgt.2011.9; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mikhaylov G, 2011, NAT NANOTECHNOL, V6, P594, DOI [10.1038/nnano.2011.112, 10.1038/NNANO.2011.112]; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Schurigt U, 2008, BIOL CHEM, V389, P1067, DOI 10.1515/BC.2008.115; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; SINHA AA, 1993, ANAT REC, V235, P233, DOI 10.1002/ar.1092350207; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Victor BC, 2007, BIOL CHEM, V388, P1131, DOI 10.1515/BC.2007.150; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823	55	70	71	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4474	4484		10.1038/onc.2013.395	http://dx.doi.org/10.1038/onc.2013.395			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24077280	Green Accepted			2022-12-25	WOS:000341158800003
J	Ochala, J; Gokhin, DS; Iwamoto, H; Fowler, VM				Ochala, Julien; Gokhin, David S.; Iwamoto, Hiroyuki; Fowler, Velia M.			Pointed-end capping by tropomodulin modulates actomyosin crossbridge formation in skeletal muscle fibers	FASEB JOURNAL			English	Article						tropomyosin; thin-filament activation	X-RAY-DIFFRACTION; BETA-TROPOMYOSIN MUTATION; THIN-FILAMENTS; CALCIUM ACTIVATION; NEBULIN RULER; CONTRACTILE; PROTEINS; LENGTHS; FORCE; HEART	In skeletal muscle, thick and thin filaments are arranged in a myofibrillar lattice. Tropomodulin 1 (Tmod1) is a pointed-end capping and tropomyosin-binding protein that controls thin-filament assembly, stability, and lengths. It remains unknown whether Tmods have other functional roles, such as regulating muscle contractility. To investigate this, we recorded and analyzed the mechanical properties and X-ray diffraction patterns of single membrane-permeabilized skeletal muscle fibers from mice lacking Tmod1. Results show that absence of Tmod1 and its replacement by Tmod3 and Tmod4 may impair initial tropomyosin movement over actin subunits during thin-filament activation, thus reducing both the fraction of actomyosin crossbridges in the strongly bound state (-29%) and fiber force-generating capacity (-31%). Therefore, Tmods are novel regulators of actomyosin crossbridge formation and muscle contractility, and future investigations and models of skeletal muscle force production must incorporate Tmods.Ochala, J., Gokhin, D. S., Iwamoto, H., Fowler, V. M. Pointed-end capping by tropomodulin modulates actomyosin crossbridge formation in skeletal muscle fibers.	[Ochala, Julien] Kings Coll London, Sch Biomed Sci, Ctr Human & Aerosp Physiol Sci, London SE1 1UL, England; [Gokhin, David S.; Fowler, Velia M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Iwamoto, Hiroyuki] Japan Synchrotron Radiat Res Inst, Nishinomiya, Hyogo, Japan	University of London; King's College London; Scripps Research Institute; Japan Synchrotron Radiation Research Institute	Ochala, J (corresponding author), Kings Coll London, Sch Biomed Sci, Ctr Human & Aerosp Physiol Sci, Rm 3-3,Shepherds House,Guys Campus, London SE1 1UL, England.	julien.ochala@kcl.ac.uk	Ochala, Julien/K-4120-2017	Ochala, Julien/0000-0002-6358-2920; Fowler, Velia/0000-0002-3161-8802	Swedish Research Council; National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health (NIH) [R01-HL083464]; National Institute of Arthritis and Musculoskeletal and Skin Diseases at the NIH [P30-AR061303]; Muscular Dystrophy Association; NATIONAL EYE INSTITUTE [P30EY012598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Swedish Research Council (to J.O.), a grant from the National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health (NIH; R01-HL083464 to V. M. F), a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the NIH to the Imaging Core of the San Diego Skeletal Muscle Research Center (P30-AR061303 to V. M. F.), and a development grant from the Muscular Dystrophy Association (to D. S. G.). The X-ray experiments were performed under approval of the SPring-8 Proposal Review Committee (2011B1058). The authors thank Nancy E. Kim, Yvette Hedstrom, and Ann-Marie Gustafsson for excellent technical assistance. The authors declare no conflicts of interest.	Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gokhin DS, 2013, NAT REV MOL CELL BIO, V14, P113, DOI 10.1038/nrm3510; Gokhin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC555, DOI 10.1152/ajpcell.00299.2011; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Iwamoto H, 2003, BIOPHYS J, V85, P2492, DOI 10.1016/S0006-3495(03)74672-4; Iwamoto H, 2002, J MOL BIOL, V317, P707, DOI 10.1006/jmbi.2002.5449; Iwamoto H, 2001, J MOL BIOL, V305, P863, DOI 10.1006/jmbi.2000.4334; Iwamoto H, 2009, J MOL BIOL, V390, P99, DOI 10.1016/j.jmb.2009.05.002; KNIGHT PJ, 1982, METHOD ENZYMOL, V85, P9; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Ochala J, 2011, FASEB J, V25, P1903, DOI 10.1096/fj.10-176727; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Yagi N, 2003, BIOPHYS J, V84, P1093, DOI 10.1016/S0006-3495(03)74925-X	32	12	12	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					408	415		10.1096/fj.13-239640	http://dx.doi.org/10.1096/fj.13-239640			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24072783	Green Published			2022-12-25	WOS:000333526100038
J	Lee, THY; Mitchell, A; Lau, SL; An, HY; Rajeaskariah, P; Wasinger, V; Raftery, M; Bryant, K; Tedla, N				Lee, Terry H. Y.; Mitchell, Ainslie; Lau, Sydney Liu; An, Hongyan; Rajeaskariah, Poornima; Wasinger, Valerie; Raftery, Mark; Bryant, Katherine; Tedla, Nicodemus			Glycosylation in a Mammalian Expression System Is Critical for the Production of Functionally Active Leukocyte Immunoglobulin-like Receptor A3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein; Glycosylation; Leukocyte; Mass Spectrometry (MS); Monocytes; Protein Deamidation; Protein Expression; Protein Purification; Recombinant Protein Expression; Tumor Necrosis Factor (TNF)	RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; LIGAND-BINDING; ASSOCIATION; CELLS; GLYCOPROTEOME; STABILITY; GLYCANS	Background: LILRA3 is a soluble receptor with unknown functions that is abundantly present in human serum. Results: Optimally glycosylated recombinant LILRA3 protein produced only in a mammalian system binds potential ligands and suppresses monocyte function. Conclusion: LILRA3 suppresses LPS-mediated TNF production, suggesting that it is a new anti-inflammatory protein. Significance: This work provides first insight into the biochemical characteristics and functions of LILRA3. The leukocyte immunoglobulin-like receptor (LILR) A3 is a member of the highly homologous activating and inhibitory receptors expressed on leukocytes. LILRA3 is a soluble receptor of unknown functions but is predicted to act as a broad antagonist to other membrane-bound LILRs. Functions of LILRA3 are unclear primarily because of the lack of high quality functional recombinant protein and insufficient knowledge regarding its ligand(s). Here, we expressed and characterized recombinant LILRA3 (rLILRA3) proteins produced in 293T cells, Escherichia coli, and Pichia pastoris. We found that the purified rLILRA3 produced in the mammalian system was the same size as a 70-kDa native macrophage LILRA3. This is 20 kDa larger than the calculated size, suggesting significant post-translational modifications. In contrast, rLILRA3 produced in E. coli was similar in size to the unprocessed protein, but yeast-produced protein was 2-4 times larger than the unprocessed protein. Treatment with peptide-N-glycosidase F reduced the size of the mammalian cell- and yeast-produced rLILRA3 to 50 kDa, suggesting that most modifications are due to glycosylation. Consistent with this, mass spectrometric analysis of the mammalian rLILRA3 revealed canonical N-glycosylation at the predicted Asn(140), Asn(281), Asn(302), Asn(341), and Asn(431) sites. Functionally, only mammalian cell-expressed rLILRA3 bound onto the surface of monocytes with high affinity, and importantly, only this significantly abrogated LPS-induced TNF production by monocytes. Binding to monocytes was partially blocked by -lactose, indicating that optimally glycosylated LILRA3 might be critical for ligand binding and function. Overall, our data demonstrated for the first time that LILRA3 is a potential new anti-inflammatory protein, and optimal glycosylation is required for its functions.	[Lee, Terry H. Y.; Mitchell, Ainslie; An, Hongyan; Rajeaskariah, Poornima; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW 2052, Australia; [Bryant, Katherine] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Lau, Sydney Liu; Wasinger, Valerie; Raftery, Mark] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Mark Wainwright Analyt Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Bryant, K (corresponding author), Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia.	katherine.bryant@unsw.edu.au; n.tedla@unsw.edu.au	Wasinger, Valerie/AAC-5004-2021; Bryant, Katherine/E-8574-2010	Wasinger, Valerie/0000-0001-5338-0869; Bryant, Katherine/0000-0002-8686-623X				Alavi A, 2000, J RHEUMATOL, V27, P1379; An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P262; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; Guo MJ, 2008, ENZYME MICROB TECH, V42, P340, DOI 10.1016/j.enzmictec.2007.10.013; Guseva NV, 2010, EUR J IMMUNOL, V40, P2618, DOI 10.1002/eji.200940134; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Kalli A, 2008, J PROTEOME RES, V7, P2834, DOI 10.1021/pr800038y; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kunicki TJ, 2005, BLOOD, V106, P2744, DOI 10.1182/blood-2005-04-1454; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Martinez-Donato G, 2006, BIOCHEM BIOPH RES CO, V342, P625, DOI 10.1016/j.bbrc.2006.01.157; Nakajima H, 1999, J IMMUNOL, V162, P5; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Palmisano G, 2012, J PROTEOME RES, V11, P1949, DOI 10.1021/pr2011268; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tedla N, 2011, TISSUE ANTIGENS, V77, P305, DOI 10.1111/j.1399-0039.2011.01633.x; Tedla N, 2003, P NATL ACAD SCI USA, V100, P1174, DOI 10.1073/pnas.0337567100; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Uchibori-Iwaki H, 2000, GLYCOBIOLOGY, V10, P865, DOI 10.1093/glycob/10.9.865; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zou SP, 2013, J BIOTECHNOL, V164, P75, DOI 10.1016/j.jbiotec.2012.12.015	42	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32873	32885		10.1074/jbc.M113.478578	http://dx.doi.org/10.1074/jbc.M113.478578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085305	hybrid, Green Published			2022-12-25	WOS:000328841700006
J	Sasaki-Osugi, K; Imoto, C; Takahara, T; Shibata, H; Maki, M				Sasaki-Osugi, Kanae; Imoto, Chiaki; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi			Nuclear ALG-2 Protein Interacts with Ca2+ Homeostasis Endoplasmic Reticulum Protein (CHERP) Ca2+-dependently and Participates in Regulation of Alternative Splicing of Inositol Trisphosphate Receptor Type 1 (IP(3)R1) Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium; Calcium-binding Proteins; Calcium Signaling; Protein-Protein Interactions; RNA Polymerase II; Subcellular Organelles; SR Proteins; Nuclear Speckles	1,4,5-TRISPHOSPHATE RECEPTORS; BINDING PROTEIN; SR PROTEINS; EXIT SITES; CA2+-BINDING PROTEINS; CELL-PROLIFERATION; II TRANSCRIPTION; POLYMERASE-II; CALCIUM; IDENTIFICATION	Background: ALG-2 is present both in the cytoplasm and nucleus, but little is known about its nuclear function. Results: ALG-2 interacts with the SR superfamily protein CHERP and accumulates at nuclear speckles in a Ca2+-dependent manner. Conclusion: ALG-2 and CHERP participate in alternative splicing. Significance: We propose a new role of ALG-2 and CHERP in post-transcriptional processing in the nucleus. The intracellular Ca2+ signaling pathway is important for the control of broad cellular processes from fertilization to cell death. ALG-2 is a Ca2+-binding protein that contains five serially repeated EF-hand motifs and interacts with various proteins in a Ca2+-dependent manner. Although ALG-2 is present both in the cytoplasm and in the nucleus, little is known about its nuclear function. Ca2+ homeostasis endoplasmic reticulum protein (CHERP) was first identified as an endoplasmic reticulum protein that regulates intracellular Ca2+ mobilization in human cells, but recent proteomics data suggest an association between CHERP and spliceosomes. Here, we report that CHERP, containing a Pro-rich region and a phosphorylated Ser/Arg-rich RS-like domain, is a novel Ca2+-dependent ALG-2-interactive target in the nucleus. Immunofluorescence microscopic analysis revealed localization of CHERP to the nucleoplasm with prominent accumulation at nuclear speckles, which are the sites of storage and modification for pre-mRNA splicing factors. Live cell time-lapse imaging showed that nuclear ALG-2 was recruited to the CHERP-localizing speckles upon Ca2+ mobilization. Results of co-immunoprecipitation assays revealed binding of CHERP to a phosphorylated form of RNA polymerase II. Knockdown of CHERP or ALG-2 in HT1080 cells resulted in generation of alternatively spliced isoforms of the inositol 1,4,5-trisphosphate receptor 1 (IP(3)R1) pre-mRNA that included exons 41 and 42 in addition to the major isoform lacking exons 40-42. Furthermore, binding between CHERP and IP(3)R1 RNA was detected by an RNA immunoprecipitation assay using a polyclonal antibody against CHERP. These results indicate that CHERP and ALG-2 participate in regulation of alternative splicing of IP(3)R1 pre-mRNA and provide new insights into post-transcriptional regulation of splicing variants in Ca2+ signaling pathways.	[Sasaki-Osugi, Kanae; Imoto, Chiaki; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Maki, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	mmaki@agr.nagoya-u.ac.jp	Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491	Japan Society for the Promotion of Science [23380056]; Japan Society for the Promotion of Science Fellows Project [25-3584]; Japan Society for the Promotion of Science research fellowship	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Fellows Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (B) Project No. 23380056 from the Japan Society for the Promotion of Science (to M. M.) and Grant-in-aid from the Japan Society for the Promotion of Science Fellows Project No. 25-3584 (to K. S.).; Recipient of a Japan Society for the Promotion of Science research fellowship for young scientists (DC2).	Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Choi JY, 2004, AM J PHYSIOL-CELL PH, V287, pC971, DOI 10.1152/ajpcell.00571.2003; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Draeby I, 2007, ARCH BIOCHEM BIOPHYS, V467, P87, DOI 10.1016/j.abb.2007.07.028; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Krebs J, 2011, NEUROCHEM RES, V36, P1198, DOI 10.1007/s11064-011-0431-4; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; Lamond AI, 2011, COLD SPRING HARB PER, V3; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 1997, BIOCHEM J, V328, P718; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Montaville P, 2006, BBA-MOL CELL RES, V1763, P1335, DOI 10.1016/j.bbamcr.2006.09.003; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; NAKAGAWA T, 1991, J NEUROCHEM, V57, P1807, DOI 10.1111/j.1471-4159.1991.tb06385.x; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Osugi Kanae, 2013, Methods Mol Biol, V963, P187, DOI 10.1007/978-1-62703-230-8_12; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; SCHELL MJ, 1993, MOL BRAIN RES, V17, P212, DOI 10.1016/0169-328X(93)90004-9; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	54	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33361	33375		10.1074/jbc.M113.497479	http://dx.doi.org/10.1074/jbc.M113.497479			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078636	Green Published, hybrid			2022-12-25	WOS:000328841700050
J	Rowley, J; Fonov, V; Wu, O; Eskildsen, SF; Schoemaker, D; Wu, LY; Mohades, S; Shin, M; Sziklas, V; Cheewakriengkrai, L; Shmuel, A; Dagher, A; Gauthier, S; Rosa-Neto, P				Rowley, Jared; Fonov, Vladimir; Wu, Ona; Eskildsen, Simon Fristed; Schoemaker, Dorothee; Wu, Liyong; Mohades, Sara; Shin, Monica; Sziklas, Viviane; Cheewakriengkrai, Laksanun; Shmuel, Amir; Dagher, Alain; Gauthier, Serge; Rosa-Neto, Pedro		Alzheimer's Dis Neuroimaging Initi	White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							DIFFUSION-TENSOR; MICROGLIAL ACTIVATION; POSTERIOR CINGULATE; UNCINATE FASCICULUS; TRACT INTEGRITY; DAMAGE; MRI; CORTEX; REGISTRATION; VALIDATION	The purpose of this project was to evaluate white matter degeneration and its impact on hippocampal structural connectivity in patients with amnestic mild cognitive impairment, non-amnestic mild cognitive impairment and Alzheimer's disease. We estimated white matter fractional anisotropy, mean diffusivity and hippocampal structural connectivity in two independent cohorts. The ADNI cohort included 108 subjects [25 cognitively normal, 21 amnestic mild cognitive impairment, 47 non-amnestic mild cognitive impairment and 15 Alzheimer's disease]. A second cohort included 34 subjects [15 cognitively normal and 19 amnestic mild cognitive impairment] recruited in Montreal. All subjects underwent clinical and neuropsychological assessment in addition to diffusion and T1 MRI. Individual fractional anisotropy and mean diffusivity maps were generated using FSL-DTIfit. In addition, hippocampal structural connectivity maps expressing the probability of connectivity between the hippocampus and cortex were generated using a pipeline based on FSL-probtrackX. Voxel-based group comparison statistics of fractional anisotropy, mean diffusivity and hippocampal structural connectivity were estimated using Tract-Based Spatial Statistics. The proportion of abnormal to total white matter volume was estimated using the total volume of the white matter skeleton. We found that in both cohorts, amnestic mild cognitive impairment patients had 27-29% white matter volume showing higher mean diffusivity but no significant fractional anisotropy abnormalities. No fractional anisotropy or mean diffusivity differences were observed between non-amnestic mild cognitive impairment patients and cognitively normal subjects. Alzheimer's disease patients had 66.3% of normalized white matter volume with increased mean diffusivity and 54.3% of the white matter had reduced fractional anisotropy. Reduced structural connectivity was found in the hippocampal connections to temporal, inferior parietal, posterior cingulate and frontal regions only in the Alzheimer's group. The severity of white matter degeneration appears to be higher in advanced clinical stages, supporting the construct that these abnormalities are part of the pathophysiological processes of Alzheimer's disease.	[Rowley, Jared; Schoemaker, Dorothee; Wu, Liyong; Mohades, Sara; Shin, Monica; Cheewakriengkrai, Laksanun; Gauthier, Serge; Rosa-Neto, Pedro] McGill Univ, MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada; [Wu, Liyong] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Shmuel, Amir; Dagher, Alain; Rosa-Neto, Pedro] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Fonov, Vladimir; Sziklas, Viviane] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Wu, Ona] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Eskildsen, Simon Fristed] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark	McGill University; Capital Medical University; McGill University; McGill University; Aarhus University	Rosa-Neto, P (corresponding author), McGill Univ, MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada.	Pedro.Rosa@mcgill.ca	wu, liyong/GVT-7509-2022; Eskildsen, Simon/K-3934-2019; Fonov, Vladimir/AAG-9572-2019; ROSA-NETO, PEDRO/F-5077-2015	Eskildsen, Simon/0000-0003-4242-9158; Fonov, Vladimir/0000-0003-3402-7749; Rowley, Jared/0000-0001-9690-7683; ROSA-NETO, PEDRO/0000-0001-9116-1376; Wu, Ona/0000-0002-5509-9461	Canadian institutes of Health Research (CIHR) [MOP-11-51-31]; Alzheimer's Association [NIRG-08-92090]; National Nature Science Foundation of China (NSFC) [3070024]; Beijing Scientific and Technological New Star Program [2007B069]; Nussia & Andre Aisenstadt Foundation; Fonds de la recherche en sante du Quebec; Scotia Bank Trust; Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	Canadian institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer's Association(Alzheimer's Association); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Scientific and Technological New Star Program; Nussia & Andre Aisenstadt Foundation; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Scotia Bank Trust; Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The MCSA data, analysis and writing of this paper were supported by Canadian institutes of Health Research (CIHR) (MOP-11-51-31); Alzheimer's Association (NIRG-08-92090); National Nature Science Foundation of China (NSFC) (3070024); Beijing Scientific and Technological New Star Program (2007B069); Nussia & Andre Aisenstadt Foundation, Fonds de la recherche en sante du Quebec, and the Scotia Bank Trust. Additionally, data collection and sharing for this project was funded by the Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association, Alzheimer's Drug Discovery Foundation, BioClinica, Inc., Biogen Idec Inc., Bristol-Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd. and its affiliated company, Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., NeuroRx Research, Novartis Pharmaceuticals Corporation, Pfizer Inc., Piramal Imaging, Servier, Synarc Inc., and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are Rev November 7, 2012 facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; AUGUSTINACK JC, 2013, NEUROIMAGE, P2414; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Beattie BL, 2007, CAN J NEUROL SCI, V34, pS27, DOI 10.1017/S0317167100005527; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Cagnin A, 2006, ACTA NEUROL SCAND, V114, P107, DOI 10.1111/j.1600-0404.2006.00694.x; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Ibrahim I, 2009, NEUROENDOCRINOL LETT, V30, P39; INSAUSTI R, 2004, INSAUSTI HIPPOCAMPAL; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JENKINSON M, 2005, ET2 MR BASED ESTIMAT; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; KRSTIC D, 2012, NAT REV NEUROL; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P194, DOI 10.1076/jcen.20.2.194.1173; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Miller A. K., 2008, NEUROPATHOL APPL NEU, V6, P119; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schmidt M., 1996, W PSYCHOL SERVICES; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; SELTZER B, 1979, BRAIN RES, V179, P157, DOI 10.1016/0006-8993(79)90499-2; SEXTON CE, 2009, BIOL PSYCHIAT; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Takahashi E, 2007, NEUROIMAGE, V34, P827, DOI 10.1016/j.neuroimage.2006.10.009; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D., 1984, WMS R WECHSLER MEMOR; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	89	22	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74776	10.1371/journal.pone.0074776	http://dx.doi.org/10.1371/journal.pone.0074776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086371	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900030
J	Brander, SM; Connon, RE; He, GC; Hobbs, JA; Smalling, KL; Teh, SJ; White, JW; Werner, I; Denison, MS; Cherr, GN				Brander, Susanne M.; Connon, Richard E.; He, Guochun; Hobbs, James A.; Smalling, Kelly L.; Teh, Swee J.; White, J. Wilson; Werner, Inge; Denison, Michael S.; Cherr, Gary N.			From 'Omics to Otoliths: Responses of an Estuarine Fish to Endocrine Disrupting Compounds across Biological Scales	PLOS ONE			English	Article							IN-VITRO; SEX DETERMINATION; MENIDIA-MENIDIA; GENE-EXPRESSION; TREATMENT-PLANT; DELTA SMELT; WATER; MODEL; EXPOSURE; TEMPERATURE	Endocrine disrupting chemicals (EDCs) cause physiological abnormalities and population decline in fishes. However, few studies have linked environmental EDC exposures with responses at multiple tiers of the biological hierarchy, including population-level effects. To this end, we undertook a four-tiered investigation in the impacted San Francisco Bay estuary with the Mississippi silverside (Menidia audens), a small pelagic fish. This approach demonstrated links between different EDC sources and fish responses at different levels of biological organization. First we determined that water from a study site primarily impacted by ranch run-off had only estrogenic activity in vitro, while water sampled from a site receiving a combination of urban, limited ranch run-off, and treated wastewater effluent had both estrogenic and androgenic activity. Secondly, at the molecular level we found that fish had higher mRNA levels for estrogen-responsive genes at the site where only estrogenic activity was detected but relatively lower expression levels where both estrogenic and androgenic EDCs were detected. Thirdly, at the organism level, males at the site exposed to both estrogens and androgens had significantly lower mean gonadal somatic indices, significantly higher incidence of severe testicular necrosis and altered somatic growth relative to the site where only estrogens were detected. Finally, at the population level, the sex ratio was significantly skewed towards males at the site with measured androgenic and estrogenic activity. Our results suggest that mixtures of androgenic and estrogenic EDCs have antagonistic and potentially additive effects depending on the biological scale being assessed, and that mixtures containing androgens and estrogens may produce unexpected effects. In summary, evaluating EDC response at multiple tiers is necessary to determine the source of disruption (lowest scale, i.e. cell line) and what the ecological impact will be (largest scale, i.e. sex ratio).	[Brander, Susanne M.; Cherr, Gary N.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Brander, Susanne M.; He, Guochun; Denison, Michael S.; Cherr, Gary N.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Brander, Susanne M.; White, J. Wilson] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Connon, Richard E.; Teh, Swee J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Hobbs, James A.] Univ Calif Davis, Dept Wildlife Fisheries & Conservat Biol, Davis, CA 95616 USA; [Smalling, Kelly L.] US Geol Survey, Sacramento, CA USA; [Werner, Inge] Eawag Ecole Polytech Fed Lausanne, Swiss Ctr Appl Ecotoxicol, Dubendorf, Switzerland; [Cherr, Gary N.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Brander, SM (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	branders@uncw.edu		Smalling, Kelly/0000-0002-1214-4920	Delta Science [R/SF-27, SCI-05-C111]; National Science Foundation [GK-12, 0841297]; Sacramento Regional County Sanitation District; Interagency Ecological Program, Sacramento, California [4600008070]; National Institutes of Environmental Health Sciences [P42-ES004699]; California Department of Fish and Wildlife [E1183010]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	Delta Science; National Science Foundation(National Science Foundation (NSF)); Sacramento Regional County Sanitation District; Interagency Ecological Program, Sacramento, California; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Department of Fish and Wildlife; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from Delta Science (Pre-Doctoral Fellowship R/SF-27 to SMB and grant no. SCI-05-C111), the National Science Foundation (GK-12 Pre-Doctoral Fellowship to SMB, grant no. 0841297), the Sacramento Regional County Sanitation District, and the Interagency Ecological Program, Sacramento, California (Contract No. 4600008070 to IW), a Superfund Research Grant from the National Institutes of Environmental Health Sciences (P42-ES004699 to M. Denison), and continuing funding from the California Department of Fish and Wildlife (Contract No. E1183010 to REC and SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RG, 2007, ENVIRON SCI TECHNOL, V41, P1317, DOI 10.1021/es0621593; Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Anderson SL, 2006, MAR ENVIRON RES, V62, pS317, DOI 10.1016/j.marenvres.2006.04.011; Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005; Ankley GT, 2010, AQUAT TOXICOL, V99, P389, DOI 10.1016/j.aquatox.2010.05.020; [Anonymous], 2008, SAN FRANCISCO ESTUAR; Banks JE, 2010, RISK ANAL, V30, P175, DOI 10.1111/j.1539-6924.2009.01349.x; BARKMAN RC, 1987, J FISH BIOL, V31, P683, DOI 10.1111/j.1095-8649.1987.tb05271.x; Blazer VS, 2002, FISH PHYSIOL BIOCHEM, V26, P85, DOI 10.1023/A:1023332216713; Bogers R, 2006, AQUAT TOXICOL, V80, P119, DOI 10.1016/j.aquatox.2006.07.020; Brander SM, 2012, ENV TOXICOLOGY CHEM; Brander SM, 2013, MONITORING WATER QUALITY: POLLUTION ASSESSMENT, ANALYSIS, AND REMEDIATION, P103, DOI 10.1016/B978-0-444-59395-5.00005-4; Brander SM, 2012, ECOTOXICOLOGY, V21, P1272, DOI 10.1007/s10646-012-0879-2; Brander SM, 2009, ENVIRON TOXICOL CHEM, V28, P1493, DOI 10.1897/08-374.1; Braun AM, 2003, BIOL REPROD, V69, P1642, DOI 10.1095/biolreprod.103.015479; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046; Clements William H., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P113, DOI 10.1023/A:1009927612391; Connon RE, 2011, AQUAT TOXICOL, V105, P369, DOI 10.1016/j.aquatox.2011.07.002; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CONOVER DO, 1990, SCIENCE, V250, P1556, DOI 10.1126/science.250.4987.1556; Crago J, 2011, CHEMOSPHERE, V82, P1669, DOI 10.1016/j.chemosphere.2010.11.011; Dang ZC, 2011, TOXICOL LETT, V202, P36, DOI 10.1016/j.toxlet.2011.01.016; Denslow Nancy, 2007, P255, DOI 10.1007/978-1-4020-6235-3_10; Doyle MA, 2011, J ENV MONITORING, V13; Duffy TA, 2010, J EXP ZOOL PART A, V313A, P421, DOI 10.1002/jez.612; Duffy TA, 2009, MAR ECOL PROG SER, V380, P245, DOI 10.3354/meps07928; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Filby AL, 2007, ENVIRON HEALTH PERSP, V115, P1704, DOI 10.1289/ehp.10443; Giudice BD, 2011, ENVIRON TOXICOL CHEM, V30, P2220, DOI 10.1002/etc.631; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Gurney WSC, 2006, ENVIRON HEALTH PERSP, V114, P122, DOI 10.1289/ehp.8064; Gutjahr-Gobell RE, 2005, ECOTOXICOLOGY ENV SA, V63, P244; Harris CA, 2011, ENV HLTH PERSPECT, V119; Heinze G, 2003, COMPUT METH PROG BIO, V71, P181, DOI 10.1016/S0169-2607(02)00088-3; Hladik ML, 2008, B ENVIRON CONTAM TOX, V80, P139, DOI 10.1007/s00128-007-9332-2; Hobbs JA, 2007, FISH B-NOAA, V105, P30; Houtman CJ, 2004, ENVIRON TOXICOL CHEM, V23, P32, DOI 10.1897/02-544; Houtman CJ, 2007, ENVIRON TOXICOL CHEM, V26, P898, DOI 10.1897/06-326R.1; HUBBS C, 1976, COPEIA, P386; Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008; Johnson R, 2009, OECD GUIDAN IN PRESS; KENNEDY WJ, 1971, ANN MATH STAT, V42, P1273, DOI 10.1214/aoms/1177693240; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Knapp R, 2011, BIOL LETTERS, V7, P150, DOI 10.1098/rsbl.2010.0514; Kolodziej EP, 2003, ENVIRON TOXICOL CHEM, V22, P2622, DOI 10.1897/03-42; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LEDREAN Y, 1995, MOL CELL ENDOCRINOL, V109, P27, DOI 10.1016/0303-7207(95)03482-M; Leon A, 2007, AQUAT TOXICOL, V82, P195, DOI 10.1016/j.aquatox.2007.02.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; MIDDAUGH DP, 1992, COPEIA, P53; Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1; Moyle P.B., 2002, INLAND FISHES CALIFO; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Nimrod AC, 1998, AQUAT TOXICOL, V44, P141, DOI 10.1016/S0166-445X(98)00062-9; O'Rear T. A., 2009, TRENDS FISH POPULATI; Orton F, 2009, ENVIRON SCI TECHNOL, V43, P2144, DOI 10.1021/es8028928; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pottinger TG, 2010, ENVIRON INT, V37, P158; R Development Core Team, 2012, R LANG ENV STAT COMP; Rempel MA, 2008, INT REV CEL MOL BIO, V267, P207, DOI 10.1016/S1937-6448(08)00605-9; Rempel MA, 2006, AQUAT TOXICOL, V77, P241, DOI 10.1016/j.aquatox.2005.12.007; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rose WL, 2005, ENVIRON TOXICOL CHEM, V24, P2612, DOI 10.1897/04-516R.1; Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002; Scholz NL, 2012, BIOSCIENCE, V62, P428, DOI 10.1525/bio.2012.62.4.13; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1; Singh PB, 2008, CHEMOSPHERE, V72, P422, DOI 10.1016/j.chemosphere.2008.02.026; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tamura H, 2006, BIOORGAN MED CHEM, V14, P7160, DOI 10.1016/j.bmc.2006.06.064; Thomas P, 2011, P ROYAL SOC B; Tilton F, 2002, AQUAT TOXICOL, V61, P211, DOI 10.1016/S0166-445X(02)00058-9; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Velasco-Santamaria YM, 2010, MAR ENVIRON RES, V69, pS67, DOI 10.1016/j.marenvres.2009.09.009; Yamahira K, 2003, COPEIA, P155, DOI 10.1643/0045-8511(2003)003[0155:IVITDS]2.0.CO;2; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	80	32	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74251	10.1371/journal.pone.0074251	http://dx.doi.org/10.1371/journal.pone.0074251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086325	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700019
J	Lee, NM; Lucke, J; Hall, WD; Meurk, C; Boyle, FM; Carter, A				Lee, Natalia M.; Lucke, Jayne; Hall, Wayne D.; Meurk, Carla; Boyle, Frances M.; Carter, Adrian			Public Views on Food Addiction and Obesity: Implications for Policy and Treatment	PLOS ONE			English	Article							NEUROBIOLOGY; DISORDER; HEALTH; BRAIN; MEDICALIZATION; OPINION; STIGMA; SUGAR; TAXES	Background: According to their advocates, neurobiological explanations of overeating, or "food addiction", have the potential to impact public understanding and treatment of obesity. In this study, we examine the public's acceptance of the concept of food addiction as an explanation of overeating and assess its effects upon their attitudes toward obese persons and the treatment of obesity. Methods and Findings: We conducted an online survey of 479 adults from the US (n = 215) and Australia (n = 264). There was substantial support for the idea of food addiction, particularly among obese participants. Over half favoured treating obesity as a type of addiction. Psychotherapy was believed to be the most effective treatment and educational and support programs were the preferred policies to address food addiction. There was very little support for increasing taxes on obesogenic foods. Despite the strong support for seeing obesity as a form of addiction, respondents still saw obesity as primarily the result of personal choices and emphasized the need for individuals to take responsibility for their eating. Conclusions: Our sample of the general public strongly supported the idea of obesity as a form of food addiction; but this did not translate into support of clinical and public health policies that experts believe are most likely to reduce the prevalence of obesity. The reasons for the apparent disjunction between support for food addiction and a strong emphasis on personal choice for weight warrant further examination.	[Lee, Natalia M.; Boyle, Frances M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Lucke, Jayne; Hall, Wayne D.; Meurk, Carla; Carter, Adrian] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Hall, Wayne D.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Carter, A (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	adrian.carter@uq.edu.au	Lucke, Jayne C/A-5538-2008; Hall, Wayne D/A-3283-2008; Meurk, Carla/A-7571-2013; Carter, Adrian/AAG-2830-2020; Carter, Adrian N/A-1282-2008; Boyle, Fran/F-9139-2012	Lucke, Jayne C/0000-0002-2885-5292; Hall, Wayne D/0000-0003-1984-0096; Meurk, Carla/0000-0002-5792-5229; Carter, Adrian/0000-0002-3593-0772; Carter, Adrian N/0000-0002-3593-0772; Boyle, Fran/0000-0003-1665-2137	National Health and Medical Research Fellowships [628935, 569738]	National Health and Medical Research Fellowships	This work was supported by National Health and Medical Research Fellowships to Dr. Carter (Grant No. 628935) and Professor Wayne Hall (Grant No. 569738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2012, PHYSIOL BEHAV, V107, P126, DOI 10.1016/j.physbeh.2012.05.005; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2011, CENS POP HOUS; Australian Bureau of Statistics, 2011, OV OB AD AUSTR SNAPS; Avena NM, 2012, NUTRITION, V28, P341, DOI 10.1016/j.nut.2011.11.002; Avena NM, 2011, PSYCHIAT ANN, V41, P478, DOI 10.3928/00485713-20110921-06; Berghmans R, 2009, THEOR MED BIOETH, V30, P311, DOI 10.1007/s11017-009-9103-7; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Carter A, 2012, ADDICTION NEUROETHICS: THE ETHICS OF ADDICTION NEUROSCIENCE RESEARCH AND TREATMENT, P1; CDC.gov, 2012, OV OB; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Easter MM, 2012, SOC SCI MED, V75, P1408, DOI 10.1016/j.socscimed.2012.05.042; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gearhardt AN, 2012, ANNU REV CLIN PSYCHO, V8, P405, DOI 10.1146/annurev-clinpsy-032511-143129; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; GREEN DP, 1989, PUBLIC OPIN QUART, V53, P1, DOI 10.1086/269138; Halpern CH, 2011, ACTA NEUROCHIR, V153, P2293, DOI 10.1007/s00701-011-1166-3; Kennett GA, 2010, PHARMACOL BIOCHEM BE, V97, P63, DOI 10.1016/j.pbb.2010.07.020; Lee NM, 2012, EMBO REP, V13, P785, DOI 10.1038/embor.2012.115; Lee S, 2004, SOC SCI MED, V58, P1709, DOI 10.1016/S0277-9536(03)00340-X; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Luty J, 2006, PSYCHIATR BULL, V30, P257, DOI 10.1192/pb.30.7.257; Moreno C, 2011, CURR PHARM DESIGN, V17, P1128, DOI 10.2174/138161211795656701; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Pisapia JM, 2013, AM J BIOETH IN PRESS; Puhl RM, 2011, OBESITY, V19, P74, DOI 10.1038/oby.2010.126; Salant T, 2006, SOC SCI MED, V62, P2445, DOI 10.1016/j.socscimed.2005.10.021; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; U.S. Census Bureau, 2010, AM COMM SURV; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; World Health Organization, 2014, 311 WHO; Yanamadala S, 2012, PUBLIC HEALTH NUTR, V15, P1331, DOI 10.1017/S1368980012003187; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	34	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74836	10.1371/journal.pone.0074836	http://dx.doi.org/10.1371/journal.pone.0074836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086382	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700042
J	Martire, S; Fuso, A; Rotili, D; Tempera, I; Giordano, C; De Zottis, I; Muzi, A; Vernole, P; Graziani, G; Lococo, E; Faraldi, M; Maras, B; Scarpa, S; Mosca, L; d'Erme, M				Martire, Sara; Fuso, Andrea; Rotili, Dante; Tempera, Italo; Giordano, Cesare; De Zottis, Ivana; Muzi, Alessia; Vernole, Patrizia; Graziani, Grazia; Lococo, Emanuela; Faraldi, Martina; Maras, Bruno; Scarpa, Sigfrido; Mosca, Luciana; d'Erme, Maria			PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage	PLOS ONE			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; OXIDATIVE STRESS; A-BETA; DNA-BINDING; SIGNAL-TRANSDUCTION; CELL-DEATH; ACTIVATION; BRAIN; TARGET	Amyloid beta peptide (A beta) causes neurodegeneration by several mechanisms including oxidative stress, which is known to induce DNA damage with the consequent activation of poly (ADP-ribose) polymerase (PARP-1). To elucidate the role of PARP-1 in the neurodegenerative process, SH-SY5Y neuroblastoma cells were treated with A beta(25-35) fragment in the presence or absence of MC2050, a new PARP-1 inhibitor. A beta(25-35) induces an enhancement of PARP activity which is prevented by cell pre-treatment with MC2050. These data were confirmed by measuring PARP-1 activity in CHO cells transfected with amylod precursor protein and in vivo in brains specimens of TgCRND8 transgenic mice overproducing the amyloid peptide. Following A beta(25-35) exposure a significant increase in intracellular ROS was observed. These data were supported by the finding that A beta(25-35) induces DNA damage which in turn activates PARP-1. Challenge with A beta(25-35) is also able to activate NF-kB via PARP-1, as demonstrated by NF-kB impairment upon MC2050 treatment. Moreover, A beta(25-35) via PARP-1 induces a significant increase in the p53 protein level and a parallel decrease in the anti-apoptotic Bcl-2 protein. These overall data support the hypothesis of PARP-1 involvment in cellular responses induced by A beta and hence a possible rationale for the implication of PARP-1 in neurodegeneration is discussed.	[Martire, Sara; De Zottis, Ivana; Faraldi, Martina; Maras, Bruno; Mosca, Luciana; d'Erme, Maria] Sapienza Univ, Dept Biochem Sci, Rome, Italy; [Fuso, Andrea] Sapienza Univ, Dept Psychol Sec Neurosci, Rome, Italy; [Rotili, Dante; Giordano, Cesare] Sapienza Univ, Dept Pharmaceut Studies, Rome, Italy; [Tempera, Italo] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA USA; [Muzi, Alessia; Graziani, Grazia] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Vernole, Patrizia] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Lococo, Emanuela] Sapienza Univ, Dept Expt Med, Rome, Italy; [Scarpa, Sigfrido] Sapienza Univ, Dept Surg P Valdoni, Rome, Italy; [d'Erme, Maria] Sapienza Univ, Fdn Cenci Bolognetti, Inst Pasteur, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	d'Erme, M (corresponding author), Sapienza Univ, Dept Biochem Sci, Rome, Italy.	maria.derme@uniroma1.it	Graziani, Grazia/G-5747-2012; Martire, Sara/AAH-2808-2020; Rotili, Dante/J-9157-2016; Faraldi, Martina/B-1378-2017; Tempera, Italo/N-2495-2019; Mosca, Luciana/K-8101-2015	Graziani, Grazia/0000-0002-0221-768X; Martire, Sara/0000-0002-1570-3476; Faraldi, Martina/0000-0003-2047-7255; Tempera, Italo/0000-0001-7893-2914; Mosca, Luciana/0000-0003-2748-9021; Muzi, Alessia/0000-0001-6946-3888; d'erme, maria/0000-0001-7160-570X; Fuso, Andrea/0000-0001-9467-5671; Rotili, Dante/0000-0002-8428-8763	MIUR; Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy	MIUR(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by funds from MIUR and from Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Abeti R, 2012, NEUROCHEM RES, V37, P2589, DOI 10.1007/s11064-012-0895-x; Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; de la Lastra CA, 2007, CURR PHARM DESIGN, V13, P933; Atherton E, 1989, SOLID PHASE PEPTIDE, P203; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Chen Jiao-Jiao, 2008, Neurosci Bull, V24, P183, DOI 10.1007/s12264-008-0183-6; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Czapski GA, 2006, NEUROCHEM INT, V49, P751, DOI 10.1016/j.neuint.2006.06.006; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; d'Avila JC, 2012, J NEUROINFLAMM, V15, P9; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Frozza RL, 2009, NEUROCHEM RES, V34, P295, DOI 10.1007/s11064-008-9776-8; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hayashi M, 2009, NEUROPATHOLOGY, V29, P1, DOI 10.1111/j.1440-1789.2008.00888.x; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Maki CG, 1996, CANCER RES, V56, P2649; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Mosca L, 2011, CHEMMEDCHEM, V6, P606, DOI 10.1002/cmdc.201000536; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Paradis E, 1996, J NEUROSCI, V16, P7533; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Pellicciari R, 2004, PROGR MED CHEM, V42, P125, DOI 10.1016/S0079-6468(04)42003-7; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Poojari C, 2012, BIOCHIM BIOPHYS ACTA, P327; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Song YS, 2004, NEUROSCI RES, V49, P69, DOI 10.1016/j.neures.2004.01.010; Strosznajder JB, 2000, ACTA BIOCHIM POL, V47, P847, DOI 10.18388/abp.2000_4003; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Strosznajder RP, 2005, MOL NEUROBIOL, V31, P149, DOI 10.1385/MN:31:1-3:149; Szabo C, 1996, SHOCK, V6, P79, DOI 10.1097/00024382-199608000-00001; Tempera I, 2010, J VIROL, V84, P4988, DOI 10.1128/JVI.02333-09; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wesierska-Gadek J, 2001, CELL MOL BIOL LETT, V6, P117; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yang N, 2010, J CELL BIOCHEM, V110, P1208, DOI 10.1002/jcb.22635; ZABEL U, 1991, J BIOL CHEM, V266, P252; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646	66	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e72169	10.1371/journal.pone.0072169	http://dx.doi.org/10.1371/journal.pone.0072169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086258	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200005
J	Fang, XL; Sittadjody, S; Gyabaah, K; Opara, EC; Balaji, KC				Fang, Xiaolan; Sittadjody, Sivanandane; Gyabaah, Kenneth; Opara, Emmanuel C.; Balaji, Kethandapatti C.			Novel 3D Co-Culture Model for Epithelial-Stromal Cells Interaction in Prostate Cancer	PLOS ONE			English	Article							SOLUBLE E-CADHERIN; IN-VITRO; RECIPROCAL INTERACTIONS; EXTRACELLULAR-MATRIX; ALGINATE HYDROGELS; GROWTH; DIFFERENTIATION; PROLIFERATION; PROGRESSION; INHIBITION	Paracrine function is a major mechanism of cell-cell communication within tissue microenvironment in normal development and disease. In vitro cell culture models simulating tissue or tumor microenvironment are necessary tools to delineate epithelial-stromal interactions including paracrine function, yet an ideal three-dimensional (3D) tumor model specifically studying paracrine function is currently lacking. In order to fill this void we developed a novel 3D co-culture model in double-layered alginate hydrogel microspheres, incorporating prostate cancer epithelial and stromal cells in separate compartments of the microspheres. The cells remained confined and viable within their respective spheres for over 30 days. As a proof of principle regarding paracrine function of the model, we measured shedded component of E-cadherin (sE-cad) in the conditioned media, a major membrane bound cell adhesive molecule that is highly dysregulated in cancers including prostate cancer. In addition to demonstrating that sE-cad can be reliably quantified in the conditioned media, the time course experiments also demonstrated that the amount of sE-cad is influenced by epithelial-stromal interaction. In conclusion, the study establishes a novel 3D in vitro co-culture model that can be used to study cell-cell paracrine interaction.	[Fang, Xiaolan; Sittadjody, Sivanandane; Gyabaah, Kenneth; Opara, Emmanuel C.; Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC USA; [Fang, Xiaolan; Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Dept Canc Biol, Winston Salem, NC USA; [Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Dept Urol, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Balaji, KC (corresponding author), Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC USA.	kbalaji@wakehealth.edu			Wake Forest University; NIH [CA079448]; NATIONAL CANCER INSTITUTE [T32CA079448, P30CA012197] Funding Source: NIH RePORTER	Wake Forest University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Wake Forest University institutional funds to KC Balaji and by NIH grant CA079448 to X. Fang. Funder's website is http://www.wakehealth.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Chung LWK, 2003, CANCER-AM CANCER SOC, V97, P772, DOI 10.1002/cncr.11140; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Giatromanolaki A, 2012, CANCER BIOL THER, V13, P1284, DOI 10.4161/cbt.21785; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Henke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042516; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hwang RF, 2012, MOL CANCER RES, V10, P1147, DOI 10.1158/1541-7786.MCR-12-0022; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jiang HJ, 2009, DIABETES-METAB RES, V25, P232, DOI 10.1002/dmrr.940; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883; Kuefer R, 2003, CLIN CANCER RES, V9, P6447; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Matsumoto K, 2003, J UROLOGY, V170, P2248, DOI 10.1097/01.ju.0000094189.93805.17; Okugawa Y, 2012, J SURG RES, V175, pE67, DOI 10.1016/j.jss.2011.11.009; Olumi AF, 1999, CANCER RES, V59, P5002; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Rhee HW, 2001, IN VITRO CELL DEV-AN, V37, P127; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Spancake KM, 1999, CANCER RES, V59, P6042; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Syed V, 2008, J CELL BIOCHEM, V104, P82, DOI 10.1002/jcb.21603; Tendulkar S, 2012, BIOMED MICRODEVICES, V14, P461, DOI 10.1007/s10544-011-9623-6; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Weiss JV, 2011, INT J CANCER, V128, P1384, DOI 10.1002/ijc.25438; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375	43	41	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75187	10.1371/journal.pone.0075187	http://dx.doi.org/10.1371/journal.pone.0075187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073251	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000060
J	Farhy, C; Elgart, M; Shapira, Z; Oron-Karni, V; Yaron, O; Menuchin, Y; Rechavi, G; Ashery-Padan, R				Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Rechavi, Gideon; Ashery-Padan, Ruth			Pax6 Is Required for Normal Cell-Cycle Exit and the Differentiation Kinetics of Retinal Progenitor Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; FATE SPECIFICATION; KINASE INHIBITORS; NUCLEAR RECEPTOR; AMACRINE CELLS; GANGLION-CELL; EXPRESSION; PROLIFERATION	The coupling between cell-cycle exit and onset of differentiation is a common feature throughout the developing nervous system, but the mechanisms that link these processes are mostly unknown. Although the transcription factor Pax6 has been implicated in both proliferation and differentiation of multiple regions within the central nervous system (CNS), its contribution to the transition between these successive states remains elusive. To gain insight into the role of Pax6 during the transition from proliferating progenitors to differentiating precursors, we investigated cell-cycle and transcriptomic changes occurring in Pax6-retinal progenitor cells (RPCs). Our analyses revealed a unique cell-cycle phenotype of the Pax6-deficient RPCs, which included a reduced number of cells in the S phase, an increased number of cells exiting the cell cycle, and delayed differentiation kinetics of Pax6-precursors. These alterations were accompanied by coexpression of factors that promote (Ccnd1, Ccnd2, Ccnd3) and inhibit (P27(kip1) and P27(kip2)) the cell cycle. Further characterization of the changes in transcription profile of the Pax6-deficient RPCs revealed abrogated expression of multiple factors which are known to be involved in regulating proliferation of RPCs, including the transcription factors Vsx2, Nr2e1, Plagl1 and Hedgehog signaling. These findings provide novel insight into the molecular mechanism mediating the pleiotropic activity of Pax6 in RPCs. The results further suggest that rather than conveying a linear effect on RPCs, such as promoting their proliferation and inhibiting their differentiation, Pax6 regulates multiple transcriptional networks that function simultaneously, thereby conferring the capacity to proliferate, assume multiple cell fates and execute the differentiation program into retinal lineages.	[Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Ashery-Padan, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Ashery-Padan, Ruth] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Ashery-Padan, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	ruthash@post.tau.ac.il		Menuchin-Lasowski, Yotam/0000-0002-0756-6889	Israel Science Foundation [610/10]; Israel Ministry of Science [36494]; Ziegler Foundation; Binational Science Foundation; German Israeli Foundation; Israel Ministry of Health; Israel-Italy foundation	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Ziegler Foundation; Binational Science Foundation(US-Israel Binational Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Ministry of Health; Israel-Italy foundation	R.A.-P.'s research is supported by the Israel Science Foundation (grant number 610/10), the Israel Ministry of Science (grant number 36494), the Ziegler Foundation, the Binational Science Foundation, the German Israeli Foundation, the Israel Ministry of Health and the Israel-Italy foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Barton KM, 2008, DEV DYNAM, V237, P672, DOI 10.1002/dvdy.21449; Bassett EA, 2007, MOL CELL BIOL, V27, P7497, DOI 10.1128/MCB.00687-07; Baumer N, 2002, DEVELOPMENT, V129, P4535; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Cvekl A, 1999, INVEST OPHTH VIS SCI, V40, P1343; Cwinn MA, 2011, J NEUROSCI, V31, P5169, DOI 10.1523/JNEUROSCI.5495-10.2011; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; GERDES J, 1984, J IMMUNOL, V133, P1710; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Green ES, 2003, DEVELOPMENT, V130, P539, DOI 10.1242/dev.00275; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; HARMAN AM, 1987, ANAT EMBRYOL, V177, P123, DOI 10.1007/BF00572536; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heatley MK, 2002, HISTOPATHOLOGY, V40, P483, DOI 10.1046/j.1365-2559.2002.01390.x; Hollemann T, 1998, DEVELOPMENT, V125, P2425; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh YW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-32; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Inoue T, 2002, DEVELOPMENT, V129, P831; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lacomme M, 2012, MOL CELL BIOL, V32, P2596, DOI 10.1128/MCB.06745-11; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Lee J, 1997, DEVELOPMENT, V124, P2537; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Lin YP, 2009, INVEST OPHTH VIS SCI, V50, P68, DOI 10.1167/iovs.07-1619; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Miyawaki T, 2004, J NEUROSCI, V24, P8124, DOI 10.1523/JNEUROSCI.2235-04.2004; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pacal M, 2012, DEV DYNAM, V241, P1525, DOI 10.1002/dvdy.23840; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shaham O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003357; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sigulinsky CL, 2008, DEV BIOL, V317, P560, DOI 10.1016/j.ydbio.2008.02.055; Skapek SX, 2001, ONCOGENE, V20, P6742, DOI 10.1038/sj.onc.1204876; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Tamai H, 2007, GENES CELLS, V12, P983, DOI 10.1111/j.1365-2443.2007.01113.x; Tang XM, 2000, J CELL BIOCHEM, V76, P270, DOI 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyas DA, 2003, CEREB CORTEX, V13, P612, DOI 10.1093/cercor/13.6.612; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Warren N, 1997, DEVELOPMENT, V124, P1573; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zaccarini R, 2007, INVEST OPHTH VIS SCI, V48, P5408, DOI 10.1167/iovs.07-0413; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zheng MH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-38; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	91	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76489	10.1371/journal.pone.0076489	http://dx.doi.org/10.1371/journal.pone.0076489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073291	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000101
J	Beaufort, N; Corvazier, E; Mlanaoindrou, S; de Bentzmann, S; Pidard, D				Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; de Bentzmann, Sophie; Pidard, Dominique			Disruption of the Endothelial Barrier by Proteases from the Bacterial Pathogen Pseudomonas aeruginosa: Implication of Matrilysis and Receptor Cleavage	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; TIGHT JUNCTION PROTEINS; VE-CADHERIN; EXTRACELLULAR-MATRIX; CELL-SURVIVAL; VIRULENCE FACTORS; PROTEOLYSIS; APOPTOSIS; METALLOPROTEINASE; ADHESION	Within the vasculature, uncontrolled pericellular proteolysis can lead to disruption of cell-to-cell and cell-to-matrix interactions and subsequent detachment-induced cell apoptosis, or anoikis, contributing to inflammatory vascular diseases, with the endothelium as the major target. Most studies so far have focused on endogenous proteinases. However, during bloodstream infections, bacterial proteinases may also trigger endothelial anoikis. We thus investigated the potential apoptotic activity of the proteinases secreted by the haematotropic opportunistic pathogen, Pseudomonas aeruginosa, and particularly its predominant metalloproteinase, LasB. For this, we used the secretome of the LasB-expressing pseudomonal strain, PAO1, and compared it with that from the isogenic, LasB-deficient strain (PAO1 Delta lasB), as well as with purified LasB. Secretomes were tested for apoptotic activity on cultured human endothelial cells derived from the umbilical vein or from the cerebral microvasculature. We found that the PAO1 secretome readily induced endothelial cell anoikis, as did secretomes of LasB-positive clinical pseudomonal isolates, while the PAO1 Delta lasB secretome had only a limited impact on endothelial adherence and viability. Notably, purified LasB reproduced most of the effects of the LasB-containing secretomes, and these were drastically reduced in the presence of the LasB-selective inhibitor, phosphoramidon. A precocious and extensive LasB-dependent degradation of several proteins associated with the endothelial extracellular matrix, fibronectin and von Willebrand factor, was observed by immunofluorescence and/or immunoblotting analysis of cell cultures. Moreover, the PAO1 secretome, but not that from PAO1 Delta lasB, specifically induced rapid endoproteolysis of two major interendothelial junction components, VE-cadherin and occludin, as well as of the anti-anoikis, integrin-associated urokinase receptor, uPAR. Taken as a prototype for exogenous haemorrhagic proteinases, pseudomonal LasB thus appears to induce endothelial anoikis not only via matrilysis, as observed for many pro-apoptotic proteinases, but also via cleavage of some essential cell-to-cell and cell-to-matrix adhesion receptors implicated in the maintenance of the endothelial barrier.	[Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; Pidard, Dominique] INSERM, U698, Paris, France; [Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; Pidard, Dominique] Univ Paris 07, UMR S698, Paris, France; [de Bentzmann, Sophie] CNRS, UMR LISM 7255, Marseille, France; [de Bentzmann, Sophie] Aix Marseille Univ, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Pidard, D (corresponding author), INSERM, U698, Paris, France.	dominique.pidard@inserm.fr		Pidard, Dominique/0000-0002-5732-3279; Beaufort, Nathalie/0000-0002-7088-4206	Fondation Lefoulon-Delalande/Institut de France, Paris, France; Vaincre la Mucoviscidose, Paris, France; Fondation Bettencourt-Schueller, Paris, France; Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche (ANR), Paris, France	Fondation Lefoulon-Delalande/Institut de France, Paris, France; Vaincre la Mucoviscidose, Paris, France; Fondation Bettencourt-Schueller, Paris, France; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (ANR), Paris, France(French National Research Agency (ANR))	This work was supported by a fellowship from the Fondation Lefoulon-Delalande/Institut de France (http://lefoulon-delalande.institut-defrance.fr/), Paris, France (to NB), and by Vaincre la Mucoviscidose (http://www.vaincrelamuco.org/), Paris, France, the Fondation Bettencourt-Schueller (http://www.fondationbs.org/), Paris, France, and grants from Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr/) and Agence Nationale pour la Recherche (ANR; http://www.agence-nationale-recherche.fr/), Paris, France (to SdB). DP is Charge de Recherche at the Institut National des Sciences du Vivant within the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Basire A, 2006, THROMB HAEMOSTASIS, V95, P678, DOI 10.1160/TH05-07-0511; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Beaufort N, 2010, BIOCHEM J, V428, P473, DOI 10.1042/BJ20091806; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; Cabrol SN, 2003, J BACTERIOL, V185, P7222, DOI 10.1128/JB.185.24.7222-7230.2003; CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Colman RW, 2010, THROMB HAEMOSTASIS, V104, P875, DOI 10.1160/TH10-01-0017; Davis GE, 2001, J CELL SCI, V114, P917; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Giraud C, 2010, ENV MICROBIOL REP, V2, P343, DOI 10.1111/j.1758-2229.2009.00070.x; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hippenstiel S, 2003, THROMB HAEMOSTASIS, V89, P18; Houard X, 2006, J AM COLL CARDIOL, V48, pA3, DOI 10.1016/j.jacc.2006.04.098; Hsu SL, 2001, CANCER LETT, V167, P193, DOI 10.1016/S0304-3835(01)00479-7; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Komori Y, 2001, TOXICON, V39, P1327, DOI 10.1016/S0041-0101(01)00084-8; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; Leduc D, 2007, INFECT IMMUN, V75, P3848, DOI 10.1128/IAI.00015-07; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; Mattos Saliba A, 2009, MICROB PATHOG, V33, P153; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; McCarty SM, 2012, WOUND REPAIR REGEN, V20, P125, DOI 10.1111/j.1524-475X.2012.00763.x; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; OKAJIMA K, 1995, J LAB CLIN MED, V126, P377; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rand JH, 1997, THROMB HAEMOSTASIS, V78, P445; Ray MJ, 1997, THROMB HAEMOSTASIS, V78, P1021; Ruggeri ZM, 1999, THROMB HAEMOSTASIS, V82, P576; Sahni SK, 2007, THROMB RES, V119, P531, DOI 10.1016/j.thromres.2006.06.006; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stepinska M, 2008, MICROB PATHOGENESIS, V44, P448, DOI 10.1016/j.micpath.2007.11.008; Strateva T, 2011, ANN MICROBIOL, V61, P717, DOI 10.1007/s13213-011-0273-y; Supuran CT, 2002, MED RES REV, V22, P329, DOI 10.1002/med.10007; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Takii R, 2005, INFECT IMMUN, V73, P883, DOI 10.1128/IAI.73.2.883-893.2005; TOURNIER JM, 1985, AM REV RESPIR DIS, V132, P524; Valbuena G, 2006, ANNU REV PATHOL-MECH, V1, P171, DOI 10.1146/annurev.pathol.1.110304.100031; Valente E, 2000, MICROB PATHOGENESIS, V29, P345, DOI 10.1006/mpat.2000.0400; van Delden C, 2007, INT J ANTIMICROB AG, V30, pS71, DOI 10.1016/j.ijantimicag.2007.06.015; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Vasil ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000420; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; WAGNER DD, 1984, P NATL ACAD SCI-BIOL, V81, P471, DOI 10.1073/pnas.81.2.471; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	73	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75708	10.1371/journal.pone.0075708	http://dx.doi.org/10.1371/journal.pone.0075708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069438	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300091
J	Belham, FS; Satler, C; Garcia, A; Tomaz, C; Gasbarri, A; Rego, A; Tavares, MCH				Belham, Flavia Schechtman; Satler, Corina; Garcia, Ana; Tomaz, Carlos; Gasbarri, Antonella; Rego, Artur; Tavares, Maria Clotilde H.			Age-Related Differences in Cortical Activity during a Visuo-Spatial Working Memory Task with Facial Stimuli	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; SEX-DIFFERENCES; BRAIN ACTIVITY; GENDER-DIFFERENCES; COGNITIVE CONTROL; FACE PERCEPTION; EMOTION; ATTENTION; CORTEX; EXPRESSIONS	Emotion, importantly displayed by facial expressions, is one of the most significant memory modulators. The interaction between memory and the different emotional valences change across lifespan, while young adults (YA) are expected to better recall negative events (Negativity Bias Hypothesis), older adults (OA) tend to focus on positive stimuli (Positivity Effect Hypothesis). This research work aims at verifying whether cortical electrical activity of these two age groups would also be differently influenced by emotional valences in a visuo-spatial working memory task. 27 YA (13 males) and 25 OA (14 males), all healthy volunteers, underwent electroencephalographic recordings (21 scalp electrodes montage), while performing the Spatial Delayed Recognition Span Task using a touch screen with different stimuli categories: neutral, positive and negative faces and geometric pictures. YA obtained higher scores than OA, and showed higher activation of theta and alpha bands in the frontal and midline regions, besides a more evident right-hemispheric asymmetry on alpha band when compared to OA. For both age groups, performance in the task was worse for positive faces than to negative and to neutral faces. Facial stimuli induced a better performance and higher alpha activation on the pre-frontal region for YA, and on the midline, occipital and left temporal regions for OA when compared to geometric figures. The superior performance of YA was expected due to the natural cognitive deficits connected to ageing, as was a better performance with facial stimuli due to the evolutionary importance of faces. These results were related to cortical activity on areas of importance for action-planning, decision making and sustained attention. Taken together, they are in accordance with the Negativity Bias but do not support the Positivity Effect. The methodology used was able to identify age-related differences in cortical activity during emotional mnemonic processing and may be interesting to future investigations.	[Belham, Flavia Schechtman; Garcia, Ana; Tomaz, Carlos; Rego, Artur; Tavares, Maria Clotilde H.] Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Satler, Corina] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Gasbarri, Antonella] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy	Universidade de Brasilia; Universidade de Brasilia; University of L'Aquila	Tavares, MCH (corresponding author), Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil.	mchtavares@unb.br	Tomaz, Carlos A B/F-8626-2012; Satler, Corina/F-5870-2012; Costa, Artur/K-7996-2015; Satler, Corina/AAZ-3003-2021	Satler, Corina/0000-0001-7821-2183; Costa, Artur/0000-0001-9604-4208; Belham, Flavia/0000-0003-2986-4171; Gasbarri, Antonella/0000-0003-0708-6524				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Baddeley A., 2007, WORKING MEMORY THOUG; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323, 10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323]; Beason-Held LL, 1999, HIPPOCAMPUS, V9, P562, DOI 10.1002/(SICI)1098-1063(1999)9:5<562::AID-HIPO10>3.0.CO;2-X; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bergado JA, 2011, PROG NEUROBIOL, V94, P64, DOI 10.1016/j.pneurobio.2011.03.004; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bourne VJ, 2010, NEUROPSYCHOLOGIA, V48, P1289, DOI 10.1016/j.neuropsychologia.2009.12.032; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00217; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Damasio Antonio, 1999, FEELING WHAT HAPPENS; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dudchenko PA, 2013, NEUROSCI BIOBEHAV R, V37, P2111, DOI 10.1016/j.neubiorev.2012.03.003; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Feredoes E, 2011, P NATL ACAD SCI USA, V108, P17510, DOI 10.1073/pnas.1106439108; Folstein M.F., 2010, MMSE 2 MINIMENTAL ST; Frank JE, 2000, BRAZ J MED BIOL RES, V33, P1483, DOI 10.1590/S0100-879X2000001200013; Galli G, 2011, J NEUROSCI, V31, P12364, DOI 10.1523/JNEUROSCI.1619-11.2011; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garcia A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00082; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hamann S, 2003, NAT NEUROSCI, V6, P106, DOI 10.1038/nn0203-106; Haut KM, 2006, NEUROIMAGE, V32, P411, DOI 10.1016/j.neuroimage.2006.01.044; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keuker JIH, 2003, NEUROBIOL AGING, V24, P157, DOI 10.1016/S0197-4580(02)00062-3; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; La Cerra P, 1998, P NATL ACAD SCI USA, V95, P11290; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lacreuse A, 2002, NEUROBIOL AGING, V23, P589, DOI 10.1016/S0197-4580(02)00002-7; Lacreuse A, 2005, BEHAV NEUROSCI, V119, P118, DOI 10.1037/0735-7044.119.1.118; Lenardt MH, 2009, ACTA PAUL ENFERM, V22, P638, DOI 10.1590/S0103-21002009000500007; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; McIntyre CK, 2012, NEUROSCI BIOBEHAV R, V36, P1750, DOI 10.1016/j.neubiorev.2011.11.001; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pereira DA, 2012, ARQ NEURO-PSIQUIAT, V70, P175, DOI 10.1590/S0004-282X2012005000003; Petrican R, 2008, PSYCHOL AGING, V23, P585, DOI 10.1037/a0013176; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Santesso DL, 2008, NEUROPSYCHOLOGIA, V46, P1338, DOI 10.1016/j.neuropsychologia.2007.12.013; Sarmiento ELP, 2007, BRASILIA MED, V44, P24; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Satler C, 2011, DEMENT GER COGN D EX, V1, P124, DOI 10.1159/000329155; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Simon HA, 1990, F COGNITIVE SCI, P1; Sousa Rilva Lopes de, 2007, J. bras. psiquiatr., V56, P102, DOI 10.1590/S0047-20852007000200005; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Squire LR, 2009, J NEUROSCI, V29, P12711, DOI 10.1523/JNEUROSCI.3575-09.2009; Storey J., 2010, INT ENCY STAT SCI, V1, P1; Sutton SK, 2000, NEUROPSYCHOLOGIA, V38, P1723, DOI 10.1016/S0028-3932(00)00076-2; SUZUKI S, 1995, J EXP PSYCHOL HUMAN, V21, P901, DOI 10.1037/0096-1523.21.4.901; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	98	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75778	10.1371/journal.pone.0075778	http://dx.doi.org/10.1371/journal.pone.0075778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069447	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300097
J	Yu, J; Wang, L; Weng, SJ; Yang, XL; Zhang, DQ; Zhong, YM				Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhang, Dao-Qi; Zhong, Yong-Mei			Hyperactivity of ON-Type Retinal Ganglion Cells in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; OSCILLATORY POTENTIALS; MAINTAINED ACTIVITY; JUVENILE DIABETICS; DARK-ADAPTATION; GLIAL CHANGES; MOUSE RETINA; RETINOPATHY; RATS; ELECTRORETINOGRAM	Impairment of visual function has been detected in the early stage of diabetes but the underlying neural mechanisms involved are largely unknown. Morphological and functional alterations of retinal ganglion cells, the final output neurons of the vertebrate retina, are thought to be the major cause of visual defects in diabetes but direct evidence to support this notion is limited. In this study we investigated functional changes of retinal ganglion cells in a type 1-like diabetic mouse model. Our results demonstrated that the spontaneous spiking activity of ON-type retinal ganglion cells was increased in streptozotocin-diabetic mice after 3 to 4 months of diabetes. At this stage of diabetes, no apoptotic signals or cell loss were detected in the ganglion cell layer of the retina, suggesting that the functional alterations in ganglion cells occur prior to massive ganglion cell apoptosis. Furthermore, we found that the increased activity of ON-type ganglion cells was mainly a result of reduced inhibitory signaling to the cells in diabetes. This novel mechanism provides insight into how visual function is impaired in diabetic retinopathy.	[Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhong, Yong-Mei] Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200433, Peoples R China; [Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhong, Yong-Mei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Zhang, Dao-Qi] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Fudan University; Fudan University; Oakland University	Zhang, DQ (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	zhang@oakland.edu; ymzhong@fudan.edu.cn			National Program of Basic Research; Ministry of Science and Technology of China [2011CB504602]; National Natural Science Foundation of China [31070967, 31171055, 30930034, 31121061]; 211 Project; Ministry of Education of China; U.S. Midwest Eye-Banks Research Award	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 211 Project(Anhui UniversityMinistry of Education, China); Ministry of Education of China(Ministry of Education, China); U.S. Midwest Eye-Banks Research Award	This work was supported by grants from the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2011CB504602), the National Natural Science Foundation of China (31070967, 31171055, 30930034, 31121061), the 211 Project sponsored by the Ministry of Education of China, and a U.S. Midwest Eye-Banks Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Relevant URLs: 1) http://www.most.gov.cn/eng/ 2)http://www.nsfc.gov.cn/Portal0/default152.htm 3)http://www.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html 4)http://www.mebtc.org/	Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BLOODWORTH JMB, 1962, DIABETES, V11, P1; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P810; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; CAPUTO S, 1990, DIABETES CARE, V13, P412, DOI 10.2337/diacare.13.4.412; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; GLICKMAN RD, 1982, BRAIN RES, V234, P81, DOI 10.1016/0006-8993(82)90474-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRUNWALD JE, 1995, BRIT J OPHTHALMOL, V79, P735, DOI 10.1136/bjo.79.8.735; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P948, DOI 10.1167/iovs.03-1101; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hardikar AA, 1999, DIABETES RES CLIN PR, V46, P203, DOI 10.1016/S0168-8227(99)00098-4; IKEDA H, 1992, EUR J PHARMACOL, V210, P53; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 1996, ARCH OPHTHALMOL-CHIC, V114, P986, DOI 10.1001/archopht.1996.01100140194013; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klein R, 1995, DIABETES AM; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Layton CJ, 2007, GRAEF ARCH CLIN EXP, V245, P1335, DOI 10.1007/s00417-006-0506-0; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Mahamed DA, 2005, DIABETES, V54, P1477, DOI 10.2337/diabetes.54.5.1477; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MERIMEE TJ, 1990, NEW ENGL J MED, V322, P978, DOI 10.1056/NEJM199004053221406; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Phipps JA, 2006, INVEST OPHTH VIS SCI, V47, P3187, DOI 10.1167/iovs.05-1493; PRAGER TC, 1990, AM J OPHTHALMOL, V109, P279, DOI 10.1016/S0002-9394(14)74550-7; RERUP C C, 1970, Pharmacological Reviews, V22, P485; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; Sato Sakura, 2006, Nihon Rinsho, VSuppl 3, P161; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Shinoda K, 2007, CLIN EXP OPHTHALMOL, V35, P847, DOI 10.1111/j.1442-9071.2007.01607.x; SIMONSEN SE, 1980, ACTA OPHTHALMOL, V58, P865; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strang CE, 2005, AM J PHYSIOL-CELL PH, V289, pC644, DOI 10.1152/ajpcell.00633.2004; Strang CE, 2003, VISUAL NEUROSCI, V20, P651, DOI 10.1017/S0952523803206076; Sugimoto M, 2005, OPHTHALMOLOGICA, V219, P379, DOI 10.1159/000088382; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; WACHTMEISTER L, 1980, ACTA OPHTHALMOL, V58, P712; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Yang Y, 2012, MOL VIS, V18, P1411	60	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76049	10.1371/journal.pone.0076049	http://dx.doi.org/10.1371/journal.pone.0076049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069457	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300104
J	Frikke-Schmidt, H; Pedersen, TA; Fledelius, C; Olsen, GS; Hellerstein, M				Frikke-Schmidt, Henriette; Pedersen, Thomas Askov; Fledelius, Christian; Olsen, Grith Skytte; Hellerstein, Marc			Adipose Weight Gain during Chronic Insulin Treatment of Mice Results from Changes in Lipid Storage without Affecting De Novo Synthesis of Palmitate	PLOS ONE			English	Article							DIABETIC RATS; IN-VIVO; GLUCOSE; TISSUE; TRANSCRIPTION; LIPOGENESIS; EXPRESSION; TRANSPORT; TURNOVER; THERAPY	Insulin treatment is associated with increased adipose mass in both humans and mice. However, the underlying dynamic basis of insulin induced lipid accumulation in adipose tissue remains elusive. To assess this, young female C57BL6/J mice were fed a low fat diet for 3 weeks, treated subsequently with 7 days of constant subcutaneous insulin infusion by osmotic minipumps and compared to mice with only buffer infused. To track changes in lipid deposition during insulin treatment, metabolic labeling was conducted with heavy water for the final 4 days. Blood glucose was significantly lowered within one hour after implantation of insulin loaded mini pumps and remained lower throughout the study. Insulin treated animals gained significantly more weight during treatment and the mean weight of the subcutaneous adipose depots was significantly higher with the highest dose of insulin. Surprisingly, de novo palmitate synthesis within the subcutaneous and the gonadal depots was not affected significantly by insulin treatment. In contrast insulin treatment caused accumulation of triglycerides in both depots due to either deposition of newly synthesised triglycerides (subcutaneous depot) or inhibition of lipolysis (gonadal depot).	[Frikke-Schmidt, Henriette; Hellerstein, Marc] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Frikke-Schmidt, Henriette; Pedersen, Thomas Askov; Olsen, Grith Skytte] Novo Nordisk AS, Dept Insulin Biol, Malov, Denmark; [Fledelius, Christian] Novo Nordisk AS, Dept Insulin Pharmacol, Malov, Denmark; [Hellerstein, Marc] KineMed Inc, Emeryville, CA USA	University of California System; University of California Berkeley; Novo Nordisk; Novo Nordisk	Hellerstein, M (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	march@berkeley.edu			Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	The authors declare that the study was funded by Novo Nordisk A/S through which the authors HF-S, TAP, GSO, and CF all are employees and stakeholders. The insulin used for the experiments has been provided by Novo Nordisk A/S. All Intellectual Property Rights of the current study are owned by University of California Berkeley and there has been no compromise of the objectivity or validity of the data in the manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen M, 2006, PEDIATR SURG INT, V22, P647, DOI 10.1007/s00383-006-1704-x; DANI C, 1989, MOL CELL ENDOCRINOL, V63, P199, DOI 10.1016/0303-7207(89)90096-8; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; FRIEDMAN MI, 1994, PHYSIOL BEHAV, V56, P373, DOI 10.1016/0031-9384(94)90209-7; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Heller S, 2004, DIABETES RES CLIN PR, V65, pS23, DOI 10.1016/j.diabres.2004.07.005; HELLERSTEIN MK, 1993, AM J PHYSIOL, V265, pE814, DOI 10.1152/ajpendo.1993.265.5.E814; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Pu QH, 2009, AM J PHYSIOL-HEART C, V296, pH132, DOI 10.1152/ajpheart.00370.2008; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Sorisky A, 1999, CRIT REV CL LAB SCI, V36, P1, DOI 10.1080/10408369991239169; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Tobin BW, 2000, CAN J PHYSIOL PHARM, V78, P622, DOI 10.1139/cjpp-78-8-622; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	20	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e76060	10.1371/journal.pone.0076060	http://dx.doi.org/10.1371/journal.pone.0076060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069458	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300097
J	Miao, RZ; Guo, XB; Zhi, QM; Shi, YL; Li, LP; Mao, XH; Zhang, L; Li, CS				Miao, Ruizhen; Guo, Xiaobo; Zhi, Qiaoming; Shi, Yulong; Li, Leping; Mao, Xuehui; Zhang, Li; Li, Chensheng			VEZT, a Novel Putative Tumor Suppressor, Suppresses the Growth and Tumorigenicity of Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CPG ISLAND METHYLATION; PROMOTER METHYLATION; GENE-EXPRESSION; EPIGENETIC MECHANISMS; TRANSCRIPTION FACTOR; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; DNA METHYLATION; DOWN-REGULATION	Vezatin (VEZT), an adherens junctions transmembrane protein, was identified as a putative tumor suppressor in our previous study. However, the role of VEZT in tumorigenesis remains elusive. We aimed to clarify its epigenetic regulation and biological functions in gastric cancer. In this study, we show that the expression level of VEZT is involved in lymphatic metastasis, depth of cancer invasion and TNM stage in 104 gastric cancer patients. Bisulfate sequencing polymerase chain reaction (BSP) methods showed that VEZT was hypermethylated in tissues and corresponding blood of gastric cancer patients compared with healthy controls. Helicobacter pylori (H. pylori) infection induces the methylation and silencing of VEZT in GES-1 cells. Restoring VEZT expression in MKN-45 and NCI-N87 gastric cancer cells inhibited growth, invasion and tumorigenesis in vitro and in vivo. Global microarray analysis was applied to analyze the molecular basis of the biological functions of VEZT after VEZT transfection combined with real-time PCR and chromatin immunoprecipitation assay. G protein-coupled receptor 56(GPR56), cell growth, cell division cycle 42(CDC42), migration/invasion and transcription factor 19(TCF19), cell cycle progression, were identified as direct VEZT target genes. TCF19, a novel target of VEZT, was functionally validated. Overexpression of TCF19 in MKN-45 cells increased cell cycle progress and growth ability. This study provides novel insight into the regulation of the VEZT gene, which could represent a potential target for therapeutic anti-cancer strategies.	[Miao, Ruizhen; Guo, Xiaobo; Shi, Yulong; Li, Leping; Mao, Xuehui; Zhang, Li; Li, Chensheng] Shandong Univ, Prov Hosp, Dept Gastrointestinal Surg, Jinan 250100, Shandong, Peoples R China; [Zhi, Qiaoming] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Jiangsu, Peoples R China	Shandong University; Soochow University - China	Guo, XB (corresponding author), Shandong Univ, Prov Hosp, Dept Gastrointestinal Surg, Jinan 250100, Shandong, Peoples R China.	guo992352@hotmail.com; shiyl9889@126.com; lileping@medmail.com.cn		Li, Leping/0000-0003-2329-6791	National Youthful Science Foundation of China [81101858]; Natural Science Foundation of Shandong Province of China [ZR2011HM041, Y2007C102, ZR2011HM076]; Shandong Science and Technology Commission [2011GGB14158, 2007H2071]; Youthful Science Foundation of Shandong Province of China [BS2010YY060]	National Youthful Science Foundation of China; Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Shandong Science and Technology Commission; Youthful Science Foundation of Shandong Province of China	This work was supported in part by grants from the National Youthful Science Foundation of China (81101858), the Natural Science Foundation of Shandong Province of China (ZR2011HM041, Y2007C102, ZR2011HM076), Key Research Project from Shandong Science and Technology Commission (2011GGB14158, 2007H2071), the Youthful Science Foundation of Shandong Province of China (BS2010YY060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul A, 2009, EMBO MOL MED, V1, P125, DOI 10.1002/emmm.200900015; Banham AH, 2001, CANCER RES, V61, P8820; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Chan AOO, 2003, GUT, V52, P502, DOI 10.1136/gut.52.4.502; Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156; Choi IS, 2005, CELL RES, V15, P247, DOI 10.1038/sj.cr.7290293; Danglot L, 2012, J NEUROSCI, V32, P9007, DOI 10.1523/JNEUROSCI.3084-11.2012; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Garinis GA, 2002, HUM GENET, V111, P115, DOI 10.1007/s00439-002-0783-6; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; Guo W, 2009, EUR J MED RES, V14, P453; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Guo XB, 2011, J GASTROEN HEPATOL, V26, P1685, DOI 10.1111/j.1440-1746.2011.06808.x; Guo XB, 2011, WORLD J GASTROENTERO, V17, P1895, DOI 10.3748/wjg.v17.i14.1895; Guo XB, 2011, BIOCHEM BIOPH RES CO, V404, P622, DOI 10.1016/j.bbrc.2010.12.026; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hyenne V, 2005, DEV BIOL, V287, P180, DOI 10.1016/j.ydbio.2005.09.004; Hyenne V, 2007, MECH DEVELOP, V124, P449, DOI 10.1016/j.mod.2007.03.004; Hyenne V, 2007, REPRODUCTION, V133, P563, DOI 10.1530/REP-06-0271; Jiang J, 2011, ONCOGENE, V30, P4498, DOI 10.1038/onc.2011.154; Jones PA, 2003, ANN NY ACAD SCI, V983, P213, DOI 10.1111/j.1749-6632.2003.tb05976.x; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; Katayama Y, 2009, BIOCHEM BIOPH RES CO, V388, P496, DOI 10.1016/j.bbrc.2009.08.003; Kitajima Y, 2008, ONCOL REP, V19, P197; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lee JH, 2004, ONCOGENE, V23, P4646, DOI 10.1038/sj.onc.1207588; Liu ZF, 2006, J MED MICROBIOL, V55, P1009, DOI 10.1099/jmm.0.46456-0; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Mirshahi P, 2009, LEUKEMIA, V23, P1039, DOI 10.1038/leu.2009.10; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; TELFORD JL, 1994, TRENDS BIOTECHNOL, V12, P420, DOI 10.1016/0167-7799(94)90031-0; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Tsuji S, 2006, WORLD J GASTROENTERO, V12, P1671, DOI 10.3748/wjg.v12.i11.1671; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; Xu L, 2010, ADV EXP MED BIOL, V706, P98; Xu L, 2010, CLIN EXP METASTAS, V27, P241, DOI 10.1007/s10585-010-9322-3; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang LQ, 2012, FUTURE ONCOL, V8, P431, DOI [10.2217/FON.12.27, 10.2217/fon.12.27]	55	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74409	10.1371/journal.pone.0074409	http://dx.doi.org/10.1371/journal.pone.0074409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069310	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300041
J	Yao, R; Kondoh, Y; Natsume, Y; Yamanaka, H; Inoue, M; Toki, H; Takagi, R; Shimizu, T; Yamori, T; Osada, H; Noda, T				Yao, R.; Kondoh, Y.; Natsume, Y.; Yamanaka, H.; Inoue, M.; Toki, H.; Takagi, R.; Shimizu, T.; Yamori, T.; Osada, H.; Noda, T.			A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells	ONCOGENE			English	Article						TACC3; TOGp; spindle assembly	KINETOCHORE FIBERS CONTRIBUTES; POLE ORGANIZATION; GENE-EXPRESSION; PROTEIN; MICROTUBULES; CH-TOG/XMAP215; CAPTURE; MITOSIS; MCAK	The mitotic spindle is assembled by the coordinated action of centrosomes and kinetochore microtubules. An evolutionally conserved protein family, transforming acidic coiled-coil (TACC), has been shown to be involved in this process. In humans, TACC3 is aberrantly expressed in a variety of human cancers, but its biological significance remains to be elucidated. Here, using a novel compound targeting TACC3, spindlactone (SPL), we show that the perturbation of TACC3 selectively inhibited the nucleation of centrosome microtubules in ovarian cancer cells. In contrast to centrosome microtubules, the kinetochore microtubules were robustly assembled, forming ectopic spindle poles that resulted in multipolar spindles. Interestingly, the extensive inhibition of TACC3 partially suppressed the nucleation of kinetochore microtubules. These dose-dependent effects of SPL were consistent with the results observed by the depletion of TACC3 and its binding partner, colonic and hepatic tumor overexpressed gene protein (TOGp). Although these proteins both have roles in the assembly of centrosome and kinetochore microtubules, their contributions were spatiotemporally different. Notably, SPL did not affect spindle assembly in normal cells. Furthermore, the oral administration of SPL significantly suppressed tumor growth in vivo. The unique mechanism of action of SPL not only enables it to be used as a tool to dissect the molecular basis of spindle assembly but also to provide a rationale for the use of TACC3 as a molecular target for cancer treatment. This rationale offers an opportunity to develop new strategies for cancer chemotherapy that overcome the limitations of microtubule toxins and expand their scope and clinical efficacy.	[Yao, R.; Natsume, Y.; Yamanaka, H.; Inoue, M.; Noda, T.] Japanese Fdn Canc Res, Dept Cell Biol, Inst Canc, Tokyo 1358550, Japan; [Kondoh, Y.; Takagi, R.; Shimizu, T.; Osada, H.] RIKEN, Chem Biol Core Facil, Adv Sci Inst, Saitama, Japan; [Inoue, M.; Toki, H.; Noda, T.] RIKEN, Bioresource Ctr, Team Adv Dev & Evaluat Human Dis Models, Tsukuba, Ibaraki, Japan; [Yamori, T.] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Pharmacol, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research; RIKEN; RIKEN; Japanese Foundation for Cancer Research	Yao, R (corresponding author), Japanese Fdn Canc Res, Dept Cell Biol, Inst Canc, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	ryao@jfcr.or.jp	Osada, Hiroyuki/N-4305-2014; KONDOH, Yasumitsu/C-7461-2017; Osada, Hiroyuki/AAY-6254-2020; Noda, Tetsuo/B-1667-2016	KONDOH, Yasumitsu/0000-0002-3481-5481; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [221S0001, 26350976] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T Hirota for providing the mCherry-CENP-A construct, K Yamazaki for preparing the cells for the JFCR cancer panels, K Honda for excellent technical support with the chemical screening and T Saito for supplying compounds from NPDepo. This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan, and was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Bruning-Richardson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038945; Cappell KM, 2012, MOL CELL BIOL, V32, P4131, DOI 10.1128/MCB.00686-12; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; Cullen CF, 2001, NAT CELL BIOL, V3, P637, DOI 10.1038/35083025; DEBRABANDER M, 1981, CELL MOTIL CYTOSKEL, V1, P469, DOI 10.1002/cm.970010407; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Hayashi K, 1999, J CELL SCI, V112, P1149; Holmfeldt P, 2004, EMBO J, V23, P627, DOI 10.1038/sj.emboj.7600076; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Miyazaki I, 2010, METHODS MOL BIOL, V669, P95, DOI 10.1007/978-1-60761-845-4_8; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Peters DG, 2005, CANCER EPIDEM BIOMAR, V14, P1717, DOI 10.1158/1055-9965.EPI-04-0704; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x	44	25	25	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4242	4252		10.1038/onc.2013.382	http://dx.doi.org/10.1038/onc.2013.382			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24077290				2022-12-25	WOS:000341155800006
J	Hutchinson, JL; Rajagopal, SP; Yuan, M; Norman, JE				Hutchinson, James L.; Rajagopal, Shalini P.; Yuan, Mei; Norman, Jane E.			Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways	FASEB JOURNAL			English	Article						infection; labor; myometrium; preterm	NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; HUMAN MYOMETRIUM; PRETERM LABOR; KINASE; INTERLEUKIN-1-BETA; INHIBITOR; RECEPTORS; TERM	Myometrial contraction is a central feature of labor. Although a link between infection and preterm labor is widely accepted, surprisingly little is known about the mechanisms coupling infection-induced inflammation to myocyte contractile machinery. This study explores the myocyte response to pathogen-derived ligands in vitro. The pregnant human myometrial cell line PHM1-41 and primary cultured uterine myocytes responded to Toll-like receptor (TLR) ligands, including the bacterial wall component LPS, which at 100 ng/ml increased contraction of cells embedded within collagen gels over 72 h compared to PBS. LPS-treated myocytes secreted inflammatory mediators, including prostaglandin F2, the cytokines TNF- and IL-6, and a range of chemokines. The contractile response to LPS required TLR4 signaling and was independent of prostaglandin synthesis. Neutralizing TNF- had no effect on LPS-mediated contraction; however, the Rho-associated protein kinase (ROCK) inhibitors Y-27632 (10 M) and GSK-269962 (50 nM) both abrogated the contractile response. The finding of LPS-mediated contraction was supported by a 1.38 +/- 0.072-fold (mean +/- se) increase in myosin light-chain phosphorylation 48 h post-treatment, assessed by in-cell Western blot analysis. Together, these data suggest that, in addition to modulating the local inflammatory environment, pathogen-derived ligands may directly promote myometrial contractility via Rho/ROCK signaling, thus contributing to preterm labor-mediated preterm birth.Hutchinson, J. L., Rajagopal, S. P., Yuan, M., Norman, J. E. Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways.	[Hutchinson, James L.; Rajagopal, Shalini P.; Yuan, Mei; Norman, Jane E.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Hutchinson, JL (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	jlawrencehutchinson@gmail.com		Norman, Jane/0000-0001-6031-6953; Rajagopal, Shalini/0000-0002-7705-5523	UK Medical Research Council (MRC)-Centre for Reproductive Health (CRH); MRC; Action Medical Research [SP4275]; Medical Research Council [G1002033] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	UK Medical Research Council (MRC)-Centre for Reproductive Health (CRH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Professor B. Sanborn (Colorado State University, Fort Collins, CO, USA) for her gift of PHM1-41 cells, Dr A. Henke (University Clinic Cologne, Cologne, Germany) for his gift of rat tail collagen, the Edinburgh Reproductive Tissues BioBank for providing myometrial samples, and Professor Philippa Saunders for supporting this work within the UK Medical Research Council (MRC)-Centre for Reproductive Health (CRH). This work was funded by an MRC career development fellowship to J.L.H. and an MRC Ph.D. studentship to S. P. R., and by grants from Action Medical Research (SP4275) and Tommy's.	Aguilar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009965; Alexander HA, 2012, REPROD SCI, V19, P43, DOI 10.1177/1933719111413297; Anderson L, 2009, REPROD SCI, V16, P1052, DOI 10.1177/1933719109340926; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Dallot E, 2003, BIOL REPROD, V68, P937, DOI 10.1095/biolreprod.102.008367; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Eude-Le Parco Isabelle, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS11, DOI 10.1186/1471-2393-7-S1-S11; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; Herschman HR, 2001, MED SCI SYMP SER, V16, P41; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Holmgren C, 2008, J REPROD IMMUNOL, V78, P134, DOI 10.1016/j.jri.2007.11.003; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Monga M, 1996, BIOL REPROD, V55, P427, DOI 10.1095/biolreprod55.2.427; Norman JE, 1997, J REPROD FERTIL, V110, P249; Rinaldi SF, 2011, EXPERT REV CLIN IMMU, V7, P675, DOI [10.1586/ECI.11.58, 10.1586/eci.11.58]; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Slater DM, 1999, MOL HUM REPROD, V5, P880, DOI 10.1093/molehr/5.9.880; Tahara M, 2005, AM J OBSTET GYNECOL, V192, P903, DOI 10.1016/j.ajog.2004.09.016; Tattersall M, 2008, REPRODUCTION, V135, P569, DOI 10.1530/REP-07-0461; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Tribe RM, 2003, BIOL REPROD, V68, P1842, DOI 10.1095/biolreprod.102.011403; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wei CY, 2006, MOL PHARMACOL, V69, P960, DOI 10.1124/mol.105.017368; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621	34	45	48	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					94	105		10.1096/fj.13-237040	http://dx.doi.org/10.1096/fj.13-237040			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24076962				2022-12-25	WOS:000333526100012
J	Liu, XR; Yang, XR; Lee, CA; Moustafa, IM; Smidansky, ED; Lum, D; Arnold, JJ; Cameron, CE; Boehr, DD				Liu, Xinran; Yang, Xiaorong; Lee, Cheri A.; Moustafa, Ibrahim M.; Smidansky, Eric D.; Lum, David; Arnold, Jamie J.; Cameron, Craig E.; Boehr, David D.			Vaccine-derived Mutation in Motif D of Poliovirus RNA-dependent RNA Polymerase Lowers Nucleotide Incorporation Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; NMR; Positive-strand RNA Viruses; Protein Dynamics; Viral Polymerase	STATE KINETIC-ANALYSIS; SABIN TYPE-1 SEQUENCE; DNA-POLYMERASE; O-HELIX; RIBONUCLEOTIDE INCORPORATION; MOLECULAR-DYNAMICS; ACTIVE-SITE; CONFORMATIONAL DYNAMICS; ATTENUATION PHENOTYPE; LETHAL MUTAGENESIS	Background: The motif D loop in poliovirus RNA-dependent RNA polymerase is important for catalysis and fidelity. Results: A vaccine-derived mutation in motif D decreases RdRp fidelity by changing motif D conformational dynamics. Conclusion: Non-conserved residues of motif D can alter RdRp function. Significance: Motif D of the RdRp may be a universal target permitting creation of enzymes with perturbed fidelity and viruses with reduced virulence. All viral RNA-dependent RNA polymerases (RdRps) have a conserved structural element termed motif D. Studies of the RdRp from poliovirus (PV) have shown that a conformational change of motif D leads to efficient and faithful nucleotide addition by bringing Lys-359 into the active site where it serves as a general acid. The RdRp of the Sabin I vaccine strain has Thr-362 changed to Ile. Such a drastic change so close to Lys-359 might alter RdRp function and contribute in some way to the attenuated phenotype of Sabin type I. Here we present our characterization of the T362I RdRp. We find that the T362I RdRp exhibits a mutator phenotype in biochemical experiments in vitro. Using NMR, we show that this change in nucleotide incorporation fidelity correlates with a change in the structural dynamics of motif D. A recombinant PV expressing the T362I RdRp exhibits normal growth properties in cell culture but expresses a mutator phenotype in cells. For example, the T362I-containing PV is more sensitive to the mutagenic activity of ribavirin than wild-type PV. Interestingly, the T362I change was sufficient to cause a statistically significant reduction in viral virulence. Collectively, these studies suggest that residues of motif D can be targeted when changes in nucleotide incorporation fidelity are desired. Given the observation that fidelity mutants can serve as vaccine candidates, it may be possible to use engineering of motif D for this purpose.	[Liu, Xinran; Yang, Xiaorong; Lum, David; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA USA; [Lee, Cheri A.; Moustafa, Ibrahim M.; Smidansky, Eric D.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA USA.	ddb12@psu.edu	Liu, Xinran/GON-4955-2022	Liu, Xinran/0000-0002-3732-6632	National Institutes of Health [R01 AI45818]; Pennsylvania State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045818, R01AI104878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI45818 (to C. E. C.). This work was also supported by startup funds from Pennsylvania State University (to D. D. B.).	Arnold JJ, 2006, ANAL BIOCHEM, V350, P214, DOI 10.1016/j.ab.2005.11.001; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; BAKER S, 1995, J GEN VIROL, V76, P2081, DOI 10.1099/0022-1317-76-8-2081; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Berdis AJ, 2009, CHEM REV, V109, P2862, DOI 10.1021/cr800530b; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; GEORGESCU MM, 1995, J VIROL, V69, P5278, DOI 10.1128/JVI.69.9.5278-5286.1995; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hayden FG, 2006, CURR OPIN INFECT DIS, V19, P169, DOI 10.1097/01.qco.0000216628.51563.b1; Hayden FG, 1999, ADV EXP MED BIOL, V458, P55; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Howard RS, 2005, BMJ-BRIT MED J, V330, P1314, DOI 10.1136/bmj.330.7503.1314; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P7256, DOI 10.1021/bi960537i; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; Lang DM, 2013, NUCLEIC ACIDS RES, V41, P1464, DOI 10.1093/nar/gks1251; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Ogawa M, 2001, MUTAT RES-DNA REPAIR, V485, P197, DOI 10.1016/S0921-8777(00)00081-1; Paul AV, 2000, VIROLOGY, V272, P72, DOI 10.1006/viro.2000.0354; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Ren Z, 2011, BIOCHEMISTRY-US, V50, P1875, DOI 10.1021/bi101863g; Ren Z, 2010, NUCLEIC ACIDS RES, V38, P5105, DOI 10.1093/nar/gkq210; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Suzuki M, 1997, J BIOL CHEM, V272, P11228; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; TARDYPANIT M, 1993, J VIROL, V67, P4630, DOI 10.1128/JVI.67.8.4630-4638.1993; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069; Zemla AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-226	72	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32753	32765		10.1074/jbc.M113.484428	http://dx.doi.org/10.1074/jbc.M113.484428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085299	Green Published, hybrid			2022-12-25	WOS:000328681700059
J	Sultan, A; Raman, B; Rao, CM; Tangirala, R				Sultan, Abdullah; Raman, Bakthisaran; Rao, Ch. Mohan; Tangirala, Ramakrishna			The Extracellular Chaperone Haptoglobin Prevents Serum Fatty Acid-promoted Amyloid Fibril Formation of beta(2)-Microglobulin, Resistance to Lysosomal Degradation, and Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acidosis; Inflammation; Lysosomes; Molecular Chaperone; Protein Degradation; Amyloidosis; 2-Microglobulin; Cytotoxicity; Haptoglobin	PROTEIN; HEMOGLOBIN; EXTENSION; PH; BETA-2-MICROGLOBULIN; FLUORESCENCE; MACROPHAGES; PRODUCT; INDUCE; GROWTH	Fibril formation of (2)-microglobulin and associated inflammation occur in patients on long term dialysis. We show that the plasma protein haptoglobin prevents the fatty acid-promoted de novo fibril formation of (2)-microglobulin even at substoichiometric concentration. The fibrils are cytotoxic, and haptoglobin abolishes the cytotoxicity by preventing fibril formation. Haptoglobin does not alleviate the cytotoxicity of preformed fibrils. Fibrillar (2)-microglobulin is resistant to lysosomal degradation. However, the species of (2)-microglobulin populated in the presence of haptoglobin is susceptible to degradation. We observed that haptoglobin interacts with oligomeric prefibrillar species of (2)-microglobulin but not with monomeric or fibrillar (2)-microglobulin that may underlie the molecular mechanism. 1,1-Bis(4-anilino)naphthalene-5,5-disulfonic acid cross-linking to haptoglobin significantly compromises its chaperone activity, suggesting the involvement of hydrophobic surfaces. Haptoglobin is an acute phase protein whose level increases severalfold during inflammation, where local acidosis can occur. Our data show that haptoglobin prevents fibril formation of (2)-microglobulin under conditions of physiological acidosis (between pH 5.5 and 6.5) but with relatively decreased efficiency. However, compromise in its chaperone activity under these conditions is more than compensated by its increased level of expression under inflammation. Erythrolysis is known to release hemoglobin into the plasma. Haptoglobin forms a 1:1 (mol/mol) complex with hemoglobin. This complex, like haptoglobin, interacts with the prefibrillar species of (2)-microglobulin, preventing its fibril formation and the associated cytotoxicity and resistance to intracellular degradation. Thus, our study demonstrates that haptoglobin is a potential extracellular chaperone for (2)-microglobulin even in moderately acidic conditions relevant during inflammation, with promising therapeutic implications in (2)-microglobulin amyloid-related diseases.	[Sultan, Abdullah; Raman, Bakthisaran; Rao, Ch. Mohan; Tangirala, Ramakrishna] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, CM (corresponding author), Dept Sci & Technol, New Delhi, India.	mohan@ccmb.res.in; trk@ccmb.res.in	SULTAN, ABDULLAH/U-2028-2017	SULTAN, ABDULLAH/0000-0001-8203-4391	Department of Biotechnology (New Delhi, India); Department of Science and Technology (New Delhi, India)	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); Department of Science and Technology (New Delhi, India)(Department of Science & Technology (India))	Recipient of a Senior Research Fellowship from the Department of Biotechnology (New Delhi, India).; Recipient of the J. C. Bose National Fellowship of the Department of Science and Technology (New Delhi, India). To whom correspondence may be addressed. E-mail: mohan@ccmb.res.in.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Arredouani MS, 2005, IMMUNOLOGY, V114, P263, DOI 10.1111/j.1365-2567.2004.02071.x; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; BENESCH RE, 1976, J BIOL CHEM, V251, P465; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BUCCI E, 1988, J BIOL CHEM, V263, P6972; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Fujimoto N, 2002, J INVEST DERMATOL, V118, P479, DOI 10.1046/j.0022-202x.2001.01695.x; Fujimoto N, 2002, BRIT J DERMATOL, V147, P549, DOI 10.1046/j.1365-2133.2002.04940.x; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee HG, 2004, J ALZHEIMERS DIS, V6, P137; Liau CY, 2003, J CHROMATOGR B, V790, P209, DOI 10.1016/S1570-0232(03)00128-4; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 2005, AMYLOID, V12, P15, DOI 10.1080/13506120500032352; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sadrzadeh S.M., 2004, AM J CLIN PATHOL, V121, P97; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; TAKAMI M, 1993, J BIOL CHEM, V268, P20335; Uji Y, 1987, Biomed Chromatogr, V2, P110, DOI 10.1002/bmc.1130020306; WEJMAN JC, 1984, J MOL BIOL, V174, P343, DOI 10.1016/0022-2836(84)90342-5; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zhang PY, 2010, AMYLOID, V17, P50, DOI 10.3109/13506129.2010.483116	51	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32326	32342		10.1074/jbc.M113.498337	http://dx.doi.org/10.1074/jbc.M113.498337			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078632	hybrid, Green Published			2022-12-25	WOS:000328681700019
J	Brait, M; Maldonado, L; Noordhuis, M; Begum, S; Loyo, M; Poeta, ML; Barbosa, A; Fazio, V; Angioli, R; Rabitti, C; Marchionni, L; de Graeff, P; van der Zee, AGJ; Wisman, GBA; Sidransky, D; Hoque, MO				Brait, Mariana; Maldonado, Leonel; Noordhuis, Maartje; Begum, Shahnaz; Loyo, Myriam; Poeta, Maria Luana; Barbosa, Alvaro; Fazio, Vitom.; Angioli, Roberto; Rabitti, Carla; Marchionni, Luigi; de Graeff, Pauline; van der Zee, Ate G. J.; Wisman, G. Bea A.; Sidransky, David; Hoque, Mohammad O.			Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; DNA METHYLATION; MULTIPLE GENES; HYPERMETHYLATION; EXPRESSION; TUMORS; IDENTIFICATION; INACTIVATION; EPIGENOMICS; MECHANISMS	Purpose: To elucidate the role of biological and clinical impact of aberrant promoter hypermethylation (PH) in ovarian cancer (OC). Experimental Design: PH of PGP9.5, HIC1, AIM1, APC, PAK3, MGMT, KIF1A, CCNA1, ESR1, SSBP2, GSTP1, FKBP4 and VGF were assessed by quantitative methylation specific PCR (QMSP) in a training set. We selected two genes (VGF and PGP9.5) for further QMSP analysis in a larger independent validation (IV) set with available clinical data. Biologic relevance of VGF gene was also evaluated. Results: PH frequency for PGP9.5 and VGF were 85% (316/372) and 43% (158/366) respectively in the IV set of samples while no PH was observed in controls. In 372 OC cases with available follow up, PGP9.5 and VGF PH were correlated with better patient survival [Hazard Ratios (HR) for overall survival (OS) were 0.59 (95% Confidence Intervals (CI) = 0.42-0.84, p = 0.004), and 0.73 (95% CI = 0.55-0.97, p = 0.028) respectively, and for disease specific survival (DSS) were 0.57 (95% CI 0.39-0.82, p = 0.003) and 0.72 (95% CI 0.54-0.96, p = 0.027). In multivariate analysis, VGF PH remained an independent prognostic factor for OS (HR 0.61, 95% CI 0.43-0.86, p < 0.005) and DSS (HR 0.58, 95% CI 0.41-0.83, p < 0.003). Furthermore, PGP9.5 PH was significantly correlated with lower grade, early stage tumors, and with absence of residual disease. Forced expression of VGF in OC cell lines inhibited cell growth. Conclusions: Our results indicate that VGF and PGP9.5 PH are potential biomarkers for ovarian carcinoma. Confirmatory cohorts with longitudinal follow-up are required in future studies to define the clinical impact of VGF and PGP9.5 PH before clinical application.	[Brait, Mariana; Maldonado, Leonel; Noordhuis, Maartje; Loyo, Myriam; Sidransky, David; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Brait, Mariana] Brazilian Natl Canc Inst, Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Noordhuis, Maartje; de Graeff, Pauline; van der Zee, Ate G. J.; Wisman, G. Bea A.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands; [Begum, Shahnaz] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Poeta, Maria Luana] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Barbosa, Alvaro] Hosp San Jose Tec Monterrey, Dept Pathol, Monterrey, Nuevo Leon, Mexico; [Fazio, Vitom.] Univ Campus Biomed Rome, Mol Med Lab, Rome, Italy; [Fazio, Vitom.] Univ Campus Biomed Rome, Biotechnol Ctr Integrated Res, Rome, Italy; [Angioli, Roberto] Univ Campus Biomed Rome, Dept Gynecol, Rome, Italy; [Rabitti, Carla] Univ Campus Biomed Rome, Dept Pathol, Rome, Italy; [Marchionni, Luigi; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; National Cancer Institute (Inca); University of Groningen; Johns Hopkins University; Johns Hopkins Medicine; Universita degli Studi di Bari Aldo Moro; Tecnologico de Monterrey; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Johns Hopkins University; Johns Hopkins University	Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mhoque1@jhmi.edu	Marchionni, Luigi/S-6774-2017; Fazio, Vito Michele VMF/H-3007-2016; angioli, roberto/K-4172-2016	Marchionni, Luigi/0000-0002-7336-8071; Fazio, Vito Michele VMF/0000-0002-7751-1867; angioli, roberto/0000-0002-8528-4318; Brait, Mariana/0000-0002-1652-8921; POETA, Maria Luana/0000-0002-6364-727X; Hoque, Mohammad Obaidul/0000-0001-6701-9978	Career development award from Specialized Program of Research Excellence [P50 CA098252]; Flight Attendant Medical Research Institute; National Institutes of Health-National Cancer Institute [P30CA006973]; Dutch Cancer Society; Jo Kolk studiefonds; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA098252] Funding Source: NIH RePORTER	Career development award from Specialized Program of Research Excellence; Flight Attendant Medical Research Institute; National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding); Jo Kolk studiefonds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Career development award to Dr. Hoque from Specialized Program of Research Excellence grant P50 CA098252 (PI: T-C Wu). Dr. Hoque and Dr. Begum are supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute. Dr. Marchionni is supported by National Institutes of Health-National Cancer Institute grant P30CA006973. M. G. Noordhuis is a recipient of grants from the Dutch Cancer Society and Jo Kolk studiefonds. The funding agencies had no role in the design of the study, data collection, analysis, interpretation of the results, preparation of the manuscript, or the decision to submit the manuscript for publication.	Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; [Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1; Bartolomucci A, 2007, GENES NUTR, V2, P169, DOI 10.1007/s12263-007-0047-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brait M, 2012, BRIT J CANCER, V106, P414, DOI 10.1038/bjc.2011.468; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Brown R, 1997, ONCOGENE, V15, P45, DOI 10.1038/sj.onc.1201167; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; de Caceres Inmaculada Ibanez, 2004, Cancer Research, V64, P6476, DOI 10.1158/0008-5472.CAN-04-1529; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fiegl H, 2008, INT J CANCER, V123, P725, DOI 10.1002/ijc.23563; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holloway RW, 2002, GYNECOL ONCOL, V87, P8, DOI 10.1006/gyno.2002.6797; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Hoque MO, 2008, J UROLOGY, V179, P743, DOI 10.1016/j.juro.2007.09.019; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Liu JW, 2008, CLIN CANCER RES, V14, P3754, DOI 10.1158/1078-0432.CCR-07-4763; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyo M, 2011, INT J CANCER, V128, P1393, DOI 10.1002/ijc.25443; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Maldonado L, 2010, BIOMARK MED, V4, P543, DOI 10.2217/BMM.10.72; Mastoraki A, 2009, ARCH DERMATOL RES, V301, P653, DOI 10.1007/s00403-009-0962-6; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Ozdemir F, 2012, EXP THER MED, V4, P1092, DOI 10.3892/etm.2012.715; Pils D, 2013, CANCER-AM CANCER SOC, V119, P946, DOI 10.1002/cncr.27850; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Rosenbaum E, 2012, PROSTATE, V72, P1133, DOI 10.1002/pros.22461; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Tam KF, 2007, J CANCER RES CLIN, V133, P331, DOI 10.1007/s00432-006-0178-5; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wiley A, 2006, CANCER-AM CANCER SOC, V107, P299, DOI 10.1002/cncr.21992; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Zeller C, 2013, AM J PATHOL, V182, P668, DOI 10.1016/j.ajpath.2012.11.040	53	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70878	10.1371/journal.pone.0070878	http://dx.doi.org/10.1371/journal.pone.0070878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086249	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900004
J	Rossello, FJ; Tothill, RW; Britt, K; Marini, KD; Falzon, J; Thomas, DM; Peacock, CD; Marchionni, L; Li, J; Bennett, S; Tantoso, E; Brown, T; Chan, P; Martelotto, LG; Watkins, DN				Rossello, Fernando J.; Tothill, Richard W.; Britt, Kara; Marini, Kieren D.; Falzon, Jeanette; Thomas, David M.; Peacock, Craig D.; Marchionni, Luigi; Li, Jason; Bennett, Samara; Tantoso, Erwin; Brown, Tracey; Chan, Philip; Martelotto, Luciano G.; Watkins, D. Neil			Next-Generation Sequence Analysis of Cancer Xenograft Models	PLOS ONE			English	Article							CELL LUNG-CANCER; INTEGRATIVE GENOMICS VIEWER; BREAST-CANCER; RNA-SEQ; PANCREATIC-CANCER; IN-VITRO; METASTASIS; INFORMATION; EXPLORATION; EVOLUTION	Next-generation sequencing (NGS) studies in cancer are limited by the amount, quality and purity of tissue samples. In this situation, primary xenografts have proven useful preclinical models. However, the presence of mouse-derived stromal cells represents a technical challenge to their use in NGS studies. We examined this problem in an established primary xenograft model of small cell lung cancer (SCLC), a malignancy often diagnosed from small biopsy or needle aspirate samples. Using an in silico strategy that assign reads according to species-of-origin, we prospectively compared NGS data from primary xenograft models with matched cell lines and with published datasets. We show here that low-coverage whole-genome analysis demonstrated remarkable concordance between published genome data and internal controls, despite the presence of mouse genomic DNA. Exome capture sequencing revealed that this enrichment procedure was highly species-specific, with less than 4% of reads aligning to the mouse genome. Human-specific expression profiling with RNA-Seq replicated array-based gene expression experiments, whereas mouse-specific transcript profiles correlated with published datasets from human cancer stroma. We conclude that primary xenografts represent a useful platform for complex NGS analysis in cancer research for tumours with limited sample resources, or those with prominent stromal cell populations.	[Rossello, Fernando J.; Marini, Kieren D.; Martelotto, Luciano G.; Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Tothill, Richard W.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Tothill, Richard W.] Peter MacCallum Canc Ctr, Mol Genom Core Facil, East Melbourne, Vic, Australia; [Britt, Kara] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Britt, Kara; Thomas, David M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Falzon, Jeanette; Bennett, Samara; Brown, Tracey] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Thomas, David M.] Peter MacCallum Canc Ctr, Dept Canc Med, East Melbourne, Vic, Australia; [Peacock, Craig D.; Marchionni, Luigi] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Li, Jason] Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, Australia; [Li, Jason] Univ Melbourne, Dept Mech Engn, Parkville, Vic 3052, Australia; [Tantoso, Erwin] Partek SG Private Ltd, Singapore, Singapore; [Chan, Philip] Monash Univ, Monash eRes Ctr, Clayton, Vic, Australia; [Martelotto, Luciano G.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Monash University; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Peter Maccallum Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Memorial Sloan Kettering Cancer Center	Martelotto, LG (corresponding author), Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia.	martelol@mskcc.org; neil.watkins@monash.edu	Thomas, David/AAD-2877-2019; Rossello, Fernando/B-1208-2015; Martelotto, Luciano/D-1946-2015; Marchionni, Luigi/S-6774-2017; Britt, Kara/B-2437-2013	Thomas, David/0000-0002-2527-5428; Rossello, Fernando/0000-0003-3885-8777; Martelotto, Luciano/0000-0002-9625-1183; Marchionni, Luigi/0000-0002-7336-8071; Li, Jason/0000-0002-1150-3549; Britt, Kara/0000-0001-6069-7856; Tantoso, Erwin/0000-0002-7946-6297; Tothill, Richard William/0000-0003-4522-1184	National Health and Medical Research Council of Australia [546204]; Victorian Government Operational Infrastructure Support Program; Victorian Cancer Agency	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Victorian Cancer Agency	Funding for this work was provided by the National Health and Medical Research Council of Australia (Project Grant 546204), the Victorian Government Operational Infrastructure Support Program, and the Victorian Cancer Agency. Funding for open access charge: Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JW, 2012, BIOINFORMATICS, V28, P1272, DOI 10.1093/bioinformatics/bts128; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74432	10.1371/journal.pone.0074432	http://dx.doi.org/10.1371/journal.pone.0074432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086345	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000010
J	Wang, FL; Chen, F; Huo, XQ; Xu, RB; Wu, L; Wang, JM; Lu, C				Wang, Fengliang; Chen, Fei; Huo, Xiqian; Xu, Ruobing; Wu, Liang; Wang, Jianming; Lu, Cheng			A Neglected Issue on Sexual Well-Being following Breast Cancer Diagnosis and Treatment among Chinese Women	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; BODY-IMAGE; PSYCHOSOCIAL ADJUSTMENT; MIXED METHODS; DYSFUNCTION; SURVIVORS; RECONSTRUCTION; EXPERIENCES; STRATEGIES; MANAGEMENT	Background: Changes to sexual well-being can be one of the most problematic quality of life issues following the diagnosis and treatment of breast cancer. The objectives of the present study were to evaluate changes to sexual well-being following breast cancer, to expand upon the existing body of knowledge pertaining to breast cancer and sexuality, and to provide the necessary information for implementing future interventions that may help improve the quality of life in breast cancer patients. Methods: This study was mixed with qualitative and quantitative designs. Twenty patients with breast cancer were recruited for in-depth interviews. The central questions covered a patient's cancer experience and perceptions of sexual activities following breast cancer. According to the findings of the qualitative study, we performed a quantitative study using a structured questionnaire to collect data on patient's experience and attitude to sexual well-being following breast cancer diagnosis and treatment. Results: Based on the qualitative analysis, seven main themes emerged: (1) Decrease in sexual frequency; (2) Lack of sexual interest; (3) Menopausal symptoms; (4) Body image changes; (5) Effects on marital relationship; (6) Misconceptions about sex; (7) The need for professional consultation. Results from the quantitative study further supported the findings from the qualitative analysis, where changes to sexual well-being were common following cancer diagnosis and treatment and it was a neglected issue among Chinese women. Conclusions: The present study highlights the significant changes to sexual well-being following breast cancer, in addition to the lack of knowledge and misconceptions of sexual activity among patients. Addressing these problems will help improve a patient's quality of life. The findings of this study could help healthcare professionals recognize the sexual issues faced by women with breast cancer and ultimately promote a healthy life.	[Wang, Fengliang; Chen, Fei; Lu, Cheng] Nanjing Med Univ, Dept Breast, Nanjing Matern & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Fei; Huo, Xiqian; Xu, Ruobing; Wu, Liang; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn; lucheng66@126.com		Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81172501]; Key University Science Research Project of Jiangsu Province [12KJA330001]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China (81172501), Key University Science Research Project of Jiangsu Province (12KJA330001), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barni S, 1997, ANN ONCOL, V8, P149, DOI 10.1023/A:1008298615272; Di Gen-hong, 2007, Zhonghua Zhongliu Zazhi, V29, P62; Dizon DS, 2009, BREAST J, V15, P500, DOI 10.1111/j.1524-4741.2009.00766.x; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Fang SY, 2013, BREAST CANCER RES TR, V137, P13, DOI 10.1007/s10549-012-2349-1; Fergus KD, 2002, J HEALTH PSYCHOL, V7, P303, DOI 10.1177/1359105302007003223; Fobair P, 2006, PSYCHO-ONCOL, V15, P579, DOI 10.1002/pon.991; Gao ES, 2012, J ADOLESCENT HEALTH, V50, pS12, DOI 10.1016/j.jadohealth.2011.12.002; Hughes Mary K, 2008, Semin Oncol Nurs, V24, P91, DOI 10.1016/j.soncn.2008.02.003; Katz A, 2011, AM J NURS, V111, P63, DOI 10.1097/01.NAJ.0000396560.09620.19; Kinsinger SW, 2011, PSYCHOL HEALTH, V26, P1571, DOI 10.1080/08870446.2010.533771; Krychman ML, 2012, J SEX MED, V9, P5, DOI 10.1111/j.1743-6109.2011.02566.x; Krychman ML, 2006, GYNECOL ONCOL, V101, P380, DOI 10.1016/j.ygyno.2006.03.001; Lenahan PM, 2004, CLIN FAMILY PRACTICE, V6, P955; Loprinzi CL, 2008, LANCET ONCOL, V9, P993, DOI 10.1016/S1470-2045(08)70256-0; Maguire P, 1998, BRIT MED J, V316, P1086; Moreira H, 2013, J PSYCHOSOC ONCOL, V31, P282, DOI 10.1080/07347332.2013.778934; Rowe P, 2011, PHYSIOTHER CAN, V63, P453, DOI 10.3138/ptc.2010-41; Sbitti Y, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-29; SCHOVER LR, 1995, CANCER-AM CANCER SOC, V75, P54, DOI 10.1002/1097-0142(19950101)75:1<54::AID-CNCR2820750111>3.0.CO;2-I; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Stead ML, 2003, CURR OPIN OBSTET GYN, V15, P57, DOI 10.1097/00001703-200302000-00009; Takahashi M, 2005, SOC SCI MED, V61, P1278, DOI 10.1016/j.socscimed.2005.01.013; Ussher JM, 2013, J ADV NURS, V69, P327, DOI 10.1111/j.1365-2648.2012.06010.x; Ussher JM, 2012, CANCER NURS, V35, P456, DOI 10.1097/NCC.0b013e3182395401; White JL, 2012, ONCOL NURS FORUM, V39, P210, DOI 10.1188/12.ONF.210-217; Wilmoth MC, 2011, ONCOL NURS FORUM, V38, P699, DOI 10.1188/11.ONF.699-708; Wisdom JP, 2012, HEALTH SERV RES, V47, P721, DOI 10.1111/j.1475-6773.2011.01344.x; Yeh CJ, 2007, COUNS PSYCHOL, V35, P369, DOI 10.1177/0011000006292596; Zhang Bao-ning, 2005, Zhonghua Zhongliu Zazhi, V27, P680; Zhang WQ, 2013, MED CARE, V51, pe51, DOI 10.1097/MLR.0b013e31824642fd	31	11	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74473	10.1371/journal.pone.0074473	http://dx.doi.org/10.1371/journal.pone.0074473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086349	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700026
J	Yoon, J; Matsuo, E; Yamada, D; Mizuno, H; Morimoto, T; Miyakawa, H; Kinoshita, S; Ishimoto, H; Kamikouchi, A				Yoon, Jeonghyeon; Matsuo, Eriko; Yamada, Daichi; Mizuno, Hiroshi; Morimoto, Takako; Miyakawa, Hiroyoshi; Kinoshita, Setsuo; Ishimoto, Hiroshi; Kamikouchi, Azusa			Selectivity and Plasticity in a Sound-Evoked Male-Male Interaction in Drosophila	PLOS ONE			English	Article							COURTSHIP SONGS; BEHAVIORAL-CHARACTERISTICS; HABITUATION; MEMORY; MELANOGASTER; MUTATIONS; GENES; COMMUNICATION; EVOLUTION	During courtship, many animals, including insects, birds, fish, and mammals, utilize acoustic signals to transmit information about species identity. Although auditory communication is crucial across phyla, the neuronal and physiologic processes are poorly understood. Sound-evoked chaining behavior, a display of homosexual courtship behavior in Drosophila males, has long been used as an excellent model for analyzing auditory behavior responses, outcomes of acoustic perception and higher-order brain functions. Here we developed a new method, termed ChaIN (Chain Index Numerator), in which we use a computer-based auto detection system for chaining behavior. The ChaIN system can systematically detect the chaining behavior induced by a series of modified courtship song playbacks. Two evolutionarily related Drosophila species, Drosophila melanogaster and Drosophila simulans, exhibited dramatic selective increases in chaining behavior when exposed to specific auditory cues, suggesting that auditory discrimination processes are involved in the acceleration of chaining behavior. Prolonged monotonous pulse sounds containing courtship song components also induced high intense chaining behavior. Interestingly, the chaining behavior was gradually suppressed over time when song playback continued. This behavioral change is likely to be a plastic behavior and not a simple sensory adaptation or fatigue, because the suppression was released by applying a different pulse pattern. This behavioral plasticity is not a form of habituation because different modality stimuli did not recover the behavioral suppression. Intriguingly, this plastic behavior partially depended on the cAMP signaling pathway controlled by the rutabaga adenylyl cyclase gene that is important for learning and memory. Taken together, this study demonstrates the selectivity and behavioral kinetics of the sound-induced interacting behavior of Drosophila males, and provides a basis for the systematic analysis of genes and neural circuits underlying complex acoustic behavior.	[Yoon, Jeonghyeon; Matsuo, Eriko; Yamada, Daichi; Ishimoto, Hiroshi; Kamikouchi, Azusa] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Mizuno, Hiroshi; Morimoto, Takako; Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Kinoshita, Setsuo] ProMed Co Ltd, Shinjuku Ku, Tokyo, Japan; [Kamikouchi, Azusa] JST, PRESTO, Chiyoda Ku, Tokyo, Japan	Nagoya University; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST)	Kamikouchi, A (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	kamikouchi@bio.nagoya-u.ac.jp	Ishimoto, Hiroshi/AAV-1923-2021	Ishimoto, Hiroshi/0000-0002-8859-6931; Kamikouchi, Azusa/0000-0003-1552-6892	Human Frontier Science Program; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [25640010] Funding Source: KAKEN	Human Frontier Science Program(Human Frontier Science Program); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Human Frontier Science Program; PRESTO program "Decoding and controlling brain information" from the Japan Science and Technology Agency; Grant-in-Aid for Young Scientists from Japan Society for the Promotion of Science; a Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and Research Grants in the Natural Sciences from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Engel JE, 1996, J NEUROSCI, V16, P3486; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Fiala Andre, 2003, Sci STKE, V2003, pPL6, DOI 10.1126/stke.2003.174.pl6; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Harris C, 1988, P 4 ALV VIS C, P147, DOI DOI 10.5244/C.2.23; HOIKKALA A, 1987, EVOLUTION, V41, P827, DOI 10.1111/j.1558-5646.1987.tb05856.x; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Inagaki HK, 2010, NAT PROTOC, V5, P26, DOI 10.1038/nprot.2009.206; Jonsson T, 2011, FLY, V5, P29, DOI 10.4161/fly.5.1.13713; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2010, NAT PROTOC, V5, P1229, DOI 10.1038/nprot.2010.85; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Menda G, 2011, J EXP BIOL, V214, P2864, DOI 10.1242/jeb.055202; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paranjpe P, 2012, LEARN MEMORY, V19, P627, DOI 10.1101/lm.026641.112; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riabinina O, 2011, CURR BIOL, V21, P658, DOI 10.1016/j.cub.2011.03.001; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; SCHILCHER FV, 1975, BEHAV GENET, V5, P395, DOI 10.1007/BF01073208; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	39	22	21	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74289	10.1371/journal.pone.0074289	http://dx.doi.org/10.1371/journal.pone.0074289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086330	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200013
J	Razak, SRA; Ueno, K; Takayama, N; Nariai, N; Nagasaki, M; Saito, R; Koso, H; Lai, CY; Murakami, M; Tsuji, K; Michiue, T; Nakauchi, H; Otsu, M; Watanabe, S				Razak, Siti Razila Abdul; Ueno, Kazuko; Takayama, Naoya; Nariai, Naoki; Nagasaki, Masao; Saito, Rika; Koso, Hideto; Lai, Chen-Yi; Murakami, Miyako; Tsuji, Koichiro; Michiue, Tatsuo; Nakauchi, Hiromitsu; Otsu, Makoto; Watanabe, Sumiko			Profiling of MicroRNA in Human and Mouse ES and iPS Cells Reveals Overlapping but Distinct MicroRNA Expression Patterns	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DIFFERENTIATION; LINES; GENERATION; NAIVE	Using quantitative PCR-based miRNA arrays, we comprehensively analyzed the expression profiles of miRNAs in human and mouse embryonic stem (ES), induced pluripotent stem (iPS), and somatic cells. Immature pluripotent cells were purified using SSEA-1 or SSEA-4 and were used for miRNA profiling. Hierarchical clustering and consensus clustering by nonnegative matrix factorization showed two major clusters, human ES/iPS cells and other cell groups, as previously reported. Principal components analysis (PCA) to identify miRNAs that segregate in these two groups identified miR-187, 299-3p, 499-5p, 628-5p, and 888 as new miRNAs that specifically characterize human ES/iPS cells. Detailed direct comparisons of miRNA expression levels in human ES and iPS cells showed that several miRNAs included in the chromosome 19 miRNA cluster were more strongly expressed in iPS cells than in ES cells. Similar analysis was conducted with mouse ES/iPS cells and somatic cells, and several miRNAs that had not been reported to be expressed in mouse ES/iPS cells were suggested to be ES/iPS cell-specific miRNAs by PCA. Comparison of the average expression levels of miRNAs in ES/iPS cells in humans and mice showed quite similar expression patterns of human/mouse miRNAs. However, several mouse-or human-specific miRNAs are ranked as high expressers. Time course tracing of miRNA levels during embryoid body formation revealed drastic and different patterns of changes in their levels. In summary, our miRNA expression profiling encompassing human and mouse ES and iPS cells gave various perspectives in understanding the miRNA core regulatory networks regulating pluripotent cells characteristics.	[Razak, Siti Razila Abdul; Ueno, Kazuko; Saito, Rika; Koso, Hideto; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Ueno, Kazuko; Nariai, Naoki; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Div Biomed Informat Anal, Sendai, Miyagi 980, Japan; [Takayama, Naoya; Lai, Chen-Yi; Murakami, Miyako; Nakauchi, Hiromitsu; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Takayama, Naoya; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Stem Cell Bank, Tokyo, Japan; [Tsuji, Koichiro] Univ Tokyo, Inst Med Sci, Res Hosp, Div Pediat Hematol Oncol, Tokyo, Japan; [Michiue, Tatsuo] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo; Tohoku University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp	Razak, Siti Razila Abdul/R-2298-2016; Abdul Razak, Siti Razila/P-2754-2014	Razak, Siti Razila Abdul/0000-0003-1398-7652; Abdul Razak, Siti Razila/0000-0002-9197-1982; Nagasaki, Masao/0000-0002-4292-8785; KOSO, HIDETO/0000-0002-8986-7617; Otsu, Makoto/0000-0002-9769-0217; xing zhi, shi zhi/0000-0003-3289-5681	Project for Realization of Regenerative Medicine; MEXT of Japan	Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The project was supported by "the Project for Realization of Regenerative Medicine" and "the grants-in-aid for scientific research" by a Grant-in-Aid for Scientific Research from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Favreau AJ, 2012, LEUKEMIA RES, V36, P334, DOI 10.1016/j.leukres.2011.09.027; GEY GO, 1952, CANCER RES, V12, P264; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hirst M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r113; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim KS, 2009, FEBS J, V276, P2140, DOI 10.1111/j.1742-4658.2009.06932.x; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Neveu P, 2010, CELL STEM CELL, V7, P671, DOI 10.1016/j.stem.2010.11.012; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Watson JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053417; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	57	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73532	10.1371/journal.pone.0073532	http://dx.doi.org/10.1371/journal.pone.0073532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086284	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200010
J	Klinger, M; Kong, K; Moorhead, M; Weng, L; Zheng, JB; Faham, M				Klinger, Mark; Kong, Katherine; Moorhead, Martin; Weng, Li; Zheng, Jianbiao; Faham, Malek			Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EPITOPE SPECIFICITIES; FULL REPERTOIRE; INFLUENZA-A; CD8+T CELLS; RESPONSES; CANCER; EXPRESSION; RECOGNITION; PEPTIDE	In this study, we combined a novel sequencing method, which can identify individual clonotypes based on their unique T cell receptor (TCR) rearrangement, with existing immune assays to characterize antigen-specific T cell responses. We validated this approach using three types of assays routinely used to measure antigen-specific responses: pentamers which enable identification of T cells bearing specific TCRs, activation marker expression following antigen stimulation and antigen-induced proliferation to identify cytomegalovirus (CMV) specific clonotypes. In one individual, 8 clonotypes were identified using a pentamer reagent derived from the CMV pp65 protein. The same 8 clonotypes were also identified following sequencing of cells that upregulated an activation marker following incubation with an identical peptide derived from pp65. These 8 and an additional 8 clonotypes were identified using a more sensitive CFSE-based proliferation assay. We found clear sequence homology among some of the clonotypes identified, and the CDR3 region in one clonotype was identical to a previously published pp65-specific clonotype sequence. Many of these CMV-specific clonotypes were present at frequencies below 10 25 which are undetectable using standard flow-cytometric methods. These studies suggest that an immune response is comprised of a diverse set of clones, many of which are present at very low frequencies. Thus, the combination of immune assays and sequencing depicts the richness and diversity of an immune response at a level that is not possible using standard immune assays alone. The methods articulated in this work provide an enhanced understanding of T cell-mediated immune responses at the clonal level.	[Klinger, Mark; Kong, Katherine; Moorhead, Martin; Weng, Li; Zheng, Jianbiao; Faham, Malek] Sequenta Inc, Res, San Francisco, CA USA		Faham, M (corresponding author), Sequenta Inc, Res, San Francisco, CA USA.	Malek.Faham@sequenta.com			Sequenta Inc.	Sequenta Inc.	Sequenta Inc. funded this research and had a role in the study design, data collection, analysis, decision to publish and preparation of the manuscript.	Babel N, 2009, J AM SOC NEPHROL, V20, P344, DOI 10.1681/ASN.2007111225; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Campbell JD, 2010, CLIN EXP ALLERGY, V40, P1025, DOI 10.1111/j.1365-2222.2010.03505.x; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gawad C, 2012, BLOOD IN PRESS; Gawad C, 2012, BLOOD, V120, P4407, DOI 10.1182/blood-2012-05-429811; Gratama JW, 2008, CYTOM PART A, V73A, P971, DOI 10.1002/cyto.a.20655; Janetzki Sylvia, 2005, Methods Mol Biol, V302, P51; Keilhoz U, 2006, CLIN CANCER RES, V12, p2346S, DOI 10.1158/1078-0432.CCR-05-2540; Kern F, 2005, TRENDS IMMUNOL, V26, P477, DOI 10.1016/j.it.2005.07.005; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Meier S, 2008, CYTOMETRY A; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Pira GL, 2007, CYTOM PART B-CLIN CY, V72B, P77, DOI 10.1002/cyto.b.20186; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Rudd BD, 2010, J IMMUNOL, V184, P2958, DOI 10.4049/jimmunol.0903493; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Venturi V, 2008, J IMMUNOL, V181, P7853, DOI 10.4049/jimmunol.181.11.7853; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Wolfl M, 2008, CYTOM PART A, V73A, P1043, DOI 10.1002/cyto.a.20594; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168	34	25	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74231	10.1371/journal.pone.0074231	http://dx.doi.org/10.1371/journal.pone.0074231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069285	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300030
J	Bretherick, KL; Schuetz, JM; Morton, LM; Purdue, MP; Conde, L; Gallagher, RP; Connors, JM; Gascoyne, RD; Berry, BR; Armstrong, B; Kricker, A; Vajdic, CM; Grulich, A; Hjalgrim, H; Smedby, KE; Skibola, CF; Rothman, N; Spinelli, JJ; Brooks-Wilson, AR				Bretherick, Karla L.; Schuetz, Johanna M.; Morton, Lindsay M.; Purdue, Mark P.; Conde, Lucia; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Berry, Brian R.; Armstrong, Bruce; Kricker, Anne; Vajdic, Claire M.; Grulich, Andrew; Hjalgrim, Henrik; Smedby, Karin E.; Skibola, Christine F.; Rothman, Nathaniel; Spinelli, John J.; Brooks-Wilson, Angela R.			Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; DOUBLE-STRAND BREAKS; YIN YANG 1; HISTONE H2AX; REPRODUCTIVE FACTORS; GENETIC-VARIANTS; RISK; CANCER; PROGRESSION; WOMEN	H2AFX encodes a histone variant involved in signaling sites of DNA damage and recruiting repair factors. Genetic variants in H2AFX may influence risk of non-Hodgkin lymphoma (NHL), a heterogeneous group of lymphoid tumors that are characterized by chromosomal translocations. We previously reported that rs2509049, a common variant in the promoter of H2AFX, was associated with risk for NHL in the British Columbia population. Here we report results for 13 single nucleotide polymorphisms (SNPs) in 100 Kb surrounding H2AFX in an expanded collection of 568 NHL cases and 547 controls. After correction for multiple testing, significant associations were present for mantle cell lymphoma (p = 0.007 for rs604714) and all B-cell lymphomas (p = 0.046 for rs2509049). Strong linkage disequilibrium in the 5 Kb upstream of H2AFX limited the ability to determine which specific SNP (rs2509049, rs7759, rs8551, rs643788, rs604714, or rs603826), if any, was responsible. There was a significant interaction between sex and rs2509049 in the all B-cell lymphomas group (p = 0.002); a sex-stratified analysis revealed that the association was confined to females (p = 0.001). Neither the overall nor the female-specific association with rs2509049 was replicated in any of four independent NHL sample sets. Meta-analysis of all five study populations (3,882 B-cell NHL cases and 3,718 controls) supported a weak association with B-cell lymphoma (OR = 0.92, 95% CI = 0.86-0.99, p = 0.034), although this association was not significant after exclusion of the British Columbia data. Further research into the potential sex-specificity of the H2AFX-NHL association may identify a subset of NHL cases that are influenced by genotype at this locus.	[Bretherick, Karla L.; Schuetz, Johanna M.; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Bretherick, Karla L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Morton, Lindsay M.; Purdue, Mark P.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Conde, Lucia; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Armstrong, Bruce; Kricker, Anne] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Vajdic, Claire M.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Adult Canc Program,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Grulich, Andrew] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW 2052, Australia; [Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; Statens Serum Institut; Karolinska Institutet; University of British Columbia; Simon Fraser University	Brooks-Wilson, AR (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Morton, Lindsay/AAE-7495-2022; Spinelli, John J./B-6210-2013; Hjalgrim, Henrik/AAG-4973-2021; Conde, Lucia/D-9295-2011; Brooks-Wilson, Angela/E-9399-2012; Purdue, Mark P/C-9228-2016; Gascoyne, Randy D/A-6009-2013; Armstrong, Bruce K/K-9464-2015; Connors, Joseph/AAF-5284-2019; Vajdic, Claire/AAP-5940-2020; Morton, Lindsay M/B-5234-2015	Morton, Lindsay/0000-0001-9767-2310; Spinelli, John J./0000-0002-9119-3287; Brooks-Wilson, Angela/0000-0003-1009-6408; Purdue, Mark P/0000-0003-1177-3108; Gascoyne, Randy D/0000-0002-2610-5690; Armstrong, Bruce K/0000-0001-8940-7525; Connors, Joseph/0000-0002-1361-7531; Morton, Lindsay M/0000-0001-9767-2310; Vajdic, Claire/0000-0002-3612-8298; Bretherick, Karla/0000-0002-6606-802X; Conde, Lucia/0000-0001-5180-543X	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR) [MOP86528]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	KLB is funded by postdoctoral fellowships from the Michael Smith Foundation for Health Research (http://www.msfhr.org/) and the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). This study was funded by a grant from CIHR (MOP86528) to ARB-W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WORLD POP PROSP 2010; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castellano G, 2010, CELL CYCLE, V9, P557, DOI 10.4161/cc.9.3.10554; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; Costas L, 2012, CANCER CAUSE CONTROL, V23, P195, DOI 10.1007/s10552-011-9869-6; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan WW, 2011, J NEURO-ONCOL, V105, P211, DOI 10.1007/s11060-011-0586-5; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Hughes AM, 2004, INT J CANCER, V110, P429, DOI 10.1002/ijc.20128; Jin XM, 2011, DNA CELL BIOL, V30, P1039, DOI 10.1089/dna.2010.1130; Kane EV, 2012, ANN ONCOL, V24, P433, DOI [10.1093/annonc/mds340, DOI 10.1093/ANN0NC/MDS340.PUBMED:22967995]; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lossos IS, 2005, J CLIN ONCOL, V23, P6351, DOI 10.1200/JCO.2005.05.012; Lu JC, 2008, BREAST CANCER RES TR, V110, P357, DOI 10.1007/s10549-007-9717-2; Lu YL, 2011, INT J CANCER, V129, P974, DOI 10.1002/ijc.25730; Lumley T, 2009, RMETA METAANALYSIS R, P16; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Naidoo K, 2011, J CLIN PATHOL, V64, P125, DOI 10.1136/jcp.2010.078188; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; Norgaard M, 2006, BRIT J CANCER, V94, P1339, DOI 10.1038/sj.bjc.6603123; Novik KL, 2007, CANCER EPIDEM BIOMAR, V16, P1098, DOI 10.1158/1055-9965.EPI-06-0639; Prescott J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008135; R Core Team, 2022, R LANG ENV STAT COMP; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sakhinia E, 2007, BLOOD, V109, P3922, DOI 10.1182/blood-2006-09-046391; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; Swerdlow E., 2008, WHO CLASSIFICATION T; Vose JM, 2012, AM J HEMATOL, V87, P605, DOI 10.1002/ajh.23176; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zinzani PL, 2012, HEMATOL-AM SOC HEMAT, P426, DOI 10.1182/asheducation-2012.1.426	49	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74619	10.1371/journal.pone.0074619	http://dx.doi.org/10.1371/journal.pone.0074619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069324	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300046
J	Corsetti, PP; de Almeida, LA; Carvalho, NB; Azevedo, V; Silva, TMA; Teixeira, HC; Faria, AC; Oliveira, SC				Corsetti, Patricia P.; de Almeida, Leonardo A.; Carvalho, Natalia B.; Azevedo, Vasco; Silva, Teane M. A.; Teixeira, Henrique C.; Faria, Ana C.; Oliveira, Sergio C.			Lack of Endogenous IL-10 Enhances Production of Proinflammatory Cytokines and Leads to Brucella abortus Clearance in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; IFN-GAMMA; TH1 CELLS; INFECTION; RESISTANCE; RESPONSES; INFLAMMATION; IMMUNITY; DISEASE	IL-10 is a cytokine that regulates the balance between pathogen clearance and immunopathology. Brucella abortus is an intracellular bacterium that causes chronic disease in humans and domestic animals. Here we evaluated the contribution of IL-10 in host immune response and pathology during B. abortus infection. To assess the role of IL-10 in vivo, IL-10 knockout (KO) or 129 Sv/Ev (wild-type) mice were infected with B. abortus and the number of viable bacteria from the spleen was determined at 1, 2, 3, 6 and 14-weeks postinfection. IL-10 KO mice showed reduced bacterial loads in the spleen when compared to wild-type mice during all time points studied. Additionally, at 14-weeks postinfection IL-10 KO mice had totally cleared the infection. This clearance was preceded by an enhanced IFN-gamma, TNF-alpha and IL-17 responses in both the serum and the spleen of IL-10 KO mice. Additionally, dendritic cells from infected IL-10 KO mice produced elevated levels of IL-12 and TNF-a compared to wild-type animals. Histopathology analysis was performed and both KO and wild-type mice developed multifocal granulomas and necrosis in the liver. However, at six-weeks postinfection reduced numbers of granulomas was detected in IL-10 KO mice compared to wild-type animals. This reduced liver pathology at later stage of infection was accompanied by increased numbers of CD4+CD25+foxp3+T cells and expression of TGF-beta in IL-10 KO splenocytes. Taken together, our findings demonstrate that IL-10 modulates the proinflammatory immune response to B. abortus infection and the lack of IL-10 increases resistance to Brucella infection.	[Corsetti, Patricia P.; de Almeida, Leonardo A.; Carvalho, Natalia B.; Faria, Ana C.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Silva, Teane M. A.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [de Almeida, Leonardo A.; Teixeira, Henrique C.] Univ Fed Juiz de Fora, Dept Microbiol Imunol & Parasitol, Juiz De Fora, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora	Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	scozeus@icb.ufmg.br	de Almeida, Leonardo A/G-2482-2012; Azevedo, Vasco/B-1556-2019; Oliveira, Sergio Costa/AAG-5408-2021; Azevedo, Vasco A.C/F-4315-2011; Faria, Ana Maria/AAK-8688-2021; Corsetti, Patrícia Paiva/A-5748-2019; Carvalho, Natalia/H-3977-2015; Teixeira, Henrique C/R-2133-2019; Gomes, Teane Milagres Augusto/AAP-2686-2021	de Almeida, Leonardo A/0000-0003-1886-5080; Azevedo, Vasco/0000-0002-4775-2280; Oliveira, Sergio Costa/0000-0003-4062-5577; Azevedo, Vasco A.C/0000-0002-4775-2280; Corsetti, Patrícia Paiva/0000-0002-7037-4484; Carvalho, Natalia/0000-0003-2586-7877; Teixeira, Henrique C/0000-0002-0172-9720; Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Faria, Ana Maria/0000-0002-0604-8510	CNPq; CNPq/CONICET; FAPEMIG; FAPEMIG/CNPq (PRONEX); CAPES/PNPD; CNPq/MAPA; CNPq/REPENSA; INCT-Vacinas	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/CONICET(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/CNPq (PRONEX); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/MAPA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/REPENSA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-Vacinas	This work was supported by grants from CNPq, CNPq/CONICET, FAPEMIG, FAPEMIG/CNPq (PRONEX), CAPES/PNPD, CNPq/MAPA, CNPq/REPENSA and INCT-Vacinas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranovich I, 1999, INFECT IMMUN, V67, P4418, DOI 10.1128/IAI.67.9.4418-4426.1999; Anitescu M, 1997, J INTERF CYTOK RES, V17, P781, DOI 10.1089/jir.1997.17.781; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Goenka R, 2011, J INFECT DIS, V203, P1136, DOI 10.1093/infdis/jiq171; Gomes MTR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00130; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; Hunter CA, 1997, J IMMUNOL, V158, P3311; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; MOVAT HZ, 1987, FASEB J, V46, P97; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rasouli M, 2013, CYTOKINE, V61, P297, DOI 10.1016/j.cyto.2012.10.012; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shimmi O, 2013, J BIOCH; SVETIC A, 1993, INT IMMUNOL, V5, P877, DOI 10.1093/intimm/5.8.877; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454; ZHAN YF, 1993, INFECT IMMUN, V61, P4899, DOI 10.1128/IAI.61.11.4899-4901.1993	35	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74729	10.1371/journal.pone.0074729	http://dx.doi.org/10.1371/journal.pone.0074729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069337	gold, Green Submitted, Green Published			2022-12-25	WOS:000324547300054
J	Hu, ZY; Kong, F; Si, MF; Tian, KL; Yu, LX; Young, CYF; Yuan, HQ; Lou, HX				Hu, Zhongyi; Kong, Feng; Si, Manfei; Tian, Keli; Yu, Lin Xi; Young, Charles Y. F.; Yuan, Huiqing; Lou, Hongxiang			Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DEPENDENT MANNER; BREAK REPAIR; CHECKPOINT; ATR; POISONS; MITOXANTRONE; PREDNISONE; MECHANISMS; DOCETAXEL	We recently reported that Riccardin D (RD) was able to induce apoptosis by targeting Topo II. Here, we found that RD induced cell cycle arrest in G2/M phase in PC-3 cells, and caused remarkable DNA damage as evidenced by induction of gamma H2AX foci, micronuclei, and DNA fragmentation in Comet assay. Time kinetic and dose-dependent studies showed that ATM/Chk2 and ATR/Chk1 signaling pathways were sequentially activated in response to RD. Blockage of ATM/ATR signaling led to the attenuation of RD-induced gamma H2AX, and to the partial recovery of cell proliferation. Furthermore, RD exposure resulted in the inactivation of BRCA1, suppression of HR and NHEJ repair activity, and downregulation of the expressions and DNA-end binding activities of Ku70/86. Consistent with the observations, microarray data displayed that RD triggered the changes in genes responsible for cell proliferation, cell cycle, DNA damage and repair, and apoptosis. Administration of RD to xenograft mice reduced tumor growth, and coordinately caused alterations in the expression of genes involved in DNA damage and repair, along with cell apoptosis. Thus, this finding identified a novel mechanism by which RD affects DNA repair and acts as a DNA damage agent in prostate cancer.	[Hu, Zhongyi; Kong, Feng; Si, Manfei; Tian, Keli; Yu, Lin Xi; Yuan, Huiqing] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China; [Hu, Zhongyi; Lou, Hongxiang] Shandong Univ, Sch Pharmaceut Sci, Dept Nat Prod Chem, Jinan 250100, Peoples R China; [Yu, Lin Xi] Univ Toronto, Dept Human Biol, Toronto, ON M5S 1A1, Canada; [Young, Charles Y. F.] Mayo Clin, Mayo Clin Coll Med, Dept Urol, Rochester, MN USA	Shandong University; Shandong University; University of Toronto; Mayo Clinic	Yuan, HQ (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China.	lyuanhq@sdu.edu.cn; louhongxiang@sdu.edu.cn	hu, zhongyi/E-6103-2015	Hu, Zhongyi/0000-0002-9249-9720	National Natural Science Foundation of China [30772594, 30973551, 30925038]; Natural Science Foundation of Shandong Province [2009ZRB01346]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (30772594, 30973551, 30925038) and the Natural Science Foundation of Shandong Province (2009ZRB01346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2001, CANCER RES, V61, P4112; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Fleck O, 2004, J CELL SCI, V117, P515, DOI 10.1242/jcs.00952; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu YG, 2012, MUTAT RES-FUND MOL M, V731, P140, DOI 10.1016/j.mrfmmm.2011.12.003; Lu ZQ, 2006, J ASIAN NAT PROD RES, V8, P187, DOI 10.1080/1028602042000325537; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Singh RP, 2002, CELL CYCLE, V1, P156, DOI 10.4161/cc.1.3.117; Siu WY, 2004, MOL CANCER THER, V3, P621; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Xue X, 2012, LUNG CANCER, V76, P300, DOI 10.1016/j.lungcan.2011.12.013; Xue X, 2012, INVEST NEW DRUG, V30, P212, DOI 10.1007/s10637-010-9554-8; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	34	5	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74387	10.1371/journal.pone.0074387	http://dx.doi.org/10.1371/journal.pone.0074387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069304	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300038
J	Rai, S; Bhaskar; Goel, SK; Dwivedi, UN; Sundar, S; Goyal, N				Rai, Smita; Bhaskar; Goel, Sudhir K.; Dwivedi, Upendra Nath; Sundar, Shyam; Goyal, Neena			Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GENE-EXPRESSION ANALYSIS; INCREASED TRYPANOTHIONE LEVELS; AQUAGLYCEROPORIN AQP1 GENE; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; DRUG-RESISTANCE; PENTAVALENT ANTIMONY; PHOSPHOLIPID TRAFFICKING; ORNITHINE-DECARBOXYLASE	Background: In view of the recent upsurge in the phenomenon of therapeutic failure, drug resistance in Leishmania, developed under natural field conditions, has become a great concern yet little understood. Accordingly, the study of determinants of antimony resistance is urgently warranted. Efflux transporters have been reported in Leishmania but their role in clinical resistance is still unknown. The present study was designed to elucidate the mechanism of natural antimony resistance in L. donovani field isolates by analyzing the functionality of efflux pump(s) and expression profiles of known genes involved in transport and thiol based redox metabolism Methodology/Principal Findings: We selected 7 clinical isolates (2 sensitive and 5 resistant) in addition to laboratory sensitive reference and SbIII resistant mutant strains for the present study. Functional characterization using flow cytometry identified efflux pumps that transported substrates of both P-gp and MRPA and were inhibited by the calmodulin antagonist trifluoperazine. For the first time, verapamil sensitive efflux pumps for rhodamine 123 were observed in L. donovani that were differentially active in resistant isolates. RT-PCR confirmed the overexpression of MRPA in isolates with high resistance index only. Resistant isolates also exhibited consistent down regulation of AQP1 and elevated intracellular thiol levels which were accompanied with increased expression of ODC and TR genes. Interestingly, gamma-GCS is not implicated in clinical resistance in L. donovani isolates. Conclusions/Significance: Here we demonstrate for the first time, the role of P-gp type plasma membrane efflux transporter(s) in antimony resistance in L. donovani field isolates. Further, decreased levels of AQP1 and elevated thiols levels have emerged as biomarkers for clinical resistance.	[Rai, Smita; Bhaskar; Goyal, Neena] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India; [Goel, Sudhir K.] All India Inst Med Sci, Dept Biochem, Bhopal, India; [Dwivedi, Upendra Nath] Univ Lucknow, Dept Biochem, Lucknow 226007, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); All India Institute of Medical Sciences (AIIMS) Bhopal; Lucknow University; Banaras Hindu University (BHU)	Goyal, N (corresponding author), CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India.	neenacdri@yahoo.com	Dwivedi, Upendra/AAM-7657-2021	Dwivedi, Upendra/0000-0002-4053-2795; , Bhaskar/0000-0002-5055-121X	Department of Science and technology, India [SR/SO/BB-037/2009]; Department of Biotechnology, India [BT/PR2792/Med/14/383/2001]; ICMR	Department of Science and technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); ICMR(Indian Council of Medical Research (ICMR))	The work is supported by Department of Science and technology, India (SR/SO/BB-037/2009) and Department of Biotechnology, India (BT/PR2792/Med/14/383/2001) grants. ICMR is gratefully acknowledged for financial support to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo M G, 2003, East Mediterr Health J, V9, P837; Adaui V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001021; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; [Anonymous], 1990, World Health Organ Tech Rep Ser, V793, P1; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Basselin M, 2002, ANTIMICROB AGENTS CH, V46, P3731, DOI 10.1128/AAC.46.12.3731-3738.2002; Benerjee C, 1999, CA CALMODULIN DEPEND, V118, P567; Chiquero MJ, 1998, BIOCHEM PHARMACOL, V55, P131, DOI 10.1016/S0006-2952(97)00385-7; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; CHOW LMC, 1993, MOL BIOCHEM PARASIT, V60, P195, DOI 10.1016/0166-6851(93)90131-G; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Coelho AC, 2003, MOL BIOCHEM PARASIT, V130, P83, DOI 10.1016/S0166-6851(03)00162-2; COHEN BE, 1986, BIOCHIM BIOPHYS ACTA, V860, P57, DOI 10.1016/0005-2736(86)90498-0; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Decuypere S, 2008, PARASITOLOGY, V135, P183, DOI 10.1017/S0031182007003782; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; Essodaigui M, 1999, MOL BIOCHEM PARASIT, V100, P73, DOI 10.1016/S0166-6851(99)00036-5; Ferreira CD, 2003, BIOMETALS, V16, P441, DOI 10.1023/A:1022823605068; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Grondin K, 1997, EMBO J, V16, P3057, DOI 10.1093/emboj/16.11.3057; Gueiros FJ, 1995, EXP PARASITOL, V81, P480, DOI 10.1006/expr.1995.1141; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; Hamilton CJ, 2003, BIOCHEM J, V369, P529, DOI 10.1042/BJ20021298; HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855; Hendricks O, 2003, INT J ANTIMICROB AG, V22, P262, DOI 10.1016/S0924-8579(03)00205-X; Hidaka H, 1998, Tanpakushitsu Kakusan Koso, V43, P1732; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Katakura K, 1999, BIOCHEM BIOPH RES CO, V255, P289, DOI 10.1006/bbrc.1999.0209; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Leprohon P, 2009, ANTIMICROB AGENTS CH, V53, P2646, DOI 10.1128/AAC.01474-08; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizumi K, 2006, BIOCHIM BIOPHYS ACTA, V1978, P738; Maharjan M, 2008, AM J TROP MED HYG, V79, P69, DOI 10.4269/ajtmh.2008.79.69; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Mary C, 2010, Int J Microbiol, V2010, DOI 10.1155/2010/819060; Messaritakis I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065467; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Molnar J, 1997, ANTICANCER RES, V17, P481; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Mukherjee A, 2006, MOL BIOCHEM PARASIT, V145, P1, DOI 10.1016/j.molbiopara.2005.08.016; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; NEAL RA, 1989, T ROY SOC TROP MED H, V83, P197, DOI 10.1016/0035-9203(89)90642-1; Ouellette M, 1998, DRUG RESIST UPDATE, V1, P43, DOI 10.1016/S1368-7646(98)80213-6; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; POOT M, 1991, CYTOMETRY, V12, P184, DOI 10.1002/cyto.990120214; Prasad V, 2000, PARASITOL RES, V86, P661, DOI 10.1007/PL00008548; Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371; SANCHEZ A, 1994, BIOCHEM BIOPH RES CO, V199, P855, DOI 10.1006/bbrc.1994.1307; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Sinha S, 2011, BIOINFORMATION, V6, P107, DOI 10.6026/97320630006107; Sodre CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P85, DOI 10.1006/abbi.2000.1899; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Torres DC, 2010, INFECT GENET EVOL, V10, P727, DOI 10.1016/j.meegid.2010.05.006; URBINA JA, 1988, MOL BIOCHEM PARASIT, V30, P185, DOI 10.1016/0166-6851(88)90111-9; Valiathan R, 2006, EXP PARASITOL, V114, P103, DOI 10.1016/j.exppara.2006.02.015; WHO, 2006, CONTR LEISHM; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Yan SC, 2003, CHEM COMMUN, P266, DOI 10.1039/b210240d; Yan SC, 2003, J BIOL INORG CHEM, V8, P689, DOI 10.1007/s00775-003-0468-1; Yardley V, 2006, J INFECT DIS, V194, P1168, DOI 10.1086/507710	85	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74862	10.1371/journal.pone.0074862	http://dx.doi.org/10.1371/journal.pone.0074862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069359	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300062
J	Heuss, SF; Tarantino, N; Fantini, J; Ndiaye-Lobry, D; Moretti, J; Israel, A; Logeat, F				Heuss, Sara Farrah; Tarantino, Nadine; Fantini, Jacques; Ndiaye-Lobry, Delphine; Moretti, Julien; Israel, Alain; Logeat, Frederique			A Glycosphingolipid Binding Domain Controls Trafficking and Activity of the Mammalian Notch Ligand Delta-Like 1	PLOS ONE			English	Article							LIPID RAFTS; CELL FATE; CHOLESTEROL; RECEPTOR; PATHWAY; INTERNALIZATION; DEPLETION; AUXILIN; ADAM10	The activity of Notch ligands is tightly regulated by trafficking events occurring both before and after ligand-receptor interaction. In particular endocytosis and recycling have been shown to be required for full signaling activity of the ligands before they encounter the Notch receptor. However little is known about the precise endocytic processes that contribute to ligand internalization. Here we demonstrate that endocytosis contributes to Dll1 signaling activity by preserving the ligand from shedding and degradation. We further show that the glycosphingolipid-binding motif originally identified in Drosophila Notch ligands is conserved in mammals and is necessary for Dll1 internalization. Mutation of its conserved tryptophan residue results in a Dll1 molecule which is rapidly inactivated by shedding and degradation, does not recycle to the cell surface and does not activate Notch signaling. Finally, silencing in the signal-sending cells of glucosylceramide synthase, the enzyme implicated in the initial phase of glycosphingolipid synthesis, down-regulates Notch activation. Our data indicate that glycosphingolipids, by interacting with Dll1, may act as functional co-factors to promote its biological activity.	[Heuss, Sara Farrah; Tarantino, Nadine; Ndiaye-Lobry, Delphine; Moretti, Julien; Israel, Alain; Logeat, Frederique] Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France; [Fantini, Jacques] Univ Aix Marseille, Fac Sci St Jerome, CNRS, Lab Interact Mol & Syst Membranaires,UMR 6231, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Israel, A (corresponding author), Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	aisrael@pasteur.fr		Fantini, Jacques/0000-0001-8653-5521; Moretti, Julien/0000-0002-3415-9058	Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer; European Community (Rubicon FP6 Network of Excellence)	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); European Community (Rubicon FP6 Network of Excellence)	SFH received a doctoral fellowship from Ligue Nationale Contre le Cancer and Association pour la Recherche sur le Cancer. This work was supported in part by a grant from the European Community (Rubicon FP6 Network of Excellence) to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Banks SML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018259; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Eun SH, 2008, DEVELOPMENT, V135, P1089, DOI 10.1242/dev.009530; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Gil C, 2007, FEBS LETT, V581, P1851, DOI 10.1016/j.febslet.2007.03.080; Gonzalez-Gaitan M, 2008, DEV CELL, V15, P172, DOI 10.1016/j.devcel.2008.07.001; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hamel S, 2010, J CELL BIOL, V188, P581, DOI 10.1083/jcb.200907116; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Katic I, 2005, GENETICS, V171, P1605, DOI 10.1534/genetics.105.048041; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74392	10.1371/journal.pone.0074392	http://dx.doi.org/10.1371/journal.pone.0074392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069306	gold, Green Published, Green Submitted			2022-12-25	WOS:000326240100104
J	Bonsor, DA; Weiss, E; Iosub-Amir, A; Reingewertz, TH; Chen, TW; Haas, R; Friedler, A; Fischer, W; Sundberg, EJ				Bonsor, Daniel A.; Weiss, Evelyn; Iosub-Amir, Anat; Reingewertz, Tali H.; Chen, Tiffany W.; Haas, Rainer; Friedler, Assaf; Fischer, Wolfgang; Sundberg, Eric J.			Characterization of the Translocation-competent Complex between the Helicobacter pylori Oncogenic Protein CagA and the Accessory Protein CagF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Helicobacter pylori; Protein Secretion; Protein Translocation; Protein-Protein Interactions; CagA; CagF; Type IV Secretion System	IV SECRETION; PATHOGENICITY ISLAND; SECONDARY STRUCTURE; AGROBACTERIUM-TUMEFACIENS; HOST; SIGNAL; CELLS; ONCOPROTEIN; INDUCTION; DIVERSITY	Background: Translocation of the H. pylori oncogenic protein CagA into host cells is dependent on CagF. Results: CagF interacts with all five domains of CagA. Conclusion: CagF protects CagA from degradation such that it can be recognized by the type IV secretion system. Significance: The CagA-CagF interaction is distributed across their molecular surfaces to provide protection to the highly labile effector protein. CagA is a virulence factor that Helicobacter pylori inject into gastric epithelial cells through a type IV secretion system where it can cause gastric adenocarcinoma. Translocation is dependent on the presence of secretion signals found in both the N- and C-terminal domains of CagA and an interaction with the accessory protein CagF. However, the molecular basis of this essential protein-protein interaction is not fully understood. Herein we report, using isothermal titration calorimetry, that CagA forms a 1:1 complex with a monomer of CagF with nm affinity. Peptide arrays and isothermal titration calorimetry both show that CagF binds to all five domains of CagA, each with m affinity. More specifically, a coiled coil domain and a C-terminal helix within CagF contacts domains II-III and domain IV of CagA, respectively. In vivo complementation assays of H. pylori with a double mutant, L36A/I39A, in the coiled coil region of CagF showed a severe weakening of the CagA-CagF interaction to such an extent that it was nearly undetectable. However, it had no apparent effect on CagA translocation. Deletion of the C-terminal helix of CagF also weakened the interaction with CagA but likewise had no effect on translocation. These results indicate that the CagA-CagF interface is distributed broadly across the molecular surfaces of these two proteins to provide maximal protection of the highly labile effector protein CagA.	[Bonsor, Daniel A.; Reingewertz, Tali H.; Sundberg, Eric J.] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Dept Med, Sch Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Weiss, Evelyn; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst, D-80336 Munich, Germany; [Iosub-Amir, Anat; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Chen, Tiffany W.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Haas, Rainer] Univ Munich, German Ctr Infect Res, D-80539 Munich, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Munich; Hebrew University of Jerusalem; Boston Biomedical Research Institute; German Center for Infection Research; University of Munich	Sundberg, EJ (corresponding author), Univ Maryland, Inst Human Virol, Sch Med, 725 West Lombard St, Baltimore, MD 21201 USA.	ESundberg@ihv.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033; Chen, Tiffany/0000-0001-6926-0482	Alexander von Humboldt Foundation; Fulbright scholarship; International Sephardic Education Foundation fellowship; European Research Council under the European Community's Seventh Framework Programme [203413]; Israel Cancer Association	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fulbright scholarship; International Sephardic Education Foundation fellowship; European Research Council under the European Community's Seventh Framework Programme(European Commission); Israel Cancer Association	This work was supported in part by an Alexander von Humboldt Foundation experienced researcher fellowship (to E. J. S.) as well as a Fulbright scholarship and International Sephardic Education Foundation fellowship (to T. H. R.).; Supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/European Research Council Grant Agreement 203413 and by the Israel Cancer Association.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Angelini A, 2009, FEBS J, V276, P816, DOI 10.1111/j.1742-4658.2008.06826.x; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; BLASER MJ, 1995, CANCER RES, V55, P2111; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Couturier MR, 2006, INFECT IMMUN, V74, P273, DOI 10.1128/IAI.74.1.273-281.2006; Fattori J, 2011, PROTEIN PEPTIDE LETT, V18, P158, DOI 10.2174/092986611794475048; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Frenkiel-Krispin D, 2007, J BIOL CHEM, V282, P3458, DOI 10.1074/jbc.M605270200; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Ishikawa S, 2009, FEBS LETT, V583, P2414, DOI 10.1016/j.febslet.2009.06.043; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Moese S, 2001, PROTEOMICS, V1, P618, DOI 10.1002/1615-9861(200104)1:4<618::AID-PROT618>3.0.CO;2-C; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	40	19	20	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32897	32909		10.1074/jbc.M113.507657	http://dx.doi.org/10.1074/jbc.M113.507657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072713	Green Published, hybrid			2022-12-25	WOS:000328841700008
J	Lemaitre, C; Mahjoub-Messai, F; Dupont, D; Caro, V; Diancourt, L; Bingen, E; Bidet, P; Bonacorsi, S				Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Caro, Valerie; Diancourt, Laure; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane			A Conserved Virulence Plasmidic Region Contributes to the Virulence of the Multiresistant Escherichia coli Meningitis Strain S286 Belonging to Phylogenetic Group C	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; NEONATAL MENINGITIS; PATHOGENICITY ISLAND; CHI-7122 O78K80H9; BETA-LACTAMASE; YOUNG INFANTS; AVIAN ORIGIN; DNA-SEQUENCE; IDENTIFICATION; UROSEPSIS	Recent isolation of the non-K1 Escherichia coli neonatal meningitis strain S286, belonging to phylogroup C, which is closely related to major group B1, and producing an extended-spectrum beta-lactamase, encouraged us to seek the genetic determinants responsible for its virulence. We show that S286 belongs to the sequence O type ST23(O78) and harbors 4 large plasmids. The largest one, pS286colV (similar to 120 kb), not related to resistance, contains genes characteristic of a Conserved Virulence Plasmidic (CVP) region initially identified in B2 extra-intestinal avian pathogenic E. coli (APEC) strains and in the B2 neonatal meningitis E. coli strain S88. The sequence of this CVP region has a strong homology (98%) with that of the recently sequenced plasmid pChi7122-1 of the O78 APEC strain Chi7122. A CVP plasmid-cured variant of S286 was less virulent than the wild type strain in a neonatal rat sepsis model with a significant lower level of bacteremia at 24 h (4.1 +/- 1.41 versus 2.60 +/- 0.16 log CFU/ml, p = 0.001) and mortality. However, the mortality in the model of adult mice was comparable between wild type and variant indicating that pS286colV is not sufficient by itself to fully explain the virulence of S286. Gene expression analysis of pS286colV in iron depleted environment was very close to that of pS88, suggesting that genes of CVP region may be expressed similarly in two very different genetic backgrounds (group C versus group B2). Screening a collection of 178 human A/B1 extraintestinal pathogenic E. coli (ExPEC) strains revealed that the CVP region is highly prevalent (23%) and MLST analysis indicated that these CVP positive strains belong to several clusters and mostly to phylogroup C. The virulence of S286 is explained in part by the presence of CVP region and this region has spread in different clusters of human A/B1 ExPEC, especially in group C.	[Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Equipe Ccueil EA3105, Paris, France; [Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane] Hop Robert Debre, AP HP, Microbiol Lab, F-75019 Paris, France; [Caro, Valerie; Diancourt, Laure] Inst Pasteur, Genotyping Pathogens & Publ Hlth, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bonacorsi, S (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Equipe Ccueil EA3105, Paris, France.	stephane.bonacorsi@rdb.aphp.fr	Bonacorsi, Stéphane/HGB-3185-2022		Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by the "Fondation pour la Recherche Medicale" for CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bidet P, 2007, J INFECT DIS, V196, P297, DOI 10.1086/518897; Bingen-Bidois M, 2002, INFECT IMMUN, V70, P3216, DOI 10.1128/IAI.70.6.3216-3226.2002; Bonacorsi S, 2005, J UROLOGY, V173, P195, DOI 10.1097/01.ju.0000148606.07267.7d; Bonacorsi S, 2003, J INFECT DIS, V187, P1895, DOI 10.1086/375347; Bonacorsi S, 2009, INT J MED MICROBIOL, V299, P402, DOI 10.1016/j.ijmm.2009.04.001; BORTOLUSSI R, 1978, INFECT IMMUN, V22, P480, DOI 10.1128/IAI.22.2.480-485.1978; Christenson JK, 2009, MICROBIOL-SGM, V155, P1645, DOI 10.1099/mic.0.026666-0; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Dissanayake DRA, 2008, VET MICROBIOL, V132, P355, DOI 10.1016/j.vetmic.2008.05.024; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Grimaldi D, 2010, J CLIN MICROBIOL, V48, P3794, DOI 10.1128/JCM.00491-10; Hacker J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P321, DOI 10.1556/AMicr.50.2003.4.1; Houdouin V, 2008, ARCH PEDIATRIE, V15, pS138, DOI 10.1016/S0929-693X(08)75497-6; Houdouin V, 2002, INFECT IMMUN, V70, P5865, DOI 10.1128/IAI.70.10.5865-5869.2002; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jeziorowski A, 2007, J BACTERIOL, V189, P7045, DOI 10.1128/JB.00243-07; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; JOHNSON JR, 1988, INFECT IMMUN, V56, P405, DOI 10.1128/IAI.56.2.405-412.1988; Johnson JR, 2005, J INFECT DIS, V191, P46, DOI 10.1086/426450; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LASSITER HA, 1992, J INFECT DIS, V166, P53, DOI 10.1093/infdis/166.1.53; Lassiter HA, 1997, PEDIATR RES, V42, P128, DOI 10.1203/00006450-199707000-00020; Lemaitre C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-115; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Liu B, 2010, VET MICROBIOL, V142, P373, DOI 10.1016/j.vetmic.2009.10.019; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Mahjoub-Messai F, 2011, J INFECT DIS, V203, P1844, DOI 10.1093/infdis/jir189; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Morales Cesar, 2004, Foodborne Pathog Dis, V1, P160; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V25, P25; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Negre VL, 2004, INFECT IMMUN, V72, P1216, DOI 10.1128/IAI.72.2.1216-1220.2004; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Olesen B, 2012, J CLIN MICROBIOL, V50, P3703, DOI 10.1128/JCM.01909-12; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Ruppe E, 2006, J CLIN MICROBIOL, V44, P4204, DOI 10.1128/JCM.00918-06; Russo TA, 1999, INFECT IMMUN, V67, P5306, DOI 10.1128/IAI.67.10.5306-5314.1999; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tivendale KA, 2010, INFECT IMMUN; Tivendale KA, 2009, MICROBIOL-SGM, V155, P450, DOI 10.1099/mic.0.023143-0; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406	67	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74423	10.1371/journal.pone.0074423	http://dx.doi.org/10.1371/journal.pone.0074423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086343	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000009
J	Havermans, C; Sonet, G; d'Acoz, CD; Nagy, ZT; Martin, P; Brix, S; Riehl, T; Agrawal, S; Held, C				Havermans, Charlotte; Sonet, Gontran; d'Acoz, Cedric d'Udekem; Nagy, Zoltan T.; Martin, Patrick; Brix, Saskia; Riehl, Torben; Agrawal, Shobhit; Held, Christoph			Genetic and Morphological Divergences in the Cosmopolitan Deep-Sea Amphipod Eurythenes gryllus Reveal a Diverse Abyss and a Bipolar Species	PLOS ONE			English	Article							NECROPHAGOUS AMPHIPOD; SCAVENGING AMPHIPODS; POPULATION-STRUCTURE; VERTICAL-DISTRIBUTION; BATHYMETRIC PATTERNS; MITOCHONDRIAL-DNA; CRUSTACEA; DIFFERENTIATION; RATES; BIODIVERSITY	Eurythenes gryllus is one of the most widespread amphipod species, occurring in every ocean with a depth range covering the bathyal, abyssal and hadal zones. Previous studies, however, indicated the existence of several genetically and morphologically divergent lineages, questioning the assumption of its cosmopolitan and eurybathic distribution. For the first time, its genetic diversity was explored at the global scale (Arctic, Atlantic, Pacific and Southern oceans) by analyzing nuclear (28S rDNA) and mitochondrial (COI, 16S rDNA) sequence data using various species delimitation methods in a phylogeographic context. Nine putative species-level clades were identified within E. gryllus. A clear distinction was observed between samples collected at bathyal versus abyssal depths, with a genetic break occurring around 3,000 m. Two bathyal and two abyssal lineages showed a widespread distribution, while five other abyssal lineages each seemed to be restricted to a single ocean basin. The observed higher diversity in the abyss compared to the bathyal zone stands in contrast to the depth-differentiation hypothesis. Our results indicate that, despite the more uniform environment of the abyss and its presumed lack of obvious isolating barriers, abyssal populations might be more likely to show population differentiation and undergo speciation events than previously assumed. Potential factors influencing species' origins and distributions, such as hydrostatic pressure, are discussed. In addition, morphological findings coincided with the molecular clades. Of all specimens available for examination, those of the bipolar bathyal clade seemed the most similar to the 'true' E. gryllus. We present the first molecular evidence for a bipolar distribution in a macro-benthic deep-sea organism.	[Havermans, Charlotte; Martin, Patrick] Royal Belgian Inst Nat Sci, Direct Nat Environm, Brussels, Belgium; [Sonet, Gontran; d'Acoz, Cedric d'Udekem; Nagy, Zoltan T.; Martin, Patrick] Royal Belgian Inst Nat Sci, Direct Taxon & Phylogeny, Brussels, Belgium; [Havermans, Charlotte] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-3000 Louvain, Belgium; [Brix, Saskia; Riehl, Torben] Bioctr Grindel, Senckenberg Res Inst, Ctr Marine Biodivers Res, Hamburg, Germany; [Agrawal, Shobhit; Held, Christoph] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Sect Funct Ecol, Bremerhaven, Germany	Royal Belgian Institute of Natural Sciences; Royal Belgian Institute of Natural Sciences; Universite Catholique Louvain; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Hamburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Havermans, C (corresponding author), Royal Belgian Inst Nat Sci, Direct Nat Environm, Brussels, Belgium.	chavermans@naturalsciences.be	Martin, Patrick/V-9708-2019; Nagy, Zoltan T./C-6737-2011; Riehl, Torben/C-3711-2013	Martin, Patrick/0000-0002-6033-8412; Nagy, Zoltan T./0000-0002-8455-040X; Riehl, Torben/0000-0002-7363-4421; Havermans, Charlotte/0000-0002-1126-4074	Belgian Science Policy Office and Scientific Research Program on Antarctica; project BIANZO II; Belgian Science Policy Office [WI/36/H04, MO/36/022]; Antarctic Science Bursary; DFG [HE 3391/5-1, SPP 1158]	Belgian Science Policy Office and Scientific Research Program on Antarctica; project BIANZO II; Belgian Science Policy Office(Belgian Federal Science Policy Office); Antarctic Science Bursary; DFG(German Research Foundation (DFG))	This work was supported by the Belgian Science Policy Office and Scientific Research Program on Antarctica, with the project BIANZO II. The first author was supported by an Action II grant (contract number WI/36/H04) and CUA by an Action I grant (contract number MO/36/022) of the Belgian Science Policy Office. GS and ZTN are part of the Joint Experimental Molecular Unit, also supported by the Belgian Science Policy Office. Part of the molecular work was funded by an Antarctic Science Bursary to the first author. SA and C Held were supported by the DFG grant HE 3391/5-1 within the SPP 1158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Samples were collected during the expeditions ANDEEP I, II, III, ANT-XIII-8, ANT XXVII-3, ARK XIX-3 aboard RV Polarstern, the expedition DIVA-3 aboard RV Meteor and a cruise aboard RV Jan Mayen.	ALTABET MA, 1991, NATURE, V354, P136, DOI 10.1038/354136a0; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Barnard J. L., 1961, Galathea Report, V5, P23; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Blankenship LE, 2006, DEEP-SEA RES PT I, V53, P48, DOI 10.1016/j.dsr.2005.09.006; Blankenship LE, 2007, LIMNOL OCEANOGR, V52, P1685, DOI 10.4319/lo.2007.52.4.1685; BOWMAN T E, 1972, Crustaceana (Leiden), V23, P187, DOI 10.1163/156854072X00363; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Brandt A, 2012, POL POLAR RES, V33, P139, DOI 10.2478/v10183-012-0012-5; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Brix Saskia, 2011, Zootaxa, V2838, P79; BROWN A, 2012, BIOGEOSCIENCES DISCU, V9, pC1; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; BUCKLIN A, 1987, DEEP-SEA RES, V34, P1795, DOI 10.1016/0198-0149(87)90054-9; CHRISTIANSEN B, 1990, MAR ECOL PROG SER, V66, P35, DOI 10.3354/meps066035; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; CORFIELD R, 2003, SILENT LANDSCAPE SCI; CRAME JA, 1993, J BIOGEOGR, V20, P145, DOI 10.2307/2845668; DUFFY GA, 2012, BIOGEOSCIENCES DISCU, V9, P7831; Escobar-Briones E, 2010, REV MEX BIODIVERS, V81, pS177; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Etter RJ, 1999, DEEP-SEA RES PT I, V46, P1095, DOI 10.1016/S0967-0637(98)00100-9; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P304; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; FRANCE SC, 1994, MAR BIOL, V118, P67, DOI 10.1007/BF00699220; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; HARGRAVE BT, 1985, DEEP-SEA RES, V32, P443, DOI 10.1016/0198-0149(85)90090-1; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Havermans C, 2010, MOL PHYLOGENET EVOL, V55, P202, DOI 10.1016/j.ympev.2009.10.025; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Howell KL, 2004, MAR BIOL, V144, P977, DOI 10.1007/s00227-003-1248-8; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; INGRAM CL, 1987, DEEP-SEA RES, V34, P1889, DOI 10.1016/0198-0149(87)90090-2; INGRAM CL, 1983, DEEP-SEA RES, V30, P683, DOI 10.1016/0198-0149(83)90017-1; Jamieson AJ, 2011, DEEP-SEA RES PT I, V58, P49, DOI 10.1016/j.dsr.2010.11.003; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Katho K., 2002, NUCLEIC ACIDS RES, V30, P3059, DOI [DOI 10.1093/NAR/GKF436, 10.1093/nar/gkf436]; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2001, MAR ECOL PROG SER, V217, P135, DOI 10.3354/meps217135; Kuklinski P, 2010, MAR ECOL PROG SER, V401, P15, DOI 10.3354/meps08446; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; Lorz AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032365; Madsen F. J., 1961, Galathea Report, V4, P177; MANTYLA AW, 1983, DEEP-SEA RES, V30, P805, DOI 10.1016/0198-0149(83)90002-X; Menzel L, 2011, DEEP-SEA RES PT I, V58, P839, DOI 10.1016/j.dsr.2011.05.008; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; PATERSON GLJ, 1995, DEEP-SEA RES PT I, V42, P1199, DOI 10.1016/0967-0637(95)00041-4; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; Pawlowski J, 2008, POLAR BIOL, V31, P1205, DOI 10.1007/s00300-008-0459-3; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Premke K, 2009, VIE MILIEU, V59, P251; Premke K, 2003, J EXP MAR BIOL ECOL, V285, P283, DOI 10.1016/S0022-0981(02)00533-6; Premke K, 2006, MAR ECOL PROG SER, V325, P121, DOI 10.3354/meps325121; Quattro JM, 2001, MAR BIOL, V139, P1107; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Rex M.A., 1983, DEEP SEA BIOL SEA, V8, P453; REX MA, 2010, DEEP SEA BIODIVERSIT, P199; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schuller M, 2011, POLAR BIOL, V34, P549, DOI 10.1007/s00300-010-0913-x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Senna Andre R., 2009, Nauplius, V17, P81; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SMITH KL, 1984, DEEP-SEA RES, V31, P1179, DOI 10.1016/0198-0149(84)90057-8; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Takeuchi I, 1998, MAR ECOL PROG SER, V163, P285, DOI 10.3354/meps163285; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thoen HH, 2011, POLAR BIOL, V34, P83, DOI 10.1007/s00300-010-0861-5; Thurston MH, 2002, J MAR BIOL ASSOC UK, V82, P205, DOI 10.1017/S0025315402005374; Uriz MJ, 2011, POLAR BIOL, V34, P243, DOI 10.1007/s00300-010-0876-y; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	83	107	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74218	10.1371/journal.pone.0074218	http://dx.doi.org/10.1371/journal.pone.0074218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086322	Green Published, gold			2022-12-25	WOS:000325218700018
J	Balasubramaniam, VRMT; Wai, TH; Tejo, BA; Omar, AR; Hassan, SS				Balasubramaniam, Vinod R. M. T.; Wai, Tham Hong; Tejo, Bimo Ario; Omar, Abdul Rahman; Hassan, Sharifah Syed			Highly Pathogenic Avian Influenza Virus Nucleoprotein Interacts with TREX Complex Adaptor Protein Aly/REF	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; CAENORHABDITIS-ELEGANS; ORF57 PROTEIN; BINDING; UAP56; IDENTIFICATION; TRANSCRIPTION; ACCUMULATION; REPLICATION	We constructed a novel chicken (Gallus gallus) lung cDNA library fused inside yeast acting domain vector (pGADT7). Using yeast two-hybrid screening with highly pathogenic avian influenza (HPAI) nucleoprotein (NP) from the strain (A/chicken/Malaysia/5858/2004(H5N1)) as bait, and the Gallus gallus lung cDNA library as prey, a novel interaction between the Gallus gallus cellular RNA export adaptor protein Aly/REF and the viral NP was identified. This interaction was confirmed and validated with mammalian two hybrid studies and co-immunoprecipitation assay. Cellular localization studies using confocal microscopy showed that NP and Aly/REF co-localize primarily in the nucleus. Further investigations by mammalian two hybrid studies into the binding of NP of other subtypes of influenza virus such as the swine A/New Jersey/1976/H1N1 and pandemic A/Malaysia/854/2009(H1N1) to human Aly/REF, also showed that the NP of these viruses interacts with human Aly/REF. Our findings are also supported by docking studies which showed tight and favorable binding between H5N1 NP and human Aly/REF, using crystal structures from Protein Data Bank. siRNA knockdown of Aly/REF had little effect on the export of HPAI NP and other viral RNA as it showed no significant reduction in virus titer. However, UAP56, another component of the TREX complex, which recruits Aly/REF to mRNA was found to interact even better with H5N1 NP through molecular docking studies. Both these proteins also co-localizes in the nucleus at early infection similar to Aly/REF. Intriguingly, knockdown of UAP56 in A549 infected cells shows significant reduction in viral titer (close to 10 fold reduction). Conclusively, our study have opened new avenues for research of other cellular RNA export adaptors crucial in aiding viral RNA export such as the SRSF3, 9G8 and ASF/SF2 that may play role in influenza virus RNA nucleocytoplasmic transport.	[Balasubramaniam, Vinod R. M. T.; Wai, Tham Hong; Hassan, Sharifah Syed] Monash Univ, Sch Med & Hlth Sci, Infect Dis Lab MR3, Virus Host Interact Grp, Selangor, Malaysia; [Tejo, Bimo Ario] Univ Putra Malaysia UPM Serdang, Fac Sci, Dept Chem, Selangor, Malaysia; [Omar, Abdul Rahman] Univ Putra Malaysia UPM Serdang, Inst Biosci, Selangor, Malaysia	Monash University; Monash University Sunway; Universiti Putra Malaysia; Universiti Putra Malaysia	Hassan, SS (corresponding author), Monash Univ, Sch Med & Hlth Sci, Infect Dis Lab MR3, Virus Host Interact Grp, Sunway Campus, Selangor, Malaysia.	sharifah.syedhassan@med.monash.edu.my	Tejo, Bimo A/I-2929-2012; RMT Balasubramaniam, Vinod/B-6957-2017	Tejo, Bimo A/0000-0002-2890-0938; RMT Balasubramaniam, Vinod/0000-0001-9583-307X	Ministry of Science, Technology and Innovation [MED2009-INI(GG)-001-SH, 5140028-000-00]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The source of the funding is Ministry of Science, Technology and Innovation, Project No: MED2009-INI(GG)-001-SH Grant No: 5140028-000-00.	Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; DAVEY J, 1985, CELL, V40, P667, DOI 10.1016/0092-8674(85)90215-6; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Li DJ, 2012, J VIROL, V86, P9866, DOI 10.1128/JVI.01190-12; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ohno M, 2002, MOL CELL, V9, P659, DOI 10.1016/S1097-2765(02)00454-9; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	33	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e72429	10.1371/journal.pone.0072429	http://dx.doi.org/10.1371/journal.pone.0072429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073193	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324768000002
J	Clayson, PE; Larson, MJ				Clayson, Peter E.; Larson, Michael J.			Adaptation to Emotional Conflict: Evidence from a Novel Face Emotion Paradigm	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEPTH-RECORDED POTENTIALS; EVENT-RELATED POTENTIALS; WORD FORM AREA; COGNITIVE CONTROL; GENERALIZED ANXIETY; SPATIOTEMPORAL STAGES; IMPLICIT REGULATION; RESOLVE CONFLICT; ANGRY FACES	The preponderance of research on trial-by-trial recruitment of affective control (e.g., conflict adaptation) relies on stimuli wherein lexical word information conflicts with facial affective stimulus properties (e.g., the face-Stroop paradigm where an emotional word is overlaid on a facial expression). Several studies, however, indicate different neural time course and properties for processing of affective lexical stimuli versus affective facial stimuli. The current investigation used a novel task to examine control processes implemented following conflicting emotional stimuli with conflict-inducing affective face stimuli in the absence of affective words. Forty-one individuals completed a task wherein the affective-valence of the eyes and mouth were either congruent (happy eyes, happy mouth) or incongruent (happy eyes, angry mouth) while high-density event-related potentials (ERPs) were recorded. There was a significant congruency effect and significant conflict adaptation effects for error rates. Although response times (RTs) showed a significant congruency effect, the effect of previous-trial congruency on current-trial RTs was only present for current congruent trials. Temporospatial principal components analysis showed a P3-like ERP source localized using FieldTrip software to the medial cingulate gyrus that was smaller on incongruent than congruent trials and was significantly influenced by the recruitment of control processes following previous-trial emotional conflict (i.e., there was significant conflict adaptation in the ERPs). Results show that a face-only paradigm may be sufficient to elicit emotional conflict and suggest a system for rapidly detecting conflicting emotional stimuli and subsequently adjusting control resources, similar to cognitive conflict detection processes, when using conflicting facial expressions without words.	[Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Clayson, Peter E.; Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	University of California System; University of California Los Angeles; Brigham Young University; Brigham Young University	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012; Clayson, Peter E/AAC-9207-2019	Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065; Clayson, Peter E/0000-0003-4437-6598	Brigham Young University College of Family, Home, and Social Sciences	Brigham Young University College of Family, Home, and Social Sciences	Funding for this study was provided by the Brigham Young University College of Family, Home, and Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dichter GS, 2010, SCHIZOPHRENIA BULL, V36, P595, DOI 10.1093/schbul/sbn118; Dien J, 2006, BRAIN LANG, V97, P91, DOI 10.1016/j.bandl.2005.08.002; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; Dien J., 2005, EVENT RELATED POTENT; Dien J, 2007, HUM BRAIN MAPP, V28, P742, DOI 10.1002/hbm.20304; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Dien J, 2010, PSYCHOPHYSIOLOGY, V47, P170, DOI 10.1111/j.1469-8986.2009.00885.x; Dien J, 2009, NEUROPSYCHOLOGIA, V47, P1, DOI 10.1016/j.neuropsychologia.2008.08.024; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Ernst M, 2010, AM J PSYCHIAT, V167, P489, DOI 10.1176/appi.ajp.2010.10010234; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Hofstetter C, 2012, NEUROIMAGE, V60, P1734, DOI 10.1016/j.neuroimage.2012.01.110; Isaac L, 2012, BRAIN BEHAV, V2, P74, DOI 10.1002/brb3.38; Jackson MC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00437; Jarcho JM, 2013, BIOL PSYCHOL, V92, P306, DOI 10.1016/j.biopsycho.2012.09.008; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keselman HJ, 2003, PSYCHOPHYSIOLOGY, V40, P586, DOI 10.1111/1469-8986.00060; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Lutkenhoner B, 1998, ELECTROEN CLIN NEURO, V106, P314, DOI 10.1016/S0013-4694(97)00140-5; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ovaysikia S, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00234; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Raccuglia RA, 1997, BRIT J PSYCHOL, V88, P93, DOI 10.1111/j.2044-8295.1997.tb02623.x; Reeck C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00232; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Young AW, 2002, FACIAL EXPRESSIONS E; ZHANG LJ, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0051110.PUBMED:23227242; Zhu XR, 2010, NEUROSCI LETT, V478, P1, DOI 10.1016/j.neulet.2010.04.036	66	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75776	10.1371/journal.pone.0075776	http://dx.doi.org/10.1371/journal.pone.0075776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073278	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000088
J	Dumez, ME; Herman, J; Campisi, V; Bouaziz, A; Rosu, F; Luxen, A; Vandenberghe, I; de Pauw, E; Frere, JM; Matagne, A; Chevigne, A; Galleni, M				Dumez, Marie-Eve; Herman, Julie; Campisi, Vincenzo; Bouaziz, Ahlem; Rosu, Frederic; Luxen, Andre; Vandenberghe, Isabel; de Pauw, Edwin; Frere, Jean-Marie; Matagne, Andre; Chevigne, Andy; Galleni, Moreno			The Proline-Rich Motif of the proDer p 3 Allergen Propeptide Is Crucial for Protease-Protease Interaction	PLOS ONE			English	Article							DUST-MITE ALLERGEN; ZYMOGEN ACTIVATION; INTRAMOLECULAR CHAPERONE; ACTIVE-SITE; TRYPSIN; RECOMBINANT; IGE; SUBTILISIN; PEPTIDES; GLYCOSYLATION	The majority of proteases are synthesized in an inactive form, termed zymogen, which consists of a propeptide and a protease domain. The propeptide is commonly involved in the correct folding and specific inhibition of the enzyme. The propeptide of the house dust mite allergen Der p 3, NPILPASPNAT, contains a proline-rich motif (PRM), which is unusual for a trypsin-like protease. By truncating the propeptide or replacing one or all of the prolines in the non-glycosylated zymogen with alanine(s), we demonstrated that the full-length propeptide is not required for correct folding and thermal stability and that the PRM is important for the resistance of proDer p 3 to undesired proteolysis when the protein is expressed in Pichia pastoris. Additionally, we followed the maturation time course of proDer p 3 by coupling a quenched-flow assay to mass spectrometry analysis. This approach allowed to monitor the evolution of the different species and to determine the steady-state kinetic parameters for activation of the zymogen by the major allergen Der p 1. This experiment demonstrated that prolines 5 and 8 are crucial for proDer p 3-Der p 1 interaction and for activation of the zymogen.	[Dumez, Marie-Eve; Herman, Julie; Campisi, Vincenzo; Bouaziz, Ahlem; Frere, Jean-Marie; Chevigne, Andy; Galleni, Moreno] Univ Liege, Ctr Prot Engn, Liege, Belgium; [Campisi, Vincenzo; Chevigne, Andy] Ctr Rech Publ Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Rosu, Frederic; de Pauw, Edwin] Univ Liege, GIGA R, LSM, Liege, Belgium; [Luxen, Andre] Univ Liege, Ctr Rech Cyclotron, Liege, Belgium; [Vandenberghe, Isabel] Lab Prot Biochem & Prot Engn, Ghent, Belgium; [Frere, Jean-Marie; Matagne, Andre] Univ Liege, Ctr Prot Engn, Lab Enzymol & Repliement Prot, Liege, Belgium	University of Liege; Luxembourg Institute of Health; University of Liege; University of Liege; University of Liege	Galleni, M (corresponding author), Univ Liege, Ctr Prot Engn, Liege, Belgium.	mgalleni@ulg.ac.be	Rosu, Frédéric/E-6403-2011	Rosu, Frédéric/0000-0003-3674-7539; De Pauw, Edwin/0000-0003-3475-1315; Chevigne, Andy/0000-0003-4768-6743; Matagne, Andre/0000-0001-6417-6791	Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Fondamentale et Collective [2.4.511.06, 2.4561.07, 2.4.548.10]; Interuniversity Attraction Pole (IAP) [P6/19]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium); FRIA (Brussels, Belgium); F.R.S.-FNRS (Brussels, Belgium); "Centre de Recherche Public-Sante'', Luxembourg [20100708]	Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole (IAP)(Belgian Federal Science Policy Office); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); F.R.S.-FNRS (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); "Centre de Recherche Public-Sante'', Luxembourg	This work was supported by the Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Fondamentale et Collective (2.4.511.06, 2.4561.07, 2.4.548.10), and Interuniversity Attraction Pole (IAP) P6/19. MED was supported by the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium). JH and VC are supported by the FRIA (Brussels, Belgium). FR is supported by F.R.S.-FNRS (Brussels, Belgium). AC was an Aspirant of the F.R.S.-FNRS (Brussels, Belgium) and is now supported by the "Centre de Recherche Public-Sante'', Luxembourg (grant 20100708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jeffrey, 2009, V189, P85; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Borgono CA, 2004, MOL CANCER RES, V2, P257; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Cheong N, 2003, ALLERGY, V58, P352, DOI 10.1034/j.1398-9995.2003.00033.x; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; Chevigne A, 2010, BBA-GEN SUBJECTS, V1800, P937, DOI 10.1016/j.bbagen.2010.05.011; CHUA KY, 1992, J ALLERGY CLIN IMMUN, V89, P95, DOI 10.1016/S0091-6749(05)80045-4; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Dumez ME, 2008, J BIOL CHEM, V283, P30606, DOI 10.1074/jbc.M803041200; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; GREENE WK, 1991, J IMMUNOL, V147, P3768; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Harris J, 2004, CHEM BIOL, V11, P1361, DOI 10.1016/j.chembiol.2004.08.008; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HIGAKI JN, 1989, BIOCHEMISTRY-US, V28, P9256, DOI 10.1021/bi00450a004; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jacquet A, 2011, INT ARCH ALLERGY IMM, V155, P95, DOI 10.1159/000320375; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Ohshima Y, 2008, J BIOSCI BIOENG, V106, P345, DOI 10.1263/jbb.106.345; Potter PC, 2009, WORLD ALLERGY ORGAN, V2, P150, DOI 10.1097/WOX.0b013e3181b055f3; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Reshetniak Ia K, 1997, BIOFIZIKA, V42, P785; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOBIE G, 1994, BIOCHEM SOC T, V22, pS448, DOI 10.1042/bst022448s; Shakib F, 2002, EUROPEAN RESP MONOGR, P153; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Takai T, 2006, INT ARCH ALLERGY IMM, V139, P181, DOI 10.1159/000091163; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; VASQUEZ JR, 1989, J CELL BIOCHEM, V39, P265, DOI 10.1002/jcb.240390306; Vliagoftis Harissios, 2008, Inflammation & Allergy Drug Targets, V7, P288, DOI 10.2174/187152808786848379; Wan H, 2001, CLIN EXP ALLERGY, V31, P279, DOI 10.1046/j.1365-2222.2001.00970.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3	46	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e68014	10.1371/journal.pone.0068014	http://dx.doi.org/10.1371/journal.pone.0068014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073192	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000001
J	Horwood, C; Butler, LM; Haskins, L; Phakathi, S; Rollins, N				Horwood, Christiane; Butler, Lisa M.; Haskins, Lyn; Phakathi, Sifiso; Rollins, Nigel			HIV-Infected Adolescent Mothers and Their Infants: Low Coverage of HIV Services and High Risk of HIV Transmission in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							PREGNANCY; WOMEN; AGE	Objectives: Rates of pregnancy and HIV infection are high among South African adolescents, yet little is known about rates of mother-to-child transmission of HIV (MTCT) in this group. We report a comparison of the characteristics of adolescent mothers and adult mothers, including HIV prevalence and MTCT rates. Methods: We examined patterns of health service utilization during the antenatal and early postnatal period, HIV prevalence and MTCT amongst adolescent (<20-years-old) and adult (20 to 39-years-old) mothers with infants aged <= 16 weeks attending immunization clinics in six districts of KwaZulu-Natal between May 2008 and April 2009. Findings: Interviews were conducted with 19,093 mothers aged between 12 and 39 years whose infants were aged <= 16 weeks. Most mothers had attended antenatal care four or more times during their last pregnancy (80.3%), and reported having an HIV test (98.2%). A greater proportion of HIV-infected adult mothers, compared to adolescent mothers, reported themselves as HIV-positive (41.2% vs. 15.9%, p<0.0001), reported having a CD4 count taken during their pregnancy (81.0% vs. 66.5%, p<0.0001), and having received the CD4 count result (84.4% vs. 75.7%, p<0.0001). Significantly fewer adolescent mothers received the recommended PMTCT regimen. HIV antibody was detected in 40.4% of 7,800 infants aged 4-8 weeks tested for HIV, indicating HIV exposure. This was higher among infants of adult mothers (47.4%) compared to adolescent mothers (17.9%, p<0.0001). The MTCT rate at 4-8 weeks of age was significantly higher amongst infants of adolescent mothers compared to adult mothers (35/325 [10.8%] vs. 185/2,800 [6.1%], OR 1.7, 95% CI 1.2-2.4). Conclusion: Despite high levels of antenatal clinic attendance among pregnant adolescents in KwaZulu-Natal, the MTCT risk is higher among infants of HIV-infected adolescent mothers compared to adult mothers. Access to adolescent-friendly family planning and PMTCT services should be prioritised for this vulnerable group.	[Horwood, Christiane; Haskins, Lyn; Phakathi, Sifiso] Univ KwaZulu Natal, Ctr Rural Hlth, Durban, Kwazulu Natal, South Africa; [Butler, Lisa M.] Univ Calif San Francisco, Dept Epidemiol & Biostat & Global Hlth Sci, San Francisco, CA 94143 USA; [Rollins, Nigel] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rollins, Nigel] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of California System; University of California San Francisco; World Health Organization; University of Kwazulu Natal	Horwood, C (corresponding author), Univ KwaZulu Natal, Ctr Rural Hlth, Durban, Kwazulu Natal, South Africa.	horwoodc@ukzn.ac.za	Horwood, Christiane Marianne/GRF-4446-2022	Horwood, Christiane Marianne/0000-0003-4395-1423	Global Fund to Fight AIDS, Tuberculosis and Malaria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Global Fund to Fight AIDS, Tuberculosis and Malaria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All funding for the study was provided by the Global Fund to Fight AIDS, Tuberculosis and Malaria. (http://www.theglobalfund.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Horwood C, 2012, B WORLD HEALTH ORGAN, V90, P168, DOI 10.2471/BLT.11.092056; Jewkes R, 2012, SOC SCI MED, V74, P1729, DOI 10.1016/j.socscimed.2011.05.020; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; Jewkes R, 2009, CULT HEALTH SEX, V11, P675, DOI 10.1080/13691050902846452; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Moultrie TA, 2007, SAMJ S AFR MED J, V97, P442; Panday S., 2009, TEENAGE PREGNANCY S; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; SA Department of Health Medical Research Council, 2007, S AFR DEM HLTH SURV; Steffenson AE, 2011, SEX TRANSM DIS, V38, P459, DOI 10.1097/OLQ.0b013e3182080860; United Nations General Assembly, 2000, UN MILL DECL; United Nations secretary-general BK-M, 2010, GLOB STRAT WOM CHILD; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	14	43	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74568	10.1371/journal.pone.0074568	http://dx.doi.org/10.1371/journal.pone.0074568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073215	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000024
J	Breiderhoff, T; Christiansen, GB; Pallesen, LT; Vaegter, C; Nykjaer, A; Holm, MM; Glerup, S; Willnow, TE				Breiderhoff, Tilman; Christiansen, Gitte B.; Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Holm, Mai Marie; Glerup, Simon; Willnow, Thomas E.			Sortilin-Related Receptor SORCS3 Is a Postsynaptic Modulator of Synaptic Depression and Fear Extinction	PLOS ONE			English	Article							LONG-TERM DEPRESSION; AMYLOID PRECURSOR PROTEIN; AMPA RECEPTORS; PDZ DOMAIN; PICK1; HIPPOCAMPUS; CA1; IDENTIFICATION; PLASTICITY; DELETION	SORCS3 is an orphan receptor of the VPS10P domain receptor family, a group of sorting and signaling receptors central to many pathways in control of neuronal viability and function. SORCS3 is highly expressed in the CA1 region of the hippocampus, but the relevance of this receptor for hippocampal activity remained absolutely unclear. Here, we show that SORCS3 localizes to the postsynaptic density and that loss of receptor activity in gene-targeted mice abrogates NMDA receptor-dependent and -independent forms of long-term depression (LTD). Consistent with a loss of synaptic retraction, SORCS3-deficient mice suffer from deficits in behavioral activities associated with hippocampal LTD, particularly from an accelerated extinction of fear memory. A possible molecular mechanism for SORCS3 in synaptic depression was suggested by targeted proteomics approaches that identified the ability of SORCS3 to functionally interact with PICK1, an adaptor that sorts glutamate receptors at the postsynapse. Faulty localization of PICK1 in SORCS3-deficient neurons argues for altered glutamate receptor trafficking as the cause of altered synaptic plasticity in the SORCS3-deficient mouse model. In conclusion, our studies have identified a novel function for VPS10P domain receptors in control of synaptic depression and suggest SORCS3 as a novel factor modulating aversive memory extinction.	[Breiderhoff, Tilman; Willnow, Thomas E.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Christiansen, Gitte B.; Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Holm, Mai Marie; Glerup, Simon] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Glerup, Simon] Aarhus Univ, Lundbeck Fdn Res Ctr MIND, Aarhus, Denmark; [Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Glerup, Simon] Aarhus Univ, Danish Res Inst Translat Neurosci, Aarhus, Denmark	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Aarhus University; Aarhus University; Lundbeckfonden; Aarhus University	Willnow, TE (corresponding author), Max Delbrueck Ctr Mol Med, Berlin, Germany.	willnow@mdcberlin.de	Breiderhoff, Tilman/X-9364-2019; Vægter, Christian Bjerggaard/AFW-0912-2022	Breiderhoff, Tilman/0000-0002-1676-7498; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Holm, Mai/0000-0001-7347-8724	Lundbeck Foundation; German Research Foundation; Helmholtz Association of German Research Centers (iCEMED); Lundbeck Foundation [R77-2010-6802] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); German Research Foundation(German Research Foundation (DFG)); Helmholtz Association of German Research Centers (iCEMED); Lundbeck Foundation(Lundbeckfonden)	Funding was provided by the Lundbeck Foundation, the German Research Foundation, and the Helmholtz Association of German Research Centers (iCEMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bajor LA, 2013, J AFFECT DISORDERS, V145, P232, DOI 10.1016/j.jad.2012.08.005; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Ryu J, 2008, J NEUROSCI, V28, P8178, DOI 10.1523/JNEUROSCI.1944-08.2008; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takahashi T, 1998, J NEUROSCI, V18, P3138; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	46	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75006	10.1371/journal.pone.0075006	http://dx.doi.org/10.1371/journal.pone.0075006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069373	Green Published, gold, Green Accepted			2022-12-25	WOS:000324777300060
J	Mizuno, CM; Kimes, NE; Lopez-Perez, M; Auso, E; Rodriguez-Valera, F; Ghai, R				Megumi Mizuno, Carolina; Kimes, Nikole E.; Lopez-Perez, Mario; Auso, Eva; Rodriguez-Valera, Francisco; Ghai, Rohit			A Hybrid NRPS-PKS Gene Cluster Related to the Bleomycin Family of Antitumor Antibiotics in Alteromonas macleodii Strains	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; STREPTOMYCES-VERTICILLUS ATCC15003; POLYKETIDE SYNTHASE; NATURAL-PRODUCTS; TYROCIDINE SYNTHETASE; PHYLOGENETIC ANALYSES; CONDENSATION DOMAINS; SEQUENCE-ANALYSIS; ORGANIC-MATTER; BIOSYNTHESIS	Although numerous marine bacteria are known to produce antibiotics via hybrid NRPS-PKS gene clusters, none have been previously described in an Alteromonas species. In this study, we describe in detail a novel hybrid NRPS-PKS cluster identified in the plasmid of the Alteromonas macleodii strain AltDE1 and analyze its relatedness to other similar gene clusters in a sequence-based characterization. This is a mobile cluster, flanked by transposase-like genes, that has even been found inserted into the chromosome of some Alteromonas macleodii strains. The cluster contains separate genes for NRPS and PKS activity. The sole PKS gene appears to carry a novel acyltransferase domain, quite divergent from those currently characterized. The predicted specificities of the adenylation domains of the NRPS genes suggest that the final compound has a backbone very similar to bleomycin related compounds. However, the lack of genes involved in sugar biosynthesis indicates that the final product is not a glycopeptide. Even in the absence of these genes, the presence of the cluster appears to confer complete or partial resistance to phleomycin, which may be attributed to a bleomycin-resistance-like protein identified within the cluster. This also suggests that the compound still shares significant structural similarity to bleomycin. Moreover, transcriptomic evidence indicates that the NRPS-PKS cluster is expressed. Such sequence-based approaches will be crucial to fully explore and analyze the diversity and potential of secondary metabolite production, especially from increasingly important sources like marine microbes.	[Megumi Mizuno, Carolina; Kimes, Nikole E.; Lopez-Perez, Mario; Auso, Eva; Rodriguez-Valera, Francisco; Ghai, Rohit] Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain	Universidad Miguel Hernandez de Elche	Rodriguez-Valera, F (corresponding author), Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain.	frvalera@umh.es	Mizuno, Carolina Megumi/G-8246-2012; Eva, Ausó/AAD-8448-2022; Auso-Monreal, Eva/J-3264-2017; Rodriguez-Valera, Francisco/M-2782-2013; López-Pérez, Mario/ABG-1904-2020; Ghai, Rohit/E-7086-2012	Mizuno, Carolina Megumi/0000-0001-8016-7561; Auso-Monreal, Eva/0000-0003-2991-7659; Rodriguez-Valera, Francisco/0000-0002-9809-2059; López-Pérez, Mario/0000-0002-3996-6780; Ghai, Rohit/0000-0002-0591-6152	Spanish Ministerio de Ciencia e Innovacion [BIO2008-02444, CDS2009-00006, CGL2009-12651-C02-01]; Generalitat Valenciana [PROMETEO/2010/089, ACOMP/2009/155]; European Community [FP7-KBBE-2012-6-311975]; Juan de la Cierva from Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Community(European Commission); Juan de la Cierva from Spanish Ministerio de Ciencia e Innovacion	This work was supported by projects MAGYK (BIO2008-02444), MICROGEN (Programa CONSOLIDER-INGENIO 2010 CDS2009-00006), and CGL2009-12651-C02-01 from the Spanish Ministerio de Ciencia e Innovacion and by projects DIMEGEN (PROMETEO/2010/089) and ACOMP/2009/155 from the Generalitat Valenciana. FEDER funds and MaCuMBA funds from the European Community (Ref. FP7-KBBE-2012-6-311975) supported this project. R. G. was supported by a Juan de la Cierva scholarship from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; BAUMANN L, 1972, J BACTERIOL, V110, P402, DOI 10.1128/JB.110.1.402-429.1972; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1452, DOI 10.1271/bbb.120102; Clugston SL, 2003, BIOCHEMISTRY-US, V42, P12095, DOI 10.1021/bi035090+; Devi CS, 2011, J PHARM RES, V4; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fewer DP, 2011, APPL ENVIRON MICROB, V77, P8034, DOI 10.1128/AEM.05993-11; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fukuda D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018031; Galm U, 2011, J NAT PROD, V74, P526, DOI 10.1021/np1008152; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Garcia I, 2012, CHEM BIOL, V19, P399, DOI 10.1016/j.chembiol.2012.01.014; Garcia-Martinez J, 2002, ENVIRON MICROBIOL, V4, P42, DOI 10.1046/j.1462-2920.2002.00255.x; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Gonzaga A, 2012, GENOME BIOL EVOL, V4, P1360, DOI 10.1093/gbe/evs112; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Hoffmann D, 2003, GENE, V311, P171, DOI 10.1016/S0378-1119(03)00587-0; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BK, 2008, J MICROBIOL, V46, P274, DOI 10.1007/s12275-007-0238-9; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lopez-Perez M, 2013, GENOME BIOL IN PRESS, DOI [10.1093/gbe/evt1089, DOI 10.1093/GBE/EVT1089]; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Luo LS, 2002, BIOCHEMISTRY-US, V41, P9184, DOI 10.1021/bi026047+; MAEDA K, 1956, J ANTIBIOT, V9, P82; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Martens T, 2007, MICROB ECOL, V54, P31, DOI 10.1007/s00248-006-9165-2; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Murphy AC, 2011, ANGEW CHEM INT EDIT, V50, P3271, DOI 10.1002/anie.201007029; Olano C, 2009, MAR DRUGS, V7, P210, DOI 10.3390/md7020210; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sass AM, 2001, APPL ENVIRON MICROB, V67, P5392, DOI 10.1128/AEM.67.12.5392-5402.2001; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Tomprefa N, 2011, BIOCONTROL SCI TECHN, V21, P721, DOI 10.1080/09583157.2011.575211; Uzair B, 2012, SCI WORLD J, V10; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Wietz M, 2011, ENV MICROBIOL REP, V3, P559, DOI 10.1111/j.1758-2229.2011.00259.x; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351; Zhang JH, 1997, APPL ENVIRON MICROB, V63, P2771, DOI 10.1128/AEM.63.7.2771-2778.1997; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu P, 2009, CAN J MICROBIOL, V55, P219, DOI [10.1139/W08-125, 10.1139/w08-125]; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	67	19	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76021	10.1371/journal.pone.0076021	http://dx.doi.org/10.1371/journal.pone.0076021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069455	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300102
J	Yang, S; Kuang, Y; Li, HB; Liu, YH; Hui, XY; Li, P; Jiang, ZW; Zhou, YL; Wang, Y; Xu, AM; Li, SW; Liu, PT; Wu, DH				Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Hui, Xiaoyan; Li, Peng; Jiang, Zhiwu; Zhou, Yulai; Wang, Yu; Xu, Aimin; Li, Shiwu; Liu, Pentao; Wu, Donghai			Enhanced Production of Recombinant Secretory Proteins in Pichia pastoris by Optimizing Kex2 P1' site	PLOS ONE			English	Article							STEM-CELL FACTOR; C-KIT; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SPECIFICITY; PROTEASE; LIGAND; OVEREXPRESSION; ENDOPROTEASE; SELECTION	Pichia pastoris is one of the most widely used expression systems for the production of recombinant secretory proteins. Its universal application is, however, somewhat hampered by its unpredictable yields for different heterologous proteins, which is now believed to be caused in part by their varied efficiencies to traffic through the host secretion machinery. The yeast endoprotease Kex2 removes the signal peptides from pre-proteins and releases the mature form of secreted proteins, thus, plays a pivotal role in the yeast secretory pathways. In this study, we found that the yields of many recombinant proteins were greatly influenced by Kex2 P1' site residues and the optimized P1's amino acid residue could largely determine the final amount of secretory proteins synthesized and secreted. A further improvement of secretory yield was achieved by genomic integration of additional Kex2 copies, which again highlighted the importance of Kex2 cleavage to the production of recombinant secretory proteins in Pichia yeast.	[Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Li, Peng; Jiang, Zhiwu; Wang, Yu; Xu, Aimin; Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Li, Peng; Jiang, Zhiwu; Wang, Yu; Xu, Aimin; Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Kuang, Ye; Liu, Yuehong; Zhou, Yulai] Jilin Univ, Sch Pharmaceut Sci, Dept Biomed Engn, Changchun 130023, Peoples R China; [Li, Hongbo] Huaihua Coll, Dept Life Sci, Key Lab Res & Utilizat Ethnomed Plant Resources H, Huaihua, Peoples R China; [Hui, Xiaoyan; Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Shiwu] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Jilin University; Huaihua University; University of Hong Kong; State University System of Florida; University of Florida; Wellcome Trust Sanger Institute	Wu, DH (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	dhwu2001@gmail.com	Li, Peng/AER-7520-2022; HUI, Xiaoyan Hannah/M-5175-2019	HUI, Xiaoyan Hannah/0000-0002-7525-5812; Jiang, Zhiwu/0000-0002-9359-7779; wang, yu/0000-0001-8697-2940	National Basic Research Program of China [2011CB504004, 2010CB945500]; Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences [XDA01020303]; Science and Technology Planning Project of Guangdong Province [2011A060901019]	National Basic Research Program of China(National Basic Research Program of China); Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences; Science and Technology Planning Project of Guangdong Province	This work was supported in part by funds from the National Basic Research Program of China (2011CB504004 and 2010CB945500), the Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences (XDA01020303) and Science and Technology Planning Project of Guangdong Province (2011A060901019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM H, 1992, BLOOD, V79, P365; Bader O, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-116; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Bevan A, 1998, P NATL ACAD SCI USA, V95, P10384, DOI 10.1073/pnas.95.18.10384; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cos O, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-17; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; GERMAIN D, 1992, EUR J BIOCHEM, V204, P121, DOI 10.1111/j.1432-1033.1992.tb16613.x; Goodman M, 2009, NAT REV DRUG DISCOV, V8, P837, DOI 10.1038/nrd3040; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Inan M, 2006, BIOTECHNOL BIOENG, V93, P771, DOI 10.1002/bit.20762; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kliman RM, 2003, J MOL EVOL, V57, P98, DOI 10.1007/s00239-003-2459-9; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Love KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037915; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; MEKORI YA, 1995, INT ARCH ALLERGY IMM, V107, P136, DOI 10.1159/000236955; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Resina D, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-21; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Rockwell NC, 1997, BIOCHEMISTRY-US, V36, P1912, DOI 10.1021/bi961779l; Rockwell NC, 2004, TRENDS BIOCHEM SCI, V29, P80, DOI 10.1016/j.tibs.2003.12.006; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; ROMANOS M, 1995, CURR OPIN BIOTECH, V6, P527, DOI 10.1016/0958-1669(95)80087-5; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rosenfeld SA, 1999, METHOD ENZYMOL, V306, P154; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Sheridan C, 2010, NAT BIOTECHNOL, V28, P307, DOI 10.1038/nbt0410-307; Stadheim TA, 2008, NAT PROTOC, V3, P1026, DOI 10.1038/nprot.2008.76; Stadlmayr G, 2010, BIOTECHNOL BIOENG, V105, P543, DOI 10.1002/bit.22573; Sumi A, 1999, BIOSEPARATION, V8, P195, DOI 10.1023/A:1008081314112; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	54	41	43	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75347	10.1371/journal.pone.0075347	http://dx.doi.org/10.1371/journal.pone.0075347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069404	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300073
J	Zhu, R; Wang, SC; Sun, C; Tao, Y; Piao, HL; Wang, XQ; Du, MR; Li, DJ				Zhu, Rui; Wang, Song-Cun; Sun, Chan; Tao, Yu; Piao, Hai-Lan; Wang, Xiao-Qiu; Du, Mei-Rong; Li, Da-Jin			Hyaluronan-CD44 Interaction Promotes Growth of Decidual Stromal Cells in Human First-Trimester Pregnancy	PLOS ONE			English	Article							T-CELLS; EXTRACELLULAR-MATRIX; TH2 BIAS; EXPRESSION; CD44; IMPLANTATION; INTERFACE; INFLAMMATION; TROPHOBLASTS; MAINTENANCE	Hyaluronan (HA) and its receptor CD44 are expressed at the maternal-fetal interface, but its role in early pregnancy remains unclear. Here, we found that primary decidual stromal cells (DSCs) continuously secreted HA and expressed its receptor CD44. Pregnancy-associated hormones up-regulated HA synthetase (HAS) 2 transcription and HA release from DSCs. High molecular weight-HA (HMW-HA), but not medium molecular weight (MMW-HA) or low molecular weight (LMW-HA), promoted proliferation and inhibited apoptosis of DSCs in a CD44-dependent manner. The in-cell Western analysis revealed HMW-HA activated PI3K/AKT and mitogen-activated protein kinase (MAPK)/ERK1/2 signaling pathways time-dependently. Blocking these pathways by specific inhibitor LY294002 or U0126 abrogated HMW-HA-regulated DSc proliferation and apoptosis. Finally, we have found that HA content, HA molecular weight, HAS2 mRNA level, and CD44 expression were significantly decreased in DSCs from unexplained miscarriage compared with the normal pregnancy. Collectively, our results indicate that higher level and greater molecular mass of HA at maternal-fetal interface contributes to DSc growth and maintenance of DSCs in human early pregnancy.	[Zhu, Rui; Wang, Song-Cun; Sun, Chan; Tao, Yu; Piao, Hai-Lan; Wang, Xiao-Qiu; Du, Mei-Rong; Li, Da-Jin] Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol,IBS, Shanghai 200433, Peoples R China; [Zhu, Rui] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Peoples R China	Fudan University; Soochow University - China	Du, MR (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol,IBS, Shanghai 200433, Peoples R China.	dmrlq1973@sina.cn; djli@shmu.edu.cn			Key Project of Shanghai Basic Research [12JC1401600]; Shanghai Shenkang Foundation [SHDC12010122]; Shanghai PuJiang Talent Program [10PJ1401600]; National Nature Science Foundation of China [NSFC30910103909, NSFC31270969, NSFC81070537, NSFC31171437]; Natural Science Research Program for Colleges and Universities of Jiangsu Province [10KJB320021]	Key Project of Shanghai Basic Research; Shanghai Shenkang Foundation; Shanghai PuJiang Talent Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research Program for Colleges and Universities of Jiangsu Province	This work was supported by the Key Project of Shanghai Basic Research [12JC1401600 to D-JL]; Shanghai Shenkang Foundation [SHDC12010122 to D-JL]; Shanghai PuJiang Talent Program [10PJ1401600 to M-RD]; and National Nature Science Foundation of China [NSFC30910103909 and NSFC31270969 to D-JL, NSFC81070537 and NSFC31171437 to M-RD]; and the Natural Science Research Program for Colleges and Universities of Jiangsu Province [10KJB320021 to RZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz L, 2006, GLYCOBIOLOGY, V16, P359, DOI 10.1093/glycob/cwj085; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419; Chang CC, 2012, CARBOHYD POLYM, V90, P1168, DOI 10.1016/j.carbpol.2012.06.071; Cordo-Russo R, 2009, PLACENTA, V30, P88, DOI 10.1016/j.placenta.2008.10.013; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Du MR, 2012, HUM REPROD, V27, P1955, DOI 10.1093/humrep/des111; Egorina EM, 2006, J THROMB HAEMOST, V4, P614, DOI 10.1111/j.1538-7836.2005.01781.x; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Goshen R, 1996, MOL HUM REPROD, V2, P685, DOI 10.1093/molehr/2.9.685; Guo PF, 2010, BLOOD, V116, P2061, DOI 10.1182/blood-2009-11-252940; Hambiliki F, 2010, FERTIL STERIL, V94, P1669, DOI 10.1016/j.fertnstert.2009.10.019; Hao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040716; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jung T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208421; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Lockwood CJ, 2009, REPROD SCI, V16, P162, DOI 10.1177/1933719108325758; Marzioni D, 2001, EUR J HISTOCHEM, V45, P131; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nakagawa K, 2012, J ASSIST REPROD GEN, V29, P679, DOI 10.1007/s10815-012-9758-2; Olivares EG, 1997, BIOL REPROD, V57, P609, DOI 10.1095/biolreprod57.3.609; Patriarca MT, 2013, MENOPAUSE, V20, P336, DOI [10.1097/GME.0b013e318269898c, 10.1097/gme.0b013e318269898c]; Piao HL, 2012, CELL MOL IMMUNOL, V9, P423, DOI 10.1038/cmi.2012.23; Ruiz C, 1997, J REPROD IMMUNOL, V33, P15, DOI 10.1016/S0165-0378(96)01009-1; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Silasi M, 2012, AM J REPROD IMMUNOL, V68, P279, DOI 10.1111/aji.12006; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stock AE, 2002, ENDOCRINOLOGY, V143, P4375, DOI 10.1210/en.2002-220563; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Xu BF, 2012, FERTIL STERIL, V98, P389, DOI 10.1016/j.fertnstert.2012.04.032; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308	41	27	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74812	10.1371/journal.pone.0074812	http://dx.doi.org/10.1371/journal.pone.0074812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069351	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300049
J	Yamagishi, N; Anderson, SJ				Yamagishi, Noriko; Anderson, Stephen J.			The Relationship between Self-Awareness of Attentional Status, Behavioral Performance and Oscillatory Brain Rhythms	PLOS ONE			English	Article							CINGULATE MOTOR AREAS; NEURONAL SYNCHRONIZATION; VOLUNTARY MOVEMENT; VISUAL-ATTENTION; NEURAL BASIS; CORTEX; TASK; EEG; GAMMA; DESYNCHRONIZATION	High-level cognitive factors, including self-awareness, are believed to play an important role in human visual perception. The principal aim of this study was to determine whether oscillatory brain rhythms play a role in the neural processes involved in self-monitoring attentional status. To do so we measured cortical activity using magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI) while participants were asked to self-monitor their internal status, only initiating the presentation of a stimulus when they perceived their attentional focus to be maximal. We employed a hierarchical Bayesian method that uses fMRI results as soft-constrained spatial information to solve the MEG inverse problem, allowing us to estimate cortical currents in the order of millimeters and milliseconds. Our results show that, during self-monitoring of internal status, there was a sustained decrease in power within the 7-13 Hz (alpha) range in the rostral cingulate motor area (rCMA) on the human medial wall, beginning approximately 430 msec after the trial start (p < 0.05, FDR corrected). We also show that gamma-band power (41-47 Hz) within this area was positively correlated with task performance from 40-640 msec after the trial start (r = 0.71, p < 0.05). We conclude: (1) the rCMA is involved in processes governing self-monitoring of internal status; and (2) the qualitative differences between alpha and gamma activity are reflective of their different roles in self-monitoring internal states. We suggest that alpha suppression may reflect a strengthening of top-down interareal connections, while a positive correlation between gamma activity and task performance indicates that gamma may play an important role in guiding visuomotor behavior.	[Yamagishi, Noriko] Dept Cognit Neurosci, ATR Cognit Mech Labs, Kyoto, Japan; [Yamagishi, Noriko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yamagishi, Noriko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Brain Networks & Commun Lab, Osaka, Japan; [Anderson, Stephen J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Aston University	Yamagishi, N (corresponding author), Dept Cognit Neurosci, ATR Cognit Mech Labs, Kyoto, Japan.	n.yamagishi@nict.go.jp			JST PRESTO program	JST PRESTO program	This work was supported by the JST PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; de Jong R, 2006, BRAIN RES, V1105, P73, DOI 10.1016/j.brainres.2006.03.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hoshi E, 2005, J NEUROPHYSIOL, V94, P640, DOI 10.1152/jn.01201.2004; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Morgan HM, 2011, J NEUROPHYSIOL, V106, P3185, DOI 10.1152/jn.00246.2011; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pashler HE., 1998, PSYCHOL ATTENTION, DOI [10.7551/mitpress/5677.001.0001, DOI 10.7551/MITPRESS/5677.001.0001]; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Qin PM, 2012, HUM BRAIN MAPP, V33, P154, DOI 10.1002/hbm.21201; Richardson AG, 2008, J NEUROPHYSIOL, V99, P1253, DOI 10.1152/jn.01096.2007; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shaw JC, 2003, BRAINS ALPHA PHYTHMS; Shibata K, 2008, CEREB CORTEX, V18, P1664, DOI 10.1093/cercor/bhm194; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Smith EL, 2008, CURR BIOL, V18, pR414, DOI 10.1016/j.cub.2008.03.009; Szurhaj W, 2003, CLIN NEUROPHYSIOL, V114, P107, DOI 10.1016/S1388-2457(02)00333-4; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0; Yamagishi N, 2005, COGNITIVE BRAIN RES, V25, P799, DOI 10.1016/j.cogbrainres.2005.09.006; Yamagishi N, 2008, BRAIN RES, V1197, P115, DOI 10.1016/j.brainres.2007.12.063; Yamagishi N, 2010, P ROY SOC B-BIOL SCI, V277, P3421, DOI 10.1098/rspb.2010.0891; Yoshioka T, 2008, NEUROIMAGE, V42, P1397, DOI 10.1016/j.neuroimage.2008.06.013	54	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74962	10.1371/journal.pone.0074962	http://dx.doi.org/10.1371/journal.pone.0074962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069368	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324547300066
J	Li, D; Jin, LT; Alesi, GN; Kim, YM; Fan, J; Seo, JH; Wang, DS; Tucker, M; Gu, TL; Lee, BH; Taunton, J; Magliocca, KR; Chen, ZG; Shin, DM; Khuri, FR; Kang, SM				Li, Dan; Jin, Lingtao; Alesi, Gina N.; Kim, Young-Mee; Fan, Jun; Seo, Jae Ho; Wang, Dongsheng; Tucker, Meghan; Gu, Ting-Lei; Lee, Benjamin H.; Taunton, Jack; Magliocca, Kelly R.; Chen, Zhuo G.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin			The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Migration; Metastasis; Serine Threonine Protein Kinase; Signal Transduction; Fascin-1; Ribosomal S6 Kinase 2; cAMP Response Element-binding; Filopodia	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CANCER METASTASIS; CELL INVASION; BETA-CATENIN; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; COLON-CANCER; IN-VITRO; CREB; TARGET	Metastasis is the leading cause of death in patients with breast, lung, and head and neck cancers. However, the molecular mechanisms underlying metastases in these cancers remain unclear. We found that the p90 ribosomal S6 kinase 2 (RSK2)-cAMP response element-binding protein (CREB) pathway is commonly activated in diverse metastatic human cancer cells, leading to up-regulation of a CREB transcription target Fascin-1. We also observed that the protein expression patterns of RSK2 and Fascin-1 correlate in primary human tumor tissue samples from head and neck squamous cell carcinoma patients. Moreover, knockdown of RSK2 disrupts filopodia formation and bundling in highly invasive cancer cells, leading to attenuated cancer cell invasion in vitro and tumor metastasis in vivo, whereas expression of Fascin-1 significantly rescues these phenotypes. Furthermore, targeting RSK2 with the small molecule RSK inhibitor FMK-MEA effectively attenuated the invasive and metastatic potential of cancer cells in vitro and in vivo, respectively. Taken together, our findings for the first time link RSK2-CREB signaling to filopodia formation and bundling through the up-regulation of Fascin-1, providing a proinvasive and prometastatic advantage to human cancers. Therefore, protein effectors of the RSK2-CREB-Fascin-1 pathway represent promising biomarkers and therapeutic targets in the clinical prognosis and treatment of metastatic human cancers.	[Li, Dan; Jin, Lingtao; Alesi, Gina N.; Kim, Young-Mee; Fan, Jun; Seo, Jae Ho; Wang, Dongsheng; Chen, Zhuo G.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin] Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Tucker, Meghan; Gu, Ting-Lei] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Lee, Benjamin H.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Magliocca, Kelly R.] Emory Univ Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Novartis; University of California System; University of California San Francisco; Emory University	Kang, SM (corresponding author), Emory Univ Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	smkang@emory.edu	Shin, Dong Moon/G-9649-2013; Khuri, Fadlo R./AAU-4942-2020; Jin, Lingtao/O-4316-2014	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; 	American Cancer Society [RSG-11-081-01]; National Institutes of Health/NCI SPORE in Head and Neck Cancer Career Development Program Award [P50CA128613]; Robbins Scholar Award; National Institutes of Health [GM071434]; NATIONAL CANCER INSTITUTE [P50CA128613, R01CA175316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health/NCI SPORE in Head and Neck Cancer Career Development Program Award; Robbins Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the American Cancer Society Grant RSG-11-081-01 (to S.K.), the National Institutes of Health/NCI SPORE in Head and Neck Cancer P50CA128613 Career Development Program Award (to S.K.), and a Robbins Scholar Award (to S.K.). M.T. and T.-L.G. are employees of Cell Signaling Technology, Inc. J.T. is as an inventor on a patent application filed by the University of California that describes the RSK inhibitor FMK.; Supported by National Institutes of Health Grant GM071434.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aucoin R, 2004, J CELL BIOCHEM, V93, P215, DOI 10.1002/jcb.20231; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Dimova EY, 2010, ANTIOXID REDOX SIGN, V13, P413, DOI 10.1089/ars.2009.2999; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Elf S, 2011, BLOOD, V117, P6885, DOI 10.1182/blood-2010-10-315721; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gutierrez LS, 2000, CANCER RES, V60, P5839; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; Hayashi Y, 2008, CELL TISSUE RES, V334, P219, DOI 10.1007/s00441-008-0683-8; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Jalvy S, 2007, CIRC RES, V100, P1292, DOI 10.1161/01.RES.0000266609.28312.de; Jiang H, 2012, MOL BIOL REP, V39, P2773, DOI 10.1007/s11033-011-1035-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2011, EXPERT OPIN THER TAR, V15, P11, DOI 10.1517/14728222.2010.531013; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Small J V, 1988, Electron Microsc Rev, V1, P155; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith JA, 2005, CANCER RES, V65, P1027; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837	46	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32528	32538		10.1074/jbc.M113.500561	http://dx.doi.org/10.1074/jbc.M113.500561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085294	Green Published, hybrid			2022-12-25	WOS:000328681700036
J	van Hateren, A; Carter, R; Bailey, A; Kontouli, N; Williams, AP; Kaufman, J; Elliott, T				van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Kaufman, Jim; Elliott, Tim			A Mechanistic Basis for the Co-evolution of Chicken Tapasin and Major Histocompatibility Complex Class I (MHC I) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Evolution; Immunology; Major Histocompatibility Complex (MHC); Protein-Protein Interactions; Chicken MHC; Co-evolution; Peptide Selection; Tapasin	ANTIGEN PRESENTATION; PEPTIDE BINDING; REVEALS POLYMORPHISM; CELL LINE; MOLECULES; SELECTION; TAP; GENES; HETERODIMER; EXPRESSION	Background: Tapasin edits the MHC I peptide repertoire and is highly polymorphic in birds but not mammals. Results: Two chicken MHC I alleles differ in peptide binding properties and participate in an allele-specific interaction with tapasin. Conclusion: Tapasin-MHC alleles have co-evolved by balancing interaction characteristics against MHC peptide-binding ability. Significance: Variations in the functional attributes of tapasin and MHC I alleles determine effective antigen presentation. MHC class I molecules display peptides at the cell surface to cytotoxic T cells. The co-factor tapasin functions to ensure that MHC I becomes loaded with high affinity peptides. In most mammals, the tapasin gene appears to have little sequence diversity and few alleles and is located distal to several classical MHC I loci, so tapasin appears to function in a universal way to assist MHC I peptide loading. In contrast, the chicken tapasin gene is tightly linked to the single dominantly expressed MHC I locus and is highly polymorphic and moderately diverse in sequence. Therefore, tapasin-assisted loading of MHC I in chickens may occur in a haplotype-specific way, via the co-evolution of chicken tapasin and MHC I. Here we demonstrate a mechanistic basis for this co-evolution, revealing differences in the ability of two chicken MHC I alleles to bind and release peptides in the presence or absence of tapasin, where, as in mammals, efficient self-loading is negatively correlated with tapasin-assisted loading. We found that a polymorphic residue in the MHC I 3 domain thought to bind tapasin influenced both tapasin function and intrinsic peptide binding properties. Differences were also evident between the MHC alleles in their interactions with tapasin. Last, we show that a mismatched combination of tapasin and MHC alleles exhibit significantly impaired MHC I maturation in vivo and that polymorphic MHC residues thought to contact tapasin influence maturation efficiency. Collectively, this supports the possibility that tapasin and BF2 proteins have co-evolved, resulting in allele-specific peptide loading in vivo.	[van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Elliott, Tim] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Elliott, Tim] Univ Southampton, Inst Life Sci, Southampton SO16 6YD, Hants, England; [Kaufman, Jim] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Kaufman, Jim] Univ Cambridge, Dept Vet Med, Cambridge CB2 1QP, England	University of Southampton; University of Southampton; University of Cambridge; University of Cambridge	Kaufman, J (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	jfk31@cam.ac.uk; tje@soton.ac.uk	van Hateren, Andy/GZL-0129-2022	van Hateren, Andy/0000-0002-3915-0239; Bailey, Alistair/0000-0003-0023-8679; Elliott, Tim/0000-0003-1097-0222; Kaufman, Jim/0000-0002-7216-8422	Cancer Research UK Program Grant [C7056A]	Cancer Research UK Program Grant(Cancer Research UK)	This work was supported by Cancer Research UK Program Grant C7056A (to T. E.).	Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bennett EM, 1999, J IMMUNOL, V162, P5049; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Furukawa H, 1998, TISSUE ANTIGENS, V52, P279, DOI 10.1111/j.1399-0039.1998.tb03044.x; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hee CS, 2013, IMMUNOGENETICS, V65, P157, DOI 10.1007/s00251-012-0667-4; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Rizvi SM, 2006, P NATL ACAD SCI USA, V103, P18220, DOI 10.1073/pnas.0605131103; Rizvi SM, 2010, TRAFFIC, V11, P332, DOI 10.1111/j.1600-0854.2009.01025.x; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Shaw I, 2007, J IMMUNOL, V178, P5744, DOI 10.4049/jimmunol.178.9.5744; Suh WK, 1999, J IMMUNOL, V162, P1530; van Hateren A, 2010, TISSUE ANTIGENS, V76, P259, DOI 10.1111/j.1399-0039.2010.01550.x; VANHATEREN A, 2006, THESIS U SOUTHAMPTON; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	37	35	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32797	32808		10.1074/jbc.M113.474031	http://dx.doi.org/10.1074/jbc.M113.474031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078633	Green Published, hybrid			2022-12-25	WOS:000328681700063
J	Huang, SF; Wang, DN; Chen, P; Yang, P; Cao, J; Zhang, LP				Huang Shifeng; Wang Danni; Chen Pu; Yang Ping; Cao Ju; Zhang Liping			Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PLASMA MICRORNAS; IDENTIFICATION; MIR-29	Background: Circulating microRNA-122 (miR-122) has been increasingly reported to be a potential biomarker for drug-, viral-, alcohol-and chemical-induced liver injury. The present study was initiated to determine the potential of circulating miR-122 as a biomarker for cholestatic liver injury. Methods: Both bile-duct ligation (BDL) mice and patients with biliary calculi were employed as cholestatic liver injury models, and serum miR-122 level was determined by stem-loop real-time reverse-transcription PCR (SLqRT-PCR). All quantitative PCR values were normalized to those for U6 RNA and calculated with the 2(-Delta Ct) method. Results: Serum miR-122 increased significantly after BDL-induced cholestatic injury and showed a similar time course to ALT concentrations. Compared with the sham controls, BDL mice had increased serum levels of miR-122 by 24.36+/-12.86, 423.63+/-322.89, 4.43+/-2.02 and 12.23+/-8.92 folds after 1, 3, 7 and 14 days, respectively. Moreover, serum miR-122 level was substantially higher in patients with biliary calculi than that in the healthy control group. In addition, patients with severe liver injury showed significantly higher levels of serum miR-122 when compared with healthy controls or patients with mild or moderate liver injury. Furthermore, serum miR-122 was found to show significant diagnostic value for biliary calculi by yielding an AUC (the areas under the receiver operating characteristic curve) of 0.931 with 77.4% sensitivity and 96.4% specificity in discriminating biliary calculi from healthy controls. Conclusion: Collectively, these data suggest that serum miR-122 has strong potential as a novel, specific and noninvasive biomarker for diagnosis of cholestasis-induced liver injury.	[Huang Shifeng; Wang Danni; Chen Pu; Yang Ping; Cao Ju; Zhang Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378]; Natural Science Foundation of Chongqing, China [CSTC, 2010BB5390]; Science Foundation of Chongqing Municipal Bureau of Health [2010-2-090]; Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University [YXJJ 2009-12]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing); Science Foundation of Chongqing Municipal Bureau of Health; Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University	This work was supported in part by the National Science Foundation of China (Grant No. 81071621 and 30973378), the Natural Science Foundation of Chongqing, China (Grant No. CSTC, 2010BB5390), the Science Foundation of Chongqing Municipal Bureau of Health (Grant No. 2010-2-090) and the Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University (Grant No. YXJJ 2009-12). The authors thank Erding Hu for the revision of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Dufour DR, 2000, CLIN CHEM, V46, P2050; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Kanda T, 2010, HEPATO-GASTROENTEROL, V57, P1013; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lebovitz HE, 2002, DIABETES CARE, V25, P815, DOI 10.2337/diacare.25.5.815; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qin X, 2012, EUR J CLIN NUTR, V66, P541, DOI 10.1038/ejcn.2011.192; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	29	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73133	10.1371/journal.pone.0073133	http://dx.doi.org/10.1371/journal.pone.0073133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086271	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900010
J	Gardberg, M; Kaipio, K; Lehtinen, L; Mikkonen, P; Heuser, VD; Talvinen, K; Iljin, K; Kampf, C; Uhlen, M; Grenman, R; Koivisto, M; Carpen, O				Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Iljin, Kristiina; Kampf, Caroline; Uhlen, Mathias; Grenman, Reidar; Koivisto, Mari; Carpen, Olli			FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion	PLOS ONE			English	Article							INVADOPODIA FORMATION; PROTEIN FHOD1; CARCINOMA-CELLS; DOMAIN; ROCK; TISSUES; FMNL2; RAC	Cancer cells can obtain their ability to invade and metastasise by undergoing epithelial-to-mesenchymal transition (EMT). Exploiting this mechanism of cellular plasticity, malignant cells can remodel their actin cytoskeleton and down-regulate proteins needed for cell-cell contacts. The mechanisms of cytoskeletal reorganisation resulting in mesenchymal morphology and increased invasive potential are poorly understood. Actin nucleating formins have been implicated as key players in EMT. Here, we analysed which formins are altered in squamous cell carcinoma related EMT. FHOD1, a poorly studied formin, appeared to be markedly upregulated upon EMT. In human tissues FHOD1 was primarily expressed in mesenchymal cells, with little expression in epithelia. However, specimens from oral squamous cell cancers demonstrated consistent FHOD1 upregulation in mesenchymally transformed cells at the invasive edge. This upregulation was confirmed in an oral squamous carcinoma model, where FHOD1 expression was markedly increased upon EMT in a PI3K signalling dependent manner. In the EMT cells FHOD1 contributed to the spindle-shaped morphology and mesenchymal F-actin organization. Furthermore, functional assays demonstrated that FHOD1 contributes to cell migration and invasion. Finally, FHOD1 depletion reduced the ability of EMT cancer cells to form invadopodia and to degrade extracellular matrix. Our results indicate that FHOD1 participates in cytoskeletal changes in EMT. In addition, we show that FHOD1 upregulation occurs during cancer cell EMT in vivo, which indicates that FHOD1 may contribute to tumour progression.	[Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Carpen, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Iljin, Kristiina] VTT Tech Res Ctr Finland, Turku, Finland; [Iljin, Kristiina] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kampf, Caroline] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, Albanova Univ Ctr, Stockholm, Sweden; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Grenman, Reidar] Univ Turku, Turku, Finland; [Koivisto, Mari] Univ Turku, Dept Biostat, Turku, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; Uppsala University; Royal Institute of Technology; Royal Institute of Technology; University of Turku; University of Turku; University of Turku; University of Turku	Gardberg, M (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.	maria.gardberg@utu.fi	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Dahlstrom-Heuser, Vanina/0000-0002-7044-4649; Iljin, Kristiina/0000-0002-5161-0584	Academy of Finland; Finska Lakaresallskapet; Sigrid Juselius Foundation; K Albin Johansson Foundation; Finnish Cancer Organizations; Turku University Hospital Research Funds; National Graduate School of Clinical Investigation	Academy of Finland(Academy of Finland); Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); K Albin Johansson Foundation; Finnish Cancer Organizations; Turku University Hospital Research Funds; National Graduate School of Clinical Investigation	This research was supported by funding from The Academy of Finland, Finska Lakaresallskapet, Sigrid Juselius Foundation, K Albin Johansson Foundation, The Finnish Cancer Organizations and Turku University Hospital Research Funds. Maria Gardberg is a Ph.D. student supported by the National Graduate School of Clinical Investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Chen C, 2012, CANC LETT IN PRESS; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gill MB, 2004, J CELL SCI, V117, P2709, DOI 10.1242/jcs.01113; Haikonen J, 2003, INT J CANCER, V103, P784, DOI 10.1002/ijc.10890; Hwang YS, 2012, ARCH ORAL BIOL, V57, P335, DOI 10.1016/j.archoralbio.2011.08.019; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Krisanaprakornkit S, 2012, ONCOLOGY, V2012; Li YF, 2010, MOL CANCER RES, V8, P1579, DOI 10.1158/1541-7786.MCR-10-0081; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schonichen A, 2013, J CELL SCI IN PRESS; Sibony-Benyamini H, 2012, EUR J CELL BIOL, V91, P896, DOI 10.1016/j.ejcb.2012.04.001; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200	27	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74923	10.1371/journal.pone.0074923	http://dx.doi.org/10.1371/journal.pone.0074923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086398	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000011
J	Wang, L; Rao, CM; Gao, K; Li, YH; Fu, ZH; Bi, H; Wang, JZ				Wang, Lan; Rao, Chunming; Gao, Kai; Li, Yonghong; Fu, Zhihao; Bi, Hua; Wang, Junzhi			Development of a Reference Standard of Escherichia coli DNA for Residual DNA Determination in China	PLOS ONE			English	Article							QUANTITATION; ASSAY; PROTEINS	This collaborative study developed the first national Escherichia coli (E. coli) DNA reference standard for standardizing quantitative residual DNA assay methods, fluorescence dye (PicoGreen) and quantitative PCR (q-PCR), which were widely employed to measure residual DNA contents of prokaryotic-derived recombinant products. High purity of E. coli strain BL21 was extracted by the cetyl triethyl ammonium bromide (CTAB)/phenol chloroform method, analyzed by UV-visible spectrophotometry and electrophoresis, diluted with tris-EDTA (TE) buffer and manually dispensed. Then, with a cooperative calibration among six laboratories, including five manufacturers and one national control laboratory, the concentration of E. coli DNA standard solution was determined as 96.2 mu g/mL (95% C.I: 95.5-96.9 mu g/mL, CV 3.4%). The candidate showed excellent stability both from accelerated degradation study and real time stability study. The applicability study showed that the E. coli DNA reference could reach the sensitivity of 0.781 ng/mL and 1 fg/mu L, respectively, in fluorescent dye and q-PCR assay, and also had good linearity and precision. The consistency of the reference could meet the requirements of the national reference standard. As a conclusion, the candidate material was suitable to serve as a China national standard for E. coli residual DNA determination. The successful establishment of the E. coli DNA standard will facilitate the standardization of quantitative methods for testing residual host cell DNA.	[Wang, Lan; Rao, Chunming; Gao, Kai; Li, Yonghong; Fu, Zhihao; Bi, Hua; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Wang, JZ (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	wangjz_nifdc@163.com			National Science and Technology Major Project [2012ZX09304010]; National High Technology Research and Development Program of China [SS2012AA020406]	National Science and Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by grants from the National Science and Technology Major Project (No. 2012ZX09304010) and the National High Technology Research and Development Program of China (No. SS2012AA020406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL PJ, 1974, J BIOL STAND, V2, P249, DOI 10.1016/0092-1157(74)90033-X; Cao S, 2012, HUM VACC IMMUNOTHER, V9, P1; Desjardins P, 2010, J VIS EXP, V22; European Commission, 2006, COMM REG EC NO 1881, P5; European Union, 2001, CPMPBWP114300 EUR UN; Gao K, 2012, BIOLOGICALS, V40, P151, DOI 10.1016/j.biologicals.2011.08.013; Health Canada, 2013, GUID SPONS INF SUBM, P7; Ji XY, 2002, BIOTECHNIQUES, V32, P1162, DOI 10.2144/02325dd06; Kang MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028661; Kline MC, 2009, ANAL BIOANAL CHEM, V394, P1183, DOI 10.1007/s00216-009-2782-0; Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019; KUNG VT, 1990, ANAL BIOCHEM, V187, P220, DOI 10.1016/0003-2697(90)90447-H; Niimi S, 2002, BIOLOGICALS, V30, P69, DOI 10.1006/biol.2001.0318; Nissom PM, 2007, BIOLOGICALS, V35, P211, DOI 10.1016/j.biologicals.2006.09.001; Rathore AS, 2003, J PHARMACEUT BIOMED, V32, P1199, DOI 10.1016/S0731-7085(03)00157-2; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; U.S. Food and Drug Administration, 2013, QUAL CONS DEM BIOS R, P10; US Food and Drug Administration, 1997, POINTS CONS MAN TEST; WHO, 2013, GUID EV SIM BIOTH PR; WHO Expert Committee on Biological Standardization, 2006, WHO TECH REP SER, V932, p[v, 1]	20	4	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74166	10.1371/journal.pone.0074166	http://dx.doi.org/10.1371/journal.pone.0074166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086318	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700017
J	Huan, XL; Shi, JH; Lim, LZ; Mitra, S; Zhu, WL; Qin, HN; Pasquale, EB; Song, JX				Huan, Xuelu; Shi, Jiahai; Lim, Liangzhong; Mitra, Sayantan; Zhu, Wanlong; Qin, Haina; Pasquale, Elena B.; Song, Jianxing			Unique Structure and Dynamics of the EphA5 Ligand Binding Domain Mediate Its Binding Specificity as Revealed by X-ray Crystallography, NMR and MD Simulations	PLOS ONE			English	Article							EPHRIN-BINDING; CRYSTAL-STRUCTURE; CONFORMATIONAL SELECTION; RECEPTOR SPECIFICITY; BACKBONE DYNAMICS; PROTEIN DYNAMICS; NERVOUS-SYSTEM; RELAXATION; COMPLEX; EXPRESSION	The 16 EphA and EphB receptors represent the largest family of receptor tyrosine kinases, and their interactions with 9 ephrin-A and ephrin-B ligands initiate bidirectional signals controlling many physiological and pathological processes. Most interactions occur between receptor and ephrins of the same class, and only EphA4 can bind all A and B ephrins. To understand the structural and dynamic principles that enable Eph receptors to utilize the same jellyroll beta-sandwich fold to bind ephrins, the VAPB-MSP domain, peptides and small molecules, we have used crystallography, NMR and molecular dynamics (MD) simulations to determine the first structure and dynamics of the EphA5 ligand-binding domain (LBD), which only binds ephrin-A ligands. Unexpectedly, despite being unbound, the high affinity ephrin-binding pocket of EphA5 resembles that of other Eph receptors bound to ephrins, with a helical conformation over the J-K loop and an open pocket. The openness of the pocket is further supported by NMR hydrogen/deuterium exchange data and MD simulations. Additionally, the EphA5 LBD undergoes significant picosecond-nanosecond conformational exchanges over the loops, as revealed by NMR and MD simulations, but lacks global conformational exchanges on the microsecond-millisecond time scale. This is markedly different from the EphA4 LBD, which shares 74% sequence identity and 87% homology. Consequently, the unbound EphA5 LBD appears to comprise an ensemble of open conformations that have only small variations over the loops and appear ready to bind ephrin-A ligands. These findings show how two proteins with high sequence homology and structural similarity are still able to achieve distinctive binding specificities through different dynamics, which may represent a general mechanism whereby the same protein fold can serve for different functions. Our findings also suggest that a promising strategy to design agonists/antagonists with high affinity and selectivity might be to target specific dynamic states of the Eph receptor LBDs.	[Huan, Xuelu; Song, Jianxing] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Shi, Jiahai; Lim, Liangzhong; Zhu, Wanlong; Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mitra, Sayantan; Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Zhu, Wan Long/GYA-3382-2022; Shi, Jiahai/AAH-1103-2019; Qin, Haina/AAB-7486-2020; shi, jiahai/D-7650-2013	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Haina, Qin/0000-0002-9175-8014; Song, Jianxing/0000-0003-0224-6322; zhu, Wanlong/0000-0003-0025-6674	National Medical Research Council of Singapore (NMRC) [R-154-000-382-213 (NMRC/1216/2009)]; Ministry of Education of Singapore (MOE) [MOE 2011-T2-1-096]; National Institutes of Health (NIH) [P01CA138390]; NATIONAL CANCER INSTITUTE [P01CA138390] Funding Source: NIH RePORTER	National Medical Research Council of Singapore (NMRC)(National Medical Research Council, Singapore); Ministry of Education of Singapore (MOE)(Ministry of Education, Singapore); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants: National Medical Research Council of Singapore (NMRC) grant R-154-000-382-213 (NMRC/1216/2009) and Ministry of Education of Singapore (MOE) Tier 2 Grant MOE 2011-T2-1-096 to JXS; and National Institutes of Health (NIH) grant P01CA138390 to EBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Giorgio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018128; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kimura K, 2011, P NATL ACAD SCI USA, V108, P9981, DOI 10.1073/pnas.1107592108; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JX, 2008, BIOPHYS J, V95, P4803, DOI 10.1529/biophysj.107.125641; Long D, 2008, J AM CHEM SOC, V130, P2432, DOI 10.1021/ja710477h; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mamiya PC, 2008, BRAIN RES, V1205, P91, DOI 10.1016/j.brainres.2008.02.047; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2011, CHEM BIOL DRUG DES, V78, P667, DOI 10.1111/j.1747-0285.2011.01199.x; Numachi Y, 2007, NEUROSCI LETT, V424, P116, DOI 10.1016/j.neulet.2007.07.025; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-2; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sun Bingsheng, 2008, Cancer Biol Ther, V7, P387; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Zhou RP, 1997, CELL TISSUE RES, V290, P251, DOI 10.1007/s004410050929	69	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74040	10.1371/journal.pone.0074040	http://dx.doi.org/10.1371/journal.pone.0074040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086308	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200008
J	Hanauske-Abel, HM; Saxena, D; Palumbo, PE; Hanauske, AR; Luchessi, AD; Cambiaghi, TD; Hoque, M; Spino, M; Gandolfi, DD; Heller, DS; Singh, S; Park, MH; Cracchiolo, BM; Tricta, F; Connelly, J; Popowicz, AM; Cone, RA; Holland, B; Pe'ery, T; Mathews, MB				Hanauske-Abel, Hartmut M.; Saxena, Deepti; Palumbo, Paul E.; Hanauske, Axel-Rainer; Luchessi, Augusto D.; Cambiaghi, Tavane D.; Hoque, Mainul; Spino, Michael; Gandolfi, Darlene D'Alliessi; Heller, Debra S.; Singh, Sukhwinder; Park, Myung Hee; Cracchiolo, Bernadette M.; Tricta, Fernando; Connelly, John; Popowicz, Anthony M.; Cone, Richard A.; Holland, Bart; Pe'ery, Tsafi; Mathews, Michael B.			Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INITIATION-FACTOR 5A; ACTIVE ANTIRETROVIRAL THERAPY; INTRACELLULAR LABILE IRON; CD4(+) T-CELLS; BLOOD MONONUCLEAR-CELLS; TYPE-1 TAT PROTEIN; GENE-EXPRESSION; IN-VITRO; MOTEXAFIN GADOLINIUM	HIV-1 blocks apoptosis, programmed cell death, an innate defense of cells against viral invasion. However, apoptosis can be selectively reactivated in HIV-infected cells by chemical agents that interfere with HIV-1 gene expression. We studied two globally used medicines, the topical antifungal ciclopirox and the iron chelator deferiprone, for their effect on apoptosis in HIV-infected H9 cells and in peripheral blood mononuclear cells infected with clinical HIV-1 isolates. Both medicines activated apoptosis preferentially in HIV-infected cells, suggesting that the drugs mediate escape from the viral suppression of defensive apoptosis. In infected H9 cells, ciclopirox and deferiprone enhanced mitochondrial membrane depolarization, initiating the intrinsic pathway of apoptosis to execution, as evidenced by caspase-3 activation, poly(ADP-ribose) polymerase proteolysis, DNA degradation, and apoptotic cell morphology. In isolate-infected peripheral blood mononuclear cells, ciclopirox collapsed HIV-1 production to the limit of viral protein and RNA detection. Despite prolonged monotherapy, ciclopirox did not elicit breakthrough. No viral re-emergence was observed even 12 weeks after drug cessation, suggesting elimination of the proviral reservoir. Tests in mice predictive for cytotoxicity to human epithelia did not detect tissue damage or activation of apoptosis at a ciclopirox concentration that exceeded by orders of magnitude the concentration causing death of infected cells. We infer that ciclopirox and deferiprone act via therapeutic reclamation of apoptotic proficiency (TRAP) in HIV-infected cells and trigger their preferential elimination. Perturbations in viral protein expression suggest that the antiretroviral activity of both drugs stems from their ability to inhibit hydroxylation of cellular proteins essential for apoptosis and for viral infection, exemplified by eIF5A. Our findings identify ciclopirox and deferiprone as prototypes of selectively cytocidal antivirals that eliminate viral infection by destroying infected cells. A drug-based drug discovery program, based on these compounds, is warranted to determine the potential of such agents in clinical trials of HIV-infected patients.	[Hanauske-Abel, Hartmut M.; Luchessi, Augusto D.; Cambiaghi, Tavane D.; Hoque, Mainul; Pe'ery, Tsafi; Mathews, Michael B.] Rutgers State Univ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA; [Hanauske-Abel, Hartmut M.; Saxena, Deepti; Palumbo, Paul E.] Rutgers State Univ, New Jersey Med Sch, Dept Pediat, Newark, NJ 07102 USA; [Hanauske-Abel, Hartmut M.; Cracchiolo, Bernadette M.] Rutgers State Univ, Dept Obstet Gynecol & Womens Hlth, New Jersey Med Sch, Newark, NJ 07102 USA; [Hanauske, Axel-Rainer] Asklepios Clin St George, Ctr Oncol, Hamburg, Germany; [Hanauske, Axel-Rainer] Asklepios Clin St George, Med Clin 3, Hamburg, Germany; [Spino, Michael] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Spino, Michael; Tricta, Fernando; Connelly, John] ApoPharma Inc, Toronto, ON, Canada; [Gandolfi, Darlene D'Alliessi] Manhattanville Coll, Dept Chem, Purchase, NY USA; [Heller, Debra S.; Singh, Sukhwinder] Rutgers State Univ, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07102 USA; [Park, Myung Hee] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, Bethesda, MD USA; [Popowicz, Anthony M.] Rockefeller Univ, Dept Informat Technol, New York, NY 10021 USA; [Cone, Richard A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Holland, Bart] Rutgers State Univ, Dept Prevent Med & Community Hlth, New Jersey Med Sch, Newark, NJ 07102 USA; [Pe'ery, Tsafi] Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Asklepios Klinik St. Georg; Asklepios Klinik St. Georg; University of Toronto; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Rockefeller University; Johns Hopkins University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hanauske-Abel, HM (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA.	hanaushm@njms.rutgers.edu; mathews@njms.rutgers.edu	Luchessi, Augusto Ducati/Y-7400-2019	Luchessi, Augusto Ducati/0000-0003-2080-3524; Heller, Debra/0000-0002-8378-4642; Singh, Sukhwinder/0000-0002-7061-0096	Foundation of UMDNJ; National Institutes of Health [HD-1457, AI034552, AI060403]; National Institutes of Health (NIH-NIDCR); State of New Jersey, through its Commission on Cancer Research [05-2405-CCR-EO]; Pediatric AIDS Clinical Trials Group, the National Institutes of Health; DAIDS [202PVCL05]; Foundation IND Synergen; The State of SApoundo Paulo Research Foundation (FAPESP) [08/50355-1, 04/040181-6]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552, R21AI060403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	Foundation of UMDNJ; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH-NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); State of New Jersey, through its Commission on Cancer Research; Pediatric AIDS Clinical Trials Group, the National Institutes of Health; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation IND Synergen; The State of SApoundo Paulo Research Foundation (FAPESP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the Foundation of UMDNJ to MBM and HMHA. The BIRCWH (Building Interdisciplinary Research Careers in Women's Health) Program of the National Institutes of Health (HD-1457), in which HMHA was a Scholar, supported this study. MBM and TP were funded by the National Institutes of Health (AI034552 and AI060403). MHP and ECW were supported by the Intramural Research Program of the National Institutes of Health (NIH-NIDCR); BMC by the State of New Jersey, through its Commission on Cancer Research (05-2405-CCR-EO); PEP by the Pediatric AIDS Clinical Trials Group, the National Institutes of Health, and DAIDS (202PVCL05); and ARH by the Foundation IND Synergen. ADL and TDC were recipients of grants (08/50355-1 and 04/040181-6) from The State of SA o pound Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE A, 1991, BIOCHIM BIOPHYS ACTA, V1077, P159, DOI 10.1016/0167-4838(91)90053-3; ABRAMOVITCH RA, 1975, J HETEROCYCLIC CHEM, V12, P683, DOI 10.1002/jhet.5570120414; ACTG Laboratory Technologist Committee, 2004, PREP PHA STIM UN DON; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; ALREFAIE FN, 1995, BRIT J HAEMATOL, V91, P224, DOI 10.1111/j.1365-2141.1995.tb05274.x; Andrus L, 1998, BIOCHEM PHARMACOL, V55, P1807, DOI 10.1016/S0006-2952(98)00053-7; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; BALZARINI J, 1995, P NATL ACAD SCI USA, V92, P5470, DOI 10.1073/pnas.92.12.5470; Balzarini J, 2001, AIDS RES HUM RETROV, V17, P1625, DOI 10.1089/088922201753342031; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Berro R, 2007, J BIOL CHEM, V282, P8207, DOI 10.1074/jbc.M606324200; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; BEVEC D, 1994, P NATL ACAD SCI USA, V91, P10829, DOI 10.1073/pnas.91.23.10829; Bhavsar H, 2008, NATL J INTEGR RES ME, V2, P47; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Breuer D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-94; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Calzada AA, 2013, EXP HEMATOL, V41, P253, DOI 10.1016/j.exphem.2012.10.013; Calzado MA, 2000, CLIN EXP IMMUNOL, V120, P317, DOI 10.1046/j.1365-2249.2000.01203.x; Cano VSP, 2010, AMINO ACIDS, V38, P479, DOI 10.1007/s00726-009-0407-8; Caraglia M, 2003, J BIOCHEM, V133, P757, DOI 10.1093/jb/mvg097; Carambula SF, 2002, ENDOCRINOLOGY, V143, P1495, DOI 10.1210/en.143.4.1495; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Chen J, 2005, APOPTOSIS, V10, P1131, DOI 10.1007/s10495-005-0887-2; CHOW YK, 1993, NATURE, V361, P650, DOI 10.1038/361650a0; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Clement PMJ, 2002, INT J CANCER, V100, P491, DOI 10.1002/ijc.10515; Cohen AR, 2000, BRIT J HAEMATOL, V108, P305; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; Cohen SBA, 1997, IMMUNOLOGY, V92, P1, DOI 10.1046/j.1365-2567.1997.00348.x; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Cracchiolo BM, 2004, GYNECOL ONCOL, V94, P217, DOI 10.1016/j.ygyno.2004.03.018; Debatin KMFS, 2006, APOPTOSIS CANC THERA; Debebe Z, 2007, VIROLOGY, V367, P324, DOI 10.1016/j.virol.2007.06.011; Debebe Z, 2011, MOL PHARMACOL, V79, P185, DOI 10.1124/mol.110.069062; Decker RH, 2001, CELL DEATH DIFFER, V8, P715, DOI 10.1038/sj.cdd.4400868; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fakih S, 2009, J PHARM SCI-US, V98, P2212, DOI 10.1002/jps.21583; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Garcia F, 2003, AIDS, V17, P43, DOI 10.1097/00002030-200301030-00007; Gee K, 2006, J BIOL CHEM, V281, P31647, DOI 10.1074/jbc.M512109200; Georgiou NA, 2002, EUR J CLIN INVEST, V32, P91, DOI 10.1046/j.1365-2362.2002.0320s1091.x; Georgiou NA, 2000, J INFECT DIS, V181, P484, DOI 10.1086/315223; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; GOUGEON ML, 1991, CR ACAD SCI III-VIE, V312, P529; GROUX H, 1991, CR ACAD SCI III-VIE, V312, P599; GUNZLER V, 1986, BIOCHIM BIOPHYS ACTA, V873, P38, DOI 10.1016/0167-4838(86)90187-1; Gupta AK, 2001, INT J DERMATOL, V40, P305, DOI 10.1046/j.1365-4362.2001.01156.x; Halicka HD, 2000, EXP CELL RES, V260, P248, DOI 10.1006/excr.2000.5027; Hanauske-Abel H. M., 1996, HEPATOLOGY TXB LIVER, P465; Hanauske-Abel HM, 2003, CURR MED CHEM, V10, P1005, DOI 10.2174/0929867033457601; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hart RA, 2002, VIROLOGY, V304, P97, DOI 10.1006/viro.2002.1659; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hinkula J, 2009, VACCINE, V27, P6424, DOI 10.1016/j.vaccine.2009.06.016; Hirasawa K, 2000, BIOCHEM BIOPH RES CO, V273, P1025, DOI 10.1006/bbrc.2000.3056; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; HUNT J, 1979, BRIT J HAEMATOL, V41, P69, DOI 10.1111/j.1365-2141.1979.tb03682.x; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; Huyghe P, 2004, ONCOL RES, V14, P235, DOI 10.3727/000000003772505362; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jasiulionis MG, 2007, CELL BIOCHEM FUNCT, V25, P109, DOI 10.1002/cbf.1351; Jin BF, 2003, ONCOGENE, V22, P4819, DOI 10.1038/sj.onc.1206738; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Jonckheere H, 1998, AIDS RES HUM RETROV, V14, P249, DOI 10.1089/aid.1998.14.249; Jones K, 2011, MED INDIA; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; KONTOGHIORGHES GJ, 1990, CLIN PHARMACOL THER, V48, P255, DOI 10.1038/clpt.1990.147; Kubota S, 1996, J VIROL, V70, P1282, DOI 10.1128/JVI.70.2.1282-1287.1996; Lafeuillade Alain, 2002, HIV Clin Trials, V3, P263; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; LAZDINS JK, 1991, LANCET, V338, P1341, DOI 10.1016/0140-6736(91)92651-H; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Lee SK, 2009, J ORAL PATHOL MED, V38, P792, DOI 10.1111/j.1600-0714.2009.00809.x; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Lukmantara AY, 2013, BIOORG MED CHEM LETT, V23, P967, DOI 10.1016/j.bmcl.2012.12.044; Lum JJ, 2003, CURR HIV RES, V1, P261, DOI 10.2174/1570162033485203; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MALLEY SD, 1994, P NATL ACAD SCI USA, V91, P11017, DOI 10.1073/pnas.91.23.11017; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Mathur M, 2008, INDIAN J MED MICROBI, V26, P205, DOI 10.4103/0255-0857.40552; MCCAFFREY TA, 1995, J CLIN INVEST, V95, P446, DOI 10.1172/JCI117684; McLean JE, 2008, CURR PHARM DESIGN, V14, P198; MELLORS JW, 1995, ANTIMICROB AGENTS CH, V39, P1087, DOI 10.1128/AAC.39.5.1087; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Minden MD, 2012, 54 ASH ANN M ATL GA; Montagnier L, 2009, ANGEW CHEM INT EDIT, V48, P5815, DOI 10.1002/anie.200902130; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Muthumani K, 2009, CURR HIV RES, V7, P144, DOI 10.2174/157016209787581481; Neidig ML, 2006, J INORG BIOCHEM, V100, P2108, DOI 10.1016/j.jinorgbio.2006.08.021; Nekhai S, 2013, FUTURE VIROL, V8, P301, DOI 10.2217/FVL.13.6; Nenoff P, 1999, MYCOSES, V42, P55, DOI 10.1046/j.1439-0507.1999.00268.x; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; New EJ, 2013, DALTON T, V42, P3210, DOI 10.1039/c2dt31933k; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Nonaka M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-20; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Nunez R, 2010, CELL DEATH DIFFER, V17, P1665, DOI 10.1038/cdd.2010.96; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; Okamoto M, 1996, ANTIVIR RES, V31, P69, DOI 10.1016/0166-3542(96)00946-1; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Paintsil Elijah, 2009, AIDS Res Ther, V6, P5, DOI 10.1186/1742-6405-6-5; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1993, BIOFACTORS, V4, P95; Pearse G, 2006, TOXICOL PATHOL, V34, P515, DOI 10.1080/01926230600978458; Perez OD, 2002, P NATL ACAD SCI USA, V99, P2270, DOI 10.1073/pnas.261711499; Petrovas C, 2005, CELL DEATH DIFFER, V12, P859, DOI 10.1038/sj.cdd.4401595; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Poon B, 2003, J VIROL, V77, P3962, DOI 10.1128/JVI.77.7.3962-3972.2003; Poon B, 2007, J VIROL, V81, P10515, DOI 10.1128/JVI.00947-07; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Reno F, 1999, APOPTOSIS, V4, P469, DOI 10.1023/A:1009608628076; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Rider TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022572; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salhi Y, 1998, J ACQ IMMUN DEF SYND, V18, P473, DOI 10.1097/00042560-199808150-00009; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schafer B, 2006, J INFECT DIS, V194, P740, DOI 10.1086/507043; Scheuring UJ, 1999, AIDS, V13, P167, DOI 10.1097/00002030-199902040-00004; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; Schrell UMH, 1997, J NEUROSURG, V86, P840, DOI 10.3171/jns.1997.86.5.0840; Schrell UMH, 1997, J NEUROSURG, V86, P845, DOI 10.3171/jns.1997.86.5.0845; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Sen S, 1993, Indian Pediatr, V30, P455; Shive CL, 2012, JAIDS-J ACQ IMM DEF, V61, P145, DOI 10.1097/QAI.0b013e31825ddbbf; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; SMITH MS, 1987, J VIROL, V61, P3769, DOI 10.1128/JVI.61.12.3769-3773.1987; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Spetz AL, 2002, J IMMUNOL, V169, P5771, DOI 10.4049/jimmunol.169.10.5771; Spinillo A, 2005, AM J OBSTET GYNECOL, V192, P774, DOI 10.1016/j.ajog.2004.10.609; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Theil EC, 2007, BIOMETALS, V20, P513, DOI 10.1007/s10534-006-9063-6; Tome ME, 1997, BIOCHEM J, V328, P847; Traore HN, 2004, J CLIN VIROL, V31, pS92, DOI 10.1016/j.jcv.2004.09.011; TSCHANK G, 1991, BIOCHEM J, V275, P469, DOI 10.1042/bj2750469; Ullum H, 1997, AIDS RES HUM RETROV, V13, P1039, DOI 10.1089/aid.1997.13.1039; VALLORY EAL, 1989, EUR J PEDIATR, V148, P503; van Asbeck BS, 2001, J CLIN VIROL, V20, P141, DOI 10.1016/S1386-6532(00)00122-0; Venkatachari NJ, 2008, VIROLOGY, V376, P140, DOI 10.1016/j.virol.2008.03.015; Vila J, 1997, LANCET, V350, P635, DOI 10.1016/S0140-6736(97)24035-3; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; WANG GL, 1993, BLOOD, V82, P3610; Wang JF, 2008, DNA CELL BIOL, V27, P267, DOI 10.1089/dna.2007.0707; Wang ZD, 1999, VIROLOGY, V257, P502, DOI 10.1006/viro.1999.9688; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463; Witvrouw M, 2000, ANTIVIR RES, V46, P215, DOI 10.1016/S0166-3542(00)00084-X; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; YARCHOAN R, 1986, LANCET, V1, P575; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zhao LJ, 2004, FEBS LETT, V563, P170, DOI 10.1016/S0014-5793(04)00299-6; Zheng L, 2007, INTERVIROLOGY, V50, P224, DOI 10.1159/000100565; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zhu Y, 2003, APOPTOSIS, V8, P71, DOI 10.1023/A:1021653119934	218	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74414	10.1371/journal.pone.0074414	http://dx.doi.org/10.1371/journal.pone.0074414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086341				2022-12-25	WOS:000326520200030
J	Czeisler, C; Mikawa, T				Czeisler, Catherine; Mikawa, Takashi			Microtubules Coordinate VEGFR2 Signaling and Sorting	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; RECEPTOR; KDR; DOMAIN; AUTOPHOSPHORYLATION; LETHALITY; BINDING	VEGF signaling is a key regulator of vessel formation and function. In vascular endothelial cells, this signaling is mediated through its cognate receptor VEGFR2, which is dynamically sorted in response to ligand. Little is known about the underlying mechanism of this intracellular sorting. Here we examined the role of different components of the cytoskeleton in this process. We found that VEGFR2 mainly associates with microtubule fibers and to a lesser extent with intermediate filaments and actin. Microtubule disruption leads to accumulation of VEGFR2 protein in the membrane and cytoplasm leading to defects in VEGF signaling. In contrast, inhibition of actin filaments results in no accumulation of VEGFR2 total protein or apparent changes in microtubule association. Instead, actin inhibition leads to a more global signaling disruption of the ERK1/2 pathway. This is the first report demonstrating that VEGFR2 associates closely with microtubules in modulating the subcellular sorting and signaling of VEGFR2.	[Czeisler, Catherine; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Czeisler, Catherine] Ohio State Univ, Med Ctr, Dept Neuropathol, Columbus, OH 43210 USA	University of California System; University of California San Francisco; University System of Ohio; Ohio State University	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA.	Takashi.Mikawa@ucsf.edu		Czeisler, Catherine/0000-0001-7895-6449	National Institutes of Health (NIH) [R37HL08921, R01HL92429]; NIH [T32 HL007731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112268, R01HL092429, R37HL078921, T32HL007731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by grants from the National Institutes of Health (NIH) (R37HL08921 and R01HL92429 to TM; CC was also supported by NIH T32 HL007731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fox SB, 2004, J PATHOL, V202, P313, DOI 10.1002/path.1520; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Lu HY, 2006, MOL PHARMACOL, V69, P1207, DOI 10.1124/mol.105.019075; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047	16	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75833	10.1371/journal.pone.0075833	http://dx.doi.org/10.1371/journal.pone.0075833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073279	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000089
J	Gonzalez-Serrano, AF; Pirro, V; Ferreira, CR; Oliveri, P; Eberlin, LS; Heinzmann, J; Lucas-Hahn, A; Niemann, H; Cooks, RG				Gonzalez-Serrano, Andres Felipe; Pirro, Valentina; Ferreira, Christina R.; Oliveri, Paolo; Eberlin, Livia S.; Heinzmann, Julia; Lucas-Hahn, Andrea; Niemann, Heiner; Cooks, Robert Graham			Desorption Electrospray Ionization Mass Spectrometry Reveals Lipid Metabolism of Individual Oocytes and Embryos	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FATTY-ACID-COMPOSITION; BOVINE-OOCYTES; DAIRY-COWS; DNA METHYLATION; SINGLE EMBRYO; CULTURE; FERTILIZATION; SQUALENE; SHEEP	Alteration of maternal lipid metabolism early in development has been shown to trigger obesity, insulin resistance, type 2 diabetes and cardiovascular diseases later in life in humans and animal models. Here, we set out to determine (i) lipid composition dynamics in single oocytes and preimplantation embryos by high mass resolution desorption electrospray ionization mass spectrometry (DESI-MS), using the bovine species as biological model, (ii) the metabolically most relevant lipid compounds by multivariate data analysis and (iii) lipid upstream metabolism by quantitative real-time PCR (qRT-PCR) analysis of several target genes (ACAT1, CPT 1b, FASN, SREBP1 and SCAP). Bovine oocytes and blastocysts were individually analyzed by DESI-MS in both positive and negative ion modes, without lipid extraction and under ambient conditions, and were profiled for free fatty acids (FFA), phospholipids (PL), cholesterol-related molecules, and triacylglycerols (TAG). Principal component analysis (PCA) and linear discriminant analysis (LDA), performed for the first time on DESI-MS fused data, allowed unequivocal discrimination between oocytes and blastocysts based on specific lipid profiles. This analytical approach resulted in broad and detailed lipid annotation of single oocytes and blastocysts. Results of DESI-MS and transcript regulation analysis demonstrate that blastocysts produced in vitro and their in vivo counterparts differed significantly in the homeostasis of cholesterol and FFA metabolism. These results should assist in the production of viable and healthy embryos by elucidating in vivo embryonic lipid metabolism.	[Gonzalez-Serrano, Andres Felipe; Heinzmann, Julia; Lucas-Hahn, Andrea; Niemann, Heiner] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany; [Pirro, Valentina] Univ Turin, Dept Chem, Turin, Italy; [Ferreira, Christina R.; Eberlin, Livia S.; Cooks, Robert Graham] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Oliveri, Paolo] Univ Genoa, Dept Pharm, Genoa, Italy	Friedrich Loeffler Institute; University of Turin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Genoa	Niemann, H (corresponding author), Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany.	heiner.niemann@fli.bund.de; cooks@purdue.edu	Pirro, Valentina/M-5678-2014; Ferreira, Christina Ramires/F-4744-2012; Cooks, R Graham/G-1051-2015; Oliveri, Paolo/K-4359-2015	Ferreira, Christina Ramires/0000-0003-3988-6454; Cooks, R Graham/0000-0002-9581-9603; Oliveri, Paolo/0000-0002-3722-9461	German Academic Exchange Service (DAAD); Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); L'Oreal/UNESCO Italia per le Donne e la Scienza grant; Purdue University Center for Cancer Research; Brazilian National Council for Scientific and Technological Development (CNPq); NSF IDBR [0852740]; Direct For Biological Sciences [0852740] Funding Source: National Science Foundation	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); L'Oreal/UNESCO Italia per le Donne e la Scienza grant; Purdue University Center for Cancer Research; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF IDBR(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AFGS was supported from the German Academic Exchange Service (DAAD) and the Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); VP was supported from the "L'Oreal/UNESCO Italia per le Donne e la Scienza 2013" grant; CF was supported from the Purdue University Center for Cancer Research Small Grants and from the Brazilian National Council for Scientific and Technological Development (CNPq); RGC by NSF IDBR 0852740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardema H, 2011, BIOL REPROD, V85, P62, DOI 10.1095/biolreprod.110.088815; Adamiak SJ, 2006, REPRODUCTION, V131, P247, DOI 10.1530/rep.1.00871; Blanchet L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-254; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BUNGARTZ L, 1995, THERIOGENOLOGY, V43, P667, DOI 10.1016/0093-691X(94)00072-3; Campbell BK, 2003, REPRODUCTION, P429; Chen MX, 2011, CURR DIABETES REV, V7, P426, DOI 10.2174/157339911797579151; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Diederich M, 2012, REPRODUCTION, V144, P319, DOI 10.1530/REP-12-0134; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Eberlin LS, 2013, P NATL ACAD SCI USA, V110, P1611, DOI 10.1073/pnas.1215687110; Eberlin LS, 2011, CHEMBIOCHEM, V12, P2129, DOI 10.1002/cbic.201100411; ECKERT J, 1995, THERIOGENOLOGY, V43, P1211, DOI 10.1016/0093-691X(95)00093-N; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Ferreira CR, 2012, ANAL BIOANAL CHEM, V404, P2915, DOI 10.1007/s00216-012-6426-4; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fouladi-Nashta AA, 2009, REPRODUCTION, V138, P771, DOI 10.1530/REP-08-0391; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Garcia-Reyes JF, 2009, ANAL CHEM, V81, P820, DOI 10.1021/ac802166v; Gulliver CE, 2012, ANIM REPROD SCI, V131, P9, DOI 10.1016/j.anireprosci.2012.02.002; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Heinzmann J, 2011, MOL REPROD DEV, V78, P188, DOI 10.1002/mrd.21281; Jackson AU, 2011, ANAL BIOANAL CHEM, V399, P367, DOI 10.1007/s00216-010-4349-5; Jolliffe, 2002, PRINCIPAL COMPONENT; Jungheim ES, 2011, BIOL REPROD, V85, P678, DOI 10.1095/biolreprod.111.092148; Kennedy JH, 2010, ANAL CHEM, V82, P7502, DOI 10.1021/ac101295g; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SK, 2012, ADV FOOD NUTR RES, V65, P223, DOI 10.1016/B978-0-12-416003-3.00014-7; Konigsdorf CAI, 2012, OBESITY FACTS, V5, P575, DOI 10.1159/000342583; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; Leroy JLMR, 2005, THERIOGENOLOGY, V64, P2022, DOI 10.1016/j.theriogenology.2005.05.003; LOEWENSTEIN JE, 1964, J EMBRYOL EXP MORPH, V12, P113; Marei WF, 2012, REPROD FERT DEVELOP, V24, P679, DOI 10.1071/RD11204; Marei WF, 2010, REPRODUCTION, V139, P979, DOI 10.1530/REP-09-0503; Marei WF, 2009, BIOL REPROD, V81, P1064, DOI 10.1095/biolreprod.109.076851; Matorras R, 1998, HUM REPROD, V13, P2227, DOI 10.1093/humrep/13.8.2227; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Pirro V, 2012, ANALYST, V137, P2374, DOI 10.1039/c2an35122f; Prates EG, 2013, IN VITRO CELL DEV-AN, V49, P335, DOI 10.1007/s11626-013-9624-2; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Seal JR, 2003, J AM SOC MASS SPECTR, V14, P872, DOI 10.1016/S1044-0305(03)00339-8; Sinclair KD, 2000, HUM REPROD, V15, P68, DOI 10.1093/humrep/15.suppl_5.68; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; Van Hoeck V, 2013, REPRODUCTION, V145, P33, DOI 10.1530/REP-12-0174; Van Hoeck V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023183; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WALKER SK, 1992, THERIOGENOLOGY, V37, P111, DOI 10.1016/0093-691X(92)90250-U; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2007, THERIOGENOLOGY, V68, pS77, DOI 10.1016/j.theriogenology.2007.04.028; Wrenzycki C, 2000, J REPROD FERTIL, V118, P69, DOI 10.1530/reprod/118.1.69; Wrenzycki Christine, 2005, Birth Defects Res C Embryo Today, V75, P1, DOI 10.1002/bdrc.20035; Wu LDL, 2012, MOL ENDOCRINOL, V26, P562, DOI 10.1210/me.2011-1362; Wu LLY, 2012, REPROD FERT DEVELOP, V24, P29, DOI 10.1071/RD11904; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; 2013, FERTIL STERIL, V99, P37, DOI DOI 10.1016/J.FERTNSTERT.2012.09.028.PUBMED:23083924	64	54	57	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74981	10.1371/journal.pone.0074981	http://dx.doi.org/10.1371/journal.pone.0074981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073231	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000040
J	O'Donoghue, AJ; Jin, Y; Knudsen, GM; Perera, NC; Jenne, DE; Murphy, JE; Craik, CS; Hermiston, TW				O'Donoghue, Anthony J.; Jin, Ye; Knudsen, Giselle M.; Perera, Natascha C.; Jenne, Dieter E.; Murphy, John E.; Craik, Charles S.; Hermiston, Terry W.			Global Substrate Profiling of Proteases in Human Neutrophil Extracellular Traps Reveals Consensus Motif Predominantly Contributed by Elastase	PLOS ONE			English	Article							SERINE PROTEASES; PROTEINASE-3; SPECIFICITY; INHIBITION; ACTIVATION; STRATEGY; NETOSIS	Neutrophil extracellular traps (NETs) consist of antimicrobial molecules embedded in a web of extracellular DNA. Formation of NETs is considered to be a defense mechanism utilized by neutrophils to ensnare and kill invading pathogens, and has been recently termed NETosis. Neutrophils can be stimulated to undergo NETosis ex vivo, and are predicted to contain high levels of serine proteases, such as neutrophil elastase (NE), cathepsin G (CG) and proteinase 3 (PR3). Serine proteases are important effectors of neutrophil-mediated immunity, which function directly by degrading pathogenic virulent factors and indirectly via proteolytic activation or deactivation of cytokines, chemokines and receptors. In this study, we utilized a diverse and unbiased peptide library to detect and profile protease activity associated with NETs induced by phorbol-12-myristate-13-acetate (PMA). We obtained a "proteolytic signature" from NETs derived from healthy donor neutrophils and used proteomics to assist in the identification of the source of this proteolytic activity. In addition, we profiled each neutrophil serine protease and included the newly identified enzyme, neutrophil serine protease 4 (NSP4). Each enzyme had overlapping yet distinct endopeptidase activities and often cleaved at unique sites within the same peptide substrate. The dominant proteolytic activity in NETs was attributed to NE; however, cleavage sites corresponding to CG and PR3 activity were evident. When NE was immunodepleted, the remaining activity was attributed to CG and to a lesser extent PR3 and NSP4. Our results suggest that blocking NE activity would abrogate the major protease activity associated with NETs. In addition, the newly identified substrate specificity signatures will guide the design of more specific probes and inhibitors that target NET-associated proteases.	[Jin, Ye; Murphy, John E.; Hermiston, Terry W.] Bayer Healthcare Pharmaceut, US Innovat Ctr, San Francisco, CA USA; [O'Donoghue, Anthony J.; Knudsen, Giselle M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Perera, Natascha C.; Jenne, Dieter E.] Helmholtz Zentrum Munchen, ILBD, Comprehens Pneumol Ctr, Munich, Germany; [Jenne, Dieter E.] Max Planck Inst Neurobiol, Planegg Martinsried, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; University of California System; University of California San Francisco; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Hermiston, TW (corresponding author), Bayer Healthcare Pharmaceut, US Innovat Ctr, San Francisco, CA USA.	Terry.Hermiston@bayer.com	Jenne, Dieter Erich/AAP-1414-2020		Bayer HealthCare; NIH [R01CA128765]; Biomedical Technology Research Centers program, NIH NIGMS [8P41GM103481]; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P50GM082250] Funding Source: NIH RePORTER	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Research Centers program, NIH NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by Bayer HealthCare and by NIH grant R01CA128765 (CSC). Mass spectrometry was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF supported by the Biomedical Technology Research Centers program, NIH NIGMS 8P41GM103481 (AL Burlingame). Bayer HealthCare authors were involved in study design, decision to publish, and preparation of the manuscript.	Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meyer-Hoffert U, 2010, CURR OPIN HEMATOL; O'Donoghue AJ, 2008, J BIOL CHEM, V283, P29186, DOI 10.1074/jbc.M802366200; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	40	93	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75141	10.1371/journal.pone.0075141	http://dx.doi.org/10.1371/journal.pone.0075141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073241	Green Published, gold			2022-12-25	WOS:000324768000050
J	Shoghi, KI; Xu, JB; Su, Y; He, J; Rowland, D; Yan, Y; Garbow, JR; Tu, ZD; Jones, LA; Higashikubo, R; Wheeler, KT; Lubet, RA; Mach, RH; You, M				Shoghi, Kooresh I.; Xu, Jinbin; Su, Yi; He, June; Rowland, Douglas; Yan, Ying; Garbow, Joel R.; Tu, Zhude; Jones, Lynne A.; Higashikubo, Ryuji; Wheeler, Kenneth T.; Lubet, Ronald A.; Mach, Robert H.; You, Ming			Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [F-18]ISO-1	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERFORMANCE EVALUATION; ENDOCRINE THERAPY; IN-VIVO; FDG PET; CANCER; EXPRESSION; RECRUITMENT; MANAGEMENT; EFFICACY	The sigma-2 receptor is expressed in higher density in proliferating (P) tumor cells versus quiescent (Q) tumor cells, thus providing an attractive target for imaging the proliferative status (i.e., P:Q ratio) of solid tumors. Here we evaluate the utility of the sigma-2 receptor ligand 2-(2-[F-18]fluoroethoxy)-N-(4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl)-5-methyl-benzamide, [F-18]ISO-1, in two different rodent models of breast cancer. In the first study, small animal Positron Emission Tomography (PET) imaging studies were conducted with [F-18]ISO-1 and (18)FDG in xenografts of mouse mammary tumor 66 and tracer uptake was correlated with the in vivo P: Q ratio determined by flow cytometric measures of BrdU-labeled tumor cells. The second model utilized a chemically-induced (N-methyl-N-nitrosourea [MNU]) model of rat mammary carcinoma to correlate measures of [F-18]ISO-1 and FDG uptake with MR-based volumetric measures of tumor growth. In addition, [F-18]ISO-1 and FDG were used to assess the response of MNU-induced tumors to bexarotene and Vorozole therapy. In the mouse mammary 66 tumors, a strong linear correlation was observed between the [F-18]ISO-1 tumor: background ratio and the proliferative status (P: Q ratio) of the tumor (R = 0.87). Similarly, measures of [F-18]ISO-1 uptake in MNU-induced tumors significantly correlated (R = 0.68, P<0.003) with changes in tumor volume between consecutive MR imaging sessions. Our data suggest that PET studies of [F-18]ISO-1 provide a measure of both the proliferative status and tumor growth rate, which would be valuable in designing an appropriate treatment strategy.	[Shoghi, Kooresh I.; Xu, Jinbin; Su, Yi; Garbow, Joel R.; Tu, Zhude; Jones, Lynne A.; Mach, Robert H.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [He, June; Yan, Ying; Higashikubo, Ryuji; You, Ming] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Mach, Robert H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Mach, Robert H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Shoghi, Kooresh I.; Mach, Robert H.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO USA; [Rowland, Douglas] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Wheeler, Kenneth T.] Wake Forest Univ, Hlth Sci Ctr, Dept Radiol, Winston Salem, NC 27109 USA; [Lubet, Ronald A.] NIH, Bethesda, MD 20892 USA; [You, Ming] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; Wake Forest University; National Institutes of Health (NIH) - USA; Medical College of Wisconsin; Medical College of Wisconsin	Shoghi, KI (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	shoghik@wustl.edu	Xu, Jinbin/ABG-1280-2020; Rowland, Douglas J/F-3104-2014; Shoghi, Kooresh/H-7398-2014	Xu, Jinbin/0000-0002-2120-8287; Rowland, Douglas J/0000-0001-8059-6905; Shoghi, Kooresh/0000-0003-3204-457X; Mach, Robert/0000-0002-7645-2869; Su, Yi/0000-0002-1946-8063; Jones, Lynne/0000-0003-0235-9538	NIH/NCI [N01-CN-43308]; Siteman Cancer Center [P30CA091842]; NIH [CA102869]; NATIONAL CANCER INSTITUTE [P30CA091842, R33CA102869, R21CA102869] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siteman Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by NIH/NCI contract N01-CN-43308, Siteman Cancer Center support grant P30CA091842, NIH grant CA102869 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nabulsi I, 1999, BRIT J CANCER, V81, P925, DOI 10.1038/sj.bjc.6690789; Alves FA, 2004, INT J ORAL MAX SURG, V33, P593, DOI 10.1016/j.ijom.2004.01.010; Avril N, 2001, J NUCL MED, V42, P9; BEM WT, 1991, CANCER RES, V51, P6558; Christov K, 2000, BREAST CANCER RES TR, V60, P117, DOI 10.1023/A:1006384026252; Christov K, 2007, CLIN CANCER RES, V13, P5488, DOI 10.1158/1078-0432.CCR-07-0404; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Dehdashti F, 2013, J NUCL MED, V54, P350, DOI 10.2967/jnumed.112.111948; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Endo Keigo, 2006, Int J Clin Oncol, V11, P286, DOI 10.1007/s10147-006-0595-0; Eubank WB, 2005, SEMIN NUCL MED, V35, P84, DOI 10.1053/j.semnuclmed.2004.11.001; Fornace A. J., 2001, MOL BASIS CANC, P423; GULLINO PM, 1975, J NATL CANCER I, V54, P401; HABERKORN U, 1994, NUCL MED BIOL, V21, P827, DOI 10.1016/0969-8051(94)90162-7; HUGGINS C, 1965, CANCER RES, V25, P1163; Kashiwagi H, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-48; Kumar R, 2004, RADIOL CLIN N AM, V42, P1113, DOI 10.1016/j.rcl.2004.08.005; Laforest R, 2007, IEEE T NUCL SCI, V54, P42, DOI 10.1109/TNS.2006.889312; Loddo M, 2009, BRIT J CANCER, V100, P959, DOI 10.1038/sj.bjc.6604924; Lubet RA, 2005, CARCINOGENESIS, V26, P441, DOI 10.1093/carcin/bgh338; Lubet RA, 1998, CARCINOGENESIS, V19, P1345, DOI 10.1093/carcin/19.8.1345; Mach R.H., 2013, J MED CHEM; Mach RH, 1997, CANCER RES, V57, P156; Miele E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-52; Rosen EL, 2007, RADIOGRAPHICS, V27, pS215, DOI 10.1148/rg.27si075517; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sun HH, 2005, J NUCL MED, V46, P292; Tai YC, 2005, J NUCL MED, V46, P455; Tu ZD, 2005, NUCL MED BIOL, V32, P423, DOI 10.1016/j.nucmedbio.2005.03.008; Tu ZD, 2007, J MED CHEM, V50, P3194, DOI 10.1021/jm0614883; van Waarde A, 2004, J NUCL MED, V45, P1939; VILNER BJ, 1995, CANCER RES, V55, P408; WALLEN CA, 1984, CELL TISSUE KINET, V17, P65, DOI 10.1111/j.1365-2184.1984.tb00569.x; WALLEN CA, 1984, CELL TISSUE KINET, V17, P79, DOI 10.1111/j.1365-2184.1984.tb00570.x; Wheeler KT, 2000, BRIT J CANCER, V82, P1223, DOI 10.1054/bjoc.1999.1067; Xu JB, 2005, EUR J PHARMACOL, V525, P8, DOI 10.1016/j.ejphar.2005.09.063	39	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74188	10.1371/journal.pone.0074188	http://dx.doi.org/10.1371/journal.pone.0074188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073202	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000011
J	de Souza, WF; Fortunato-Miranda, N; Robbs, BK; de Araujo, WM; de-Freitas, JC; Bastos, LG; Viola, JPB; Morgado-Diaz, JA				de Souza, Waldemir F.; Fortunato-Miranda, Natalia; Robbs, Bruno K.; de Araujo, Wallace M.; de-Freitas-Junior, Julio C.; Bastos, Lilian G.; Viola, Joao P. B.; Morgado-Diaz, Jose A.			Claudin-3 Overexpression Increases the Malignant Potential of Colorectal Cancer Cells: Roles of ERK1/2 and PI3K-Akt as Modulators of EGFR signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TIGHT JUNCTION; E-CADHERIN; EXPRESSION; PROTEIN; TRANSFORMATION; ACTIVATION; FAMILY; TRANSDUCTION; PERMEABILITY	The altered expressions of claudin proteins have been reported during the tumorigenesis of colorectal cancer. However, the molecular mechanisms that regulate these events in this cancer type are poorly understood. Here, we report that epidermal growth factor (EGF) increases the expression of claudin-3 in human colorectal adenocarcinoma HT-29 cells. This increase was related to increased cell migration and the formation of anchorage-dependent and anchorage-independent colonies. We further showed that the ERK1/2 and PI3K-Akt pathways were involved in the regulation of these effects because specific pharmacological inhibition blocked these events. Genetic manipulation of claudin-1 and claudin-3 in HT-29 cells showed that the overexpression of claudin-1 resulted in decreased cell migration; however, migration was not altered in cells that overexpressed claudin-3. Furthermore, the overexpression of claudin-3, but not that of claudin-1, increased the tight junction-related paracellular flux of macromolecules. Additionally, an increased formation of anchorage-dependent and anchorage-independent colonies were observed in cells that overexpressed claudin-3, while no such changes were observed when claudin-1 was overexpressed. Finally, claudin-3 silencing alone despite induce increase proliferation, and the formation of anchoragedependent and -independent colonies, it was able to prevent the EGF-induced increased malignant potential. In conclusion, our results show a novel role for claudin-3 overexpression in promoting the malignant potential of colorectal cancer cells, which is potentially regulated by the EGF-activated ERK1/2 and PI3K-Akt pathways.	[de Souza, Waldemir F.; Fortunato-Miranda, Natalia; de Araujo, Wallace M.; de-Freitas-Junior, Julio C.; Bastos, Lilian G.; Morgado-Diaz, Jose A.] Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Biol Estrutural, Rio De Janeiro, Brazil; [Robbs, Bruno K.; Viola, Joao P. B.] Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Regulacao Genica, Rio De Janeiro, Brazil	Centro Brasileiro de Pesquisas Fisicas; National Cancer Institute (Inca); Centro Brasileiro de Pesquisas Fisicas; National Cancer Institute (Inca)	Morgado-Diaz, JA (corresponding author), Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Biol Estrutural, Rio De Janeiro, Brazil.	jmorgado@inca.gov.br	Araujo, Wallace/O-7736-2015; Viola, Joao P.B./AAP-4125-2020; Fortunato de Miranda, Natalia/O-7750-2015; de Souza, Waldemir/B-3612-2015; de Freitas Junior, Julio Cesar/M-5754-2013; Morgado-Diaz, Jose A./A-9649-2010	Viola, Joao P.B./0000-0002-0698-3146; de Souza, Waldemir/0000-0003-3258-6758; de Freitas Junior, Julio Cesar/0000-0002-2070-1432; DE ARAUJO, WALLACE/0000-0003-2979-4070; Robbs, Bruno Kaufmann/0000-0002-3972-5530	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Saude - Brasil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ); Instituto nacional de Ciencia e Tecnologia em Cancer [573806/2008-0, 170.026/2008]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude - Brasil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto nacional de Ciencia e Tecnologia em Cancer	This study was sponsored by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Saude - Brasil, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) and Instituto nacional de Ciencia e Tecnologia em Cancer (573806/2008-0 and 170.026/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Asaka M, 2011, AM J PHYSIOL-CELL PH, V300, pC87, DOI 10.1152/ajpcell.00565.2010; Barbosa LA, 2003, CELL TISSUE RES, V312, P319, DOI 10.1007/s00441-003-0727-z; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; CHANTRET I, 1988, CANCER RES, V48, P1936; Chicaybam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060298; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Contreras RG, 2004, J MEMBRANE BIOL, V198, P147, DOI 10.1007/s00232-004-0670-2; de Araujo WM, 2010, J CANCER RES CLIN, V136, P1773, DOI 10.1007/s00432-010-0836-5; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Ersoz S, 2011, PATHOL RES PRACT, V207, P285, DOI 10.1016/j.prp.2011.01.011; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hashimoto K, 2008, BIOCHEM BIOPH RES CO, V376, P154, DOI 10.1016/j.bbrc.2008.08.140; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ikari A, 2011, J CELL PHYSIOL, V226, P1471, DOI 10.1002/jcp.22386; Kinugasa T, 2012, ANTICANCER RES, V32, P2309; Kwon MJ, 2010, CARCINOGENESIS, V31, P974, DOI 10.1093/carcin/bgp336; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; de Freitas JCM, 2011, CANCER CHEMOTH PHARM, V68, P227, DOI 10.1007/s00280-010-1477-8; De-Freitas JCM, 2012, J CELL BIOCHEM, V113, P2957, DOI 10.1002/jcb.24173; MARCIAL MA, 1987, LAB INVEST, V56, P424; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Ogawa M, 2012, HISTOCHEM CELL BIOL, V138, P323, DOI 10.1007/s00418-012-0956-x; Ohmori K, 2009, FOOD ADDIT CONTAM A, V26, P568, DOI 10.1080/02652030802471221; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Resnick MB, 2005, MODERN PATHOL, V18, P511, DOI 10.1038/modpathol.3800301; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Singh AB, 2007, AM J PHYSIOL-CELL PH, V293, pC1660, DOI 10.1152/ajpcell.00274.2007; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Takizawa Y, 2012, INT J PHARMACEUT, V426, P82, DOI 10.1016/j.ijpharm.2012.01.023; Vidal F, 2011, INT J ONCOL, V38, P1365, DOI 10.3892/ijo.2011.955; Vivekanand P, 2006, ANNU REV GENET, V40, P139, DOI 10.1146/annurev.genet.40.110405.090555; Weber CR, 2012, ANN NY ACAD SCI, V1257, P77, DOI 10.1111/j.1749-6632.2012.06528.x; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300	50	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74994	10.1371/journal.pone.0074994	http://dx.doi.org/10.1371/journal.pone.0074994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069372	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300059
J	Friman, VP; Ghoul, M; Molin, S; Johansen, HK; Buckling, A				Friman, Ville-Petri; Ghoul, Melanie; Molin, Soren; Johansen, Helle Krogh; Buckling, Angus			Pseudomonas aeruginosa Adaptation to Lungs of Cystic Fibrosis Patients Leads to Lowered Resistance to Phage and Protist Enemies	PLOS ONE			English	Article							EVOLUTION; VIRULENCE; BACTERIA; HOST; PREDATION; DYNAMICS; COEVOLUTION; MULTIPLE; SURVIVAL; PROTOZOA	Pathogenic life styles can lead to highly specialized interactions with host species, potentially resulting in fitness trade-offs in other ecological contexts. Here we studied how adaptation of the environmentally transmitted bacterial pathogen, Pseudomonas aeruginosa, to cystic fibrosis (CF) patients affects its survival in the presence of natural phage (14/1, Phi KZ, PNM and PT7) and protist (Tetrahymena thermophila and Acanthamoebae polyphaga) enemies. We found that most of the bacteria isolated from relatively recently intermittently colonised patients (1-25 months), were innately phage-resistant and highly toxic for protists. In contrast, bacteria isolated from long time chronically infected patients (2-23 years), were less efficient in both resisting phages and killing protists. Moreover, chronic isolates showed reduced killing of wax moth larvae (Galleria mellonella) probably due to weaker in vitro growth and protease expression. These results suggest that P. aeruginosa long-term adaptation to CF-lungs could trade off with its survival in aquatic environmental reservoirs in the presence of microbial enemies, while lowered virulence could reduce pathogen opportunities to infect insect vectors; factors that are both likely to result in poorer environmental transmission. From an applied perspective, phage therapy could be useful against chronic P. aeruginosa lung infections that are often characterized by multidrug resistance: chronic isolates were least resistant to phages and their poor growth will likely slow down the emergence of beneficial resistance mutations.	[Friman, Ville-Petri; Ghoul, Melanie] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Friman, Ville-Petri; Buckling, Angus] Univ Exeter, Penryn, England; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Johansen, Helle Krogh] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark	University of Oxford; University of Exeter; Technical University of Denmark; Rigshospitalet; University of Copenhagen	Friman, VP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Silwood Pk Campus, Ascot, Berks, England.	vifriman@gmail.com		Friman, Ville-Petri/0000-0002-1592-157X; Molin, Soren/0000-0002-7973-2639; Buckling, Angus/0000-0003-1170-4604	Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme; Wellcome Trust Institutional Strategic Support Fund fellowship; Novo Nordisk Foundation; Danish Research Agency; European Research Council; NERC; BBSRC; Royal Society Wolfson Research Merit award; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); Wellcome Trust Institutional Strategic Support Fund fellowship(Wellcome Trust); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Agency; European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit award(Royal Society of London); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme and Wellcome Trust Institutional Strategic Support Fund fellowship (V. F.). H.K.J. was supported by a Novo Nordisk Foundation clinical research stipend and S. M. was funded by the Danish Research Agency. A. B. acknowledges support from the European Research Council, NERC, BBSRC, and a Royal Society Wolfson Research Merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2012, ADV EXP MED BIOL, V751, P347, DOI 10.1007/978-1-4614-3567-9_16; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; de Bentzmann Sophie, 2011, Environ Microbiol, V13, P1655, DOI 10.1111/j.1462-2920.2011.02469.x; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ELLIOTT AM, 1959, ANNU REV MICROBIOL, V13, P79, DOI 10.1146/annurev.mi.13.100159.000455; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Hauer G, 2005, HYDROBIOLOGIA, V549, P33, DOI 10.1007/s10750-005-2210-1; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P2862, DOI 10.1128/AEM.03817-12; James CE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-216; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OJENIYI B, 1991, APMIS, V99, P925, DOI 10.1111/j.1699-0463.1991.tb01280.x; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Price P W, 1980, Monogr Popul Biol, V15, P1; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Selezska K, 2012, ENVIRON MICROBIOL, V14, P1952, DOI 10.1111/j.1462-2920.2012.02719.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Thompson JN, 1994, COEVOLUTIONARY PROCE, Vxi; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106	59	31	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75380	10.1371/journal.pone.0075380	http://dx.doi.org/10.1371/journal.pone.0075380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069407	gold, Green Published			2022-12-25	WOS:000324777300075
J	Martin, V; Ratel, S; Siracusa, J; Le Ruyet, P; Savary-Auzeloux, I; Combaret, L; Guillet, C; Dardevet, D				Martin, Vincent; Ratel, Sebastien; Siracusa, Julien; Le Ruyet, Pascale; Savary-Auzeloux, Isabelle; Combaret, Lydie; Guillet, Christelle; Dardevet, Dominique			Whey Proteins Are More Efficient than Casein in the Recovery of Muscle Functional Properties following a Casting Induced Muscle Atrophy	PLOS ONE			English	Article							RAT SOLEUS MUSCLE; SKELETAL-MUSCLE; BED REST; UBIQUITIN-PROTEASOME; ELECTRICAL-STIMULATION; RESISTANCE EXERCISE; HINDLIMB SUSPENSION; APOPTOTIC PATHWAYS; BODY-COMPOSITION; DISUSE ATROPHY	The purpose of this study was to investigate the effect of whey supplementation, as compared to the standard casein diet, on the recovery of muscle functional properties after a casting-induced immobilization period. After an initial (I0) evaluation of the contractile properties of the plantarflexors (isometric torque-frequency relationship, concentric power-velocity relationship and a fatigability test), the ankle of 20 male adult rats was immobilized by casting for 8 days. During this period, rats were fed a standard diet with 13% of casein (CAS). After cast removal, rats received either the same diet or a diet with 13% of whey proteins (WHEY). A control group (n = 10), non-immobilized but pair-fed to the two other experimental groups, was also studied and fed with the CAS diet. During the recovery period, contractile properties were evaluated 7 (R7), 21 (R21) and 42 days (R42) after cast removal. The immobilization procedure induced a homogeneous depression of average isometric force at R7 (CAS: - 19.0 +/- 8.2%; WHEY: - 21.7 +/- 8.4%; P<0.001) and concentric power (CAS: - 26.8 +/- 16.4%, P<0.001; WHEY: - 13.5 +/- 21.8%, P<0.05) as compared to I0. Conversely, no significant alteration of fatigability was observed. At R21, isometric force had fully recovered in WHEY, especially for frequencies above 50 Hz, whereas it was still significantly depressed in CAS, where complete recovery occurred only at R42. Similarly, recovery of concentric power was faster at R21 in the 500-700 degrees/s range in the WHEY group. These results suggest that recovery kinetics varied between diets, the diet with the whey proteins promoting a faster recovery of isometric force and concentric power output as compared to the casein diet. These effects were more specifically observed at force level and movement velocities that are relevant for functional abilities, and thus natural locomotion.	[Martin, Vincent; Ratel, Sebastien; Siracusa, Julien] Univ Blaise Pascal, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533,CRNH Auvergne, Clermont Ferrand, France; [Le Ruyet, Pascale] Lactalis Rech & Dev, Retiers, France; [Savary-Auzeloux, Isabelle; Combaret, Lydie; Guillet, Christelle; Dardevet, Dominique] CRNH Auvergne, Unite Nutr Humaine, UMR 1019, INRA, Clermont Ferrand, France; [Guillet, Christelle] Univ Auvergne, Clermont Univ, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE; Universite Clermont Auvergne (UCA)	Martin, V (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533,CRNH Auvergne, Clermont Ferrand, France.	vincent.martin@univ-bpclermont.fr	Martin, Vincent/ABF-7135-2020; SIRACUSA, Julien/I-4344-2016	Martin, Vincent/0000-0002-6681-1610; SIRACUSA, Julien/0000-0001-7715-5199; Dardevet, Dominique/0000-0001-7320-9970; Combaret, Lydie/0000-0001-6550-8700; Savary-Auzeloux, Isabelle/0000-0002-3298-9787	Lactalis Recherche et Developpement	Lactalis Recherche et Developpement	Lactalis Recherche et Developpement funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; BAKER JH, 1988, MUSCLE NERVE, V11, P231, DOI 10.1002/mus.880110308; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Clark BC, 2009, MED SCI SPORT EXER, V41, P1869, DOI 10.1249/MSS.0b013e3181a645a6; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Dangin M, 2001, AM J PHYSIOL-ENDOC M, V280, pE340, DOI 10.1152/ajpendo.2001.280.2.E340; Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630; Dardevet D, 2012, SCI WORLD J, DOI 10.1100/2012/269531; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Ferrando AA, 1997, J APPL PHYSIOL, V82, P807, DOI 10.1152/jappl.1997.82.3.807; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; GIBSON JNA, 1988, LANCET, V2, P767; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Gillette PD, 1996, J APPL PHYSIOL, V81, P724, DOI 10.1152/jappl.1996.81.2.724; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002, DOI 10.1152/jn.2000.83.4.2002; Groskreutz JJ, 2002, AGING CLIN EXP RES, V14, P347; Hoang PD, 2007, MED SCI SPORT EXER, V39, P849, DOI 10.1249/MSS.0b013e318033499b; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; Ishihara A, 1997, AVIAT SPACE ENVIR MD, V68, P421; Jacobsen DE, 2007, MATURITAS, V58, P7, DOI 10.1016/j.maturitas.2007.04.012; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lynn R, 1998, J APPL PHYSIOL, V85, P98, DOI 10.1152/jappl.1998.85.1.98; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; MCDONALD KS, 1992, J APPL PHYSIOL, V73, P1135, DOI 10.1152/jappl.1992.73.3.1135; MERCIER C, 1993, MECH AGEING DEV, V68, P117, DOI 10.1016/0047-6374(93)90144-G; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Slimani L, 2012, AM J PHYSIOL-ENDOC M, V303, pE1335, DOI 10.1152/ajpendo.00379.2012; Snih SA, 2004, AGING CLIN EXP RES, V16, P481, DOI 10.1007/BF03327406; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Varejao ASP, 2002, MUSCLE NERVE, V26, P630, DOI 10.1002/mus.10242; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Warren GL, 2004, EUR J APPL PHYSIOL, V93, P130, DOI 10.1007/s00421-004-1185-3; Washington TA, 2004, J APPL PHYSIOL, V97, P1424, DOI 10.1152/japplphysiol.00222.2004	49	17	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75408	10.1371/journal.pone.0075408	http://dx.doi.org/10.1371/journal.pone.0075408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069411	Green Submitted, gold, Green Published			2022-12-25	WOS:000324777300078
J	Garcia-Vedrenne, AE; Groner, M; Page-Karjian, A; Siegmund, GF; Singhal, S; Sziklay, J; Roberts, S				Garcia-Vedrenne, Ana Elisa; Groner, Maya; Page-Karjian, Annie; Siegmund, Gregor-Fausto; Singhal, Sonia; Sziklay, Jamie; Roberts, Steven			Development of Genomic Resources for a thraustochytrid Pathogen and Investigation of Temperature Influences on Gene Expression	PLOS ONE			English	Article							MERCENARIA-MERCENARIA IMMUNITY; PARASITE UNKNOWN DISEASE; HARD CLAMS; ULTRASTRUCTURAL OBSERVATIONS; LINEAR GRAMICIDIN; WASTING DISEASE; QPX DISEASE; QUAHOG; STRAINS; METALLOPROTEINASE	Understanding how environmental changes influence the pathogenicity and virulence of infectious agents is critical for predicting epidemiological patterns of disease. Thraustochytrids, part of the larger taxonomic class Labyrinthulomycetes, contain several highly pathogenic species, including the hard clam pathogen quahog parasite unknown (QPX). QPX has been associated with large-scale mortality events along the northeastern coast of North America. Growth and physiology of QPX is temperature-dependent, and changes in local temperature profiles influence pathogenicity. In this study we characterize the partial genome of QPX and examine the influence of temperature on gene expression. Genes involved in several biological processes are differentially expressed upon temperature change, including those associated with altered growth and metabolism and virulence. The genomic and transcriptomic resources developed in this study provide a foundation for better understanding virulence, pathogenicity and life history of thraustochytrid pathogens.	[Garcia-Vedrenne, Ana Elisa] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Groner, Maya] Univ Prince Edward Isl, Ctr Vet Epidemiol Res, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Page-Karjian, Annie] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Siegmund, Gregor-Fausto] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Singhal, Sonia] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sziklay, Jamie] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Roberts, Steven] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of Prince Edward Island; University System of Georgia; University of Georgia; University of Chicago; University of Washington; University of Washington Seattle; University of Hawaii System; University of Washington; University of Washington Seattle	Roberts, S (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	sr320@uw.edu	Page-Karjian, Annie/AAX-5668-2021; Groner, Maya L/J-4261-2014	Page-Karjian, Annie/0000-0001-6279-529X; Groner, Maya L/0000-0002-3381-6415; Roberts, Steven/0000-0001-8302-1138; Siegmund, Gregor-Fausto/0000-0002-8967-8816; Sziklay, Jamie/0000-0002-6220-918X; Garcia-Vedrenne, Ana/0000-0002-3518-1564	National Science Foundation [OCE-1215977]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (OCE-1215977 - RCN: Evaluating the Impacts of a Changing Ocean on Management and Ecology of Infectious Marine Disease) to D. Harvell, C. Friedman, E. Hofmann, K. Lafferty and K. McComas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson Robert S., 2002, Journal of Shellfish Research, V21, P404; Anderson RS, 2006, J SHELLFISH RES, V25, P708; Azevedo C, 1997, DIS AQUAT ORGAN, V31, P73, DOI 10.3354/dao031073; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Bongiorni L, 2005, AQUAT MICROB ECOL, V41, P299, DOI 10.3354/ame041299; Bower S. M., 2010, SYNOPSIS INFECT DIS; BOWER SM, 1987, CAN J ZOOL, V65, P2013, DOI 10.1139/z87-306; Brothers C, 2000, BIOL BULL, V199, P200, DOI 10.2307/1542897; Burge CA, 2012, DIS AQUAT ORGAN, V101, P1, DOI 10.3354/dao02487; Calvo LMR, 1998, DIS AQUAT ORGAN, V33, P209, DOI 10.3354/dao033209; Chen RQ, 2003, BIOCHEM BIOPH RES CO, V310, P182, DOI 10.1016/j.bbrc.2003.09.009; Coceres VM, 2012, EXP PARASITOL, V132, P274, DOI 10.1016/j.exppara.2012.08.003; Craven KD, 2005, MYCOLOGIA, V97, P160, DOI 10.3852/mycologia.97.1.160; Dahl SF, 2011, J INVERTEBR PATHOL, V106, P314, DOI 10.1016/j.jip.2010.11.005; Dahl SF, 2010, J SHELLFISH RES, V29, P83, DOI 10.2983/035.029.0131; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Decker Christie-Sue, 2002, Journal of Shellfish Research, V21, P404; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dove ADM, 2004, J AQUAT ANIM HEALTH, V16, P246, DOI 10.1577/H03-052.1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ford SE, 2002, AQUACULTURE, V208, P23, DOI 10.1016/S0044-8486(01)00795-5; Gast RJ, 2008, DIS AQUAT ORGAN, V81, P219, DOI 10.3354/dao01948; Gomez-Chiarri M, 2012, J SHELLFISH RES, V31, P583, DOI 10.2983/035.031.0219; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Holt R. A., 1989, Journal of Aquatic Animal Health, V1, P94, DOI 10.1577/1548-8667(1989)001&lt;0094:ROWTTB&gt;2.3.CO;2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONES GM, 1983, J PARASITOL, V69, P903, DOI 10.2307/3281055; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kleinschuster SJ, 1998, J SHELLFISH RES, V17, P75; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Liu K.-J., 2007, J CANC MOL, V3, P45; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lyons MM, 2006, DIS AQUAT ORGAN, V72, P45, DOI 10.3354/dao072045; MacCallum GS, 2000, DIS AQUAT ORGAN, V77, P159; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; MANDL J, 1985, ARCH MICROBIOL, V143, P248, DOI 10.1007/BF00411244; MCLEAN N, 1987, J INVERTEBR PATHOL, V49, P223, DOI 10.1016/0022-2011(87)90165-0; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1991, MYCOLOGIA, V83, P180, DOI 10.2307/3759933; Ostersetzer O, 1996, PLANT MOL BIOL, V31, P673, DOI 10.1007/BF00042238; Perrigault M, 2011, J INVERTEBR PATHOL, V106, P322, DOI 10.1016/j.jip.2010.11.004; Perrigault M, 2010, J INVERTEBR PATHOL, V104, P83, DOI 10.1016/j.jip.2010.02.005; Perrigault M, 2009, PARASITOLOGY, V136, P1281, DOI 10.1017/S0031182009990606; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rahimian H, 1996, DIS AQUAT ORGAN, V27, P187, DOI 10.3354/dao027187; RISTOW H, 1975, BIOCHIM BIOPHYS ACTA, V390, P246, DOI 10.1016/0005-2787(75)90345-7; Roberts SB, 2013, QPX GENOME BROWSER F, DOI DOI 10.6084/M9.FIGSHARE.701214; Robold AV, 2005, CURR GENET, V47, P307, DOI 10.1007/s00294-004-0559-8; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; SINDERMANN CJ, 1956, MAINE DEP SEA SHORE, V25, P1; Singer S, 1997, J IND MICROBIOL BIOT, V18, P226, DOI 10.1038/sj.jim.2900371; Smolowitz R, 1998, J INVERTEBR PATHOL, V71, P9, DOI 10.1006/jipa.1997.4706; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Wan SG, 2006, TOXICON, V47, P480, DOI 10.1016/j.toxicon.2006.01.006; WHYTE SK, 1994, DIS AQUAT ORGAN, V19, P129, DOI 10.3354/dao019129	63	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74196	10.1371/journal.pone.0074196	http://dx.doi.org/10.1371/journal.pone.0074196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069279	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300031
J	Krieg, SM; Sollmann, N; Hauck, T; Ille, S; Foerschler, A; Meyer, B; Ringel, F				Krieg, Sandro M.; Sollmann, Nico; Hauck, Theresa; Ille, Sebastian; Foerschler, Annette; Meyer, Bernhard; Ringel, Florian			Functional Language Shift to the Right Hemisphere in Patients with Language-Eloquent Brain Tumors	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TEMPORAL-LOBE EPILEPSY; DIRECT CORTICAL STIMULATION; GRADE-II GLIOMAS; DOMINANT HEMISPHERE; WORD RETRIEVAL; CLINICAL ARTICLE; VIRTUAL LESION; AWAKE SURGERY; NAMING ERRORS	Objectives: Language function is mainly located within the left hemisphere of the brain, especially in right-handed subjects. However, functional MRI (fMRI) has demonstrated changes of language organization in patients with left-sided perisylvian lesions to the right hemisphere. Because intracerebral lesions can impair fMRI, this study was designed to investigate human language plasticity with a virtual lesion model using repetitive navigated transcranial magnetic stimulation (rTMS). Experimental design: Fifteen patients with lesions of left-sided language-eloquent brain areas and 50 healthy and purely right-handed participants underwent bilateral rTMS language mapping via an object-naming task. All patients were proven to have left-sided language function during awake surgery. The rTMS-induced language errors were categorized into 6 different error types. The error ratio (induced errors/number of stimulations) was determined for each brain region on both hemispheres. A hemispheric dominance ratio was then defined for each region as the quotient of the error ratio (left/right) of the corresponding area of both hemispheres (ratio >1 = left dominant; ratio <1 = right dominant). Results: Patients with language-eloquent lesions showed a statistically significantly lower ratio than healthy participants concerning "all errors'' and "all errors without hesitations'', which indicates a higher participation of the right hemisphere in language function. Yet, there was no cortical region with pronounced difference in language dominance compared to the whole hemisphere. Conclusions: This is the first study that shows by means of an anatomically accurate virtual lesion model that a shift of language function to the non-dominant hemisphere can occur.	[Krieg, Sandro M.; Sollmann, Nico; Hauck, Theresa; Ille, Sebastian; Meyer, Bernhard; Ringel, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany; [Foerschler, Annette] Tech Univ Munich, Klinikum Rechts Isar, Sect Neuroradiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich	Ringel, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany.	Florian.Ringel@lrz.tum.de	Krieg, Sandro M./L-8902-2016; TUM, Forschung Neurorad/C-1202-2014; Meyer, Bernhard/Q-9413-2016; Ringel, Florian/E-4933-2014; Meyer, Bernhard/AAH-3329-2019; Forschler, Annette/O-9390-2015	Krieg, Sandro M./0000-0003-4050-1531; Meyer, Bernhard/0000-0001-6486-7955; Sollmann, Nico/0000-0002-8120-2223; Forschler, Annette/0000-0001-9665-5228	Department of Neurosurgery; Section of Neuroradiology; TU Munich	Department of Neurosurgery; Section of Neuroradiology; TU Munich	The study was mostly financed by institutional grants from the Department of Neurosurgery and the Section of Neuroradiology, TU Munich, and the authors declare that they have no conflict of interest affecting this study. Moreover, SK received a grant of the "Stiftung Neurochirurgische Forschung" of the German Neurosurgical Society (DGNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum SH, 2012, NEUROIMAGE; Baumgaertner A, 2012, HUM BRAIN MAPP; Billingsley RL, 2001, BRAIN, V124, P1218, DOI 10.1093/brain/124.6.1218; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Briganti C, 2012, AJNR AM J NEURORADIO; Candidi M, 2008, SOC NEUROSCI-UK, V3, P388, DOI 10.1080/17470910701676269; Chang EF, 2011, J NEUROSURG, V114, P893, DOI 10.3171/2010.11.JNS10888; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; Cousin E, 2007, EUR J RADIOL, V63, P274, DOI 10.1016/j.ejrad.2007.01.030; Cousin Emilie, 2008, Neuropsychiatr Dis Treat, V4, P235; Davidson DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00219; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; FitzGerald DB, 1997, AM J NEURORADIOL, V18, P1529; Galluzzi S, 2008, J NEUROL SCI, V273, P3, DOI 10.1016/j.jns.2008.06.023; Geva S, 2012, J COGNITIVE NEUROSCI, V24, P2135, DOI 10.1162/jocn_a_00278; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Goldmann RE, 2005, EPILEPSY BEHAV, V6, P473, DOI 10.1016/j.yebeh.2005.03.012; Griffiths JD, 2012, CEREB CORTEX; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hund-Georgiadis M, 2001, J MAGN RESON IMAGING, V13, P668, DOI 10.1002/jmri.1094; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; Krieg SM, 2012, J NEUROSURG, V116, P994, DOI 10.3171/2011.12.JNS111524; Krieg SM, 2012, CLIN NEUROPHYSIOL; Lioumis P, 2012, J NEUROSCI METH, V204, P349, DOI 10.1016/j.jneumeth.2011.11.003; McGraw P, 2001, NEUROIMAG CLIN N AM, V11, P343; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; OJEMANN GA, 1978, BRAIN LANG, V6, P239, DOI 10.1016/0093-934X(78)90061-5; Orosz A, 2012, NEUROIMAGE, V61, P599, DOI 10.1016/j.neuroimage.2012.03.084; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pellicciari MC, 2009, NEUROSCIENCE, V163, P266, DOI 10.1016/j.neuroscience.2009.06.013; Perrone-Bertolotti M, 2012, EPILEPSY BEHAV, V23, P81, DOI 10.1016/j.yebeh.2011.11.011; Picht T, 2013, NEUROSURGERY, V72, P808, DOI 10.1227/NEU.0b013e3182889e01; Picht T, 2009, NEUROSURGERY, V65, P93, DOI 10.1227/01.NEU.0000348009.22750.59; Robles SG, 2008, J NEUROSURG, V109, P615, DOI 10.3171/JNS/2008/109/10/0615; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Ruohonen J, 1999, EEG CL N SU, P30; Salmelin R, 2000, J CLIN NEUROPHYSIOL, V17, P163, DOI 10.1097/00004691-200003000-00005; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sarubbo S, 2012, ACTA NEUROCHIR, V154, P1653, DOI 10.1007/s00701-012-1416-z; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schuhmann T, 2012, CEREB CORTEX, V22, P701, DOI 10.1093/cercor/bhr155; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Smith AE, 2009, EXP BRAIN RES, V198, P489, DOI 10.1007/s00221-009-1945-8; Sollmann N, 2013, J NEUROSURG, V118, P175, DOI 10.3171/2012.9.JNS121053; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Thiel A, 2005, ANN NEUROL, V57, P128, DOI 10.1002/ana.20342; Thivard L, 2005, NEUROIMAGE, V24, P841, DOI 10.1016/j.neuroimage.2004.10.001; Tracy JI, 2009, CORTEX, V45, P1178, DOI 10.1016/j.cortex.2009.01.007; van de Meerendonk N, 2011, NEUROIMAGE, V54, P2350, DOI 10.1016/j.neuroimage.2010.10.022; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059657; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X; Wheat KL, 2012, BRAIN LANG; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	66	65	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75403	10.1371/journal.pone.0075403	http://dx.doi.org/10.1371/journal.pone.0075403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069410	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300081
J	Shieh, AWY; Chalker, DL				Shieh, Annie Wan Yi; Chalker, Douglas L.			LIA5 Is Required for Nuclear Reorganization and Programmed DNA Rearrangements Occurring during Tetrahymena Macronuclear Differentiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; GENOME-WIDE CHARACTERIZATION; DICER-LIKE PROTEIN; CHROMOSOME BREAKAGE; CHROMODOMAIN PROTEIN; THERMOPHILA; ELIMINATION; HETEROCHROMATIN; REPAIR	During macronuclear differentiation of the ciliate Tetrahymena thermophila, genome-wide DNA rearrangements eliminate nearly 50 Mbp of germline derived DNA, creating a streamlined somatic genome. The transposon-like and other repetitive sequences to be eliminated are identified using a piRNA pathway and packaged as heterochromatin prior to their removal. In this study, we show that LIA5, which encodes a zinc-finger protein likely of transposon origin, is required for both chromosome fragmentation and DNA elimination events. Lia5p acts after the establishment of RNAi-directed heterochromatin modifications, but prior to the excision of the modified sequences. In Delta LIA5 cells, DNA elimination foci, large nuclear sub-structures containing the sequences to be eliminated and the essential chromodomain protein Pdd1p, do not form Lia5p, unlike Pdd1p, is not stably associated with these structures, but is required for their formation. In the absence of Lia5p, we could recover foci formation by ectopically inducing DNA damage by UV treatment. Foci in both wild-type or UV-treated Delta LIA5 cells contain dephosphorylated Pdd1p. These studies of LIA5 reveal that DNA elimination foci form after the excision of germ-line limited sequences occurs and indicate that Pdd1p reorganization is likely mediated through a DNA damage response.	[Shieh, Annie Wan Yi; Chalker, Douglas L.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Chalker, DL (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	dchalker@biology2.wustl.edu		Chalker, Douglas/0000-0002-0285-3344	National Institutes of Health [GM069593]; Biology Department of Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biology Department of Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Institutes of Health research grant (GM069593) to D.L.C. A.W.Y.S. was also supported by funds provided by the Biology Department of Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SL, 1967, GENETICS, V55, P797; AUSTERBERRY CF, 1988, MOL CELL BIOL, V8, P3947, DOI 10.1128/MCB.8.9.3947; Ayoub N, 2009, CELL CYCLE, V8, P2945; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Bruns PJ, 2000, METHOD CELL BIOL, V62, P501; Cassidy-Hanley D, 2005, GENETICS, V170, P1623, DOI 10.1534/genetics.104.031435; CassidyHanley D, 1997, GENETICS, V146, P135; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chalker DL, 2008, BBA-MOL CELL RES, V1783, P2130, DOI 10.1016/j.bbamcr.2008.07.012; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chalker DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-224; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fan QC, 2000, METHOD CELL BIOL, V62, P533; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Hamilton E, 2005, GENETICS, V170, P1611, DOI 10.1534/genetics.104.031401; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lin IT, 2012, MOL BIOL CELL, V23, P2213, DOI 10.1091/mbc.E11-11-0952; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Motl JA, 2011, EUKARYOT CELL, V10, P1648, DOI 10.1128/EC.05216-11; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Orias E, 2000, METHOD CELL BIOL, V62, P189; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Smothers JF, 1997, DEVELOPMENT, V124, P4537; Smothers JF, 1997, J EUKARYOT MICROBIOL, V44, P79, DOI 10.1111/j.1550-7408.1997.tb05942.x; Song XY, 2007, MOL CELL BIOL, V27, P2648, DOI 10.1128/MCB.01910-06; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; YAO M, 1974, CHROMOSOMA, V48, P1; YAO MC, 1994, NUCLEIC ACIDS RES, V22, P5702, DOI 10.1093/nar/22.25.5702; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	59	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75337	10.1371/journal.pone.0075337	http://dx.doi.org/10.1371/journal.pone.0075337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069402	Green Submitted, gold, Green Published			2022-12-25	WOS:000324547300079
J	Zheng, Q; Zeng, TT; Chen, J; Liu, H; Zhang, H; Su, J				Zheng, Qin; Zeng, Ting-ting; Chen, Jiao; Liu, Hua; Zhang, He; Su, Jun			Association between DNA Methyltransferases 3B Gene Polymorphisms and the Susceptibility to Acute Myeloid Leukemia in Chinese Han Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; T PROMOTER POLYMORPHISM; LUNG-CANCER; DNMT3B POLYMORPHISMS; EPIGENETIC CHANGES; BREAST-CANCER; RISK; METHYLATION; MALIGNANCIES; ADENOCARCINOMA	DNMT3B plays a crucial role in the generation of aberrant methylation during carcinogenesis. Polymorphisms in the DNMT3B gene may influence the DNA methylation enzymatic activity of DNMT3B, thereby modulating the susceptibility to AML. Thus, we investigated the association between SNPs in the DNMT3B gene and their haplotypes with the risk of AML in the Chinese Han population. The DNMT3B genotype was determined by HRM in 317 de novo AML patients and 406 healthy control subjects matched for age and gender. Among the 5 SNPs investigated in this study, rs2424913 demonstrated no polymorphisms in the Chinese Han populations, rs1569686 and rs2424908 were significantly associated with AML risk. The GG genotype of rs1569686 was associated with increased AML risk (OR: 5.76; 95% CI: 2.60-12.73; P<0.01) compared with the TT genotype, and individuals with a G allele had a significantly increased risk (OR: 1.89; 95% CI: 1.41-2.52; P<0.01) for AML compared with those harboring a C allele, this polymorphism can predict the risk of AML in a minority of patients. While the CC genotype of rs2424908 appeared to reduce the AML risk (OR: 0.57; 95% CI: 0.36-0.91; P=0.01) compared with the TT genotype, individuals with a C allele were associated with a lower risk (OR: 0.79, 95% CI: 0.64-0.97, P=0.03) for developing AML compared with those harboring a T allele. The other 2 SNPs, rs6087990 and rs6119954, had no significant association with AML risk in the study population. The CGGT, CTAT, TGAT, and CGAT haplotypes of rs6087990, rs1569686, rs6119954, and rs2424908 appeared to significantly increase the AML risk, and the TTGC haplotype appeared to significantly reduce the risk. These results suggest that DNMT3B polymorphisms may contribute to the genetic susceptibility to AML; in particular, the G allele of rs1569686 serves as a risk factor for AML, whereas the C allele of rs2424908 represents a potential protective factor.	[Zheng, Qin; Zeng, Ting-ting; Chen, Jiao; Liu, Hua; Zhang, He; Su, Jun] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Su, J (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	sjhuaxi1667@163.com	chen, JJ/HGB-6029-2022; CHEN, JIAO/GZA-5784-2022		National Natural Science Foundation of China [81201343]; science and technology project of Sichuan Province of China [2011SZ0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology project of Sichuan Province of China	This work received financial support from the National Natural Science Foundation of China (Grant no. 81201343) and the science and technology project of Sichuan Province of China (Grant no. 2011SZ0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung PP, 2005, ONCOL REP, V14, P1151; Bao Q, 2011, INT J COLORECTAL DIS, V26, P1107, DOI 10.1007/s00384-011-1199-3; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Chang KP, 2007, ORAL ONCOL, V43, P345, DOI 10.1016/j.oraloncology.2006.04.006; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fan H, 2008, WORLD J GASTROENTERO, V14, P2230, DOI 10.3748/wjg.14.2230; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Greif PA, 2012, BLOOD, V120, P395, DOI 10.1182/blood-2012-01-403220; Gronbaek K, 2012, HAEMATOL-HEMATOL J, V97, P1380, DOI 10.3324/haematol.2011.058305; Hong YS, 2007, BIOCHEM GENET, V45, P155, DOI 10.1007/s10528-006-9047-9; Juhl-Christensen C, 2012, PEDIATR BLOOD CANCER, V58, P525, DOI 10.1002/pbc.23397; Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31; Khandanpour C, 2012, BLOOD, V120, P4006, DOI 10.1182/blood-2011-02-334722; Khorshied MM, 2012, GENE, V511, P34, DOI 10.1016/j.gene.2012.09.024; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Liu H, 2012, EXP THER MED, V3, P525, DOI 10.3892/etm.2011.420; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Montgomery KG, 2004, BREAST CANCER RES, V6, pR390, DOI 10.1186/bcr807; Rithidech KN, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2007.01.019; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schoofs T, 2013, BLOOD, V121, P178, DOI 10.1182/blood-2012-08-448860; Shen HB, 2002, CANCER RES, V62, P4992; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sun MY, 2012, GENET MOL RES, V11, P4330, DOI 10.4238/2012.September.26.1; Thomas A, 2012, BLOOD, V119, P2731, DOI 10.1182/blood-2011-12-381426; Wang J, 2006, CANCER RES, V66, P8361, DOI 10.1158/0008-5472.CAN-06-2031; Wang YM, 2005, WORLD J GASTROENTERO, V11, P3623, DOI 10.3748/wjg.v11.i23.3623; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yan P, 2012, BLOOD, V120, P2466, DOI 10.1182/blood-2012-05-429175	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74626	10.1371/journal.pone.0074626	http://dx.doi.org/10.1371/journal.pone.0074626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069326	Green Submitted, gold, Green Published			2022-12-25	WOS:000324547300047
J	Jensen, AB; Hoestgaard-Jensen, K; Jensen, AA				Jensen, Anne B.; Hoestgaard-Jensen, Kirsten; Jensen, Anders A.			Elucidation of Molecular Impediments in the alpha 6 Subunit for in Vitro Expression of Functional alpha 6 beta 4* Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Cys-loop Receptors; Ion Channels; Neurotransmitter Receptors; Nicotinic Acetylcholine Receptors	SINGLE-CHANNEL CONDUCTANCE; DOPAMINE RELEASE; PARTIAL AGONIST; SAZETIDINE-A; NEURONS; ALPHA-4-BETA-2; DETERMINANTS; PHARMACOLOGY; ACTIVATION; SUBTYPES	Explorations into the 6-containing nicotinic acetylcholine receptors (6* nAChRs) as putative drug targets have been severely hampered by the inefficient functional expression of the receptors in heterologous expression systems. In this study, the molecular basis for the problem was investigated through the construction of chimeric 6/3 and mutant 3 and 6 subunits and functional characterization of these co-expressed with 4 or 43 subunits in tsA201 cells in a fluorescence-based assay and in Xenopus oocytes using two-electrode voltage clamp electrophysiology. Substitution of a small C-terminal segment in the second intracellular loop or the Phe(223) residue in transmembrane helix 1 of 6 with the corresponding 3 segment or residue was found to enhance 64 functionality in tsA201 cells significantly, in part due to increased cell surface expression of the receptors. The gain-of-function effects of these substitutions appeared to be additive since incorporation of both 3 elements into 6 resulted in assembly of 64* receptors exhibiting robust functional responses to acetylcholine. The pharmacological properties exhibited by 643 receptors comprising one of these novel 6/3 chimeras in oocytes were found to be in good agreement with those from previous studies of 6* nAChRs formed from other surrogate 6 subunits or concatenated subunits and studies of other heteromeric nAChRs. In contrast, co-expression of this 6/3 chimera with 2 or 23 subunits in oocytes did not result in efficient formation of functional receptors, indicating that the identified molecular elements in 6 could be specific impediments for the expression of functional 64* nAChRs.	[Jensen, Anne B.; Hoestgaard-Jensen, Kirsten; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	aaj@sund.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052	Lundbeck Foundation; Aase and Ejner Danielsen Foundation; Carlsberg Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R9-2007-928, R77-2010-6692] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Aase and Ejner Danielsen Foundation; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, The Aase and Ejner Danielsen Foundation, the Carlsberg Foundation, and the Novo Nordisk Foundation. Part of this work was presented in the form of a poster at the Society of Neuroscience conference in New Orleans on October 15, 2012.	Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; CACHELIN AB, 1995, PFLUG ARCH EUR J PHY, V429, P449, DOI 10.1007/BF00374164; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Hansen KB, 2009, METHODS MOL BIOL, V552, P343, DOI 10.1007/978-1-60327-317-6_25; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2007, PHARMACOGENET GENOM, V17, P255, DOI 10.1097/FPC.0b013e3280117269; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Perez XA, 2010, MOL PHARMACOL, V78, P971, DOI 10.1124/mol.110.067561; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Zhang J, 1999, MOL PHARMACOL, V55, P970, DOI 10.1124/mol.55.6.970; Zoli M, 2002, J NEUROSCI, V22, P8785; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	54	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33708	33721		10.1074/jbc.M113.509356	http://dx.doi.org/10.1074/jbc.M113.509356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24085295	hybrid, Green Published			2022-12-25	WOS:000327250200018
J	Gupta, SC; Francis, SK; Nair, MS; Mo, YY; Aggarwal, BB				Gupta, Subash C.; Francis, Sajin K.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.			Azadirone, a Limonoid Tetranortriterpene, Induces Death Receptors and Sensitizes Human Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) through a p53 Protein-independent Mechanism EVIDENCE FOR THE ROLE OF THE ROS-ERK-CHOP-DEATH RECEPTOR PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Cancer Therapy; MAP Kinases (MAPKs); Reactive Oxygen Species (ROS); Trail; CHOP; Death Receptor; Limonoid	NF-KAPPA-B; MELIA-AZADIRACHTA L; DOWN-REGULATION; UP-REGULATION; APO2L/TRAIL-INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; MEDIATED APOPTOSIS; ANTITUMOR-ACTIVITY; SURVIVAL PROTEINS; COLON-CARCINOMA	Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown efficacy in a phase 2 clinical trial, development of resistance to TRAIL by tumor cells is a major roadblock. We investigated whether azadirone, a limonoidal tetranortriterpene, can sensitize human tumor cells to TRAIL. Results indicate that azadirone sensitized cancer cells to TRAIL. The limonoid induced expression of death receptor (DR) 5 and DR4 but did not affect expression of decoy receptors in cancer cells. The induction of DRs was mediated through activation of ERK and through up-regulation of a transcription factor CCAAT enhancer-binding protein homologous protein (CHOP) as silencing of these signaling molecules abrogated the effect of azadirone. These effects of azadirone were cancer cell-specific. The CHOP binding site on the DR5 gene was required for induction of DR5 by azadirone. Up-regulation of DRs was mediated through the generation of reactive oxygen species (ROS) as ROS scavengers reduced the effect of azadirone on ERK activation, CHOP up-regulation, DR induction, and TRAIL sensitization. The induction of DRs by this limonoid was independent of p53, but sensitization to TRAIL was p53-dependent. The limonoid down-regulated the expression of cell survival proteins and up-regulated the proapoptotic proteins. The combination of azadirone with TRAIL was found to be additive at concentrations lower than IC50, whereas at higher concentrations, the combination was synergistic. Overall, this study indicates that azadirone can sensitize cancer cells to TRAIL through ROS-ERK-CHOP-mediated up-regulation of DR5 and DR4 signaling, down-regulation of cell survival proteins, and up-regulation of proapoptotic proteins.	[Gupta, Subash C.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Francis, Sajin K.; Nair, Mangalam S.] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India; [Gupta, Subash C.; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); University of Mississippi; University of Mississippi Medical Center	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Gupta, Subash/AAF-2563-2019; Mo, Yin-Yuan/R-8255-2019; Aggarwal, Bharat B/G-3388-2013	Gupta, Subash/0000-0002-0418-1940; 	National Institutes of Health [CA124787-01A2]; Malaysian Palm Oil Board; NATIONAL CANCER INSTITUTE [P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaysian Palm Oil Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant CA124787-01A2. This work was also supported by a grant from the Malaysian Palm Oil Board.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chianese G, 2010, J NAT PROD, V73, P1448, DOI 10.1021/np100325q; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ekong D.E.U, 1967, CHEM COMMUN, DOI [10.1039/C1967000808A, DOI 10.1039/C1967000808A]; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; Kim JH, 2012, ANTIOXID REDOX SIGN, V16, P413, DOI 10.1089/ars.2011.3982; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; LAVIE D, 1967, CHEM COMMUN, P278, DOI 10.1039/c19670000278; LAVIE D, 1971, TETRAHEDRON, V27, P3927, DOI 10.1016/S0040-4020(01)98254-7; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nanduri S, 2003, BIOORG MED CHEM LETT, V13, P4111, DOI 10.1016/j.bmcl.2003.08.030; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Paul R, 2011, CANCER BIOL THER, V12, P467, DOI 10.4161/cbt.12.6.16850; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Rodriguez B, 2003, MAGN RESON CHEM, V41, P206, DOI 10.1002/mrc.1159; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Schwinger M., 1984, P 2 INT NEEM C RAUIS, P181; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siddiqui BS, 2006, NAT PROD RES, V20, P241, DOI 10.1080/14786410500059318; Siddiqui S, 1942, CURR SCI, V11, P278; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; Velculescu VE, 1996, CLIN CHEM, V42, P858; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161	54	57	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32343	32356		10.1074/jbc.M113.455188	http://dx.doi.org/10.1074/jbc.M113.455188			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078627	Green Published, hybrid			2022-12-25	WOS:000328681700020
J	Isticato, R; Sirec, T; Giglio, R; Baccigalupi, L; Rusciano, G; Pesce, G; Zito, G; Sasso, A; De Felice, M; Ricca, E				Isticato, Rachele; Sirec, Teja; Giglio, Rosa; Baccigalupi, Loredana; Rusciano, Giulia; Pesce, Giuseppe; Zito, Gianluigi; Sasso, Antonio; De Felice, Maurilio; Ricca, Ezio			Flexibility of the Programme of Spore Coat Formation in Bacillus subtilis: Bypass of CotE Requirement by Over-Production of CotH	PLOS ONE			English	Article							SURFACE-ENHANCED RAMAN; GENE; SPORULATION; RESISTANCE; EXPRESSION; ENDOSPORE; LOCALIZATION	Bacterial spores are surrounded by the coat, a multilayered shell that contributes in protecting the genome during stress conditions. In Bacillus subtilis, the model organism for spore formers, the coat is composed by about seventy different proteins, organized into four layers by the action of several regulatory proteins. A major component of this regulatory network, CotE, is needed to assemble the outer coat and develop spores fully resistant to lysozyme and able to germinate efficiently. Another regulator, CotH, is controlled by CotE and is present in low amounts both during sporulation and in mature spores. In spite of this CotH controls the assembly of at least nine outer coat proteins and cooperates with CotE in producing fully resistant and efficiently germinating spores. In order to improve our understanding of CotH role in spore formation, we over-produced CotH by placing its coding region under the control of a promoter stronger than its own promoter but with a similar timing of activity during sporulation. Over-production of CotH in an otherwise wild type strain did not cause any major effect, whereas in a cotE null background a partial recovery of the phenotypes associated to the cotE null mutation was observed. Western blot, fluorescence microscopy and Surface-Enhanced Raman Scattering spectroscopy data indicate that, in the absence of CotE, over-production of CotH allowed the formation of spores overall resembling wild type spores and carrying in their coat some CotE-/CotH-dependant proteins. Our results suggest that the B. subtilis spore differentiation programme is flexible, and that an increase in the amount of a regulatory protein can replace a missing partner and partially substitute its function in the assembly of the spore coat.	[Isticato, Rachele; Sirec, Teja; Giglio, Rosa; Baccigalupi, Loredana; De Felice, Maurilio; Ricca, Ezio] Univ Naples Federico II, Dept Biol, Naples, Italy; [Rusciano, Giulia; Pesce, Giuseppe; Zito, Gianluigi; Sasso, Antonio] Univ Naples Federico II, Dept Phys, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Ricca, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	ericca@unina.it	Pesce, Giuseppe/AAX-8652-2020; Zito, Gianluigi/AAY-2420-2020; Isticato, Rachele/J-3476-2012; Ricca, Ezio/AAG-2998-2020; Rusciano, Giulia/A-2079-2010; ISTICATO, Rachele/AAX-9972-2021; Zito, Gianluigi/P-9424-2018; Pesce, Giuseppe/B-9618-2009	Zito, Gianluigi/0000-0003-2376-0080; Ricca, Ezio/0000-0002-7355-0332; Rusciano, Giulia/0000-0002-7152-5352; ISTICATO, Rachele/0000-0001-9141-4038; Zito, Gianluigi/0000-0003-2376-0080; Pesce, Giuseppe/0000-0002-2806-9769; Sasso, Antonio/0000-0003-3591-3531; Baccigalupi, Loredana/0000-0003-3070-161X	EU [KBBE-476 2007-207948]	EU(European Commission)	This work was supported by a grant (KBBE-476 2007-207948) from the EU 7th Framework to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccigalupi L, 2004, MICROBIOL-SGM, V150, P3441, DOI 10.1099/mic.0.27356-0; Costa T, 2007, J BACTERIOL, V189, P2401, DOI 10.1128/JB.01353-06; Cutting S., 1990, MOL BIOL METHODS BAC; DRIKS A, 1994, GENE DEV, V8, P234, DOI 10.1101/gad.8.2.234; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Giglio R, 2011, J BACTERIOL, V193, P6664, DOI 10.1128/JB.06121-11; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2008, J BACTERIOL, V190, P1267, DOI 10.1128/JB.01425-07; Isticato R, 2007, BIOTECHNIQUES, V42, P149, DOI 10.2144/000112329; Isticato R, 2010, J BACTERIOL, V192, P949, DOI 10.1128/JB.01408-09; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; LOSICK R, 1986, ANNU REV GENET, V20, P625, DOI 10.1146/annurev.ge.20.120186.003205; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Naclerio G, 1996, J BACTERIOL, V178, P4375, DOI 10.1128/jb.178.15.4375-4380.1996; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; RICCA E, 1992, J BACTERIOL, V174, P3177, DOI 10.1128/jb.174.10.3177-3184.1992; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDMAN K, 1988, J MOL BIOL, V200, P461, DOI 10.1016/0022-2836(88)90536-0; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Svedberg F, 2006, FARADAY DISCUSS, V132, P35, DOI 10.1039/b509301p; Vepachedu VR, 2005, J BACTERIOL, V187, P5677, DOI 10.1128/JB.187.16.5677-5682.2005; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; Zilhao R, 2004, J BACTERIOL, V186, P1110, DOI 10.1128/JB.186.4.1110-1119.2004; Zilhao R, 1999, J BACTERIOL, V181, P2631	31	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74949	10.1371/journal.pone.0074949	http://dx.doi.org/10.1371/journal.pone.0074949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086406	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900032
J	Liu, NM; Yokota, T; Maekawa, S; Lu, P; Tei, I; Taniguchi, H; Yokoyama, U; Kato, T; Minamisawa, S				Liu, Norika Mengchia; Yokota, Tomohiro; Maekawa, Shun; Lue, Ping; Tei, Inbun; Taniguchi, Hideki; Yokoyama, Utako; Kato, Takashi; Minamisawa, Susumu			Transcription Profiles of Endothelial Cells in the Rat Ductus Arteriosus during a Perinatal Period	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; VITAMIN-A; PULMONARY-ARTERY; PROGENITOR CELLS; EXPRESSION; CLOSURE; MATURATION; PLASTICITY; PATENCY; SYSTEM	Endothelial cells (ECs) lining the blood vessels serve a variety of functions and play a central role in the homeostasis of the circulatory system. Since the ductus arteriosus (DA) has different arterial characteristics from its connecting vessels, we hypothesized that ECs of the DA exhibited a unique gene profile involved in the regulation of DA-specific morphology and function. Using a fluorescence-activated cell sorter, we isolated ECs from pooled tissues from the DA or the descending aorta of Wistar rat fetuses at full-term of gestation (F group) or neonates 30 minutes after birth (N group). Using anti-CD31 and anti-CD45 antibodies as cell surface markers for ECs and hematopoietic derived cells, respectively, cDNAs from the CD31-positive and CD45-negative cells were hybridized to the Affymetrix GeneChip (R) Rat Gene 1.0 ST Array. Among 26,469 gene-level probe sets, 82 genes in the F group and 81 genes in the N group were expressed at higher levels in DA ECs than in aortic ECs (p<0.05, fold change>2.0). In addition to well-known endothelium-enriched genes such as Tgfb2 and Vegfa, novel DA endothelium-dominant genes including Slc38a1, Capn6, and Lrat were discovered. Enrichment analysis using GeneGo MetaCore software showed that DA endothelium-related biological processes were involved in morphogenesis and development. We identified many overlapping genes in each process including neural crest-related genes (Hoxa1, Hoxa4, and Hand2, etc) and the second heart field-related genes (Tbx1, Isl1, and Fgf10, etc). Moreover, we found that regulation of epithelial-to-mesenchymal transition, cell adhesion, and retinol metabolism are the active pathways involved in the network via potential interactions with many of the identified genes to form DA-specific endothelia. In conclusion, the present study uncovered several significant differences of the transcriptional profile between the DA and aortic ECs. Newly identified DA endothelium-dominant genes may play an important role in DA-specific functional and morphologic characteristics.	[Liu, Norika Mengchia; Yokota, Tomohiro; Lue, Ping; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Maekawa, Shun; Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; [Lue, Ping; Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Tokyo, Japan; [Tei, Inbun; Taniguchi, Hideki] Yokohama City Univ, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan; [Yokoyama, Utako] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan	Waseda University; Waseda University; Jikei University; Yokohama City University; Yokohama City University	Minamisawa, S (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan.	sminamis@jikei.ac.jp	Maekawa, Shun/AAL-2657-2020; Zheng, Yun-Wen/R-2874-2019; Kato, Takashi/AFO-2557-2022; Yokoyama, Utako/AAD-1404-2022	Maekawa, Shun/0000-0002-2406-2201; Zheng, Yun-Wen/0000-0001-9002-3190; Kato, Takashi/0000-0003-0384-7971; Yokoyama, Utako/0000-0003-1803-0155; Yokota, Tomohiro/0000-0003-2540-3810; Minamisawa, Susumu/0000-0003-4728-2116; Liu, Norika/0000-0002-0033-9253	Ministry of Education, Culture, Sports, Science and Technology of Japan; Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; MEXT; Vehicle Racing Commemorative Foundation; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Shimabara Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Shimabara Science Promotion Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (U.Y., S. M.), a Grant-in-Aid for Scientific Research on Innovative Areas (U.Y.,), the Yokohama Foundation for Advanced Medical Science (U.Y., S. M.), the "High-Tech Research Center" Project for Private Universities: MEXT (T. K., S. M.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (T. K., S. M.), the Vehicle Racing Commemorative Foundation (U.Y., S. M.), Miyata Cardiology Research Promotion Funds (U.Y.), the Takeda Science Foundation (U.Y., S. M.), and the Shimabara Science Promotion Foundation (S. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren P, 2008, J PHYSIOL PHARMACOL, V59, P55; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Akaike T, 2009, J BIOL CHEM, V284, P24025, DOI 10.1074/jbc.M109.017061; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Baragatti B, 2007, BRIT J PHARMACOL, V151, P54, DOI 10.1038/sj.bjp.0707211; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1998, CIRC RES, V82, P221; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Bokenkamp R, 2006, PEDIATR RES, V60, P407, DOI 10.1203/01.pdr.0000238243.37116.a6; Bokenkamp R, 2010, NEONATOLOGY, V98, P6, DOI 10.1159/000262481; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; BOUDREAU N, 1992, LAB INVEST, V67, P350; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; COBURN RF, 1986, CIRC RES, V58, P341, DOI 10.1161/01.RES.58.3.341; Colbert MC, 1996, CIRC RES, V78, P790, DOI 10.1161/01.RES.78.5.790; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; DEREEDER EG, 1988, AM J PATHOL, V132, P574; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Fox JJ, 1996, AM J PHYSIOL-HEART C, V271, pH2638, DOI 10.1152/ajpheart.1996.271.6.H2638; Golzio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030677; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537; Makki N, 2012, HUM MOL GENET, V21, P26, DOI 10.1093/hmg/ddr434; Momma K, 1998, PEDIATR RES, V43, P629, DOI 10.1203/00006450-199805000-00011; Moonen JRAJ, 2010, CARDIOVASC RES, V86, P506, DOI 10.1093/cvr/cvq012; RANA MS, 2013, AM J MED GENETICS A; Ravishankar C, 2003, J PEDIATR-US, V143, P644, DOI 10.1067/S0022-3476(03)00501-8; Smith GCS, 1998, PHARMACOL REV, V50, P35; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Watanabe Y, 2010, ANN NY ACAD SCI, V1188, P15, DOI 10.1111/j.1749-6632.2009.05078.x; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Wu GR, 2001, PEDIATR RES, V49, P747, DOI 10.1203/00006450-200106000-00006; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2007, PHYSIOL GENOMICS, V31, P139, DOI 10.1152/physiolgenomics.00007.2006; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Zhou B, 1998, PEDIATR RES, V44, P865, DOI 10.1203/00006450-199812000-00007; Zile MH, 2010, NUTRIENTS, V2, P532, DOI 10.3390/nu2050532	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73685	10.1371/journal.pone.0073685	http://dx.doi.org/10.1371/journal.pone.0073685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086288	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900018
J	Powers, SP; Hernandez, FJ; Condon, RH; Drymon, JM; Free, CM				Powers, Sean P.; Hernandez, Frank J.; Condon, Robert H.; Drymon, J. Marcus; Free, Christopher M.			Novel Pathways for Injury from Offshore Oil Spills: Direct, Sublethal and Indirect Effects of the Deepwater Horizon Oil Spill on Pelagic Sargassum Communities	PLOS ONE			English	Article							GULF-OF-MEXICO; PATTERNS; HABITAT; FISHES	The pelagic brown alga Sargassum forms an oasis of biodiversity and productivity in an otherwise featureless ocean surface. The vast pool of oil resulting from the Deepwater Horizon oil spill came into contact with a large portion of the Gulf of Mexico's floating Sargassum mats. Aerial surveys performed during and after the oil spill show compelling evidence of loss and subsequent recovery of Sargassum. Expanding on the trends observed in the aerial surveys, we conducted a series of mesocosm experiments to test the effect of oil and dispersants on the vertical position and weight of the Sargassum complex (Sargassum natans and S. fluitans), as well as on the dissolved oxygen concentrations surrounding the algae. Dispersant and dispersed-oil had significant effects on the vertical position of both species of Sargassum over a period of 72 hours. Similarly, dissolved oxygen concentrations were lowest in dispersant and dispersed-oil treatments, respectively. Cumulatively, our findings suggest three pathways for oil-spill related injury: (1) Sargassum accumulated oil on the surface exposing animals to high concentrations of contaminants; (2) application of dispersant sank Sargassum, thus removing the habitat and potentially transporting oil and dispersant vertically; and (3) low oxygen surrounded the habitat potentially stressing animals that reside in the alga. These pathways represent direct, sublethal, and indirect effects of oil and dispersant release that minimize the ecosystem services provided by floating Sargassum - the latter two effects are rarely considered in assessing impacts of oil spills or response procedures.	[Powers, Sean P.; Drymon, J. Marcus] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Powers, Sean P.; Hernandez, Frank J.; Condon, Robert H.; Drymon, J. Marcus; Free, Christopher M.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Powers, SP (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	spowers@disl.org	Free, Christopher/N-2813-2013; Free, Christopher Michael/AAC-5103-2019	Free, Christopher/0000-0002-2557-8920; Free, Christopher Michael/0000-0002-2557-8920; Hernandez, Frank/0000-0002-0757-2525; Powers, Sean/0000-0002-4770-9944	NSF RAPID grant from the Division of Ocean Sciences; Gulf of Mexico Research Initiative Phase I; Gulf of Mexico Research Initiative Phase III	NSF RAPID grant from the Division of Ocean Sciences; Gulf of Mexico Research Initiative Phase I; Gulf of Mexico Research Initiative Phase III	The study was funded by a NSF RAPID grant from the Division of Ocean Sciences (SPP and FJH), Gulf of Mexico Research Initiative Phase I (RHC) and III (SPP and FJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbriano RM, 2011, OCEANOGRAPHY, V24, P294, DOI 10.5670/oceanog.2011.80; BORTONE S A, 1977, Northeast Gulf Science, V1, P60; CARPENTER EJ, 1974, LIMNOL OCEANOGR, V19, P429, DOI 10.4319/lo.1974.19.3.0429; Coston-Clements L., 1991, NMFSSEFSC296 NOAA; Craig BA, 2004, MAR MAMMAL SCI, V20, P386, DOI 10.1111/j.1748-7692.2004.tb01168.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DOOLEY JK, 1972, CONTRIB MAR SCI, V16, P1; Driskell WB, 2001, ECOL APPL, V11, P815; Environmental Response Management Application (ERMA), ACT REP DEEPW HOR MC; FALLER AJ, 1964, J MAR RES, V22, P22; Fingas M., 2008, REV LIT RELATED OIL; Gower J., 2008, NATURE P; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Henry C, 2005, P 2005 INT OIL SPILL, P4; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; HURKA H, 1971, MAR BIOL, V11, P82, DOI 10.1007/BF00348024; JOHNSON DL, 1977, J EXP MAR BIOL ECOL, V28, P255, DOI 10.1016/0022-0981(77)90095-8; LAPOINTE BE, 1995, LIMNOL OCEANOGR, V40, P625, DOI 10.4319/lo.1995.40.3.0625; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Ortmann AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042548; PARR ALBERT EIDE, 1939, BULL BINGHAM OCEANOGR COLL PEABODY MUS NAT HIST, V6, P1; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; South Atlantic Fishery Management Council, 2002, FISH MAN PLAN PEL SA, P1; Szekielda KH, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3431044; Wells RJD, 2004, B MAR SCI, V74, P81; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970	30	21	23	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74802	10.1371/journal.pone.0074802	http://dx.doi.org/10.1371/journal.pone.0074802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086378	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700039
J	Cheng, XF; Virk, N; Chen, W; Ji, SQ; Ji, SX; Sun, YQ; Wu, XY				Cheng, Xiaofei; Virk, Nasar; Chen, Wei; Ji, Shuqin; Ji, Shuxian; Sun, Yuqiang; Wu, Xiaoyun			CpG Usage in RNA Viruses: Data and Hypotheses	PLOS ONE			English	Article							DNA METHYLATION; STRANDED-RNA; CYTOSINE METHYLATION; TOLL; DINUCLEOTIDE; PATTERNS; GENOMES; HOST; BIAS; RECOGNITION	CpG repression in RNA viruses has been known for decades, but a reasonable explanation has not yet been proposed to explain this phenomenon. In this study, we calculated the CpG odds ratio of all RNA viruses that have available genome sequences and analyzed the correlation with their genome polarity, base composition, synonymous codon usage, phylogenetic relationship, and host. The results indicated that the viral base composition, synonymous codon usage and host selection were the dominant factors that determined the CpG bias in RNA viruses. CpG usage variation between the different viral groups was caused by different combinations of these pressures, which also differed from each other in strength. The consistent under-representation of CpG usage in -ssRNA viruses is determined predominantly by base composition, which may be a consequence of the U/A preferred mutation bias of -ssRNA viruses, whereas the CpG usage of +ssRNA viruses is affected greatly by their hosts. As a result, most +ssRNA viruses mimic their hosts' CpG usage. Unbiased CpG usage in dsRNA viruses is most likely a result of their dsRNA genome, which allows the viruses to escape from the host-driven CpG elimination pressure. CpG was under-represented in all reverse-transcribing viruses (RT viruses), suggesting that DNA methylation is an important factor affecting the CpG usage of retroviruses. However, vertebrate-infecting RT viruses may also suffer host' CpG elimination pressure that also acts on +ssRNA viruses, which results in further under-representation of CpG in the vertebrate-infecting RT viruses.	[Cheng, Xiaofei; Chen, Wei; Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Virk, Nasar] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Islamabad, Pakistan; [Ji, Shuqin; Wu, Xiaoyun] Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Linan, Zhejiang, Peoples R China; [Ji, Shuxian] Zhejiang Univ Sci & Technol, Sch Econ & Management, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; National University of Sciences & Technology - Pakistan; Zhejiang A&F University; Zhejiang University of Science & Technology	Cheng, XF (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	xfcheng@hznu.edu.cn; wxy@zafu.edu.cn	Cheng, Xiaofei/M-6239-2014; Cheng, Xiaofei/AAT-2600-2020	Cheng, Xiaofei/0000-0002-9771-9059; 	Natural Science Foundation of China [31101417, 31101415]; Natural Science Foundation of Zhejiang Province [Y3110175, Y3110277]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the Natural Science Foundation of China (Project No. 31101417 and 31101415) and the Natural Science Foundation of Zhejiang Province (Project No: Y3110175 and Y3110277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Cheng XF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-113; De Amicis F, 2000, NUCLEIC ACIDS RES, V28, P3339, DOI 10.1093/nar/28.17.3339; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Elango N, 2008, MOL BIOL EVOL, V25, P1602, DOI 10.1093/molbev/msn110; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Ellis J, 2007, CELL, V131, P13, DOI 10.1016/j.cell.2007.09.029; Eyre-Walker A, 1999, GENETICS, V152, P675; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hohn T, 2011, BBA-GENE REGUL MECH, V1809, P588, DOI 10.1016/j.bbagrm.2011.06.002; Hollander M, 1973, NONPARAMETRIC STAT M; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Leung DC, 2012, TRENDS BIOCHEM SCI, V37, P127, DOI 10.1016/j.tibs.2011.11.006; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Megremis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044557; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; SHPAER EG, 1990, NUCLEIC ACIDS RES, V18, P5793, DOI 10.1093/nar/18.19.5793; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; Wang Y, 2004, J MOL EVOL, V58, P692, DOI 10.1007/s00239-004-2591-1; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	44	88	90	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74109	10.1371/journal.pone.0074109	http://dx.doi.org/10.1371/journal.pone.0074109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086312	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200021
J	Miller, KA; Williams, LH; Dahl, HHM; Manji, SSM				Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.			Eeyore: A Novel Mouse Model of Hereditary Deafness	PLOS ONE			English	Article							HEARING-LOSS; MOLECULAR CHARACTERIZATION; XERODERMA-PIGMENTOSUM; HISTAMINE-RECEPTOR; CADHERIN GENE; HUMAN-DISEASE; INNER-EAR; TIP-LINK; MUTATIONS; EXPRESSION	Animal models that recapitulate human disease are proving to be an invaluable tool in the identification of novel disease-associated genes. These models can improve our understanding of the complex genetic mechanisms involved in disease and provide a basis to guide therapeutic strategies to combat these conditions. We have identified a novel mouse model of non-syndromic sensorineural hearing loss with linkage to a region on chromosome 18. Eeyore mutant mice have early onset progressive hearing impairment and show abnormal structure of the sensory epithelium from as early as 4 weeks of age. Ultrastructural and histological analyses show irregular hair cell structure and degeneration of the sensory hair bundles in the cochlea. The identification of new genes involved in hearing is central to understanding the complex genetic pathways involved in the hearing process and the loci at which these pathways are interrupted in people with a genetic hearing loss. We therefore discuss possible candidate genes within the linkage region identified in eeyore that may underlie the deafness phenotype in these mice. Eeyore provides a new model of hereditary sensorineural deafness and will be an important tool in the search for novel deafness genes.	[Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Univ Melbourne, HEARing CRC Audiol Hearing & Speech Sci, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Manji, Shehnaaz S. M.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Otolaryngol, East Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Victorian Eye & Ear Hospital; University of Melbourne	Miller, KA (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	kerry.miller@mcri.edu.au			NHMRC [436944]; J. & J. Calvert-Jones; Victorian Government's Operational Infrastructure Support (OIS) Program; HEARing CRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones; Victorian Government's Operational Infrastructure Support (OIS) Program; HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by NHMRC grant #436944, J. & J. Calvert-Jones and the Victorian Government's Operational Infrastructure Support (OIS) Program. The authors acknowledge the financial support from the HEARing CRC, established and supported under the Cooperative Research Centers Program, an Australian Government Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2002, TRENDS MOL MED, V8, P447, DOI 10.1016/S1471-4914(02)02388-2; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Avraham KB, 2003, EAR HEARING, V24, P332, DOI 10.1097/01.AUD.0000079840.96472.DB; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P11767; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bruzzone R, 2005, NAT CELL BIOL, V7, P14, DOI 10.1038/ncb0105-14; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; KANDA Y, 1974, J BIOL CHEM, V249, P6796; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi N, 2008, BIOINFORMATICS, V24, P1002, DOI 10.1093/bioinformatics/btn054; Lammens T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031206; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Manji SSM, 2012, AM J PATHOL, V180, P1560, DOI 10.1016/j.ajpath.2011.12.034; Manji SSM, 2011, AM J PATHOL, V179, P903, DOI 10.1016/j.ajpath.2011.04.002; Manji SSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017607; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Mburu Philomena, 1997, Genes and Function, V1, P191; Mhatre AN, 2002, BIOCHEM BIOPH RES CO, V297, P987, DOI 10.1016/S0006-291X(02)02296-9; Miller KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051284; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; Nicchia GP, 2011, NEUROSCIENCE, V197, P80, DOI 10.1016/j.neuroscience.2011.09.023; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rozen S, 2003, BIOINFORMATICS METHO, P365; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Wada T, 2001, BIOCHEM BIOPH RES CO, V283, P113, DOI 10.1006/bbrc.2001.4724; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Yonezawa S, 2006, HUM MUTAT, V27, P88, DOI 10.1002/humu.20266; Yoshida Y, 2009, NUCLEIC ACIDS RES, V37, pW147, DOI 10.1093/nar/gkp384; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74243	10.1371/journal.pone.0074243	http://dx.doi.org/10.1371/journal.pone.0074243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086324	Green Published, gold			2022-12-25	WOS:000326520200025
J	Ren, LL; Xiao, Y; Li, JG; Chen, L; Zhang, J; Vernet, G; Wang, JW				Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Vernet, Guy; Wang, Jianwei			Multiple Genomic Recombination Events in the Evolution of Saffold Cardiovirus	PLOS ONE			English	Article							RNA RECOMBINATION; PHYLOGENETIC ANALYSIS; VIRUS-INFECTIONS; CHILDREN; FREQUENCY; DYNAMICS; SEQUENCE; CIRCULATION; SELECTION; GENETICS	Background: Saffold cardiovirus (SAFV) is a new human cardiovirus with 11 identified genotypes. Little is known about the natural history and pathogenicity of SAFVs. Methodology/Principal Findings: We sequenced the genome of five SAFV-1 strains which were identified from fecal samples taken from children with viral diarrhea in Beijing, China between March 2006 and November 2007, and analyzed the phylogenetic and phylodynamic properties of SAFVs using the genome sequences of every known SAFV genotypes. We identified multiple recombination events in our SAFV-1 strains, specifically recombination between SAFV-2, -3, -4, -9, -10 and the prototype SAFV-1 strain in the VP4 region and recombination between SAFV-4, -6, -8, -10, -11 and prototype SAFV-1 in the VP1/2A region. Notably, recombination in the structural gene VP4 is a rare event in Cardiovirus. The ratio of nonsynonymous substitutions to synonymous substitutions indicates a purifying selection of the SAFV genome. Phylogenetic and molecular clock analysis indicates the existence of at least two subclades of SAFV-1 with different origins. Subclade 1 includes two strains isolated from Pakistan, whereas subclade 2 includes the prototype strain and strains isolated in China, Pakistan, and Afghanistan. The most recent common ancestor of all SAFV genotypes dates to the 1710s, and SAFV-1, -2, and -3 to the 1940s, 1950s, and 1960s, respectively. No obvious relationship between variation and pathogenicity exists in the critical domains of the CD and EF loops of viral capsid proteins or the multi-functional proteins L based on animo acid sequence identity comparison between SAFV genotypes. Conclusions/Significance: Our findings suggest that intertypic recombination plays an important role in the diversity of SAFVs, highlighting the diversity of the five strains with the previously described SAFV-1 strains.	[Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, Dr Christophe Merieux Lab, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JW (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559	China National Funds for Distinguished Young Scientists [81225014]; International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by China National Funds for Distinguished Young Scientists (81225014) (http://www.nsfc.gov.cn), the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Austermann-Busch S, 2012, J VIROL, V86, P7393, DOI 10.1128/JVI.00864-12; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Borghese F, 2011, J VIROL, V85, P9614, DOI 10.1128/JVI.00480-11; Brown DWG, 1997, REV MED VIROL, V7, P239, DOI 10.1002/(SICI)1099-1654(199712)7:4&lt;239::AID-RMV210&gt;3.0.CO;2-Q; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Drexler JF, 2010, J GEN VIROL, V91, P1418, DOI 10.1099/vir.0.018887-0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Itagaki T, 2010, SCAND J INFECT DIS, V42, P950, DOI 10.3109/00365548.2010.496791; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lam TTY, 2010, CRIT REV CL LAB SCI, V47, P5, DOI 10.3109/10408361003633318; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Nora T, 2007, J VIROL, V81, P7620, DOI 10.1128/JVI.00083-07; Norstrom MM, 2012, NEW MICROBIOL, V35, P101; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; Shapka N, 2004, J VIROL, V78, P2288, DOI 10.1128/JVI.78.5.2288-2300.2004; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Sun GM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-439; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tosh C, 2002, J GEN VIROL, V83, P2455, DOI 10.1099/0022-1317-83-10-2455; van Eyll O, 2002, J VIROL, V76, P10665, DOI 10.1128/JVI.76.21.10665-10673.2002; Xu ZQ, 2009, EMERG INFECT DIS, V15, P993, DOI 10.3201/eid1506.090109; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74947	10.1371/journal.pone.0074947	http://dx.doi.org/10.1371/journal.pone.0074947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086404	Green Published, gold			2022-12-25	WOS:000326520200059
J	Gigandet, X; Griffa, A; Kober, T; Daducci, A; Gilbert, G; Connelly, A; Hagmann, P; Meuli, R; Thiran, JP; Krueger, G				Gigandet, Xavier; Griffa, Alessandra; Kober, Tobias; Daducci, Alessandro; Gilbert, Guillaume; Connelly, Alan; Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe; Krueger, Gunnar			A Connectome-Based Comparison of Diffusion MRI Schemes	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN CONNECTIVITY; MOTION CORRECTION; FIBER PATHWAYS; TENSOR; TRACTOGRAPHY; TRACKING; ROBUST; OPTIMIZATION; VALIDATION	Diffusion MRI has evolved towards an important clinical diagnostic and research tool. Though clinical routine is using mainly diffusion weighted and tensor imaging approaches, Q-ball imaging and diffusion spectrum imaging techniques have become more widely available. They are frequently used in research-oriented investigations in particular those aiming at measuring brain network connectivity. In this work, we aim at assessing the dependency of connectivity measurements on various diffusion encoding schemes in combination with appropriate data modeling. We process and compare the structural connection matrices computed from several diffusion encoding schemes, including diffusion tensor imaging, q-ball imaging and high angular resolution schemes, such as diffusion spectrum imaging with a publically available processing pipeline for data reconstruction, tracking and visualization of diffusion MR imaging. The results indicate that the high angular resolution schemes maximize the number of obtained connections when applying identical processing strategies to the different diffusion schemes. Compared to the conventional diffusion tensor imaging, the added connectivity is mainly found for pathways in the 50-100mm range, corresponding to neighboring association fibers and long-range associative, striatal and commissural fiber pathways. The analysis of the major associative fiber tracts of the brain reveals striking differences between the applied diffusion schemes. More complex data modeling techniques (beyond tensor model) are recommended 1) if the tracts of interest run through large fiber crossings such as the centrum semi-ovale, or 2) if non-dominant fiber populations, e. g. the neighboring association fibers are the subject of investigation. An important finding of the study is that since the ground truth sensitivity and specificity is not known, the comparability between results arising from different strategies in data reconstruction and/or tracking becomes implausible to understand.	[Gigandet, Xavier; Griffa, Alessandra; Daducci, Alessandro; Hagmann, Patric; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Labs LTS5, Lausanne, Switzerland; [Kober, Tobias; Krueger, Gunnar] Siemens Schweiz AG CIBM, Adv Clin Imaging Technol, Lausanne, Switzerland; [Gilbert, Guillaume] CHU Montreal, Dept Radiol, Montreal, PQ, Canada; [Connelly, Alan] Florey Neurosci Inst Austin, Brain Res Inst, Melbourne, Vic, Australia; [Connelly, Alan] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe] Univ Lausanne, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Siemens AG; Universite de Montreal; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Gigandet, X (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Labs LTS5, Lausanne, Switzerland.	xavier.gigandet@epfl.ch	Connelly, Alan/A-9065-2013	Connelly, Alan/0000-0001-7159-8079; Griffa, Alessandra/0000-0003-1923-1653; Thiran, Jean-Philippe/0000-0003-2938-9657	Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gilbert G, 2007, IEEE T MED IMAGING, V26, P1428, DOI 10.1109/TMI.2007.907699; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Granziera C, 2011, P INT SOC MAGN RESON, V19; Granziera C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005101; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2004, P INT SOC MAGN RESON, V12; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Kober T, 2012, NEUROIMAGE, V59, P389, DOI 10.1016/j.neuroimage.2011.07.004; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Menzel MI, 2011, MAGN RESON MED, V66, P1226, DOI 10.1002/mrm.23064; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; O'Brien KR, 2013, IEEE T MED IN PRESS; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reese TG, 2009, J MAGN RESON IMAGING, V29, P517, DOI 10.1002/jmri.21497; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Thottakara P, 2006, NEUROIMAGE, V29, P868, DOI 10.1016/j.neuroimage.2005.08.051; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tristan-Vega A, 2009, NEUROIMAGE, V47, P638, DOI 10.1016/j.neuroimage.2009.04.049; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang R, 2007, P INT SOC MAGN RESON, V15; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wedeen VJ, 2000, P INT SOC MAGN RESON, V8; Wedeen VJ, 1996, 2 INT C FUNCT MAPP H, V2, P146; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yo TS, 2009, LECT NOTES COMPUT SC, V5761, P886	59	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75061	10.1371/journal.pone.0075061	http://dx.doi.org/10.1371/journal.pone.0075061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073235	Green Published			2022-12-25	WOS:000324768000044
J	Imamura, T; Suzuki, A; Lupisan, S; Okamoto, M; Aniceto, R; Egos, RJ; Daya, EE; Tamaki, R; Saito, M; Fuji, N; Roy, CN; Opinion, JM; Santo, AV; Macalalad, NG; Tandoc, A; Sombrero, L; Olveda, R; Oshitani, H				Imamura, Tadatsugu; Suzuki, Akira; Lupisan, Socorro; Okamoto, Michiko; Aniceto, Rapunzel; Egos, Rutchie J.; Daya, Edgardo E.; Tamaki, Raita; Saito, Mariko; Fuji, Naoko; Roy, Chandra Nath; Opinion, Jaime M.; Santo, Arlene V.; Macalalad, Noel G.; Tandoc, Amado, III; Sombrero, Lydia; Olveda, Remigio; Oshitani, Hitoshi			Molecular Evolution of Enterovirus 68 Detected in the Philippines	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; RECOMBINATION; RHINOVIRUS; EMERGENCE; DYNAMICS	Background: Detection of Enterovirus 68 (EV68) has recently been increased. However, underlying evolutionary mechanism of this increasing trend is not fully understood. Methods: Nasopharyngeal swabs were collected from 5,240 patients with acute respiratory infections in the Philippines from June 2009 to December 2011. EV68 was detected by polymerase chain reaction (PCR) targeting for 5' untranslated region (5' UTR), viral protein 1 (VP1), and VP4/VP2. Phylogenetic trees were generated using the obtained sequences. Results: Of the 5,240 tested samples, 12 EV68 positive cases were detected between August and December in 2011 (detection rate, 0.23%). The detection rate was higher among inpatients than outpatients (p<0.0001). Among VP1 sequences detected from 7 patients in 2011, 5 in lineage 2 were diverged from those detected in the Philippines in 2008, however, 2 in lineage 3 were not diverged from strains detected in the Philippines in 2008 but closely associated with strains detected in the United States. Combined with our previous report, EV68 occurrences were observed twice in the Philippines within the last four years. Conclusions: EV68 detections might be occurring in cyclic patterns, and viruses might have been maintained in the community while some strains might have been newly introduced.	[Imamura, Tadatsugu; Suzuki, Akira; Okamoto, Michiko; Fuji, Naoko; Roy, Chandra Nath; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Aniceto, Rapunzel; Tamaki, Raita; Saito, Mariko] Tohoku RITM Res Ctr Emerging & Reemerging Infect, Muntinlupa, Philippines; [Aniceto, Rapunzel; Egos, Rutchie J.] Eastern Visayas Reg Med Ctr, Tacloban City, Philippines; [Daya, Edgardo E.] Leyte Prov Hosp, Palo City, Philippines; [Opinion, Jaime M.] Tacloban City Hlth Catchment Ctr, Tacloban City, Philippines; [Santo, Arlene V.] Tanuan Rural Hlth Unit, Tanuan City, Philippines; [Lupisan, Socorro; Macalalad, Noel G.; Tandoc, Amado, III; Sombrero, Lydia; Olveda, Remigio] Res Inst Trop Med, Muntinlupa, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Oshitani, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019; Roy, Chandra Nath/X-5769-2019; Okamoto, Michiko/AAE-4373-2019	Roy, Chandra Nath/0000-0001-6667-1550; Okamoto, Michiko/0000-0002-3505-5939; Suzuki, Akira/0000-0002-8223-0314; Tandoc, Amado III/0000-0002-2186-4989	Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS), Japan	Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), and Research Fellowships for Young Scientists from Japan Society for the Promotion of Science (JSPS), Japan. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fouzas S, 2011, PEDIATRICS, V128, P740, DOI 10.1542/peds.2011-0271; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10	23	30	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74221	10.1371/journal.pone.0074221	http://dx.doi.org/10.1371/journal.pone.0074221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073203	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000012
J	Planes, R; Bahraoui, E				Planes, Remi; Bahraoui, Elmostafa			HIV-1 Tat Protein Induces the Production of IDO in Human Monocyte Derived-Dendritic Cells through a Direct Mechanism: Effect on T Cells Proliferation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; TYPE-1 CLADE B; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; CYTOKINE EXPRESSION; QUINOLINIC ACID; INHIBITION	During HIV-1 infection, an increase of indoleamine 2,3 dioxygenase (IDO) expression, and dendritic cells (DC) dysfunction were often associated with AIDS disease progression. In this work, we investigated the effect of HIV-1 Tat protein on the expression of IDO, in MoDCs. We show that Tat induces IDO protein expression and activity in a dose dependent manner by acting at the cell membrane. Using Tat-mutants, we show that the N-Terminal domain, Tat 1-45, but not the central region, Tat 30-72, is sufficient to induce the expression of active IDO. Tat protein is also able to induce several cytokines in MoDCs, including IFN-gamma, a strong inducer of IDO. In order to understand whether IDO is induced directly by Tat protein or indirectly following IFN-gamma production, complementary experiments were performed and showed that: i) at the kinetic level, Tat induced IDO expression before the production of IFN-gamma ii) treatment of MoDCs with Tat-conditioned medium was unable to stimulate IDO expression, iii) coculture of MoDCs in a transwell cell system did not allow IDO expression in MoDCs not previously treated by Tat, iv) direct contact between Tat-treated and untreated MoDCs was not sufficient to induce IDO expression in a Tat-independent manner, and v) treatment of MoDCs in the presence of IFN-gamma pathway inhibitors, Jak I and Ly294002, inhibited IFN-gamma-induced IDO but had no effect on Tat-induced IDO. At the functional level, our data showed that treatment of MoDCs with Tat led to the inhibition of their capacity to stimulate T cell proliferation. This impairement was totally abolished when the stimulation was performed in the presence of 1MT, an inhibitor of IDO activity, arguing for the implication of the kynurenine pathway. By inducing IDO, Tat protein may be considered, as a viral pathogenic factor, in the dysregulation of the DC functions during HIV-1 infection.	[Planes, Remi; Bahraoui, Elmostafa] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] CNRS, U5282, Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] Univ Toulouse 3, EA 3038, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bahraoui, E (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	bahraoui@cict.fr		BAHRAOUI, ELMOSTAFA/0000-0003-1852-389X	Agence Nationale de Recherche sur le Sida (ANRS); SIDACTION; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre national de la recherche scientifique (CNRS); ministere de la recherche et des technologies	Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); SIDACTION; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ministere de la recherche et des technologies	This work was supported by the Agence Nationale de Recherche sur le Sida (ANRS), SIDACTION, Institut National de la Sante et de la Recherche Medicale (INSERM), Centre national de la recherche scientifique (CNRS) and ministere de la recherche et des technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Buscemi L, 2007, NEUROBIOL DIS, V26, P661, DOI 10.1016/j.nbd.2007.03.004; Che KF, 2010, EUR J IMMUNOL, V40, P2248, DOI 10.1002/eji.201040377; Chuenchitra Thippawan, 2012, J Med Assoc Thai, V95 Suppl 5, pS116; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Contreras X, 2005, VIROLOGY, V332, P316, DOI 10.1016/j.virol.2004.11.032; Dang YH, 2000, FREE RADICAL BIO MED, V28, P615, DOI 10.1016/S0891-5849(99)00272-5; Debin A, 2002, VACCINE, V20, P2752, DOI 10.1016/S0264-410X(02)00191-3; Dunham RM, 2013, AIDS RES HUM RETROV, V29, P207, DOI [10.1089/AID.2012.0162, 10.1089/aid.2012.0162]; EMILIE D, 1994, RES IMMUNOL, V145, P595, DOI 10.1016/S0923-2494(05)80039-2; Fairman P, 2012, CLIN EXP IMMUNOL, V170, P101, DOI 10.1111/j.1365-2249.2012.04628.x; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Favre D, SCI TRANSL MED, V2; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Gendelman HE, 1997, AIDS, V11, pS35; Granelli-Piperno A, 2006, J IMMUNOL, V176, P991, DOI 10.4049/jimmunol.176.2.991; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; GRAZIOSI C, 1994, RES IMMUNOL, V145, P602, DOI 10.1016/S0923-2494(05)80040-9; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Heyes MP, 2001, BRAIN, V124, P1033, DOI 10.1093/brain/124.5.1033; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li JC, AIDS, V24, P1609; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lob S, 2008, LANGENBECK ARCH SURG, V393, P995, DOI 10.1007/s00423-007-0245-7; Martinson JA, 2010, ANTIMICROB AGENTS CH, V54, P871, DOI 10.1128/AAC.01246-09; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Monini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048781; Morini M, 2000, BIOCHEM BIOPH RES CO, V273, P267, DOI 10.1006/bbrc.2000.2941; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Noonan D, 2000, Adv Pharmacol, V48, P229; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Presicce P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042802; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Rizzardi GP, 1996, AIDS, V10, pF45, DOI 10.1097/00002030-199611000-00001; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Samikkannu T, 2010, J NEUROVIROL, V16, P255, DOI 10.3109/13550284.2010.497809; Samikkannu T, 2009, AIDS RES HUM RETROV, V25, P329, DOI 10.1089/aid.2008.0225; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Secchiero P, 1999, J IMMUNOL, V162, P2427; Smith DG, 2001, J NEUROVIROL, V7, P56; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; vanBaalen CA, 1997, J GEN VIROL, V78, P1913, DOI 10.1099/0022-1317-78-8-1913; Wang Xi-cheng, 2010, Zhonghua Yi Xue Za Zhi, V90, P588; WERNER ER, 1988, BIOL CHEM H-S, V369, P337, DOI 10.1515/bchm3.1988.369.1.337; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Williams A, 2013, CYTOKINE, V61, P521, DOI 10.1016/j.cyto.2012.11.006; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720; ZAULI G, 1993, MICROBIOLOGICA, V16, P115; Zheng Lin, 2005, J Zhejiang Univ Sci B, V6, P668, DOI 10.1631/jzus.2005.B0668; Zocchi MR, 1998, J IMMUNOL, V161, P2938	87	38	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74551	10.1371/journal.pone.0074551	http://dx.doi.org/10.1371/journal.pone.0074551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073214	Green Published, gold			2022-12-25	WOS:000324768000023
J	Alamilla, J; Gillespie, DC				Alamilla, Javier; Gillespie, Deda C.			Maturation of Calcium-Dependent GABA, Glycine, and Glutamate Release in the Glycinergic MNTB-LSO Pathway	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; LATERAL SUPERIOR OLIVE; SHORT-TERM PLASTICITY; TRANSMITTER RELEASE; TEMPERATURE-DEPENDENCE; MULTIPLE TYPES; SYNAPTIC-TRANSMISSION; CHANNEL CURRENTS; OMEGA-CONOTOXINS; CA2+ CHANNELS	The medial nucleus of the trapezoid body (MNTB) is a key nucleus in high-fidelity temporal processing that underlies sound localization in the auditory brainstem. While the glycinergic principal cells of the MNTB project to all primary nuclei of the superior olive, during development the projection from MNTB to the lateral superior olive (LSO) is of interest because this immature inhibitory projection is known to undergo tonotopic refinement during an early postnatal period, and because during this period individual MNTB terminals in the LSO transiently release glycine GABA and glutamate. Developmental changes in calcium-dependent release are understood to be required to allow various auditory nuclei to follow high frequency activity; however, little is known about maturation of calcium-dependent release in the MNTB-LSO pathway, which has been presumed to have less stringent requirements for high-fidelity temporal following. In acute brainstem slices of rats age postnatal day 1 to 15 we recorded whole-cell responses in LSO principal neurons to electrical stimulation in the MNTB in order to measure sensitivity to external calcium, the contribution of different voltage-gated calcium channel subtypes to vesicular release, and the maturation of these measures for both GABA/glycine and glutamate transmission. Our results establish that release of glutamate at MNTB-LSO synapses is calcium-dependent. Whereas no significant developmental changes were evident for glutamate release, GABA/glycine release underwent substantial changes over the first two postnatal weeks: soon after birth L-type, N-type, and P/Q-type voltage-gated calcium channels (VGCCs) together mediated release, but after hearing onset P/Q-type VGCCs predominated. Blockade of P/Q-type VGCCs reduced the estimated quantal number for GABA/gly and glutamate transmission at P5-8 and the frequency of evoked miniature glycinergic events at P12-15, without apparent effects on spontaneous release of neurotransmitter, supporting a model in which P/Q-type VGCCs are required for mature synchronous synaptic transmission, but not for spontaneous vesicle release.	[Alamilla, Javier; Gillespie, Deda C.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Alamilla, J (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	alamill@mcmaster.ca			CIHR; NSERC; CONACyT	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a CIHR operating grant and an NSERC discovery grant (to DCG), and a CONACyT postdoctoral fellowship (to JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Barnes-Davies M, 2001, HEARING RES, V162, P134, DOI 10.1016/S0378-5955(01)00378-1; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; CAIRD D, 1983, EXP BRAIN RES, V52, P385; CANT NB, 1986, J COMP NEUROL, V247, P457, DOI 10.1002/cne.902470406; Case DT, 2011, J NEUROPHYSIOL, V106, P2570, DOI 10.1152/jn.00644.2010; Cooper AP, 2011, J COMP NEUROL, V519, P2417, DOI 10.1002/cne.22634; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Ene FA, 2003, J NEUROPHYSIOL, V90, P2581, DOI 10.1152/jn.00238.2003; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Giugovaz-Tropper B, 2011, NEUROSCIENCE, V192, P219, DOI 10.1016/j.neuroscience.2011.06.021; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Iftinca M, 2006, NEUROSCIENCE, V142, P1031, DOI 10.1016/j.neuroscience.2006.07.010; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; KANDLER K, 1995, J NEUROSCI, V15, P6890; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kotak VC, 1998, J NEUROSCI, V18, P4646; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; MCALLISTERWILLIAMS RH, 1995, NEUROPHARMACOLOGY, V34, P1479, DOI 10.1016/0028-3908(95)00130-X; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rosen AD, 1996, AM J PHYSIOL-CELL PH, V271, pC863, DOI 10.1152/ajpcell.1996.271.3.C863; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Stocker JW, 1997, J NEUROSCI, V17, P3002; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024	45	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75688	10.1371/journal.pone.0075688	http://dx.doi.org/10.1371/journal.pone.0075688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069436	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300089
J	Song, YZ; Zhang, ZH; Lin, WX; Zhao, XJ; Ma, MDYL; Ma, YL; Guo, L; Chen, FP; Long, XL; He, XL; Sunada, Y; Soneda, S; Nakatomi, A; Dateki, S; Ngu, LH; Kobayashi, K; Saheki, T				Song, Yuan-Zong; Zhang, Zhan-Hui; Lin, Wei-Xia; Zhao, Xin-Jing; Deng, Mei; Ma, Yan-Li; Guo, Li; Chen, Feng-Ping; Long, Xiao-Ling; He, Xiang-Ling; Sunada, Yoshihide; Soneda, Shun; Nakatomi, Akiko; Dateki, Sumito; Ngu, Lock-Hock; Kobayashi, Keiko; Saheki, Takeyori			SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China	PLOS ONE			English	Article							NEONATAL INTRAHEPATIC CHOLESTASIS; II CITRULLINEMIA; LIVER-DISEASE; IDENTIFICATION; NICCD; POPULATIONS; FREQUENCY; DIAGNOSIS; SIBLINGS; PROTEIN	Background: The human SLC25A13 gene encodes citrin, the liver-type mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), and SLC25A13 mutations cause citrin deficiency (CD), a disease entity that encompasses different age-dependant clinical phenotypes such as Adult-onset Citrullinemia Type II (CTLN2) and Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency (NICCD). The analyses of SLC25A13 gene and its protein/mRNA products remain reliable tools for the definitive diagnoses of CD patients, and so far, the SLC25A13 mutation spectrum in Chinese CD patients has not been well-characterized yet. Methods and Results: By means of direct DNA sequencing, cDNA cloning and SNP analyses, 16 novel pathogenic mutations, including 9 missense, 4 nonsense, 1 splice-site, 1 deletion and 1 large transposal insertion IVS4ins6kb (GenBank accession number KF425758), were identified in CTLN2 or NICCD patients from China, Japan and Malaysia, respectively, making the SLC25A13 variations worldwide reach the total number of 81. A large NICCD cohort of 116 Chinese cases was also established, and the 4 high-frequency mutations contributed a much larger proportion of the mutated alleles in the patients from south China than in those from the north (chi(2) = 14.93, P<0.01), with the latitude of 30uN as the geographic dividing line in mainland China. Conclusions: This paper further enriched the SLC25A13 variation spectrum worldwide, and formed a substantial contribution to the in-depth understanding of the genotypic feature of Chinese CD patients.	[Song, Yuan-Zong; Zhang, Zhan-Hui; Lin, Wei-Xia; Zhao, Xin-Jing; Deng, Mei; Ma, Yan-Li; Guo, Li] Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Chen, Feng-Ping] Jinan Univ, Dept Lab Sci, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Long, Xiao-Ling] Zhongshan Boai Hosp, Dept Pediat, Zhongshan, Peoples R China; [He, Xiang-Ling] Hunan Prov Peoples Hosp, Children Med Ctr, Changsha, Hunan, Peoples R China; [Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kawasaki, Kanagawa, Japan; [Soneda, Shun] St Marianna Univ, Dept Pediat, Sch Med, Kanagawa, Japan; [Nakatomi, Akiko; Dateki, Sumito] Nagasaki Univ Hosp, Dept Pediat, Nagasaki, Japan; [Ngu, Lock-Hock] Hosp Kuala Lumpur, Dept Clin Genet, Kuala Lumpur, Malaysia; [Kobayashi, Keiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Metab & Biochem Genet, Kagoshima 890, Japan; [Saheki, Takeyori] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan	Jinan University; Jinan University; Kawasaki Medical School; Saint Marianna University; Nagasaki University; Kagoshima University; Kumamoto University	Song, YZ (corresponding author), Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	songyuanzong@vip.tom.com	Ngu, Lock Hock/R-4473-2019; Ngu, Lock-Hock/Y-6055-2019	Ngu, Lock Hock/0000-0002-2396-1686	Fundamental Research Funds for the Central Universities [21612430]; National Natural Science Foundation of China (NSFC) [81070279, 81270957]; Japan Society for the Promotion of Science	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Fundamental Research Funds for the Central Universities (No. 21612430), the projects supported by the National Natural Science Foundation of China (NSFC, Nos. 81070279 and 81270957), and Grants-in-Aid for Asia-Africa Scientific Platform Program from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ben-Shalom E, 2002, MOL GENET METAB, V77, P202, DOI 10.1016/S1096-7192(02)00167-1; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Fu HY, 2011, J GASTROENTEROL, V46, P510, DOI 10.1007/s00535-010-0329-y; Hayasaka K, 2012, JIMD REP, V2, P37, DOI 10.1007/8904_2011_42; Hutchin T, 2006, J INHERIT METAB DIS, V29, P112; Hutchin T, 2009, J INHERIT METAB DIS, V32, pS151, DOI 10.1007/s10545-009-1116-x; Kikuchi A, 2012, MOL GENET METAB, V105, P553, DOI 10.1016/j.ymgme.2011.12.024; Ko JM, 2007, INT J MOL MED, V20, P809; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Kobayashi K, 1993, GENEREVIEWS; Kobayashi K., 2008, J APPL CLIN PEDIAT, V23, P1553; Komatsu M, 2008, J HEPATOL, V49, P810, DOI 10.1016/j.jhep.2008.05.016; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1881, DOI 10.1007/s00216-011-4766-0; Lee BH, 2010, J PEDIATR GASTR NUTR, V50, P682, DOI 10.1097/MPG.0b013e3181d67fbf; Lin JT, 2011, CLIN CHIM ACTA, V412, P460, DOI 10.1016/j.cca.2010.11.027; Lin S, 1987, ACTA ANTHR SINICA, V6, P190; Lin WX, 2012, GENE, V505, P269, DOI 10.1016/j.gene.2012.06.012; Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8; Luder AS, 2006, J INHERIT METAB DIS, V29, P59; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; Nagasaka H, 2009, MOL GENET METAB, V97, P21, DOI 10.1016/j.ymgme.2009.01.009; Ohura T, 2007, J INHERIT METAB DIS, V30, P139, DOI 10.1007/s10545-007-0506-1; Ohura T, 2001, HUM GENET, V108, P87, DOI 10.1007/s004390000448; Okano Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/j.ymgme.2013.01.020; Saheki T, 2002, METAB BRAIN DIS, V17, P335, DOI 10.1023/A:1021961919148; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Saheki T, 2011, MOL GENET METAB, V104, P492, DOI 10.1016/j.ymgme.2011.08.015; Sheng JS, 2006, J INHERIT METAB DIS, V29, P163; Song YZ, 2009, DIGEST LIVER DIS, V41, P683, DOI 10.1016/j.dld.2008.11.014; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Song Yuan-zong, 2008, Zhonghua Er Ke Za Zhi, V46, P411; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Takahashi Y, 2012, INTERNAL MED, V51, P2131, DOI 10.2169/internalmedicine.51.7644; Takaya J, 2005, METABOLISM, V54, P1615, DOI 10.1016/j.metabol.2005.06.009; Tazawa Y, 2001, J PEDIATR-US, V138, P735, DOI 10.1067/mpd.2001.113264; Thong MK, 2010, SINGAP MED J, V51, pE12; Tokuhara D, 2007, MOL GENET METAB, V90, P30, DOI 10.1016/j.ymgme.2006.09.009; Tomomasa T, 2001, J PEDIATR-US, V138, P741, DOI 10.1067/mpd.2001.113361; Wen Peng-Qiang, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P303; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Wongkittichote P, 2012, J INHERIT METAB DIS; Xing Ya-zhi, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P180, DOI 10.3760/cma.j.issn.1003-9406.2010.02.014; Yamaguchi N, 2002, HUM MUTAT, V19, P122, DOI 10.1002/humu.10022; Yasuda T, 2000, HUM GENET, V107, P537, DOI 10.1007/s004390000430; Zhang ZH, 2012, GENE, V511, P227, DOI 10.1016/j.gene.2012.09.049; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699; Zhao XJ, 2011, TOHOKU J EXP MED, V225, P273, DOI 10.1620/tjem.225.273	51	37	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74544	10.1371/journal.pone.0074544	http://dx.doi.org/10.1371/journal.pone.0074544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069319	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300036
J	Wanner, SP; Yoshida, K; Kulchitsky, VA; Ivanov, AI; Kanosue, K; Romanovsky, AA				Wanner, Samuel P.; Yoshida, Kyoko; Kulchitsky, Vladimir A.; Ivanov, Andrei I.; Kanosue, Kazuyuki; Romanovsky, Andrej A.			Lipopolysaccharide-Induced Neuronal Activation in the Paraventricular and Dorsomedial Hypothalamus Depends on Ambient Temperature	PLOS ONE			English	Article							COLD-SEEKING BEHAVIOR; SYMPATHETIC OUTFLOW; FEVER; NUCLEUS; HYPOTHERMIA; MEDIATOR	Systemic inflammatory response syndrome is associated with either fever or hypothermia, but the mechanisms responsible for switching from one to the other are unknown. In experimental animals, systemic inflammation is often induced by bacterial lipopolysaccharide (LPS). To identify the diencephalic and brainstem structures involved in the fever-hypothermia switch, we studied the expression of c-Fos protein, a marker of neuronal activation, in rats treated with the same high dose of LPS (0.5 mg/kg, intravenously) either in a thermoneutral (30 degrees C) or cool (24 degrees C) environment. At 30 degrees C, LPS caused fever; at 24 degrees C, the same dose caused profound hypothermia. Both fever and hypothermia were associated with the induction of c-Fos in many brain areas, including several structures of the anterior preoptic, paraventricular, lateral, and dorsal hypothalamus, the bed nucleus of the stria terminalis, the posterior pretectal nucleus, ventrolateral periaqueductal gray, lateral parabrachial nucleus, area postrema, and nucleus of the solitary tract. Every brain area studied showed a comparable response to LPS at the two different ambient temperatures used, with the exception of two areas: the dorsomedial hypothalamic nucleus (DMH), which we studied together with the adjacent dorsal hypothalamic area (DA), and the paraventricular hypothalamic nucleus (PVH). Both structures had much stronger c-Fos expression during LPS hypothermia than during fever. We propose that PVH and DMH/DA neurons are involved in a circuit, which - depending on the ambient temperature - determines whether the thermoregulatory response to bacterial LPS will be fever or hypothermia.	[Wanner, Samuel P.; Kulchitsky, Vladimir A.; Ivanov, Andrei I.; Romanovsky, Andrej A.] St Josephs Hosp, System Inflammat Lab, FeverLab, Phoenix, AZ USA; [Wanner, Samuel P.] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Yoshida, Kyoko; Kanosue, Kazuyuki] Osaka Univ, Fac Med, Sch Allied Hlth Sci, Dept Physiol, Osaka, Japan; [Kulchitsky, Vladimir A.] Natl Acad Sci, Inst Physiol, Minsk, BELARUS; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Virginia Inst Mol Med, Richmond, VA USA; [Kanosue, Kazuyuki] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Romanovsky, Andrej A.] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA	St. Joseph's Hospital and Medical Center; Universidade Federal de Minas Gerais; Osaka University; National Academy of Sciences of Belarus (NASB); Institute of Physiology of the National Academy of Sciences of Belarus; Virginia Commonwealth University; Virginia Commonwealth University; Waseda University; Arizona State University; Arizona State University-Tempe	Romanovsky, AA (corresponding author), St Josephs Hosp, System Inflammat Lab, FeverLab, Phoenix, AZ USA.	aromano@chw.edu	Wanner, Samuel P./F-9654-2012; Kulchitsky, Vladimir/AAS-1322-2021; Ivanov, Andrei/V-1672-2019	Wanner, Samuel P./0000-0002-4659-1032; Romanovsky, Andrej/0000-0003-3772-8575; Yoshida-Court, Kyoko/0000-0002-7558-9943	National Institutes of Health [R01NS41233]; Ministry of Education, Science and Culture of Japan [12307001, 11557003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported in part by the National Institutes of Health (grant R01NS41233 to A.A.R.) and by the Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (grants 12307001 and 11557003 to K.K.). S.P.W. was a fellow of the National Council for Scientific and Technological Development, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Almeida MC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000001; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Belevych N, 2010, BRAIN BEHAV IMMUN, V24, P1137, DOI 10.1016/j.bbi.2010.05.007; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Ivanov AI, 2003, J PHYSIOL-LONDON, V553, P221, DOI 10.1113/jphysiol.2003.055616; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Liu E, 2012, AM J PHYSIOL-REG I, V302, pR1372, DOI 10.1152/ajpregu.00023.2012; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Morrison SF, 2012, FRONT ENDOCRINOL LAU, V3; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Romanovsky AA, 1998, MED HYPOTHESES, V50, P219, DOI 10.1016/S0306-9877(98)90022-6; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V271, pR244, DOI 10.1152/ajpregu.1996.271.1.R244; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR323, DOI 10.1152/ajpregu.1998.275.1.R323; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR332, DOI 10.1152/ajpregu.1998.275.1.R332; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Smith JE, 1998, BRAIN RES, V786, P153, DOI 10.1016/S0006-8993(97)01437-6; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2007, PROG LIPID RES, V46, P89, DOI 10.1016/j.plipres.2006.11.001; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2009, AM J PHYSIOL-REG I, V297, pR485, DOI 10.1152/ajpregu.91026.2008; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	36	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75733	10.1371/journal.pone.0075733	http://dx.doi.org/10.1371/journal.pone.0075733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069444	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300095
J	Crouzin, N; Baranger, K; Cavalier, M; Marchalant, Y; Cohen-Solal, C; Roman, FS; Khrestchatisky, M; Rivera, S; Feron, F; Vignes, M				Crouzin, Nadine; Baranger, Kevin; Cavalier, Melanie; Marchalant, Yannick; Cohen-Solal, Catherine; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois; Vignes, Michel			Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer's Disease: Dissociation between Somatosensory Cortex and Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; MEMORY; IMPAIRMENT; PATHOLOGY; PLAQUE; TRANSMISSION; STIMULATION; SYNAPSES; FAILURES	Transgenic mouse models of Alzheimer's disease (AD) that overproduce the amyloid beta peptide (A beta) have highlighted impairments of hippocampal long-term synaptic plasticity associated with the progression of the disease. Here we examined whether the characteristics of one of the hallmarks of AD, i.e. A beta deposition, in both the somatosensory cortex and the hippocampus, correlated with specific losses of synaptic plasticity in these areas. For this, we evaluated the occurrence of long-term potentiation (LTP) in the cortex and the hippocampus of 6-month old 5xFAD transgenic mice that exhibited massive A beta deposition in both regions but with different features: in cortical areas a majority of A beta deposits comprised a dense core surrounded by a diffuse corona while such kind of A beta deposition was less frequently observed in the hippocampus. In order to simultaneously monitor synaptic changes in both areas, we developed a method based on the use of Multi-Electrode Arrays (MEA). When compared with wild-type (WT) mice, basal transmission was significantly reduced in both areas in 5xFAD mice, while short-term synaptic plasticity was unaffected. The induction of long-term changes of synaptic transmission by different protocols revealed that in 5xFAD mice, LTP in the layer 5 of the somatosensory cortex was more severely impaired than LTP triggered in the CA1 area of the hippocampus. We conclude that cortical plasticity is deficient in the 5xFAD model and that this deficit could be correlated with the proportion of diffuse plaques in 5xFAD mice.	[Crouzin, Nadine; Baranger, Kevin; Marchalant, Yannick; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois] Aix Marseille Univ, Lab Neurobiol Interact Cellulaires & Neurophysiop, Marseille, France; [Crouzin, Nadine; Baranger, Kevin; Marchalant, Yannick; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois] CNRS, Lab Neurobiol Interact Cellulaires & Neurophysiop, Marseille, France; [Cavalier, Melanie; Cohen-Solal, Catherine; Vignes, Michel] Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab Inst Biomol Max Mousseron UMR5247, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Montpellier	Vignes, M (corresponding author), Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab Inst Biomol Max Mousseron UMR5247, Montpellier, France.	Michel.Vignes@univ-montp2.fr	Vignes, Michel/AAA-7693-2019; Feron, Francois/J-5639-2014	Vignes, Michel/0000-0003-0969-2966; 	Centre National de la Recherche Scientifique, Aix-Marseille University; University of Montpellier 2; French National Agency for Research ANR; "Fonds Europeen de Developpement Regional" FEDER in PACA; French Alzheimer's Plan	Centre National de la Recherche Scientifique, Aix-Marseille University; University of Montpellier 2; French National Agency for Research ANR(French National Research Agency (ANR)); "Fonds Europeen de Developpement Regional" FEDER in PACA; French Alzheimer's Plan	This work was supported in part by the Centre National de la Recherche Scientifique, Aix-Marseille University and University of Montpellier 2 and by grants from the French National Agency for Research ANR funding to NC, SR and MK (ADHOC, TIMPAD and PREVENTAD projects, respectively) within the frame of the French Alzheimer's Plan. The work was also supported by grants to SR and MK from "Fonds Europeen de Developpement Regional" FEDER in PACA. KB was granted a research associate fellowship by the French Alzheimer's Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Bell KFS, 2006, NEUROBIOL AGING, V27, P1644, DOI 10.1016/j.neurobiolaging.2005.09.034; Bell KFS, 2006, EUR J PHARMACOL, V545, P11, DOI 10.1016/j.ejphar.2006.06.045; Bozzao A, 2001, AM J NEURORADIOL, V22, P1030; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CastroAlamancos MA, 1996, P NATL ACAD SCI USA, V93, P1335, DOI 10.1073/pnas.93.3.1335; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Delatour B, 2004, NEUROBIOL DIS, V16, P41, DOI 10.1016/j.nbd.2004.01.008; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Esiri MM, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P79; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerlai R, 2002, HIPPOCAMPUS, V12, P657, DOI 10.1002/hipo.10101; Girard SD, 2013, J ALZHEIMERS DIS, V33, P781, DOI 10.3233/JAD-2012-120982; GONATAS NK, 1967, J NEUROPATH EXP NEUR, V26, P25, DOI 10.1097/00005072-196701000-00003; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; HOM J, 1992, ARCH CLIN NEUROPSYCH, V7, P121, DOI 10.1016/0887-6177(92)90006-9; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Johnson Micah A., 2012, Yale Journal of Biology and Medicine, V85, P481; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Koliatsos VE, 2006, ACTA NEUROPATHOL, V112, P147, DOI 10.1007/s00401-006-0068-6; Kopanitsa MV, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-61; Lante Fabien, 2008, Journal of Integrative Neuroscience, V7, P249, DOI 10.1142/S0219635208001800; Leon-Espinosa G, 2012, J ALZHEIMERS DIS, V29, P841, DOI 10.3233/JAD-2012-112036; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Nguyen PV, 2006, J EXP BIOL, V209, P2293, DOI 10.1242/jeb.01985; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, REV NEUROSCIENCE, V17, P429; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Stephen JM, 2010, J NEURAL TRANSM, V117, P217, DOI 10.1007/s00702-009-0343-5; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	57	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74667	10.1371/journal.pone.0074667	http://dx.doi.org/10.1371/journal.pone.0074667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069328	gold, Green Published			2022-12-25	WOS:000324547300048
J	Niedworok, C; Kretschmer, I; Rock, K; vom Dorp, F; Szarvas, T; Hess, J; Freudenberger, T; Melchior-Becker, A; Rubben, H; Fischer, JW				Niedworok, Christian; Kretschmer, Inga; Roeck, Katharina; vom Dorp, Frank; Szarvas, Tibor; Hess, Jochen; Freudenberger, Till; Melchior-Becker, Ariane; Ruebben, Herbert; Fischer, Jens W.			The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder	PLOS ONE			English	Article							URINARY-BLADDER; OVER-EXPRESSION; PROSTATE-CANCER; FOCAL ADHESIONS; CARCINOMA; CD44; ACID; GROWTH; PROGRESSION; OLIGOSACCHARIDES	Hyaluronan (HA) is a carbohydrate of the extracellular matrix with tumor promoting effects in a variety of cancers. The present study addressed the role of HA matrix for progression and prognosis of human bladder cancer by studying the expression and function of HA-related genes. Methods: Tissue samples of 120 patients with different stages of transitional cell bladder cancer, who underwent surgical treatment for bladder cancer at the University Hospital of Essen were analysed. mRNA-expression levels of HA synthases (HAS1-3) and HA-receptors (RHAMM and CD44) were evaluated by real time RT-PCR in comparison to healthy bladder tissue as control. In uni- and multivariate cox proportional hazard survival regression analysis, the impact of the gene expression levels on survival was assessed. In vitro knock-down of RHAMM, CD44 and HAS isoenzymes was achieved by siRNA and lentiviral shRNA in J82 bladder cancer cells. Transfected cells were analysed in vitro with regard to proliferation, cell cycle and apoptosis. J82 cells after knock-down of RHAMM were xenografted into male nu/nu athymic mice to monitor tumor progression in vivo. Results: In invasive tumor stages RHAMM-, HAS1 and HAS2 mRNA-expression levels were elevated whereas HAS3v1 was reduced as compared to non-invasive tumors. Subsequently, Kaplan-Meier analysis revealed reduced bladder cancer specific survival in patients with high RHAMM mRNA and low HAS3v1 expression. Elevated RHAMM in invasive tumors was confirmed by RHAMM immunohistochemistry. Furthermore, multivariate analysis revealed that only RHAMM expression was associated with poor prognosis independent from other survival factors (HR=2.389, 95% CI 1.227-4.651, p=0.01). Lentiviral RHAMM knock-down revealed reduced J82 cell proliferation in vitro and reduced xenograft tumor growth in vivo. Conclusion: The data suggest that RHAMM plays a crucial role in mediating progression of muscle-invasive bladder cancer and recommends RHAMM for further evaluation as a prognostic marker or therapeutic target in bladder cancer therapy.	[Niedworok, Christian; vom Dorp, Frank; Hess, Jochen; Ruebben, Herbert] Univ Duisburg Essen, Dept Urol, Essen Med Sch, Essen, Germany; [Kretschmer, Inga; Roeck, Katharina; Freudenberger, Till; Melchior-Becker, Ariane; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Szarvas, Tibor] Med Univ Vienna, Dept Urol, Vienna Gen Hosp, Vienna, Austria	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Medical University of Vienna	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany.	Jens.Fischer@uni-duesseldorf.de	Hess, Jochen/AAA-2388-2020; SZARVAS, t./L-4422-2017	Hess, Jochen/0000-0002-9902-5368; SZARVAS, t./0000-0002-6321-0799	DFG [Fi682/4-1]; IFORES Program of the University of Essen	DFG(German Research Foundation (DFG)); IFORES Program of the University of Essen	The study was supported by DFG Fi682/4-1 and the IFORES Program of the University of Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAND M, 1991, CHEM-BIOL INTERACT, V77, P97, DOI 10.1016/0009-2797(91)90008-U; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Eissa S, 2005, CANCER-AM CANCER SOC, V103, P1356, DOI 10.1002/cncr.20902; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Golshani R, 2007, INT J CANCER, V120, P1712, DOI 10.1002/ijc.22222; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017; Greiner J, 2010, HAEMATOL-HEMATOL J, V95, P1191, DOI 10.3324/haematol.2009.014704; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Hall CL, 2002, CELL COMMUN ADHES, V9, P273, DOI 10.1080/15419060216306; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Herr HW, 1998, J CLIN ONCOL, V16, P1298, DOI 10.1200/JCO.1998.16.4.1298; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kong QY, 2003, ONCOL REP, V10, P51; Kosaki R, 1999, CANCER RES, V59, P1141; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Liberman D, 2011, BJU INT, V107, P905, DOI 10.1111/j.1464-410X.2010.09590.x; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Lokeshwar VB, 2002, CANCER-AM CANCER SOC, V95, P61, DOI 10.1002/cncr.10652; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Millan-Rodriguez F, 2000, J UROLOGY, V164, P680, DOI 10.1016/S0022-5347(05)67280-1; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Muramaki M, 2004, J UROLOGY, V171, P426, DOI 10.1097/01.ju.0000093446.54115.b6; Nagel S, 2010, EXP HEMATOL, V38, P38, DOI 10.1016/j.exphem.2009.10.010; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; OTOOLE C, 1978, BRIT J CANCER, V38, P64, DOI 10.1038/bjc.1978.164; Passerotti CC, 2011, UROL ONCOL-SEMIN ORI, V29, P710, DOI 10.1016/j.urolonc.2009.10.006; Passerotti CC, 2006, EUR UROL, V49, P71, DOI 10.1016/j.eururo.2005.09.015; Pectasides D, 2009, CRIT REV ONCOL HEMAT, V70, P114, DOI 10.1016/j.critrevonc.2008.07.018; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rock K, 2012, J BIOL CHEM, V287, P20056, DOI 10.1074/jbc.M112.353151; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; SKINNER DG, 1988, EUR UROL, V14, P30; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146	48	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75681	10.1371/journal.pone.0075681	http://dx.doi.org/10.1371/journal.pone.0075681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069434	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300090
J	Seifert, L; Harbeck, M; Thomas, A; Hoke, N; Zoller, L; Wiechmann, I; Grupe, G; Scholz, HC; Riehm, JM				Seifert, Lisa; Harbeck, Michaela; Thomas, Astrid; Hoke, Nadja; Zoeller, Lothar; Wiechmann, Ingrid; Grupe, Gisela; Scholz, Holger C.; Riehm, Julia M.			Strategy for Sensitive and Specific Detection of Yersinia pestis in Skeletons of the Black Death Pandemic	PLOS ONE			English	Article							ANCIENT DNA EXTRACTION; REAL-TIME PCR; GENOME SEQUENCE; PLAGUE; BONE; AMPLIFICATION; PRESERVATION; AGENT; CONTAMINATION; VICTIMS	Yersinia pestis has been identified as the causative agent of the Black Death pandemic in the 14th century. However, retrospective diagnostics in human skeletons after more than 600 years are critical. We describe a strategy following a modern diagnostic algorithm and working under strict ancient DNA regime for the identification of medieval human plague victims. An initial screening and DNA quantification assay detected the Y. pestis specific pla gene of the high copy number plasmid pPCP1. Results were confirmed by conventional PCR and sequence analysis targeting both Y. pestis specific virulence plasmids pPCP1 and pMT1. All assays were meticulously validated according to human clinical diagnostics requirements (ISO 15189) regarding efficiency, sensitivity, specificity, and limit of detection (LOD). Assay specificity was 100% tested on 41 clinically relevant bacteria and 29 Y. pseudotuberculosis strains as well as for DNA of 22 Y. pestis strains and 30 previously confirmed clinical human plague samples. The optimized LOD was down to 4 gene copies. 29 individuals from three different multiple inhumations were initially assessed as possible victims of the Black Death pandemic. 7 samples (24%) were positive in the pPCP1 specific screening assay. Confirmation through second target pMT1 specific PCR was successful for 4 of the positive individuals (14%). A maximum of 700 and 560 copies per mu l aDNA were quantified in two of the samples. Those were positive in all assays including all repetitions, and are candidates for future continuative investigations such as whole genome sequencing. We discuss that all precautions taken here for the work with aDNA are sufficient to prevent external sample contamination and fulfill the criteria of authenticity. With regard to retrospective diagnostics of a human pathogen and the uniqueness of ancient material we strongly recommend using a careful strategy and validated assays as presented in our study.	[Seifert, Lisa; Hoke, Nadja; Grupe, Gisela] Univ Munich, Dept Biol 1, Martinsried, Germany; [Harbeck, Michaela; Grupe, Gisela] State Collect Anthropol & Palaeoanat, Munich, Germany; [Thomas, Astrid; Zoeller, Lothar; Scholz, Holger C.; Riehm, Julia M.] Bundeswehr Inst Microbiol, Munich, Germany; [Wiechmann, Ingrid] Univ Munich, Dept Vet Sci, Inst Palaeoanat Domesticat Res & Hist Vet Med, Munich, Germany	University of Munich; Bundeswehr Institute of Microbiology (IMB); University of Munich	Riehm, JM (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	juliariehm@bundeswehr.org			Bavarian State Ministry of Sciences	Bavarian State Ministry of Sciences	This work was supported by a grant of the Bavarian State Ministry of Sciences according to the Bavarian Elite Aid Act (BayEFG) and regarding the collagen preservation experiments by the Deutsche Forschungsgemeinschaft (DFG Ha 5979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Benedictow OJ, 2004, BLACK DEATH 1346 135, VXVI; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Cohn SK, 2002, BLACK DEATH TRANSFOR, Vx; Cooper A, 2000, SCIENCE, V289, P1139; Dalitz S, 2012, HIST VEREIN BRANDENB, V2011-2012, P67; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Drancourt M, 2011, LANCET INFECT DIS, V11, P894, DOI 10.1016/S1473-3099(11)70292-4; Duncan CJ, 2005, POSTGRAD MED J, V81, P315, DOI 10.1136/pgmj.2004.024075; Eurogentec, 2004, YOUR ON STOP SHOP RE; Fulton TL, 2012, METHODS MOL BIOL, V840, P111, DOI 10.1007/978-1-61779-516-9_15; Garrelt Christina, 2003, DOC ARCHAEOBIOL, P247; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gotherstrom A, 2002, ARCHAEOMETRY, V44, P395, DOI 10.1111/1475-4754.00072; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Harbeck M, 2009, ARCHAEOL ANTHROP SCI, V1, P43, DOI 10.1007/s12520-009-0004-5; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoke N, 2011, PALAEOGEOGR PALAEOCL, V310, P23, DOI 10.1016/j.palaeo.2011.03.021; Janse I, 2013, EMERG INFECT DIS, V19, P342, DOI 10.3201/eid1902.120659; Kemp BM, 2010, HUM BIOL, V82, P227, DOI 10.3378/027.082.0207; Little LK, 2007, PLAGUE END ANTIQUITY, Vxiv; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Matt CP, 2008, JAHRESBERICHT 2006 A, P37; Mohammadi T, 2004, TRANSFUSION, V44, P1314, DOI 10.1111/j.0041-1132.2004.04114.x; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Nolte FS, 2011, MOL DIAGNOSTIC METHO; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Poinar HN, 2003, INT CONGR SER, V1239, P575, DOI 10.1016/S0531-5131(02)00624-6; Pruvost M, 2005, BIOTECHNIQUES, V38, P569, DOI 10.2144/05384ST03; Rabenau HF, 2007, J CLIN VIROL, V40, P93, DOI 10.1016/j.jcv.2007.07.009; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Riehm JM, 2011, EMERG INFECT DIS, V17, P1320, DOI 10.3201/eid1707.100740; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Tsangaras K, 2012, ANN ANAT, V194, P58, DOI 10.1016/j.aanat.2011.04.003; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; WHO, 2010, EEKLY EPIDEMIOLOGICA, V85, P37; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Wiechmann I, 2013, DOCUMENTA A IN PRESS, V10; Wiechmann I, 2010, EMERG INFECT DIS, V16, P1806, DOI 10.3201/eid1611.100598; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; World Health Organization, 2009, OP GUID PLAG SURV DI; Xu Z, 2009, ELECTROPHORESIS, V30, P1282, DOI 10.1002/elps.200800473; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	64	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75742	10.1371/journal.pone.0075742	http://dx.doi.org/10.1371/journal.pone.0075742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069445	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300093
J	Buttner, K; Krieter, J; Traulsen, A; Traulsen, I				Buettner, Kathrin; Krieter, Joachim; Traulsen, Arne; Traulsen, Imke			Efficient Interruption of Infection Chains by Targeted Removal of Central Holdings in an Animal Trade Network	PLOS ONE			English	Article							POTENTIAL EPIDEMIC SIZE; COMMUNITY STRUCTURE; SOCIAL NETWORKS; DISEASE-CONTROL; PIG-MOVEMENTS; PATTERNS; CATTLE; SPREAD; INTERNET; ONTARIO	Centrality parameters in animal trade networks typically have right-skewed distributions, implying that these networks are highly resistant against the random removal of holdings, but vulnerable to the targeted removal of the most central holdings. In the present study, we analysed the structural changes of an animal trade network topology based on the targeted removal of holdings using specific centrality parameters in comparison to the random removal of holdings. Three different time periods were analysed: the three-year network, the yearly and the monthly networks. The aim of this study was to identify appropriate measures for the targeted removal, which lead to a rapid fragmentation of the network. Furthermore, the optimal combination of the removal of three holdings regardless of their centrality was identified. The results showed that centrality parameters based on ingoing trade contacts, e. g. in-degree, ingoing infection chain and ingoing closeness, were not suitable for a rapid fragmentation in all three time periods. More efficient was the removal based on parameters considering the outgoing trade contacts. In all networks, a maximum percentage of 7.0% (on average 5.2%) of the holdings had to be removed to reduce the size of the largest component by more than 75%. The smallest difference from the optimal combination for all three time periods was obtained by the removal based on out-degree with on average 1.4% removed holdings, followed by outgoing infection chain and outgoing closeness. The targeted removal using the betweenness centrality differed the most from the optimal combination in comparison to the other parameters which consider the outgoing trade contacts. Due to the pyramidal structure and the directed nature of the pork supply chain the most efficient interruption of the infection chain for all three time periods was obtained by using the targeted removal based on out-degree.	[Buettner, Kathrin; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany; [Buettner, Kathrin; Krieter, Joachim; Traulsen, Imke] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Max Planck Society; University of Kiel	Buttner, K (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	buettner@evolbio.mpg.de	Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; ben Avraham D., 2000, DIFFUSION REACTIONS; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Buttner K, 2013, TRANSBOUND IN PRESS; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, PREV VET MED, V99, P102, DOI 10.1016/j.prevetmed.2011.01.013; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Havlin S, 2010, COMPLEX NETWORKS STR; Heckathorn DD, 1999, SOCIOL FOCUS, V32, P159, DOI [DOI 10.1080/00380237.1999.10571133, 10.1080/00380237.1999.10571133]; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Kiss IZ, 2006, J R SOC INTERFACE, V3, P55, DOI 10.1098/rsif.2005.0079; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lurette A, 2011, PREV VET MED, V102, P30, DOI 10.1016/j.prevetmed.2011.06.007; Martinez-Lopez B, 2009, PREV VET MED, V91, P29, DOI 10.1016/j.prevetmed.2009.05.007; Masuda Naoki, 2013, F1000Prime Rep, V5, P6, DOI 10.12703/P5-6; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123018; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; MORRIS M, 1993, SOCIOL METHOD RES, V22, P99, DOI 10.1177/0049124193022001005; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Ribbens S, 2009, PREV VET MED, V88, P57, DOI 10.1016/j.prevetmed.2008.08.002; Sahimi M, 1994, APPL PERCOLATION THE; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; SAS&REG;Institute Inc, 2008, US GUID REL 9 2; STAUFFER D, 1994, INTRO PERCOLATION TH; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Webb CR, 2006, EPIDEMIOL INFECT, V134, P31, DOI 10.1017/S095026880500467X; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	47	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74292	10.1371/journal.pone.0074292	http://dx.doi.org/10.1371/journal.pone.0074292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069293	gold, Green Published			2022-12-25	WOS:000326240100099
J	Li, L; Chakraborty, S; Yang, CR; Hatanpaa, KJ; Cipher, DJ; Puliyappadamba, VT; Rehman, A; Jiwani, AJ; Mickey, B; Madden, C; Raisanen, J; Burma, S; Saha, D; Wang, Z; Pingle, SC; Kesari, S; Boothman, DA; Habib, AA				Li, L.; Chakraborty, S.; Yang, C-R; Hatanpaa, K. J.; Cipher, D. J.; Puliyappadamba, V. T.; Rehman, A.; Jiwani, A. J.; Mickey, B.; Madden, C.; Raisanen, J.; Burma, S.; Saha, D.; Wang, Z.; Pingle, S. C.; Kesari, S.; Boothman, D. A.; Habib, A. A.			An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII	ONCOGENE			English	Article						EGFRvIII; glioblastoma; EGFR wild type; activation; dimerization; HB-EGF	GROWTH-FACTOR RECEPTOR; CONFERS ENHANCED TUMORIGENICITY; TYROSINE KINASES; SIGNAL-TRANSDUCTION; TARGETED THERAPIES; GLIOBLASTOMA CELLS; GLIOMA-CELLS; EXPRESSION; GENE; PATHWAYS	EGFRvIII is a key oncogene in glioblastoma (GBM). EGFRvIII results from an in-frame deletion in the extracellular domain of EGFR, does not bind ligand and is thought to be constitutively active. Although EGFRvIII dimerization is known to activate EGFRvIII, the factors that drive EGFRvIII dimerization and activation are not well understood. Here we present a new model of EGFRvIII activation and propose that oncogenic activation of EGFRvIII in glioma cells is driven by co-expressed activated EGFR wild type (EGFRwt). Increasing EGFRwt leads to a striking increase in EGFRvIII tyrosine phosphorylation and activation while silencing EGFRwt inhibits EGFRvIII activation. Both the dimerization arm and the kinase activity of EGFRwt are required for EGFRvIII activation. EGFRwt activates EGFRvIII by facilitating EGFRvIII dimerization. We have previously identified HB-EGF, a ligand for EGFRwt, as a gene induced specifically by EGFRvIII. In this study, we show that HB-EGF is induced by EGFRvIII only when EGFRwt is present. Remarkably, altering HB-EGF recapitulates the effect of EGFRwt on EGFRvIII activation. Thus, increasing HB-EGF leads to a striking increase in EGFRvIII tyrosine phosphorylation while silencing HB-EGF attenuates EGFRvIII phosphorylation, suggesting that an EGFRvIII-HB-EGF-EGFRwt feed-forward loop regulates EGFRvIII activation. Silencing EGFRwt or HB-EGF leads to a striking inhibition of EGFRvIII-induced tumorigenicity, while increasing EGFRwt or HB-EGF levels resulted in accelerated EGFRvIII-mediated oncogenicity in an orthotopic mouse model. Furthermore, we demonstrate the existence of this loop in human GBM. Thus, our data demonstrate that oncogenic activation of EGFRvIII in GBM is likely maintained by a continuous EGFRwt-EGFRvIII-HB-EGF loop, potentially an attractive target for therapeutic intervention.	[Li, L.; Chakraborty, S.; Puliyappadamba, V. T.; Rehman, A.; Jiwani, A. J.; Habib, A. A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75216 USA; [Yang, C-R; Boothman, D. A.; Habib, A. A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Simmons Comprehens Canc Ctr, Dallas, TX 75216 USA; [Hatanpaa, K. J.; Raisanen, J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75216 USA; [Cipher, D. J.] Univ Texas Arlington, Coll Nursing, Arlington, TX 76019 USA; [Mickey, B.; Madden, C.] Univ Texas SW Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75216 USA; [Burma, S.; Saha, D.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75216 USA; [Wang, Z.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Pingle, S. C.; Kesari, S.] Moores Canc Ctr, Translat Neurooncol Labs, Dept Neurosci, UC San Diego, CA USA; [Habib, A. A.] VA North Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alberta; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Habib, AA (corresponding author), Univ Texas SW Med Ctr Dallas, North Texas VA Healthcare Syst, Dept Neurol & Neurotherapeut, Mail Code 151,4500 S Lancaster Rd, Dallas, TX 75216 USA.	Amyn.Habib@UTSouthwestern.edu	Kesari, Santosh/E-8461-2013; Boothman, David/Q-7776-2019		NIH [RO1NS062080, RO1 CA139217]; National Institutes of Health [RO1 CA149461]; National Aeronautics and Space Administration [NNX13AI13G]; Cancer Prevention and Research Institute of Texas [RP100644]; NATIONAL CANCER INSTITUTE [R01CA149461, P30CA142543, R01CA139217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Mien-Chie Hung (MD Anderson Cancer Center) for the EGFRwt-Myc plasmid and Dr James Van Brocklyn (Ohio State University) for GBM9 cells. This work was supported in part by NIH grant RO1NS062080 to AH and by RO1 CA139217 to DAB. SB is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX13AI13G) and the Cancer Prevention and Research Institute of Texas (RP100644).	Acquaviva J, 2011, CANCER RES, V71, P7198, DOI 10.1158/0008-5472.CAN-11-1514; Barkovich KJ, 2012, CANCER DISCOV, V2, P450, DOI 10.1158/2159-8290.CD-11-0287; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Dowlati A, 2004, MOL CANCER THER, V3, P459; Estrada-Bernal A, 2011, J NEURO-ONCOL, V102, P353, DOI 10.1007/s11060-010-0345-z; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Johns TG, 2007, CLIN CANCER RES, V13, P1911, DOI 10.1158/1078-0432.CCR-06-1453; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Luwor RB, 2004, ONCOGENE, V23, P6095, DOI 10.1038/sj.onc.1207870; Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Moscatello DK, 1996, ONCOGENE, V13, P85; Nagane M, 1996, CANCER RES, V56, P5079; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Pillay V, 2009, NEOPLASIA, V11, P448, DOI 10.1593/neo.09230; Puliyappadamba VT, 2013, CELL REP, V4, P764, DOI 10.1016/j.celrep.2013.07.025; Ramnarain DB, 2008, CELL DEATH DIFFER, V15, P344, DOI 10.1038/sj.cdd.4402268; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; SAMUELS V, 1989, AM J PATHOL, V134, P895; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tang CK, 2000, CANCER RES, V60, P3081; Thomas CY, 2003, INT J CANCER, V104, P19, DOI 10.1002/ijc.10880; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	43	33	36	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4253	4264		10.1038/onc.2013.400	http://dx.doi.org/10.1038/onc.2013.400			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24077285	Green Accepted			2022-12-25	WOS:000341155800007
J	Lee, KH; Jeong, J; Yoo, CG				Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu			Long-term Incubation with Proteasome Inhibitors (PIs) Induces I kappa B alpha Degradation via the Lysosomal Pathway in an I kappa B Kinase (IKK)-dependent and IKK-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Lung Cancer; Lysosomes; Proteasome; Signal Transduction; GSK-3; IKK; IB; Lysosome; Proteasome Inhibitor	RESPIRATORY EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; TUMOR-NECROSIS-FACTOR; LUNG-CANCER; THERAPEUTIC TARGET; INDUCED APOPTOSIS; ACTIVATION; PS-341; BORTEZOMIB; TRANSCRIPTION	Background: IB, a cytoplasmic inhibitor of NF-B, is degraded via the proteasome. Results: Paradoxically, proteasome inhibitors (PIs) induce IB degradation via the lysosome in an IKK-dependent and IKK-independent manner. Conclusion: PI-induced IB degradation results in NF-B activation that confers resistance to PI-induced cancer cell death. Significance: This provides a molecular mechanism to enhance the anti-cancer efficacy of PIs. Proteasome inhibitors (PIs) have been reported to induce apoptosis in many types of tumor. Their apoptotic activities have been suggested to be associated with the up-regulation of molecules implicated in pro-apoptotic cascades such as p53, p21(Waf1), and p27(Kip1). Moreover, the blocking of NF-B nuclear translocation via the stabilization of IB is an important mechanism of PI-induced apoptosis. However, we found that long-term incubation with PIs (PS-341 or MG132) increased NF-B-regulated gene expression such as COX-2, cIAP2, XIAP, and IL-8 in a dose- and time-dependent manner, which was mediated by phosphorylation of IB and its subsequent degradation via the alternative route, lysosome. Overexpression of the IB superrepressor (IB-SR) blocked PI-induced NF-B activation. Treatment with lysosomal inhibitors (ammonium chloride or chloroquine) or inhibitors of cathepsins (Z-FF-FMK or Z-FA-FMK) or knock-down of LC3B expression by siRNAs suppressed PI-induced IB degradation. Furthermore, we found that both IKK-dependent and IKK-independent pathways were required for PI-induced IB degradation. Pretreatment with IKK specific inhibitor, SC-514, partially suppressed IB degradation and IL-8 production by PIs. Blockade of IKK activity using insolubilization by heat shock (HS) and knock-down by siRNAs for IKK only delayed IB degradation up to 8 h after treatment with PIs. In addition, PIs induced Akt-dependent inactivation of GSK-3. Inactive GSK-3 accelerated PI-induced IB degradation. Overexpression of active GSK-3 (S9A) or knock-down of GSK-3 delayed PI-induced IB degradation. Collectively, our data demonstrate that long-term incubation with PIs activates NF-B, which is mediated by IB degradation via the lysosome in an IKK-dependent and IKK-independent manner.	[Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110799, South Korea; [Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Lung Inst, Med Res Ctr, Seoul 110799, South Korea; [Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yoo, CG (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, 101 Daehak Ro, Seoul 110744, South Korea.	cgyoo@snu.ac.kr			Seoul National University Hospital [0320030170]	Seoul National University Hospital	This work was supported by Grant 0320030170 from the Seoul National University Hospital.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cusack JC, 2001, CANCER RES, V61, P3535; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Denlinger CE, 2004, ANN THORAC SURG, V78, P1207, DOI 10.1016/j.athoracsur.2004.04.029; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Eto M, 2005, CIRCULATION, V112, P1316, DOI 10.1161/CIRCULATIONAHA.105.564112; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; Hideshima T, 2001, CANCER RES, V61, P3071; Kim JY, 2000, BIOCHEM BIOPH RES CO, V273, P140, DOI 10.1006/bbrc.2000.2909; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee KH, 2004, EXP CELL RES, V299, P49, DOI 10.1016/j.yexcr.2004.05.013; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Park GY, 2001, EUR RESPIR J, V18, P801, DOI 10.1183/09031936.01.00099801; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2005, CELL CYCLE, V4, P290; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; White DW, 1996, ONCOGENE, V13, P891; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416	36	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32777	32786		10.1074/jbc.M113.480921	http://dx.doi.org/10.1074/jbc.M113.480921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085292	Green Published, hybrid			2022-12-25	WOS:000328681700061
J	Smaniotto, S; Schneider, E; Goudin, N; Bricard-Rignault, R; Machavoine, F; Dardenne, M; Dy, M; Savino, W				Smaniotto, Salete; Schneider, Elke; Goudin, Nicolas; Bricard-Rignault, Rachel; Machavoine, Francois; Dardenne, Mireille; Dy, Michel; Savino, Wilson			Mouse Basophils Reside in Extracellular Matrix-Enriched Bone Marrow Niches Which Control Their Motility	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; IN-VIVO; MIGRATION; SURVIVAL; IL-4	Basophils co-express Fc epsilon RI alpha and CD49b, the alpha-2 chain of integrin-type receptor VLA-2 (alpha 2 beta 1), which recognizes type-1 collagen as a major natural ligand. The physiological relevance of this integrin for interactions with extracellular bone marrow matrix remains unknown. Herein, we examined the expression of several receptors of this family by bone marrow-derived basophils sorted either ex-vivo or after culture with IL-3. Having established that both populations display CD49d, CD49e and CD49f (alpha-4, alpha-5 and alpha-6 integrins subunits, respectively), we addressed receptor functions by measuring migration, adhesion, proliferation and survival after interacting with matched natural ligands. Type I collagen, laminin and fibronectin promoted basophil migration/adhesion, the former being the most effective. None of these ligands affected basophil viability and expansion. Interactions between basophils and extracellular matrix are likely to play a role in situ, as supported by confocal 3D cell imaging of femoral bone marrow sections, which revealed basophils exclusively in type-1 collagen-enriched niches that contained likewise laminin and fibronectin. This is the first evidence for a structure/function relationship between basophils and extracellular matrix proteins inside the mouse bone marrow.	[Smaniotto, Salete] Univ Fed Alagoas, Inst Biol & Hlth Sci, Cell Biol Lab, Maceio, Brazil; [Schneider, Elke; Bricard-Rignault, Rachel; Machavoine, Francois; Dardenne, Mireille; Dy, Michel] Univ Paris 05, Hop Necker, CNRS, UMR 8147, Paris, France; [Goudin, Nicolas] Univ Paris 05, Hop Necker, Paris, France; [Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil	Universidade Federal de Alagoas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz	Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.	savino@fiocruz.br	Smaniotto, Salete/AAT-4056-2020; Smaniotto, Salete/T-3796-2017	Smaniotto, Salete/0000-0003-1527-5894	Capes/Cofecub French/Brazilian conjoint program; CNRS (France); Fiocruz (Brazil); CNPq (Brazil); Faperj (Brazil); Fapeal (Brazil)	Capes/Cofecub French/Brazilian conjoint program; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Fiocruz (Brazil); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fapeal (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL))	This work was developed in the context of the CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology, being funded by the Capes/Cofecub French/Brazilian conjoint program, as well as CNRS (France), Fiocruz, CNPq, Faperj and Fapeal (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Bochner BS, 2001, IMMUNOL REV, V179, P5, DOI 10.1034/j.1600-065X.2001.790101.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; ERLE DJ, 1992, AM J RESP CELL MOL, V6, P459, DOI 10.1165/ajrcmb/6.5.459; Heinemann A, 2005, J ALLERGY CLIN IMMUN, V116, P820, DOI 10.1016/j.jaci.2005.06.008; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Pinto-Mariz F, 2010, J NEUROIMMUNOL, V223, P128, DOI 10.1016/j.jneuroim.2010.03.006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Schneider E, 1999, EXP HEMATOL, V27, P1010, DOI 10.1016/S0301-472X(99)00039-9; Schneider E, 2011, J ALLERGY CLIN IMMUN, V128, P864, DOI 10.1016/j.jaci.2011.04.043; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709; Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014; SONE KD, 2010, J ALLERGY CLIN IM S2, V125, pS73; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	25	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70292	10.1371/journal.pone.0070292	http://dx.doi.org/10.1371/journal.pone.0070292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086246	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900002
J	Liu, C; Yang, DR; Compton, SG; Peng, YQ				Liu, Cong; Yang, Da-Rong; Compton, Stephen G.; Peng, Yan-Qiong			Larger Fig Wasps Are More Careful About Which Figs to Enter - With Good Reason	PLOS ONE			English	Article							SEX-RATIO ADJUSTMENT; BODY-SIZE; POLLINATOR; LONGEVITY; SELECTION; COEVOLUTION; STABILITY; CONSEQUENCES; ATTRACTION; MECHANISM	Floral longevity reflects a balance between gains in pollinator visitation and the costs of flower maintenance. Because rewards to pollinators change over time, older flowers may be less attractive, reducing the value of extended longevity. Un-pollinated figs, the inflorescences of Ficus species, can remain receptive for long periods, but figs that are older when entered by their host-specific fig wasp pollinators produce fewer seeds and fig wasp offspring. Our field experiments with Ficus hispida, a dioecious fig tree, examined how the length of time that receptive figs have remained un-pollinated influences the behaviour and reproductive success of its short-lived fig wasp pollinator, Ceratosolen solmsi marchali. The results were consistent in three different seasons, and on male and female trees, although receptivity was greatly extended during colder months. Pollinators took longer to find the ostioles of older figs, and longer to penetrate them. They also became increasingly unwilling to enter figs as they aged, and increasing numbers of the wasps became trapped in the ostiolar bracts. Larger individuals were particularly unwilling to enter older figs, resulting in older figs being pollinated by smaller wasps. On female trees, where figs produce only seeds, seed production declined rapidly with fig age. On male trees, the numbers and size of fig wasp offspring declined, and a higher proportion were male. Older male figs are harder to enter, especially for larger individuals, and offer poorer quality oviposition opportunities. This study opens an interesting new perspective on the coevolution of figs and their pollinators, especially factors influencing pollinator body size and emphasises the subtleties of interactions between mutualists.	[Liu, Cong; Yang, Da-Rong; Peng, Yan-Qiong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Liu, Cong] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Okinawa Institute of Science & Technology Graduate University; Rhodes University	Peng, YQ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	pengyq@xtbg.ac.cn	Liu, Cong/B-9927-2015	Liu, Cong/0000-0002-8664-6931; Compton, Stephen/0000-0002-1247-8058	CAS 135 program [XTBG-T01]; Chinese Natural Science Foundation [31120002];  [2011HB041]	CAS 135 program; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 	This work was funded by Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province (2011HB041), and the CAS 135 program (XTBG-T01), and the Chinese Natural Science Foundation (31120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstett MC, 1996, J BIOGEOGR, V23, P459, DOI 10.1111/j.1365-2699.1996.tb00007.x; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Berg CC, 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bronstein JL, 1998, ENTOMOL EXP APPL, V87, P321, DOI 10.1023/A:1003242205324; Charnov EL, 1996, EVOL ECOL, V10, P245, DOI 10.1007/BF01237682; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Gibernau M, 1996, J BIOGEOGR, V23, P425, DOI 10.1111/j.1365-2699.1996.tb00004.x; GRAFEN A, 1991, P ROY SOC B-BIOL SCI, V245, P73, DOI 10.1098/rspb.1991.0090; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Hu HY, 2010, ECOL ENTOMOL, V35, P115, DOI 10.1111/j.1365-2311.2009.01170.x; KHADARI B, 1995, AM J BOT, V82, P992, DOI 10.2307/2446228; Kjellberg F, 2005, BIOL ECOLOGY EVOLUTI, V1, P539; Liu C, 2011, ENTOMOL EXP APPL, V138, P249, DOI 10.1111/j.1570-7458.2011.01096.x; Moore JC, 2003, OIKOS, V101, P180, DOI 10.1034/j.1600-0706.2003.12212.x; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Parker Joseph, 2006, J Biol, V5, P15, DOI 10.1186/jbiol47; Partridge L, 1999, GENET RES, V74, P43, DOI 10.1017/S0016672399003778; Patel A, 1998, OECOLOGIA, V115, P391, DOI 10.1007/s004420050533; PATEL A, 1995, J EVOLUTION BIOL, V8, P301, DOI 10.1046/j.1420-9101.1995.8030301.x; Peng YQ, 2010, PLANT ECOL, V209, P227, DOI 10.1007/s11258-009-9690-4; Peng YQ, 2005, ECOL ENTOMOL, V30, P70, DOI 10.1111/j.0307-6946.2005.00650.x; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; Raja S, 2008, P ROY SOC B-BIOL SCI, V275, P1603, DOI 10.1098/rspb.2008.0136; RAMIREZ W, 1969, SCIENCE, V163, P580, DOI 10.1126/science.163.3867.580; Rathcke BJ, 2003, AM J BOT, V90, P1328, DOI 10.3732/ajb.90.9.1328; Roff Derek A., 1992; Schreiber SJ, 2002, EVOL ECOL RES, V4, P701; Slansky F. Jr, 1985, P87; Suleman N, 2011, ECOL ENTOMOL, V36, P417, DOI 10.1111/j.1365-2311.2011.01284.x; Teder T, 2008, AM NAT, V172, P223, DOI 10.1086/589896; VANNOORT S, 1989, S AFR J SCI, V85, P323; VOLLRATH F, 1980, Z TIERPSYCHOL, V53, P61; Wang RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007802; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030833; Zhang Y, 2012, EVOL ECOL, V26, P513, DOI 10.1007/s10682-011-9525-3	46	11	18	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74117	10.1371/journal.pone.0074117	http://dx.doi.org/10.1371/journal.pone.0074117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086315	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200023
J	Askovich, PS; Sanders, CJ; Rosenberger, CM; Diercks, AH; Dash, P; Navarro, G; Vogel, P; Doherty, PC; Thomas, PG; Aderem, A				Askovich, Peter S.; Sanders, Catherine J.; Rosenberger, Carrie M.; Diercks, Alan H.; Dash, Pradyot; Navarro, Garnet; Vogel, Peter; Doherty, Peter C.; Thomas, Paul G.; Aderem, Alan			Differential Host Response, Rather Than Early Viral Replication Efficiency, Correlates with Pathogenicity Caused by Influenza Viruses	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; A H1N1 VIRUS; PANDEMIC INFLUENZA; IMMUNE-RESPONSE; BINDING-SITES; HUMAN AIRWAY; TNF-ALPHA; INFECTION; RECEPTOR; MICE	Influenza viruses exhibit large, strain-dependent differences in pathogenicity in mammalian hosts. Although the characteristics of severe disease, including uncontrolled viral replication, infection of the lower airway, and highly inflammatory cytokine responses have been extensively documented, the specific virulence mechanisms that distinguish highly pathogenic strains remain elusive. In this study, we focused on the early events in influenza infection, measuring the growth rate of three strains of varying pathogenicity in the mouse airway epithelium and simultaneously examining the global host transcriptional response over the first 24 hours. Although all strains replicated equally rapidly over the first viral life-cycle, their growth rates in both lung and tracheal tissue strongly diverged at later times, resulting in nearly 10-fold differences in viral load by 24 hours following infection. We identified separate networks of genes in both the lung and tracheal tissues whose rapid up-regulation at early time points by specific strains correlated with a reduced viral replication rate of those strains. The set of early-induced genes in the lung that led to viral growth restriction is enriched for both NF-kappa B binding site motifs and members of the TREM1 and IL-17 signaling pathways, suggesting that rapid, NF-kappa B -mediated activation of these pathways may contribute to control of viral replication. Because influenza infection extending into the lung generally results in severe disease, early activation of these pathways may be one factor distinguishing high- and low-pathogenicity strains.	[Askovich, Peter S.; Rosenberger, Carrie M.; Diercks, Alan H.; Navarro, Garnet; Doherty, Peter C.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sanders, Catherine J.; Dash, Pradyot; Vogel, Peter; Doherty, Peter C.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Center for Infectious Disease Research; St Jude Children's Research Hospital	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Thomas, Paul G./H-1063-2018; Vogel, Peter/N-2490-2018; Doherty, Peter Charles/C-4185-2013	Thomas, Paul G./0000-0001-7955-0256; Vogel, Peter/0000-0002-7535-0545; Dash, Pradyot/0000-0001-5467-0657; Doherty, Peter Charles/0000-0002-5028-3489	NIAID [HHSN272200800058C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610, U19AI100627] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID's Systems Influenza contract (HHSN272200800058C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Behrens G, 2006, INFLUENZA REPORT; Belisle SE, 2010, J VIROL, V84, P12576, DOI 10.1128/JVI.01310-10; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Crapo J D, 1982, Am Rev Respir Dis, V125, P740; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Dash P, 2010, J VIROL, V84, P9149, DOI 10.1128/JVI.00642-10; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Faruqui F, 2010, CURR OPIN PEDIATR, V22, P530, DOI 10.1097/MOP.0b013e32833bb81a; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Ivan FX, 2012, FUNCT INTEGR GENOMIC, V12, P105, DOI 10.1007/s10142-011-0247-y; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; LaRussa P, 2011, SEMIN RESP CRIT CARE, V32, P393, DOI 10.1055/s-0031-1283279; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Loeffelholz MJ, 2010, CLIN LAB MED, V30, P1, DOI 10.1016/j.cll.2009.10.005; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Neumann G, 2004, CURR TOP MICROBIOL, V283, P43; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Nordhoff C, 2012, CELL MICROBIOL, V14, P1135, DOI 10.1111/j.1462-5822.2012.01787.x; Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Rahman MS, 2005, CLIN IMMUNOL, V115, P268, DOI 10.1016/j.clim.2005.01.014; Reading PC, 2010, IMMUNOL CELL BIOL, V88, P641, DOI 10.1038/icb.2010.11; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Rutigliano JA, 2010, J VIROL, V84, P1047, DOI 10.1128/JVI.01535-09; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith JH, 2011, VIRAL IMMUNOL, V24, P131, DOI 10.1089/vim.2010.0085; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Van Stry M, 2012, J VIROL, V86, P4151, DOI 10.1128/JVI.05303-11; Vasilescu DM, 2012, P NATL ACAD SCI USA, V109, P17105, DOI 10.1073/pnas.1215112109; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; World Health Organization (WHO), 2009, INFLUENZA; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172	64	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74863	10.1371/journal.pone.0074863	http://dx.doi.org/10.1371/journal.pone.0074863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073225	Green Published, gold			2022-12-25	WOS:000324768000034
J	Chen, LY; Zhong, NS; Lai, KF				Chen, Liyan; Zhong, Nanshan; Lai, Kefang			Re-Challenge with Ovalbumin Failed to Induce Bronchial Asthma in Mice with Eosinophilic Bronchitis	PLOS ONE			English	Article							TOLERANCE	Objective: To investigate whether eosinophilic bronchitis without airway hyperresponsiveness will develop bronchial asthma in allergic mice. Methods: Mice were sensitized with OVA on days 0, 7, and 14, challenged on days 21 to 23 (1st OVA challenge), and re-challenged on days 46 to 48 (2nd OVA challenge), intranasally with 10 (the EB group) and 200 (the AS group) mu g OVA. Lung resistance (R-L) was assessed 24 h after each challenge and on day 45 followed by analysis of leukocyte distribution in the bronchoalveolar lavage (BAL) fluid and histological examination. Results: Twenty-four hours after the 1st OVA challenge, aerosolized methacholine caused a dose-dependent increase in R-L in all groups. At doses >= 1.56 mg/mL, R-L in the AS group was significantly higher than that of the NS-1 group (P<0.01 or 0.05) and at doses >= 12.5 mg/mL, R-L was markedly higher in the AS group than that of the EB group (P<0.01). The percentage of eosinophils in both the EB group and the AS group was markedly higher than that of the control group. Twenty-four hours after the 2nd OVA challenge, at doses >= 12.5 mg/mL, there was no significant difference in R-L among all groups (P>0.05). At doses >= 12.5 mg/mL, R-L in the AS group was significantly higher than that of the control group and EB group (P<0.01 or 0.05). The percentage of eosinophils in the AS group was noticeably higher than that of the EB group(P<0.05). Furthermore, there was apparent infiltration by inflammatory cells, predominantly eosinophils, into the sub-epithelial region of the bronchus and the bronchioles and around the vessels in the EB and AS group. Conclusion: Re-challenge with low doses of ovalbumin did not increase airway reactivity and failed to induce bronchial asthma in mice with ovalbumin-induced EB.	[Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Lai, KF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	klai@163.com			National Natural Science Foundation of China [81100009, 30670934]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants of the National Natural Science Foundation of China (No. 81100009 and No. 30670934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry MA, 2005, CLIN EXP ALLERGY, V35, P598, DOI 10.1111/j.1365-2222.2005.02222.x; Chen LY, 2011, CLIN EXP MED, V11, P19, DOI 10.1007/s10238-010-0106-5; Chung Y, 2002, IMMUNOBIOLOGY, V206, P408, DOI 10.1078/0171-2985-00190; GIBSON PG, 1989, LANCET, V1, P1346; Glaab T, 2001, AM J PHYSIOL-LUNG C, V280, pL565, DOI 10.1152/ajplung.2001.280.3.L565; Natarajan S, 2012, INT ARCH ALLERGY IMM, V158, P120, DOI 10.1159/000330896; Park SW, 2004, CHEST, V125, P1998, DOI 10.1378/chest.125.6.1998; Tournoy KG, 2006, CURR ALLERGY ASTHM R, V6, P437, DOI 10.1007/s11882-996-0018-3; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; Vanoirbeek JAJ, 2009, TOXICOLOGY, V257, P144, DOI 10.1016/j.tox.2008.12.020	10	5	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75195	10.1371/journal.pone.0075195	http://dx.doi.org/10.1371/journal.pone.0075195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073252	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000061
J	Garcia-Martinez, V; Villanueva, J; Torregrosa-Hetland, CJ; Bittman, R; Higdon, A; Darley-Usmar, VM; Davletov, B; Gutierrez, LM				Garcia-Martinez, Virginia; Villanueva, Jose; Torregrosa-Hetland, Cristina J.; Bittman, Robert; Higdon, Ashlee; Darley-Usmar, Victor M.; Davletov, Bazbek; Gutierrez, Luis M.			Lipid Metabolites Enhance Secretion Acting on SNARE Microdomains and Altering the Extent and Kinetics of Single Release Events in Bovine Adrenal Chromaffin Cells	PLOS ONE			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; ARACHIDONIC-ACID; C-TERMINUS; VESICLE DOCKING; T-SNARE; SNAP-25; FUSION; MEMBRANE; EXOCYTOSIS; SYNAPTOBREVIN	Lipid molecules such as arachidonic acid (AA) and sphingolipid metabolites have been implicated in modulation of neuronal and endocrine secretion. Here we compare the effects of these lipids on secretion from cultured bovine chromaffin cells. First, we demonstrate that exogenous sphingosine and AA interact with the secretory apparatus as confirmed by FRET experiments. Examination of plasma membrane SNARE microdomains and chromaffin granule dynamics using total internal reflection fluorescent microscopy (TIRFM) suggests that sphingosine production promotes granule tethering while arachidonic acid promotes full docking. Our analysis of single granule release kinetics by amperometry demonstrated that both sphingomyelinase and AA treatments enhanced drastically the amount of catecholamines released per individual event by either altering the onset phase of or by prolonging the off phase of single granule catecholamine release kinetics. Together these results demonstrate that the kinetics and extent of the exocytotic fusion pore formation can be modulated by specific signalling lipids through related functional mechanisms.	[Garcia-Martinez, Virginia; Villanueva, Jose; Torregrosa-Hetland, Cristina J.; Gutierrez, Luis M.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY USA; [Higdon, Ashlee; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Davletov, Bazbek] MRC Lab Mol Biol, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); City University of New York (CUNY) System; Queens College NY (CUNY); University of Alabama System; University of Alabama Birmingham; MRC Laboratory Molecular Biology	Gutierrez, LM (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain.	luisguti@umh.es	Villanueva, José/K-4448-2014; Gutierrez, Luis/K-8633-2014; Davletov, Bazbek/ABA-8569-2021	Villanueva, José/0000-0002-4057-2113; Gutierrez, Luis/0000-0002-0512-7858; Darley-Usmar, Victor/0000-0001-8921-7086; Torregrosa, Jose-Vicente/0000-0001-5160-3248; Davletov, Bazbek/0000-0003-4658-3275	Spanish Ministry of Science and Innovation (MICINN) [BFU2011-25095]; FPU program of Ministry of Education and Culture of Spain; MRC [MC_U105178791] Funding Source: UKRI; Medical Research Council [MC_U105178791] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU program of Ministry of Education and Culture of Spain; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Spanish Ministry of Science and Innovation (MICINN, BFU2011-25095) to LMG. C T-H is recipient of a fellowship from the FPU program of Ministry of Education and Culture of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhuvula P, 2009, BIOCHEM BIOPH RES CO, V380, P366, DOI 10.1016/j.bbrc.2009.01.106; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; Davletov B, 2007, CELL MOL LIFE SCI, V64, P1597, DOI 10.1007/s00018-007-6557-5; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Gil A, 1998, EUR J NEUROSCI, V10, P3369, DOI 10.1046/j.1460-9568.1998.00341.x; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henkel AW, 2006, J CELL BIOCHEM, V97, P1393, DOI 10.1002/jcb.20751; Higdon AN, 2009, FREE RADICAL BIO MED, V47, P201, DOI 10.1016/j.freeradbiomed.2009.05.009; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lopez I, 2009, TRAFFIC, V10, P172, DOI 10.1111/j.1600-0854.2008.00861.x; Lopez-Font I, 2010, J NEUROCHEM, V114, P1550, DOI 10.1111/j.1471-4159.2010.06872.x; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; RINDLISBACHER B, 1990, J NEUROCHEM, V54, P1247, DOI 10.1111/j.1471-4159.1990.tb01955.x; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Torregrosa-Hetland CJ, 2013, INT J BIOCHEM CELL B, V45, P583, DOI 10.1016/j.biocel.2012.11.021; Uchiyama Y, 2007, BRAIN RES, V1151, P46, DOI 10.1016/j.brainres.2007.03.012; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; ZIMMERBERG J, 1991, ANN NY ACAD SCI, V635, P307, DOI 10.1111/j.1749-6632.1991.tb36501.x	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75845	10.1371/journal.pone.0075845	http://dx.doi.org/10.1371/journal.pone.0075845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073281	gold, Green Published, Green Accepted			2022-12-25	WOS:000324768000091
J	Wang, YR; Qin, S; Han, R; Wu, JC; Liang, ZQ; Qin, ZH; Wang, Y				Wang, Yan-Ru; Qin, Shu; Han, Rong; Wu, Jun-Chao; Liang, Zhong-Qin; Qin, Zheng-Hong; Wang, Yan			Cathepsin L Plays a Role in Quinolinic Acid- Induced NF-Kb Activation and Excitotoxicity in Rat Striatal Neurons	PLOS ONE			English	Article							KAPPA-B ACTIVATION; RADICAL SCAVENGER OPC-14117; CELL-DEATH; KAINIC ACID; INDUCED APOPTOSIS; MEMBRANE PERMEABILIZATION; MITOCHONDRIA DYSFUNCTION; AUTOPHAGOSOME FORMATION; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS	The present study seeks to investigate the role of cathepsin L in glutamate receptor-induced transcription factor nuclear factor-kappa B (NF-kappa B) activation and excitotoxicity in rats striatal neurons. Stereotaxic administration of the N-methyl-d-aspartate (NMDA) receptor agonist Quinolinic acid (QA) into the unilateral striatum was used to produce the in vivo excitotoxic model. Co-administration of QA and the cathepsin L inhibitor Z-FF-FMK or 1-Naphthalenesulfonyl-IW-CHO (NaphthaCHO) was used to assess the contribution of cathepsin L to QA-induced striatal neuron death. Western blot analysis and cathepsin L activity assay were used to assess the changes in the levels of cathepsin L after QA treatment. Western blot analysis was used to assess the changes in the protein levels of inhibitor of NF-kappa B alpha isoform (I kappa B-alpha) and phospho-I kappa B alpha (p-I kappa B alpha) after QA treatment. Immunohistochemical analysis was used to detect the effects of Z-FF-FMK or NaphthaCHO on QA-induced NF-kappa B. Western blot analysis was used to detect the effects of Z-FF-FMK or NaphthaCHO on QA-induced I kappa B-alpha phosphorylation and degradation, changes in the levels of IKK alpha, p-IKK alpha, TP53, caspase-3, beclin1, p62, and LC3II/LC3I. The results show that QA-induced loss of striatal neurons were strongly inhibited by Z-FF-FMK or NaphthaCHO. QA-induced degradation of I kappa B-alpha, NF-kappa B nuclear translocation, up-regulation of NF-kappa B responsive gene TP53, and activation of caspase-3 was strongly inhibited by Z-FF-FMK or NaphthaCHO. QA-induced increases in beclin 1, LC3II/LC3I, and down-regulation of p62 were reduced by Z-FF-FMK or NaphthaCHO. These results suggest that cathepsin L is involved in glutamate receptor-induced NF-kB activation. Cathepsin L inhibitors have neuroprotective effects by inhibiting glutamate receptor-induced I kappa B-alpha degradation and NF-kappa B activation.	[Wang, Yan] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis SZS0703, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Wang, Y (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Wen Jing Rd, Suzhou, Peoples R China.	yanwang@suda.edu.cn			National Natural Science Foundation of China [81000547, 30930035, 81072656]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (No 81000547; 30930035; 81072656) and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dai C, 2011, P NATL ACAD SCI USA, V108, P18937, DOI 10.1073/pnas.1110988108; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dong XX, 2012, NEUROSCIENCE, V207, P52, DOI 10.1016/j.neuroscience.2012.01.018; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fei XF, 2009, BRAIN RES, V1264, P85, DOI 10.1016/j.brainres.2009.01.057; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Funkelstein L, 2010, NEUROPEPTIDES, V44, P457, DOI 10.1016/j.npep.2010.08.003; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; GOTO T, 1994, HISTOCHEMISTRY, V101, P33, DOI 10.1007/BF00315829; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384; Henkels KM, 1999, CANCER RES, V59, P3077; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Miyoshi N, 2005, BIOCHEM BIOPH RES CO, V334, P466, DOI 10.1016/j.bbrc.2005.06.113; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakai M, 2000, BRAIN RES, V859, P207, DOI 10.1016/S0006-8993(00)01959-4; Nakai M, 1999, MOL BRAIN RES, V64, P59, DOI 10.1016/S0169-328X(98)00310-6; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pan JA, 2013, J BIOL CHEM, V288, P2952, DOI 10.1074/jbc.M112.441063; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin ZH, 1996, BRAIN RES, V725, P166, DOI 10.1016/S0006-8993(96)00200-4; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qin ZH, 1998, MOL PHARMACOL, V53, P33, DOI 10.1124/mol.53.1.33; Ryvnyak VV, 2004, B EXP BIOL MED+, V137, P90, DOI 10.1023/B:BEBM.0000024396.17895.77; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; WAGURI S, 1995, EUR J CELL BIOL, V67, P308; Wang N, 2011, BRIT J PHARMACOL, V164, P731, DOI 10.1111/j.1476-5381.2011.01349.x; Wang Y, 2006, BRAIN RES, V1071, P245, DOI 10.1016/j.brainres.2005.10.074; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang Y, 2013, ACTA PHARMACOL SIN, V34, P585, DOI 10.1038/aps.2012.194; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Xiang B, 2011, BRAIN RES, V1387, P29, DOI 10.1016/j.brainres.2011.02.092; Yamakura T, 1999, PROG NEUROBIOL, V59, P279, DOI 10.1016/S0301-0082(99)00007-6; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; YOKOTA S, 1988, HISTOCHEMISTRY, V90, P277, DOI 10.1007/BF00495971; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174	66	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75702	10.1371/journal.pone.0075702	http://dx.doi.org/10.1371/journal.pone.0075702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073275	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000085
J	Wu, WL; Wu, BY; Ye, T; Huang, HG; Dai, CJ; Yuan, JJ; Wang, W				Wu, Wenlin; Wu, Bingyan; Ye, Ting; Huang, Huagen; Dai, Congjie; Yuan, Jianjun; Wang, Wei			TCTP Is a Critical Factor in Shrimp Immune Response to Virus Infection	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; INDUCED CELL-DEATH; ANTIAPOPTOTIC ACTIVITY; GTPASE; SURVIVAL; STRESS; GROWTH; GENES; PHAGOCYTOSIS; EXPRESSION	The translationally controlled tumor protein (TCTP) is an abundant, ubiquitous, and conserved protein which plays important roles in a number of biological processes. In the present study, the TCTP in shrimp Litopenaeus vannamei was analyzed. The TCTP of L. vannamei, a 168-amino-acid polypeptide, shares a high degree of similarity with TCTPs from other species, having two TCTP protein signatures at the 45-55 aa and 123-145 aa motif. The mRNA and protein levels from different tissues were detected with the highest in muscle and the lowest in heart among all examined tissues. In addition, temporal TCTP expression was significantly up-regulated at 16 h and 48 h following infection with white spot syndrome virus (WSSV). Lastly, silencing of TCTP with dsRNA led to a significant increase of WSSV loads. These results provide new insights into the importance of TCTP as an evolutionarily conserved molecule for shrimp innate immunity against virus infection.	[Wu, Wenlin; Wu, Bingyan; Huang, Huagen; Dai, Congjie; Yuan, Jianjun] Quanzhou Normal Univ, Dept Biol, Quanzhou, Peoples R China; [Ye, Ting] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Wei] State Ocean Adm, Inst Oceanog 3, Xiamen, Peoples R China	Quanzhou Normal University; Zhejiang Sci-Tech University; State Oceanic Administration	Wu, WL (corresponding author), Quanzhou Normal Univ, Dept Biol, Quanzhou, Peoples R China.	wenlinw@hotmail.Com; wangw.sz@gmail.com	ye, ting/HGC-5924-2022		National Natural Science Foundation of China [31072236]; Education Office of Fujian Province [JK2009043]; Haixi Project of Fujian [A101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Office of Fujian Province; Haixi Project of Fujian	This research was supported by the National Natural Science Foundation of China (31072236), the Education Office of Fujian Province (JK2009043) and Haixi Project of Fujian (A101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Bonnet C, 2000, YEAST, V16, P23, DOI 10.1002/(SICI)1097-0061(20000115)16:1<23::AID-YEA503>3.0.CO;2-A; Burgents JE, 2005, DEV COMP IMMUNOL, V29, P681, DOI 10.1016/j.dci.2005.01.004; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chitpatima ST, 1998, NUCLEIC ACIDS RES, V16, P23; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Huang TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050581; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049711; Li CH, 2010, FISH SHELLFISH IMMUN, V29, P530, DOI 10.1016/j.fsi.2010.04.018; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Lucibello M, 2011, EXP CELL RES, V317, P2479, DOI 10.1016/j.yexcr.2011.07.012; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Martin GG, 2000, J CRUSTACEAN BIOL, V20, P209, DOI 10.1651/0278-0372(2000)020[0209:EOSMFT]2.0.CO;2; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nagano-Ito M, 2009, FEBS LETT, V583, P1363, DOI 10.1016/j.febslet.2009.03.045; PAY A, 1992, PLANT MOL BIOL, V19, P501, DOI 10.1007/BF00023399; RASMUSSEN SW, 1994, YEAST, V10, pS63, DOI 10.1002/yea.320100008; Sirois I, 2011, CELL DEATH DIFFER, V18, P549, DOI 10.1038/cdd.2010.126; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thiele H, 1998, EUR J BIOCHEM, V257, P62, DOI 10.1046/j.1432-1327.1998.2570062.x; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wang Q, 2011, BIOL BULL-US, V221, P290, DOI 10.1086/BBLv221n3p290; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu WL, 2007, FISH SHELLFISH IMMUN, V23, P438, DOI 10.1016/j.fsi.2007.01.001; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	36	14	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74460	10.1371/journal.pone.0074460	http://dx.doi.org/10.1371/journal.pone.0074460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073212	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000021
J	Minnery, M; Contreras, C; Perez, R; Solorzano, N; Tintaya, K; Jimenez, J; Soto, S; Lecca, L				Minnery, Mark; Contreras, Carmen; Perez, Rosa; Solorzano, Ninfa; Tintaya, Karen; Jimenez, Judith; Soto, Silvia; Lecca, Leonid			A Cross Sectional Study of Knowledge and Attitudes Towards Tuberculosis amongst Front-Line Tuberculosis Personnel in High Burden Areas of Lima, Peru	PLOS ONE			English	Article							STAFF	Introduction: Tuberculosis, reported as the second most common infectious cause of death worldwide, is a key mortality contributor in developing countries and globally. The disease is endemic in Peru and while relative success was achieved during the 1990s in its control, this slowed as new complications, such as multi drug resistant TB arose. Health centre workers participating in the national DOTS program, create the front-line TB work-force in Peru meaning their knowledge and attitudes about the disease are key in its control. Methods: A Spanish language, multiple choice knowledge and attitudes survey was designed based on previous successful studies and the national Peruvian TB control guidelines. It was applied to two health networks in Lima, Peru amongst 301health workers participating in the national TB control program from 66 different health centres. The study results were analysed to test mean knowledge scores amongst different groups, overall gaps in key areas of TB treatment and control knowledge, and attitudes towards the disease and the national TB control program. Results: A mean knowledge score of 10.1 (+/- 1.7) out of 15 or 67.3% correct was shown. Demographics shown to have an effect on knowledge score were age and level of education. Major knowledge gaps were noted primarily in themes relating to treatment and diagnostics. Greater community involvement including better patient education about TB was seen as important in implementing the national TB control program. Participants were in disagreement about the current distribution of health resources throughout the study area. Discussion Serious knowledge gaps were identified from the survey; these reflect findings from a previous study in Lima and other studies from TB endemic areas throughout the world. Understanding these gaps and observations made by front-line TB workers in Lima may help to improve the national TB control program and other control efforts globally.	[Minnery, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Contreras, Carmen; Tintaya, Karen; Jimenez, Judith; Soto, Silvia; Lecca, Leonid] Socios Salud Surcusal Peru, Lima, Peru; [Perez, Rosa; Solorzano, Ninfa] Minist Salud Lima, Direcc Salud Lima Ciudad 5, Lima, Peru	University of Queensland	Lecca, L (corresponding author), Socios Salud Surcusal Peru, Lima, Peru.	llecca_ses@pih.org	Soto, Silvia/HGB-5950-2022	Lecca, Leonid/0000-0003-1363-3985				Aguilar-Najera MJ, 2008, MED UNAB, V11, P213; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Ayaya S O, 2003, East Afr Med J, V80, P83; Chakaya JM, 2005, INT J TUBERC LUNG D, V9, P403; Cruz Martínez Óscar Andrés, 2011, av.enferm., V29, P143; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1997, ANN C GLOB LUNG HLTH; Hashim D S, 2003, East Mediterr Health J, V9, P718; Hoa NP, 2005, HEALTH POLICY, V72, P1, DOI 10.1016/j.healthpol.2004.02.013; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Minsa Peru, 2012, SIT PREV CONTR UNPUB; PAHO, 2006, EG PLAN TUB CONTR 20, P2006; Peru Minsa, 2011, IMP SOC TUB PER 2010; Peru Minsa, 2006, NORM TECN SAL UNPUB; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Watkins RE, 2005, PATIENT EDUC COUNS, V56, P340, DOI 10.1016/j.pec.2004.03.009; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, 4 WHO; WHO, 2009, TUB PROF	22	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75698	10.1371/journal.pone.0075698	http://dx.doi.org/10.1371/journal.pone.0075698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069437	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300090
J	Person, B; Schilling, K; Owuor, M; Ogange, L; Quick, R				Person, Bobbie; Schilling, Katharine; Owuor, Mercy; Ogange, Lorraine; Quick, Rob			A Qualitative Evaluation of Hand Drying Practices among Kenyans	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; HYGIENE; DISEASE; RISK	Background: Recommended disease prevention behaviors of hand washing, hygienic hand drying, and covering one's mouth and nose in a hygienic manner when coughing and sneezing appear to be simple behaviors but continue to be a challenge to successfully promote and sustain worldwide. We conducted a qualitative inquiry to better understand current hand drying behaviors associated with activities of daily living, and mouth and nose covering practices, among Kenyans. Methods and Findings: We conducted 7 focus group discussions; 30 in-depth interviews; 10 structured household observations; and 75 structured observations in public venues in the urban area of Kisumu; rural communities surrounding Kisumu; and a peri-urban area outside Nairobi, Kenya. Using a grounded theory approach, we transcribed and coded the narrative data followed by thematic analysis of the emergent themes. Hand drying, specifically on a clean towel, was not a common practice among our participants. Most women dried their hands on their waist cloth, called a leso, or their clothes whether they were cooking, eating or cleaning the nose of a young child. If men dried their hands, they used their trousers or a handkerchief. Children rarely dried their hands; they usually just wiped them on their clothes, shook them, or left them wet as they continued with their activities. Many people sneezed into their hands and wiped them on their clothes. Men and women used a handkerchief fairly often when they had a runny nose, cold, or the flu. Most people coughed into the air or their hand. Conclusions: Drying hands on dirty clothes, rags and lesos can compromise the benefits of handwashing. Coughing and sneezing in to an open hand can contribute to spread of disease as well. Understanding these practices can inform health promotion activities and campaigns for the prevention and control of diarrheal disease and influenza.	[Person, Bobbie] Ctr Dis Control & Prevent, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA; [Schilling, Katharine; Quick, Rob] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Owuor, Mercy; Ogange, Lorraine] Kenya Govt Med Res Ctr, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Person, B (corresponding author), Ctr Dis Control & Prevent, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.	bperson@cdc.gov			Vestergaard Frandsen SA	Vestergaard Frandsen SA	This qualitative inquiry was funded by Vestergaard Frandsen SA(http://www.vestergaard-frandsen.com/) as part of a larger hand hygiene investigation but they had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Burt RS, 2005, BROKERAGE CLOSURE IN; *CDCP, 2009, COUGH SNEEZ; *CDCP, 2011, HANDW CLEAN HANDS SA; Dewalt K., 2002, PARTICIPANT OBSERVAT; Glaser B, 1978, DISCOV GROUNDED THEO; *GLOB PUBL PRIV PA, 2011, PARTN; Gulis G, 2004, ENVIRON RES, V96, P219, DOI 10.1016/j.envres.2004.01.016; Gustafson DR, 2000, MAYO CLIN PROC, V75, P705; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MERCY KJ, 2008, THESIS METROPOLIA U; Miles M., 1994, EARLY STEPS ANAL QUA, P50; Patrick DR, 1997, EPIDEMIOL INFECT, V119, P319, DOI 10.1017/S0950268897008261; Patton M. Q, 2002, QUALITATIVE RES EVAL, P431; Ray Sandip Kumar, 2010, Indian J Public Health, V54, P126, DOI 10.4103/0019-557X.75734; Suchdev PS, 2010, FOOD NUTR BULL, V31, pS168, DOI 10.1177/15648265100312S209; Todd ECD, 2010, J FOOD PROTECT, V73, P1937, DOI 10.4315/0362-028X-73.10.1937; *WHO, 2010, KEN HLTH PROF	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74370	10.1371/journal.pone.0074370	http://dx.doi.org/10.1371/journal.pone.0074370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069302	Green Published, gold			2022-12-25	WOS:000324777300033
J	Yu, WB; Huang, PH; Li, DZ; Wang, H				Yu, Wen-Bin; Huang, Pan-Hui; Li, De-Zhu; Wang, Hong			Incongruence between Nuclear and Chloroplast DNA Phylogenies in Pedicularis Section Cyathophora (Orobanchaceae)	PLOS ONE			English	Article							BAYESIAN POSTERIOR PROBABILITIES; POLLINATION ECOLOGY; INFERRING PHYLOGENY; QUATERNARY CLIMATE; POLLEN MORPHOLOGY; GENE TREES; BOOTSTRAP; EVOLUTION; PHYLOGEOGRAPHY; ASTERACEAE	Pedicularis section Cyathophora is a monophyletic group characterized by perfoliate leaf and/or bract bases at each node. This section comprises four series, corresponding to four general corolla types of Pedicularis, i.e. toothless, toothed, beaked and long-tubed corollas. In this study, we aim to reconstruct a comprehensive phylogeny of section Cyathophora, and compare phylogenetic incongruence between nuclear and chloroplast datasets. Sixty-seven accessions belonging to section Cyathophora and 9 species for other Pedicularis were sampled, and one nuclear gene (nrITS) and four chloroplast genes (matK, rbcL, trnH-psbA and trnL-F) were sequenced. Phylogenetic analyses show that the topologies and networks inferred from nrITS and the concatenated chloroplast datasets were incongruent, and the nrITS phylogenies and network agreed with the morphology-based taxonomy to some degree. The chloroplast genome of two Sichuan samples of P. cyathophylloides (E4 and E5) may show introgression from an ancestor of P. cyathophylla. Neither the nrITS dataset nor the concatenated chloroplast dataset were able to adequately resolve relationships among species in the series Reges; this is most likely due to incomplete lineage sorting and/or introgression/hybridization. The nrITS phylogeny indicates the beakless (toothed and toothless) and beaked galeas may have evolved independently within section Cyathophora, and the chloroplast phylogeny reveals that the long corolla tube with beaked galea is derived from the short one.	[Yu, Wen-Bin; Huang, Pan-Hui; Li, De-Zhu; Wang, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Yu, Wen-Bin; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Yu, Wen-Bin; Huang, Pan-Hui] Chinese Acad Sci, Grad Univ, Beijing, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn; wanghong@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011; Yu, Wen-Bin/H-8339-2014	Li, De-Zhu/0000-0002-4990-724X; Yu, Wen-Bin/0000-0002-7643-2112	National Natural Science Foundation of China [31200185]; West Light Foundation of the Chinese Academy of Sciences; National High-tech Research & Development Program of China [2012AA021801]; National Science and Technology on Basic Research Program [2013FY112600]; Key Research Program of the Chinese Academy of Sciences [KJZD-EW-L07]; Large-Scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; National Key Basic Research Program of China [2014CB954100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); National Science and Technology on Basic Research Program; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Large-Scale Scientific Facilities of the Chinese Academy of Sciences; National Key Basic Research Program of China(National Basic Research Program of China)	This study is supported by grants from the National Natural Science Foundation of China (31200185), the West Light Foundation of the Chinese Academy of Sciences, the National High-tech Research & Development Program of China (2012AA021801), the National Science and Technology on Basic Research Program (2013FY112600), the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L07), the Large-Scale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01), and the National Key Basic Research Program of China (2014CB954100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Bonati G., 1910, B SOC BOT FRANCE, V57, P1; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Li H-L, 1948, P ACAD NAT SCI PHILA, V100, P205; LI HL, 1951, EVOLUTION, V5, P158, DOI 10.1111/j.1558-5646.1951.tb02771.x; Limpricht W, 1924, REPERT SPEC NOV REGN, V20, P161, DOI DOI 10.1002/FEDR.19240200612; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Lu L, 2010, MOL PHYLOGENET EVOL, V57, P364, DOI 10.1016/j.ympev.2010.06.002; Macior L.W., 1982, P29; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maximovicz CJ, 1888, B ACAD SCI ST PETERS, P477; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Okuyama Y, 2005, MOL BIOL EVOL, V22, P285, DOI 10.1093/molbev/msi016; P-C Tsoong, 1955, ACTA PHYTOTAX SINICA, V4, P71; P-C Tsoong, 1965, ACTA PHYTOTAX SINICA, V10, P357; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; REE RH, 2001, THESIS HAVARD U CAMB; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt-Lebuhn AN, 2012, MOL PHYLOGENET EVOL, V65, P23, DOI 10.1016/j.ympev.2012.05.015; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tang Y, 2007, FLORA, V202, P209, DOI 10.1016/j.flora.2006.09.001; Tang Y, 2006, ARCT ANTARCT ALP RES, V38, P446, DOI 10.1657/1523-0430(2006)38[446:APESOP]2.0.CO;2; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; Tsoong P-C., 1963, FLORA REIPUBLICAE PO, V68, P1; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VanRaamsdonk LWD, 1997, BOT J LINN SOC, V123, P91, DOI 10.1006/bojl.1996.0075; Wang H, 1998, ACTA BOT SIN, V40, P781; Wang H, 2009, PLANT SYST EVOL, V277, P153, DOI 10.1007/s00606-008-0112-1; Wang S, 2004, CHINA SPECIES RED LI, VI; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Wu ZY., 2003, FAMILIES GENERA ANGI; Yang FS, 2007, PLANT SYST EVOL, V264, P251, DOI 10.1007/s00606-006-0510-1; Yang FS, 2003, PLANT SYST EVOL, V240, P91, DOI 10.1007/s00606-003-0005-2; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang H.-P., 1990, ACTA PHYTOTAX SINICA, V28, P136; Yang ZY, 2012, J SYST EVOL, V50, P316, DOI 10.1111/j.1759-6831.2012.00199.x; Yoo KO, 2002, AM J BOT, V89, P966, DOI 10.3732/ajb.89.6.966; Yu W-B, 2011, THESIS CHINESE ACAD; Yu WB, 2008, J INTEGR PLANT BIOL, V50, P244, DOI 10.1111/j.1744-7909.2007.00364.x; Yu WB, 2013, J SYST EVOL, V51, P435, DOI 10.1111/jse.12018; Yu WB, 2011, J SYST EVOL, V49, P507, DOI 10.1111/j.1759-6831.2011.00159_3.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang YX, 2012, MOL PHYLOGENET EVOL, V63, P777, DOI 10.1016/j.ympev.2012.02.023; Zou XH, 2008, J SYST EVOL, V46, P795, DOI 10.3724/SP.J.1002.2008.08081	63	38	38	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74828	10.1371/journal.pone.0074828	http://dx.doi.org/10.1371/journal.pone.0074828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069353	gold, Green Published			2022-12-25	WOS:000324777300050
J	Becherelli, M; Prachi, P; Viciani, E; Biagini, M; Fiaschi, L; Chiarot, E; Nosari, S; Brettoni, C; Marchi, S; Biancucci, M; Fontana, MR; Montagnani, F; Bagnoli, F; Barocchi, MA; Manetti, AGO				Becherelli, Marco; Prachi, Prachi; Viciani, Elisa; Biagini, Massimiliano; Fiaschi, Luigi; Chiarot, Emiliano; Nosari, Sarah; Brettoni, Cecilia; Marchi, Sara; Biancucci, Marco; Fontana, Maria Rita; Montagnani, Francesca; Bagnoli, Fabio; Barocchi, Michele A.; Manetti, Andrea G. O.			Protective Activity of the CnaBE3 Domain Conserved among Staphylococcus aureus Sdr Proteins	PLOS ONE			English	Article							STABILIZING ISOPEPTIDE; SURFACE-PROTEINS; NASAL-CARRIAGE; VACCINE; ADHESIN; GENES; BONDS; IDENTIFICATION; POPULATIONS; ANTIBODIES	Staphylococcus aureus is an opportunistic pathogen, commensal of the human skin and nares, but also responsible for invasive nosocomial as well as community acquired infections. Staphylococcus aureus adheres to the host tissues by means of surface adhesins, such as SdrC, SdrD, and SdrE proteins. The Sdr family of proteins together with a functional A domain, contain respectively two, three or five repeated sequences called B motifs which comprise the CnaB domains. SdrD and SdrE proteins were reported to be protective in animal models against invasive diseases or lethal challenge with human clinical S. aureus isolates. In this study we identified a 126 amino acid sequence containing a CnaB domain, conserved among the three Sdr proteins. The three fragments defined here as CnaBC2, D5 and E3 domains even though belonging to phylogenetically distinct strains, displayed high sequence similarity. Based on the sequence conservation data, we selected the CnaBE3 domain for further analysis and characterization. Polyclonal antibodies raised against the recombinant CnaBE3 domain recognized SdrE, SdrC and SdrD proteins of different S. aureus lineages. Moreover, we demonstrated that the CnaBE3 domain was expressed in vivo during S. aureus infections, and that immunization of this domain alone significantly reduces the bacterial load in mice challenged with S. aureus. Furthermore, we show that the reduction of bacteria by CnaBE3 vaccination is due to functional antibodies. Finally, we demonstrated that the region of the SdrE protein containing the CnaBE3 domain was resistant to trypsin digestion, a characteristic often associated with the presence of an isopeptide bond.	[Becherelli, Marco; Prachi, Prachi; Viciani, Elisa; Biagini, Massimiliano; Fiaschi, Luigi; Chiarot, Emiliano; Nosari, Sarah; Brettoni, Cecilia; Marchi, Sara; Biancucci, Marco; Fontana, Maria Rita; Bagnoli, Fabio; Barocchi, Michele A.; Manetti, Andrea G. O.] Novartis Vaccines & Diagnost, Siena, Italy; [Montagnani, Francesca] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy	Novartis; University of Siena	Manetti, AGO (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	Andrea_guido.manetti@novartis.com	Montagnani, Francesca/R-3334-2016	Montagnani, Francesca/0000-0002-2267-1337	Univerity of Siena; Novartis Vaccines and Diagnostics	Univerity of Siena; Novartis Vaccines and Diagnostics	EV is a recipient of a Novartis Fellowship from the PhD program in cellular biology and physiology of the Univerity of Siena. This work was funded by Novartis Vaccines and Diagnostics. The funders had a role in study design, data collection and analysis, preparation of the manuscript and decision to publish.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bartlett John G, 2008, Top HIV Med, V16, P151; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hagan RM, 2010, ANGEW CHEM INT EDIT, V49, P8421, DOI 10.1002/anie.201004340; Jensen SO, 2009, FUTURE MICROBIOL, V4, P565, DOI 10.2217/FMB.09.30; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kabanova A, 2010, VACCINE, V29, P104, DOI 10.1016/j.vaccine.2010.09.018; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krause M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-11; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; Mishra RPN, 2012, J INFECT DIS, V206, P1041, DOI 10.1093/infdis/jis463; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Niall H D, 1973, Methods Enzymol, V27, P942; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Panula-Perala J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-31; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sitkiewicz I, 2011, ANTON LEEUW INT J G, V99, P409, DOI 10.1007/s10482-010-9476-7; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stapleton MR, 2012, J MED MICROBIOL, V61, P766, DOI 10.1099/jmm.0.040915-0; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tchernychev B, 1997, P NATL ACAD SCI USA, V94, P6335, DOI 10.1073/pnas.94.12.6335; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332	58	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74718	10.1371/journal.pone.0074718	http://dx.doi.org/10.1371/journal.pone.0074718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069334	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300052
J	Cano, LM; Raffaele, S; Haugen, RH; Saunders, DGO; Leonelli, L; MacLean, D; Hogenhout, SA; Kamoun, S				Cano, Liliana M.; Raffaele, Sylvain; Haugen, Riston H.; Saunders, Diane G. O.; Leonelli, Lauriebeth; MacLean, Dan; Hogenhout, Saskia A.; Kamoun, Sophien			Major Transcriptome Reprogramming Underlies Floral Mimicry Induced by the Rust Fungus Puccinia monoica in Boechera stricta	PLOS ONE			English	Article							HOMEOBOX GENES PENNYWISE; ARABIDOPSIS-THALIANA; INFLORESCENCE ARCHITECTURE; SCENT PRODUCTION; ZINC-FINGER; LEAF SHAPE; PROTEIN; MERISTEM; FLOWER; BIOSYNTHESIS	Puccinia monoica is a spectacular plant parasitic rust fungus that triggers the formation of flower-like structures (pseudoflowers) in its Brassicaceae host plant Boechera stricta. Pseudoflowers mimic in shape, color, nectar and scent co-occurring and unrelated flowers such as buttercups. They act to attract insects thereby aiding spore dispersal and sexual reproduction of the rust fungus. Although much ecological research has been performed on P. monoica-induced pseudoflowers, this system has yet to be investigated at the molecular or genomic level. To date, the molecular alterations underlying the development of pseudoflowers and the genes involved have not been described. To address this, we performed gene expression profiling to reveal 256 plant biological processes that are significantly altered in pseudoflowers. Among these biological processes, plant genes involved in cell fate specification, regulation of transcription, reproduction, floral organ development, anthocyanin (major floral pigments) and terpenoid biosynthesis (major floral volatile compounds) were down-regulated in pseudoflowers. In contrast, plant genes involved in shoot, cotyledon and leaf development, carbohydrate transport, wax biosynthesis, cutin transport and L-phenylalanine metabolism (pathway that results in phenylethanol and phenylacetaldehyde volatile production) were up-regulated. These findings point to an extensive reprogramming of host genes by the rust pathogen to induce floral mimicry. We also highlight 31 differentially regulated plant genes that are enriched in the biological processes mentioned above, and are potentially involved in the formation of pseudoflowers. This work illustrates the complex perturbations induced by rust pathogens in their host plants, and provides a starting point for understanding the molecular mechanisms of pathogen-induced floral mimicry.	[Cano, Liliana M.; Raffaele, Sylvain; Saunders, Diane G. O.; MacLean, Dan; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Raffaele, Sylvain] INRA, CNRS, Lab Interact Plantes Microorganismes, UMR441,UMR2594, F-31326 Castanet Tolosan, France; [Haugen, Riston H.] Black Hills State Univ, Integrat Genom Program, Spearfish, SD 57799 USA; [Leonelli, Lauriebeth] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Hogenhout, Saskia A.] John Innes Ctr, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Black Hills State University; University of California System; University of California Berkeley; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kamoun, S (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Kamoun, Sophien/B-3529-2009; Raffaele, Sylvain/F-7187-2012; Saunders, Diane GO/N-1916-2015; Leonelli, Lauriebeth/GYU-8762-2022; Cano, Liliana M/O-7041-2016; Hogenhout, Saskia A/D-9266-2012; Raffaele, Sylvain/K-6673-2019; MacLean, Dan/C-7046-2013	Kamoun, Sophien/0000-0002-0290-0315; Raffaele, Sylvain/0000-0002-2442-9632; Leonelli, Lauriebeth/0000-0001-7536-523X; Cano, Liliana M/0000-0002-7996-4181; Hogenhout, Saskia A/0000-0003-1371-5606; Raffaele, Sylvain/0000-0002-2442-9632; MacLean, Dan/0000-0003-1032-0887	Gatsby Charitable Foundation; Marie Curie IEF Fellowship [255104]; Leverhulme Early Career Fellowship	Gatsby Charitable Foundation; Marie Curie IEF Fellowship(European Commission); Leverhulme Early Career Fellowship(Leverhulme Trust)	The Gatsby Charitable Foundation provided funding for this work. S.R. received support from Marie Curie IEF Fellowship contract 255104 and D.G.O.S. from a Leverhulme Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondada BR, 1996, ENVIRON EXP BOT, V36, P61, DOI 10.1016/0098-8472(96)00128-1; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Colasanti J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-158; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Deng Jian-yu, 2004, Journal of Zhejiang University Science, V5, P1577, DOI 10.1631/jzus.2004.1577; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Giurfa M, 1999, INT J PLANT SCI, V160, pS41, DOI 10.1086/314214; Gorai M., 2010, Emirates Journal of Food and Agriculture, V22, P1; Gutensohn M, 2011, PLANT J, V66, P591, DOI 10.1111/j.1365-313X.2011.04515.x; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Kammenga JE, 2007, TRENDS ECOL EVOL, V22, P273, DOI 10.1016/j.tree.2007.01.013; Kanrar S, 2008, PLANT J, V54, P924, DOI 10.1111/j.1365-313X.2008.03458.x; Kanrar S, 2006, PLANTA, V224, P1163, DOI 10.1007/s00425-006-0298-9; KOLATTUKUDY PE, 1995, P NATL ACAD SCI USA, V92, P4080, DOI 10.1073/pnas.92.10.4080; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; MOLLER AP, 1995, P NATL ACAD SCI USA, V92, P2288, DOI 10.1073/pnas.92.6.2288; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Roy BA, 1998, MYCOLOGIA, V90, P846, DOI 10.2307/3761326; ROY BA, 1993, EVOLUTION, V47, P111, DOI 10.1111/j.1558-5646.1993.tb01203.x; Roy BA, 1996, ECOLOGY, V77, P2445, DOI 10.2307/2265745; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; ROY BA, 1994, ECOLOGY, V75, P352, DOI 10.2307/1939539; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Schranz ME, 2007, PLANT PHYSIOL, V144, P286, DOI 10.1104/pp.107.096685; Scofield S, 2008, PLANT SIGNAL BEHAV, V3, P257, DOI 10.4161/psb.3.4.5194; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; Simpson B.B., 1983, P142; Smit MA, 2006, FIELD CROP RES, V98, P91, DOI 10.1016/j.fcr.2005.12.009; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Venglat SP, 2002, P NATL ACAD SCI USA, V99, P4730, DOI 10.1073/pnas.072626099; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Weiss J, 2005, INT J DEV BIOL, V49, P513, DOI 10.1387/ijdb.051998jw; Wen JQ, 2004, PLANT J, V37, P668, DOI 10.1111/j.1365-313X.2003.01994.x; Windsor AJ, 2006, PLANT PHYSIOL, V140, P1169, DOI 10.1104/pp.105.073981; Zhang JH, 2004, PHYTOPATHOLOGY, V94, P842, DOI 10.1094/PHYTO.2004.94.8.842	71	17	17	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75293	10.1371/journal.pone.0075293	http://dx.doi.org/10.1371/journal.pone.0075293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069397	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300076
J	Levanon, K; Sapoznik, S; Bahar-Shany, K; Brand, H; Shapira-Frommer, R; Korach, J; Hirsch, MS; Roh, MH; Miron, A; Liu, JF; Vena, N; Ligon, AH; Fotheringham, S; Bailey, D; Flavin, RJ; Birrer, MJ; Drapkin, RI				Levanon, K.; Sapoznik, S.; Bahar-Shany, K.; Brand, H.; Shapira-Frommer, R.; Korach, J.; Hirsch, M. S.; Roh, M. H.; Miron, A.; Liu, J. F.; Vena, N.; Ligon, A. H.; Fotheringham, S.; Bailey, D.; Flavin, R. J.; Birrer, M. J.; Drapkin, R. I.			FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis	ONCOGENE			English	Article						serous ovarian carcinoma; fallopian tube epithelium; FOXO3a; AKT; ERK; miRNA-182	LUNG-CANCER CELLS; TRANSCRIPTION FACTOR; OVARIAN-CANCER; FALLOPIAN-TUBE; PROMOTES TUMORIGENESIS; CANDIDATE PRECURSOR; EXPRESSION; INHIBITORS; CARCINOMA; CHEMOTHERAPY	Serous ovarian carcinoma is the most lethal gynecological malignancy in Western countries. The molecular events that underlie the development of the disease have been elusive for many years. The recent identification of the fallopian tube secretory epithelial cells (FTSECs) as the cell-of-origin for most cases of this disease has led to studies aimed at elucidating new candidate therapeutic pathways through profiling of normal FTSECs and serous carcinomas. Here we describe the results of transcriptional profiles that identify the loss of the tumor suppressive transcription factor FOXO3a in a vast majority of high-grade serous ovarian carcinomas. We show that FOXO3a loss is a hallmark of the earliest stages of serous carcinogenesis and occurs both at the DNA, RNA and protein levels. We describe several mechanisms responsible for FOXO3a inactivity, including chromosomal deletion (chromosome 6q21), upregulation of miRNA-182 and destabilization by activated PI3K and MEK. The identification of pathways involved in the pathogenesis of ovarian cancer can advance the management of this disease from being dependant on surgery and cytotoxic chemotherapy alone to the era of targeted therapy. Our data strongly suggest FOXO3a as a possible target for clinical intervention.	[Levanon, K.] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Ramat Gan, Israel; [Levanon, K.; Drapkin, R. I.] Dept Med Oncol, Boston, MA USA; [Levanon, K.; Drapkin, R. I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sapoznik, S.; Bahar-Shany, K.; Brand, H.] Sheba Canc Res Ctr, Ramat Gan, Israel; [Sapoznik, S.; Bahar-Shany, K.; Brand, H.] Chaim Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Brand, H.] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Shapira-Frommer, R.] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Ramat Gan, Israel; [Korach, J.; Ligon, A. H.] Chaim Sheba Med Ctr, Dept Gynecol Oncol, IL-52621 Ramat Gan, Israel; [Hirsch, M. S.; Roh, M. H.; Drapkin, R. I.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Miron, A.; Liu, J. F.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, J. F.; Ligon, A. H.; Drapkin, R. I.] Harvard Univ, Sch Med, Boston, MA USA; [Vena, N.; Ligon, A. H.; Fotheringham, S.; Bailey, D.; Flavin, R. J.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Birrer, M. J.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Chaim Sheba Medical Center; Harvard University; Dana-Farber Cancer Institute; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Levanon, K (corresponding author), Chaim Sheba Med Ctr, Sheba Canc Res Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Ramat Gan, Israel.	Keren.Levanon@sheba.health.gov.il	Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; Levanon, Keren/0000-0002-5122-064X; Fotheringham, Susan/0000-0001-5440-8747; Flavin, Richard/0000-0002-4993-4563	National Institutes of Health/National Cancer Institute [P50 CA105009, U01 CA152990, R21 CA156021]; Ovarian Cancer Research Fund; Mary Kay Foundation; Tina Brozman Foundation; Robert and Debra First Fund; Gamel Family Fund for Ovarian Cancer; Marsha Rivkin Foundation Scientific Scholar Award; AACR- George and Patricia Sehl Fellowship; American Physicians Fellowship for Medicine in Israel-Claire and Emmanuel G. Rosenblatt Foundation Grant; Israel Science Foundation Legacy Heritage Clinical Research Initiative; Israel Cancer Research Fund Clinical Research Career Development Award; Chaim Sheba Medical Center Dr Pinchas Bornstein Talpiot Medical Leadership Program; NATIONAL CANCER INSTITUTE [P50CA105009, U01CA152990, R21CA156021] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Mary Kay Foundation; Tina Brozman Foundation; Robert and Debra First Fund; Gamel Family Fund for Ovarian Cancer; Marsha Rivkin Foundation Scientific Scholar Award; AACR- George and Patricia Sehl Fellowship; American Physicians Fellowship for Medicine in Israel-Claire and Emmanuel G. Rosenblatt Foundation Grant; Israel Science Foundation Legacy Heritage Clinical Research Initiative; Israel Cancer Research Fund Clinical Research Career Development Award; Chaim Sheba Medical Center Dr Pinchas Bornstein Talpiot Medical Leadership Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the National Institutes of Health/National Cancer Institute (P50 CA105009, U01 CA152990, and R21 CA156021), the Ovarian Cancer Research Fund, The Mary Kay Foundation, The Tina Brozman Foundation, The Robert and Debra First Fund, the Gamel Family Fund for Ovarian Cancer, the Marsha Rivkin Foundation Scientific Scholar Award, the AACR- George and Patricia Sehl Fellowship for Cancer Genetics Research, the American Physicians Fellowship for Medicine in Israel-Claire and Emmanuel G. Rosenblatt Foundation Grant, The Israel Science Foundation Legacy Heritage Clinical Research Initiative, The Israel Cancer Research Fund Clinical Research Career Development Award and the Chaim Sheba Medical Center Dr Pinchas Bornstein Talpiot Medical Leadership Program. We thank Drs. John Quackenbush, Massimo Loda, Keith Ligon and Sekhar Duraisamy, Dana-Farber Cancer Institute, for their suggestions and generous assistance with reagents and bioinformatics; Dr Ravid Straussman, the Broad Institute, for his guidance with methylation detection; Dr Sol Efroni and Rotem Ben-Hamo, Bar Ilan University, Israel, for bioinformatic support; and The Chaim Sheba Tissue Bank.	Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fei M, 2009, CANCER INVEST, V27, P52, DOI 10.1080/07357900802146204; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Folkins AK, 2008, GYNECOL ONCOL, V109, P168, DOI 10.1016/j.ygyno.2008.01.012; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Kim W, 2013, PHARMACOL RES, V70, P90, DOI 10.1016/j.phrs.2013.01.005; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kornblau SM, 2010, CLIN CANCER RES, V16, P1865, DOI 10.1158/1078-0432.CCR-09-2551; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Lu MD, 2012, MED ONCOL, V29, P3409, DOI 10.1007/s12032-012-0275-z; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rathbone CR, 2008, MUSCLE NERVE, V37, P84, DOI 10.1002/mus.20897; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Santo EE, 2007, CANCER RES, V73, P2189; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Su JL, 2011, CANCER RES, V71, P6878, DOI 10.1158/0008-5472.CAN-11-0295; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yamaguchi H, 2013, CLIN CANCER RES, V19, P845, DOI 10.1158/1078-0432.CCR-12-2621; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhao Fung, 2012, Front Med, V6, P376, DOI 10.1007/s11684-012-0228-0	47	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4424	4432		10.1038/onc.2013.394	http://dx.doi.org/10.1038/onc.2013.394			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24077281	Green Accepted, Green Submitted			2022-12-25	WOS:000341157800007
J	Lamming, DW; Demirkan, G; Boylan, JM; Mihaylova, MM; Peng, T; Ferreira, J; Neretti, N; Salomon, A; Sabatini, DM; Gruppuso, PA				Lamming, Dudley W.; Demirkan, Gokhan; Boylan, Joan M.; Mihaylova, Maria M.; Peng, Tao; Ferreira, Jonathan; Neretti, Nicola; Salomon, Arthur; Sabatini, David M.; Gruppuso, Philip A.			Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)	FASEB JOURNAL			English	Article						gene expression; proteomics; liver; metabolism; signal transduction	EXTENDS LIFE-SPAN; PHOSPHORYLATION; INHIBITION; EXPRESSION; LIVER; P38; IDENTIFICATION; STIMULATION; GLUCOKINASE; LIPOGENESIS	The mechanistic target of rapamycin (mTOR) exists in two complexes that regulate diverse cellular processes. mTOR complex 1 (mTORC1), the canonical target of rapamycin, has been well studied, whereas the physiological role of mTORC2 remains relatively uncharacterized. In mice in which the mTORC2 component Rictor is deleted in liver [Rictor-knockout (RKO) mice], we used genomic and phosphoproteomic analyses to characterize the role of hepatic mTORC2 in vivo. Overnight food withdrawal followed by refeeding was used to activate mTOR signaling. Rapamycin was administered before refeeding to specify mTORC2-mediated events. Hepatic mTORC2 regulated a complex gene expression and post-translational network that affects intermediary metabolism, ribosomal biogenesis, and proteasomal biogenesis. Nearly all changes in genes related to intermediary metabolic regulation were replicated in cultured fetal hepatocytes, indicating a cell-autonomous effect of mTORC2 signaling. Phosphoproteomic profiling identified mTORC2-related signaling to 144 proteins, among which were metabolic enzymes and regulators. A reduction of p38 MAPK signaling in the RKO mice represents a link between our phosphoproteomic and gene expression results. We conclude that hepatic mTORC2 exerts a broad spectrum of biological effects under physiological conditions. Our findings provide a context for the development of targeted therapies to modulate mTORC2 signaling.Lamming, D. W., Demirkan, G., Boylan, J. M., Mihaylova, M. M., Peng, T., Ferreira, J., Neretti, N., Salomon, A., Sabatini, D. M., Gruppuso, P. A. Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2).	[Lamming, Dudley W.; Mihaylova, Maria M.; Peng, Tao; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Mihaylova, Maria M.; Peng, Tao; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA USA; [Lamming, Dudley W.; Mihaylova, Maria M.; Peng, Tao; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Lamming, Dudley W.; Mihaylova, Maria M.; Peng, Tao; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Mihaylova, Maria M.; Peng, Tao; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Demirkan, Gokhan; Ferreira, Jonathan; Neretti, Nicola; Salomon, Arthur; Gruppuso, Philip A.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA; [Boylan, Joan M.; Gruppuso, Philip A.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Demirkan, Gokhan; Boylan, Joan M.; Gruppuso, Philip A.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Gruppuso, PA (corresponding author), Rhode Isl Hosp, Div Pediat Endocrinol, 593 Eddy St, Providence, RI 02903 USA.	philip_gruppuso@brown.edu	Mihaylova, Maria M./ACZ-4949-2022; Lamming, Dudley/O-7191-2015	Mihaylova, Maria M./0000-0002-2725-767X; Lamming, Dudley/0000-0002-0079-4467; /0000-0002-1446-7256; Neretti, Nicola/0000-0002-9552-1663	NIH [AG041765]; Damon Runyon Foundation; Julie Martin Mid-Career Award in Aging Research from the American Federation of Aging Research (AFAR); U.S. National Institute on Aging (NIA) [R01 AI083636]; U.S. National Institutes of Health (NIH)/NIA [K25 AG028753]; U.S. National Institute of Child Health and Human Development (NICHD) [R01 HD024455]; NSF/EPSCoR [1004057]; Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041765, K25AG028753, K99AG041765] Funding Source: NIH RePORTER; Office Of The Director [1004057] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Foundation; Julie Martin Mid-Career Award in Aging Research from the American Federation of Aging Research (AFAR); U.S. National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health (NIH)/NIA; U.S. National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF/EPSCoR; Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine at Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors thank all the members of the D. M. S. and P. A. G. laboratories for their insightful comments and suggestions. The XBP1 S61 antibody was the kind gift of Umut Ozcan (Boston Children's Hospital, Boston, MA, USA), and the XBP1 and MKK4 antibodies were the kind gifts of Yuxiong Feng and Sandhya Sanduja (laboratory of Piyush Gupta, Whitehead Institute, Cambridge, MA, USA). The total STAT1 antibody was the kind gift of Christine Patterson (laboratory of Harvey Lodish, Whitehead Institute). The Rictor conditional-knockout mice were the generous gift of Mark Magnuson (Vanderbilt University Medical Center, Nashville, TN, USA). The authors thank Tom DiCesare (Whitehead Institute, Cambridge, MA, USA) for assistance with graphic design. D. W. L. is supported by an NIH K99/R00 Pathway to Independence Award (AG041765). M. M. is supported by a fellowship from the Damon Runyon Foundation. This project was funded in part by a Julie Martin Mid-Career Award in Aging Research from the American Federation of Aging Research (AFAR) to D. M. S., by U.S. National Institute on Aging (NIA) grant R01 AI083636 to A. S., by a Mentored Quantitative Research Development Award from the U.S. National Institutes of Health (NIH)/NIA K25 AG028753 to N.N., and by U.S. National Institute of Child Health and Human Development (NICHD) grant R01 HD024455 to P. A. G. This research is based in part on work conducted in the Rhode Island National Science Foundation (NSF)/Experimental Program to Stimulate Competitive Research (EPSCoR) Proteomics Shared Resource Facility, which is supported in part by NSF/EPSCoR grant 1004057, NIH grant S10 RR020923, a Rhode Island Science and Technology Advisory Council grant, and the Division of Biology and Medicine at Brown University. D. M. S. is an investigator at the Howard Hughes Medical Institute.	Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cho KW, 2011, MOL CELL BIOL, V31, P450, DOI 10.1128/MCB.00459-10; Chun J, 2003, J BIOCHEM, V133, P103, DOI 10.1093/jb/mvg010; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Cohen SE, 2007, J BIOL CHEM, V282, P23672, DOI 10.1074/jbc.M704053200; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Festuccia WT, 2010, AM J PHYSIOL-REG I, V299, pR159, DOI 10.1152/ajpregu.00821.2009; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Giubellino A, 2013, ENDOCRINOLOGY, V154, P646, DOI 10.1210/en.2012-1854; Gruppuso PA, 2011, CELL CYCLE, V10, P1050, DOI 10.4161/cc.10.7.15230; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hu HY, 2007, GENOMICS, V90, P421, DOI 10.1016/j.ygeno.2007.07.003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KURLAND IJ, 1992, J BIOL CHEM, V267, P4416; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Payne VA, 2005, DIABETES, V54, P1949, DOI 10.2337/diabetes.54.7.1949; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tonner P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-412; Willems L, 2012, LEUKEMIA, V26, P1195, DOI 10.1038/leu.2011.339; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281	51	60	61	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					300	315		10.1096/fj.13-237743	http://dx.doi.org/10.1096/fj.13-237743			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24072782	Green Published			2022-12-25	WOS:000333526100029
J	Parker, BW; Schwessinger, EA; Jakob, U; Gray, MJ				Parker, Benjamin W.; Schwessinger, Emily A.; Jakob, Ursula; Gray, Michael J.			The RclR Protein Is a Reactive Chlorine-specific Transcription Factor in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Escherichia coli; Oxidative Stress; Redox Signaling; Transcription Regulation; Hypochlorous Acid (HOCl); Reactive Chlorine Species (RCS); YkgD	OXIDATIVE STRESS; HYPOCHLOROUS ACID; N-CHLOROTAURINE; REDOX-SWITCH; THIOL; MECHANISMS; REGULATOR; DEFENSE; SENSORS; BLEACH	Reactive chlorine species (RCS) such as hypochlorous acid are powerful antimicrobial oxidants. Used extensively for disinfection in household and industrial settings (i.e. as bleach), RCS are also naturally generated in high quantities during the innate immune response. Bacterial responses to RCS are complex and differ substantially from the well characterized responses to other physiologically relevant oxidants, like peroxide or superoxide. Several RCS-sensitive transcription factors have been identified in bacteria, but most of them respond to multiple stressors whose damaging effects overlap with those of RCS, including reactive oxygen species and electrophiles. We have now used in vivo genetic and in vitro biochemical methods to identify and demonstrate that Escherichia coli RclR (formerly YkgD) is a redox-regulated transcriptional activator of the AraC family, whose highly conserved cysteine residues are specifically sensitive to oxidation by RCS. Oxidation of these cysteines leads to strong, highly specific activation of expression of genes required for survival of RCS stress. These results demonstrate the existence of a widely conserved bacterial regulon devoted specifically to RCS resistance.	[Parker, Benjamin W.; Schwessinger, Emily A.; Jakob, Ursula; Gray, Michael J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jakob, Ursula] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	ujakob@umich.edu; mikegray@umich.edu		Gray, Michael/0000-0002-7112-4188	National Institutes of Health [R01-GM065318, R21-AI097893]; National Research Service Award [F32GM096613]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM065318 and R21-AI097893 (to U.J.).; Supported by National Research Service Award F32GM096613.	ANDEREGG G, 1977, HELV CHIM ACTA, V60, P123, DOI 10.1002/hlca.19770600115; Antelmann H, 2008, EXPERT REV PROTEOMIC, V5, P77, DOI 10.1586/14789450.5.1.77; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bengtson P, 2009, ENVIRON MICROBIOL, V11, P1330, DOI 10.1111/j.1462-2920.2009.01915.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105; Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen EH, 2005, J APPL MICROBIOL, V98, P581, DOI 10.1111/j.1365-2672.2004.02491.x; Holder D., 2007, P WATER ENV FED DISI, V11, P63; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lee C, 2013, MOL MICROBIOL, V88, P395, DOI 10.1111/mmi.12192; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Nagl M, 2000, ANTIMICROB AGENTS CH, V44, P2507, DOI 10.1128/AAC.44.9.2507-2513.2000; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Okun D. A., 2005, WATER ENCY, P281; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Poole L. B., 2008, CURR PROTOC TOXICOL, V17, P12; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; Rutala WA, 1997, CLIN MICROBIOL REV, V10, P597, DOI 10.1128/CMR.10.4.597; Sambrook J., 1989, MOL CLONING LAB MANU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Spiro S, 2012, ANTIOXID REDOX SIGN, V17, P1264, DOI 10.1089/ars.2012.4533; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	64	51	56	2	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32574	32584		10.1074/jbc.M113.503516	http://dx.doi.org/10.1074/jbc.M113.503516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078635	Green Published, hybrid			2022-12-25	WOS:000328681700040
J	Steinbach, S; Reindl, W; Dempfle, A; Schuster, A; Wolf, P; Hundt, W; Huber, W				Steinbach, Silke; Reindl, Wolfgang; Dempfle, Astrid; Schuster, Anna; Wolf, Petra; Hundt, Walter; Huber, Wolfgang			Smell and Taste in Inflammatory Bowel Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; NUTRITIONAL-STATUS; DIETARY-INTAKE; QUANTITATIVE ASSESSMENT; OLFACTORY DYSFUNCTION; FLAVOR ENHANCEMENT; SUGAR CONSUMPTION; DISORDERS; IDENTIFICATION	Objective: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. Patients and Methods: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using "Sniffin' sticks" and "taste strips" for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. Results: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. Conclusion: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life.	[Steinbach, Silke] Univ Marburg, Dept Otorhinolaryngol, Marburg, Germany; [Reindl, Wolfgang; Schuster, Anna; Huber, Wolfgang] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, Dept Gastroenterol, D-80290 Munich, Germany; [Dempfle, Astrid] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Wolf, Petra] Tech Univ Munich, Klinikum Rechts Isar, Dept Med Stat & Epidemiol, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Hundt, Walter] Univ Marburg, Dept Radiol, Marburg, Germany	Philipps University Marburg; Technical University of Munich; Philipps University Marburg; Technical University of Munich; Philipps University Marburg	Steinbach, S (corresponding author), Univ Marburg, Dept Otorhinolaryngol, Marburg, Germany.	silkesteinbach@hotmail.com	Dempfle, Astrid/ABB-8889-2020; Dempfle, Astrid/D-1513-2012	Dempfle, Astrid/0000-0002-2618-3920				Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; AUVIN S, 2003, GUT, V35, pA53; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; DUFFY VB, 1995, J AM DIET ASSOC, V95, P879, DOI 10.1016/S0002-8223(95)00244-8; Ellul P, 2007, AM J GASTROENTEROL, V102, P689, DOI 10.1111/j.1572-0241.2007.01040_6.x; Eloy P, 2007, EUR ARCH OTO-RHINO-L, V264, P103, DOI 10.1007/s00405-006-0146-3; Fasunla JA, 2012, EUR ARCH OTO-RHINO-L, V269, P179, DOI 10.1007/s00405-011-1691-y; Gilat T, 1986, FRONT GASTROINTEST R, V11, P158; Griffiths A., 2000, PAEDIAT GASTROINTEST, V3rd ed., P613; Hartman C, 2009, WORLD J GASTROENTERO, V15, P2570, DOI 10.3748/wjg.15.2570; Heckmann SM, 2005, J DENT RES, V84, P35, DOI 10.1177/154405910508400105; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katz J, 2003, ORAL DIS, V9, P34, DOI 10.1034/j.1601-0825.2003.00879.x; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Lambert B, 2012, DIGEST DIS SCI, V57, P2171, DOI 10.1007/s10620-012-2232-2; Landis BN, 2010, ORL-J OTO-RHIN-LARYN, V72, P252, DOI 10.1159/000317024; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; LEDERER PC, 1985, Z GASTROENTEROL, V23, P470; Mahmud N, 2001, EUR J GASTROEN HEPAT, V13, P93, DOI 10.1097/00042737-200102000-00001; MARTINI GA, 1976, KLIN WOCHENSCHR, V54, P367, DOI 10.1007/BF01469792; Mathey MFAM, 2001, J GERONTOL A-BIOL, V56, pM200, DOI 10.1093/gerona/56.4.M200; MAYBERRY JF, 1980, DIGESTION, V20, P323, DOI 10.1159/000198454; MAYBERRY JF, 1981, DIGEST DIS SCI, V26, P444, DOI 10.1007/BF01313588; MILLER B, 1976, Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin, V82, P922; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Mueller C, 2003, RHINOLOGY, V41, P2; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; MURPHY C, 1977, SENS PROCESS, V1, P204; O'Sullivan M, 2006, BEST PRACT RES CL GA, V20, P561, DOI 10.1016/j.bpg.2006.03.001; PENNY WJ, 1983, GUT, V24, P288, DOI 10.1136/gut.24.4.288; Perricone C, 2013, CLIN REV ALLERG IMMU, V45, P87, DOI 10.1007/s12016-012-8343-x; Prescott J, 2004, APPETITE, V42, P143, DOI 10.1016/j.appet.2003.08.013; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rowland M, 2010, INFLAMM BOWEL DIS, V16, P332, DOI 10.1002/ibd.20983; Sakagami M, 2009, ACTA OTO-LARYNGOL, V129, P1115, DOI 10.1080/00016480802552550; Sari S, 2007, DIGEST DIS SCI, V52, P1285, DOI 10.1007/s10620-006-9584-4; Schiffman SS, 2007, J NUTR HEALTH AGING, V11, P439; Schutz T, 2003, DIGEST DIS, V21, P252, DOI 10.1159/000073343; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; Steinbach S, 2011, SCAND J RHEUMATOL, V40, P169, DOI 10.3109/03009742.2010.517547; Steinbach S, 2008, Laryngorhinootologie, V87, P657, DOI 10.1055/s-2008-1077547; Steinbach S, 2012, AM J RHINOL ALLERGY, V26, P463, DOI 10.2500/ajra.2012.26.3824; Steinbach S, 2010, EUR ARCH OTO-RHINO-L, V267, P1081, DOI 10.1007/s00405-009-1181-7; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; Szczeklik K, 2012, POL ARCH MED WEWN, V122, P200, DOI 10.20452/pamw.1256; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Turner JH, 2010, AM J RHINOL ALLERGY, V24, P336, DOI 10.2500/ajra.2010.24.3498; Yamamoto T, 2009, ALIMENT PHARM THER, V30, P99, DOI 10.1111/j.1365-2036.2009.04035.x; Yeomans MR, 2008, PHYSIOL BEHAV, V93, P958, DOI 10.1016/j.physbeh.2007.12.009; Yoshida H, 2011, INFLAMM BOWEL DIS, V17, P2217, DOI 10.1002/ibd.21593; Zopf Y, 2009, J CLIN GASTROENTEROL, V43, P617, DOI 10.1097/MCG.0b013e31818acf91	58	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73454	10.1371/journal.pone.0073454	http://dx.doi.org/10.1371/journal.pone.0073454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086282	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700010
J	Wu, SF; Sun, FD; Qi, YX; Yao, Y; Fang, Q; Huang, J; Stanley, D; Ye, GY				Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Stanley, David; Ye, Gong-Yin			Parasitization by Cotesia chilonis Influences Gene Expression in Fatbody and Hemocytes of Chilo suppressalis	PLOS ONE			English	Article							RICE STEM BORER; PLUTELLAE BRACOVIRUS SUPPRESSES; HELIOTHIS-VIRESCENS LARVAE; SERINE PROTEINASE HOMOLOGS; MANDUCA-SEXTA; DIAMONDBACK MOTH; TRANSCRIPTOME ANALYSIS; ACTIVATING PROTEINASE; DEVELOPMENTAL ARREST; CALYX FLUID	Background: During oviposition many parasitoid wasps inject various factors, such as polydnaviruses (PDVs), along with eggs that manipulate the physiology and development of their hosts. These manipulations are thought to benefit the parasites. However, the detailed mechanisms of insect host-parasitoid interactions are not fully understood at the molecular level. Based on recent findings that some parasitoids influence gene expression in their hosts, we posed the hypothesis that parasitization by a braconid wasp, Cotesia chilonis, influences the expression of genes responsible for development, metabolism and immune functions in the fatbody and hemocytes of its host, Chilo suppressalis. Methodology/Principal Findings: We obtained 39,344,452 reads, which were assembled into 146,770 scaffolds, and 76,016 unigenes. Parasitization impacted gene expression in fatbody and hemocytes. Of these, 8096 fatbody or 5743 hemocyte unigenes were down-regulated, and 2572 fatbody or 1452 hemocyte unigenes were up-regulated. Gene ontology data showed that the majority of the differentially expressed genes are involved in enzyme-regulated activity, binding, transcription regulator activity and catalytic activity. qPCR results show that most anti-microbial peptide transcription levels were up-regulated after parasitization. Expression of bracovirus genes was detected in parasitized larvae with 19 unique sequences identified from six PDV gene families including ankyrin, CrV1 protein, cystatin, early-expressed (EP) proteins, lectin, and protein tyrosine phosphatase. Conclusions: The current study supports our hypothesis that parasitization influences the expression of fatbody and hemocyte genes in the host, C. suppressalis. The general view is that manipulation of host metabolism and immunity benefits the development and emergence of the parasitoid offsprings. The accepted beneficial mechanisms include the direct impact of parasitoid-associated virulence factors such as venom and polydnavirus on host tissues (such as cell damage) and, more deeply, the ability of these factors to influence gene expression. We infer that insect parasitoids generally manipulate their environments, the internal milieu of their hosts.	[Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Ye, Gong-Yin] Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Ye, Gong-Yin] Zhejiang Univ, Minist Agr, Inst Insect Sci, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; United States Department of Agriculture (USDA)	Huang, J (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	Huangj@zju.edu.cn; chu@zju.edu.cn	Wu, Shunfan/AAU-9200-2020; HUANG, JIA/AGH-2069-2022	Wu, Shunfan/0000-0003-0096-147X; HUANG, JIA/0000-0001-8336-1562	China National Science Fund for Distinguished Young Scholars [31025021]; National Program on Key Basic Research Projects (973 Program) [2013CB127600]; China National Science Fund for Innovative Research Groups of Biological Control [31021003]; National Nature Science Foundation of China [31101488]	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China National Science Fund for Innovative Research Groups of Biological Control(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China National Science Fund for Distinguished Young Scholars (Grant no. 31025021, http://www.nsfc.gov.cn), the National Program on Key Basic Research Projects (973 Program, 2013CB127600), the China National Science Fund for Innovative Research Groups of Biological Control (Grant no. 31021003, http://www.nsfc.gov.cn), and the National Nature Science Foundation of China (Grant no. 31101488, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-222; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2003, ARCH INSECT BIOCHEM, V53, P92, DOI 10.1002/arch.10088; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Barandoc KP, 2010, J MICROBIOL, V48, P117, DOI 10.1007/s12275-009-9261-3; Beck M, 2000, J INSECT PHYSIOL, V46, P1275, DOI 10.1016/S0022-1910(00)00048-2; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen HuaCai, 2002, Chinese Journal of Biological Control, V18, P90; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Cui YD, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10001; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; DOVER BA, 1987, J INSECT PHYSIOL, V33, P333, DOI 10.1016/0022-1910(87)90121-1; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fang Q, 2011, INSECT BIOCHEM MOLEC, V41, P852, DOI 10.1016/j.ibmb.2011.07.001; Fang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-484; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Gundersen-Rindal DE, 2010, ARCH VIROL, V155, P783, DOI 10.1007/s00705-010-0616-1; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Han LZ, 2012, ANN ENTOMOL SOC AM, V105, P253, DOI 10.1603/AN10170; Hang S., 1989, Chinese Journal of Biological Control, V5, P16; Hang SB, 1989, J JIANGSU AGR COLL, V10, P33; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; He YP, 2008, PEST MANAG SCI, V64, P308, DOI 10.1002/ps.1522; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hwang SH, 2010, ARCH INSECT BIOCHEM, V75, P107, DOI 10.1002/arch.20384; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Jiang H, 1999, INSECT MOL BIOL, V8, P39, DOI 10.1046/j.1365-2583.1999.810039.x; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X., 2011, THESIS CHINESE ACAD, P1, DOI DOI 10.1177/0142331211410101; Li XiuHua, 2011, Acta Phytophylacica Sinica, V38, P313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Reineke A, 2005, J INSECT PHYSIOL, V51, P923, DOI 10.1016/j.jinsphys.2005.04.007; Schafellner C, 2007, J INSECT PHYSIOL, V53, P858, DOI 10.1016/j.jinsphys.2007.05.010; Sheng CF, 2005, B CHINESE ACAD SCI, V20, P200; Sheng Cheng-Fa, 2003, Entomological Knowledge, V40, P289; Shi M, 2009, ARCH INSECT BIOCHEM, V70, P3, DOI 10.1002/arch.20249; Soller M, 1996, J INSECT PHYSIOL, V42, P471, DOI 10.1016/0022-1910(95)00132-8; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sonoda S, 2006, INSECT MOL BIOL, V15, P853, DOI 10.1111/j.1365-2583.2006.00670.x; Strand MR, 2010, INSECT VIROLOGY, P171; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; WEBB BA, 1985, ARCH INSECT BIOCHEM, V2, P131, DOI 10.1002/arch.940020203; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang SG, 2011, INSECT BIOCHEM MOLEC, V41, P733, DOI 10.1016/j.ibmb.2011.05.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P93, DOI 10.1631/jzus.B1000158; Zhu JY, 2009, ARCH INSECT BIOCHEM, V71, P45, DOI 10.1002/arch.20304	73	29	32	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74309	10.1371/journal.pone.0074309	http://dx.doi.org/10.1371/journal.pone.0074309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086331	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200027
J	Arumugam, G; Nair, AG; Hariharaputran, S; Ramanathan, S				Arumugam, Gandhimathi; Nair, Anu G.; Hariharaputran, Sridhar; Ramanathan, Sowdhamini			Rebelling for a Reason: Protein Structural "Outliers''	PLOS ONE			English	Article							ASPARTATE-ALPHA-DECARBOXYLASE; RAY CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DOMAIN SUPERFAMILIES; FOLD SPACE; HOMOLOGOUS PROTEINS; BETA-ALANINE; DATABASE; ALIGNMENTS; SEQUENCE	Analysis of structural variation in domain superfamilies can reveal constraints in protein evolution which aids protein structure prediction and classification. Structure-based sequence alignment of distantly related proteins, organized in PASS2 database, provides clues about structurally conserved regions among different functional families. Some superfamily members show large structural differences which are functionally relevant. This paper analyses the impact of structural divergence on function for multi-member superfamilies, selected from the PASS2 superfamily alignment database. Functional annotations within superfamilies, with structural outliers or 'rebels', are discussed in the context of structural variations. Overall, these data reinforce the idea that functional similarities cannot be extrapolated from mere structural conservation. The implication for fold-function prediction is that the functional annotations can only be inherited with very careful consideration, especially at low sequence identities.	[Arumugam, Gandhimathi; Nair, Anu G.; Hariharaputran, Sridhar; Ramanathan, Sowdhamini] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Ramanathan, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Gandhi Krishi Vigyana Kendra Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	mo, qin/O-7877-2014	Nair, Anu/0000-0002-1952-9583; Hariharaputran, Sridhar/0000-0002-9979-3244	Council of Scientific and Industrial Research (CSIR); Centre for Excellence; Department of Biotechnology, India; National Centre for Biological Sciences (NCBS)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Centre for Excellence; Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences (NCBS)(Tata Institute of Fundamental Research (TIFR))	Gandhimathi Arumugam is supported by Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR). The work is supported by Centre for Excellence Grant by Department of Biotechnology, India and The National Centre for Biological Sciences (NCBS) for financial and infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; Bhaduri A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-35; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Cuff A, 2009, STRUCTURE, V17, P1051, DOI 10.1016/j.str.2009.06.015; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Devedjiev Y, 2004, J MOL BIOL, V343, P395, DOI 10.1016/j.jmb.2004.08.037; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Gandhimathi A, 2012, NUCLEIC ACIDS RES, V40, pD531, DOI 10.1093/nar/gkr1096; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Gupta K, 2004, J MOL BIOL, V335, P503, DOI 10.1016/j.jmb.2003.10.073; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUBBARD TJP, 1987, PROTEIN ENG, V1, P159, DOI 10.1093/protein/1.3.159; Kanagarajadurai K, 2011, IJKDB IN PRESS; Kolodny R, 2006, CURR OPIN STRUC BIOL, V16, P393, DOI 10.1016/j.sbi.2006.04.007; Lee B, 2004, J MOL BIOL, V340, P1, DOI 10.1016/j.jmb.2004.04.049; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Mallika V, 2002, NUCLEIC ACIDS RES, V30, P284, DOI 10.1093/nar/30.1.284; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MURZIN AG, 1994, CURR OPIN STRUC BIOL, V4, P441, DOI 10.1016/S0959-440X(94)90114-7; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Pershad HR, 1999, BBA-BIOENERGETICS, V1412, P262, DOI 10.1016/S0005-2728(99)00066-3; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pirovano W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-556; POULOS TL, 1980, J BIOL CHEM, V255, P8199; PTITSYN OB, 1980, Q REV BIOPHYS, V13, P339, DOI 10.1017/S0033583500001724; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sowdhamini R, 1998, STRUCTURE, V6, P1087, DOI 10.1016/S0969-2126(98)00110-5; SUTCLIFFE MJ, 1987, PROTEIN ENG, V1, P377, DOI 10.1093/protein/1.5.377; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Teng ZX, 2013, BIOINFORMATICS, V29, P1424, DOI 10.1093/bioinformatics/btt160; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; Webb Edwin C., 1992, ENZYME NOMENCLATURE; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	54	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74416	10.1371/journal.pone.0074416	http://dx.doi.org/10.1371/journal.pone.0074416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073209	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000018
J	Vorimore, F; Hsia, RC; Huot-Creasy, H; Bastian, S; Deruyter, L; Passet, A; Sachse, K; Bavoil, P; Myers, G; Laroucau, K				Vorimore, Fabien; Hsia, Ru-ching; Huot-Creasy, Heather; Bastian, Suzanne; Deruyter, Lucie; Passet, Anne; Sachse, Konrad; Bavoil, Patrik; Myers, Garry; Laroucau, Karine			Isolation of a New Chlamydia species from the Feral Sacred Ibis (Threskiornis aethiopicus): Chlamydia ibidis	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI INFECTIONS; EMPHASIS; PIGEONS; HUMANS; BIRDS; PCR	Investigations conducted on feral African Sacred Ibises (Threskiornis aethiopicus) in western France led to the isolation of a strain with chlamydial genetic determinants. Ultrastructural analysis, comparative sequence analysis of the 16S rRNA gene, ompA, and of a concatenate of 31 highly conserved genes, as well as determination of the whole genome sequence confirmed the relatedness of the new isolate to members of the Chlamydiaceae, while, at the same time demonstrating a unique position outside the currently recognized species of this family. We propose to name this new chlamydial species Chlamydia ibidis.	[Vorimore, Fabien; Deruyter, Lucie; Laroucau, Karine] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Hsia, Ru-ching] Univ Maryland, Core Imaging Facil, Baltimore, MD 21201 USA; [Huot-Creasy, Heather; Myers, Garry] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Bastian, Suzanne; Passet, Anne] Univ Nantes Angers, Nantes, France; [Bastian, Suzanne] ONIRIS, UMR1300, Nantes, France; [Bastian, Suzanne] INRA, UMR1300, F-44026 Nantes, France; [Passet, Anne] ONIRIS, Ctr Wildlife & Ecosyst Hlth, Nantes, France; [Sachse, Konrad] Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Bavoil, Patrik] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; University System of Maryland; University of Maryland Baltimore	Laroucau, K (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France.	karine.laroucau@anses.fr	Sachse, Konrad/GWC-4999-2022; Laroucau, Karine/GSO-1980-2022; Myers, Garry/E-7708-2011	Sachse, Konrad/0000-0003-1230-1786; Laroucau, Karine/0000-0001-7605-8602; Myers, Garry/0000-0002-4756-4810; Bastian, Suzanne/0000-0003-4903-9742	NIH [U19 AI084044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Patrik Bavoil was supported by NIH U19 AI084044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BERGEYS MANUAL SYSTE; Barret J, 2010, REV SCI TECH OIE, V29, P113, DOI 10.20506/rst.29.1.1968; Bastian S, 2010, 9 EWDA C DUTCH ISL V; Christerson L, 2010, ENV MICROBIOL REP, V2, P605, DOI 10.1111/j.1758-2229.2010.00174.x; Clergeau P, 2006, BIOL INVASIONS, V8, P1381, DOI 10.1007/s10530-006-0002-9; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gasparini J, 2011, ENVIRON MICROBIOL, V13, P3186, DOI 10.1111/j.1462-2920.2011.02575.x; Guerin JL, 2006, P 7 JOURN RECH PALM, P37; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; HENRY MC, 1977, B SOC PATHOL EXOT, V70, P144; Herrmann B, 2000, APPL ENVIRON MICROB, V66, P3654, DOI 10.1128/AEM.66.8.3654-3656.2000; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Lemus JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013512; Leon O, 2004, 6 JOURN RECH PALM FO; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Matsumoto A., 1988, MICROBIOLOGY CHLAMYD, P21; Menard A, 2006, J MED MICROBIOL, V55, P471, DOI 10.1099/jmm.0.46335-0; Myers GSA, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P27, DOI 10.1128/9781555817329.ch2; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Prukner-Radovcic E, 2009, P 1 EUR M AN CHLAM Z; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Sachse K, 2012, VET MICROBIOL, V157, P476, DOI 10.1016/j.vetmic.2012.01.002; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; SPENCER WN, 1983, VET REC, V113, P535; Travnicek M, 2002, ANN AGR ENV MED, V9, P253; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vicari N, 2009, P 1 EUR M AN CHLAM Z; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zocevic A, 2012, ENVIRON MICROBIOL, V14, P2212, DOI 10.1111/j.1462-2920.2012.02800.x	34	69	71	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74823	10.1371/journal.pone.0074823	http://dx.doi.org/10.1371/journal.pone.0074823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073223	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000032
J	Barthels, C; Puchalka, J; Racek, T; Klein, C; Brocker, T				Barthels, Christian; Puchalka, Jacek; Racek, Tomas; Klein, Christoph; Brocker, Thomas			Novel Spontaneous Deletion of Artemis Exons 10 and 11 in Mice Leads to T- and B-Cell Deficiency	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; DEPENDENT PROTEIN-KINASE; DNA-LIGASE IV; COMBINED IMMUNE-DEFICIENCY; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; GENE-MUTATIONS; NUCLEIC-ACIDS; BONE-MARROW; MOUSE	Here we describe a novel, spontaneous, 4035 basepairs long deletion in the DNA cross-link repair 1C (Dclre1c)-locus in C57BL/6-mice, which leads to loss of exons 10 and 11 of the gene encoding for Artemis, a protein involved into V(D) J-recombination of antigen receptors of T and B cells. While several spontaneous mutations of Artemis have been described to cause SCID in humans, in mice, only targeted deletions by knockout technology are known to cause the same phenotype so far. The deletion we observed causes a loss of Artemis function in the C57BL/6 strain and, consequently, the absence of T and B cells, in presence of normal numbers of NK cells and cells of the myeloid lineage. Thus, for the first time we present T-B-NK+ severe combined immunodeficiency (SCID) phenotype after spontaneously occurring modification of Artemis gene in mice. Our mouse model may serve as a valuable tool to study mechanisms as well as potential therapies of SCID in humans.	[Barthels, Christian; Brocker, Thomas] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Puchalka, Jacek; Racek, Tomas; Klein, Christoph] Univ Munich, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany	University of Munich; University of Munich	Brocker, T (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80539 Munich, Germany.	tbrocker@med.uni-muenchen.de		Brocker, Thomas/0000-0001-7060-5433	Deutsche Forschungsgemeinschaft [SFB 1054/B03, SFB 1054/A05]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft SFB 1054/B03 (TB) and SFB 1054/A05 (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chistiakov DA, 2009, EUR J MED GENET, V52, P373, DOI 10.1016/j.ejmg.2009.05.009; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kobayashi N, 2003, HUM GENET, V112, P348, DOI 10.1007/s00439-002-0897-x; Laurent J, 2004, INT IMMUNOL, V16, P1069, DOI 10.1093/intimm/dxh108; Li LY, 2005, J IMMUNOL, V174, P2420, DOI 10.4049/jimmunol.174.4.2420; Li LY, 2002, J IMMUNOL, V168, P6323, DOI 10.4049/jimmunol.168.12.6323; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pannicke U, 2010, HUM MUTAT, V31, P197, DOI 10.1002/humu.21168; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Rivera-Munoz P, 2009, BLOOD, V114, P3601, DOI 10.1182/blood-2008-11-188383; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rucci F, 2010, P NATL ACAD SCI USA, V107, P3024, DOI 10.1073/pnas.0914865107; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; van der Burg M, 2009, CURR OPIN ALLERGY CL, V9, P503, DOI 10.1097/ACI.0b013e3283327e41; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Van der Burg M, 2007, EUR J IMMUNOL, V37, P3522, DOI 10.1002/eji.200737624; van Zelm MC, 2008, AM J HUM GENET, V82, P320, DOI 10.1016/j.ajhg.2007.10.011; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Xiao Z, 2009, BIOL BLOOD MARROW TR, V15, P1, DOI 10.1016/j.bbmt.2008.10.026	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74838	10.1371/journal.pone.0074838	http://dx.doi.org/10.1371/journal.pone.0074838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069355	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300060
J	Chevaleyre, J; Duchez, P; Rodriguez, L; Vlaski, M; Villacreces, A; Conrad-Lapostolle, V; Praloran, V; Ivanovic, Z; de la Grange, PB				Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet			Busulfan Administration Flexibility Increases the Applicability of Scid Repopulating Cell Assay in NSG Mouse Model	PLOS ONE			English	Article							TAIL VEIN; ENGRAFTMENT; MICE; EFFICIENT; PROGENITORS	Background: Xenotransplantation models allowing the identification and quantification of human Hematopoietic stem cells (HSC) in immunodeficient mice remain the only way to appropriately address human HSC function despite the recent progress in phenotypic characterization. However, these in vivo experiments are technically demanding, time consuming and expensive. Indeed, HSCs engraftment in mouse requires pre-conditioning of animals either by irradiation or cytotoxic drugs to allow homing of injected cells in specific stem cell niches and their subsequent expansion and differentiation in bone marrow. Recently, the development of busulfan pre-conditioning of animals improved the flexibility of experimentation in comparison with irradiation. Design and Methods: In order to further facilitate the organization of these complex experiments we investigated the effect of extending the period between mice pre-conditioning and cell injection on the engraftment efficiency. In the meantime, we also explored the role of busulfan doses, mouse gender and intravenous injection route (caudal or retro orbital) on engraftment efficiency. Results and Conclusion: We showed that a period of up to 7 days did not modify engraftment efficiency of human HSCs in NSG model. Moreover, retro orbital cell injection to female mice pre-conditioned with 2x25 mg/kg of busulfan seems to be the best adapted schema to detect the human HSC in xenotransplantation experiments.	[Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Ivanovic, Zoran; de la Grange, Philippe Brunet] EFS AqLi, Bordeaux, France; [Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet] CNRS, UMR 5164, Bordeaux, France; [Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet] Univ Bordeaux Segalen, UMR 5164, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	de la Grange, PB (corresponding author), EFS AqLi, Bordeaux, France.	philippe.brunet-de-la-grange@efs.sante.fr	Ivanovic, Zoran/ABC-7667-2020; Lafarge, Marija Vlaski/ABD-8047-2020; Rodriguez, Laura/ABC-8732-2020	Ivanovic, Zoran/0000-0001-6158-0270; Lafarge, Marija Vlaski/0000-0002-1961-1157; Rodriguez, Laura/0000-0001-8968-8873; VILLACRECES, Arnaud/0000-0002-2868-2264; BRUNET DE LA GRANGE, Philippe/0000-0001-5002-6012; DUCHEZ, PASCALE/0000-0003-1474-3764	French Blood Institute	French Blood Institute	The source of funding for this work is the French Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Bueno C, 2010, CYTOTHERAPY, V12, P45, DOI 10.3109/14653240903377052; DOWN JD, 1993, EXP HEMATOL, V21, P913; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Lowry P A, 1996, Biol Blood Marrow Transplant, V2, P15; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; PRICE JE, 1984, P SOC EXP BIOL MED, V177, P347; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Robert-Richard E, 2006, HAEMATOLOGICA, V91, P1384; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Steel CD, 2008, LAB ANIMAL, V37, P26, DOI 10.1038/laban0108-26; Sugimoto K, 2001, GROWTH FACTORS, V19, P219, DOI 10.3109/08977190109001088; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	17	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74361	10.1371/journal.pone.0074361	http://dx.doi.org/10.1371/journal.pone.0074361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069300	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300036
J	Gueguen, P; Rouault, K; Chen, JM; Raguenes, O; Fichou, Y; Hardy, E; Gobin, E; Pan-petesch, B; Kerbiriou, M; Trouve, P; Marcorelles, P; Abgrall, JF; Le Marechal, C; Ferec, C				Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Raguenes, Odile; Fichou, Yann; Hardy, Elisabeth; Gobin, Eric; Pan-petesch, Brigitte; Kerbiriou, Mathieu; Trouve, Pascal; Marcorelles, Pascale; Abgrall, Jean-francois; Le Marechal, Cedric; Ferec, Claude			A Missense Mutation in the Alpha-Actinin 1 Gene (ACTN1) Is the Cause of Autosomal Dominant Macrothrombocytopenia in a Large French Family	PLOS ONE			English	Article							GRAY PLATELET SYNDROME; CONGENITAL MACROTHROMBOCYTOPENIA; THROMBOCYTOPENIA; NBEAL2; LEUKEMIA; DISEASE; ITGA2B; MYH9	Inherited thrombocytopenia is a heterogeneous group of disorders characterized by a reduced number of blood platelets. Despite the identification of nearly 20 causative genes in the past decade, approximately half of all subjects with inherited thrombocytopenia still remain unexplained in terms of the underlying pathogenic mechanisms. Here we report a six-generation French pedigree with an autosomal dominant mode of inheritance and the identification of its genetic basis. Of the 55 subjects available for analysis, 26 were diagnosed with isolated macrothrombocytopenia. Genome-wide linkage analysis mapped a 10.9 Mb locus to chromosome 14 (14q22) with a LOD score of 7.6. Candidate gene analysis complemented by targeted next-generation sequencing identified a missense mutation (c.137GA; p.Arg46Gln) in the alpha-actinin 1 gene (ACTN1) that segregated with macrothrombocytopenia in this large pedigree. The missense mutation occurred within actin-binding domain of alpha-actinin 1, a functionally critical domain that crosslinks actin filaments into bundles. The evaluation of cultured mutation-harboring megakaryocytes by electron microscopy and the immunofluorescence examination of transfected COS-7 cells suggested that the mutation causes disorganization of the cellular cytoplasm. Our study concurred with a recently published whole-exome sequence analysis of six small Japanese families with congenital macrothrombocytopenia, adding ACTN1 to the growing list of thrombocytopenia genes.	[Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Fichou, Yann; Kerbiriou, Mathieu; Trouve, Pascal; Le Marechal, Cedric; Ferec, Claude] INSERM, U1078, Brest, France; [Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Kerbiriou, Mathieu; Trouve, Pascal; Marcorelles, Pascale; Abgrall, Jean-francois; Le Marechal, Cedric; Ferec, Claude] UBO, Fac Med & Sci Sante, Brest, France; [Gueguen, Paul; Rouault, Karen; Raguenes, Odile; Le Marechal, Cedric; Ferec, Claude] Hop Morvan, CHU Brest, Lab Genet Mol & Histocompatibil, Brest, France; [Chen, Jian-Min; Fichou, Yann; Hardy, Elisabeth; Le Marechal, Cedric; Ferec, Claude] Hop Cavale Blanche, CHU Brest, Hematol Lab, Brest, France; [Gobin, Eric; Marcorelles, Pascale] Etab Francais Sang EFS Bretagne, Brest, France; [Pan-petesch, Brigitte; Abgrall, Jean-francois] Hop Morvan, CHU Brest, Serv Anat Pathol, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Gueguen, P (corresponding author), INSERM, U1078, Brest, France.	paul.gueguen@chu-brest.fr	Ferec, Claude/ABG-9699-2020; Fichou, Yann/AAJ-9179-2020	Ferec, Claude/0000-0002-2325-0710; Fichou, Yann/0000-0002-5104-9125; PAN-PETESCH, Brigitte/0000-0001-9853-2635; GUEGUEN, Paul/0000-0003-2533-3226; ROUAULT, Karen/0000-0001-7586-3212; Chen, Jian-Min/0000-0002-2424-3969	Institut National de la Sante et de la Recherche Medicale (INSERM), France	Institut National de la Sante et de la Recherche Medicale (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was partly supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), France. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Balduini CL, 2012, HUM GENET, V131, P1821, DOI 10.1007/s00439-012-1215-x; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; DEBILI N, 1993, BLOOD, V82, P84, DOI 10.1182/blood.V82.1.84.bloodjournal82184; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Johnson HJ, 2009, EXP HEMATOL, V37, P901, DOI 10.1016/j.exphem.2009.05.005; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Kunishima S, 2009, BLOOD, V113, P458, DOI 10.1182/blood-2008-06-162610; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Seri M, 2000, NAT GENET, V26, P103; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793	24	38	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74728	10.1371/journal.pone.0074728	http://dx.doi.org/10.1371/journal.pone.0074728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069336	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300053
J	Guo, CC; Lu, HB; Gao, W; Wang, L; Lu, KH; Wu, SH; Pataer, A; Huang, MS; El-Zein, R; Lin, TY; Roth, JA; Mehran, R; Hofstetter, W; Swisher, SG; Wu, XF; Fang, BL				Guo, Chengcheng; Lu, Haibo; Gao, Wen; Wang, Li; Lu, Kaihua; Wu, Shuhong; Pataer, Apar; Huang, Maosheng; El-Zein, Randa; Lin, Tongyu; Roth, Jack A.; Mehran, Reza; Hofstetter, Wayne; Swisher, Stephen G.; Wu, Xifeng; Fang, Bingliang			Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival	PLOS ONE			English	Article							FACTOR BINDING-PROTEIN-2; CANDIDATE BIOMARKER; HIGH EXPRESSION; MESSENGER-RNA; IGF-I; SERUM; DIAGNOSIS; IGFBP-2; MARKER; ANGIOGENESIS	Background: We recently showed that IGFBP2 is overexpressed in primary lung cancer tissues. This study aims to determine whether IGFBP2 is elevated in blood samples of lung cancer patients and whether its level is associated with clinical outcomes. Methodology/Principal Findings: Plasma IGFBP2 levels were determined blindly by enzyme-linked immunosorbent assay in 80 lung cancer patients and 80 case-matched healthy controls for comparison. We analyzed blood samples for IGFBP2 levels from an additional 84 patients with lung cancer and then tested for associations between blood IGFBP2 levels and clinical parameters in all 164 lung cancer patients. All statistical tests were two-sided and differences with p<0.05 were considered significant. The mean plasma concentration of IGFBP2 in lung cancer patients was significantly higher than that in healthy controls (388.12 +/- 261.00 ng/ml vs 219.30 +/- 172.84 ng/ml, p<0.001). IGFBP2 was increased in all types of lung cancer, including adenocarcinoma, squamous cell cancer, and small-cell cancer, regardless of patients' age, sex, or smoking status. IGFBP2 levels were mildly but significantly associated with tumor size and were significantly higher in stage IV than stage I or III disease. A multivariate analysis showed that lung cancer patients whose blood IGFBP2 was higher than 160.9 ng/ml had a poor survival outcome, with a hazard ratio of 8.76 (95% CI 1.12-68.34, p=0.038 after adjustment for tumor size, pathology, and stage). The median survival time for patients with blood IGFBP2 > 160.9 ng/ml is 15.1 months; whereas median survival time was 128.2 months for the patients whose blood IGFBP2 was <= 160.9 ng/ml (p =0.0002). Conclusions/Significance: Blood IGFBP2 is significantly increased in lung cancer patients. A high circulating level of IGFBP2 is significantly associated with poor survival, suggesting that blood IGFBP2 levels could be a prognostic biomarker for lung cancer.	[Guo, Chengcheng; Lu, Haibo; Gao, Wen; Wang, Li; Lu, Kaihua; Wu, Shuhong; Pataer, Apar; Roth, Jack A.; Mehran, Reza; Hofstetter, Wayne; Swisher, Stephen G.; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Huang, Maosheng; El-Zein, Randa; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Guo, Chengcheng] Sun Yat Sen Univ, Ctr Canc, Dept Neurosurg Neurooncol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Tongyu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Haibo] Harbin Med Univ, Affiliated Hosp 3, Dept Internal Med 8, Harbin, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; Sun Yat Sen University; Harbin Medical University	Fang, BL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	bfang@mdanderson.org			National Institutes of Health [R01 CA092481, R01 CA124951]; Specialized Program of Research Excellence (SPORE) Grant [CA070907]; University of Texas MD Anderson Cancer Center [CA-016672]; Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora & Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; George O. Sweeney Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; M. W. Elkins Endowed Fund for Thoracic Surgical Oncology; Chapman Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907, R01CA124951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Program of Research Excellence (SPORE) Grant; University of Texas MD Anderson Cancer Center; Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora & Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; George O. Sweeney Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; M. W. Elkins Endowed Fund for Thoracic Surgical Oncology; Chapman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health through R01 CA092481 and R01 CA124951 to B. Fang, Specialized Program of Research Excellence (SPORE) Grant CA070907, The University of Texas MD Anderson Cancer Center, Support Grant CA-016672, Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility, and the Homer Flower Gene Therapy Research Fund, the Charles Rogers Gene Therapy Fund, the Flora & Stuart Mason Lung Cancer Research Fund, the Charles B. Swank Memorial Fund for Esophageal Cancer Research, the George O. Sweeney Fund for Esophageal Cancer Research, the Phalan Thoracic Gene Therapy Fund, and the M. W. Elkins Endowed Fund for Thoracic Surgical Oncology, and Chapman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ambrosini-Spaltro A, 2011, APPL IMMUNOHISTO M M, V19, P318, DOI 10.1097/PAI.0b013e3128052936; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Becher OJ, 2008, J CHILD NEUROL, V23, P1205, DOI 10.1177/0883073808321766; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; CLEMMONS DR, 1991, J CLIN ENDOCR METAB, V73, P727, DOI 10.1210/jcem-73-4-727; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Goulart BHL, 2012, J NATL COMPR CANC NE, V10, P267, DOI 10.6004/jnccn.2012.0023; He Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031087; Ho PJ, 1997, CLIN ENDOCRINOL, V46, P333; Holdenrieder S, 2010, CANCER BIOMARK, V6, P179, DOI 10.3233/CBM-2009-0128; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Inman BA, 2005, EUR UROL, V47, P695, DOI 10.1016/j.eururo.2004.12.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuhnl A, 2011, LEUKEMIA RES, V35, P1585, DOI 10.1016/j.leukres.2011.08.006; Ladd JJ, 2012, CANCER PREV RES, V5, P655, DOI 10.1158/1940-6207.CAPR-11-0412; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1529, DOI 10.1111/j.1525-1438.2006.00623.x; Lee HY, 2002, CANCER RES, V62, P3530; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Mattsson A, 2008, GROWTH HORM IGF RES, V18, P506, DOI 10.1016/j.ghir.2008.04.005; Matuschek C, 2011, EUR J MED RES, V16, P451; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Mishra L, 1998, GROWTH HORM IGF RES, V8, P473, DOI 10.1016/S1096-6374(98)80300-6; Moore LM, 2009, P NATL ACAD SCI USA, V106, P16675, DOI 10.1073/pnas.0900807106; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Probst-Hensch NM, 2010, CLIN CANCER RES, V16, P1025, DOI 10.1158/1078-0432.CCR-09-0957; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Salgia R, 2011, CANCER-AM CANCER SOC, V117, P3889, DOI 10.1002/cncr.25935; Schneider J, 2006, ADV CLIN CHEM, V42, P1, DOI 10.1016/S0065-2423(06)42001-1; STIEBER P, 1993, CANCER, V72, P707, DOI 10.1002/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X; Uzoh CC, 2011, BRIT J CANCER, V104, P1587, DOI 10.1038/bjc.2011.127; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Zhang LH, 2007, DIGEST DIS SCI, V52, P248, DOI 10.1007/s10620-006-9358-z; Zhang Y, 2013, INT J ONCOL, V42, P93, DOI 10.3892/ijo.2012.1699; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190	42	32	32	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74973	10.1371/journal.pone.0074973	http://dx.doi.org/10.1371/journal.pone.0074973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069370	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300067
J	Cagnet, S; Faraldo, MM; Kreft, M; Sonnenberg, A; Raymond, K; Glukhova, MA				Cagnet, S.; Faraldo, M. M.; Kreft, M.; Sonnenberg, A.; Raymond, K.; Glukhova, M. A.			Signaling events mediated by alpha 3 beta 1 integrin are essential for mammary tumorigenesis	ONCOGENE			English	Article						integrin signaling; basal-like breast cancer; mouse models of breast cancer; Wnt/beta-catenin pathway; survival; proliferation	FOCAL ADHESION KINASE; BREAST-CANCER CELLS; GENE-EXPRESSION; EPITHELIAL-CELLS; PATHWAY ACTIVATION; BASAL; SURVIVAL; DIFFERENTIATION; LOCALIZATION; PROGENITORS	The constitutive activation of beta-catenin signaling in the mammary basal epithelial cell layer in transgenic K5 Delta N beta cat mice leads to basal-type tumor development. Integrins of the beta 1 family and integrin-mediated signaling events have an important role in breast tumor growth and progression. We show here that the deletion of alpha 3 beta 1 integrin, a major laminin receptor, from the basal layer of the mammary epithelium of K5 Delta N beta cat mice completely prevented the tumorigenesis induced by beta-catenin signaling. Moreover, the depletion of alpha 3 beta 1 integrin from a spontaneously transformed mouse mammary basal epithelial cell line (MEC) prevented the cells from forming colonies in soft agar and greatly reduced tumor development in orthotopic grafts. Inhibition of the integrin signaling intermediates Rac1 or PAK1 (P21-activated Kinase 1) in MEC affected tumor cell growth in soft agar, whereas the expression of activated forms of these effectors in alpha 3-depleted cells rescued the capacity of these cells to grow in non-adherent conditions. Similarly, the tumorigenic potential of alpha 3-depleted cells was restored by the expression of activated PAK1, as assessed by orthotopic transplantation assay. In three-dimensional Matrigel culture, MEC survival and proliferation were affected by the depletion of alpha 3 beta 1 integrin, which also significantly decreased the activation of focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK) and c-Jun NH2-terminal kinase (JNK). Our data suggest that the activation of signaling cascades downstream from alpha 3 beta 1 and involving the Rac1/PAK1 pathway, MAPK and JNK, promotes prosurvival and proproliferative signals required for the malignant growth of basal mammary epithelial cells, providing further insight into the molecular mechanisms underlying breast cancer initiation and progression.	[Cagnet, S.; Faraldo, M. M.; Raymond, K.; Glukhova, M. A.] Inst Curie, Ctr Rech, Paris, France; [Cagnet, S.; Faraldo, M. M.; Raymond, K.; Glukhova, M. A.] Inst Curie, CNRS, UMR144, Sect Rech, Paris, France; [Kreft, M.; Sonnenberg, A.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Netherlands Cancer Institute	Raymond, K (corresponding author), Univ Paris 06, St Antoine Res Ctr, INSERM U938, F-75005 Paris, France.	karine.raymond@inserm.fr; marina.glukhova@curie.fr	Martin-Faraldo, Maria-Luisa/M-5811-2018; Raymond, Karine/E-2693-2017	Raymond, Karine/0000-0001-5892-8117; Faraldo, Marisa/0000-0001-9497-1171	La Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [ANR-08-BLAN-0078-01]; Association pour la Recherche sur le Cancer	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We are particularly grateful to Dr JL Jorcano for providing K5Cre transgenic mice. We thank Dr I Grandjean and S Jannet for excellent assistance with animal care, Z Maciorowski, A Viguier and S Grondin for excellent assistance with FACS analyses and M Denoyelle and A Di Cicco for technical help. We also thank the Nikon Imaging Centre at Institut Curie-CNRS for providing confocal microscopy facilities. This work was supported by La Ligue Nationale Contre le Cancer (Equipe Labelisee e 2009, 2013) and a grant from the Agence Nationale de la Recherche ANR-08-BLAN-0078-01 to MAG. SC received funding from Association pour la Recherche sur le Cancer; MAG is Directeur de Recherche and MMF and KR are Charge de Recherche at the Institut National de la Sante et de la Recherche Medicale (INSERM).	Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JONJIC N, 1993, PATHOL RES PRACT, V189, P979; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905; Lambert Arthur W, 2012, ISRN Oncol, V2012, P493283, DOI 10.5402/2012/493283; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Moumen M, MOL CANC; Moumen M, 2012, STEM CELLS, V30, P1246, DOI 10.1002/stem.1090; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; PELTONEN J, 1989, J CLIN INVEST, V84, P1916, DOI 10.1172/JCI114379; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Raymond K, 2012, SEMIN CELL DEV BIOL, V23, P599, DOI 10.1016/j.semcdb.2012.03.008; Raymond K, 2011, EMBO J, V30, P1896, DOI 10.1038/emboj.2011.113; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	49	39	40	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4286	4295		10.1038/onc.2013.391	http://dx.doi.org/10.1038/onc.2013.391			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24077284				2022-12-25	WOS:000341156900002
J	Wu, M; Bu, LT; Vuong, TV; Wilson, DB; Crowley, MF; Sandgren, M; Stahlberg, J; Beckham, GT; Hansson, H				Wu, Miao; Bu, Lintao; Vuong, Thu V.; Wilson, David B.; Crowley, Michael F.; Sandgren, Mats; Stahlberg, Jerry; Beckham, Gregg T.; Hansson, Henrik			Loop Motions Important to Product Expulsion in the Thermobifida fusca Glycoside Hydrolase Family 6 Cellobiohydrolase from Structural and Computational Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Enzyme Structure; Glycoside Hydrolases; Molecular Dynamics; X-ray Crystallography; Thermobifida fusca; Cellobiohydrolase	SITE-DIRECTED MUTATION; MOLECULAR-DYNAMICS; TRICHODERMA-REESEI; HUMICOLA-INSOLENS; CRYSTAL-STRUCTURE; LIGNOCELLULOSIC BIOMASS; PROCESSIVE CELLULASE; DEGRADING ENZYMES; CATALYTIC CORE; FORCE-FIELDS	Background: Family 6 glycoside hydrolases represent an important, diverse enzyme class in cellulolytic organisms. Results: We solved structures of two Thermobifida fusca Cel6B (TfuCel6B) cellobiohydrolase mutants and examined ligand dynamics and product release with simulation. Conclusion: These results suggest mechanisms for product release in TfuCel6B. Significance: This study further elucidates the mechanism of a unique cellobiohydrolase with an extended, enclosed active site tunnel. Cellobiohydrolases (CBHs) are typically major components of natural enzyme cocktails for biomass degradation. Their active sites are enclosed in a tunnel, enabling processive hydrolysis of cellulose chains. Glycoside hydrolase Family 6 (GH6) CBHs act from nonreducing ends by an inverting mechanism and are present in many cellulolytic fungi and bacteria. The bacterial Thermobifida fusca Cel6B (TfuCel6B) exhibits a longer and more enclosed active site tunnel than its fungal counterparts. Here, we determine the structures of two TfuCel6B mutants co-crystallized with cellobiose, D274A (catalytic acid), and the double mutant D226A/S232A, which targets the putative catalytic base and a conserved serine that binds the nucleophilic water. The ligand binding and the structure of the active site are retained when compared with the wild type structure, supporting the hypothesis that these residues are directly involved in catalysis. One structure exhibits crystallographic waters that enable construction of a model of the alpha-anomer product after hydrolysis. Interestingly, the product sites of TfuCel6B are completely enclosed by an "exit loop" not present in fungal GH6 CBHs and by an extended "bottom loop". From the structures, we hypothesize that either of the loops enclosing the product subsites in the TfuCel6B active site tunnel must open substantially for product release. With simulation, we demonstrate that both loops can readily open to allow product release with equal probability in solution or when the enzyme is engaged on cellulose. Overall, this study reveals new structural details of GH6 CBHs likely important for functional differences among enzymes from this important family.	[Wu, Miao; Sandgren, Mats; Stahlberg, Jerry; Hansson, Henrik] Swedish Univ Agr Sci, Dept Mol Biol, SE-75007 Uppsala, Sweden; [Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Vuong, Thu V.; Wilson, David B.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; Henrik.Hansson@slu.se	; Stahlberg, Jerry/D-4163-2013; crowley, michael/A-4852-2013	Hansson, Henrik/0000-0002-6003-2982; Stahlberg, Jerry/0000-0003-4059-8580; Sandgren, Mats/0000-0002-2358-4534; crowley, michael/0000-0001-5163-9398	Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) [MCB090159]; National Renewable Energy Laboratory (NREL) Computational Sciences Center; Department of Energy Efficiency and Renewable Energy (EERE) [DE-AC36-08GO28308]	Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE); National Renewable Energy Laboratory (NREL) Computational Sciences Center; Department of Energy Efficiency and Renewable Energy (EERE)(United States Department of Energy (DOE))	Computer time for this research was provided by the Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant number MCB090159 and the National Renewable Energy Laboratory (NREL) Computational Sciences Center supported by the Department of Energy Efficiency and Renewable Energy (EERE) under Contract DE-AC36-08GO28308.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung H, 2003, BIOTECHNOL BIOENG, V84, P151, DOI 10.1002/bit.10743; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; REESE ET, 1976, BIOTECHNOL BIOENG, P9; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandgren M, 2013, J MOL BIOL, V425, P622, DOI 10.1016/j.jmb.2012.11.039; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tamura M, 2012, FEBS J, V279, P1871, DOI 10.1111/j.1742-4658.2012.08568.x; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Varrot A, 2002, ACTA CRYSTALLOGR D, V58, P2201, DOI 10.1107/S0907444902017006; Varrot A, 1999, BIOCHEM J, V337, P297, DOI 10.1042/0264-6021:3370297; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Vuong TV, 2009, FEBS J, V276, P4261, DOI 10.1111/j.1742-4658.2009.07097.x; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	79	23	23	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33107	33117		10.1074/jbc.M113.502765	http://dx.doi.org/10.1074/jbc.M113.502765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085303	Green Published, hybrid			2022-12-25	WOS:000328841700026
J	Quiroz-Martinez, B; Salgado-Maldonado, G				Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo			Taxonomic Distinctness and Richness of Helminth Parasite Assemblages of Freshwater Fishes in Mexican Hydrological Basins	PLOS ONE			English	Article							SPECIES RICHNESS; TRANSITION ZONE; BIODIVERSITY; DIVERSITY; BIOGEOGRAPHY; COMMUNITIES; ECOLOGY; SIMILARITY; INDEX	In this paper, we analyse the distributional patterns of adult helminth parasites of freshwater fishes with respect to the main hydrological basins of Mexico. We use the taxonomic distinctness and the variation in taxonomic distinctness to explore patterns of parasite diversity and how these patterns change between zoogeographical regions. We address questions about the factors that determine the variation of observed diversity of helminths between basins. We also investigate patterns of richness, taxonomic distinctness and distance decay of similarity amongst basins. Our analyses suggest that the evolution of the fauna of helminth parasites in Mexico is mostly dominated by independent host colonization events and that intra - host speciation could be a minor factor explaining the origin of this diversity. This paper points out a clear separation between the helminth faunas of northern - nearctic and southern - neotropical components in Mexican continental waters, suggesting the availability of two distinct taxonomic pools of parasites in Mexican drainage basins. Data identifies Mexican drainage basins as unities inhabited by freshwater fishes, hosting a mixture of neotropical and nearctic species, in addition, data confirms neotropical and neartic basins/helminth faunas. The neotropical basins of Mexico are host to a richest and more diversified helminth fauna, including more families, genera and species, compared to the less rich and less diverse helminth fauna in the nearctic basins. The present analysis confirms distance - decay as one of the important factors contributing to the patterns of diversity observed. The hypothesis that helminth diversity could be explained by the ichthyological diversity of the basin received no support from present analysis.	[Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo] Univ Nacl Autonoma Mexico, Lab Helmintol, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Salgado-Maldonado, G (corresponding author), Univ Nacl Autonoma Mexico, Lab Helmintol, Inst Biol, Mexico City 04510, DF, Mexico.	gsalgado@ib.unam.mx	Salgado-Maldonado, Guillermo/AAB-4960-2021; Quiroz-Martinez, Benjamin/AAG-2856-2019	Salgado-Maldonado, Guillermo/0000-0002-0772-0938; Quiroz-Martinez, Benjamin/0000-0001-9791-7031	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [155372]; "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM [174861]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM	This study was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) through Project no. 155372 awarded to GSM and a postdoctoral fellowship grant (no. 174861) awarded to BQM, through the "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Aguilar R, 2008, BIOL J LINN SOC, V94, P435, DOI 10.1111/j.1095-8312.2008.00994.x; Bhat A, 2006, ECOGRAPHY, V29, P104, DOI 10.1111/j.2006.0906-7590.04418.x; Choudhury A, 2000, J BIOGEOGR, V27, P935, DOI 10.1046/j.1365-2699.2000.00450.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Garrido-Olvera L, 2012, PARASITOLOGY, V139, P1652, DOI 10.1017/S003118201200100X; HALFFTER G, 1987, ANNU REV ENTOMOL, V32, P95, DOI 10.1146/annurev.ento.32.1.95; Halfter G., 1976, Folia Ent Mex, VNo. 35, P1; HUIDOBRO L, 2006, J BIOGEOGRAPHY, V33; Leonard DRP, 2006, J ENVIRON MANAGE, V78, P52, DOI 10.1016/j.jenvman.2005.04.008; Luque JL, 2008, J FISH BIOL, V72, P189, DOI 10.1111/j.1095-8649.2007.01695.x; Luque JL, 2007, PARASITOLOGY, V134, P865, DOI 10.1017/S0031182007002272; Luque JL, 2004, PARASITOLOGY, V128, P671, DOI 10.1017/S0031182004005050; MALDONADO GS, 2013, PARASITOL RES, V112, P1; Caspeta-Mandujano JM, 2009, J PARASITOL, V95, P403, DOI 10.1645/GE-1768.1; Mendoza-Franco EF, 2009, J PARASITOL, V95, P46, DOI 10.1645/GE-1592.1; MILLER RR, 1966, COPEIA, P773, DOI 10.2307/1441406; Mittermeier R. A., 1999, BIODIVERSIDAD AMENAZ; Monks S, 2011, COMP PARASITOL, V78, P21, DOI 10.1654/4462.1; Morrone JJ, 2001, J BIOGEOGR, V28, P635, DOI 10.1046/j.1365-2699.2001.00571.x; Morrone JJ, 2010, ECOGRAPHY, V33, P355, DOI 10.1111/j.1600-0587.2010.06266.x; Morrone Juan J., 2002, Acta Zool. Mex, P83; Mouillot D, 2004, OIKOS, V104, P205, DOI 10.1111/j.0030-1299.2004.12833.x; NORRIS S. M., 2005, FRESHWATER FISHES ME; Ponlet N, 2011, PARASITOLOGY, V138, P1804, DOI 10.1017/S003118201100028X; Poulin R, 2004, EVOL ECOL, V18, P231, DOI 10.1023/B:EVEC.0000035029.55952.68; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Poulin R, 2011, PHILOS T R SOC B, V366, P2379, DOI 10.1098/rstb.2011.0048; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; QUIROZMARTINEZ B, 2013, PLOS ONE, V8, P1; Rubio-Godoy M, 2010, ZOOTAXA, P1; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P196; Salgado-Maldonado G, 2008, ZOOTAXA, P29; Salgado-Maldonado G, 2006, ZOOTAXA, P1; SalgadoMaldonado G, 1997, PARASITOLOGY, V114, P581; SALGADOMALDONADO G, 1992, MEM I OSWALDO CRUZ, V87, P239, DOI 10.1590/S0074-02761992000500044; Sanchez-Nava P, 2004, PARASITOL RES, V93, P396, DOI 10.1007/s00436-004-1146-0; Shimatani K, 2001, OIKOS, V93, P135, DOI 10.1034/j.1600-0706.2001.930115.x; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Vidal-Martinez V.M., 2000, P227; VIDALMARTINEZ VM, 1995, PROCESSES STRUCTURIN; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207	50	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74419	10.1371/journal.pone.0074419	http://dx.doi.org/10.1371/journal.pone.0074419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086342	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900025
J	Svensson, CR; Messing, ME; Lundqvist, M; Schollin, A; Deppert, K; Pagels, JH; Rissler, J; Cedervall, T				Svensson, Christian R.; Messing, Maria E.; Lundqvist, Martin; Schollin, Alexander; Deppert, Knut; Pagels, Joakim H.; Rissler, Jenny; Cedervall, Tommy			Direct Deposition of Gas Phase Generated Aerosol Gold Nanoparticles into Biological Fluids - Corona Formation and Particle Size Shifts	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; HUMAN RESPIRATORY-TRACT; AIR-LIQUID INTERFACE; CARBON NANOTUBES; EPITHELIAL-CELLS; PROTEIN CORONA; EXPOSURE; TOXICITY; MOBILITY; ANALYZER	An ongoing discussion whether traditional toxicological methods are sufficient to evaluate the risks associated with nanoparticle inhalation has led to the emergence of Air-Liquid interface toxicology. As a step in this process, this study explores the evolution of particle characteristics as they move from the airborne state into physiological solution. Airborne gold nanoparticles (AuNP) are generated using an evaporation-condensation technique. Spherical and agglomerate AuNPs are deposited into physiological solutions of increasing biological complexity. The AuNP size is characterized in air as mobility diameter and in liquid as hydrodynamic diameter. AuNP: Protein aggregation in physiological solutions is determined using dynamic light scattering, particle tracking analysis, and UV absorption spectroscopy. AuNPs deposited into homocysteine buffer form large gold-aggregates. Spherical AuNPs deposited in solutions of albumin were trapped at the Air-Liquid interface but was readily suspended in the solutions with a size close to that of the airborne particles, indicating that AuNP: Protein complex formation is promoted. Deposition into serum and lung fluid resulted in larger complexes, reflecting the formation of a more complex protein corona. UV absorption spectroscopy indicated no further aggregation of the AuNPs after deposition in solution. The corona of the deposited AuNPs shows differences compared to AuNPs generated in suspension. Deposition of AuNPs from the aerosol phase into biological fluids offers a method to study the protein corona formed, upon inhalation and deposition in the lungs in a more realistic way compared to particle liquid suspensions. This is important since the protein corona together with key particle properties (e. g. size, shape and surface reactivity) to a large extent may determine the nanoparticle effects and possible translocation to other organs.	[Svensson, Christian R.; Pagels, Joakim H.; Rissler, Jenny] Lund Univ, Dept Design Sci, Div Ergon & Aerosol Technol, Lund, Sweden; [Messing, Maria E.; Deppert, Knut] Lund Univ, Dept Phys, Div Solid State Phys, S-22362 Lund, Sweden; [Messing, Maria E.] Lund Univ, Dept Phys, Div Synchrotron Radiat Res, S-22362 Lund, Sweden; [Lundqvist, Martin; Schollin, Alexander; Cedervall, Tommy] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Svensson, CR (corresponding author), Lund Univ, Dept Design Sci, Div Ergon & Aerosol Technol, Lund, Sweden.	Christian.Svensson@design.lth.se	Lundqvist, Martin/K-3908-2012; Cedervall, Tommy/AAT-9766-2021; Pagels, Joakim/G-9118-2014; Rissler, Jenny/B-9176-2014; Messing, Maria E/D-5546-2009; Deppert, Knut/A-6719-2008	Lundqvist, Martin/0000-0003-1175-9103; Cedervall, Tommy/0000-0003-2255-8446; Pagels, Joakim/0000-0002-7423-3240; Rissler, Jenny/0000-0001-8650-4741; Messing, Maria E/0000-0003-1834-236X; Deppert, Knut/0000-0002-0471-951X	Forte - Swedish Research Council for Health, Working Life and Welfare [2009-1291]; FORMAS [216-2009-1294]; VINNOVA [2009-01117]; Nanometer Structure Consortium at Lund University	Forte - Swedish Research Council for Health, Working Life and Welfare; FORMAS(Swedish Research Council Formas); VINNOVA(Vinnova); Nanometer Structure Consortium at Lund University	The authors acknowledge Forte - Swedish Research Council for Health, Working Life and Welfare, Grant nr. 2009-1291; FORMAS, Grant nr. 216-2009-1294; VINNOVA, Grant nr. 2009-01117; and the Nanometer Structure Consortium at Lund University for their generous funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, TOXICOL IN VITRO, V25, P930, DOI 10.1016/j.tiv.2011.02.015; Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035; Blank F, 2006, J AEROSOL MED, V19, P392, DOI 10.1089/jam.2006.19.392; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deppert K., 1996, J AEROSOL SCI, V27, P151, DOI DOI 10.1016/0021-8502(96)00148-6; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130; Ehara K, 1996, J AEROSOL SCI, V27, P217, DOI 10.1016/0021-8502(95)00562-5; Gaschen A, 2010, ENVIRON SCI TECHNOL, V44, P1424, DOI 10.1021/es902261m; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Ji ZX, 2010, ENVIRON SCI TECHNOL, V44, P7309, DOI 10.1021/es100417s; Knutson E. O., 1975, Journal of Aerosol Science, V6, P443, DOI 10.1016/0021-8502(75)90060-9; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Link S, 1999, J PHYS CHEM B, V103, P4212, DOI 10.1021/jp984796o; Londahl J, 2008, INHAL TOXICOL, V20, P923, DOI 10.1080/08958370802087124 ; Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; McMurry PH, 2002, AEROSOL SCI TECH, V36, P227, DOI 10.1080/027868202753504083; Messing ME, 2013, NANOTOXICOLOGY, V7, P1052, DOI 10.3109/17435390.2012.697589; Messing ME, 2009, GOLD BULL, V42, P20, DOI 10.1007/BF03214902; Miyabara Y, 1998, EUR RESPIR J, V11, P291, DOI 10.1183/09031936.98.11020291; Montes-Burgos I, 2010, J NANOPART RES, V12, P47, DOI 10.1007/s11051-009-9774-z; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Park K, 2008, AEROSOL SCI TECH, V42, P801, DOI 10.1080/02786820802339561; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Reischl GP, 1997, AEROSOL SCI TECH, V27, P651, DOI 10.1080/02786829708965503; Rissler J, 2012, J AEROSOL SCI, V48, P18, DOI 10.1016/j.jaerosci.2012.01.005; Royal Commission on Environmental Pollution, 2008, NOV MAT ENV CAS NAN; SCHEIBEL HG, 1983, J AEROSOL SCI, V14, P113, DOI 10.1016/0021-8502(83)90035-6; Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P3218, DOI 10.1002/1521-3773(20020902)41:17<3218::AID-ANIE3218>3.0.CO;2-P; Shin WG, 2010, J AEROSOL SCI, V41, P665, DOI 10.1016/j.jaerosci.2010.04.009; Shin WG, 2009, J AEROSOL SCI, V40, P573, DOI 10.1016/j.jaerosci.2009.02.006; Tantra R, 2010, COLLOID SURFACE B, V75, P275, DOI 10.1016/j.colsurfb.2009.08.049; Tippe A, 2002, J AEROSOL SCI, V33, P207, DOI 10.1016/S0021-8502(01)00158-6; Trouiller B, 2009, CANCER RES, V69, P8784, DOI 10.1158/0008-5472.CAN-09-2496; Tsai DH, 2011, LANGMUIR, V27, P2464, DOI 10.1021/la104124d; Tsurudome Y, 1999, CARCINOGENESIS, V20, P1573, DOI 10.1093/carcin/20.8.1573; Weir E, 2008, ANALYST, V133, P835, DOI 10.1039/b715532h; WIEDENSOHLER A, 1988, J AEROSOL SCI, V19, P387, DOI 10.1016/0021-8502(88)90278-9; Xie YM, 2012, TOXICOL SCI, V125, P450, DOI 10.1093/toxsci/kfr251	54	6	6	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74702	10.1371/journal.pone.0074702	http://dx.doi.org/10.1371/journal.pone.0074702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086363	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900029
J	Tyler, AD; Knox, N; Kabakchiev, B; Milgrom, R; Kirsch, R; Cohen, Z; McLeod, RS; Guttman, DS; Krause, DO; Silverberg, MS				Tyler, Andrea D.; Knox, Natalie; Kabakchiev, Boyko; Milgrom, Raquel; Kirsch, Richard; Cohen, Zane; McLeod, Robin S.; Guttman, David S.; Krause, Denis O.; Silverberg, Mark S.			Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis	PLOS ONE			English	Article							MUCOSA-ASSOCIATED MICROBIOTA; CROHNS-DISEASE; ULCERATIVE-COLITIS; FECAL MICROBIOTA; BOWEL-DISEASE; RISK-FACTORS; COMMENSAL; MARKERS; NUMBER; TWIN	Introduction: Inflammatory complications following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC) are common and thought to arise through mechanisms similar to de novo onset inflammatory bowel disease. The aim of this study was to determine whether specific organisms in the tissue-associated microbiota are associated with inflammatory pouch complications. Methods: Patients having previously undergone IPAA were recruited from Mount Sinai Hospital. Clinical and demographic information were collected and a pouchoscopy with biopsy of both the pouch and afferent limb was performed. Patients were classified based on post-surgical phenotype into four outcome groups: familial adenomatous polyposis controls (FAP), no pouchitis, pouchitis, and Crohn's disease-like (CDL). Pyrosequencing of the 16S rRNA V1-V3 hypervariable region, and quantitative PCR for bacteria of interest, were used to identify organisms present in the afferent limb and pouch. Associations with outcomes were evaluated using exact and non-parametric tests of significance. Results: Analysis at the phylum level indicated that Bacteroidetes were detected significantly less frequently (P<0.0001) in the inflammatory outcome groups (pouchitis and CDL) compared to both FAP and no pouchitis. Conversely, Proteobacteria were detected more frequently in the inflammatory groups (P=0.01). At the genus level, organisms associated with outcome were detected less frequently among the inflammatory groups compared to those without inflammation. Several of these organisms, including Bacteroides (P<0.0001), Parabacteroides (P <= 2.2x10(-3)), Blautia (P <= 3.0x10(-3)) and Sutterella (P <= 2.5x10(-3)), were associated with outcome in both the pouch and afferent limb. These associations remained significant even following adjustment for antibiotic use, smoking, country of birth and gender. Individuals with quiescent disease receiving antibiotic therapy displayed similar reductions in these organisms as those with active pouch inflammation. Conclusions: Specific genera are associated with inflammation of the ileal pouch, with a reduction of typically ubiquitous organisms characterizing the inflammatory phenotypes.	[Tyler, Andrea D.; Kabakchiev, Boyko; Cohen, Zane; Silverberg, Mark S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tyler, Andrea D.; Kabakchiev, Boyko; Milgrom, Raquel; Cohen, Zane; McLeod, Robin S.; Silverberg, Mark S.] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Knox, Natalie; Krause, Denis O.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Krause, Denis O.] Univ Manitoba, Winnipeg, MB, Canada; [Kirsch, Richard] Mt Sinai Hosp, Lab Med & Pathol, Toronto, ON M5G 1X5, Canada; [Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Manitoba; University of Manitoba; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Silverberg, MS (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	msilverberg@mtsinai.on.ca	Guttman, David S/A-7839-2011; Silverberg, Mark/B-4183-2008; McLeod, Robin/K-1476-2013; Kirsch, Richard/J-2335-2016	Guttman, David S/0000-0001-8479-3869; Knox, Natalie/0000-0001-6133-7799	Crohn's and Colitis Foundation of Canada (CCFC)	Crohn's and Colitis Foundation of Canada (CCFC)	This research was funded through a grant from the Crohn's and Colitis Foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2008, INFLAMM BOWEL DIS, V14, P401, DOI 10.1002/ibd.20276; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carlier JP, 2007, INT J SYST EVOL MICR, V57, P725, DOI 10.1099/ijs.0.64705-0; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; FARMER RG, 1993, DIGEST DIS SCI, V38, P1137, DOI 10.1007/BF01295733; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Fleshner P, 2008, CLIN GASTROENTEROL H, V6, P561, DOI 10.1016/j.cgh.2008.01.002; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Heuschen UA, 2002, DIS COLON RECTUM, V45, P776, DOI 10.1007/s10350-004-6297-7; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kuisma J, 2004, SCAND J GASTROENTERO, V39, P544, DOI 10.1080/00365520410004668; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; McLaughlin SD, 2010, ANN SURG, V252, P90, DOI 10.1097/SLA.0b013e3181e3dc8b; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon CE, 1997, M D COMPUT, V14, P306; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shen B, 2008, INFLAMM BOWEL DIS, V14, P942, DOI 10.1002/ibd.20409; SHEPHERD NA, 1993, GUT, V34, P101, DOI 10.1136/gut.34.1.101; Simchuk EJ, 2000, WORLD J SURG, V24, P851, DOI 10.1007/s002680010136; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyler AD, 2013, GUT, V62, P1433, DOI 10.1136/gutjnl-2011-301957; Tyler AD, 2012, CLIN GASTROENTEROL H, V10, P507, DOI 10.1016/j.cgh.2011.09.016; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Zella GC, 2011, INFLAMM BOWEL DIS, V17, P1092, DOI 10.1002/ibd.21460	49	63	64	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e66934	10.1371/journal.pone.0066934	http://dx.doi.org/10.1371/journal.pone.0066934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086242	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200001
J	Zhang, JW; Jaeck, O; Menegat, A; Zhang, ZJ; Gerhards, R; Ni, HW				Zhang, Jinwei; Jaeck, Ortrud; Menegat, Alexander; Zhang, Zongjian; Gerhards, Roland; Ni, Hanwen			The Mechanism of Methylated Seed Oil on Enhancing Biological Efficacy of Topramezone on Weeds	PLOS ONE			English	Article							ZEA-MAYS L.; PRIMISULFURON DROPLET SPREAD; OPTIMIZING FOLIAR ACTIVITY; FOXTAIL SETARIA-FABERI; ECHINOCHLOA-CRUS-GALLI; ABSORPTION; ADJUVANTS; TRANSLOCATION; SELECTIVITY; HERBICIDES	Methylated seed oil (MSO) is a recommended adjuvant for the newly registered herbicide topramezone in China and also in other countries of the world, but the mechanism of MSO enhancing topramezone efficacy is still not clear. Greenhouse and laboratory experiments were conducted to determine the effects of MSO on efficacy, solution property, droplet spread and evaporation, active ingredient deposition, foliar absorption and translocation of topramezone applied to giant foxtail (Setaria faberi Herrm.) and velvetleaf (Abutilon theophrasti Medic.). Experimental results showed that 0.3% MSO enhanced the efficacy of topramezone by 1.5-fold on giant foxtail and by 1.0-fold on velvetleaf. When this herbicide was mixed with MSO, its solution surface tension and leaf contact angle decreased significantly, its spread areas on weed leaf surfaces increased significantly, its wetting time was shortened on giant foxtail but not changed on velvetleaf, and less of its active ingredient crystal was observed on the treated weed leaf surfaces. MSO increased the absorption of topramezone by 68.9% for giant foxtail and by 45.9% for velvetleaf 24 hours after treatment. It also apparently promoted the translocation of this herbicide in these two weeds.	[Zhang, Jinwei; Ni, Hanwen] China Agr Univ, Coll Agr & Biotechnol, Weed Management Lab, Beijing 100094, Peoples R China; [Zhang, Jinwei] Tianjin Acad Agr Sci, Inst Plant Protect, Tianjin, Peoples R China; [Jaeck, Ortrud; Menegat, Alexander; Gerhards, Roland] Univ Hohenheim, Dept Weed Sci, Inst Phytomed, Stuttgart, Germany; [Zhang, Zongjian] Cent Res Inst China Chem Sci & Technol, Off Natl Pesticide R&D South Ctr, R&D Ctr Funct Addit, Beijing, Peoples R China	China Agricultural University; University Hohenheim	Ni, HW (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Weed Management Lab, Beijing 100094, Peoples R China.	hanwenni@cau.edu.cn	Menegat, Alexander/X-6759-2019	Menegat, Alexander/0000-0002-0735-3293; Gerhards, Roland/0000-0002-6720-5938	Special Fund for Agro-scientific Research in the Public Interest [201303022]; Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, IRTG Sustainable Resource Use in North China) [DFG GRK 1070]	Special Fund for Agro-scientific Research in the Public Interest; Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, IRTG Sustainable Resource Use in North China)(German Research Foundation (DFG))	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022) and the Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, DFG GRK 1070, IRTG Sustainable Resource Use in North China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett TH, 1991, WEED SCI, V41, P218; Bhushan B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/48/485004; Blackshaw RE, 2006, WEED BIOL MANAG, V6, P10, DOI 10.1111/j.1445-6664.2006.00190.x; Bollman J., 2007, P 2007 WISC FERT AGL, P216; Bukun B, 2010, WEED SCI, V58, P96, DOI 10.1614/WS-09-086.1; Bunting JA, 2004, WEED SCI, V52, P513, DOI 10.1614/WS-03-135R; CAPE JN, 1983, NEW PHYTOL, V93, P293, DOI 10.1111/j.1469-8137.1983.tb03432.x; Dodds DM, 2007, WEED SCI, V55, P406, DOI 10.1614/WS-06-147.1; Enloe SF, 1999, WEED SCI, V47, P136, DOI 10.1017/S0043174500091530; GAUVRIT C, 1993, PESTIC SCI, V37, P147, DOI 10.1002/ps.2780370207; Gitsopoulos TK, 2010, CROP PROT, V29, P1091, DOI 10.1016/j.cropro.2010.06.020; Green JM, 2000, WEED TECHNOL, V14, P819, DOI 10.1614/0890-037X(2000)014[0819:ATDIAP]2.0.CO;2; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; HART SE, 1992, WEED TECHNOL, V6, P592, DOI 10.1017/S0890037X00035855; HESS FD, 1990, WEED SCI, V38, P280, DOI 10.1017/S004317450005654X; KIRKWOOD RC, 1993, PESTIC SCI, V38, P93, DOI 10.1002/ps.2780380205; Li YB, 2011, ANAL BIOANAL CHEM, V400, P3097, DOI 10.1007/s00216-011-4967-6; Miller P, 1996, B COLORADO STATE U C; Penner D, 2000, WEED TECHNOL, V14, P785, DOI 10.1614/0890-037X(2000)014[0785:AA]2.0.CO;2; Pester TA, 2001, WEED SCI, V49, P607, DOI 10.1614/0043-1745(2001)049[0607:ATAMOI]2.0.CO;2; Porter RM, 2005, P N CENTR WEED SCI S, P60; R Development Core Team, 2011, R LANG ENV STAT COMP; Ransom CV, 2005, MALHEUR EXPT STATION, P27; Rasmussen J, 2008, WEED RES, V48, P523, DOI 10.1111/j.1365-3180.2008.00661.x; Rasmussen J, 2009, WEED SCI, V57, P338, DOI 10.1614/WS-08-109.1; Ritz C, 2006, WEED SCI, V54, P407, DOI 10.1614/WS-05-185R.1; Sanyal D, 2006, WEED SCI, V54, P16, DOI 10.1614/WS-05-019R.1; Sanyal D, 2006, WEED SCI, V54, P627, DOI 10.1614/WS-05-173R.1; Schonhammer A, 2006, J PLANT DIS PROTECT, P1023; Senesac A, 2007, CROP TALK, V3, P7; Sharma SD, 2000, WEED RES, V40, P523, DOI 10.1046/j.1365-3180.2000.00209.x; Soltani N, 2007, HORTSCIENCE, V42, P110, DOI 10.21273/HORTSCI.42.1.110; Streibig J. C., 1993, Herbicide bioassays., P29; Sun JX, 1998, AM SOC TEST MATER, V1347, P281, DOI 10.1520/STP14171S; Thompson WM, 1996, WEED SCI, V44, P469, DOI 10.1017/S0043174500094200; Xu L, 2010, T ASABE, V53, P13; Xu LY, 2011, PEST MANAG SCI, V67, P842, DOI 10.1002/ps.2122; Young B.G., 2007, N CENTRAL WEED SCI S, V62, P141; Young BG, 1998, WEED SCI, V46, P397, DOI 10.1017/S0043174500090792; Zabkiewicz JA, 2000, WEED RES, V40, P139, DOI 10.1046/j.1365-3180.2000.00172.x; Zhang JW, 2013, CROP PROT, V52, P26, DOI 10.1016/j.cropro.2013.05.001; Zheng L., 2011, AGROCHEMICALS, V50, P597; Zhou X, 2010, PHYTOMEDICINE, V23, P41; Zollinger R, 2006, P N CENT WEED SCI SO, V61, P114	44	9	13	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74280	10.1371/journal.pone.0074280	http://dx.doi.org/10.1371/journal.pone.0074280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086329	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200012
J	Schgoer, W; Theurl, M; Albrecht-Schgoer, K; Jonach, V; Koller, B; Lener, D; Franz, WM; Kirchmair, R				Schgoer, Wilfried; Theurl, Markus; Albrecht-Schgoer, Karin; Jonach, Verena; Koller, Bernhard; Lener, Daniela; Franz, Wolfgang M.; Kirchmair, Rudolf			Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLLATERAL VESSEL DEVELOPMENT; DOUBLE-BLIND; MELLITUS; ANGIOGENESIS; PLACEBO; NEUROPEPTIDE; EXPRESSION; PATHWAY; VECTOR	Deficient angiogenesis after ischemia may contribute to worse outcome of peripheral arterial disease in patients with diabetes mellitus. Based on our previous work where we demonstrated that Secretoneurin (SN) is up-regulated under hypoxic conditions and enhances angiogenesis, we analyzed the therapeutic potential of SN gene therapy using a model of severe hind limb ischemia in streptozotocin-induced diabetic mice (STZ-DM). After induction of hind limb ischemia, blood flow was assessed by means of laser Doppler perfusion imaging (LDPI) and increased blood perfusion in the SN-treated animal group was observed. These results were complemented by the clinical observation of reduced necrosis and by an increased number of capillaries and arterioles in the SN-treated animal group. In vitro, we found that SN is capable of promoting proliferation and chemotaxis and reduces apoptosis in HUVECs cultured under hyperglycemic conditions. Additionally, SN activated ERK, eNOS and especially AKT as well as EGF-receptor in hyperglycemic HUVECs. In conclusion, we show that SN gene therapy improves post-ischemic neovascularization in diabetic mice through stimulation of angiogenesis and arteriogenesis indicating a possible therapeutic role of this factor in ischemia-related diseases in diabetic patients.	[Schgoer, Wilfried; Theurl, Markus; Albrecht-Schgoer, Karin; Jonach, Verena; Koller, Bernhard; Lener, Daniela; Franz, Wolfgang M.; Kirchmair, Rudolf] Med Univ Innsbruck, Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Kirchmair, R (corresponding author), Med Univ Innsbruck, Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria.	Rudolf.Kirchmair@i-med.ac.at	Albrecht-Schgoer, Karin/AAG-4463-2020	Albrecht-Schgoer, Karin/0000-0001-8551-4067; Theurl, Markus/0000-0002-3609-9730	Austrian Science Fund [P-21021-B05]	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund grant P-21021-B05 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahari A, 1999, EUR J VASC ENDOVASC, V18, P122, DOI 10.1053/ejvs.1999.0852; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Brem Harold, 2003, Surg Technol Int, V11, P85; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Federman DG, 2004, GERIATRICS-US, V59, P26; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Katare R, 2013, CARDIOVASC RES, V97, P55, DOI 10.1093/cvr/cvs291; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Rajagopalan S, 2002, AM J CARDIOL, V90, P512, DOI 10.1016/S0002-9149(02)02524-9; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Roguin A, 2003, P NATL ACAD SCI USA, V100, P4644, DOI 10.1073/pnas.0330833100; Roguin A, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-18; Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74029	10.1371/journal.pone.0074029	http://dx.doi.org/10.1371/journal.pone.0074029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086307	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200018
J	Zhang, Y; Wang, L; Sun, Y; Liang, GP; Wu, D; Lv, SJ; Wu, W; Peng, X				Zhang Yong; Wang Lin; Sun Yong; Liang Guang-ping; Wu Dan; Lv Shang-jun; Wu Wei; Peng Xi			Kinetic Characterization of an Intestinal Trefoil Factor Receptor	PLOS ONE			English	Article							FACTOR FAMILY-PEPTIDES; EPITHELIAL-CELLS; BINDING	Objective: To determine whether intestinal epithelial cells have a receptor for intestinal trefoil factor and characterize receptor-ligand binding kinetics. Methods: Radioligand binding assays were performed to characterize the binding kinetics between [I-125]-labeled ITF and IEC-6, HT-29, Caco2 and HaCaT cells. The K-d, B-max and other kinetic variables describing the interaction between ITF and its potential receptors were determined. Results: Radioligand binding assays performed at 4 degrees C showed that the K-d value for the association between [I-125]-ITF and IEC-6, HT-29, and Caco2 cells were 1.99 +/- 0.12x10(-9) M, 3.89 +/- 0.42x10(-9) M, and 2.04 +/- 0.17x10(-9) M, respectively. B-max values were 1.17 +/- 0.04x10(11), 3.97 +/- 0.29x10(11), and 2.03 +/- 0.08x10(11) sites/cell, respectively. The K-i values for the interaction between IEC-6, HT-29, and Caco2 cells and non-labeled ITF were 20.98 +/- 0.57 nM, 36.87 +/- 3.35 nM, and 21.38 +/- 0.93 nM, respectively, and the IC50 values were 25.21 +/- 0.39 nM, 40.68 +/- 0.27 nM, and 23.61 +/- 0.25 nM, respectively. Radioligand binding kinetic results showed the association rate constants (k(+1)) for IEC-6, HT-29, and Caco2 cells were 0.22 +/- 0.04 min(-1), 0.29 +/- 0.04 min(-1), and 0.26 +/- 0.05 min(-1), respectively, and the dissociation rate constants (k(-1)) were 0.06 +/- 0.02 min(-1), 0.03 +/- 0.01 min(-1), and 0.04 +/- 0.01 min(-1), respectively. For the HaCaT cells, the K-d was 4.86 +/- 0.28x10(-8) M and B-max was 5.81 +/- 0.15x10(8) sites/cell, the very low specific binding between [I-125]-ITF and these cells made it impossible to calculate binding kinetic parameters. Conclusions: An ITF-specific receptor appears to be present on the three types of intestinal epithelial cells (IEC-6, HT-29, and Caco-2), and there may be no ITF receptor on epidermal cells.	[Zhang Yong; Wang Lin; Sun Yong; Liang Guang-ping; Wu Dan; Lv Shang-jun; Wu Wei; Peng Xi] Third Mil Med Univ, Southwest Hosp, Inst Burns PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Peng, X (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burns PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	pxlrmm@tmmu.edu.cn	wang, lina/HGC-1592-2022; wang, lin/HHM-2225-2022		National Natural Science Foundation of China [30971075]; State Key Laboratory of independent subject [SKLZZ200807]; Project of National Great New Drug Research and Development [2009ZX09103-647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of independent subject; Project of National Great New Drug Research and Development	This work was supported by the National Natural Science Foundation of China (Grant No. 30971075), the State Key Laboratory of independent subject (No. SKLZZ200807), and Project of National Great New Drug Research and Development (No. 2009ZX09103-647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2008, BIOL PHARM BULL, V31, P598, DOI 10.1248/bpb.31.598; Borniquel S, 2012, J NUTR, V142, P2135, DOI 10.3945/jn.112.163931; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Hoffmann W, 2007, CURR MED CHEM, V14, P2716, DOI 10.2174/092986707782023226; Barrera GJ, 2012, BOSNIAN J BASIC MED, V12, P256; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Li J, 2011, MOL BIOL REP, V38, P4787, DOI 10.1007/s11033-010-0616-y; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Podosky, 2002, OFFICIAL GAZETTE US, Patent No. 1260; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Sun Y, 2008, PROTEIN PEPTIDE LETT, V15, P255; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; Tomov S, 2005, J BUON, V10, P241; Xi P, 2003, CHINESE J BURNS, V19, P285; Xu LF, 2012, INFLAMMATION, V35, P308, DOI 10.1007/s10753-011-9320-x; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; zum Buschenfelde DM, 2004, PEPTIDES, V25, P873, DOI 10.1016/j.peptides.2003.11.024	21	4	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74669	10.1371/journal.pone.0074669	http://dx.doi.org/10.1371/journal.pone.0074669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086361	gold, Green Submitted, Green Published			2022-12-25	WOS:000326520200037
J	Ban, KC; Peng, ZL; Kozar, RA				Ban, Kechen; Peng, Zhanglong; Kozar, Rosemary A.			Inhibition of ERK1/2 Worsens Intestinal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSES; CELL-DEATH; KINASE; MTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; PATHWAY; IDENTIFICATION	Background: The role of extracellular signal-regulated protein kinase (ERK) in intestinal ischemia/reperfusion (I/R) injury has not been well investigated. The aim of the current study was to examine the effect of inhibition of the ERK pathway in an in vitro and in vivo model of intestinal I/R injury. Methods: ERK1/2 activity was inhibited using the specific inhibitor, U0126, in intestinal epithelial cells under hypoxia/reoxygenation conditions and in mice subjected to 1 hour of intestinal ischemia followed by 6 hours reperfusion. In vitro, cell proliferation was assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, apoptosis by DNA fragmentation, and migration using an in vitro model of intestinal wound healing. Cells were also transfected with a p70S6K plasmid and the effects of overexpression similarly analyzed. In vivo, the effects of U0126 on intestinal cell proliferation and apoptosis, intestinal permeability, lung and intestinal neutrophil infiltration and injury, and plasma cytokine levels were measured. Survival was also assessed after U0126. Activity of p70S6 kinase (p70S6K) was measured by Western blot. Results: In vitro, inhibition of ERK1/2 by U0126 significantly decreased cell proliferation and migration but enhanced cell apoptosis. Overexpression of p70S6K promoted cell proliferation and decreased cell apoptosis. In vivo, U0126 significantly increased cell apoptosis and decreased cell proliferation in the intestine, increased intestinal permeability, intestinal and lung neutrophil infiltration, and injury, as well as systemic pro-inflammatory cytokines, TNF-alpha, IL-6 and IL-1 beta. Mortality was also significantly increased by U0126. Inhibition of ERK1/2 by U0126 also abolished activity of p70S6K both in vitro and in vivo models. Conclusion: Pharmacologic inhibition of ERK1/2 by U0126 worsens intestinal IR injury. The detrimental effects are mediated, at least in part, by inhibition of p70S6K, the major effector of mammalian target of rapamycin pathway.	[Ban, Kechen; Peng, Zhanglong; Kozar, Rosemary A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Ban, KC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA.	Kechen.Ban@uth.tmc.edu			National Institutes of Health [R01 GM077282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM077282. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Ban KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041584; Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Deng ZH, 2012, J TRAUMA ACUTE CARE, V72, P143, DOI 10.1097/TA.0b013e3182222f67; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Gorelik G, 2010, AUTOIMMUNITY, V43, P17, DOI 10.3109/08916930903374832; Grishin A, 2004, SURGERY, V136, P329, DOI 10.1016/j.surg.2004.05.008; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Jeong S, 2012, J NEUROSURG ANESTH, V24, P51, DOI 10.1097/ANA.0b013e3182368d70; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Marampon F, 2011, MOL CANCER THER, V10, P159, DOI 10.1158/1535-7163.MCT-10-0631; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rocker GM, 1997, THORAX, V52, P841, DOI 10.1136/thx.52.10.841; Rocourt DV, 2007, J SURG RES, V139, P269, DOI 10.1016/j.jss.2006.10.047; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato N, 2006, AM J PHYSIOL-GASTR L, V290, pG616, DOI 10.1152/ajpgi.00248.2005; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Wang H, 2012, BIOSCI TRENDS, V6, P325, DOI 10.5582/bst.2012.v6.6.325; Wattanasirichaigoon S, 1999, SHOCK, V11, P269, DOI 10.1097/00024382-199904000-00008; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yang RK, 2005, INTENS CARE MED, V31, P709, DOI 10.1007/s00134-005-2601-9; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	39	23	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76790	10.1371/journal.pone.0076790	http://dx.doi.org/10.1371/journal.pone.0076790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073294	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000104
J	Duka, V; Lee, JH; Credle, J; Wills, J; Oaks, A; Smolinsky, C; Shah, K; Mash, DC; Masliah, E; Sidhu, A				Duka, Valeriy; Lee, Jae-Hoon; Credle, Joel; Wills, Jonathan; Oaks, Adam; Smolinsky, Ciaran; Shah, Ketul; Mash, Deborah C.; Masliah, Eliezer; Sidhu, Anita			Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MOUSE MODEL; PHOSPHORYLATION; NEURODEGENERATION; TAUOPATHY; PATHOLOGY; PATHWAYS; BRAIN	Objective: Most neurodegenerative diseases contain hyperphosphorylated Tau [p-Tau]. We examined for the first time epitopes at which Tau is hyperphosphorylated in Parkinson's disease, dementia with Lewy bodies and Alzheimer's disease, and also select Tau kinases. Methods: Postmortem frontal cortex from Parkinson's disease, dementia with Lewy bodies, Alzheimer's disease and striata from Parkinson's disease, were analyzed by immunoblots using commercially available antibodies against 20 different phospho-epitopes of Tau. Major Tau kinases were also screened. Results in diseased tissues were compared to nondiseased controls. Results: In Alzheimer's disease, Tau was hyperphosphorylated at all the 20 epitopes of p-Tau. In dementia with Lewy bodies, p-Tau formation occurred at 6 sites sharing 30% overlap with Alzheimer's disease, while in Parkinson's frontal cortex, an area which does not degenerate, Tau hyperphosphorylation was seen at just 3 epitopes, indicating 15% overlap with Alzheimer's disease. In Parkinson's disease striatum, an area which undergoes considerable neurodegeneration, Tau was hyperphosphorylated at 10 epitopes, sharing 50% overlap with Alzheimer's disease. Between frontal cortex of Parkinson's disease and dementia with Lewy bodies, there were only two p-Tau epitopes in common. In striata of Parkinson's disease, there were 3 clusters of Tau hyperphosphorylated at 3 contiguous sites, while two such clusters were detected in dementia with Lewy bodies; such clusters disrupt axonal transport of mitochondria, cause microtubule remodeling and result in cell death. p-GSK-3 beta, a major Tau kinase, was activated in all brain regions examined, except in dementia with Lewy bodies. Activation of other Tau kinases was seen in all brain regions, with no clear pattern of activation. Interpretation: Our studies suggest that the three neurodegenerative diseases each have a signature-specific profile of p-Tau formation which may be useful in understanding the genesis of the diseases and for the development of a panel of specific biomarkers.	[Duka, Valeriy; Lee, Jae-Hoon; Credle, Joel; Wills, Jonathan; Oaks, Adam; Smolinsky, Ciaran; Shah, Ketul; Sidhu, Anita] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol & Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Georgetown University; University of Miami; University of California System; University of California San Diego	Sidhu, A (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	sidhua@georgetown.edu		Lipton, Stuart/0000-0002-3490-1259	National Institutes of Health [R01AGO28108]; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institutes of Health R01AGO28108 [AS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Ando K, 2011, J BIOL CHEM, V286, P7619, DOI 10.1074/jbc.M110.158477; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Echeverria V, 2004, NEUROSCIENCE, V129, P583, DOI 10.1016/j.neuroscience.2004.07.036; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Gilley J, 2011, BIOCHEM SOC T, V39, P933, DOI 10.1042/BST0390933; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; HAGGERTY T, 2011, EUR J NEUROSCI, P1; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kaul T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-79; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Lippens G, 2012, BIOCHEM SOC T, V40, P698, DOI 10.1042/BST20120050; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Papapetropoulos S, 2005, ACTA NEUROL SCAND, V111, P353, DOI 10.1111/j.1600-0404.2005.00411.x; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	37	67	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75025	10.1371/journal.pone.0075025	http://dx.doi.org/10.1371/journal.pone.0075025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073234	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000043
J	Xiong, CH; Wang, DM; Wang, Q; Benton, MJ; Xue, JZ; Meng, MC; Zhao, Q; Zhang, J				Xiong, Conghui; Wang, Deming; Wang, Qi; Benton, Michael J.; Xue, Jinzhuang; Meng, Meicen; Zhao, Qi; Zhang, Jing			Diversity Dynamics of Silurian-Early Carboniferous Land Plants in South China	PLOS ONE			English	Article							FAMENNIAN MASS EXTINCTION; EARLY EVOLUTION; BIODIVERSITY; ARTHROPOD; EVENTS	New megafossil and microfossil data indicate four episodes in the diversification of Silurian-Early Carboniferous land plants of South China, a relatively continuous regional record. Plant diversity increased throughout, but the rising curve was punctuated by three major falls. There were peaks of origination in the Ludlow-Pragian, Givetian, late Famennian and Visean and peaks of extinction in the Pragian-Emsian, Givetian and early Tournaisian. Speciation and extinction rates were highest in the Lochkovian-Pragian and became progressively lower in subsequent stages. High correlation coefficients indicate that these events are associated with the availability of land habitat contingent on eustatic variations and increasing numbers of cosmopolitan genera. Meanwhile, proportions of endemic genera declined gradually. Due to less endemism and more migrations, both speciation and species extinction rates reduced. The changes of diversity and the timing of the three extinctions of land plants in South China are similar to those known already from Laurussia. However, the largest events in the Lochkovian-Pragian and subsequent smaller ones have not been seen in the global pattern of plant evolution. These land plant events do not correspond well temporally with those affecting land vertebrates or marine invertebrates. In South China, the diversity curve of land plants is generally opposite to that of marine faunas, showing a strong effect of eustatic variations. The increasing diversity of both land vertebrates and plants was punctuated above the Devonian-Carboniferous boundary, known as Romer's Gap, implying common underlying constraints on macroevolution of land animals and plants.	[Xiong, Conghui; Wang, Deming; Xue, Jinzhuang; Meng, Meicen] Peking Univ, Dept Geol, Minist Educ, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China; [Wang, Qi; Zhang, Jing] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Benton, Michael J.; Zhao, Qi] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Zhao, Qi] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Botany, CAS; University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, DM (corresponding author), Peking Univ, Dept Geol, Minist Educ, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China.	dmwang@pku.edu.cn; happyking@ibcas.ac.cn	Xue, Jinzhuang/D-3331-2009; Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Xue, Jinzhuang/0000-0003-4397-4641	National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [40830211, 41172007, 40972015]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123106]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	This study is supported by the National Basic Research Program of China (973 Program, Grant no. 2012CB821900), the National Natural Science Foundation of China (Grant nos. 40830211, 41172007, 40972015), and State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123106) to DW and QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton MJ, 2011, GEOL SOC SPEC PUBL, V358, P63, DOI 10.1144/SP358.6; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BENTON MJ, 1993, FOSS REC, V2, P845; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bond D, 2004, GEOL MAG, V141, P173, DOI 10.1017/S0016756804008866; Cascales-Minana B, 2013, EARTH SCI R IN PRESS, DOI [10.1016/j.earscirev.2013.05.013, DOI 10.1016/J.EARSCIREV.2013.05.013)]; Cascales-Minana B, 2012, LETHAIA, V45, P71, DOI 10.1111/j.1502-3931.2011.00262.x; Chen DZ, 2003, PALAEOGEOGR PALAEOCL, V193, P87, DOI 10.1016/S0031-0182(02)00716-2; Coates Michael I., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P373; COPPER P, 1986, GEOLOGY, V14, P835, DOI 10.1130/0091-7613(1986)14<835:FMEACO>2.0.CO;2; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gutak JM, 2011, PALAEOGEOGR PALAEOCL, V299, P240, DOI 10.1016/j.palaeo.2010.11.005; Hao S.-G., 2013, EARLY DEVONIAN POSON, P366; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; JOACHIMSKI MM, 1993, GEOLOGY, V21, P675, DOI 10.1130/0091-7613(1993)021<0675:AEITLF>2.3.CO;2; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Ma XP, 2002, PALAEOGEOGR PALAEOCL, V181, P325, DOI 10.1016/S0031-0182(01)00484-9; Ma XPP, 2009, GEOL SOC SPEC PUBL, V314, P241, DOI 10.1144/SP314.13; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Niklas K.J., 1997, EVOLUTIONARY BIOL PL, P449; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; RAYMOND A, 1985, PALEOBIOLOGY, V11, P293, DOI 10.1017/S009483730001160X; RAYMOND A, 1995, PALEOBIOLOGY, V21, P74, DOI 10.1017/S0094837300013087; Rees PM, 2002, GEOLOGY, V30, P827; Rong JY, 2007, GEOL J, V42, P431, DOI 10.1002/gj.1073; Ruban Dmitry A., 2008, Geologos, V14, P37; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; Sandberg CA, 2002, GEOL SOC AM SPEC PAP, V356, P473; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Simon L, 2007, CHEM GEOL, V246, P19, DOI 10.1016/j.chemgeo.2007.08.014; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; Tiffney, 1985, GEOLOGICAL FACTORS E, P169; WANG Y, 1984, GEOL SOC AM BULL, V95, P265; Wang Y, 2007, GEOL J, V42, P339, DOI 10.1002/gj.1082; Wang Y, 2010, SCI CHINA EARTH SCI, V53, P1828, DOI 10.1007/s11430-010-4079-8; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Xiong CH, 2011, PALEOBIOLOGY, V37, P157, DOI 10.1666/09029.1	42	19	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75706	10.1371/journal.pone.0075706	http://dx.doi.org/10.1371/journal.pone.0075706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073276	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000086
J	Fradet, A; Sorel, H; Depalle, B; Serre, CM; Farlay, D; Turtoi, A; Bellahcene, A; Follet, H; Castronovo, V; Clezardin, P; Bonnelye, E				Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Turtoi, Andrei; Bellahcene, Akeila; Follet, Helene; Castronovo, Vincent; Clezardin, Philippe; Bonnelye, Edith			A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer	PLOS ONE			English	Article							CARCINOMA CELL-LINE; BONE METASTASIS; OSTEOBLAST DIFFERENTIATION; ENDOTHELIN AXIS; BREAST-CANCER; ERR-ALPHA; IN-VITRO; ESTABLISHMENT; EXPRESSION; SIALOPROTEIN	Background: Up to 80% of patients dying from prostate carcinoma have developed bone metastases that are incurable. Castration is commonly used to treat prostate cancer. Although the disease initially responds to androgen blockade strategies, it often becomes castration-resistant (CRPC for Castration Resistant Prostate Cancer). Most of the murine models of mixed lesions derived from prostate cancer cells are androgen sensitive. Thus, we established a new model of CRPC (androgen receptor (AR) negative) that causes mixed lesions in bone. Methods: PC3 and its derived new cell clone PC3c cells were directly injected into the tibiae of SCID male mice. Tumor growth was analyzed by radiography and histology. Direct effects of conditioned medium of both cell lines were tested on osteoclasts, osteoblasts and osteocytes. Results: We found that PC3c cells induced mixed lesions 10 weeks after intratibial injection. In vitro, PC3c conditioned medium was able to stimulate tartrate resistant acid phosphatase (TRAP)-positive osteoclasts. Osteoprotegerin (OPG) and endothelin-1 (ET1) were highly expressed by PC3c while dikkopf-1 (DKK1) expression was decreased. Finally, PC3c highly expressed bone associated markers osteopontin (OPN), Runx2, alkaline phosphatase (ALP), bone sialoprotein (BSP) and produced mineralized matrix in vitro in osteogenic conditions. Conclusions: We have established a new CRPC cell line as a useful system for modeling human metastatic prostate cancer which presents the mixed phenotype of bone metastases that is commonly observed in prostate cancer patients with advanced disease. This model will help to understand androgen-independent mechanisms involved in the progression of prostate cancer in bone and provides a preclinical model for testing the effects of new treatments for bone metastases.	[Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Follet, Helene; Clezardin, Philippe; Bonnelye, Edith] INSERM, U1033, F-69008 Lyon, France; [Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Follet, Helene; Clezardin, Philippe; Bonnelye, Edith] Univ Lyon, Lyon, France; [Turtoi, Andrei; Bellahcene, Akeila; Castronovo, Vincent] Univ Liege, Metastasis Res Lab, GIGA CANC, Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege	Bonnelye, E (corresponding author), INSERM, U1033, F-69008 Lyon, France.	edith.bonnelye@inserm.fr	Bonnelye, Edith/AAT-9134-2021; Follet, Hélène/E-5536-2010; Clezardin, Philippe/M-8071-2014; FARLAY, Delphine/AGF-1234-2022; Depalle, Baptiste/J-6068-2019; Turtoi, Andrei/ABD-1271-2021	Follet, Hélène/0000-0002-3290-2899; Clezardin, Philippe/0000-0003-0149-4463; FARLAY, Delphine/0000-0001-6487-0337; Depalle, Baptiste/0000-0002-5789-0636; Turtoi, Andrei/0000-0003-3813-6635	CNRS; Inserm; University of Lyon; "Ligue Regionale contre le Cancer" (Isere); "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)"; Ligue Nationale contre le Cancer; Region Rhone Alpes "Cible" program	CNRS(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Lyon; "Ligue Regionale contre le Cancer" (Isere); "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)"; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Region Rhone Alpes "Cible" program(Region Auvergne-Rhone-Alpes)	This work was supported by the CNRS (Edith Bonnelye), Inserm, the University of Lyon, "Ligue Regionale contre le Cancer" (Isere) (EB) http://www.ligue-cancer.net/ and "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)" (Edith Bonnelye) http://www.artp.org/. Anais Fradet is supported by the Ligue Nationale contre le Cancer, http://www.ligue-cancer.net/ Baptiste Depalle by a grant from the Region Rhone Alpes "Cible" program and Akeila Bellahcene is a Senior Research Associate from the National Fund for Scientific Research, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; Chauchereau A, 2011, EXP CELL RES, V317, P262, DOI 10.1016/j.yexcr.2010.10.012; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Coleman R, 2012, JNCI-J NATL CANCER I, V104, P1059, DOI 10.1093/jnci/djs263; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Flajollet S, 2011, MOL CANCER RES, V9, P914, DOI 10.1158/1541-7786.MCR-10-0537; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Harris S. E., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P313; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Jimeno A, 2004, EXPERT OPIN INV DRUG, V13, P1631, DOI 10.1517/13543784.13.12.1631; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kamiya N, 2011, INT J CLIN ONCOL, V16, P366, DOI 10.1007/s10147-011-0193-7; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Korenchuk S, 2001, IN VIVO, V15, P163; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Navone NM, 1997, CLIN CANCER RES, V3, P2493; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Theriault RL, 2012, CANCER CONTROL, V19, P92, DOI 10.1177/107327481201900203; Tian TV, 2013, ONCOGENE, DOI [10.1038/onc.2013.176, DOI 10.1038/0NC.2013.176.PUBMED:23708657]; Vela I, 2007, BJU INT, V99, P735, DOI 10.1111/j.1464-410X.2006.06670.x; von Schroeder HP, 2003, BONE, V33, P673, DOI 10.1016/S8756-3282(03)00215-1; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	39	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75092	10.1371/journal.pone.0075092	http://dx.doi.org/10.1371/journal.pone.0075092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069383	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000324777300064
J	Gubert, P; Aguiar, GC; Mourao, T; Bridi, JC; Barros, AG; Soares, FA; Romano-Silva, MA				Gubert, Priscila; Aguiar, Gabriel Costa; Mourao, Tacito; Bridi, Jessika Cristina; Barros, Alexandre Guimaraes; Soares, Felix Alexandre; Romano-Silva, Marco Aurelio			Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							SEROTONIN; FAT; DAF-16; DOPAMINE; SCHIZOPHRENIA; MECHANISMS; OCTOPAMINE; LONGEVITY; NEURONS; PATHWAY	Atypical antipsychotics are associated with metabolic syndrome, primarily associated with weight gain. The effects of Ziprasidone, an atypical antipsychotic, on metabolic syndrome has yet to be evaluated. Here in, we evaluated lipid accumulation and behavioral changes in a new experimental model, the nematode Caenorhabditis elegans (C. elegans). Behavioral parameters in the worms were evaluated 24 h after Ziprasidone treatment. Subsequently, lipid accumulation was examined using Nile red, LipidTox green and BODIPY labeling. Ziprasidone at 40 mu M for 24 h effectively decreased the fluorescence labeling of all markers in intestinal cells of C. elegans compared to control (0.16% dimethyl sulfoxide). Ziprasidone did not alter behaviors related to energetic balance, such as pharynx pumping, defecation cycles and movement. There was, however, a reduction in egg-production, egg-laying and body-length in nematodes exposed to Ziprasidone without any changes in the progression of larval stages. The serotoninergic pathway did not appear to modulate Ziprasidone's effects on Nile red fluorescence. Additionally, Ziprasidone did not alter lipid accumulation in daf-16 or crh-1 deletion mutants (orthologous of the transcription factors DAF-16 and CREB, respectively). These results suggest that Ziprasidone alters reproductive behavior, morphology and lipid reserves in the intestinal cells of C. elegans. Our results highlight that the DAF-16 and CREB transcription factors are essential for Ziprasidone-induced fat store reduction.	[Bridi, Jessika Cristina; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Dept Saude Mental, Fac Med, Belo Horizonte, MG, Brazil; [Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Gubert, Priscila; Aguiar, Gabriel Costa; Mourao, Tacito; Barros, Alexandre Guimaraes; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, INCT Med Mol, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Minas Gerais	Romano-Silva, MA (corresponding author), Univ Fed Minas Gerais, Dept Saude Mental, Fac Med, Belo Horizonte, MG, Brazil.	romanosilva@gmail.com	Soares, Félix/AAE-6251-2020; Gubert, Priscila/ABC-1059-2020; Romano-Silva, Marco Aurelio/A-1790-2008; Romano-Silva, Marco Aurelio/T-8321-2019; Soares, Félix AA/K-7611-2012	Soares, Félix/0000-0002-6453-7902; Gubert, Priscila/0000-0002-3598-8050; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Soares, Félix AA/0000-0002-6453-7902; Bridi, Jessika/0000-0002-7692-9866	INCT; CAPES; CNPQ (The National Council for Scientific and Technological Development); FAPEMIG	INCT; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by INCT, CAPES, CNPQ (The National Council for Scientific and Technological Development), and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitlhadj L, 2011, ENVIRON HEALTH PERSP, V119, P20, DOI 10.1289/ehp.1002522; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BRENNER S, 1974, GENETICS, V77, P71; Donohoe DR, 2006, PHARMACOL RES, V54, P361, DOI 10.1016/j.phrs.2006.07.002; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Karmacharya R, 2009, NEUROPSYCHOPHARMACOL, V34, P1968, DOI 10.1038/npp.2009.35; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mamo D, 2004, AM J PSYCHIAT, V161, P818, DOI 10.1176/appi.ajp.161.5.818; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stimmel GL, 2002, CLIN THER, V24, P21, DOI 10.1016/S0149-2918(02)85003-2; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang PW, 2011, J PSYCHIATR RES, V45, P1128, DOI 10.1016/j.jpsychires.2011.01.019; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002	36	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74780	10.1371/journal.pone.0074780	http://dx.doi.org/10.1371/journal.pone.0074780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069346	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300044
J	Lin, TW; Wu, JW; Chang, DTH				Lin, Tzu-Wen; Wu, Jian-Wei; Chang, Darby Tien-Hao			Combining Phylogenetic Profiling-Based and Machine Learning-Based Techniques to Predict Functional Related Proteins	PLOS ONE			English	Article							FUSION EVENTS; SEQUENCES; LINKAGES; GENOMES; INFORMATION; DATABASE; SYSTEMS	Annotating protein functions and linking proteins with similar functions are important in systems biology. The rapid growth rate of newly sequenced genomes calls for the development of computational methods to help experimental techniques. Phylogenetic profiling (PP) is a method that exploits the evolutionary co-occurrence pattern to identify functional related proteins. However, PP-based methods delivered satisfactory performance only on prokaryotes but not on eukaryotes. This study proposed a two-stage framework to predict protein functional linkages, which successfully enhances a PP-based method with machine learning. The experimental results show that the proposed two-stage framework achieved the best overall performance in comparison with three PP-based methods.	[Lin, Tzu-Wen; Wu, Jian-Wei; Chang, Darby Tien-Hao] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Cheng Kung University	Chang, DTH (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	darby@mail.ncku.edu.tw	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Science Council of the Republic of China, Taiwan [NSC 101-2221-E-006-264-]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for financially supporting this research under Contract No. NSC 101-2221-E-006-264-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artin E, 1964, GAMMA FUNCTION; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Oyang YJ, 2005, IEEE T NEURAL NETWOR, V16, P225, DOI 10.1109/TNN.2004.836229; Pellegrini M, 2003, GOOGLE PATENTS; Ruano-Rubio V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-383; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Strong M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r59; Sun JC, 2005, BIOINFORMATICS, V21, P3409, DOI 10.1093/bioinformatics/bti532; Vapnik V., 1998, STAT LEARNING THEORY; Witten IH, 2005, DATA MINING PRACTICA, Vxxxi; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Yu CY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-167	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75940	10.1371/journal.pone.0075940	http://dx.doi.org/10.1371/journal.pone.0075940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069454	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300101
J	Monz, D; Tutdibi, E; Mildau, C; Shen, J; Kasoha, M; Laschke, MW; Roolfs, T; Schmiedl, A; Tschernig, T; Bieback, K; Gortner, L				Monz, Dominik; Tutdibi, Erol; Mildau, Celine; Shen, Jie; Kasoha, Mariz; Laschke, Matthias W.; Roolfs, Torge; Schmiedl, Andreas; Tschernig, Thomas; Bieback, Karen; Gortner, Ludwig			Human Umbilical Cord Blood Mononuclear Cells in a Double-Hit Model of Bronchopulmonary Dysplasia in Neonatal Mice	PLOS ONE			English	Article							INDUCED LUNG INJURY; MESENCHYMAL STEM-CELLS; REAL-TIME PCR; MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MTOR; PREVENTION; THERAPY; HYPOXIA; INFANTS	Background: Bronchopulmonary dysplasia (BPD) presents a major threat of very preterm birth and treatment options are still limited. Stem cells from different sources have been used successfully in experimental BPD, induced by postnatal hyperoxia. Objectives: We investigated the effect of umbilical cord blood mononuclear cells (MNCs) in a new double-hit mouse model of BPD. Methods: For the double-hit, date mated mice were subjected to hypoxia and thereafter the offspring was exposed to hyperoxia. Human umbilical cord blood MNCs were given intraperitoneally by day P7. As outcome variables were defined: physical development (auxology), lung structure (histomorphometry), expression of markers for lung maturation and inflammation on mRNA and protein level. Pre- and postnatal normoxic pups and sham treated double-hit pups served as control groups. Results: Compared to normoxic controls, sham treated double-hit animals showed impaired physical and lung development with reduced alveolarization and increased thickness of septa. Electron microscopy revealed reduced volume density of lamellar bodies. Pulmonary expression of mRNA for surfactant proteins B and C, Mtor and Crabp1 was reduced. Expression of Igf1 was increased. Treatment with umbilical cord blood MNCs normalized thickness of septa and mRNA expression of Mtor to levels of normoxic controls. Tgfb3 mRNA expression and pro-inflammatory IL-1 beta protein concentration were decreased. Conclusion: The results of our study demonstrate the therapeutic potential of umbilical cord blood MNCs in a new double-hit model of BPD in newborn mice. We found improved lung structure and effects on molecular level. Further studies are needed to address the role of systemic administration of MNCs in experimental BPD.	[Monz, Dominik; Tutdibi, Erol; Mildau, Celine; Shen, Jie; Kasoha, Mariz; Gortner, Ludwig] Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany; [Shen, Jie] Third Mil Med Univ, Daping Hosp, Dept Pediat, Chongqing, Peoples R China; [Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Saar, Germany; [Roolfs, Torge; Schmiedl, Andreas] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Tschernig, Thomas] Univ Saarland, Inst Anat & Cell Biol, Homburg, Saar, Germany; [Bieback, Karen] Heidelberg Univ, Inst Transfus Med & Immunol, Mannheim, Germany	Saarland University; Army Medical University; Saarland University; Hannover Medical School; Saarland University; Ruprecht Karls University Heidelberg	Gortner, L (corresponding author), Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany.	ludwig.gortner@uks.eu			Sino-German Center for Research Promotion	Sino-German Center for Research Promotion	This work was in part supported by the Sino-German Center for Research Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Baker CD, 2013, THORAX, V68, P402, DOI 10.1136/thoraxjnl-2012-202661; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bry K, 2010, SEMIN PERINATOL, V34, P211, DOI 10.1053/j.semperi.2010.02.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerny L, 2008, LUNG, V186, P75, DOI 10.1007/s00408-007-9069-z; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Deakins KM, 2009, RESP CARE, V54, P1252; Fehrenbach H, 1998, METHODS PULMONARY RE, P429, DOI DOI 10.1007/978-3-0348-8855-4_17; Fielhaber JA, 2012, J IMMUNOL, V188, P4535, DOI 10.4049/jimmunol.1003655; Gauldie J, 2003, AM J PATHOL, V163, P2575, DOI 10.1016/S0002-9440(10)63612-7; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; Gortner L, 2005, BIOL NEONATE, V88, P129, DOI 10.1159/000085895; Gortner L, 2013, ANN ANAT, V195, P351, DOI 10.1016/j.aanat.2013.02.010; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Heimfeld S, 2003, LEUKEMIA, V17, P856, DOI 10.1038/sj.leu.2402893; Hochberg Ze'ev, 2011, Front Endocrinol (Lausanne), V2, P41, DOI 10.3389/fendo.2011.00041; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hwang SK, 2011, BMB REP, V44, P506, DOI 10.5483/BMBRep.2011.44.8.506; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kogler G, 2009, BONE MARROW TRANSPL, V44, P683, DOI 10.1038/bmt.2009.287; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Mayani H, 2003, ARCH MED RES, V34, P476, DOI 10.1016/j.arcmed.2003.08.004; O'Reilly M, 2013, CLIN EXP PHARM PHYSL; Pereira-Cunha FG, 2013, TRANSFUSION, V53, P2034, DOI 10.1111/trf.12078; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Sng J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/521343; Tutdibi E, 2012, J PERINAT MED, V40, P527, DOI 10.1515/jpm-2011-0204; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Van Marter LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF20, DOI 10.1136/adc.2010.183012; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Warburton D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S2; Wright RJ, 2010, BIOL PSYCHOL, V84, P46, DOI 10.1016/j.biopsycho.2010.01.007; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002; Zhang XY, 2012, CELL BIOL INT, V36, P589, DOI 10.1042/CBI20110447	48	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74740	10.1371/journal.pone.0074740	http://dx.doi.org/10.1371/journal.pone.0074740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069341	Green Submitted, gold, Green Published			2022-12-25	WOS:000324777300042
J	Auner, HW; Moody, AM; Ward, TH; Kraus, M; Milan, E; May, P; Chaidos, A; Driessen, C; Cenci, S; Dazzi, F; Rahemtulla, A; Apperley, JF; Karadimitris, A; Dillon, N				Auner, Holger W.; Moody, Anne Marie; Ward, Theresa H.; Kraus, Marianne; Milan, Enrico; May, Philippa; Chaidos, Aristeidis; Driessen, Christoph; Cenci, Simone; Dazzi, Francesco; Rahemtulla, Amin; Apperley, Jane F.; Karadimitris, Anastasios; Dillon, Niall			Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SIGNAL INTEGRATION; MAMMALIAN-CELLS; DEGRADATION; BORTEZOMIB; APOPTOSIS; ATPASE; ER; RETROTRANSLOCATION	Inhibition of the proteasome is a widely used strategy for treating multiple myeloma that takes advantage of the heavy secretory load that multiple myeloma cells (MMCs) have to deal with. Resistance of MMCs to proteasome inhibition has been linked to incomplete disruption of proteasomal endoplasmic-reticulum (ER)-associated degradation (ERAD) and activation of non-proteasomal protein degradation pathways. The ATPase p97 (VCP/Cdc48) has key roles in mediating both ERAD and non-proteasomal protein degradation and can be targeted pharmacologically by small molecule inhibition. In this study, we compared the effects of p97 inhibition with Eeyarestatin 1 and DBeQ on the secretory apparatus of MMCs with the effects induced by the proteasome inhibitor bortezomib, and the effects caused by combined inhibition of p97 and the proteasome. We found that p97 inhibition elicits cellular responses that are different from those induced by proteasome inhibition, and that the responses differ considerably between MMC lines. Moreover, we found that dual inhibition of both p97 and the proteasome terminally disrupts ER configuration and intracellular protein metabolism in MMCs. Dual inhibition of p97 and the proteasome induced high levels of apoptosis in all of the MMC lines that we analysed, including bortezomib-adapted AMO-1 cells, and was also effective in killing primary MMCs. Only minor toxicity was observed in untransformed and non-secretory cells. Our observations highlight non-redundant roles of p97 and the proteasome in maintaining secretory homeostasis in MMCs and provide a preclinical conceptual framework for dual targeting of p97 and the proteasome as a potential new therapeutic strategy in multiple myeloma.	[Auner, Holger W.; Moody, Anne Marie; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London, England; [Auner, Holger W.; May, Philippa; Chaidos, Aristeidis; Dazzi, Francesco; Rahemtulla, Amin; Apperley, Jane F.; Karadimitris, Anastasios] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Haematol, London, England; [Ward, Theresa H.] London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1, England; [Kraus, Marianne; Driessen, Christoph] Kantonsspital, St Gallen, Switzerland; [Milan, Enrico; Cenci, Simone] Ist Sci San Raffaele, Div Genet & Cell Biol, Age Related Dis Grp, I-20132 Milan, Italy	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Auner, HW (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London, England.	holger.auner04@imperial.ac.uk; niall.dillon@csc.mrc.ac.uk	Cenci, Simone/J-7700-2016; Ward, Theresa H./E-9650-2013; Dazzi, Francesco/ABD-6171-2021; May, Philippa/G-4496-2010; Milan, Enrico/J-8343-2016; Driessen, C/F-7061-2016; Milan, Enrico/AAH-3354-2021	Cenci, Simone/0000-0003-1215-7518; Ward, Theresa H./0000-0002-9881-8649; Dazzi, Francesco/0000-0003-2407-236X; May, Philippa/0000-0002-9033-4041; Milan, Enrico/0000-0003-3094-4275; Driessen, C/0000-0002-1124-7303; Milan, Enrico/0000-0003-3094-4275; Chaidos, Aristeidis/0000-0003-1453-8576; Auner, Holger/0000-0003-4040-0642	Medical Research Council UK; Cancer Research UK; Leuka (registered UK charity) [286231]; Wellcome Trust/Imperial College London; Cancer Research UK [15448] Funding Source: researchfish; Medical Research Council [G0400373, MC_U120036884] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10275] Funding Source: researchfish; MRC [MC_U120036884, G0400373] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Leuka (registered UK charity); Wellcome Trust/Imperial College London; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in ND's lab was supported by the Medical Research Council UK. Part of this work was funded by a Cancer Research UK Clinician Scientist Fellowship to HWA. HWA was supported by Leuka (registered UK charity no. 286231) and a Wellcome Trust/Imperial College London Value in People Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Aronson LI, 2012, HAEMATOL-HEMATOL J, V97, P1119, DOI 10.3324/haematol.2012.064923; Auner HW, 2010, BLOOD, V116, P3445, DOI 10.1182/blood-2009-10-250423; Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; David E, 2010, BLOOD, V116, P5285, DOI 10.1182/blood-2010-03-272393; Dimopoulos MA, 2011, EUR J HAEMATOL, V86, P1, DOI 10.1111/j.1600-0609.2010.01542.x; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Hideshima T, 2005, ONCOGENE, V24, P3121, DOI 10.1038/sj.onc.1208522; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kirk SJ, 2010, J LEUKOCYTE BIOL, V87, P245, DOI 10.1189/jlb.1208774; Kraus M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.2; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mannava S, 2012, BLOOD, V119, P1450, DOI 10.1182/blood-2011-04-346676; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Morley SJ, 2005, CELL DEATH DIFFER, V12, P571, DOI 10.1038/sj.cdd.4401591; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Steinbrunn T, 2011, BLOOD, V117, P1998, DOI 10.1182/blood-2010-05-284422; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij N, 2011, EXPERT OPIN THER TAR, V15, P233, DOI 10.1517/14728222.2011.553610; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Ward Theresa H., 2007, V390, P281; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516	57	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74415	10.1371/journal.pone.0074415	http://dx.doi.org/10.1371/journal.pone.0074415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069311	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000324547300042
J	Eastwood, SV; Tillin, T; Wright, A; Heasman, J; Willis, J; Godsland, IF; Forouhi, N; Whincup, P; Hughes, AD; Chaturvedi, N				Eastwood, Sophie V.; Tillin, Therese; Wright, Andrew; Heasman, John; Willis, Joseph; Godsland, Ian F.; Forouhi, Nita; Whincup, Peter; Hughes, Alun D.; Chaturvedi, Nishi			Estimation of CT-Derived Abdominal Visceral and Subcutaneous Adipose Tissue Depots from Anthropometry in Europeans, South Asians and African Caribbeans	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; METABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; WHITE ADULTS; MEN; WOMEN; ACCUMULATION; ASSOCIATION; OBESITY	Background: South Asians and African Caribbeans experience more cardiometabolic disease than Europeans. Risk factors include visceral (VAT) and subcutaneous abdominal (SAT) adipose tissue, which vary with ethnicity and are difficult to quantify using anthropometry. Objective: We developed and cross-validated ethnicity and gender-specific equations using anthropometrics to predict VAT and SAT. Design: 669 Europeans, 514 South Asians and 227 African Caribbeans (70 +/- 7 years) underwent anthropometric measurement and abdominal CT scanning. South Asian and African Caribbean participants were first-generation migrants living in London. Prediction equations were derived for CT-measured VAT and SAT using stepwise regression, then cross-validated by comparing actual and predicted means. Results: South Asians had more and African Caribbeans less VAT than Europeans. For basic VAT prediction equations (age and waist circumference), model fit was better in men (R-2 range 0.59-0.71) than women (range 0.35-0.59). Expanded equations (+ weight, height, hip and thigh circumference) improved fit for South Asian and African Caribbean women (R-2 0.35 to 0.55, and 0.43 to 0.56 respectively). For basic SAT equations, R2 was 0.69-0.77, and for expanded equations it was 0.72-0.86. Cross-validation showed differences between actual and estimated VAT of <7%, and SAT of <8% in all groups, apart from VAT in South Asian women which disagreed by 16%. Conclusion: We provide ethnicity-and gender-specific VAT and SAT prediction equations, derived from a large tri-ethnic sample. Model fit was reasonable for SAT and VAT in men, while basic VAT models should be used cautiously in South Asian and African Caribbean women. These equations will aid studies of mechanisms of cardiometabolic disease in later life, where imaging data are not available.	[Eastwood, Sophie V.; Tillin, Therese; Willis, Joseph; Hughes, Alun D.; Chaturvedi, Nishi] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Wright, Andrew; Heasman, John] Imperial Coll Healthcare NHS Trust, Dept Med, London, England; [Godsland, Ian F.] Univ London Imperial Coll Sci Technol & Med, Dept Endocrinol & Metab Med, London, England; [Forouhi, Nita] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Whincup, Peter] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England	Imperial College London; Imperial College London; Imperial College London; University of Cambridge; St Georges University London	Eastwood, SV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	s.eastwood@imperial.ac.uk	Hughes, Alun David/N-3781-2013; Wright, Andrew/HDM-9615-2022	Hughes, Alun David/0000-0001-5432-5271; Tillin, Therese/0000-0003-1590-9826; Whincup, Peter/0000-0002-5589-4107; Forouhi, Nita/0000-0002-5041-248X; Eastwood, Sophie/0000-0002-1883-8771	Medical Research Council; Diabetes UK; British Heart Foundation [SP/07/001/23603]; Wellcome Trust [082464/Z/07/Z]; MRC [MC_UU_12015/5, MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_UU_12015/5, MC_UP_A100_1003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded at baseline by the Medical Research Council (www.mrc.ac.uk), Diabetes UK (www.diabetes.org.uk) and British Heart Foundation (www.bhf.org.uk), and at follow-up by the Wellcome Trust (grant number: 082464/Z/07/Z, www.wellcome.ac.uk) and British Heart Foundation (grant number: SP/07/001/23603). The funders played no role in the study design and conduct or in these analyses or the decision to submit the manuscript for publication. The SABRE study group is entirely independent from the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brundavani V, 2006, EUR J CLIN NUTR, V60, P658, DOI 10.1038/sj.ejcn.1602366; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Conway JM, 1997, AM J CLIN NUTR, V66, P1345, DOI 10.1093/ajcn/66.6.1345; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; DESPRES JP, 1991, AM J CLIN NUTR, V54, P471, DOI 10.1093/ajcn/54.3.471; FERLAND M, 1989, BRIT J NUTR, V61, P139, DOI 10.1079/BJN19890104; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Kekes-Szabo T, 1994, Obes Res, V2, P450; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LARSSON B, 1992, AM J EPIDEMIOL, V135, P266, DOI 10.1093/oxfordjournals.aje.a116280; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; LEMIEUX S, 1994, DIABETOLOGIA, V37, P757, DOI 10.1007/BF00404332; Maislin G, 2012, OBESITY, V20, P2124, DOI 10.1038/oby.2012.53; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Pascot A, 1999, DIABETES CARE, V22, P1471, DOI 10.2337/diacare.22.9.1471; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Springer F, 2012, EUR J RADIOL, V81, P1488, DOI 10.1016/j.ejrad.2011.04.006; Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2013, DIABETES CARE, V36, P383, DOI 10.2337/dc12-0544; Tillin T, 2012, INT J EPIDEMIOL, V41, P33, DOI 10.1093/ije/dyq175; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010	41	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75085	10.1371/journal.pone.0075085	http://dx.doi.org/10.1371/journal.pone.0075085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069381	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300069
J	Eom, JS; Kim, JS; Jang, JI; Kim, BH; Yoo, SY; Choi, JH; Bang, IS; Lee, IS; Park, YK				Eom, Jeong Seon; Kim, Jin Seok; Jang, Jung Im; Kim, Bae-Hoon; Yoo, So Young; Choi, Ji Hyeon; Bang, Iel-Soo; Lee, In Soo; Park, Yong Keun			Enhancement of Host Immune Responses by Oral Vaccination to Salmonella enterica serovar Typhimurium Harboring Both FliC and FljB Flagella	PLOS ONE			English	Article							FACTOR-KAPPA-B; PHASE VARIATION; BACTERIAL FLAGELLIN; GENE-EXPRESSION; IN-VIVO; ACTIVATION; CELLS; INTERLEUKIN-1-BETA; MACROPHAGES; IPAF	Flagellin, the structural component of the flagellar filament in various motile bacteria, can contribute to the activation of NF-kappa B and proinflammatory cytokine expression during the innate immune response in host cells. Thus, flagellin proteins represent a particularly attractive target for the development of vaccine candidates. In this study, we investigated the immune response by increasing the flagella number in the iacP mutant strain and the adjuvant activity of the flagellin component FljB of Salmonella enterica serovar Typhimurium. We found that the iacP mutant strain expresses two flagellin proteins (FliC and FljB), which result in increased NF-kappa B-dependent gene expression in bone marrow derived macrophages. Using an oral immunization mouse model, we observed that the administration of a live attenuated S. typhimurium BRD509 strain expressing the FliC and FljB flagellins induced significantly enhanced flagellin-specific IgG responses in the systemic compartment. The mice immunized with the recombinant attenuated S. typhimurium strain that has two types of flagella were protected from lethal challenge with the Salmonella SL1344 strain. These results indicate that overexpression of flagella in the iacP mutant strain enhance the induction of an antigen-specific immune responses in macrophage cell, and both the FliC and FljB flagellar filament proteins-producing S. typhimurium can induce protective immune responses against salmonellosis.	[Eom, Jeong Seon; Kim, Jin Seok; Jang, Jung Im; Kim, Bae-Hoon; Yoo, So Young; Choi, Ji Hyeon; Park, Yong Keun] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Bang, Iel-Soo] Chosun Univ, Sch Dent, Dept Microbiol & Immunol, Kwangju, South Korea; [Lee, In Soo] Hannam Univ, Dept Biotechnol, Taejon, South Korea	Korea University; Chosun University; Hannam University	Park, YK (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea.	ykpark@korea.ac.kr	Kim, Bae-Hoon/A-8847-2014; Kim, Bae-Hoon/F-3289-2012	Kim, Bae-Hoon/0000-0001-6866-7248	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0012804]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0012804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhaya A, 2008, MICROB PATHOGENESIS, V44, P524, DOI 10.1016/j.micpath.2008.01.004; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; CHATFIELD SN, 1992, BIO-TECHNOL, V10, P888, DOI 10.1038/nbt0892-888; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Dunstan SJ, 1998, INFECT IMMUN, V66, P732, DOI 10.1128/IAI.66.2.732-740.1998; Ehrbar K, 2006, MOL MICROBIOL, V59, P248, DOI 10.1111/j.1365-2958.2005.04931.x; Eom JS, 2012, J BACTERIOL, V194, P4332, DOI 10.1128/JB.00076-12; Foley S L, 2008, J Anim Sci, V86, pE173; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gauley J, 2010, J LEUKOCYTE BIOL, V87, P1115, DOI 10.1189/jlb.0709465; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hur J, 2011, CLIN VACCINE IMMUNOL, V18, P203, DOI 10.1128/CVI.00407-10; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Liang HY, 2010, LETT APPL MICROBIOL, V50, P181, DOI 10.1111/j.1472-765X.2009.02768.x; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moreno M, 2000, J MOL MICROB BIOTECH, V2, P245; Nalbantsoy A, 2010, ANN MICROBIOL, V60, P565, DOI 10.1007/s13213-010-0093-5; Olusesan AG, 2010, AFR J PHARM PHARMACO, V4, P151; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Pietila TE, 2005, J LEUKOCYTE BIOL, V78, P909, DOI 10.1189/jlb.1204721; Rosu V, 2006, J BACTERIOL, V188, P4497, DOI 10.1128/JB.01552-05; Scharf B, 2002, J BACTERIOL, V184, P5979, DOI 10.1128/JB.184.21.5979-5986.2002; Simon R, 2008, J INTERF CYTOK RES, V28, P661, DOI 10.1089/jir.2008.0022; Simon R, 2007, BIOCHEM BIOPH RES CO, V355, P280, DOI 10.1016/j.bbrc.2007.01.148; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Uchiya K, 2008, MICROBIOL-SGM, V154, P3491, DOI 10.1099/mic.0.2008/021667-0; Wang SW, 2002, BIOCHEM J, V367, P729, DOI 10.1042/BJ20020752; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046828; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194	40	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74850	10.1371/journal.pone.0074850	http://dx.doi.org/10.1371/journal.pone.0074850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069357	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300061
J	Pace, E; Zhang, JS				Pace, Edward; Zhang, Jinsheng			Noise-Induced Tinnitus Using Individualized Gap Detection Analysis and Its Relationship with Hyperacusis, Anxiety, and Spatial Cognition	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; INDUCED HEARING-LOSS; NEURAL ACTIVITY; PSYCHIATRIC-DISORDERS; BEHAVIORAL PARADIGM; SLEEP COMPLAINTS; AUDITORY-CORTEX; C57BL/6J MICE; ANIMAL-MODEL; C-FOS	Tinnitus has a complex etiology that involves auditory and non-auditory factors and may be accompanied by hyperacusis, anxiety and cognitive changes. Thus far, investigations of the interrelationship between tinnitus and auditory and non-auditory impairment have yielded conflicting results. To further address this issue, we noise exposed rats and assessed them for tinnitus using a gap detection behavioral paradigm combined with statistically-driven analysis to diagnose tinnitus in individual rats. We also tested rats for hearing detection, responsivity, and loss using prepulse inhibition and auditory brainstem response, and for spatial cognition and anxiety using Morris water maze and elevated plus maze. We found that our tinnitus diagnosis method reliably separated noise-exposed rats into tinnitus((+)) and tinnitus((-)) groups and detected no evidence of tinnitus in tinnitus((-)) and control rats. In addition, the tinnitus((+)) group demonstrated enhanced startle amplitude, indicating hyperacusis-like behavior. Despite these results, neither tinnitus, hyperacusis nor hearing loss yielded any significant effects on spatial learning and memory or anxiety, though a majority of rats with the highest anxiety levels had tinnitus. These findings showed that we were able to develop a clinically relevant tinnitus((+)) group and that our diagnosis method is sound. At the same time, like clinical studies, we found that tinnitus does not always result in cognitive-emotional dysfunction, although tinnitus may predispose subjects to certain impairment like anxiety. Other behavioral assessments may be needed to further define the relationship between tinnitus and anxiety, cognitive deficits, and other impairments.	[Pace, Edward; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI USA	Wayne State University; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022		Tinnitus Research Consortium; Wayne State University	Tinnitus Research Consortium; Wayne State University	This work was supported by the Tinnitus Research Consortium and the Wayne State University President's Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P F, 1995, Vital Health Stat 10, P1; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson G, 2009, SCAND J PSYCHOL, V50, P517, DOI 10.1111/j.1467-9450.2009.00752.x; Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Blaesing L, 2012, INT J AUDIOL, V51, P611, DOI 10.3109/14992027.2012.664290; BRANDY WT, 1995, AMJ AUDIOL, V4, P5; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Evans KC, 2008, DEPRESS ANXIETY, V25, P496, DOI 10.1002/da.20347; FALKENBERG E, 2012, J OTOLARYNGOL, V2012, P75460; GABR TA, 2011, AURIS NASUS LARYNX; Goble TJ, 2009, HEARING RES, V253, P52, DOI 10.1016/j.heares.2009.03.002; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gopinath B, 2010, ANN EPIDEMIOL, V20, P129, DOI 10.1016/j.annepidem.2009.09.002; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hardoy MC, 2005, SOC PSYCH PSYCH EPID, V40, P24, DOI 10.1007/s00127-005-0837-x; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, 2004, HEARING RES, V190, P1, DOI 10.1016/S0378-5955(04)00021-8; Hebert S, 2007, EAR HEARING, V28, P649; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 2003, JARO-J ASSOC RES OTO, V4, P495, DOI 10.1007/s10162-002-3046-2; JAKES S, 1988, ADV BEHAV RES THER, V10, P53, DOI 10.1016/0146-6402(88)90016-1; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1988, LARYNGOSCOPE, V98, P280; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Kim JU, 2005, LARYNGOSCOPE, V115, P1996, DOI 10.1097/01.mlg.0000180173.81034.4d; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; LOBARINAS E, 2008, ACOUSTIC OVERSTIMULA; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Lyche P, 2011, CLIN NEUROPSYCHOL, V25, P359, DOI 10.1080/13854046.2010.547518; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mahoney CJ, 2011, J NEUROL NEUROSUR PS, V82, P1274, DOI 10.1136/jnnp.2010.235473; MAO J, 2011, JNEUROTRAUMA; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Moon IS, 2011, J OCCUP ENVIRON HYG, V8, P618, DOI 10.1080/15459624.2011.609013; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nobre MJ, 2011, BRAIN RES, V1421, P20, DOI 10.1016/j.brainres.2011.09.013; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Rizzardo R, 1998, J OTOLARYNGOL, V27, P21; Rosow DE, 2013, CASE REP OTOLARYNGOL, V2013, DOI 10.1155/2013/480676; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Salonen J, 2007, GEN HOSP PSYCHIAT, V29, P431, DOI 10.1016/j.genhosppsych.2007.05.002; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shulman, 1995, Int Tinnitus J, V1, P13; SOOD SK, 1998, BRIT J AUDIOL, V22, P1; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Tambs K, 2004, PSYCHOSOM MED, V66, P776, DOI 10.1097/01.psy.0000133328.03596.fb; Test T, 2011, SLEEP, V34, P25, DOI 10.1093/sleep/34.1.25; TURNER J, 2012, J NEUROSCI RES; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Uran SL, 2010, BRAIN RES, V1361, P102, DOI 10.1016/j.brainres.2010.09.022; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P420; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; ZHENG Y, 2011, NEUROSCIENCE; Zoger S, 2001, AUDIOLOGY, V40, P133; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	105	37	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75011	10.1371/journal.pone.0075011	http://dx.doi.org/10.1371/journal.pone.0075011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069375	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100119
J	Ahsberg, J; Ungerback, J; Strid, T; Welinder, E; Stjernberg, J; Larsson, M; Qian, H; Sigvardsson, M				Ahsberg, Josefine; Ungerback, Jonas; Strid, Tobias; Welinder, Eva; Stjernberg, Jenny; Larsson, Malin; Qian, Hong; Sigvardsson, Mikael			Early B-cell Factor 1 Regulates the Expansion of B-cell Progenitors in a Dose-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Differentiation; Immunology; Lymphocyte; Transcription Factors	COMMON LYMPHOID PROGENITORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTORS; FACTOR EBF; FACTOR PAX5; EXPRESSION; E2A; DIFFERENTIATION; GENES; COMMITMENT	Transcription factor doses are of importance for normal and malignant B-lymphocyte development; however, the understanding of underlying mechanisms and functional consequences of reduced transcription factor levels is limited. We have analyzed progenitor and B-lineage compartments in mice carrying heterozygote mutations in the E2a, Ebf1, or Pax5 gene. Although lymphoid progenitors from Ebf1 or Pax5 heterozygote mice were specified and lineage-restricted in a manner comparable with Wt progenitors, this process was severely impaired in E2a heterozygote mutant mice. This defect was not significantly enhanced upon combined deletion of E2a with Ebf1 or Pax5. Analysis of the pre-B-cell compartment in Ebf1 heterozygote mice revealed a reduction in cell numbers. These cells expressed Pax5 and other B-lineage-associated genes, and global gene expression analysis suggested that the reduction of the pre-B-cell compartment was a result of impaired pre-B-cell expansion. This idea was supported by a reduction in IL2R-expressing late pre-B-cells as well as by cell cycle analysis and by the finding that the complexity of the VDJ rearrangement patterns was comparable in Wt and Ebf1(+/-) pre-B-cells, although the number of progenitors was reduced. Heterozygote deletion of Ebf1 resulted in impaired response to IL7 in vitro and reduced expression levels of pre-BCR on the cell surface, providing possible explanations for the observed stage-specific reduction in cellular expansion. Thus, transcription factor doses are critical for specification as well as expansion of B-lymphoid progenitors, providing increased insight into the molecular regulation of B-cell development.	[Ahsberg, Josefine; Ungerback, Jonas; Strid, Tobias; Welinder, Eva; Stjernberg, Jenny; Qian, Hong; Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med,Univ Lab 1, SE-58185 Linkoping, Sweden; [Larsson, Malin] Linkoping Univ, IFM Bioinformat, SE-58185 Linkoping, Sweden; [Qian, Hong] Karolinska Inst Huddinge, Dept Med, Ctr Hematol & Regenerat Med, SE-17177 Stockholm, Sweden	Linkoping University; Linkoping University; Karolinska Institutet	Sigvardsson, M (corresponding author), Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med,Univ Lab 1, Level 13, SE-58185 Linkoping, Sweden.	mikael.sigvardsson@liu.se	Qian, Hong/D-5588-2014	Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Cancer Society; Swedish Research Council; Hemato-Linne; Faculty of Medicine at Linkoping University	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hemato-Linne; Faculty of Medicine at Linkoping University	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council through project grants, and Hemato-Linne and the Faculty of Medicine at Linkoping University.	CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; hsberg J., 2010, J BIOL CHEM, V285, P36275; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Lukin K, 2010, P NATL ACAD SCI USA, V107, P7869, DOI 10.1073/pnas.1003525107; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Sandoval GJ, 2013, J IMMUNOL, V190, P2485, DOI 10.4049/jimmunol.1203208; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Welinder E, 2011, SEMIN IMMUNOL, V23, P335, DOI 10.1016/j.smim.2011.08.005; Welinder E, 2011, P NATL ACAD SCI USA, V108, P17402, DOI 10.1073/pnas.1111766108; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	48	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33449	33461		10.1074/jbc.M113.506261	http://dx.doi.org/10.1074/jbc.M113.506261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078629	Green Published, hybrid			2022-12-25	WOS:000328841700057
J	Acharya, BR; Espenel, C; Kreitzer, G				Acharya, Bipul R.; Espenel, Cedric; Kreitzer, Geri			Direct Regulation of Microtubule Dynamics by KIF17 Motor and Tail Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Epithelial Cell; Kinesin; Microtubules; Protein Domains	MOLECULAR-WEIGHT PROTEINS; KINESIN; TUBULIN; LENGTH; EB1; DEPOLYMERASE; MECHANISM; TRANSPORT; BINDING; MCAK	KIF17 is a kinesin-2 family motor that interacts with EB1 at microtubule (MT) plus-ends and contributes to MT stabilization in epithelial cells. The mechanism by which KIF17 affects MTs and how its activity is regulated are not yet known. Here, we show that EB1 and the KIF17 autoinhibitory tail domain (KIF17-Tail) interacted competitively with the KIF17 catalytic motor domain (K370). Both EB1 and KIF17-Tail decreased the K-0.5MT of K370, with opposing effects on MT-stimulated ATPase activity. Importantly, K370 had independent effects on MT dynamic instability, resulting in formation of long MTs without affecting polymerization rate or total polymer mass. K370 also inhibited MT depolymerization induced by dilution in vitro and by nocodazole in cells, suggesting that it acts by protecting MT plus-ends. Interestingly, KIF17-Tail bound MTs and tubulin dimers, delaying initial MT polymerization in vitro and MT regrowth in cells. However, neither EB1 nor KIF17-Tail affected K370-mediated MT polymerization or stabilization significantly in vitro, and EB1 was dispensable for MT stabilization by K370 in cells. Thus, although EB1 and KIF17-Tail may coordinate KIF17 catalytic activity, our data reveal a novel and direct role for KIF17 in regulating MT dynamics.	[Acharya, Bipul R.; Espenel, Cedric; Kreitzer, Geri] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University	Kreitzer, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10021 USA.	gek2006@med.cornell.edu	ACHARYA, BIPUL/C-9733-2017; Acharya, Bipul/AAW-6685-2020	ACHARYA, BIPUL/0000-0002-2819-0120; Acharya, Bipul/0000-0001-9670-1204; espenel, cedric/0000-0002-8246-2879	National Institutes of Health [R01 GM087575]; Irma T. Hirschl Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM087575 (to G. K.). This work was also supported by the Irma T. Hirschl Trust (to G. K.).	Boehlke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062165; BORISY GG, 1975, ANN NY ACAD SCI, V253, P107, DOI 10.1111/j.1749-6632.1975.tb19196.x; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Daire V, 2011, ARCH BIOCHEM BIOPHYS, V510, P83, DOI 10.1016/j.abb.2011.02.012; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Drummond DR, 2011, SEMIN CELL DEV BIOL, V22, P927, DOI 10.1016/j.semcdb.2011.09.021; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Espenel C., 2013, J CELL BIOL IN PRESS; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Seeger MA, 2010, J BIOL CHEM, V285, P8155, DOI 10.1074/jbc.M109.068247; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2012, TRENDS CELL BIOL, V22, P567, DOI 10.1016/j.tcb.2012.08.003; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; ten Hoopen R, 2012, CURR BIOL, V22, P1075, DOI 10.1016/j.cub.2012.04.059; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; WEISENBERG RC, 1981, BIOCHEM BIOPH RES CO, V102, P924, DOI 10.1016/0006-291X(81)91626-0; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585; Zhu ZQC, 2009, J BIOL CHEM, V284, P32651, DOI 10.1074/jbc.M109.013466	46	14	14	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32302	32313		10.1074/jbc.M113.494989	http://dx.doi.org/10.1074/jbc.M113.494989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072717	Green Published, hybrid			2022-12-25	WOS:000328681700017
J	Schafer, KN; Cisek, K; Huseby, CJ; Chang, E; Kuret, J				Schafer, Kelsey N.; Cisek, Katryna; Huseby, Carol J.; Chang, Edward; Kuret, Jeff			Structural Determinants of Tau Aggregation Inhibitor Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Alzheimer Disease; Chemical biology; Protein Structure; Tau	PAIRED HELICAL FILAMENTS; TAUOPATHIC NEURODEGENERATIVE DISEASES; SMALL-MOLECULE INHIBITORS; E-STATE INDEXES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; IN-VITRO; FRONTOTEMPORAL DEMENTIA; MECHANISTIC BASIS; BINDING-AFFINITY	Small-molecule Tau aggregation inhibitors are under investigation as potential therapeutic agents against Alzheimer disease. Many such inhibitors have been identified in vitro, but their potency-driving features, and their molecular targets in the Tau aggregation pathway, have resisted identification. Previously we proposed ligand polarizability, a measure of electron delocalization, as a candidate descriptor of inhibitor potency. Here we tested this hypothesis by correlating the ground state polarizabilities of cyanine, phenothiazine, and arylmethine derivatives calculated using ab initio quantum methods with inhibitory potency values determined in the presence of octadecyl sulfate inducer under reducing conditions. A series of rhodanine analogs was analyzed as well using potency values disclosed in the literature. Results showed that polarizability and inhibitory potency directly correlated within all four series. To identify putative binding targets, representative members of the four chemotypes were added to aggregation reactions, where they were found to stabilize soluble, but SDS-resistant Tau species at the expense of filamentous aggregates. Using SDS resistance as a secondary assay, and a library of Tau deletion and missense mutants as targets, interaction with cyanine was localized to the microtubule binding repeat region. Moreover, the SDS-resistant phenotype was completely dependent on the presence of octadecyl sulfate inducer, but not intact PHF6/PH6* hexapeptide motifs, indicating that cyanine interacted with a species in the aggregation pathway prior to nucleus formation. Together the data suggest that flat, highly polarizable ligands inhibit Tau aggregation by interacting with folded species in the aggregation pathway and driving their assembly into soluble but highly stable Tau oligomers.	[Schafer, Kelsey N.; Cisek, Katryna; Huseby, Carol J.; Chang, Edward; Kuret, Jeff] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kuret, J (corresponding author), 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Cisek, Katryna/0000-0002-2888-9943; Huseby, Carol/0000-0002-9558-5560	National Institutes of Health [AG14452]; Alzheimer's Disease Drug Discovery Foundation [281205]; Ohio Supercomputer Center [PAS0453]; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Drug Discovery Foundation; Ohio Supercomputer Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14452, Alzheimer's Disease Drug Discovery Foundation Grant 281205, and an allocation of computing time from the Ohio Supercomputer Center (PAS0453).	Abraha A, 2000, J CELL SCI, V113, P3737; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Akoury E, 2013, J AM CHEM SOC, V135, P2853, DOI 10.1021/ja312471h; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chang E, 2008, J NEUROCHEM, V107, P1113, DOI 10.1111/j.1471-4159.2008.05692.x; Chang E, 2009, J MED CHEM, V52, P3539, DOI 10.1021/jm900116d; Chirita C, 2004, BIOCHEMISTRY-US, V43, P2879, DOI 10.1021/bi036094h; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Cisek K, 2012, BIOPHYS CHEM, V170, P25, DOI 10.1016/j.bpc.2012.09.001; Cisek K, 2012, BIOORGAN MED CHEM, V20, P1434, DOI 10.1016/j.bmc.2011.12.062; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Congdon EE, 2009, J BIOL CHEM, V284, P20830, DOI 10.1074/jbc.M109.016089; Consonni V., 2000, HDB MOL DESCRIPTORS; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; DAHNE S, 1978, SCIENCE, V199, P1163, DOI 10.1126/science.199.4334.1163; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Honson NS, 2008, J ALZHEIMERS DIS, V14, P417; Honson NS, 2007, NEUROBIOL DIS, V28, P251, DOI 10.1016/j.nbd.2007.07.018; Jacquemin D, 2009, ACCOUNTS CHEM RES, V42, P326, DOI 10.1021/ar800163d; Jensen JR, 2011, J ALZHEIMERS DIS, V26, P147, DOI 10.3233/JAD-2011-0003; Jensen JR, 2011, BIOORGAN MED CHEM, V19, P5147, DOI 10.1016/j.bmc.2011.07.016; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Konovalov DA, 2008, J CHEM INF MODEL, V48, P2081, DOI 10.1021/ci800209k; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kuret J., 2007, PROTEIN FOLDING DIS, P287; Kurunczi L, 2007, INT J QUANTUM CHEM, V107, P2057, DOI 10.1002/qua.21384; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Liu XR, 2004, DRUG METAB DISPOS, V32, P132, DOI 10.1124/dmd.32.1.132; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237; Metivier-Pignon H, 2007, CHEMOSPHERE, V66, P887, DOI 10.1016/j.chemosphere.2006.06.032; Necula M, 2005, BIOCHEMISTRY-US, V44, P10227, DOI 10.1021/bi050387o; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Schafer KN, 2011, BIOORG MED CHEM LETT, V21, P3273, DOI 10.1016/j.bmcl.2011.04.039; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Smith MC, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.10; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1407, DOI 10.1021/ci010368v; Tomoo K, 2005, J BIOCHEM, V138, P413, DOI 10.1093/jb/mvi142; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Verhaar HJM, 2000, CHEMOSPHERE, V40, P875, DOI 10.1016/S0045-6535(99)00317-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wischik C. M., 2005, U. S. Patent, Patent No. [6,953,794, 6953794]; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 2008, 11 INT C ALZH DIS CH	76	35	35	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32599	32611		10.1074/jbc.M113.503474	http://dx.doi.org/10.1074/jbc.M113.503474			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072703	Green Published, hybrid			2022-12-25	WOS:000328681700042
J	Nesbitt, SJ; Butler, RJ; Gower, DJ				Nesbitt, Sterling J.; Butler, Richard J.; Gower, David J.			A New Archosauriform (Reptilia: Diapsida) from the Manda Beds (Middle Triassic) of Southwestern Tanzania	PLOS ONE			English	Article							VANCLEAVEA-CAMPI; REDESCRIPTION; PHYLOGENY; DINOSAUR; ARIZONA; ORIGIN	Background: Archosauria and their closest relatives, the non-archosaurian archosauriforms, diversified in the Early and Middle Triassic, soon after the end-Permian extinction. This diversification is poorly documented in most Lower and Middle Triassic rock sequences because fossils of early groups of archosauriforms are relatively rare compared to those of other amniotes. The early Middle Triassic (? late Anisian) Manda beds of southwestern Tanzania form an exception, with early archosaur skeletons being relatively common and preserved as articulated or associated specimens. The Manda archosaur assemblage is exceptionally diverse for the Middle Triassic. However, to date, no non-archosaurian archosauriforms have been reported from these rocks. Methodology/Principal Findings: Here, we name a new taxon, Asperoris mnyama gen. et sp. nov., from the Manda beds and thoroughly describe the only known specimen. The specimen consists of a well-preserved partial skull including tooth-bearing elements (premaxilla, maxilla), the nasal, partial skull roof, and several incomplete elements. All skull elements are covered in an autapomorphic highly rugose sculpturing. A unique combination of character states indicates that A. mnyama lies just outside Archosauria as a stem archosaur within Archosauriformes, but more precise relationships of A. mnyama relative to other early archosauriform clades (e. g., Erythrosuchidae) cannot be determined currently. Conclusions/Significance: Asperoris mnyama is the first confirmed non-archosaurian archosauriform from the Manda beds and increases the morphological and taxonomic diversity of early archosauriforms known from the Middle Triassic. The direct association of A. mnyama with species referable to Archosauria demonstrates that non-archosaurian archosauriforms were present during the rise and early diversification of Archosauria. Non-archosaurian archosauriforms and archosaurs co-occur in fossil reptile assemblages across Pangaea from the late Early Triassic to the end of the Late Triassic.	[Nesbitt, Sterling J.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Nesbitt, Sterling J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Gower, David J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Munich; Natural History Museum London	Nesbitt, SJ (corresponding author), Univ Washington, Burke Museum, Seattle, WA 98195 USA.	sjn2104@uw.edu	Butler, Richard J./A-5239-2011	Butler, Richard J./0000-0003-2136-7541; Nesbitt, Sterling/0000-0002-7017-1652	National Science Foundation EAR (Division of Earth Sciences) [1024036]; Natural History Museum (United Kingdom); DFG Emmy Noether Programme award [BU 2587/3-1]	National Science Foundation EAR (Division of Earth Sciences); Natural History Museum (United Kingdom); DFG Emmy Noether Programme award(German Research Foundation (DFG))	This work was supported by National Science Foundation EAR (Division of Earth Sciences)-1024036 (to Christian Sidor) and a Natural History Museum (United Kingdom) collections improvement grant to curate Manda beds fossils (to P. Barrett). RJB was supported by a DFG Emmy Noether Programme award (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTRIDGE J, 1964, NATURE, V201, P445, DOI 10.1038/201445a0; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Benton M.J., 1990, P11; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Charig A, 1967, FOSS REC, P708; Charig AJ, 1956, NEW TRIASSIC ARCHOSA; Charig AJ, 1957, ABSTR DISS U CAMBR, V1955-56, P28; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; COX CB, 1991, PALAEONTOLOGY, V34, P767; Desojo JB, 2011, ZOOL J LINN SOC-LOND, V161, P839, DOI 10.1111/j.1096-3642.2010.00655.x; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Ezcurra MD, 2013, GEOL SOC LOND SPEC P, DOI [10.1144/SP379.11, DOI 10.1144/SP379.11)]; Fraser NC., 2006, DAWN DINOSAURS LIFE; Galton PM, STUTTGARTER BEITRAGE, V116, P1; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J.A., 1988, Systematics Association Special Volume Series, P103; Gauthier J.A., 1984, CLADISTIC ANAL HIGHE; Gebauer E. V. I., 2004, NEUES JB GEOLOGIE PA, V231, P1; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; Gower David J., 2000, P140; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Gower David John, 2003, Annals of the South African Museum, V110, P1; Huene F.v., 1938, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, V80, P264; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; HUNT A.P., 2002, NEW MEXICO MUSEUM NA, V21, P269; Hunt Adrian P., 2005, Bulletin of the New Mexico Museum of Natural History and Science, P59; Juul Lars, 1994, Palaeontologia Africana, V31, P1; Kalandadze NN, 1985, PALEONTOL J, V1995, P73; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Nesbitt SJ, 2005, NEUES JAHRB GEOL P-M, P332; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt SJ, EARTH ENV S IN PRESS; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL MAG, V150, P225, DOI 10.1017/S0016756812000362; Nesbitt SJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0949; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; OCHEV VG, 1958, DOKL AKAD NAUK SSSR+, V123, P749; Parker WG, 2005, P ROY SOC B-BIOL SCI, V272, P963, DOI 10.1098/rspb.2004.3047; Parrish J.M., 1992, Journal of Vertebrate Paleontology, V12, P93; Parrish J. Michael, 1993, Journal of Vertebrate Paleontology, V13, P287; Romer A. S., 1971, Breviora, VNo. 379, P1; Romer A.S., 1972, Breviora, VNo. 389, P1; Sennikov A.G., 1988, Paleontologicheskii Zhurnal, V1988, P124; Sookias RB, 2013, SPECIAL PUBLICATIONS, DOI [10.1144/SP379.6, DOI 10.1144/SP379.6)]; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Stockley G.M., 1932, Q J GEOL SOC LOND, V88, P610, DOI DOI 10.1016/S0031-0182(03)00230-X; Sues HD., 2010, TRIASSIC LIFE LAND G; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; WELLES S. P., 1947, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P241; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1; Young C-C, 1973, MEMOIRS I VERTEBRATE, V10, P38	64	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72753	10.1371/journal.pone.0072753	http://dx.doi.org/10.1371/journal.pone.0072753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086264	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900008
J	Rosso, C; Valabregue, R; Attal, Y; Vargas, P; Gaudron, M; Baronnet, F; Bertasi, E; Humbert, F; Peskine, A; Perlbarg, V; Benali, H; Lehericy, S; Samson, Y				Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Baronnet, Flore; Bertasi, Eric; Humbert, Frederic; Peskine, Anne; Perlbarg, Vincent; Benali, Habib; Lehericy, Stephane; Samson, Yves			Contribution of Corticospinal Tract and Functional Connectivity in Hand Motor Impairment after Stroke	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; CORTICAL ACTIVATION; UPPER-LIMB; RECOVERY; BRAIN; REORGANIZATION; STIMULATION; DAMAGE; FMRI; CEREBELLAR	Background: Motor outcome after stroke is associated with reorganisation of cortical networks and corticospinal tract (CST) integrity. However, the relationships between motor severity, CST damage, and functional brain connectivity are not well understood. Here, the main objective was to study the effect of CST damage on the relationship between functional motor network connectivity and hand motor function in two groups of stroke patients: the severely (n=8) and the mildly impaired (n=14). Methods: Twenty-two carotid stroke patients with motor deficits were studied with magnetic resonance imaging (MRI) at 3 weeks, at 3 and 6 months. Healthy subjects (n=28) were scanned once. The CST injury was assessed by fractional anisotropy values. Functional connectivity was studied from a whole-hand grip task fMRI in a cortical and cerebellar motor network. Functional connectivity indexes were computed between these regions at each time point. The relationship between hand motor strength, ipsilesional CST damage and functional connectivity from the primary motor cortex (M1) was investigated using global and partial correlations. Findings: In mildly impaired patients, cortico-cortical connectivity was disturbed at three weeks but returned to a normal pattern after 3 months. Cortico-cerebellar connectivity was still decreased at 6 months. In severely impaired patients, the cortico-cortical connectivity tended to return to a normal pattern, but the cortico-cerebellar connectivity was totally abolished during the follow-up. In the entire group of patients, the hand motor strength was correlated to the ipsilesional functional connectivity from M1. Partial correlations revealed that these associations were not anymore significant when the impact of CST damage was removed, except for the ipsilesional M1-contralateral cerebellum connectivity. Conclusion: Functional brain connectivity changes can be observed, even in severely impaired patients with no recovery. Upper limb function is mainly explained by the CST damage and by the ipsilesional cortico-cerebellar connectivity.	[Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Bertasi, Eric; Humbert, Frederic; Perlbarg, Vincent; Benali, Habib; Lehericy, Stephane; Samson, Yves] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France; [Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Bertasi, Eric; Humbert, Frederic; Lehericy, Stephane; Samson, Yves] CNRS, INSERM, U975, UMR 7225, Paris, France; [Rosso, Charlotte; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Samson, Yves] CRICM, COGIMAGE, Paris, France; [Rosso, Charlotte; Baronnet, Flore; Samson, Yves] Hop La Pitie Salpetriere, APHP, Paris, France; [Rosso, Charlotte] Univ Paris 11, IFR49, DSV NeuroSpin I2BM, Gif Sur Yvette, France; [Valabregue, Romain; Bertasi, Eric; Humbert, Frederic] Ctr Neuroimagerie Rech CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Gaudron, Marie] CHU Tours, Serv Neurol, Tours, France; [Baronnet, Flore] CEA NEUROSPIN, INSERM, U562, Saclay, France; [Peskine, Anne] Hop La Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Perlbarg, Vincent; Benali, Habib] Hop La Pitie Salpetriere, Lab Imagerie Fonct, INSERM, UMR S678, Paris, France; [Lehericy, Stephane] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rosso, C (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France.	charlotte.rosso@gmail.com	samson, yves/C-5647-2013; valabregue, romain/GWQ-7484-2022	valabregue, romain/0000-0002-1814-9570; Peskine, Anne/0000-0003-0083-493X; samson, yves/0000-0002-8080-1427	IFR 49 institute (Institut Federatif de Recherche, Gif sur Yvette, France) [49]; program "Investissements d'avenir" [ANR-10-IAIHU-06]	IFR 49 institute (Institut Federatif de Recherche, Gif sur Yvette, France); program "Investissements d'avenir"(French National Research Agency (ANR))	This work was partially supported by the IFR 49 institute (Institut Federatif de Recherche no 49, Gif sur Yvette, France). The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN D, 1991, SCIENCE, V266, P458; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Buma FE, 2010, NEUROREHAB NEURAL RE, V24, P589, DOI 10.1177/1545968310364058; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Calautti C, 2010, J NEUROL NEUROSUR PS, V81, P788, DOI 10.1136/jnnp.2009.190512; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Catano A, 1996, ELECTROMYOGR MOTOR C, V101, P233, DOI 10.1016/0924-980X(96)95656-8; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Deen Ben, 2012, Nature, V491, pS20; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Jang SH, 2004, NEUROREPORT, V15, P395, DOI 10.1097/00001756-200403010-00002; Jang SH, 2003, NEUROREPORT, V14, P1305, DOI 10.1097/01.wnr.0000078700.79393.09; Johansen-Berg H, 2009, BRAIN STRUCT FUNCT, V213, P499, DOI 10.1007/s00429-009-0220-x; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Kokotilo KJ, 2009, J NEUROL PHYS THER, V33, P45, DOI 10.1097/NPT.0b013e31819824f0; Kwon YH, 2011, J REHABIL MED, V43, P430, DOI 10.2340/16501977-0793; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Lu MK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00260; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mintzopoulos D, 2009, NEUROIMAGE, V47, pT90, DOI 10.1016/j.neuroimage.2009.03.007; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Noskin O, 2008, J NEUROL NEUROSUR PS, V79, P401, DOI 10.1136/jnnp.2007.118463; Pannek K, 2009, J MAGN RESON IMAGING, V29, P529, DOI 10.1002/jmri.21627; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Puig J, 2010, AM J NEURORADIOL, V31, P1324, DOI 10.3174/ajnr.A2038; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Riley JD, 2011, STROKE, V42, P421, DOI 10.1161/STROKEAHA.110.599340; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Seitz RJ, 2010, NEUROLOGY, V74, P276, DOI 10.1212/WNL.0b013e3181ccc758; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Stagg CJ, 2012, BRAIN, V135, P276, DOI 10.1093/brain/awr313; Sterr A, 2010, NEUROREHAB NEURAL RE, V24, P413, DOI 10.1177/1545968309348310; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Vargas P, 2013, J MAGN RESON IMAGING, V37, P836, DOI 10.1002/jmri.23870; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Ward NS, 2006, NEUROREHAB NEURAL RE, V20, P398, DOI 10.1177/1545968306286322; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Westlake KP, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00008; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	60	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73164	10.1371/journal.pone.0073164	http://dx.doi.org/10.1371/journal.pone.0073164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086272	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900011
J	Hoffman, MT; Gunatilaka, MK; Wijeratne, K; Gunatilaka, L; Arnold, AE				Hoffman, Michele T.; Gunatilaka, Malkanthi K.; Wijeratne, Kithsiri; Gunatilaka, Leslie; Arnold, A. Elizabeth			Endohyphal Bacterium Enhances Production of Indole-3-Acetic Acid by a Foliar Fungal Endophyte	PLOS ONE			English	Article							COLLETOTRICHUM-GLOEOSPORIOIDES; PLANT-GROWTH; GEOGRAPHIC STRUCTURE; SALKOWSKI REAGENT; USTILAGO-MAYDIS; PESTALOTIOPSIS; HOST; IDENTIFICATION; BIOSYNTHESIS; DIVERSITY	Numerous plant pathogens, rhizosphere symbionts, and endophytic bacteria and yeasts produce the important phytohormone indole-3-acetic acid (IAA), often with profound effects on host plants. However, to date IAA production has not been documented among foliar endophytes - the diverse guild of primarily filamentous Ascomycota that live within healthy, above-ground tissues of all plant species studied thus far. Recently bacteria that live within hyphae of endophytes (endohyphal bacteria) have been detected, but their effects have not been studied previously. Here we show not only that IAA is produced in vitro by a foliar endophyte (here identified as Pestalotiopsis aff. neglecta, Xylariales), but that IAA production is enhanced significantly when the endophyte hosts an endohyphal bacterium (here identified as Luteibacter sp., Xanthomonadales). Both the endophyte and the endophyte/bacterium complex appear to rely on an L-tryptophan dependent pathway for IAA synthesis. The bacterium can be isolated from the fungus when the symbiotic complex is cultivated at 36 degrees C. In pure culture the bacterium does not produce IAA. Culture filtrate from the endophyte-bacterium complex significantly enhances growth of tomato in vitro relative to controls and to filtrate from the endophyte alone. Together these results speak to a facultative symbiosis between an endophyte and endohyphal bacterium that strongly influences IAA production, providing a new framework in which to explore endophyte-plant interactions.	[Hoffman, Michele T.; Gunatilaka, Malkanthi K.; Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Wijeratne, Kithsiri; Gunatilaka, Leslie] Sch Nat Resources & Environm, Southwest Ctr Nat Prod Res & Commercializat, Tucson, AZ USA	University of Arizona	Arnold, AE (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	Arnold@ag.arizona.edu	Hoffman, Michele T/D-2537-2011		Division of Plant Pathology and Microbiology; School of Plant Sciences; College of Agriculture and Life Sciences at The University of Arizona; National Science Foundation [NSF-0626520, 0702825]	Division of Plant Pathology and Microbiology; School of Plant Sciences; College of Agriculture and Life Sciences at The University of Arizona; National Science Foundation(National Science Foundation (NSF))	We thank the Division of Plant Pathology and Microbiology, the School of Plant Sciences, and the College of Agriculture and Life Sciences at The University of Arizona for logistical and financial support. Additional support from the National Science Foundation (NSF-0626520 and 0702825 to AEA; NSF-IGERT to MTH) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Bajo J, 2008, FOREST PATHOL, V38, P263, DOI 10.1111/j.1439-0329.2008.00545.x; Barash I, 2009, ANNU REV PHYTOPATHOL, V47, P133, DOI 10.1146/annurev-phyto-080508-081803; Barbieri E, 2000, APPL ENVIRON MICROB, V66, P5035, DOI 10.1128/AEM.66.11.5035-5042.2000; Bertaux J, 2003, APPL ENVIRON MICROB, V69, P4243, DOI 10.1128/AEM.69.7.4243-4248.2003; Bianciotto V, 1996, APPL ENVIRON MICROB, V62, P3005, DOI 10.1128/AEM.62.8.3005-3010.1996; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; CARROLL G, 1983, MYCOLOGIA, V75, P53, DOI 10.2307/3792923; Chague V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-173; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GRUEN HE, 1959, ANNU REV PLANT PHYS, V10, P405, DOI 10.1146/annurev.pp.10.060159.002201; Herre EA, 2007, ECOLOGY, V88, P550, DOI 10.1890/05-1606; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; HOFFMAN MT, 2010, THESIS U ARIZONA TUC; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeewon R, 2004, FUNGAL DIVERS, V17, P39; Jeewon R, 2003, MOL PHYLOGENET EVOL, V27, P372, DOI 10.1016/S1055-7903(03)00010-1; Kobayashi DY, 2009, ANNU REV PHYTOPATHOL, V47, P63, DOI 10.1146/annurev-phyto-080508-081729; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Levy A, 2003, APPL ENVIRON MICROB, V69, P6250, DOI 10.1128/AEM.69.10.6250-6256.2003; Lindow SE, 1998, PHYTOPATHOLOGY, V88, P1149, DOI 10.1094/PHYTO.1998.88.11.1149; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Maddison, 2019, MESQUITE MODULAR SYS; Maor R, 2004, APPL ENVIRON MICROB, V70, P1852, DOI 10.1128/AEM.70.3.1852-1854.2004; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Nassar AH, 2005, BIOL FERT SOILS, V42, P97, DOI 10.1007/s00374-005-0008-y; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sharma M, 2008, CELL MICROBIOL, V10, P2235, DOI 10.1111/j.1462-5822.2008.01202.x; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Sosa-Morales ME, 1997, APPL MICROBIOL BIOT, V48, P726, DOI 10.1007/s002530051123; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STEYAERT R. L., 1953, TRANS BRIT MYCOL SOC, V36, P81; Strack D, 2003, J CHEM ECOL, V29, P1955, DOI 10.1023/A:1025695032113; Suwannarach N, 2013, J GEN PLANT PATHOL, V79, P277, DOI 10.1007/s10327-013-0453-7; Swofford DL, 2001, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tudzynski B, 2002, MYCOTA, V10, P183; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Watanabe K, 2010, MYCOSCIENCE, V51, P182, DOI 10.1007/s10267-009-0025-z; Wei JG, 2007, FUNGAL DIVERS, V24, P55; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	62	89	112	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e73132	10.1371/journal.pone.0073132	http://dx.doi.org/10.1371/journal.pone.0073132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086270	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200007
J	Lu, DY; Liu, XF; Gao, YX; Huo, B; Kang, YY; Chen, J; Sun, SJ; Chen, L; Luo, XD; Long, MA				Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Chen, Li; Luo, Xiangdong; Long, Mian			Asymmetric Migration of Human Keratinocytes under Mechanical Stretch and Cocultured Fibroblasts in a Wound Repair Model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; VACUUM-ASSISTED CLOSURE; GENE-EXPRESSION; FACTOR-ALPHA; TGF-ALPHA; CELL-PROLIFERATION; SKIN; REGENERATION; MICE; EPITHELIALIZATION	Keratinocyte migration during re-epithelization is crucial in wound healing under biochemical and biomechanical microenvironment. However, little is known about the underlying mechanisms whereby mechanical tension and cocultured fibroblasts or keratinocytes modulate the migration of keratinocytes or fibroblasts. Here we applied a tensile device together with a modified transwell assay to determine the lateral and transmembrane migration dynamics of human HaCaT keratinocytes or HF fibroblasts. A novel pattern of asymmetric migration was observed for keratinocytes when they were cocultured with non-contact fibroblasts, i.e., the accumulative distance of HaCaT cells was significantly higher when moving away from HF cells or migrating from down to up cross the membrane than that when moving close to HF cells or when migrating from up to down, whereas HF migration was symmetric. This asymmetric migration was mainly regulated by EGF derived from fibroblasts, but not transforming growth factor alpha or beta 1 production. Mechanical stretch subjected to fibroblasts fostered keratinocyte asymmetric migration by increasing EGF secretion, while no role of mechanical stretch was found for EGF secretion by keratinocytes. These results provided a new insight into understanding the regulating mechanisms of two- or three-dimensional migration of keratinocytes or fibroblasts along or across dermis and epidermis under biomechanical microenvironment.	[Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Chen, Li; Luo, Xiangdong] Third Mil Med Univ, Southwest Hosp, Burn Res Inst, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Army Medical University	Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China.	mlong@imech.ac.cn	Huo, Bo/G-6186-2010; Huo, Bo/AAA-1331-2020	Huo, Bo/0000-0003-3194-3725; Huo, Bo/0000-0003-3194-3725	National Natural Science Foundation of China [30730032, 30730093, 31000421, 30870601]; National Key Basic Research Foundation of China [2011CB710904]; National High Technology Research and Development Program of China [2011AA020109]; Chinese Academy of Sciences [KJCX2-YW-L08]; Scientific Research Equipment Project [Y2010030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Equipment Project	This work was supported by National Natural Science Foundation of China grants 30730032, 30730093, 31000421, and 30870601 (http://www.nsfc.gov.cn/Portal0/default106.htm); National Key Basic Research Foundation of China grant 2011CB710904, and National High Technology Research and Development Program of China grant 2011AA020109 (http://www.most.gov.cn/eng/index.htm), and Chinese Academy of Sciences Knowledge Innovation Program grant KJCX2-YW-L08 and Scientific Research Equipment Project of grant Y2010030 (http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bartkova J, 2003, ARCH ORAL BIOL, V48, P125, DOI 10.1016/S0003-9969(02)00202-9; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Blumenberg M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-85; BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019; BROWN GL, 1986, J EXP MED, V163, P1319; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; GUO M, 1990, J CELL SCI, V96, P197; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Kim I, 2001, WOUND REPAIR REGEN, V9, P386, DOI 10.1046/j.1524-475x.2001.00386.x; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; KREJCI NC, 1991, J INVEST DERMATOL, V97, P843, DOI 10.1111/1523-1747.ep12491522; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lohman RF, 2004, PLAST RECONSTR SURG, V114, P1097, DOI 10.1097/01.prs.0000135338.78447.4e; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morris VL, 2007, WOUND REPAIR REGEN, V15, P907, DOI 10.1111/j.1524-475X.2007.00315.x; Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S, DOI 10.1097/01.prs.0000225450.12593.12; NICKOLOFF BJ, 1988, AM J PATHOL, V132, P543; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orgill DP, 2009, SURGERY, V146, P40, DOI 10.1016/j.surg.2009.02.002; Puccinelli TJ, 2010, ACTA BIOMATER, V6, P3415, DOI 10.1016/j.actbio.2010.04.006; Raja, 2007, Front Biosci, V12, P2849; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; URSCHEL JD, 1988, BRIT J PLAST SURG, V41, P182, DOI 10.1016/0007-1226(88)90049-5; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054; Yamamoto M, 2011, BIOMATERIALS, V32, P4238, DOI 10.1016/j.biomaterials.2011.02.043; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009	49	27	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74563	10.1371/journal.pone.0074563	http://dx.doi.org/10.1371/journal.pone.0074563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086354	Green Published, gold			2022-12-25	WOS:000326520200036
J	Ragonese, S; Vitale, S; Dimech, M; Mazzola, S				Ragonese, Sergio; Vitale, Sergio; Dimech, Mark; Mazzola, Salvatore			Abundances of Demersal Sharks and Chimaera from 1994-2009 Scientific Surveys in the Central Mediterranean Sea	PLOS ONE			English	Article							DOGFISH SCYLIORHINUS-CANICULA; SQUALUS-BLAINVILLEI RISSO; REPRODUCTIVE-BIOLOGY; FISH ASSEMBLAGES; CANTABRIAN SEA; STRAIT; WATERS; GULF; RESOURCES; FISHERIES	Bibliographic and data gathered in scientific bottom trawl surveys carried out off the Southern Coasts of Sicily (Mediterranean Sea), from 1994 to 2009 and between a depth of 10 and 800 m, were analysed in order to prepare a checklist of demersal sharks and chimaera, which are species sensitive to fisheries exploitation. Out of the 27 previously reported demersal shark and chimaera taxa in the Mediterranean, only 23 were found in literature and 20 sampled during the surveys in the investigated area. Among the species sampled in the surveys, only 2 ubiquitous (Squalus blainville and Scyliorhinus canicula) and 3 deep-water (Chimaera monstrosa, Centrophorus granulosus and Galeus melastomus) species showed a wide geographical distribution with a consistent abundance. Excluding the rare (such as Oxynotus centrina) or uncommon shark (e.g. Squalus acanthias), the estimated frequencies of occurrence and abundance indexes show a possible risk of local extinction for the almost exclusively (e.g. angelshark, Squatina spp.) or preferential (e.g. Scyliorhinus stellaris) neritic species.	[Ragonese, Sergio; Vitale, Sergio; Mazzola, Salvatore] Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Mazara Del Vallo, Sicily, Italy; [Dimech, Mark] Malta Ctr Fisheries Sci, Ft San Lucjan Marsaxlokk, Birzebbuga, Malta	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Vitale, S (corresponding author), Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Mazara Del Vallo, Sicily, Italy.	sergio.vitale@cnr.it	Vitale, Sergio/AAX-5418-2020	Mazzola, Salvatore/0000-0002-4622-8129; vitale, sergio/0000-0001-6063-4126	Ministro delle Politiche Agricole e Forestali (MiPAF); European Community	Ministro delle Politiche Agricole e Forestali (MiPAF); European Community(European Commission)	The present research was jointly funded by Ministro delle Politiche Agricole e Forestali (MiPAF) and European Community. The funders have established the study design and data collection, but had no role in analysis, decision to publish, or preparation of the manuscript.	Abella A. J., 2005, Journal of Northwest Atlantic Fishery Science, V35, P345; Aldebert Y, 1997, VIE MILIEU, V47, P275; Andreoli MG, 1995, SPECIAL PUBLICATION, VII; Andreoli MG, 1982, 266 FAO, P111; Arena P, 1985, STUDIO POSSIBILITA R; Arena P, 1973, QUAD LAB TECHNOL PES, V1, P157; Baino R, 2001, RAPP COMM INT MER ME; Bauchot ML, 1987, FICHES FAO IDENTIFIC, P767; Bianchini ML, 2006, NATURALISTA SICIL, VXXX, P469; Bini G, 1967, ATLANTE PESCI DELLE, V1; Bombace G, 1970, ICHTYOL ROME JOURNEE, P157; Bourgois F, 1961, ESSAIS CHALUTAGE LAR; Bradai M.N., 2012, BIBLIOGRAPHIC ANAL S, V91; Bradai MN, 2000, THESIS U SFAX TUNISA; Bradai Mohamed Nejmeddine, 2004, Mesogee, V60, P61; Briand F, 2000, RAPPCOMM INT MER MED, V10, P85; Campillo A, 1992, RIDRV 92 019 RH SETE; CANNIZZARO L, 1995, FISH RES, V23, P113, DOI 10.1016/0165-7836(94)00333-R; Capape C., 1985, Bulletin de l'Institut National Scientifique et Technique d'Oceanographie et de Peche de Salammbo, V12, P97; Capape C, 2000, VIE MILIEU, V50, P123; Capape Christian, 2005, Acta Adriatica, V46, P109; Castro J. I., 1999, PRELIMINARY EVALUATI; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Celona A, 2005, B MUS CIV ST NAT VEN, V56; Cingolani N, 1986, QUADERNI I RICERCH S, V5, P283; Compagno L. J. V., 1984, SHARKS WORLD ANNOTAT, V4; Compagno LJV, 2005, SHARKS WORLD, P480; Dagit DD, 2007, IUCN 2012 IUCN RED L; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Delattre G, 1986, 3 C ASS PLEN CIESM P; Dell'Apa A, 2012, ICES J MAR SCI, V69, P1045, DOI 10.1093/icesjms/fss067; Dimech M, 2012, MAR ECOL PROG SER, V449, P41, DOI 10.3354/meps09475; Dimech M, 2008, SCI MAR, V72, P669, DOI 10.3989/scimar.2008.72n4669; Ebert DA, 2013, SHARKS; Eschmeyer WN, 2012, CATALOG FISHES CALIF; European Union, 2006, MANAGEMENT MEASURES; Ferretti F, 2005, ICES CM, V25, P1; Fredj G, 1987, CYBIUM, P299; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; FROESE R., 2012, FISHBASE; Garofalo G., 2007, BIOL MAR MEDITERR, V14, P250; Giudicelli M, 1978, MALTA SIMULATED COMM; Giudicelli M, 1983, RESULTATS OPERATIONS; Golani D, 1996, ISRAEL J ZOOL, V42, P15; GOLANI D, 1986, Israel Journal of Zoology, V34, P23; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; Hassan M, 2013, SYRIAN WATERS E MEDI, V6, pe7; HILBORN R, 1988, MAR POLICY, V12, P112, DOI 10.1016/0308-597X(88)90039-5; Iglesias SP, 2012, CLASSIFICATION NATUR, VI; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Jukic-Peladic S, 2000, FISH RES, V11, P1; Levi D., 1998, Biologia Marina Mediterranea, V5, P130; Macpherson E, 1980, VIE MILIEU, V30, P139; Marouani S, 2012, SCI MAR, V76, P97, DOI 10.3989/scimar.03440.22B; Medits, 2002, FIN REP 2000 2001 RA; Mifsud R, 2013, MEDITERR MAR SCI, V14, P298, DOI 10.12681/mms.413; Musick AJ, 2011, FAO FISHERIES AQUACU, P245; Olaso I, 1998, ICES J MAR SCI, V55, P331, DOI 10.1006/jmsc.1997.0263; Pipitone C, 1992, OEBALIA, V17, P151; Potoschi A., 2010, RAPPORTS PROCES VERB, V39, P636; Quero JC, 1984, FISHES NE ATLANTIC M, P95; Quignard J.P., 1971, B L INSTITUT NATL SC, V2, P131; Ragonese S, 2009, MEDITERR MAR SCI, V10, P55, DOI 10.12681/mms.122; Ragonese S., 2000, Biologia Marina Mediterranea, V7, P400; Ragonese S, 2001, HYDROBIOLOGIA, V449, P279, DOI 10.1023/A:1017564530716; RAGONESE S, 2008, NATURALISTA SICILIAN, V32, P3; Relini G, 2008, BIOL MAR MEDITERR, V15, P1; Relini G, 1999, BIOL MAR MEDIT S1, V6; RELINI G, 2000, ACTES C IFREMER, V26, P76; Revill AS, 2005, FISH RES, V71, P121, DOI 10.1016/j.fishres.2004.07.006; Rizzo P, 1993, BIOL MAR MEDIT, V1, P389; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rodriguez-Cabello C, 2005, J MAR BIOL ASSOC UK, V85, P1145, DOI 10.1017/S002531540501221X; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Saidi B, 2008, J FISH BIOL, V72, P1343, DOI 10.1111/j.1095-8649.2008.01801.x; Saidi B, 2009, SCI MAR, V73, P249, DOI 10.3989/scimar.2009.73n2249; Sara, 1972, MIN MAR MERC MEM, V33, P63; Sara R, 1969, PESCA STRASCICO FOND; SCACCINI A, 1970, B PESCA PISCIC IDROB, V25, P5; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Schembri Titian, 2003, Central Mediterranean Naturalist, V4, P71; Serena F., 2005, FIELD IDENTIFICATION; Serena F, 2008, ATT WORKSH HMAP MED, P127; Serena F, 2005, FAO REPORT DEEP SEA, P395; Serena F, 2009, BIOLOGY AND MANAGEMENT OF DOGFISH SHARKS, P139; Sion L, 2004, SCI MAR, V68, P153, DOI 10.3989/scimar.2004.68s3153; Smedbol RK, 2002, FISH RES, V55, P161; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tortonese E., 1956, FAUNA ITALIA LEPTOCA; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Walker TI, 2005, 474 FAO, V474, P216; [No title captured]; 2006, REPORT WORKING GROUP	93	47	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74865	10.1371/journal.pone.0074865	http://dx.doi.org/10.1371/journal.pone.0074865			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086386	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200045
J	Talaei, N; Cheung, YH; Landolt-Marticorena, C; Noamani, B; Li, T; Wither, JE				Talaei, Nafiseh; Cheung, Yui-Ho; Landolt-Marticorena, Carolina; Noamani, Babak; Li, Timothy; Wither, Joan E.			T Cell and Dendritic Cell Abnormalities Synergize to Expand Pro-Inflammatory T Cell Subsets Leading to Fatal Autoimmunity in B6.NZBc1 Lupus-Prone Mice	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; B-CELL; SUSCEPTIBILITY; RECEPTOR; IL-21; GENERATION; T-HELPER-1; LY108; TH1	We have previously shown that B6 congenic mice with a New Zealand Black chromosome 1 (c1) 96-100 cM interval produce anti-nuclear Abs and that at least two additional genetic loci are required to convert this subclinical disease to fatal glomerulonephritis in mice with a c1 70-100 cM interval (c1(70-100)). Here we show that the number of T follicular helper and IL-21-, IFN-gamma-, and IL-17-secreting CD4(+) T cells parallels disease severity and the number of susceptibility loci in these mice. Immunization of pre-autoimmune mice with OVA recapitulated these differences. Differentiation of nave T cells in-vitro under polarizing conditions and in-vivo following adoptive transfer of OVA-specific TCR transgenic cells into c1(70-100) or B6 recipient mice, revealed T cell functional defects leading to increased differentiation of IFN-gamma- and IL-17-producing cells in the 96-100 cM and 88-96 cM intervals, respectively. However, in-vivo enhanced differentiation of pro-inflammatory T cell subsets was predominantly restricted to c1(70-100) recipient mice, which demonstrated altered dendritic cell function, with increased production of IL-6 and IL-12. The data provide support for the role of pro-inflammatory T cells in the conversion of subclinical disease to fatal autoimmunity and highlight the importance of synergistic interactions between individual susceptibility loci in this process.	[Talaei, Nafiseh; Cheung, Yui-Ho; Noamani, Babak; Li, Timothy; Wither, Joan E.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada; [Talaei, Nafiseh; Cheung, Yui-Ho; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Landolt-Marticorena, Carolina; Wither, Joan E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wither, JE (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Canadian Institutes of Health Research; Arthritis Centre of Excellence; Arthritis and Autoimmunity Research Foundation; Government of Ontario Scholarship; Government of Ontario/Edward Dunlop Scholarship in Science and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence; Arthritis and Autoimmunity Research Foundation; Government of Ontario Scholarship; Government of Ontario/Edward Dunlop Scholarship in Science and Technology	This work was supported by a research grant from the Canadian Institutes of Health Research awarded to JW. JW receives salary support from The Arthritis Centre of Excellence and The Arthritis and Autoimmunity Research Foundation. NT is the recipient of a Government of Ontario Scholarship and a Government of Ontario/Edward Dunlop Scholarship in Science and Technology. Y-HC was supported by a studentship from The Arthritis Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Cheung YH, 2011, GENES IMMUN, V12, P251, DOI 10.1038/gene.2010.71; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Cuda CM, 2012, J IMMUNOL, V188, P604, DOI 10.4049/jimmunol.1002362; Du X, 2005, EUR J IMMUNOL, V35, P3414, DOI 10.1002/eji.200535366; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Keszei M, 2013, FASEB J, V27, P3123, DOI 10.1096/fj.12-226951; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Kim CH, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/416910; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Loh C, 2011, J IMMUNOL, V186, P5845, DOI 10.4049/jimmunol.1003426; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Pau E, 2011, CLIN IMMUNOL, V139, P215, DOI 10.1016/j.clim.2011.02.005; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Spilianakis CG, 2005, EUR J IMMUNOL, V35, P3400, DOI 10.1002/eji.200535588; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75166	10.1371/journal.pone.0075166	http://dx.doi.org/10.1371/journal.pone.0075166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073245	Green Published, Green Submitted, gold			2022-12-25	WOS:000324768000054
J	Donnelly, JM; Chawla, A; Houghton, J; Zavros, Y				Donnelly, Jessica M.; Chawla, Ambreesh; Houghton, JeanMarie; Zavros, Yana			Sonic Hedgehog Mediates the Proliferation and Recruitment of Transformed Mesenchymal Stem Cells to the Stomach	PLOS ONE			English	Article							BONE-MARROW; HELICOBACTER-PYLORI; CONDITIONED MEDIUM; GENE-EXPRESSION; IFN-GAMMA; MODEL; GASTRITIS; GROWTH; CANCER; MICE	Studies using Helicobacter-infected mice show that bone marrow-derived mesenchymal stem cells (MSCs) can repopulate the gastric epithelium and promote gastric cancer progression. Within the tumor microenvironment of the stomach, pro-inflammatory cytokine interferon-gamma (IFN gamma) and Sonic hedgehog (Shh) are elevated. IFN gamma is implicated in tumor proliferation via activation of the Shh signaling pathway in various tissues but whether a similar mechanism exists in the stomach is unknown. We tested the hypothesis that IFN gamma drives MSC proliferation and recruitment, a response mediated by Shh signaling. The current study uses transplantation of an in vitro transformed mesenchymal stem cell line (stMSC(vect)), that over-expresses hedgehog signaling, in comparison to non-transformed wild-type MSCs (wtMSCs), wtMSCs transfected to over-express Shh (wtMSC(Shh)), and stMSCs transduced with lentiviral constructs containing shRNA targeting the Shh gene (stMSC(ShhKO)). The effect of IFN gamma on MSC proliferation was assessed by cell cycle analysis in vitro using cells treated with recombinant IFN gamma (rmIFN gamma) alone, or in combination with anti-Shh 5E1 antibody, and in vivo using mice transplanted with MSCs treated with PBS or rmIFN gamma. In vitro, IFN gamma significantly increased MSC proliferation, a response mediated by Shh that was blocked by 5E1 antibody. The MSC population collected from bone marrow of PBS- or IFN gamma-treated mice showed that IFN gamma significantly increased the percentage of all MSC cell lines in S phase, with the exception of the stMSCs(ShhKO) cells. While the MSC cell lines with intact Shh expression were recruited to the gastric mucosa in response to IFN gamma, stMSCs(ShhKO) were not. Hedgehog signaling is required for MSC proliferation and recruitment to the stomach in response to IFN gamma.	[Donnelly, Jessica M.; Chawla, Ambreesh; Zavros, Yana] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA; [Houghton, JeanMarie] Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA USA; [Houghton, JeanMarie] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati	Zavros, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA.	yana.zavros@uc.edu		Houghton, JeanMarie/0000-0002-1727-373X	American Cancer Society [119072-RSG-10-167-01-MPC]; Albert J. Ryan Foundation Fellowship; Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease) [CHTF/SUB DK078392]; National Institutes of Health (NIH) [AR-47363]; NIH [AR-47363]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Albert J. Ryan Foundation Fellowship; Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Cancer Society Research Scholar Award 119072-RSG-10-167-01-MPC (Y. Zavros), Albert J. Ryan Foundation Fellowship (J. Donnelly) and in part by the Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease) CHTF/SUB DK078392. The authors would like to acknowledge the assistance of Monica DeLay manager of the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by National Institutes of Health (NIH) AR-47363. All flow cytometric data were acquired using equipment maintained by the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by NIH AR-47363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; CORREA P, 1975, LANCET, V2, P58; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Houghton J, 2010, STEM CELLS DEV, V19, P1153, DOI 10.1089/scd.2009.0439; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Okumura T, 2009, LAB INVEST, V89, P1410, DOI 10.1038/labinvest.2009.88; Padol IT, 2004, GUT, V53, P1075, DOI 10.1136/gut.2003.026435; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Shibata W, 2013, GUT, V62, P192, DOI 10.1136/gutjnl-2011-301824; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Son SM, 2006, VET IMMUNOL IMMUNOP, V112, P284, DOI 10.1016/j.vetimm.2006.02.005; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75225	10.1371/journal.pone.0075225	http://dx.doi.org/10.1371/journal.pone.0075225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069395	Green Published, gold			2022-12-25	WOS:000324777300070
J	Ghorashian, N; Gokce, SK; Guo, SX; Everett, WN; Ben-Yakar, A				Ghorashian, Navid; Goekce, Sertan Kutal; Guo, Sam Xun; Everett, William Neil; Ben-Yakar, Adela			An Automated Microfluidic Multiplexer for Fast Delivery of C. elegans Populations from Multiwells	PLOS ONE			English	Article							LARGE-SCALE INTEGRATION; CAENORHABDITIS-ELEGANS; HIGH-THROUGHPUT; SYSTEM; IMMOBILIZATION; REGENERATION; CHEMISTRY; VERSATILE; ORGANISM; PLATFORM	Automated biosorter platforms, including recently developed microfluidic devices, enable and accelerate high-throughput and/or high-resolution bioassays on small animal models. However, time-consuming delivery of different organism populations to these systems introduces a major bottleneck to executing large-scale screens. Current population delivery strategies rely on suction from conventional well plates through tubing periodically exposed to air, leading to certain disadvantages: 1) bubble introduction to the sample, interfering with analysis in the downstream system, 2) substantial time drain from added bubble-cleaning steps, and 3) the need for complex mechanical systems to manipulate well plate position. To address these concerns, we developed a multiwell-format microfluidic platform that can deliver multiple distinct animal populations from on-chip wells using multiplexed valve control. This Population Delivery Chip could operate autonomously as part of a relatively simple setup that did not require any of the major mechanical moving parts typical of plate-handling systems to address a given well. We demonstrated automatic serial delivery of 16 distinct C. elegans worm populations to a single outlet without introducing any bubbles to the samples, causing cross-contamination, or damaging the animals. The device achieved delivery of more than 90% of the population preloaded into a given well in 4.7 seconds; an order of magnitude faster than delivery modalities in current use. This platform could potentially handle other similarly sized model organisms, such as zebrafish and drosophila larvae or cellular micro-colonies. The device's architecture and microchannel dimensions allow simple expansion for processing larger numbers of populations.	[Ghorashian, Navid; Goekce, Sertan Kutal; Guo, Sam Xun; Everett, William Neil; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ben-Yakar, A (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	ben-yakar@mail.utexas.edu	Everett, William Neil/AAE-2101-2021	Ghorashian, Navid/0000-0002-5783-4933	National Institutes of Health [NIH R01 AG041135, NIH R21 NS067340, NIH R01 NS060129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129, R21NS067340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the National Institutes of Health (www.nih.gov) for its generous support of this research. Specifically, the grants that made this work possible are the NIH Director's Transformative Award (NIH R01 AG041135), NIH R21 NS067340, and NIH R01 NS060129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Caceres ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035037; Carr JA, 2011, LAB CHIP, V11, P2385, DOI 10.1039/c1lc20170k; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Chung K, 2009, LAB CHIP, V9, P2764, DOI 10.1039/b910703g; Crane MM, 2012, NAT METHODS, V9, P977, DOI [10.1038/NMETH.2141, 10.1038/nmeth.2141]; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Gilleland CL, 2010, NAT PROTOC, V5, P1888, DOI 10.1038/nprot.2010.143; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Han M, 2010, DEV DYNAM, V239, P1263, DOI 10.1002/dvdy.22291; Hardy BS, 2009, LAB CHIP, V9, P935, DOI 10.1039/b813061b; Hua ZS, 2006, J MICROMECH MICROENG, V16, P1433, DOI 10.1088/0960-1317/16/8/001; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kim N, 2007, SENSOR ACTUAT B-CHEM, V122, P511, DOI 10.1016/j.snb.2006.06.026; Lockery SR, 2012, LAB CHIP, V12, P2211, DOI 10.1039/c2lc00001f; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Nguyen NT, 2002, FUNDAMENTALS APPL MI, P35; Pulak R, 2001, INT C EL M; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Singhal A, 2010, ANAL CHEM, V82, P8671, DOI 10.1021/ac101956e; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Suiban B, 2012, J VIS EXP, V60; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wang JY, 2006, ANGEW CHEM INT EDIT, V45, P5276, DOI 10.1002/anie.200601677; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	35	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74480	10.1371/journal.pone.0074480	http://dx.doi.org/10.1371/journal.pone.0074480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069313	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300043
J	Shigematsu, M; Ogawa, T; Tanaka, W; Takahashi, K; Kitamoto, HK; Hidaka, M; Masaki, H				Shigematsu, Megumi; Ogawa, Tetsuhiro; Tanaka, Wataru; Takahashi, Kazutoshi; Kitamoto, Hiroko K.; Hidaka, Makoto; Masaki, Haruhiko			Evidence for DNA Cleavage Caused Directly by a transfer RNA-Targeting Toxin	PLOS ONE			English	Article							LACTIS GAMMA-TOXIN; KLUYVEROMYCES-LACTIS; KILLER TOXIN; SACCHAROMYCES-CEREVISIAE; PICHIA-ACACIAE; CYTOTOXIC RIBONUCLEASE; ANTICODON NUCLEASE; PHASE ARREST; YEAST; DAMAGE	The killer yeast species Pichia acaciae produces a heteromeric killer protein, PaT, that causes DNA damage and arrests the cell cycle of sensitive Saccharomyces cerevisiae in the S phase. However, the mechanism by which DNA damage occurs remains elusive. A previous study has indicated that Orf2p, a subunit of PaT, specifically cleaves an anticodon loop of an S. cerevisiae transfer RNA (tRNA(mcm5s2UUG)(Gln)). This finding raised a question about whether the DNA damage is a result of the tRNA cleavage or whether Orf2p directly associates with and cleaves the genomic DNA of sensitive yeast cells. We showed that Orf2p cleaves genomic DNA in addition to cleaving tRNA in vitro. This DNA cleavage requires the same Orf2p residue as that needed for tRNA cleavage, His299. The expression of Orf2p, in which His299 was substituted to alanine, abolished the cell cycle arrest of the host cell. Moreover, the translation impairment induced by tRNA cleavage enabled Orf2p to enter the nucleus, thereby inducing histone phosphorylation.	[Shigematsu, Megumi; Ogawa, Tetsuhiro; Tanaka, Wataru; Takahashi, Kazutoshi; Hidaka, Makoto; Masaki, Haruhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan; [Kitamoto, Hiroko K.] Natl Inst Agroenvironm Sci, Ibaraki, Japan	University of Tokyo; National Institute for Agro-Environmental Sciences (NIAES) Japan	Ogawa, T (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	atetsu@mail.ecc.u-tokyo.ac.jp; amasaki@mail.ecc.u-tokyo.ac.jp	Ogawa, Tetsuhiro/AAO-2961-2021	Takahashi, Kazutoshi/0000-0003-3275-4109	Japan Society for the Promotion of Science [21658029]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No.21658029, HM), and by Takeda Science Foundation to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUTLER AR, 1991, J GEN MICROBIOL, V137, P1749, DOI 10.1099/00221287-137-7-1749; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Jablonowski D, 2007, BIOCHEM SOC T, V35, P1533, DOI 10.1042/BST0351533; Jablonowski D, 2002, J BIOL CHEM, V277, P26276, DOI 10.1074/jbc.M203354200; Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703; KAMIMURA K, 1981, CURR MICROBIOL, V6, P175, DOI 10.1007/BF01642394; Keppetipola N, 2009, RNA, V15, P1036, DOI 10.1261/rna.1637809; Klassen R, 2006, FEMS YEAST RES, V6, P404, DOI 10.1111/j.1567-1364.2005.00006.x; Klassen R, 2005, CELL MICROBIOL, V7, P393, DOI 10.1111/j.1462-5822.2004.00469.x; Klassen R, 2004, MOL MICROBIOL, V53, P263, DOI 10.1111/j.1365-2958.2004.04119.x; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; Klassen R, 2007, DNA REPAIR, V6, P1864, DOI 10.1016/j.dnarep.2007.07.010; Klassen R, 2011, MOL GENET GENOMICS, V285, P185, DOI 10.1007/s00438-010-0597-5; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Meineke B, 2012, RNA, V18, P1716, DOI 10.1261/rna.034132.112; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Ogawa T, 2006, NUCLEIC ACIDS RES, V34, P6065, DOI 10.1093/nar/gkl629; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Shigematsu M, 2012, BIOCHEM BIOPH RES CO, V420, P750, DOI 10.1016/j.bbrc.2012.03.061; Shigematsu M, 2009, YEAST, V26, P663, DOI 10.1002/yea.1725; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203	26	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75512	10.1371/journal.pone.0075512	http://dx.doi.org/10.1371/journal.pone.0075512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069426	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300087
J	Hirota, Y; Tsugawa, N; Nakagawa, K; Suhara, Y; Tanaka, K; Uchino, Y; Takeuchi, A; Sawada, N; Kamao, M; Wada, A; Okitsu, T; Okano, T				Hirota, Yoshihisa; Tsugawa, Naoko; Nakagawa, Kimie; Suhara, Yoshitomo; Tanaka, Kiyoshi; Uchino, Yuri; Takeuchi, Atsuko; Sawada, Natsumi; Kamao, Maya; Wada, Akimori; Okitsu, Takashi; Okano, Toshio			Menadione (Vitamin K-3) Is a Catabolic Product of Oral Phylloquinone (Vitamin K-1) in the Intestine and a Circulating Precursor of Tissue Menaquinone-4 (Vitamin K-2) in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Intestine; Metabolism; Rat; Vitamin K; UBIAD1; Conversion; Menadione; Menaquinone-4; Phylloquinone	CELL-LINES; CONVERSION; METABOLISM; CANNULATION	Background: Menadione is an intermediate in phylloquinone to menaquinone-4 conversion in mammals. Results: Menadione is released from phylloquinone in the intestine and converted to menaquinone-4 in tissues after being reduced. Conclusion: Menadione is a catabolic product of phylloquinone and circulating precursor of tissue menaquinone-4. Significance: Determining how phylloquinone is metabolized in the body is crucial for understanding vitamin K biology. Mice have the ability to convert dietary phylloquinone (vitamin K-1) into menaquinone-4 (vitamin K-2) and store the latter in tissues. A prenyltransferase enzyme, UbiA prenyltransferase domain-containing 1 (UBIAD1), is involved in this conversion. There is evidence that UBIAD1 has a weak side chain cleavage activity for phylloquinone but a strong prenylation activity for menadione (vitamin K-3), which has long been postulated as an intermediate in this conversion. Further evidence indicates that when intravenously administered in mice phylloquinone can enter into tissues but is not converted further to menaquinone-4. These findings raise the question whether phylloquinone is absorbed and delivered to tissues in its original form and converted to menaquinone-4 or whether it is converted to menadione in the intestine followed by delivery of menadione to tissues and subsequent conversion to menaquinone-4. To answer this question, we conducted cannulation experiments using stable isotope tracer technology in rats. We confirmed that the second pathway is correct on the basis of structural assignments and measurements of phylloquinone-derived menadione using high resolution MS analysis and a bioassay using recombinant UBIAD1 protein. Furthermore, high resolution MS and H-1 NMR analyses of the product generated from the incubation of menadione with recombinant UBIAD1 revealed that the hydroquinone, but not the quinone form of menadione, was an intermediate of the conversion. Taken together, these results provide unequivocal evidence that menadione is a catabolic product of oral phylloquinone and a major source of tissue menaquinone-4.	[Hirota, Yoshihisa; Tsugawa, Naoko; Nakagawa, Kimie; Uchino, Yuri; Sawada, Natsumi; Kamao, Maya; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 6588558, Japan; [Wada, Akimori; Okitsu, Takashi] Kobe Pharmaceut Univ, Dept Bioorgan Chem, Kobe, Hyogo 6588558, Japan; [Takeuchi, Atsuko] Kobe Pharmaceut Univ, Analyt Ctr, Kobe, Hyogo 6588558, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama 3308570, Japan; [Tanaka, Kiyoshi] Kyoto Womens Univ, Dept Food & Nutr, Kyoto 6058501, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University; Kobe Pharmaceutical University; Shibaura Institute of Technology; Kyoto Womens University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp	Okitsu, Takashi/V-9676-2019; Hirota, Yoshihisa/R-6741-2019	Okitsu, Takashi/0000-0001-5836-4470; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	Japan Society for the Promotion of Science (JSPS) [23390022, 23790110];  [24-7941]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research (B) 23390022 (to T. O.), Grant-in-aid for Scientific Research (Young Scientists-B) 23790110 (to K. N.) from the Japan Society for the Promotion of Science (JSPS), and Grant-in-aid for JSPS Fellows 24-7941 (to Y. H.).	Al Rajabi A, 2012, J NUTR, V142, P841, DOI 10.3945/jn.111.155804; Al Rajabi A, 2010, J CHROMATOGR B, V878, P2457, DOI 10.1016/j.jchromb.2010.07.016; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; Ionac M, 2003, MICROSURG, V23, P239, DOI 10.1002/micr.10136; MEDINSKY MA, 1983, TOXICOL APPL PHARM, V68, P359, DOI 10.1016/0041-008X(83)90279-X; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Ronden JE, 1998, BBA-GEN SUBJECTS, V1379, P69, DOI 10.1016/S0304-4165(97)00089-5; Shearer MJ, 2012, ADV NUTR, V3, P182, DOI 10.3945/an.111.001800; SPEEK AJ, 1984, J CHROMATOGR, V301, P441, DOI 10.1016/S0021-9673(01)89217-7; Strubbe JH, 1999, PHYSIOL BEHAV, V65, P885; Suhara Y, 2010, BIOORGAN MED CHEM, V18, P3116, DOI 10.1016/j.bmc.2010.03.035; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033	17	78	81	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33071	33080		10.1074/jbc.M113.477356	http://dx.doi.org/10.1074/jbc.M113.477356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085302	Green Published, hybrid			2022-12-25	WOS:000328841700023
J	Sathitsuksanoh, N; Xu, B; Zhao, BY; Zhang, YHP				Sathitsuksanoh, Noppadon; Xu, Bin; Zhao, Bingyu; Zhang, Y-H. Percival			Overcoming Biomass Recalcitrance by Combining Genetically Modified Switchgrass and Cellulose Solvent-Based Lignocellulose Pretreatment	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; FERMENTABLE SUGAR YIELDS; ENZYMATIC-HYDROLYSIS; LIGNIN; FRACTIONATION; SACCHARIFICATION; MANIPULATION; IMPROVEMENT; DEPOSITION	Decreasing lignin content of plant biomass by genetic engineering is believed to mitigate biomass recalcitrance and improve saccharification efficiency of plant biomass. In this study, we compared two different pretreatment methods (i.e., dilute acid and cellulose solvent) on transgenic plant biomass samples having different lignin contents and investigated biomass saccharification efficiency. Without pretreatment, no correlation was observed between lignin contents of plant biomass and saccharification efficiency. After dilute acid pretreatment, a strong negative correlation between lignin content of plant samples and overall glucose release was observed, wherein the highest overall enzymatic glucan digestibility was 70% for the low-lignin sample. After cellulose solvent- and organic solvent-based lignocellulose fractionation pretreatment, there was no strong correlation between lignin contents and high saccharification efficiencies obtained (i.e., 80-90%). These results suggest that the importance of decreasing lignin content in plant biomass to saccharification was largely dependent on pretreatment choice and conditions.	[Sathitsuksanoh, Noppadon; Zhang, Y-H. Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Xu, Bin; Zhao, Bingyu] Virginia Tech, Dept Hort, Blacksburg, VA USA; [Sathitsuksanoh, Noppadon; Zhang, Y-H. Percival] Virginia Tech, ICTAS, Blacksburg, VA USA; [Zhang, Y-H. Percival] DOE BioEnergy Sci Ctr BESC, Oak Ridge, TN USA; [Zhang, Y-H. Percival] Gate Fuels Inc, Blacksburg, VA USA; [Zhang, Y-H. Percival] Cell Free Bioinnovat Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Sathitsuksanoh, N (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	sathino@vt.edu	sathitsuksanoh, noppadon/O-6305-2014	sathitsuksanoh, noppadon/0000-0003-1521-9155	Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech; Biological Systems Engineering Department of Virginia Tech; Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech; U.S. Department of Energy [DE-FG02-08ER64629]	Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech; Biological Systems Engineering Department of Virginia Tech; Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech; U.S. Department of Energy(United States Department of Energy (DOE))	This project was partly supported by a grant from the Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech, the Biological Systems Engineering Department of Virginia Tech, the Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech, and the U.S. Department of Energy (under contract number DE-FG02-08ER64629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-3; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; DeMartini JD, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-52; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Guo DG, 2001, TRANSGENIC RES, V10, P457, DOI 10.1023/A:1012278106147; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Moxley G, 2007, ENERG FUEL, V21, P3684, DOI 10.1021/ef7003893; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Rollin JA, 2011, BIOTECHNOL BIOENG, V108, P22, DOI 10.1002/bit.22919; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Saha BC, 2005, BIOTECHNOL PROGR, V21, P816, DOI 10.1021/bp049564n; Sathitsuksanoh N, 2013, J CHEM TECHNOL BIOT, V88, P169, DOI 10.1002/jctb.3959; Sathitsuksanoh N, 2012, BIORESOURCE TECHNOL, V117, P228, DOI 10.1016/j.biortech.2012.04.088; Sathitsuksanoh N, 2011, BIOTECHNOL BIOENG, V108, P521, DOI 10.1002/bit.22964; Selig MJ, 2007, BIOTECHNOL PROGR, V23, P1333, DOI 10.1021/bp0702018; Shi J, 2011, BIORESOURCE TECHNOL, V102, P8930, DOI 10.1016/j.biortech.2011.07.042; Shi J, 2011, BIORESOURCE TECHNOL, V102, P5952, DOI 10.1016/j.biortech.2011.03.027; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Sluiter A., 2008, NREL, P1; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Zhang YHP, 2011, PROCESS BIOCHEM, V46, P2091, DOI 10.1016/j.procbio.2011.08.005; Zhu ZG, 2009, BIOTECHNOL BIOENG, V103, P715, DOI 10.1002/bit.22307	26	19	19	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73523	10.1371/journal.pone.0073523	http://dx.doi.org/10.1371/journal.pone.0073523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086283	Green Published, gold			2022-12-25	WOS:000325223900015
J	Gallagher, N; Fear, EC; Byrd, IA; Vigmond, EJ				Gallagher, Neal; Fear, Elise C.; Byrd, Israel A.; Vigmond, Edward J.			Contact Geometry Affects Lesion Formation in Radio-Frequency Cardiac Catheter Ablation	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; ATRIAL-FIBRILLATION; TISSUE TEMPERATURE; ELECTRODE; BIOMATERIALS; DIFFUSIVITY; IMPEDANCE; DENSITY; MUSCLE; MODEL	One factor which may be important for determining proper lesion creation during atrial ablation is catheter-endocardial contact. Little information is available that relates geometric contact, depth and angle, to ablation lesion formation. We present an electrothermal computer model of ablation that calculated lesion volume and temperature development over time. The Pennes bioheat equation was coupled to a quasistatic electrical problem to investigate the effect of catheter penetration depth, as well as incident catheter angle as may occur in practice. Biological experiments were performed to verify the modelling of electrical phenomena. Results show that for deeply penetrating tips, acute catheter angles reduced the rate of temperature buildup, allowing larger lesions to form before temperatures elevated excessively. It was also found that greater penetration did not lead to greater transmurality of lesions. We conclude that catheter contact angle plays a significant role in lesion formation, and the time course must be considered. This is clinically relevant because proper identification and prediction of geometric contact variables could improve ablation efficacy.	[Gallagher, Neal; Fear, Elise C.; Vigmond, Edward J.] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada; [Byrd, Israel A.] St Jude Med, Atrial Fibrillat Technol Dev, St Paul, MN USA; [Vigmond, Edward J.] Univ Bordeaux 1, Lab Inst Modelisat, LIRYC Electrophysiol & Heart Modeling Inst, Pessac, France	University of Calgary; St. Jude Medical; UDICE-French Research Universities; Universite de Bordeaux	Vigmond, EJ (corresponding author), Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada.	edward.vigmond@u-bordeaux1.fr		Fear, Elise/0000-0002-9984-8188	Natural Sciences and Engineering Research Councils of Canada; French Government through the Agence National de la Recherche programme A"Investissements d'AvenirA [ANR-10-IAHU-04]	Natural Sciences and Engineering Research Councils of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); French Government through the Agence National de la Recherche programme A"Investissements d'AvenirA(French National Research Agency (ANR))	This research was partly supported by a grant from the Natural Sciences and Engineering Research Councils of Canada (http://www.nserc-crsng.gc.ca/), and the French Government through the Agence National de la Recherche (http://www.agence-nationale-recherche.fr/) programme A "Investissements d'AvenirA with grant ANR-10-IAHU-04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, J BIOMECH ENG T ASME, DOI DOI 10.1115/1.3426282; Berjano EJ, 2004, IEEE T BIO-MED ENG, V51, P1348, DOI 10.1109/TBME.2004.827545; Berjano EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-24; Bruce GK, 2005, CIRCULATION, V112, P954, DOI 10.1161/CIRCULATIONAHA.104.492439; Calkins H, 2007, EUROPACE, V9, P335, DOI 10.1093/europace/eum120; Cao H, 2002, IEEE T BIO-MED ENG, V49, P247, DOI 10.1109/10.983459; CHURCHILL SW, 1977, J HEAT TRANS-T ASME, V99, P300, DOI 10.1115/1.3450685; COOPER TE, 1971, AEROSPACE MED, V42, P24; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Gallagher N, 2011, INT J BIOELECTROMAGN, V13, P190; Gopalakrishnan J, 2002, ANN BIOMED ENG, V30, P884, DOI 10.1114/1.1507845; HAINES DE, 1990, CIRC RES, V67, P124, DOI 10.1161/01.RES.67.1.124; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Houben RPM, 2004, HEART RHYTHM, V1, P639, DOI 10.1016/j.hrthm.2004.08.015; Kongsgaard E, 1997, PACE, V20, P1252, DOI 10.1111/j.1540-8159.1997.tb06778.x; MENDLOWITZ M, 1948, SCIENCE, V107, P97, DOI 10.1126/science.107.2769.97; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; NATH S, 1993, CIRCULATION, V88, P1826, DOI 10.1161/01.CIR.88.4.1826; PANESCU D, 1995, IEEE T BIO-MED ENG, V42, P879, DOI 10.1109/10.412649; Peyman A, 2007, BIOELECTROMAGNETICS, V28, P264, DOI 10.1002/bem.20271; Schutt D, 2009, INT J HYPERTHER, V25, P99, DOI 10.1080/02656730802563051; SHAHIDI AV, 1994, IEEE T BIO-MED ENG, V41, P963, DOI 10.1109/10.324528; Suarez Ana Gonzalez, 2010, Open Biomed Eng J, V4, P47, DOI 10.2174/1874120701004020047; Tangwongsan C, 2004, IEEE T BIO-MED ENG, V51, P1478, DOI 10.1109/TBME.2004.828035; Tungjitkusolmun S, 2001, IEEE T BIO-MED ENG, V48, P194, DOI 10.1109/10.909640; VALVANO JW, 1985, INT J THERMOPHYS, V6, P301, DOI 10.1007/BF00522151; Wittkampf FHM, 2006, PACE, V29, P1285, DOI 10.1111/j.1540-8159.2006.00533.x; Wood MA, 2009, J CARDIOVASC ELECTR, V20, P1262, DOI 10.1111/j.1540-8167.2009.01538.x; YIPINTSOI T, 1972, P SOC EXP BIOL MED, V141, P1032; Zheng XS, 2000, J INTERV CARD ELECTR, V4, P645, DOI 10.1023/A:1026586119600	32	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73242	10.1371/journal.pone.0073242	http://dx.doi.org/10.1371/journal.pone.0073242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086275	gold, Green Published			2022-12-25	WOS:000326520200008
J	Lambotte, O; Pollara, J; Boufassa, F; Moog, C; Venet, A; Haynes, BF; Delfraissy, JF; Saez-Cirion, A; Ferrari, G				Lambotte, Olivier; Pollara, Justin; Boufassa, Faroudy; Moog, Christiane; Venet, Alain; Haynes, Barton F.; Delfraissy, Jean-Francois; Saez-Cirion, Asier; Ferrari, Guido			High Antibody-Dependent Cellular Cytotoxicity Responses Are Correlated with Strong CD8 T Cell Viral Suppressive Activity but Not with B57 Status in HIV-1 Elite Controllers	PLOS ONE			English	Article							HETEROGENEITY; INFECTION; MEMORY; ADCC; NK	The role of Antibody-dependent cellular cytotoxicity (ADCC) responses in HIV-1 controllers is still unclear due to the heterogeneity of these patients. We analyzed 67 HIV-1 controllers and found significantly higher levels of ADCC antibodies in controllers versus viremic subjects (p = 0.017). Moreover, multivariate analysis revealed significantly higher ADCC titers in HLA B57-controllers compared to HLA-B57+ ones (p = 0.0086). These data suggest a role for ADCC in immune control of HIV, especially in HLA B57 negative controllers.	[Lambotte, Olivier; Venet, Alain; Delfraissy, Jean-Francois] INSERM, U1012, Le Kremlin Bicetre, France; [Lambotte, Olivier; Delfraissy, Jean-Francois] Bicetre Hosp, AP HP, Dept Internal Med & Infect Dis, Le Kremlin Bicetre, France; [Lambotte, Olivier; Delfraissy, Jean-Francois] Univ Paris 11, Le Kremlin Bicetre, France; [Pollara, Justin; Haynes, Barton F.; Ferrari, Guido] Duke Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC USA; [Pollara, Justin; Haynes, Barton F.; Ferrari, Guido] Duke Sch Med, Dept Surg, Durham, NC USA; [Boufassa, Faroudy] INSERM, CESP U1018, Le Kremlin Bicetre, France; [Moog, Christiane] INSERM, U778, Strasbourg, France; [Saez-Cirion, Asier] Inst Pasteur, Regulat Retroviral Infect Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Duke University; Duke University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lambotte, O (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	olivier.lambotte@bct.aphp.fr	Lambotte, Olivier/GRT-0160-2022; Saez-Cirion, Asier/A-8640-2008; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; C, Moog/E-3962-2016	Saez-Cirion, Asier/0000-0003-2406-7536; Ferrari, Guido/0000-0001-7747-3349; C, Moog/0000-0002-0916-156X	Agence pour la Recherche Contre le SIDA (ANRS); Ensemble contre le SIDA (SIDACTION); INSERM; University Paris-Sud; Duke CFAR [1P30 AI 64518]; National Institutes of Health [AI 0678501, AI61734]; National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [AI007392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392] Funding Source: NIH RePORTER	Agence pour la Recherche Contre le SIDA (ANRS); Ensemble contre le SIDA (SIDACTION); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud; Duke CFAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Agence pour la Recherche Contre le SIDA (ANRS), Ensemble contre le SIDA (SIDACTION), INSERM, University Paris-Sud, Duke CFAR (1P30 AI 64518), and National Institutes of Health grants AI 0678501 and AI61734. J.P. was supported by the National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant AI007392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Van Grevenynghe J, 2011, J CLIN INVEST, V121, P3877, DOI 10.1172/JCI59211; Wang J., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M110.004655; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016	21	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74855	10.1371/journal.pone.0074855	http://dx.doi.org/10.1371/journal.pone.0074855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086385	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200044
J	te Pas, MFW; Koopmans, SJ; Kruijt, L; Calus, MPL; Smits, MA				te Pas, Marinus F. W.; Koopmans, Sietse-Jan; Kruijt, Leo; Calus, Mario P. L.; Smits, Mari A.			Plasma Proteome Profiles Associated with Diet-Induced Metabolic Syndrome and the Early Onset of Metabolic Syndrome in a Pig Model	PLOS ONE			English	Article							EARLY ATHEROSCLEROSIS; BIOMARKER DISCOVERY; GENE-EXPRESSION; STREPTOZOTOCIN; FAT; DYSFUNCTION; OBESITY; LEPTIN; SENSOR	Obesity and related diabetes are important health threatening multifactorial metabolic diseases and it has been suggested that 25% of all diabetic patients are unaware of their patho-physiological condition. Biomarkers for monitoring and control are available, but early stage predictive biomarkers enabling prevention of these diseases are still lacking. We used the pig as a model to study metabolic disease because humans and pigs share a multitude of metabolic similarities. Diabetes was chemically induced and control and diabetic pigs were either fed a high unsaturated fat (Mediterranean) diet or a high saturated fat/cholesterol/sugar (cafeteria) diet. Physiological parameters related to fat metabolism and diabetes were measured. Diabetic pigs' plasma proteome profiles differed more between the two diets than control pigs plasma proteome profiles. The expression levels of several proteins correlated well with (patho) physiological parameters related to the fat metabolism (cholesterol, VLDL, LDL, NEFA) and diabetes (Glucose) and to the diet fed to the animals. Studying only the control pigs as a model for metabolic syndrome when fed the two diets showed correlations to the same parameters but now more focused on insulin, glucose and abdominal fat depot parameters. We conclude that proteomic profiles can be used as a biomarker to identify pigs with developing metabolic syndrome (prediabetes) and diabetes when fed a cafeteria diet. It could be developed into a potential biomarkers for the early recognition of metabolic diseases.	[te Pas, Marinus F. W.; Kruijt, Leo; Calus, Mario P. L.; Smits, Mari A.] Wageningen UR Livestock Res, ABGC, Lelystad, Netherlands; [Koopmans, Sietse-Jan] Wageningen Univ, Adaptat Physiol Grp, Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	te Pas, MFW (corresponding author), Wageningen UR Livestock Res, ABGC, Lelystad, Netherlands.	marinus.tepas@wur.nl	smits, mari/J-4892-2013; Calus, Mario/H-7627-2019	smits, mari/0000-0002-3493-291X; Calus, Mario/0000-0002-3213-704X	Dutch ministry ELI [KB 15-011-003-ASG-V-1]	Dutch ministry ELI	The proteomics work has been funded by a grant from the Dutch ministry EL&I, grant no. KB 15-011-003-ASG-V-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell LN, 2010, AM J PHYSIOL-GASTR L, V298, pG746, DOI 10.1152/ajpgi.00485.2009; Doherty MK, 2008, PROTEOM CLIN APPL, V2, P135, DOI 10.1002/prca.200780085; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koopmans SJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-64; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Mach N, 2010, J ANIM SCI, V88, P1522, DOI 10.2527/jas.2009-2256; MANSFORD KR, 1968, LANCET, V1, P670; Merks JWM., 2000, CHALLENGE GENETIC CH, V27, P8, DOI 10.1017/S1463981500040498; Moore RE, 2007, BIOMARK INSIGHTS, V2, P185; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; RERUP C C, 1970, Pharmacological Reviews, V22, P485; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Sundsten T, 2009, MOL CELL ENDOCRINOL, V297, P93, DOI 10.1016/j.mce.2008.06.018; Szkudelski T, 2001, PHYSIOL RES, V50, P537; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001	26	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73087	10.1371/journal.pone.0073087	http://dx.doi.org/10.1371/journal.pone.0073087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086269	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200006
J	Jaramillo, J; Torto, B; Mwenda, D; Troeger, A; Borgemeister, C; Poehling, HM; Francke, W				Jaramillo, Juliana; Torto, Baldwyn; Mwenda, Dickson; Troeger, Armin; Borgemeister, Christian; Poehling, Hans-Michael; Francke, Wittko			Coffee Berry Borer Joins Bark Beetles in Coffee Klatch	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE HOPKINS; HYPOTHENEMUS-HAMPEI FERRARI; REDBAY AMBROSIA BEETLE; SLAVE-MAKING ANT; COLEOPTERA-CURCULIONIDAE; CHEMICAL ECOLOGY; SECONDARY ATTRACTION; PHEROMONE PRODUCTION; ANTENNAL RESPONSES	Unanswered key questions in bark beetle-plant interactions concern host finding in species attacking angiosperms in tropical zones and whether management strategies based on chemical signaling used for their conifer-attacking temperate relatives may also be applied in the tropics. We hypothesized that there should be a common link in chemical signaling mediating host location by these Scolytids. Using laboratory behavioral assays and chemical analysis we demonstrate that the yellow-orange exocarp stage of coffee berries, which attracts the coffee berry borer, releases relatively high amounts of volatiles including conophthorin, chalcogran, frontalin and sulcatone that are typically associated with Scolytinae chemical ecology. The green stage of the berry produces a much less complex bouquet containing small amounts of conophthorin but no other compounds known as bark beetle semiochemicals. In behavioral assays, the coffee berry borer was attracted to the spiroacetals conophthorin and chalcogran, but avoided the monoterpenes verbenone and a-pinene, demonstrating that, as in their conifer-attacking relatives in temperate zones, the use of host and non-host volatiles is also critical in host finding by tropical species. We speculate that microorganisms formed a common basis for the establishment of crucial chemical signals comprising inter-and intraspecific communication systems in both temperate-and tropical-occurring bark beetles attacking gymnosperms and angiosperms.	[Jaramillo, Juliana; Poehling, Hans-Michael] Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany; [Jaramillo, Juliana; Torto, Baldwyn; Mwenda, Dickson; Borgemeister, Christian] Icipe, Nairobi, Kenya; [Troeger, Armin; Francke, Wittko] Univ Hamburg, Inst Organ Chem, Hamburg, Germany	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE); University of Hamburg	Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany.	jjaramillo@icipe.org			German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation - Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; Beck JJ, 2012, J AGR FOOD CHEM, V60, P11869, DOI 10.1021/jf304157q; Berenbaum MR, 2008, SCIENCE, V322, P52, DOI 10.1126/science.1164873; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Borbon-Martinez MO, 1989, THESIS U P SABATIER; Borden JH, 2003, FOREST CHRON, V79, P685, DOI 10.5558/tfc79685-3; BORDEN JH, 1979, J CHEM ECOL, V5, P79, DOI 10.1007/BF00987689; Borden JH, 1997, INSECT PHEROMONE RESEARCH, P421; Borden JH, 1998, CHEMOECOLOGY, V8, P69, DOI 10.1007/PL00001806; Broberg CL, 2005, CAN ENTOMOL, V137, P716; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Brun L. O., 1997, P714; BUHRING M, 1976, Z NATURFORSCH C, V31, P748, DOI 10.1515/znc-1976-11-1223; Burbano EG, 2012, ENVIRON ENTOMOL, V41, P133, DOI 10.1603/EN11112; Byers JA, 2000, NATURWISSENSCHAFTEN, V87, P503, DOI 10.1007/s001140050768; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Cantergiani E, 2001, EUR FOOD RES TECHNOL, V212, P648, DOI 10.1007/s002170100305; Castracani C, 2008, INSECT SOC, V55, P137, DOI 10.1007/s00040-008-0981-x; Citron CA, 2012, J NAT PROD, V75, P1765, DOI 10.1021/np300468h; COULSON RN, 1979, ANNU REV ENTOMOL, V24, P417, DOI 10.1146/annurev.en.24.010179.002221; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; Dodds KJ, 2011, J ECON ENTOMOL, V104, P879, DOI 10.1603/EC10358; Dufour BP, 2008, J APPL ENTOMOL, V132, P591, DOI 10.1111/j.1439-0418.2008.01291.x; FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; Francke W, 2001, CURR ORG CHEM, V5, P233, DOI 10.2174/1385272013375652; Francke W, 1999, CURR ORG CHEM, V3, P407; Francke-Grosmann H., 1967, P141; Goodwin TE, 2006, J CHEM ECOL, V32, P1849, DOI 10.1007/s10886-006-9094-z; Greenberg L, 2007, J CHEM ECOL, V33, P935, DOI 10.1007/s10886-007-9269-2; Hanula JL, 2011, J ECON ENTOMOL, V104, P501, DOI 10.1603/EC10263; HARDIE J, 1994, J CHEM ECOL, V20, P2847, DOI 10.1007/BF02098393; Harrington Thomas C., 2005, P257; Huber DPW, 2001, AGR FOREST ENTOMOL, V3, P225, DOI 10.1046/j.1461-9555.2001.00111.x; Huber DPW, 1999, J CHEM ECOL, V25, P805, DOI 10.1023/A:1020892700653; Huber DPW, 2001, ENTOMOL EXP APPL, V99, P131, DOI 10.1023/A:1018979916210; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Huber DPW, 2000, CHEMOECOLOGY, V10, P103, DOI 10.1007/PL00001811; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Kendra PE, 2011, J CHEM ECOL, V37, P932, DOI 10.1007/s10886-011-9998-0; Khan ZR, 2000, PEST MANAG SCI, V56, P957, DOI 10.1002/1526-4998(200011)56:11<957::AID-PS236>3.0.CO;2-T; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Liu SS, 2005, ECOL LETT, V8, P722, DOI 10.1111/j.1461-0248.2005.00776.x; Mathieu F, 1998, J AGR FOOD CHEM, V46, P1106, DOI 10.1021/jf970851z; Mathieu F, 1999, J APPL ENTOMOL, V123, P535, DOI 10.1046/j.1439-0418.1999.00400.x; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; MILLER JR, 1990, J CHEM ECOL, V16, P3197, DOI 10.1007/BF00979619; Nijholt W. W., 1976, Bi-monthly Research Notes, V32, P31; Ortiz A, 2004, J AGR FOOD CHEM, V52, P5914, DOI 10.1021/jf049537c; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Raffa KF, 2001, CHEMOECOLOGY, V11, P49, DOI 10.1007/PL00001833; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; Rasmussen LEL, 2003, CHEM SENSES, V28, P433, DOI 10.1093/chemse/28.5.433; Reding ME, 2011, J ECON ENTOMOL, V104, P2017, DOI 10.1603/EC11119; Rochat D, 2000, J CHROMATOGR A, V885, P433, DOI 10.1016/S0021-9673(99)01049-3; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; SAS Institute, 1999, SAS STAT US GUID; SCHROEDER LM, 1989, J CHEM ECOL, V15, P807, DOI 10.1007/BF01015179; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 2004, SYMBIOSIS, V37, P207; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P835; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zhang QH, 1999, J CHEM ECOL, V25, P1923, DOI 10.1023/A:1020994119019; Zhang QH, 2000, CHEMOECOLOGY, V10, P69, DOI 10.1007/s000490050010; Zhang QH, 2002, J CHEM ECOL, V28, P1839, DOI 10.1023/A:1020569303433	73	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74277	10.1371/journal.pone.0074277	http://dx.doi.org/10.1371/journal.pone.0074277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073204	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000013
J	Lalmansingh, AS; Arora, K; DeMarco, RA; Hager, GL; Nagaich, AK				Lalmansingh, Avin S.; Arora, Kamalpreet; DeMarco, Richard A.; Hager, Gordon L.; Nagaich, Akhilesh K.			High-Throughput RNA FISH Analysis by Imaging Flow Cytometry Reveals That Pioneer Factor Foxa1 Reduces Transcriptional Stochasticity	PLOS ONE			English	Article							TUMOR VIRUS PROMOTER; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; LIVING CELLS; NATURAL PROMOTER; CHROMATIN; BINDING; MODES	Genes are regulated at the single-cell level. Here, we performed RNA FISH of thousands of cells by flow cytometry (flow-RNA FISH) to gain insight into transcriptional variability between individual cells. These experiments utilized the murine adenocarcinoma 3134 cell line with 200 copies of the MMTV-Ras reporter integrated at a single genomic locus. The MMTV array contains approximately 800-1200 binding sites for the glucocorticoid receptor (GR) and 600 binding sites for the pioneer factor Foxa1. Hormone activation of endogenous GR by dexamethasone treatment resulted in highly variable changes in the RNA FISH intensity (25-300 pixel intensity units) and size (1.25-15 mu m), indicative of probabilistic or stochastic mechanisms governing GR and cofactor activation of the MMTV promoter. Exogenous expression of the pioneer factor Foxa1 increased the FISH signal intensity and size as expected for a chromatin remodeler that enhances transcriptional competence through increased chromatin accessibility. In addition, specific analysis of Foxa1-enriched cell sub-populations showed that low and high Foxa1 levels substantially lowered the cell-to-cell variability in the FISH intensity as determined by a noise calculation termed the % coefficient of variation. These results suggest that an additional function of the pioneer factor Foxa1 may be to decrease transcriptional noise.	[Lalmansingh, Avin S.; Arora, Kamalpreet; Nagaich, Akhilesh K.] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [DeMarco, Richard A.] EMD Millipore Corp, Amnis, Seattle, WA USA; [Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Merck KGaA; MilliporeSigma; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagaich, AK (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	akhilesh.nagaich@fda.hhs.gov			United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER); United States Department of Energy; FDA; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER); United States Department of Energy(United States Department of Energy (DOE)); FDA(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER). This project was supported in part by an appointment to the Research Participation Program at CDER administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the United States Department of Energy and FDA [to A.S.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Belikov S, 2012, EXP CELL RES, V318, P61, DOI 10.1016/j.yexcr.2011.09.016; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Georgel PT, 2003, GENE DEV, V17, P1617, DOI 10.1101/gad.1097603; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; OSTROWSKI MC, 1983, MOL CELL BIOL, V3, P2045, DOI 10.1128/MCB.3.11.2045; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Voss TC, 2009, J CELL SCI, V122, P345, DOI 10.1242/jcs.035865; Zaret KS, 2010, COLD SH Q B, V75, P219, DOI 10.1101/sqb.2010.75.061; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	31	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76043	10.1371/journal.pone.0076043	http://dx.doi.org/10.1371/journal.pone.0076043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073287	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000097
J	Xu, ST; Zhang, Y; Zhu, Z; Liu, CY; Mao, NY; Ji, YX; Wang, HL; Jiang, XH; Li, CS; Tang, W; Feng, DX; Wang, CY; Zheng, L; Lei, Y; Ling, H; Zhao, CF; Ma, Y; He, JL; Wang, Y; Li, P; Guan, RH; Zhou, SJ; Zhou, JH; Wang, S; Zhang, H; Zheng, HY; Liu, L; Ma, HMT; Guan, J; Lu, PS; Feng, Y; Zhang, YJ; Zhou, SD; Xiong, Y; Ba, ZM; Chen, H; Yang, XH; Bo, F; Ma, YJ; Liang, Y; Lei, YK; Gu, SY; Liu, W; Chen, M; Featherstone, D; Jee, Y; Bellini, WJ; Rota, PA; Xu, W				Xu, Songtao; Zhang, Yan; Zhu, Zhen; Liu, Chunyu; Mao, Naiying; Ji, Yixin; Wang, Huiling; Jiang, Xiaohong; Li, Chongshan; Tang, Wei; Feng, Daxing; Wang, Changyin; Zheng, Lei; Lei, Yue; Ling, Hua; Zhao, Chunfang; Ma, Yan; He, Jilan; Wang, Yan; Li, Ping; Guan, Ronghui; Zhou, Shujie; Zhou, Jianhui; Wang, Shuang; Zhang, Hong; Zheng, Huanying; Liu, Leng; Ma, Hemuti; Guan, Jing; Lu, Peishan; Feng, Yan; Zhang, Yanjun; Zhou, Shunde; Xiong, Ying; Ba, Zhuoma; Chen, Hui; Yang, Xiuhui; Bo, Fang; Ma, Yujie; Liang, Yong; Lei, Yake; Gu, Suyi; Liu, Wei; Chen, Meng; Featherstone, David; Jee, Youngmee; Bellini, William J.; Rota, Paul A.; Xu, Wenbo			Genetic Characterization of the Hemagglutinin Genes of Wild-Type Measles Virus Circulating in China, 1993-2009	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; RECEPTOR; IDENTIFICATION; ANTIGENICITY; EVOLUTION; GENOTYPES; SOFTWARE; RESIDUES; EPITOPES; BINDING	Background: China experienced several large measles outbreaks in the past two decades, and a series of enhanced control measures were implemented to achieve the goal of measles elimination. Molecular epidemiologic surveillance of wild-type measles viruses (MeV) provides valuable information about the viral transmission patterns. Since 1993, virologic surveillnace has confirmed that a single endemic genotype H1 viruses have been predominantly circulating in China. A component of molecular surveillance is to monitor the genetic characteristics of the hemagglutinin (H) gene of MeV, the major target for virus neutralizing antibodies. Principal Findings: Analysis of the sequences of the complete H gene from 56 representative wild-type MeV strains circulating in China during 1993-2009 showed that the H gene sequences were clustered into 2 groups, cluster 1 and cluster 2. Cluster1 strains were the most frequently detected cluster and had a widespread distribution in China after 2000. The predicted amino acid sequences of the H protein were relatively conserved at most of the functionally significant amino acid positions. However, most of the genotype H1 cluster1 viruses had an amino acid substitution (Ser240Asn), which removed a predicted N-linked glycosylation site. In addition, the substitution of Pro397Leu in the hemagglutinin noose epitope (HNE) was identified in 23 of 56 strains. The evolutionary rate of the H gene of the genotype H1 viruses was estimated to be approximately 0.76x10(-3) substitutions per site per year, and the ratio of dN to dS (dN/dS) was <1 indicating the absence of selective pressure. Conclusions: Although H genes of the genotype H1 strains were conserved and not subjected to selective pressure, several amino acid substitutions were observed in functionally important positions. Therefore the antigenic and genetic properties of H genes of wild-type MeVs should be monitored as part of routine molecular surveillance for measles in China.	[Xu, Songtao; Zhang, Yan; Zhu, Zhen; Mao, Naiying; Ji, Yixin; Wang, Huiling; Jiang, Xiaohong; Xu, Wenbo] China Ctr Dis Control & Prevent, Reg Reference Measles Lab WHO Western Pacific Reg, Key Lab Med Virol, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Liu, Chunyu; Bellini, William J.; Rota, Paul A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Li, Chongshan; Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Feng, Daxing] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China; [Wang, Changyin] Shandong Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Zheng, Lei] Shanxi Ctr Dis Control & Prevent, Taiyuan, Shanxi Province, Peoples R China; [Lei, Yue] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Ling, Hua; Zhao, Chunfang] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Ma, Yan] Hainan Ctr Dis Control & Prevent, Haikou, Hainan Province, Peoples R China; [He, Jilan] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yan] Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Li, Ping; Guan, Ronghui] Shaanxi Ctr Dis Control & Prevent, Xian, Shannxi Provinc, Peoples R China; [Zhou, Shujie] Anhui Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Zhou, Jianhui; Wang, Shuang] Jilin Ctr Dis Control & Prevent, Changchun, Jilin Province, Peoples R China; [Zhang, Hong] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Zheng, Huanying; Liu, Leng] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangzhou Provi, Peoples R China; [Ma, Hemuti; Guan, Jing] Xinjiang Ctr Dis Control & Prevent, Urumchi City, Xinjiang Provin, Peoples R China; [Lu, Peishan] Jiangsu Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Feng, Yan; Zhang, Yanjun] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhou, Shunde; Xiong, Ying] Jiangxi Ctr Dis Control & Prevent, Nanchang City, Jiangxi, Peoples R China; [Ba, Zhuoma] Qinghai Ctr Dis Control & Prevent, Xining, Qinghai Provinc, Peoples R China; [Chen, Hui] Ningxia Ctr Dis Control & Prevent, Yinchuan City, Ningxia Provinc, Peoples R China; [Yang, Xiuhui] Fujian Ctr Dis Control & Prevent, Fuzhou, Fujian Province, Peoples R China; [Bo, Fang; Ma, Yujie] Heilongjiang Ctr Dis Control & Prevent, Harbin, Heilongjiang Pr, Peoples R China; [Liang, Yong] Hebei Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China; [Lei, Yake] Hubei Ctr Dis Control & Prevent, Wuhan, Hunan, Peoples R China; [Gu, Suyi] Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China; [Liu, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi Provinc, Peoples R China; [Chen, Meng] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Featherstone, David] WHO, CH-1211 Geneva, Switzerland; [Jee, Youngmee] WHO, Western Pacific Reg Off, Manila, Philippines	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Shanghai Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Xu, W (corresponding author), China Ctr Dis Control & Prevent, Reg Reference Measles Lab WHO Western Pacific Reg, Key Lab Med Virol, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	ma, yujie/GYA-3957-2022; Jee, Youngmee/AGW-0164-2022	Jee, Youngmee/0000-0001-5369-6628	Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004215, 2013ZX10004-101, 2012ZX10004401, 2012ZX10004201-003]; WHO Measles Regional Reference Laboratory; WHO [WP CHN AAA 011 XZ 08]	Key Technologies R&D Program of National Ministry of Science; WHO Measles Regional Reference Laboratory; WHO(World Health Organization)	This work is supported by the Key Technologies R&D Program of National Ministry of Science (2013ZX10004-202, 2012ZX10004215, 2013ZX10004-101, 2012ZX10004401, 2012ZX10004201-003), WHO Measles Regional Reference Laboratory funding and WHO funding (number WP CHN AAA 011 XZ 08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHATIB G, 1986, VIROLOGY, V150, P479, DOI 10.1016/0042-6822(86)90312-0; Bolt G, 1999, VIRUS RES, V61, P43, DOI 10.1016/S0168-1702(99)00025-8; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Griffin D., 1996, FIELDS VIROLOGY, V3rd ed., P1267; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; HU AH, 1994, J GEN VIROL, V75, P1043, DOI 10.1099/0022-1317-75-5-1043; HU AH, 1994, J GEN VIROL, V75, P2173, DOI 10.1099/0022-1317-75-9-2173; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Ji YX, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-105; Ji Yixin, 2009, Virol J, V6, P135, DOI 10.1186/1743-422X-6-135; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Liffick SL, 2001, VIRUS RES, V77, P81, DOI 10.1016/S0168-1702(01)00268-4; MAKELA MJ, 1989, SCAND J IMMUNOL, V30, P225, DOI 10.1111/j.1365-3083.1989.tb01205.x; Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; SAITO H, 1995, MOL CELL PROBE, V9, P1, DOI 10.1016/S0890-8508(95)90902-8; Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0; Shi JW, 2011, VIRUS GENES, V43, P319, DOI 10.1007/s11262-011-0638-0; Tahara M, 2013, J VIROL, V87, P3583, DOI 10.1128/JVI.03029-12; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vongpunsawad S, 2004, J VIROL, V78, P302, DOI 10.1128/JVI.78.1.302-313.2004; World Health Organization (WHO), 2012, WKLY EPIDEMIOL REC, V87, P73; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	39	14	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73374	10.1371/journal.pone.0073374	http://dx.doi.org/10.1371/journal.pone.0073374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073194	Green Published, gold			2022-12-25	WOS:000324768000003
J	Plesnar-Bielak, A; Skrzynecka, AM; Prokop, ZM; Kolasa, M; Dzialo, M; Radwan, J				Plesnar-Bielak, Agata; Skrzynecka, Anna M.; Prokop, Zofia M.; Kolasa, Michal; Dzialo, Maciej; Radwan, Jacek			No Evidence for Reproductive Isolation through Sexual Conflict in the Bulb Mite Rhizoglyphus robini	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; DROSOPHILA-MELANOGASTER; SELECTION; SPECIATION; EVOLUTION; ADAPTATION; MANIPULATION; ASSOCIATION; POPULATIONS; RESISTANCE	Sexual conflict leading to sexual antagonistic coevolution has been hypothesized to drive reproductive isolation in allopatric populations and hence lead to speciation. However, the generality of this speciation mechanism is under debate. We used experimental evolution in the bulb mite Rhizoglyphus robini to investigate whether sexual conflict promotes reproductive isolation measured comprehensively to include all possible pre- and post-zygotic mechanisms. We established replicate populations in which we either enforced monogamy, and hence removed sexual conflict by making male and female evolutionary interests congruent, or allowed promiscuity. After 35 and 45 generations of experimental evolution, we found no evidence of reproductive isolation between the populations in any of the mating systems. Our results indicate that sexual conflict does not necessarily drive fast reproductive isolation and it may not be a ubiquitous mechanism leading to speciation.	[Plesnar-Bielak, Agata; Skrzynecka, Anna M.; Prokop, Zofia M.; Kolasa, Michal; Dzialo, Maciej; Radwan, Jacek] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Radwan, Jacek] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Poznan, Poland	Jagiellonian University; Adam Mickiewicz University	Plesnar-Bielak, A (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	agata.plesnar@uj.edu.pl	PLESNAR-BIELAK, Agata/F-3391-2015; Kolasa, Michał/AAB-6336-2020	PLESNAR-BIELAK, Agata/0000-0002-7806-8908; Kolasa, Michał/0000-0003-2143-429X; Dzialo, Maciej/0000-0002-3632-8572; Radwan, Jacek/0000-0001-8503-5701	Polish Ministry of Science and Higher Education [N303 529438]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The project was supported by grant number N303 529438 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Bacigalupe LD, 2007, J EVOLUTION BIOL, V20, P1763, DOI 10.1111/j.1420-9101.2007.01389.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Coyne JA, 2004, SPECIATION, V37; Fisher R.A., 1930, GENETICAL THEORY NAT; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2005, EVOL ECOL, V19, P167, DOI 10.1007/s10682-004-7916-4; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gay L, 2009, BIOL LETTERS, V5, P693, DOI 10.1098/rsbl.2009.0072; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kolodziejczyk M, 2003, BEHAV ECOL SOCIOBIOL, V53, P110, DOI 10.1007/s00265-002-0557-0; Konior M, 2006, P ROY SOC B-BIOL SCI, V273, P309, DOI 10.1098/rspb.2005.3302; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Michalczyk L, 2008, THESIS U E ANGLIA; Michalczyk L, 2011, SCIENCE, V333, P1739, DOI 10.1126/science.1207314; Morrow EH, 2003, ECOL LETT, V6, P228, DOI 10.1046/j.1461-0248.2003.00418.x; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Parker GA, 1979, SEXUAL SELECTION REP, P126; Plesnar-Bielak A, 2012, P ROY SOC B-BIOL SCI, V279, P4661, DOI 10.1098/rspb.2012.1867; Radwan J, 1996, ANIM BEHAV, V52, P651, DOI 10.1006/anbe.1996.0209; Radwan J, 1997, ETHOL ECOL EVOL, V9, P373, DOI 10.1080/08927014.1997.9522879; Radwan J, 2000, ETHOLOGY, V106, P53, DOI 10.1046/j.1439-0310.2000.00498.x; Radwan J, 2007, EXP APPL ACAROL, V42, P151, DOI 10.1007/s10493-007-9086-x; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rowe L, 2006, PHILOS T R SOC B, V361, P277, DOI 10.1098/rstb.2005.1788; Tilszer M, 2006, EVOLUTION, V60, P1868, DOI 10.1111/j.0014-3820.2006.tb00530.x; Wigby S, 2006, J EVOLUTION BIOL, V19, P1033, DOI 10.1111/j.1420-9101.2006.01107.x; Wigby S, 2004, EVOLUTION, V58, P1028	43	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74971	10.1371/journal.pone.0074971	http://dx.doi.org/10.1371/journal.pone.0074971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069369	Green Published, gold			2022-12-25	WOS:000324777300057
J	Al-Sammak, F; Kalinski, T; Weinert, S; Link, A; Wex, T; Malfertheiner, P				Al-Sammak, Fadi; Kalinski, Thomas; Weinert, Soenke; Link, Alexander; Wex, Thomas; Malfertheiner, Peter			Gastric Epithelial Expression of IL-12 Cytokine Family in Helicobacter pylori Infection in Human: Is it Head or Tail of the Coin?	PLOS ONE			English	Article							HETERODIMERIC CYTOKINE; T-CELLS; GENE-EXPRESSION; HOST-CELL; RECEPTOR; INTERLEUKIN-12; PROTEIN; SUBUNIT; DISEASE; CLONING	Recently, there has been a growing interest in an expanding group of cytokines known as "IL-12 family". The so far gained knowledge about these cytokines, as crucial playmakers in mucosal immunity, has not yet been sufficiently investigated in the context of Helicobacter pylori infection. All genes encoding the monomeric components of these cytokines and their corresponding receptors were examined in gastric epithelial cell lines (AGS and MKN-28) after being infected with 4 H. pylori strains: BCM-300, P1 wild-type, and P1-derived isogenic mutants lacking cytotoxin-associated gene A (cagA) or virulence gene virB7 (multiplicity of infection=50). Both infected and uninfected samples were analyzed after 24h and 48h using real-time quantitative polymerase chain reaction (RT-qPCR). Gene expression analysis demonstrated a strong upregulation of IL23A (encodes p19) by infection, whereas IL23R, Epstein-Barr virus-induced gene 3 (EBI3), IL6ST, IL12A, and IL27RA were found to be expressed, but not regulated, or to a lesser extent. Transcripts of IL12RB2, IL12B, IL12RB1, and IL27A were not detected. Interestingly, P1 resulted in stronger alterations of expression than CagA mutant and BCM-300, particularly for IL23A (59.7-fold versus 32.4- and 6.7-fold, respectively in AGS after 48h, P<.05), whereas no changes were seen with VirB7 mutant. In a proof-of-principle experiment, we demonstrated epithelial-derived expression of IL-12, p19, and Ebi3 in gastric mucosa of gastritis patients using immunohistochemistry (IHC). Unlike IL-12 and Ebi3, increased immunostaining of p19 was observed in H. pylori gastritis. Herein, we highlight the potential role of gastric epithelial cells in mucosal immunity, not only because they are predominant cell type in mucosa and initial site of host-bacterial interaction, but also as a major contributor to molecules that are thought to be primarily expressed by immune cells so far. Of these molecules, p19 was the most relevant one to H. pylori infection in terms of expression and localization.	[Al-Sammak, Fadi; Link, Alexander; Wex, Thomas; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Kalinski, Thomas] Otto Von Guericke Univ, Dept Pathol, Magdeburg, Germany; [Weinert, Soenke] Otto Von Guericke Univ, Dept Cardiol Angiol & Pneumol, Magdeburg, Germany; [Wex, Thomas] Dept Mol Genet, Med Lab Clin Chem Microbiol & Infect Dis, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University	Wex, T (corresponding author), Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	t.wex@schenk-ansorge.de	Al-Sammak, Fadi F./ABD-8552-2020	Link, Alexander/0000-0002-9514-4562; Al-Sammak, Fadi F./0000-0001-7765-6612; Weinert, Sonke/0000-0002-7201-0836	German Academic Exchange Service (DAAD); Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine; BMBF [BMBF-0315905D]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by a joint scholarship program between the German Academic Exchange Service (DAAD) and the Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine. This work was also supported in part by a grant from the BMBF (BMBF-0315905D) in the frame of ERA-Net PathoGenoMics project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2002, HAEMATOLOGICA, V87, P434; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bliss SK, 2000, J IMMUNOL, V165, P4515, DOI 10.4049/jimmunol.165.8.4515; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Core R Team, 2012, R LANG ENV STAT COMP; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; CRABTREE JE, 1994, J CLIN PATHOL, V47, P945, DOI 10.1136/jcp.47.10.945; DESAI BB, 1992, J IMMUNOL, V148, P3125; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Liu Jianguo, 2005, Curr Immunol Rev, V1, P119, DOI 10.2174/1573395054065115; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Malfertheiner P, 2012, GASTROENTEROLOGY S1, V142, pS; Matthias Kohl, 2007, SLQPCR FUNCTIONS ANA; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Maul J, 2012, LANGENBECK ARCH SURG, V397, P1, DOI 10.1007/s00423-011-0789-4; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; WOLF SF, 1991, J IMMUNOL, V146, P3074; Wu CY, 1997, EUR J IMMUNOL, V27, P147, DOI 10.1002/eji.1830270122	50	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75192	10.1371/journal.pone.0075192	http://dx.doi.org/10.1371/journal.pone.0075192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069393	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300073
J	Galatola, M; Izzo, V; Cielo, D; Morelli, M; Gambino, G; Zanzi, D; Strisciuglio, C; Sperandeo, MP; Greco, L; Auricchio, R				Galatola, Martina; Izzo, Valentina; Cielo, Donatella; Morelli, Marinita; Gambino, Giuseppina; Zanzi, Delia; Strisciuglio, Caterina; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata			Gene Expression Profile of Peripheral Blood Monocytes: A Step towards the Molecular Diagnosis of Celiac Disease?	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; MULTIPLE COMMON; LPP EXPRESSION; T(H)17 CELLS; KAPPA-B; DIFFERENTIATION; ASSOCIATION; VARIANTS; IL-21	Aim: Celiac disease (CD) is a multifactorial autoimmune disease induced by ingestion of gluten in genetically predisposed individuals. Despite technological progress, the diagnosis of CD is still based on duodenal biopsy as it was 50 years ago. In this study we analysed the expression of CD-associated genes in small bowel biopsies of patients and controls in order to explore the multivariate pathway of the expression profile of CD patients. Then, using multivariant discriminant analysis, we evaluated whether the expression profiles of these genes in peripheral blood monocytes (PBMs) differed between patients and controls. Participants: Thirty-seven patients with active and 11 with treated CD, 40 healthy controls and 9 disease controls (Crohn's disease patients) were enrolled. Results: Several genes were differentially expressed in CD patients versus controls, but the analysis of each single gene did not provided a comprehensive picture. A multivariate discriminant analysis showed that the expression of 5 genes in intestinal mucosa accounted for 93% of the difference between CD patients and controls. We then applied the same approach to PBMs, on a training set of 20 samples. The discriminant equation obtained was validated on a testing cohort of 10 additional cases and controls, and we obtained a correct classification of all CD cases and of 91% of the control samples. We applied this equation to treated CD patients and to disease controls and obtained a discrimination of 100%. Conclusions: The combined expression of 4 genes allows one to discriminate between CD patients and controls, and between CD patients on a gluten-free diet and disease controls. Our results contribute to the understanding of the complex interactions among CD-associated genes, and they may represent a starting point for the development of a molecular diagnosis of celiac disease.	[Galatola, Martina; Izzo, Valentina; Cielo, Donatella; Morelli, Marinita; Gambino, Giuseppina; Zanzi, Delia; Strisciuglio, Caterina; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Galatola, Martina; Cielo, Donatella; Zanzi, Delia; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata] Univ Naples Federico II, ELFID, Naples, Italy; [Galatola, Martina] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Greco, L (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	ydongre@unina.it	Strisciuglio, Caterina/ABD-2466-2020; AURICCHIO, RENATA/AAC-7718-2022	STRISCIUGLIO, Caterina/0000-0002-9005-6571	PREVENT-CD project [036383]	PREVENT-CD project	This work was funded by the PREVENT-CD project: EU-FP6-2005-FOOD4B-contract no. 036383. The authors thank Associazione Italiana Celiachia (AIC), European Laboratory for food induced disease (ELFID) and the Italian Ministry of Health, International Affairs, (EUROMED action - MEDICEL project) for a supporting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bragde H, 2011, PEDIATR RES, V69, P530, DOI 10.1203/PDR.0b013e318217ecec; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Gibbons DL, 2011, J IMMUNOL, V187, P2067, DOI 10.4049/jimmunol.1100833; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Greco L, 2011, WORLD J GASTROENTERO, V17, P4971, DOI 10.3748/wjg.v17.i45.4971; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Hollis-Moffatt JE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3053; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; IRVINE EJ, 1995, J CLIN GASTROENTEROL, V20, P27; Izzo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026920; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Oberhuber G, 2001, Z GASTROENTEROL, V39, P157, DOI 10.1055/s-2001-11147; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Qu ZL, 2012, J HUAZHONG U SCI-MED, V32, P459, DOI 10.1007/s11596-012-0080-0; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; VECCHI M, 1992, GASTROENTEROLOGY, V102, P1499, DOI 10.1016/0016-5085(92)91707-B; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang MM, 2012, MOL VIS, V18, P1865	33	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74747	10.1371/journal.pone.0074747	http://dx.doi.org/10.1371/journal.pone.0074747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069342	gold, Green Published			2022-12-25	WOS:000324547300055
J	Cuppini, L; Calleri, A; Bruzzone, MG; Prodi, E; Anghileri, E; Pellegatta, S; Mancuso, P; Porrati, P; Di Stefano, AL; Ceroni, M; Bertolini, F; Finocchiaro, G; Eoli, M				Cuppini, Lucia; Calleri, Angelica; Bruzzone, Maria Grazia; Prodi, Elena; Anghileri, Elena; Pellegatta, Serena; Mancuso, Patrizia; Porrati, Paola; Di Stefano, Anna Luisa; Ceroni, Mauro; Bertolini, Francesco; Finocchiaro, Gaetano; Eoli, Marica			Prognostic Value of CD109+Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan	PLOS ONE			English	Article							PHASE-II TRIAL; PROGENITOR CELLS; 1ST-LINE CHEMOTHERAPY; RESPONSE ASSESSMENT; HEMATOPOIETIC STEM; FLOW-CYTOMETRY; CLINICAL-VALUE; VEGF; TEMOZOLOMIDE; GLIOMAS	Background: Recent data suggest that circulating endothelial and progenitor cells (CECs and CEPs, respectively) may have predictive potential in cancer patients treated with bevacizumab, the antibody recognizing vascular endothelial growth factor (VEGF). Here we report on CECs and CEPs investigated in 68 patients affected by recurrent glioblastoma (rGBM) treated with bevacizumab and irinotecan and two Independent Datasets of rGBM patients respectively treated with bevacizumab alone (n=32, independent dataset A: IDA) and classical antiblastic chemotherapy (n=14, independent dataset B: IDB). Methods: rGBM patients with KPS >= 50 were treated until progression, as defined by MRI with RANO criteria. CECs expressing CD109, a marker of tumor endothelial cells, as well as other CEC and CEP subtypes, were investigated by six-color flow cytometry. Results: A baseline count of CD109+ CEC higher than 41.1/ml (1st quartile) was associated with increased progression free survival (PFS; 20 versus 9 weeks, P=0.008) and overall survival (OS; 32 versus 23 weeks, P=0.03). Longer PFS (25 versus 8 weeks, P=0.02) and OS (27 versus 17 weeks, P=0.03) were also confirmed in IDA with CD109+ CECs higher than 41.1/ml but not in IDB. Patients treated with bevacizumab with or without irinotecan that were free from MRI progression after two months of treatment had significant decrease of CD109+ CECs: median PFS was 19 weeks; median OS 29 weeks. The presence of two non-contiguous lesions (distant disease) at baseline was an independent predictor of shorter PFS and OS (P<0.001). Conclusions: Data encourage further studies on the predictive potential of CD109+ CECs in GBM patients treated with bevacizumab.	[Cuppini, Lucia; Anghileri, Elena; Pellegatta, Serena; Porrati, Paola; Di Stefano, Anna Luisa; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C, Dept Neurooncol Unit, Milan, Italy; [Calleri, Angelica; Mancuso, Patrizia; Bertolini, Francesco] European Inst Oncol, Dept Hematol Oncol, Milan, Italy; [Bruzzone, Maria Grazia; Prodi, Elena] Fdn IRCCS Ist Neurol C, Dept Neuroradiol, Milan, Italy; [Di Stefano, Anna Luisa; Ceroni, Mauro] Fdn IRCCS Ist Neurol Nazl C, Dept Neurol, Pavia, Italy	IRCCS European Institute of Oncology (IEO)	Finocchiaro, G (corresponding author), Fdn IRCCS Ist Neurol C, Dept Neurooncol Unit, Milan, Italy.	gaetano.finocchiaro@gmail.com	Bruzzone, Maria/AAM-4478-2021; Pellegatta, Serena/AAL-3693-2021; bertolini, francesco/AAC-9780-2019; Eoli, Marica/K-7748-2016; Anghileri, Elena/AAK-4180-2021; ceroni, mauro/G-7080-2011; Di Stefano, Anna Luisa/AAS-7836-2020; Calleri, Angelica/AAO-3747-2020; Finocchiaro, Gaetano/AAG-6791-2020	Bruzzone, Maria/0000-0002-2786-1471; Pellegatta, Serena/0000-0001-7804-9486; bertolini, francesco/0000-0001-5660-3255; Eoli, Marica/0000-0003-4744-9377; Anghileri, Elena/0000-0001-7383-3108; ceroni, mauro/0000-0002-8947-5007; Di Stefano, Anna Luisa/0000-0003-1746-0647; Prodi, Elena/0000-0003-1200-0465; Finocchiaro, Gaetano/0000-0003-3583-4040	Italian Ministry of Health [RF-INN-2008-1142520, RF-2009-1524104]; Italian Association for Research on Cancer [IG 10249]; Fondazione Umberto Veronesi	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was partially supported by a grant from Italian Ministry of Health (http://www.salute.gov.it/ricercaSanitaria/paginaMenuRicercaSanitaria.jsp?menu=finalizzata&lingua=italiano; http://ricerca.cbim.it/index.html) [RF-INN-2008-1142520 to GF, RF-2009-1524104 to FB]; Italian Association for Research on Cancer; (http://www.airc.it/) [IG 10249 to FB]; and Fondazione Umberto Veronesi (http://www.fondazioneveronesi.it/) [Call 2010 to FB]. Drugs were supplied by Roche S. p. A. (Monza, Italy) and Hospira (Napoli, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bertolini F, 2011, LANCET ONCOL, V12, P217, DOI 10.1016/S1470-2045(11)70051-1; Bidard FC, 2010, ANN ONCOL, V21, P1765, DOI 10.1093/annonc/mdq052; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Cao Y, 2012, CANCER, V119, P313; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Desjardins A, 2012, CANCER-AM CANCER SOC, V118, P1302, DOI 10.1002/cncr.26381; Estes ML, 2010, CYTOM PART A, V77A, P831, DOI 10.1002/cyto.a.20921; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Perez-Larraya JG, 2012, NEURO-ONCOLOGY, V14, P667, DOI 10.1093/neuonc/nos070; Gila MJ, 2012, ANTI-CANCER DRUG, V23, P659, DOI 10.1097/CAD.0b013e3283534d3e; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Iwamoto FM, 2010, ARCH NEUROL-CHICAGO, V67, P285, DOI 10.1001/archneurol.2010.11; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Malka D, 2012, ANN ONCOL, V23, P919, DOI 10.1093/annonc/mdr365; Mancuso P, 2011, INT J CANCER, V129, P1344, DOI 10.1002/ijc.25816; Mancuso P, 2009, CLIN CANCER RES, V15, P267, DOI 10.1158/1078-0432.CCR-08-0432; Matsusaka S, 2011, CANCER CHEMOTH PHARM, V68, P763, DOI 10.1007/s00280-010-1543-2; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Murakami H, 2011, EXP THER MED, V2, P595, DOI 10.3892/etm.2011.253; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Perry JR, 2010, J CLIN ONCOL, V28, P2051, DOI 10.1200/JCO.2009.26.5520; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Ronzoni M, 2010, ANN ONCOL, V21, P2382, DOI 10.1093/annonc/mdq261; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Simkens LHJ, 2010, ANN ONCOL, V21, P2447, DOI 10.1093/annonc/mdq640; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Weisshardt P, 2012, HISTOCHEM CELL BIOL, V137, P391, DOI 10.1007/s00418-011-0898-8; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong ET, 2011, J NATL COMPR CANC NE, V9, P403, DOI 10.6004/jnccn.2011.0037	51	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74345	10.1371/journal.pone.0074345	http://dx.doi.org/10.1371/journal.pone.0074345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069296	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100101
J	Swierts, T; Peijnenburg, KTCA; de Leeuw, C; Cleary, DFR; Hornlein, C; Setiawan, E; Worheide, G; Erpenbeck, D; de Voogd, NJ				Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan; Cleary, Daniel F. R.; Hornlein, Christine; Setiawan, Edwin; Worheide, Gert; Erpenbeck, Dirk; de Voogd, Nicole J.			Lock, Stock and Two Different Barrels: Comparing the Genetic Composition of Morphotypes of the Indo-Pacific Sponge Xestospongia testudinaria	PLOS ONE			English	Article							ENVIRONMENTAL-CONDITIONS; SPERMONDE ARCHIPELAGO; MARINE BIODIVERSITY; DIVERSITY; REEF; PORIFERA; ELECTROPHORESIS; DEMOSPONGIAE; POPULATIONS; PHYLOGENIES	The giant barrel sponge Xestospongia testudinaria is an ecologically important species that is widely distributed across the Indo-Pacific. Little is known, however, about the precise biogeographic distribution and the amount of morphological and genetic variation in this species. Here we provide the first detailed, fine-scaled (<200 km(2)) study of the morphological and genetic composition of X. testudinaria around Lembeh Island, Indonesia. Two mitochondrial (CO1 and ATP6 genes) and one nuclear (ATP synthase beta intron) DNA markers were used to assess genetic variation. We identified four distinct morphotypes of X. testudinaria around Lembeh Island. These morphotypes were genetically differentiated with both mitochondrial and nuclear markers. Our results indicate that giant barrel sponges around Lembeh Island, which were all morphologically identified as X. testudinaria, consist of at least two different lineages that appear to be reproductively isolated. The first lineage is represented by individuals with a digitate surface area, CO1 haplotype C5, and is most abundant around the harbor area of Bitung city. The second lineage is represented by individuals with a predominantly smooth surface area, CO1 haplotype C1 and can be found all around Lembeh Island, though to a lesser extent around the harbor of Bitung city. Our findings of two additional unique genetic lineages suggests the presence of an even broader species complex possibly containing more than two reproductively isolated species. The existence of X. testudinaria as a species complex is a surprising result given the size, abundance and conspicuousness of the sponge.	[Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Cleary, Daniel F. R.] Univ Aveiro, CESAM, Ctr Estudos Ambiente & Mar, Dept Biol, P-3800 Aveiro, Portugal; [Hornlein, Christine] Royal Netherlands Inst Sea Res, Yerseke Marine Microbiol, Yerseke, Netherlands; [Setiawan, Edwin; Worheide, Gert; Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Worheide, Gert; Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Worheide, Gert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany	Naturalis Biodiversity Center; University of Amsterdam; Universidade de Aveiro; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Munich; University of Munich	de Voogd, NJ (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	nicole.devoogd@naturalis.nl	Cleary, Daniel/D-2582-2012; Peijnenburg, Katja TCA/F-7176-2016; Cleary, Daniel/ABA-9393-2021; de Voogd, Nicole/I-9280-2012; Edwin, Setiawan/AAB-5988-2021; Setiawan, Edwin/U-1706-2019; Wörheide, Gert/C-1080-2008	Cleary, Daniel/0000-0002-6143-3390; Peijnenburg, Katja TCA/0000-0001-7544-1079; Cleary, Daniel/0000-0002-6143-3390; de Voogd, Nicole/0000-0002-7985-5604; Edwin, Setiawan/0000-0003-3947-3334; Setiawan, Edwin/0000-0003-3947-3334; Wörheide, Gert/0000-0002-6380-7421; Erpenbeck, Dirk/0000-0003-2716-1085	Percy Sladen Memorial Fund of the Linnean Society of London; Treub-Maatschappij Fund	Percy Sladen Memorial Fund of the Linnean Society of London; Treub-Maatschappij Fund	The project was supported by the Percy Sladen Memorial Fund of the Linnean Society of London and the Treub-Maatschappij Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bentlage B, 2007, CORAL REEFS, V26, P807, DOI 10.1007/s00338-007-0267-1; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Cleary DFR, 2012, MAR POLLUT BULL, V64, P263, DOI 10.1016/j.marpolbul.2011.11.020; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de Voogd NJ, 2008, MAR ECOL-EVOL PERSP, V29, P205, DOI 10.1111/j.1439-0485.2008.00238.x; de Voogd NJ, 2006, MAR ECOL PROG SER, V309, P131, DOI 10.3354/meps309131; Diaz MC, 2001, B MAR SCI, V69, P535; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; FROMONT J, 1991, Beagle, V8, P73; FROMONT J, 1994, CORAL REEFS, V13, P119, DOI 10.1007/BF00300772; Fromont J., 1988, P685; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hoeksema Bert W., 2007, V29, P117; HOEKSEMA BW, 2004, CHALLENGING COASTS T, P49; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; KEIGWIN LD, 1978, GEOLOGY, V6, P630, DOI 10.1130/0091-7613(1978)6<630:PCOTIO>2.0.CO;2; Kelly-Borges M., 1988, INDOMALAYAN ZOOLOGY, V5, P121; KERR RG, 1994, SPONGES IN TIME AND SPACE, P65; KERR RG, 1991, NAT PROD REP, V8, P465, DOI 10.1039/np9910800465; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; MUNRO MHG, 1994, SPONGES IN TIME AND SPACE, P473; Oksanen J, 2009, COMMUNITY ECOLOGY PA; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Rachello-Dolmen PG, 2007, ESTUAR COAST SHELF S, V73, P816, DOI 10.1016/j.ecss.2007.03.017; Reveillaud J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016533; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Riesgo A, 2008, INVERTEBR BIOL, V127, P357, DOI 10.1111/j.1744-7410.2008.00128.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Sarano F, 1991, CORAL REEFS, V10, P166, DOI [10.1007/BF00572176, DOI 10.1007/BF00572176]; Suchanek TH, 1985, ECOLOGY DEEP SHALLOW, P55; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Teske PR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-176; THORPE JP, 1994, ZOOL SCR, V23, P3, DOI 10.1111/j.1463-6409.1994.tb00368.x; van Oppen M.J.H., 2002, P131; VANSOEST RWM, 1989, NETH J SEA RES, V23, P223, DOI 10.1016/0077-7579(89)90016-1; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030	63	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74396	10.1371/journal.pone.0074396	http://dx.doi.org/10.1371/journal.pone.0074396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069308	Green Published, gold, Green Submitted			2022-12-25	WOS:000326240100105
J	Teixeira-da-Cunha, MGA; Gomes, RN; Roehrs, N; Bozza, FA; Prescott, SM; Stafforini, D; Zimmerman, GA; Bozza, PT; Castro-Faria-Neto, HC				Teixeira-da-Cunha, Mariana G. A.; Gomes, Rachel N.; Roehrs, Nathassia; Bozza, Fernando A.; Prescott, Stephen M.; Stafforini, Diana; Zimmerman, Guy A.; Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.			Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE PRODUCTION; MCP-1 PROTECTS MICE; ENDOTOXIC-SHOCK; CLINICAL-TRIAL; SEVERE SEPSIS; HOST-DEFENSE; LUNG INJURY; IN-VITRO	Current evidence indicates that dysregulation of the host inflammatory response to infectious agents is central to the mortality of patients with sepsis. Strategies to block inflammatory mediators such as PAF have been investigated as adjuvant therapies for sepsis. PAF-AH, the enzyme responsible for PAF degradation, showed positive results in pre-clinical studies and phase II clinical trials, but the results of a phase III study were disappointing. In this study, we investigated the potential protective mechanism of PAF-AH in sepsis using the murine model of cecal ligation and puncture (CLP). Treatment with rPAF-AH increased peritoneal fluid levels of the anti-inflammatory mediators MCP-1/CCL2 after CLP. The numbers of bacteria (CFU) in the peritoneal cavity were decreased in the rPAF-AH-treated group, indicating more efficient bacterial clearance after rPAF-AH treatment. Interestingly, we observed increased levels of nitric oxide (NO) after PAF-AH administration, and rPAF-AH treatment did not decrease CFU numbers either in iNOS-deficient mice or in CCR2-deficient mice. We concluded that administration of exogenous rPAF-AH reduced inflammatory injury, altered cytokine levels and favored bacterial clearance with a clear impact on mortality through modulation of MCP-1/CCL2 and NO levels in a clinically relevant sepsis model.	[Prescott, Stephen M.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Stafforini, Diana] Huntsman Canc Inst, Salt Lake City, UT USA; [Zimmerman, Guy A.] Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT USA	Oklahoma Medical Research Foundation; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah		rachelngomes@gmail.com	Bozza, Patricia T./AAE-2933-2021; Bozza, Patricia T./AAM-4537-2021; Gomes, Rachel N/I-7643-2013; Bozza, Fernando A/A-2618-2013	Bozza, Patricia T./0000-0001-8349-9529; Bozza, Fernando A/0000-0003-4878-0256	PAPES-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil); NATIONAL CANCER INSTITUTE [P01CA073992] Funding Source: NIH RePORTER	PAPES-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by PAPES-FIOCRUZ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), and Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1999, INFECT IMMUN, V67, P2810, DOI 10.1128/IAI.67.6.2810-2814.1999; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Benjamim CF, 2002, INFECT IMMUN, V70, P3602, DOI 10.1128/IAI.70.7.3602-3610.2002; Biswas SK, 2001, NITRIC OXIDE-BIOL CH, V5, P566, DOI 10.1006/niox.2001.0370; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; DePaolo RW, 2005, INFECT IMMUN, V73, P6514, DOI 10.1128/IAI.73.10.6514-6522.2005; Fierro IM, 1999, J LEUKOCYTE BIOL, V65, P508, DOI 10.1002/jlb.65.4.508; Forslund T, 1997, BIOCHEM BIOPH RES CO, V233, P492, DOI 10.1006/bbrc.1997.6490; Franchini A, 1995, ADV NEUROIMMUNOL, V5, P463, DOI 10.1016/0960-5428(95)00029-1; GERRA G, 1995, INT CLIN PSYCHOPHARM, V10, P245, DOI 10.1097/00004850-199511000-00006; Gomes RN, 2006, SHOCK, V26, P457, DOI 10.1097/01.shk.0000228801.56223.92; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; Gomes RN, 2013, SHOCK, V39, P63, DOI 10.1097/SHK.0b013e31827802b5; Guo HT, 2002, IMMUNOL LETT, V80, P21, DOI 10.1016/S0165-2478(01)00284-X; Hauser B, 2004, SHOCK, V22, P588, DOI 10.1097/00024382-200412000-00016; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaplan SS, 1996, INFECT IMMUN, V64, P69, DOI 10.1128/IAI.64.1.69-76.1996; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Linares E, 2001, FREE RADICAL BIO MED, V30, P1234, DOI 10.1016/S0891-5849(01)00516-0; MAKRISTATHIS A, 1993, INFECT IMMUN, V61, P1996, DOI 10.1128/IAI.61.5.1996-2002.1993; MALAWISTA SE, 1992, J CLIN INVEST, V90, P631, DOI 10.1172/JCI115903; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moreno SE, 2006, J IMMUNOL, V177, P1264, DOI 10.4049/jimmunol.177.2.1264; MOZES T, 1991, J LIPID MEDIATOR, V4, P309; NAKANO Y, 1994, INFECT IMMUN, V62, P377, DOI 10.1128/IAI.62.2.377-383.1994; NARAHARA H, 1993, J CLIN ENDOCR METAB, V77, P1258, DOI 10.1210/jc.77.5.1258; Neto HCCF, 2005, MEM I OSWALDO CRUZ, V100, P83, DOI 10.1590/S0074-02762005000900014; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Rijneveld AW, 2004, J INFECT DIS, V189, P711, DOI 10.1086/381392; Schuster DP, 2003, CRIT CARE MED, V31, P1612, DOI 10.1097/01.CCM.0000063267.79824.DB; Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74567	10.1371/journal.pone.0074567	http://dx.doi.org/10.1371/journal.pone.0074567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069320	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100111
J	Decker, C; Hesker, P; Zhang, KH; Faccio, R				Decker, Corinne; Hesker, Pamela; Zhang, Kaihua; Faccio, Roberta			Targeted Inhibition of Phospholipase C gamma 2 Adaptor Function Blocks Osteoclastogenesis and Protects from Pathological Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Differentiation; Osteoclast; Phospholipase C; Signaling; Gab2; PLC gamma 2; RANK; Bone Erosion; Osteolysis	T-CELL-ACTIVATION; INFLAMMATORY ARTHRITIS; MURINE MODEL; IDENTIFICATION; MECHANISMS; PLC-GAMMA-2; PROTEINS; RECEPTOR; KINASE; BONE	Phospholipase C 2 (PLC2) is a critical regulator of innate immune cells and osteoclasts (OCs) during inflammatory arthritis. Both the catalytic domain and the adaptor motifs of PLC2 are required for OC formation and function. Due to the high homology between the catalytic domains of PLC2 and the ubiquitously expressed PLC1, molecules encompassing the adaptor motifs of PLC2 were designed to test the hypothesis that uncoupling the adaptor and catalytic functions of PLC2 could specifically inhibit osteoclastogenesis and bone erosion. Wild-type (WT) bone marrow macrophages (BMM) that overexpress the tandem Src homology 2 (SH2) domains of PLC2 (SH2(N+C)) failed to form mature OCs and resorb bone in vitro. Activation of the receptor activator of NF-B (RANK) signaling pathway, which is critical for OC development, was impaired in cells expressing SH2(N+C). Arrest in OC differentiation was evidenced by a reduction of p38 and I-B phosphorylation as well as decreased NFATc1 and c-Fos/c-Jun levels. Consistent with our hypothesis, SH2(N+C) abrogated formation of the RANK-Gab2 complex, which mediates NF-B and AP-1 activation following RANK ligand (RANKL) stimulation. Furthermore, the ability of SH2(N+C) to prevent inflammatory osteolysis was examined in vivo following RANKL or LPS injections over the calvaria. Both models induced osteolysis in the control group, whereas the SH2(N+C)-treated cohort was largely protected from bone erosion. Collectively, these data indicate that inflammatory osteolysis can be abrogated by treatment with a molecule composed of the tandem SH2 domains of PLC gamma 2.	[Decker, Corinne; Hesker, Pamela; Zhang, Kaihua; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA.	faccior@wustl.edu			National Institutes of Health [P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053628, P30AR057235, T32AR060719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Washington University Center for Musculoskeletal Research was supported by National Institutes of Health Grant P30 AR057235.	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Goldring SR, 2000, ARTHRITIS RES, V2, P33, DOI 10.1186/ar67; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Taguchi Y, 2012, J BONE MINER METAB, V30, P543, DOI 10.1007/s00774-012-0353-5; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Turner T, 1997, CLIN CANCER RES, V3, P2275; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002	23	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33634	33641		10.1074/jbc.M113.477281	http://dx.doi.org/10.1074/jbc.M113.477281			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24081142	Green Published, hybrid			2022-12-25	WOS:000327250200012
J	Angulo, J; Yu, HL; Langousis, A; Kolovos, A; Wang, JF; Madrid, AE; Christakos, G				Angulo, Jose; Yu, Hwa-Lung; Langousis, Andrea; Kolovos, Alexander; Wang, Jinfeng; Esther Madrid, Ana; Christakos, George			Spatiotemporal Infectious Disease Modeling: A BME-SIR Approach	PLOS ONE			English	Article							SPATIAL DYNAMICS; EPIDEMICS; SPREAD; IMPACT; ASSIMILATION; TRANSMISSION; UNCERTAINTY; SYNCHRONY; PATTERNS	This paper is concerned with the modeling of infectious disease spread in a composite space-time domain under conditions of uncertainty. We focus on stochastic modeling that accounts for basic mechanisms of disease distribution and multi-sourced in situ uncertainties. Starting from the general formulation of population migration dynamics and the specification of transmission and recovery rates, the model studies the functional formulation of the evolution of the fractions of susceptible-infected-recovered individuals. The suggested approach is capable of: a) modeling population dynamics within and across localities, b) integrating the disease representation (i.e. susceptible-infected-recovered individuals) with observation time series at different geographical locations and other sources of information (e. g. hard and soft data, empirical relationships, secondary information), and c) generating predictions of disease spread and associated parameters in real time, while considering model and observation uncertainties. Key aspects of the proposed approach are illustrated by means of simulations (i.e. synthetic studies), and a real-world application using hand-foot-mouth disease (HFMD) data from China.	[Angulo, Jose] Univ Granada, Dept Stat & Operat Res, Granada, Spain; [Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Langousis, Andrea] Univ Patras, Dept Civil Engn, GR-26110 Patras, Greece; [Kolovos, Alexander] SpaceTimeWorks LLC, San Diego, CA USA; [Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Esther Madrid, Ana] MDE UPCT, Spanish Air Force Acad, Univ Ctr Def, Murcia, Spain; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Christakos, George] Zhejiang Univ, Dept Environm & Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China	University of Granada; National Taiwan University; University of Patras; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; California State University System; San Diego State University; Zhejiang University	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw	Angulo, José/I-5066-2015; Madrid, Ana Esther/I-4488-2015; Kolovos, Alexander/AAI-7091-2020	Angulo, José/0000-0002-6863-7847; Madrid, Ana Esther/0000-0002-1024-0038; Yu, Hwa Lung/0000-0001-9558-2100; Wang, Jinfeng/0000-0002-6687-9420; Christakos, George/0000-0002-1865-5764; Langousis, Andreas/0000-0002-0643-2520	SGPI [MTM2009-13250, MTM2012-32666]; Andalusian CICE, Spain [P08-FQM-3834]; National Science Council of Taiwan [NSC101-2628-E-002-017-MY3, NSC102-2221-E-002-140-MY3]; SpaceTimeWorks, LLC.; Yongqian Chair Professorship (Zhejiang University, China)	SGPI; Andalusian CICE, Spain; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); SpaceTimeWorks, LLC.; Yongqian Chair Professorship (Zhejiang University, China)	J.M. Angulo and A. E. Madrid have been partially supported by grants MTM2009-13250 and MTM2012-32666 of SGPI, and P08-FQM-3834 of the Andalusian CICE, Spain. H-L Yu has been partially supported by a grant from National Science Council of Taiwan (NSC101-2628-E-002-017-MY3 and NSC102-2221-E-002-140-MY3). A. Kolovos was supported by SpaceTimeWorks, LLC. G. Christakos was supported by a Yongqian Chair Professorship (Zhejiang University, China). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1986, STAT ANAL COMPOSITIO, pR15; Allen LJS, 2000, MATH BIOSCI, V163, P1, DOI 10.1016/S0025-5564(99)00047-4; Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; ANGULO J, 2012, INT J GEOGRAPHICAL I; Baker R, 2007, STOCH ENV RES RISK A, V21, P435, DOI 10.1007/s00477-006-0076-z; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; CHRISTAKOS G, 1990, MATH GEOL, V22, P763, DOI 10.1007/BF00890661; Christakos G, 2005, STOCH ENV RES RISK A, V19, P307, DOI 10.1007/s00477-005-0236-6; Christakos G, 2002, ADV WATER RESOUR, V25, P1257, DOI 10.1016/S0309-1708(02)00064-7; CHRISTAKOS G, 1998, SPATIOTEMPORAL ENVIR; Christakos G., 2000, MODERN SPATIOTEMPORA; Christakos G., 2005, INTERDISCIPLINARY PU; Cummings DAT, 2009, AM J EPIDEMIOL, V169, pS40; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Elderd BD, 2006, P NATL ACAD SCI USA, V103, P15693, DOI 10.1073/pnas.0600816103; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; KALNAY E, 2003, ATMOSPHERIC MODELLIN, pR22, DOI DOI 10.1256/00359000360683511; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Li LJ, 2010, FRONT MED-PRC, V4, P139; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Orton TG, 2007, STOCH ENV RES RISK A, V21, P773, DOI 10.1007/s00477-006-0089-7; Park S.K., 2009, DATA ASSIMILATION AT; Pawlowsky-Glahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, pXVII; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Schrodle B, 2012, BIOMETRICS, V68, P736, DOI 10.1111/j.1541-0420.2011.01717.x; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang JF, 2006, B WORLD HEALTH ORGAN, V84, P965, DOI 10.2471/BLT.06.030247; West RW, 1997, MATH BIOSCI, V141, P29; Yu HL, 2007, STOCH ENV RES RISK A, V21, P555, DOI 10.1007/s00477-007-0135-0	38	24	24	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72168	10.1371/journal.pone.0072168	http://dx.doi.org/10.1371/journal.pone.0072168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086257	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900006
J	Howell, NA; Worbe, Y; Lange, I; Tait, R; Irvine, M; Banca, P; Harrison, NA; Bullmore, ET; Hutchison, WD; Voon, V				Howell, Nicholas A.; Worbe, Yulia; Lange, Iris; Tait, Roger; Irvine, Michael; Banca, Paula; Harrison, Neil A.; Bullmore, Edward T.; Hutchison, William D.; Voon, Valerie			Increased Ventral Striatal Volume in College-Aged Binge Drinkers	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; HIPPOCAMPAL VOLUME; DOPAMINE RELEASE; NUCLEUS-ACCUMBENS; ETHANOL EXPOSURE; AMYGDALA; DRINKING; CORTEX; NEUROGENESIS; DEFICITS	Background: Binge drinking is a serious public health issue associated with cognitive, physiological, and anatomical differences from healthy individuals. No studies, however, have reported subcortical grey matter differences in this population. To address this, we compared the grey matter volumes of college-age binge drinkers and healthy controls, focusing on the ventral striatum, hippocampus and amygdala. Method: T1-weighted images of 19 binge drinkers and 19 healthy volunteers were analyzed using voxel-based morphometry. Structural data were also covaried with Alcohol Use Disorders Identification Test (AUDIT) scores. Cluster-extent threshold and small volume corrections were both used to analyze imaging data. Results: Binge drinkers had significantly larger ventral striatal grey matter volumes compared to controls. There were no between group differences in hippocampal or amygdalar volume. Ventral striatal, amygdalar, and hippocampal volumes were also negatively related to AUDIT scores across groups. Conclusions: Our findings stand in contrast to the lower ventral striatal volume previously observed in more severe forms of alcohol use disorders, suggesting that college-age binge drinkers may represent a distinct population from those groups. These findings may instead represent early sequelae, compensatory effects of repeated binge and withdrawal, or an endophenotypic risk factor.	[Howell, Nicholas A.; Hutchison, William D.] Univ Hlth Network, Toronto Western Hosp, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Toronto, ON, Canada; [Howell, Nicholas A.; Hutchison, William D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Howell, Nicholas A.; Lange, Iris; Irvine, Michael; Banca, Paula; Voon, Valerie] Univ Cambridge, Dept Psychiat, Cambridge, England; [Worbe, Yulia; Harrison, Neil A.; Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Tait, Roger] Univ Cambridge, Dept Psychol, Cambridge, England; [Banca, Paula] Univ Coimbra, Inst Biomed Imaging & Life Sci, P-3000 Coimbra, Portugal; [Harrison, Neil A.; Voon, Valerie] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Bullmore, Edward T.] Addenbrookes Hosp, GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Bullmore, Edward T.; Voon, Valerie] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Hutchison, William D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Hutchison, William D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge; University of Cambridge; University of Cambridge; Universidade de Coimbra; University of Brighton; University of Sussex; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; University of Cambridge; University of Toronto; University of Toronto	Voon, V (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	vv247@cam.ac.uk	Voon, Valerie/O-7038-2017; Bullmore, Ed/C-1706-2012; Banca, Paula/G-8330-2017; Worbe, Yulia/GYV-3751-2022	Voon, Valerie/0000-0001-6790-1776; Bullmore, Ed/0000-0002-8955-8283; Banca, Paula/0000-0001-7617-3635; Lange, Iris/0000-0002-6251-8978; Worbe, Yulia/0000-0001-5903-9370; Hutchison, William/0000-0002-3866-4940; Harrison, Neil/0000-0002-9584-3769	Unilever/Lipton Graduate Fellowship in Neuroscience; University of Toronto Open Fellowship; Fyssen Foundation; MRC Studentship; WT; MRC; NIHR Cambridge Biomedical Research Centre; Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK; Medical Research Council [G0001354, G1000183B, G0001354B] Funding Source: researchfish	Unilever/Lipton Graduate Fellowship in Neuroscience; University of Toronto Open Fellowship(University of Toronto); Fyssen Foundation; MRC Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Nicholas A Howell is supported by the Unilever/Lipton Graduate Fellowship in Neuroscience and a University of Toronto Open Fellowship. Valerie Voon is a Wellcome Trust (WT) intermediate Clinical Fellow. Yulia Worbe is supported by the Fyssen Foundation and MRC Studentship. The BCNI is supported by a WT and MRC grant. This study was partly supported by the NIHR Cambridge Biomedical Research Centre, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Anderson P, 2007, BINGE DRINKING EUROP; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barros-Loscertales A, 2011, NEUROIMAGE, V56, P1021, DOI 10.1016/j.neuroimage.2011.02.035; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Chang L, 2005, BIOL PSYCHIAT, V57, P967, DOI 10.1016/j.biopsych.2005.01.039; Claus ED, 2011, NEUROPSYCHOPHARMACOL, V36, P2086, DOI 10.1038/npp.2011.99; Corson PW, 1999, AM J PSYCHIAT, V156, P1200; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; Engleman EA, 2009, ALCOHOL CLIN EXP RES, V33, P2162, DOI 10.1111/j.1530-0277.2009.01055.x; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Grucza RA, 2009, J AM ACAD CHILD PSY, V48, P692, DOI 10.1097/CHI.0b013e3181a2b32f; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hibell B., 2012, 2011 ESPAD REPORT SU; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Johnston L. D., 2012, MONITORING FUTURE NA, VII; KESHAVAN MS, 1994, LANCET, V344, P1434, DOI 10.1016/S0140-6736(94)90599-1; Kirby ED, 2012, MOL PSYCHIATR, V17, P527, DOI 10.1038/mp.2011.71; Lisdahl KM, 2013, PSYCHIAT RES-NEUROIM, V211, P17, DOI 10.1016/j.pscychresns.2012.07.009; Lynam D.R., 2006, UPPS P ASSESSING 5 P; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Mitchell J, 2012, TLS-TIMES LIT SUPPL, P6; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; NIAAA, 2004, NIAAA NEWSLETTER, V3; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Paul CA, 2008, ARCH NEUROL-CHICAGO, V65, P1363, DOI 10.1001/archneur.65.10.1363; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger CD, 1985, SO PSYCHOL, V2, P6; Squeglia Lindsay M, 2012, Psychopharmacology (Berl), V220, P529, DOI 10.1007/s00213-011-2500-4; STACEY D, P NATL ACAD SCI US; Stephens DN, 2005, BIOL PSYCHIAT, V58, P392, DOI 10.1016/j.biopsych.2005.04.025; Sullivan EV, 2005, BIOL PSYCHIAT, V57, P768, DOI 10.1016/j.biopsych.2004.12.012; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; Taki Y, 2006, ALCOHOL CLIN EXP RES, V30, P1045, DOI 10.1111/j.1530-0277.2006.00118.x; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Weiss F, 1996, J NEUROSCI, V16, P3474; Wrase J, 2008, AM J PSYCHIAT, V165, P1179, DOI 10.1176/appi.ajp.2008.07121877	53	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74164	10.1371/journal.pone.0074164	http://dx.doi.org/10.1371/journal.pone.0074164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086317	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325223900021
J	MacDonald, AA; Seergobin, KN; Owen, AM; Tamjeedi, R; Monchi, O; Ganjavi, H; MacDonald, PA				MacDonald, Alex A.; Seergobin, Ken N.; Owen, Adrian M.; Tamjeedi, Ruzbeh; Monchi, Oury; Ganjavi, Hooman; MacDonald, Penny A.			Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval	PLOS ONE			English	Article							VERBAL-LEARNING TEST; WORKING-MEMORY; COGNITIVE FUNCTION; STRIATUM; REWARD; RECOLLECTION; PERFORMANCE; MODULATION; RECOGNITION; MEDICATION	Increasingly memory deficits are recognized in Parkinson's disease (PD). In PD, the dopamine-producing cells of the substantia nigra (SN) are significantly degenerated whereas those in the ventral tegmental area (VTA) are relatively spared. Dopamine-replacement medication improves cognitive processes that implicate the SN-innervated dorsal striatum but is thought to impair those that depend upon the VTA-supplied ventral striatum, limbic and prefrontal cortices. Our aim was to examine memory encoding and retrieval in PD and how they are affected by dopamine replacement. Twenty-nine PD patients performed the Rey Auditory Verbal Learning Test (RAVLT) and a non-verbal analogue, the Aggie Figures Learning Test (AFLT), both on and off dopaminergic medications. Twenty-seven, age-matched controls also performed these memory tests twice and their data were analyzed to correspond to the ON-OFF order of the PD patients to whom they were matched. We contrasted measures that emphasized with those that accentuated retrieval and investigated the effect of PD and dopamine-replacement on these processes separately. For PD patients relative to controls, encoding performance was normal in the off state and was impaired on dopaminergic medication. Retrieval was impaired off medication and improved by dopamine repletion. This pattern of findings suggests that VTA-innervated brain regions such as ventral striatum, limbic and prefrontal cortices are implicated in encoding, whereas the SN-supplied dorsal striatum mediates retrieval. Understanding this pattern of spared functions and deficits in PD, and the effect of dopamine replacement on these distinct memory processes, should prompt closer scrutiny of patients' cognitive complaints to inform titration of dopamine replacement dosages along with motor symptoms.	[MacDonald, Alex A.; Seergobin, Ken N.; Owen, Adrian M.; MacDonald, Penny A.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Owen, Adrian M.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Tamjeedi, Ruzbeh] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Ganjavi, Hooman] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada; [MacDonald, Penny A.] Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Universite de Montreal; Universite de Montreal; Western University (University of Western Ontario); Western University (University of Western Ontario)	MacDonald, PA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	penny.macdonald@gmail.com	Williams, Jackie/B-3495-2015		Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1	Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1(Canadian Institutes of Health Research (CIHR))	This research was supported by a Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1 to Dr. Penny MacDonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2003, J NEUROL NEUROSUR PS, V74, P1215, DOI 10.1136/jnnp.74.9.1215; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Algarabel S, 2010, NEUROPSYCHOLOGY, V24, P599, DOI 10.1037/a0019221; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beato R, 2008, ARQ NEURO-PSIQUIAT, V66, P147, DOI 10.1590/S0004-282X2008000200001; Benjamin AS, 2010, COGNITIVE PSYCHOL, V61, P228, DOI 10.1016/j.cogpsych.2010.05.004; Benke T, 2003, NEUROCASE, V9, P70, DOI 10.1076/neur.9.1.70.14374; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Bronnick K, 2011, NEUROPSYCHOLOGY, V25, P114, DOI 10.1037/a0020857; Cohn M, 2010, NEUROPSYCHOLOGIA, V48, P4142, DOI 10.1016/j.neuropsychologia.2010.10.013; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2006, J COGNITIVE NEUROSCI, V18, P1973, DOI 10.1162/jocn.2006.18.12.1973; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Costa A, 2003, DEMENT GERIATR COGN, V15, P55, DOI 10.1159/000067968; Costa A, 2009, NEUROPSYCHOLOGIA, V47, P1374, DOI 10.1016/j.neuropsychologia.2009.01.039; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Davidson PSR, 2006, BRAIN, V129, P1768, DOI 10.1093/brain/awl115; de Zubicaray GI, 2005, COGNITIVE BRAIN RES, V22, P439, DOI 10.1016/j.cogbrainres.2004.10.002; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Drag LL, 2009, J INT NEUROPSYCH SOC, V15, P399, DOI 10.1017/S1355617709090572; Edelstyn NMJ, 2010, NEUROPSYCHOLOGIA, V48, P1367, DOI 10.1016/j.neuropsychologia.2009.12.039; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Feigin A, 2003, NEUROLOGY, V60, P1744, DOI 10.1212/01.WNL.0000072263.03608.42; Floel A, 2008, NEUROBIOL AGING, V29, P267, DOI 10.1016/j.neurobiolaging.2006.10.009; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Ghilardi MF, 2007, PARKINSONISM RELAT D, V13, P146, DOI 10.1016/j.parkreldis.2006.08.006; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Graef S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00169; Helie S, 2010, J NEUROSCI, V30, P14225, DOI 10.1523/JNEUROSCI.2393-10.2010; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huijbers W, 2013, J COGNITIVE NEUROSCI, V25, P1163, DOI 10.1162/jocn_a_00366; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Jahanshahi M, 2010, NEUROPSYCHOLOGIA, V48, P1096, DOI 10.1016/j.neuropsychologia.2009.12.010; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; LANG AE, 1984, CAN MED ASSOC J, V131, P1031; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, pxiv; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; LUCIANA M, 1992, J COGNITIVE NEUROSCI, V4, P58, DOI 10.1162/jocn.1992.4.1.58; Luciana M, 1997, J COGNITIVE NEUROSCI, V9, P330, DOI 10.1162/jocn.1997.9.3.330; MacDonald AA, 2013, MOVEMENT DISORD, V28, P153, DOI 10.1002/mds.25152; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Macmillan NA, 2005, DETECTION THEORY USE, VXIX; Mattay VS, 2002, ANN NEUROL, V51, P156, DOI 10.1002/ana.10078; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Mitrushina MN, 1999, HDB NORMATIVE DATA N, Vxxii; Mollion H, 2003, NEUROPSYCHOLOGIA, V41, P1442, DOI 10.1016/S0028-3932(03)00114-3; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Muller U, 1998, J NEUROSCI, V18, P2720; Nelson H., 1991, NATL ADULT READING T; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Pizzagalli DA, 2008, PSYCHOPHARMACOLOGY, V196, P221, DOI 10.1007/s00213-007-0957-y; Pollak Y, 2008, DEV NEUROPSYCHOL, V33, P62, DOI 10.1080/87565640701729789; Reiss JP, 2005, NEUROREPORT, V16, P1291, DOI 10.1097/01.wnr.0000175615.93312.1a; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Santesso DL, 2009, HUM BRAIN MAPP, V30, P1963, DOI 10.1002/hbm.20642; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seger CA, 2010, NEUROIMAGE, V50, P644, DOI 10.1016/j.neuroimage.2009.11.083; Seo M, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00036; Shohamy D, 2006, NEUROPSYCHOLOGIA, V44, P774, DOI 10.1016/j.neuropsychologia.2005.07.013; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Slabosz A, 2006, NEUROPSYCHOLOGY, V20, P578, DOI 10.1037/0894-4105.20.5.578; Su CY, 2007, ARCH CLIN NEUROPSYCH, V22, P465, DOI 10.1016/j.acn.2007.01.025; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; TAYLOR AE, 1990, BRAIN COGNITION, V13, P211, DOI 10.1016/0278-2626(90)90051-O; Tomer R, 2007, NEUROPSYCHOLOGIA, V45, P357, DOI 10.1016/j.neuropsychologia.2006.06.014; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vakil E, 2010, CLIN NEUROPSYCHOL, V24, P662, DOI 10.1080/13854040903493522; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Weiermann B, 2010, INT J NEUROSCI, V120, P211, DOI 10.3109/00207450903506510; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Woodard JL, 1999, J CLIN EXP NEUROPSYC, V21, P666, DOI 10.1076/jcen.21.5.666.872; World Medical Association, 1991, Law Med Health Care, V19, P264; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	95	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74044	10.1371/journal.pone.0074044	http://dx.doi.org/10.1371/journal.pone.0074044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086309	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000006
J	Laloy, F; Rage, JC; Evans, SE; Boistel, R; Lenoir, N; Laurin, M				Laloy, Fabien; Rage, Jean-Claude; Evans, Susan E.; Boistel, Renaud; Lenoir, Nicolas; Laurin, Michel			A Re-Interpretation of the Eocene Anuran Thaumastosaurus Based on MicroCT Examination of a 'Mummified' Specimen	PLOS ONE			English	Article							FROG; PHYLOGENY; DIVERSIFICATION; LEPTODACTYLIDAE; AMPHIBIANS; AFFINITIES; OSTEOLOGY; ENGLAND; RANIDAE; EUROPE	What originally appeared to be only an external cast of an anuran 'mummy' from the Quercy Phosphorites (southwestern France) was described as Rana plicata during the 19th century. Its geographical provenance is only vaguely known; therefore its precise age within the Paleogene was uncertain. The taxon was erected on the basis of the external morphology of the specimen, which includes few diagnostic characters. As a further complication, the name Rana plicata was recently shown to be unavailable at the time of the description, and the name Rana cadurcorum was proposed as a replacement. In order to see whether internal features were fossilized, the fossil was CT scanned. This showed that a large part of the skeleton is preserved. Unexpectedly, the scans revealed that the skull of the mummy is almost identical to that of Thaumastosaurus gezei, another anuran from the late middle or late Eocene of the Quercy Phosphorites. The few observed differences are attributable to intraspecific and ontogenetic variation, and R. cadurcorum is a junior subjective synonym of T. gezei. The mummy is therefore probably from the same time interval as T. gezei. The latter was previously known only by its skull, but the mummy provides important information on the postcranial skeleton. Earlier assessments, based only on the skull, placed Thaumastosaurus close to South American hyloid anurans, but a new phylogenetic analysis including postcranial characters reveals ranoid affinities. This study exemplifies the usefulness of modern imaging technologies that allow non-destructive study of previously inaccessible internal anatomical features.	[Laloy, Fabien; Rage, Jean-Claude; Laurin, Michel] Univ Paris 06, CNRS, Museum Natl Hist Nat, Unite Mixte Rech 7207, Paris, France; [Evans, Susan E.] UCL, Dept Cell & Dev Biol, London, England; [Boistel, Renaud] Univ Poitiers, CNRS, Unite Mixte Rech 7262, Inst Int Paleoprimatol & Paleontol Humaine, Poitiers, France; [Lenoir, Nicolas] Ecole Natl Ponts & Chaussees, CNRS, Inst Francais Sci & Technol Transports Amenagemen, Lab Navier,Unite Mixte Rech 8205, Marne La Vallee, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; Universite Gustave-Eiffel	Laurin, M (corresponding author), Univ Paris 06, CNRS, Museum Natl Hist Nat, Unite Mixte Rech 7207, Paris, France.	laurin@mnhn.fr	Laurin, Michel/B-7884-2008; Evans, Susan/C-1888-2008	Laurin, Michel/0000-0003-2974-9835; Evans, Susan/0000-0002-0799-4154	Region Ile-de-France; French Ministry of Research; CNRS	Region Ile-de-France(Region Ile-de-France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	The Laboratoire Navier microtomograph used to scan the specimens has been acquired with the financial support of Region Ile-de-France. J.-C. Rage and M. Laurin were funded by the French Ministry of Research and CNRS grants to UMR 7207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Boulenger GA, 1886, B SOC ZOOL FRANCE, V11, P320; Cope E. D., 1864, Proceedings of the Academy of Natural Sciences of Philadelphia, P181; Cope ED, 1865, NAT HIST REV, V5, P97; Daudin FM, 1802, HIST NATURELLE RAINE; Duellman W. E., 1986, BIOL AMPHIBIANS; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Fabrezi M, 2006, J ZOOL SYST EVOL RES, V44, P153, DOI 10.1111/j.1439-0469.2005.00349.x; Filhol H, 1876, B SOC PHILOMATIQUE P, V11, P27; Filhol H, 1877, RECHERCHES PHOSPHORI; Filhol H., 1873, CR HEBD ACAD SCI, V77, P1556; Fischer von Waldheim G, 1813, ZOOGNOSIA TABULIS SY, V1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Grand A, BIOL J LINN IN PRESS; Holman JA, 2003, ACTA PALAEONTOL POL, V48, P157; Holman JA, 2002, J HERPETOL, V36, P621, DOI 10.1670/0022-1511(2002)036[0621:ANTAFI]2.0.CO;2; JAROSOVA J, 1982, Amphibia-Reptilia, V3, P111, DOI 10.1163/156853882X00347; Laloy F, 2012, THESIS MUSEUM NATL H; Legendre S, 1992, N JB GEOL PALAONT MH, V7, P414; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; Lynch J. D., 1973, EVOLUTIONARY BIOL AN, P131; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin C., 2012, Graellsia, V68, P159, DOI 10.3989/graellsia.2012.v68.056; Nicholls G. E., 1916, Proceedings of the Linnean Society London, V128; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Noble G.K., 1931, BIOL AMPHIBIA; Noble GK, 1922, B AM MUS NAT HIST, V56; Pelissie T, 2006, STRATA, V13, P3; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rage J.-C., 2006, Strata Series 1 Communications, V13, P161; Rage JC, 2007, J VERTEBR PALEONTOL, V27, P329, DOI 10.1671/0272-4634(2007)27[329:ANSOTA]2.0.CO;2; Rocek Z, 1995, J VERTEBR PALEONTOL, V15, P506; Rocek Z, 1980, ACTA U CAROLINAE BIO, V1-2, P1; Rocek Zbynik, 2003, Amphibian Biology, V5, P1877; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sheil CA, 1999, J MORPHOL, V240, P49, DOI 10.1002/(SICI)1097-4687(199904)240:1<49::AID-JMOR5>3.0.CO;2-Z; SIGE B, 1991, GEOBIOS-LYON, V24, P497, DOI 10.1016/S0016-6995(06)80251-2; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5	46	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74874	10.1371/journal.pone.0074874	http://dx.doi.org/10.1371/journal.pone.0074874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086389	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700044
J	Shin, RM; Higuchi, M; Suhara, T				Shin, Ryong-Moon; Higuchi, Makoto; Suhara, Tetsuya			Nitric Oxide Signaling Exerts Bidirectional Effects on Plasticity Inductions in Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; LATERAL AMYGDALA; MEMORY CONSOLIDATION; SYNAPTIC PLASTICITY; CA2+ CHANNELS; PATHWAY; LTP; ACTIVATION; INVOLVEMENT	It has been well known that long-term potentiation (LTP) of synaptic transmission in the lateral nucleus of the amygdala (LA) constitutes an essential cellular mechanism contributing to encoding of conditioned fear. Nitric oxide (NO), produced by activation of the postsynaptic N-methyl-D-aspartate receptors (NMDAR) in thalamic input to the LA, has been thought to promote LTP, contributing to the establishment of conditioned fear. However, it is not known whether and how NO, released from cortical input to the LA, plays the role on the plasticity induction and fear memory. Here we report that the diffusion of NO, released in response to activation of presynaptic NMDAR on cortical afferent fibers in the LA, could suppress heterosynaptically a form of presynaptic kainate receptor (KAR) dependent LTP (pre-LTP) in thalamic input, which was induced by low-frequency presynaptic stimuli without postsynaptic depolarization. We also confirmed that NO, produced by activation of postsynaptic NMDAR in thalamic input, can promote postsynaptic NMDAR-dependent LTP (post-LTP), which was induced by pairing protocol. These LTPs were occluded following fear conditioning, indicating that they could contribute to encoding of conditioned fear memory. However, their time courses are different; Post-LTP was more rapidly formed than pre-LTP in the course of fear conditioning. NO, produced by activation of presynaptic NMDAR in cortical input and postsynaptic NMDAR in thalamic input, may control conditioned fear by suppressing pre-LTP and promoting post-LTP, respectively, in thalamic input to the LA.	[Shin, Ryong-Moon; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Shin, RM (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Anagawa 4-9-1, Chiba 260, Japan.	moon@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2311109]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Japan Advanced Molecular Imaging Program (R-M.S., M.H. and T.S) and Scientific Research on innovative Areas ("Brain Environment") 2311109 (M.H) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cho JH, 2012, NAT NEUROSCI, V15, P113, DOI 10.1038/nn.2993; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; Paul C, 2008, J NEUROSCI, V28, P14202, DOI 10.1523/JNEUROSCI.2216-08.2008; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sato T, 2006, NEUROPSYCHOBIOLOGY, V53, P142, DOI 10.1159/000093100; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sequeira SM, 2001, MOL BRAIN RES, V89, P111, DOI 10.1016/S0169-328X(01)00069-9; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Sugita S, 1997, J PHYSL, V460, P705; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; WATANABE Y, 1995, BRAIN RES, V688, P233, DOI 10.1016/0006-8993(95)00563-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74668	10.1371/journal.pone.0074668	http://dx.doi.org/10.1371/journal.pone.0074668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086360	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700030
J	Yu, Y; Xiang, ZF; Yao, H; Grueter, CC; Li, M				Yu, Yang; Xiang, Zuo-Fu; Yao, Hui; Grueter, Cyril C.; Li, Ming			Female Snub-Nosed Monkeys Exchange Grooming for Sex and Infant Handling	PLOS ONE			English	Article							RHINOPITHECUS-ROXELLANA; AGONISTIC SUPPORT; QINLING MOUNTAINS; SOCIAL-BEHAVIOR; RECIPROCITY; EVOLUTION; RECONCILIATION; INTERCHANGE; BABOONS	Allogrooming in primates has acquired an important social function beyond its original hygienic function and can be exchanged either for itself or used as a currency to obtain other benefits such as copulations, access to infants or agonistic support. We explore the strategic use of grooming as a social tool in semi-wild golden snub-nosed monkeys (Rhinopithecus roxellana) in central China, a species where two desirable resources, viz. reproductive males and infants, are restricted to the mating and birth season, respectively. We predict that females expend their grooming selectively to different individuals according to their "value". Our results show that in the mating season, females devoted more grooming to the resident male than in the birth season, and this effect was particularly strong in non-mothers (females without newborn infants). Moreover, females were more likely to groom the resident male after copulation than during baseline social conditions. In the birth season, females devoted more grooming to other females than in the mating season, and mothers (females with newborn infants) were the most valuable grooming partners. The mean rate of contact by non-mothers toward infants of other females was significantly higher after grooming the mothers than in baseline social conditions. In conclusion, our findings lend credence to the notion that primate females use grooming as a strategic tool to obtain limited resources such as males and infants and vary preference for particular individuals depending on the seasonal availability of valuable resources.	[Yu, Yang; Xiang, Zuo-Fu] Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China; [Yao, Hui] Key Lab Conservat Biol Shennongjia Golden Monkey, Shennongjia Forest Dist, Hubei, Peoples R China; [Grueter, Cyril C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Central South University of Forestry & Technology; University of Western Australia; Chinese Academy of Sciences; Institute of Zoology, CAS	Xiang, ZF (corresponding author), Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China.	xiangzf@csuft.edu.cn	Yao, Huiqin/AAX-3787-2020; Grueter, Cyril C./H-9319-2014	Yao, Huiqin/0000-0003-4742-8971; Grueter, Cyril C./0000-0001-8770-8148; Xiang, Zuofu/0000-0001-6133-3261	National Key Technology R&D Program of China [2013BAD03B03]; National Natural Science Foundation of China [31071937]; Innovation Platform Open Projects of Education Bureau of Hunan Province [11K078]; State Forestry Administration of China	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Platform Open Projects of Education Bureau of Hunan Province; State Forestry Administration of China	This study was supported by National Key Technology R&D Program of China (2013BAD03B03), the National Natural Science Foundation of China (31071937), Innovation Platform Open Projects of Education Bureau of Hunan Province (11K078) and the State Forestry Administration of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold K, 2003, BEHAVIOUR, V140, P519, DOI 10.1163/156853903322127968; Barelli C, 2011, ANIM BEHAV, V82, P801, DOI 10.1016/j.anbehav.2011.07.012; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; CHEN F, 1983, Acta Theriologica Sinica, V3, P141; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Grueter CC, 2013, EVOL HUM BEHAV, V34, P61, DOI 10.1016/j.evolhumbehav.2012.09.004; Gruter CC, 2004, PRIMATES, V45, P197; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HART BL, 1992, ANIM BEHAV, V44, P615, DOI 10.1016/S0003-3472(05)80290-8; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; HENZI SP, 2002, ANIM BEHAV, V63, P1; Kirkpatrick RC, 2010, EVOL ANTHROPOL, V19, P98, DOI 10.1002/evan.20259; Kirkpatrick RC, 2011, PRIMATES PERSPECTIVE, P189; Koyama NF, 2006, INT J PRIMATOL, V27, P1293, DOI 10.1007/s10764-006-9074-8; LANCASTER JB, 1971, FOLIA PRIMATOL, V15, P161, DOI 10.1159/000155377; Leone A, 2010, PRIMATES, V51, P203, DOI 10.1007/s10329-010-0188-4; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li Yin-Hua, 2005, Acta Zoologica Sinica, V51, P953; Nicolson NA, 1987, PRIMATE SOC, P330, DOI DOI 10.1017/S0952836903004576; PACKER C, 1977, NATURE, V265, P441, DOI 10.1038/265441a0; Perez AP, 2000, PRIMATES, V41, P199, DOI 10.1007/BF02557801; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Ren R, 2000, FIELD STUDY SOC RHIN; Ren RM, 2010, ZOOL STUD, V49, P1; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; SCHINO G, 1990, BEHAVIOUR, V113, P264, DOI 10.1163/156853990X00518; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Smuts B.B., 1987, P385; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Tiddi B, 2011, BEHAV ECOL, V22, P663, DOI 10.1093/beheco/arr028; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang XW, 2013, INTEGR ZOOL, V8, P400, DOI 10.1111/1749-4877.12026; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036802; Xiang ZF, 2011, CHINESE SCI BULL, V56, P2553, DOI 10.1007/s11434-011-4613-x; Zhang P, 2003, ACTA ZOOL SINICA, V49, P722; Zhang P, 2008, AM J PRIMATOL, V70, P1013, DOI 10.1002/ajp.20591; Zhang SY, 2000, AM J PRIMATOL, V51, P265, DOI 10.1002/1098-2345(200008)51:4<265::AID-AJP6>3.3.CO;2-#	53	18	20	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74822	10.1371/journal.pone.0074822	http://dx.doi.org/10.1371/journal.pone.0074822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086380	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700041
J	Bubnell, J; Pfister, P; Sapar, ML; Rogers, ME; Feinstein, P				Bubnell, Jaclyn; Pfister, Patrick; Sapar, Maria L.; Rogers, Matthew E.; Feinstein, Paul			beta(2) Adrenergic Receptor Fluorescent Protein Fusions Traffic to the Plasma Membrane and Retain Functionality	PLOS ONE			English	Article							TAGGED BETA(2)-ADRENERGIC RECEPTOR; COUPLED-RECEPTORS; STRUCTURAL BIOLOGY; DRUG DISCOVERY; LIVING CELLS; GPCRS; RED; ACTIVATION; DIVERSITY; SURFACE	Green fluorescent protein (GFP) has proven useful for the study of protein interactions and dynamics for the last twenty years. A variety of new fluorescent proteins have been developed that expand the use of available excitation spectra. We have undertaken an analysis of seven of the most useful fluorescent proteins (XFPs), Cerulean (and mCerulean3), Teal, GFP, Venus, mCherry and TagRFP657, as fusions to the archetypal G-protein coupled receptor, the beta(2) adrenergic receptor (beta(2)AR). We have characterized these beta(2)AR:: XFP fusions in respect to membrane trafficking and G-protein activation. We noticed that in the mouse neural cell line, OP 6, that membrane bound beta(2)AR:: XFP fusions robustly localized in the filopodia identical to gap::XFP fusions. All beta(2)AR::XFP fusions show responses indistinguishable from each other and the non-fused form after isoprenaline exposure. Our results provide a platform by which G-protein coupled receptors can be dissected for their functionality.	[Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY, Grad Ctr Biochem, Biol Program, New York, NY 10021 USA; [Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA; [Pfister, Patrick; Rogers, Matthew E.] Firmenich Inc, Corp Res & Dev, Plainsboro, NJ USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Firmenich	Feinstein, P (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	Feinstein@genectr.hunter.cuny.edu		Pfister, Patrick/0000-0002-1192-8600	National Institutes of Health (NIH) [R21 DC011100-01, RCMI 41398-01-27]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011100] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	JB, MS and PF used National Institutes of Health (NIH) R21 Grant: R21 DC011100-01 for experiments and NIH grant: RCMI 41398-01-27 for departmental infrastructure, PP and MB, Firmenich Inc (no website available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barak LS, 1999, METHOD ENZYMOL, V302, P153, DOI 10.1016/S0076-6879(99)02016-9; Bohme I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-16; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kennedy DC, 2009, ACS NANO, V3, P2329, DOI 10.1021/nn900488u; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LIU YC, 1994, J NEUROSCI, V14, P5807; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lundstrom K, 2005, BIOORG MED CHEM LETT, V15, P3654, DOI 10.1016/j.bmcl.2005.05.041; Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Luttrell LM, 2002, J CELL SCI, V115, P455; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2009, COLD SPRING HARBOR P, V2009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sunaguchi M, 2003, BRAIN RES, V984, P21, DOI 10.1016/S0006-8993(03)03004-X; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vobornik D, 2009, BIOCHEM BIOPH RES CO, V382, P85, DOI 10.1016/j.bbrc.2009.02.144; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74941	10.1371/journal.pone.0074941	http://dx.doi.org/10.1371/journal.pone.0074941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086401	Green Published, gold			2022-12-25	WOS:000326520200056
J	de Kreuk, BJ; Schaefer, A; Anthony, EC; Tol, S; Fernandez-Borja, M; Geerts, D; Pool, J; Hambach, L; Goulmy, E; Hordijk, PL				de Kreuk, Bart-Jan; Schaefer, Antje; Anthony, Eloise C.; Tol, Simon; Fernandez-Borja, Mar; Geerts, Dirk; Pool, Jos; Hambach, Lothar; Goulmy, Els; Hordijk, Peter L.			The Human Minor Histocompatibility Antigen1 Is a RhoGAP	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GTPASE-ACTIVATING PROTEIN; BAR DOMAIN; BINDING-PROTEIN; CELL-MIGRATION; CDC42 GTPASES; GRAF FAMILY; ADHESION; RAC; ACTIN	The human minor Histocompatibility Antigen HMHA-1 is a major target of immune responses after allogeneic stem cell transplantation applied for the treatment of leukemia and solid tumors. The restriction of its expression to hematopoietic cells and many solid tumors raised questions regarding its cellular functions. Sequence analysis of the HMHA-1 encoding HMHA1 protein revealed the presence of a possible C-terminal RhoGTPase Activating Protein (GAP) domain and an N-terminal BAR domain. Rho-family GTPases, including Rac1, Cdc42, and RhoA are key regulators of the actin cytoskeleton and control cell spreading and migration. RhoGTPase activity is under tight control as aberrant signaling can lead to pathology, including inflammation and cancer. Whereas Guanine nucleotide Exchange Factors (GEFs) mediate the exchange of GDP for GTP resulting in RhoGTPase activation, GAPs catalyze the low intrinsic GTPase activity of active RhoGTPases, resulting in inactivation. Here we identify the HMHA1 protein as a novel RhoGAP. We show that HMHA1 constructs, lacking the N-terminal region, negatively regulate the actin cytoskeleton as well as cell spreading. Furthermore, we show that HMHA1 regulates RhoGTPase activity in vitro and in vivo. Finally, we demonstrate that the HMHA1 N-terminal BAR domain is auto-inhibitory as HMHA1 mutants lacking this region, but not full-length HMHA1, showed GAP activity towards RhoGTPases. In conclusion, this study shows that HMHA1 acts as a RhoGAP to regulate GTPase activity, cytoskeletal remodeling and cell spreading, which are crucial functions in normal hematopoietic and cancer cells.	[de Kreuk, Bart-Jan; Schaefer, Antje; Anthony, Eloise C.; Tol, Simon; Fernandez-Borja, Mar; Hordijk, Peter L.] Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Pool, Jos; Goulmy, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, Hannover, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School	Hordijk, PL (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	p.hordijk@sanquin.nl	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X; Schaefer, Antje/0000-0002-2716-9899	LSBR (Landsteiner Foundation for Blood Transfusion Research) [0731]; LSBR [0903]	LSBR (Landsteiner Foundation for Blood Transfusion Research); LSBR	BJDK was supported by LSBR (Landsteiner Foundation for Blood Transfusion Research) grant 0731. AS was supported by LSBR grant 0903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; de Kreuk Bart-Jan, 2012, Small GTPases, V3, P45, DOI 10.4161/sgtp.18960; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Elvers M, 2012, CARDIOVASC RES, V94, P526, DOI 10.1093/cvr/cvs079; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GOULMY E, 1983, NATURE, V302, P159, DOI 10.1038/302159a0; Goulmy E, 1996, CURR OPIN IMMUNOL, V8, P75, DOI 10.1016/S0952-7915(96)80108-7; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Hambach L, 2006, LEUKEMIA, V20, P371, DOI 10.1038/sj.leu.2404056; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jelen F, 2009, J STRUCT BIOL, V165, P10, DOI 10.1016/j.jsb.2008.09.007; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schaefer A, 2011, J MOL BIOL, V411, P808, DOI 10.1016/j.jmb.2011.06.033; Spierings E, 2004, TRENDS IMMUNOL, V25, P56, DOI 10.1016/j.it.2003.12.002; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Wilke Martina, 2003, Hematol J, V4, P315, DOI 10.1038/sj.thj.6200318; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	44	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73962	10.1371/journal.pone.0073962	http://dx.doi.org/10.1371/journal.pone.0073962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086303	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200017
J	Gu, SH; Wu, KM; Guo, YY; Field, LM; Pickett, JA; Zhang, YJ; Zhou, JJ				Gu, Shao-Hua; Wu, Kong-Ming; Guo, Yu-Yuan; Field, Linda M.; Pickett, John A.; Zhang, Yong-Jun; Zhou, Jing-Jiang			Identification and Expression Profiling of Odorant Binding Proteins and Chemosensory Proteins between Two Wingless Morphs and a Winged Morph of the Cotton Aphid Aphis gossypii Glover	PLOS ONE			English	Article							PHEROMONE-BINDING; INSECT CHEMORECEPTION; MAMESTRA-BRASSICAE; GENOME ANNOTATION; CHEMICAL ECOLOGY; SOLUBLE-PROTEINS; ALARM PHEROMONE; CIS-JASMONE; LOCALIZATION; PURIFICATION	Insects interact with their environment and respond to the changes in host plant conditions using semiochemicals. Such ecological interactions are facilitated by the olfactory sensilla and the use of olfactory recognition proteins. The cotton aphid Aphis gossypii can change its phenotype in response to ecological conditions. They reproduce mainly as wingless asexual morphs but develop wings to find mates or new plant hosts under the influence of environmental factors such as temperature, plant nutrition and population density. Two groups of small soluble proteins, odorant binding proteins (OBPs) and chemosensory proteins (CSPs) are believed to be involved in the initial biochemical recognition steps in semiochemical perception. However, the exact molecular roles that these proteins play in insect olfaction remain to be discovered. In this study, we compared the transcriptomes of three asexual developmental stages (wingless spring and summer morphs and winged adults) and characterised 9 OBP and 9 CSP genes. The gene structure analysis showed that the number and length of introns in these genes are much higher and this appears to be unique feature of aphid OBP and CSP genes in general. Another unique feature in aphids is a higher abundance of CSP transcripts than OBP transcripts, suggesting an important role of CSPs in aphid physiology and ecology. We showed that some of the transcripts are overexpressed in the antennae in comparison to the bodies and highly expressed in the winged aphids compared to wingless morphs, suggesting a role in host location. We examined the differential expression of these olfactory genes in ten aphid species and compared the expression profile with the RNA-seq analyses of 25 pea aphid transcriptome libraries hosted on AphidBase.	[Gu, Shao-Hua; Wu, Kong-Ming; Guo, Yu-Yuan; Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Field, Linda M.; Pickett, John A.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn; jing-jiang.zhou@rothamsted.ac.uk		Field, Linda/0000-0002-3328-2513	China National "973" Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858, 31272048]; Royal Society, UK [31111130203, JP100849]; BBSRC International Partnering Award [BB/J020281]; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/J020281/1, BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BB/J020281/1, BBS/E/C/00005194] Funding Source: UKRI	China National "973" Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, UK(Royal Society of London); BBSRC International Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China National "973" Basic Research Program (2012CB114104) and the National Natural Science Foundation of China (31071694, 31171858 and 31272048). YJZ and JJZ acknowledge the financial support from the Royal Society, UK for the international joint project between China and UK (31111130203; JP100849) and BBSRC International Partnering Award (BB/J020281). Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; CAMPBELL CAM, 1993, J CHEM ECOL, V19, P1569, DOI 10.1007/BF00984897; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; DAWSON GW, 1984, ENTOMOL EXP APPL, V36, P197, DOI 10.1007/BF00569962; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Dewhirst SY, 2012, PEST MANAG SCI, V68, P1419, DOI 10.1002/ps.3326; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hegde M, 2012, PHYTOCHEMISTRY, V78, P81, DOI 10.1016/j.phytochem.2012.03.004; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Pickett JA, 2007, CHEM ECOLOGY; Pickett JA, 2012, PHYSIOL ENTOMOL, V37, P2, DOI 10.1111/j.1365-3032.2011.00828.x; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Sachse S., 2011, E NEUROFORUM, V2, P49, DOI [10.1007/s13295-011-0020-7, DOI 10.1007/S13295-011-0020-7]; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandermoten S, 2012, INSECT BIOCHEM MOLEC, V42, P155, DOI 10.1016/j.ibmb.2011.11.008; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	49	50	58	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73524	10.1371/journal.pone.0073524	http://dx.doi.org/10.1371/journal.pone.0073524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073197	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000006
J	Cui, BY; Yang, X; Li, SW; Lin, ZJ; Wang, Z; Dong, C; Shen, YQ				Cui, Boyang; Yang, Xue; Li, Siwei; Lin, Zhijie; Wang, Zheng; Dong, Cheng; Shen, Yuequan			The Inhibitory Helix Controls the Intramolecular Conformational Switching of the C-Terminus of STIM1	PLOS ONE			English	Article							MECHANISTIC INSIGHTS; ORAI1; OLIGOMERIZATION; MACROMOLECULES; ACTIVATION; INITIATION; DOMAIN; PORE	Store-operated Ca2+ entry (SOCE) is a critical Ca2+ signaling pathway in many cell types. After sensing Ca2+ store depletion in the endoplasmic reticulum (ER) lumen, STIM1 (STromal Interaction Molecule 1) oligomerizes and then interacts with and activates the Orai1 calcium channel. Our previous research has demonstrated that the inhibitory helix (IH) adjacent to the first coiled-coil region (CC1) of STIM1 may keep the whole C-terminus of STIM1 in an inactive state. However, the specific conformational change of CC1-IH that drives the transition of STIM1 from the resting state to the active state remains elusive. Herein, we report the structural analysis of CC1-IH, which revealed that the entire CC1-IH molecule forms a very long helix. Structural and biochemical analyses indicated that IH, and not the CC1 region, contributes to the oligomerization of STIM1. Small-angle X-ray scattering (SAXS) analysis suggested that the C-terminus of STIM1 including the IH region displays a collapsed conformation, whereas the construct without the IH region has an extended conformation. These two conformations may correspond to the conformational states of the C-terminus of STIM1 before and after activation. Taken together, our results provide direct biochemical evidence that the IH region controls the conformational switching of the C-terminus of STIM1.	[Cui, Boyang; Yang, Xue; Li, Siwei; Wang, Zheng; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Cui, Boyang; Li, Siwei; Lin, Zhijie; Wang, Zheng; Dong, Cheng; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Lin, Zhijie/Y-4836-2019		973 Program [2012CB917200, 2013CB910400]; Natural Science Foundation of China [31170684]; Fundamental Research Funds for the Central Universities [65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 973 Program (grants 2012CB917200 and 2013CB910400), the Natural Science Foundation of China (grant 31170684), and the Fundamental Research Funds for the Central Universities (grant 65020241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	32	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74735	10.1371/journal.pone.0074735	http://dx.doi.org/10.1371/journal.pone.0074735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069340	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300041
J	Hindrikson, M; Remm, J; Mannil, P; Ozolins, J; Tammeleht, E; Saarma, U				Hindrikson, Maris; Remm, Jaanus; Maennil, Peep; Ozolins, Janis; Tammeleht, Egle; Saarma, Urmas			Spatial Genetic Analyses Reveal Cryptic Population Structure and Migration Patterns in a Continuously Harvested Grey Wolf (Canis lupus) Population in North-Eastern Europe	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; COMPUTER-PROGRAM; SOCIAL BONDS; BROWN BEARS; WOLVES; SIZE; HYBRIDIZATION; DIVERSITY; REPEAT; IDENTIFICATION	Spatial genetics is a relatively new field in wildlife and conservation biology that is becoming an essential tool for unravelling the complexities of animal population processes, and for designing effective strategies for conservation and management. Conceptual and methodological developments in this field are therefore critical. Here we present two novel methodological approaches that further the analytical possibilities of STRUCTURE and DResD. Using these approaches we analyse structure and migrations in a grey wolf (Canis lupus) population in north-eastern Europe. We genotyped 16 microsatellite loci in 166 individuals sampled from the wolf population in Estonia and Latvia that has been under strong and continuous hunting pressure for decades. Our analysis demonstrated that this relatively small wolf population is represented by four genetic groups. We also used a novel methodological approach that uses linear interpolation to statistically test the spatial separation of genetic groups. The new method, which is capable of using program STRUCTURE output, can be applied widely in population genetics to reveal both core areas and areas of low significance for genetic groups. We also used a recently developed spatially explicit individual-based method DResD, and applied it for the first time to microsatellite data, revealing a migration corridor and barriers, and several contact zones.	[Hindrikson, Maris; Remm, Jaanus; Tammeleht, Egle; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia; [Maennil, Peep] Estonian Environm Informat Ctr, Tartu, Estonia; [Ozolins, Janis] State Forest Res Inst Silava, Salaspils, Latvia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Latvian State Forest Research Institute "Silava"	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Remm, Jaanus/G-9347-2012; Saarma, Urmas/J-6448-2015; Tammeleht, Egle/J-6528-2015; Saarma, Urmas/AAC-9813-2019; Hindrikson, Maris/G-4573-2017	Remm, Jaanus/0000-0002-8896-0772; Saarma, Urmas/0000-0002-3222-571X; Tammeleht, Egle/0000-0003-0871-051X; Saarma, Urmas/0000-0002-3222-571X; Hindrikson, Maris/0000-0001-8094-1860	Environmental Investment Centre; Estonian Ministry of Education and Sciences [SF0180122s08]; Estonian Science Foundation [7040, 8525]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); European Commission [PIRSES-GA-2009-247652]; Estonian Doctoral School of Ecology and Environmental Sciences	Environmental Investment Centre; Estonian Ministry of Education and Sciences(Ministry of Education and Research, Estonia); Estonian Science Foundation; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by grants from the Environmental Investment Centre, the Estonian Ministry of Education and Sciences (target financing project SF0180122s08), the Estonian Science Foundation (grants 7040 and 8525), from the European Union through the European Regional Development Fund (Centre of Excellence FIBIR), from European Commission's project No. PIRSES-GA-2009-247652 (BIOGEAST), and from the Estonian Doctoral School of Ecology and Environmental Sciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; Allendorf F. W., 2007, CONSERV GENET, P642, DOI DOI 10.1515/MAMM.2007.038; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Belkhir K, 2004, GENETIX SOFTWARE WIN; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Boitani L, 2009, NEW ERA WOLVES PEOPL; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Brzustowski J, 2002, DOH ASSIGNMENT TEST; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Caro T, 2012, CONSERV BIOL, V26, P185, DOI 10.1111/j.1523-1739.2011.01752.x; Carroll C, 2013, CONSERV BIO IN PRESS; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Cordoni G, 2009, BEHAVIOUR, V146, P1363, DOI 10.1163/156853909X427722; Cornuet JM, 1996, GENETICS, V144, P2001; Coster SS, 2012, CONSERV GENET, V13, P1247, DOI 10.1007/s10592-012-0368-4; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Galpern P, 2012, MOL ECOL, V21, P3996, DOI 10.1111/j.1365-294X.2012.05677.x; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hedrick P., 1983, GENETICS POPULATIONS; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Jedrzejewski W., 2010, WORLD WOLVES NEW PER; Karmapa HHG, 2011, CONSERV BIOL, V25, P1094, DOI 10.1111/j.1523-1739.2011.01765.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mech DL, 2007, OLVES BEHAV ECOLOGY; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; NEI M, 1978, GENETICS, V89, P583; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Paetkau D, 1997, GENETICS, V147, P1943; Palsboll PJ, 2010, MOL ECOL RESOUR, V10, P797, DOI 10.1111/j.1755-0998.2010.02887.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2011, R LANG ENV STAT COMP; Randall DA, 2007, BEHAV ECOL, V18, P579, DOI 10.1093/beheco/arm010; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; ROUSSET F, 1995, GENETICS, V140, P1413; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tiilikainen R, 2010, ANN ZOOL FENN, V47, P159, DOI 10.5735/086.047.0301; Valdmann Harri, 2004, Baltic Forestry, V10, P83; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, CONSERV BIOL, V13, P195, DOI 10.1046/j.1523-1739.1999.97425.x; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	80	18	18	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75765	10.1371/journal.pone.0075765	http://dx.doi.org/10.1371/journal.pone.0075765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069446	gold, Green Published, Green Submitted			2022-12-25	WOS:000324777300096
J	Cummins, J; Casey, PG; Joyce, SA; Gahan, CGM				Cummins, Joanne; Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.			A Mariner Transposon-Based Signature-Tagged Mutagenesis System for the Analysis of Oral Infection by Listeria monocytogenes	PLOS ONE			English	Article							PROTOPORPHYRINOGEN OXIDASE; GASTROINTESTINAL PHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; VIRULENCE GENES; CRP/FNR FAMILY; IDENTIFICATION; GENOME; INTERNALIN; HEME	Listeria monocytogenes is a Gram-positive foodborne pathogen and the causative agent of listerosis a disease that manifests predominately as meningitis in the non-pregnant individual or infection of the fetus and spontaneous abortion in pregnant women. Common-source outbreaks of foodborne listeriosis are associated with significant morbidity and mortality. However, relatively little is known concerning the mechanisms that govern infection via the oral route. In order to aid functional genetic analysis of the gastrointestinal phase of infection we designed a novel signature-tagged mutagenesis (STM) system based upon the invasive L. monocytogenes 4b serotype H7858 strain. To overcome the limitations of gastrointestinal infection by L. monocytogenes in the mouse model we created a H7858 strain that is genetically optimised for oral infection in mice. Furthermore our STM system was based upon a mariner transposon to favour numerous and random transposition events throughout the L. monocytogenes genome. Use of the STM bank to investigate oral infection by L. monocytogenes identified 21 insertion mutants that demonstrated significantly reduced potential for infection in our model. The sites of transposon insertion included lmOh7858_0671 (encoding an internalin homologous to Lmo0610), lmOh7858_0898 (encoding a putative surface-expressed LPXTG protein homologous to Lmo0842), lmOh7858_2579 (encoding the HupDGC hemin transport system) and lmOh7858_0399 (encoding a putative fructose specific phosphotransferase system). We propose that this represents an optimised STM system for functional genetic analysis of foodborne/oral infection by L. monocytogenes.	[Cummins, Joanne; Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University College Cork	Gahan, CGM (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	c.gahan@ucc.ie	Joyce, Susan/ABE-2616-2020; Gahan, Cormac G/AAE-9346-2019	Joyce, Susan/0000-0003-4771-3123; Gahan, Cormac G/0000-0003-2385-8192	Science Foundation Ireland [08/RFP/GEN1320]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by a grant from Science Foundation Ireland under the Research Frontiers Programme (08/RFP/GEN1320). The authors also acknowledge the funding received from Science Foundation Ireland under the Centers for Science Engineering and Technology programme which funds the Alimentary Pharmabiotic Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; [Anonymous], 1998, MMWR WEEKLY, V47, P1085; [Anonymous], 2001, PROGR PROP IN PRESS; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bayles DO, 2006, J FOOD PROTECT, V69, P2758, DOI 10.4315/0362-028X-69.11.2758; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Betney R, 2010, RNA, V16, P655, DOI 10.1261/rna.1796210; BEUMER RR, 1992, INT J FOOD MICROBIOL, V15, P153, DOI 10.1016/0168-1605(92)90144-R; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; CAMILLI A, 1990, J BACTERIOL, V172, P3738, DOI 10.1128/jb.172.7.3738-3744.1990; Campbell I, 2009, INTENS CARE MED, V10, P336, DOI [10.1016/j.mpaic.2009.04.018, DOI 10.1016/J.MPAIC.2009.04.018]; Cao M, 2007, APPL ENVIRON MICROB, V73, P2758, DOI 10.1128/AEM.02844-06; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; Csonka LNa E W, 1996, ESCHERICHIA COLI SAL, P1210; Cummins J, 2012, GUT MICROBES, V3, P93, DOI 10.4161/gmic.19578; Dharmarha V, 2008, FOCUS LISTERIA MONOC; Dowd GC, 2011, INFECT IMMUN, V79, P369, DOI 10.1128/IAI.00330-10; Dreyfus M, 2011, MOL MICROBIOL, V79, P288, DOI 10.1111/j.1365-2958.2010.07468.x; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Garsin DA, 2004, J BACTERIOL, V186, P7280, DOI 10.1128/JB.186.21.7280-7289.2004; Gaurivaud P, 2000, MOL PLANT MICROBE IN, V13, P1145, DOI 10.1094/MPMI.2000.13.10.1145; Ghanem ENB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003015; Harvey PC, INFECT IMMUN; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Homuth G, 1999, J BACTERIOL, V181, P5922, DOI 10.1128/JB.181.19.5922-5929.1999; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Kana BD, 2010, J BACTERIOL, V192, P2220, DOI 10.1128/JB.01135-09; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Loo CY, 2003, J BACTERIOL, V185, P6241, DOI 10.1128/JB.185.21.6241-6254.2003; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McGann P, 2008, FOODBORNE PATHOG DIS, V5, P417, DOI 10.1089/fpd.2008.0085; MELDRUM SJ, 1972, BRIT MED J, V2, P104; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Monk IR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-318; Nakamura T, 1998, MICROBIOL-SGM, V144, P2281, DOI 10.1099/00221287-144-8-2281; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Picardeau M, 2010, GENETICA, V138, P551, DOI 10.1007/s10709-009-9408-5; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SASARMAN A, 1993, CAN J MICROBIOL, V39, P1155, DOI 10.1139/m93-174; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Sleator RD, 2007, MED HYPOTHESES, V69, P1090, DOI 10.1016/j.mehy.2007.02.028; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stumpe SB, 1996, WN KONINGS HRKAJSL, P474; Uhlich GA, 2006, FOOD MICROBIOL, V23, P300, DOI 10.1016/j.fm.2005.03.007; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09	70	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75437	10.1371/journal.pone.0075437	http://dx.doi.org/10.1371/journal.pone.0075437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069416	Green Published, Green Submitted, gold			2022-12-25	WOS:000326240100125
J	Wang, F; Chen, X; Li, C; Sun, Q; Chen, Y; Wang, Y; Peng, H; Liu, Z; Chen, R; Liu, K; Yan, H; Ye, BH; Kwiatkowski, DJ; Zhang, H				Wang, F.; Chen, X.; Li, C.; Sun, Q.; Chen, Y.; Wang, Y.; Peng, H.; Liu, Z.; Chen, R.; Liu, K.; Yan, H.; Ye, B. H.; Kwiatkowski, D. J.; Zhang, H.			Pivotal role of augmented alpha B-crystallin in tumor development induced by deficient TSC1/2 complex	ONCOGENE			English	Article						alpha B-crystallin; mTOR; NF kappa B; TSC; tumor	TUBEROUS SCLEROSIS COMPLEX; SUPPRESSOR GENE-PRODUCT; NF-KAPPA-B; MAMMALIAN TARGET; INDUCED APOPTOSIS; BINDING PARTNER; CELL-ADHESION; UP-REGULATION; CANCER-CELLS; MTOR	Tuberous sclerosis complex 1 (TSC1) and TSC2 are suppressors of mechanistic target of rapamycin (mTOR). mTOR is the major component of two protein complexes: mTOR complex 1 (mTORC1) and mTORC2. Inactive mutation of either TSC1 or TSC2 unleashes mTOR signaling and consequently causes TSC, a benign tumor syndrome affecting multiple organs. We report here that expression of alpha B-crystallin was upregulated in Tsc1-/- or Tsc2-/- mouse embryonic fibroblasts, Eker rat uterine leiomyoma-derived Tsc2-deficient ELT3 cells, mutant Tsc2-associated mouse kidney tumors, and human lung lymphangioleiomyomatosis nodules. alpha B-crystallin was transcriptionally activated by mTOR complex 2 (mTORC2): nuclear factor-kappa B (NF kappa B) signaling cascade. The augmented alpha B-crystallin was critical for the migration, invasion and apoptotic resistance of Tsc2-defective cells. Disruption of alpha B-crystallin suppressed Tsc2-null cell proliferation and tumorigenesis. Therefore, enhanced alpha B-crystallin has an essential role in TSC1/2 complex deficiency-mediated tumorigenesis, and inhibition of alpha B-crystallin may complement the current therapy for TSC.	[Wang, F.; Chen, X.; Li, C.; Wang, Y.; Liu, Z.; Chen, R.; Zhang, H.] Peking Union Med Coll, Grad Sch, Inst Basic Med Sci, State Key Lab Med Mol Biol,Dept Physiol & Pathoph, Beijing 100005, Peoples R China; [Wang, F.; Chen, X.; Li, C.; Wang, Y.; Liu, Z.; Chen, R.; Zhang, H.] Peking Union Med Coll, Grad Sch, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, F.; Chen, X.; Li, C.; Chen, Y.; Wang, Y.; Liu, Z.; Chen, R.; Yan, H.; Zhang, H.] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Sun, Q.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China; [Chen, Y.; Yan, H.] Peking Union Med Coll, Cardiovasc Inst, Ctr Coronary Heart Dis, Beijing 100005, Peoples R China; [Chen, Y.; Yan, H.] Peking Union Med Coll, Fu Wai Hosp, Beijing 100005, Peoples R China; [Peng, H.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Liu, K.] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450052, Henan, Peoples R China; [Ye, B. H.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Kwiatkowski, D. J.] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; [Kwiatkowski, D. J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Scripps Research Institute; Zhengzhou University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zhang, H (corresponding author), Peking Union Med Coll, Grad Sch, Inst Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100005, Peoples R China.	hbzhang@ibms.pumc.edu.cn	Peng, Haiyong/S-8045-2016		National Basic Research Program of China 973 Program [2009CB522203, 2011CB965002]; National Natural Science Foundation of China [81130085, 81101516]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China 973 Program Grants 2009CB522203 and 2011CB965002 and National Natural Science Foundation of China Grants 81130085 and 81101516.	AOYAMA A, 1993, INT J CANCER, V55, P760, DOI 10.1002/ijc.2910550511; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bittmann I, 2003, HUM PATHOL, V34, P95, DOI 10.1053/hupa.2003.50; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; European Chromosome 16 Tuberous Sclerosis C., 1993, CELL, V75, P1305; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; HOWE SR, 1995, AM J PATHOL, V146, P1568; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; IWAKI T, 1991, AM J PATHOL, V139, P1303; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; KUPSKY WJ, 1993, PEDIATR PATHOL, V13, P869, DOI 10.3109/15513819309048274; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lang SA, 2010, BBA-MOL CELL RES, V1803, P435, DOI 10.1016/j.bbamcr.2010.01.009; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Ozes ON, 1999, NATURE, V401, P82; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shi T, 2004, MOL CARCINOGEN, V40, P47, DOI 10.1002/mc.20015; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Young LR, 2008, NEW ENGL J MED, V358, P199, DOI 10.1056/NEJMc0707517; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	49	7	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4352	4358		10.1038/onc.2013.401	http://dx.doi.org/10.1038/onc.2013.401			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24077282				2022-12-25	WOS:000341156900008
J	Yumimoto, K; Muneoka, T; Tsuboi, T; Nakayama, KI				Yumimoto, Kanae; Muneoka, Tetsuya; Tsuboi, Tomohiro; Nakayama, Keiichi I.			Substrate Binding Promotes Formation of the Skp1-Cul1-Fbxl3 (SCFFbxl3) Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Protein Assembly; Protein Degradation; Ubiquitin Ligase; Ubiquitylation	F-BOX PROTEIN; UBIQUITIN LIGASE; CIRCADIAN CLOCK; NEDD8 MODIFICATION; BETA-TRCP; SCF; DEGRADATION; CUL1; ACTIVATION; CRYPTOCHROMES	Background: The Skp1-Cul1-Fbxl3 (SCFFbxl3) complex regulates oscillation of the circadian clock by targeting Cry proteins for degradation. Results: Fbxl3 interacts with Skp1 and Cul1 only in the presence of its substrate Cry1 in vivo. Conclusion: Association of Cry1 with Fbxl3 is essential for SCFFbxl3 complex formation in vivo. Significance: Our findings provide important insight into the regulation of SCF ubiquitin ligase activity and circadian rhythmicity. The Skp1-Cul1-F-box protein (SCF) complex is one of the most well characterized types of ubiquitin ligase (E3), with the E3 activity of the complex being regulated in part at the level of complex formation. Fbxl3 is an F-box protein that is responsible for the ubiquitylation and consequent degradation of cryptochromes (Crys) and thus regulates oscillation of the circadian clock. Here we show that formation of the SCFFbxl3 complex is regulated by substrate binding in vivo. Fbxl3 did not associate with Skp1 and Cul1 to a substantial extent in transfected mammalian cells. Unexpectedly, however, formation of the SCFFbxl3 complex was markedly promoted by forced expression of its substrate Cry1 in these cells. A mutant form of Fbxl3 that does not bind to Cry1 was unable to form an SCF complex, suggesting that interaction of Cry1 with Fbxl3 is essential for formation of SCFFbxl3. In contrast, recombinant Fbxl3 associated with recombinant Skp1 and Cul1 in vitro even in the absence of recombinant Cry1. Domain-swap analysis revealed that the COOH-terminal leucine-rich repeat domain of Fbxl3 attenuates the interaction of Skp1, suggesting that a yet unknown protein associated with the COOH-terminal domain of Fbxl3 and inhibited SCF complex formation. Our results thus provide important insight into the regulation of both SCF ubiquitin ligase activity and circadian rhythmicity.	[Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	56	17	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32766	32776		10.1074/jbc.M113.511303	http://dx.doi.org/10.1074/jbc.M113.511303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085301	Green Published, hybrid			2022-12-25	WOS:000328681700060
J	Lee, SH; Shin, HJ; Kim, DY; Shim, DW; Kim, TJ; Ye, SK; Won, HS; Koppula, S; Kang, TB; Lee, KH				Lee, Seung-Hwan; Shin, Hee Jae; Kim, Dong-Young; Shim, Do-Wan; Kim, Tack-Joong; Ye, Sang-Kyu; Won, Hyung-Sik; Koppula, Sushruta; Kang, Tae-Bong; Lee, Kwang-Ho			Streptochlorin Suppresses Allergic Dermatitis and Mast Cell Activation via Regulation of Lyn/Fyn and Syk Signaling Pathways in Cellular and Mouse Models	PLOS ONE			English	Article								Allergic diseases are chronic inflammatory conditions with specific immune and inflammatory mechanisms. Scientific interest in understanding the mechanisms and discovering novel agents for the prevention and treatment of allergic disease is increasing. Streptochlorin, a small compound derived from marine actinomycete possesses anti-angiogenic and anti-tumor activities. However, the anti-allergic effects and underlying mechanisms remain to be elucidated. In the present study, we investigated the effect of streptochlorin on allergic responses in vitro and in vivo. Streptochlorin inhibited degranulation and production of tumor necrosis factor-alpha and IL-4 by antigen-stimulated mast cells. Streptochlorin also inhibited the phosphorylation of Akt and the mitogen-activated protein kinases (MAPKs), including p38, ERK, and JNK. Further, streptochlorin reduced the phosphorylation of Syk in RBL-2H3 cells and inhibited the activity of Lyn and Fyn. Furthermore, administration of streptochlorin suppressed the allergic reactions in both passive cutaneous anaphylaxis reaction and 2, 4-dinitrofluorobenzene (DNFB)-induced allergic dermatitis in mice model. Considering the data obtained, we report for the first time that streptochlorin possess anti-allergic properties. The underlying mechanism of streptochlorin in exhibiting potent anti-allergic activity might be through the inhibition of the Lyn/Fyn and Syk signaling pathways.	[Lee, Seung-Hwan; Kim, Dong-Young; Shim, Do-Wan; Won, Hyung-Sik; Koppula, Sushruta; Kang, Tae-Bong; Lee, Kwang-Ho] Konkuk Univ, Res Inst Inflammatory Dis, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea; [Shin, Hee Jae] Korea Inst Ocean Sci & Technol, Marine Nat Prod Chem Lab, Ansan, South Korea; [Kim, Tack-Joong] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea	Konkuk University; Korea Institute of Ocean Science & Technology (KIOST); Yonsei University; Seoul National University (SNU)	Lee, KH (corresponding author), Konkuk Univ, Res Inst Inflammatory Dis, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea.	kwangho@kku.ac.kr	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470; Shim, Do-Wan/0000-0003-1893-8323	Ministry of Education, Science Technology (MEST); Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation; Korea Institute of Ocean Science and Technology [PE99121]	Ministry of Education, Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation; Korea Institute of Ocean Science and Technology	This work was financially supported by the Ministry of Education, Science Technology (MEST) and Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation and also supported in part by Korea Institute of Ocean Science and Technology (Grant PE99121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi IK, 2007, J MICROBIOL BIOTECHN, V17, P1338; Costanzo R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/815269; de Castro RO, 2011, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2011/507291; Debbab A, 2010, MICROB BIOTECHNOL, V3, P544, DOI 10.1111/j.1751-7915.2010.00179.x; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jiang J, 2013, FOOD CHEM TOXICOL, V57, P256, DOI 10.1016/j.fct.2013.03.040; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Longui CA, 2007, J PEDIAT-BRAZIL, V83, pS163, DOI 10.2223/JPED.1713; MacDonald AJ, 1989, IMMUNOLOGY; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Perez A, 2004, CONTACT DERMATITIS, V51, P314, DOI 10.1111/j.0105-1873.2004.0459e.x; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Schweder T, 2005, ADV BIOCHEM ENG BIOT, V96, P1, DOI 10.1007/b135781; Shichijo M, 2003, BIOL PHARM BULL, V26, P1685, DOI 10.1248/bpb.26.1685; Shin HJ, 2007, J MICROBIOL BIOTECHN, V17, P1403; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Toncic RJ, 2011, ACTA DERMATOVENER CR, V19, P51; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11	27	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74194	10.1371/journal.pone.0074194	http://dx.doi.org/10.1371/journal.pone.0074194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086321	Green Submitted, gold, Green Published			2022-12-25	WOS:000325223900023
J	Lima, AA; Aragao, CWS; de Castro, MEB; Oliveira, JVD; Gomez, DRS; Ribeiro, BM				Lima, Anabele Azevedo; Silva Aragao, Clara Wandenkolck; Batista de Castro, Maria Elita; de Castro Oliveira, Juliana Velasco; Sosa Gomez, Daniel Ricardo; Ribeiro, Bergmann Morais			A Recombinant Anticarsia gemmatalis MNPV Harboring chiA and v-cath Genes from Choristoneura fumiferana Defective NPV Induce Host Liquefaction and Increased Insecticidal Activity	PLOS ONE			English	Article							CALIFORNICA NUCLEOPOLYHEDROVIRUS CHITINASE; VELVETBEAN CATERPILLAR; HUBNER LEPIDOPTERA; BACULOVIRUS; EXPRESSION; DELETION; CONSTRUCTION; PROTEINS; FORMS	One of the interesting features of Anticarsia gemmatalis multiple nucleopolyhedrovirus isolate 2D (AgMNPV-2D) genome is the absence of chitinase (chiA) and cathepsin (v-cath) genes. This characteristic may be responsible for the lack of liquefaction and melanization in A. gemmatalis larvae killed by AgMNPV-2D infection. This study aimed to test the hypothesis that CHIA and V-CATH proteins from Choristonera fumiferana DEF multiple nucleopolyhedrovirus (CfDEFNPV) are able to liquefy and melanize the cuticle of A. gemmatalis larvae infected by a recombinant AgMNPV containing chiA and v-cath genes inserted in its genome. A fragment from the CfDefNPV genome containing chiA and v-cath genes was inserted into the genome of AgMNPV-2D. The recombinant virus (vAgp2100Cf.chiA/v-cath) was purified and used to infect insect cells and larvae. Transcripts of v-cath and chiA genes were detected along the infection of insect cells by qRT-PCR, from early to late phases of infection. The analysis of A. gemmatalis larvae killed by vAgp2100Cf.chiA/v-cath infection confirmed the hypothesis proposed. The vAgp2100Cf.chiA/v-cath showed higher insecticidal activity against third instar A. gemmatalis larvae when compared to AgMNPV-2D. The mean time to death was also lower for the vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D at 10 days post infection. Occlusion body production was higher in A. gemmatalis larvae infected with vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D. Enzyme assays showed higher chitinase and cysteine protease activities in insect cells and insects infected with vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D. The introduction of chiA and v-cath genes into the genome of AgMNPV improves its insecticidal activity against A. gemmatalis larvae and this recombinant virus could be used as an alternative to the wild type virus to control this important insect pest.	[Lima, Anabele Azevedo; Silva Aragao, Clara Wandenkolck; Ribeiro, Bergmann Morais] Univ Brasilia, Grad Program Mol Pathol, Brasilia, DF, Brazil; [Batista de Castro, Maria Elita] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [de Castro Oliveira, Juliana Velasco] Univ Sao Paulo, Dept Microbiol, Sao Paulo, Brazil; [Sosa Gomez, Daniel Ricardo] Embrapa Soybean, Londrina, Parana, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ribeiro, BM (corresponding author), Univ Brasilia, Grad Program Mol Pathol, Brasilia, DF, Brazil.	bergmann@unb.br	GUO, Zhaoyu/AAS-5699-2020; Sosa-Gomez, Daniel Ricardo/J-3421-2012; Ribeiro, Bergmann Morais/C-7114-2015; Sosa-Gomez, Daniel/AAH-7223-2019	Sosa-Gomez, Daniel Ricardo/0000-0003-2633-1644; Ribeiro, Bergmann Morais/0000-0002-1061-196X; Sosa-Gomez, Daniel/0000-0003-2633-1644	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico [475579/2010-0, 490253/2011-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE-PROCAD/NF 886/2010]; Fundacao de Apoio a Pesquisa do Distrito Federal [193.000.583/2009]	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) grant numbers 475579/2010-0 and 490253/2011-3, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) grant number AUXPE-PROCAD/NF 886/2010, Fundacao de Apoio a Pesquisa do Distrito Federal (www.fap.df.gov.br) grant number: 193.000.583/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SB, 1998, QUANTIFICACAO INOCUL, P765; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cordeiro BA, 2008, J INVERTEBR PATHOL, V98, P7, DOI 10.1016/j.jip.2008.01.001; Daimon T, 2006, BIOCHEM BIOPH RES CO, V345, P825, DOI 10.1016/j.bbrc.2006.04.112; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; FEDERICI BA, 1997, BACULOVIRUSES; GOPALAKRISHNAN B, 1995, INSECT BIOCHEM MOLEC, V25, P255, DOI 10.1016/0965-1748(94)00070-X; Gramkow AW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-143; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Harrison RL, 2001, BIOL CONTROL, V20, P199, DOI 10.1006/bcon.2000.0899; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hawtin RE, 1995, VIROLOGY, V238, P243; Herniou EA, 2012, VIRUS TAXONOMY, P163; Hill EJ, 1995, BIOCHIM BIOPHYS ACTA, V1264, P275; Hodgson JJ, 2007, J GEN VIROL, V88, P2479, DOI 10.1099/vir.0.82863-0; Hodgson JJ, 2011, J VIROL, V85, P3918, DOI 10.1128/JVI.02165-10; Hoffmann-Campo CB, 2003, INTEGRATED PEST MANA, P285; Hom LG, 2000, VIROLOGY, V277, P178, DOI 10.1006/viro.2000.0586; Hom LG, 2002, VIROLOGY, V296, P212, DOI 10.1006/viro.2002.1378; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; JOHNSON DW, 1989, J GEN VIROL, V70, P1877, DOI 10.1099/0022-1317-70-7-1877; Kamita SG, 2005, COMPREHENSIVE MOL IN, P271; Katsuma S, 2009, VIRUS RES, V140, P155, DOI 10.1016/j.virusres.2008.11.014; Kramer KJ, 1997, INSECT BIOCHEM MOLEC, V27, P887, DOI 10.1016/S0965-1748(97)00078-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauzon HAM, 2005, J GEN VIROL, V86, P945, DOI 10.1099/vir.0.80489-0; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; LEE HH, 1978, J VIROL, V27, P754, DOI 10.1128/JVI.27.3.754-767.1978; LeOra Software Company, 2003, POLOPLUS PROB LOG AN; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOLANO J, 1977, ANAL BIOCHEM, V83, P648, DOI 10.1016/0003-2697(77)90069-0; Morales Lauro, 1993, Anais da Sociedade Entomologica do Brasil, V22, P535; OHKAWA T, 1994, J VIROL, V68, P6619, DOI 10.1128/JVI.68.10.6619-6625.1994; Oliveira JVC, 2010, THESIS U SAO PAULO U; Oliveira VC, 2011, VIRUS RES, V155, P259, DOI 10.1016/j.virusres.2010.10.019; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OREILLY DR, 1991, BIO-TECHNOL, V9, P1086, DOI 10.1038/nbt1191-1086; Pinedo FJR, 2003, BIOL CONTROL, V27, P336, DOI 10.1016/S1049-9644(03)00026-4; Reed RJ, 1938, AM J HYG, V7, P493; RIBEIRO BM, 1993, J INVERTEBR PATHOL, V62, P121, DOI 10.1006/jipa.1993.1087; Ribeiro BM, 2001, ARCH VIROL, V146, P1355, DOI 10.1007/s007050170096; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Saville GP, 2004, J GEN VIROL, V85, P821, DOI 10.1099/vir.0.19732-0; Saville GP, 2002, J GEN VIROL, V83, P685, DOI 10.1099/0022-1317-83-3-685; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; SIEBURTH PJ, 1988, IN VITRO CELL DEV B, V24, P195, DOI 10.1007/bf02623546; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; SMITH GE, 1983, J VIROL, V45, P215, DOI 10.1128/JVI.45.1.215-225.1983; Souza ML, 2002, BIOTECNOLOGIA CIENCI, V24, P18; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Thomas CJ, 2000, J GEN VIROL, V81, P1403, DOI 10.1099/0022-1317-81-5-1403; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; TRUDEL J, 1989, MOL PLANT MICROBE IN, V2, P315, DOI 10.1094/MPMI-2-315; VOLKMAN L.E., 1990, SEMIN VIROL, V1, P249; Wang F, 2005, ARCH VIROL, V150, P981, DOI 10.1007/s00705-004-0458-9	56	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74592	10.1371/journal.pone.0074592	http://dx.doi.org/10.1371/journal.pone.0074592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086357	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700028
J	Nakada, Y; Stewart, TG; Pena, CG; Zhang, S; Zhao, N; Bardeesy, N; Sharpless, NE; Wong, KK; Hayes, DN; Castrillon, DH				Nakada, Yuji; Stewart, Thomas G.; Pena, Christopher G.; Zhang, Song; Zhao, Ni; Bardeesy, Nabeel; Sharpless, Norman E.; Wong, Kwok-Kin; Hayes, D. Neil; Castrillon, Diego H.			The LKB1 Tumor Suppressor as a Biomarker in Mouse and Human Tissues	PLOS ONE			English	Article							LUNG-CANCER; GROWTH-CONTROL; EXPRESSION; DIFFERENTIATION; INACTIVATION; LKB1/STK11; MELANOMA; GENE	Germline mutations in the LKB1 gene (also known as STK11) cause the Peutz-Jeghers Syndrome, and somatic loss of LKB1 has emerged as causal event in a wide range of human malignancies, including melanoma, lung cancer, and cervical cancer. The LKB1 protein is a serine-threonine kinase that phosphorylates AMP-activated protein kinase (AMPK) and other downstream targets. Conditional knockout studies in mouse models have consistently shown that LKB1 loss promotes a highly-metastatic phenotype in diverse tissues, and human studies have demonstrated a strong association between LKB1 inactivation and tumor recurrence. Furthermore, LKB1 deficiency confers sensitivity to distinct classes of anticancer drugs. The ability to reliably identify LKB1-deficient tumors is thus likely to have important prognostic and predictive implications. Previous research studies have employed polyclonal antibodies with limited success, and there is no widely-employed immunohistochemical assay for LKB1. Here we report an assay based on a rabbit monoclonal antibody that can reliably detect endogenous LKB1 protein (and its absence) in mouse and human formalin-fixed, paraffin-embedded tissues. LKB1 protein levels determined through this assay correlated strongly with AMPK phosphorylation both in mouse and human tumors, and with mRNA levels in human tumors. Our studies fully validate this immunohistochemical assay for LKB1 in paraffin-embedded formalin tissue sections. This assay should be broadly useful for research studies employing mouse models and also for the development of human tissue-based assays for LKB1 in diverse clinical settings.	[Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Chapel Hill, NC 27599 USA; [Zhang, Song] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Cambridge, MA USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wong, Kwok-Kin] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hayes, DN (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu; diego.castrillon@utsouthwestern.edu	Zhao, Ni/P-9086-2014	Zhao, Ni/0000-0002-7762-3949; wong, kwok kin/0000-0001-6323-235X; Sharpless, Norman/0000-0001-7078-9455	National Institutes of Health/National Cancer Institute [R01CA137181, RO1CA163896, U01CA141576]; Cancer Prevention Research Institute of Texas [RP100550]; NATIONAL CANCER INSTITUTE [R01CA137181, P01CA154303, R01CA163896, T32CA106209, R01CA122794, U01CA141576, R01CA166480] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported through National Institutes of Health/National Cancer Institute grants R01CA137181 (DC), RO1CA163896 (NS, KW), U01CA141576 (DC, KW, NB, NS), and Cancer Prevention Research Institute of Texas grant RP100550 (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Amin RMS, 2008, PATHOL INT, V58, P84, DOI 10.1111/j.1440-1827.2007.02194.x; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kline ER, 2011, HEAD NECK-J SCI SPEC, V33, P1501, DOI 10.1002/hed.21638; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu S, 2012, APPL IMMUNOHISTOCHEM; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shackelford DB, 2009, P NATL ACAD SCI US; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Zhao N, 2012, BRIT J CANCER, V107, P482, DOI 10.1038/bjc.2012.264	26	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73449	10.1371/journal.pone.0073449	http://dx.doi.org/10.1371/journal.pone.0073449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086281	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700009
J	Rogers, GB; van der Gast, CJ; Bruce, KD; Marsh, P; Collins, JE; Sutton, J; Wright, M				Rogers, Geraint B.; van der Gast, Christopher J.; Bruce, Kenneth D.; Marsh, Peter; Collins, Jane E.; Sutton, Julian; Wright, Mark			Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; PROPIDIUM MONOAZIDE; QUANTITATIVE PCR; DNA; DISCRIMINATION; IDENTIFICATION; COMMUNITIES; COMBINATION; MANAGEMENT; DIVERSITY	Identification of pathogenic bacteria in ascites correlates with poor clinical outcomes. Ascites samples are commonly reported culture-negative, even where frank infection is indicated. Culture-independent methods have previously reported bacterial DNA in ascites, however, whether this represents viable bacterial populations has not been determined. We report the first application of 16S rRNA gene pyrosequencing and quantitative PCR in conjunction with propidium monoazide sample treatment to characterise the viable bacterial composition of ascites. Twenty five cirrhotic patients undergoing paracentesis provided ascites. Samples were treated with propidium monoazide to exclude non-viable bacterial DNA. Total bacterial load was quantified by 16S rRNA Q-PCR with species identity and relative abundance determined by 16S rRNA gene pyrosequencing. Correlation of molecular microbiology data with clinical measures and diagnostic microbiology was performed. Viable bacterial signal was obtained in 84% of ascites samples, both by Q-PCR and pyrosequencing. Approximately 190,000 ribosomal pyrosequences were obtained, representing 236 species, including both gut and non gut-associated species. Substantial variation in the species detected was observed between patients. Statistically significant relationships were identified between the bacterial community similarity and clinical measures, including ascitic polymorphonuclear leukocyte count and Child-Pugh class. Viable bacteria are present in the ascites of a majority of patients with cirrhosis including those with no clinical signs of infection. Microbiota composition significantly correlates with clinical measures. Entry of bacteria into ascites is unlikely to be limited to translocation from the gut, raising fundamental questions about the processes that underlie the development of spontaneous bacterial peritonitis.	[Rogers, Geraint B.; Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, London, England; [van der Gast, Christopher J.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Marsh, Peter; Sutton, Julian] Southampton Gen Hosp, Hlth Protect Agcy, Southampton SO9 4XY, Hants, England; [Collins, Jane E.; Wright, Mark] Southampton Gen Hosp, Hepatol Grp, Southampton SO9 4XY, Hants, England	University of London; King's College London; UK Centre for Ecology & Hydrology (UKCEH); Health Protection Agency; University of Southampton; University of Southampton	Rogers, GB (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London, England.	geraint.rogers@kcl.ac.uk	Rogers, Geraint B/N-1957-2013; Rogers, Geraint/AAD-1011-2020; van der Gast, Christopher/G-1153-2011	Rogers, Geraint B/0000-0003-4054-1947; van der Gast, Christopher/0000-0003-1101-4048; Collins, Jane/0000-0002-9914-3890	Southampton Hospital Charity Hepatology Research Fund; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Southampton Hospital Charity Hepatology Research Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by Southampton Hospital Charity Hepatology Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Bruns T, 2009, LIVER INT, V29, P1206, DOI 10.1111/j.1478-3231.2009.02073.x; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards ML, 2001, FEMS MICROBIOL ECOL, V35, P295, DOI 10.1111/j.1574-6941.2001.tb00815.x; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Kralik P, 2010, INT J FOOD MICROBIOL, V141, pS80, DOI 10.1016/j.ijfoodmicro.2010.03.018; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nam S, 2011, MICROBIOL IMMUNOL, V55, P841, DOI 10.1111/j.1348-0421.2011.00388.x; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Rogers GB, 2010, CLIN MICROBIOL INFEC, V16, P1656, DOI 10.1111/j.1469-0691.2010.03189.x; Rogers GB, 2010, EUR J CLIN MICROBIOL, V29, P533, DOI 10.1007/s10096-010-0891-5; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Rogers Geraint B, 2009, BMC Pulm Med, V9, P14, DOI 10.1186/1471-2466-9-14; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Roges GB, 2008, DIAGN MICR INFEC DIS, V62, P133, DOI 10.1016/j.diagmicrobio.2008.06.011; RUNYON BA, 1990, J CLIN MICROBIOL, V28, P2811, DOI 10.1128/JCM.28.12.2811-2812.1990; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74884	10.1371/journal.pone.0074884	http://dx.doi.org/10.1371/journal.pone.0074884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086392	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325218700045
J	Brookes, ZLS; Stedman, EN; Brown, NJ; Hebbes, CP; Guerrini, R; Calo, G; Reilly, CS; Lambert, DG				Brookes, Zoe L. S.; Stedman, Emily N.; Brown, Nicola J.; Hebbes, Christopher P.; Guerrini, Remo; Calo, Girolamo; Reilly, Charles S.; Lambert, David G.			The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo	PLOS ONE			English	Article							RECOMBINANT HUMAN; PEPTIDE; EXPRESSION; RESPONSES; CELLS; BRADYCARDIA; HYPOTENSION; LYMPHATICS; DIURESIS; BINDING	Microvascular inflammation occurs during sepsis and the endogenous opioid-like peptide nociceptin/orphanin FQ (N/OFQ) is known to regulate inflammation. This study aimed to determine the inflammatory role of N/OFQ and its receptor NOP (ORL1) within the microcirculation, along with anti-inflammatory effects of the NOP antagonist UFP-101 (University of Ferrara Peptide-101) in an animal model of sepsis (endotoxemia). Male Wistar rats (220 to 300 g) were administered lipopolysaccharide (LPS) for 24 h (-24 h, 1 mg kg(-1); -2 h, 1 mg kg(-1) i.v., tail vein). They were then either anesthetised for observation of the mesenteric microcirculation using fluorescent in vivo microscopy, or isolated arterioles (similar to 200 mu m) were studied in vitro with pressure myography. 200 nM kg(-1) fluorescently labelled N/OFQ (FITC-N/OFQ, i.a., mesenteric artery) bound to specific sites on the microvascular endothelium in vivo, indicating sparse distribution of NOP receptors. In vitro, arterioles (similar to 200 mu m) dilated to intraluminal N/OFQ (10(-5)M) (32.6 +/- 8.4%) and this response was exaggerated with LPS (62.0 +/- 7.9%, p=0.031). In vivo, LPS induced macromolecular leak of FITC-BSA (0.02 g kg(-1) i.v.) (LPS: 95.3 (86.7 to 97.9)%, p=0.043) from post-capillary venules (<40 mu m) and increased leukocyte rolling as endotoxemia progressed (p=0.027), both being reduced by 150 nmol kg(-1) UFP-101 (i. v., jugular vein). Firstly, the rat mesenteric microcirculation expresses NOP receptors and secondly, NOP function (ability to induce dilation) is enhanced with LPS. UFP-101 also reduced microvascular inflammation to endotoxemia in vivo. Hence inhibition of the microvascular N/OFQ-NOP pathway may have therapeutic potential during sepsis and warrants further investigation.	[Brookes, Zoe L. S.; Stedman, Emily N.; Brown, Nicola J.; Reilly, Charles S.] Univ Sheffield, Microcirculat Res Grp, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Hebbes, Christopher P.; Lambert, David G.] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester, Leics, England; [Guerrini, Remo; Calo, Girolamo] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy; [Guerrini, Remo; Calo, Girolamo] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44100 Ferrara, Italy; [Calo, Girolamo] Italian Inst Neurosci, Ferrara, Italy	University of Sheffield; University of Leicester; University of Ferrara; University of Ferrara; University of Ferrara	Lambert, DG (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester, Leics, England.	dgl3@leicester.ac.uk	; Hebbes, Christopher/J-7683-2015	Guerrini, Remo/0000-0002-7619-0918; Brown, Nicola/0000-0002-2100-1905; Lambert, David/0000-0003-4769-8090; Hebbes, Christopher/0000-0002-2816-714X; Brookes, Zoe/0000-0002-8096-6256	British Journal of Anaesthesia project grant; Anaesthetic Research Society	British Journal of Anaesthesia project grant; Anaesthetic Research Society	This work was funded by a British Journal of Anaesthesia project grant and Emily Stedman was the recipient of an Anaesthetic Research Society summer studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2008, J NEUROSCI RES, V86, P1077, DOI 10.1002/jnr.21565; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Brookes ZLS, 2005, J PHYSIOL-LONDON, V565, P269, DOI 10.1113/jphysiol.2005.083147; Brookes ZLS, 2003, AM J PHYSIOL-REG I, V284, pR1604, DOI 10.1152/ajpregu.00411.2002; Brookes ZLS, 2007, AM J PHYSIOL-HEART C, V293, pH2977, DOI 10.1152/ajpheart.00448.2007; Brookes Zoe L. S., 2009, Lymphatic Research and Biology, V7, P131, DOI 10.1089/lrb.2008.1019; Burmeister MA, 2008, J PHARMACOL EXP THER, V326, P897, DOI 10.1124/jpet.107.135905; Burmeister MA, 2007, J PHARMACOL EXP THER, V322, P324, DOI 10.1124/jpet.107.120394; BYCROFT BW, 1993, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39930000778; Calo G, 2005, CNS DRUG REV, V11, P97; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Champion HC, 1998, REGUL PEPTIDES, V78, P69, DOI 10.1016/S0167-0115(98)00117-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; GARDINER SM, 1995, BRIT J PHARMACOL, V116, P2005, DOI 10.1111/j.1476-5381.1995.tb16405.x; Granata F, 2003, EUR J PHARMACOL, V482, P17, DOI 10.1016/j.ejphar.2003.09.049; Guerrini R, 1997, J MED CHEM, V40, P1789, DOI 10.1021/jm970011b; Hashiba E, 2003, N-S ARCH PHARMACOL, V367, P342, DOI 10.1007/s00210-003-0704-9; Hashiba E, 2002, NEUROSCI LETT, V328, P5, DOI 10.1016/S0304-3940(02)00259-8; HEBERT MT, 1988, J PHYSIOL-LONDON, V400, P29, DOI 10.1113/jphysiol.1988.sp017108; Ibba M, 2008, N-S ARCH PHARMACOL, V378, P553, DOI 10.1007/s00210-008-0350-3; Kapusta DR, 1999, AM J PHYSIOL-REG I, V277, pR987, DOI 10.1152/ajpregu.1999.277.4.R987; Kitayama M, 2003, N-S ARCH PHARMACOL, V368, P528, DOI 10.1007/s00210-003-0821-5; Krowicki ZK, 2006, J PHARMACOL EXP THER, V317, P446, DOI 10.1124/jpet.105.094441; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Leggett JD, 2009, J NEUROENDOCRINOL, V21, P888, DOI 10.1111/j.1365-2826.2009.01912.x; Madeddu P, 1999, HYPERTENSION, V33, P914, DOI 10.1161/01.HYP.33.3.914; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; McGown CC, 2010, BRIT J ANAESTH, V104, P183, DOI 10.1093/bja/aep361; Miller TR, 2007, PEPTIDES, V28, P2243, DOI 10.1016/j.peptides.2007.09.004; Niwa H, 2012, BRIT J ANAESTH, V108, P530, DOI 10.1093/bja/aes015; REED MWR, 1988, J SURG RES, V45, P452, DOI 10.1016/0022-4804(88)90195-3; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Williams JP, 2008, ANESTH ANALG, V106, P865, DOI 10.1213/ane.0b013e3181617646; Williams JP, 2007, ANESTH ANALG, V105, P998, DOI 10.1213/01.ane.0000278865.11991.9d; Williams JP, 2010, BRIT J ANAESTH, V100, P810	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74943	10.1371/journal.pone.0074943	http://dx.doi.org/10.1371/journal.pone.0074943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086402	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000326520200057
J	Morrison, NA; Stephens, AS; Osato, M; Pasco, JA; Fozzard, N; Stein, GS; Polly, P; Griffiths, LR; Nicholson, GC				Morrison, Nigel A.; Stephens, Alexandre S.; Osato, Motomi; Pasco, Julie A.; Fozzard, Nicolette; Stein, Gary S.; Polly, Patsie; Griffiths, Lyn R.; Nicholson, Geoff C.			Polyalanine Repeat Polymorphism in RUNX2 Is Associated with Site-Specific Fracture in Post-Menopausal Females	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FEMORAL-NECK BMD; CLEIDOCRANIAL DYSPLASIA; GEELONG-OSTEOPOROSIS; OSTEOBLAST DIFFERENTIATION; TANDEM REPEATS; FACIAL LENGTH; GENE; PROMOTER; WOMEN	Runt related transcription factor 2 (RUNX2) is a key regulator of osteoblast differentiation. Several variations within the RUNX2 gene have been found to be associated with significant changes in BMD, which is a major risk factor for fracture. In this study we report that an 18 bp deletion within the polyalanine tract (17A>11A) of RUNX2 is significantly associated with fracture. Carriers of the 11A allele were found to be nearly twice as likely to have sustained fracture. Within the fracture category, there was a significant tendency of 11A carriers to present with fractures of distal radius and bones of intramembranous origin compared to bones of endochondral origin (p = 0.0001). In a population of random subjects, the 11A allele was associated with decreased levels of serum collagen cross links (CTx, p = 0.01), suggesting decreased bone turnover. The transactivation function of the 11A allele showed a minor quantitative decrease. Interestingly, we found no effect of the 11A allele on BMD at multiple skeletal sites. These findings suggest that the 11A allele is a biologically relevant polymorphism that influences serum CTx and confers enhanced fracture risk in a site-selective manner related to intramembranous bone ossification.	[Morrison, Nigel A.; Stephens, Alexandre S.; Fozzard, Nicolette; Griffiths, Lyn R.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst, Ctr Translat Med, Singapore 117548, Singapore; [Pasco, Julie A.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Stein, Gary S.] Univ Vermont, Vermont Canc Ctr Basic & Translat Res, Burlington, VT USA; [Polly, Patsie] Univ New S Wales, Fac Med, Sch Med Sci, Dept Pathol & Inflammat, Sydney, NSW, Australia; [Polly, Patsie] Univ New S Wales, Fac Med, Sch Med Sci, Infect Res Ctr, Sydney, NSW, Australia; [Nicholson, Geoff C.] Univ Queensland, Sch Med, Rural Clin Sch, Toowoomba, Qld, Australia	Griffith University; National University of Singapore; Deakin University; University of Vermont; University of New South Wales Sydney; University of New South Wales Sydney; University of Queensland	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.	N.Morrison@griffith.edu.au	Nicholson, Geoffrey C/F-1901-2010; Morrison, Nigel A/F-4082-2012; Osato, Motomi/N-5056-2014; Stephens, Alexandre S/P-1396-2016	Nicholson, Geoffrey C/0000-0002-0152-1153; Morrison, Nigel A/0000-0003-4774-3808; Osato, Motomi/0000-0003-3982-9054; Stephens, Alexandre S/0000-0003-2465-8117; Griffiths, Lyn/0000-0002-6774-5475	Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by grants from the Australian National Health and Medical Research Council to NAM, PP, GS, JAP, LRG and GCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONLINE MENDELIAN INH; Biver E, 2012, JOINT BONE SPINE, V79, P20, DOI 10.1016/j.jbspin.2011.05.003; Bustamante M, 2007, CALCIFIED TISSUE INT, V81, P327, DOI 10.1007/s00223-007-9069-2; CARTER DR, 1992, J BONE MINER RES, V7, P137; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Crisci JL, 2011, GENOME BIOL EVOL, V3, P791, DOI 10.1093/gbe/evr075; Doecke JD, 2006, J BONE MINER RES, V21, P265, DOI 10.1359/JBMR; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Ermakov S, 2008, ANN HUM GENET, V72, P510, DOI 10.1111/j.1469-1809.2008.00441.x; Ermakov S, 2006, BONE, V38, P199, DOI 10.1016/j.bone.2005.08.008; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Franz-Odendaal TA, 2011, FRONT BIOSCI-LANDMRK, V16, P2734, DOI 10.2741/3882; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RM, 2012, THESIS U FLORIDA; Henry MJ, 2000, J CLIN DENSITOM, V3, P261, DOI 10.1385/JCD:3:3:261; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HJ, 2009, CALCIFIED TISSUE INT, V84, P439, DOI 10.1007/s00223-009-9246-6; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; McGuigan FEA, 2002, J BONE MINER RES, V17, P1273, DOI 10.1359/jbmr.2002.17.7.1273; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morrison NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042617; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pasco JA, 1999, AUST NZ J MED, V29, P203, DOI 10.1111/j.1445-5994.1999.tb00684.x; Pineda B, 2010, J BONE MINER METAB, V28, P696, DOI 10.1007/s00774-010-0183-2; Pointer MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-103; Rosen HN, 2000, CALCIFIED TISSUE INT, V66, P100, DOI 10.1007/PL00005830; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Vaughan T, 2002, J BONE MINER RES, V17, P1527, DOI 10.1359/jbmr.2002.17.8.1527; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e72740	10.1371/journal.pone.0072740	http://dx.doi.org/10.1371/journal.pone.0072740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086263	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200003
J	Bollegala, D; Shutova, E				Bollegala, Danushka; Shutova, Ekaterina			Metaphor Interpretation Using Paraphrases Extracted from the Web	PLOS ONE			English	Article								Interpreting metaphor is a hard but important problem in natural language processing that has numerous applications. One way to address this task is by finding a paraphrase that can replace the metaphorically used word in a given context. This approach has been previously implemented only within supervised frameworks, relying on manually constructed lexical resources, such as WordNet. In contrast, we present a fully unsupervised metaphor interpretation method that extracts literal paraphrases for metaphorical expressions from the Web. It achieves a precision of 0: 42, which is high for an unsupervised paraphrasing approach. Moreover, the method significantly outperforms both the baseline and the selectional preference-based method of Shutova employed in an unsupervised setting.	[Bollegala, Danushka] Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan; [Shutova, Ekaterina] Univ Calif Berkeley, Inst Cognit & Brain Sci, Berkeley, CA 94720 USA	University of Tokyo; University of California System; University of California Berkeley	Bollegala, D (corresponding author), Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan.	danushka@iba.t.u-tokyo.ac.jp			Japanese Society for the Promotion of Science (JSPS)	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Danushka Bollegala is supported by the Japanese Society for the Promotion of Science (JSPS) under the Young Researcher Grant and Microsoft Research Asia (MSRA) under the CORE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerri Rodrigo, 2008, COLING 08; Ahmad K., 2011, AFFECTIVE COMPUTING, P27; Barnden J.A., 2002, THEORIA HIST SCI, V6, P399; Barzilay R, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P50; Bejar I. I., 1991, COGNITIVE PSYCHOMETR; Bollegala D., 2009, P 18 INT C WORLD WID, P651, DOI DOI 10.1145/1526709.1526797; Briscoe T, 2006, COLING ACL 2006 INT; Burnard Lou, 2007, REFERENCE GUIDE BRIT; Carbonell JG, 1980, ACL, P17, DOI [10.3115/981436.981441, DOI 10.3115/981436.981441]; Chan TP, 2011, GEMS 11 WORKSH MOD N, P33; CHARLES WG, 1989, APPL PSYCHOLINGUIST, V10, P357, DOI 10.1017/S0142716400008675; Chen D., 2011, P 49 ANN M ASS COMP, P190; Chklovski T., 2004, P 2004 C EMP METH NA, P33; Crisp P, 2007, METAPHOR SYMBOL, V22, P1; Dagan I, 2004, PASCAL WORKSH TEXT U; Davidov D, 2008, P ACL 08; Dekang Lin, 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P323; Duc N. T., 2011, AAAI 11, P1237; Fass D., 1991, Computational Linguistics, V17, P49; Firth J.R., 1957, SYNOPSIS LINGUISTIC, P1; Fujita Atsushi, 2012, P 2012 JOINT C EMP M, P631; Glickman O, 2005, 1 RTE WORKSH; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hashimoto C, 2011, ACL 11, P19; Hearst MA, 1992, P 14 C COMP LING, V2, P539, DOI DOI 10.3115/992133.992154; Hovy E., 2009, P 2009 C EMP METH NA, P948; Jurgens David, 2012, P 1 JOINT C LEX COMP; Justeson J. S., 1991, Computational Linguistics, V17, P1; Kilgarriff A, 2006, COMPUT LINGUIST, V1, P1; Kozareva Z, 2010, NAACL HLT 2010; Lakoff G., 2003, METAPHORS WE LIVE; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Lin D, 1998, P 36 ANN M ASS COMP, P768, DOI DOI 10.3115/980432.980696; Lin D., 2003, IJCAI, V3, P1492; Lin D., 2001, NAT LANG ENG, V7, P343, DOI DOI 10.1017/S1351324901002765; Manning C.D., 2008, INTRO INFORM RETRIEV; Martin J., 1990, COMPUTATIONAL MODEL; Martin JH, 1988, P 12 C COMP LING, P396; Matsuo Y, 2007, AAAI 07, P1395; McCarthy D, 2009, LANG RESOUR EVAL, V43, P139, DOI 10.1007/s10579-009-9084-1; Mohammad Saif M., 2008, P C EMP METH NAT LAN, P982, DOI DOI 10.3115/1613715.1613843; Narayanan S, 1997, TECHNICAL REPORT; Pantel P, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P113; Ravichandran D, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P41; RESNIK P, 1993, THESIS U PENNSYLVANI; Shutova E, 2010, COLING 10; Shutova E., 2010, P LREC 2010 MALT, P3255; Shutova E, 2012, COLING 12; Shutova E, 2011, THESIS U CAMBRIDGE U; Shutova Ekaterina, 2010, P NAACL 2010 LOS ANG, P1; Snow R., 2005, ADV NEURAL INFORM PR, V17, P1297; Sun L., 2009, P 2009 C EMP METH NA, V2, P638; Szpektor Idan, 2004, P 2004 C EMP METH NA, P41; Turney Peter, 2008, P 22 INT C COMP LING, P905, DOI DOI 10.3115/1599081.1599195; Turney PD, 2006, COMPUT LINGUIST, V32, P379, DOI 10.1162/coli.2006.32.3.379; Turney PD, 2012, J ARTIF INTELL RES, V44, P533, DOI 10.1613/jair.3640; Veale T., 2008, P 22 INT C COMP LING, V1, P945; Veale T, 2011, ACL 11, P19; Zanzotto FM, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P849; Zhao Shiqi, 2008, ACL, P780	60	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74304	10.1371/journal.pone.0074304	http://dx.doi.org/10.1371/journal.pone.0074304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073207	Green Submitted, gold, Green Published			2022-12-25	WOS:000324768000016
J	Chang, SLY; Chen, SY; Huang, HH; Ko, HA; Liu, PT; Liu, YC; Chen, PH; Liu, FC				Chang, Sunny Li-Yun; Chen, Shih-Yun; Huang, Huai-Huei; Ko, Hsin-An; Liu, Pei-Tsen; Liu, Ya-Chi; Chen, Ping-Hau; Liu, Fu-Chin			Ectopic Expression of Nolz-1 in Neural Progenitors Promotes Cell Cycle Exit/Premature Neuronal Differentiation Accompanying with Abnormal Apoptosis in the Developing Mouse Telencephalon	PLOS ONE			English	Article							SELECTIVE EXPRESSION; GENE-EXPRESSION; FAMILY; HINDBRAIN; STRIATUM; REGION; IDENTIFICATION; NOLZ-1/ZFP503; MORPHOGENESIS; PROGRESSION	Nolz-1, as a murine member of the NET zinc-finger protein family, is expressed in post-mitotic differentiating neurons of striatum during development. To explore the function of Nolz-1 in regulating the neurogenesis of forebrain, we studied the effects of ectopic expression of Nolz-1 in neural progenitors. We generated the Cre-loxP dependent conditional transgenic mice in which Nolz-1 was ectopically expressed in proliferative neural progenitors. Ectopic expression of Nolz-1 in neural progenitors by intercrossing the Nolz-1 conditional transgenic mice with the nestin-Cre mice resulted in hypoplasia of telencephalon in double transgenic mice. Decreased proliferation of neural progenitor cells were found in the telencephalon, as evidenced by the reduction of BrdU-, Ki67- and phospho-histone 3-positive cells in E11.5-12.5 germinal zone of telencephalon. Transgenic Nolz-1 also promoted cell cycle exit and as a consequence might facilitate premature differentiation of progenitors, because TuJ1-positive neurons were ectopically found in the ventricular zone and there was a general increase of TuJ1 immunoreactivity in the telencephalon. Moreover, clusters of strong TuJ1-expressing neurons were present in E12.5 germinal zone. Some of these strong TuJ1-positive clusters, however, contained apoptotic condensed DNA, suggesting that inappropriate premature differentiation may lead to abnormal apoptosis in some progenitor cells. Consistent with the transgenic mouse analysis in vivo, similar effects of Nozl-1 over-expression in induction of apoptosis, inhibition of cell proliferation and promotion of neuronal differentiation were also observed in three different N18, ST14A and N2A neural cell lines in vitro. Taken together, our study indicates that ectopic expression of Nolz-1 in neural progenitors promotes cell cycle exit/premature neuronal differentiation and induces abnormal apoptosis in the developing telencephalon.	[Chang, Sunny Li-Yun; Chen, Shih-Yun; Ko, Hsin-An; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Chang, Sunny Li-Yun; Huang, Huai-Huei] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Sunny Li-Yun; Huang, Huai-Huei; Liu, Pei-Tsen; Liu, Ya-Chi] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chen, Ping-Hau] China Med Univ, Sch Pharm Undergrad Program, Taichung, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Liu, FC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	fuchin@ym.edu.tw			National Science Council [NSC95-3112-B-010-014, NSC96-3112-B-010-007, NSC97-3112-B-010-005, NSC99-2311-B-010-005-MY3, NSC98-2320-B-039-034-MY3]; National Health Research Institutes [NHRI-PD940]; China Medical University [CMU96-132]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); China Medical University(China Medical University); Ministry of Education	This work was supported by National Science Council (http://web1.nsc.gov.tw/) grants NSC95-3112-B-010-014, NSC96-3112-B-010-007, NSC97-3112-B-010-005, NSC99-2311-B-010-005-MY3 (to FCL), NSC98-2320-B-039-034-MY3 (to SLYC); National Health Research Institutes (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do) Postdoctoral Fellowship Award (NHRI-PD940 (to SLYC); China Medical University (CMU96-132 (to SLYC); and Aiming for Top University grant, Ministry of Education (to FCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chang SLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054485; Chang SLY, 2011, GENE EXPR PATTERNS, V11, P525, DOI 10.1016/j.gep.2011.09.003; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Inoue T, 1999, J HUM GENET, V44, P152, DOI 10.1007/s100380050133; Ji SJ, 2009, DEVELOPMENT, V136, P231, DOI 10.1242/dev.028043; Ko HA, 2013, NEUROSCI LETT, V548, P44, DOI 10.1016/j.neulet.2013.05.020; Kuiperij HB, 2004, NOVEL CAMP TARGETS C, P54; Liao WL, 2008, P NATL ACAD SCI USA, V105, P6765, DOI 10.1073/pnas.0802109105; Luque CM, 2007, DEV BIOL, V301, P327, DOI 10.1016/j.ydbio.2006.07.050; McGlinn E, 2008, DEV DYNAM, V237, P1172, DOI 10.1002/dvdy.21508; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Nakamura M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-108; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Runko AP, 2003, DEV BIOL, V262, P254, DOI 10.1016/S0012-1606(03)00388-9; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tseng ASK, 2002, GENETICS, V162, P229; Urban N, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-21; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao XJ, 2002, DEVELOPMENT, V129, P1497; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74975	10.1371/journal.pone.0074975	http://dx.doi.org/10.1371/journal.pone.0074975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073229	Green Published, gold, Green Submitted			2022-12-25	WOS:000324768000038
J	Germain, J; Bruel-Jungerman, E; Grannec, G; Denis, C; Lepousez, G; Giros, B; Francis, F; Nosten-Bertrand, M				Germain, Johanne; Bruel-Jungerman, Elodie; Grannec, Gael; Denis, Cecile; Lepousez, Gabriel; Giros, Bruno; Francis, Fiona; Nosten-Bertrand, Marika			Doublecortin Knockout Mice Show Normal Hippocampal-Dependent Memory Despite CA3 Lamination Defects	PLOS ONE			English	Article							ABNORMAL NEURONAL MIGRATION; MENTAL-RETARDATION GENE; LIS1 MUTANT MICE; NMDA RECEPTORS; DORSAL HIPPOCAMPUS; INTERNEURON MIGRATION; ENHANCED EXCITABILITY; SOCIAL-INTERACTION; ADULT FOREBRAIN; OLFACTORY-BULB	Mutations in the human X-linked doublecortin gene (DCX) cause major neocortical disorganization associated with severe intellectual disability and intractable epilepsy. Although Dcx knockout (KO) mice exhibit normal isocortical development and architecture, they show lamination defects of the hippocampal pyramidal cell layer largely restricted to the CA3 region. Dcx-KO mice also exhibit interneuron abnormalities. As well as the interest of testing their general neurocognitive profile, Dcx-KO mice also provide a relatively unique model to assess the effects of a disorganized CA3 region on learning and memory. Based on its prominent anatomical and physiological features, the CA3 region is believed to contribute to rapid encoding of novel information, formation and storage of arbitrary associations, novelty detection, and short-term memory. We report here that Dcx-KO adult males exhibit remarkably preserved hippocampal-and CA3-dependant cognitive processes using a large battery of classical hippocampus related tests such as the Barnes maze, contextual fear conditioning, paired associate learning and object recognition. In addition, we show that hippocampal adult neurogenesis, in terms of proliferation, survival and differentiation of granule cells, is also remarkably preserved in Dcx-KO mice. In contrast, following social deprivation, Dcx-KO mice exhibit impaired social interaction and reduced aggressive behaviors. In addition, Dcx-KO mice show reduced behavioral lateralization. The Dcx-KO model thus reinforces the association of neuropsychiatric behavioral impairments with mouse models of intellectual disability.	[Germain, Johanne; Grannec, Gael; Denis, Cecile; Giros, Bruno; Nosten-Bertrand, Marika] INSERM UMRS 952, Paris, France; [Germain, Johanne; Grannec, Gael; Denis, Cecile; Giros, Bruno; Nosten-Bertrand, Marika] CNRS UMR 7224, Paris, France; [Germain, Johanne; Bruel-Jungerman, Elodie; Grannec, Gael; Denis, Cecile; Giros, Bruno; Francis, Fiona; Nosten-Bertrand, Marika] Univ Paris 06, Paris, France; [Germain, Johanne] Univ Paris 05, Paris, France; [Bruel-Jungerman, Elodie; Francis, Fiona] INSERM UMR S 839, Paris, France; [Bruel-Jungerman, Elodie; Francis, Fiona] Inst Fer Moulin, Paris, France; [Lepousez, Gabriel] Inst Pasteur, Unite Percept & Memoire, Paris, France; [Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; McGill University	Nosten-Bertrand, M (corresponding author), INSERM UMRS 952, Paris, France.	Marika.Nosten@snv.jussieu.fr	Francis, Fiona/B-5854-2016; GIROS, Bruno/ABD-5790-2021	GIROS, Bruno/0000-0001-5876-9822; Gael, Grannec/0000-0002-9694-9899; Francis, Fiona/0000-0001-8542-7537	Agence National de la Recherche [ANR-08-MNP-013]; INSERM; Avenir program; CNRS; UPMC; Fondation Bettencourt Schueller; Region Ile-de-France (NERF); Fondation Jerome Lejeune; Ministere de l'Education et de la Technologie; Fondation pour la Recherche Medicale (FRM)	Agence National de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Avenir program; CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; Fondation Bettencourt Schueller; Region Ile-de-France (NERF)(Region Ile-de-France); Fondation Jerome Lejeune; Ministere de l'Education et de la Technologie; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The authors are grateful for financial support from the Agence National de la Recherche (ANR-08-MNP-013; FF), as well as from INSERM, including the Avenir program (FF), the CNRS and UPMC, the Fondation Bettencourt Schueller (FF), the Region Ile-de-France (NERF; EBJ, FF), and the Fondation Jerome Lejeune (FF). JG was supported by a fellowship from the Ministere de l'Education et de la Technologie and the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; COLLINS RL, 1968, J HERED, V59, P9, DOI 10.1093/oxfordjournals.jhered.a107656; Corbo JC, 2002, J NEUROSCI, V22, P7548; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; ELY DL, 1977, PHYSIOL BEHAV, V18, P1075, DOI 10.1016/0031-9384(77)90014-2; Fleck MW, 2000, J NEUROSCI, V20, P2439; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; Glasper ER, 2012, BEHAV BRAIN RES, V227, P380, DOI 10.1016/j.bbr.2011.05.013; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Grouios G, 1999, J INTELL DISABIL RES, V43, P306, DOI 10.1046/j.1365-2788.1999.00217.x; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hunsaker MR, 2007, BEHAV NEUROSCI, V121, P742, DOI 10.1037/0735-7044.121.4.742; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones DL, 2007, J NEUROPHYSIOL, V98, P2737, DOI 10.1152/jn.00938.2007; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Marcorelles P, 2010, ACTA NEUROPATHOL, V120, P503, DOI 10.1007/s00401-010-0692-z; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2009, HIPPOCAMPUS, V19, P1153, DOI 10.1002/hipo.20684; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mitsui S, 2009, EUR J NEUROSCI, V30, P2368, DOI 10.1111/j.1460-9568.2009.07029.x; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; Morice E, 2005, NEUROPSYCHOPHARMACOL, V30, P575, DOI 10.1038/sj.npp.1300570; MORRIS RD, 1993, AM J MENT RETARD, V97, P443; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nasrallah IM, 2006, J COMP NEUROL, V496, P847, DOI 10.1002/cne.20966; Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Salinger WL, 2003, BEHAV NEUROSCI, V117, P1257, DOI 10.1037/0735-7044.117.6.1257; SamsDodd F, 1997, PSYCHOPHARMACOLOGY, V132, P303, DOI 10.1007/s002130050349; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Slomianka L, 2011, BRAIN STRUCT FUNCT, V216, P301, DOI 10.1007/s00429-011-0322-0; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070	77	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74992	10.1371/journal.pone.0074992	http://dx.doi.org/10.1371/journal.pone.0074992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073232	Green Submitted, Green Published, gold			2022-12-25	WOS:000324768000041
J	Korgaonkar, MS; Antees, C; Williams, LM; Gatt, JM; Bryant, RA; Cohen, R; Paul, R; O'Hara, R; Grieve, SM				Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Bryant, Richard A.; Cohen, Ronald; Paul, Robert; O'Hara, Ruth; Grieve, Stuart M.			Early Exposure to Traumatic Stressors Impairs Emotional Brain Circuitry	PLOS ONE			English	Article							EARLY-LIFE STRESS; HUMAN CEREBRAL-CORTEX; HIPPOCAMPAL VOLUME; SEXUAL-ABUSE; DEPRESSION; DISORDER; IMPACT; ADULTS; RISK; MORPHOMETRY	Exposure to early life trauma (ELT) is known to have a profound impact on mental development, leading to a higher risk for depression and anxiety. Our aim was to use multiple structural imaging methods to systematically investigate how traumatic stressors early in life impact the emotional brain circuits, typically found impaired with clinical diagnosis of depression and anxiety, across the lifespan in an otherwise healthy cohort. MRI data and self-reported histories of ELT from 352 healthy individuals screened for no psychiatric disorders were analyzed in this study. The volume and cortical thickness of the limbic and cingulate regions were assessed for all participants. A large subset of the cohort also had diffusion tensor imaging data, which was used to quantify white matter structural integrity of these regions. We found a significantly smaller amygdala volume and cortical thickness in the rostral anterior cingulate cortex associated with higher ELT exposure only for the adolescence group. White matter integrity of these regions was not affected. These findings demonstrate that exposure to early life trauma is associated with alterations in the gray matter of cingulate-limbic regions during adolescence in an otherwise healthy sample. These findings are interesting in the context that the affected regions are central neuroanatomical components in the psychopathology of depression, and adolescence is a peak period for risk and onset of the disorder.	[Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Grieve, Stuart M.] Univ Sydney Med Sch Westmead, Brain Dynam Ctr, Sydney, NSW, Australia; [Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Grieve, Stuart M.] Westmead Millennium Inst, Sydney, NSW, Australia; [Korgaonkar, Mayuresh S.; Williams, Leanne M.; Gatt, Justine M.] Univ Sydney Med Sch Western, Discipline Psychiat, Westmead Hosp, Sydney, NSW, Australia; [Williams, Leanne M.; O'Hara, Ruth] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Cohen, Ronald] Univ Florida, McKnight Inst Aging, Gainesville, FL USA; [Paul, Robert] Univ Missouri, St Louis, MO 63121 USA; [Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Grieve, Stuart M.] Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Stanford University; University of New South Wales Sydney; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Saint Louis; University of Sydney; University of Sydney	Korgaonkar, MS (corresponding author), Univ Sydney Med Sch Westmead, Brain Dynam Ctr, Sydney, NSW, Australia.	M.Korgaonkar@sydney.edu.au	Williams, Leanne/GLU-4975-2022; Bryant, Richard/AAA-6479-2019; Williams, Leanne M/B-4095-2012; Gatt, Justine M/C-4624-2008; Korgaonkar, Mayuresh/K-7447-2014; Grieve, Stuart/A-5093-2012	Williams, Leanne/0000-0001-9987-7360; Bryant, Richard/0000-0002-9607-819X; Gatt, Justine M/0000-0002-9276-6358; Korgaonkar, Mayuresh/0000-0002-1339-2221; Grieve, Stuart/0000-0002-2712-157X	National Health & Medical Research Council (NHMRC) of Australia [1008080]; ARC APDI [LP0883621]	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC APDI(Australian Research Council)	This research was supported by the National Health & Medical Research Council (NHMRC) of Australia project grants scheme (Project Grant number 1008080). Dr. Justine Gatt was supported by an ARC APDI Fellowship (LP0883621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P347, DOI 10.1002/gps.1939; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersson J.L.R, 2007, TR07JA2 FMRIB; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Chu DA, 2013, J PSYCHIATR RES, V47, P23, DOI 10.1016/j.jpsychires.2012.08.006; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Frodl T, 2012, J PSYCHIATR NEUROSCI, V37, P37, DOI 10.1503/jpn.110028; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gatt JM, 2012, TWIN RES HUM GENET, V15, P419, DOI 10.1017/thg.2012.12; Gatt JM, 2010, BIOL PSYCHIAT, V68, P818, DOI 10.1016/j.biopsych.2010.06.025; Gatt JM, 2010, DEPRESS ANXIETY, V27, P752, DOI 10.1002/da.20726; Gershon A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0352-9; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Lui S, 2013, J PSYCHIATR NEUROSCI, V38; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; O'Hara Ruth, 2007, Curr Psychiatry Rep, V9, P173, DOI 10.1007/s11920-007-0014-x; Seckfort DL, 2008, BRAIN IMAGING BEHAV, V2, P49, DOI 10.1007/s11682-007-9015-y; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yehuda Rachel, 2004, Psychoneuroendocrinology, V29, P1212, DOI 10.1016/j.psyneuen.2004.01.006; Zannas AS, 2013, J PSYCHIATR RES, V47, P829, DOI 10.1016/j.jpsychires.2013.02.008	40	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75524	10.1371/journal.pone.0075524	http://dx.doi.org/10.1371/journal.pone.0075524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073270	Green Published, gold			2022-12-25	WOS:000324768000080
J	Frazao, N; Hiller, NL; Powell, E; Earl, J; Ahmed, A; Sa-Leao, R; de Lencastre, H; Ehrlich, GD; Tomasz, A				Frazao, Nelson; Hiller, N. Luisa; Powell, Evan; Earl, Josh; Ahmed, Azad; Sa-Leao, Raquel; de Lencastre, Herminia; Ehrlich, Garth D.; Tomasz, Alexander			Virulence Potential and Genome-Wide Characterization of Drug Resistant Streptococcus pneumoniae Clones Selected In Vivo by the 7-Valent Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							DAY-CARE-CENTERS; ANTIBIOTIC-RESISTANCE; PENICILLIN RESISTANCE; CAPSULAR SEROTYPES; HEALTHY-CHILDREN; SEQUENCE; CARRIAGE; DISEASE; IMPACT; COLONIZATION	We used mouse models of pneumococcal colonization and disease combined with full genome sequencing to characterize three major drug resistant clones of S. pneumoniae that were recovered from the nasopharynx of PCV7-immunized children in Portugal. The three clones - serotype 6A (ST2191), serotype 15A (ST63) and serotype 19A (ST276) carried some of the same drug resistance determinants already identified in nasopharyngeal isolates from the pre-PCV7 era. The three clones were able to colonize efficiently the mouse nasopharyngeal mucosa where populations of these pneumococci were retained for as long as 21 days. During this period, the three clones were able to asymptomatically invade the olfactory bulbs, brain, lungs and the middle ear mucosa and established populations in these tissues. The virulence potential of the three clones was poor even at high inoculum (10(5) CFU per mouse) concentrations in the mouse septicemia model and was undetectable in the pneumonia model. Capsular type 3 transformants of clones 6A and 19A prepared in the laboratory produced lethal infection at low cell concentration (10(3) CFU per mouse) but the same transformants became impaired in their potential to colonize, indicating the importance of the capsular polysaccharide in both disease and colonization. The three clones were compared to the genomes of 56 S. pneumoniae strains for which sequence information was available in the public databank. Clone 15A (ST63) only differed from the serotype 19F clone G54 in a very few genes including serotype so that this clone may be considered the product of a capsular switch. While no strain with comparable degree of similarity to clone 19A (ST276) was found among the sequenced isolates, by MLST this clone is a single locust variant (SLV) of Denmark14-ST230 international clone. Clone 6A (ST2191) was most similar to the penicillin resistant Hungarian serotype 19A clone.	[Frazao, Nelson; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Hiller, N. Luisa; Powell, Evan; Earl, Josh; Ahmed, Azad; Ehrlich, Garth D.] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Frazao, Nelson; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Allegheny General Hospital; Carnegie Mellon University; Universidade Nova de Lisboa; Rockefeller University	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, 1230 York Ave, New York, NY 10021 USA.	tomasz@mail.rockefeller.edu	Hiller, N. Luisa/A-3739-2016; Sá-Leão, Raquel/A-9341-2011	Hiller, N. Luisa/0000-0001-6572-1368; Sá-Leão, Raquel/0000-0001-9804-827X; Frazao, Nelson/0000-0003-3509-8338; Ehrlich, Garth/0000-0003-1140-6594; Tomasz, Alexander/0000-0003-1520-1983; /0000-0001-6816-8932	Rockefeller University; PNEUMOPATH project from the European Commission [HEALTH-F3-2009-222983]; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/73229/2010]; National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH) [R00DC011322]; Allegheny General Hospital, Allegheny-Singer Research Institute; NIH [DC002148, DC02148 - 16S1, AI080935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148, R00DC011322] Funding Source: NIH RePORTER	Rockefeller University; PNEUMOPATH project from the European Commission; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH); Allegheny General Hospital, Allegheny-Singer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant (Bridges to Better Medicine Technology Innovation Fund) from the Rockefeller University to AT and the PNEUMOPATH project (contract HEALTH-F3-2009-222983) from the European Commission to HL. NF was supported by a Postdoctoral fellowship from Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/73229/2010). NLH was supported by the National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH) Award Number R00DC011322. GDH, EP, JE and AA were supported by Allegheny General Hospital, Allegheny-Singer Research Institute and NIH grants DC002148 (GDE), DC02148 - 16S1 (GDE), AI080935 (GDE). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Frazao N, 2010, VACCINE, V28, P3445, DOI 10.1016/j.vaccine.2010.02.070; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; Hanage WP, 2007, J INFECT DIS, V195, P347, DOI 10.1086/510249; Hanage WP, 2011, PEDIATR INFECT DIS J, V30, P302, DOI 10.1097/INF.0b013e318201a154; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Hiller NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028850; Hu FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047983; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kharat AS, 2006, MOL MICROBIOL, V60, P93, DOI 10.1111/j.1365-2958.2006.05082.x; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; LAI WC, 1986, J CLIN MICROBIOL, V23, P817, DOI 10.1128/JCM.23.5.817-821.1986; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Marra A, 2001, INFECT IMMUN, V69, P7318, DOI 10.1128/IAI.69.12.7318-7325.2001; Mato R, 2005, MICROB DRUG RESIST, V11, P309, DOI 10.1089/mdr.2005.11.309; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Munoz-Almagro C, 2009, J INFECTION, V59, P75, DOI 10.1016/j.jinf.2009.05.012; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rambaut A, 2012, IGTREE, V1, P4; Roberts RB, 2001, MICROB DRUG RESIST, V7, P137, DOI 10.1089/10766290152045011; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sa-Leao R, 2001, J INFECT DIS, V184, P1206, DOI 10.1086/323663; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tleyjeh IM, 2006, CLIN INFECT DIS, V42, P788, DOI 10.1086/500140; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Yildirim I, 2012, PEDIATR INFECT DIS J, V31, P1016, DOI 10.1097/INF.0b013e3182615615; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	56	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74867	10.1371/journal.pone.0074867	http://dx.doi.org/10.1371/journal.pone.0074867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069360	Green Submitted, gold, Green Published			2022-12-25	WOS:000324777300053
J	Azari, EK; Leitner, C; Jaggi, T; Langhans, W; Mansouri, A				Azari, Elnaz Karimian; Leitner, Claudia; Jaggi, Thomas; Langhans, Wolfgang; Mansouri, Abdelhak			Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-alpha Agonist Wy-14643 in High-Fat Diet Fed Rats	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; SPONTANEOUS MEAL SIZE; FOOD-INTAKE; GENE-EXPRESSION; BODY-WEIGHT; PEROXISOME PROLIFERATORS; ENERGY-METABOLISM; LIPID-METABOLISM; C57BL/6J MICE	PPAR-alpha plays a key role in lipid metabolism; it enhances fatty acid oxidation (FAO) and ketogenesis. Pharmacological PPAR-alpha activation improves insulin sensitivity and reduces food intake, but its mechanisms of action remain unknown. We here report that intraperitoneal (IP) administration of the PPAR-alpha agonist Wy-14643 (40 mg/kg BW) reduced food intake in adult male rats fed a high-fat diet (HFD, 49% of the energy) mainly through an increase in the latency to eat after injection, and without inducing a conditioned taste avoidance. Also, IP administered Wy-14643 caused an acute (the first 60 min) decrease in the respiratory quotient (RQ) and an increase in hepatic portal vein beta-hydroxybutyrate level (at 35 min) without affecting plasma non-esterified fatty acids. Given the known stimulatory effect of PPAR-alpha on FAO and ketogenesis, we measured the protein expression level of carnitine palmitoyltransferase-1 (CPT 1A) and mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase (HMG-CoAS2), two key enzymes for FAO and ketogenesis, respectively, in liver, duodenum and jejunum. Wy-14643 induced a significant increase in the expression of CPT 1A in the jejunum and duodenum and of HMG-CoAS2 in the jejunum, but neither CPT 1A nor HMG-CoAS2 expression was increased in the liver. The induction of CPT 1A and HMG-CoAS2 expression was associated with a decrease in the lipid droplet content selectively in the jejunum. Our findings indicate that Wy-14643 stimulates FAO and ketogenesis in the intestine, in particular in the jejunum, rather than in the liver, thus supporting the hypothesis that PPAR-alpha activation inhibits eating by stimulating intestinal FAO.	[Azari, Elnaz Karimian; Leitner, Claudia; Jaggi, Thomas; Langhans, Wolfgang; Mansouri, Abdelhak] Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mansouri, A (corresponding author), Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland.	abdelhak-mansouri@ethz.ch	Mansouri, Abdelhak/D-9100-2013; Langhans, Wolfgang/C-4073-2016	Mansouri, Abdelhak/0000-0003-4471-7276; 	Swiss National Science Foundation [31_130665]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was funded by Swiss National Science Foundation Grant No. 31_130665 WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkan B, 2000, AM J PHYSIOL-REG I, V279, pR1449, DOI 10.1152/ajpregu.2000.279.4.R1449; Baumgartner I, 2010, J NEUROENDOCRINOL, V22, P557, DOI 10.1111/j.1365-2826.2010.01995.x; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Colin S, 2012, EUR HEART J; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; de Vogel-van den Bosch HM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-231; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; FRIEDMAN MI, 1995, AM J CLIN NUTR, V62, P1096; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gaetani S, 2010, J NEUROSCI, V30, P8096, DOI 10.1523/JNEUROSCI.0036-10.2010; Gomez R, 2002, J NEUROSCI, V22, P9612; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Horn CC, 2004, PHYSIOL BEHAV, V81, P157, DOI 10.1016/j.physbeh.2004.01.007; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; LANGHANS W, 1985, PHYSIOL BEHAV, V34, P579, DOI 10.1016/0031-9384(85)90052-6; LANGHANS W, 1987, BEHAV NEURAL BIOL, V47, P7, DOI 10.1016/S0163-1047(87)90112-9; LANGHANS W, 1991, PHYSIOL BEHAV, V49, P1203, DOI 10.1016/0031-9384(91)90352-O; Langhans W, 2011, AM J PHYSIOL-REG I, V300, pR554, DOI 10.1152/ajpregu.00610.2010; Langhans W, 2010, FORUM NUTR, V63, P9, DOI 10.1159/000264392; Leonhardt M, 2004, PHYSIOL BEHAV, V83, P645, DOI 10.1016/j.physbeh.2004.07.033; Mansouri A, 2008, AM J PHYSIOL-REG I, V295, pR799, DOI 10.1152/ajpregu.90381.2008; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; Michalik L, 2011, PROSTAG LEUKOTR ESS, V85, P235, DOI 10.1016/j.plefa.2011.04.016; Mochizuki K, 2001, BBA-MOL CELL BIOL L, V1531, P68, DOI 10.1016/S0167-4889(01)00071-4; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Park MK, 2012, KOREAN J PHYSIOL PHA, V16, P181, DOI 10.4196/kjpp.2012.16.3.181; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Riediger T, 2010, PHARMACOL BIOCHEM BE, V97, P112, DOI 10.1016/j.pbb.2010.04.015; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; Scharrer E, 1999, NUTRITION, V15, P704, DOI 10.1016/S0899-9007(99)00125-2; SCHEURINK AJW, 1990, PHYSIOL BEHAV, V48, P909, DOI 10.1016/0031-9384(90)90248-3; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SERRA D, 1993, ARCH BIOCHEM BIOPHYS, V307, P40, DOI 10.1006/abbi.1993.1557; Silberbauer CJ, 2000, AM J PHYSIOL-REG I, V278, pR646, DOI 10.1152/ajpregu.2000.278.3.R646; SURINABAUMGARTNER DM, 1995, AM J PHYSIOL-REG I, V269, pR978, DOI 10.1152/ajpregu.1995.269.5.R978; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; THUMELIN S, 1993, BIOCHEM J, V292, P493, DOI 10.1042/bj2920493; Uchida A, 2011, BBA-MOL CELL BIOL L, V1811, P170, DOI 10.1016/j.bbalip.2010.12.011; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; WIERSMA J, 1986, LAB ANIM, V20, P57, DOI 10.1258/002367786781062115; Yuan HD, 2009, DRUG METAB DISPOS, V37, P1443, DOI 10.1124/dmd.108.026245; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	60	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74869	10.1371/journal.pone.0074869	http://dx.doi.org/10.1371/journal.pone.0074869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069361	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300063
J	Cui, GL; Zhu, RA; Qian, Y; Deng, J; Zhao, LQ; Sun, Y; Wang, F				Cui, Guanglin; Zhu, Runan; Qian, Yuan; Deng, Jie; Zhao, Linqing; Sun, Yu; Wang, Fang			Genetic Variation in Attachment Glycoprotein Genes of Human Respiratory Syncytial Virus Subgroups A and B in Children in Recent Five Consecutive Years	PLOS ONE			English	Article							G-PROTEIN GENE; GROUP-A; MOLECULAR EPIDEMIOLOGY; CIRCULATION PATTERNS; STRAIN VARIATION; SOUTH-AFRICA; VARIABILITY; GENOTYPE; PREVALENCE; DUPLICATION	Human respiratory syncytial virus (HRSV) outranks other viral agents as the cause of respiratory tract diseases in children worldwide. Molecular epidemiological study of the virus provides useful information for the development of globally effective vaccine. We investigated the circulating pattern and genetic variation in the attachment glycoprotein genes of HRSV in Beijing during 5 consecutive seasons from 2007 to 2012. Out of 19,942 tested specimens, 3,160 (15.8%) were HRSV antigen-positive. The incidence of HRSV infection in males was significantly higher than in females. Of the total 723 (23.1%) randomly selected HRSV antigen-positive samples, 462 (63.9%) and 239 (33.1%) samples were identified as subgroup A and B, respectively. Subgroups A and B co-circulated in the 5 consecutive HRSV seasons, which showed a shifting mixed pattern of subgroup dominance. Complete G gene sequences were obtained from 190 HRSV-A and 72 HRSV-B by PCR for phylogenetic analysis. Although 4 new genotypes, NA3 and NA4 for HRSV-A and BA-C and CB1 for HRSV-B, were identified here, they were not predominant; NA1 and BA9 were the prevailing HRSV-A and -B genotypes, respectively. We provide the first report of a 9 consecutive nucleotide insertion in 3 CB1 genotype strains. One Beijing strain of ON1 genotype with a 72 nucleotide insertion was found among samples collected in February 2012. The reversion of codon states in glycosylation sites to previous ones were found from HRSV strains in this study, suggesting an immune-escape strategy of this important virus.	[Cui, Guanglin; Qian, Yuan] Peking Univ, Capital Inst Pediat, Teaching Hosp, Virol Lab, Beijing 100871, Peoples R China; [Cui, Guanglin; Zhu, Runan; Qian, Yuan; Deng, Jie; Zhao, Linqing; Sun, Yu; Wang, Fang] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Peking University; Capital Institute of Pediatrics (CIP)	Qian, Y (corresponding author), Peking Univ, Capital Inst Pediat, Teaching Hosp, Virol Lab, Beijing 100871, Peoples R China.	yqianbjc@263.net	wang, fang/GYD-4295-2022		Beijing Municipal Science and Technology Commission [Z111107056811041]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Key Technologies R&D Program of National Ministry of Science	This work was supported by the grant no. Z111107056811041 from the Beijing Municipal Science (http://www.bjkw.gov.cn) and Technology Commission and grant no. 2013ZX10004-202 from Key Technologies R&D Program of National Ministry of Science (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; BEEM M, 1967, J IMMUNOL, V98, P1115; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Cane P., 2006, PERSPECT MED VIROL, V14, P89; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Collins P.L., 2007, FIELDS VIROLOGY, P1602; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Deng Jie, 2006, Zhonghua Er Ke Za Zhi, V44, P924; ENGLUND JA, 1991, J CLIN MICROBIOL, V29, P115, DOI 10.1128/JCM.29.1.115-119.1991; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Galiano MC, 2005, J MED VIROL, V77, P311, DOI 10.1002/jmv.20456; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HENDRICKS DA, 1988, J VIROL, V62, P2228, DOI 10.1128/JVI.62.7.2228-2233.1988; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Khor C.S., 2013, INFECT GENET EVOL; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Maitreyi RS, 2000, J CLIN VIROL, V16, P41, DOI 10.1016/S1386-6532(99)00075-X; Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUELENAER PM, 1991, J INFECT DIS, V164, P15, DOI 10.1093/infdis/164.1.15; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Oliveira TFM, 2008, MEM I OSWALDO CRUZ, V103, P417, DOI 10.1590/S0074-02762008000500002; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1991, J CLIN MICROBIOL, V29, P1255, DOI 10.1128/JCM.29.6.1255-1257.1991; Sun Yu, 2006, Zhonghua Er Ke Za Zhi, V44, P450; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; WATHEN MW, 1991, BIOCHEMISTRY-US, V30, P2863, DOI 10.1021/bi00225a019; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xiang ZC, 2013, J MED VIROL, V85, P348, DOI 10.1002/jmv.23467; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	60	67	77	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75020	10.1371/journal.pone.0075020	http://dx.doi.org/10.1371/journal.pone.0075020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069376	Green Submitted, gold, Green Published			2022-12-25	WOS:000324547300068
J	Saba, ES; Gueyffier, L; Dichtel-Danjoy, ML; Pozzetto, B; Bourlet, T; Gueyffier, F; Mekki, Y; Pottel, H; Sabino, EC; Vanhems, P; Zrein, MA				Saba, Esber S.; Gueyffier, Lucie; Dichtel-Danjoy, Marie-Laure; Pozzetto, Bruno; Bourlet, Thomas; Gueyffier, Francois; Mekki, Yahia; Pottel, Hans; Sabino, Ester C.; Vanhems, Philippe; Zrein, Maan A.			Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies	PLOS ONE			English	Article							PARASITE PERSISTENCE; AUTOANTIBODIES; INFECTION; PROTEIN; CARDIOMYOPATHY; PATHOGENESIS; DISEASE	Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated.	[Saba, Esber S.; Gueyffier, Lucie; Dichtel-Danjoy, Marie-Laure; Zrein, Maan A.] InfYn Biomarkers, Ecully, France; [Saba, Esber S.; Pozzetto, Bruno; Bourlet, Thomas] Fac Med Jacques Lisfranc, GIMAP EA3064, Lab Bacteriol Virol, St Etienne, France; [Gueyffier, Francois; Mekki, Yahia; Vanhems, Philippe; Zrein, Maan A.] UCBL Hosp Civils Lyon, Fac Med Rockefeller, Lyon, France; [Pottel, Hans] Katholieke Univ Leuven, Interdisciplinary Res Ctr, Kortrijk, Belgium; [Sabino, Ester C.] Univ Sao Paulo, Fac Med, Dep Molestias Infecciosas & Parasitarias, BR-09500900 Sao Paulo, Brazil	KU Leuven; Universidade de Sao Paulo	Zrein, MA (corresponding author), InfYn Biomarkers, Ecully, France.	maan.zrein@chu-lyon.fr	ZREIN, Maan/C-7666-2018; Sabino, Ester C/F-7750-2010; Gueyffier, François/B-8545-2008; Pottel, Hans/AAD-9444-2019	ZREIN, Maan/0000-0002-3301-4252; Sabino, Ester C/0000-0003-2623-5126; Gueyffier, François/0000-0002-9921-0977; Pottel, Hans/0000-0003-0074-8919; BOURLET, Thomas/0000-0002-9226-1149; Saba, Esber/0000-0003-1525-6394; POZZETTO, Bruno/0000-0002-2603-8467	Infynity Biomarkers; region Rhone Alpes	Infynity Biomarkers; region Rhone Alpes(Region Auvergne-Rhone-Alpes)	This study was funded by Infynity Biomarkers and the region Rhone Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Benvenuti LA, 2008, ANN TROP MED PARASIT, V102, P481, DOI 10.1179/136485908X311740; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias FE, 2003, AM J TROP MED HYG, V68, P242, DOI 10.4269/ajtmh.2003.68.242; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Flores-Chavez M, 2012, CLIN VACCINE IMMUNOL, V19, P1353, DOI 10.1128/CVI.00227-12; Giordanengo L, 2002, EUR J IMMUNOL, V32, P1003, DOI 10.1002/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; Ribeiro CH, 2009, MOL IMMUNOL, V46, P1092, DOI 10.1016/j.molimm.2008.10.034; HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Levin MJ, 2008, AUTOIMMUNITY, V41, P429, DOI 10.1080/08916930802031702; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Oelemann WMR, 1999, TRANSFUSION, V39, P711, DOI 10.1046/j.1537-2995.1999.39070711.x; Pais FS, 2008, MICROBES INFECT, V10, P716, DOI 10.1016/j.micinf.2008.03.005; Palomino SAP, 2000, ANN TROP MED PARASIT, V94, P571, DOI 10.1080/00034983.2000.11813580; Rashid T, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/539282; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Talvani A, 2006, MICROBES INFECT, V8, P2459, DOI 10.1016/j.micinf.2006.06.006; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Teixeira ARL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001000; Tischer BK, 2010, VET MICROBIOL, V140, P266, DOI 10.1016/j.vetmic.2009.06.020; VANVOORHIS WC, 1993, J EXP MED, V178, P681, DOI 10.1084/jem.178.2.681; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001	29	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74493	10.1371/journal.pone.0074493	http://dx.doi.org/10.1371/journal.pone.0074493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069315	Green Published, Green Submitted, gold			2022-12-25	WOS:000324547300044
J	Skinner, C; Patfield, S; Stanker, L; He, XH				Skinner, Craig; Patfield, Stephanie; Stanker, Larry; He, Xiaohua			Development of Monoclonal Antibodies and Immunoassays for Sensitive and Specific Detection of Shiga Toxin Stx2f	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; IN-VITRO; SEQUENCE; GROWTH; ASSAY; SITE	Background: Shiga toxin 2 (Stx2) is a major virulence factor in gastrointestinal diseases caused by Escherichia coli. Although Stx2a (prototypical Stx2) is well-studied, all seven subtypes of Stx2 have been associated with disease in mammals. Several subtypes of Stx2, including Stx2f, are difficult to detect immunologically. Methods And Findings: Four novel monoclonal antibodies (mAbs) against the Stx2f subtype were produced and characterized. These mAbs react exclusively to the Stx2f A subunit, and do not cross-react with other subtypes of Stx2. A Stx2f-specific sandwich ELISA was established and a limit of detection of 0.123 ng/mL was obtained using one pair of the mAbs. The receptor preference of Stx2f was confirmed using this sandwich ELISA. Three out of four mAbs can partially neutralize the toxicity of Stx2f in a cell-based assay. These mAbs were also demonstrated to be highly specific and reactive when applied to colony immunoblot assays. Conclusions: Novel mAbs specific to Stx2f were developed for the first time, providing new assets for the STEC community. Immunoassays with improved sensitivity and specificity will be useful for the detection of Stx2f present in food, environmental, and clinical samples.	[Skinner, Craig; Patfield, Stephanie; Stanker, Larry; He, Xiaohua] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	xiaohua.he@ars.usda.gov			USDA-ARS National Program [NP108]; CRIS [5325-42000-048-00D]	USDA-ARS National Program; CRIS	This research was supported by USDA-ARS National Program NP108, CRIS project 5325-42000-048-00D. The U.S. Department of Agriculture is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DET IS ID ESCH COL O; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; CANTEY JR, 1985, J INFECT DIS, V151, P766, DOI 10.1093/infdis/151.5.766; CDC, 2013, ULT OUTBR SHIG TOX P; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043845; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gamage SD, 2004, INFECT IMMUN, V72, P7131, DOI 10.1128/IAI.72.12.7131-7139.2004; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Hertig A, 2010, NEPHROL THER, V6, P258, DOI 10.1016/j.nephro.2010.03.002; HULL AE, 1993, J CLIN MICROBIOL, V31, P1167, DOI 10.1128/JCM.31.5.1167-1172.1993; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Kalchayanand N, 2012, J FOOD PROTECT, V75, P1207, DOI 10.4315/0362-028X.JFP-11-531; LAW D, 1992, J MED MICROBIOL, V36, P198, DOI 10.1099/00222615-36-3-198; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Momtaz H, 2013, POULTRY SCI, V92, P1305, DOI 10.3382/ps.2012-02542; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Oloomi M, 2006, PROTEIN PEPTIDE LETT, V13, P509, DOI 10.2174/092986606776819538; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; PAI CH, 1986, INFECT IMMUN, V51, P16, DOI 10.1128/IAI.51.1.16-23.1986; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton AW, 2001, INFECT IMMUN, V69, P1967, DOI 10.1128/IAI.69.3.1967-1970.2001; Paton AW, 1996, J CLIN MICROBIOL, V34, P463, DOI 10.1128/JCM.34.2.463-465.1996; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; SUGASAWARA RJ, 1985, J IMMUNOL METHODS, V79, P263, DOI 10.1016/0022-1759(85)90106-1; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	45	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e76563	10.1371/journal.pone.0076563	http://dx.doi.org/10.1371/journal.pone.0076563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069462	gold, Green Published, Green Submitted			2022-12-25	WOS:000324547300098
J	Corum, DG; Tsichlis, PN; Muise-Helmericks, RC				Corum, Daniel G.; Tsichlis, Philip N.; Muise-Helmericks, Robin C.			AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1	FASEB JOURNAL			English	Article						angiogenesis; endothelial cells; mitophagy	KINASE-B-GAMMA; PATHOLOGICAL ANGIOGENESIS; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; ENERGY-METABOLISM; PGC-1-ALPHA; ISOFORMS; SURVIVAL; GROWTH; MICE	Our previous work has shown that Akt3 is required for mitochondrial biogenesis in primary human endothelial cells (ECs) and in Akt3-null mice; Akt3 affects subcellular localization of peroxisome proliferator-activated receptor coactivator-1 (PGC-1), the master regulator of mitochondrial biogenesis. The purpose of this study is to determine the mechanism by which Akt3 controls the subcellular distribution of PGC-1 and to explore the effect on mitochondrial biogenesis and turnover during angiogenesis. Here we use standard biochemical analyses and Akt3-knockdown strategies to show that Akt3 controls the stabilization of chromosome maintenance region-1 (CRM-1), the major nuclear export receptor. Site-directed mutagenesis and association analyses show that PGC-1 nuclear export is CRM-1 dependent. Akt3 knockdown and CRM-1 overexpression cause 3-fold reductions in PGC-1 target gene expression, compared to control levels. Akt3 inhibition causes autophagy, as measured by autophagosome formation, in a CRM-1-dependent, Akt1/mTOR-independent pathway. In vivo, Akt3-null and heterozygous mice show dose-dependent decreases in angiogenesis compared to wild-type littermates (approximate to 5- and 2.5-fold decreases, respectively), as assessed by Matrigel plug assays. This correlates with an approximate to 1.5-fold decrease in mitochondrial Cox IV expression. Our studies suggest that Akt3 is a regulator of mitochondrial dynamics in the vasculature via regulation of CRM-1-dependent nuclear export.Corum, D. G., Tsichlis, P. N., Muise-Helmericks, R. C. AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1.	[Corum, Daniel G.; Muise-Helmericks, Robin C.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Corum, Daniel G.; Muise-Helmericks, Robin C.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Tsichlis, Philip N.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Medical University of South Carolina; Medical University of South Carolina; Tufts Medical Center	Muise-Helmericks, RC (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,BSB654, Charleston, SC 29425 USA.	musehelm@musc.edu			U.S. National Heart, Blood and Lung Institute [HL084565, 2T32HL007260-36]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084565, T32HL007260] Funding Source: NIH RePORTER	U.S. National Heart, Blood and Lung Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Yong Gong for help with Matrigel assays, Amy Phelps [Center of Biomedical Research Excellence (COBRE) Histology Core Facility, Medical University of South Carolina] for help with sectioning, and C. Beeson and R. Schnellman for their helpful suggestions. This work was supported in part by U.S. National Heart, Blood and Lung Institute grants HL084565 (to R. M. H.) and 2T32HL007260-36 (to D.G.C.).	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; CAIN AJ, 1948, Q J MICROSC SCI, V89, P229; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gentile C, 2013, DEV BIOL, V373, P163, DOI 10.1016/j.ydbio.2012.10.020; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu M, 2013, J MOL CELL CARDIOL, V54, P25, DOI 10.1016/j.yjmcc.2012.10.011; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; Maroulakou IG, 2008, J CELL PHYSIOL, V217, P468, DOI 10.1002/jcp.21518; Papaioannou V. E., 2005, MOUSE PHENOTYPES HDB; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	58	27	28	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					395	407		10.1096/fj.13-235382	http://dx.doi.org/10.1096/fj.13-235382			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24081905	Green Published			2022-12-25	WOS:000333526100037
J	Matsubayashi, M; Teramoto-Kimata, I; Uni, S; Lillehoj, HS; Matsuda, H; Furuya, M; Tani, H; Sasai, K				Matsubayashi, Makoto; Teramoto-Kimata, Isao; Uni, Shigehiko; Lillehoj, Hyun S.; Matsuda, Haruo; Furuya, Masaru; Tani, Hiroyuki; Sasai, Kazumi			Elongation Factor-1 alpha Is a Novel Protein Associated with Host Cell Invasion and a Potential Protective Antigen of Cryptosporidium parvum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-penetrating Peptides; Cytoskeleton; Electron Microscopy (EM); Protozoan; Transcription Elongation Factors; Translation Elongation Factors; Western Blotting	SEA-URCHIN EGGS; FACTOR-I ALPHA; MONOCLONAL-ANTIBODY; TOXOPLASMA INVASION; ACTIN CYTOSKELETON; BINDING PROTEIN; FACTOR 1A; IDENTIFICATION; SPOROZOITES; EIMERIA	Background: Apicomplexan parasites, including Cryptosporidium, possess organelles associated with host cell invasion. Results: A chicken-derived monoclonal antibody inhibited host cell invasion by C. parvum. The corresponding antigen, which localizes to the apical region of the parasite, was identified as elongation factor-1 (EF-1). Conclusion: EF-1 mediates cryptosporidial cytoskeletal complex critical for host cell invasion. Significance: The findings suggest that cryptosporidial EF-1 could serve as a novel anti-infective target antigen. The phylum Apicomplexa comprises obligate intracellular parasites that infect vertebrates. All invasive forms of Apicomplexa possess an apical complex, a unique assembly of organelles localized to the anterior end of the cell and involved in host cell invasion. Previously, we generated a chicken monoclonal antibody (mAb), 6D-12-G10, with specificity for an antigen located in the apical cytoskeleton of Eimeria acervulina sporozoites. This antigen was highly conserved among Apicomplexan parasites, including other Eimeria spp., Toxoplasma, Neospora, and Cryptosporidium. In the present study, we identified the apical cytoskeletal antigen of Cryptosporidium parvum (C. parvum) and further characterized this antigen in C. parvum to assess its potential as a target molecule against cryptosporidiosis. Indirect immunofluorescence demonstrated that the reactivity of 6D-12-G10 with C. parvum sporozoites was similar to those of anti-- and anti--tubulins antibodies. Immunoelectron microscopy with the 6D-12-G10 mAb detected the antigen both on the sporozoite surface and underneath the inner membrane at the apical region of zoites. The 6D-12-G10 mAb significantly inhibited in vitro host cell invasion by C. parvum. MALDI-TOF/MS and LC-MS/MS analysis of tryptic peptides revealed that the mAb 6D-12-G10 target antigen was elongation factor-1 (EF-1). These results indicate that C. parvum EF-1 plays an essential role in mediating host cell entry by the parasite and, as such, could be a candidate vaccine antigen against cryptosporidiosis.	[Matsubayashi, Makoto] Osaka Yuhigaoka Gakuen Jr Coll, Dept Food & Nutr, Tennoji Ku, Osaka 5430073, Japan; [Matsubayashi, Makoto] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan; [Teramoto-Kimata, Isao; Uni, Shigehiko] Osaka City Univ, Grad Sch Med, Dept Parasitol, Abeno Ku, Osaka 5458585, Japan; [Uni, Shigehiko] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Lillehoj, Hyun S.] USDA, Anim Biosci & Biotechnol Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Matsuda, Haruo] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Immunobiol Lab, Higashihiroshima 7398528, Japan; [Furuya, Masaru; Tani, Hiroyuki; Sasai, Kazumi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, Izumisano, Osaka 5988531, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; Universiti Malaya; United States Department of Agriculture (USDA); Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Osaka Metropolitan University	Sasai, K (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, Izumisano, Osaka 5988531, Japan.	ksasai@vet.osakafu-u.ac.jp	uni, shigehiko/A-8940-2012; Sasai, Kazumi/GLV-2527-2022	Furuya, Masaru/0000-0003-3276-7903	Public Trust for Home Economics Research Support Fund; Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation [22700773];  [23580445]; Grants-in-Aid for Scientific Research [23580445] Funding Source: KAKEN	Public Trust for Home Economics Research Support Fund; Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Public Trust for Home Economics Research Support Fund (to M.M.), Grants-in-aid for Scientific Research 23580445 (to K.S., H.T., M.F., and M.M.) and 22700773 (to M.M.) from the Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation (to K.S., H.T., and M.M.).	Abe N, 2002, J VET MED SCI, V64, P165, DOI 10.1292/jvms.64.165; Arrowood MJ, 2002, CLIN MICROBIOL REV, V15, P390, DOI 10.1128/CMR.15.3.390-400.2002; Beeley J. G., 1985, LAB TECHNIQUES BIOCH, V16, p[160, 279]; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Bonafonte MT, 1997, BBA-GENE STRUCT EXPR, V1351, P256, DOI 10.1016/S0167-4781(97)00013-4; Brown WC, 1999, PARASITOL TODAY, V15, P275, DOI 10.1016/S0169-4758(99)01471-4; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Chappell C. L., 2003, CRYPTOSPORIDIUM MOL, P19; Chen XM, 2002, NEW ENGL J MED, V346, P1723, DOI 10.1056/NEJMra013170; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Doyle A, 2011, J STRUCT BIOL, V176, P370, DOI 10.1016/j.jsb.2011.09.004; DURSO NA, 1994, PLANT CELL, V6, P1699, DOI 10.2307/3869901; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HAMER DH, 1994, INFECT IMMUN, V62, P2208, DOI 10.1128/IAI.62.6.2208-2213.1994; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Kristensen R, 2005, MYCOL RES, V109, P173, DOI 10.1017/S0953756204002114; KURIYAMA R, 1990, J CELL SCI, V95, P231; Lovett JL, 2000, MOL BIOCHEM PARASIT, V107, P33, DOI 10.1016/S0166-6851(99)00228-5; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Matsubayashi M, 2008, PARASITOLOGY, V135, P295, DOI 10.1017/S003118200700385X; Matsubayashi M, 2005, VET PARASITOL, V128, P47, DOI 10.1016/j.vetpar.2004.11.004; Matsubayashi M, 2011, INT J PARASITOL, V41, P287, DOI 10.1016/j.ijpara.2010.09.009; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OHTA K, 1990, J BIOL CHEM, V265, P3240; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Ransom-Hodgkins WD, 2009, MOL GENET GENOMICS, V281, P391, DOI 10.1007/s00438-008-0418-2; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Ridgley EL, 1996, MOL BIOCHEM PARASIT, V79, P119, DOI 10.1016/0166-6851(96)02639-4; Riggs MW, 1999, INFECT IMMUN, V67, P1317, DOI 10.1128/IAI.67.3.1317-1322.1999; RIGGS MW, 1997, CRYPTOSPORIDIUM CRYP, P129; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Sasai K, 1996, J PARASITOL, V82, P82, DOI 10.2307/3284120; Sasai K, 1998, J PARASITOL, V84, P654, DOI 10.2307/3284748; Schaefer DA, 2000, INFECT IMMUN, V68, P2608, DOI 10.1128/IAI.68.5.2608-2616.2000; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SONG CS, 1985, J IMMUNOL, V135, P3354; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tomley FM, 1996, MOL BIOCHEM PARASIT, V79, P195, DOI 10.1016/0166-6851(96)02662-X; Toueille M, 2007, PLANT PHYSIOL BIOCH, V45, P113, DOI 10.1016/j.plaphy.2007.01.006; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; WEILL JC, 1987, SCIENCE, V238, P1094, DOI 10.1126/science.3317827; Wetzel DM, 2005, INFECT IMMUN, V73, P5379, DOI 10.1128/IAI.73.9.5379-5387.2005; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YANG WN, 1993, J BIOL CHEM, V268, P392	46	31	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34111	34120		10.1074/jbc.M113.515544	http://dx.doi.org/10.1074/jbc.M113.515544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24085304	Green Published, hybrid			2022-12-25	WOS:000327250200055
J	Miller, TR; Beversdorf, L; Chaston, SD; McMahon, KD				Miller, Todd R.; Beversdorf, Lucas; Chaston, Sheena D.; McMahon, Katherine D.			Spatiotemporal Molecular Analysis of Cyanobacteria Blooms Reveals Microcystis-Aphanizomenon Interactions	PLOS ONE			English	Article							LARGE SHALLOW LAKE; GENETIC DIVERSITY; BACTERIAL COMMUNITIES; PHYTOPLANKTON ASSEMBLAGES; PLANKTOTHRIX-AGARDHII; FORMING CYANOBACTERIA; EUTROPHIC LAKES; ALGAL BLOOMS; DOMINANCE; AERUGINOSA	Spatial and temporal variability in cyanobacterial community composition (CCC) within and between eutrophic lakes is not well-described using culture independent molecular methods. We analyzed CCC across twelve locations in four eutrophic lakes and within-lake locations in the Yahara Watershed, WI, on a weekly basis, for 5 months. Taxa were discriminated by length of MspI-digested cpcB/A intergenic spacer gene sequences and identified by comparison to a PCR-based clone library. CCC across all stations was spatially segregated by depth of sampling locations (ANOSIM R = 0.23, p < 0.001). Accordingly, CCC was correlated with thermal stratification, nitrate and soluble reactive phosphorus (SRP, R = 0.2-0.3). Spatial variability in CCC and temporal trends in taxa abundances were rarely correlative between sampling locations in the same lake indicating significant within lake spatiotemporal heterogeneity. Across all stations, a total of 37 bloom events were observed based on distinct increases in phycocyanin. Out of 97 taxa, a single Microcystis, and two different Aphanizomenon taxa were the dominant cyanobacteria detected during bloom events. The Microcystis and Aphanizomenon taxa rarely bloomed together and were significantly anti-correlated with each other at 9 of 12 stations with Pearson R values of -0.6 to -0.9 (p < 0.001). Of all environmental variables measured, nutrients, especially nitrate were significantly greater during periods of Aphanizomenon dominance while the nitrate+nitrite: SRP ratio was lower. This study shows significant spatial variability in CCC within and between lakes structured by depth of the sampling location. Furthermore, our study reveals specific genotypes involved in bloom formation. More in-depth characterization of these genotypes should lead to a better understanding of factors promoting bloom events in these lakes and more reliable bloom prediction models.	[Miller, Todd R.; Chaston, Sheena D.; McMahon, Katherine D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Beversdorf, Lucas; McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miller, TR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	millertr@uwm.edu	Miller, Todd/Y-3612-2019	McMahon, Katherine D./0000-0002-7038-026X; Miller, Todd/0000-0002-2113-1662	Wisconsin SeaGrant [R/BT-24]; National Science Foundation [CAREER CBET-0644949, MCB-0702395, NTL-LTER DEB-0822700]	Wisconsin SeaGrant; National Science Foundation(National Science Foundation (NSF))	Funding provided by a Wisconsin SeaGrant (R/BT-24; http://www.seagrant.wisc.edu/home/), and the National Science Foundation (CAREER CBET-0644949; NTL-Microbial Observatory MCB-0702395; NTL-LTER DEB-0822700; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association APH, 1995, STAND METH EX WAT WA; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Birge EA, 1926, P NATL ACAD SCI USA, V12, P515, DOI 10.1073/pnas.12.8.515; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Budikova D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009206; Carraro E, 2012, HYDROBIOLOGIA, V698, P77, DOI 10.1007/s10750-012-1096-y; Chakraborty S, 2012, ECOL COMPLEX, V11, P144, DOI 10.1016/j.ecocom.2012.05.006; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deblois CP, 2012, J PHYCOL, V48, P1002, DOI 10.1111/j.1529-8817.2012.01191.x; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Fewer DP, 2009, ENVIRON MICROBIOL, V11, P855, DOI 10.1111/j.1462-2920.2008.01806.x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flowers JJ, 2009, ENV MICROBIOL REP, V1, P583, DOI 10.1111/j.1758-2229.2009.00090.x; JACOBSON L, 1982, J PLANKTON RES, V4, P481, DOI 10.1093/plankt/4.3.481; Kanoshina I, 2003, HARMFUL ALGAE, V2, P29, DOI 10.1016/S1568-9883(02)00085-9; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Kim SG, 2006, APPL ENVIRON MICROB, V72, P3252, DOI 10.1128/AEM.72.5.3252-3258.2006; LAMPERT W, 1987, NEW ZEAL J MAR FRESH, V21, P483, DOI 10.1080/00288330.1987.9516244; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marsac NTD, 1988, METHODS ENZYMOL, V167; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Nixdorf B, 2003, HYDROBIOLOGIA, V502, P111, DOI 10.1023/B:HYDR.0000004274.65831.e5; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl Hans W., 1996, Phycologia, V35, P25, DOI 10.2216/i0031-8884-35-6S-25.1; POOLE H. H., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P297; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; REYNOLDS CS, 1987, NEW ZEAL J MAR FRESH, V21, P379, DOI 10.1080/00288330.1987.9516234; Ricke P, 2005, APPL ENVIRON MICROB, V71, P1671, DOI 10.1128/AEM.71.3.1671-1673.2005; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Rucker J, 1997, HYDROBIOLOGIA, V342, P107, DOI 10.1023/A:1017013208039; Scheffer M, 1997, ECOLOGY, V78, P272; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; SIMON RD, 1971, P NATL ACAD SCI USA, V68, P265, DOI 10.1073/pnas.68.2.265; STEINBERG CEW, 1988, FRESHWATER BIOL, V20, P279, DOI 10.1111/j.1365-2427.1988.tb00452.x; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Tonno I, 2003, HYDROBIOLOGIA, V490, P23, DOI 10.1023/A:1023452828667; van Gremberghe I, 2009, OIKOS, V118, P1647, DOI 10.1111/j.1600-0706.2009.17538.x; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Walsby A E, 1972, Symp Soc Exp Biol, V26, P233; Wang XY, 2012, MICROB ECOL, V64, P986, DOI 10.1007/s00248-012-0083-1; WATSON VJ, 1979, J WATER POLLUT CON F, V51, P2876; Willen T, 1997, HYDROBIOLOGIA, V353, P181, DOI 10.1023/A:1003047019422; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Yang Z, 2005, ANN LIMNOL-INT J LIM, V41, P169, DOI 10.1051/limn:20054130169; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	51	27	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74933	10.1371/journal.pone.0074933	http://dx.doi.org/10.1371/journal.pone.0074933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086400	gold, Green Published			2022-12-25	WOS:000325223900031
J	Zabet, NR; Foy, R; Adryan, B				Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris			The Influence of Transcription Factor Competition on the Relationship between Occupancy and Affinity	PLOS ONE			English	Article							DNA-BINDING SITES; FACILITATED DIFFUSION; PHYSICAL CONSTRAINTS; GENE-REGULATION; SPECIFICITY; MODELS; SIMULATIONS; PROTEINS; SEQUENCE; BEHAVIOR	Transcription factors (TFs) are proteins that bind to specific sites on the DNA and regulate gene activity. Identifying where TF molecules bind and how much time they spend on their target sites is key to understanding transcriptional regulation. It is usually assumed that the free energy of binding of a TF to the DNA (the affinity of the site) is highly correlated to the amount of time the TF remains bound (the occupancy of the site). However, knowing the binding energy is not sufficient to infer actual binding site occupancy. This mismatch between the occupancy predicted by the affinity and the observed occupancy may be caused by various factors, such as TF abundance, competition between TFs or the arrangement of the sites on the DNA. We investigated the relationship between the affinity of a TF for a set of binding sites and their occupancy. In particular, we considered the case of the transcription factor lac repressor (lacI) in E. coli, and performed stochastic simulations of the TF dynamics on the DNA for various combinations of lacI abundance and competing TFs that contribute to macromolecular crowding. We also investigated the relationship of site occupancy and the information content of position weight matrices (PWMs) used to represent binding sites. Our results showed that for medium and high affinity sites, TF competition does not play a significant role for genomic occupancy except in cases when the abundance of the TF is significantly increased, or when the PWM displays relatively low information content. Nevertheless, for medium and low affinity sites, an increase in TF abundance (for both cognate and non-cognate molecules) leads to an increase in occupancy at several sites.	[Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge	Zabet, NR (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	n.r.zabet@gen.cam.ac.uk; ba255@cam.ac.uk		Zabet, Nicolae Radu/0000-0001-9964-6271	Medical Research Council [G1002110]; Royal Society (URF); MRC [G1002110] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society (URF)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [G1002110 to N.R.Z.] and the Royal Society (URF to B. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Chu D, 2009, J THEOR BIOL, V257, P419, DOI 10.1016/j.jtbi.2008.11.026; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flyvbjerg H, 2006, NUCLEIC ACIDS RES, V34, P2550, DOI 10.1093/nar/gkl271; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Kampmann M, 2004, J BIOL CHEM, V279, P38715, DOI 10.1074/jbc.M404504200; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zabet NR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-121; Zabet NR, 2012, MOL BIOSYST, V8, P2815, DOI 10.1039/c2mb25201e; Zabet NR, 2012, BIOINFORMATICS, V28, P1517, DOI 10.1093/bioinformatics/bts178; Zabet NR, 2012, BIOINFORMATICS, V28, P1287, DOI 10.1093/bioinformatics/bts132; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	45	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73714	10.1371/journal.pone.0073714	http://dx.doi.org/10.1371/journal.pone.0073714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086290	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900019
J	Chu, HY; Liao, YL; Tsai, YJ; Chu, YC; Wu, SY; Ma, L				Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih			Use of Extraocular Muscle Flaps in the Correction of Orbital Implant Exposure	PLOS ONE			English	Article							RETROAURICULAR MYOPERIOSTEAL GRAFT; DERMIS-FAT GRAFT; PATCH GRAFT; REPAIR	Purposes: The study is to describe a new surgical technique for correcting large orbital implant exposure with extraocular muscle flaps and to propose a treatment algorithm for orbital implant exposure. Methods: In a retrospective study, seven patients with orbital implant exposure were treated with extraocular muscle flaps. All data were collected from patients in Chang Gung Memorial Hospital, Taiwan during 2007-2012. All surgeries were performed by one surgeon (Y.J.T). Patient demographics, the original etiology, details of surgical procedures, implant types, and follow-up interval were recorded. Small exposure, defined as exposure area smaller than 3 mm in diameter, was treated conservatively first with topical lubricant and prophylactic antibiotics. Larger defects were managed surgically. Results: Seven patients consisting of two males and five females were successfully treated for orbital implant exposure with extraocular muscle flaps. The average age was 36.4 (range, 3-55) years old. Five patients were referred from other hospitals. One eye was enucleated for retinoblastoma. The other six eyes were eviscerated, including one for endophthalmitis and five for trauma. Mean follow-up time of all seven patients was 19.5 (range, 2-60) months. No patient developed recurrence of exposure during follow-up. All patients were fitted with an acceptable prosthesis and had satisfactory cosmetic and functional results. Conclusions: The most common complication of orbital implant is exposure, caused by breakdown of the covering layers, leading to extrusion. Several methods were reported to manage the exposed implants. We report our experience of treating implant exposure with extraocular muscle flaps to establish a well-vascularized environment that supplies both the wrapping material and the overlying ocular surface tissue. We believe it can work as a good strategy to manage or to prevent orbital implant exposure.	[Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Tsai, YJ (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	erinyjtsai@gmail.com						Inkster CF, 2002, OPHTHALMOLOGY, V109, P389, DOI 10.1016/S0161-6420(01)00904-6; Jordan DR, 2010, OPHTHAL PLAST RECONS, V26, P80, DOI 10.1097/IOP.0b013e3181b80c30; Karslioglu S, 2012, OPHTHAL PLAST RECONS, V28, P264, DOI 10.1097/IOP.0b013e3182541315; Lee BJ, 2010, OPHTHAL PLAST RECONS, V26, P273, DOI 10.1097/IOP.0b013e3181bf24db; Lee MJ, 2011, AM J OPHTHALMOL, V152, P244, DOI 10.1016/j.ajo.2011.01.048; Lee-Wing MW, 2003, OPHTHALMIC PLAST REC, V19, P401, DOI 10.1097/01.IOP.0000087029.00333.C2; Liao SL, 2005, BRIT J OPHTHALMOL, V89, P92, DOI 10.1136/bjo.2003.038778; Lu LN, 2011, J CRANIOFAC SURG, V22, P1452, DOI 10.1097/SCS.0b013e31821d1860; McInnes AW, 2011, OPHTHAL PLAST RECONS, V27, P52, DOI 10.1097/IOP.0b013e3181e4a770; Mules P H, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P69; Naugle TC, 1999, AM J OPHTHALMOL, V128, P495, DOI 10.1016/S0002-9394(99)00159-2; Naugle TC, 1997, OPHTHALMOLOGY, V104, P1480, DOI 10.1016/S0161-6420(97)30107-9; Perry A C, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P75; Ramey N, 2011, OPHTHAL SURG LAS IM, V42, P434, DOI 10.3928/15428877-20110812-03; Sagoo MS, 2004, BRIT J OPHTHALMOL, V88, P942, DOI 10.1136/bjo.2003.026823; SHIELDS CL, 1994, BRIT J OPHTHALMOL, V78, P702, DOI 10.1136/bjo.78.9.702; Wang JK, 2008, OPHTHAL SURG LAS IM, V39, P399, DOI 10.3928/15428877-20080901-17	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72223	10.1371/journal.pone.0072223	http://dx.doi.org/10.1371/journal.pone.0072223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086260	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700005
J	Mascarenhas, R; Dougherty, JA; Schoenberg, DR				Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.			SMG6 Cleavage Generates Metastable Decay Intermediates from Nonsense-Containing beta-Globin mRNA	PLOS ONE			English	Article							ENDONUCLEOLYTIC CLEAVAGE; POLYSOMAL RIBONUCLEASE-1; ERYTHROID TISSUES; IN-VIVO; CELLS; PMR1; IDENTIFICATION; DEGRADATION; TERMINATION; EXPRESSION	mRNAs targeted by endonuclease decay generally disappear without detectable decay intermediates. The exception to this is nonsense-containing human beta-globin mRNA, where the destabilization of full-length mRNA is accompanied by the cytoplasmic accumulation of 5'-truncated transcripts in erythroid cells of transgenic mice and in transfected erythroid cell lines. The relationship of the shortened RNAs to the decay process was characterized using an inducible erythroid cell system and an assay for quantifying full-length mRNA and a truncated RNA missing 169 nucleotides from the 5' end. In cells knocked down for Upf1 a reciprocal increase in full-length and decrease in shortened RNA confirmed the role of NMD in this process. Kinetic analysis demonstrated that the 5'-truncated RNAs are metastable intermediates generated during the decay process. SMG6 previously was identified as an endonuclease involved in NMD. Consistent with involvement of SMG6 in the decay process full-length nonsense-containing beta-globin mRNA was increased and the Delta 169 decay intermediate was decreased in cells knocked down for SMG6. This was reversed by complementation with siRNA-resistant SMG6, but not by SMG6 with inactivating PIN domain mutations. Importantly, none of these altered the phosphorylation state of Upf1. These data provide the first proof for accumulation of stable NMD products by SMG6 endonuclease cleavage.	[Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schoenberg, DR (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.	schoenberg.3@osu.edu	Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946; Dougherty, Julie/0000-0001-5778-1512	National Institute of General Medical Sciences of the United States National Institutes of Health [GM038277, GM079707, GM084177]; Ohio State University Center for RNA Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084177, R01GM038277, R01GM079707] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the United States National Institutes of Health; Ohio State University Center for RNA Biology(Ohio State University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences of the United States National Institutes of Health grant numbers GM038277, GM079707, and GM084177. JA was supported by a fellowship from The Ohio State University Center for RNA Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremer KA, 2003, RNA, V9, P1157, DOI 10.1261/rna.5720303; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Hanson MN, 2001, J BIOL CHEM, V276, P12331, DOI 10.1074/jbc.M010483200; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lasham A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1076; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Otsuka Y, 2008, METHOD ENZYMOL, V448, P241, DOI 10.1016/S0076-6879(08)02613-X; Peng Y, 2007, MOL CELL, V25, P779, DOI 10.1016/j.molcel.2007.01.026; Poddie D, 2003, HEMOGLOBIN, V27, P219, DOI 10.1081/HEM-120026046; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schoenberg DR, 2011, WIRES RNA, V2, P582, DOI 10.1002/wrna.78; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Yang F, 2004, J BIOL CHEM, V279, P48993, DOI 10.1074/jbc.M409776200	25	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74791	10.1371/journal.pone.0074791	http://dx.doi.org/10.1371/journal.pone.0074791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086375	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700037
J	Godin, JP; Ross, AB; Cleroux, M; Pouteau, E; Montoliu, I; Moser, M; Kochhar, S				Godin, Jean-Philippe; Ross, Alastair B.; Cleroux, Marilyn; Pouteau, Etienne; Montoliu, Ivan; Moser, Mireille; Kochhar, Sunil			Natural Carbon Isotope Abundance of Plasma Metabolites and Liver Tissue Differs between Diabetic and Non-Diabetic Zucker Diabetic Fatty Rats	PLOS ONE			English	Article							MASS-SPECTROMETRY; STABLE-ISOTOPES; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; NITROGEN-BALANCE; AMINO-ACIDS; ZDF RAT; FRACTIONATION; TRACER; EAT	Background: 'You are what you eat' is an accurate summary for humans and animals when it comes to carbon isotope abundance. In biological material, natural(13)C/C-12 ratio is subject to minute variations due to diet composition (mainly from ingestion of C-3 and C-4 metabolism plants) and to the discrimination between 'light' and 'heavy' isotopes during biochemical reactions (isotope effects and isotopic fractionation). Methodology/Principal Findings: Carbon isotopic abundance was measured in ZDF (fa/+) and ZDF (fa/fa), (lean and obese-diabetic rats respectively) fed the same diet. By analysing plasma metabolites (glucose and non-esterified fatty acids), breath and liver tissue by high-precision isotope ratio mass spectrometry, we demonstrate for the first time statistically distinguishable metabolic carbon isotope abundance between ZDF (fa/+) and ZDF (fa/fa) rats based on plasma glucose, palmitic, oleic, linoleic, arachidonic acids and bulk analysis of liver tissue (P<0.005) resulting into clear isotopic fingerprints using principal component analysis. We studied the variation of isotopic abundance between both groups for each metabolite and through the metabolic pathways using the precursor/product approach. We confirmed that lipids were depleted in C-13 compared to glucose in both genotypes. We found that isotopic abundance of linoleic acid (C18: 2n-6), even though both groups had the same feed, differed significantly between both groups. The likely reason for these changes between ZDF (fa/+) and ZDF (fa/fa) are metabolic dysregulation associated with various routing and fluxes of metabolites. Conclusion/Significance: This work provides evidence that measurement of natural abundance isotope ratio of both bulk tissue and individual metabolites can provide meaningful information about metabolic changes either associated to phenotype or to genetic effects; irrespective of concentration. In the future measuring the natural abundance delta C-13 of key metabolites could be used as endpoints for studying in vivo metabolism, especially with regards to metabolic dysregulation, and development and progression of metabolic diseases.	[Godin, Jean-Philippe; Ross, Alastair B.; Cleroux, Marilyn; Pouteau, Etienne; Montoliu, Ivan; Moser, Mireille; Kochhar, Sunil] Nestle Res Ctr, Analyt Sci, CH-1000 Lausanne, Switzerland	Nestle SA	Godin, JP (corresponding author), Nestle Res Ctr, Analyt Sci, CH-1000 Lausanne, Switzerland.	jean-philippe.godin@rdls.nestle.com		Ross, Alastair/0000-0002-9585-0141	Nestle	Nestle(Nestle SA)	Nestle has funded the work. The funder had no role in the study design, data collection and analysis or preparation of the manuscript.	ABELSON PH, 1961, P NATL ACAD SCI USA, V47, P623, DOI 10.1073/pnas.47.5.623; Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Brenna JT, 1997, MASS SPECTROM REV, V16, P227, DOI 10.1002/(SICI)1098-2787(1997)16:5<227::AID-MAS1>3.3.CO;2-U; Brenna JT, 2001, RAPID COMMUN MASS SP, V15, P1252, DOI 10.1002/rcm.325; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; CUNNANE SC, 1995, LIPIDS, V30, P781, DOI 10.1007/BF02537807; Friedman MI, 1998, AM J CLIN NUTR, V67, p513S, DOI 10.1093/ajcn/67.3.513S; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Godin JP, 2007, MASS SPECTROM REV, V26, P751, DOI 10.1002/mas.20149; Godin JP, 2011, RAPID COMMUN MASS SP, V25, P2989, DOI 10.1002/rcm.5179; Godin JP, 2010, ANAL CHEM, V82, P646, DOI 10.1021/ac902086g; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hellerstein MK, 2004, METAB ENG, V6, P85, DOI 10.1016/j.ymben.2003.10.005; Jones DP, 2012, ANNU REV NUTR, V10, P1146; KALHAN SC, 1977, J LAB CLIN MED, V89, P285; Kuo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032137; Lee WNP, 2005, J NUTR, V135, p3027S, DOI 10.1093/jn/135.12.3027S; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; OLEARY MH, 1989, ANNU REV BIOCHEM, V58, P377; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Pickavance L, 1998, BRIT J PHARMACOL, V125, P767, DOI 10.1038/sj.bjp.0702158; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Rhee SK, 1997, LIPIDS, V32, P1257, DOI 10.1007/s11745-006-0161-6; Schoeller DA, 1999, J ARCHAEOL SCI, V26, P667, DOI 10.1006/jasc.1998.0391; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Thompson DR, 2005, OECOLOGIA, V144, P517, DOI 10.1007/s00442-005-0171-8; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74866	10.1371/journal.pone.0074866	http://dx.doi.org/10.1371/journal.pone.0074866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086387	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200046
J	Wright, DM; Allen, AR; Mallon, TR; McDowell, SWJ; Bishop, SC; Glass, EJ; Bermingham, ML; Woolliams, JA; Skuce, RA				Wright, David M.; Allen, Adrian R.; Mallon, Thomas R.; McDowell, Stanley W. J.; Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.; Skuce, Robin A.			Field-Isolated Genotypes of Mycobacterium bovis Vary in Virulence and Influence Case Pathology but Do Not Affect Outbreak Size	PLOS ONE			English	Article							NORTHERN-IRELAND; MOLECULAR EPIDEMIOLOGY; CATTLE FARMS; TUBERCULOSIS; MODEL; PATHOGENESIS; DETERMINANTS; SURVEILLANCE; TRANSMISSION; EVOLUTION	Strains of many infectious agents differ in fundamental epidemiological parameters including transmissibility, virulence and pathology. We investigated whether genotypes of Mycobacterium bovis (the causative agent of bovine tuberculosis, bTB) differ significantly in transmissibility and virulence, combining data from a nine-year survey of the genetic structure of the M. bovis population in Northern Ireland with detailed records of the cattle population during the same period. We used the size of herd breakdowns as a proxy measure of transmissibility and the proportion of skin test positive animals (reactors) that were visibly lesioned as a measure of virulence. Average breakdown size increased with herd size and varied depending on the manner of detection (routine herd testing or tracing of infectious contacts) but we found no significant variation among M. bovis genotypes in breakdown size once these factors had been accounted for. However breakdowns due to some genotypes had a greater proportion of lesioned reactors than others, indicating that there may be variation in virulence among genotypes. These findings indicate that the current bTB control programme may be detecting infected herds sufficiently quickly so that differences in virulence are not manifested in terms of outbreak sizes. We also investigated whether pathology of infected cattle varied according to M. bovis genotype, analysing the distribution of lesions recorded at post mortem inspection. We concentrated on the proportion of cases lesioned in the lower respiratory tract, which can indicate the relative importance of the respiratory and alimentary routes of infection. The distribution of lesions varied among genotypes and with cattle age and there were also subtle differences among breeds. Age and breed differences may be related to differences in susceptibility and husbandry, but reasons for variation in lesion distribution among genotypes require further investigation.	[Wright, David M.; Skuce, Robin A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Allen, Adrian R.; Mallon, Thomas R.; McDowell, Stanley W. J.; Skuce, Robin A.] Agri Food & Biosci Inst, Vet Sci Div, Bacteriol Branch, Belfast, Antrim, North Ireland; [Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	Queens University Belfast; Agri-Food & Biosciences Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Wright, DM (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	david.m.wright@cantab.net	Glass, Elizabeth J/L-4612-2016; Bermingham, Mairead L./A-3372-2015; Allen, Adrian R/C-6242-2009	Glass, Elizabeth J/0000-0002-6183-0185; Bermingham, Mairead L./0000-0002-0931-0051; McDowell, Stanley/0000-0002-9081-1469; Wright, David/0000-0001-8948-3691	BBSRC under CEDFAS initiative [BB/E018335/1, BB/E018335/2]; Northern Ireland Department of Agriculture and Rural Development [DARD0407]; BBSRC Institute Strategic Programme; BBSRC [BB/E018386/1, BB/E018335/2, BB/E018335/1, BBS/E/D/20231761] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/E018335/1, BB/E018335/2, BB/E018386/1] Funding Source: researchfish	BBSRC under CEDFAS initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Northern Ireland Department of Agriculture and Rural Development; BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC (http://www.bbsrc.ac.uk/) under the CEDFAS initiative, grant numbers BB/E018335/1 and BB/E018335/2; and by the Northern Ireland Department of Agriculture and Rural Development (http://www.dardni.gov.uk/), grant number DARD0407. SCB, JAW, and EJG also acknowledge BBSRC Institute Strategic Programme funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Abernethy DA, 2006, VET MICROBIOL, V112, P231, DOI 10.1016/j.vetmic.2005.11.023; Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Leon DA, 2009, CLIN EXP IMMUNOL, V157, P139, DOI 10.1111/j.1365-2249.2009.03923.x; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Amos W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058245; Bates D, 2012, LME4 LINEAR MIXED EF; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Biffa D, 2012, TROP ANIM HEALTH PRO, V44, P991, DOI 10.1007/s11250-011-0031-y; Blanco FC, 2009, MICROBES INFECT, V11, P956, DOI 10.1016/j.micinf.2009.06.006; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Boukary AR, 2012, TRANSBOUND EMERG DIS, V59, P490, DOI 10.1111/j.1865-1682.2011.01302.x; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Brooks-Pollock E, 2009, PREV VET MED, V92, P360, DOI 10.1016/j.prevetmed.2009.08.022; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Defra, 2011, BOV TB ER PROGR ENGL; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Frankena K, 2007, VET REC, V161, P679, DOI 10.1136/vr.161.20.679; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI 10.1086/498245; Garske T, 2008, J THEOR BIOL, V253, P228, DOI 10.1016/j.jtbi.2008.02.038; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Goodchild A. V., 2003, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at University of Warwick, England, 31st March-2nd April 2003, P45; Hernandez-Pando R, 2012, INFECT GENET EVOL, V12, P725, DOI 10.1016/j.meegid.2012.02.013; Houston R, 2001, REV SCI TECH OIE, V20, P652, DOI 10.20506/rst.20.2.1293; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; James A, 2007, P ROY SOC B-BIOL SCI, V274, P741, DOI 10.1098/rspb.2006.0219; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lloyd-Smith JO, 2006, CONTEMP MATH, V410, P235; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Matthews L, 2009, EPIDEMICS-NETH, V1, P221, DOI 10.1016/j.epidem.2009.10.002; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Neill SD, 2005, J APPL MICROBIOL, V98, P1261, DOI 10.1111/j.1365-2672.2005.02599.x; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Nickbakhsh S, 2011, BMC VET RES, V7, DOI [10.1186/1746-6148-7-66, 10.1186/1746-6148-8-51]; Olea-Popelka F, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-2; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Palmer MV, 2006, VET MICROBIOL, V112, P181, DOI 10.1016/j.vetmic.2005.11.028; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Porco TC, 2001, J ACQ IMMUN DEF SYND, V28, P437, DOI 10.1097/00042560-200112150-00005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhee JT, 1999, J CLIN MICROBIOL, V37, P1764, DOI 10.1128/JCM.37.6.1764-1770.1999; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Wolfe DM, 2010, PREV VET MED, V94, P170, DOI 10.1016/j.prevetmed.2010.02.010; Wright DM, 2013, INFECT GENET EVOL, V19, P15, DOI 10.1016/j.meegid.2013.05.011	66	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74503	10.1371/journal.pone.0074503	http://dx.doi.org/10.1371/journal.pone.0074503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086351	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200033
J	Costa, BS; Sachse, M; Jungandreas, A; Bartulos, CR; Gruber, A; Jakob, T; Kroth, PG; Wilhelm, C				Costa, Benjamin Schellenberger; Sachse, Matthias; Jungandreas, Anne; Bartulos, Carolina Rio; Gruber, Ansgar; Jakob, Torsten; Kroth, Peter G.; Wilhelm, Christian			Aureochrome 1a Is Involved in the Photoacclimation of the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							HIGH LIGHT ACCLIMATION; BLUE-LIGHT; XANTHOPHYLL CYCLE; RED-LIGHT; THALASSIOSIRA-PSEUDONANA; SECONDARY PLASTIDS; PROTEIN; PHYTOCHROME; PHOTOTROPIN; PHOTOPROTECTION	Aureochromes constitute a family of blue light (BL) receptors which are found exclusively in heterokont algae such as diatoms (Bacillariophyceae) and yellow-green algae (Xanthophyceae). Previous studies on the diatom Phaeodactylum tricornutum indicate that the formation of a high light acclimated phenotype is mediated by the absorption of BL and that aureochromes might play an important role in this process. P. tricornutum possesses four genes encoding aureochromes. In this study we confirm the nuclear localisation of the PtAUREO1a, 1b and 2 proteins. Furthermore we studied the physiology of light quality acclimation in genetically transformed P. tricornutum cell lines with reduced expression of the aureochrome 1a gene. The results demonstrate that the AUREO1a protein has a distinct function in light acclimation. However, rather unexpectedly AUREO1a seems to repress high light acclimation which resulted in a state of 'hyper' high light acclimation in aureo1a silenced strains. This was indicated by characteristic changes of several photosynthetic parameters, including increased maximum photosynthesis rates, decreased chlorophyll a contents per cell and increased values of non-photochemical quenching in AUREO1a silenced strains compared to wild type cultures. Strikingly, AUREO1a silenced strains exhibited phenotypic differences compared to wild type cells during cultivation under BL as well as under red light (RL) conditions. Therefore, AUREO1a might influence the RL signalling process, suggesting an interaction of AUREO1a with RL perception pathways.	[Costa, Benjamin Schellenberger; Jungandreas, Anne; Jakob, Torsten; Wilhelm, Christian] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Sachse, Matthias; Bartulos, Carolina Rio; Gruber, Ansgar; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, Constance, Germany	Leipzig University; University of Konstanz	Costa, BS (corresponding author), Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany.	b_schellenberger@web.de	Rio Bartulos, Carolina/AAX-8484-2021; Gruber, Ansgar/B-9587-2008; Kroth, Peter G/A-9728-2008; Rio Bartulos, Carolina/AAX-8411-2021	Rio Bartulos, Carolina/0000-0003-1203-127X; Gruber, Ansgar/0000-0002-5876-4391; Kroth, Peter G/0000-0003-4734-8955; Rio Bartulos, Carolina/0000-0003-1203-127X	Universitat Konstanz; Deutsche Forschungsgemeinschaft; research group FOR 1261 [KR 1661/8-1, WI 764/19]	Universitat Konstanz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); research group FOR 1261	Funding came from Universitat Konstanz (http://www.uni-konstanz.de), Deutsche Forschungsgemeinschaft (http://www.dfg.de) and research group FOR 1261, Projects KR 1661/8-1 (MS, PGK) and WI 764/19 (AJ, BSC, CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; Beer A, 2011, J PHYCOL, V47, P1266, DOI 10.1111/j.1529-8817.2011.01060.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brautigam K, 2010, PLANT SIGNAL BEHAV, V5, P81, DOI 10.4161/psb.5.1.10294; Brautigam K, 2009, PLANT CELL, V21, P2715, DOI 10.1105/tpc.108.062018; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Durnford DG, 1997, PHOTOSYNTH RES, V53, P229, DOI 10.1023/A:1005815725371; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Gallagher S, 2008, JOVE-J VIS EXP; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han IS, 2008, PLANT CELL, V20, P2835, DOI 10.1105/tpc.108.059915; Herman E, 2013, BIOCHEMISTRY-US, V52, P3094, DOI 10.1021/bi400197u; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jaedicke K, 2012, P NATL ACAD SCI USA, V109, P12231, DOI 10.1073/pnas.1120203109; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kami C, 2012, PLANT CELL, V24, P566, DOI 10.1105/tpc.111.095083; Kasahara M, 2004, PLANT PHYSIOL, V135, P1388, DOI 10.1104/pp.104.042705; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kroth Peter G., 2007, V390, P257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LOPEZFIGUEROA F, 1989, PHYSIOL PLANTARUM, V76, P391; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Stork S, 2012, EUKARYOT CELL, V11, P1472, DOI 10.1128/EC.00183-12; Sturm S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-159; Su WW, 2012, J PHYCOL, V48, P336, DOI 10.1111/j.1529-8817.2012.01128.x; Suetsugu N, 2013, PLANT CELL PHYSIOL, V54, P8, DOI 10.1093/pcp/pcs165; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tsuchida-Mayama T, 2010, PLANT J, V62, P653, DOI 10.1111/j.1365-313X.2010.04180.x; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Walters RG, 1999, PLANTA, V209, P517, DOI 10.1007/s004250050756; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	67	46	47	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74451	10.1371/journal.pone.0074451	http://dx.doi.org/10.1371/journal.pone.0074451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073211	gold, Green Published, Green Submitted			2022-12-25	WOS:000324768000020
J	Samelius, G; Andren, H; Kjellander, P; Liberg, O				Samelius, Gustaf; Andren, Henrik; Kjellander, Petter; Liberg, Olof			Habitat Selection and Risk of Predation: Re-colonization by Lynx had Limited Impact on Habitat Selection by Roe Deer	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; FUNCTIONAL-RESPONSES; CAPREOLUS-CAPREOLUS; EURASIAN LYNX; WOLVES; ELK; AVAILABILITY; DYNAMICS; SURVIVAL; BEHAVIOR	Risk of predation is an evolutionary force that affects behaviors of virtually all animals. In this study, we examined how habitat selection by roe deer was affected by risk of predation by Eurasian lynx - the main predator of roe deer in Scandinavia. Specifically, we compared how habitat selection by roe deer varied (1) before and after lynx re-established in the study area and (2) in relation to habitat-specific risk of predation by lynx. All analyses were conducted at the spatial and temporal scales of home ranges and seasons. We did not find any evidence that roe deer avoided habitats in which the risk of predation by lynx was greatest and information-theoretic model selection showed that re-colonization by lynx had limited impact on habitat selection by roe deer despite lynx predation causing 65% of known mortalities after lynx re-colonized the area. Instead we found that habitat selection decreased when habitat availability increased for 2 of 5 habitat types (a pattern referred to as functional response in habitat selection). Limited impact of re-colonization by lynx on habitat selection by roe deer in this study differs from elk in North America altering both daily and seasonal patterns in habitat selection at the spatial scales of habitat patches and home ranges when wolves were reintroduced to Yellowstone National Park. Our study thus provides further evidence of the complexity by which animals respond to risk of predation and suggest that it may vary between ecosystems and predator-prey constellations.	[Samelius, Gustaf; Andren, Henrik; Kjellander, Petter; Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Samelius, G (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Riddarhyttan, Sweden.	gustaf.samelius@slu.se	Andrén, Henrik/C-8995-2015	Kjellander, Petter/0000-0002-4272-6737; Andren, Henrik/0000-0002-5616-2426	Swedish Environmental Protection Agency; Swedish Hunting Association; Swedish University of Agricultural Sciences	Swedish Environmental Protection Agency; Swedish Hunting Association; Swedish University of Agricultural Sciences	This study was funded by the Swedish Environmental Protection Agency, the Swedish Hunting Association, and the Swedish University of Agricultural Sciences. Please note that the Swedish Hunting Association is not a profit making body, they are part of wildlife management in Sweden and are partly working on commission by the Swedish government. They also fund research which is part of where the funding for our study came from. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K. P., 1998, MODEL SELECTION INFE; CEDERLUND G, 1983, ACTA THERIOL, V28, P443, DOI 10.4098/AT.arch.83-39; Cederlund G, 1981, SWE WILDL RES, V11, P313; Cederlund G, 1979, 1136 SWED ENV PROT A; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Haglund B, 1966, SWEDISH WILDLIFE RES, V4, P81; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hewison AJM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P189; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Jarnemo A, 2005, J WILDLIFE MANAGE, V69, P1090, DOI 10.2193/0022-541X(2005)069[1090:RFRARD]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kjellander P, 2003, OIKOS, V101, P338, DOI 10.1034/j.1600-0706.2003.11986.x; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Liberg O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P221; Liberg O., 2006, LYNX POPULATION SWED; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Manly B.F.J., 2002, RESOURCE SELECTION A; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; MITCHELL B, 1985, J ZOOL, V207, P1; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Osko TJ, 2004, J WILDLIFE MANAGE, V68, P576, DOI 10.2193/0022-541X(2004)068[0576:MHPIRT]2.0.CO;2; Ratikainen II, 2007, J ZOOL, V273, P192, DOI 10.1111/j.1469-7998.2007.00314.x; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Sempere Antoine J., 1996, Mammalian Species, V538, P1; White G. C., 1990, ANAL WILDLIFE RADIO, P383, DOI 10.1016/B978-0-08-092657-5.50008-2	37	18	18	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75469	10.1371/journal.pone.0075469	http://dx.doi.org/10.1371/journal.pone.0075469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069419	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300080
J	Lin, Z; Su, YS; Zhang, CF; Xing, MJ; Ding, WH; Liao, LW; Guan, YT; Li, ZZ; Cui, DH				Lin, Zheng; Su, Yousong; Zhang, Chengfang; Xing, Mengjuan; Ding, Wenhua; Liao, Liwei; Guan, Yangtai; Li, Zezhi; Cui, Donghong			The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia	PLOS ONE			English	Article							NEUROTROPHIC FACTOR VAL66MET; HAN CHINESE POPULATION; PREFRONTAL CORTEX; BIPOLAR DISORDER; POLYMORPHISM; ASSOCIATION; METAANALYSIS; RECEPTOR; RISK; ONSET	The association between BDNF gene functional Val66Met polymorphism rs6265 and the schizophrenia is far from being consistent. In addition to the heterogeneous in schizophrenia per se leading to the inconsistent results, the interaction among multi-genes is probably playing the main role in the pathogenesis of schizophrenia, but not a single gene. Neurotrophic tyrosine kinase receptor 2 (NTRK2) is the high-affinity receptor of BDNF, and was reported to be associated with mood disorders, though no literature reported the association with schizophrenia. Thus, in the present study, total 402 patients with paranoid schizophrenia (the most common subtype of schizophrenia) and matched 406 healthy controls were recruited to investigate the role of rs6265 in BDNF, three polymorphisms in NTRK2 gene (rs1387923, rs2769605 and rs1565445) and their interaction in the susceptibility to paranoid schizophrenia in a Chinese Han population. We did not observe significant differences in allele and genotype frequencies between patients and healthy controls for all four polymorphisms separately. The haplotype analysis also showed no association between haplotype of NTRK2 genes (rs1387923, rs2769605, and rs1565445) and paranoid schizophrenia. However, we found the association between the interaction of BDNF and NTRK2 with paranoid schizophrenia by using the MDR method followed by conventional statistical analysis. The best gene-gene interaction model was a three-locus model (BDNF rs6265, NTRK2 rs1387923 and NTRK2 rs2769605), in which one low-risk and three high-risk four-locus genotype combinations were identified. Our findings implied that single polymorphism of rs6265 rs1387923, rs2769605, and rs1565445 in BDNF and NTRK2 were not associated with the development of paranoid schizophrenia in a Han population, however, the interaction of BDNF and NTRK2 genes polymorphisms (BDNF-rs6265, NTRK2-rs1387923 and NTRK2-rs2769605) may be involved in the susceptibility to paranoid schizophrenia.	[Lin, Zheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Yousong; Zhang, Chengfang; Xing, Mengjuan; Ding, Wenhua; Liao, Liwei; Cui, Donghong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Guan, Yangtai; Li, Zezhi] Secondary Mil Med Univ, Shanghai Changhai Hosp, Dept Neurol, Shanghai, Peoples R China; [Cui, Donghong] Shanghai Jiao Tong Univ, Sch Med, Bio X Inst, Shanghai 200030, Peoples R China	Zhejiang University; Shanghai Jiao Tong University; Naval Medical University; Shanghai Jiao Tong University	Li, ZZ (corresponding author), Secondary Mil Med Univ, Shanghai Changhai Hosp, Dept Neurol, Shanghai, Peoples R China.	lizezhi1981@aliyun.com; manyucc@126.com	Li, Zezhi/I-5524-2018; cui, donghong/AAV-2619-2020		National Natural Science Foundation of China [81171266, 81271481]; Natural Science Foundation of Shanghai [13ZR1460500]; Shanghai Pujiang Program [10PJ1408800]; Shanghai science and technology innovation program [11140900400]; Shanghai outstanding leaders plan of public health [GWDTR201230]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai science and technology innovation program; Shanghai outstanding leaders plan of public health	This study was supported by the National Natural Science Foundation of China (81171266, 81271481), the Natural Science Foundation of Shanghai (13ZR1460500), Shanghai Pujiang Program (10PJ1408800), Shanghai science and technology innovation program (11140900400), Shanghai outstanding leaders plan of public health (GWDTR201230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremer T, 2007, MOL DIAGN THER, V11, P161, DOI 10.1007/BF03256238; Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Dervieux T, 2012, PHARMACOGENET GENOM, V22, P1, DOI 10.1097/FPC.0b013e32834d3e0b; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Favalli G, 2012, J PSYCHIATR RES, V46, P1, DOI 10.1016/j.jpsychires.2011.09.022; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Issa G, 2010, NEUROBIOL DIS, V39, P327, DOI 10.1016/j.nbd.2010.04.017; Kanazawa T, 2007, PSYCHIAT GENET, V17, P165, DOI 10.1097/YPG.0b013e32801da2e2; Kawanishi Y, 1999, J HUM GENET, V44, P428, DOI 10.1007/s100380050196; Lee AH, 2011, J CLIN PSYCHOPHARM, V31, P334, DOI 10.1097/JCP.0b013e31821895c1; Li ZZ, 2013, J PSYCHIATR RES, V47, P8, DOI 10.1016/j.jpsychires.2012.10.003; Lu WH, 2012, J MOL NEUROSCI, V47, P505, DOI 10.1007/s12031-012-9750-4; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Muglia P, 2003, MOL PSYCHIATR, V8, P146, DOI 10.1038/sj.mp.4001221; Neves-Pereira M, 2005, MOL PSYCHIATR, V10, P208, DOI 10.1038/sj.mp.4001575; Pandya CD, 2013, ASIAN J PSYCHIATR, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Suchanek R, 2013, J NEUROPSYCH CLIN N, V25, P88, DOI 10.1176/appi.neuropsych.11100234; Sun MM, 2013, PSYCHIAT GENET; Sun RF, 2011, NEUROSCI LETT, V489, P34, DOI 10.1016/j.neulet.2010.11.061; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Wang Y, 2010, SCHIZOPHR RES, V120, P240, DOI 10.1016/j.schres.2010.03.020; Wang Z, 2012, GENES BRAIN BEHAV, V11, P524, DOI 10.1111/j.1601-183X.2012.00797.x; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Xu MQ, 2007, SCHIZOPHR RES, V91, P6, DOI 10.1016/j.schres.2006.12.008; Yi ZH, 2011, BRAIN RES, V1417, P146, DOI 10.1016/j.brainres.2011.08.037; Zhang C, 2011, J MOL NEUROSCI, V43, P406, DOI 10.1007/s12031-010-9458-2; Zhang XY, 2012, PSYCHOPHARMACOLOGY, V222, P277, DOI 10.1007/s00213-012-2643-y; Zhang XY, 2012, HUM GENET, V131, P1187, DOI 10.1007/s00439-012-1150-x	37	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74264	10.1371/journal.pone.0074264	http://dx.doi.org/10.1371/journal.pone.0074264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069289	Green Submitted, Green Published, gold			2022-12-25	WOS:000324547300033
J	Hou, JM; Lin, Y; Zhang, W; Song, LH; Wu, WJ; Wang, J; Zhou, DQ; Zou, QH; Fang, YF; He, M; Li, HT				Hou, Jingming; Lin, Yun; Zhang, Wei; Song, Lingheng; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Zou, Qinghua; Fang, Yongfei; He, Mei; Li, Haitao			Abnormalities of Frontal-Parietal Resting-State Functional Connectivity Are Related to Disease Activity in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							SERIAL ADDITION TEST; DEFAULT MODE; COGNITIVE DYSFUNCTION; BRAIN REORGANIZATION; MRI; FMRI; PREVALENCE; ACTIVATION; PATTERN; IMPAIRMENT	Cerebral involvement is common in patients with systemic Lupus erythematosus (SLE) and is characterized by multiple clinical presentations, including cognitive disorders, headaches, and syncope. Several neuroimaging studies have demonstrated cerebral dysfunction during different tasks among SLE patients; however, there have been few studies designed to characterize network alterations or to identify clinical markers capable of reflecting the cerebral involvement in SLE patients. This study was designed to characterize the profile of the cerebral activation area and the functional connectivity of cognitive function in SLE patients by using a task-based and a resting state functional magnetic resonance imaging (fMRI) technique, and to determine whether or not any clinical biomarkers could serve as an indicator of cerebral involvement in this disease. The well-established cognitive function test (Paced Visual Serial Adding Test [PVSAT]) was used. Thirty SLE patients without neuropsychiatric symptoms and 25 age- and gender-matched healthy controls were examined using PVSAT task-based and resting state fMRI. Outside the scanner, the performance of patients and the healthy controls was similar. In the PVSAT task-based fMRI, patients presented significantly expanded areas of activation, and the activated areas exhibited significantly higher functional connectivity strength in patients in the resting state. A positive correlation existed between individual connectivity strength and disease activity scoring. No correlation with cerebral involvement existed for serum markers, such as C3, C4, and anti-dsDNA. Thus, our findings may shed new light on the pathologic mechanism underlying neuropsychiatric SLE, and suggests that disease activity may be a potential effective biomarker reflecting cerebral involvement in SLE.	[Hou, Jingming; Lin, Yun; Zhang, Wei; Song, Lingheng; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Li, Haitao] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Zou, Qinghua; Fang, Yongfei] Third Mil Med Univ, Southwest Hosp, Dept Rheumatol, Chongqing, Peoples R China; [He, Mei] Third Mil Med Univ, Dept Clin Psychol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	He, M (corresponding author), Third Mil Med Univ, Dept Clin Psychol, Chongqing, Peoples R China.	sunnusunny0105@gmail.com; liihaitao@163.com		Hou, Jing-ming/0000-0002-8964-0359; Hou, Jingming/0000-0002-4991-7587	National Nature Science Foundation of China [81171283]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (grant no. 81171283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Appenzeller S, 2007, NEUROIMAGE, V34, P694, DOI 10.1016/j.neuroimage.2006.09.029; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Brunner HI, 2007, ARTHRIT RHEUM-ARTHR, V57, P1174, DOI 10.1002/art.23005; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Diamond B, 2003, ARTHRITIS RHEUM, V48, P2710, DOI 10.1002/art.11278; DiFrancesco MW, 2007, ARTHRITIS RHEUM-US, V56, P4151, DOI 10.1002/art.23132; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Emmer BJ, 2006, PLOS MED, V3, P2285, DOI 10.1371/journal.pmed.0030499; Fitzgibbon BM, 2008, RHEUMATOLOGY, V47, P50, DOI 10.1093/rheumatology/kem287; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; HAWKER G, 1993, J RHEUMATOL, V20, P657; Helekar SA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00219; Hiraki LT, 2008, J PEDIATR-US, V152, P550, DOI 10.1016/j.jpeds.2007.09.019; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Ikenouchi-Sugita A, 2010, WORLD J BIOL PSYCHIA, V11, P121, DOI 10.3109/15622970903521131; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009302; Kozora E, 2012, LUPUS, V21, P402, DOI 10.1177/0961203311429116; Kozora E, 2011, J INT NEUROPSYCH SOC, V17, P385, DOI 10.1017/S1355617711000191; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Leistritz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060956; Levy DM, 2009, NAT CLIN PRACT RHEUM, V5, P106, DOI 10.1038/ncprheum0988; Li BJ, 2013, BIOL PSYCHIAT, V74, P48, DOI 10.1016/j.biopsych.2012.11.007; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lin Y, 2011, HUM BRAIN MAPP, V32, P1847, DOI 10.1002/hbm.21158; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Luyendijk J, 2011, ARTHRITIS RHEUM-US, V63, P722, DOI 10.1002/art.30157; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Mak A, 2012, SEMIN ARTHRITIS RHEU, V41, P849, DOI 10.1016/j.semarthrit.2011.11.010; Monastero R, 2001, J NEUROL SCI, V184, P33, DOI 10.1016/S0022-510X(00)00492-5; Nagels G, 2005, CLIN NEUROL NEUROSUR, V107, P218, DOI 10.1016/j.clineuro.2004.11.016; Narayanan A, 2010, BRAIN IMAGING BEHAV, V4, P189, DOI 10.1007/s11682-010-9098-8; Olazaran J, 2009, EUR NEUROL, V62, P49, DOI 10.1159/000215879; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Podrazilova L, 2008, CLIN EXP RHEUMATOL, V26, P604; Prakash RS, 2008, NEUROPSYCHOLOGIA, V46, P2888, DOI 10.1016/j.neuropsychologia.2008.05.027; Rachbauer D, 2006, J NEUROL SCI, V244, P11, DOI 10.1016/j.jns.2005.11.035; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ren T, 2012, ARTHRITIS RHEUM-US, V64, P4048, DOI 10.1002/art.34660; Rish I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050625; Rocca MA, 2006, NEUROIMAGE, V30, P478, DOI 10.1016/j.neuroimage.2005.09.047; Rocca MA, 2007, J NEUROIMAGING, V17, p36S, DOI 10.1111/j.1552-6569.2007.00135.x; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Sibbitt WL, 2002, J RHEUMATOL, V29, P1536; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Xu J, 2010, J RHEUMATOL, V37, P974, DOI 10.3899/jrheum.090967; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yu Y, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-10; Zeng L., 2013, HUM BRAIN MAPP; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74530	10.1371/journal.pone.0074530	http://dx.doi.org/10.1371/journal.pone.0074530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069318	Green Submitted, Green Published, gold			2022-12-25	WOS:000326240100110
J	Li, LL; Howell, K; Sands, M; Banahan, M; Frohlich, S; Rowan, SC; Neary, R; Ryan, D; McLoughlin, P				Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; Ryan, Donal; McLoughlin, Paul			The alpha and Delta Isoforms of CREB1 Are Required to Maintain Normal Pulmonary Vascular Resistance	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MUSCLE-CELL-PROLIFERATION; TRANSCRIPTION FACTOR; GENETIC EMPHYSEMA; KEY ROLE; CAMP; ANGIOGENESIS; INHIBITION; EXPRESSION; LUNG	Chronic hypoxia causes pulmonary hypertension associated with structural alterations in pulmonary vessels and sustained vasoconstriction. The transcriptional mechanisms responsible for these distinctive changes are unclear. We have previously reported that CREB1 is activated in the lung in response to alveolar hypoxia but not in other organs. To directly investigate the role of alpha and Delta isoforms of CREB1 in the regulation of pulmonary vascular resistance we examined the responses of mice in which these isoforms of CREB1 had been inactivated by gene mutation, leaving only the beta isoform intact (CREB alpha Delta mice). Here we report that expression of CREB regulated genes was altered in the lungs of CREB alpha Delta mice. CREB alpha Delta mice had greater pulmonary vascular resistance than wild types, both basally in normoxia and following exposure to hypoxic conditions for three weeks. There was no difference in rho kinase mediated vasoconstriction between CREB alpha Delta and wild type mice. Stereological analysis of pulmonary vascular structure showed characteristic wall thickening and lumen reduction in hypoxic wild-type mice, with similar changes observed in CREB alpha Delta. CREB alpha Delta mice had larger lungs with reduced epithelial surface density suggesting increased pulmonary compliance. These findings show that alpha and Delta isoforms of CREB1 regulate homeostatic gene expression in the lung and that normal activity of these isoforms is essential to maintain low pulmonary vascular resistance in both normoxic and hypoxic conditions and to maintain the normal alveolar structure. Interventions that enhance the actions of alpha and Delta isoforms of CREB1 warrant further investigation in hypoxic lung diseases.	[Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; McLoughlin, Paul] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland; [Frohlich, Stephen; Ryan, Donal] St Vincents Univ Hosp, Dept Anaesthesia & Crit Care, Dublin 4, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital	McLoughlin, P (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland.	Paul.mcloughlin@ucd.ie	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	Health Research Board, Ireland; Science Foundation Ireland; St Vincent's Hospital Anaesthesia Foundation; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); St Vincent's Hospital Anaesthesia Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the Health Research Board, Ireland (www.hrb.ie), Science Foundation Ireland (www.sfi.ie) and St Vincent's Hospital Anaesthesia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; Bierer R, 2011, AM J PHYSIOL-LUNG C, V301, pL872, DOI 10.1152/ajplung.00405.2010; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Cadogan E, 1999, AM J PHYSIOL-LUNG C, V277, pL616, DOI 10.1152/ajplung.1999.277.3.L616; Cahill E, 2012, EXP PHYSIOL, V97, P796, DOI 10.1113/expphysiol.2012.065474; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Costa M, 2001, EUR J BIOCHEM, V268, P987, DOI 10.1046/j.1432-1327.2001.01957.x; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Dimova E, 2007, THROMB HAEMOSTASIS, V98, P296, DOI 10.1160/TH07-02-0140; Eberhardt W, 2002, KIDNEY INT, V62, P809, DOI 10.1046/j.1523-1755.2002.00538.x; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fediuk J, 2012, AM J PHYSIOL-LUNG C, V302, pL13, DOI 10.1152/ajplung.00016.2011; Fonseca C, 2011, AM J RESP CELL MOL, V44, P1, DOI 10.1165/rcmb.2009-0388TR; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Garat CV, 2010, J CARDIOVASC PHARM, V55, P469, DOI 10.1097/FJC.0b013e3181d64dbe; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Hai CM, 2005, J APPL PHYSIOL, V98, P1356, DOI 10.1152/japplphysiol.00834.2004; HAKIM TS, 1982, J APPL PHYSIOL, V53, P1110, DOI 10.1152/jappl.1982.53.5.1110; Hardy CL, 2013, THORAX, V68, P9, DOI 10.1136/thoraxjnl-2011-201128; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Howell K, 2009, AM J PHYSIOL-LUNG C, V296, pL1042, DOI 10.1152/ajplung.90327.2008; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Hyvelin JM, 2004, AM J PHYSIOL-LUNG C, V287, pL673, DOI 10.1152/ajplung.00331.2003; Illi B, 2000, CIRC RES, V86, pE110; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Klemm DJ, 2011, J CARDIOVASC PHARM, V58, P181, DOI 10.1097/FJC.0b013e31821f2773; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MARTORANA PA, 1990, AM REV RESPIR DIS, V142, P333, DOI 10.1164/ajrccm/142.2.333; MARTORANA PA, 1989, AM REV RESPIR DIS, V139, P226, DOI 10.1164/ajrccm/139.1.226; McLoughlin P, 2011, COMPR PHYSIOL, V1, P1473, DOI 10.1002/cphy.c100034; Meyuhas R, 2008, MOL CANCER RES, V6, P1397, DOI 10.1158/1541-7786.MCR-07-2086; MORI Y, 1993, J BIOL CHEM, V268, P26482; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nakayama K, 2013, J BIOL CHEM; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Tokunou T, 2003, CIRCULATION, V108, P1246, DOI 10.1161/01.CIR.0000085164.13439.89; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004	58	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80637	10.1371/journal.pone.0080637	http://dx.doi.org/10.1371/journal.pone.0080637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349008	gold, Green Published, Green Submitted			2022-12-25	WOS:000328705200009
J	Tagliati, F; Gagliano, T; Gentilin, E; Minoia, M; Mole, D; Uberti, ECD; Zatelli, MC				Tagliati, Federico; Gagliano, Teresa; Gentilin, Erica; Minoia, Mariella; Mole, Daniela; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara			Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; PROTEIN IMPORT MOTOR; IN-VITRO; PRESEQUENCE TRANSLOCASE; ANTERIOR-PITUITARY; THYROID-CARCINOMA; GROWTH; EXPRESSION; MITOCHONDRIA; RECEPTOR	Magmas is a nuclear gene that encodes for the mitochondrial import inner membrane translocase subunit Tim16. Magmas is overexpressed in the majority of human pituitary adenomas and in a mouse ACTH-secreting pituitary adenoma cell line. Here we report that Magmas is highly expressed in two out of four rat pituitary adenoma cell lines and its expression levels inversely correlate to the extent of cellular response to staurosporine in terms of apoptosis activation and cell viability. Magmas over-expression in rat GH/PRL-secreting pituitary adenoma GH4C1 cells leads to an increase in cell viability and to a reduction in staurosporine-induced apoptosis and DNA fragmentation, in parallel with the increase in Magmas protein expression. These results indicate that Magmas plays a pivotal role in response to pro-apoptotic stimuli and confirm and extend the finding that Magmas protects pituitary cells from staurosporine-induced apoptosis, suggesting its possible involvement in pituitary adenoma development.	[Tagliati, Federico; Gagliano, Teresa; Gentilin, Erica; Minoia, Mariella; Mole, Daniela; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara] Univ Ferrara, Endocrinol Sect, Dept Med Sci, I-44100 Ferrara, Italy; [Gentilin, Erica; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara] Univ Ferrara, Lab Rete Tecnopolo Tecnol Terapie Avanzate LTTA, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Zatelli, MC (corresponding author), Univ Ferrara, Endocrinol Sect, Dept Med Sci, I-44100 Ferrara, Italy.	ztlmch@unife.it	Gentilin, Erica/K-9044-2017; Zatelli, Maria Chiara/Y-1160-2019; Gagliano, Teresa/G-1645-2015; Zatelli, Maria Chiara/U-2649-2018	Gentilin, Erica/0000-0003-3198-6506; Gagliano, Teresa/0000-0002-4877-6292; degli Uberti, Ettore/0000-0002-9441-7223; Zatelli, Maria Chiara/0000-0001-8408-7796	Italian Ministry of Education, Research and University [FIRB RBAP11884M, RBAP1153LS]; Fondazione Cassa di Risparmio di Ferrara; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Italian Ministry of Education, Research and University(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Education, Research and University (FIRB RBAP11884M and RBAP1153LS); Fondazione Cassa di Risparmio di Ferrara; and from Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom E, 1998, ENDOCRINOLOGY, V139, P2465, DOI 10.1210/en.139.5.2465; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bondanelli M, 2003, NEUROENDOCRINOLOGY, V77, P380, DOI 10.1159/000071310; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Fusco A, 2008, J CLIN ENDOCR METAB, V93, P2746, DOI 10.1210/jc.2008-0126; Gentilin E, 2013, J ENDOCRINO IN PRESS; Gentilin E, 2013, ENDOCRINOLOGY, V154, P1690, DOI 10.1210/en.2012-2070; GOEBEL HH, 1980, ACTA NEUROCHIR, V51, P195, DOI 10.1007/BF01406745; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Jubinsky PT, 2005, J MOL HISTOL, V36, P69, DOI 10.1007/s10735-004-3840-8; Jubinsky PT, 2003, J HISTOCHEM CYTOCHEM, V51, P585, DOI 10.1177/002215540305100504; Jubinsky PT, 2001, EXP HEMATOL, V29, P1392, DOI 10.1016/S0301-472X(01)00749-4; Lee M, 2011, MOL CANCER THER, V10, P1450, DOI 10.1158/1535-7163.MCT-11-0188; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Minoia M, 2012, J CLIN ENDOCR METAB, V97, pE907, DOI 10.1210/jc.2011-3340; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Molatore S, 2010, HUM MUTAT, V31, pE1825, DOI 10.1002/humu.21354; Nicolier M, 2009, BIOL CELL, V101, P455, DOI 10.1042/BC20080164; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Peng Jianbin, 2005, In Silico Biology, V5, P251; Roy S, 2012, FASEB J, V26, P3822, DOI 10.1096/fj.11-193540; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Short MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039428; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Tafani M, 2011, CANCER RES, V61, P2459; Tagliati F, 2006, ENDOCRINOLOGY, V147, P3530, DOI 10.1210/en.2005-1479; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Yang QH, 2007, J PINEAL RES, V42, P172, DOI 10.1111/j.1600-079X.2006.00403.x; Zatelli C, 2005, J MOL ENDOCRINOL, V35, P333, DOI 10.1677/jme.1.01876; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P1029, DOI 10.1677/ERC-07-0114; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P91, DOI 10.1677/ERC-06-0026; Zatelli MC, 2009, EUR J ENDOCRINOL, V161, P467, DOI 10.1530/EJE-09-0353; Zatelli MC, 2009, J CLIN ENDOCR METAB, V94, P3931, DOI 10.1210/jc.2009-1026; Zatelli MC, 2005, J CLIN ENDOCR METAB, V90, P2104, DOI 10.1210/jc.2004-2156; Zhan XQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-13	42	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75194	10.1371/journal.pone.0075194	http://dx.doi.org/10.1371/journal.pone.0075194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069394	Green Published, gold, Green Submitted			2022-12-25	WOS:000324547300074
J	Song, Y; Garg, S; Girotra, M; Maddox, C; von Rosenvinge, EC; Dutta, A; Dutta, S; Fricke, WF				Song, Yang; Garg, Shashank; Girotra, Mohit; Maddox, Cynthia; von Rosenvinge, Erik C.; Dutta, Anand; Dutta, Sudhir; Fricke, W. Florian			Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; SEQUENCE-ANALYSIS; DISEASE; THERAPY; VANCOMYCIN; COLITIS; DIARRHEA; COMBINATION; SENSITIVITY	Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refractory to antibiotic therapy. It has recently been discussed favorably in the clinical and scientific communities and is receiving increasing public attention. However, short-and long-term health consequences of FMT remain a concern, as the effects of the transplanted microbiota on the patient remain unknown. To shed light on microbial events associated with RCDI and treatment by FMT, we performed fecal microbiota analysis by 16S rRNA gene amplicon pyrosequencing of 14 pairs of healthy donors and RCDI patients treated successfully by FMT. Post-FMT patient and healthy donor samples collected up to one year after FMT were studied longitudinally, including one post-FMT patient with antibiotic-associated relapse three months after FMT. This analysis allowed us not only to confirm prior reports that RCDI is associated with reduced diversity and compositional changes in the fecal microbiota, but also to characterize previously undocumented post-FMT microbiota dynamics. Members of the Streptococcaceae, Enterococcaceae, or Enterobacteriaceae were significantly increased and putative butyrate producers, such as Lachnospiraceae and Ruminococcaceae were significantly reduced in samples from RCDI patients before FMT as compared to post-FMT patient and healthy donor samples. RCDI patient samples showed more case-specific variations than post-FMT patient and healthy donor samples. However, none of the bacterial groups were invariably associated with RCDI or successful treatment by FMT. Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after FMT.	[Song, Yang; Maddox, Cynthia; Fricke, W. Florian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Garg, Shashank; Girotra, Mohit; Dutta, Anand; Dutta, Sudhir] Sinai Hosp, Div Gastroenterol, Baltimore, MD 21215 USA; [von Rosenvinge, Erik C.] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA; [Dutta, Sudhir] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Sinai Hospital of Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fricke, WF (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	wffricke@som.umaryland.edu	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	This study or parts thereof were funded by the Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD and Gastroenterology Research Funds from the Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2013, GRID EN STOR; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Berman AL, 2007, J CLIN GASTROENTEROL, V41, P932, DOI 10.1097/01.mcg.0000225685.37465.e7; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; BUGGY BP, 1987, J CLIN GASTROENTEROL, V9, P155, DOI 10.1097/00004836-198704000-00009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daneman N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001268; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dutta SK, 2013, GASTROENTEROLO UNPUB; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Garey KW, 2009, J CLIN GASTROENTEROL, V43, P91, DOI 10.1097/MCG.0b013e31814a4e97; Gorkiewicz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055817; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; James White WFF, 2011, NATURE PRECEDINGS; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Johnson S, 2007, CLIN INFECT DIS, V44, P846, DOI 10.1086/511870; Johnson S, 2009, ANAEROBE, V15, P290, DOI 10.1016/j.anaerobe.2009.08.004; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; KORUDA MJ, 1990, AM J CLIN NUTR, V51, P685, DOI 10.1093/ajcn/51.4.685; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Lawley B, 2012, GASTROENTEROL CLIN N, V41, P855, DOI 10.1016/j.gtc.2012.08.010; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Musa S, 2010, SCAND J GASTROENTERO, V45, P261, DOI 10.3109/00365520903497098; Musher DM, 2007, J ANTIMICROB CHEMOTH, V59, P705, DOI 10.1093/jac/dkl553; Navaneethan U, 2010, WORLD J GASTROENTERO, V16, P4892, DOI 10.3748/wjg.v16.i39.4892; O'Keefe SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/wjg.v16.i2.139; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pohl JF, 2012, CURR OPIN PEDIATR, V24, P627, DOI 10.1097/MOP.0b013e328355a3e1; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Skraban J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058005; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Vrieze A, 2013, BEST PRACT RES CL GA, V27, P127, DOI 10.1016/j.bpg.2013.03.003; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wettstein A, 2007, 15 GUT UN EUR GAS S1, V39, pA303; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	70	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81330	10.1371/journal.pone.0081330	http://dx.doi.org/10.1371/journal.pone.0081330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303043	Green Submitted, Green Published, gold			2022-12-25	WOS:000327546400060
J	Li, L; Wang, CM; Calvisi, DF; Evert, M; Pilo, MG; Jiang, LJ; Yuneva, M; Chen, X				Li, Lei; Wang, Chunmei; Calvisi, Diego F.; Evert, Matthias; Pilo, Maria G.; Jiang, Lijie; Yuneva, Mariia; Chen, Xin			SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHASE; HEPATOCELLULAR-CARCINOMA; COMPLEX 1; CANCER; LIVER; ACTIVATION; HYPERTRIGLYCERIDEMIA; CARCINOGENESIS; INTEGRATION	Increased de novo lipogenesis is one of the major metabolic events in cancer. In human hepatocellular carcinoma (HCC), de novo lipogenesis has been found to be increased and associated with the activation of AKT/mTOR signaling. In mice, overexpression of an activated form of AKT results in increased lipogenesis and hepatic steatosis, ultimately leading to liver tumor development. Hepatocarcinogenesis is dramatically accelerated when AKT is co-expressed with an oncogenic form of N-Ras. SCD1, the major isoform of stearoyl-CoA desaturases, catalyzing the conversion of saturated fatty acids (SFA) into monounsaturated fatty acids (MUFA), is a key enzyme involved in de novo lipogenesis. While many studies demonstrated the requirement of SCD1 for tumor cell growth in vitro, whether SCD1 is necessary for tumor development in vivo has not been previously investigated. Here, we show that genetic ablation of SCD1 neither inhibits lipogenesis and hepatic steatosis in AKT-overexpressing mice nor affects liver tumor development in mice co-expressing AKT and Ras oncogenes. Molecular analysis showed that SCD2 was strongly upregulated in liver tumors from AKT/Ras injected SCD1(-/-) mice. Noticeably, concomitant silencing of SCD1 and SCD2 genes was highly detrimental for the growth of AKT/Ras cells in vitro. Altogether, our study provides the evidence, for the first time, that SCD1 expression is dispensable for AKT/mTOR-dependent hepatic steatosis and AKT/Ras-induced hepatocarcinogenesis in mice. Complete inhibition of stearoyl-CoA desaturase activity may be required to efficiently suppress liver tumor development.	[Li, Lei; Wang, Chunmei; Jiang, Lijie; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Li, Lei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Calvisi, Diego F.; Pilo, Maria G.] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Evert, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany; [Yuneva, Mariia] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Huazhong University of Science & Technology; University of Sassari; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	xin.chen@ucsf.edu	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	NIH [R01CA136606, R03CA165122]; AIRC [IG12139]; National Natural Science Foundation of China [81201553]; Deutsche Forschungsgemeinschaft [EV 168/2-1]; Government of China through China Scholarship Council (CSC) [2010616508]; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Government of China through China Scholarship Council (CSC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from NIH R01CA136606, R03CA165122 (to X. C.), AIRC (IG12139 to D. F. C.), National Natural Science Foundation of China (Grant No. 81201553 to Lei Li) and the Deutsche Forschungsgemeinschaft (EV 168/2-1 to M. E.). Lei Li is also supported by the Government of China through China Scholarship Council (CSC) Contract No. 2010616508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; MORRISON WR, 1964, J LIPID RES, V5, P600; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Spangenberg HC, 2009, NAT REV GASTRO HEPAT, V6, P423, DOI 10.1038/nrgastro.2009.86; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026	34	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75104	10.1371/journal.pone.0075104	http://dx.doi.org/10.1371/journal.pone.0075104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24349008	Green Published, Green Submitted, gold			2022-12-25	WOS:000324777300066
J	Xu, XJ; Shou, XJ; Li, J; Jia, MX; Zhang, JS; Guo, Y; Wei, QY; Zhang, XT; Han, SP; Zhang, R; Han, JS				Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Jia, Mei-Xiang; Zhang, Ji-Shui; Guo, Yan; Wei, Qing-Yun; Zhang, Xiu-Ting; Han, Song-Ping; Zhang, Rong; Han, Ji-Sheng			Mothers of Autistic Children: Lower Plasma Levels of Oxytocin and Arg-Vasopressin and a Higher Level of Testosterone	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; SPECTRUM; GENES; BRAIN; DISORDERS; PHENOTYPE; PARENTS; BROADER; WOMEN	Background: Autism is a pervasive neurodevelopmental disorder, thought to be caused by a combination of genetic heritability and environmental risk factors. Some autistic-like traits have been reported in mothers of autistic children. We hypothesized that dysregulation of oxytocin (OXT), Arg-vasopressin (AVP) and sex hormones, found in autistic children, may also exist in their mothers. Methods: We determined plasma levels of OXT (40 in autism vs. 26 in control group), AVP (40 vs. 17) and sex hormones (61 vs. 47) in mothers of autistic and normal children by enzyme immunoassay and radioimmunoassay, respectively and investigated their relationships with the children's autistic behavior scores (Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC)). Results: Significantly lower plasma concentrations of OXT (p<0.001) and AVP (p<0.001), as well as a higher level of plasma testosterone (p<0.05), were found in mothers of autistic children vs. those of control. The children's autistic behavior scores were negatively associated with maternal plasma levels of OXT and AVP. Conclusions: These results suggest that dysregulation of OXT, AVP and/or testosterone systems exist in mothers of autistic children, which may impact children's susceptibility to autism.	[Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Minist Educ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China; [Jia, Mei-Xiang] Peking Univ, Mental Hlth Inst, Beijing 100871, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Ctr Rehabil, Beijing, Peoples R China; [Guo, Yan] Beijing Univ Chinese Med, Dept Ophthalmol, Affiliated Hosp 3, Beijing, Peoples R China; [Wei, Qing-Yun] Beijing Yangguang Youyi Rehabil Ctr, Beijing, Peoples R China; [Zhang, Xiu-Ting] Beijing Tongkang Rehabil Ctr, Beijing, Peoples R China; [Han, Song-Ping] HANS Int Inc, Belle Mead, NJ USA	Peking University; Peking University; Peking University; Peking University; Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine	Zhang, R (corresponding author), Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China.	zhangrong@bjmu.edu.cn; hanjisheng@bjmu.edu.cn	XU, XINJIE/GQH-5210-2022; Jia, Mei/GXZ-9967-2022; Zhang, Rong/O-5078-2017; Wang, Minggui/AAR-8281-2020	Zhang, Rong/0000-0002-6889-5571; Wang, Minggui/0000-0001-7682-5859	National Natural Science Foundation of China [81271507]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University)	This project was supported by grants from the National Natural Science Foundation of China (81271507, http://www.nsfc.gov.cn/) to JSH. The study was also supported by Peking University Special Project for promoting joint research between basic and clinical sciences (http://www.pku.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Green JJ, 2010, NEUROTHERAPEUTICS, V7, P250, DOI 10.1016/j.nurt.2010.05.006; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Keefe DL, 2002, ARCH SEX BEHAV, V31, P401, DOI 10.1023/A:1019883923346; Kose S, 2013, PSYCHIAT CLIN NEUROS, V67, P20, DOI 10.1111/pcn.12005; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lukas M, 2012, BEHAV BRAIN RES; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Mohammadi Mohammad Reza, 2012, Iran J Psychiatry, V7, P157; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Ufer F, 2013, CLIN ENDOCRINOL, V78, P431, DOI 10.1111/cen.12006; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Xu XJ, 2012, NEUROCHEM RES, V37, P2270; Zhang R, 2012, RES DEV DISABIL, V33, P1136, DOI 10.1016/j.ridd.2012.02.001	37	50	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74849	10.1371/journal.pone.0074849	http://dx.doi.org/10.1371/journal.pone.0074849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086383	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700043
J	Gridley, DS; Mao, XW; Stodieck, LS; Ferguson, VL; Bateman, TA; Moldovan, M; Cunningham, CE; Jones, TA; Slater, JM; Pecaut, MJ				Gridley, Daila S.; Mao, Xiao Wen; Stodieck, Louis S.; Ferguson, Virginia L.; Bateman, Ted A.; Moldovan, Maria; Cunningham, Christopher E.; Jones, Tamako A.; Slater, Jerry M.; Pecaut, Michael J.			Changes in Mouse Thymus and Spleen after Return from the STS-135 Mission in Space	PLOS ONE			English	Article							PARTICLE EVENT PROTONS; PERIPHERAL-BLOOD LEUKOCYTES; ACTIVATOR INHIBITOR TYPE-2; T-CELL-ACTIVATION; DOSE GAMMA-RAYS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; MICROGLIAL RESPONSE; CYTOKINE EXPRESSION; APPLIED PHYSIOLOGY	Our previous results with flight (FLT) mice showed abnormalities in thymuses and spleens that have potential to compromise immune defense mechanisms. In this study, the organs were further evaluated in C57BL/6 mice after Space Shuttle Atlantis returned from a 13-day mission. Thymuses and spleens were harvested from FLT mice and ground controls housed in similar animal enclosure modules (AEM). Organ and body mass, DNA fragmentation and expression of genes related to T cells and cancer were determined. Although significance was not obtained for thymus mass, DNA fragmentation was greater in the FLT group (P<0.01). Spleen mass alone and relative to body mass was significantly decreased in FLT mice (P<0.05). In FLT thymuses, 6/84 T cell-related genes were affected versus the AEM control group (P<0.05; up: IL10, Il18bp, Il18r1, Spp1; down: Ccl7, IL6); 15/84 cancer-related genes had altered expression (P<0.05; up: Casp8, FGFR2, Figf, Hgf, IGF1, Itga4, Ncam1, Pdgfa, Pik3r1, Serpinb2, Sykb; down: Cdc25a, E2F1, Mmp9, Myc). In the spleen, 8/84 cancer-related genes were affected in FLT mice compared to AEM controls (P<0.05; up: Cdkn2a; down: Birc5, Casp8, Ctnnb1, Map2k1, Mdm2, NFkB1, Pdgfa). Pathway analysis (apoptosis signaling and checkpoint regulation) was used to map relationships among the cancer-related genes. The results showed that a relatively short mission in space had a significant impact on both organs. The findings also indicate that immune system aberrations due to stressors associated with space travel should be included when estimating risk for pathologies such as cancer and infection and in designing appropriate countermeasures. Although this was the historic last flight of NASA's Space Shuttle Program, exploration of space will undoubtedly continue.	[Gridley, Daila S.; Mao, Xiao Wen; Moldovan, Maria; Cunningham, Christopher E.; Jones, Tamako A.; Slater, Jerry M.; Pecaut, Michael J.] Loma Linda Univ, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA; [Stodieck, Louis S.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Ferguson, Virginia L.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Bateman, Ted A.] Univ N Carolina, Dept Bioengn, Chapel Hill, NC USA	Loma Linda University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill	Gridley, DS (corresponding author), Loma Linda Univ, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA.	dgridley@llu.edu	Gridley, Daila S/P-7711-2015; Ferguson, Virginia/K-6962-2012; Pecaut, Michael J/P-6481-2015	Ferguson, Virginia/0000-0002-8448-4406; Pecaut, Michael J/0000-0002-2915-9686	NASA [NNX09AQ76G]; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059221] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by NASA grant NNX09AQ76G and the LLUMC Department of Radiation Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Allen BJ, 2003, BRIT J CANCER, V88, P944, DOI 10.1038/sj.bjc.6600838; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bejarano-Escobar R, 2012, J EXP BIOL, V215, P3799, DOI 10.1242/jeb.072124; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; CHAPES SK, 1992, J LEUKOCYTE BIOL, V52, P104, DOI 10.1002/jlb.52.1.104; Chapes SK, 2004, J GRAVIT PHYSL, V11, P45; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Cowley MJ, 2009, MAMM GENOME, V20, P281, DOI 10.1007/s00335-009-9181-x; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fedorenko B S, 2010, Aviakosm Ekolog Med, V44, P9; Garcia-Suarez O, 2002, J NEUROIMMUNOL, V129, P25, DOI 10.1016/S0165-5728(02)00166-2; George K, 2010, MUTAT RES-GEN TOX EN, V701, P75, DOI 10.1016/j.mrgentox.2010.02.007; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Gridley DS, 2013, INT J RADIAT BIOL, V89, P26, DOI 10.3109/09553002.2012.715792; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; Gridley DS, 2012, J PROTEOM BIOINFORM, V5, P256; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guo FJ, 2012, MOL BIOL REP, V39, P6923, DOI 10.1007/s11033-012-1519-x; Hatton JP, 1999, FASEB J, V13, pS23, DOI 10.1096/fasebj.13.9001.s23; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Kajioka EH, 2000, COMPARATIVE MED, V50, P288; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kominami R, 2006, CANCER SCI, V97, P575, DOI 10.1111/j.1349-7006.2006.00218.x; Lebsack TW, 2010, J CELL BIOCHEM, V110, P372, DOI 10.1002/jcb.22547; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mao XW, 2012, RADIAT RES, V178, P118, DOI 10.1667/RR2821.1; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; MILLER ES, 1995, J APPL PHYSIOL, V78, P810, DOI 10.1152/jappl.1995.78.3.810; Misurova E, 1981, Adv Space Res, V1, P225, DOI 10.1016/0273-1177(81)90265-9; Moeller R, 2012, ASTROBIOLOGY, V12, P457, DOI 10.1089/ast.2011.0739; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Onishi Y, 2004, INT J HEMATOL, V80, P43, DOI 10.1532/IJH97.04061; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Porter BO, 2000, SEMIN IMMUNOL, V12, P465, DOI 10.1006/smim.2000.0264; Qiu XF, 2010, ONCOL LETT, V1, P579, DOI 10.3892/ol_00000102; Rizvi A, 2011, J RADIAT RES, V52, P701, DOI 10.1269/jrr.10107; Rizvi A, 2011, INT J RADIAT BIOL, V87, P24, DOI 10.3109/09553002.2010.518206; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Schieke SM, 2012, J CUTAN PATHOL, V39, P540, DOI 10.1111/j.1600-0560.2012.01874.x; Sekai M, 2013, MOL IMMUNOL, V54, P378, DOI 10.1016/j.molimm.2013.01.002; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; SONNENFELD G, 1993, J LEUKOCYTE BIOL, V54, P253, DOI 10.1002/jlb.54.3.253; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Stacchini A, 2012, HISTOPATHOLOGY, V60, P452, DOI 10.1111/j.1365-2559.2011.04098.x; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stowe RP, 2011, J MED VIROL, V83, P1071, DOI 10.1002/jmv.22079; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Sun XQ, 2009, BEHAV BRAIN RES, V199, P197, DOI 10.1016/j.bbr.2008.11.035; Surova O, 2012, ONCOGENE; Terada T, 2012, WORLD J GASTROENTERO, V18, P1545, DOI 10.3748/wjg.v18.i13.1545; Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009; Tian J, 2009, RADIAT RES, V172, P30, DOI 10.1667/RR1670.1; Uva BM, 2005, J ENDOCRINOL INVES S, V11, P84; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	81	53	58	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75097	10.1371/journal.pone.0075097	http://dx.doi.org/10.1371/journal.pone.0075097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24116253	Green Published, gold, Green Submitted			2022-12-25	WOS:000324777300065
J	Shin, H; Song, H; Suh, CS; Lim, HJ				Shin, Hyejin; Song, Haengseok; Suh, Chang Suk; Lim, Hyunjung Jade			The Formin Protein mDia2 Serves as a Marker of Spindle Pole Dynamics in Vitrified-Warmed Mouse Oocytes	PLOS ONE			English	Article							POLARIZED-LIGHT MICROSCOPY; LIVING HUMAN OOCYTES; MEIOTIC SPINDLE; DEVELOPMENTAL COMPETENCE; THAWED OOCYTES; GAMMA-TUBULIN; CRYOPRESERVATION; VITRIFICATION; MICROTUBULES; ORGANIZATION	The mouse diaphanous 2 (mDia2) protein belongs to the formin family and has been shown to nucleate actin filaments and stabilize microtubules, thus indicating a role in cytoskeleton organization. Our previous study, which showed that mDia2 specifically localizes to spindle poles of metaphase I mouse oocytes and NIH3T3 cells, provided the first evidence of its spindle pole-associated cellular function. In the present study, we aim to determine whether spindle pole proteins, such as mDia2 and pericentrin, can be used to monitor the status of spindle poles in cryopreserved mouse oocytes. We show herein that mDia2 exhibits an overlapping distribution with pericentrin, which is a crucial component of centrosomes and microtubule organizing centers (MTOCs). In vitrified-warmed oocytes, the overlapping distribution of mDia2 and pericentrin was immediately detected after thawing, thereby suggesting that mDia2 maintains a tight association with the spindle pole machinery. Interestingly, we observed that microtubules extend from mDia2 clusters in cytoplasmic MTOCs after thawing. This result suggests that mDia2 is a major MTOC component that is closely associated with pericentrin and that it plays a role in microtubule growth from MTOCs. Collectively, our results provide evidence that mDia2 is a novel marker of spindle pole dynamics before and after cryopreservation.	[Shin, Hyejin; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Song, Haengseok] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Songnam, South Korea	Konkuk University; Pochon Cha University; Seoul National University (SNU)	Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.	hlim@konkuk.ac.kr	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055) (https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bromfield JJ, 2009, HUM REPROD, V24, P2114, DOI 10.1093/humrep/dep182; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Chen CK, 2004, FERTIL STERIL, V82, P666, DOI 10.1016/j.fertnstert.2003.12.053; Ciotti PM, 2009, FERTIL STERIL, V91, P2399, DOI 10.1016/j.fertnstert.2008.03.013; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; DIDION BA, 1990, J ANIM SCI, V68, P2803; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; George MA, 1996, MOL HUM REPROD, V2, P445, DOI 10.1093/molehr/2.6.445; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Kwon Sojung, 2011, Clin Exp Reprod Med, V38, P1, DOI 10.5653/cerm.2011.38.1.1; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; LANZENDORF SE, 1990, BIOL REPROD, V42, P703, DOI 10.1095/biolreprod42.4.703; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; MANDELBAUM J, 1988, HUM REPROD, V3, P117, DOI 10.1093/oxfordjournals.humrep.a136642; Moon JH, 2005, HUM REPROD, V20, P2207, DOI 10.1093/humrep/dei044; Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165; Otoi T, 1997, CRYOBIOLOGY, V34, P36, DOI 10.1006/cryo.1996.1988; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Sereni E, 2009, REPROD BIOMED ONLINE, V19, P191, DOI 10.1016/S1472-6483(10)60071-5; Wang WH, 2001, HUM REPROD, V16, P2374, DOI 10.1093/humrep/16.11.2374; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	39	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75729	10.1371/journal.pone.0075729	http://dx.doi.org/10.1371/journal.pone.0075729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24303043	Green Submitted, Green Published, gold			2022-12-25	WOS:000324777300094
J	Martin, RM; Patel, R; Oken, E; Thompson, J; Zinovik, A; Kramer, MS; Vilchuck, K; Bogdanovich, N; Sergeichick, N; Foo, Y; Gusina, N				Martin, Richard M.; Patel, Rita; Oken, Emily; Thompson, Jennifer; Zinovik, Alexander; Kramer, Michael S.; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Foo, Ying; Gusina, Nina			Filter Paper Blood Spot Enzyme Linked Immunoassay for Adiponectin and Application in the Evaluation of Determinants of Child Insulin Sensitivity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA ADIPONECTIN; MYOCARDIAL-INFARCTION; RESISTANCE; OBESITY; SAMPLES; FAT; SEX; OVERWEIGHT; ADIPOSITY	Background: Adiponectin is an adipocyte-derived hormone that acts as a marker of insulin sensitivity. Bloodspot sampling by fingerstick onto filter paper may increase the feasibility of large-scale studies of the determinants of insulin sensitivity. We first describe the validation of an enzyme-linked immunoassay (ELISA) for quantifying adiponectin from dried blood spots and then demonstrate its application in a large trial (PROBIT). Methods: We quantified adiponectin from 3-mm diameter discs (approximate to 3 mu L of blood) punched from dried blood spots obtained from: i) whole blood standards (validation); and ii) PROBIT trial samples (application) in which paediatricians collected blood spots from 13,879 children aged 11.5 years from 31 sites across Belarus. We examined the distribution of bloodspot adiponectin by demographic and anthropometric factors, fasting insulin and glucose. Results: In the validation study, mean intra-assay coefficients of variation (n = 162) were 15%, 13% and 10% for 'low' (6.78 mg/ml), 'medium' (18.18 mg/ml) and 'high' (33.13 mg/ml) internal quality control (IQC) samples, respectively; the respective inter-assay values (n = 40) were 23%, 21% and 14%. The correlation coefficient between 50 paired whole bloodspot versus plasma samples, collected simultaneously, was 0.87 (95% CI: 0.78 to 0.93). Recovery of known quantities of adiponectin (between 4.5 to 36 mu g/ml) was 100.3-133%. Bloodspot adiponectin was stable for at least 30 months at -80 degrees C. In PROBIT, we successfully quantified fasting adiponectin from dried blood spots in 13,329 of 13,879 (96%) children. Mean adiponectin (standard deviation) concentrations were 17.34 mu g/ml (7.54) in boys and 18.41 mu g/ml (7.92) in girls and were inversely associated with body mass index, fat mass, triceps and subscapular skin-fold thickness, waist circumference, height and fasting glucose. Conclusions: Bloodspot ELISA is suitable for measuring adiponectin in very small volumes of blood collected on filter paper and can be applied to large-scale studies.	[Martin, Richard M.; Patel, Rita; Foo, Ying] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Bristol, Nutr Biomed Res Unit, Bristol, Avon, England; [Oken, Emily; Thompson, Jennifer] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily; Thompson, Jennifer] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Zinovik, Alexander; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	University of Bristol; University of Bristol; University of Bristol; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; McGill University; McGill University	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	richard.martin@bristol.ac.uk		Poynter, Matthew/0000-0002-7578-4570; Lundblad, Lennart/0000-0002-1749-8242; Ather, Jennifer/0000-0003-0484-5599; Hoyt, Laura/0000-0002-0350-4154	European Union [FOOD-DT-2005-007036]; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research [MOP - 53155]; USA National Institutes of Health [R01 HD 050758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050758] Funding Source: NIH RePORTER	European Union(European Commission); Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by European Union, grant no. FOOD-DT-2005-007036; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research (MOP - 53155); and the USA National Institutes of Health (reference: R01 HD 050758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Barker DJP, 1998, MOTHERS BABIES HLTH; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cruz M, 2004, DIABETES CARE, V27, P1451, DOI 10.2337/diacare.27.6.1451; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Klamer A, 2007, EUR J ENDOCRINOL, V157, P189, DOI 10.1530/EJE-06-0710; Kuh D, 1997, LIFE COURSE APPROACH; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lynch JF, 1998, MED J AUSTRALIA, V168, P61, DOI 10.5694/j.1326-5377.1998.tb126712.x; Martin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046752; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; McDowell MA, 2010, ANTHROPOMETRIC REFER; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; National Committee for Clinical Laboratory Standards (NCCLS), 1997, A4A3 NCCLS; Okada T, 2006, ATHEROSCLEROSIS, V188, P179, DOI 10.1016/j.atherosclerosis.2005.10.030; Ong KK, 2006, DIABETES, V55, P1337, DOI 10.2337/db05-1272; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Punthakee Z, 2006, J CLIN ENDOCR METAB, V91, P2119, DOI 10.1210/jc.2005-2346; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Shand BI, 2003, DIABETES OBES METAB, V5, P349, DOI 10.1046/j.1463-1326.2003.00279.x; Singhal A, 2005, J CLIN ENDOCR METAB, V90, P4615, DOI 10.1210/jc.2005-0131; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; WARNICK GR, 1994, ARCH PATHOL LAB MED, V118, P1110; Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williams SR, 2009, J GERONTOL B; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	45	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71315	10.1371/journal.pone.0071315	http://dx.doi.org/10.1371/journal.pone.0071315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936498	Green Published, Green Submitted, gold			2022-12-25	WOS:000324518400101
J	McGarry, LJ; Krishnarajah, G; Hill, G; Skornicki, M; Pruttivarasin, N; Masseria, C; Arondekar, B; Pelton, SI; Weinstein, MC				McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Masseria, Cristina; Arondekar, Bhakti; Pelton, Stephen I.; Weinstein, Milton C.			Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; VACCINE; POPULATION; AGE; US	Objectives: Health benefits and costs of combined reduced-antigen-content tetanus, diphtheria, and pertussis (Tdap) immunization among adults >= 65 years have not been evaluated. In February 2012, the Advisory Committee on Immunization Practices (ACIP) recommended expanding Tdap vaccination (one single dose) to include adults >= 65 years not previously vaccinated with Tdap. Our study estimated the health and economic outcomes of one-time replacement of the decennial tetanus and diphtheria (Td) booster with Tdap in the 10% of individuals aged 65 years assumed eligible each year compared with a baseline scenario of continued Td vaccination. Methods: We constructed a model evaluating the cost-effectiveness of vaccinating a cohort of adults aged 65 with Tdap, by calculating pertussis cases averted due to direct vaccine effects only. Results are presented from societal and payer perspectives for a range of pertussis incidences (25-200 cases per 100,000), due to the uncertainty in estimating true annual incidence. Cases averted were accrued throughout the patient's lifetime, and a probability tree used to estimate the clinical outcomes and costs (US$ 2010) for each case. Quality-adjusted life-years (QALYs) lost to acute disease were calculated by multiplying cases of mild/moderate/severe pertussis by the associated health-state disutility; QALY losses due to death and long-term sequelae were also considered. Incremental costs and QALYs were summed over the cohort to derive incremental cost-effectiveness ratios. Scenario analyses evaluated the effect of alternative plausible parameter estimates on results. Results: At incidence levels of 25, 100, 200 cases/100,000, vaccinating adults aged 65 years costs an additional $336,000, $63,000 and $17,000/QALY gained, respectively. Vaccination has a cost-effectiveness ratio less than $50,000/QALY if pertussis incidence is >116 cases/100,000 from societal and payer perspectives. Results were robust to scenario analyses. Conclusions: Tdap immunization of adults aged 65 years according to current ACIP recommendations is a cost-effective health-care intervention at plausible incidence assumptions.	[McGarry, Lisa J.; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Weinstein, Milton C.] OptumInsight, Cambridge, MA USA; [Krishnarajah, Girishanthy; Masseria, Cristina; Arondekar, Bhakti] GlaxoSmithKline, Philadelphia, PA USA; [Pelton, Stephen I.] Boston Univ, Boston, MA 02215 USA; [Weinstein, Milton C.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Optum; GlaxoSmithKline; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	McGarry, LJ (corresponding author), OptumInsight, Cambridge, MA USA.	lisa.mcgarry@ariad.com	Williams, Mathew/G-6140-2016	Williams, Mathew/0000-0001-6117-5208; Mitchard, Edward/0000-0002-5690-4055; Pelton, Stephen/0000-0003-4862-5344; Ryan, Casey/0000-0002-1802-0128	GSK	GSK(GlaxoSmithKline)	Funding for this research was provided by GSK. GSK employees listed as coauthors may have participated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bureau of Labor Statistics, 2011, CONS PRIC IND; California Department of Public Health, 2011, PERT REP FIG 5 PERT; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Centers for Disease Control and Prevention, 2012, ADV COMM IMM PRACT S; Centers for Disease Control and Prevention, 2011, PERT SUMM VACC REC; Centers for Disease Control and Prevention, 2011, SURV REP TRENDS; Centers for Disease Control and Prevention, 2010, VACC PRIC LIST; Centers for Disease Control and Prevention, 2012, ACIP PROV TDAP REC; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P13; Cortese MM, 2007, AM J PREV MED, V32, P177, DOI 10.1016/j.amepre.2006.10.015; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Gold MR, 1996, COST EFFECTIVENESS H; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; McDowell Margaret A, 2009, Vital Health Stat 11, P1; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; PDR Network LLC, 2010, RED BOOK PHARM FUND; Pellissier JM, 2007, VACCINE, V25, P8326, DOI 10.1016/j.vaccine.2007.09.066; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; U.S. Bureau of Labor Statistics, 2011, CONS EXP SURV 2010 A; U. S. Bureau of the Census, 2009, AM COMM SURV; US Bureau of Labor Statistics, 2011, CURR POP SURV 2010; US Bureau of Labor Statistics, 2011, EMPL HOURS EARN CURR; Washington State Department of Health, 2012, WEEKL PERT PERT UPD; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e67260	10.1371/journal.pone.0067260	http://dx.doi.org/10.1371/journal.pone.0067260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24069275	Green Submitted, Green Published, gold			2022-12-25	WOS:000324338200001
J	Nakamura, K; Aizawa, K; Nakabayashi, K; Kato, N; Yamauchi, J; Hata, K; Tanoue, A				Nakamura, Kazuaki; Aizawa, Kazuko; Nakabayashi, Kazuhiko; Kato, Natsuko; Yamauchi, Junji; Hata, Kenichiro; Tanoue, Akito			DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYCLE ARREST; METHYLATION INHIBITOR; CANCER-CELLS; G(1) ARREST; HEPG2 CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION	Hepatocellular carcinoma is one of the most common cancers worldwide. During tumorigenesis, tumor suppressor and cancer-related genes are commonly silenced by aberrant DNA methylation in their promoter regions. Zebularine (1-(beta-(D)-ribofuranosyl)- 1,2-dihydropyrimidin-2-one) acts as an inhibitor of DNA methylation and exhibits chemical stability and minimal cytotoxicity both in vitro and in vivo. In this study, we explore the effect and possible mechanism of action of zebularine on hepatocellular carcinoma cell line HepG2. We demonstrate that zebularine exhibits antitumor activity on HepG2 cells by inhibiting cell proliferation and inducing apoptosis, however, it has little effect on DNA methylation in HepG2 cells. On the other hand, zebularine treatment downregulated CDK2 and the phosphorylation of retinoblastoma protein (Rb), and upregulated p21(WAF/CIP1) and p53. We also found that zebularine treatment upregulated the phosphorylation of p44/42 mitogen-activated protein kinase (MAPK). These results suggest that the p44/42 MAPK pathway plays a role in zebularine-induced cell-cycle arrest by regulating the activity of p21(WAF/CIP1) and Rb. Furthermore, although the proapoptotic protein Bax levels were not affected, the antiapoptotic protein Bcl-2 level was downregulated with zebularine treatment. In addition, the data in the present study indicate that inhibition of the double-stranded RNA-dependent protein kinase (PKR) is involved in inducing apoptosis with zebularine. These results suggest a novel mechanism of zebularine-induced cell growth arrest and apoptosis via a DNA methylation-independent pathway in hepatocellular carcinoma.	[Nakamura, Kazuaki; Aizawa, Kazuko; Kato, Natsuko; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nakamura, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	nakamura-kz@ncchd.go.jp		Nakayama, Karina/0000-0001-5426-7446	Takeda Science Foundation (Osaka, Japan); Grant of National Center for Child Health and Development (Tokyo, Japan) [22A-6]	Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Grant of National Center for Child Health and Development (Tokyo, Japan)	This work was supported in part by research grants from the Takeda Science Foundation (Osaka, Japan, http://www.takeda-sci.or.jp/index.html), and The Grant of National Center for Child Health and Development (22A-6) (Tokyo, Japan, http://www.ncchd.go.jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; LEIST M, 1994, J IMMUNOL, V153, P1778; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; MICHIELI P, 1994, CANCER RES, V54, P3391; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; Neureiter D, 2007, SCAND J GASTROENTERO, V42, P103, DOI 10.1080/00365520600874198; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PINTO A, 1993, LEUKEMIA, V7, P51; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Samonakis DN, 2002, ONCOL REP, V9, P903; Schwartsmann G, 2000, INVEST NEW DRUG, V18, P83, DOI 10.1023/A:1006388031954; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; You BR, 2012, MOL BIOL REP, V39, P9723, DOI 10.1007/s11033-012-1837-z	59	113	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54036	10.1371/journal.pone.0054036	http://dx.doi.org/10.1371/journal.pone.0054036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	24086366	Green Submitted, Green Published, gold			2022-12-25	WOS:000313429800086
